PGSC0003DMT200080135	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMT200080135	K00517	ko00626	Naphthalene and anthracene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMT200080135	K00517	ko00903	Limonene and pinene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMT200080135	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMT200080135	K00517	ko01110	Biosynthesis of secondary metabolites	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMT200080139	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMT200080139	K00517	ko00626	Naphthalene and anthracene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMT200080139	K00517	ko00903	Limonene and pinene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMT200080139	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMT200080139	K00517	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMT200080154	K00558	ko00270	Cysteine and methionine metabolism	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMT200080154	K00558	ko01100	Metabolic pathways	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMT200080162	K12929	ko00904	Diterpenoid biosynthesis	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMT200080162	K12929	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMT200080164	K12929	ko00904	Diterpenoid biosynthesis	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMT200080164	K12929	ko01110	Biosynthesis of secondary metabolites	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMT200080180	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.3e-09	0.36	0.52	0.60
PGSC0003DMT200080181	K11294	ko05130	Pathogenic Escherichia coli infection	399	3.6e-16	0.28	0.50	0.85
PGSC0003DMT200079108	K01692	ko00071	Fatty acid metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00280	Valine, leucine and isoleucine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00281	Geraniol degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00310	Lysine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00380	Tryptophan metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00410	beta-Alanine metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00632	Benzoate degradation via CoA ligation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00640	Propanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00650	Butanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00903	Limonene and pinene degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko00930	Caprolactam degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko01100	Metabolic pathways	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079108	K01692	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMT200079109	K01692	ko00071	Fatty acid metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00280	Valine, leucine and isoleucine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00281	Geraniol degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00310	Lysine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00380	Tryptophan metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00410	beta-Alanine metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00632	Benzoate degradation via CoA ligation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00640	Propanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00650	Butanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00903	Limonene and pinene degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko00930	Caprolactam degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko01100	Metabolic pathways	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079109	K01692	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMT200079110	K01692	ko00071	Fatty acid metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00280	Valine, leucine and isoleucine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00281	Geraniol degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00310	Lysine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00380	Tryptophan metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00410	beta-Alanine metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00632	Benzoate degradation via CoA ligation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00640	Propanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00650	Butanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00903	Limonene and pinene degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko00930	Caprolactam degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko01100	Metabolic pathways	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079110	K01692	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMT200079111	K00472	ko00330	Arginine and proline metabolism	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMT200079111	K00472	ko01100	Metabolic pathways	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMT200062010	K03108	ko03060	Protein export	412	1.0e-16	0.90	0.97	0.67
PGSC0003DMT200062012	K11778	ko00900	Terpenoid backbone biosynthesis	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMT200062012	K11778	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMT200062020	K04120	ko00904	Diterpenoid biosynthesis	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMT200062020	K04120	ko01100	Metabolic pathways	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMT200062020	K04120	ko01110	Biosynthesis of secondary metabolites	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMT200062022	K13065	ko00940	Phenylpropanoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMT200062022	K13065	ko00941	Flavonoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMT200062022	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMT200062022	K13065	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMT200062024	K13065	ko00940	Phenylpropanoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMT200062024	K13065	ko00941	Flavonoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMT200062024	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMT200062024	K13065	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMT200062026	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMT200062029	K11866	ko04144	Endocytosis	601	8.0e-27	0.30	0.46	0.91
PGSC0003DMT200062030	K11866	ko04144	Endocytosis	600	9.2e-27	0.30	0.46	0.91
PGSC0003DMT200062032	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMT200062044	K04121	ko00904	Diterpenoid biosynthesis	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMT200062044	K04121	ko01100	Metabolic pathways	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMT200062044	K04121	ko01110	Biosynthesis of secondary metabolites	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMT200062050	K01177	ko00500	Starch and sucrose metabolism	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMT200062050	K01177	ko01100	Metabolic pathways	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMT200062057	K04733	ko04210	Apoptosis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMT200062057	K04733	ko04620	Toll-like receptor signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMT200062057	K04733	ko04722	Neurotrophin signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMT200062057	K04733	ko05140	Leishmaniasis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMT200062057	K04733	ko05142	Chagas disease	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMT200073565	K00826	ko00280	Valine, leucine and isoleucine degradation	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMT200073565	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMT200073565	K00826	ko00770	Pantothenate and CoA biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMT200073565	K00826	ko01100	Metabolic pathways	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMT200073565	K00826	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMT200073566	K00826	ko00280	Valine, leucine and isoleucine degradation	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMT200073566	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMT200073566	K00826	ko00770	Pantothenate and CoA biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMT200073566	K00826	ko01100	Metabolic pathways	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMT200073566	K00826	ko01110	Biosynthesis of secondary metabolites	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMT200073575	K10601	ko04120	Ubiquitin mediated proteolysis	313	2.0e-11	0.28	0.42	0.63
PGSC0003DMT200073576	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMT200073577	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMT200073587	K00869	ko00900	Terpenoid backbone biosynthesis	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMT200073587	K00869	ko01100	Metabolic pathways	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMT200073587	K00869	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMT200073587	K00869	ko04146	Peroxisome	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMT200073588	K00869	ko00900	Terpenoid backbone biosynthesis	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMT200073588	K00869	ko01100	Metabolic pathways	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMT200073588	K00869	ko01110	Biosynthesis of secondary metabolites	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMT200073588	K00869	ko04146	Peroxisome	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMT200073593	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3380	1.4e-180	0.87	0.95	1.00
PGSC0003DMT200046370	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMT200046370	K00517	ko00626	Naphthalene and anthracene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMT200046370	K00517	ko00903	Limonene and pinene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMT200046370	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMT200046370	K00517	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMT200046371	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMT200046371	K00517	ko00626	Naphthalene and anthracene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMT200046371	K00517	ko00903	Limonene and pinene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMT200046371	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMT200046371	K00517	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMT200094795	K02703	ko00195	Photosynthesis	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMT200094795	K02703	ko01100	Metabolic pathways	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMT200037628	K11816	ko00380	Tryptophan metabolism	2400	1.5e-126	0.69	0.81	0.99
PGSC0003DMT200037637	K00558	ko00270	Cysteine and methionine metabolism	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMT200037637	K00558	ko01100	Metabolic pathways	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMT200037638	K00558	ko00270	Cysteine and methionine metabolism	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMT200037638	K00558	ko01100	Metabolic pathways	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMT200037647	K01899	ko00020	Citrate cycle (TCA cycle)	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMT200037647	K01899	ko00640	Propanoate metabolism	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMT200037647	K01899	ko01100	Metabolic pathways	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMT200037647	K01899	ko01110	Biosynthesis of secondary metabolites	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMT200037648	K01899	ko00020	Citrate cycle (TCA cycle)	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMT200037648	K01899	ko00640	Propanoate metabolism	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMT200037648	K01899	ko01100	Metabolic pathways	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMT200037648	K01899	ko01110	Biosynthesis of secondary metabolites	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMT200027217	K10879	ko03440	Homologous recombination	215	5.0e-06	0.44	0.65	0.52
PGSC0003DMT200027230	K10879	ko03440	Homologous recombination	510	2.7e-22	0.49	0.60	0.82
PGSC0003DMT200027252	K06062	ko04330	Notch signaling pathway	1349	1.4e-68	0.70	0.79	0.89
PGSC0003DMT200027253	K06062	ko04330	Notch signaling pathway	1211	5.9e-61	0.84	0.90	0.75
PGSC0003DMT200027254	K06062	ko04330	Notch signaling pathway	3448	2.4e-184	0.79	0.88	1.00
PGSC0003DMT200027255	K06062	ko04330	Notch signaling pathway	1277	1.3e-64	0.72	0.82	0.97
PGSC0003DMT200027256	K06062	ko04330	Notch signaling pathway	3429	2.7e-183	0.79	0.87	1.00
PGSC0003DMT200058300	K05757	ko04666	Fc gamma R-mediated phagocytosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMT200058300	K05757	ko04810	Regulation of actin cytoskeleton	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMT200058300	K05757	ko05100	Bacterial invasion of epithelial cells	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMT200058300	K05757	ko05130	Pathogenic Escherichia coli infection	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMT200058300	K05757	ko05131	Shigellosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMT200058301	K05757	ko04666	Fc gamma R-mediated phagocytosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMT200058301	K05757	ko04810	Regulation of actin cytoskeleton	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMT200058301	K05757	ko05100	Bacterial invasion of epithelial cells	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMT200058301	K05757	ko05130	Pathogenic Escherichia coli infection	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMT200058301	K05757	ko05131	Shigellosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMT200058302	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058302	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058302	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058302	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058302	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058303	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058303	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058303	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058303	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058303	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMT200058304	K04512	ko04310	Wnt signaling pathway	630	1.3e-28	0.27	0.48	0.77
PGSC0003DMT200058306	K12131	ko04712	Circadian rhythm - plant	302	8.8e-11	0.31	0.51	0.90
PGSC0003DMT200058308	K08243	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMT200058308	K08243	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMT200058309	K08243	ko00941	Flavonoid biosynthesis	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMT200058309	K08243	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMT200058324	K03354	ko04110	Cell cycle	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058324	K03354	ko04111	Cell cycle - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058324	K03354	ko04113	Meiosis - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058324	K03354	ko04114	Oocyte meiosis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058324	K03354	ko04120	Ubiquitin mediated proteolysis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058324	K03354	ko04914	Progesterone-mediated oocyte maturation	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMT200058330	K01046	ko00561	Glycerolipid metabolism	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMT200058330	K01046	ko01100	Metabolic pathways	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMT200058334	K10144	ko04115	p53 signaling pathway	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMT200058334	K10144	ko04120	Ubiquitin mediated proteolysis	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMT200058335	K10144	ko04115	p53 signaling pathway	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMT200058335	K10144	ko04120	Ubiquitin mediated proteolysis	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMT200087109	K00021	ko00900	Terpenoid backbone biosynthesis	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMT200087109	K00021	ko01100	Metabolic pathways	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMT200087109	K00021	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMT200084963	K11644	ko05016	Huntington's disease	422	1.8e-16	0.32	0.48	0.73
PGSC0003DMT200050361	K01501	ko00380	Tryptophan metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050361	K01501	ko00460	Cyanoamino acid metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050361	K01501	ko00632	Benzoate degradation via CoA ligation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050361	K01501	ko00643	Styrene degradation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050361	K01501	ko00910	Nitrogen metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050361	K01501	ko01100	Metabolic pathways	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMT200050368	K01255	ko00480	Glutathione metabolism	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMT200050368	K01255	ko01100	Metabolic pathways	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMT200050381	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMT200050381	K01602	ko00710	Carbon fixation in photosynthetic organisms	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMT200050381	K01602	ko01100	Metabolic pathways	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMT200050384	K12655	ko04622	RIG-I-like receptor signaling pathway	222	6.5e-06	0.31	0.45	0.87
PGSC0003DMT200050387	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050387	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050387	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050388	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050388	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050388	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMT200050389	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050389	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050389	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050390	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050390	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050390	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMT200050391	K12886	ko03040	Spliceosome	402	2.4e-16	0.29	0.43	0.55
PGSC0003DMT200050393	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMT200050394	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMT200075840	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMT200075841	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075841	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075841	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075841	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075841	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075841	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMT200075843	K00100	ko00051	Fructose and mannose metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075843	K00100	ko00363	Bisphenol A degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075843	K00100	ko00591	Linoleic acid metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075843	K00100	ko00625	Tetrachloroethene degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075843	K00100	ko00650	Butanoate metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075843	K00100	ko01100	Metabolic pathways	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMT200075849	K12356	ko00940	Phenylpropanoid biosynthesis	745	3.0e-35	0.50	0.62	0.51
PGSC0003DMT200075850	K12356	ko00940	Phenylpropanoid biosynthesis	538	7.7e-24	0.31	0.52	0.94
PGSC0003DMT200075851	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.46	0.59	0.77
PGSC0003DMT200075855	K13228	ko00402	Benzoxazinoid biosynthesis	230	8.0e-11	0.35	0.54	0.70
PGSC0003DMT200075862	K12356	ko00940	Phenylpropanoid biosynthesis	285	8.7e-10	0.33	0.53	0.86
PGSC0003DMT200075868	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.53	0.93
PGSC0003DMT200075873	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMT200075873	K01078	ko00740	Riboflavin metabolism	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMT200075875	K04498	ko04110	Cell cycle	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04310	Wnt signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04330	Notch signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04350	TGF-beta signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04520	Adherens junction	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04630	Jak-STAT signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04720	Long-term potentiation	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko04916	Melanogenesis	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko05016	Huntington's disease	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko05200	Pathways in cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko05211	Renal cell carcinoma	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200075875	K04498	ko05215	Prostate cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMT200002112	K11091	ko03040	Spliceosome	269	3.7e-08	0.41	0.49	0.08
PGSC0003DMT200002129	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002129	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200002130	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMT200093052	K10643	ko03018	RNA degradation	264	1.1e-06	0.27	0.44	0.92
PGSC0003DMT200093060	K10591	ko04120	Ubiquitin mediated proteolysis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMT200093060	K10591	ko04144	Endocytosis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMT200040670	K00799	ko00480	Glutathione metabolism	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMT200040670	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMT200040670	K00799	ko00982	Drug metabolism - cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMT200040673	K00117	ko00030	Pentose phosphate pathway	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMT200040673	K00117	ko01100	Metabolic pathways	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMT200040673	K00117	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMT200040675	K00117	ko00030	Pentose phosphate pathway	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMT200040675	K00117	ko01100	Metabolic pathways	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMT200040675	K00117	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMT200040676	K00117	ko00030	Pentose phosphate pathway	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMT200040676	K00117	ko01100	Metabolic pathways	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMT200040676	K00117	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMT200040681	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMT200040681	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMT200040682	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMT200040682	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMT200040684	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMT200040684	K00430	ko00680	Methane metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMT200040684	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMT200040684	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMT200040684	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMT200040686	K07199	ko04910	Insulin signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMT200040686	K07199	ko04920	Adipocytokine signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMT200040686	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMT200040687	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040687	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040687	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040688	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040688	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040688	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMT200040694	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMT200040695	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMT200015091	K12581	ko03018	RNA degradation	1253	2.8e-63	0.59	0.76	0.99
PGSC0003DMT200015107	K03012	ko00230	Purine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMT200015107	K03012	ko00240	Pyrimidine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMT200015107	K03012	ko01100	Metabolic pathways	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMT200015107	K03012	ko03020	RNA polymerase	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMT200015107	K03012	ko05016	Huntington's disease	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMT200015108	K03012	ko00230	Purine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMT200015108	K03012	ko00240	Pyrimidine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMT200015108	K03012	ko01100	Metabolic pathways	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMT200015108	K03012	ko03020	RNA polymerase	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMT200015108	K03012	ko05016	Huntington's disease	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMT200015111	K02183	ko04020	Calcium signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04070	Phosphatidylinositol signaling system	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04114	Oocyte meiosis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04270	Vascular smooth muscle contraction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04626	Plant-pathogen interaction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04720	Long-term potentiation	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04722	Neurotrophin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04740	Olfactory transduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04744	Phototransduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04745	Phototransduction - fly	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04910	Insulin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04912	GnRH signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04916	Melanogenesis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04970	Salivary secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko04971	Gastric acid secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko05010	Alzheimer's disease	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015111	K02183	ko05214	Glioma	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMT200015117	K02949	ko03010	Ribosome	1197	3.5e-60	0.91	0.93	0.84
PGSC0003DMT200007465	K07297	ko04920	Adipocytokine signaling pathway	1729	1.6e-89	0.61	0.77	0.98
PGSC0003DMT200007466	K07297	ko04920	Adipocytokine signaling pathway	1213	4.5e-61	0.67	0.82	0.94
PGSC0003DMT200007496	K06653	ko04111	Cell cycle - yeast	324	3.9e-11	0.30	0.48	0.93
PGSC0003DMT200007497	K00510	ko00860	Porphyrin and chlorophyll metabolism	1655	1.9e-85	0.85	0.92	0.99
PGSC0003DMT200007505	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMT200007505	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMT200007506	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMT200007506	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMT200033163	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMT200033163	K00766	ko01100	Metabolic pathways	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMT200033163	K00766	ko01110	Biosynthesis of secondary metabolites	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMT200033180	K10245	ko01040	Biosynthesis of unsaturated fatty acids	419	2.8e-17	0.38	0.56	0.69
PGSC0003DMT200033208	K04514	ko04062	Chemokine signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04270	Vascular smooth muscle contraction	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04310	Wnt signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04350	TGF-beta signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04360	Axon guidance	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04510	Focal adhesion	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04670	Leukocyte transendothelial migration	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko04810	Regulation of actin cytoskeleton	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko05130	Pathogenic Escherichia coli infection	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033208	K04514	ko05131	Shigellosis	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMT200033210	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMT200033210	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMT200033211	K10352	ko04530	Tight junction	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMT200033211	K10352	ko05416	Viral myocarditis	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMT200021388	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200021388	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200021389	K08912	ko00196	Photosynthesis - antenna proteins	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMT200021389	K08912	ko01100	Metabolic pathways	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMT200021390	K08912	ko00196	Photosynthesis - antenna proteins	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMT200021390	K08912	ko01100	Metabolic pathways	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMT200021391	K08912	ko00196	Photosynthesis - antenna proteins	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMT200021391	K08912	ko01100	Metabolic pathways	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMT200021392	K08912	ko00196	Photosynthesis - antenna proteins	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMT200021392	K08912	ko01100	Metabolic pathways	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMT200021403	K02084	ko04115	p53 signaling pathway	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko04210	Apoptosis	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko05010	Alzheimer's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko05012	Parkinson's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko05016	Huntington's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021403	K02084	ko05222	Small cell lung cancer	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMT200021412	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMT200021414	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMT200021415	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMT200021416	K00356	ko00190	Oxidative phosphorylation	305	5.5e-11	0.37	0.50	0.55
PGSC0003DMT200021417	K00356	ko00190	Oxidative phosphorylation	303	7.1e-11	0.37	0.51	0.55
PGSC0003DMT200021418	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMT200021419	K02541	ko03030	DNA replication	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMT200021419	K02541	ko04110	Cell cycle	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMT200021419	K02541	ko04111	Cell cycle - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMT200021419	K02541	ko04113	Meiosis - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMT200021420	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021420	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021420	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021420	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021421	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021421	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021421	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021421	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMT200021422	K08912	ko00196	Photosynthesis - antenna proteins	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMT200021422	K08912	ko01100	Metabolic pathways	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMT200021423	K03015	ko00230	Purine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMT200021423	K03015	ko00240	Pyrimidine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMT200021423	K03015	ko01100	Metabolic pathways	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMT200021423	K03015	ko03020	RNA polymerase	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMT200021423	K03015	ko05016	Huntington's disease	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMT200021424	K09458	ko00061	Fatty acid biosynthesis	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMT200021424	K09458	ko01100	Metabolic pathways	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMT200060121	K02639	ko00195	Photosynthesis	849	5.4e-41	0.68	0.81	0.99
PGSC0003DMT200060122	K11099	ko03040	Spliceosome	604	1.8e-27	0.90	0.96	0.99
PGSC0003DMT200060125	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMT200060126	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMT200060127	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMT200060139	K03885	ko00190	Oxidative phosphorylation	367	2.1e-14	0.28	0.47	0.96
PGSC0003DMT200060140	K03885	ko00190	Oxidative phosphorylation	318	1.1e-11	0.28	0.46	0.88
PGSC0003DMT200060141	K12198	ko04144	Endocytosis	1583	1.8e-81	0.84	0.94	0.96
PGSC0003DMT200060142	K12198	ko04144	Endocytosis	900	8.3e-44	0.84	0.91	0.99
PGSC0003DMT200060143	K12198	ko04144	Endocytosis	1699	7.1e-88	0.84	0.94	1.00
PGSC0003DMT200060144	K12198	ko04144	Endocytosis	784	2.1e-37	0.84	0.91	0.92
PGSC0003DMT200085904	K00430	ko00360	Phenylalanine metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMT200085904	K00430	ko00680	Methane metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMT200085904	K00430	ko00940	Phenylpropanoid biosynthesis	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMT200085904	K00430	ko01100	Metabolic pathways	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMT200085904	K00430	ko01110	Biosynthesis of secondary metabolites	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMT200085909	K03469	ko03030	DNA replication	268	6.0e-09	0.52	0.70	0.63
PGSC0003DMT200085920	K00058	ko00260	Glycine, serine and threonine metabolism	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMT200085920	K00058	ko01100	Metabolic pathways	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMT200085921	K01184	ko00040	Pentose and glucuronate interconversions	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMT200085921	K01184	ko00500	Starch and sucrose metabolism	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMT200085921	K01184	ko01100	Metabolic pathways	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMT200077602	K05658	ko02010	ABC transporters	3516	4.3e-188	0.38	0.58	0.96
PGSC0003DMT200077603	K05658	ko02010	ABC transporters	3583	8.7e-192	0.38	0.59	0.96
PGSC0003DMT200077604	K02918	ko03010	Ribosome	922	5.1e-45	0.93	0.98	0.99
PGSC0003DMT200077607	K12830	ko03040	Spliceosome	9560	0.	0.91	0.97	1.00
PGSC0003DMT200077611	K01051	ko00040	Pentose and glucuronate interconversions	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMT200077611	K01051	ko00500	Starch and sucrose metabolism	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMT200077611	K01051	ko01100	Metabolic pathways	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMT200077616	K00412	ko00190	Oxidative phosphorylation	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077616	K00412	ko01100	Metabolic pathways	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077616	K00412	ko04260	Cardiac muscle contraction	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077616	K00412	ko05010	Alzheimer's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077616	K00412	ko05012	Parkinson's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077616	K00412	ko05016	Huntington's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMT200077623	K02006	ko02010	ABC transporters	746	2.6e-35	0.46	0.65	0.81
PGSC0003DMT200077624	K02006	ko02010	ABC transporters	357	7.4e-14	0.40	0.59	0.70
PGSC0003DMT200077625	K02006	ko02010	ABC transporters	745	3.0e-35	0.46	0.65	0.81
PGSC0003DMT200077626	K02006	ko02010	ABC transporters	416	4.1e-17	0.46	0.62	0.88
PGSC0003DMT200077641	K00889	ko00562	Inositol phosphate metabolism	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200077641	K00889	ko01100	Metabolic pathways	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200077641	K00889	ko04070	Phosphatidylinositol signaling system	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200077641	K00889	ko04144	Endocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200077641	K00889	ko04666	Fc gamma R-mediated phagocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200077641	K00889	ko04810	Regulation of actin cytoskeleton	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMT200052214	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052214	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052214	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052214	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052214	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052215	K00430	ko00360	Phenylalanine metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMT200052215	K00430	ko00680	Methane metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMT200052215	K00430	ko00940	Phenylpropanoid biosynthesis	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMT200052215	K00430	ko01100	Metabolic pathways	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMT200052215	K00430	ko01110	Biosynthesis of secondary metabolites	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMT200052216	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052216	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052216	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052216	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052216	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMT200052217	K10808	ko00230	Purine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMT200052217	K10808	ko00240	Pyrimidine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMT200052217	K10808	ko00480	Glutathione metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMT200052217	K10808	ko01100	Metabolic pathways	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMT200052217	K10808	ko04115	p53 signaling pathway	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMT200052229	K01046	ko00561	Glycerolipid metabolism	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMT200052229	K01046	ko01100	Metabolic pathways	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMT200052233	K02183	ko04020	Calcium signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04070	Phosphatidylinositol signaling system	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04114	Oocyte meiosis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04270	Vascular smooth muscle contraction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04626	Plant-pathogen interaction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04720	Long-term potentiation	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04722	Neurotrophin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04740	Olfactory transduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04744	Phototransduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04745	Phototransduction - fly	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04910	Insulin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04912	GnRH signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04916	Melanogenesis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04970	Salivary secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko04971	Gastric acid secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko05010	Alzheimer's disease	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200052233	K02183	ko05214	Glioma	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMT200066105	K07203	ko04012	ErbB signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko04150	mTOR signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko04910	Insulin signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko04920	Adipocytokine signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko04930	Type II diabetes mellitus	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko05200	Pathways in cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko05214	Glioma	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko05215	Prostate cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066105	K07203	ko05221	Acute myeloid leukemia	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMT200066106	K07203	ko04012	ErbB signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko04150	mTOR signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko04910	Insulin signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko04920	Adipocytokine signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko04930	Type II diabetes mellitus	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko05200	Pathways in cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko05214	Glioma	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko05215	Prostate cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066106	K07203	ko05221	Acute myeloid leukemia	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMT200066110	K07203	ko04012	ErbB signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko04150	mTOR signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko04910	Insulin signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko04920	Adipocytokine signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko04930	Type II diabetes mellitus	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko05200	Pathways in cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko05214	Glioma	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko05215	Prostate cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066110	K07203	ko05221	Acute myeloid leukemia	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMT200066112	K00873	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko00230	Purine metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko00620	Pyruvate metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko00710	Carbon fixation in photosynthetic organisms	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko01100	Metabolic pathways	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066112	K00873	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMT200066113	K00873	ko00010	Glycolysis / Gluconeogenesis	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko00230	Purine metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko00620	Pyruvate metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko00710	Carbon fixation in photosynthetic organisms	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko01100	Metabolic pathways	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066113	K00873	ko04930	Type II diabetes mellitus	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMT200066114	K00873	ko00010	Glycolysis / Gluconeogenesis	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko00230	Purine metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko00620	Pyruvate metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko01100	Metabolic pathways	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko01110	Biosynthesis of secondary metabolites	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066114	K00873	ko04930	Type II diabetes mellitus	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMT200066141	K12478	ko04144	Endocytosis	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMT200066141	K12478	ko04145	Phagosome	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMT200042417	K01759	ko00620	Pyruvate metabolism	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMT200042417	K01759	ko04011	MAPK signaling pathway - yeast	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMT200042428	K00430	ko00360	Phenylalanine metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMT200042428	K00430	ko00680	Methane metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMT200042428	K00430	ko00940	Phenylpropanoid biosynthesis	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMT200042428	K00430	ko01100	Metabolic pathways	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMT200042428	K00430	ko01110	Biosynthesis of secondary metabolites	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMT200013344	K01184	ko00040	Pentose and glucuronate interconversions	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMT200013344	K01184	ko00500	Starch and sucrose metabolism	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMT200013344	K01184	ko01100	Metabolic pathways	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMT200013350	K01051	ko00040	Pentose and glucuronate interconversions	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMT200013350	K01051	ko00500	Starch and sucrose metabolism	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMT200013350	K01051	ko01100	Metabolic pathways	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMT200013351	K01051	ko00040	Pentose and glucuronate interconversions	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMT200013351	K01051	ko00500	Starch and sucrose metabolism	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMT200013351	K01051	ko01100	Metabolic pathways	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMT200013352	K01051	ko00040	Pentose and glucuronate interconversions	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMT200013352	K01051	ko00500	Starch and sucrose metabolism	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMT200013352	K01051	ko01100	Metabolic pathways	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMT200013354	K13065	ko00940	Phenylpropanoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMT200013354	K13065	ko00941	Flavonoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMT200013354	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMT200013354	K13065	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMT200013355	K01051	ko00040	Pentose and glucuronate interconversions	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMT200013355	K01051	ko00500	Starch and sucrose metabolism	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMT200013355	K01051	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMT200013371	K06573	ko04966	Collecting duct acid secretion	701	7.9e-33	0.29	0.44	0.82
PGSC0003DMT200013372	K06573	ko04966	Collecting duct acid secretion	736	9.3e-35	0.29	0.44	0.83
PGSC0003DMT200013377	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMT200039251	K08066	ko04612	Antigen processing and presentation	472	3.4e-20	0.41	0.63	0.66
PGSC0003DMT200039253	K08066	ko04612	Antigen processing and presentation	452	4.3e-19	0.51	0.76	0.46
PGSC0003DMT200039254	K08066	ko04612	Antigen processing and presentation	456	2.6e-19	0.37	0.58	0.56
PGSC0003DMT200031514	K01823	ko00900	Terpenoid backbone biosynthesis	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMT200031514	K01823	ko01100	Metabolic pathways	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMT200031514	K01823	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMT200031523	K12879	ko03040	Spliceosome	408	2.0e-15	0.32	0.62	0.77
PGSC0003DMT200031531	K04507	ko04310	Wnt signaling pathway	1384	1.7e-70	0.76	0.88	0.97
PGSC0003DMT200031538	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.51	0.66	0.89
PGSC0003DMT200031543	K02917	ko03010	Ribosome	895	1.6e-43	0.90	0.95	0.99
PGSC0003DMT200031544	K05741	ko04810	Regulation of actin cytoskeleton	340	4.1e-11	0.26	0.42	0.87
PGSC0003DMT200005718	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMT200005718	K02367	ko01100	Metabolic pathways	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMT200005723	K12813	ko03040	Spliceosome	5131	3.6e-277	0.73	0.83	0.99
PGSC0003DMT200005749	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMT200005750	K11294	ko05130	Pathogenic Escherichia coli infection	272	3.7e-06	0.32	0.48	0.27
PGSC0003DMT200005751	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMT200005752	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMT200005754	K12489	ko04144	Endocytosis	5103	1.3e-275	0.78	0.87	0.96
PGSC0003DMT200005755	K12489	ko04144	Endocytosis	5539	1.1e-299	0.80	0.89	1.00
PGSC0003DMT200000439	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMT200000439	K00517	ko00626	Naphthalene and anthracene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMT200000439	K00517	ko00903	Limonene and pinene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMT200000439	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMT200000439	K00517	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMT200000440	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000440	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000440	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000440	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000440	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000443	K09480	ko00561	Glycerolipid metabolism	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMT200000443	K09480	ko01100	Metabolic pathways	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMT200000444	K09480	ko00561	Glycerolipid metabolism	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMT200000444	K09480	ko01100	Metabolic pathways	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMT200000445	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMT200000445	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMT200000446	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMT200000446	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMT200000447	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMT200000447	K01491	ko00670	One carbon pool by folate	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMT200000447	K01491	ko01100	Metabolic pathways	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMT200000464	K05765	ko04360	Axon guidance	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMT200000464	K05765	ko04666	Fc gamma R-mediated phagocytosis	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMT200000464	K05765	ko04810	Regulation of actin cytoskeleton	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMT200000473	K12604	ko03018	RNA degradation	782	3.8e-36	0.48	0.63	0.94
PGSC0003DMT200000477	K11752	ko00740	Riboflavin metabolism	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMT200000477	K11752	ko01100	Metabolic pathways	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMT200082399	K13228	ko00402	Benzoxazinoid biosynthesis	294	2.2e-10	0.33	0.51	0.73
PGSC0003DMT200082408	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	232	5.8e-07	0.44	0.52	0.97
PGSC0003DMT200082410	K01046	ko00561	Glycerolipid metabolism	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMT200082410	K01046	ko01100	Metabolic pathways	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMT200082421	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMT200082421	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMT200082421	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMT200082422	K00799	ko00480	Glutathione metabolism	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMT200082422	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMT200082422	K00799	ko00982	Drug metabolism - cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMT200082423	K00799	ko00480	Glutathione metabolism	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMT200082423	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMT200082423	K00799	ko00982	Drug metabolism - cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMT200082424	K02717	ko00195	Photosynthesis	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMT200082424	K02717	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMT200082429	K12816	ko03040	Spliceosome	688	4.1e-32	0.34	0.55	0.70
PGSC0003DMT200082431	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082431	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082432	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082433	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMT200082435	K00817	ko00340	Histidine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko00350	Tyrosine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko00360	Phenylalanine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko00401	Novobiocin biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko01100	Metabolic pathways	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082435	K00817	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMT200082441	K12859	ko03040	Spliceosome	1208	8.6e-61	0.96	1.00	0.99
PGSC0003DMT200044501	K01087	ko00500	Starch and sucrose metabolism	4897	2.9e-264	0.76	0.89	0.98
PGSC0003DMT200044502	K01087	ko00500	Starch and sucrose metabolism	5427	1.7e-293	0.75	0.89	0.98
PGSC0003DMT200044512	K07424	ko00140	Steroid hormone biosynthesis	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00591	Linoleic acid metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00830	Retinol metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00982	Drug metabolism - cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko00983	Drug metabolism - other enzymes	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044512	K07424	ko01100	Metabolic pathways	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMT200044514	K07424	ko00140	Steroid hormone biosynthesis	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00591	Linoleic acid metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00830	Retinol metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00982	Drug metabolism - cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko00983	Drug metabolism - other enzymes	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044514	K07424	ko01100	Metabolic pathways	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMT200044516	K06685	ko04111	Cell cycle - yeast	424	4.1e-15	0.30	0.46	0.65
PGSC0003DMT200044531	K01757	ko00901	Indole alkaloid biosynthesis	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMT200044531	K01757	ko01100	Metabolic pathways	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMT200044531	K01757	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMT200071814	K04733	ko04210	Apoptosis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMT200071814	K04733	ko04620	Toll-like receptor signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMT200071814	K04733	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMT200071814	K04733	ko05140	Leishmaniasis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMT200071814	K04733	ko05142	Chagas disease	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMT200071819	K10949	ko05110	Vibrio cholerae infection	426	1.2e-17	0.35	0.61	0.75
PGSC0003DMT200071820	K10949	ko05110	Vibrio cholerae infection	518	9.8e-23	0.36	0.59	0.77
PGSC0003DMT200071821	K10949	ko05110	Vibrio cholerae infection	399	3.6e-16	0.34	0.55	0.95
PGSC0003DMT200071831	K06628	ko04110	Cell cycle	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMT200071831	K06628	ko04111	Cell cycle - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMT200071831	K06628	ko04113	Meiosis - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMT200071840	K00754	ko00051	Fructose and mannose metabolism	797	4.0e-38	0.36	0.46	0.74
PGSC0003DMT200071842	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.54
PGSC0003DMT200071843	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMT200071844	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMT200071849	K02154	ko00190	Oxidative phosphorylation	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko01100	Metabolic pathways	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko04142	Lysosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko04145	Phagosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko04966	Collecting duct acid secretion	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko05110	Vibrio cholerae infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071849	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMT200071851	K02154	ko00190	Oxidative phosphorylation	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko01100	Metabolic pathways	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko04142	Lysosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko04145	Phagosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko04966	Collecting duct acid secretion	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko05110	Vibrio cholerae infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200071851	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMT200035859	K12356	ko00940	Phenylpropanoid biosynthesis	354	1.1e-13	0.36	0.51	0.96
PGSC0003DMT200035862	K00485	ko00982	Drug metabolism - cytochrome P450	1248	5.3e-63	0.59	0.73	0.93
PGSC0003DMT200035863	K00485	ko00982	Drug metabolism - cytochrome P450	1357	5.2e-69	0.59	0.72	0.98
PGSC0003DMT200035864	K00485	ko00982	Drug metabolism - cytochrome P450	1727	2.0e-89	0.61	0.74	0.98
PGSC0003DMT200035865	K00485	ko00982	Drug metabolism - cytochrome P450	811	6.8e-39	0.55	0.68	0.84
PGSC0003DMT200035866	K00485	ko00982	Drug metabolism - cytochrome P450	2294	1.1e-120	0.60	0.74	0.98
PGSC0003DMT200035867	K00485	ko00982	Drug metabolism - cytochrome P450	2009	5.7e-105	0.62	0.75	0.98
PGSC0003DMT200035869	K01087	ko00500	Starch and sucrose metabolism	1454	2.3e-74	0.60	0.75	0.88
PGSC0003DMT200035870	K01087	ko00500	Starch and sucrose metabolism	1134	1.0e-56	0.49	0.65	0.95
PGSC0003DMT200035883	K00287	ko00670	One carbon pool by folate	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMT200035883	K00287	ko00790	Folate biosynthesis	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMT200035883	K00287	ko01100	Metabolic pathways	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMT200035884	K00287	ko00670	One carbon pool by folate	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMT200035884	K00287	ko00790	Folate biosynthesis	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMT200035884	K00287	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMT200034726	K13066	ko00940	Phenylpropanoid biosynthesis	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMT200034726	K13066	ko01110	Biosynthesis of secondary metabolites	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMT200034732	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMT200034732	K01870	ko00970	Aminoacyl-tRNA biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMT200034733	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMT200034733	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMT200034734	K03138	ko03022	Basal transcription factors	2460	7.6e-130	0.75	0.85	0.99
PGSC0003DMT200034735	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMT200034736	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMT200034737	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMT200034738	K03955	ko00190	Oxidative phosphorylation	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMT200034738	K03955	ko01100	Metabolic pathways	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMT200034738	K03955	ko05010	Alzheimer's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMT200034738	K03955	ko05012	Parkinson's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMT200034738	K03955	ko05016	Huntington's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMT200034739	K03020	ko00230	Purine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMT200034739	K03020	ko00240	Pyrimidine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMT200034739	K03020	ko01100	Metabolic pathways	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMT200034739	K03020	ko03020	RNA polymerase	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMT200034739	K03020	ko04623	Cytosolic DNA-sensing pathway	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMT200034743	K12462	ko04722	Neurotrophin signaling pathway	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMT200034743	K12462	ko04962	Vasopressin-regulated water reabsorption	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMT200034750	K10591	ko04120	Ubiquitin mediated proteolysis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMT200034750	K10591	ko04144	Endocytosis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMT200016992	K09561	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.72	0.86	0.82
PGSC0003DMT200016993	K09561	ko04120	Ubiquitin mediated proteolysis	1069	4.0e-53	0.67	0.81	0.86
PGSC0003DMT200016994	K09561	ko04120	Ubiquitin mediated proteolysis	597	4.3e-27	0.58	0.72	0.76
PGSC0003DMT200017006	K00962	ko00230	Purine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMT200017006	K00962	ko00240	Pyrimidine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMT200017006	K00962	ko03018	RNA degradation	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMT200017018	K08905	ko00195	Photosynthesis	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMT200017018	K08905	ko01100	Metabolic pathways	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMT200029078	K13065	ko00940	Phenylpropanoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMT200029078	K13065	ko00941	Flavonoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMT200029078	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMT200029078	K13065	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMT200029079	K13065	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMT200029079	K13065	ko00941	Flavonoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMT200029079	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMT200029079	K13065	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMT200029084	K03260	ko05416	Viral myocarditis	1004	1.5e-49	0.51	0.74	0.92
PGSC0003DMT200029085	K03260	ko05416	Viral myocarditis	781	3.1e-37	0.53	0.73	0.80
PGSC0003DMT200029086	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.84
PGSC0003DMT200029087	K03260	ko05416	Viral myocarditis	1072	2.7e-53	0.53	0.74	0.72
PGSC0003DMT200029088	K03260	ko05416	Viral myocarditis	1070	3.5e-53	0.51	0.72	0.84
PGSC0003DMT200029089	K03260	ko05416	Viral myocarditis	1049	5.1e-52	0.52	0.74	0.85
PGSC0003DMT200029090	K03260	ko05416	Viral myocarditis	1040	1.6e-51	0.52	0.73	0.93
PGSC0003DMT200029091	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.93
PGSC0003DMT200029096	K02943	ko03010	Ribosome	600	2.9e-27	0.71	0.81	0.98
PGSC0003DMT200029102	K03260	ko05416	Viral myocarditis	2356	4.1e-124	0.48	0.63	0.88
PGSC0003DMT200003718	K02924	ko03010	Ribosome	445	1.0e-18	0.96	0.98	0.98
PGSC0003DMT200003726	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMT200003728	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMT200003732	K04733	ko04210	Apoptosis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMT200003732	K04733	ko04620	Toll-like receptor signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMT200003732	K04733	ko04722	Neurotrophin signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMT200003732	K04733	ko05140	Leishmaniasis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMT200003732	K04733	ko05142	Chagas disease	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMT200093792	K12356	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.42	0.61	0.90
PGSC0003DMT200093802	K00033	ko00030	Pentose phosphate pathway	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMT200093802	K00033	ko00480	Glutathione metabolism	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMT200093802	K00033	ko01100	Metabolic pathways	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMT200093802	K00033	ko01110	Biosynthesis of secondary metabolites	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMT200090397	K05282	ko00904	Diterpenoid biosynthesis	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMT200090397	K05282	ko01100	Metabolic pathways	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMT200090397	K05282	ko01110	Biosynthesis of secondary metabolites	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMT200090406	K10760	ko00908	Zeatin biosynthesis	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMT200090406	K10760	ko01100	Metabolic pathways	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMT200090406	K10760	ko01110	Biosynthesis of secondary metabolites	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMT200090419	K05282	ko00904	Diterpenoid biosynthesis	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMT200090419	K05282	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMT200090419	K05282	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMT200094256	K09658	ko00510	N-Glycan biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMT200094256	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMT200094256	K09658	ko01100	Metabolic pathways	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMT200094265	K04733	ko04210	Apoptosis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMT200094265	K04733	ko04620	Toll-like receptor signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMT200094265	K04733	ko04722	Neurotrophin signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMT200094265	K04733	ko05140	Leishmaniasis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMT200094265	K04733	ko05142	Chagas disease	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMT200003829	K08739	ko03430	Mismatch repair	1887	3.0e-98	0.38	0.52	0.99
PGSC0003DMT200003830	K08739	ko03430	Mismatch repair	338	6.5e-12	0.82	0.92	0.82
PGSC0003DMT200003859	K11778	ko00900	Terpenoid backbone biosynthesis	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMT200003859	K11778	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMT200003868	K05868	ko04110	Cell cycle	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMT200003868	K05868	ko04115	p53 signaling pathway	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMT200003868	K05868	ko04914	Progesterone-mediated oocyte maturation	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMT200003869	K00831	ko00260	Glycine, serine and threonine metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMT200003869	K00831	ko00750	Vitamin B6 metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMT200003869	K00831	ko01100	Metabolic pathways	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMT200003870	K00030	ko00020	Citrate cycle (TCA cycle)	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMT200003870	K00030	ko01100	Metabolic pathways	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMT200003870	K00030	ko01110	Biosynthesis of secondary metabolites	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMT200003877	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1185	1.6e-59	0.57	0.72	0.89
PGSC0003DMT200003878	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1294	1.6e-65	0.64	0.75	0.89
PGSC0003DMT200035609	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMT200035609	K00517	ko00626	Naphthalene and anthracene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMT200035609	K00517	ko00903	Limonene and pinene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMT200035609	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMT200035609	K00517	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMT200035613	K12598	ko03018	RNA degradation	6159	0.	0.86	0.93	0.99
PGSC0003DMT200035614	K12598	ko03018	RNA degradation	7232	0.	0.85	0.93	1.00
PGSC0003DMT200035618	K03678	ko03018	RNA degradation	2544	1.8e-134	0.68	0.81	1.00
PGSC0003DMT200035620	K03678	ko03018	RNA degradation	2594	3.1e-137	0.68	0.80	1.00
PGSC0003DMT200035622	K01840	ko00051	Fructose and mannose metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMT200035622	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMT200035622	K01840	ko01100	Metabolic pathways	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMT200035622	K01840	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMT200035623	K01840	ko00051	Fructose and mannose metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMT200035623	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMT200035623	K01840	ko01100	Metabolic pathways	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMT200035623	K01840	ko01110	Biosynthesis of secondary metabolites	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMT200035624	K01840	ko00051	Fructose and mannose metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMT200035624	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMT200035624	K01840	ko01100	Metabolic pathways	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMT200035624	K01840	ko01110	Biosynthesis of secondary metabolites	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMT200035626	K00967	ko00440	Phosphonate and phosphinate metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMT200035626	K00967	ko00564	Glycerophospholipid metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMT200035626	K00967	ko01100	Metabolic pathways	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMT200035627	K00967	ko00440	Phosphonate and phosphinate metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMT200035627	K00967	ko00564	Glycerophospholipid metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMT200035627	K00967	ko01100	Metabolic pathways	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMT200035636	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMT200035636	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMT200035636	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMT200035636	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMT200035636	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMT200035637	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200035637	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200035637	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200035637	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200035637	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200019520	K01046	ko00561	Glycerolipid metabolism	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMT200019520	K01046	ko01100	Metabolic pathways	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMT200019522	K01046	ko00561	Glycerolipid metabolism	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMT200019522	K01046	ko01100	Metabolic pathways	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMT200019541	K11866	ko04144	Endocytosis	861	1.2e-41	0.53	0.66	0.96
PGSC0003DMT200019542	K11866	ko04144	Endocytosis	2621	1.0e-138	0.66	0.74	1.00
PGSC0003DMT200019560	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019560	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019560	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019560	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019560	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019560	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200019561	K09843	ko00906	Carotenoid biosynthesis	1012	5.5e-50	0.34	0.53	0.98
PGSC0003DMT200011225	K04733	ko04210	Apoptosis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMT200011225	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMT200011225	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMT200011225	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMT200011225	K04733	ko05142	Chagas disease	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMT200011239	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.3e-12	0.32	0.49	0.42
PGSC0003DMT200011263	K03514	ko03018	RNA degradation	274	5.7e-06	0.29	0.48	0.24
PGSC0003DMT200034922	K00599	ko00340	Histidine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMT200034922	K00599	ko00350	Tyrosine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMT200034922	K00599	ko00450	Selenoamino acid metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMT200034922	K00599	ko00626	Naphthalene and anthracene degradation	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMT200034923	K00599	ko00340	Histidine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMT200034923	K00599	ko00350	Tyrosine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMT200034923	K00599	ko00450	Selenoamino acid metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMT200034923	K00599	ko00626	Naphthalene and anthracene degradation	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMT200034924	K01052	ko00100	Steroid biosynthesis	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMT200034924	K01052	ko04142	Lysosome	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMT200034927	K02183	ko04020	Calcium signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04070	Phosphatidylinositol signaling system	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04114	Oocyte meiosis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04270	Vascular smooth muscle contraction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04626	Plant-pathogen interaction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04720	Long-term potentiation	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04722	Neurotrophin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04740	Olfactory transduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04744	Phototransduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04745	Phototransduction - fly	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04910	Insulin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04912	GnRH signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04916	Melanogenesis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04970	Salivary secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko04971	Gastric acid secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko05010	Alzheimer's disease	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034927	K02183	ko05214	Glioma	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMT200034933	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034933	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034933	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034934	K00231	ko00860	Porphyrin and chlorophyll metabolism	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMT200034934	K00231	ko01100	Metabolic pathways	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMT200034934	K00231	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMT200034935	K00231	ko00860	Porphyrin and chlorophyll metabolism	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMT200034935	K00231	ko01100	Metabolic pathways	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMT200034935	K00231	ko01110	Biosynthesis of secondary metabolites	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMT200034936	K00231	ko00860	Porphyrin and chlorophyll metabolism	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMT200034936	K00231	ko01100	Metabolic pathways	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMT200034936	K00231	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMT200034937	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034937	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034937	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMT200034938	K00231	ko00860	Porphyrin and chlorophyll metabolism	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMT200034938	K00231	ko01100	Metabolic pathways	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMT200034938	K00231	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMT200034946	K12386	ko04142	Lysosome	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMT200034947	K00276	ko00260	Glycine, serine and threonine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko00350	Tyrosine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko00360	Phenylalanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko00410	beta-Alanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko00950	Isoquinoline alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko01100	Metabolic pathways	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034947	K00276	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMT200034958	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.91	0.92	0.99
PGSC0003DMT200034959	K00958	ko00230	Purine metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMT200034959	K00958	ko00450	Selenoamino acid metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMT200034959	K00958	ko00920	Sulfur metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMT200034959	K00958	ko01100	Metabolic pathways	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMT200034962	K00958	ko00230	Purine metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMT200034962	K00958	ko00450	Selenoamino acid metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMT200034962	K00958	ko00920	Sulfur metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMT200034962	K00958	ko01100	Metabolic pathways	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMT200034966	K05748	ko04520	Adherens junction	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMT200034966	K05748	ko04666	Fc gamma R-mediated phagocytosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMT200034966	K05748	ko04810	Regulation of actin cytoskeleton	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMT200034966	K05748	ko05100	Bacterial invasion of epithelial cells	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMT200034966	K05748	ko05131	Shigellosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMT200034972	K00660	ko00941	Flavonoid biosynthesis	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMT200034972	K00660	ko01100	Metabolic pathways	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMT200034972	K00660	ko01110	Biosynthesis of secondary metabolites	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMT200034972	K00660	ko04712	Circadian rhythm - plant	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMT200034973	K00660	ko00941	Flavonoid biosynthesis	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMT200034973	K00660	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMT200034973	K00660	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMT200034973	K00660	ko04712	Circadian rhythm - plant	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMT200016837	K12869	ko03040	Spliceosome	1216	3.1e-61	0.34	0.47	0.98
PGSC0003DMT200016844	K00873	ko00010	Glycolysis / Gluconeogenesis	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko00230	Purine metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko00620	Pyruvate metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko00710	Carbon fixation in photosynthetic organisms	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko01100	Metabolic pathways	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko01110	Biosynthesis of secondary metabolites	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016844	K00873	ko04930	Type II diabetes mellitus	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMT200016845	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1762	2.4e-91	0.68	0.83	0.97
PGSC0003DMT200016849	K05666	ko02010	ABC transporters	2670	2.0e-141	0.33	0.52	0.97
PGSC0003DMT200016850	K05673	ko02010	ABC transporters	290	4.0e-09	0.49	0.71	0.83
PGSC0003DMT200016865	K10595	ko04120	Ubiquitin mediated proteolysis	275	1.2e-07	0.40	0.55	0.98
PGSC0003DMT200062607	K13065	ko00940	Phenylpropanoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMT200062607	K13065	ko00941	Flavonoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMT200062607	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMT200062607	K13065	ko01110	Biosynthesis of secondary metabolites	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMT200062617	K04725	ko04120	Ubiquitin mediated proteolysis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062617	K04725	ko04210	Apoptosis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062617	K04725	ko04510	Focal adhesion	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062617	K04725	ko04621	NOD-like receptor signaling pathway	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062617	K04725	ko05200	Pathways in cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062617	K04725	ko05222	Small cell lung cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMT200062618	K04725	ko04120	Ubiquitin mediated proteolysis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200062618	K04725	ko04210	Apoptosis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200062618	K04725	ko04510	Focal adhesion	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200062618	K04725	ko04621	NOD-like receptor signaling pathway	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200062618	K04725	ko05200	Pathways in cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200062618	K04725	ko05222	Small cell lung cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMT200054412	K01054	ko00561	Glycerolipid metabolism	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMT200054412	K01054	ko01100	Metabolic pathways	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMT200054414	K04506	ko04115	p53 signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMT200054414	K04506	ko04120	Ubiquitin mediated proteolysis	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMT200054414	K04506	ko04310	Wnt signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMT200054415	K04506	ko04115	p53 signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMT200054415	K04506	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMT200054415	K04506	ko04310	Wnt signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMT200054416	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.41	0.58	0.85
PGSC0003DMT200054418	K08064	ko04612	Antigen processing and presentation	455	2.9e-19	0.58	0.75	0.81
PGSC0003DMT200054440	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMT200054440	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMT200054441	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMT200054441	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMT200082017	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2743	1.9e-145	0.78	0.89	0.99
PGSC0003DMT200082023	K00454	ko00591	Linoleic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMT200082023	K00454	ko00592	alpha-Linolenic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMT200082023	K00454	ko01100	Metabolic pathways	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMT200082025	K00454	ko00591	Linoleic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMT200082025	K00454	ko00592	alpha-Linolenic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMT200082025	K00454	ko01100	Metabolic pathways	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMT200082031	K00423	ko00053	Ascorbate and aldarate metabolism	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMT200082031	K00423	ko01100	Metabolic pathways	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMT200082043	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	760	4.4e-36	0.38	0.45	0.89
PGSC0003DMT200082044	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	909	2.7e-44	0.36	0.44	0.93
PGSC0003DMT200082063	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMT200082063	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMT200082064	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMT200082064	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMT200082065	K00547	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMT200082065	K00547	ko01100	Metabolic pathways	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMT200082065	K00547	ko01110	Biosynthesis of secondary metabolites	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMT200091391	K12356	ko00940	Phenylpropanoid biosynthesis	373	9.7e-15	0.39	0.49	0.61
PGSC0003DMT200091399	K10760	ko00908	Zeatin biosynthesis	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMT200091399	K10760	ko01100	Metabolic pathways	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMT200091399	K10760	ko01110	Biosynthesis of secondary metabolites	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMT200013473	K02134	ko00190	Oxidative phosphorylation	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMT200013473	K02134	ko01100	Metabolic pathways	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMT200013473	K02134	ko05010	Alzheimer's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMT200013473	K02134	ko05012	Parkinson's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMT200013473	K02134	ko05016	Huntington's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMT200013474	K03363	ko04110	Cell cycle	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMT200013474	K03363	ko04111	Cell cycle - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMT200013474	K03363	ko04113	Meiosis - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMT200013474	K03363	ko04114	Oocyte meiosis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMT200013474	K03363	ko04120	Ubiquitin mediated proteolysis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMT200013485	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013485	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013485	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013486	K10717	ko00908	Zeatin biosynthesis	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMT200013486	K10717	ko01100	Metabolic pathways	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMT200013486	K10717	ko01110	Biosynthesis of secondary metabolites	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMT200013487	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013487	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013487	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMT200013488	K10717	ko00908	Zeatin biosynthesis	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMT200013488	K10717	ko01100	Metabolic pathways	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMT200013488	K10717	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMT200013502	K03950	ko00190	Oxidative phosphorylation	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMT200013502	K03950	ko01100	Metabolic pathways	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMT200013502	K03950	ko05010	Alzheimer's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMT200013502	K03950	ko05012	Parkinson's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMT200013502	K03950	ko05016	Huntington's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMT200013503	K00430	ko00360	Phenylalanine metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMT200013503	K00430	ko00680	Methane metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMT200013503	K00430	ko00940	Phenylpropanoid biosynthesis	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMT200013503	K00430	ko01100	Metabolic pathways	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMT200013503	K00430	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMT200013504	K00430	ko00360	Phenylalanine metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMT200013504	K00430	ko00680	Methane metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMT200013504	K00430	ko00940	Phenylpropanoid biosynthesis	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMT200013504	K00430	ko01100	Metabolic pathways	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMT200013504	K00430	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMT200013505	K00430	ko00360	Phenylalanine metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMT200013505	K00430	ko00680	Methane metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMT200013505	K00430	ko00940	Phenylpropanoid biosynthesis	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMT200013505	K00430	ko01100	Metabolic pathways	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMT200013505	K00430	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMT200023513	K01087	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.53	0.73	0.95
PGSC0003DMT200039467	K03010	ko00230	Purine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMT200039467	K03010	ko00240	Pyrimidine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMT200039467	K03010	ko01100	Metabolic pathways	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMT200039467	K03010	ko03020	RNA polymerase	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMT200039467	K03010	ko05016	Huntington's disease	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMT200039468	K03010	ko00230	Purine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMT200039468	K03010	ko00240	Pyrimidine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMT200039468	K03010	ko01100	Metabolic pathways	7907	0.	0.76	0.87	1.00
PGSC0003DMT200039468	K03010	ko03020	RNA polymerase	7907	0.	0.76	0.87	1.00
PGSC0003DMT200039468	K03010	ko05016	Huntington's disease	7907	0.	0.76	0.87	1.00
PGSC0003DMT200039470	K08066	ko04612	Antigen processing and presentation	685	6.0e-32	0.44	0.56	0.87
PGSC0003DMT200039471	K08066	ko04612	Antigen processing and presentation	420	2.5e-17	0.44	0.64	0.79
PGSC0003DMT200039488	K01114	ko00562	Inositol phosphate metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMT200039488	K01114	ko00564	Glycerophospholipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMT200039488	K01114	ko00565	Ether lipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMT200039488	K01114	ko01100	Metabolic pathways	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMT200039489	K01114	ko00562	Inositol phosphate metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMT200039489	K01114	ko00564	Glycerophospholipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMT200039489	K01114	ko00565	Ether lipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMT200039489	K01114	ko01100	Metabolic pathways	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMT200039493	K10684	ko04120	Ubiquitin mediated proteolysis	2068	3.2e-108	0.75	0.88	0.98
PGSC0003DMT200039496	K05681	ko02010	ABC transporters	1119	7.0e-56	0.34	0.51	0.92
PGSC0003DMT200039497	K02998	ko03010	Ribosome	1850	3.3e-96	0.73	0.79	1.00
PGSC0003DMT200039504	K07407	ko00052	Galactose metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMT200039504	K07407	ko00561	Glycerolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMT200039504	K07407	ko00600	Sphingolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMT200039504	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMT200039505	K07407	ko00052	Galactose metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMT200039505	K07407	ko00561	Glycerolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMT200039505	K07407	ko00600	Sphingolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMT200039505	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMT200031293	K02433	ko00970	Aminoacyl-tRNA biosynthesis	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMT200031293	K02433	ko01100	Metabolic pathways	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMT200031294	K02433	ko00970	Aminoacyl-tRNA biosynthesis	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMT200031294	K02433	ko01100	Metabolic pathways	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMT200031295	K02433	ko00970	Aminoacyl-tRNA biosynthesis	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMT200031295	K02433	ko01100	Metabolic pathways	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMT200031296	K02433	ko00970	Aminoacyl-tRNA biosynthesis	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMT200031296	K02433	ko01100	Metabolic pathways	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMT200031297	K02433	ko00970	Aminoacyl-tRNA biosynthesis	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMT200031297	K02433	ko01100	Metabolic pathways	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMT200031301	K04077	ko03018	RNA degradation	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMT200031301	K04077	ko04940	Type I diabetes mellitus	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMT200031308	K05681	ko02010	ABC transporters	573	9.1e-26	0.35	0.54	0.77
PGSC0003DMT200031309	K05681	ko02010	ABC transporters	651	4.5e-30	0.31	0.51	0.87
PGSC0003DMT200031310	K05681	ko02010	ABC transporters	676	1.9e-31	0.31	0.51	0.82
PGSC0003DMT200031311	K05683	ko02010	ABC transporters	739	6.3e-35	0.31	0.52	0.83
PGSC0003DMT200031312	K05683	ko02010	ABC transporters	838	2.2e-40	0.31	0.51	0.83
PGSC0003DMT200031313	K05683	ko02010	ABC transporters	638	2.4e-29	0.37	0.57	0.71
PGSC0003DMT200048126	K13065	ko00940	Phenylpropanoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMT200048126	K13065	ko00941	Flavonoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMT200048126	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMT200048126	K13065	ko01110	Biosynthesis of secondary metabolites	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMT200048130	K13065	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMT200048130	K13065	ko00941	Flavonoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMT200048130	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMT200048130	K13065	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMT200048131	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMT200048131	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMT200048131	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMT200048131	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMT200048132	K02908	ko03010	Ribosome	920	6.6e-45	0.96	1.00	0.99
PGSC0003DMT200048136	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.90
PGSC0003DMT200048137	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.92
PGSC0003DMT200048143	K01426	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048143	K01426	ko00360	Phenylalanine metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048143	K01426	ko00380	Tryptophan metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048143	K01426	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048143	K01426	ko00632	Benzoate degradation via CoA ligation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048143	K01426	ko00643	Styrene degradation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMT200048144	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048144	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048144	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048144	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048144	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048144	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200048145	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMT200060244	K00249	ko00071	Fatty acid metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko00280	Valine, leucine and isoleucine degradation	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko00410	beta-Alanine metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko00640	Propanoate metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko01100	Metabolic pathways	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko01110	Biosynthesis of secondary metabolites	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060244	K00249	ko03320	PPAR signaling pathway	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMT200060245	K00249	ko00071	Fatty acid metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko00280	Valine, leucine and isoleucine degradation	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko00410	beta-Alanine metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko00640	Propanoate metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko01100	Metabolic pathways	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko01110	Biosynthesis of secondary metabolites	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060245	K00249	ko03320	PPAR signaling pathway	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMT200060246	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMT200060246	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMT200060246	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMT200060256	K10594	ko04120	Ubiquitin mediated proteolysis	367	1.0e-12	0.40	0.56	0.46
PGSC0003DMT200060257	K10615	ko04120	Ubiquitin mediated proteolysis	681	1.8e-31	0.33	0.52	0.89
PGSC0003DMT200060258	K10615	ko04120	Ubiquitin mediated proteolysis	545	1.2e-23	0.35	0.54	0.84
PGSC0003DMT200060259	K10615	ko04120	Ubiquitin mediated proteolysis	674	4.7e-31	0.33	0.52	0.89
PGSC0003DMT200060260	K10615	ko04120	Ubiquitin mediated proteolysis	483	3.9e-20	0.35	0.54	0.80
PGSC0003DMT200069897	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMT200069897	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMT200069897	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMT200069897	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMT200069898	K13065	ko00940	Phenylpropanoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMT200069898	K13065	ko00941	Flavonoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMT200069898	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMT200069898	K13065	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMT200069911	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMT200069912	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMT200069913	K02917	ko03010	Ribosome	901	7.4e-44	0.91	0.95	0.99
PGSC0003DMT200077372	K00681	ko00430	Taurine and hypotaurine metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077372	K00681	ko00450	Selenoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077372	K00681	ko00460	Cyanoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077372	K00681	ko00480	Glutathione metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077372	K00681	ko00590	Arachidonic acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077372	K00681	ko01100	Metabolic pathways	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMT200077373	K00681	ko00430	Taurine and hypotaurine metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077373	K00681	ko00450	Selenoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077373	K00681	ko00460	Cyanoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077373	K00681	ko00480	Glutathione metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077373	K00681	ko00590	Arachidonic acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077373	K00681	ko01100	Metabolic pathways	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMT200077392	K03013	ko00230	Purine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMT200077392	K03013	ko00240	Pyrimidine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMT200077392	K03013	ko01100	Metabolic pathways	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMT200077392	K03013	ko03020	RNA polymerase	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMT200077392	K03013	ko05016	Huntington's disease	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMT200025250	K03660	ko03410	Base excision repair	270	2.6e-08	0.41	0.55	0.71
PGSC0003DMT200025256	K12192	ko04144	Endocytosis	1157	5.6e-58	0.74	0.89	0.85
PGSC0003DMT200025257	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMT200025258	K12192	ko04144	Endocytosis	886	4.9e-43	0.72	0.87	0.99
PGSC0003DMT200025260	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMT200025264	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMT200025264	K00517	ko00626	Naphthalene and anthracene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMT200025264	K00517	ko00903	Limonene and pinene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMT200025264	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMT200025264	K00517	ko01110	Biosynthesis of secondary metabolites	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMT200025267	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMT200025267	K00517	ko00626	Naphthalene and anthracene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMT200025267	K00517	ko00903	Limonene and pinene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMT200025267	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMT200025267	K00517	ko01110	Biosynthesis of secondary metabolites	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMT200025271	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMT200025271	K00517	ko00626	Naphthalene and anthracene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMT200025271	K00517	ko00903	Limonene and pinene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMT200025271	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMT200025271	K00517	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMT200025272	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMT200025272	K00517	ko00626	Naphthalene and anthracene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMT200025272	K00517	ko00903	Limonene and pinene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMT200025272	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMT200025272	K00517	ko01110	Biosynthesis of secondary metabolites	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMT200025274	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMT200025274	K00517	ko00626	Naphthalene and anthracene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMT200025274	K00517	ko00903	Limonene and pinene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMT200025274	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMT200025274	K00517	ko01110	Biosynthesis of secondary metabolites	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMT200025275	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMT200025275	K00517	ko00626	Naphthalene and anthracene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMT200025275	K00517	ko00903	Limonene and pinene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMT200025275	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMT200025275	K00517	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMT200025281	K00558	ko00270	Cysteine and methionine metabolism	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMT200025281	K00558	ko01100	Metabolic pathways	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMT200025290	K12606	ko03018	RNA degradation	273	3.2e-09	0.62	0.71	0.80
PGSC0003DMT200025292	K12606	ko03018	RNA degradation	187	6.3e-13	0.56	0.66	0.83
PGSC0003DMT200015210	K05864	ko04020	Calcium signaling pathway	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMT200015210	K05864	ko05012	Parkinson's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMT200015210	K05864	ko05016	Huntington's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMT200015222	K01188	ko00460	Cyanoamino acid metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMT200015222	K01188	ko00500	Starch and sucrose metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMT200015222	K01188	ko00940	Phenylpropanoid biosynthesis	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMT200015222	K01188	ko01110	Biosynthesis of secondary metabolites	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMT200015224	K01188	ko00460	Cyanoamino acid metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMT200015224	K01188	ko00500	Starch and sucrose metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMT200015224	K01188	ko00940	Phenylpropanoid biosynthesis	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMT200015224	K01188	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMT200015231	K01188	ko00460	Cyanoamino acid metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMT200015231	K01188	ko00500	Starch and sucrose metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMT200015231	K01188	ko00940	Phenylpropanoid biosynthesis	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMT200015231	K01188	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMT200015232	K01188	ko00460	Cyanoamino acid metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMT200015232	K01188	ko00500	Starch and sucrose metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMT200015232	K01188	ko00940	Phenylpropanoid biosynthesis	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMT200015232	K01188	ko01110	Biosynthesis of secondary metabolites	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMT200015233	K01188	ko00460	Cyanoamino acid metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMT200015233	K01188	ko00500	Starch and sucrose metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMT200015233	K01188	ko00940	Phenylpropanoid biosynthesis	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMT200015233	K01188	ko01110	Biosynthesis of secondary metabolites	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMT200015234	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.57	0.89
PGSC0003DMT200015240	K03361	ko04111	Cell cycle - yeast	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMT200015240	K03361	ko04120	Ubiquitin mediated proteolysis	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMT200015243	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015243	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015243	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015244	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015244	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015244	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMT200015245	K05868	ko04110	Cell cycle	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMT200015245	K05868	ko04115	p53 signaling pathway	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMT200015245	K05868	ko04914	Progesterone-mediated oocyte maturation	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMT200032939	K10839	ko03420	Nucleotide excision repair	2396	2.6e-126	0.76	0.85	1.00
PGSC0003DMT200032940	K10839	ko03420	Nucleotide excision repair	1128	2.2e-56	0.71	0.84	0.95
PGSC0003DMT200032941	K10839	ko03420	Nucleotide excision repair	2464	4.6e-130	0.77	0.86	1.00
PGSC0003DMT200032945	K10615	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.49	0.96
PGSC0003DMT200032948	K10579	ko04120	Ubiquitin mediated proteolysis	1200	2.4e-60	0.72	0.83	0.73
PGSC0003DMT200032949	K10579	ko04120	Ubiquitin mediated proteolysis	1219	2.1e-61	0.77	0.85	0.99
PGSC0003DMT200032957	K12356	ko00940	Phenylpropanoid biosynthesis	1238	1.9e-62	0.57	0.72	0.96
PGSC0003DMT200032958	K12356	ko00940	Phenylpropanoid biosynthesis	1953	7.0e-102	0.51	0.71	0.98
PGSC0003DMT200032959	K04427	ko04010	MAPK signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04310	Wnt signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04520	Adherens junction	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04620	Toll-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04621	NOD-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04622	RIG-I-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko04660	T cell receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032959	K04427	ko05140	Leishmaniasis	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMT200032970	K01939	ko00230	Purine metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMT200032970	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMT200032970	K01939	ko01100	Metabolic pathways	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMT200032975	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032975	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032975	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032976	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032976	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032976	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032977	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMT200032977	K01602	ko00710	Carbon fixation in photosynthetic organisms	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMT200032977	K01602	ko01100	Metabolic pathways	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMT200032978	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032978	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032978	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMT200032979	K00430	ko00360	Phenylalanine metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMT200032979	K00430	ko00680	Methane metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMT200032979	K00430	ko00940	Phenylpropanoid biosynthesis	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMT200032979	K00430	ko01100	Metabolic pathways	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMT200032979	K00430	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMT200032983	K00430	ko00360	Phenylalanine metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMT200032983	K00430	ko00680	Methane metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMT200032983	K00430	ko00940	Phenylpropanoid biosynthesis	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMT200032983	K00430	ko01100	Metabolic pathways	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMT200032983	K00430	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMT200097181	K10760	ko00908	Zeatin biosynthesis	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMT200097181	K10760	ko01100	Metabolic pathways	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMT200097181	K10760	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMT200097200	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2561	2.0e-135	0.72	0.84	0.99
PGSC0003DMT200092587	K05282	ko00904	Diterpenoid biosynthesis	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMT200092587	K05282	ko01100	Metabolic pathways	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMT200092587	K05282	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMT200092597	K13248	ko00750	Vitamin B6 metabolism	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMT200092597	K13248	ko01100	Metabolic pathways	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMT200001954	K05280	ko00941	Flavonoid biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMT200001954	K05280	ko00944	Flavone and flavonol biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMT200001954	K05280	ko01100	Metabolic pathways	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMT200001954	K05280	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMT200001956	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMT200001956	K00517	ko00626	Naphthalene and anthracene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMT200001956	K00517	ko00903	Limonene and pinene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMT200001956	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMT200001956	K00517	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMT200001958	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMT200001958	K00517	ko00626	Naphthalene and anthracene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMT200001958	K00517	ko00903	Limonene and pinene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMT200001958	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMT200001958	K00517	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMT200001959	K05280	ko00941	Flavonoid biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMT200001959	K05280	ko00944	Flavone and flavonol biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMT200001959	K05280	ko01100	Metabolic pathways	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMT200001959	K05280	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMT200001960	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMT200001960	K00517	ko00626	Naphthalene and anthracene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMT200001960	K00517	ko00903	Limonene and pinene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMT200001960	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMT200001960	K00517	ko01110	Biosynthesis of secondary metabolites	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMT200001965	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMT200001965	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMT200001965	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMT200001965	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMT200001965	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMT200001966	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMT200001966	K00517	ko00626	Naphthalene and anthracene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMT200001966	K00517	ko00903	Limonene and pinene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMT200001966	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMT200001966	K00517	ko01110	Biosynthesis of secondary metabolites	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMT200001972	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMT200001972	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMT200001972	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMT200001972	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMT200001972	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMT200001980	K11228	ko04011	MAPK signaling pathway - yeast	960	4.1e-47	0.34	0.49	0.79
PGSC0003DMT200001981	K11228	ko04011	MAPK signaling pathway - yeast	956	6.8e-47	0.35	0.49	0.79
PGSC0003DMT200001983	K01834	ko00010	Glycolysis / Gluconeogenesis	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMT200001983	K01834	ko01100	Metabolic pathways	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMT200001983	K01834	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMT200001984	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001984	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001984	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001985	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001985	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001985	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMT200001986	K01834	ko00010	Glycolysis / Gluconeogenesis	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMT200001986	K01834	ko01100	Metabolic pathways	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMT200001986	K01834	ko01110	Biosynthesis of secondary metabolites	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMT200001987	K01834	ko00010	Glycolysis / Gluconeogenesis	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMT200001987	K01834	ko01100	Metabolic pathways	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMT200001987	K01834	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMT200001992	K08233	ko00901	Indole alkaloid biosynthesis	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMT200001992	K08233	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMT200001994	K08233	ko00901	Indole alkaloid biosynthesis	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMT200001994	K08233	ko01110	Biosynthesis of secondary metabolites	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMT200001995	K08233	ko00901	Indole alkaloid biosynthesis	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMT200001995	K08233	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMT200001996	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMT200001996	K00517	ko00626	Naphthalene and anthracene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMT200001996	K00517	ko00903	Limonene and pinene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMT200001996	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMT200001996	K00517	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMT200001997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMT200001997	K00517	ko00626	Naphthalene and anthracene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMT200001997	K00517	ko00903	Limonene and pinene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMT200001997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMT200001997	K00517	ko01110	Biosynthesis of secondary metabolites	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMT200001998	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMT200001998	K00517	ko00626	Naphthalene and anthracene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMT200001998	K00517	ko00903	Limonene and pinene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMT200001998	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMT200001998	K00517	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMT200001999	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMT200001999	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMT200001999	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMT200001999	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMT200001999	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMT200068121	K10781	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMT200068121	K10781	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMT200068129	K08916	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMT200068129	K08916	ko01100	Metabolic pathways	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMT200068136	K02145	ko00190	Oxidative phosphorylation	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068136	K02145	ko01100	Metabolic pathways	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068136	K02145	ko04145	Phagosome	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068136	K02145	ko04966	Collecting duct acid secretion	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068136	K02145	ko05110	Vibrio cholerae infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068136	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMT200068147	K01230	ko00510	N-Glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMT200068147	K01230	ko00513	High-mannose type N-glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMT200068147	K01230	ko01100	Metabolic pathways	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMT200068148	K01230	ko00510	N-Glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMT200068148	K01230	ko00513	High-mannose type N-glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMT200068148	K01230	ko01100	Metabolic pathways	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMT200068149	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068149	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068149	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068150	K01230	ko00510	N-Glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMT200068150	K01230	ko00513	High-mannose type N-glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMT200068150	K01230	ko01100	Metabolic pathways	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMT200068151	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068151	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068151	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMT200068159	K02135	ko00190	Oxidative phosphorylation	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMT200068159	K02135	ko01100	Metabolic pathways	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMT200068159	K02135	ko05010	Alzheimer's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMT200068159	K02135	ko05012	Parkinson's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMT200068159	K02135	ko05016	Huntington's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMT200058435	K02183	ko04020	Calcium signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04070	Phosphatidylinositol signaling system	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04114	Oocyte meiosis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04270	Vascular smooth muscle contraction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04626	Plant-pathogen interaction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04720	Long-term potentiation	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04722	Neurotrophin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04740	Olfactory transduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04744	Phototransduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04745	Phototransduction - fly	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04910	Insulin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04912	GnRH signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04916	Melanogenesis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04970	Salivary secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko04971	Gastric acid secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko05010	Alzheimer's disease	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058435	K02183	ko05214	Glioma	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMT200058437	K08101	ko00860	Porphyrin and chlorophyll metabolism	1562	2.6e-80	0.56	0.72	0.97
PGSC0003DMT200058438	K08101	ko00860	Porphyrin and chlorophyll metabolism	655	2.7e-30	0.49	0.64	0.90
PGSC0003DMT200058439	K08101	ko00860	Porphyrin and chlorophyll metabolism	910	2.3e-44	0.66	0.83	0.93
PGSC0003DMT200058440	K08101	ko00860	Porphyrin and chlorophyll metabolism	1472	2.4e-75	0.64	0.81	0.94
PGSC0003DMT200058450	K12796	ko04621	NOD-like receptor signaling pathway	422	1.3e-13	0.29	0.47	0.33
PGSC0003DMT200058457	K05868	ko04110	Cell cycle	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMT200058457	K05868	ko04115	p53 signaling pathway	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMT200058457	K05868	ko04914	Progesterone-mediated oocyte maturation	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMT200085100	K09757	ko00940	Phenylpropanoid biosynthesis	252	4.6e-08	0.65	0.77	0.57
PGSC0003DMT200085101	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.40	0.56	0.56
PGSC0003DMT200075608	K05298	ko00710	Carbon fixation in photosynthetic organisms	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMT200075608	K05298	ko01100	Metabolic pathways	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMT200075611	K03781	ko00380	Tryptophan metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMT200075611	K03781	ko00680	Methane metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMT200075611	K03781	ko01100	Metabolic pathways	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMT200075611	K03781	ko04146	Peroxisome	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMT200075611	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMT200075612	K08332	ko04140	Regulation of autophagy	326	1.4e-09	0.29	0.51	0.42
PGSC0003DMT200075616	K00121	ko00010	Glycolysis / Gluconeogenesis	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00071	Fatty acid metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00350	Tyrosine metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00641	3-Chloroacrylic acid degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00680	Methane metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00830	Retinol metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko00982	Drug metabolism - cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko01100	Metabolic pathways	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075616	K00121	ko01110	Biosynthesis of secondary metabolites	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMT200075617	K00121	ko00010	Glycolysis / Gluconeogenesis	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00071	Fatty acid metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00350	Tyrosine metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00641	3-Chloroacrylic acid degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00680	Methane metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00830	Retinol metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko00982	Drug metabolism - cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko01100	Metabolic pathways	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075617	K00121	ko01110	Biosynthesis of secondary metabolites	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMT200075618	K00121	ko00010	Glycolysis / Gluconeogenesis	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00071	Fatty acid metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00350	Tyrosine metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00641	3-Chloroacrylic acid degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00680	Methane metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00830	Retinol metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko00982	Drug metabolism - cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko01100	Metabolic pathways	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075618	K00121	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMT200075620	K00423	ko00053	Ascorbate and aldarate metabolism	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMT200075620	K00423	ko01100	Metabolic pathways	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMT200075624	K06685	ko04111	Cell cycle - yeast	350	2.2e-10	0.31	0.48	0.42
PGSC0003DMT200075625	K06685	ko04111	Cell cycle - yeast	350	6.8e-10	0.31	0.48	0.28
PGSC0003DMT200075626	K00799	ko00480	Glutathione metabolism	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMT200075626	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMT200075626	K00799	ko00982	Drug metabolism - cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMT200075627	K00799	ko00480	Glutathione metabolism	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMT200075627	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMT200075627	K00799	ko00982	Drug metabolism - cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMT200075646	K12619	ko03018	RNA degradation	6012	0.	0.67	0.76	0.98
PGSC0003DMT200075647	K12619	ko03018	RNA degradation	5999	0.	0.67	0.76	0.98
PGSC0003DMT200037386	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMT200037387	K12188	ko04144	Endocytosis	1076	1.6e-53	0.83	0.95	0.96
PGSC0003DMT200037388	K12188	ko04144	Endocytosis	1892	1.6e-98	0.88	0.96	0.99
PGSC0003DMT200037401	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	0.99
PGSC0003DMT200037402	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	1.00
PGSC0003DMT200037403	K08770	ko03320	PPAR signaling pathway	4360	1.2e-234	1.00	1.00	1.00
PGSC0003DMT200037410	K08770	ko03320	PPAR signaling pathway	331	2.0e-12	0.76	0.88	0.95
PGSC0003DMT200009492	K04371	ko04010	MAPK signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04012	ErbB signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04013	MAPK signaling pathway - fly	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04062	Chemokine signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04114	Oocyte meiosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04150	mTOR signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04270	Vascular smooth muscle contraction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04320	Dorso-ventral axis formation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04350	TGF-beta signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04360	Axon guidance	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04370	VEGF signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04510	Focal adhesion	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04520	Adherens junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04540	Gap junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04620	Toll-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04621	NOD-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04650	Natural killer cell mediated cytotoxicity	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04660	T cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04662	B cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04664	Fc epsilon RI signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04666	Fc gamma R-mediated phagocytosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04720	Long-term potentiation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04722	Neurotrophin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04730	Long-term depression	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04810	Regulation of actin cytoskeleton	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04910	Insulin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04912	GnRH signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04914	Progesterone-mediated oocyte maturation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04916	Melanogenesis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04930	Type II diabetes mellitus	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko04960	Aldosterone-regulated sodium reabsorption	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05010	Alzheimer's disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05020	Prion diseases	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05131	Shigellosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05140	Leishmaniasis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05142	Chagas disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05200	Pathways in cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05210	Colorectal cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05211	Renal cell carcinoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05212	Pancreatic cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05213	Endometrial cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05214	Glioma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05215	Prostate cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05216	Thyroid cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05218	Melanoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05219	Bladder cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05220	Chronic myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05221	Acute myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009492	K04371	ko05223	Non-small cell lung cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMT200009493	K04371	ko04010	MAPK signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04012	ErbB signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04013	MAPK signaling pathway - fly	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04062	Chemokine signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04114	Oocyte meiosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04150	mTOR signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04270	Vascular smooth muscle contraction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04320	Dorso-ventral axis formation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04360	Axon guidance	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04370	VEGF signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04510	Focal adhesion	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04520	Adherens junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04540	Gap junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04620	Toll-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04621	NOD-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04650	Natural killer cell mediated cytotoxicity	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04660	T cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04662	B cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04664	Fc epsilon RI signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04666	Fc gamma R-mediated phagocytosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04720	Long-term potentiation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04722	Neurotrophin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04730	Long-term depression	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04810	Regulation of actin cytoskeleton	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04910	Insulin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04912	GnRH signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04914	Progesterone-mediated oocyte maturation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04916	Melanogenesis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04930	Type II diabetes mellitus	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko04960	Aldosterone-regulated sodium reabsorption	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05010	Alzheimer's disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05020	Prion diseases	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05131	Shigellosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05140	Leishmaniasis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05142	Chagas disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05200	Pathways in cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05210	Colorectal cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05211	Renal cell carcinoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05212	Pancreatic cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05213	Endometrial cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05214	Glioma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05215	Prostate cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05216	Thyroid cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05218	Melanoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05219	Bladder cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05220	Chronic myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05221	Acute myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009493	K04371	ko05223	Non-small cell lung cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMT200009496	K01190	ko00052	Galactose metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMT200009496	K01190	ko00511	Other glycan degradation	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMT200009496	K01190	ko00600	Sphingolipid metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMT200009496	K01190	ko01100	Metabolic pathways	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMT200009499	K01338	ko04112	Cell cycle - Caulobacter	805	1.4e-38	0.51	0.68	0.74
PGSC0003DMT200009521	K04618	ko00052	Galactose metabolism	468	6.4e-20	0.29	0.44	0.81
PGSC0003DMT200009526	K04618	ko00052	Galactose metabolism	437	4.6e-18	0.29	0.44	0.81
PGSC0003DMT200009529	K04618	ko00052	Galactose metabolism	470	4.8e-20	0.29	0.46	0.81
PGSC0003DMT200017679	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMT200017685	K04457	ko04010	MAPK signaling pathway	558	3.6e-24	0.35	0.51	0.24
PGSC0003DMT200017691	K01184	ko00040	Pentose and glucuronate interconversions	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMT200017691	K01184	ko00500	Starch and sucrose metabolism	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMT200017691	K01184	ko01100	Metabolic pathways	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMT200017697	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.52	0.67	0.65
PGSC0003DMT200017698	K08064	ko04612	Antigen processing and presentation	591	9.2e-27	0.40	0.55	0.75
PGSC0003DMT200017710	K02137	ko00190	Oxidative phosphorylation	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMT200017710	K02137	ko01100	Metabolic pathways	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMT200017710	K02137	ko05010	Alzheimer's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMT200017710	K02137	ko05012	Parkinson's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMT200017710	K02137	ko05016	Huntington's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMT200089200	K01955	ko00240	Pyrimidine metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMT200089200	K01955	ko00250	Alanine, aspartate and glutamate metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMT200089200	K01955	ko01100	Metabolic pathways	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMT200056161	K01087	ko00500	Starch and sucrose metabolism	1309	2.3e-66	0.69	0.81	0.98
PGSC0003DMT200056166	K05658	ko02010	ABC transporters	342	4.7e-12	0.57	0.77	0.95
PGSC0003DMT200056167	K05658	ko02010	ABC transporters	324	4.7e-11	0.55	0.71	0.99
PGSC0003DMT200056168	K05658	ko02010	ABC transporters	544	2.3e-23	0.54	0.73	0.97
PGSC0003DMT200056192	K01858	ko00521	Streptomycin biosynthesis	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMT200056192	K01858	ko00562	Inositol phosphate metabolism	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMT200056192	K01858	ko01100	Metabolic pathways	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMT200056192	K01858	ko01110	Biosynthesis of secondary metabolites	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMT200064307	K10151	ko04110	Cell cycle	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMT200064307	K10151	ko04115	p53 signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMT200064307	K10151	ko04310	Wnt signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMT200064307	K10151	ko04510	Focal adhesion	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMT200064307	K10151	ko04630	Jak-STAT signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMT200064308	K01110	ko00562	Inositol phosphate metabolism	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko04070	Phosphatidylinositol signaling system	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko04115	p53 signaling pathway	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko04510	Focal adhesion	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko04530	Tight junction	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05200	Pathways in cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05213	Endometrial cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05214	Glioma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05215	Prostate cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05218	Melanoma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064308	K01110	ko05222	Small cell lung cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMT200064309	K01110	ko00562	Inositol phosphate metabolism	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko04070	Phosphatidylinositol signaling system	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko04115	p53 signaling pathway	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko04510	Focal adhesion	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko04530	Tight junction	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05200	Pathways in cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05213	Endometrial cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05214	Glioma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05215	Prostate cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05218	Melanoma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064309	K01110	ko05222	Small cell lung cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMT200064310	K01110	ko00562	Inositol phosphate metabolism	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko04070	Phosphatidylinositol signaling system	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko04115	p53 signaling pathway	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko04510	Focal adhesion	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko04530	Tight junction	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05200	Pathways in cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05213	Endometrial cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05214	Glioma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05215	Prostate cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05218	Melanoma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064310	K01110	ko05222	Small cell lung cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMT200064323	K05849	ko04020	Calcium signaling pathway	413	1.6e-16	0.35	0.52	0.51
PGSC0003DMT200064326	K00851	ko00030	Pentose phosphate pathway	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMT200064326	K00851	ko01100	Metabolic pathways	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMT200064326	K00851	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMT200064328	K00851	ko00030	Pentose phosphate pathway	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMT200064328	K00851	ko01100	Metabolic pathways	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMT200064328	K00851	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMT200079911	K00963	ko00040	Pentose and glucuronate interconversions	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079911	K00963	ko00052	Galactose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079911	K00963	ko00500	Starch and sucrose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079911	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079911	K00963	ko01100	Metabolic pathways	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079911	K00963	ko01110	Biosynthesis of secondary metabolites	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMT200079912	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079912	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079912	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079912	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079912	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079912	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079914	K00963	ko00040	Pentose and glucuronate interconversions	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079914	K00963	ko00052	Galactose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079914	K00963	ko00500	Starch and sucrose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079914	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079914	K00963	ko01100	Metabolic pathways	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079914	K00963	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMT200079915	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079915	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079915	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079915	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079915	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079915	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMT200079930	K12373	ko00511	Other glycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko00531	Glycosaminoglycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko01100	Metabolic pathways	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079930	K12373	ko04142	Lysosome	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMT200079931	K12373	ko00511	Other glycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko00531	Glycosaminoglycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko01100	Metabolic pathways	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079931	K12373	ko04142	Lysosome	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMT200079934	K04382	ko04111	Cell cycle - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04113	Meiosis - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04114	Oocyte meiosis	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04310	Wnt signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04350	TGF-beta signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04530	Tight junction	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko04730	Long-term depression	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079934	K04382	ko05142	Chagas disease	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMT200079935	K04382	ko04111	Cell cycle - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04113	Meiosis - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04114	Oocyte meiosis	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04310	Wnt signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04350	TGF-beta signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04530	Tight junction	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko04730	Long-term depression	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079935	K04382	ko05142	Chagas disease	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMT200079303	K06685	ko04111	Cell cycle - yeast	1620	1.6e-83	0.96	0.98	0.99
PGSC0003DMT200079304	K06685	ko04111	Cell cycle - yeast	1816	2.5e-94	0.97	0.99	1.00
PGSC0003DMT200079305	K11422	ko00310	Lysine degradation	288	1.3e-06	0.30	0.41	0.63
PGSC0003DMT200079306	K04512	ko04310	Wnt signaling pathway	833	4.1e-40	0.33	0.57	0.97
PGSC0003DMT200079309	K08762	ko03320	PPAR signaling pathway	606	1.4e-27	0.82	0.91	0.97
PGSC0003DMT200079310	K02873	ko03010	Ribosome	1563	2.3e-80	0.88	0.95	1.00
PGSC0003DMT200079311	K02948	ko03010	Ribosome	795	5.2e-38	0.61	0.77	0.99
PGSC0003DMT200079312	K02948	ko03010	Ribosome	854	2.9e-41	0.50	0.66	0.97
PGSC0003DMT200079319	K02895	ko03010	Ribosome	424	1.5e-17	0.53	0.72	0.61
PGSC0003DMT200079335	K03010	ko00230	Purine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMT200079335	K03010	ko00240	Pyrimidine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMT200079335	K03010	ko01100	Metabolic pathways	7637	0.	0.72	0.83	0.99
PGSC0003DMT200079335	K03010	ko03020	RNA polymerase	7637	0.	0.72	0.83	0.99
PGSC0003DMT200079335	K03010	ko05016	Huntington's disease	7637	0.	0.72	0.83	0.99
PGSC0003DMT200079336	K03010	ko00230	Purine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMT200079336	K03010	ko00240	Pyrimidine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMT200079336	K03010	ko01100	Metabolic pathways	6880	0.	0.79	0.89	1.00
PGSC0003DMT200079336	K03010	ko03020	RNA polymerase	6880	0.	0.79	0.89	1.00
PGSC0003DMT200079336	K03010	ko05016	Huntington's disease	6880	0.	0.79	0.89	1.00
PGSC0003DMT200061863	K12669	ko00510	N-Glycan biosynthesis	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMT200061863	K12669	ko01100	Metabolic pathways	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMT200061874	K02917	ko03010	Ribosome	838	2.2e-40	0.85	0.90	0.99
PGSC0003DMT200062813	K03039	ko03050	Proteasome	2881	4.6e-153	0.89	0.96	1.00
PGSC0003DMT200062814	K00059	ko00061	Fatty acid biosynthesis	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMT200062814	K00059	ko01040	Biosynthesis of unsaturated fatty acids	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMT200062814	K00059	ko01100	Metabolic pathways	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMT200062817	K01581	ko00330	Arginine and proline metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMT200062817	K01581	ko00480	Glutathione metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMT200062817	K01581	ko01100	Metabolic pathways	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMT200062817	K01581	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMT200062829	K00100	ko00051	Fructose and mannose metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062829	K00100	ko00363	Bisphenol A degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062829	K00100	ko00591	Linoleic acid metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062829	K00100	ko00625	Tetrachloroethene degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062829	K00100	ko00650	Butanoate metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062829	K00100	ko01100	Metabolic pathways	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMT200062832	K00117	ko00030	Pentose phosphate pathway	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMT200062832	K00117	ko01100	Metabolic pathways	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMT200062832	K00117	ko01110	Biosynthesis of secondary metabolites	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMT200062841	K10418	ko04962	Vasopressin-regulated water reabsorption	337	9.4e-13	0.52	0.66	0.32
PGSC0003DMT200062842	K12126	ko04712	Circadian rhythm - plant	274	5.1e-09	0.35	0.48	0.61
PGSC0003DMT200062844	K12126	ko04712	Circadian rhythm - plant	302	1.1e-10	0.34	0.52	0.62
PGSC0003DMT200062852	K12843	ko03040	Spliceosome	1429	5.6e-73	0.35	0.56	0.91
PGSC0003DMT200062853	K10643	ko03018	RNA degradation	266	1.3e-08	0.46	0.73	0.15
PGSC0003DMT200055124	K12850	ko03040	Spliceosome	349	2.1e-13	0.24	0.48	0.98
PGSC0003DMT200055146	K10352	ko04530	Tight junction	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMT200055146	K10352	ko05416	Viral myocarditis	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMT200055153	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMT200055155	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMT200090298	K04121	ko00904	Diterpenoid biosynthesis	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMT200090298	K04121	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMT200090298	K04121	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMT200003516	K04371	ko04010	MAPK signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04012	ErbB signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04013	MAPK signaling pathway - fly	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04062	Chemokine signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04114	Oocyte meiosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04150	mTOR signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04270	Vascular smooth muscle contraction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04320	Dorso-ventral axis formation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04350	TGF-beta signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04360	Axon guidance	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04370	VEGF signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04510	Focal adhesion	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04520	Adherens junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04540	Gap junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04620	Toll-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04621	NOD-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04650	Natural killer cell mediated cytotoxicity	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04660	T cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04662	B cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04664	Fc epsilon RI signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04666	Fc gamma R-mediated phagocytosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04720	Long-term potentiation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04722	Neurotrophin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04730	Long-term depression	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04810	Regulation of actin cytoskeleton	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04910	Insulin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04912	GnRH signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04914	Progesterone-mediated oocyte maturation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04916	Melanogenesis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04930	Type II diabetes mellitus	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko04960	Aldosterone-regulated sodium reabsorption	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05010	Alzheimer's disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05020	Prion diseases	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05131	Shigellosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05140	Leishmaniasis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05142	Chagas disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05200	Pathways in cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05210	Colorectal cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05211	Renal cell carcinoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05212	Pancreatic cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05213	Endometrial cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05214	Glioma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05215	Prostate cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05216	Thyroid cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05218	Melanoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05219	Bladder cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05220	Chronic myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05221	Acute myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003516	K04371	ko05223	Non-small cell lung cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMT200003517	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMT200003518	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMT200019717	K01187	ko00052	Galactose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMT200019717	K01187	ko00500	Starch and sucrose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMT200019717	K01187	ko01100	Metabolic pathways	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMT200019718	K01187	ko00052	Galactose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMT200019718	K01187	ko00500	Starch and sucrose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMT200019718	K01187	ko01100	Metabolic pathways	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMT200019724	K02890	ko03010	Ribosome	387	1.6e-15	0.44	0.66	0.47
PGSC0003DMT200019725	K12872	ko03040	Spliceosome	3548	7.4e-190	0.83	0.91	0.99
PGSC0003DMT200019729	K01633	ko00790	Folate biosynthesis	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMT200019729	K01633	ko01100	Metabolic pathways	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMT200019734	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMT200019734	K03860	ko01100	Metabolic pathways	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMT200019735	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMT200019735	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMT200019736	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMT200019736	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMT200019740	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200019740	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200019740	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200019741	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200019741	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200019741	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMT200011910	K05185	ko04080	Neuroactive ligand-receptor interaction	908	3.0e-44	0.30	0.33	0.96
PGSC0003DMT200011911	K05185	ko04080	Neuroactive ligand-receptor interaction	841	1.5e-40	0.31	0.34	0.85
PGSC0003DMT200011918	K01081	ko00230	Purine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMT200011918	K01081	ko00240	Pyrimidine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMT200011918	K01081	ko00760	Nicotinate and nicotinamide metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMT200011918	K01081	ko01100	Metabolic pathways	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMT200011918	K01081	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMT200011930	K05658	ko02010	ABC transporters	6786	0.	0.64	0.80	1.00
PGSC0003DMT200011931	K02881	ko03010	Ribosome	1026	9.4e-51	0.77	0.86	0.98
PGSC0003DMT200011934	K01139	ko00230	Purine metabolism	797	4.0e-38	0.38	0.56	0.80
PGSC0003DMT200011935	K01139	ko00230	Purine metabolism	853	3.3e-41	0.39	0.57	0.65
PGSC0003DMT200011938	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMT200011939	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMT200011942	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011942	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011942	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011942	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011943	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011943	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011943	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200011943	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMT200034605	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMT200034605	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMT200034605	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMT200034606	K07199	ko04910	Insulin signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMT200034606	K07199	ko04920	Adipocytokine signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMT200034606	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMT200034611	K08065	ko04612	Antigen processing and presentation	451	4.9e-19	0.54	0.73	0.79
PGSC0003DMT200034617	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034617	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034618	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMT200034621	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMT200034621	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMT200034622	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMT200034622	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMT200034628	K06678	ko04111	Cell cycle - yeast	3346	1.0e-178	0.63	0.78	1.00
PGSC0003DMT200034637	K03934	ko00190	Oxidative phosphorylation	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMT200034637	K03934	ko01100	Metabolic pathways	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMT200034637	K03934	ko05010	Alzheimer's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMT200034637	K03934	ko05012	Parkinson's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMT200034637	K03934	ko05016	Huntington's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMT200034638	K03934	ko00190	Oxidative phosphorylation	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMT200034638	K03934	ko01100	Metabolic pathways	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMT200034638	K03934	ko05010	Alzheimer's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMT200034638	K03934	ko05012	Parkinson's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMT200034638	K03934	ko05016	Huntington's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMT200034639	K06171	ko04330	Notch signaling pathway	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMT200034639	K06171	ko05010	Alzheimer's disease	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMT200034640	K06171	ko04330	Notch signaling pathway	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMT200034640	K06171	ko05010	Alzheimer's disease	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMT200034641	K06171	ko04330	Notch signaling pathway	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMT200034641	K06171	ko05010	Alzheimer's disease	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMT200048317	K10872	ko04113	Meiosis - yeast	256	9.8e-08	0.30	0.45	0.87
PGSC0003DMT200048318	K10872	ko04113	Meiosis - yeast	252	1.7e-07	0.35	0.56	0.67
PGSC0003DMT200048319	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.86
PGSC0003DMT200048320	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.76
PGSC0003DMT200048324	K05894	ko00592	alpha-Linolenic acid metabolism	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMT200048324	K05894	ko01100	Metabolic pathways	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMT200048325	K05894	ko00592	alpha-Linolenic acid metabolism	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMT200048325	K05894	ko01100	Metabolic pathways	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMT200048327	K05894	ko00592	alpha-Linolenic acid metabolism	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMT200048327	K05894	ko01100	Metabolic pathways	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMT200048328	K05894	ko00592	alpha-Linolenic acid metabolism	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMT200048328	K05894	ko01100	Metabolic pathways	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMT200048331	K05894	ko00592	alpha-Linolenic acid metabolism	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMT200048331	K05894	ko01100	Metabolic pathways	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMT200059923	K12347	ko04142	Lysosome	2945	1.3e-156	0.72	0.86	0.93
PGSC0003DMT200059933	K11294	ko05130	Pathogenic Escherichia coli infection	308	4.0e-08	0.28	0.48	0.30
PGSC0003DMT200059935	K00001	ko00010	Glycolysis / Gluconeogenesis	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00071	Fatty acid metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00350	Tyrosine metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00641	3-Chloroacrylic acid degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00830	Retinol metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko00982	Drug metabolism - cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko01100	Metabolic pathways	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059935	K00001	ko01110	Biosynthesis of secondary metabolites	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMT200059936	K00001	ko00010	Glycolysis / Gluconeogenesis	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00071	Fatty acid metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00350	Tyrosine metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00641	3-Chloroacrylic acid degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00830	Retinol metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko00982	Drug metabolism - cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko01100	Metabolic pathways	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059936	K00001	ko01110	Biosynthesis of secondary metabolites	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMT200059942	K01082	ko00920	Sulfur metabolism	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMT200059942	K01082	ko01100	Metabolic pathways	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMT200059943	K01082	ko00920	Sulfur metabolism	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMT200059943	K01082	ko01100	Metabolic pathways	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMT200059944	K12843	ko03040	Spliceosome	1417	2.5e-72	0.39	0.60	0.81
PGSC0003DMT200059949	K00901	ko00561	Glycerolipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMT200059949	K00901	ko00564	Glycerophospholipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMT200059949	K00901	ko01100	Metabolic pathways	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMT200059949	K00901	ko04070	Phosphatidylinositol signaling system	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMT200069410	K02900	ko03010	Ribosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200069411	K00276	ko00260	Glycine, serine and threonine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko00350	Tyrosine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko00360	Phenylalanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko00410	beta-Alanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko00950	Isoquinoline alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko01100	Metabolic pathways	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069411	K00276	ko01110	Biosynthesis of secondary metabolites	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMT200069418	K06067	ko04110	Cell cycle	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMT200069418	K06067	ko04330	Notch signaling pathway	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMT200069418	K06067	ko05016	Huntington's disease	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMT200069418	K06067	ko05200	Pathways in cancer	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMT200069418	K06067	ko05220	Chronic myeloid leukemia	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMT200069419	K06067	ko04110	Cell cycle	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMT200069419	K06067	ko04330	Notch signaling pathway	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMT200069419	K06067	ko05016	Huntington's disease	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMT200069419	K06067	ko05200	Pathways in cancer	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMT200069419	K06067	ko05220	Chronic myeloid leukemia	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMT200069426	K12393	ko04142	Lysosome	1001	2.2e-49	0.89	0.95	0.98
PGSC0003DMT200069435	K12854	ko03040	Spliceosome	1505	8.2e-77	0.54	0.69	1.00
PGSC0003DMT200069443	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMT200069443	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMT200069443	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMT200069444	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMT200069444	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMT200069444	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMT200069445	K03143	ko03022	Basal transcription factors	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMT200069445	K03143	ko03420	Nucleotide excision repair	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMT200069446	K03143	ko03022	Basal transcription factors	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMT200069446	K03143	ko03420	Nucleotide excision repair	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMT200069449	K04424	ko04010	MAPK signaling pathway	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMT200069449	K04424	ko04530	Tight junction	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMT200069454	K05278	ko00941	Flavonoid biosynthesis	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMT200069454	K05278	ko01100	Metabolic pathways	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMT200069454	K05278	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMT200069463	K02604	ko04110	Cell cycle	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMT200069463	K02604	ko04111	Cell cycle - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMT200069463	K02604	ko04113	Meiosis - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMT200069464	K02604	ko04110	Cell cycle	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMT200069464	K02604	ko04111	Cell cycle - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMT200069464	K02604	ko04113	Meiosis - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMT200052432	K12343	ko00140	Steroid hormone biosynthesis	1649	4.1e-85	0.71	0.83	0.99
PGSC0003DMT200052439	K00368	ko00910	Nitrogen metabolism	1577	3.8e-81	0.41	0.56	0.95
PGSC0003DMT200052440	K00368	ko00910	Nitrogen metabolism	1640	1.3e-84	0.43	0.57	0.89
PGSC0003DMT200052443	K08769	ko03320	PPAR signaling pathway	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMT200052443	K08769	ko05016	Huntington's disease	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMT200052444	K08769	ko03320	PPAR signaling pathway	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMT200052444	K08769	ko05016	Huntington's disease	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMT200052461	K00847	ko00051	Fructose and mannose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMT200052461	K00847	ko00500	Starch and sucrose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMT200052461	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMT200052461	K00847	ko01100	Metabolic pathways	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMT200052463	K03841	ko00010	Glycolysis / Gluconeogenesis	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko00030	Pentose phosphate pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko00051	Fructose and mannose metabolism	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko00710	Carbon fixation in photosynthetic organisms	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko01100	Metabolic pathways	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko01110	Biosynthesis of secondary metabolites	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200052463	K03841	ko04910	Insulin signaling pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMT200091754	K12837	ko03040	Spliceosome	362	1.9e-13	0.25	0.53	0.99
PGSC0003DMT200091759	K10592	ko04120	Ubiquitin mediated proteolysis	397	1.1e-14	0.28	0.46	0.95
PGSC0003DMT200091761	K03469	ko03030	DNA replication	270	1.7e-08	0.35	0.59	0.65
PGSC0003DMT200091775	K00368	ko00910	Nitrogen metabolism	1684	4.8e-87	0.44	0.57	0.91
PGSC0003DMT200013106	K00026	ko00020	Citrate cycle (TCA cycle)	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013106	K00026	ko00620	Pyruvate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013106	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013106	K00026	ko00710	Carbon fixation in photosynthetic organisms	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013106	K00026	ko01100	Metabolic pathways	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013106	K00026	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMT200013119	K12489	ko04144	Endocytosis	772	9.6e-37	0.55	0.69	0.90
PGSC0003DMT200013143	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMT200013144	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMT200013145	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMT200013146	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2036	1.8e-106	0.84	0.91	0.97
PGSC0003DMT200013147	K01876	ko00970	Aminoacyl-tRNA biosynthesis	3232	2.0e-172	0.76	0.85	0.99
PGSC0003DMT200013148	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2785	9.0e-148	0.86	0.93	0.99
PGSC0003DMT200013154	K01199	ko00500	Starch and sucrose metabolism	834	3.6e-40	0.38	0.55	0.76
PGSC0003DMT200023020	K03850	ko00510	N-Glycan biosynthesis	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMT200023020	K03850	ko01100	Metabolic pathways	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMT200023021	K03850	ko00510	N-Glycan biosynthesis	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMT200023021	K03850	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMT200023023	K03850	ko00510	N-Glycan biosynthesis	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMT200023023	K03850	ko01100	Metabolic pathways	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMT200023024	K03850	ko00510	N-Glycan biosynthesis	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMT200023024	K03850	ko01100	Metabolic pathways	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMT200023025	K03850	ko00510	N-Glycan biosynthesis	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMT200023025	K03850	ko01100	Metabolic pathways	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMT200023030	K06053	ko04330	Notch signaling pathway	233	2.6e-06	0.31	0.43	0.65
PGSC0003DMT200023034	K09392	ko04110	Cell cycle	600	2.9e-27	0.42	0.61	0.72
PGSC0003DMT200023035	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMT200023035	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMT200039064	K00430	ko00360	Phenylalanine metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMT200039064	K00430	ko00680	Methane metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMT200039064	K00430	ko00940	Phenylpropanoid biosynthesis	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMT200039064	K00430	ko01100	Metabolic pathways	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMT200039064	K00430	ko01110	Biosynthesis of secondary metabolites	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMT200039065	K00430	ko00360	Phenylalanine metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMT200039065	K00430	ko00680	Methane metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMT200039065	K00430	ko00940	Phenylpropanoid biosynthesis	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMT200039065	K00430	ko01100	Metabolic pathways	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMT200039065	K00430	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMT200039066	K00430	ko00360	Phenylalanine metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMT200039066	K00430	ko00680	Methane metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMT200039066	K00430	ko00940	Phenylpropanoid biosynthesis	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMT200039066	K00430	ko01100	Metabolic pathways	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMT200039066	K00430	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMT200039067	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMT200039067	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMT200039067	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMT200039067	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMT200039067	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMT200039073	K05745	ko04810	Regulation of actin cytoskeleton	334	1.1e-11	0.40	0.55	0.54
PGSC0003DMT200039084	K09561	ko04120	Ubiquitin mediated proteolysis	224	2.7e-06	0.36	0.56	0.22
PGSC0003DMT200005972	K05933	ko00270	Cysteine and methionine metabolism	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMT200005972	K05933	ko01110	Biosynthesis of secondary metabolites	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMT200005988	K01053	ko00030	Pentose phosphate pathway	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMT200005988	K01053	ko00053	Ascorbate and aldarate metabolism	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMT200005988	K01053	ko00930	Caprolactam degradation	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMT200005988	K01053	ko01100	Metabolic pathways	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMT200005988	K01053	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMT200005989	K01053	ko00030	Pentose phosphate pathway	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMT200005989	K01053	ko00053	Ascorbate and aldarate metabolism	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMT200005989	K01053	ko00930	Caprolactam degradation	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMT200005989	K01053	ko01100	Metabolic pathways	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMT200005989	K01053	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMT200005990	K01053	ko00030	Pentose phosphate pathway	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMT200005990	K01053	ko00053	Ascorbate and aldarate metabolism	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMT200005990	K01053	ko00930	Caprolactam degradation	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMT200005990	K01053	ko01100	Metabolic pathways	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMT200005990	K01053	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMT200005999	K13229	ko00402	Benzoxazinoid biosynthesis	480	1.2e-20	0.41	0.58	0.81
PGSC0003DMT200006008	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006008	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006008	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006008	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006008	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006008	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMT200006009	K00100	ko00051	Fructose and mannose metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006009	K00100	ko00363	Bisphenol A degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006009	K00100	ko00591	Linoleic acid metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006009	K00100	ko00625	Tetrachloroethene degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006009	K00100	ko00650	Butanoate metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006009	K00100	ko01100	Metabolic pathways	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMT200006010	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006010	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006010	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006010	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006010	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006010	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMT200006013	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMT200067648	K12456	ko04110	Cell cycle	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMT200067648	K12456	ko04114	Oocyte meiosis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMT200067648	K12456	ko04120	Ubiquitin mediated proteolysis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMT200067648	K12456	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMT200067650	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMT200067650	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMT200067651	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMT200067651	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMT200067652	K00648	ko00061	Fatty acid biosynthesis	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMT200067652	K00648	ko01100	Metabolic pathways	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMT200067656	K12128	ko04712	Circadian rhythm - plant	219	6.0e-06	0.52	0.67	0.57
PGSC0003DMT200067657	K12135	ko04712	Circadian rhythm - plant	598	3.8e-27	0.38	0.62	0.54
PGSC0003DMT200067677	K12896	ko03040	Spliceosome	1435	2.6e-73	0.89	0.95	0.99
PGSC0003DMT200067678	K00301	ko00260	Glycine, serine and threonine metabolism	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMT200067678	K00301	ko01100	Metabolic pathways	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMT200058085	K08492	ko04130	SNARE interactions in vesicular transport	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMT200058085	K08492	ko04145	Phagosome	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMT200058086	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMT200058086	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMT200058087	K08492	ko04130	SNARE interactions in vesicular transport	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMT200058087	K08492	ko04145	Phagosome	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMT200058094	K12897	ko03040	Spliceosome	301	9.1e-11	0.50	0.54	0.81
PGSC0003DMT200058107	K06689	ko04120	Ubiquitin mediated proteolysis	1176	5.0e-59	0.88	0.97	0.99
PGSC0003DMT200058114	K03029	ko03050	Proteasome	1884	4.5e-98	0.65	0.79	0.86
PGSC0003DMT200058115	K03029	ko03050	Proteasome	2069	2.8e-108	0.65	0.79	0.99
PGSC0003DMT200058116	K03029	ko03050	Proteasome	2020	1.4e-105	0.62	0.75	1.00
PGSC0003DMT200058121	K10772	ko03410	Base excision repair	2944	1.5e-156	0.59	0.70	0.99
PGSC0003DMT200084873	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMT200084873	K01657	ko01100	Metabolic pathways	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMT200084873	K01657	ko01110	Biosynthesis of secondary metabolites	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMT200050566	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMT200050566	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMT200050568	K03135	ko03022	Basal transcription factors	573	9.1e-26	0.54	0.70	0.98
PGSC0003DMT200050569	K03135	ko03022	Basal transcription factors	1070	3.5e-53	0.62	0.77	1.00
PGSC0003DMT200050577	K01246	ko03410	Base excision repair	576	6.2e-26	0.43	0.46	0.78
PGSC0003DMT200050578	K01246	ko03410	Base excision repair	689	3.6e-32	0.80	0.92	0.98
PGSC0003DMT200050580	K12356	ko00940	Phenylpropanoid biosynthesis	692	2.5e-32	0.33	0.50	0.97
PGSC0003DMT200050584	K12126	ko04712	Circadian rhythm - plant	277	3.4e-09	0.37	0.52	0.54
PGSC0003DMT200050585	K12126	ko04712	Circadian rhythm - plant	311	3.8e-09	0.28	0.45	0.72
PGSC0003DMT200050586	K12126	ko04712	Circadian rhythm - plant	307	6.7e-09	0.27	0.44	0.70
PGSC0003DMT200050589	K05683	ko02010	ABC transporters	825	1.1e-39	0.29	0.50	0.84
PGSC0003DMT200050591	K06685	ko04111	Cell cycle - yeast	440	8.5e-15	0.27	0.40	0.85
PGSC0003DMT200024693	K04733	ko04210	Apoptosis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMT200024693	K04733	ko04620	Toll-like receptor signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMT200024693	K04733	ko04722	Neurotrophin signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMT200024693	K04733	ko05140	Leishmaniasis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMT200024693	K04733	ko05142	Chagas disease	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMT200014861	K02701	ko00195	Photosynthesis	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMT200014861	K02701	ko01100	Metabolic pathways	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMT200014862	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMT200014862	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMT200014862	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMT200014862	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMT200014863	K01840	ko00051	Fructose and mannose metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMT200014863	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMT200014863	K01840	ko01100	Metabolic pathways	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMT200014863	K01840	ko01110	Biosynthesis of secondary metabolites	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMT200014864	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014864	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014864	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014864	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014865	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014865	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014865	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014865	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMT200014873	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMT200014873	K08680	ko01100	Metabolic pathways	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMT200014873	K08680	ko01110	Biosynthesis of secondary metabolites	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMT200014889	K01838	ko00500	Starch and sucrose metabolism	509	3.1e-22	0.45	0.64	0.95
PGSC0003DMT200014890	K01838	ko00500	Starch and sucrose metabolism	307	4.3e-11	0.47	0.59	0.94
PGSC0003DMT200014891	K01838	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.43	0.64	0.67
PGSC0003DMT200014892	K01838	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.43	0.62	0.77
PGSC0003DMT200014893	K12356	ko00940	Phenylpropanoid biosynthesis	716	1.2e-33	0.32	0.51	0.90
PGSC0003DMT200014902	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014902	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014902	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014906	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014906	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014906	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMT200014907	K09587	ko00905	Brassinosteroid biosynthesis	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMT200014907	K09587	ko01100	Metabolic pathways	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMT200014907	K09587	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMT200014918	K12235	ko00260	Glycine, serine and threonine metabolism	2022	1.1e-105	0.72	0.85	0.99
PGSC0003DMT200014919	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMT200007707	K06685	ko04111	Cell cycle - yeast	464	3.9e-16	0.25	0.41	0.86
PGSC0003DMT200007732	K01757	ko00901	Indole alkaloid biosynthesis	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMT200007732	K01757	ko01100	Metabolic pathways	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMT200007732	K01757	ko01110	Biosynthesis of secondary metabolites	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMT200096714	K10760	ko00908	Zeatin biosynthesis	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMT200096714	K10760	ko01100	Metabolic pathways	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMT200096714	K10760	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMT200092966	K00993	ko00440	Phosphonate and phosphinate metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMT200092966	K00993	ko00564	Glycerophospholipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMT200092966	K00993	ko00565	Ether lipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMT200092966	K00993	ko01100	Metabolic pathways	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMT200092970	K01051	ko00040	Pentose and glucuronate interconversions	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMT200092970	K01051	ko00500	Starch and sucrose metabolism	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMT200092970	K01051	ko01100	Metabolic pathways	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMT200056960	K05692	ko04145	Phagosome	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04510	Focal adhesion	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04520	Adherens junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04530	Tight junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04670	Leukocyte transendothelial migration	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04745	Phototransduction - fly	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko04810	Regulation of actin cytoskeleton	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05100	Bacterial invasion of epithelial cells	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05110	Vibrio cholerae infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05130	Pathogenic Escherichia coli infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05131	Shigellosis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05414	Dilated cardiomyopathy	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056960	K05692	ko05416	Viral myocarditis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMT200056966	K12880	ko03040	Spliceosome	2486	2.8e-131	0.90	0.96	1.00
PGSC0003DMT200056967	K12880	ko03040	Spliceosome	1245	7.8e-63	0.93	0.97	0.91
PGSC0003DMT200056970	K06699	ko03050	Proteasome	5875	0.	0.74	0.86	1.00
PGSC0003DMT200056971	K06699	ko03050	Proteasome	5243	2.4e-283	0.74	0.86	1.00
PGSC0003DMT200056974	K06699	ko03050	Proteasome	8480	0.	0.74	0.86	1.00
PGSC0003DMT200056979	K06699	ko03050	Proteasome	5997	0.	0.75	0.86	0.99
PGSC0003DMT200056983	K06699	ko03050	Proteasome	346	4.4e-12	0.49	0.67	0.81
PGSC0003DMT200064482	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMT200064482	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMT200064482	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMT200064483	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMT200064483	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMT200064483	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMT200064485	K01099	ko00562	Inositol phosphate metabolism	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMT200064485	K01099	ko01100	Metabolic pathways	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMT200064485	K01099	ko04070	Phosphatidylinositol signaling system	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMT200064490	K01528	ko04144	Endocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMT200064490	K01528	ko04666	Fc gamma R-mediated phagocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMT200064490	K01528	ko05100	Bacterial invasion of epithelial cells	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMT200064492	K01834	ko00010	Glycolysis / Gluconeogenesis	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMT200064492	K01834	ko01100	Metabolic pathways	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMT200064492	K01834	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMT200064495	K01834	ko00010	Glycolysis / Gluconeogenesis	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMT200064495	K01834	ko01100	Metabolic pathways	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMT200064495	K01834	ko01110	Biosynthesis of secondary metabolites	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMT200064504	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1519	6.0e-78	0.66	0.75	0.98
PGSC0003DMT200064505	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	886	4.9e-43	0.70	0.81	0.99
PGSC0003DMT200064506	K12124	ko04712	Circadian rhythm - plant	7647	0.	0.79	0.86	1.00
PGSC0003DMT200064507	K12124	ko04712	Circadian rhythm - plant	6348	0.	0.79	0.87	0.99
PGSC0003DMT200064512	K09841	ko00906	Carotenoid biosynthesis	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMT200064512	K09841	ko01100	Metabolic pathways	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMT200064512	K09841	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMT200064513	K09841	ko00906	Carotenoid biosynthesis	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMT200064513	K09841	ko01100	Metabolic pathways	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMT200064513	K09841	ko01110	Biosynthesis of secondary metabolites	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMT200064514	K09841	ko00906	Carotenoid biosynthesis	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMT200064514	K09841	ko01100	Metabolic pathways	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMT200064514	K09841	ko01110	Biosynthesis of secondary metabolites	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMT200078965	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMT200078965	K03183	ko01100	Metabolic pathways	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMT200078965	K03183	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMT200078966	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMT200078966	K03183	ko01100	Metabolic pathways	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMT200078966	K03183	ko01110	Biosynthesis of secondary metabolites	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMT200078967	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMT200078967	K03183	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMT200078967	K03183	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMT200078968	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMT200078968	K03183	ko01100	Metabolic pathways	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMT200078968	K03183	ko01110	Biosynthesis of secondary metabolites	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMT200078969	K00485	ko00982	Drug metabolism - cytochrome P450	443	1.3e-18	0.34	0.49	0.75
PGSC0003DMT200078978	K12852	ko03040	Spliceosome	7668	0.	0.90	0.96	1.00
PGSC0003DMT200010162	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010162	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010162	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010163	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010163	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010163	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010164	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010164	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010164	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMT200010171	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMT200010172	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMT200010183	K12622	ko03018	RNA degradation	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMT200010183	K12622	ko03040	Spliceosome	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMT200017857	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMT200017858	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMT200017861	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMT200017861	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMT200017862	K01728	ko00040	Pentose and glucuronate interconversions	1615	3.1e-83	0.53	0.69	0.92
PGSC0003DMT200017863	K01728	ko00040	Pentose and glucuronate interconversions	1819	1.7e-94	0.58	0.70	0.86
PGSC0003DMT200017879	K01184	ko00040	Pentose and glucuronate interconversions	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMT200017879	K01184	ko00500	Starch and sucrose metabolism	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMT200017879	K01184	ko01100	Metabolic pathways	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMT200094311	K11251	ko05322	Systemic lupus erythematosus	471	3.8e-20	0.66	0.82	0.77
PGSC0003DMT200037271	K12741	ko03040	Spliceosome	1355	6.7e-69	0.44	0.56	0.98
PGSC0003DMT200037272	K12741	ko03040	Spliceosome	874	2.3e-42	0.39	0.52	0.93
PGSC0003DMT200037273	K02995	ko03010	Ribosome	1624	9.8e-84	0.87	0.93	0.99
PGSC0003DMT200037284	K12606	ko03018	RNA degradation	258	2.1e-08	0.60	0.68	0.80
PGSC0003DMT200037285	K08908	ko00196	Photosynthesis - antenna proteins	1319	6.5e-67	0.95	0.98	0.99
PGSC0003DMT200037303	K01696	ko00260	Glycine, serine and threonine metabolism	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMT200037303	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMT200037303	K01696	ko01100	Metabolic pathways	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMT200037303	K01696	ko01110	Biosynthesis of secondary metabolites	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMT200027962	K05658	ko02010	ABC transporters	3916	3.7e-210	0.44	0.64	0.99
PGSC0003DMT200027987	K03841	ko00010	Glycolysis / Gluconeogenesis	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko00030	Pentose phosphate pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko00051	Fructose and mannose metabolism	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko00710	Carbon fixation in photosynthetic organisms	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko01100	Metabolic pathways	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027987	K03841	ko04910	Insulin signaling pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMT200027988	K03841	ko00010	Glycolysis / Gluconeogenesis	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko00030	Pentose phosphate pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko00051	Fructose and mannose metabolism	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko00710	Carbon fixation in photosynthetic organisms	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko01100	Metabolic pathways	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027988	K03841	ko04910	Insulin signaling pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMT200027994	K03364	ko04110	Cell cycle	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMT200027994	K03364	ko04111	Cell cycle - yeast	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMT200027994	K03364	ko04120	Ubiquitin mediated proteolysis	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMT200027994	K03364	ko04914	Progesterone-mediated oocyte maturation	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMT200028003	K03801	ko00785	Lipoic acid metabolism	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMT200028003	K03801	ko01100	Metabolic pathways	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMT200079823	K00975	ko00500	Starch and sucrose metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMT200079823	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMT200079823	K00975	ko01100	Metabolic pathways	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMT200061653	K05712	ko00360	Phenylalanine metabolism	289	5.5e-10	0.33	0.46	0.74
PGSC0003DMT200061660	K05712	ko00360	Phenylalanine metabolism	254	6.5e-08	0.31	0.45	0.74
PGSC0003DMT200061662	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.87
PGSC0003DMT200061663	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.88
PGSC0003DMT200061679	K00104	ko00630	Glyoxylate and dicarboxylate metabolism	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMT200061679	K00104	ko01100	Metabolic pathways	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMT200061699	K04077	ko03018	RNA degradation	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMT200061699	K04077	ko04940	Type I diabetes mellitus	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMT200046569	K10712	ko00430	Taurine and hypotaurine metabolism	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMT200046569	K10712	ko01100	Metabolic pathways	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMT200046571	K10573	ko04120	Ubiquitin mediated proteolysis	1318	7.4e-67	0.97	0.99	0.99
PGSC0003DMT200046572	K05645	ko02010	ABC transporters	986	1.4e-47	0.38	0.57	0.96
PGSC0003DMT200046578	K05645	ko02010	ABC transporters	980	3.1e-47	0.38	0.58	0.96
PGSC0003DMT200046584	K01785	ko00010	Glycolysis / Gluconeogenesis	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMT200046584	K01785	ko01110	Biosynthesis of secondary metabolites	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMT200046603	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMT200001760	K01895	ko00010	Glycolysis / Gluconeogenesis	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001760	K01895	ko00620	Pyruvate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001760	K01895	ko00640	Propanoate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001760	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001760	K01895	ko01100	Metabolic pathways	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001760	K01895	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMT200001761	K01895	ko00010	Glycolysis / Gluconeogenesis	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001761	K01895	ko00620	Pyruvate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001761	K01895	ko00640	Propanoate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001761	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001761	K01895	ko01100	Metabolic pathways	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001761	K01895	ko01110	Biosynthesis of secondary metabolites	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMT200001762	K01895	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001762	K01895	ko00620	Pyruvate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001762	K01895	ko00640	Propanoate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001762	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001762	K01895	ko01100	Metabolic pathways	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001762	K01895	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMT200001770	K04459	ko04010	MAPK signaling pathway	1564	2.0e-80	0.73	0.86	0.94
PGSC0003DMT200001771	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMT200001772	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMT200001779	K00799	ko00480	Glutathione metabolism	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMT200001779	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMT200001779	K00799	ko00982	Drug metabolism - cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMT200001780	K00799	ko00480	Glutathione metabolism	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMT200001780	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMT200001780	K00799	ko00982	Drug metabolism - cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMT200001781	K01179	ko00500	Starch and sucrose metabolism	1757	4.5e-91	0.48	0.63	0.96
PGSC0003DMT200001785	K00895	ko00051	Fructose and mannose metabolism	3818	9.5e-205	0.81	0.89	1.00
PGSC0003DMT200041400	K05280	ko00941	Flavonoid biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMT200041400	K05280	ko00944	Flavone and flavonol biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMT200041400	K05280	ko01100	Metabolic pathways	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMT200041400	K05280	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMT200041403	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMT200041403	K00517	ko00626	Naphthalene and anthracene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMT200041403	K00517	ko00903	Limonene and pinene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMT200041403	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMT200041403	K00517	ko01110	Biosynthesis of secondary metabolites	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMT200041422	K12356	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.45	0.95
PGSC0003DMT200025411	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMT200025411	K00517	ko00626	Naphthalene and anthracene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMT200025411	K00517	ko00903	Limonene and pinene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMT200025411	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMT200025411	K00517	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMT200025412	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMT200025412	K00517	ko00626	Naphthalene and anthracene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMT200025412	K00517	ko00903	Limonene and pinene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMT200025412	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMT200025412	K00517	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMT200025414	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMT200025414	K00517	ko00626	Naphthalene and anthracene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMT200025414	K00517	ko00903	Limonene and pinene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMT200025414	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMT200025414	K00517	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMT200025418	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMT200025418	K00517	ko00626	Naphthalene and anthracene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMT200025418	K00517	ko00903	Limonene and pinene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMT200025418	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMT200025418	K00517	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMT200025446	K09755	ko00940	Phenylpropanoid biosynthesis	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMT200025446	K09755	ko01100	Metabolic pathways	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMT200025446	K09755	ko01110	Biosynthesis of secondary metabolites	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMT200025448	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMT200025448	K00517	ko00626	Naphthalene and anthracene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMT200025448	K00517	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMT200025448	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMT200025448	K00517	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMT200025452	K09755	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMT200025452	K09755	ko01100	Metabolic pathways	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMT200025452	K09755	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMT200025454	K02997	ko03010	Ribosome	1593	5.0e-82	0.94	0.99	0.99
PGSC0003DMT200006999	K08232	ko00053	Ascorbate and aldarate metabolism	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMT200006999	K08232	ko01100	Metabolic pathways	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMT200007000	K08232	ko00053	Ascorbate and aldarate metabolism	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMT200007000	K08232	ko01100	Metabolic pathways	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMT200007009	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMT200032824	K04424	ko04010	MAPK signaling pathway	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMT200032824	K04424	ko04530	Tight junction	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMT200021559	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMT200021559	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMT200021560	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMT200021560	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMT200021561	K03842	ko00510	N-Glycan biosynthesis	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMT200021561	K03842	ko01100	Metabolic pathways	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMT200021570	K00059	ko00061	Fatty acid biosynthesis	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMT200021570	K00059	ko01040	Biosynthesis of unsaturated fatty acids	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMT200021570	K00059	ko01100	Metabolic pathways	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMT200021571	K00059	ko00061	Fatty acid biosynthesis	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMT200021571	K00059	ko01040	Biosynthesis of unsaturated fatty acids	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMT200021571	K00059	ko01100	Metabolic pathways	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMT200021572	K00059	ko00061	Fatty acid biosynthesis	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMT200021572	K00059	ko01040	Biosynthesis of unsaturated fatty acids	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMT200021572	K00059	ko01100	Metabolic pathways	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMT200021573	K02896	ko03010	Ribosome	312	2.3e-11	0.78	0.88	0.59
PGSC0003DMT200021574	K02896	ko03010	Ribosome	361	4.5e-14	0.82	0.89	0.98
PGSC0003DMT200021575	K02896	ko03010	Ribosome	1239	1.7e-62	0.90	0.93	0.80
PGSC0003DMT200021577	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMT200021578	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMT200021584	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.34	0.55	0.72
PGSC0003DMT200021585	K01199	ko00500	Starch and sucrose metabolism	618	3.0e-28	0.34	0.55	0.92
PGSC0003DMT200021586	K00889	ko00562	Inositol phosphate metabolism	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021586	K00889	ko01100	Metabolic pathways	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021586	K00889	ko04070	Phosphatidylinositol signaling system	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021586	K00889	ko04144	Endocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021586	K00889	ko04666	Fc gamma R-mediated phagocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021586	K00889	ko04810	Regulation of actin cytoskeleton	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMT200021589	K12625	ko03018	RNA degradation	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMT200021589	K12625	ko03040	Spliceosome	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMT200021592	K04683	ko04110	Cell cycle	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMT200021592	K04683	ko04350	TGF-beta signaling pathway	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMT200021593	K04683	ko04110	Cell cycle	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMT200021593	K04683	ko04350	TGF-beta signaling pathway	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMT200021594	K13034	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMT200021594	K13034	ko00450	Selenoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMT200021594	K13034	ko00460	Cyanoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMT200021594	K13034	ko00920	Sulfur metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMT200021594	K13034	ko01100	Metabolic pathways	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMT200068271	K00791	ko00908	Zeatin biosynthesis	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMT200068271	K00791	ko01100	Metabolic pathways	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMT200068271	K00791	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMT200068272	K00791	ko00908	Zeatin biosynthesis	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMT200068272	K00791	ko01100	Metabolic pathways	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMT200068272	K00791	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMT200068273	K00791	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMT200068273	K00791	ko01100	Metabolic pathways	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMT200068273	K00791	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMT200068274	K00791	ko00908	Zeatin biosynthesis	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMT200068274	K00791	ko01100	Metabolic pathways	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMT200068274	K00791	ko01110	Biosynthesis of secondary metabolites	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMT200068281	K12873	ko03040	Spliceosome	1148	1.8e-57	0.86	0.92	0.99
PGSC0003DMT200087588	K12796	ko04621	NOD-like receptor signaling pathway	326	9.8e-09	0.32	0.49	0.32
PGSC0003DMT200087595	K10760	ko00908	Zeatin biosynthesis	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMT200087595	K10760	ko01100	Metabolic pathways	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMT200087595	K10760	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMT200049820	K01968	ko00280	Valine, leucine and isoleucine degradation	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMT200049820	K01968	ko01100	Metabolic pathways	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMT200049821	K01968	ko00280	Valine, leucine and isoleucine degradation	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMT200049821	K01968	ko01100	Metabolic pathways	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMT200049836	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMT200049840	K12817	ko03040	Spliceosome	2608	5.2e-138	0.77	0.87	1.00
PGSC0003DMT200049859	K02291	ko00906	Carotenoid biosynthesis	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMT200049859	K02291	ko01100	Metabolic pathways	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMT200049859	K02291	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMT200075490	K01184	ko00040	Pentose and glucuronate interconversions	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMT200075490	K01184	ko00500	Starch and sucrose metabolism	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMT200075490	K01184	ko01100	Metabolic pathways	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMT200075491	K01184	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMT200075491	K01184	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMT200075491	K01184	ko01100	Metabolic pathways	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMT200075492	K01184	ko00040	Pentose and glucuronate interconversions	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMT200075492	K01184	ko00500	Starch and sucrose metabolism	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMT200075492	K01184	ko01100	Metabolic pathways	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMT200075496	K01099	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMT200075496	K01099	ko01100	Metabolic pathways	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMT200075496	K01099	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMT200075497	K01099	ko00562	Inositol phosphate metabolism	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMT200075497	K01099	ko01100	Metabolic pathways	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMT200075497	K01099	ko04070	Phosphatidylinositol signaling system	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMT200075500	K12195	ko04144	Endocytosis	1518	6.8e-78	0.82	0.91	1.00
PGSC0003DMT200075501	K01239	ko00230	Purine metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMT200075501	K01239	ko00760	Nicotinate and nicotinamide metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMT200075501	K01239	ko01100	Metabolic pathways	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMT200075503	K01239	ko00230	Purine metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMT200075503	K01239	ko00760	Nicotinate and nicotinamide metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMT200075503	K01239	ko01100	Metabolic pathways	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMT200075504	K01239	ko00230	Purine metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMT200075504	K01239	ko00760	Nicotinate and nicotinamide metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMT200075504	K01239	ko01100	Metabolic pathways	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMT200075515	K01516	ko00230	Purine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMT200075515	K01516	ko00730	Thiamine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMT200075515	K01516	ko01100	Metabolic pathways	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMT200075516	K01516	ko00230	Purine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMT200075516	K01516	ko00730	Thiamine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMT200075516	K01516	ko01100	Metabolic pathways	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMT200075519	K12135	ko04712	Circadian rhythm - plant	588	1.3e-26	0.35	0.55	0.95
PGSC0003DMT200075520	K12135	ko04712	Circadian rhythm - plant	584	2.2e-26	0.40	0.60	0.54
PGSC0003DMT200075526	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMT200075526	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMT200075526	K00734	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMT200043117	K00695	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMT200043117	K00695	ko01100	Metabolic pathways	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMT200043118	K00695	ko00500	Starch and sucrose metabolism	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMT200043118	K00695	ko01100	Metabolic pathways	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMT200043119	K02876	ko03010	Ribosome	592	8.1e-27	0.41	0.55	0.78
PGSC0003DMT200043126	K09658	ko00510	N-Glycan biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMT200043126	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMT200043126	K09658	ko01100	Metabolic pathways	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMT200043152	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMT200043152	K08081	ko01100	Metabolic pathways	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMT200043152	K08081	ko01110	Biosynthesis of secondary metabolites	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMT200043154	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMT200043154	K08081	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMT200043154	K08081	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMT200043158	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMT200043158	K08081	ko01100	Metabolic pathways	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMT200043158	K08081	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMT200023630	K00889	ko00562	Inositol phosphate metabolism	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023630	K00889	ko01100	Metabolic pathways	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023630	K00889	ko04070	Phosphatidylinositol signaling system	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023630	K00889	ko04144	Endocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023630	K00889	ko04666	Fc gamma R-mediated phagocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023630	K00889	ko04810	Regulation of actin cytoskeleton	9580	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko00562	Inositol phosphate metabolism	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko01100	Metabolic pathways	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko04070	Phosphatidylinositol signaling system	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko04144	Endocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko04666	Fc gamma R-mediated phagocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023631	K00889	ko04810	Regulation of actin cytoskeleton	9591	0.	0.65	0.76	1.00
PGSC0003DMT200023634	K00889	ko00562	Inositol phosphate metabolism	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023634	K00889	ko01100	Metabolic pathways	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023634	K00889	ko04070	Phosphatidylinositol signaling system	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023634	K00889	ko04144	Endocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023634	K00889	ko04666	Fc gamma R-mediated phagocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023634	K00889	ko04810	Regulation of actin cytoskeleton	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMT200023642	K04554	ko04120	Ubiquitin mediated proteolysis	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMT200023642	K04554	ko05012	Parkinson's disease	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMT200023643	K04554	ko04120	Ubiquitin mediated proteolysis	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMT200023643	K04554	ko05012	Parkinson's disease	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMT200023644	K04554	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMT200023644	K04554	ko05012	Parkinson's disease	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMT200023645	K04554	ko04120	Ubiquitin mediated proteolysis	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMT200023645	K04554	ko05012	Parkinson's disease	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMT200023656	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.98	1.00
PGSC0003DMT200023659	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.64
PGSC0003DMT200023665	K02293	ko00906	Carotenoid biosynthesis	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMT200023665	K02293	ko01100	Metabolic pathways	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMT200023665	K02293	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMT200023666	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200023666	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200023666	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200031142	K02084	ko04115	p53 signaling pathway	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko04210	Apoptosis	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko05010	Alzheimer's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko05012	Parkinson's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko05016	Huntington's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031142	K02084	ko05222	Small cell lung cancer	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMT200031146	K00475	ko00941	Flavonoid biosynthesis	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMT200031146	K00475	ko01100	Metabolic pathways	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMT200031146	K00475	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMT200031147	K05277	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMT200031147	K05277	ko01100	Metabolic pathways	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMT200031147	K05277	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMT200031148	K05278	ko00941	Flavonoid biosynthesis	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMT200031148	K05278	ko01100	Metabolic pathways	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMT200031148	K05278	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMT200031149	K05278	ko00941	Flavonoid biosynthesis	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMT200031149	K05278	ko01100	Metabolic pathways	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMT200031149	K05278	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMT200031167	K12356	ko00940	Phenylpropanoid biosynthesis	721	6.2e-34	0.34	0.51	0.83
PGSC0003DMT200031172	K05857	ko00562	Inositol phosphate metabolism	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMT200031172	K05857	ko01100	Metabolic pathways	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMT200031172	K05857	ko04020	Calcium signaling pathway	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMT200031172	K05857	ko04070	Phosphatidylinositol signaling system	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMT200031173	K05857	ko00562	Inositol phosphate metabolism	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMT200031173	K05857	ko01100	Metabolic pathways	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMT200031173	K05857	ko04020	Calcium signaling pathway	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMT200031173	K05857	ko04070	Phosphatidylinositol signaling system	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMT200031174	K05857	ko00562	Inositol phosphate metabolism	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMT200031174	K05857	ko01100	Metabolic pathways	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMT200031174	K05857	ko04020	Calcium signaling pathway	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMT200031174	K05857	ko04070	Phosphatidylinositol signaling system	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMT200031178	K01190	ko00052	Galactose metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMT200031178	K01190	ko00511	Other glycan degradation	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMT200031178	K01190	ko00600	Sphingolipid metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMT200031178	K01190	ko01100	Metabolic pathways	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMT200005153	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00270	Cysteine and methionine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00350	Tyrosine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00360	Phenylalanine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00401	Novobiocin biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko01100	Metabolic pathways	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005153	K00815	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMT200005163	K01610	ko00010	Glycolysis / Gluconeogenesis	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005163	K01610	ko00020	Citrate cycle (TCA cycle)	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005163	K01610	ko00620	Pyruvate metabolism	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005163	K01610	ko00710	Carbon fixation in photosynthetic organisms	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005163	K01610	ko01100	Metabolic pathways	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005163	K01610	ko01110	Biosynthesis of secondary metabolites	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMT200005170	K01610	ko00010	Glycolysis / Gluconeogenesis	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200005170	K01610	ko00020	Citrate cycle (TCA cycle)	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200005170	K01610	ko00620	Pyruvate metabolism	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200005170	K01610	ko00710	Carbon fixation in photosynthetic organisms	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200005170	K01610	ko01100	Metabolic pathways	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200005170	K01610	ko01110	Biosynthesis of secondary metabolites	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMT200070007	K00754	ko00051	Fructose and mannose metabolism	1841	1.0e-95	0.49	0.70	0.83
PGSC0003DMT200070008	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMT200070009	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMT200070010	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMT200070015	K00914	ko00562	Inositol phosphate metabolism	6073	0.	0.86	0.92	1.00
PGSC0003DMT200070015	K00914	ko01100	Metabolic pathways	6073	0.	0.86	0.92	1.00
PGSC0003DMT200070015	K00914	ko04070	Phosphatidylinositol signaling system	6073	0.	0.86	0.92	1.00
PGSC0003DMT200070015	K00914	ko04140	Regulation of autophagy	6073	0.	0.86	0.92	1.00
PGSC0003DMT200070015	K00914	ko04145	Phagosome	6073	0.	0.86	0.92	1.00
PGSC0003DMT200070016	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070016	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070016	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070016	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070016	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070017	K00914	ko00562	Inositol phosphate metabolism	6138	0.	0.89	0.94	1.00
PGSC0003DMT200070017	K00914	ko01100	Metabolic pathways	6138	0.	0.89	0.94	1.00
PGSC0003DMT200070017	K00914	ko04070	Phosphatidylinositol signaling system	6138	0.	0.89	0.94	1.00
PGSC0003DMT200070017	K00914	ko04140	Regulation of autophagy	6138	0.	0.89	0.94	1.00
PGSC0003DMT200070017	K00914	ko04145	Phagosome	6138	0.	0.89	0.94	1.00
PGSC0003DMT200070018	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070018	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070018	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070018	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070018	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMT200070026	K04733	ko04210	Apoptosis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMT200070026	K04733	ko04620	Toll-like receptor signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMT200070026	K04733	ko04722	Neurotrophin signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMT200070026	K04733	ko05140	Leishmaniasis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMT200070026	K04733	ko05142	Chagas disease	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMT200070029	K03405	ko00860	Porphyrin and chlorophyll metabolism	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMT200070029	K03405	ko01100	Metabolic pathways	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMT200070029	K03405	ko01110	Biosynthesis of secondary metabolites	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMT200070030	K03405	ko00860	Porphyrin and chlorophyll metabolism	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMT200070030	K03405	ko01100	Metabolic pathways	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMT200070030	K03405	ko01110	Biosynthesis of secondary metabolites	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMT200070039	K01184	ko00040	Pentose and glucuronate interconversions	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMT200070039	K01184	ko00500	Starch and sucrose metabolism	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMT200070039	K01184	ko01100	Metabolic pathways	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMT200070040	K01184	ko00040	Pentose and glucuronate interconversions	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMT200070040	K01184	ko00500	Starch and sucrose metabolism	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMT200070040	K01184	ko01100	Metabolic pathways	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMT200070041	K01188	ko00460	Cyanoamino acid metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMT200070041	K01188	ko00500	Starch and sucrose metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMT200070041	K01188	ko00940	Phenylpropanoid biosynthesis	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMT200070041	K01188	ko01110	Biosynthesis of secondary metabolites	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMT200086403	K01307	ko00790	Folate biosynthesis	1800	1.9e-93	0.63	0.78	0.98
PGSC0003DMT200077230	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.97
PGSC0003DMT200077231	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.93
PGSC0003DMT200077257	K02960	ko03010	Ribosome	1151	1.2e-57	0.91	0.94	0.99
PGSC0003DMT200077272	K04371	ko04010	MAPK signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04012	ErbB signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04013	MAPK signaling pathway - fly	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04062	Chemokine signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04114	Oocyte meiosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04270	Vascular smooth muscle contraction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04320	Dorso-ventral axis formation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04350	TGF-beta signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04360	Axon guidance	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04370	VEGF signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04520	Adherens junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04540	Gap junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04620	Toll-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04621	NOD-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04650	Natural killer cell mediated cytotoxicity	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04660	T cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04662	B cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04664	Fc epsilon RI signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04666	Fc gamma R-mediated phagocytosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04720	Long-term potentiation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04722	Neurotrophin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04730	Long-term depression	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04810	Regulation of actin cytoskeleton	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04912	GnRH signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04914	Progesterone-mediated oocyte maturation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04916	Melanogenesis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04930	Type II diabetes mellitus	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05010	Alzheimer's disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05020	Prion diseases	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05131	Shigellosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05140	Leishmaniasis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05142	Chagas disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05200	Pathways in cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05210	Colorectal cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05211	Renal cell carcinoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05212	Pancreatic cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05214	Glioma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05216	Thyroid cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05218	Melanoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05219	Bladder cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05220	Chronic myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05221	Acute myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077272	K04371	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMT200077273	K04371	ko04010	MAPK signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04012	ErbB signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04013	MAPK signaling pathway - fly	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04062	Chemokine signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04114	Oocyte meiosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04150	mTOR signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04270	Vascular smooth muscle contraction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04320	Dorso-ventral axis formation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04350	TGF-beta signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04360	Axon guidance	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04370	VEGF signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04510	Focal adhesion	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04520	Adherens junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04540	Gap junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04620	Toll-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04621	NOD-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04650	Natural killer cell mediated cytotoxicity	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04660	T cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04662	B cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04664	Fc epsilon RI signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04666	Fc gamma R-mediated phagocytosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04720	Long-term potentiation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04722	Neurotrophin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04730	Long-term depression	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04810	Regulation of actin cytoskeleton	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04910	Insulin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04912	GnRH signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04914	Progesterone-mediated oocyte maturation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04916	Melanogenesis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04930	Type II diabetes mellitus	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05010	Alzheimer's disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05020	Prion diseases	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05131	Shigellosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05140	Leishmaniasis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05142	Chagas disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05200	Pathways in cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05210	Colorectal cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05211	Renal cell carcinoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05212	Pancreatic cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05213	Endometrial cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05214	Glioma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05215	Prostate cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05216	Thyroid cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05218	Melanoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05219	Bladder cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05220	Chronic myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05221	Acute myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077273	K04371	ko05223	Non-small cell lung cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMT200077275	K10643	ko03018	RNA degradation	1364	2.1e-69	0.39	0.56	0.95
PGSC0003DMT200077276	K10643	ko03018	RNA degradation	1160	3.8e-58	0.38	0.54	0.94
PGSC0003DMT200077277	K10643	ko03018	RNA degradation	2747	1.1e-145	0.46	0.61	0.99
PGSC0003DMT200077278	K10643	ko03018	RNA degradation	4216	1.1e-226	0.53	0.67	1.00
PGSC0003DMT200051744	K03062	ko03050	Proteasome	3588	4.6e-192	0.97	0.98	1.00
PGSC0003DMT200051755	K03024	ko00230	Purine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMT200051755	K03024	ko00240	Pyrimidine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMT200051755	K03024	ko01100	Metabolic pathways	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMT200051755	K03024	ko03020	RNA polymerase	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMT200051755	K03024	ko04623	Cytosolic DNA-sensing pathway	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMT200051756	K03024	ko00230	Purine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMT200051756	K03024	ko00240	Pyrimidine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMT200051756	K03024	ko01100	Metabolic pathways	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMT200051756	K03024	ko03020	RNA polymerase	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMT200051756	K03024	ko04623	Cytosolic DNA-sensing pathway	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMT200051760	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMT200051760	K08081	ko01100	Metabolic pathways	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMT200051760	K08081	ko01110	Biosynthesis of secondary metabolites	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMT200051761	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMT200051761	K08081	ko01100	Metabolic pathways	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMT200051761	K08081	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMT200051762	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051762	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051762	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051763	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051763	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051763	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051764	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMT200051764	K08081	ko01100	Metabolic pathways	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMT200051764	K08081	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMT200051765	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMT200051765	K08081	ko01100	Metabolic pathways	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMT200051765	K08081	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMT200051766	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMT200051766	K08081	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMT200051766	K08081	ko01110	Biosynthesis of secondary metabolites	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMT200051767	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051767	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051767	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMT200051769	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMT200051769	K08081	ko01100	Metabolic pathways	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMT200051769	K08081	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMT200051770	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMT200051770	K08081	ko01100	Metabolic pathways	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMT200051770	K08081	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMT200051771	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMT200051771	K08081	ko01100	Metabolic pathways	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMT200051771	K08081	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMT200066283	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066283	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066283	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066284	K01528	ko04144	Endocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMT200066284	K01528	ko04666	Fc gamma R-mediated phagocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMT200066284	K01528	ko05100	Bacterial invasion of epithelial cells	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMT200066286	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066286	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066286	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMT200066293	K01528	ko04144	Endocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMT200066293	K01528	ko04666	Fc gamma R-mediated phagocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMT200066293	K01528	ko05100	Bacterial invasion of epithelial cells	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMT200066305	K00753	ko00510	N-Glycan biosynthesis	1682	6.2e-87	0.76	0.91	0.99
PGSC0003DMT200066306	K00753	ko00510	N-Glycan biosynthesis	2269	2.6e-119	0.78	0.89	0.97
PGSC0003DMT200066307	K00753	ko00510	N-Glycan biosynthesis	2996	2.1e-159	0.69	0.83	0.99
PGSC0003DMT200066309	K00753	ko00510	N-Glycan biosynthesis	2380	2.0e-125	0.79	0.90	1.00
PGSC0003DMT200035477	K00384	ko00240	Pyrimidine metabolism	2442	7.4e-129	0.79	0.88	0.99
PGSC0003DMT200035479	K12741	ko03040	Spliceosome	318	1.1e-11	0.43	0.60	0.34
PGSC0003DMT200035487	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	412	2.6e-16	0.36	0.51	0.45
PGSC0003DMT200035507	K08139	ko04113	Meiosis - yeast	611	5.5e-53	0.38	0.59	0.60
PGSC0003DMT200016582	K10577	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.92	0.96	0.99
PGSC0003DMT200016590	K13065	ko00940	Phenylpropanoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMT200016590	K13065	ko00941	Flavonoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMT200016590	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMT200016590	K13065	ko01110	Biosynthesis of secondary metabolites	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMT200016599	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	549	3.6e-24	0.35	0.50	0.88
PGSC0003DMT200016600	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	498	3.3e-21	0.34	0.47	0.99
PGSC0003DMT200016601	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMT200016601	K12567	ko05414	Dilated cardiomyopathy	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMT200016603	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMT200016603	K12567	ko05414	Dilated cardiomyopathy	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMT200016607	K02903	ko03010	Ribosome	971	1.0e-47	0.83	0.92	0.99
PGSC0003DMT200016615	K02957	ko03010	Ribosome	835	3.2e-40	0.72	0.90	0.99
PGSC0003DMT200016628	K01178	ko00500	Starch and sucrose metabolism	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMT200016628	K01178	ko01100	Metabolic pathways	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMT200029759	K00208	ko00061	Fatty acid biosynthesis	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMT200029759	K00208	ko01100	Metabolic pathways	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMT200029779	K03021	ko00230	Purine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMT200029779	K03021	ko00240	Pyrimidine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMT200029779	K03021	ko01100	Metabolic pathways	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMT200029779	K03021	ko03020	RNA polymerase	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMT200029779	K03021	ko04623	Cytosolic DNA-sensing pathway	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMT200029780	K03021	ko00230	Purine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMT200029780	K03021	ko00240	Pyrimidine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMT200029780	K03021	ko01100	Metabolic pathways	8032	0.	0.82	0.91	0.98
PGSC0003DMT200029780	K03021	ko03020	RNA polymerase	8032	0.	0.82	0.91	0.98
PGSC0003DMT200029780	K03021	ko04623	Cytosolic DNA-sensing pathway	8032	0.	0.82	0.91	0.98
PGSC0003DMT200029782	K03021	ko00230	Purine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMT200029782	K03021	ko00240	Pyrimidine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMT200029782	K03021	ko01100	Metabolic pathways	7627	0.	0.79	0.89	0.98
PGSC0003DMT200029782	K03021	ko03020	RNA polymerase	7627	0.	0.79	0.89	0.98
PGSC0003DMT200029782	K03021	ko04623	Cytosolic DNA-sensing pathway	7627	0.	0.79	0.89	0.98
PGSC0003DMT200029795	K12603	ko03018	RNA degradation	4537	2.1e-244	0.87	0.94	1.00
PGSC0003DMT200029796	K02889	ko03010	Ribosome	1223	1.3e-61	0.85	0.92	0.99
PGSC0003DMT200094155	K00799	ko00480	Glutathione metabolism	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMT200094155	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMT200094155	K00799	ko00982	Drug metabolism - cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMT200095511	K10591	ko04120	Ubiquitin mediated proteolysis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMT200095511	K10591	ko04144	Endocytosis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMT200095518	K00901	ko00561	Glycerolipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMT200095518	K00901	ko00564	Glycerophospholipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMT200095518	K00901	ko01100	Metabolic pathways	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMT200095518	K00901	ko04070	Phosphatidylinositol signaling system	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMT200095524	K07385	ko00902	Monoterpenoid biosynthesis	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMT200095524	K07385	ko01100	Metabolic pathways	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMT200081907	K00008	ko00051	Fructose and mannose metabolism	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMT200081907	K00008	ko01100	Metabolic pathways	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMT200081908	K00008	ko00051	Fructose and mannose metabolism	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMT200081908	K00008	ko01100	Metabolic pathways	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMT200081909	K00454	ko00591	Linoleic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMT200081909	K00454	ko00592	alpha-Linolenic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMT200081909	K00454	ko01100	Metabolic pathways	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMT200081911	K00454	ko00591	Linoleic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMT200081911	K00454	ko00592	alpha-Linolenic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMT200081911	K00454	ko01100	Metabolic pathways	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMT200081918	K10418	ko04962	Vasopressin-regulated water reabsorption	307	4.3e-11	0.46	0.62	0.66
PGSC0003DMT200044700	K04460	ko04010	MAPK signaling pathway	3733	4.6e-200	0.89	0.95	1.00
PGSC0003DMT200044701	K00754	ko00051	Fructose and mannose metabolism	779	3.9e-37	0.34	0.53	0.72
PGSC0003DMT200044702	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMT200044703	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMT200044704	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMT200044705	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMT200044713	K00948	ko00030	Pentose phosphate pathway	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMT200044713	K00948	ko00230	Purine metabolism	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMT200044713	K00948	ko01100	Metabolic pathways	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMT200044713	K00948	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMT200044716	K10955	ko05110	Vibrio cholerae infection	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMT200044716	K10955	ko05146	Amoebiasis	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMT200044717	K01213	ko00040	Pentose and glucuronate interconversions	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMT200044717	K01213	ko00500	Starch and sucrose metabolism	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMT200044717	K01213	ko01100	Metabolic pathways	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMT200044731	K12639	ko00905	Brassinosteroid biosynthesis	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMT200044731	K12639	ko01100	Metabolic pathways	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMT200044731	K12639	ko01110	Biosynthesis of secondary metabolites	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMT200044744	K01835	ko00010	Glycolysis / Gluconeogenesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00030	Pentose phosphate pathway	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00052	Galactose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00230	Purine metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00500	Starch and sucrose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko00521	Streptomycin biosynthesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko01100	Metabolic pathways	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200044744	K01835	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMT200072532	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMT200072532	K08081	ko01100	Metabolic pathways	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMT200072532	K08081	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMT200072533	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMT200072533	K08081	ko01100	Metabolic pathways	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMT200072533	K08081	ko01110	Biosynthesis of secondary metabolites	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMT200072534	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMT200072534	K08081	ko01100	Metabolic pathways	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMT200072534	K08081	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMT200072535	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMT200072535	K08081	ko01100	Metabolic pathways	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMT200072535	K08081	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMT200072540	K09835	ko00906	Carotenoid biosynthesis	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMT200072540	K09835	ko01100	Metabolic pathways	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMT200072540	K09835	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMT200072541	K09835	ko00906	Carotenoid biosynthesis	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMT200072541	K09835	ko01100	Metabolic pathways	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMT200072541	K09835	ko01110	Biosynthesis of secondary metabolites	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMT200072542	K09835	ko00906	Carotenoid biosynthesis	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMT200072542	K09835	ko01100	Metabolic pathways	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMT200072542	K09835	ko01110	Biosynthesis of secondary metabolites	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMT200072543	K09835	ko00906	Carotenoid biosynthesis	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMT200072543	K09835	ko01100	Metabolic pathways	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMT200072543	K09835	ko01110	Biosynthesis of secondary metabolites	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMT200072553	K03504	ko00230	Purine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko00240	Pyrimidine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko01100	Metabolic pathways	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko03030	DNA replication	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko03410	Base excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko03420	Nucleotide excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko03430	Mismatch repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072553	K03504	ko03440	Homologous recombination	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMT200072559	K09480	ko00561	Glycerolipid metabolism	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMT200072559	K09480	ko01100	Metabolic pathways	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMT200072562	K09480	ko00561	Glycerolipid metabolism	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMT200072562	K09480	ko01100	Metabolic pathways	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMT200072563	K09480	ko00561	Glycerolipid metabolism	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMT200072563	K09480	ko01100	Metabolic pathways	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMT200060942	K04506	ko04115	p53 signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMT200060942	K04506	ko04120	Ubiquitin mediated proteolysis	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMT200060942	K04506	ko04310	Wnt signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMT200060943	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060943	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060943	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060944	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060944	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060944	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060945	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060945	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060945	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060946	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060946	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060946	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMT200060947	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060947	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060947	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMT200060948	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMT200060949	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMT200060950	K03652	ko03410	Base excision repair	1514	1.1e-77	0.69	0.77	0.99
PGSC0003DMT200060952	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060952	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060953	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMT200060964	K04124	ko00904	Diterpenoid biosynthesis	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMT200060964	K04124	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMT200060967	K13082	ko00941	Flavonoid biosynthesis	839	1.9e-40	0.38	0.57	0.98
PGSC0003DMT200060969	K02999	ko00230	Purine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMT200060969	K02999	ko00240	Pyrimidine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMT200060969	K02999	ko01100	Metabolic pathways	8494	0.	0.62	0.77	1.00
PGSC0003DMT200060969	K02999	ko03020	RNA polymerase	8494	0.	0.62	0.77	1.00
PGSC0003DMT200051363	K12599	ko03018	RNA degradation	4266	1.9e-229	0.68	0.78	0.98
PGSC0003DMT200051364	K12599	ko03018	RNA degradation	3887	1.5e-208	0.68	0.79	0.97
PGSC0003DMT200051365	K12599	ko03018	RNA degradation	4529	5.8e-244	0.70	0.80	0.99
PGSC0003DMT200051366	K12599	ko03018	RNA degradation	4112	5.8e-221	0.69	0.79	0.99
PGSC0003DMT200051367	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMT200051367	K01657	ko01100	Metabolic pathways	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMT200051367	K01657	ko01110	Biosynthesis of secondary metabolites	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMT200051373	K04733	ko04210	Apoptosis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMT200051373	K04733	ko04620	Toll-like receptor signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMT200051373	K04733	ko04722	Neurotrophin signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMT200051373	K04733	ko05140	Leishmaniasis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMT200051373	K04733	ko05142	Chagas disease	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMT200051375	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMT200051375	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMT200051375	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMT200078425	K04733	ko04210	Apoptosis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMT200078425	K04733	ko04620	Toll-like receptor signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMT200078425	K04733	ko04722	Neurotrophin signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMT200078425	K04733	ko05140	Leishmaniasis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMT200078425	K04733	ko05142	Chagas disease	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMT200078426	K04733	ko04210	Apoptosis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMT200078426	K04733	ko04620	Toll-like receptor signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMT200078426	K04733	ko04722	Neurotrophin signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMT200078426	K04733	ko05140	Leishmaniasis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMT200078426	K04733	ko05142	Chagas disease	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMT200078428	K04733	ko04210	Apoptosis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMT200078428	K04733	ko04620	Toll-like receptor signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMT200078428	K04733	ko04722	Neurotrophin signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMT200078428	K04733	ko05140	Leishmaniasis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMT200078428	K04733	ko05142	Chagas disease	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMT200078430	K04733	ko04210	Apoptosis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMT200078430	K04733	ko04620	Toll-like receptor signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMT200078430	K04733	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMT200078430	K04733	ko05140	Leishmaniasis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMT200078430	K04733	ko05142	Chagas disease	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMT200078432	K04733	ko04210	Apoptosis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMT200078432	K04733	ko04620	Toll-like receptor signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMT200078432	K04733	ko04722	Neurotrophin signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMT200078432	K04733	ko05140	Leishmaniasis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMT200078432	K04733	ko05142	Chagas disease	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMT200078433	K04733	ko04210	Apoptosis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMT200078433	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMT200078433	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMT200078433	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMT200078433	K04733	ko05142	Chagas disease	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMT200078434	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMT200078434	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMT200078434	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMT200078434	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMT200078434	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMT200078435	K04733	ko04210	Apoptosis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMT200078435	K04733	ko04620	Toll-like receptor signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMT200078435	K04733	ko04722	Neurotrophin signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMT200078435	K04733	ko05140	Leishmaniasis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMT200078435	K04733	ko05142	Chagas disease	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMT200078436	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMT200078436	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMT200078436	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMT200078436	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMT200078436	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMT200078437	K04733	ko04210	Apoptosis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMT200078437	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMT200078437	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMT200078437	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMT200078437	K04733	ko05142	Chagas disease	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMT200078438	K04733	ko04210	Apoptosis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMT200078438	K04733	ko04620	Toll-like receptor signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMT200078438	K04733	ko04722	Neurotrophin signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMT200078438	K04733	ko05140	Leishmaniasis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMT200078438	K04733	ko05142	Chagas disease	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMT200078439	K04733	ko04210	Apoptosis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMT200078439	K04733	ko04620	Toll-like receptor signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMT200078439	K04733	ko04722	Neurotrophin signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMT200078439	K04733	ko05140	Leishmaniasis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMT200078439	K04733	ko05142	Chagas disease	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMT200078440	K04733	ko04210	Apoptosis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMT200078440	K04733	ko04620	Toll-like receptor signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMT200078440	K04733	ko04722	Neurotrophin signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMT200078440	K04733	ko05140	Leishmaniasis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMT200078440	K04733	ko05142	Chagas disease	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMT200078443	K04733	ko04210	Apoptosis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMT200078443	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMT200078443	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMT200078443	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMT200078443	K04733	ko05142	Chagas disease	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMT200078448	K04733	ko04210	Apoptosis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMT200078448	K04733	ko04620	Toll-like receptor signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMT200078448	K04733	ko04722	Neurotrophin signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMT200078448	K04733	ko05140	Leishmaniasis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMT200078448	K04733	ko05142	Chagas disease	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMT200078452	K04733	ko04210	Apoptosis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMT200078452	K04733	ko04620	Toll-like receptor signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMT200078452	K04733	ko04722	Neurotrophin signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMT200078452	K04733	ko05140	Leishmaniasis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMT200078452	K04733	ko05142	Chagas disease	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMT200078453	K02910	ko03010	Ribosome	717	1.0e-33	0.92	0.97	0.92
PGSC0003DMT200078454	K02910	ko03010	Ribosome	940	5.2e-46	0.93	0.97	0.99
PGSC0003DMT200057077	K01692	ko00071	Fatty acid metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00280	Valine, leucine and isoleucine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00281	Geraniol degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00310	Lysine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00380	Tryptophan metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00410	beta-Alanine metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00632	Benzoate degradation via CoA ligation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00640	Propanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00650	Butanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00903	Limonene and pinene degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko00930	Caprolactam degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko01100	Metabolic pathways	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057077	K01692	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMT200057079	K01692	ko00071	Fatty acid metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00280	Valine, leucine and isoleucine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00281	Geraniol degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00310	Lysine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00380	Tryptophan metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00410	beta-Alanine metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00632	Benzoate degradation via CoA ligation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00640	Propanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00650	Butanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00903	Limonene and pinene degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko00930	Caprolactam degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko01100	Metabolic pathways	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057079	K01692	ko01110	Biosynthesis of secondary metabolites	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMT200057095	K00640	ko00270	Cysteine and methionine metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMT200057095	K00640	ko00920	Sulfur metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMT200057095	K00640	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMT200057099	K05665	ko02010	ABC transporters	3210	3.3e-171	0.38	0.58	0.95
PGSC0003DMT200001297	K01673	ko00910	Nitrogen metabolism	1970	8.0e-103	0.74	0.84	1.00
PGSC0003DMT200001303	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMT200001303	K00122	ko00680	Methane metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMT200001303	K00122	ko01100	Metabolic pathways	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMT200001327	K04733	ko04210	Apoptosis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMT200001327	K04733	ko04620	Toll-like receptor signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMT200001327	K04733	ko04722	Neurotrophin signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMT200001327	K04733	ko05140	Leishmaniasis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMT200001327	K04733	ko05142	Chagas disease	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMT200097422	K12831	ko03040	Spliceosome	370	3.5e-28	0.66	0.83	0.82
PGSC0003DMT200097433	K01051	ko00040	Pentose and glucuronate interconversions	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMT200097433	K01051	ko00500	Starch and sucrose metabolism	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMT200097433	K01051	ko01100	Metabolic pathways	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMT200097436	K11644	ko05016	Huntington's disease	777	1.4e-36	0.44	0.58	0.56
PGSC0003DMT200014211	K03965	ko00190	Oxidative phosphorylation	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMT200014211	K03965	ko01100	Metabolic pathways	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMT200014211	K03965	ko05010	Alzheimer's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMT200014211	K03965	ko05012	Parkinson's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMT200014211	K03965	ko05016	Huntington's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMT200014212	K03965	ko00190	Oxidative phosphorylation	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMT200014212	K03965	ko01100	Metabolic pathways	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMT200014212	K03965	ko05010	Alzheimer's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMT200014212	K03965	ko05012	Parkinson's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMT200014212	K03965	ko05016	Huntington's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMT200014216	K04079	ko04612	Antigen processing and presentation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014216	K04079	ko04621	NOD-like receptor signaling pathway	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014216	K04079	ko04626	Plant-pathogen interaction	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014216	K04079	ko04914	Progesterone-mediated oocyte maturation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014216	K04079	ko05200	Pathways in cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014216	K04079	ko05215	Prostate cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMT200014217	K04079	ko04612	Antigen processing and presentation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014217	K04079	ko04621	NOD-like receptor signaling pathway	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014217	K04079	ko04626	Plant-pathogen interaction	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014217	K04079	ko04914	Progesterone-mediated oocyte maturation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014217	K04079	ko05200	Pathways in cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014217	K04079	ko05215	Prostate cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMT200014232	K05280	ko00941	Flavonoid biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMT200014232	K05280	ko00944	Flavone and flavonol biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMT200014232	K05280	ko01100	Metabolic pathways	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMT200014232	K05280	ko01110	Biosynthesis of secondary metabolites	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMT200014233	K09754	ko00360	Phenylalanine metabolism	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014233	K09754	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014233	K09754	ko00941	Flavonoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014233	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014233	K09754	ko01100	Metabolic pathways	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014233	K09754	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMT200014234	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMT200014234	K00517	ko00626	Naphthalene and anthracene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMT200014234	K00517	ko00903	Limonene and pinene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMT200014234	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMT200014234	K00517	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMT200041662	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMT200041664	K10352	ko04530	Tight junction	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMT200041664	K10352	ko05416	Viral myocarditis	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMT200041672	K00599	ko00340	Histidine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMT200041672	K00599	ko00350	Tyrosine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMT200041672	K00599	ko00450	Selenoamino acid metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMT200041672	K00599	ko00626	Naphthalene and anthracene degradation	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMT200041673	K00599	ko00340	Histidine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMT200041673	K00599	ko00350	Tyrosine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMT200041673	K00599	ko00450	Selenoamino acid metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMT200041673	K00599	ko00626	Naphthalene and anthracene degradation	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMT200041674	K00599	ko00340	Histidine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMT200041674	K00599	ko00350	Tyrosine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMT200041674	K00599	ko00450	Selenoamino acid metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMT200041674	K00599	ko00626	Naphthalene and anthracene degradation	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMT200004830	K12126	ko04712	Circadian rhythm - plant	342	7.2e-12	0.26	0.43	0.76
PGSC0003DMT200004832	K12126	ko04712	Circadian rhythm - plant	251	2.2e-07	0.33	0.50	0.49
PGSC0003DMT200004838	K03469	ko03030	DNA replication	370	1.4e-14	0.43	0.63	0.34
PGSC0003DMT200004841	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.48	0.97
PGSC0003DMT200004842	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.49	0.79
PGSC0003DMT200004851	K00161	ko00010	Glycolysis / Gluconeogenesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko00020	Citrate cycle (TCA cycle)	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko00620	Pyruvate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko00650	Butanoate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko01100	Metabolic pathways	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004851	K00161	ko01110	Biosynthesis of secondary metabolites	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMT200004853	K04382	ko04111	Cell cycle - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04113	Meiosis - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04114	Oocyte meiosis	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04310	Wnt signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04350	TGF-beta signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04530	Tight junction	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko04730	Long-term depression	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004853	K04382	ko05142	Chagas disease	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMT200004854	K04382	ko04111	Cell cycle - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04113	Meiosis - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04114	Oocyte meiosis	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04310	Wnt signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04350	TGF-beta signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04530	Tight junction	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko04730	Long-term depression	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004854	K04382	ko05142	Chagas disease	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMT200004855	K12126	ko04712	Circadian rhythm - plant	298	2.0e-10	0.34	0.54	0.80
PGSC0003DMT200004859	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004859	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004859	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004859	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004860	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004860	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004860	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004860	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004861	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004861	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004861	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004861	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMT200004864	K00558	ko00270	Cysteine and methionine metabolism	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMT200004864	K00558	ko01100	Metabolic pathways	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMT200004865	K00558	ko00270	Cysteine and methionine metabolism	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMT200004865	K00558	ko01100	Metabolic pathways	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMT200004866	K00558	ko00270	Cysteine and methionine metabolism	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMT200004866	K00558	ko01100	Metabolic pathways	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMT200032298	K12893	ko03040	Spliceosome	305	1.3e-10	0.33	0.47	0.40
PGSC0003DMT200032299	K12893	ko03040	Spliceosome	305	1.2e-10	0.33	0.47	0.41
PGSC0003DMT200032309	K00074	ko00632	Benzoate degradation via CoA ligation	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMT200032309	K00074	ko00650	Butanoate metabolism	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMT200032317	K09880	ko00270	Cysteine and methionine metabolism	3448	2.4e-184	0.78	0.88	1.00
PGSC0003DMT200032319	K09880	ko00270	Cysteine and methionine metabolism	226	1.7e-10	0.78	0.90	0.43
PGSC0003DMT200032321	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032321	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032321	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032322	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032322	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032322	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMT200032324	K02435	ko00970	Aminoacyl-tRNA biosynthesis	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMT200032324	K02435	ko01100	Metabolic pathways	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMT200032328	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMT200032328	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMT200032329	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMT200032329	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMT200083882	K05673	ko02010	ABC transporters	1594	4.4e-82	0.32	0.50	0.80
PGSC0003DMT200083883	K05673	ko02010	ABC transporters	1655	1.9e-85	0.32	0.50	0.81
PGSC0003DMT200083884	K05666	ko02010	ABC transporters	2909	1.3e-154	0.34	0.55	0.92
PGSC0003DMT200083885	K00059	ko00061	Fatty acid biosynthesis	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMT200083885	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMT200083885	K00059	ko01100	Metabolic pathways	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMT200083886	K00059	ko00061	Fatty acid biosynthesis	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMT200083886	K00059	ko01040	Biosynthesis of unsaturated fatty acids	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMT200083886	K00059	ko01100	Metabolic pathways	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMT200083894	K01190	ko00052	Galactose metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMT200083894	K01190	ko00511	Other glycan degradation	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMT200083894	K01190	ko00600	Sphingolipid metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMT200083894	K01190	ko01100	Metabolic pathways	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMT200083895	K01190	ko00052	Galactose metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMT200083895	K01190	ko00511	Other glycan degradation	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMT200083895	K01190	ko00600	Sphingolipid metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMT200083895	K01190	ko01100	Metabolic pathways	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMT200083896	K01190	ko00052	Galactose metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMT200083896	K01190	ko00511	Other glycan degradation	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMT200083896	K01190	ko00600	Sphingolipid metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMT200083896	K01190	ko01100	Metabolic pathways	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMT200083900	K00558	ko00270	Cysteine and methionine metabolism	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMT200083900	K00558	ko01100	Metabolic pathways	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMT200083902	K06130	ko00564	Glycerophospholipid metabolism	213	6.5e-06	0.38	0.49	0.75
PGSC0003DMT200083903	K06130	ko00564	Glycerophospholipid metabolism	551	1.5e-24	0.37	0.55	0.85
PGSC0003DMT200070975	K01599	ko00860	Porphyrin and chlorophyll metabolism	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMT200070975	K01599	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMT200070986	K03283	ko03040	Spliceosome	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMT200070986	K03283	ko04010	MAPK signaling pathway	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMT200070986	K03283	ko04144	Endocytosis	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMT200070986	K03283	ko04612	Antigen processing and presentation	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMT200071003	K00430	ko00360	Phenylalanine metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMT200071003	K00430	ko00680	Methane metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMT200071003	K00430	ko00940	Phenylpropanoid biosynthesis	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMT200071003	K00430	ko01100	Metabolic pathways	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMT200071003	K00430	ko01110	Biosynthesis of secondary metabolites	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMT200071012	K00654	ko00600	Sphingolipid metabolism	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMT200071012	K00654	ko01100	Metabolic pathways	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMT200071022	K01933	ko00230	Purine metabolism	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMT200071022	K01933	ko01100	Metabolic pathways	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMT200071022	K01933	ko01110	Biosynthesis of secondary metabolites	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMT200071027	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMT200071027	K00015	ko01100	Metabolic pathways	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMT200071028	K00058	ko00260	Glycine, serine and threonine metabolism	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMT200071028	K00058	ko01100	Metabolic pathways	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMT200071029	K00058	ko00260	Glycine, serine and threonine metabolism	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMT200071029	K00058	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMT200071030	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMT200071030	K00015	ko01100	Metabolic pathways	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMT200045404	K07199	ko04910	Insulin signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMT200045404	K07199	ko04920	Adipocytokine signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMT200045404	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMT200096620	K04508	ko04310	Wnt signaling pathway	422	1.9e-17	0.42	0.52	0.71
PGSC0003DMT200036762	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMT200036763	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036763	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036763	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036764	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036764	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036764	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMT200036801	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMT200036802	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMT200036803	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMT200036804	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMT200026064	K12135	ko04712	Circadian rhythm - plant	330	2.3e-12	0.39	0.55	0.75
PGSC0003DMT200026065	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMT200026066	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMT200026067	K12135	ko04712	Circadian rhythm - plant	959	4.6e-47	0.47	0.60	0.91
PGSC0003DMT200026068	K12135	ko04712	Circadian rhythm - plant	922	5.1e-45	0.46	0.61	0.71
PGSC0003DMT200026069	K12135	ko04712	Circadian rhythm - plant	327	3.4e-12	0.40	0.55	0.48
PGSC0003DMT200026079	K05864	ko04020	Calcium signaling pathway	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMT200026079	K05864	ko05012	Parkinson's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMT200026079	K05864	ko05016	Huntington's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMT200026080	K05864	ko04020	Calcium signaling pathway	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMT200026080	K05864	ko05012	Parkinson's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMT200026080	K05864	ko05016	Huntington's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMT200026081	K00430	ko00360	Phenylalanine metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMT200026081	K00430	ko00680	Methane metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMT200026081	K00430	ko00940	Phenylpropanoid biosynthesis	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMT200026081	K00430	ko01100	Metabolic pathways	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMT200026081	K00430	ko01110	Biosynthesis of secondary metabolites	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMT200026082	K00430	ko00360	Phenylalanine metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMT200026082	K00430	ko00680	Methane metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMT200026082	K00430	ko00940	Phenylpropanoid biosynthesis	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMT200026082	K00430	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMT200026082	K00430	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMT200026090	K00430	ko00360	Phenylalanine metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMT200026090	K00430	ko00680	Methane metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMT200026090	K00430	ko00940	Phenylpropanoid biosynthesis	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMT200026090	K00430	ko01100	Metabolic pathways	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMT200026090	K00430	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMT200026091	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMT200026093	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMT200026094	K02897	ko03010	Ribosome	1277	1.3e-64	0.63	0.78	1.00
PGSC0003DMT200026095	K02897	ko03010	Ribosome	1300	7.2e-66	0.65	0.81	1.00
PGSC0003DMT200028202	K02918	ko03010	Ribosome	719	8.0e-34	0.89	0.96	0.44
PGSC0003DMT200028203	K02918	ko03010	Ribosome	913	1.6e-44	0.92	0.96	0.99
PGSC0003DMT200028204	K07195	ko04910	Insulin signaling pathway	2086	3.2e-109	0.47	0.67	0.94
PGSC0003DMT200028221	K04123	ko00904	Diterpenoid biosynthesis	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMT200028221	K04123	ko01100	Metabolic pathways	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMT200028221	K04123	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMT200081190	K01718	ko00240	Pyrimidine metabolism	778	4.5e-37	0.41	0.58	0.99
PGSC0003DMT200081192	K01718	ko00240	Pyrimidine metabolism	1059	1.4e-52	0.41	0.58	0.91
PGSC0003DMT200081202	K00648	ko00061	Fatty acid biosynthesis	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMT200081202	K00648	ko01100	Metabolic pathways	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMT200081220	K07466	ko03030	DNA replication	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMT200081220	K07466	ko03420	Nucleotide excision repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMT200081220	K07466	ko03430	Mismatch repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMT200081220	K07466	ko03440	Homologous recombination	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMT200070694	K04731	ko04210	Apoptosis	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMT200070694	K04731	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMT200070721	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	318	2.2e-09	0.28	0.44	0.63
PGSC0003DMT200070723	K12190	ko04144	Endocytosis	1875	1.4e-97	0.70	0.82	0.87
PGSC0003DMT200070724	K12190	ko04144	Endocytosis	2563	1.6e-135	0.70	0.82	1.00
PGSC0003DMT200070725	K12190	ko04144	Endocytosis	735	1.1e-34	0.72	0.89	0.87
PGSC0003DMT200047242	K04852	ko04010	MAPK signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMT200047242	K04852	ko04020	Calcium signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMT200047242	K04852	ko04930	Type II diabetes mellitus	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMT200072735	K07424	ko00140	Steroid hormone biosynthesis	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00591	Linoleic acid metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00830	Retinol metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00982	Drug metabolism - cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko00983	Drug metabolism - other enzymes	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072735	K07424	ko01100	Metabolic pathways	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMT200072736	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072736	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072738	K07424	ko00140	Steroid hormone biosynthesis	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00591	Linoleic acid metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00830	Retinol metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00982	Drug metabolism - cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko00983	Drug metabolism - other enzymes	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072738	K07424	ko01100	Metabolic pathways	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMT200072739	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072739	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMT200072740	K07424	ko00140	Steroid hormone biosynthesis	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00591	Linoleic acid metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00830	Retinol metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00982	Drug metabolism - cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko00983	Drug metabolism - other enzymes	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072740	K07424	ko01100	Metabolic pathways	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMT200072748	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	368	1.8e-14	0.38	0.62	0.93
PGSC0003DMT200072749	K00847	ko00051	Fructose and mannose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMT200072749	K00847	ko00500	Starch and sucrose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMT200072749	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMT200072749	K00847	ko01100	Metabolic pathways	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMT200072750	K00847	ko00051	Fructose and mannose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMT200072750	K00847	ko00500	Starch and sucrose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMT200072750	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMT200072750	K00847	ko01100	Metabolic pathways	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMT200072766	K01940	ko00250	Alanine, aspartate and glutamate metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMT200072766	K01940	ko00330	Arginine and proline metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMT200072766	K01940	ko01100	Metabolic pathways	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMT200072766	K01940	ko01110	Biosynthesis of secondary metabolites	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMT200038474	K02516	ko04111	Cell cycle - yeast	273	1.0e-08	0.49	0.60	0.95
PGSC0003DMT200038476	K02516	ko04111	Cell cycle - yeast	4430	1.7e-238	0.78	0.87	1.00
PGSC0003DMT200038477	K00999	ko00562	Inositol phosphate metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMT200038477	K00999	ko00564	Glycerophospholipid metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMT200038477	K00999	ko01100	Metabolic pathways	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMT200038477	K00999	ko04070	Phosphatidylinositol signaling system	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMT200038480	K00999	ko00562	Inositol phosphate metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMT200038480	K00999	ko00564	Glycerophospholipid metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMT200038480	K00999	ko01100	Metabolic pathways	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMT200038480	K00999	ko04070	Phosphatidylinositol signaling system	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMT200038481	K00999	ko00562	Inositol phosphate metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMT200038481	K00999	ko00564	Glycerophospholipid metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMT200038481	K00999	ko01100	Metabolic pathways	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMT200038481	K00999	ko04070	Phosphatidylinositol signaling system	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMT200038482	K00999	ko00562	Inositol phosphate metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMT200038482	K00999	ko00564	Glycerophospholipid metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMT200038482	K00999	ko01100	Metabolic pathways	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMT200038482	K00999	ko04070	Phosphatidylinositol signaling system	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMT200038486	K06675	ko04111	Cell cycle - yeast	280	1.4e-06	0.25	0.47	0.84
PGSC0003DMT200038487	K06675	ko04111	Cell cycle - yeast	285	5.3e-07	0.26	0.49	0.83
PGSC0003DMT200038488	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200038488	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200038488	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200038491	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMT200038491	K02366	ko01100	Metabolic pathways	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMT200026358	K01924	ko00471	D-Glutamine and D-glutamate metabolism	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMT200026358	K01924	ko00550	Peptidoglycan biosynthesis	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMT200026358	K01924	ko01100	Metabolic pathways	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMT200026361	K01924	ko00471	D-Glutamine and D-glutamate metabolism	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMT200026361	K01924	ko00550	Peptidoglycan biosynthesis	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMT200026361	K01924	ko01100	Metabolic pathways	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMT200026362	K01924	ko00471	D-Glutamine and D-glutamate metabolism	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMT200026362	K01924	ko00550	Peptidoglycan biosynthesis	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMT200026362	K01924	ko01100	Metabolic pathways	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMT200026363	K02294	ko00906	Carotenoid biosynthesis	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMT200026363	K02294	ko01100	Metabolic pathways	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMT200026363	K02294	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMT200086532	K08967	ko00270	Cysteine and methionine metabolism	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMT200086532	K08967	ko01100	Metabolic pathways	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMT200086547	K02896	ko03010	Ribosome	333	1.6e-12	0.56	0.71	0.96
PGSC0003DMT200086553	K11251	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.54	0.68	0.92
PGSC0003DMT200059110	K01046	ko00561	Glycerolipid metabolism	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMT200059110	K01046	ko01100	Metabolic pathways	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMT200059143	K01500	ko00791	Atrazine degradation	385	2.1e-15	0.36	0.45	0.72
PGSC0003DMT200059145	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMT200059146	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMT200059147	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMT200059148	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMT200059149	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMT200076653	K06268	ko04010	MAPK signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04020	Calcium signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04114	Oocyte meiosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04210	Apoptosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04310	Wnt signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04360	Axon guidance	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04370	VEGF signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04650	Natural killer cell mediated cytotoxicity	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04660	T cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04662	B cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko04720	Long-term potentiation	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko05010	Alzheimer's disease	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076653	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMT200076678	K07466	ko03030	DNA replication	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMT200076678	K07466	ko03420	Nucleotide excision repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMT200076678	K07466	ko03430	Mismatch repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMT200076678	K07466	ko03440	Homologous recombination	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMT200076679	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076679	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076679	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076679	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076680	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076680	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076680	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076680	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076682	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076682	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076682	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200076682	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMT200049547	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMT200049548	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMT200049549	K10418	ko04962	Vasopressin-regulated water reabsorption	389	1.3e-15	0.56	0.73	0.73
PGSC0003DMT200049550	K08914	ko00196	Photosynthesis - antenna proteins	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMT200049550	K08914	ko01100	Metabolic pathways	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMT200049551	K08914	ko00196	Photosynthesis - antenna proteins	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMT200049551	K08914	ko01100	Metabolic pathways	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMT200015899	K00588	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015899	K00588	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015899	K00588	ko00941	Flavonoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015899	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015899	K00588	ko01100	Metabolic pathways	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015899	K00588	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMT200015900	K00588	ko00360	Phenylalanine metabolism	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015900	K00588	ko00940	Phenylpropanoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015900	K00588	ko00941	Flavonoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015900	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015900	K00588	ko01100	Metabolic pathways	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015900	K00588	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMT200015905	K05402	ko04620	Toll-like receptor signaling pathway	262	1.3e-08	0.29	0.41	0.93
PGSC0003DMT200015906	K00933	ko00330	Arginine and proline metabolism	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMT200015906	K00933	ko01100	Metabolic pathways	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMT200015907	K12869	ko03040	Spliceosome	1106	3.6e-55	0.43	0.59	0.93
PGSC0003DMT200015911	K02184	ko04320	Dorso-ventral axis formation	979	2.3e-47	0.43	0.50	0.99
PGSC0003DMT200015916	K00753	ko00510	N-Glycan biosynthesis	1316	9.5e-67	0.62	0.74	0.89
PGSC0003DMT200015917	K00753	ko00510	N-Glycan biosynthesis	1405	1.2e-71	0.73	0.88	0.93
PGSC0003DMT200015918	K00753	ko00510	N-Glycan biosynthesis	2979	1.8e-158	0.68	0.81	0.97
PGSC0003DMT200015919	K00753	ko00510	N-Glycan biosynthesis	2247	4.2e-118	0.77	0.89	0.85
PGSC0003DMT200039845	K02926	ko03010	Ribosome	1940	3.6e-101	0.78	0.84	1.00
PGSC0003DMT200039846	K02926	ko03010	Ribosome	1963	2.0e-102	0.80	0.86	1.00
PGSC0003DMT200039853	K01046	ko00561	Glycerolipid metabolism	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMT200039853	K01046	ko01100	Metabolic pathways	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMT200039854	K01046	ko00561	Glycerolipid metabolism	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMT200039854	K01046	ko01100	Metabolic pathways	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMT200039871	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMT200039871	K00517	ko00626	Naphthalene and anthracene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMT200039871	K00517	ko00903	Limonene and pinene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMT200039871	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMT200039871	K00517	ko01110	Biosynthesis of secondary metabolites	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMT200039875	K12815	ko03040	Spliceosome	5735	0.	0.73	0.83	0.94
PGSC0003DMT200039876	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMT200039877	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMT200039878	K10579	ko04120	Ubiquitin mediated proteolysis	1427	7.2e-73	0.87	0.96	0.99
PGSC0003DMT200039881	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMT200039882	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMT200033984	K02906	ko03010	Ribosome	751	1.4e-35	0.72	0.84	0.65
PGSC0003DMT200033985	K02906	ko03010	Ribosome	272	3.6e-09	0.51	0.66	0.83
PGSC0003DMT200033986	K02906	ko03010	Ribosome	947	2.1e-46	0.50	0.59	0.75
PGSC0003DMT200033987	K02906	ko03010	Ribosome	1542	3.2e-79	0.71	0.83	0.81
PGSC0003DMT200033990	K01051	ko00040	Pentose and glucuronate interconversions	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMT200033990	K01051	ko00500	Starch and sucrose metabolism	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMT200033990	K01051	ko01100	Metabolic pathways	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMT200033991	K01051	ko00040	Pentose and glucuronate interconversions	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMT200033991	K01051	ko00500	Starch and sucrose metabolism	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMT200033991	K01051	ko01100	Metabolic pathways	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMT200034005	K01046	ko00561	Glycerolipid metabolism	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMT200034005	K01046	ko01100	Metabolic pathways	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMT200034023	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMT200034023	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMT200034025	K01046	ko00561	Glycerolipid metabolism	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMT200034025	K01046	ko01100	Metabolic pathways	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMT200006654	K01190	ko00052	Galactose metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMT200006654	K01190	ko00511	Other glycan degradation	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMT200006654	K01190	ko00600	Sphingolipid metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMT200006654	K01190	ko01100	Metabolic pathways	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMT200006656	K01190	ko00052	Galactose metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMT200006656	K01190	ko00511	Other glycan degradation	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMT200006656	K01190	ko00600	Sphingolipid metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMT200006656	K01190	ko01100	Metabolic pathways	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMT200006661	K01115	ko00564	Glycerophospholipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006661	K01115	ko00565	Ether lipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006661	K01115	ko01100	Metabolic pathways	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006661	K01115	ko04144	Endocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006661	K01115	ko04666	Fc gamma R-mediated phagocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006661	K01115	ko04912	GnRH signaling pathway	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMT200006664	K00558	ko00270	Cysteine and methionine metabolism	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMT200006664	K00558	ko01100	Metabolic pathways	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMT200006665	K01112	ko00051	Fructose and mannose metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMT200006665	K01112	ko00730	Thiamine metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMT200006665	K01112	ko00740	Riboflavin metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMT200006665	K01112	ko01100	Metabolic pathways	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMT200006666	K01112	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMT200006666	K01112	ko00730	Thiamine metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMT200006666	K01112	ko00740	Riboflavin metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMT200006666	K01112	ko01100	Metabolic pathways	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMT200006668	K01112	ko00051	Fructose and mannose metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMT200006668	K01112	ko00730	Thiamine metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMT200006668	K01112	ko00740	Riboflavin metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMT200006668	K01112	ko01100	Metabolic pathways	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMT200006670	K01112	ko00051	Fructose and mannose metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMT200006670	K01112	ko00730	Thiamine metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMT200006670	K01112	ko00740	Riboflavin metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMT200006670	K01112	ko01100	Metabolic pathways	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMT200006673	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006673	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006673	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006673	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006674	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006674	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006674	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006674	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMT200006675	K01112	ko00051	Fructose and mannose metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMT200006675	K01112	ko00730	Thiamine metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMT200006675	K01112	ko00740	Riboflavin metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMT200006675	K01112	ko01100	Metabolic pathways	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMT200006676	K13248	ko00750	Vitamin B6 metabolism	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMT200006676	K13248	ko01100	Metabolic pathways	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMT200006677	K01112	ko00051	Fructose and mannose metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMT200006677	K01112	ko00730	Thiamine metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMT200006677	K01112	ko00740	Riboflavin metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMT200006677	K01112	ko01100	Metabolic pathways	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMT200006680	K12197	ko04144	Endocytosis	1509	2.1e-77	0.91	0.97	1.00
PGSC0003DMT200006681	K02903	ko03010	Ribosome	980	3.2e-48	0.84	0.91	0.99
PGSC0003DMT200006692	K04733	ko04210	Apoptosis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMT200006692	K04733	ko04620	Toll-like receptor signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMT200006692	K04733	ko04722	Neurotrophin signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMT200006692	K04733	ko05140	Leishmaniasis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMT200006692	K04733	ko05142	Chagas disease	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMT200012073	K01051	ko00040	Pentose and glucuronate interconversions	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMT200012073	K01051	ko00500	Starch and sucrose metabolism	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMT200012073	K01051	ko01100	Metabolic pathways	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMT200012077	K01369	ko04142	Lysosome	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMT200012077	K01369	ko04612	Antigen processing and presentation	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMT200091045	K03006	ko00230	Purine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMT200091045	K03006	ko00240	Pyrimidine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMT200091045	K03006	ko01100	Metabolic pathways	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMT200091045	K03006	ko03020	RNA polymerase	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMT200091045	K03006	ko05016	Huntington's disease	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMT200091048	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMT200091048	K00517	ko00626	Naphthalene and anthracene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMT200091048	K00517	ko00903	Limonene and pinene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMT200091048	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMT200091048	K00517	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMT200002995	K01066	ko00623	2,4-Dichlorobenzoate degradation	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMT200002995	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMT200003004	K00754	ko00051	Fructose and mannose metabolism	310	5.0e-11	0.30	0.50	0.67
PGSC0003DMT200003013	K11294	ko05130	Pathogenic Escherichia coli infection	2615	2.1e-138	0.54	0.64	1.00
PGSC0003DMT200003016	K01051	ko00040	Pentose and glucuronate interconversions	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMT200003016	K01051	ko00500	Starch and sucrose metabolism	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMT200003016	K01051	ko01100	Metabolic pathways	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMT200002782	K00748	ko00540	Lipopolysaccharide biosynthesis	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMT200002782	K00748	ko01100	Metabolic pathways	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMT200002783	K00748	ko00540	Lipopolysaccharide biosynthesis	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMT200002783	K00748	ko01100	Metabolic pathways	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMT200002784	K00748	ko00540	Lipopolysaccharide biosynthesis	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMT200002784	K00748	ko01100	Metabolic pathways	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMT200002789	K02153	ko00190	Oxidative phosphorylation	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002789	K02153	ko01100	Metabolic pathways	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002789	K02153	ko04145	Phagosome	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002789	K02153	ko04966	Collecting duct acid secretion	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002789	K02153	ko05110	Vibrio cholerae infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002789	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMT200002794	K12606	ko03018	RNA degradation	547	2.5e-24	0.48	0.68	0.82
PGSC0003DMT200002796	K12606	ko03018	RNA degradation	606	1.4e-27	0.36	0.49	0.66
PGSC0003DMT200002808	K12356	ko00940	Phenylpropanoid biosynthesis	633	4.4e-29	0.31	0.46	0.93
PGSC0003DMT200030030	K02084	ko04115	p53 signaling pathway	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko04210	Apoptosis	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko05010	Alzheimer's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko05012	Parkinson's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko05016	Huntington's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030030	K02084	ko05222	Small cell lung cancer	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMT200030034	K02084	ko04115	p53 signaling pathway	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko04210	Apoptosis	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko05010	Alzheimer's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko05012	Parkinson's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko05016	Huntington's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030034	K02084	ko05222	Small cell lung cancer	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMT200030042	K02084	ko04115	p53 signaling pathway	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko04210	Apoptosis	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko05010	Alzheimer's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko05012	Parkinson's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko05016	Huntington's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030042	K02084	ko05222	Small cell lung cancer	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMT200030050	K05298	ko00710	Carbon fixation in photosynthetic organisms	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMT200030050	K05298	ko01100	Metabolic pathways	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMT200030051	K12855	ko03040	Spliceosome	236	2.4e-06	0.28	0.48	0.97
PGSC0003DMT200030052	K12869	ko03040	Spliceosome	306	4.2e-08	0.25	0.44	0.70
PGSC0003DMT200016111	K12891	ko03040	Spliceosome	218	3.4e-06	0.43	0.66	0.53
PGSC0003DMT200016112	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMT200016113	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMT200016114	K12900	ko03040	Spliceosome	415	4.7e-17	0.45	0.58	0.80
PGSC0003DMT200016115	K12900	ko03040	Spliceosome	570	1.3e-25	0.43	0.53	0.87
PGSC0003DMT200016116	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMT200016135	K05663	ko02010	ABC transporters	839	1.9e-40	0.52	0.65	0.98
PGSC0003DMT200016136	K05663	ko02010	ABC transporters	2998	1.6e-159	0.73	0.83	0.96
PGSC0003DMT200024306	K03028	ko03050	Proteasome	6579	0.	0.88	0.95	0.99
PGSC0003DMT200024307	K09561	ko04120	Ubiquitin mediated proteolysis	318	5.5e-11	0.32	0.46	0.68
PGSC0003DMT200024308	K12581	ko03018	RNA degradation	408	2.7e-14	0.29	0.44	0.75
PGSC0003DMT200024309	K12581	ko03018	RNA degradation	297	1.2e-07	0.30	0.45	0.59
PGSC0003DMT200024310	K12581	ko03018	RNA degradation	341	3.8e-10	0.29	0.44	0.71
PGSC0003DMT200033855	K06685	ko04111	Cell cycle - yeast	1629	5.2e-84	0.87	0.94	0.99
PGSC0003DMT200033856	K06685	ko04111	Cell cycle - yeast	959	4.6e-47	0.86	0.94	0.98
PGSC0003DMT200033857	K06685	ko04111	Cell cycle - yeast	919	7.5e-45	0.83	0.92	0.79
PGSC0003DMT200033859	K01213	ko00040	Pentose and glucuronate interconversions	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMT200033859	K01213	ko00500	Starch and sucrose metabolism	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMT200033859	K01213	ko01100	Metabolic pathways	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMT200033868	K03097	ko04310	Wnt signaling pathway	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMT200033868	K03097	ko04520	Adherens junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMT200033868	K03097	ko04530	Tight junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMT200033868	K03097	ko04712	Circadian rhythm - plant	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMT200033869	K03097	ko04310	Wnt signaling pathway	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMT200033869	K03097	ko04520	Adherens junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMT200033869	K03097	ko04530	Tight junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMT200033869	K03097	ko04712	Circadian rhythm - plant	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMT200033873	K12857	ko03040	Spliceosome	261	1.5e-08	0.28	0.48	0.58
PGSC0003DMT200033874	K10140	ko03420	Nucleotide excision repair	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMT200033874	K10140	ko04115	p53 signaling pathway	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMT200033874	K10140	ko04120	Ubiquitin mediated proteolysis	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMT200033875	K12857	ko03040	Spliceosome	216	4.4e-06	0.28	0.47	0.81
PGSC0003DMT200033876	K12857	ko03040	Spliceosome	261	6.9e-08	0.28	0.48	0.33
PGSC0003DMT200033877	K12857	ko03040	Spliceosome	261	5.2e-08	0.28	0.48	0.38
PGSC0003DMT200033879	K01066	ko00623	2,4-Dichlorobenzoate degradation	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMT200033879	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMT200000161	K12604	ko03018	RNA degradation	812	6.1e-38	0.51	0.70	1.00
PGSC0003DMT200000162	K12604	ko03018	RNA degradation	572	1.4e-24	0.51	0.70	0.94
PGSC0003DMT200000163	K12604	ko03018	RNA degradation	493	4.3e-20	0.50	0.67	0.84
PGSC0003DMT200000164	K12604	ko03018	RNA degradation	379	9.1e-14	0.55	0.74	0.59
PGSC0003DMT200000191	K04371	ko04010	MAPK signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04012	ErbB signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04013	MAPK signaling pathway - fly	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04062	Chemokine signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04114	Oocyte meiosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04150	mTOR signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04270	Vascular smooth muscle contraction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04320	Dorso-ventral axis formation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04350	TGF-beta signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04360	Axon guidance	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04370	VEGF signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04510	Focal adhesion	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04520	Adherens junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04540	Gap junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04620	Toll-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04621	NOD-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04650	Natural killer cell mediated cytotoxicity	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04660	T cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04662	B cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04664	Fc epsilon RI signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04666	Fc gamma R-mediated phagocytosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04720	Long-term potentiation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04722	Neurotrophin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04730	Long-term depression	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04810	Regulation of actin cytoskeleton	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04910	Insulin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04912	GnRH signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04914	Progesterone-mediated oocyte maturation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04916	Melanogenesis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04930	Type II diabetes mellitus	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05010	Alzheimer's disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05020	Prion diseases	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05131	Shigellosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05140	Leishmaniasis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05142	Chagas disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05200	Pathways in cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05210	Colorectal cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05211	Renal cell carcinoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05212	Pancreatic cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05213	Endometrial cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05214	Glioma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05215	Prostate cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05216	Thyroid cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05218	Melanoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05219	Bladder cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05220	Chronic myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05221	Acute myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000191	K04371	ko05223	Non-small cell lung cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMT200000192	K04371	ko04010	MAPK signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04012	ErbB signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04013	MAPK signaling pathway - fly	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04062	Chemokine signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04114	Oocyte meiosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04150	mTOR signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04270	Vascular smooth muscle contraction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04320	Dorso-ventral axis formation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04350	TGF-beta signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04360	Axon guidance	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04370	VEGF signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04510	Focal adhesion	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04520	Adherens junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04540	Gap junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04620	Toll-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04621	NOD-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04650	Natural killer cell mediated cytotoxicity	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04660	T cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04662	B cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04664	Fc epsilon RI signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04666	Fc gamma R-mediated phagocytosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04720	Long-term potentiation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04722	Neurotrophin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04730	Long-term depression	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04810	Regulation of actin cytoskeleton	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04910	Insulin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04912	GnRH signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04914	Progesterone-mediated oocyte maturation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04916	Melanogenesis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04930	Type II diabetes mellitus	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05010	Alzheimer's disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05020	Prion diseases	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05131	Shigellosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05140	Leishmaniasis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05142	Chagas disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05200	Pathways in cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05210	Colorectal cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05211	Renal cell carcinoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05212	Pancreatic cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05213	Endometrial cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05214	Glioma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05215	Prostate cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05216	Thyroid cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05218	Melanoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05219	Bladder cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05220	Chronic myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05221	Acute myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000192	K04371	ko05223	Non-small cell lung cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMT200000200	K12356	ko00940	Phenylpropanoid biosynthesis	557	6.9e-25	0.30	0.47	0.90
PGSC0003DMT200059370	K00901	ko00561	Glycerolipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMT200059370	K00901	ko00564	Glycerophospholipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMT200059370	K00901	ko01100	Metabolic pathways	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMT200059370	K00901	ko04070	Phosphatidylinositol signaling system	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMT200059375	K03111	ko03030	DNA replication	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMT200059375	K03111	ko03430	Mismatch repair	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMT200059375	K03111	ko03440	Homologous recombination	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMT200059376	K03111	ko03030	DNA replication	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMT200059376	K03111	ko03430	Mismatch repair	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMT200059376	K03111	ko03440	Homologous recombination	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMT200059395	K06100	ko04530	Tight junction	4555	2.1e-245	0.53	0.67	0.98
PGSC0003DMT200059396	K06100	ko04530	Tight junction	5034	8.1e-272	0.53	0.67	0.99
PGSC0003DMT200067289	K01177	ko00500	Starch and sucrose metabolism	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMT200067289	K01177	ko01100	Metabolic pathways	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMT200067297	K06654	ko04111	Cell cycle - yeast	295	2.0e-10	0.35	0.49	0.69
PGSC0003DMT200076546	K02925	ko03010	Ribosome	3182	1.1e-169	0.94	0.98	1.00
PGSC0003DMT200076556	K13289	ko04142	Lysosome	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMT200076556	K13289	ko04614	Renin-angiotensin system	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMT200088629	K02992	ko03010	Ribosome	1060	1.2e-52	0.98	0.98	0.99
PGSC0003DMT200088638	K05282	ko00904	Diterpenoid biosynthesis	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMT200088638	K05282	ko01100	Metabolic pathways	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMT200088638	K05282	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMT200088646	K12356	ko00940	Phenylpropanoid biosynthesis	648	6.6e-30	0.30	0.48	0.98
PGSC0003DMT200018573	K12486	ko04144	Endocytosis	466	1.1e-19	0.27	0.41	0.69
PGSC0003DMT200018574	K05870	ko04612	Antigen processing and presentation	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMT200018574	K05870	ko04916	Melanogenesis	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMT200018574	K05870	ko04962	Vasopressin-regulated water reabsorption	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMT200018574	K05870	ko05016	Huntington's disease	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMT200018574	K05870	ko05215	Prostate cancer	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMT200018589	K01046	ko00561	Glycerolipid metabolism	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMT200018589	K01046	ko01100	Metabolic pathways	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMT200018620	K00697	ko00500	Starch and sucrose metabolism	5931	0.	0.78	0.87	0.97
PGSC0003DMT200008605	K01762	ko00270	Cysteine and methionine metabolism	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMT200008605	K01762	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMT200008611	K03040	ko00230	Purine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMT200008611	K03040	ko00240	Pyrimidine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMT200008611	K03040	ko01100	Metabolic pathways	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMT200008611	K03040	ko03020	RNA polymerase	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMT200008622	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMT200008622	K00517	ko00626	Naphthalene and anthracene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMT200008622	K00517	ko00903	Limonene and pinene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMT200008622	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMT200008622	K00517	ko01110	Biosynthesis of secondary metabolites	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMT200008624	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMT200008624	K00517	ko00626	Naphthalene and anthracene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMT200008624	K00517	ko00903	Limonene and pinene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMT200008624	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMT200008624	K00517	ko01110	Biosynthesis of secondary metabolites	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMT200008625	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMT200008625	K00517	ko00626	Naphthalene and anthracene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMT200008625	K00517	ko00903	Limonene and pinene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMT200008625	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMT200008625	K00517	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMT200008634	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMT200008634	K00517	ko00626	Naphthalene and anthracene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMT200008634	K00517	ko00903	Limonene and pinene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMT200008634	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMT200008634	K00517	ko01110	Biosynthesis of secondary metabolites	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMT200008635	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMT200008635	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMT200008635	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMT200008635	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMT200008635	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMT200008636	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMT200008636	K00517	ko00626	Naphthalene and anthracene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMT200008636	K00517	ko00903	Limonene and pinene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMT200008636	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMT200008636	K00517	ko01110	Biosynthesis of secondary metabolites	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMT200008637	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMT200008637	K00517	ko00626	Naphthalene and anthracene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMT200008637	K00517	ko00903	Limonene and pinene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMT200008637	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMT200008637	K00517	ko01110	Biosynthesis of secondary metabolites	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMT200008638	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMT200008638	K00517	ko00626	Naphthalene and anthracene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMT200008638	K00517	ko00903	Limonene and pinene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMT200008638	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMT200008638	K00517	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMT200038346	K00630	ko00561	Glycerolipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMT200038346	K00630	ko00564	Glycerophospholipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMT200038346	K00630	ko01100	Metabolic pathways	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMT200038351	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038351	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038352	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038353	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMT200038357	K08488	ko04130	SNARE interactions in vesicular transport	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMT200038357	K08488	ko04145	Phagosome	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMT200038360	K02830	ko04111	Cell cycle - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMT200038360	K02830	ko04113	Meiosis - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMT200038361	K02830	ko04111	Cell cycle - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMT200038361	K02830	ko04113	Meiosis - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMT200038374	K11229	ko04011	MAPK signaling pathway - yeast	532	1.4e-22	0.35	0.52	0.95
PGSC0003DMT200038379	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMT200038379	K07541	ko01100	Metabolic pathways	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMT200038380	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMT200038380	K07541	ko01100	Metabolic pathways	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMT200043348	K09680	ko00770	Pantothenate and CoA biosynthesis	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMT200043348	K09680	ko01100	Metabolic pathways	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMT200043349	K09680	ko00770	Pantothenate and CoA biosynthesis	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMT200043349	K09680	ko01100	Metabolic pathways	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMT200043353	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.67
PGSC0003DMT200043354	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.64
PGSC0003DMT200043355	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.63
PGSC0003DMT200043356	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.61
PGSC0003DMT200043368	K11816	ko00380	Tryptophan metabolism	676	1.9e-31	0.47	0.64	0.96
PGSC0003DMT200043369	K11816	ko00380	Tryptophan metabolism	355	9.6e-14	0.44	0.70	0.98
PGSC0003DMT200043370	K11816	ko00380	Tryptophan metabolism	652	4.0e-30	0.47	0.65	0.96
PGSC0003DMT200043372	K11816	ko00380	Tryptophan metabolism	412	6.9e-17	0.60	0.79	0.94
PGSC0003DMT200043373	K11816	ko00380	Tryptophan metabolism	649	5.8e-30	0.49	0.72	0.98
PGSC0003DMT200043384	K08769	ko03320	PPAR signaling pathway	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMT200043384	K08769	ko05016	Huntington's disease	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMT200080912	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080912	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080912	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080913	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMT200080913	K00517	ko00626	Naphthalene and anthracene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMT200080913	K00517	ko00903	Limonene and pinene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMT200080913	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMT200080913	K00517	ko01110	Biosynthesis of secondary metabolites	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMT200080914	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080914	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080914	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMT200080915	K11818	ko00380	Tryptophan metabolism	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMT200080915	K11818	ko00966	Glucosinolate biosynthesis	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMT200080915	K11818	ko01110	Biosynthesis of secondary metabolites	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMT200080916	K11818	ko00380	Tryptophan metabolism	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMT200080916	K11818	ko00966	Glucosinolate biosynthesis	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMT200080916	K11818	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMT200080919	K11818	ko00380	Tryptophan metabolism	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMT200080919	K11818	ko00966	Glucosinolate biosynthesis	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMT200080919	K11818	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMT200080920	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMT200080920	K00517	ko00626	Naphthalene and anthracene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMT200080920	K00517	ko00903	Limonene and pinene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMT200080920	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMT200080920	K00517	ko01110	Biosynthesis of secondary metabolites	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMT200080921	K11818	ko00380	Tryptophan metabolism	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMT200080921	K11818	ko00966	Glucosinolate biosynthesis	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMT200080921	K11818	ko01110	Biosynthesis of secondary metabolites	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMT200080922	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMT200080922	K00517	ko00626	Naphthalene and anthracene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMT200080922	K00517	ko00903	Limonene and pinene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMT200080922	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMT200080922	K00517	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMT200080923	K11818	ko00380	Tryptophan metabolism	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMT200080923	K11818	ko00966	Glucosinolate biosynthesis	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMT200080923	K11818	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMT200080924	K11818	ko00380	Tryptophan metabolism	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMT200080924	K11818	ko00966	Glucosinolate biosynthesis	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMT200080924	K11818	ko01110	Biosynthesis of secondary metabolites	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMT200080925	K11818	ko00380	Tryptophan metabolism	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMT200080925	K11818	ko00966	Glucosinolate biosynthesis	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMT200080925	K11818	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMT200080926	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMT200080926	K00517	ko00626	Naphthalene and anthracene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMT200080926	K00517	ko00903	Limonene and pinene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMT200080926	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMT200080926	K00517	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMT200080927	K11818	ko00380	Tryptophan metabolism	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMT200080927	K11818	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMT200080927	K11818	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMT200080928	K11818	ko00380	Tryptophan metabolism	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMT200080928	K11818	ko00966	Glucosinolate biosynthesis	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMT200080928	K11818	ko01110	Biosynthesis of secondary metabolites	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMT200080929	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080929	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080930	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMT200080937	K12823	ko03040	Spliceosome	253	1.0e-07	0.59	0.62	0.75
PGSC0003DMT200065231	K03018	ko00230	Purine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMT200065231	K03018	ko00240	Pyrimidine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMT200065231	K03018	ko01100	Metabolic pathways	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMT200065231	K03018	ko03020	RNA polymerase	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMT200065231	K03018	ko04623	Cytosolic DNA-sensing pathway	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMT200065232	K03018	ko00230	Purine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMT200065232	K03018	ko00240	Pyrimidine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMT200065232	K03018	ko01100	Metabolic pathways	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMT200065232	K03018	ko03020	RNA polymerase	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMT200065232	K03018	ko04623	Cytosolic DNA-sensing pathway	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMT200065237	K03018	ko00230	Purine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMT200065237	K03018	ko00240	Pyrimidine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMT200065237	K03018	ko01100	Metabolic pathways	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMT200065237	K03018	ko03020	RNA polymerase	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMT200065237	K03018	ko04623	Cytosolic DNA-sensing pathway	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMT200065242	K07512	ko00062	Fatty acid elongation in mitochondria	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMT200065242	K07512	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMT200065244	K07512	ko00062	Fatty acid elongation in mitochondria	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMT200065244	K07512	ko01100	Metabolic pathways	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMT200065245	K07512	ko00062	Fatty acid elongation in mitochondria	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMT200065245	K07512	ko01100	Metabolic pathways	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMT200065246	K07512	ko00062	Fatty acid elongation in mitochondria	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMT200065246	K07512	ko01100	Metabolic pathways	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMT200065252	K01627	ko00540	Lipopolysaccharide biosynthesis	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMT200065252	K01627	ko01100	Metabolic pathways	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMT200065253	K01627	ko00540	Lipopolysaccharide biosynthesis	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMT200065253	K01627	ko01100	Metabolic pathways	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMT200065254	K01627	ko00540	Lipopolysaccharide biosynthesis	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMT200065254	K01627	ko01100	Metabolic pathways	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMT200065255	K01627	ko00540	Lipopolysaccharide biosynthesis	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMT200065255	K01627	ko01100	Metabolic pathways	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMT200065261	K04371	ko04010	MAPK signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04012	ErbB signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04013	MAPK signaling pathway - fly	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04062	Chemokine signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04114	Oocyte meiosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04150	mTOR signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04270	Vascular smooth muscle contraction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04320	Dorso-ventral axis formation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04350	TGF-beta signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04360	Axon guidance	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04370	VEGF signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04510	Focal adhesion	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04520	Adherens junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04540	Gap junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04620	Toll-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04621	NOD-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04650	Natural killer cell mediated cytotoxicity	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04660	T cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04662	B cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04664	Fc epsilon RI signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04666	Fc gamma R-mediated phagocytosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04720	Long-term potentiation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04722	Neurotrophin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04730	Long-term depression	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04810	Regulation of actin cytoskeleton	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04910	Insulin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04912	GnRH signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04914	Progesterone-mediated oocyte maturation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04916	Melanogenesis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04930	Type II diabetes mellitus	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05010	Alzheimer's disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05020	Prion diseases	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05131	Shigellosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05140	Leishmaniasis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05142	Chagas disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05200	Pathways in cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05210	Colorectal cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05211	Renal cell carcinoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05212	Pancreatic cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05213	Endometrial cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05214	Glioma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05215	Prostate cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05216	Thyroid cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05218	Melanoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05219	Bladder cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05220	Chronic myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05221	Acute myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065261	K04371	ko05223	Non-small cell lung cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMT200065267	K10352	ko04530	Tight junction	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMT200065267	K10352	ko05416	Viral myocarditis	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMT200065268	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMT200065268	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMT200065269	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMT200065269	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMT200065270	K10352	ko04530	Tight junction	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMT200065270	K10352	ko05416	Viral myocarditis	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMT200055243	K00860	ko00230	Purine metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMT200055243	K00860	ko00450	Selenoamino acid metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMT200055243	K00860	ko00920	Sulfur metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMT200055243	K00860	ko01100	Metabolic pathways	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMT200055247	K05862	ko04020	Calcium signaling pathway	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMT200055247	K05862	ko05012	Parkinson's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMT200055247	K05862	ko05016	Huntington's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMT200055249	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.76
PGSC0003DMT200055250	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.66
PGSC0003DMT200055263	K12134	ko04712	Circadian rhythm - plant	656	2.4e-30	0.38	0.52	0.63
PGSC0003DMT200055268	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.71
PGSC0003DMT200055269	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.43
PGSC0003DMT200055271	K06027	ko04962	Vasopressin-regulated water reabsorption	345	1.1e-12	0.40	0.60	0.53
PGSC0003DMT200055272	K01578	ko00410	beta-Alanine metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMT200055272	K01578	ko00640	Propanoate metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMT200055272	K01578	ko01100	Metabolic pathways	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMT200055272	K01578	ko04146	Peroxisome	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMT200055273	K01578	ko00410	beta-Alanine metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMT200055273	K01578	ko00640	Propanoate metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMT200055273	K01578	ko01100	Metabolic pathways	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMT200055273	K01578	ko04146	Peroxisome	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMT200055274	K01578	ko00410	beta-Alanine metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMT200055274	K01578	ko00640	Propanoate metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMT200055274	K01578	ko01100	Metabolic pathways	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMT200055274	K01578	ko04146	Peroxisome	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMT200055275	K01578	ko00410	beta-Alanine metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMT200055275	K01578	ko00640	Propanoate metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMT200055275	K01578	ko01100	Metabolic pathways	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMT200055275	K01578	ko04146	Peroxisome	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMT200055276	K01578	ko00410	beta-Alanine metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMT200055276	K01578	ko00640	Propanoate metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMT200055276	K01578	ko01100	Metabolic pathways	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMT200055276	K01578	ko04146	Peroxisome	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMT200055277	K01578	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMT200055277	K01578	ko00640	Propanoate metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMT200055277	K01578	ko01100	Metabolic pathways	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMT200055277	K01578	ko04146	Peroxisome	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMT200055278	K01578	ko00410	beta-Alanine metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMT200055278	K01578	ko00640	Propanoate metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMT200055278	K01578	ko01100	Metabolic pathways	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMT200055278	K01578	ko04146	Peroxisome	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMT200053128	K00235	ko00020	Citrate cycle (TCA cycle)	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko00190	Oxidative phosphorylation	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko01100	Metabolic pathways	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko05010	Alzheimer's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko05012	Parkinson's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053128	K00235	ko05016	Huntington's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMT200053140	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMT200053140	K08081	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMT200053140	K08081	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMT200053141	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMT200053141	K08081	ko01100	Metabolic pathways	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMT200053141	K08081	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMT200053142	K01087	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.76	0.86	0.79
PGSC0003DMT200053143	K01087	ko00500	Starch and sucrose metabolism	1903	4.0e-99	0.78	0.86	0.82
PGSC0003DMT200053144	K01087	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.77	0.86	0.78
PGSC0003DMT200053145	K00232	ko00071	Fatty acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053145	K00232	ko00592	alpha-Linolenic acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053145	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053145	K00232	ko01100	Metabolic pathways	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053145	K00232	ko03320	PPAR signaling pathway	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053145	K00232	ko04146	Peroxisome	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMT200053156	K01099	ko00562	Inositol phosphate metabolism	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMT200053156	K01099	ko01100	Metabolic pathways	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMT200053156	K01099	ko04070	Phosphatidylinositol signaling system	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMT200053157	K01834	ko00010	Glycolysis / Gluconeogenesis	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMT200053157	K01834	ko01100	Metabolic pathways	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMT200053157	K01834	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMT200053158	K01834	ko00010	Glycolysis / Gluconeogenesis	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMT200053158	K01834	ko01100	Metabolic pathways	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMT200053158	K01834	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMT200010287	K09838	ko00906	Carotenoid biosynthesis	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMT200010287	K09838	ko01100	Metabolic pathways	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMT200010287	K09838	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMT200010288	K09838	ko00906	Carotenoid biosynthesis	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMT200010288	K09838	ko01100	Metabolic pathways	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMT200010288	K09838	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMT200010291	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3188	5.3e-170	0.78	0.85	0.99
PGSC0003DMT200010292	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3551	5.1e-190	0.84	0.91	0.99
PGSC0003DMT200010295	K10840	ko03420	Nucleotide excision repair	784	2.1e-37	0.56	0.85	0.92
PGSC0003DMT200010306	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMT200010306	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMT200010306	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMT200010306	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMT200010308	K03360	ko04111	Cell cycle - yeast	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMT200010308	K03360	ko04120	Ubiquitin mediated proteolysis	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMT200010310	K00588	ko00360	Phenylalanine metabolism	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010310	K00588	ko00940	Phenylpropanoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010310	K00588	ko00941	Flavonoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010310	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010310	K00588	ko01100	Metabolic pathways	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010310	K00588	ko01110	Biosynthesis of secondary metabolites	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMT200010311	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010311	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010311	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010311	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010311	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010311	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko00360	Phenylalanine metabolism	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko00940	Phenylpropanoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko00941	Flavonoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko01100	Metabolic pathways	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010312	K00588	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010313	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010314	K00588	ko00360	Phenylalanine metabolism	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010314	K00588	ko00940	Phenylpropanoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010314	K00588	ko00941	Flavonoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010314	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010314	K00588	ko01100	Metabolic pathways	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010314	K00588	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMT200010315	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010315	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010315	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010315	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010315	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010315	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010316	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko00360	Phenylalanine metabolism	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko00940	Phenylpropanoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko00941	Flavonoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko01100	Metabolic pathways	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010318	K00588	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMT200010320	K02320	ko00230	Purine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMT200010320	K02320	ko00240	Pyrimidine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMT200010320	K02320	ko01100	Metabolic pathways	8469	0.	0.66	0.79	1.00
PGSC0003DMT200010320	K02320	ko03030	DNA replication	8469	0.	0.66	0.79	1.00
PGSC0003DMT200020524	K10577	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.87	0.94	0.99
PGSC0003DMT200020526	K13065	ko00940	Phenylpropanoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMT200020526	K13065	ko00941	Flavonoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMT200020526	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMT200020526	K13065	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMT200020532	K12126	ko04712	Circadian rhythm - plant	422	1.9e-17	0.52	0.65	0.59
PGSC0003DMT200020533	K12126	ko04712	Circadian rhythm - plant	467	6.4e-20	0.40	0.55	0.71
PGSC0003DMT200020534	K12126	ko04712	Circadian rhythm - plant	485	6.5e-21	0.40	0.54	0.70
PGSC0003DMT200020559	K01046	ko00561	Glycerolipid metabolism	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMT200020559	K01046	ko01100	Metabolic pathways	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMT200020560	K01046	ko00561	Glycerolipid metabolism	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMT200020560	K01046	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMT200036645	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3749	6.1e-201	0.84	0.93	0.98
PGSC0003DMT200036668	K00864	ko00561	Glycerolipid metabolism	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMT200036668	K00864	ko01100	Metabolic pathways	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMT200036668	K00864	ko03320	PPAR signaling pathway	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMT200036668	K00864	ko04626	Plant-pathogen interaction	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMT200036670	K10563	ko03410	Base excision repair	1000	2.5e-49	0.84	0.96	0.98
PGSC0003DMT200036671	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMT200036672	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMT200036673	K10563	ko03410	Base excision repair	1843	8.1e-96	0.82	0.95	0.98
PGSC0003DMT200036674	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMT200036675	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMT200036676	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMT200036677	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMT200008370	K12126	ko04712	Circadian rhythm - plant	293	3.9e-10	0.35	0.56	0.74
PGSC0003DMT200008389	K00029	ko00620	Pyruvate metabolism	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMT200008389	K00029	ko00710	Carbon fixation in photosynthetic organisms	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMT200008389	K00029	ko01100	Metabolic pathways	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMT200008390	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008390	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008390	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008392	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008392	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008392	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMT200008401	K09756	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.43	0.60	0.98
PGSC0003DMT200008407	K09489	ko04612	Antigen processing and presentation	423	5.5e-17	0.66	0.81	0.51
PGSC0003DMT200008408	K09489	ko04612	Antigen processing and presentation	474	6.5e-20	0.72	0.84	0.86
PGSC0003DMT200089836	K01051	ko00040	Pentose and glucuronate interconversions	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMT200089836	K01051	ko00500	Starch and sucrose metabolism	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMT200089836	K01051	ko01100	Metabolic pathways	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMT200083749	K07385	ko00902	Monoterpenoid biosynthesis	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMT200083749	K07385	ko01100	Metabolic pathways	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMT200083750	K07385	ko00902	Monoterpenoid biosynthesis	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMT200083750	K07385	ko01100	Metabolic pathways	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMT200083751	K07385	ko00902	Monoterpenoid biosynthesis	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMT200083751	K07385	ko01100	Metabolic pathways	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMT200083752	K07385	ko00902	Monoterpenoid biosynthesis	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMT200083752	K07385	ko01100	Metabolic pathways	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMT200083753	K07385	ko00902	Monoterpenoid biosynthesis	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMT200083753	K07385	ko01100	Metabolic pathways	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMT200083754	K07385	ko00902	Monoterpenoid biosynthesis	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMT200083754	K07385	ko01100	Metabolic pathways	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMT200083755	K07385	ko00902	Monoterpenoid biosynthesis	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMT200083755	K07385	ko01100	Metabolic pathways	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMT200083756	K07385	ko00902	Monoterpenoid biosynthesis	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMT200083756	K07385	ko01100	Metabolic pathways	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMT200083757	K07385	ko00902	Monoterpenoid biosynthesis	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMT200083757	K07385	ko01100	Metabolic pathways	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMT200083758	K07385	ko00902	Monoterpenoid biosynthesis	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMT200083758	K07385	ko01100	Metabolic pathways	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMT200083773	K12127	ko04712	Circadian rhythm - plant	250	2.8e-07	0.39	0.58	0.29
PGSC0003DMT200083774	K12127	ko04712	Circadian rhythm - plant	250	1.4e-07	0.39	0.58	0.33
PGSC0003DMT200053327	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053327	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053327	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053328	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053328	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053328	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMT200053330	K00849	ko00052	Galactose metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMT200053330	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMT200053330	K00849	ko01100	Metabolic pathways	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMT200053331	K00849	ko00052	Galactose metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMT200053331	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMT200053331	K00849	ko01100	Metabolic pathways	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMT200053337	K00849	ko00052	Galactose metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMT200053337	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMT200053337	K00849	ko01100	Metabolic pathways	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMT200053340	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	312	2.3e-11	0.60	0.77	0.92
PGSC0003DMT200053347	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMT200053347	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMT200053348	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMT200053348	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMT200053355	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	297	1.5e-10	0.60	0.71	0.62
PGSC0003DMT200053357	K12836	ko03040	Spliceosome	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMT200053357	K12836	ko05131	Shigellosis	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMT200053360	K12836	ko03040	Spliceosome	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMT200053360	K12836	ko05131	Shigellosis	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMT200053364	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMT200053365	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMT200063545	K09490	ko03060	Protein export	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMT200063545	K09490	ko05020	Prion diseases	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMT200063549	K01358	ko04112	Cell cycle - Caulobacter	824	1.3e-39	0.48	0.70	0.67
PGSC0003DMT200063552	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMT200063552	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMT200063552	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMT200063552	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMT200063552	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMT200063553	K00680	ko00350	Tyrosine metabolism	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMT200063553	K00680	ko00624	1- and 2-Methylnaphthalene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMT200063553	K00680	ko00632	Benzoate degradation via CoA ligation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMT200063553	K00680	ko00642	Ethylbenzene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMT200063553	K00680	ko00903	Limonene and pinene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMT200063554	K00680	ko00350	Tyrosine metabolism	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMT200063554	K00680	ko00624	1- and 2-Methylnaphthalene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMT200063554	K00680	ko00632	Benzoate degradation via CoA ligation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMT200063554	K00680	ko00642	Ethylbenzene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMT200063554	K00680	ko00903	Limonene and pinene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMT200063561	K10532	ko00531	Glycosaminoglycan degradation	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMT200063561	K10532	ko01100	Metabolic pathways	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMT200063561	K10532	ko04142	Lysosome	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMT200063570	K12623	ko03018	RNA degradation	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMT200063570	K12623	ko03040	Spliceosome	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMT200063574	K03065	ko03050	Proteasome	3408	3.9e-182	0.96	0.99	1.00
PGSC0003DMT200063586	K02891	ko03010	Ribosome	897	1.2e-43	0.84	0.94	0.99
PGSC0003DMT200022585	K07203	ko04012	ErbB signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko04150	mTOR signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko04910	Insulin signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko04920	Adipocytokine signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko04930	Type II diabetes mellitus	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko05200	Pathways in cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko05214	Glioma	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko05215	Prostate cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022585	K07203	ko05221	Acute myeloid leukemia	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMT200022594	K12478	ko04144	Endocytosis	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMT200022594	K12478	ko04145	Phagosome	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMT200022596	K02921	ko03010	Ribosome	631	5.7e-29	0.88	0.94	0.99
PGSC0003DMT200022626	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022626	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022626	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022626	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022626	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022626	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200022627	K10747	ko03030	DNA replication	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMT200022627	K10747	ko03410	Base excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMT200022627	K10747	ko03420	Nucleotide excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMT200022627	K10747	ko03430	Mismatch repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMT200014424	K12861	ko03040	Spliceosome	1593	5.0e-82	0.75	0.87	0.99
PGSC0003DMT200014442	K03211	ko04013	MAPK signaling pathway - fly	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMT200014442	K03211	ko04320	Dorso-ventral axis formation	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMT200014443	K02563	ko00550	Peptidoglycan biosynthesis	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMT200014443	K02563	ko01100	Metabolic pathways	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMT200014443	K02563	ko04112	Cell cycle - Caulobacter	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMT200014444	K02563	ko00550	Peptidoglycan biosynthesis	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMT200014444	K02563	ko01100	Metabolic pathways	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMT200014444	K02563	ko04112	Cell cycle - Caulobacter	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMT200014449	K03821	ko00650	Butanoate metabolism	281	1.3e-09	0.24	0.41	0.87
PGSC0003DMT200032154	K00432	ko00480	Glutathione metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMT200032154	K00432	ko00590	Arachidonic acid metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMT200032158	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMT200032158	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMT200032159	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMT200032159	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMT200091965	K12606	ko03018	RNA degradation	618	3.0e-28	0.43	0.65	0.94
PGSC0003DMT200001102	K04565	ko04146	Peroxisome	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMT200001102	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMT200001102	K04565	ko05016	Huntington's disease	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMT200001102	K04565	ko05020	Prion diseases	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMT200001103	K04565	ko04146	Peroxisome	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMT200001103	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMT200001103	K04565	ko05016	Huntington's disease	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMT200001103	K04565	ko05020	Prion diseases	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMT200001108	K11252	ko05322	Systemic lupus erythematosus	1034	3.4e-51	0.89	0.94	0.99
PGSC0003DMT200001124	K13083	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMT200001124	K13083	ko00944	Flavone and flavonol biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMT200001124	K13083	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMT200001125	K13083	ko00941	Flavonoid biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMT200001125	K13083	ko00944	Flavone and flavonol biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMT200001125	K13083	ko01110	Biosynthesis of secondary metabolites	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMT200074414	K08008	ko04145	Phagosome	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMT200074414	K08008	ko04670	Leukocyte transendothelial migration	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMT200074415	K08008	ko04145	Phagosome	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMT200074415	K08008	ko04670	Leukocyte transendothelial migration	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMT200074416	K08008	ko04145	Phagosome	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMT200074416	K08008	ko04670	Leukocyte transendothelial migration	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMT200074417	K08008	ko04145	Phagosome	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMT200074417	K08008	ko04670	Leukocyte transendothelial migration	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMT200074418	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMT200074418	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMT200074444	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMT200074444	K01904	ko00360	Phenylalanine metabolism	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMT200074444	K01904	ko00940	Phenylpropanoid biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMT200074444	K01904	ko01100	Metabolic pathways	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMT200074444	K01904	ko01110	Biosynthesis of secondary metabolites	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMT200074449	K08054	ko04145	Phagosome	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMT200074449	K08054	ko04612	Antigen processing and presentation	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMT200074450	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMT200074450	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMT200074451	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMT200074451	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMT200074452	K02978	ko03010	Ribosome	588	1.3e-26	0.82	0.89	0.85
PGSC0003DMT200068995	K01199	ko00500	Starch and sucrose metabolism	736	9.3e-35	0.32	0.56	0.85
PGSC0003DMT200069000	K05759	ko04810	Regulation of actin cytoskeleton	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMT200069000	K05759	ko05131	Shigellosis	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMT200061142	K10245	ko01040	Biosynthesis of unsaturated fatty acids	479	1.4e-20	0.35	0.49	0.87
PGSC0003DMT200061148	K00889	ko00562	Inositol phosphate metabolism	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061148	K00889	ko01100	Metabolic pathways	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061148	K00889	ko04070	Phosphatidylinositol signaling system	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061148	K00889	ko04144	Endocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061148	K00889	ko04666	Fc gamma R-mediated phagocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061148	K00889	ko04810	Regulation of actin cytoskeleton	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMT200061149	K00889	ko00562	Inositol phosphate metabolism	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061149	K00889	ko01100	Metabolic pathways	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061149	K00889	ko04070	Phosphatidylinositol signaling system	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061149	K00889	ko04144	Endocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061149	K00889	ko04666	Fc gamma R-mediated phagocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061149	K00889	ko04810	Regulation of actin cytoskeleton	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMT200061157	K00600	ko00260	Glycine, serine and threonine metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061157	K00600	ko00460	Cyanoamino acid metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061157	K00600	ko00670	One carbon pool by folate	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061157	K00600	ko00680	Methane metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061157	K00600	ko01100	Metabolic pathways	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061157	K00600	ko01110	Biosynthesis of secondary metabolites	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMT200061165	K10901	ko03440	Homologous recombination	1531	1.3e-78	0.63	0.81	0.98
PGSC0003DMT200078319	K08311	ko03018	RNA degradation	554	1.0e-24	0.46	0.65	0.83
PGSC0003DMT200078324	K03655	ko03440	Homologous recombination	334	1.3e-11	0.57	0.71	0.91
PGSC0003DMT200078325	K03655	ko03440	Homologous recombination	2856	1.1e-151	0.77	0.88	0.94
PGSC0003DMT200078326	K03655	ko03440	Homologous recombination	3680	3.9e-197	0.62	0.73	1.00
PGSC0003DMT200078327	K03655	ko03440	Homologous recombination	5420	4.2e-293	0.67	0.77	1.00
PGSC0003DMT200078328	K03655	ko03440	Homologous recombination	1562	2.6e-80	0.85	0.92	1.00
PGSC0003DMT200078342	K00767	ko00760	Nicotinate and nicotinamide metabolism	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMT200078342	K00767	ko01100	Metabolic pathways	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMT200078346	K00889	ko00562	Inositol phosphate metabolism	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078346	K00889	ko01100	Metabolic pathways	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078346	K00889	ko04070	Phosphatidylinositol signaling system	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078346	K00889	ko04144	Endocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078346	K00889	ko04666	Fc gamma R-mediated phagocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078346	K00889	ko04810	Regulation of actin cytoskeleton	8412	0.	0.60	0.74	1.00
PGSC0003DMT200078348	K00889	ko00562	Inositol phosphate metabolism	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200078348	K00889	ko01100	Metabolic pathways	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200078348	K00889	ko04070	Phosphatidylinositol signaling system	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200078348	K00889	ko04144	Endocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200078348	K00889	ko04666	Fc gamma R-mediated phagocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200078348	K00889	ko04810	Regulation of actin cytoskeleton	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMT200058957	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMT200058957	K11517	ko01100	Metabolic pathways	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMT200058957	K11517	ko04146	Peroxisome	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMT200058958	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMT200058958	K11517	ko01100	Metabolic pathways	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMT200058958	K11517	ko04146	Peroxisome	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMT200058959	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMT200058959	K11517	ko01100	Metabolic pathways	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMT200058959	K11517	ko04146	Peroxisome	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMT200058960	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMT200058960	K11517	ko01100	Metabolic pathways	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMT200058960	K11517	ko04146	Peroxisome	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMT200058971	K08517	ko04130	SNARE interactions in vesicular transport	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMT200058971	K08517	ko04145	Phagosome	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMT200058972	K08517	ko04130	SNARE interactions in vesicular transport	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMT200058972	K08517	ko04145	Phagosome	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMT200058977	K05658	ko02010	ABC transporters	3808	3.4e-204	0.43	0.62	0.80
PGSC0003DMT200058987	K12893	ko03040	Spliceosome	310	2.9e-08	0.28	0.42	0.55
PGSC0003DMT200058996	K08233	ko00901	Indole alkaloid biosynthesis	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMT200058996	K08233	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMT200059001	K10260	ko04120	Ubiquitin mediated proteolysis	402	2.4e-16	0.28	0.45	0.68
PGSC0003DMT200059009	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMT200059009	K00224	ko00364	Fluorobenzoate degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMT200059009	K00224	ko00628	Fluorene degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMT200059009	K00224	ko00640	Propanoate metabolism	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMT200059012	K08233	ko00901	Indole alkaloid biosynthesis	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMT200059012	K08233	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMT200059013	K08233	ko00901	Indole alkaloid biosynthesis	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMT200059013	K08233	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMT200059014	K08233	ko00901	Indole alkaloid biosynthesis	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMT200059014	K08233	ko01110	Biosynthesis of secondary metabolites	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMT200066791	K01051	ko00040	Pentose and glucuronate interconversions	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMT200066791	K01051	ko00500	Starch and sucrose metabolism	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMT200066791	K01051	ko01100	Metabolic pathways	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMT200066792	K08495	ko04130	SNARE interactions in vesicular transport	1720	4.9e-89	0.89	0.95	0.98
PGSC0003DMT200066797	K06096	ko04530	Tight junction	411	7.8e-17	0.34	0.54	0.94
PGSC0003DMT200066807	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.76
PGSC0003DMT200066808	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.80
PGSC0003DMT200066816	K01692	ko00071	Fatty acid metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00280	Valine, leucine and isoleucine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00281	Geraniol degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00310	Lysine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00380	Tryptophan metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00410	beta-Alanine metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00632	Benzoate degradation via CoA ligation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00640	Propanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00650	Butanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko00930	Caprolactam degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko01100	Metabolic pathways	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066816	K01692	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMT200066819	K01509	ko00230	Purine metabolism	948	3.9e-46	0.42	0.59	0.90
PGSC0003DMT200049655	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049655	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049655	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049655	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049655	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049656	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049656	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049656	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049656	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049656	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMT200049657	K01758	ko00260	Glycine, serine and threonine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMT200049657	K01758	ko00270	Cysteine and methionine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMT200049657	K01758	ko00450	Selenoamino acid metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMT200049657	K01758	ko00910	Nitrogen metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMT200049657	K01758	ko01100	Metabolic pathways	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMT200049667	K05681	ko02010	ABC transporters	1336	7.5e-68	0.37	0.55	0.97
PGSC0003DMT200049673	K00008	ko00051	Fructose and mannose metabolism	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMT200049673	K00008	ko01100	Metabolic pathways	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMT200049674	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMT200049674	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMT200049675	K00008	ko00051	Fructose and mannose metabolism	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMT200049675	K00008	ko01100	Metabolic pathways	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMT200049676	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMT200049676	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMT200049678	K03943	ko00190	Oxidative phosphorylation	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMT200049678	K03943	ko01100	Metabolic pathways	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMT200049678	K03943	ko05010	Alzheimer's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMT200049678	K03943	ko05012	Parkinson's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMT200049678	K03943	ko05016	Huntington's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMT200049683	K00648	ko00061	Fatty acid biosynthesis	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMT200049683	K00648	ko01100	Metabolic pathways	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMT200049686	K11251	ko05322	Systemic lupus erythematosus	1025	1.1e-50	0.91	0.96	0.99
PGSC0003DMT200049690	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMT200049690	K12502	ko01100	Metabolic pathways	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMT200049690	K12502	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMT200049691	K01047	ko00564	Glycerophospholipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko00565	Ether lipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko00590	Arachidonic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko00591	Linoleic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko00592	alpha-Linolenic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko01100	Metabolic pathways	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04010	MAPK signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04270	Vascular smooth muscle contraction	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04370	VEGF signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04664	Fc epsilon RI signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04730	Long-term depression	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200049691	K01047	ko04912	GnRH signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMT200093516	K10601	ko04120	Ubiquitin mediated proteolysis	261	4.2e-08	0.31	0.41	0.93
PGSC0003DMT200093540	K00472	ko00330	Arginine and proline metabolism	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMT200093540	K00472	ko01100	Metabolic pathways	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMT200030755	K09526	ko04144	Endocytosis	327	1.8e-11	0.40	0.59	0.64
PGSC0003DMT200030757	K00858	ko00760	Nicotinate and nicotinamide metabolism	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMT200030757	K00858	ko01100	Metabolic pathways	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMT200030758	K00858	ko00760	Nicotinate and nicotinamide metabolism	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMT200030758	K00858	ko01100	Metabolic pathways	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMT200030759	K00858	ko00760	Nicotinate and nicotinamide metabolism	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMT200030759	K00858	ko01100	Metabolic pathways	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMT200030760	K00858	ko00760	Nicotinate and nicotinamide metabolism	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMT200030760	K00858	ko01100	Metabolic pathways	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMT200030762	K12929	ko00904	Diterpenoid biosynthesis	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMT200030762	K12929	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMT200030767	K04506	ko04115	p53 signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMT200030767	K04506	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMT200030767	K04506	ko04310	Wnt signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMT200030778	K05863	ko04020	Calcium signaling pathway	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMT200030778	K05863	ko05012	Parkinson's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMT200030778	K05863	ko05016	Huntington's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMT200015758	K00943	ko00240	Pyrimidine metabolism	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMT200015758	K00943	ko01100	Metabolic pathways	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMT200015759	K00943	ko00240	Pyrimidine metabolism	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMT200015759	K00943	ko01100	Metabolic pathways	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMT200015774	K03033	ko03050	Proteasome	3555	3.0e-190	0.87	0.92	1.00
PGSC0003DMT200015775	K03033	ko03050	Proteasome	2690	1.6e-142	0.73	0.84	0.92
PGSC0003DMT200015776	K03033	ko03050	Proteasome	3578	1.6e-191	0.88	0.93	1.00
PGSC0003DMT200015779	K10581	ko04120	Ubiquitin mediated proteolysis	5128	3.2e-279	0.63	0.74	0.94
PGSC0003DMT200015780	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMT200015781	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMT200015790	K01190	ko00052	Galactose metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMT200015790	K01190	ko00511	Other glycan degradation	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMT200015790	K01190	ko00600	Sphingolipid metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMT200015790	K01190	ko01100	Metabolic pathways	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMT200023797	K12876	ko03040	Spliceosome	1160	3.8e-58	0.74	0.84	0.78
PGSC0003DMT200023798	K12876	ko03040	Spliceosome	1290	2.6e-65	0.76	0.86	0.99
PGSC0003DMT200023800	K13065	ko00940	Phenylpropanoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMT200023800	K13065	ko00941	Flavonoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMT200023800	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMT200023800	K13065	ko01110	Biosynthesis of secondary metabolites	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMT200023821	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	238	2.7e-07	0.30	0.42	0.70
PGSC0003DMT200023822	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1028	7.3e-51	0.42	0.56	0.89
PGSC0003DMT200023823	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	374	8.6e-15	0.32	0.50	0.81
PGSC0003DMT200023825	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	327	3.4e-12	0.52	0.69	0.99
PGSC0003DMT200006781	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMT200006781	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMT200006782	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMT200006782	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMT200006784	K06664	ko04146	Peroxisome	902	6.5e-44	0.47	0.53	0.71
PGSC0003DMT200006786	K06664	ko04146	Peroxisome	411	7.8e-17	0.81	0.84	0.57
PGSC0003DMT200006787	K06664	ko04146	Peroxisome	746	2.6e-35	0.77	0.85	0.86
PGSC0003DMT200006809	K03843	ko00510	N-Glycan biosynthesis	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMT200006809	K03843	ko01100	Metabolic pathways	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMT200065411	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065411	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065411	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065411	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065411	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065411	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200065412	K07195	ko04910	Insulin signaling pathway	464	9.3e-20	0.71	0.84	0.66
PGSC0003DMT200065428	K13229	ko00402	Benzoxazinoid biosynthesis	1271	2.9e-64	0.45	0.65	0.98
PGSC0003DMT200065429	K13229	ko00402	Benzoxazinoid biosynthesis	1249	4.7e-63	0.45	0.64	0.99
PGSC0003DMT200065430	K13229	ko00402	Benzoxazinoid biosynthesis	1063	8.5e-53	0.47	0.66	0.95
PGSC0003DMT200065431	K13229	ko00402	Benzoxazinoid biosynthesis	1066	5.8e-53	0.48	0.66	0.96
PGSC0003DMT200055922	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055922	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055923	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055923	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055924	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055924	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMT200055925	K07385	ko00902	Monoterpenoid biosynthesis	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMT200055925	K07385	ko01100	Metabolic pathways	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMT200055931	K08901	ko00195	Photosynthesis	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMT200055931	K08901	ko01100	Metabolic pathways	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMT200055936	K04733	ko04210	Apoptosis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMT200055936	K04733	ko04620	Toll-like receptor signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMT200055936	K04733	ko04722	Neurotrophin signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMT200055936	K04733	ko05140	Leishmaniasis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMT200055936	K04733	ko05142	Chagas disease	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMT200055940	K04733	ko04210	Apoptosis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMT200055940	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMT200055940	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMT200055940	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMT200055940	K04733	ko05142	Chagas disease	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMT200055941	K04733	ko04210	Apoptosis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMT200055941	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMT200055941	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMT200055941	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMT200055941	K04733	ko05142	Chagas disease	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMT200055943	K04733	ko04210	Apoptosis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMT200055943	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMT200055943	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMT200055943	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMT200055943	K04733	ko05142	Chagas disease	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMT200055944	K00558	ko00270	Cysteine and methionine metabolism	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMT200055944	K00558	ko01100	Metabolic pathways	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMT200055956	K05933	ko00270	Cysteine and methionine metabolism	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMT200055956	K05933	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMT200055957	K05278	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMT200055957	K05278	ko01100	Metabolic pathways	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMT200055957	K05278	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMT200055959	K11820	ko00380	Tryptophan metabolism	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMT200055959	K11820	ko00966	Glucosinolate biosynthesis	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMT200055959	K11820	ko01110	Biosynthesis of secondary metabolites	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMT200052600	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMT200052600	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMT200052602	K04424	ko04010	MAPK signaling pathway	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMT200052602	K04424	ko04530	Tight junction	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMT200052603	K04424	ko04010	MAPK signaling pathway	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMT200052603	K04424	ko04530	Tight junction	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMT200052604	K04424	ko04010	MAPK signaling pathway	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMT200052604	K04424	ko04530	Tight junction	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMT200052607	K05741	ko04810	Regulation of actin cytoskeleton	280	3.4e-07	0.32	0.45	0.63
PGSC0003DMT200052608	K01595	ko00620	Pyruvate metabolism	7500	0.	0.91	0.97	1.00
PGSC0003DMT200052608	K01595	ko00710	Carbon fixation in photosynthetic organisms	7500	0.	0.91	0.97	1.00
PGSC0003DMT200052608	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7500	0.	0.91	0.97	1.00
PGSC0003DMT200052608	K01595	ko01100	Metabolic pathways	7500	0.	0.91	0.97	1.00
PGSC0003DMT200052609	K01595	ko00620	Pyruvate metabolism	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMT200052609	K01595	ko00710	Carbon fixation in photosynthetic organisms	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMT200052609	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMT200052609	K01595	ko01100	Metabolic pathways	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMT200052611	K01595	ko00620	Pyruvate metabolism	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMT200052611	K01595	ko00710	Carbon fixation in photosynthetic organisms	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMT200052611	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMT200052611	K01595	ko01100	Metabolic pathways	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMT200052619	K06630	ko04110	Cell cycle	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMT200052619	K06630	ko04114	Oocyte meiosis	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMT200052619	K06630	ko04722	Neurotrophin signaling pathway	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMT200052620	K00861	ko00740	Riboflavin metabolism	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMT200052620	K00861	ko01100	Metabolic pathways	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMT200052621	K00861	ko00740	Riboflavin metabolism	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMT200052621	K00861	ko01100	Metabolic pathways	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMT200070918	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070918	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070920	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMT200070920	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMT200070921	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070921	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070922	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070922	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070923	K04564	ko04146	Peroxisome	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMT200070923	K04564	ko05016	Huntington's disease	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMT200070924	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070924	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMT200070925	K04564	ko04146	Peroxisome	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMT200070925	K04564	ko05016	Huntington's disease	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMT200070926	K04564	ko04146	Peroxisome	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMT200070926	K04564	ko05016	Huntington's disease	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMT200070928	K03348	ko04110	Cell cycle	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070928	K03348	ko04111	Cell cycle - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070928	K03348	ko04113	Meiosis - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070928	K03348	ko04114	Oocyte meiosis	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070928	K03348	ko04120	Ubiquitin mediated proteolysis	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070928	K03348	ko04914	Progesterone-mediated oocyte maturation	8324	0.	0.69	0.80	0.99
PGSC0003DMT200070929	K03348	ko04110	Cell cycle	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070929	K03348	ko04111	Cell cycle - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070929	K03348	ko04113	Meiosis - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070929	K03348	ko04114	Oocyte meiosis	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070929	K03348	ko04120	Ubiquitin mediated proteolysis	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070929	K03348	ko04914	Progesterone-mediated oocyte maturation	10013	0.	0.66	0.78	1.00
PGSC0003DMT200070930	K03348	ko04110	Cell cycle	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200070930	K03348	ko04111	Cell cycle - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200070930	K03348	ko04113	Meiosis - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200070930	K03348	ko04114	Oocyte meiosis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200070930	K03348	ko04120	Ubiquitin mediated proteolysis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200070930	K03348	ko04914	Progesterone-mediated oocyte maturation	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMT200088528	K05282	ko00904	Diterpenoid biosynthesis	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMT200088528	K05282	ko01100	Metabolic pathways	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMT200088528	K05282	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMT200088530	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.9e-10	0.34	0.51	0.82
PGSC0003DMT200018810	K00901	ko00561	Glycerolipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMT200018810	K00901	ko00564	Glycerophospholipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMT200018810	K00901	ko01100	Metabolic pathways	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMT200018810	K00901	ko04070	Phosphatidylinositol signaling system	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMT200018811	K00901	ko00561	Glycerolipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMT200018811	K00901	ko00564	Glycerophospholipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMT200018811	K00901	ko01100	Metabolic pathways	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMT200018811	K00901	ko04070	Phosphatidylinositol signaling system	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMT200018812	K05658	ko02010	ABC transporters	7400	0.	0.62	0.76	0.98
PGSC0003DMT200018820	K05658	ko02010	ABC transporters	8550	0.	0.79	0.89	1.00
PGSC0003DMT200018829	K04733	ko04210	Apoptosis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMT200018829	K04733	ko04620	Toll-like receptor signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMT200018829	K04733	ko04722	Neurotrophin signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMT200018829	K04733	ko05140	Leishmaniasis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMT200018829	K04733	ko05142	Chagas disease	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMT200018832	K04371	ko04010	MAPK signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04012	ErbB signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04013	MAPK signaling pathway - fly	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04062	Chemokine signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04114	Oocyte meiosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04150	mTOR signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04270	Vascular smooth muscle contraction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04320	Dorso-ventral axis formation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04350	TGF-beta signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04360	Axon guidance	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04370	VEGF signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04510	Focal adhesion	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04520	Adherens junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04540	Gap junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04620	Toll-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04621	NOD-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04650	Natural killer cell mediated cytotoxicity	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04660	T cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04662	B cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04664	Fc epsilon RI signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04666	Fc gamma R-mediated phagocytosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04720	Long-term potentiation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04722	Neurotrophin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04730	Long-term depression	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04810	Regulation of actin cytoskeleton	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04910	Insulin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04912	GnRH signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04914	Progesterone-mediated oocyte maturation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04916	Melanogenesis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04930	Type II diabetes mellitus	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko04960	Aldosterone-regulated sodium reabsorption	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05010	Alzheimer's disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05020	Prion diseases	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05131	Shigellosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05140	Leishmaniasis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05142	Chagas disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05200	Pathways in cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05210	Colorectal cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05211	Renal cell carcinoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05212	Pancreatic cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05213	Endometrial cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05214	Glioma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05215	Prostate cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05216	Thyroid cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05218	Melanoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05219	Bladder cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05220	Chronic myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05221	Acute myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200018832	K04371	ko05223	Non-small cell lung cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMT200009303	K00754	ko00051	Fructose and mannose metabolism	281	3.2e-08	0.30	0.48	0.55
PGSC0003DMT200009304	K10688	ko04120	Ubiquitin mediated proteolysis	1349	1.4e-68	0.93	0.97	0.99
PGSC0003DMT200009311	K00128	ko00010	Glycolysis / Gluconeogenesis	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00053	Ascorbate and aldarate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00071	Fatty acid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00280	Valine, leucine and isoleucine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00310	Lysine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00330	Arginine and proline metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00340	Histidine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00380	Tryptophan metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00410	beta-Alanine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00561	Glycerolipid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00620	Pyruvate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00631	1,2-Dichloroethane degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00640	Propanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00641	3-Chloroacrylic acid degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00650	Butanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko01100	Metabolic pathways	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009311	K00128	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMT200009312	K00128	ko00010	Glycolysis / Gluconeogenesis	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00053	Ascorbate and aldarate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00071	Fatty acid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00280	Valine, leucine and isoleucine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00310	Lysine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00330	Arginine and proline metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00340	Histidine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00380	Tryptophan metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00410	beta-Alanine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00561	Glycerolipid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00620	Pyruvate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00631	1,2-Dichloroethane degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00640	Propanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00641	3-Chloroacrylic acid degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00650	Butanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko00903	Limonene and pinene degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko01100	Metabolic pathways	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009312	K00128	ko01110	Biosynthesis of secondary metabolites	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMT200009313	K00128	ko00010	Glycolysis / Gluconeogenesis	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00053	Ascorbate and aldarate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00071	Fatty acid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00280	Valine, leucine and isoleucine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00310	Lysine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00330	Arginine and proline metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00340	Histidine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00380	Tryptophan metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00410	beta-Alanine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00561	Glycerolipid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00620	Pyruvate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00631	1,2-Dichloroethane degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00640	Propanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00641	3-Chloroacrylic acid degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00650	Butanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko00903	Limonene and pinene degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko01100	Metabolic pathways	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009313	K00128	ko01110	Biosynthesis of secondary metabolites	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMT200009314	K00128	ko00010	Glycolysis / Gluconeogenesis	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00053	Ascorbate and aldarate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00071	Fatty acid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00280	Valine, leucine and isoleucine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00310	Lysine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00330	Arginine and proline metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00340	Histidine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00380	Tryptophan metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00410	beta-Alanine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00561	Glycerolipid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00620	Pyruvate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00631	1,2-Dichloroethane degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00640	Propanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00641	3-Chloroacrylic acid degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00650	Butanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko00903	Limonene and pinene degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko01100	Metabolic pathways	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009314	K00128	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMT200009324	K01051	ko00040	Pentose and glucuronate interconversions	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMT200009324	K01051	ko00500	Starch and sucrose metabolism	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMT200009324	K01051	ko01100	Metabolic pathways	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMT200044064	K00001	ko00010	Glycolysis / Gluconeogenesis	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00071	Fatty acid metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00350	Tyrosine metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00641	3-Chloroacrylic acid degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00830	Retinol metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko00982	Drug metabolism - cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko01100	Metabolic pathways	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044064	K00001	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMT200044065	K00001	ko00010	Glycolysis / Gluconeogenesis	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00071	Fatty acid metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00350	Tyrosine metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00641	3-Chloroacrylic acid degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00830	Retinol metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko00982	Drug metabolism - cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko01100	Metabolic pathways	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044065	K00001	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMT200044068	K00826	ko00280	Valine, leucine and isoleucine degradation	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMT200044068	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMT200044068	K00826	ko00770	Pantothenate and CoA biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMT200044068	K00826	ko01100	Metabolic pathways	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMT200044068	K00826	ko01110	Biosynthesis of secondary metabolites	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMT200044069	K00826	ko00280	Valine, leucine and isoleucine degradation	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMT200044069	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMT200044069	K00826	ko00770	Pantothenate and CoA biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMT200044069	K00826	ko01100	Metabolic pathways	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMT200044069	K00826	ko01110	Biosynthesis of secondary metabolites	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMT200044070	K10606	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.49	0.64	0.99
PGSC0003DMT200044071	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMT200044073	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMT200044074	K10606	ko04120	Ubiquitin mediated proteolysis	219	3.0e-06	0.55	0.67	0.94
PGSC0003DMT200044099	K12606	ko03018	RNA degradation	676	1.9e-31	0.44	0.61	0.86
PGSC0003DMT200054145	K00454	ko00591	Linoleic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMT200054145	K00454	ko00592	alpha-Linolenic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMT200054145	K00454	ko01100	Metabolic pathways	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMT200054151	K12877	ko03040	Spliceosome	1044	9.5e-52	0.90	0.96	0.58
PGSC0003DMT200054152	K12877	ko03040	Spliceosome	1194	5.1e-60	0.92	0.97	0.97
PGSC0003DMT200054154	K11420	ko00310	Lysine degradation	698	4.1e-32	0.38	0.52	0.34
PGSC0003DMT200054163	K11420	ko00310	Lysine degradation	710	8.5e-33	0.38	0.52	0.34
PGSC0003DMT200054167	K11421	ko00310	Lysine degradation	485	1.1e-34	0.34	0.50	0.68
PGSC0003DMT200054176	K00020	ko00280	Valine, leucine and isoleucine degradation	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMT200054176	K00020	ko01100	Metabolic pathways	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMT200054177	K00020	ko00280	Valine, leucine and isoleucine degradation	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMT200054177	K00020	ko01100	Metabolic pathways	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMT200054196	K01583	ko00330	Arginine and proline metabolism	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMT200054196	K01583	ko01100	Metabolic pathways	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMT200054197	K01583	ko00330	Arginine and proline metabolism	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMT200054197	K01583	ko01100	Metabolic pathways	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMT200054198	K01583	ko00330	Arginine and proline metabolism	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMT200054198	K01583	ko01100	Metabolic pathways	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMT200063706	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMT200063726	K01051	ko00040	Pentose and glucuronate interconversions	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMT200063726	K01051	ko00500	Starch and sucrose metabolism	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMT200063726	K01051	ko01100	Metabolic pathways	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMT200063727	K01051	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMT200063727	K01051	ko00500	Starch and sucrose metabolism	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMT200063727	K01051	ko01100	Metabolic pathways	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMT200063728	K01051	ko00040	Pentose and glucuronate interconversions	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMT200063728	K01051	ko00500	Starch and sucrose metabolism	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMT200063728	K01051	ko01100	Metabolic pathways	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMT200088220	K03094	ko04110	Cell cycle	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04111	Cell cycle - yeast	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04114	Oocyte meiosis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04120	Ubiquitin mediated proteolysis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04310	Wnt signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04350	TGF-beta signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200088220	K03094	ko04710	Circadian rhythm - mammal	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMT200010985	K08913	ko00196	Photosynthesis - antenna proteins	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMT200010985	K08913	ko01100	Metabolic pathways	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMT200010990	K09828	ko00100	Steroid biosynthesis	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMT200010990	K09828	ko01100	Metabolic pathways	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMT200010990	K09828	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMT200010993	K12478	ko04144	Endocytosis	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMT200010993	K12478	ko04145	Phagosome	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMT200011002	K12590	ko03018	RNA degradation	935	9.8e-46	0.59	0.67	0.85
PGSC0003DMT200011003	K12590	ko03018	RNA degradation	1612	4.5e-83	0.78	0.91	1.00
PGSC0003DMT200011004	K12590	ko03018	RNA degradation	844	1.0e-40	0.83	0.93	0.86
PGSC0003DMT200011005	K12590	ko03018	RNA degradation	799	3.1e-38	0.84	0.93	0.87
PGSC0003DMT200020689	K09756	ko00940	Phenylpropanoid biosynthesis	1781	2.1e-92	0.47	0.67	0.99
PGSC0003DMT200020708	K03030	ko03050	Proteasome	2584	1.1e-136	0.97	0.99	1.00
PGSC0003DMT200007864	K05592	ko03018	RNA degradation	786	1.6e-37	0.31	0.52	0.78
PGSC0003DMT200007891	K10755	ko03030	DNA replication	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMT200007891	K10755	ko03420	Nucleotide excision repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMT200007891	K10755	ko03430	Mismatch repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMT200007892	K10755	ko03030	DNA replication	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMT200007892	K10755	ko03420	Nucleotide excision repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMT200007892	K10755	ko03430	Mismatch repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMT200007893	K10755	ko03030	DNA replication	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMT200007893	K10755	ko03420	Nucleotide excision repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMT200007893	K10755	ko03430	Mismatch repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMT200007897	K01784	ko00052	Galactose metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMT200007897	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMT200007897	K01784	ko01100	Metabolic pathways	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMT200007898	K01784	ko00052	Galactose metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMT200007898	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMT200007898	K01784	ko01100	Metabolic pathways	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMT200026278	K00020	ko00280	Valine, leucine and isoleucine degradation	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMT200026278	K00020	ko01100	Metabolic pathways	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMT200026302	K07151	ko00510	N-Glycan biosynthesis	5704	0.	0.92	0.95	1.00
PGSC0003DMT200026302	K07151	ko01100	Metabolic pathways	5704	0.	0.92	0.95	1.00
PGSC0003DMT200026304	K07151	ko00510	N-Glycan biosynthesis	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMT200026304	K07151	ko01100	Metabolic pathways	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMT200026308	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMT200026309	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMT200026313	K11097	ko03040	Spliceosome	687	4.7e-32	0.98	0.98	0.91
PGSC0003DMT200089725	K01213	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMT200089725	K01213	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMT200089725	K01213	ko01100	Metabolic pathways	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMT200089728	K12126	ko04712	Circadian rhythm - plant	322	7.2e-12	0.29	0.47	0.82
PGSC0003DMT200075131	K12872	ko03040	Spliceosome	422	1.9e-17	0.83	0.88	0.55
PGSC0003DMT200075132	K12356	ko00940	Phenylpropanoid biosynthesis	404	1.9e-16	0.59	0.65	0.90
PGSC0003DMT200075138	K08241	ko00592	alpha-Linolenic acid metabolism	609	9.4e-28	0.34	0.53	0.92
PGSC0003DMT200075158	K13230	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.42	0.58	0.97
PGSC0003DMT200075159	K13230	ko00402	Benzoxazinoid biosynthesis	362	3.9e-14	0.47	0.66	0.74
PGSC0003DMT200068422	K01392	ko04614	Renin-angiotensin system	3227	3.8e-172	0.55	0.76	0.99
PGSC0003DMT200068423	K01392	ko04614	Renin-angiotensin system	3298	4.6e-176	0.57	0.79	0.99
PGSC0003DMT200068437	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMT200068437	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMT200068437	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMT200068437	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMT200068437	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMT200068448	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMT200068448	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMT200068449	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMT200068449	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMT200068450	K08233	ko00901	Indole alkaloid biosynthesis	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMT200068450	K08233	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMT200060816	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMT200060816	K00517	ko00626	Naphthalene and anthracene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMT200060816	K00517	ko00903	Limonene and pinene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMT200060816	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMT200060816	K00517	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMT200060817	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMT200060817	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMT200060817	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMT200060817	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMT200060817	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMT200060821	K00889	ko00562	Inositol phosphate metabolism	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060821	K00889	ko01100	Metabolic pathways	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060821	K00889	ko04070	Phosphatidylinositol signaling system	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060821	K00889	ko04144	Endocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060821	K00889	ko04666	Fc gamma R-mediated phagocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060821	K00889	ko04810	Regulation of actin cytoskeleton	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMT200060831	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3596	1.7e-192	0.74	0.84	0.99
PGSC0003DMT200060833	K00860	ko00230	Purine metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMT200060833	K00860	ko00450	Selenoamino acid metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMT200060833	K00860	ko00920	Sulfur metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMT200060833	K00860	ko01100	Metabolic pathways	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMT200060835	K00860	ko00230	Purine metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMT200060835	K00860	ko00450	Selenoamino acid metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMT200060835	K00860	ko00920	Sulfur metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMT200060835	K00860	ko01100	Metabolic pathways	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMT200060836	K03259	ko04150	mTOR signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMT200060836	K03259	ko04910	Insulin signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMT200060837	K12830	ko03040	Spliceosome	733	1.6e-31	0.25	0.41	0.95
PGSC0003DMT200060838	K12830	ko03040	Spliceosome	627	2.1e-25	0.24	0.40	0.94
PGSC0003DMT200060840	K02889	ko03010	Ribosome	1211	5.9e-61	0.84	0.92	0.99
PGSC0003DMT200051520	K04733	ko04210	Apoptosis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMT200051520	K04733	ko04620	Toll-like receptor signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMT200051520	K04733	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMT200051520	K04733	ko05140	Leishmaniasis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMT200051520	K04733	ko05142	Chagas disease	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMT200051528	K01199	ko00500	Starch and sucrose metabolism	1076	1.6e-53	0.41	0.57	0.94
PGSC0003DMT200051530	K01199	ko00500	Starch and sucrose metabolism	634	3.9e-29	0.45	0.69	0.91
PGSC0003DMT200051531	K01199	ko00500	Starch and sucrose metabolism	531	1.9e-23	0.45	0.67	0.93
PGSC0003DMT200051535	K04733	ko04210	Apoptosis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMT200051535	K04733	ko04620	Toll-like receptor signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMT200051535	K04733	ko04722	Neurotrophin signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMT200051535	K04733	ko05140	Leishmaniasis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMT200051535	K04733	ko05142	Chagas disease	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMT200051546	K04733	ko04210	Apoptosis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMT200051546	K04733	ko04620	Toll-like receptor signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMT200051546	K04733	ko04722	Neurotrophin signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMT200051546	K04733	ko05140	Leishmaniasis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMT200051546	K04733	ko05142	Chagas disease	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMT200051560	K02738	ko03050	Proteasome	468	5.6e-20	0.72	0.82	0.61
PGSC0003DMT200051579	K01853	ko00100	Steroid biosynthesis	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMT200051579	K01853	ko01100	Metabolic pathways	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMT200051579	K01853	ko01110	Biosynthesis of secondary metabolites	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMT200051580	K01853	ko00100	Steroid biosynthesis	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMT200051580	K01853	ko01100	Metabolic pathways	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMT200051580	K01853	ko01110	Biosynthesis of secondary metabolites	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMT200022068	K01069	ko00620	Pyruvate metabolism	657	2.1e-30	0.55	0.67	0.94
PGSC0003DMT200022069	K01069	ko00620	Pyruvate metabolism	861	1.2e-41	0.56	0.69	0.95
PGSC0003DMT200022070	K01069	ko00620	Pyruvate metabolism	987	1.3e-48	0.53	0.68	0.98
PGSC0003DMT200022072	K08914	ko00196	Photosynthesis - antenna proteins	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMT200022072	K08914	ko01100	Metabolic pathways	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMT200022073	K11252	ko05322	Systemic lupus erythematosus	892	2.3e-43	0.84	0.88	0.40
PGSC0003DMT200022074	K11252	ko05322	Systemic lupus erythematosus	1043	1.1e-51	0.89	0.93	0.99
PGSC0003DMT200022081	K01082	ko00920	Sulfur metabolism	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMT200022081	K01082	ko01100	Metabolic pathways	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMT200022094	K12484	ko04144	Endocytosis	280	2.2e-07	0.26	0.42	0.98
PGSC0003DMT200022095	K12484	ko04144	Endocytosis	272	1.7e-06	0.25	0.42	0.69
PGSC0003DMT200022097	K12484	ko04144	Endocytosis	272	1.3e-06	0.25	0.42	0.78
PGSC0003DMT200022099	K11252	ko05322	Systemic lupus erythematosus	1062	9.7e-53	0.89	0.91	0.99
PGSC0003DMT200014071	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMT200014071	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMT200014072	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMT200014072	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMT200014073	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMT200014073	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMT200014074	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMT200014074	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMT200014085	K01728	ko00040	Pentose and glucuronate interconversions	1570	9.3e-81	0.55	0.68	0.92
PGSC0003DMT200014086	K01728	ko00040	Pentose and glucuronate interconversions	1831	3.7e-95	0.59	0.71	0.84
PGSC0003DMT200014094	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMT200014094	K00517	ko00626	Naphthalene and anthracene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMT200014094	K00517	ko00903	Limonene and pinene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMT200014094	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMT200014094	K00517	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMT200004949	K12741	ko03040	Spliceosome	312	4.5e-11	0.36	0.45	0.32
PGSC0003DMT200004951	K09843	ko00906	Carotenoid biosynthesis	3082	3.7e-164	0.78	0.88	0.99
PGSC0003DMT200004952	K09843	ko00906	Carotenoid biosynthesis	1301	6.4e-66	0.75	0.86	0.99
PGSC0003DMT200004953	K09843	ko00906	Carotenoid biosynthesis	1713	1.2e-88	0.81	0.91	0.94
PGSC0003DMT200004969	K02886	ko03010	Ribosome	681	1.0e-31	0.48	0.64	0.96
PGSC0003DMT200004970	K06066	ko04330	Notch signaling pathway	697	1.3e-32	0.29	0.44	0.85
PGSC0003DMT200004971	K05681	ko02010	ABC transporters	1011	6.3e-50	0.41	0.59	0.91
PGSC0003DMT200004973	K05681	ko02010	ABC transporters	1391	6.9e-71	0.38	0.57	0.96
PGSC0003DMT200004975	K09840	ko00906	Carotenoid biosynthesis	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMT200004975	K09840	ko01100	Metabolic pathways	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMT200004975	K09840	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMT200004976	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004976	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004976	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004977	K09840	ko00906	Carotenoid biosynthesis	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMT200004977	K09840	ko01100	Metabolic pathways	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMT200004977	K09840	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMT200004978	K09840	ko00906	Carotenoid biosynthesis	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMT200004978	K09840	ko01100	Metabolic pathways	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMT200004978	K09840	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMT200004979	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004979	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004979	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMT200004980	K09840	ko00906	Carotenoid biosynthesis	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMT200004980	K09840	ko01100	Metabolic pathways	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMT200004980	K09840	ko01110	Biosynthesis of secondary metabolites	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMT200004981	K09840	ko00906	Carotenoid biosynthesis	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMT200004981	K09840	ko01100	Metabolic pathways	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMT200004981	K09840	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMT200097591	K12194	ko04144	Endocytosis	331	2.0e-12	0.50	0.71	0.33
PGSC0003DMT200000985	K06063	ko03040	Spliceosome	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMT200000985	K06063	ko04330	Notch signaling pathway	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMT200000988	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMT200000988	K02367	ko01100	Metabolic pathways	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMT200000989	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMT200000989	K02367	ko01100	Metabolic pathways	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMT200000990	K08139	ko04113	Meiosis - yeast	846	7.9e-41	0.35	0.56	0.87
PGSC0003DMT200001016	K10527	ko00592	alpha-Linolenic acid metabolism	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMT200001016	K10527	ko01100	Metabolic pathways	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMT200001017	K10527	ko00592	alpha-Linolenic acid metabolism	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMT200001017	K10527	ko01100	Metabolic pathways	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMT200097660	K10591	ko04120	Ubiquitin mediated proteolysis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMT200097660	K10591	ko04144	Endocytosis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMT200097662	K02183	ko04020	Calcium signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04070	Phosphatidylinositol signaling system	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04114	Oocyte meiosis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04270	Vascular smooth muscle contraction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04626	Plant-pathogen interaction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04720	Long-term potentiation	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04722	Neurotrophin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04740	Olfactory transduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04744	Phototransduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04745	Phototransduction - fly	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04910	Insulin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04912	GnRH signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04916	Melanogenesis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04970	Salivary secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko04971	Gastric acid secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko05010	Alzheimer's disease	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097662	K02183	ko05214	Glioma	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMT200097683	K12132	ko04712	Circadian rhythm - plant	1051	3.9e-52	0.51	0.67	0.77
PGSC0003DMT200022817	K00620	ko00330	Arginine and proline metabolism	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMT200022817	K00620	ko01100	Metabolic pathways	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMT200022817	K00620	ko01110	Biosynthesis of secondary metabolites	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMT200022844	K12611	ko03018	RNA degradation	452	4.3e-19	0.34	0.55	0.90
PGSC0003DMT200022845	K12611	ko03018	RNA degradation	543	4.1e-24	0.29	0.49	0.94
PGSC0003DMT200022846	K12611	ko03018	RNA degradation	526	3.5e-23	0.30	0.49	0.87
PGSC0003DMT200022847	K12611	ko03018	RNA degradation	281	1.2e-09	0.28	0.45	0.90
PGSC0003DMT200022848	K05746	ko04810	Regulation of actin cytoskeleton	237	1.7e-06	0.36	0.45	0.63
PGSC0003DMT200022853	K12733	ko03040	Spliceosome	1300	7.2e-66	0.90	0.96	0.99
PGSC0003DMT200042294	K00558	ko00270	Cysteine and methionine metabolism	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMT200042294	K00558	ko01100	Metabolic pathways	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMT200042325	K01252	ko01053	Biosynthesis of siderophore group nonribosomal peptides	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMT200042325	K01252	ko01110	Biosynthesis of secondary metabolites	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMT200004294	K10742	ko03030	DNA replication	4201	7.1e-226	0.70	0.82	0.98
PGSC0003DMT200004295	K10742	ko03030	DNA replication	3430	2.4e-183	0.68	0.81	1.00
PGSC0003DMT200004308	K10601	ko04120	Ubiquitin mediated proteolysis	233	1.4e-06	0.38	0.59	0.46
PGSC0003DMT200004309	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMT200004309	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMT200004310	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMT200004310	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMT200004314	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMT200004314	K03861	ko01100	Metabolic pathways	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMT200004319	K01528	ko04144	Endocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMT200004319	K01528	ko04666	Fc gamma R-mediated phagocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMT200004319	K01528	ko05100	Bacterial invasion of epithelial cells	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMT200004326	K03849	ko00510	N-Glycan biosynthesis	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMT200004326	K03849	ko01100	Metabolic pathways	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMT200031955	K03031	ko03050	Proteasome	1854	2.0e-96	0.82	0.90	1.00
PGSC0003DMT200031956	K03031	ko03050	Proteasome	1867	3.9e-97	0.83	0.91	1.00
PGSC0003DMT200031966	K09458	ko00061	Fatty acid biosynthesis	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMT200031966	K09458	ko01100	Metabolic pathways	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMT200031967	K09458	ko00061	Fatty acid biosynthesis	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMT200031967	K09458	ko01100	Metabolic pathways	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMT200085819	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMT200085819	K00517	ko00626	Naphthalene and anthracene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMT200085819	K00517	ko00903	Limonene and pinene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMT200085819	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMT200085819	K00517	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMT200069241	K08488	ko04130	SNARE interactions in vesicular transport	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMT200069241	K08488	ko04145	Phagosome	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMT200069245	K13056	ko04114	Oocyte meiosis	259	1.9e-08	0.29	0.43	0.60
PGSC0003DMT200069246	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMT200069247	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMT200069254	K00071	ko00140	Steroid hormone biosynthesis	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMT200069254	K00071	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMT200069254	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMT200069255	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	411	3.2e-16	0.30	0.44	0.98
PGSC0003DMT200069263	K00162	ko00010	Glycolysis / Gluconeogenesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko00020	Citrate cycle (TCA cycle)	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko00620	Pyruvate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko00650	Butanoate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko01100	Metabolic pathways	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200069263	K00162	ko01110	Biosynthesis of secondary metabolites	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMT200050771	K00308	ko04146	Peroxisome	288	1.2e-09	0.45	0.66	0.66
PGSC0003DMT200050775	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMT200050775	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMT200050775	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMT200050775	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMT200050775	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMT200050776	K04733	ko04210	Apoptosis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMT200050776	K04733	ko04620	Toll-like receptor signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMT200050776	K04733	ko04722	Neurotrophin signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMT200050776	K04733	ko05140	Leishmaniasis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMT200050776	K04733	ko05142	Chagas disease	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMT200050783	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200050783	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200050783	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200050783	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200050786	K04733	ko04210	Apoptosis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMT200050786	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMT200050786	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMT200050786	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMT200050786	K04733	ko05142	Chagas disease	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMT200050787	K04733	ko04210	Apoptosis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMT200050787	K04733	ko04620	Toll-like receptor signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMT200050787	K04733	ko04722	Neurotrophin signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMT200050787	K04733	ko05140	Leishmaniasis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMT200050787	K04733	ko05142	Chagas disease	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMT200050791	K00799	ko00480	Glutathione metabolism	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMT200050791	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMT200050791	K00799	ko00982	Drug metabolism - cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMT200050792	K12864	ko03040	Spliceosome	3476	6.9e-186	0.78	0.88	1.00
PGSC0003DMT200050793	K12864	ko03040	Spliceosome	2287	2.6e-120	0.72	0.80	0.99
PGSC0003DMT200078129	K02866	ko03010	Ribosome	1779	2.8e-92	0.93	0.97	0.99
PGSC0003DMT200078138	K08008	ko04145	Phagosome	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMT200078138	K08008	ko04670	Leukocyte transendothelial migration	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMT200078145	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.48	0.65	0.99
PGSC0003DMT200078146	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.98	0.99
PGSC0003DMT200078153	K03946	ko00190	Oxidative phosphorylation	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMT200078153	K03946	ko01100	Metabolic pathways	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMT200078153	K03946	ko05010	Alzheimer's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMT200078153	K03946	ko05012	Parkinson's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMT200078153	K03946	ko05016	Huntington's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMT200078154	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200078155	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200078156	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200078157	K11254	ko05322	Systemic lupus erythematosus	513	1.8e-22	1.00	1.00	0.94
PGSC0003DMT200078163	K03283	ko03040	Spliceosome	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMT200078163	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMT200078163	K03283	ko04144	Endocytosis	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMT200078163	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMT200078165	K08332	ko04140	Regulation of autophagy	310	5.5e-11	0.30	0.52	0.77
PGSC0003DMT200078166	K08332	ko04140	Regulation of autophagy	310	1.4e-08	0.30	0.52	0.39
PGSC0003DMT200057721	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMT200057721	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMT200057723	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMT200057723	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMT200057730	K02183	ko04020	Calcium signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04070	Phosphatidylinositol signaling system	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04114	Oocyte meiosis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04270	Vascular smooth muscle contraction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04626	Plant-pathogen interaction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04720	Long-term potentiation	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04740	Olfactory transduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04744	Phototransduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04745	Phototransduction - fly	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04910	Insulin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04912	GnRH signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04916	Melanogenesis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04970	Salivary secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko04971	Gastric acid secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko05010	Alzheimer's disease	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057730	K02183	ko05214	Glioma	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMT200057731	K02183	ko04020	Calcium signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04070	Phosphatidylinositol signaling system	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04114	Oocyte meiosis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04270	Vascular smooth muscle contraction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04626	Plant-pathogen interaction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04720	Long-term potentiation	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04722	Neurotrophin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04740	Olfactory transduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04744	Phototransduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04745	Phototransduction - fly	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04910	Insulin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04912	GnRH signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04916	Melanogenesis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04970	Salivary secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko04971	Gastric acid secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko05010	Alzheimer's disease	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057731	K02183	ko05214	Glioma	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMT200057732	K02183	ko04020	Calcium signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04070	Phosphatidylinositol signaling system	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04114	Oocyte meiosis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04270	Vascular smooth muscle contraction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04626	Plant-pathogen interaction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04720	Long-term potentiation	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04740	Olfactory transduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04744	Phototransduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04745	Phototransduction - fly	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04910	Insulin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04912	GnRH signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04916	Melanogenesis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04970	Salivary secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko04971	Gastric acid secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko05010	Alzheimer's disease	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200057732	K02183	ko05214	Glioma	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMT200096136	K02893	ko03010	Ribosome	483	8.3e-21	0.84	0.87	0.92
PGSC0003DMT200036430	K10702	ko00642	Ethylbenzene degradation	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMT200036430	K10702	ko01100	Metabolic pathways	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMT200036434	K00951	ko00230	Purine metabolism	1234	3.2e-62	0.40	0.57	0.67
PGSC0003DMT200036435	K00951	ko00230	Purine metabolism	940	5.2e-46	0.43	0.65	0.59
PGSC0003DMT200036436	K00951	ko00230	Purine metabolism	1219	2.1e-61	0.45	0.64	0.61
PGSC0003DMT200036437	K00430	ko00360	Phenylalanine metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMT200036437	K00430	ko00680	Methane metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMT200036437	K00430	ko00940	Phenylpropanoid biosynthesis	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMT200036437	K00430	ko01100	Metabolic pathways	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMT200036437	K00430	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMT200036438	K00430	ko00360	Phenylalanine metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMT200036438	K00430	ko00680	Methane metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMT200036438	K00430	ko00940	Phenylpropanoid biosynthesis	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMT200036438	K00430	ko01100	Metabolic pathways	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMT200036438	K00430	ko01110	Biosynthesis of secondary metabolites	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMT200036439	K00430	ko00360	Phenylalanine metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMT200036439	K00430	ko00680	Methane metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMT200036439	K00430	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMT200036439	K00430	ko01100	Metabolic pathways	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMT200036439	K00430	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMT200036440	K00430	ko00360	Phenylalanine metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMT200036440	K00430	ko00680	Methane metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMT200036440	K00430	ko00940	Phenylpropanoid biosynthesis	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMT200036440	K00430	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMT200036440	K00430	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMT200036443	K03217	ko03060	Protein export	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMT200036443	K03217	ko03070	Bacterial secretion system	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMT200036453	K05849	ko04020	Calcium signaling pathway	323	2.2e-11	0.34	0.52	0.65
PGSC0003DMT200008535	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMT200008535	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMT200008535	K12366	ko05131	Shigellosis	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMT200008541	K12885	ko03040	Spliceosome	434	4.2e-18	0.33	0.42	0.87
PGSC0003DMT200008543	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMT200008543	K00517	ko00626	Naphthalene and anthracene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMT200008543	K00517	ko00903	Limonene and pinene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMT200008543	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMT200008543	K00517	ko01110	Biosynthesis of secondary metabolites	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMT200008547	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMT200008547	K00517	ko00626	Naphthalene and anthracene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMT200008547	K00517	ko00903	Limonene and pinene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMT200008547	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMT200008547	K00517	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMT200008548	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMT200008548	K00517	ko00626	Naphthalene and anthracene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMT200008548	K00517	ko00903	Limonene and pinene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMT200008548	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMT200008548	K00517	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMT200008550	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMT200008550	K00517	ko00626	Naphthalene and anthracene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMT200008550	K00517	ko00903	Limonene and pinene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMT200008550	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMT200008550	K00517	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMT200008551	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMT200008551	K00517	ko00626	Naphthalene and anthracene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMT200008551	K00517	ko00903	Limonene and pinene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMT200008551	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMT200008551	K00517	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMT200008555	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMT200008555	K00517	ko00626	Naphthalene and anthracene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMT200008555	K00517	ko00903	Limonene and pinene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMT200008555	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMT200008555	K00517	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMT200008556	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMT200008556	K00517	ko00626	Naphthalene and anthracene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMT200008556	K00517	ko00903	Limonene and pinene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMT200008556	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMT200008556	K00517	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMT200025589	K01115	ko00564	Glycerophospholipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025589	K01115	ko00565	Ether lipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025589	K01115	ko01100	Metabolic pathways	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025589	K01115	ko04144	Endocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025589	K01115	ko04666	Fc gamma R-mediated phagocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025589	K01115	ko04912	GnRH signaling pathway	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMT200025590	K01115	ko00564	Glycerophospholipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025590	K01115	ko00565	Ether lipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025590	K01115	ko01100	Metabolic pathways	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025590	K01115	ko04144	Endocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025590	K01115	ko04666	Fc gamma R-mediated phagocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025590	K01115	ko04912	GnRH signaling pathway	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMT200025592	K01115	ko00564	Glycerophospholipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025592	K01115	ko00565	Ether lipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025592	K01115	ko01100	Metabolic pathways	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025592	K01115	ko04144	Endocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025592	K01115	ko04666	Fc gamma R-mediated phagocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025592	K01115	ko04912	GnRH signaling pathway	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMT200025599	K01176	ko00500	Starch and sucrose metabolism	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMT200025599	K01176	ko01100	Metabolic pathways	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMT200025601	K01176	ko00500	Starch and sucrose metabolism	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMT200025601	K01176	ko01100	Metabolic pathways	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMT200025602	K01176	ko00500	Starch and sucrose metabolism	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMT200025602	K01176	ko01100	Metabolic pathways	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMT200025608	K07466	ko03030	DNA replication	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMT200025608	K07466	ko03420	Nucleotide excision repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMT200025608	K07466	ko03430	Mismatch repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMT200025608	K07466	ko03440	Homologous recombination	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMT200025617	K00121	ko00010	Glycolysis / Gluconeogenesis	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00071	Fatty acid metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00350	Tyrosine metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00641	3-Chloroacrylic acid degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00680	Methane metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00830	Retinol metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko00982	Drug metabolism - cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko01100	Metabolic pathways	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200025617	K00121	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMT200028964	K06268	ko04010	MAPK signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04020	Calcium signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04114	Oocyte meiosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04210	Apoptosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04310	Wnt signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04360	Axon guidance	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04370	VEGF signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04650	Natural killer cell mediated cytotoxicity	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04660	T cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04662	B cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko04720	Long-term potentiation	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko05010	Alzheimer's disease	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028964	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMT200028980	K07297	ko04920	Adipocytokine signaling pathway	1710	1.8e-88	0.56	0.73	0.99
PGSC0003DMT200028981	K07297	ko04920	Adipocytokine signaling pathway	1087	4.1e-54	0.68	0.81	0.95
PGSC0003DMT200028982	K11424	ko00310	Lysine degradation	1074	2.1e-53	0.38	0.52	0.39
PGSC0003DMT200028983	K04514	ko04062	Chemokine signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04270	Vascular smooth muscle contraction	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04310	Wnt signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04350	TGF-beta signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04360	Axon guidance	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04510	Focal adhesion	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04670	Leukocyte transendothelial migration	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko04810	Regulation of actin cytoskeleton	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028983	K04514	ko05131	Shigellosis	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMT200028984	K04514	ko04062	Chemokine signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04270	Vascular smooth muscle contraction	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04310	Wnt signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04350	TGF-beta signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04360	Axon guidance	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04510	Focal adhesion	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04670	Leukocyte transendothelial migration	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko04810	Regulation of actin cytoskeleton	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028984	K04514	ko05131	Shigellosis	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMT200028985	K11424	ko00310	Lysine degradation	859	1.5e-41	0.51	0.68	0.83
PGSC0003DMT200028986	K11424	ko00310	Lysine degradation	602	2.3e-27	0.52	0.67	0.77
PGSC0003DMT200083203	K10760	ko00908	Zeatin biosynthesis	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMT200083203	K10760	ko01100	Metabolic pathways	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMT200083203	K10760	ko01110	Biosynthesis of secondary metabolites	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMT200083218	K12524	ko00260	Glycine, serine and threonine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMT200083218	K12524	ko00270	Cysteine and methionine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMT200083218	K12524	ko00300	Lysine biosynthesis	5788	0.	0.75	0.86	1.00
PGSC0003DMT200083218	K12524	ko01100	Metabolic pathways	5788	0.	0.75	0.86	1.00
PGSC0003DMT200083218	K12524	ko01110	Biosynthesis of secondary metabolites	5788	0.	0.75	0.86	1.00
PGSC0003DMT200083225	K02084	ko04115	p53 signaling pathway	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko04210	Apoptosis	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko05010	Alzheimer's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko05012	Parkinson's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko05016	Huntington's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083225	K02084	ko05222	Small cell lung cancer	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMT200083227	K03544	ko04112	Cell cycle - Caulobacter	3973	2.7e-213	0.74	0.81	0.98
PGSC0003DMT200083228	K03544	ko04112	Cell cycle - Caulobacter	3866	2.1e-207	0.75	0.82	0.97
PGSC0003DMT200083237	K02936	ko03010	Ribosome	1691	2.0e-87	0.86	0.94	0.92
PGSC0003DMT200083239	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMT200083240	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMT200083241	K02936	ko03010	Ribosome	405	1.7e-16	0.87	0.98	0.98
PGSC0003DMT200083243	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMT200083243	K02367	ko01100	Metabolic pathways	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMT200071689	K01366	ko04142	Lysosome	581	3.3e-26	0.57	0.69	0.90
PGSC0003DMT200071690	K01366	ko04142	Lysosome	2092	1.5e-109	0.71	0.82	0.99
PGSC0003DMT200071702	K05849	ko04020	Calcium signaling pathway	436	3.1e-15	0.34	0.55	0.18
PGSC0003DMT200038109	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMT200038120	K02875	ko03010	Ribosome	1015	3.8e-50	0.90	0.96	0.99
PGSC0003DMT200038121	K12192	ko04144	Endocytosis	1153	9.3e-58	0.77	0.91	0.95
PGSC0003DMT200038133	K12126	ko04712	Circadian rhythm - plant	745	3.0e-35	0.37	0.49	0.77
PGSC0003DMT200038134	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.72
PGSC0003DMT200038135	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.73
PGSC0003DMT200038139	K11816	ko00380	Tryptophan metabolism	2517	5.4e-133	0.72	0.86	0.97
PGSC0003DMT200038140	K03869	ko04120	Ubiquitin mediated proteolysis	437	6.3e-18	0.33	0.54	0.95
PGSC0003DMT200027118	K04733	ko04210	Apoptosis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMT200027118	K04733	ko04620	Toll-like receptor signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMT200027118	K04733	ko04722	Neurotrophin signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMT200027118	K04733	ko05140	Leishmaniasis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMT200027118	K04733	ko05142	Chagas disease	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMT200027129	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMT200027129	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMT200027129	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMT200027129	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMT200027129	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMT200027130	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMT200027130	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMT200027130	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMT200027130	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMT200027130	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMT200094929	K01213	ko00040	Pentose and glucuronate interconversions	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMT200094929	K01213	ko00500	Starch and sucrose metabolism	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMT200094929	K01213	ko01100	Metabolic pathways	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMT200094948	K02893	ko03010	Ribosome	1066	5.8e-53	0.85	0.90	0.99
PGSC0003DMT200080638	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMT200080638	K12448	ko01100	Metabolic pathways	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMT200080645	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMT200080645	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMT200080647	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko04210	Apoptosis	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko05016	Huntington's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080647	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMT200080649	K02084	ko04115	p53 signaling pathway	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko04210	Apoptosis	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko05010	Alzheimer's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko05012	Parkinson's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko05016	Huntington's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080649	K02084	ko05222	Small cell lung cancer	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMT200080677	K00279	ko00908	Zeatin biosynthesis	453	3.8e-19	0.58	0.74	0.96
PGSC0003DMT200080678	K00279	ko00908	Zeatin biosynthesis	1140	4.8e-57	0.61	0.72	0.95
PGSC0003DMT200080679	K00279	ko00908	Zeatin biosynthesis	2560	2.3e-135	0.60	0.74	0.99
PGSC0003DMT200080680	K00279	ko00908	Zeatin biosynthesis	2652	1.9e-140	0.62	0.77	0.92
PGSC0003DMT200080689	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMT200080689	K00517	ko00626	Naphthalene and anthracene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMT200080689	K00517	ko00903	Limonene and pinene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMT200080689	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMT200080689	K00517	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMT200080690	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMT200080690	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMT200080690	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMT200080690	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMT200080690	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMT200070156	K00889	ko00562	Inositol phosphate metabolism	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070156	K00889	ko01100	Metabolic pathways	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070156	K00889	ko04070	Phosphatidylinositol signaling system	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070156	K00889	ko04144	Endocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070156	K00889	ko04666	Fc gamma R-mediated phagocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070156	K00889	ko04810	Regulation of actin cytoskeleton	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMT200070159	K05279	ko00944	Flavone and flavonol biosynthesis	1066	5.8e-53	0.51	0.70	0.99
PGSC0003DMT200070160	K13066	ko00940	Phenylpropanoid biosynthesis	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMT200070160	K13066	ko01110	Biosynthesis of secondary metabolites	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMT200070176	K03403	ko00860	Porphyrin and chlorophyll metabolism	9108	0.	0.85	0.93	0.91
PGSC0003DMT200070176	K03403	ko01100	Metabolic pathways	9108	0.	0.85	0.93	0.91
PGSC0003DMT200070176	K03403	ko01110	Biosynthesis of secondary metabolites	9108	0.	0.85	0.93	0.91
PGSC0003DMT200070184	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMT200070184	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMT200070186	K09756	ko00940	Phenylpropanoid biosynthesis	1094	1.7e-54	0.45	0.69	0.89
PGSC0003DMT200070187	K09756	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.52	0.73	0.87
PGSC0003DMT200070189	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMT200070189	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMT200047383	K01510	ko00230	Purine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMT200047383	K01510	ko00240	Pyrimidine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMT200047384	K01510	ko00230	Purine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMT200047384	K01510	ko00240	Pyrimidine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMT200047390	K13030	ko00460	Cyanoamino acid metabolism	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMT200047390	K13030	ko01110	Biosynthesis of secondary metabolites	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMT200047391	K13030	ko00460	Cyanoamino acid metabolism	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMT200047391	K13030	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMT200047405	K08243	ko00941	Flavonoid biosynthesis	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMT200047405	K08243	ko01110	Biosynthesis of secondary metabolites	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMT200047407	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047407	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047407	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047407	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047407	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047407	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMT200047408	K08243	ko00941	Flavonoid biosynthesis	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMT200047408	K08243	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMT200047409	K02881	ko03010	Ribosome	289	4.2e-10	0.43	0.61	0.60
PGSC0003DMT200047410	K02881	ko03010	Ribosome	352	1.4e-13	0.39	0.54	0.85
PGSC0003DMT200073437	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.57
PGSC0003DMT200073438	K01507	ko00190	Oxidative phosphorylation	2272	1.8e-119	0.96	0.99	1.00
PGSC0003DMT200073439	K01507	ko00190	Oxidative phosphorylation	228	5.0e-06	0.64	0.87	0.68
PGSC0003DMT200073443	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMT200073443	K01563	ko00626	Naphthalene and anthracene degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMT200073443	K01563	ko00631	1,2-Dichloroethane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMT200073443	K01563	ko00641	3-Chloroacrylic acid degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMT200073443	K01563	ko01100	Metabolic pathways	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMT200073450	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	271	2.3e-08	0.34	0.45	0.97
PGSC0003DMT200073451	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	340	4.4e-12	0.29	0.45	0.91
PGSC0003DMT200073466	K01115	ko00564	Glycerophospholipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073466	K01115	ko00565	Ether lipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073466	K01115	ko01100	Metabolic pathways	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073466	K01115	ko04144	Endocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073466	K01115	ko04666	Fc gamma R-mediated phagocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073466	K01115	ko04912	GnRH signaling pathway	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMT200073467	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073467	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073467	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073467	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073467	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073467	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMT200000279	K04427	ko04010	MAPK signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04310	Wnt signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04520	Adherens junction	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04620	Toll-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04621	NOD-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04622	RIG-I-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko04660	T cell receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000279	K04427	ko05140	Leishmaniasis	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMT200000307	K12356	ko00940	Phenylpropanoid biosynthesis	690	3.2e-32	0.31	0.50	0.94
PGSC0003DMT200024492	K01834	ko00010	Glycolysis / Gluconeogenesis	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMT200024492	K01834	ko01100	Metabolic pathways	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMT200024492	K01834	ko01110	Biosynthesis of secondary metabolites	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMT200024493	K01834	ko00010	Glycolysis / Gluconeogenesis	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMT200024493	K01834	ko01100	Metabolic pathways	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMT200024493	K01834	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMT200024495	K06634	ko03420	Nucleotide excision repair	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMT200024495	K06634	ko04110	Cell cycle	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMT200024496	K06634	ko03420	Nucleotide excision repair	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMT200024496	K06634	ko04110	Cell cycle	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMT200024497	K06634	ko03420	Nucleotide excision repair	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMT200024497	K06634	ko04110	Cell cycle	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMT200024498	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024498	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024499	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024499	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024500	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024500	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMT200024501	K06634	ko03420	Nucleotide excision repair	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMT200024501	K06634	ko04110	Cell cycle	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMT200024511	K01087	ko00500	Starch and sucrose metabolism	1865	5.0e-97	0.73	0.84	0.82
PGSC0003DMT200040528	K01768	ko00230	Purine metabolism	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMT200040528	K01768	ko04113	Meiosis - yeast	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMT200040562	K12881	ko03040	Spliceosome	1485	4.5e-76	0.68	0.79	1.00
PGSC0003DMT200040563	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMT200040564	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMT200040565	K12881	ko03040	Spliceosome	814	4.6e-39	0.65	0.78	0.99
PGSC0003DMT200040566	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMT200033674	K01213	ko00040	Pentose and glucuronate interconversions	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMT200033674	K01213	ko00500	Starch and sucrose metabolism	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMT200033674	K01213	ko01100	Metabolic pathways	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMT200033686	K12815	ko03040	Spliceosome	415	4.4e-16	0.27	0.45	0.93
PGSC0003DMT200033687	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.35	0.55	0.70
PGSC0003DMT200033688	K01199	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.38	0.58	0.53
PGSC0003DMT200033689	K00889	ko00562	Inositol phosphate metabolism	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200033689	K00889	ko01100	Metabolic pathways	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200033689	K00889	ko04070	Phosphatidylinositol signaling system	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200033689	K00889	ko04144	Endocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200033689	K00889	ko04666	Fc gamma R-mediated phagocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200033689	K00889	ko04810	Regulation of actin cytoskeleton	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMT200006164	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMT200006167	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMT200006167	K05928	ko01100	Metabolic pathways	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMT200006167	K05928	ko01110	Biosynthesis of secondary metabolites	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMT200006168	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMT200006168	K05928	ko01100	Metabolic pathways	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMT200006168	K05928	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMT200006169	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMT200006169	K05928	ko01100	Metabolic pathways	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMT200006169	K05928	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMT200006174	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMT200006174	K00517	ko00626	Naphthalene and anthracene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMT200006174	K00517	ko00903	Limonene and pinene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMT200006174	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMT200006174	K00517	ko01110	Biosynthesis of secondary metabolites	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMT200006183	K02866	ko03010	Ribosome	1450	3.9e-74	0.92	0.95	0.99
PGSC0003DMT200006190	K03063	ko03050	Proteasome	2698	5.7e-143	0.98	0.99	1.00
PGSC0003DMT200006195	K03063	ko03050	Proteasome	366	2.4e-14	0.67	0.79	0.99
PGSC0003DMT200012763	K01598	ko00770	Pantothenate and CoA biosynthesis	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMT200012763	K01598	ko01100	Metabolic pathways	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMT200012770	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMT200012770	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMT200012770	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMT200012771	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMT200012771	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMT200012771	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMT200012772	K00432	ko00480	Glutathione metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMT200012772	K00432	ko00590	Arachidonic acid metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMT200012773	K00432	ko00480	Glutathione metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMT200012773	K00432	ko00590	Arachidonic acid metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMT200012774	K00432	ko00480	Glutathione metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMT200012774	K00432	ko00590	Arachidonic acid metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMT200012775	K00432	ko00480	Glutathione metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMT200012775	K00432	ko00590	Arachidonic acid metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMT200012776	K00432	ko00480	Glutathione metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMT200012776	K00432	ko00590	Arachidonic acid metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMT200012777	K00432	ko00480	Glutathione metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMT200012777	K00432	ko00590	Arachidonic acid metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMT200090908	K10760	ko00908	Zeatin biosynthesis	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMT200090908	K10760	ko01100	Metabolic pathways	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMT200090908	K10760	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMT200002642	K02112	ko00190	Oxidative phosphorylation	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMT200002642	K02112	ko00195	Photosynthesis	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMT200002642	K02112	ko01100	Metabolic pathways	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMT200002644	K01112	ko00051	Fructose and mannose metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMT200002644	K01112	ko00730	Thiamine metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMT200002644	K01112	ko00740	Riboflavin metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMT200002644	K01112	ko01100	Metabolic pathways	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMT200002645	K01112	ko00051	Fructose and mannose metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMT200002645	K01112	ko00730	Thiamine metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMT200002645	K01112	ko00740	Riboflavin metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMT200002645	K01112	ko01100	Metabolic pathways	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMT200002668	K05746	ko04810	Regulation of actin cytoskeleton	371	4.1e-14	0.36	0.42	0.55
PGSC0003DMT200002684	K00600	ko00260	Glycine, serine and threonine metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200002684	K00600	ko00460	Cyanoamino acid metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200002684	K00600	ko00670	One carbon pool by folate	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200002684	K00600	ko00680	Methane metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200002684	K00600	ko01100	Metabolic pathways	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200002684	K00600	ko01110	Biosynthesis of secondary metabolites	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMT200087008	K03122	ko03022	Basal transcription factors	321	7.2e-12	0.31	0.55	0.84
PGSC0003DMT200067503	K00030	ko00020	Citrate cycle (TCA cycle)	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMT200067503	K00030	ko01100	Metabolic pathways	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMT200067503	K00030	ko01110	Biosynthesis of secondary metabolites	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMT200067504	K11419	ko00310	Lysine degradation	655	6.0e-30	0.39	0.54	0.25
PGSC0003DMT200067510	K02214	ko04110	Cell cycle	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMT200067510	K02214	ko04111	Cell cycle - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMT200067510	K02214	ko04113	Meiosis - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMT200067512	K02214	ko04110	Cell cycle	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMT200067512	K02214	ko04111	Cell cycle - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMT200067512	K02214	ko04113	Meiosis - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMT200067513	K02214	ko04110	Cell cycle	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMT200067513	K02214	ko04111	Cell cycle - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMT200067513	K02214	ko04113	Meiosis - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMT200067515	K06096	ko04530	Tight junction	297	1.5e-10	0.34	0.51	0.81
PGSC0003DMT200067516	K02884	ko03010	Ribosome	380	4.0e-15	0.43	0.68	0.50
PGSC0003DMT200076326	K03364	ko04110	Cell cycle	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMT200076326	K03364	ko04111	Cell cycle - yeast	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMT200076326	K03364	ko04120	Ubiquitin mediated proteolysis	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMT200076326	K03364	ko04914	Progesterone-mediated oocyte maturation	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMT200076327	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076327	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076327	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076327	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076328	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076328	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076328	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076328	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMT200076329	K05350	ko00460	Cyanoamino acid metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMT200076329	K05350	ko00500	Starch and sucrose metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMT200076329	K05350	ko00940	Phenylpropanoid biosynthesis	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMT200076329	K05350	ko01110	Biosynthesis of secondary metabolites	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMT200076330	K05350	ko00460	Cyanoamino acid metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMT200076330	K05350	ko00500	Starch and sucrose metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMT200076330	K05350	ko00940	Phenylpropanoid biosynthesis	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMT200076330	K05350	ko01110	Biosynthesis of secondary metabolites	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMT200076339	K10591	ko04120	Ubiquitin mediated proteolysis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMT200076339	K10591	ko04144	Endocytosis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMT200076344	K12397	ko04142	Lysosome	3043	5.3e-162	0.60	0.75	1.00
PGSC0003DMT200076345	K12397	ko04142	Lysosome	6116	0.	0.67	0.79	1.00
PGSC0003DMT200076346	K12397	ko04142	Lysosome	1204	1.4e-60	0.66	0.77	0.98
PGSC0003DMT200076347	K12397	ko04142	Lysosome	1599	2.3e-82	0.55	0.73	0.91
PGSC0003DMT200076353	K03127	ko03022	Basal transcription factors	929	2.1e-45	0.86	0.97	0.98
PGSC0003DMT200048927	K01915	ko00250	Alanine, aspartate and glutamate metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMT200048927	K01915	ko00330	Arginine and proline metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMT200048927	K01915	ko00910	Nitrogen metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMT200048927	K01915	ko01100	Metabolic pathways	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMT200048927	K01915	ko02020	Two-component system	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMT200048941	K12126	ko04712	Circadian rhythm - plant	244	2.9e-07	0.37	0.56	0.35
PGSC0003DMT200048945	K02918	ko03010	Ribosome	566	2.2e-25	0.89	0.95	0.80
PGSC0003DMT200048954	K12828	ko03040	Spliceosome	2880	5.2e-153	0.90	0.94	0.99
PGSC0003DMT200048955	K00901	ko00561	Glycerolipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMT200048955	K00901	ko00564	Glycerophospholipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMT200048955	K00901	ko01100	Metabolic pathways	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMT200048955	K00901	ko04070	Phosphatidylinositol signaling system	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMT200048960	K03014	ko00230	Purine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMT200048960	K03014	ko00240	Pyrimidine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMT200048960	K03014	ko01100	Metabolic pathways	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMT200048960	K03014	ko03020	RNA polymerase	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMT200048960	K03014	ko05016	Huntington's disease	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMT200048965	K05391	ko04626	Plant-pathogen interaction	3502	2.6e-187	0.65	0.77	0.92
PGSC0003DMT200064222	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064222	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064222	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064222	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064222	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064223	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064223	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064223	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064223	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064223	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMT200064224	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMT200064224	K00517	ko00626	Naphthalene and anthracene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMT200064224	K00517	ko00903	Limonene and pinene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMT200064224	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMT200064224	K00517	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMT200064225	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMT200064225	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMT200064225	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMT200064225	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMT200064225	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMT200056256	K03028	ko03050	Proteasome	2079	7.8e-109	0.73	0.84	0.92
PGSC0003DMT200056257	K03028	ko03050	Proteasome	5725	0.	0.78	0.88	0.99
PGSC0003DMT200056258	K03028	ko03050	Proteasome	3223	6.2e-172	0.81	0.90	0.99
PGSC0003DMT200056259	K03028	ko03050	Proteasome	3400	1.1e-181	0.81	0.91	1.00
PGSC0003DMT200056260	K03028	ko03050	Proteasome	1064	7.5e-53	0.79	0.85	0.94
PGSC0003DMT200056263	K05863	ko04020	Calcium signaling pathway	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMT200056263	K05863	ko05012	Parkinson's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMT200056263	K05863	ko05016	Huntington's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMT200056264	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056264	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056265	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMT200056270	K07466	ko03030	DNA replication	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMT200056270	K07466	ko03420	Nucleotide excision repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMT200056270	K07466	ko03430	Mismatch repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMT200056270	K07466	ko03440	Homologous recombination	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMT200056271	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00270	Cysteine and methionine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00350	Tyrosine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00360	Phenylalanine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00401	Novobiocin biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko01100	Metabolic pathways	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056271	K00815	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMT200056272	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00270	Cysteine and methionine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00350	Tyrosine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00360	Phenylalanine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00401	Novobiocin biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko01100	Metabolic pathways	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056272	K00815	ko01110	Biosynthesis of secondary metabolites	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMT200056281	K12929	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMT200056281	K12929	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMT200056292	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMT200056292	K00517	ko00626	Naphthalene and anthracene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMT200056292	K00517	ko00903	Limonene and pinene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMT200056292	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMT200056292	K00517	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMT200056296	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMT200056296	K00517	ko00626	Naphthalene and anthracene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMT200056296	K00517	ko00903	Limonene and pinene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMT200056296	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMT200056296	K00517	ko01110	Biosynthesis of secondary metabolites	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMT200056298	K11818	ko00380	Tryptophan metabolism	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMT200056298	K11818	ko00966	Glucosinolate biosynthesis	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMT200056298	K11818	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMT200056301	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMT200056301	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMT200056301	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMT200056301	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMT200056301	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMT200056306	K11818	ko00380	Tryptophan metabolism	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMT200056306	K11818	ko00966	Glucosinolate biosynthesis	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMT200056306	K11818	ko01110	Biosynthesis of secondary metabolites	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMT200056307	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMT200056307	K00517	ko00626	Naphthalene and anthracene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMT200056307	K00517	ko00903	Limonene and pinene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMT200056307	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMT200056307	K00517	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMT200056308	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMT200056308	K00517	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMT200056308	K00517	ko00903	Limonene and pinene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMT200056308	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMT200056308	K00517	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMT200079216	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMT200079218	K00434	ko00053	Ascorbate and aldarate metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMT200079218	K00434	ko00480	Glutathione metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMT200079219	K00434	ko00053	Ascorbate and aldarate metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMT200079219	K00434	ko00480	Glutathione metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMT200079237	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.30	0.48	0.67
PGSC0003DMT200074333	K05666	ko02010	ABC transporters	3169	5.9e-169	0.36	0.56	0.88
PGSC0003DMT200074343	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMT200074343	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMT200074344	K12134	ko04712	Circadian rhythm - plant	468	5.6e-20	0.54	0.68	0.33
PGSC0003DMT200074346	K02294	ko00906	Carotenoid biosynthesis	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMT200074346	K02294	ko01100	Metabolic pathways	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMT200074346	K02294	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMT200074349	K03127	ko03022	Basal transcription factors	501	8.7e-22	0.52	0.67	0.18
PGSC0003DMT200074350	K03127	ko03022	Basal transcription factors	771	1.1e-36	0.73	0.88	0.96
PGSC0003DMT200074363	K12795	ko04621	NOD-like receptor signaling pathway	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMT200074363	K12795	ko04626	Plant-pathogen interaction	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMT200074364	K12795	ko04621	NOD-like receptor signaling pathway	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMT200074364	K12795	ko04626	Plant-pathogen interaction	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMT200074366	K12795	ko04621	NOD-like receptor signaling pathway	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMT200074366	K12795	ko04626	Plant-pathogen interaction	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMT200074367	K03949	ko00190	Oxidative phosphorylation	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMT200074367	K03949	ko01100	Metabolic pathways	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMT200074367	K03949	ko05010	Alzheimer's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMT200074367	K03949	ko05012	Parkinson's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMT200074367	K03949	ko05016	Huntington's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMT200017594	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017594	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017594	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017595	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017595	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017595	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017596	K09842	ko00906	Carotenoid biosynthesis	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMT200017596	K09842	ko01100	Metabolic pathways	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMT200017596	K09842	ko01110	Biosynthesis of secondary metabolites	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMT200017597	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017597	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017597	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMT200017598	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMT200017599	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMT200017600	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMT200017601	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMT200017619	K01759	ko00620	Pyruvate metabolism	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMT200017619	K01759	ko04011	MAPK signaling pathway - yeast	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMT200017628	K00658	ko00020	Citrate cycle (TCA cycle)	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMT200017628	K00658	ko00310	Lysine degradation	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMT200017628	K00658	ko01100	Metabolic pathways	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMT200017628	K00658	ko01110	Biosynthesis of secondary metabolites	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMT200009584	K00088	ko00230	Purine metabolism	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMT200009584	K00088	ko00983	Drug metabolism - other enzymes	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMT200009584	K00088	ko01100	Metabolic pathways	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMT200009584	K00088	ko01110	Biosynthesis of secondary metabolites	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMT200009588	K02725	ko03050	Proteasome	1981	2.0e-103	0.85	0.90	1.00
PGSC0003DMT200009589	K00611	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMT200009589	K00611	ko01100	Metabolic pathways	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMT200009589	K00611	ko01110	Biosynthesis of secondary metabolites	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMT200009590	K00611	ko00330	Arginine and proline metabolism	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMT200009590	K00611	ko01100	Metabolic pathways	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMT200009590	K00611	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMT200009591	K00611	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMT200009591	K00611	ko01100	Metabolic pathways	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMT200009591	K00611	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMT200009594	K08241	ko00592	alpha-Linolenic acid metabolism	1558	4.3e-80	0.52	0.66	0.99
PGSC0003DMT200009595	K10610	ko03420	Nucleotide excision repair	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMT200009595	K10610	ko04120	Ubiquitin mediated proteolysis	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMT200009605	K13065	ko00940	Phenylpropanoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMT200009605	K13065	ko00941	Flavonoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMT200009605	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMT200009605	K13065	ko01110	Biosynthesis of secondary metabolites	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMT200028088	K00680	ko00350	Tyrosine metabolism	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMT200028088	K00680	ko00624	1- and 2-Methylnaphthalene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMT200028088	K00680	ko00632	Benzoate degradation via CoA ligation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMT200028088	K00680	ko00642	Ethylbenzene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMT200028088	K00680	ko00903	Limonene and pinene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMT200028093	K00600	ko00260	Glycine, serine and threonine metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028093	K00600	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028093	K00600	ko00670	One carbon pool by folate	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028093	K00600	ko00680	Methane metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028093	K00600	ko01100	Metabolic pathways	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028093	K00600	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMT200028097	K11090	ko05322	Systemic lupus erythematosus	2332	8.7e-123	0.62	0.78	0.99
PGSC0003DMT200028102	K01590	ko00340	Histidine metabolism	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMT200028102	K01590	ko01100	Metabolic pathways	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMT200028102	K01590	ko01110	Biosynthesis of secondary metabolites	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMT200028103	K01590	ko00340	Histidine metabolism	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMT200028103	K01590	ko01100	Metabolic pathways	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMT200028103	K01590	ko01110	Biosynthesis of secondary metabolites	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMT200028105	K00813	ko00250	Alanine, aspartate and glutamate metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00270	Cysteine and methionine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00330	Arginine and proline metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00350	Tyrosine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00360	Phenylalanine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00401	Novobiocin biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00710	Carbon fixation in photosynthetic organisms	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00950	Isoquinoline alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko01100	Metabolic pathways	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028105	K00813	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMT200028106	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00270	Cysteine and methionine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00330	Arginine and proline metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00350	Tyrosine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00360	Phenylalanine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00401	Novobiocin biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00710	Carbon fixation in photosynthetic organisms	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko01100	Metabolic pathways	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200028106	K00813	ko01110	Biosynthesis of secondary metabolites	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMT200058336	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.30	0.48	0.99
PGSC0003DMT200068224	K12836	ko03040	Spliceosome	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMT200068224	K12836	ko05131	Shigellosis	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMT200068225	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMT200068225	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMT200068226	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMT200068226	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMT200068230	K08488	ko04130	SNARE interactions in vesicular transport	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMT200068230	K08488	ko04145	Phagosome	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMT200068240	K06067	ko04110	Cell cycle	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMT200068240	K06067	ko04330	Notch signaling pathway	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMT200068240	K06067	ko05016	Huntington's disease	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMT200068240	K06067	ko05200	Pathways in cancer	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMT200068240	K06067	ko05220	Chronic myeloid leukemia	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMT200068241	K06067	ko04110	Cell cycle	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMT200068241	K06067	ko04330	Notch signaling pathway	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMT200068241	K06067	ko05016	Huntington's disease	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMT200068241	K06067	ko05200	Pathways in cancer	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMT200068241	K06067	ko05220	Chronic myeloid leukemia	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMT200068246	K01193	ko00052	Galactose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMT200068246	K01193	ko00500	Starch and sucrose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMT200068246	K01193	ko01100	Metabolic pathways	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMT200068249	K01193	ko00052	Galactose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMT200068249	K01193	ko00500	Starch and sucrose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMT200068249	K01193	ko01100	Metabolic pathways	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMT200068261	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMT200068261	K04518	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMT200087679	K00789	ko00270	Cysteine and methionine metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMT200087679	K00789	ko00450	Selenoamino acid metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMT200087679	K00789	ko01100	Metabolic pathways	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMT200087679	K00789	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMT200087694	K03094	ko04110	Cell cycle	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04111	Cell cycle - yeast	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04114	Oocyte meiosis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04310	Wnt signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04350	TGF-beta signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200087694	K03094	ko04710	Circadian rhythm - mammal	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMT200085026	K00128	ko00010	Glycolysis / Gluconeogenesis	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00053	Ascorbate and aldarate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00071	Fatty acid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00280	Valine, leucine and isoleucine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00310	Lysine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00330	Arginine and proline metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00340	Histidine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00380	Tryptophan metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00410	beta-Alanine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00561	Glycerolipid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00620	Pyruvate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00631	1,2-Dichloroethane degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00640	Propanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00641	3-Chloroacrylic acid degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00650	Butanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko00903	Limonene and pinene degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko01100	Metabolic pathways	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085026	K00128	ko01110	Biosynthesis of secondary metabolites	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMT200085031	K10760	ko00908	Zeatin biosynthesis	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMT200085031	K10760	ko01100	Metabolic pathways	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMT200085031	K10760	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMT200085038	K09866	ko04962	Vasopressin-regulated water reabsorption	298	1.3e-10	0.30	0.45	0.98
PGSC0003DMT200085041	K08059	ko04612	Antigen processing and presentation	457	2.3e-19	0.54	0.69	0.91
PGSC0003DMT200041568	K00002	ko00010	Glycolysis / Gluconeogenesis	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMT200041568	K00002	ko00561	Glycerolipid metabolism	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMT200041568	K00002	ko00930	Caprolactam degradation	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMT200041568	K00002	ko01100	Metabolic pathways	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMT200041568	K00002	ko01110	Biosynthesis of secondary metabolites	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMT200041581	K12857	ko03040	Spliceosome	224	1.6e-06	0.28	0.44	0.92
PGSC0003DMT200041583	K12857	ko03040	Spliceosome	223	1.8e-06	0.29	0.48	0.82
PGSC0003DMT200041589	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMT200041589	K02366	ko01100	Metabolic pathways	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMT200041591	K01662	ko00900	Terpenoid backbone biosynthesis	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMT200041591	K01662	ko01100	Metabolic pathways	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMT200041591	K01662	ko01110	Biosynthesis of secondary metabolites	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMT200041592	K01662	ko00900	Terpenoid backbone biosynthesis	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMT200041592	K01662	ko01100	Metabolic pathways	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMT200041592	K01662	ko01110	Biosynthesis of secondary metabolites	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMT200041593	K12356	ko00940	Phenylpropanoid biosynthesis	671	3.6e-31	0.32	0.49	0.93
PGSC0003DMT200041594	K12356	ko00940	Phenylpropanoid biosynthesis	654	3.1e-30	0.33	0.47	0.93
PGSC0003DMT200041595	K12356	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.38	0.54	0.84
PGSC0003DMT200041604	K00558	ko00270	Cysteine and methionine metabolism	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMT200041604	K00558	ko01100	Metabolic pathways	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMT200015118	K02949	ko03010	Ribosome	1231	4.6e-62	0.91	0.93	0.99
PGSC0003DMT200015119	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMT200015120	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMT200015122	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMT200015123	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMT200015124	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200015125	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMT200015126	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMT200015129	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMT200015132	K06669	ko04110	Cell cycle	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMT200015132	K06669	ko04111	Cell cycle - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMT200015132	K06669	ko04113	Meiosis - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMT200015132	K06669	ko04114	Oocyte meiosis	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMT200015133	K06669	ko04110	Cell cycle	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMT200015133	K06669	ko04111	Cell cycle - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMT200015133	K06669	ko04113	Meiosis - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMT200015133	K06669	ko04114	Oocyte meiosis	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMT200015134	K06669	ko04110	Cell cycle	7897	0.	0.79	0.90	1.00
PGSC0003DMT200015134	K06669	ko04111	Cell cycle - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMT200015134	K06669	ko04113	Meiosis - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMT200015134	K06669	ko04114	Oocyte meiosis	7897	0.	0.79	0.90	1.00
PGSC0003DMT200015135	K06669	ko04110	Cell cycle	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMT200015135	K06669	ko04111	Cell cycle - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMT200015135	K06669	ko04113	Meiosis - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMT200015135	K06669	ko04114	Oocyte meiosis	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMT200015140	K06669	ko04110	Cell cycle	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMT200015140	K06669	ko04111	Cell cycle - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMT200015140	K06669	ko04113	Meiosis - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMT200015140	K06669	ko04114	Oocyte meiosis	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMT200015149	K12627	ko03018	RNA degradation	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMT200015149	K12627	ko03040	Spliceosome	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMT200015150	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMT200015150	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMT200015151	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMT200015151	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMT200025354	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMT200025354	K00517	ko00626	Naphthalene and anthracene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMT200025354	K00517	ko00903	Limonene and pinene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMT200025354	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMT200025354	K00517	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMT200025359	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMT200025359	K00517	ko00626	Naphthalene and anthracene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMT200025359	K00517	ko00903	Limonene and pinene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMT200025359	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMT200025359	K00517	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMT200025361	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMT200025361	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMT200025361	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMT200025361	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMT200025361	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMT200025364	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMT200025364	K00517	ko00626	Naphthalene and anthracene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMT200025364	K00517	ko00903	Limonene and pinene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMT200025364	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMT200025364	K00517	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMT200025365	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMT200025365	K00517	ko00626	Naphthalene and anthracene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMT200025365	K00517	ko00903	Limonene and pinene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMT200025365	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMT200025365	K00517	ko01110	Biosynthesis of secondary metabolites	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMT200025370	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMT200025370	K00517	ko00626	Naphthalene and anthracene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMT200025370	K00517	ko00903	Limonene and pinene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMT200025370	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMT200025370	K00517	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMT200025376	K06674	ko04111	Cell cycle - yeast	271	4.9e-06	0.29	0.47	0.78
PGSC0003DMT200025380	K05663	ko02010	ABC transporters	1305	3.8e-66	0.82	0.92	0.88
PGSC0003DMT200097139	K10760	ko00908	Zeatin biosynthesis	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMT200097139	K10760	ko01100	Metabolic pathways	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMT200097139	K10760	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMT200092532	K03094	ko04110	Cell cycle	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04111	Cell cycle - yeast	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04114	Oocyte meiosis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04120	Ubiquitin mediated proteolysis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04310	Wnt signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04350	TGF-beta signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092532	K03094	ko04710	Circadian rhythm - mammal	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMT200092551	K03403	ko00860	Porphyrin and chlorophyll metabolism	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMT200092551	K03403	ko01100	Metabolic pathways	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMT200092551	K03403	ko01110	Biosynthesis of secondary metabolites	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMT200048025	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMT200048026	K00485	ko00982	Drug metabolism - cytochrome P450	442	1.5e-18	0.31	0.47	0.96
PGSC0003DMT200048027	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMT200048037	K00384	ko00240	Pyrimidine metabolism	2354	5.3e-124	0.83	0.93	1.00
PGSC0003DMT200048038	K08139	ko04113	Meiosis - yeast	578	3.1e-51	0.36	0.59	0.62
PGSC0003DMT200048061	K05868	ko04110	Cell cycle	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMT200048061	K05868	ko04115	p53 signaling pathway	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMT200048061	K05868	ko04914	Progesterone-mediated oocyte maturation	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMT200048062	K05868	ko04110	Cell cycle	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMT200048062	K05868	ko04115	p53 signaling pathway	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMT200048062	K05868	ko04914	Progesterone-mediated oocyte maturation	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMT200069961	K04125	ko00904	Diterpenoid biosynthesis	1058	1.6e-52	0.45	0.61	0.93
PGSC0003DMT200069971	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMT200069972	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMT200069973	K12121	ko04712	Circadian rhythm - plant	2256	1.4e-118	0.72	0.85	0.98
PGSC0003DMT200069974	K12121	ko04712	Circadian rhythm - plant	7381	0.	0.78	0.87	0.99
PGSC0003DMT200069975	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069975	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069975	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069975	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069976	K01648	ko00020	Citrate cycle (TCA cycle)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMT200069976	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMT200069976	K01648	ko01100	Metabolic pathways	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMT200069976	K01648	ko01110	Biosynthesis of secondary metabolites	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMT200069977	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069977	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069977	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069977	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMT200069978	K03017	ko00230	Purine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMT200069978	K03017	ko00240	Pyrimidine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMT200069978	K03017	ko01100	Metabolic pathways	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMT200069978	K03017	ko03020	RNA polymerase	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMT200069978	K03017	ko05016	Huntington's disease	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMT200069988	K00382	ko00010	Glycolysis / Gluconeogenesis	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko00020	Citrate cycle (TCA cycle)	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko00260	Glycine, serine and threonine metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko00620	Pyruvate metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko01100	Metabolic pathways	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069988	K00382	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMT200069996	K00878	ko00730	Thiamine metabolism	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMT200069996	K00878	ko01100	Metabolic pathways	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMT200069997	K03013	ko00230	Purine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMT200069997	K03013	ko00240	Pyrimidine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMT200069997	K03013	ko01100	Metabolic pathways	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMT200069997	K03013	ko03020	RNA polymerase	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMT200069997	K03013	ko05016	Huntington's disease	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMT200060162	K06269	ko04113	Meiosis - yeast	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04114	Oocyte meiosis	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04270	Vascular smooth muscle contraction	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04510	Focal adhesion	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04720	Long-term potentiation	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04810	Regulation of actin cytoskeleton	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060162	K06269	ko04910	Insulin signaling pathway	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMT200060163	K06269	ko04113	Meiosis - yeast	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04114	Oocyte meiosis	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04270	Vascular smooth muscle contraction	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04510	Focal adhesion	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04720	Long-term potentiation	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04810	Regulation of actin cytoskeleton	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060163	K06269	ko04910	Insulin signaling pathway	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMT200060175	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMT200060176	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMT200060177	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMT200060192	K03075	ko03060	Protein export	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMT200060192	K03075	ko03070	Bacterial secretion system	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMT200086481	K02183	ko04020	Calcium signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04070	Phosphatidylinositol signaling system	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04114	Oocyte meiosis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04270	Vascular smooth muscle contraction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04626	Plant-pathogen interaction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04720	Long-term potentiation	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04722	Neurotrophin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04740	Olfactory transduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04744	Phototransduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04745	Phototransduction - fly	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04910	Insulin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04912	GnRH signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04916	Melanogenesis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04970	Salivary secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko04971	Gastric acid secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko05010	Alzheimer's disease	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086481	K02183	ko05214	Glioma	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMT200086487	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMT200086487	K00517	ko00626	Naphthalene and anthracene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMT200086487	K00517	ko00903	Limonene and pinene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMT200086487	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMT200086487	K00517	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMT200091340	K11093	ko03040	Spliceosome	248	7.6e-08	0.29	0.49	0.83
PGSC0003DMT200091342	K03006	ko00230	Purine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMT200091342	K03006	ko00240	Pyrimidine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMT200091342	K03006	ko01100	Metabolic pathways	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMT200091342	K03006	ko03020	RNA polymerase	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMT200091342	K03006	ko05016	Huntington's disease	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMT200043261	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043261	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043261	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043261	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043262	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043262	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043262	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043262	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMT200043263	K00599	ko00340	Histidine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMT200043263	K00599	ko00350	Tyrosine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMT200043263	K00599	ko00450	Selenoamino acid metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMT200043263	K00599	ko00626	Naphthalene and anthracene degradation	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMT200043266	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043266	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043266	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043266	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043267	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043267	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043267	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043267	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMT200043270	K05681	ko02010	ABC transporters	1091	2.4e-54	0.35	0.53	0.80
PGSC0003DMT200043287	K05681	ko02010	ABC transporters	1154	8.2e-58	0.34	0.54	0.78
PGSC0003DMT200043289	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMT200043290	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMT200043300	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMT200043301	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMT200043302	K12796	ko04621	NOD-like receptor signaling pathway	434	3.7e-15	0.32	0.47	0.63
PGSC0003DMT200023629	K00889	ko00562	Inositol phosphate metabolism	8174	0.	0.63	0.74	1.00
PGSC0003DMT200023629	K00889	ko01100	Metabolic pathways	8174	0.	0.63	0.74	1.00
PGSC0003DMT200023629	K00889	ko04070	Phosphatidylinositol signaling system	8174	0.	0.63	0.74	1.00
PGSC0003DMT200023629	K00889	ko04144	Endocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMT200023629	K00889	ko04666	Fc gamma R-mediated phagocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMT200023629	K00889	ko04810	Regulation of actin cytoskeleton	8174	0.	0.63	0.74	1.00
PGSC0003DMT200013378	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMT200013379	K02874	ko03010	Ribosome	847	7.0e-41	0.86	0.94	0.99
PGSC0003DMT200013389	K03921	ko00061	Fatty acid biosynthesis	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMT200013389	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMT200013390	K03921	ko00061	Fatty acid biosynthesis	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMT200013390	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMT200013392	K03921	ko00061	Fatty acid biosynthesis	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMT200013392	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMT200013395	K03921	ko00061	Fatty acid biosynthesis	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMT200013395	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMT200013396	K03921	ko00061	Fatty acid biosynthesis	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMT200013396	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMT200013409	K00599	ko00340	Histidine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMT200013409	K00599	ko00350	Tyrosine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMT200013409	K00599	ko00450	Selenoamino acid metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMT200013409	K00599	ko00626	Naphthalene and anthracene degradation	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMT200013423	K01564	ko00791	Atrazine degradation	1060	1.2e-52	0.38	0.57	0.96
PGSC0003DMT200013425	K01564	ko00791	Atrazine degradation	927	2.7e-45	0.38	0.56	0.92
PGSC0003DMT200039355	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMT200039355	K00517	ko00626	Naphthalene and anthracene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMT200039355	K00517	ko00903	Limonene and pinene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMT200039355	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMT200039355	K00517	ko01110	Biosynthesis of secondary metabolites	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMT200039384	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMT200039384	K00517	ko00626	Naphthalene and anthracene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMT200039384	K00517	ko00903	Limonene and pinene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMT200039384	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMT200039384	K00517	ko01110	Biosynthesis of secondary metabolites	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMT200039385	K01728	ko00040	Pentose and glucuronate interconversions	2622	8.8e-139	0.74	0.85	0.98
PGSC0003DMT200039404	K02495	ko00860	Porphyrin and chlorophyll metabolism	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMT200039404	K02495	ko01100	Metabolic pathways	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMT200039404	K02495	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMT200054490	K08507	ko04130	SNARE interactions in vesicular transport	216	4.4e-06	0.29	0.49	0.90
PGSC0003DMT200054508	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	609	9.4e-28	0.34	0.50	0.45
PGSC0003DMT200054510	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	606	1.4e-27	0.34	0.50	0.84
PGSC0003DMT200054511	K09832	ko00100	Steroid biosynthesis	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMT200054511	K09832	ko01110	Biosynthesis of secondary metabolites	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMT200054512	K02955	ko03010	Ribosome	1205	1.3e-60	0.95	0.98	0.99
PGSC0003DMT200054514	K01000	ko00550	Peptidoglycan biosynthesis	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMT200054514	K01000	ko01100	Metabolic pathways	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMT200054515	K01000	ko00550	Peptidoglycan biosynthesis	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMT200054515	K01000	ko01100	Metabolic pathways	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMT200054517	K11090	ko05322	Systemic lupus erythematosus	400	3.2e-16	0.31	0.52	0.70
PGSC0003DMT200054518	K11090	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.33	0.54	0.68
PGSC0003DMT200062515	K00430	ko00360	Phenylalanine metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMT200062515	K00430	ko00680	Methane metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMT200062515	K00430	ko00940	Phenylpropanoid biosynthesis	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMT200062515	K00430	ko01100	Metabolic pathways	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMT200062515	K00430	ko01110	Biosynthesis of secondary metabolites	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMT200062519	K00430	ko00360	Phenylalanine metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMT200062519	K00430	ko00680	Methane metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMT200062519	K00430	ko00940	Phenylpropanoid biosynthesis	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMT200062519	K00430	ko01100	Metabolic pathways	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMT200062519	K00430	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMT200062520	K00430	ko00360	Phenylalanine metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMT200062520	K00430	ko00680	Methane metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMT200062520	K00430	ko00940	Phenylpropanoid biosynthesis	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMT200062520	K00430	ko01100	Metabolic pathways	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMT200062520	K00430	ko01110	Biosynthesis of secondary metabolites	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMT200062533	K00430	ko00360	Phenylalanine metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMT200062533	K00430	ko00680	Methane metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMT200062533	K00430	ko00940	Phenylpropanoid biosynthesis	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMT200062533	K00430	ko01100	Metabolic pathways	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMT200062533	K00430	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMT200062534	K00430	ko00360	Phenylalanine metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMT200062534	K00430	ko00680	Methane metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMT200062534	K00430	ko00940	Phenylpropanoid biosynthesis	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMT200062534	K00430	ko01100	Metabolic pathways	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMT200062534	K00430	ko01110	Biosynthesis of secondary metabolites	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMT200062557	K08266	ko04150	mTOR signaling pathway	2614	2.4e-138	0.94	0.98	0.99
PGSC0003DMT200072645	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMT200072645	K00517	ko00626	Naphthalene and anthracene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMT200072645	K00517	ko00903	Limonene and pinene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMT200072645	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMT200072645	K00517	ko01110	Biosynthesis of secondary metabolites	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMT200072646	K05280	ko00941	Flavonoid biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMT200072646	K05280	ko00944	Flavone and flavonol biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMT200072646	K05280	ko01100	Metabolic pathways	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMT200072646	K05280	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMT200072647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMT200072647	K00517	ko00626	Naphthalene and anthracene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMT200072647	K00517	ko00903	Limonene and pinene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMT200072647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMT200072647	K00517	ko01110	Biosynthesis of secondary metabolites	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMT200072648	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMT200072648	K00517	ko00626	Naphthalene and anthracene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMT200072648	K00517	ko00903	Limonene and pinene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMT200072648	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMT200072648	K00517	ko01110	Biosynthesis of secondary metabolites	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMT200072649	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMT200072649	K00517	ko00626	Naphthalene and anthracene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMT200072649	K00517	ko00903	Limonene and pinene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMT200072649	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMT200072649	K00517	ko01110	Biosynthesis of secondary metabolites	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMT200072650	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMT200072650	K00517	ko00626	Naphthalene and anthracene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMT200072650	K00517	ko00903	Limonene and pinene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMT200072650	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMT200072650	K00517	ko01110	Biosynthesis of secondary metabolites	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMT200072651	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMT200072651	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMT200072651	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMT200072651	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMT200072651	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMT200072652	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMT200072652	K00517	ko00626	Naphthalene and anthracene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMT200072652	K00517	ko00903	Limonene and pinene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMT200072652	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMT200072652	K00517	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMT200072653	K12869	ko03040	Spliceosome	4679	3.1e-252	0.80	0.88	1.00
PGSC0003DMT200072655	K02896	ko03010	Ribosome	1255	2.2e-63	0.91	0.94	0.99
PGSC0003DMT200072656	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMT200072656	K02366	ko01100	Metabolic pathways	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMT200072657	K01754	ko00260	Glycine, serine and threonine metabolism	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMT200072657	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMT200072657	K01754	ko01100	Metabolic pathways	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMT200072657	K01754	ko01110	Biosynthesis of secondary metabolites	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMT200072658	K01754	ko00260	Glycine, serine and threonine metabolism	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMT200072658	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMT200072658	K01754	ko01100	Metabolic pathways	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMT200072658	K01754	ko01110	Biosynthesis of secondary metabolites	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMT200072663	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMT200072663	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMT200072663	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMT200072663	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMT200072663	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMT200072664	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMT200072664	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMT200072664	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMT200072664	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMT200072664	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMT200072665	K01915	ko00250	Alanine, aspartate and glutamate metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMT200072665	K01915	ko00330	Arginine and proline metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMT200072665	K01915	ko00910	Nitrogen metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMT200072665	K01915	ko01100	Metabolic pathways	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMT200072665	K01915	ko02020	Two-component system	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMT200072666	K01915	ko00250	Alanine, aspartate and glutamate metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMT200072666	K01915	ko00330	Arginine and proline metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMT200072666	K01915	ko00910	Nitrogen metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMT200072666	K01915	ko01100	Metabolic pathways	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMT200072666	K01915	ko02020	Two-component system	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMT200072678	K01674	ko00910	Nitrogen metabolism	1406	1.0e-71	0.66	0.78	0.93
PGSC0003DMT200072679	K01674	ko00910	Nitrogen metabolism	1307	3.0e-66	0.69	0.82	0.96
PGSC0003DMT200072681	K01674	ko00910	Nitrogen metabolism	1501	5.9e-77	0.66	0.79	0.97
PGSC0003DMT200072686	K01674	ko00910	Nitrogen metabolism	1487	3.5e-76	0.66	0.79	0.97
PGSC0003DMT200003777	K11294	ko05130	Pathogenic Escherichia coli infection	420	2.5e-17	0.32	0.51	0.54
PGSC0003DMT200003780	K11294	ko05130	Pathogenic Escherichia coli infection	244	4.6e-07	0.36	0.48	0.87
PGSC0003DMT200003781	K12890	ko03040	Spliceosome	232	1.1e-06	0.37	0.51	0.28
PGSC0003DMT200003786	K08737	ko03430	Mismatch repair	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMT200003786	K08737	ko05200	Pathways in cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMT200003786	K08737	ko05210	Colorectal cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMT200003787	K08737	ko03430	Mismatch repair	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMT200003787	K08737	ko05200	Pathways in cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMT200003787	K08737	ko05210	Colorectal cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMT200090456	K10760	ko00908	Zeatin biosynthesis	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMT200090456	K10760	ko01100	Metabolic pathways	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMT200090456	K10760	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMT200090460	K03094	ko04110	Cell cycle	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04111	Cell cycle - yeast	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04114	Oocyte meiosis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04310	Wnt signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04350	TGF-beta signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090460	K03094	ko04710	Circadian rhythm - mammal	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMT200090482	K11228	ko04011	MAPK signaling pathway - yeast	328	1.6e-11	0.37	0.49	0.93
PGSC0003DMT200011309	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011309	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011310	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011311	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011312	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011313	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011314	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011315	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011317	K00754	ko00051	Fructose and mannose metabolism	1355	6.7e-69	0.42	0.60	0.98
PGSC0003DMT200011328	K01159	ko03440	Homologous recombination	238	2.7e-07	0.30	0.48	0.53
PGSC0003DMT200011335	K01803	ko00010	Glycolysis / Gluconeogenesis	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011335	K01803	ko00051	Fructose and mannose metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011335	K01803	ko00562	Inositol phosphate metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011335	K01803	ko00710	Carbon fixation in photosynthetic organisms	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011335	K01803	ko01100	Metabolic pathways	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011335	K01803	ko01110	Biosynthesis of secondary metabolites	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMT200011336	K10949	ko05110	Vibrio cholerae infection	535	1.1e-23	0.36	0.58	0.82
PGSC0003DMT200019417	K12586	ko03018	RNA degradation	1996	3.0e-104	0.81	0.90	1.00
PGSC0003DMT200019418	K12586	ko03018	RNA degradation	1942	2.8e-101	0.82	0.91	1.00
PGSC0003DMT200019433	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019433	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019433	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019434	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMT200019434	K11517	ko01100	Metabolic pathways	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMT200019434	K11517	ko04146	Peroxisome	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMT200019435	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMT200019435	K11517	ko01100	Metabolic pathways	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMT200019435	K11517	ko04146	Peroxisome	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMT200019436	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019436	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019436	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMT200019437	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMT200019437	K11517	ko01100	Metabolic pathways	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMT200019437	K11517	ko04146	Peroxisome	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMT200019439	K00993	ko00440	Phosphonate and phosphinate metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMT200019439	K00993	ko00564	Glycerophospholipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMT200019439	K00993	ko00565	Ether lipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMT200019439	K00993	ko01100	Metabolic pathways	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMT200019450	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200019450	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200019450	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200019451	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200019451	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200019451	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMT200034848	K07192	ko04910	Insulin signaling pathway	1311	1.8e-66	0.39	0.60	0.97
PGSC0003DMT200034849	K07192	ko04910	Insulin signaling pathway	990	9.1e-49	0.44	0.66	0.93
PGSC0003DMT200029944	K10581	ko04120	Ubiquitin mediated proteolysis	534	5.7e-23	0.29	0.42	0.72
PGSC0003DMT200029947	K01620	ko00260	Glycine, serine and threonine metabolism	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMT200029947	K01620	ko01100	Metabolic pathways	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMT200029947	K01620	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMT200029948	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029948	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029948	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029949	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029949	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029949	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029950	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029950	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029950	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMT200029952	K12860	ko03040	Spliceosome	651	8.0e-30	0.45	0.60	0.78
PGSC0003DMT200029953	K12860	ko03040	Spliceosome	5879	0.	0.73	0.84	1.00
PGSC0003DMT200035739	K08486	ko04130	SNARE interactions in vesicular transport	1883	5.1e-98	0.77	0.87	0.96
PGSC0003DMT200035747	K02636	ko00195	Photosynthesis	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMT200035747	K02636	ko01100	Metabolic pathways	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMT200035753	K03006	ko00230	Purine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMT200035753	K03006	ko00240	Pyrimidine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMT200035753	K03006	ko01100	Metabolic pathways	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMT200035753	K03006	ko03020	RNA polymerase	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMT200035753	K03006	ko05016	Huntington's disease	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMT200011956	K10581	ko04120	Ubiquitin mediated proteolysis	980	3.2e-48	0.48	0.65	0.82
PGSC0003DMT200011959	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMT200011959	K04424	ko04530	Tight junction	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMT200011961	K04424	ko04010	MAPK signaling pathway	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMT200011961	K04424	ko04530	Tight junction	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMT200011962	K01648	ko00020	Citrate cycle (TCA cycle)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMT200011962	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMT200011962	K01648	ko01100	Metabolic pathways	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMT200011962	K01648	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMT200011963	K01648	ko00020	Citrate cycle (TCA cycle)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMT200011963	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMT200011963	K01648	ko01100	Metabolic pathways	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMT200011963	K01648	ko01110	Biosynthesis of secondary metabolites	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMT200011968	K00128	ko00010	Glycolysis / Gluconeogenesis	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00053	Ascorbate and aldarate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00071	Fatty acid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00280	Valine, leucine and isoleucine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00310	Lysine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00330	Arginine and proline metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00340	Histidine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00380	Tryptophan metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00410	beta-Alanine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00561	Glycerolipid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00620	Pyruvate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00631	1,2-Dichloroethane degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00640	Propanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00641	3-Chloroacrylic acid degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00650	Butanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko00903	Limonene and pinene degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko01100	Metabolic pathways	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011968	K00128	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMT200011969	K00128	ko00010	Glycolysis / Gluconeogenesis	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00053	Ascorbate and aldarate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00071	Fatty acid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00280	Valine, leucine and isoleucine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00310	Lysine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00330	Arginine and proline metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00340	Histidine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00380	Tryptophan metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00410	beta-Alanine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00561	Glycerolipid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00620	Pyruvate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00631	1,2-Dichloroethane degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00640	Propanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00641	3-Chloroacrylic acid degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00650	Butanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko01100	Metabolic pathways	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011969	K00128	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMT200011970	K00128	ko00010	Glycolysis / Gluconeogenesis	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00053	Ascorbate and aldarate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00071	Fatty acid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00280	Valine, leucine and isoleucine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00310	Lysine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00330	Arginine and proline metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00340	Histidine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00380	Tryptophan metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00410	beta-Alanine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00561	Glycerolipid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00620	Pyruvate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00631	1,2-Dichloroethane degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00640	Propanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00641	3-Chloroacrylic acid degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00650	Butanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko00903	Limonene and pinene degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko01100	Metabolic pathways	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011970	K00128	ko01110	Biosynthesis of secondary metabolites	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMT200011971	K10578	ko04120	Ubiquitin mediated proteolysis	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMT200011971	K10578	ko05012	Parkinson's disease	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMT200011976	K02905	ko03010	Ribosome	461	1.4e-19	0.91	0.96	0.95
PGSC0003DMT200016909	K02206	ko04110	Cell cycle	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko04114	Oocyte meiosis	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko04115	p53 signaling pathway	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko04914	Progesterone-mediated oocyte maturation	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko05200	Pathways in cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko05215	Prostate cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016909	K02206	ko05222	Small cell lung cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMT200016911	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016911	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016912	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMT200016917	K12857	ko03040	Spliceosome	238	1.4e-06	0.34	0.50	0.53
PGSC0003DMT200029149	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029149	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029149	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029149	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029149	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029149	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029150	K02144	ko00190	Oxidative phosphorylation	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029150	K02144	ko01100	Metabolic pathways	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029150	K02144	ko04142	Lysosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029150	K02144	ko04145	Phagosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029150	K02144	ko05110	Vibrio cholerae infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029150	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMT200029160	K02916	ko03010	Ribosome	272	3.6e-09	0.53	0.69	0.41
PGSC0003DMT200029170	K07424	ko00140	Steroid hormone biosynthesis	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00591	Linoleic acid metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00830	Retinol metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00982	Drug metabolism - cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko00983	Drug metabolism - other enzymes	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029170	K07424	ko01100	Metabolic pathways	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMT200029181	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMT200029181	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMT200029181	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMT200029186	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMT200029186	K05286	ko01100	Metabolic pathways	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMT200090373	K01184	ko00040	Pentose and glucuronate interconversions	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMT200090373	K01184	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMT200090373	K01184	ko01100	Metabolic pathways	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMT200090387	K01051	ko00040	Pentose and glucuronate interconversions	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMT200090387	K01051	ko00500	Starch and sucrose metabolism	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMT200090387	K01051	ko01100	Metabolic pathways	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMT200093747	K01516	ko00230	Purine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMT200093747	K01516	ko00730	Thiamine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMT200093747	K01516	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMT200095923	K05279	ko00944	Flavone and flavonol biosynthesis	738	7.2e-35	0.36	0.55	0.78
PGSC0003DMT200055175	K00619	ko00330	Arginine and proline metabolism	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMT200055175	K00619	ko01100	Metabolic pathways	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMT200055175	K00619	ko01110	Biosynthesis of secondary metabolites	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMT200055176	K00619	ko00330	Arginine and proline metabolism	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMT200055176	K00619	ko01100	Metabolic pathways	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMT200055176	K00619	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMT200055191	K02898	ko03010	Ribosome	1123	4.2e-56	0.89	0.99	0.99
PGSC0003DMT200055194	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055194	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055194	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055194	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055194	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055196	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055196	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055196	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055196	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055196	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMT200055197	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMT200055197	K00517	ko00626	Naphthalene and anthracene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMT200055197	K00517	ko00903	Limonene and pinene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMT200055197	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMT200055197	K00517	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMT200055202	K00826	ko00280	Valine, leucine and isoleucine degradation	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMT200055202	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMT200055202	K00826	ko00770	Pantothenate and CoA biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMT200055202	K00826	ko01100	Metabolic pathways	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMT200055202	K00826	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMT200055203	K01762	ko00270	Cysteine and methionine metabolism	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMT200055203	K01762	ko01110	Biosynthesis of secondary metabolites	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMT200082322	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMT200082322	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMT200082322	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMT200082322	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMT200082322	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMT200082337	K09754	ko00360	Phenylalanine metabolism	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082337	K09754	ko00940	Phenylpropanoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082337	K09754	ko00941	Flavonoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082337	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082337	K09754	ko01100	Metabolic pathways	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082337	K09754	ko01110	Biosynthesis of secondary metabolites	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMT200082349	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMT200082350	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMT200082352	K03108	ko03060	Protein export	2925	1.7e-155	0.75	0.87	0.99
PGSC0003DMT200071928	K03139	ko03022	Basal transcription factors	1519	6.0e-78	0.62	0.70	1.00
PGSC0003DMT200071929	K03139	ko03022	Basal transcription factors	1813	3.7e-94	0.80	0.89	1.00
PGSC0003DMT200071930	K03139	ko03022	Basal transcription factors	1447	5.6e-74	0.86	0.91	0.99
PGSC0003DMT200071931	K11594	ko04622	RIG-I-like receptor signaling pathway	1440	1.4e-73	0.42	0.55	0.92
PGSC0003DMT200044397	K13229	ko00402	Benzoxazinoid biosynthesis	1084	5.9e-54	0.43	0.58	0.93
PGSC0003DMT200044398	K13229	ko00402	Benzoxazinoid biosynthesis	1077	1.4e-53	0.43	0.58	0.98
PGSC0003DMT200044399	K13229	ko00402	Benzoxazinoid biosynthesis	281	1.2e-09	0.43	0.62	0.84
PGSC0003DMT200044402	K13229	ko00402	Benzoxazinoid biosynthesis	880	1.1e-42	0.39	0.54	0.98
PGSC0003DMT200044405	K13229	ko00402	Benzoxazinoid biosynthesis	426	1.2e-17	0.38	0.56	0.96
PGSC0003DMT200044406	K13229	ko00402	Benzoxazinoid biosynthesis	1047	6.5e-52	0.41	0.59	0.98
PGSC0003DMT200044407	K13229	ko00402	Benzoxazinoid biosynthesis	1020	2.0e-50	0.40	0.58	0.98
PGSC0003DMT200044408	K13229	ko00402	Benzoxazinoid biosynthesis	1038	2.0e-51	0.41	0.58	0.98
PGSC0003DMT200044409	K13229	ko00402	Benzoxazinoid biosynthesis	1036	2.6e-51	0.41	0.58	0.98
PGSC0003DMT200044410	K13229	ko00402	Benzoxazinoid biosynthesis	985	1.7e-48	0.41	0.57	0.98
PGSC0003DMT200044411	K13229	ko00402	Benzoxazinoid biosynthesis	868	4.9e-42	0.42	0.58	0.89
PGSC0003DMT200044412	K13229	ko00402	Benzoxazinoid biosynthesis	1111	1.9e-55	0.44	0.59	0.96
PGSC0003DMT200044417	K13229	ko00402	Benzoxazinoid biosynthesis	288	4.8e-10	0.33	0.52	0.97
PGSC0003DMT200044419	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.37	0.53	0.77
PGSC0003DMT200044420	K13229	ko00402	Benzoxazinoid biosynthesis	1094	1.7e-54	0.44	0.58	0.98
PGSC0003DMT200044423	K13229	ko00402	Benzoxazinoid biosynthesis	1200	2.4e-60	0.45	0.63	0.96
PGSC0003DMT200044424	K13229	ko00402	Benzoxazinoid biosynthesis	340	6.4e-13	0.41	0.57	0.88
PGSC0003DMT200044425	K13229	ko00402	Benzoxazinoid biosynthesis	833	4.1e-40	0.33	0.48	0.97
PGSC0003DMT200044428	K13229	ko00402	Benzoxazinoid biosynthesis	540	6.0e-24	0.29	0.42	0.96
PGSC0003DMT200044429	K13229	ko00402	Benzoxazinoid biosynthesis	995	4.8e-49	0.40	0.54	0.97
PGSC0003DMT200044430	K13229	ko00402	Benzoxazinoid biosynthesis	400	3.2e-16	0.55	0.69	0.68
PGSC0003DMT200044434	K13229	ko00402	Benzoxazinoid biosynthesis	1223	1.3e-61	0.45	0.63	0.93
PGSC0003DMT200044435	K13229	ko00402	Benzoxazinoid biosynthesis	1209	7.6e-61	0.44	0.63	0.92
PGSC0003DMT200044437	K13229	ko00402	Benzoxazinoid biosynthesis	1219	2.1e-61	0.46	0.62	0.94
PGSC0003DMT200044438	K13229	ko00402	Benzoxazinoid biosynthesis	963	2.8e-47	0.46	0.63	0.87
PGSC0003DMT200044439	K13229	ko00402	Benzoxazinoid biosynthesis	989	1.0e-48	0.46	0.64	0.92
PGSC0003DMT200044440	K13229	ko00402	Benzoxazinoid biosynthesis	1128	2.2e-56	0.43	0.60	0.99
PGSC0003DMT200044441	K13229	ko00402	Benzoxazinoid biosynthesis	1216	3.1e-61	0.45	0.62	0.99
PGSC0003DMT200044442	K13229	ko00402	Benzoxazinoid biosynthesis	1161	3.4e-58	0.43	0.61	0.97
PGSC0003DMT200042523	K02866	ko03010	Ribosome	642	1.4e-29	0.41	0.59	0.96
PGSC0003DMT200042526	K02866	ko03010	Ribosome	685	6.0e-32	0.41	0.55	0.95
PGSC0003DMT200042527	K02866	ko03010	Ribosome	687	4.7e-32	0.40	0.56	0.95
PGSC0003DMT200042528	K02866	ko03010	Ribosome	674	2.4e-31	0.40	0.54	0.95
PGSC0003DMT200042529	K05759	ko04810	Regulation of actin cytoskeleton	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMT200042529	K05759	ko05131	Shigellosis	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMT200042539	K06664	ko04146	Peroxisome	1976	3.8e-103	0.85	0.92	0.99
PGSC0003DMT200042540	K06664	ko04146	Peroxisome	2401	1.4e-126	0.79	0.89	1.00
PGSC0003DMT200005838	K02912	ko03010	Ribosome	1028	7.3e-51	0.89	0.95	0.99
PGSC0003DMT200005855	K06685	ko04111	Cell cycle - yeast	400	6.5e-13	0.25	0.42	0.89
PGSC0003DMT200005869	K03115	ko04310	Wnt signaling pathway	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMT200005869	K03115	ko04520	Adherens junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMT200005869	K03115	ko04530	Tight junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMT200005869	K03115	ko04712	Circadian rhythm - plant	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMT200005870	K03115	ko04310	Wnt signaling pathway	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMT200005870	K03115	ko04520	Adherens junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMT200005870	K03115	ko04530	Tight junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMT200005870	K03115	ko04712	Circadian rhythm - plant	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMT200005871	K03115	ko04310	Wnt signaling pathway	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMT200005871	K03115	ko04520	Adherens junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMT200005871	K03115	ko04530	Tight junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMT200005871	K03115	ko04712	Circadian rhythm - plant	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMT200031419	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	578	4.8e-26	0.75	0.82	0.95
PGSC0003DMT200031434	K00273	ko00260	Glycine, serine and threonine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031434	K00273	ko00311	Penicillin and cephalosporin biosynthesis	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031434	K00273	ko00330	Arginine and proline metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031434	K00273	ko00472	D-Arginine and D-ornithine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031434	K00273	ko01100	Metabolic pathways	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031434	K00273	ko04146	Peroxisome	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMT200031455	K12796	ko04621	NOD-like receptor signaling pathway	261	3.9e-08	0.31	0.46	0.96
PGSC0003DMT200000364	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMT200000378	K01115	ko00564	Glycerophospholipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000378	K01115	ko00565	Ether lipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000378	K01115	ko01100	Metabolic pathways	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000378	K01115	ko04144	Endocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000378	K01115	ko04666	Fc gamma R-mediated phagocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000378	K01115	ko04912	GnRH signaling pathway	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMT200000379	K01115	ko00564	Glycerophospholipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000379	K01115	ko00565	Ether lipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000379	K01115	ko01100	Metabolic pathways	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000379	K01115	ko04144	Endocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000379	K01115	ko04666	Fc gamma R-mediated phagocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000379	K01115	ko04912	GnRH signaling pathway	6363	0.	0.67	0.78	1.00
PGSC0003DMT200000384	K00100	ko00051	Fructose and mannose metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000384	K00100	ko00363	Bisphenol A degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000384	K00100	ko00591	Linoleic acid metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000384	K00100	ko00625	Tetrachloroethene degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000384	K00100	ko00650	Butanoate metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000384	K00100	ko01100	Metabolic pathways	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMT200000385	K00100	ko00051	Fructose and mannose metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000385	K00100	ko00363	Bisphenol A degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000385	K00100	ko00591	Linoleic acid metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000385	K00100	ko00625	Tetrachloroethene degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000385	K00100	ko00650	Butanoate metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000385	K00100	ko01100	Metabolic pathways	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMT200000386	K00100	ko00051	Fructose and mannose metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200000386	K00100	ko00363	Bisphenol A degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200000386	K00100	ko00591	Linoleic acid metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200000386	K00100	ko00625	Tetrachloroethene degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200000386	K00100	ko00650	Butanoate metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200000386	K00100	ko01100	Metabolic pathways	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMT200085959	K10760	ko00908	Zeatin biosynthesis	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMT200085959	K10760	ko01100	Metabolic pathways	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMT200085959	K10760	ko01110	Biosynthesis of secondary metabolites	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMT200085984	K03980	ko00550	Peptidoglycan biosynthesis	336	5.6e-12	0.39	0.43	0.92
PGSC0003DMT200052303	K03046	ko00230	Purine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMT200052303	K03046	ko00240	Pyrimidine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMT200052303	K03046	ko01100	Metabolic pathways	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMT200052303	K03046	ko03020	RNA polymerase	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMT200052304	K03046	ko00230	Purine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMT200052304	K03046	ko00240	Pyrimidine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMT200052304	K03046	ko01100	Metabolic pathways	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMT200052304	K03046	ko03020	RNA polymerase	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMT200052305	K03046	ko00230	Purine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMT200052305	K03046	ko00240	Pyrimidine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMT200052305	K03046	ko01100	Metabolic pathways	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMT200052305	K03046	ko03020	RNA polymerase	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMT200052308	K00088	ko00230	Purine metabolism	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMT200052308	K00088	ko00983	Drug metabolism - other enzymes	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMT200052308	K00088	ko01100	Metabolic pathways	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMT200052308	K00088	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMT200052309	K00042	ko00630	Glyoxylate and dicarboxylate metabolism	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMT200052309	K00042	ko01100	Metabolic pathways	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMT200052312	K09526	ko04144	Endocytosis	329	1.4e-11	0.46	0.65	0.94
PGSC0003DMT200052322	K02932	ko03010	Ribosome	1688	2.9e-87	0.85	0.95	1.00
PGSC0003DMT200052323	K02932	ko03010	Ribosome	2239	1.2e-117	0.86	0.94	1.00
PGSC0003DMT200052324	K02956	ko03010	Ribosome	508	3.5e-22	0.73	0.84	0.99
PGSC0003DMT200052331	K01142	ko03410	Base excision repair	297	1.5e-10	0.32	0.44	0.71
PGSC0003DMT200052339	K06119	ko00561	Glycerolipid metabolism	2888	1.9e-153	0.77	0.90	0.99
PGSC0003DMT200077543	K02882	ko03010	Ribosome	1444	8.3e-74	0.92	0.98	0.99
PGSC0003DMT200077561	K09458	ko00061	Fatty acid biosynthesis	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMT200077561	K09458	ko01100	Metabolic pathways	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMT200065981	K02915	ko03010	Ribosome	651	4.5e-30	0.90	0.93	0.99
PGSC0003DMT200065983	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMT200065983	K00517	ko00626	Naphthalene and anthracene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMT200065983	K00517	ko00903	Limonene and pinene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMT200065983	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMT200065983	K00517	ko01110	Biosynthesis of secondary metabolites	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMT200065984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMT200065984	K00517	ko00626	Naphthalene and anthracene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMT200065984	K00517	ko00903	Limonene and pinene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMT200065984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMT200065984	K00517	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMT200065985	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMT200065985	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMT200065985	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMT200065985	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMT200065985	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMT200065993	K13230	ko00402	Benzoxazinoid biosynthesis	636	3.0e-29	0.38	0.54	0.96
PGSC0003DMT200065994	K13230	ko00402	Benzoxazinoid biosynthesis	1046	7.4e-52	0.41	0.58	0.98
PGSC0003DMT200065995	K13230	ko00402	Benzoxazinoid biosynthesis	1053	3.0e-52	0.42	0.58	0.97
PGSC0003DMT200065996	K13230	ko00402	Benzoxazinoid biosynthesis	1028	7.3e-51	0.41	0.58	0.97
PGSC0003DMT200066005	K00852	ko00030	Pentose phosphate pathway	292	2.9e-10	0.28	0.45	0.95
PGSC0003DMT200066010	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMT200066011	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMT200002002	K00423	ko00053	Ascorbate and aldarate metabolism	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMT200002002	K00423	ko01100	Metabolic pathways	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMT200002003	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMT200002003	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMT200002004	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMT200002004	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMT200002011	K01955	ko00240	Pyrimidine metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMT200002011	K01955	ko00250	Alanine, aspartate and glutamate metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMT200002011	K01955	ko01100	Metabolic pathways	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMT200002013	K01955	ko00240	Pyrimidine metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMT200002013	K01955	ko00250	Alanine, aspartate and glutamate metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMT200002013	K01955	ko01100	Metabolic pathways	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMT200002020	K00100	ko00051	Fructose and mannose metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002020	K00100	ko00363	Bisphenol A degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002020	K00100	ko00591	Linoleic acid metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002020	K00100	ko00625	Tetrachloroethene degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002020	K00100	ko00650	Butanoate metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002020	K00100	ko01100	Metabolic pathways	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMT200002025	K01853	ko00100	Steroid biosynthesis	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMT200002025	K01853	ko01100	Metabolic pathways	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMT200002025	K01853	ko01110	Biosynthesis of secondary metabolites	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMT200002026	K01853	ko00100	Steroid biosynthesis	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMT200002026	K01853	ko01100	Metabolic pathways	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMT200002026	K01853	ko01110	Biosynthesis of secondary metabolites	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMT200002032	K11091	ko03040	Spliceosome	215	5.0e-06	0.31	0.51	0.51
PGSC0003DMT200002047	K05753	ko04520	Adherens junction	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMT200002047	K05753	ko04666	Fc gamma R-mediated phagocytosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMT200002047	K05753	ko04810	Regulation of actin cytoskeleton	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMT200002047	K05753	ko05100	Bacterial invasion of epithelial cells	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMT200002047	K05753	ko05131	Shigellosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMT200002049	K10955	ko05110	Vibrio cholerae infection	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMT200002049	K10955	ko05146	Amoebiasis	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMT200002056	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMT200002056	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMT200002056	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMT200002057	K01590	ko00340	Histidine metabolism	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMT200002057	K01590	ko01100	Metabolic pathways	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMT200002057	K01590	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMT200040746	K10866	ko03440	Homologous recombination	6622	0.	0.75	0.86	1.00
PGSC0003DMT200040746	K10866	ko03450	Non-homologous end-joining	6622	0.	0.75	0.86	1.00
PGSC0003DMT200040747	K10866	ko03440	Homologous recombination	8512	0.	0.78	0.88	1.00
PGSC0003DMT200040747	K10866	ko03450	Non-homologous end-joining	8512	0.	0.78	0.88	1.00
PGSC0003DMT200040760	K02872	ko03010	Ribosome	1610	5.8e-83	0.91	0.97	1.00
PGSC0003DMT200040763	K03032	ko03050	Proteasome	7019	0.	0.85	0.92	1.00
PGSC0003DMT200040764	K03032	ko03050	Proteasome	6080	0.	0.85	0.92	1.00
PGSC0003DMT200040771	K12120	ko04712	Circadian rhythm - plant	7050	0.	0.76	0.84	1.00
PGSC0003DMT200040772	K12120	ko04712	Circadian rhythm - plant	7809	0.	0.82	0.91	1.00
PGSC0003DMT200033077	K02913	ko03010	Ribosome	334	1.4e-12	0.70	0.77	0.98
PGSC0003DMT200033080	K01199	ko00500	Starch and sucrose metabolism	1464	6.5e-75	0.56	0.72	0.95
PGSC0003DMT200033081	K12662	ko03040	Spliceosome	3811	2.3e-204	0.78	0.87	0.99
PGSC0003DMT200033096	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.48	0.59	0.94
PGSC0003DMT200033101	K12356	ko00940	Phenylpropanoid biosynthesis	801	2.4e-38	0.36	0.50	0.98
PGSC0003DMT200033112	K00057	ko00564	Glycerophospholipid metabolism	362	3.9e-14	0.27	0.46	0.77
PGSC0003DMT200007561	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMT200007561	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMT200007561	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMT200007561	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMT200007564	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMT200007564	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMT200007564	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMT200007564	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMT200007571	K00161	ko00010	Glycolysis / Gluconeogenesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko00020	Citrate cycle (TCA cycle)	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko00620	Pyruvate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko00650	Butanoate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko01100	Metabolic pathways	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007571	K00161	ko01110	Biosynthesis of secondary metabolites	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMT200007572	K02961	ko03010	Ribosome	332	1.8e-12	0.70	0.75	0.98
PGSC0003DMT200007573	K02961	ko03010	Ribosome	660	1.4e-30	0.68	0.80	0.99
PGSC0003DMT200007575	K02961	ko03010	Ribosome	264	1.0e-08	0.50	0.56	0.91
PGSC0003DMT200007577	K04424	ko04010	MAPK signaling pathway	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMT200007577	K04424	ko04530	Tight junction	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMT200007584	K09458	ko00061	Fatty acid biosynthesis	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMT200007584	K09458	ko01100	Metabolic pathways	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMT200007585	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMT200007585	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMT200007586	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMT200007586	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMT200021310	K00366	ko00910	Nitrogen metabolism	4175	1.9e-224	0.82	0.91	1.00
PGSC0003DMT200021318	K07424	ko00140	Steroid hormone biosynthesis	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00591	Linoleic acid metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00830	Retinol metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00982	Drug metabolism - cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko00983	Drug metabolism - other enzymes	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021318	K07424	ko01100	Metabolic pathways	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMT200021322	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	367	1.9e-11	0.27	0.41	0.60
PGSC0003DMT200021324	K12580	ko03018	RNA degradation	312	4.6e-09	0.29	0.39	0.47
PGSC0003DMT200021325	K12580	ko03018	RNA degradation	306	1.1e-08	0.30	0.40	0.45
PGSC0003DMT200021326	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	374	7.4e-12	0.27	0.41	0.61
PGSC0003DMT200021327	K12580	ko03018	RNA degradation	306	1.5e-08	0.28	0.38	0.50
PGSC0003DMT200087169	K08243	ko00941	Flavonoid biosynthesis	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMT200087169	K08243	ko01110	Biosynthesis of secondary metabolites	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMT200075722	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMT200075722	K01078	ko00740	Riboflavin metabolism	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMT200075723	K01184	ko00040	Pentose and glucuronate interconversions	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMT200075723	K01184	ko00500	Starch and sucrose metabolism	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMT200075723	K01184	ko01100	Metabolic pathways	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMT200075724	K01184	ko00040	Pentose and glucuronate interconversions	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMT200075724	K01184	ko00500	Starch and sucrose metabolism	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMT200075724	K01184	ko01100	Metabolic pathways	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMT200075725	K01184	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMT200075725	K01184	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMT200075725	K01184	ko01100	Metabolic pathways	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMT200050451	K00873	ko00010	Glycolysis / Gluconeogenesis	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko00230	Purine metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko00620	Pyruvate metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko00710	Carbon fixation in photosynthetic organisms	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko01100	Metabolic pathways	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko01110	Biosynthesis of secondary metabolites	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050451	K00873	ko04930	Type II diabetes mellitus	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMT200050453	K00873	ko00010	Glycolysis / Gluconeogenesis	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko00230	Purine metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko00620	Pyruvate metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko00710	Carbon fixation in photosynthetic organisms	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko01100	Metabolic pathways	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko01110	Biosynthesis of secondary metabolites	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050453	K00873	ko04930	Type II diabetes mellitus	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMT200050455	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.80
PGSC0003DMT200050457	K11091	ko03040	Spliceosome	216	4.4e-06	0.36	0.51	0.61
PGSC0003DMT200050458	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.61
PGSC0003DMT200050462	K09490	ko03060	Protein export	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMT200050462	K09490	ko05020	Prion diseases	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMT200050473	K01051	ko00040	Pentose and glucuronate interconversions	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMT200050473	K01051	ko00500	Starch and sucrose metabolism	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMT200050473	K01051	ko01100	Metabolic pathways	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMT200050474	K01051	ko00040	Pentose and glucuronate interconversions	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMT200050474	K01051	ko00500	Starch and sucrose metabolism	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMT200050474	K01051	ko01100	Metabolic pathways	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMT200050476	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMT200050477	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMT200089191	K10601	ko04120	Ubiquitin mediated proteolysis	225	4.7e-06	0.31	0.51	0.67
PGSC0003DMT200094724	K05747	ko04062	Chemokine signaling pathway	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko04520	Adherens junction	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko04666	Fc gamma R-mediated phagocytosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko04810	Regulation of actin cytoskeleton	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko05100	Bacterial invasion of epithelial cells	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko05130	Pathogenic Escherichia coli infection	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094724	K05747	ko05131	Shigellosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMT200094745	K03094	ko04110	Cell cycle	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04111	Cell cycle - yeast	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04114	Oocyte meiosis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04120	Ubiquitin mediated proteolysis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04310	Wnt signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04350	TGF-beta signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200094745	K03094	ko04710	Circadian rhythm - mammal	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMT200037550	K12486	ko04144	Endocytosis	386	7.1e-14	0.26	0.42	0.98
PGSC0003DMT200037551	K12486	ko04144	Endocytosis	387	9.0e-14	0.26	0.41	0.93
PGSC0003DMT200037552	K12486	ko04144	Endocytosis	404	9.0e-15	0.25	0.40	0.94
PGSC0003DMT200037556	K02879	ko03010	Ribosome	1254	2.5e-63	0.91	0.96	0.98
PGSC0003DMT200037557	K10144	ko04115	p53 signaling pathway	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMT200037557	K10144	ko04120	Ubiquitin mediated proteolysis	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMT200037558	K10144	ko04115	p53 signaling pathway	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMT200037558	K10144	ko04120	Ubiquitin mediated proteolysis	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMT200010187	K08300	ko03018	RNA degradation	369	1.1e-13	0.35	0.48	0.94
PGSC0003DMT200010205	K08269	ko04140	Regulation of autophagy	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMT200010205	K08269	ko04150	mTOR signaling pathway	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMT200010207	K08269	ko04140	Regulation of autophagy	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMT200010207	K08269	ko04150	mTOR signaling pathway	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMT200010208	K08269	ko04140	Regulation of autophagy	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMT200010208	K08269	ko04150	mTOR signaling pathway	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMT200010209	K08269	ko04140	Regulation of autophagy	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMT200010209	K08269	ko04150	mTOR signaling pathway	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMT200010210	K08269	ko04140	Regulation of autophagy	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMT200010210	K08269	ko04150	mTOR signaling pathway	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMT200027316	K07424	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00591	Linoleic acid metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00830	Retinol metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00982	Drug metabolism - cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko00983	Drug metabolism - other enzymes	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027316	K07424	ko01100	Metabolic pathways	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMT200027324	K07424	ko00140	Steroid hormone biosynthesis	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00591	Linoleic acid metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00830	Retinol metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00982	Drug metabolism - cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko00983	Drug metabolism - other enzymes	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027324	K07424	ko01100	Metabolic pathways	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMT200027326	K07424	ko00140	Steroid hormone biosynthesis	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00591	Linoleic acid metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00830	Retinol metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00982	Drug metabolism - cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko00983	Drug metabolism - other enzymes	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027326	K07424	ko01100	Metabolic pathways	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMT200027327	K07424	ko00140	Steroid hormone biosynthesis	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00591	Linoleic acid metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00830	Retinol metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00982	Drug metabolism - cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko00983	Drug metabolism - other enzymes	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027327	K07424	ko01100	Metabolic pathways	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMT200027332	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMT200027332	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMT200027333	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMT200027333	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMT200027338	K02726	ko03050	Proteasome	1643	8.7e-85	0.87	0.89	1.00
PGSC0003DMT200027339	K02726	ko03050	Proteasome	1856	1.6e-96	0.96	0.97	1.00
PGSC0003DMT200027340	K00599	ko00340	Histidine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMT200027340	K00599	ko00350	Tyrosine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMT200027340	K00599	ko00450	Selenoamino acid metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMT200027340	K00599	ko00626	Naphthalene and anthracene degradation	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMT200027341	K00599	ko00340	Histidine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMT200027341	K00599	ko00350	Tyrosine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMT200027341	K00599	ko00450	Selenoamino acid metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMT200027341	K00599	ko00626	Naphthalene and anthracene degradation	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMT200027348	K12669	ko00510	N-Glycan biosynthesis	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMT200027348	K12669	ko01100	Metabolic pathways	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMT200027351	K00232	ko00071	Fatty acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027351	K00232	ko00592	alpha-Linolenic acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027351	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027351	K00232	ko01100	Metabolic pathways	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027351	K00232	ko03320	PPAR signaling pathway	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027351	K00232	ko04146	Peroxisome	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMT200027352	K00232	ko00071	Fatty acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027352	K00232	ko00592	alpha-Linolenic acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027352	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027352	K00232	ko01100	Metabolic pathways	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027352	K00232	ko03320	PPAR signaling pathway	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027352	K00232	ko04146	Peroxisome	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMT200027353	K05279	ko00944	Flavone and flavonol biosynthesis	465	8.2e-20	0.36	0.54	0.96
PGSC0003DMT200057003	K04079	ko04612	Antigen processing and presentation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057003	K04079	ko04621	NOD-like receptor signaling pathway	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057003	K04079	ko04626	Plant-pathogen interaction	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057003	K04079	ko04914	Progesterone-mediated oocyte maturation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057003	K04079	ko05200	Pathways in cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057003	K04079	ko05215	Prostate cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMT200057006	K12863	ko03040	Spliceosome	1614	3.5e-83	0.80	0.89	1.00
PGSC0003DMT200057007	K12863	ko03040	Spliceosome	1637	1.9e-84	0.83	0.92	1.00
PGSC0003DMT200080051	K03847	ko00510	N-Glycan biosynthesis	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMT200080051	K03847	ko01100	Metabolic pathways	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMT200080054	K03847	ko00510	N-Glycan biosynthesis	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMT200080054	K03847	ko01100	Metabolic pathways	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMT200080055	K03847	ko00510	N-Glycan biosynthesis	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMT200080055	K03847	ko01100	Metabolic pathways	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMT200080056	K03847	ko00510	N-Glycan biosynthesis	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMT200080056	K03847	ko01100	Metabolic pathways	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMT200080057	K03847	ko00510	N-Glycan biosynthesis	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMT200080057	K03847	ko01100	Metabolic pathways	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMT200080058	K03847	ko00510	N-Glycan biosynthesis	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMT200080058	K03847	ko01100	Metabolic pathways	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMT200080059	K03847	ko00510	N-Glycan biosynthesis	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMT200080059	K03847	ko01100	Metabolic pathways	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMT200080060	K07192	ko04910	Insulin signaling pathway	1265	6.2e-64	0.38	0.55	0.97
PGSC0003DMT200080072	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMT200080072	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMT200080072	K12366	ko05131	Shigellosis	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMT200046278	K02183	ko04020	Calcium signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04070	Phosphatidylinositol signaling system	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04114	Oocyte meiosis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04270	Vascular smooth muscle contraction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04626	Plant-pathogen interaction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04720	Long-term potentiation	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04722	Neurotrophin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04740	Olfactory transduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04744	Phototransduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04745	Phototransduction - fly	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04910	Insulin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04912	GnRH signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04916	Melanogenesis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04970	Salivary secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko04971	Gastric acid secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko05010	Alzheimer's disease	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046278	K02183	ko05214	Glioma	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMT200046295	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMT200046296	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMT200046297	K08332	ko04140	Regulation of autophagy	392	1.8e-13	0.31	0.53	0.38
PGSC0003DMT200046312	K10352	ko04530	Tight junction	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMT200046312	K10352	ko05416	Viral myocarditis	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMT200073650	K01423	ko00310	Lysine degradation	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMT200073650	K01423	ko00780	Biotin metabolism	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMT200073650	K01423	ko01100	Metabolic pathways	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMT200062751	K00167	ko00280	Valine, leucine and isoleucine degradation	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMT200062751	K00167	ko01100	Metabolic pathways	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMT200062751	K00167	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMT200062753	K03120	ko03022	Basal transcription factors	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMT200062753	K03120	ko05016	Huntington's disease	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMT200062754	K03120	ko03022	Basal transcription factors	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMT200062754	K03120	ko05016	Huntington's disease	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMT200062757	K00558	ko00270	Cysteine and methionine metabolism	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMT200062757	K00558	ko01100	Metabolic pathways	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMT200062758	K00558	ko00270	Cysteine and methionine metabolism	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMT200062758	K00558	ko01100	Metabolic pathways	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMT200062762	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062762	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062763	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062764	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062765	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMT200062766	K02084	ko04115	p53 signaling pathway	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko04210	Apoptosis	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko05010	Alzheimer's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko05012	Parkinson's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko05016	Huntington's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062766	K02084	ko05222	Small cell lung cancer	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMT200062773	K07195	ko04910	Insulin signaling pathway	422	1.9e-17	0.83	0.93	0.86
PGSC0003DMT200062777	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200062777	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200062777	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200062788	K12929	ko00904	Diterpenoid biosynthesis	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMT200062788	K12929	ko01110	Biosynthesis of secondary metabolites	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMT200062791	K12929	ko00904	Diterpenoid biosynthesis	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMT200062791	K12929	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMT200062792	K12929	ko00904	Diterpenoid biosynthesis	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMT200062792	K12929	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMT200062793	K12467	ko00902	Monoterpenoid biosynthesis	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMT200062793	K12467	ko01110	Biosynthesis of secondary metabolites	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMT200062798	K12929	ko00904	Diterpenoid biosynthesis	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMT200062798	K12929	ko01110	Biosynthesis of secondary metabolites	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMT200081989	K02942	ko03010	Ribosome	714	1.5e-33	0.80	0.85	0.99
PGSC0003DMT200081994	K04506	ko04115	p53 signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMT200081994	K04506	ko04120	Ubiquitin mediated proteolysis	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMT200081994	K04506	ko04310	Wnt signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMT200081995	K04506	ko04115	p53 signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMT200081995	K04506	ko04120	Ubiquitin mediated proteolysis	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMT200081995	K04506	ko04310	Wnt signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMT200081996	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200081996	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200081996	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200081997	K04506	ko04115	p53 signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMT200081997	K04506	ko04120	Ubiquitin mediated proteolysis	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMT200081997	K04506	ko04310	Wnt signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMT200081998	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200081998	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200081998	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMT200082008	K00430	ko00360	Phenylalanine metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMT200082008	K00430	ko00680	Methane metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMT200082008	K00430	ko00940	Phenylpropanoid biosynthesis	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMT200082008	K00430	ko01100	Metabolic pathways	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMT200082008	K00430	ko01110	Biosynthesis of secondary metabolites	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMT200072457	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMT200072457	K00517	ko00626	Naphthalene and anthracene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMT200072457	K00517	ko00903	Limonene and pinene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMT200072457	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMT200072457	K00517	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMT200072458	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMT200072458	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMT200072458	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMT200072458	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMT200072458	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMT200072465	K07375	ko04145	Phagosome	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMT200072465	K07375	ko04540	Gap junction	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMT200072465	K07375	ko05130	Pathogenic Escherichia coli infection	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMT200072466	K07375	ko04145	Phagosome	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMT200072466	K07375	ko04540	Gap junction	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMT200072466	K07375	ko05130	Pathogenic Escherichia coli infection	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMT200072486	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1351	1.1e-68	0.35	0.52	0.90
PGSC0003DMT200072489	K02183	ko04020	Calcium signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04070	Phosphatidylinositol signaling system	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04114	Oocyte meiosis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04270	Vascular smooth muscle contraction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04626	Plant-pathogen interaction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04720	Long-term potentiation	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04722	Neurotrophin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04740	Olfactory transduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04744	Phototransduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04745	Phototransduction - fly	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04910	Insulin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04912	GnRH signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04916	Melanogenesis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04970	Salivary secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko04971	Gastric acid secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko05010	Alzheimer's disease	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072489	K02183	ko05214	Glioma	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMT200072490	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072490	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200044794	K01178	ko00500	Starch and sucrose metabolism	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMT200044794	K01178	ko01100	Metabolic pathways	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMT200044795	K01178	ko00500	Starch and sucrose metabolism	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMT200044795	K01178	ko01100	Metabolic pathways	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMT200044796	K01178	ko00500	Starch and sucrose metabolism	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMT200044796	K01178	ko01100	Metabolic pathways	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMT200044803	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMT200044803	K02366	ko01100	Metabolic pathways	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMT200044818	K00036	ko00030	Pentose phosphate pathway	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMT200044818	K00036	ko00480	Glutathione metabolism	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMT200044818	K00036	ko01100	Metabolic pathways	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMT200044818	K00036	ko01110	Biosynthesis of secondary metabolites	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMT200044819	K00036	ko00030	Pentose phosphate pathway	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMT200044819	K00036	ko00480	Glutathione metabolism	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMT200044819	K00036	ko01100	Metabolic pathways	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMT200044819	K00036	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMT200044822	K12121	ko04712	Circadian rhythm - plant	5599	0.	0.60	0.78	0.99
PGSC0003DMT200044823	K00736	ko00510	N-Glycan biosynthesis	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMT200044823	K00736	ko01100	Metabolic pathways	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMT200044824	K07199	ko04910	Insulin signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMT200044824	K07199	ko04920	Adipocytokine signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMT200044824	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMT200044825	K07199	ko04910	Insulin signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMT200044825	K07199	ko04920	Adipocytokine signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMT200044825	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMT200044826	K07199	ko04910	Insulin signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMT200044826	K07199	ko04920	Adipocytokine signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMT200044826	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMT200044827	K07199	ko04910	Insulin signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMT200044827	K07199	ko04920	Adipocytokine signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMT200044827	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMT200035553	K12585	ko03018	RNA degradation	6422	0.	0.81	0.90	1.00
PGSC0003DMT200035559	K10840	ko03420	Nucleotide excision repair	716	1.2e-33	0.57	0.82	0.89
PGSC0003DMT200035564	K10840	ko03420	Nucleotide excision repair	798	3.5e-38	0.58	0.81	0.91
PGSC0003DMT200035565	K00948	ko00030	Pentose phosphate pathway	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMT200035565	K00948	ko00230	Purine metabolism	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMT200035565	K00948	ko01100	Metabolic pathways	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMT200035565	K00948	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMT200035566	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035566	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035566	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035566	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035567	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035567	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035567	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035567	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMT200035576	K01051	ko00040	Pentose and glucuronate interconversions	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMT200035576	K01051	ko00500	Starch and sucrose metabolism	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMT200035576	K01051	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMT200035577	K01051	ko00040	Pentose and glucuronate interconversions	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMT200035577	K01051	ko00500	Starch and sucrose metabolism	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMT200035577	K01051	ko01100	Metabolic pathways	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMT200035578	K01853	ko00100	Steroid biosynthesis	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMT200035578	K01853	ko01100	Metabolic pathways	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMT200035578	K01853	ko01110	Biosynthesis of secondary metabolites	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMT200035590	K00487	ko00360	Phenylalanine metabolism	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035590	K00487	ko00940	Phenylpropanoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035590	K00487	ko00941	Flavonoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035590	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035590	K00487	ko01100	Metabolic pathways	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035590	K00487	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMT200035591	K02738	ko03050	Proteasome	1682	6.2e-87	0.86	0.94	0.97
PGSC0003DMT200035601	K12667	ko00510	N-Glycan biosynthesis	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMT200035601	K12667	ko01100	Metabolic pathways	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMT200019655	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMT200019656	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMT200019706	K03025	ko00230	Purine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMT200019706	K03025	ko00240	Pyrimidine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMT200019706	K03025	ko01100	Metabolic pathways	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMT200019706	K03025	ko03020	RNA polymerase	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMT200019706	K03025	ko04623	Cytosolic DNA-sensing pathway	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMT200016707	K02084	ko04115	p53 signaling pathway	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko04210	Apoptosis	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko05010	Alzheimer's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko05012	Parkinson's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko05016	Huntington's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016707	K02084	ko05222	Small cell lung cancer	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMT200016731	K05282	ko00904	Diterpenoid biosynthesis	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMT200016731	K05282	ko01100	Metabolic pathways	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMT200016731	K05282	ko01110	Biosynthesis of secondary metabolites	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMT200016737	K01875	ko00970	Aminoacyl-tRNA biosynthesis	875	2.0e-42	0.82	0.92	0.96
PGSC0003DMT200029652	K01188	ko00460	Cyanoamino acid metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMT200029652	K01188	ko00500	Starch and sucrose metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMT200029652	K01188	ko00940	Phenylpropanoid biosynthesis	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMT200029652	K01188	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMT200029653	K01188	ko00460	Cyanoamino acid metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMT200029653	K01188	ko00500	Starch and sucrose metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMT200029653	K01188	ko00940	Phenylpropanoid biosynthesis	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMT200029653	K01188	ko01110	Biosynthesis of secondary metabolites	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMT200029654	K01188	ko00460	Cyanoamino acid metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMT200029654	K01188	ko00500	Starch and sucrose metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMT200029654	K01188	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMT200029654	K01188	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMT200029656	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029656	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029656	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029656	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029657	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029657	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029657	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029657	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029658	K01188	ko00460	Cyanoamino acid metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMT200029658	K01188	ko00500	Starch and sucrose metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMT200029658	K01188	ko00940	Phenylpropanoid biosynthesis	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMT200029658	K01188	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMT200029659	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029659	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029659	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029659	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMT200029661	K01188	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMT200029661	K01188	ko00500	Starch and sucrose metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMT200029661	K01188	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMT200029661	K01188	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMT200029662	K05350	ko00460	Cyanoamino acid metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMT200029662	K05350	ko00500	Starch and sucrose metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMT200029662	K05350	ko00940	Phenylpropanoid biosynthesis	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMT200029662	K05350	ko01110	Biosynthesis of secondary metabolites	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMT200029666	K12890	ko03040	Spliceosome	1966	1.3e-102	0.78	0.85	0.97
PGSC0003DMT200029667	K12890	ko03040	Spliceosome	783	2.4e-37	0.73	0.80	0.95
PGSC0003DMT200029669	K12890	ko03040	Spliceosome	1111	1.9e-55	0.85	0.91	0.96
PGSC0003DMT200029670	K11096	ko03040	Spliceosome	838	2.2e-40	0.94	0.96	0.99
PGSC0003DMT200095583	K03412	ko02020	Two-component system	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMT200095583	K03412	ko02030	Bacterial chemotaxis	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMT200048151	K09842	ko00906	Carotenoid biosynthesis	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMT200048151	K09842	ko01100	Metabolic pathways	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMT200048151	K09842	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMT200048152	K09842	ko00906	Carotenoid biosynthesis	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMT200048152	K09842	ko01100	Metabolic pathways	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMT200048152	K09842	ko01110	Biosynthesis of secondary metabolites	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMT200048153	K11817	ko00380	Tryptophan metabolism	6653	0.	0.60	0.77	1.00
PGSC0003DMT200048154	K09842	ko00906	Carotenoid biosynthesis	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMT200048154	K09842	ko01100	Metabolic pathways	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMT200048154	K09842	ko01110	Biosynthesis of secondary metabolites	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMT200048155	K09842	ko00906	Carotenoid biosynthesis	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMT200048155	K09842	ko01100	Metabolic pathways	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMT200048155	K09842	ko01110	Biosynthesis of secondary metabolites	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMT200048156	K09842	ko00906	Carotenoid biosynthesis	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMT200048156	K09842	ko01100	Metabolic pathways	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMT200048156	K09842	ko01110	Biosynthesis of secondary metabolites	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMT200048157	K09842	ko00906	Carotenoid biosynthesis	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMT200048157	K09842	ko01100	Metabolic pathways	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMT200048157	K09842	ko01110	Biosynthesis of secondary metabolites	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMT200048158	K09842	ko00906	Carotenoid biosynthesis	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMT200048158	K09842	ko01100	Metabolic pathways	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMT200048158	K09842	ko01110	Biosynthesis of secondary metabolites	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMT200048159	K09842	ko00906	Carotenoid biosynthesis	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMT200048159	K09842	ko01100	Metabolic pathways	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMT200048159	K09842	ko01110	Biosynthesis of secondary metabolites	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMT200048160	K09842	ko00906	Carotenoid biosynthesis	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMT200048160	K09842	ko01100	Metabolic pathways	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMT200048160	K09842	ko01110	Biosynthesis of secondary metabolites	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMT200048161	K11817	ko00380	Tryptophan metabolism	588	8.9e-26	0.64	0.78	0.99
PGSC0003DMT200048162	K11817	ko00380	Tryptophan metabolism	6084	0.	0.56	0.73	0.99
PGSC0003DMT200048170	K11817	ko00380	Tryptophan metabolism	6464	0.	0.58	0.76	0.99
PGSC0003DMT200048179	K00079	ko00590	Arachidonic acid metabolism	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMT200048179	K00079	ko01100	Metabolic pathways	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMT200048181	K00079	ko00590	Arachidonic acid metabolism	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMT200048181	K00079	ko01100	Metabolic pathways	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMT200048186	K02935	ko03010	Ribosome	367	2.1e-14	0.43	0.63	0.65
PGSC0003DMT200048187	K00606	ko00770	Pantothenate and CoA biosynthesis	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMT200048187	K00606	ko01100	Metabolic pathways	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMT200048187	K00606	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMT200086322	K12800	ko04621	NOD-like receptor signaling pathway	321	5.4e-09	0.30	0.50	0.50
PGSC0003DMT200086334	K02183	ko04020	Calcium signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04070	Phosphatidylinositol signaling system	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04114	Oocyte meiosis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04270	Vascular smooth muscle contraction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04626	Plant-pathogen interaction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04720	Long-term potentiation	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04722	Neurotrophin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04740	Olfactory transduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04744	Phototransduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04745	Phototransduction - fly	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04910	Insulin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04912	GnRH signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04916	Melanogenesis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04970	Salivary secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko04971	Gastric acid secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko05010	Alzheimer's disease	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086334	K02183	ko05214	Glioma	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMT200086337	K10760	ko00908	Zeatin biosynthesis	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMT200086337	K10760	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMT200086337	K10760	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMT200051664	K00551	ko00564	Glycerophospholipid metabolism	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMT200051664	K00551	ko01100	Metabolic pathways	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMT200051665	K00551	ko00564	Glycerophospholipid metabolism	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMT200051665	K00551	ko01100	Metabolic pathways	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMT200051675	K10352	ko04530	Tight junction	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMT200051675	K10352	ko05416	Viral myocarditis	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMT200051680	K01955	ko00240	Pyrimidine metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMT200051680	K01955	ko00250	Alanine, aspartate and glutamate metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMT200051680	K01955	ko01100	Metabolic pathways	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMT200051681	K05278	ko00941	Flavonoid biosynthesis	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMT200051681	K05278	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMT200051681	K05278	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMT200051684	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMT200051685	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMT200077333	K03787	ko00230	Purine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMT200077333	K03787	ko00240	Pyrimidine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMT200077333	K03787	ko00760	Nicotinate and nicotinamide metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMT200077333	K03787	ko01100	Metabolic pathways	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMT200077333	K03787	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMT200077334	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077334	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077334	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077334	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077334	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077335	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077335	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077335	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077335	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077335	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077336	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077336	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077336	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077336	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077336	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMT200077337	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077337	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077337	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077337	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077337	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077338	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077338	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077338	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077338	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077338	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMT200077342	K00276	ko00260	Glycine, serine and threonine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko00350	Tyrosine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko00410	beta-Alanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko01100	Metabolic pathways	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077342	K00276	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMT200077343	K00276	ko00260	Glycine, serine and threonine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko00350	Tyrosine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko00360	Phenylalanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko00410	beta-Alanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko01100	Metabolic pathways	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077343	K00276	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMT200077347	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077347	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077347	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077348	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077348	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077348	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMT200077351	K12132	ko04712	Circadian rhythm - plant	1254	2.5e-63	0.48	0.63	0.99
PGSC0003DMT200077352	K12132	ko04712	Circadian rhythm - plant	2032	3.1e-106	0.53	0.65	1.00
PGSC0003DMT200077353	K12132	ko04712	Circadian rhythm - plant	2679	6.3e-142	0.57	0.69	0.99
PGSC0003DMT200077354	K12132	ko04712	Circadian rhythm - plant	3548	7.4e-190	0.62	0.73	1.00
PGSC0003DMT200077355	K12132	ko04712	Circadian rhythm - plant	3126	1.4e-166	0.60	0.71	1.00
PGSC0003DMT200077357	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077357	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077357	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077357	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077358	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077358	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077358	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200077358	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMT200066358	K05864	ko04020	Calcium signaling pathway	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMT200066358	K05864	ko05012	Parkinson's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMT200066358	K05864	ko05016	Huntington's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMT200066383	K01046	ko00561	Glycerolipid metabolism	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMT200066383	K01046	ko01100	Metabolic pathways	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMT200066384	K01066	ko00623	2,4-Dichlorobenzoate degradation	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMT200066384	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMT200066385	K01046	ko00561	Glycerolipid metabolism	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMT200066385	K01046	ko01100	Metabolic pathways	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMT200066392	K01046	ko00561	Glycerolipid metabolism	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMT200066392	K01046	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMT200043040	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043040	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043040	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043040	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043040	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043041	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043041	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043041	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043041	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043041	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMT200043042	K10775	ko00360	Phenylalanine metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMT200043042	K10775	ko00910	Nitrogen metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMT200043042	K10775	ko00940	Phenylpropanoid biosynthesis	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMT200043042	K10775	ko01100	Metabolic pathways	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMT200043042	K10775	ko01110	Biosynthesis of secondary metabolites	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMT200043044	K10775	ko00360	Phenylalanine metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMT200043044	K10775	ko00910	Nitrogen metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMT200043044	K10775	ko00940	Phenylpropanoid biosynthesis	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMT200043044	K10775	ko01100	Metabolic pathways	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMT200043044	K10775	ko01110	Biosynthesis of secondary metabolites	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMT200043046	K04506	ko04115	p53 signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMT200043046	K04506	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMT200043046	K04506	ko04310	Wnt signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMT200043049	K04506	ko04115	p53 signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMT200043049	K04506	ko04120	Ubiquitin mediated proteolysis	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMT200043049	K04506	ko04310	Wnt signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMT200043050	K04506	ko04115	p53 signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMT200043050	K04506	ko04120	Ubiquitin mediated proteolysis	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMT200043050	K04506	ko04310	Wnt signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMT200043054	K08912	ko00196	Photosynthesis - antenna proteins	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMT200043054	K08912	ko01100	Metabolic pathways	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMT200043073	K13229	ko00402	Benzoxazinoid biosynthesis	298	1.3e-10	0.49	0.65	0.90
PGSC0003DMT200005027	K01081	ko00230	Purine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMT200005027	K01081	ko00240	Pyrimidine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMT200005027	K01081	ko00760	Nicotinate and nicotinamide metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMT200005027	K01081	ko01100	Metabolic pathways	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMT200005027	K01081	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMT200005028	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005028	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005028	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005028	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005028	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005029	K01081	ko00230	Purine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMT200005029	K01081	ko00240	Pyrimidine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMT200005029	K01081	ko00760	Nicotinate and nicotinamide metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMT200005029	K01081	ko01100	Metabolic pathways	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMT200005029	K01081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMT200005038	K02084	ko04115	p53 signaling pathway	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko04210	Apoptosis	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko05010	Alzheimer's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko05012	Parkinson's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko05016	Huntington's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005038	K02084	ko05222	Small cell lung cancer	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMT200005048	K07195	ko04910	Insulin signaling pathway	3859	5.2e-207	0.72	0.86	0.97
PGSC0003DMT200005054	K11818	ko00380	Tryptophan metabolism	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMT200005054	K11818	ko00966	Glucosinolate biosynthesis	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMT200005054	K11818	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMT200005055	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005055	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005055	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005055	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005055	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005056	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005056	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005056	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005056	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005056	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005057	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005057	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005057	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005057	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005057	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMT200005059	K11818	ko00380	Tryptophan metabolism	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMT200005059	K11818	ko00966	Glucosinolate biosynthesis	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMT200005059	K11818	ko01110	Biosynthesis of secondary metabolites	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMT200005077	K02703	ko00195	Photosynthesis	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMT200005077	K02703	ko01100	Metabolic pathways	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMT200031231	K08139	ko04113	Meiosis - yeast	915	1.2e-44	0.34	0.55	0.92
PGSC0003DMT200031232	K08139	ko04113	Meiosis - yeast	694	1.9e-32	0.36	0.59	0.94
PGSC0003DMT200031233	K08139	ko04113	Meiosis - yeast	1048	5.7e-52	0.36	0.58	0.89
PGSC0003DMT200031241	K12356	ko00940	Phenylpropanoid biosynthesis	780	3.5e-37	0.43	0.59	0.90
PGSC0003DMT200031258	K06627	ko04110	Cell cycle	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMT200031258	K06627	ko04914	Progesterone-mediated oocyte maturation	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMT200031260	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMT200031261	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMT200087535	K10760	ko00908	Zeatin biosynthesis	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMT200087535	K10760	ko01100	Metabolic pathways	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMT200087535	K10760	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMT200075571	K00600	ko00260	Glycine, serine and threonine metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075571	K00600	ko00460	Cyanoamino acid metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075571	K00600	ko00670	One carbon pool by folate	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075571	K00600	ko00680	Methane metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075571	K00600	ko01100	Metabolic pathways	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075571	K00600	ko01110	Biosynthesis of secondary metabolites	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMT200075572	K01369	ko04142	Lysosome	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMT200075572	K01369	ko04612	Antigen processing and presentation	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMT200075573	K00970	ko03018	RNA degradation	1893	1.4e-98	0.64	0.80	0.82
PGSC0003DMT200075574	K00970	ko03018	RNA degradation	3077	7.1e-164	0.67	0.82	0.87
PGSC0003DMT200075575	K11481	ko04114	Oocyte meiosis	431	6.2e-18	0.79	0.93	0.97
PGSC0003DMT200075576	K11481	ko04114	Oocyte meiosis	2309	1.6e-121	0.89	0.97	1.00
PGSC0003DMT200075577	K01867	ko00380	Tryptophan metabolism	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMT200075577	K01867	ko00970	Aminoacyl-tRNA biosynthesis	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMT200075578	K01867	ko00380	Tryptophan metabolism	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMT200075578	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMT200075579	K01867	ko00380	Tryptophan metabolism	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMT200075579	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMT200049767	K03111	ko03030	DNA replication	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMT200049767	K03111	ko03430	Mismatch repair	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMT200049767	K03111	ko03440	Homologous recombination	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMT200049768	K12126	ko04712	Circadian rhythm - plant	294	3.4e-10	0.47	0.81	0.24
PGSC0003DMT200049770	K12183	ko04144	Endocytosis	725	3.7e-34	0.35	0.53	0.92
PGSC0003DMT200097267	K01955	ko00240	Pyrimidine metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMT200097267	K01955	ko00250	Alanine, aspartate and glutamate metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMT200097267	K01955	ko01100	Metabolic pathways	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMT200097280	K01066	ko00623	2,4-Dichlorobenzoate degradation	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMT200097280	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMT200001833	K01199	ko00500	Starch and sucrose metabolism	872	2.9e-42	0.38	0.58	0.72
PGSC0003DMT200001840	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMT200001841	K08139	ko04113	Meiosis - yeast	446	9.2e-19	0.37	0.55	0.89
PGSC0003DMT200001843	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMT200001844	K08139	ko04113	Meiosis - yeast	491	3.0e-21	0.39	0.62	0.97
PGSC0003DMT200001847	K08139	ko04113	Meiosis - yeast	530	2.1e-23	0.42	0.64	0.65
PGSC0003DMT200001848	K00430	ko00360	Phenylalanine metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMT200001848	K00430	ko00680	Methane metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMT200001848	K00430	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMT200001848	K00430	ko01100	Metabolic pathways	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMT200001848	K00430	ko01110	Biosynthesis of secondary metabolites	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMT200001851	K00430	ko00360	Phenylalanine metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMT200001851	K00430	ko00680	Methane metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMT200001851	K00430	ko00940	Phenylpropanoid biosynthesis	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMT200001851	K00430	ko01100	Metabolic pathways	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMT200001851	K00430	ko01110	Biosynthesis of secondary metabolites	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMT200001856	K11584	ko04113	Meiosis - yeast	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMT200001856	K11584	ko04114	Oocyte meiosis	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMT200001856	K11584	ko04310	Wnt signaling pathway	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMT200001867	K00558	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMT200001867	K00558	ko01100	Metabolic pathways	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMT200001868	K00558	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMT200001868	K00558	ko01100	Metabolic pathways	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMT200041313	K02966	ko03010	Ribosome	1079	1.1e-53	0.87	0.93	0.99
PGSC0003DMT200041321	K02942	ko03010	Ribosome	685	6.0e-32	0.75	0.83	0.99
PGSC0003DMT200041325	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041325	K00261	ko00330	Arginine and proline metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041325	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041325	K00261	ko00910	Nitrogen metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041325	K00261	ko01100	Metabolic pathways	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041325	K00261	ko04964	Proximal tubule bicarbonate reclamation	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMT200041338	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041338	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041338	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041339	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041339	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041339	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMT200041342	K02183	ko04020	Calcium signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04070	Phosphatidylinositol signaling system	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04114	Oocyte meiosis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04270	Vascular smooth muscle contraction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04626	Plant-pathogen interaction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04720	Long-term potentiation	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04722	Neurotrophin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04740	Olfactory transduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04744	Phototransduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04745	Phototransduction - fly	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04910	Insulin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04912	GnRH signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04916	Melanogenesis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04970	Salivary secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko04971	Gastric acid secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko05010	Alzheimer's disease	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041342	K02183	ko05214	Glioma	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMT200041343	K00558	ko00270	Cysteine and methionine metabolism	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMT200041343	K00558	ko01100	Metabolic pathways	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMT200041344	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMT200041344	K00517	ko00626	Naphthalene and anthracene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMT200041344	K00517	ko00903	Limonene and pinene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMT200041344	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMT200041344	K00517	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMT200041346	K01597	ko00900	Terpenoid backbone biosynthesis	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMT200041346	K01597	ko01100	Metabolic pathways	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMT200041346	K01597	ko01110	Biosynthesis of secondary metabolites	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMT200032889	K03980	ko00550	Peptidoglycan biosynthesis	492	1.6e-25	0.34	0.49	0.62
PGSC0003DMT200032890	K03980	ko00550	Peptidoglycan biosynthesis	534	1.3e-23	0.41	0.62	0.92
PGSC0003DMT200032895	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMT200032895	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMT200032896	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMT200032896	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMT200032910	K01728	ko00040	Pentose and glucuronate interconversions	2728	1.3e-144	0.76	0.87	0.99
PGSC0003DMT200032913	K00100	ko00051	Fructose and mannose metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032913	K00100	ko00363	Bisphenol A degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032913	K00100	ko00591	Linoleic acid metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032913	K00100	ko00625	Tetrachloroethene degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032913	K00100	ko00650	Butanoate metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032913	K00100	ko01100	Metabolic pathways	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMT200032914	K10251	ko01040	Biosynthesis of unsaturated fatty acids	856	2.2e-41	0.41	0.61	0.93
PGSC0003DMT200032928	K01814	ko00340	Histidine metabolism	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMT200032928	K01814	ko01100	Metabolic pathways	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMT200032928	K01814	ko01110	Biosynthesis of secondary metabolites	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMT200032929	K01814	ko00340	Histidine metabolism	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMT200032929	K01814	ko01100	Metabolic pathways	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMT200032929	K01814	ko01110	Biosynthesis of secondary metabolites	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMT200006863	K10865	ko03440	Homologous recombination	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMT200006863	K10865	ko03450	Non-homologous end-joining	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMT200006864	K10865	ko03440	Homologous recombination	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMT200006864	K10865	ko03450	Non-homologous end-joining	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMT200006875	K10865	ko03440	Homologous recombination	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMT200006875	K10865	ko03450	Non-homologous end-joining	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMT200006885	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMT200006887	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMT200006891	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMT200006892	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMT200006894	K01623	ko00010	Glycolysis / Gluconeogenesis	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006894	K01623	ko00030	Pentose phosphate pathway	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006894	K01623	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006894	K01623	ko00710	Carbon fixation in photosynthetic organisms	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006894	K01623	ko01100	Metabolic pathways	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006894	K01623	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMT200006895	K01623	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006895	K01623	ko00030	Pentose phosphate pathway	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006895	K01623	ko00051	Fructose and mannose metabolism	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006895	K01623	ko00710	Carbon fixation in photosynthetic organisms	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006895	K01623	ko01100	Metabolic pathways	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006895	K01623	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMT200006905	K09540	ko03060	Protein export	4426	2.8e-238	0.76	0.87	1.00
PGSC0003DMT200006908	K09540	ko03060	Protein export	1560	3.3e-80	0.70	0.83	0.97
PGSC0003DMT200021640	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMT200021640	K02366	ko01100	Metabolic pathways	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMT200021659	K04733	ko04210	Apoptosis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMT200021659	K04733	ko04620	Toll-like receptor signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMT200021659	K04733	ko04722	Neurotrophin signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMT200021659	K04733	ko05140	Leishmaniasis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMT200021659	K04733	ko05142	Chagas disease	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMT200021660	K04733	ko04210	Apoptosis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMT200021660	K04733	ko04620	Toll-like receptor signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMT200021660	K04733	ko04722	Neurotrophin signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMT200021660	K04733	ko05140	Leishmaniasis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMT200021660	K04733	ko05142	Chagas disease	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMT200021661	K04733	ko04210	Apoptosis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMT200021661	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMT200021661	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMT200021661	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMT200021661	K04733	ko05142	Chagas disease	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMT200021664	K02087	ko04110	Cell cycle	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMT200021664	K02087	ko04114	Oocyte meiosis	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMT200021664	K02087	ko04115	p53 signaling pathway	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMT200021664	K02087	ko04540	Gap junction	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMT200021664	K02087	ko04914	Progesterone-mediated oocyte maturation	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMT200064435	K00979	ko00540	Lipopolysaccharide biosynthesis	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMT200064435	K00979	ko01100	Metabolic pathways	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMT200064436	K03514	ko03018	RNA degradation	454	3.3e-19	0.66	0.78	0.62
PGSC0003DMT200064438	K03514	ko03018	RNA degradation	998	3.3e-49	0.69	0.81	0.76
PGSC0003DMT200064439	K03514	ko03018	RNA degradation	2644	5.4e-140	0.69	0.80	0.90
PGSC0003DMT200064440	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.49
PGSC0003DMT200064444	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.53
PGSC0003DMT200064446	K02260	ko00190	Oxidative phosphorylation	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMT200064446	K02260	ko01100	Metabolic pathways	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMT200064449	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMT200064449	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMT200064449	K00771	ko01100	Metabolic pathways	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMT200064454	K09880	ko00270	Cysteine and methionine metabolism	2120	4.3e-111	0.56	0.62	0.99
PGSC0003DMT200064455	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMT200064455	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMT200064456	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMT200064456	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMT200064480	K00760	ko00230	Purine metabolism	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMT200064480	K00760	ko00983	Drug metabolism - other enzymes	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMT200064480	K00760	ko01100	Metabolic pathways	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMT200064480	K00760	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMT200079887	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMT200079887	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMT200079888	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMT200079888	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMT200079910	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMT200079910	K06127	ko01100	Metabolic pathways	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMT200079910	K06127	ko01110	Biosynthesis of secondary metabolites	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMT200061751	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	216	8.7e-06	0.40	0.54	0.82
PGSC0003DMT200061764	K02885	ko03010	Ribosome	764	2.6e-36	0.99	0.99	0.57
PGSC0003DMT200061765	K02885	ko03010	Ribosome	1005	1.3e-49	0.98	0.99	0.99
PGSC0003DMT200061770	K10532	ko00531	Glycosaminoglycan degradation	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMT200061770	K10532	ko01100	Metabolic pathways	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMT200061770	K10532	ko04142	Lysosome	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMT200061771	K10532	ko00531	Glycosaminoglycan degradation	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMT200061771	K10532	ko01100	Metabolic pathways	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMT200061771	K10532	ko04142	Lysosome	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMT200061772	K10532	ko00531	Glycosaminoglycan degradation	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMT200061772	K10532	ko01100	Metabolic pathways	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMT200061772	K10532	ko04142	Lysosome	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMT200061775	K10532	ko00531	Glycosaminoglycan degradation	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMT200061775	K10532	ko01100	Metabolic pathways	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMT200061775	K10532	ko04142	Lysosome	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMT200061777	K10532	ko00531	Glycosaminoglycan degradation	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMT200061777	K10532	ko01100	Metabolic pathways	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMT200061777	K10532	ko04142	Lysosome	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMT200061778	K02986	ko03010	Ribosome	1292	2.0e-65	0.87	0.92	0.99
PGSC0003DMT200046674	K07385	ko00902	Monoterpenoid biosynthesis	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMT200046674	K07385	ko01100	Metabolic pathways	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMT200046675	K12467	ko00902	Monoterpenoid biosynthesis	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMT200046675	K12467	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMT200046676	K12467	ko00902	Monoterpenoid biosynthesis	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMT200046676	K12467	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMT200046678	K07385	ko00902	Monoterpenoid biosynthesis	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMT200046678	K07385	ko01100	Metabolic pathways	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMT200046680	K07385	ko00902	Monoterpenoid biosynthesis	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMT200046680	K07385	ko01100	Metabolic pathways	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMT200046681	K07385	ko00902	Monoterpenoid biosynthesis	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMT200046681	K07385	ko01100	Metabolic pathways	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMT200046685	K07385	ko00902	Monoterpenoid biosynthesis	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMT200046685	K07385	ko01100	Metabolic pathways	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMT200046686	K07385	ko00902	Monoterpenoid biosynthesis	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMT200046686	K07385	ko01100	Metabolic pathways	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMT200074142	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMT200074143	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMT200074144	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMT200074151	K12741	ko03040	Spliceosome	358	6.5e-14	0.39	0.54	0.72
PGSC0003DMT200074156	K00857	ko00240	Pyrimidine metabolism	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMT200074156	K00857	ko00983	Drug metabolism - other enzymes	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMT200074156	K00857	ko01100	Metabolic pathways	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMT200037350	K03131	ko03022	Basal transcription factors	1421	1.5e-72	0.64	0.75	1.00
PGSC0003DMT200037351	K03131	ko03022	Basal transcription factors	3169	5.9e-169	0.70	0.82	1.00
PGSC0003DMT200037352	K12476	ko04144	Endocytosis	1873	1.8e-97	0.53	0.68	0.84
PGSC0003DMT200037353	K12476	ko04144	Endocytosis	1872	2.0e-97	0.53	0.68	0.84
PGSC0003DMT200037361	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037362	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037363	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMT200037364	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMT200037365	K12606	ko03018	RNA degradation	2230	3.7e-117	0.86	0.89	1.00
PGSC0003DMT200037366	K12606	ko03018	RNA degradation	1102	6.0e-55	0.83	0.88	0.98
PGSC0003DMT200037367	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037368	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037369	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037370	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037371	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037372	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037373	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMT200037374	K12606	ko03018	RNA degradation	1353	8.6e-69	0.58	0.64	0.99
PGSC0003DMT200037375	K12606	ko03018	RNA degradation	897	1.2e-43	0.84	0.90	0.98
PGSC0003DMT200017828	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMT200017828	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMT200017829	K01046	ko00561	Glycerolipid metabolism	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMT200017829	K01046	ko01100	Metabolic pathways	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMT200017830	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMT200017830	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMT200027898	K10594	ko04120	Ubiquitin mediated proteolysis	544	1.6e-22	0.32	0.49	0.89
PGSC0003DMT200027900	K10595	ko04120	Ubiquitin mediated proteolysis	606	6.1e-26	0.32	0.48	0.96
PGSC0003DMT200027901	K10615	ko04120	Ubiquitin mediated proteolysis	535	4.3e-23	0.32	0.51	0.85
PGSC0003DMT200027902	K03217	ko03060	Protein export	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMT200027902	K03217	ko03070	Bacterial secretion system	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMT200027903	K03217	ko03060	Protein export	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMT200027903	K03217	ko03070	Bacterial secretion system	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMT200027904	K03217	ko03060	Protein export	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMT200027904	K03217	ko03070	Bacterial secretion system	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMT200027906	K10251	ko01040	Biosynthesis of unsaturated fatty acids	831	5.3e-40	0.39	0.62	0.95
PGSC0003DMT200017934	K00006	ko00564	Glycerophospholipid metabolism	2140	3.4e-112	0.84	0.92	0.99
PGSC0003DMT200017935	K00006	ko00564	Glycerophospholipid metabolism	2621	1.0e-138	0.84	0.92	1.00
PGSC0003DMT200017945	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.56
PGSC0003DMT200017946	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.57
PGSC0003DMT200017947	K10652	ko04622	RIG-I-like receptor signaling pathway	265	3.9e-08	0.35	0.47	0.56
PGSC0003DMT200017948	K10652	ko04622	RIG-I-like receptor signaling pathway	260	4.1e-06	0.32	0.44	0.57
PGSC0003DMT200017950	K11584	ko04113	Meiosis - yeast	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMT200017950	K11584	ko04114	Oocyte meiosis	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMT200017950	K11584	ko04310	Wnt signaling pathway	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMT200010080	K10352	ko04530	Tight junction	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMT200010080	K10352	ko05416	Viral myocarditis	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMT200010090	K01358	ko04112	Cell cycle - Caulobacter	1751	9.6e-91	0.70	0.86	1.00
PGSC0003DMT200010092	K10845	ko03420	Nucleotide excision repair	457	2.3e-19	0.75	0.90	0.97
PGSC0003DMT200010104	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko00362	Benzoate degradation via hydroxylation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko00632	Benzoate degradation via CoA ligation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko00903	Limonene and pinene degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko00930	Caprolactam degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko01100	Metabolic pathways	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010104	K01559	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMT200010106	K08679	ko00500	Starch and sucrose metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMT200010106	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMT200010106	K08679	ko01100	Metabolic pathways	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMT200010107	K08679	ko00500	Starch and sucrose metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMT200010107	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMT200010107	K08679	ko01100	Metabolic pathways	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMT200010109	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMT200010109	K00517	ko00626	Naphthalene and anthracene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMT200010109	K00517	ko00903	Limonene and pinene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMT200010109	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMT200010109	K00517	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMT200089019	K03094	ko04110	Cell cycle	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04111	Cell cycle - yeast	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04114	Oocyte meiosis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04120	Ubiquitin mediated proteolysis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04310	Wnt signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04350	TGF-beta signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200089019	K03094	ko04710	Circadian rhythm - mammal	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMT200094880	K09490	ko03060	Protein export	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMT200094880	K09490	ko05020	Prion diseases	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMT200094882	K10760	ko00908	Zeatin biosynthesis	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMT200094882	K10760	ko01100	Metabolic pathways	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMT200094882	K10760	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMT200064567	K05280	ko00941	Flavonoid biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMT200064567	K05280	ko00944	Flavone and flavonol biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMT200064567	K05280	ko01100	Metabolic pathways	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMT200064567	K05280	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMT200064570	K05280	ko00941	Flavonoid biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMT200064570	K05280	ko00944	Flavone and flavonol biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMT200064570	K05280	ko01100	Metabolic pathways	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMT200064570	K05280	ko01110	Biosynthesis of secondary metabolites	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMT200064583	K09835	ko00906	Carotenoid biosynthesis	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMT200064583	K09835	ko01100	Metabolic pathways	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMT200064583	K09835	ko01110	Biosynthesis of secondary metabolites	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMT200064584	K09835	ko00906	Carotenoid biosynthesis	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMT200064584	K09835	ko01100	Metabolic pathways	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMT200064584	K09835	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMT200064585	K09835	ko00906	Carotenoid biosynthesis	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMT200064585	K09835	ko01100	Metabolic pathways	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMT200064585	K09835	ko01110	Biosynthesis of secondary metabolites	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMT200064586	K09835	ko00906	Carotenoid biosynthesis	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMT200064586	K09835	ko01100	Metabolic pathways	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMT200064586	K09835	ko01110	Biosynthesis of secondary metabolites	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMT200064596	K00558	ko00270	Cysteine and methionine metabolism	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMT200064596	K00558	ko01100	Metabolic pathways	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMT200064597	K00558	ko00270	Cysteine and methionine metabolism	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMT200064597	K00558	ko01100	Metabolic pathways	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMT200064600	K01500	ko00791	Atrazine degradation	596	4.9e-27	0.49	0.64	0.83
PGSC0003DMT200064601	K01500	ko00791	Atrazine degradation	610	4.4e-27	0.49	0.63	0.13
PGSC0003DMT200064604	K01423	ko00310	Lysine degradation	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMT200064604	K01423	ko00780	Biotin metabolism	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMT200064604	K01423	ko01100	Metabolic pathways	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMT200064605	K01423	ko00310	Lysine degradation	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMT200064605	K01423	ko00780	Biotin metabolism	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMT200064605	K01423	ko01100	Metabolic pathways	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMT200064606	K01066	ko00623	2,4-Dichlorobenzoate degradation	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMT200064606	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMT200064607	K01432	ko00380	Tryptophan metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMT200064607	K01432	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMT200064607	K01432	ko01100	Metabolic pathways	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMT200056866	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMT200056866	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMT200056867	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMT200056867	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMT200056868	K13237	ko04146	Peroxisome	1261	1.0e-63	0.86	0.92	0.99
PGSC0003DMT200056869	K00927	ko00010	Glycolysis / Gluconeogenesis	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMT200056869	K00927	ko00710	Carbon fixation in photosynthetic organisms	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMT200056869	K00927	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMT200056869	K00927	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMT200056870	K00927	ko00010	Glycolysis / Gluconeogenesis	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMT200056870	K00927	ko00710	Carbon fixation in photosynthetic organisms	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMT200056870	K00927	ko01100	Metabolic pathways	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMT200056870	K00927	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMT200056871	K00927	ko00010	Glycolysis / Gluconeogenesis	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMT200056871	K00927	ko00710	Carbon fixation in photosynthetic organisms	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMT200056871	K00927	ko01100	Metabolic pathways	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMT200056871	K00927	ko01110	Biosynthesis of secondary metabolites	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMT200056888	K09561	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.30	0.52	0.71
PGSC0003DMT200056896	K01749	ko00860	Porphyrin and chlorophyll metabolism	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMT200056896	K01749	ko01100	Metabolic pathways	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMT200056896	K01749	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMT200079059	K06061	ko04330	Notch signaling pathway	299	6.5e-13	0.28	0.39	0.60
PGSC0003DMT200079062	K04498	ko04110	Cell cycle	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04310	Wnt signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04330	Notch signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04350	TGF-beta signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04520	Adherens junction	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04630	Jak-STAT signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04720	Long-term potentiation	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko04916	Melanogenesis	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko05016	Huntington's disease	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko05200	Pathways in cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko05211	Renal cell carcinoma	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079062	K04498	ko05215	Prostate cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMT200079070	K00001	ko00010	Glycolysis / Gluconeogenesis	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00071	Fatty acid metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00350	Tyrosine metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00624	1- and 2-Methylnaphthalene degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00641	3-Chloroacrylic acid degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00830	Retinol metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko00982	Drug metabolism - cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko01100	Metabolic pathways	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079070	K00001	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMT200079071	K00001	ko00010	Glycolysis / Gluconeogenesis	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00071	Fatty acid metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00350	Tyrosine metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00641	3-Chloroacrylic acid degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00830	Retinol metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko00982	Drug metabolism - cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko01100	Metabolic pathways	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079071	K00001	ko01110	Biosynthesis of secondary metabolites	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMT200079073	K03921	ko00061	Fatty acid biosynthesis	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMT200079073	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMT200079074	K03921	ko00061	Fatty acid biosynthesis	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMT200079074	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMT200079075	K03921	ko00061	Fatty acid biosynthesis	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMT200079075	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMT200079076	K03921	ko00061	Fatty acid biosynthesis	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMT200079076	K03921	ko01040	Biosynthesis of unsaturated fatty acids	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMT200079078	K03921	ko00061	Fatty acid biosynthesis	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMT200079078	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMT200079080	K03921	ko00061	Fatty acid biosynthesis	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMT200079080	K03921	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMT200079085	K03921	ko00061	Fatty acid biosynthesis	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMT200079085	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMT200046420	K13065	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMT200046420	K13065	ko00941	Flavonoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMT200046420	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMT200046420	K13065	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMT200046455	K00430	ko00360	Phenylalanine metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMT200046455	K00430	ko00680	Methane metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMT200046455	K00430	ko00940	Phenylpropanoid biosynthesis	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMT200046455	K00430	ko01100	Metabolic pathways	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMT200046455	K00430	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMT200014954	K01897	ko00071	Fatty acid metabolism	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMT200014954	K01897	ko01100	Metabolic pathways	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMT200014954	K01897	ko03320	PPAR signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMT200014954	K01897	ko04146	Peroxisome	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMT200014954	K01897	ko04920	Adipocytokine signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMT200014957	K03217	ko03060	Protein export	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMT200014957	K03217	ko03070	Bacterial secretion system	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMT200014958	K03217	ko03060	Protein export	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMT200014958	K03217	ko03070	Bacterial secretion system	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMT200014959	K03217	ko03060	Protein export	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMT200014959	K03217	ko03070	Bacterial secretion system	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMT200014960	K06268	ko04010	MAPK signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04020	Calcium signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04114	Oocyte meiosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04210	Apoptosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04310	Wnt signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04360	Axon guidance	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04370	VEGF signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04660	T cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko04720	Long-term potentiation	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko05010	Alzheimer's disease	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014960	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMT200014962	K06268	ko04010	MAPK signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04020	Calcium signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04114	Oocyte meiosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04210	Apoptosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04310	Wnt signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04360	Axon guidance	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04370	VEGF signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04650	Natural killer cell mediated cytotoxicity	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04660	T cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04662	B cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko04720	Long-term potentiation	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko05010	Alzheimer's disease	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014962	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMT200014980	K00059	ko00061	Fatty acid biosynthesis	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMT200014980	K00059	ko01040	Biosynthesis of unsaturated fatty acids	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMT200014980	K00059	ko01100	Metabolic pathways	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMT200014995	K12660	ko00051	Fructose and mannose metabolism	570	1.3e-25	0.36	0.57	0.71
PGSC0003DMT200024575	K02294	ko00906	Carotenoid biosynthesis	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMT200024575	K02294	ko01100	Metabolic pathways	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMT200024575	K02294	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMT200024585	K12869	ko03040	Spliceosome	4223	4.4e-227	0.74	0.82	0.99
PGSC0003DMT200024594	K04079	ko04612	Antigen processing and presentation	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024594	K04079	ko04621	NOD-like receptor signaling pathway	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024594	K04079	ko04626	Plant-pathogen interaction	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024594	K04079	ko04914	Progesterone-mediated oocyte maturation	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024594	K04079	ko05200	Pathways in cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024594	K04079	ko05215	Prostate cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMT200024595	K01213	ko00040	Pentose and glucuronate interconversions	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMT200024595	K01213	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMT200024595	K01213	ko01100	Metabolic pathways	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMT200021522	K02084	ko04115	p53 signaling pathway	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko04210	Apoptosis	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko05010	Alzheimer's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko05012	Parkinson's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko05016	Huntington's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021522	K02084	ko05222	Small cell lung cancer	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMT200021531	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMT200021532	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMT200021533	K02989	ko03010	Ribosome	1260	1.2e-63	0.97	0.99	0.99
PGSC0003DMT200021552	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021552	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021552	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021552	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021552	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021552	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200021553	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMT200096772	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200096772	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200096772	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200096774	K02872	ko03010	Ribosome	1509	2.1e-77	0.89	0.95	0.98
PGSC0003DMT200096781	K00791	ko00908	Zeatin biosynthesis	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMT200096781	K00791	ko01100	Metabolic pathways	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMT200096781	K00791	ko01110	Biosynthesis of secondary metabolites	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMT200093022	K02707	ko00195	Photosynthesis	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMT200093022	K02707	ko01100	Metabolic pathways	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMT200093026	K04508	ko04310	Wnt signaling pathway	2837	1.2e-150	0.66	0.80	0.99
PGSC0003DMT200058196	K00117	ko00030	Pentose phosphate pathway	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMT200058196	K00117	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMT200058196	K00117	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMT200058197	K00117	ko00030	Pentose phosphate pathway	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMT200058197	K00117	ko01100	Metabolic pathways	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMT200058197	K00117	ko01110	Biosynthesis of secondary metabolites	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMT200058198	K00100	ko00051	Fructose and mannose metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058198	K00100	ko00363	Bisphenol A degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058198	K00100	ko00591	Linoleic acid metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058198	K00100	ko00625	Tetrachloroethene degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058198	K00100	ko00650	Butanoate metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058198	K00100	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMT200058203	K12126	ko04712	Circadian rhythm - plant	337	9.4e-13	0.40	0.60	0.58
PGSC0003DMT200058204	K12126	ko04712	Circadian rhythm - plant	363	3.5e-14	0.37	0.53	0.70
PGSC0003DMT200058216	K04382	ko04111	Cell cycle - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04113	Meiosis - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04114	Oocyte meiosis	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04310	Wnt signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04350	TGF-beta signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04530	Tight junction	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko04730	Long-term depression	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058216	K04382	ko05142	Chagas disease	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMT200058220	K11644	ko05016	Huntington's disease	4257	5.8e-229	0.60	0.72	1.00
PGSC0003DMT200058221	K11644	ko05016	Huntington's disease	6612	0.	0.59	0.72	0.99
PGSC0003DMT200058222	K11644	ko05016	Huntington's disease	6616	0.	0.59	0.72	0.99
PGSC0003DMT200058223	K00161	ko00010	Glycolysis / Gluconeogenesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko00020	Citrate cycle (TCA cycle)	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko00620	Pyruvate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko00650	Butanoate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko01100	Metabolic pathways	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058223	K00161	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200058224	K00754	ko00051	Fructose and mannose metabolism	366	2.4e-14	0.27	0.47	0.81
PGSC0003DMT200067570	K00588	ko00360	Phenylalanine metabolism	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067570	K00588	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067570	K00588	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067570	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067570	K00588	ko01100	Metabolic pathways	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067570	K00588	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMT200067571	K00588	ko00360	Phenylalanine metabolism	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067571	K00588	ko00940	Phenylpropanoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067571	K00588	ko00941	Flavonoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067571	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067571	K00588	ko01100	Metabolic pathways	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067571	K00588	ko01110	Biosynthesis of secondary metabolites	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMT200067572	K00588	ko00360	Phenylalanine metabolism	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067572	K00588	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067572	K00588	ko00941	Flavonoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067572	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067572	K00588	ko01100	Metabolic pathways	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067572	K00588	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMT200067573	K00588	ko00360	Phenylalanine metabolism	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067573	K00588	ko00940	Phenylpropanoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067573	K00588	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067573	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067573	K00588	ko01100	Metabolic pathways	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067573	K00588	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMT200067578	K13230	ko00402	Benzoxazinoid biosynthesis	851	4.2e-41	0.36	0.53	0.99
PGSC0003DMT200067579	K13230	ko00402	Benzoxazinoid biosynthesis	332	1.8e-12	0.40	0.59	0.99
PGSC0003DMT200067581	K05277	ko00941	Flavonoid biosynthesis	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMT200067581	K05277	ko01100	Metabolic pathways	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMT200067581	K05277	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMT200067582	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMT200067582	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMT200067582	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMT200067584	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMT200067584	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMT200067584	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMT200067586	K05277	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMT200067586	K05277	ko01100	Metabolic pathways	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMT200067586	K05277	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMT200067587	K05277	ko00941	Flavonoid biosynthesis	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMT200067587	K05277	ko01100	Metabolic pathways	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMT200067587	K05277	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMT200067594	K07385	ko00902	Monoterpenoid biosynthesis	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMT200067594	K07385	ko01100	Metabolic pathways	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMT200067599	K01590	ko00340	Histidine metabolism	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMT200067599	K01590	ko01100	Metabolic pathways	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMT200067599	K01590	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMT200067600	K01590	ko00340	Histidine metabolism	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMT200067600	K01590	ko01100	Metabolic pathways	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMT200067600	K01590	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMT200067601	K00432	ko00480	Glutathione metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMT200067601	K00432	ko00590	Arachidonic acid metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMT200067608	K01613	ko00564	Glycerophospholipid metabolism	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMT200067608	K01613	ko01100	Metabolic pathways	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMT200084908	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMT200084908	K00517	ko00626	Naphthalene and anthracene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMT200084908	K00517	ko00903	Limonene and pinene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMT200084908	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMT200084908	K00517	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMT200084916	K12818	ko03040	Spliceosome	6479	0.	0.94	0.98	1.00
PGSC0003DMT200084918	K01507	ko00190	Oxidative phosphorylation	456	2.6e-19	0.90	0.94	0.95
PGSC0003DMT200091817	K10760	ko00908	Zeatin biosynthesis	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMT200091817	K10760	ko01100	Metabolic pathways	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMT200091817	K10760	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMT200091824	K00791	ko00908	Zeatin biosynthesis	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMT200091824	K00791	ko01100	Metabolic pathways	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMT200091824	K00791	ko01110	Biosynthesis of secondary metabolites	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMT200091830	K10760	ko00908	Zeatin biosynthesis	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMT200091830	K10760	ko01100	Metabolic pathways	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMT200091830	K10760	ko01110	Biosynthesis of secondary metabolites	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMT200022922	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMT200022922	K00517	ko00626	Naphthalene and anthracene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMT200022922	K00517	ko00903	Limonene and pinene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMT200022922	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMT200022922	K00517	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMT200022933	K08269	ko04140	Regulation of autophagy	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMT200022933	K08269	ko04150	mTOR signaling pathway	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMT200022934	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMT200022934	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMT200022935	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMT200022935	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMT200022936	K08269	ko04140	Regulation of autophagy	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMT200022936	K08269	ko04150	mTOR signaling pathway	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMT200022937	K08269	ko04140	Regulation of autophagy	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMT200022937	K08269	ko04150	mTOR signaling pathway	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMT200022940	K00761	ko00240	Pyrimidine metabolism	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMT200022940	K00761	ko01100	Metabolic pathways	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMT200022949	K00002	ko00010	Glycolysis / Gluconeogenesis	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMT200022949	K00002	ko00561	Glycerolipid metabolism	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMT200022949	K00002	ko00930	Caprolactam degradation	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMT200022949	K00002	ko01100	Metabolic pathways	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMT200022949	K00002	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMT200022950	K00002	ko00010	Glycolysis / Gluconeogenesis	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMT200022950	K00002	ko00561	Glycerolipid metabolism	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMT200022950	K00002	ko00930	Caprolactam degradation	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMT200022950	K00002	ko01100	Metabolic pathways	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMT200022950	K00002	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMT200022951	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022951	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022951	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022951	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022951	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200013200	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.34	0.52	0.84
PGSC0003DMT200013201	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	416	7.0e-17	0.37	0.54	0.89
PGSC0003DMT200013213	K01520	ko00240	Pyrimidine metabolism	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMT200013213	K01520	ko01100	Metabolic pathways	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMT200013214	K01520	ko00240	Pyrimidine metabolism	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMT200013214	K01520	ko01100	Metabolic pathways	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMT200013234	K02084	ko04115	p53 signaling pathway	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko04210	Apoptosis	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko05010	Alzheimer's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko05012	Parkinson's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko05016	Huntington's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013234	K02084	ko05222	Small cell lung cancer	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMT200013241	K02084	ko04115	p53 signaling pathway	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko04210	Apoptosis	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko05010	Alzheimer's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko05012	Parkinson's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko05016	Huntington's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200013241	K02084	ko05222	Small cell lung cancer	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMT200039190	K01609	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMT200039190	K01609	ko01100	Metabolic pathways	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMT200039190	K01609	ko01110	Biosynthesis of secondary metabolites	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMT200039191	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMT200039192	K06611	ko00052	Galactose metabolism	877	1.5e-42	0.41	0.61	0.89
PGSC0003DMT200039193	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMT200039194	K06611	ko00052	Galactose metabolism	756	7.3e-36	0.40	0.58	0.98
PGSC0003DMT200039195	K06611	ko00052	Galactose metabolism	2107	2.2e-110	0.40	0.58	0.97
PGSC0003DMT200039196	K11294	ko05130	Pathogenic Escherichia coli infection	492	2.7e-21	0.36	0.56	0.77
PGSC0003DMT200039211	K02343	ko00230	Purine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039211	K02343	ko00240	Pyrimidine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039211	K02343	ko01100	Metabolic pathways	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039211	K02343	ko03030	DNA replication	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039211	K02343	ko03430	Mismatch repair	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039211	K02343	ko03440	Homologous recombination	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMT200039222	K01838	ko00500	Starch and sucrose metabolism	538	7.7e-24	0.39	0.56	0.69
PGSC0003DMT200048398	K09841	ko00906	Carotenoid biosynthesis	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMT200048398	K09841	ko01100	Metabolic pathways	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMT200048398	K09841	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMT200048399	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048399	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048399	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048400	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048400	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048400	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMT200048401	K09841	ko00906	Carotenoid biosynthesis	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMT200048401	K09841	ko01100	Metabolic pathways	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMT200048401	K09841	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMT200048402	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMT200048402	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMT200048402	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMT200048403	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048403	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048403	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048404	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048404	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048404	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMT200048405	K09841	ko00906	Carotenoid biosynthesis	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMT200048405	K09841	ko01100	Metabolic pathways	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMT200048405	K09841	ko01110	Biosynthesis of secondary metabolites	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMT200069333	K02998	ko03010	Ribosome	1911	1.4e-99	0.77	0.80	1.00
PGSC0003DMT200069334	K02998	ko03010	Ribosome	1912	1.3e-99	0.76	0.80	1.00
PGSC0003DMT200069335	K02998	ko03010	Ribosome	610	8.3e-28	0.97	1.00	0.85
PGSC0003DMT200069337	K05681	ko02010	ABC transporters	1018	2.6e-50	0.33	0.49	0.90
PGSC0003DMT200069344	K05680	ko02010	ABC transporters	311	6.6e-11	0.27	0.50	0.89
PGSC0003DMT200069346	K10684	ko04120	Ubiquitin mediated proteolysis	2010	5.0e-105	0.75	0.87	0.98
PGSC0003DMT200069352	K00940	ko00230	Purine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMT200069352	K00940	ko00240	Pyrimidine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMT200069352	K00940	ko01100	Metabolic pathways	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMT200069352	K00940	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMT200069353	K13065	ko00940	Phenylpropanoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMT200069353	K13065	ko00941	Flavonoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMT200069353	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMT200069353	K13065	ko01110	Biosynthesis of secondary metabolites	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMT200069357	K00134	ko00010	Glycolysis / Gluconeogenesis	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMT200069357	K00134	ko01100	Metabolic pathways	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMT200069357	K00134	ko01110	Biosynthesis of secondary metabolites	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMT200069357	K00134	ko05010	Alzheimer's disease	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMT200059992	K12613	ko03018	RNA degradation	2239	1.2e-117	0.80	0.90	1.00
PGSC0003DMT200059995	K08907	ko00196	Photosynthesis - antenna proteins	1801	1.7e-93	0.84	0.91	0.99
PGSC0003DMT200060021	K13228	ko00402	Benzoxazinoid biosynthesis	601	2.6e-27	0.38	0.61	0.82
PGSC0003DMT200060022	K13068	ko00940	Phenylpropanoid biosynthesis	811	6.8e-39	0.30	0.51	0.99
PGSC0003DMT200066220	K00083	ko00940	Phenylpropanoid biosynthesis	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMT200066220	K00083	ko01100	Metabolic pathways	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMT200066220	K00083	ko01110	Biosynthesis of secondary metabolites	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMT200066226	K03544	ko04112	Cell cycle - Caulobacter	413	8.3e-17	0.49	0.57	0.41
PGSC0003DMT200066267	K04733	ko04210	Apoptosis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMT200066267	K04733	ko04620	Toll-like receptor signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMT200066267	K04733	ko04722	Neurotrophin signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMT200066267	K04733	ko05140	Leishmaniasis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMT200066267	K04733	ko05142	Chagas disease	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMT200066268	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066268	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066268	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066268	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066268	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066269	K04733	ko04210	Apoptosis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMT200066269	K04733	ko04620	Toll-like receptor signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMT200066269	K04733	ko04722	Neurotrophin signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMT200066269	K04733	ko05140	Leishmaniasis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMT200066269	K04733	ko05142	Chagas disease	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMT200066270	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066270	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066270	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066270	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200066270	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMT200003588	K05658	ko02010	ABC transporters	1964	1.7e-102	0.60	0.80	0.99
PGSC0003DMT200003589	K05658	ko02010	ABC transporters	3845	3.1e-206	0.48	0.68	1.00
PGSC0003DMT200003590	K05658	ko02010	ABC transporters	4788	3.0e-258	0.48	0.68	1.00
PGSC0003DMT200003592	K02915	ko03010	Ribosome	967	1.7e-47	0.96	0.98	0.99
PGSC0003DMT200003602	K01535	ko00190	Oxidative phosphorylation	3351	5.4e-179	0.51	0.64	0.98
PGSC0003DMT200090220	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMT200090220	K00517	ko00626	Naphthalene and anthracene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMT200090220	K00517	ko00903	Limonene and pinene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMT200090220	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMT200090220	K00517	ko01110	Biosynthesis of secondary metabolites	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMT200096072	K11644	ko05016	Huntington's disease	270	5.4e-08	0.29	0.48	0.76
PGSC0003DMT200096074	K03094	ko04110	Cell cycle	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04111	Cell cycle - yeast	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04114	Oocyte meiosis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04120	Ubiquitin mediated proteolysis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04310	Wnt signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04350	TGF-beta signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200096074	K03094	ko04710	Circadian rhythm - mammal	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMT200011829	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMT200011829	K00517	ko00626	Naphthalene and anthracene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMT200011829	K00517	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMT200011829	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMT200011829	K00517	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMT200011830	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMT200011830	K00517	ko00626	Naphthalene and anthracene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMT200011830	K00517	ko00903	Limonene and pinene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMT200011830	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMT200011830	K00517	ko01110	Biosynthesis of secondary metabolites	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMT200011832	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMT200011832	K00517	ko00626	Naphthalene and anthracene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMT200011832	K00517	ko00903	Limonene and pinene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMT200011832	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMT200011832	K00517	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMT200011850	K13290	ko00250	Alanine, aspartate and glutamate metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMT200011850	K13290	ko00260	Glycine, serine and threonine metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMT200011850	K13290	ko01100	Metabolic pathways	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMT200011850	K13290	ko01110	Biosynthesis of secondary metabolites	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMT200011851	K13290	ko00250	Alanine, aspartate and glutamate metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMT200011851	K13290	ko00260	Glycine, serine and threonine metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMT200011851	K13290	ko01100	Metabolic pathways	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMT200011851	K13290	ko01110	Biosynthesis of secondary metabolites	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMT200011861	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMT200011861	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMT200011861	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMT200011867	K08679	ko00500	Starch and sucrose metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMT200011867	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMT200011867	K08679	ko01100	Metabolic pathways	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMT200011868	K00600	ko00260	Glycine, serine and threonine metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200011868	K00600	ko00460	Cyanoamino acid metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200011868	K00600	ko00670	One carbon pool by folate	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200011868	K00600	ko00680	Methane metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200011868	K00600	ko01100	Metabolic pathways	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200011868	K00600	ko01110	Biosynthesis of secondary metabolites	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMT200019806	K08233	ko00901	Indole alkaloid biosynthesis	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMT200019806	K08233	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMT200019809	K01516	ko00230	Purine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMT200019809	K01516	ko00730	Thiamine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMT200019809	K01516	ko01100	Metabolic pathways	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMT200019810	K01516	ko00230	Purine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMT200019810	K01516	ko00730	Thiamine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMT200019810	K01516	ko01100	Metabolic pathways	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMT200019814	K01874	ko00450	Selenoamino acid metabolism	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMT200019814	K01874	ko00970	Aminoacyl-tRNA biosynthesis	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMT200019815	K01874	ko00450	Selenoamino acid metabolism	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMT200019815	K01874	ko00970	Aminoacyl-tRNA biosynthesis	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMT200019823	K09753	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMT200019823	K09753	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMT200019823	K09753	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMT200019824	K09753	ko00940	Phenylpropanoid biosynthesis	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMT200019824	K09753	ko01100	Metabolic pathways	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMT200019824	K09753	ko01110	Biosynthesis of secondary metabolites	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMT200034693	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034693	K01580	ko00410	beta-Alanine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034693	K01580	ko00430	Taurine and hypotaurine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034693	K01580	ko00650	Butanoate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034693	K01580	ko01100	Metabolic pathways	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034693	K01580	ko04940	Type I diabetes mellitus	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMT200034694	K00031	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034694	K00031	ko00480	Glutathione metabolism	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034694	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034694	K00031	ko01100	Metabolic pathways	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034694	K00031	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034694	K00031	ko04146	Peroxisome	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMT200034696	K00031	ko00020	Citrate cycle (TCA cycle)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034696	K00031	ko00480	Glutathione metabolism	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034696	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034696	K00031	ko01100	Metabolic pathways	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034696	K00031	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034696	K00031	ko04146	Peroxisome	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMT200034697	K00031	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034697	K00031	ko00480	Glutathione metabolism	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034697	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034697	K00031	ko01100	Metabolic pathways	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034697	K00031	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034697	K00031	ko04146	Peroxisome	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMT200034698	K00031	ko00020	Citrate cycle (TCA cycle)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034698	K00031	ko00480	Glutathione metabolism	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034698	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034698	K00031	ko01100	Metabolic pathways	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034698	K00031	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034698	K00031	ko04146	Peroxisome	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMT200034699	K00963	ko00040	Pentose and glucuronate interconversions	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034699	K00963	ko00052	Galactose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034699	K00963	ko00500	Starch and sucrose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034699	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034699	K00963	ko01100	Metabolic pathways	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034699	K00963	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMT200034704	K10143	ko04115	p53 signaling pathway	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMT200034704	K10143	ko04120	Ubiquitin mediated proteolysis	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMT200034705	K10143	ko04115	p53 signaling pathway	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMT200034705	K10143	ko04120	Ubiquitin mediated proteolysis	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMT200034706	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMT200034706	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMT200034707	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMT200034707	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMT200034708	K10143	ko04115	p53 signaling pathway	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMT200034708	K10143	ko04120	Ubiquitin mediated proteolysis	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMT200055055	K00645	ko00061	Fatty acid biosynthesis	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMT200055055	K00645	ko01100	Metabolic pathways	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMT200055060	K11294	ko05130	Pathogenic Escherichia coli infection	432	5.4e-18	0.30	0.50	0.71
PGSC0003DMT200055061	K08064	ko04612	Antigen processing and presentation	422	1.9e-17	0.37	0.49	0.75
PGSC0003DMT200055070	K11422	ko00310	Lysine degradation	2670	2.0e-141	0.35	0.48	0.99
PGSC0003DMT200055072	K11422	ko00310	Lysine degradation	2340	3.1e-123	0.35	0.48	0.99
PGSC0003DMT200055073	K11422	ko00310	Lysine degradation	1812	4.2e-94	0.35	0.51	0.98
PGSC0003DMT200055074	K11422	ko00310	Lysine degradation	3215	1.7e-171	0.38	0.52	0.99
PGSC0003DMT200055075	K11422	ko00310	Lysine degradation	3093	9.2e-165	0.36	0.50	1.00
PGSC0003DMT200062886	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062886	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062887	K02183	ko04020	Calcium signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04070	Phosphatidylinositol signaling system	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04114	Oocyte meiosis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04270	Vascular smooth muscle contraction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04626	Plant-pathogen interaction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04720	Long-term potentiation	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04722	Neurotrophin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04740	Olfactory transduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04744	Phototransduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04745	Phototransduction - fly	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04910	Insulin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04912	GnRH signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04916	Melanogenesis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04970	Salivary secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko04971	Gastric acid secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko05010	Alzheimer's disease	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062887	K02183	ko05214	Glioma	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMT200062888	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062888	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMT200062891	K02183	ko04020	Calcium signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04070	Phosphatidylinositol signaling system	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04114	Oocyte meiosis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04270	Vascular smooth muscle contraction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04626	Plant-pathogen interaction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04720	Long-term potentiation	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04722	Neurotrophin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04740	Olfactory transduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04744	Phototransduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04745	Phototransduction - fly	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04910	Insulin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04912	GnRH signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04916	Melanogenesis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04970	Salivary secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko04971	Gastric acid secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko05010	Alzheimer's disease	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062891	K02183	ko05214	Glioma	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMT200062895	K02183	ko04020	Calcium signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04070	Phosphatidylinositol signaling system	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04114	Oocyte meiosis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04270	Vascular smooth muscle contraction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04626	Plant-pathogen interaction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04720	Long-term potentiation	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04722	Neurotrophin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04740	Olfactory transduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04744	Phototransduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04745	Phototransduction - fly	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04910	Insulin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04912	GnRH signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04916	Melanogenesis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04970	Salivary secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko04971	Gastric acid secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko05010	Alzheimer's disease	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062895	K02183	ko05214	Glioma	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMT200062930	K00128	ko00010	Glycolysis / Gluconeogenesis	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00053	Ascorbate and aldarate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00071	Fatty acid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00280	Valine, leucine and isoleucine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00310	Lysine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00330	Arginine and proline metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00340	Histidine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00380	Tryptophan metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00410	beta-Alanine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00561	Glycerolipid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00620	Pyruvate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00631	1,2-Dichloroethane degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00640	Propanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00641	3-Chloroacrylic acid degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00650	Butanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko00903	Limonene and pinene degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko01100	Metabolic pathways	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062930	K00128	ko01110	Biosynthesis of secondary metabolites	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMT200062932	K10881	ko03050	Proteasome	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMT200062932	K10881	ko03440	Homologous recombination	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMT200044542	K04424	ko04010	MAPK signaling pathway	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMT200044542	K04424	ko04530	Tight junction	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMT200044543	K04424	ko04010	MAPK signaling pathway	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMT200044543	K04424	ko04530	Tight junction	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMT200044544	K04424	ko04010	MAPK signaling pathway	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMT200044544	K04424	ko04530	Tight junction	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMT200044545	K04424	ko04010	MAPK signaling pathway	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMT200044545	K04424	ko04530	Tight junction	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMT200044556	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.38	0.59	0.97
PGSC0003DMT200044573	K04042	ko00520	Amino sugar and nucleotide sugar metabolism	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMT200044573	K04042	ko01100	Metabolic pathways	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMT200074506	K00423	ko00053	Ascorbate and aldarate metabolism	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMT200074506	K00423	ko01100	Metabolic pathways	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMT200074507	K00423	ko00053	Ascorbate and aldarate metabolism	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMT200074507	K00423	ko01100	Metabolic pathways	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMT200074508	K00423	ko00053	Ascorbate and aldarate metabolism	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMT200074508	K00423	ko01100	Metabolic pathways	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMT200074509	K00423	ko00053	Ascorbate and aldarate metabolism	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMT200074509	K00423	ko01100	Metabolic pathways	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMT200074510	K00423	ko00053	Ascorbate and aldarate metabolism	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMT200074510	K00423	ko01100	Metabolic pathways	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMT200074511	K00423	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMT200074511	K00423	ko01100	Metabolic pathways	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMT200074514	K00071	ko00140	Steroid hormone biosynthesis	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMT200074514	K00071	ko01100	Metabolic pathways	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMT200074514	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMT200074515	K00071	ko00140	Steroid hormone biosynthesis	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMT200074515	K00071	ko01100	Metabolic pathways	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMT200074515	K00071	ko04960	Aldosterone-regulated sodium reabsorption	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMT200074516	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMT200074516	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMT200074516	K00734	ko01100	Metabolic pathways	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMT200074517	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMT200074517	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMT200074517	K00734	ko01100	Metabolic pathways	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMT200061048	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMT200061048	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMT200061049	K11157	ko00830	Retinol metabolism	383	2.7e-15	0.33	0.49	0.56
PGSC0003DMT200069076	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMT200069076	K01657	ko01100	Metabolic pathways	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMT200069076	K01657	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMT200069080	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMT200069080	K01657	ko01100	Metabolic pathways	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMT200069080	K01657	ko01110	Biosynthesis of secondary metabolites	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMT200069082	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMT200069082	K00517	ko00626	Naphthalene and anthracene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMT200069082	K00517	ko00903	Limonene and pinene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMT200069082	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMT200069082	K00517	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMT200069083	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMT200069083	K00517	ko00626	Naphthalene and anthracene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMT200069083	K00517	ko00903	Limonene and pinene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMT200069083	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMT200069083	K00517	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMT200069084	K12832	ko03040	Spliceosome	739	6.3e-35	0.97	0.98	0.99
PGSC0003DMT200069107	K03821	ko00650	Butanoate metabolism	279	3.5e-09	0.31	0.48	0.43
PGSC0003DMT200069112	K04123	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMT200069112	K04123	ko01100	Metabolic pathways	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMT200069112	K04123	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMT200069113	K04123	ko00904	Diterpenoid biosynthesis	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMT200069113	K04123	ko01100	Metabolic pathways	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMT200069113	K04123	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMT200057865	K00514	ko00906	Carotenoid biosynthesis	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMT200057865	K00514	ko01100	Metabolic pathways	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMT200057865	K00514	ko01110	Biosynthesis of secondary metabolites	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMT200014362	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.31
PGSC0003DMT200014363	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.35
PGSC0003DMT200014374	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMT200014377	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMT200022684	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1868	3.4e-97	0.67	0.76	1.00
PGSC0003DMT200022685	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1425	9.2e-73	0.60	0.71	1.00
PGSC0003DMT200022698	K08912	ko00196	Photosynthesis - antenna proteins	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMT200022698	K08912	ko01100	Metabolic pathways	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMT200022699	K08912	ko00196	Photosynthesis - antenna proteins	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMT200022699	K08912	ko01100	Metabolic pathways	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMT200022700	K08912	ko00196	Photosynthesis - antenna proteins	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMT200022700	K08912	ko01100	Metabolic pathways	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMT200022704	K12126	ko04712	Circadian rhythm - plant	305	1.0e-08	0.30	0.46	0.60
PGSC0003DMT200022705	K04410	ko04010	MAPK signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko04012	ErbB signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko04360	Axon guidance	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko04510	Focal adhesion	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko04660	T cell receptor signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko04810	Regulation of actin cytoskeleton	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022705	K04410	ko05211	Renal cell carcinoma	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMT200022719	K01581	ko00330	Arginine and proline metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMT200022719	K01581	ko00480	Glutathione metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMT200022719	K01581	ko01100	Metabolic pathways	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMT200022719	K01581	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMT200042326	K01899	ko00020	Citrate cycle (TCA cycle)	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMT200042326	K01899	ko00640	Propanoate metabolism	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMT200042326	K01899	ko01100	Metabolic pathways	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMT200042326	K01899	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMT200042327	K08139	ko04113	Meiosis - yeast	467	6.4e-20	0.40	0.64	0.75
PGSC0003DMT200042344	K06620	ko04110	Cell cycle	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05200	Pathways in cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05212	Pancreatic cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05214	Glioma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05215	Prostate cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05218	Melanoma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05219	Bladder cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05220	Chronic myeloid leukemia	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05222	Small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042344	K06620	ko05223	Non-small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMT200042346	K06620	ko04110	Cell cycle	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05200	Pathways in cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05212	Pancreatic cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05214	Glioma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05215	Prostate cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05218	Melanoma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05219	Bladder cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05220	Chronic myeloid leukemia	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05222	Small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042346	K06620	ko05223	Non-small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMT200042347	K06620	ko04110	Cell cycle	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05200	Pathways in cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05212	Pancreatic cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05214	Glioma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05215	Prostate cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05218	Melanoma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05219	Bladder cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05220	Chronic myeloid leukemia	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05222	Small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042347	K06620	ko05223	Non-small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMT200042348	K06620	ko04110	Cell cycle	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05200	Pathways in cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05212	Pancreatic cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05214	Glioma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05215	Prostate cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05218	Melanoma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05219	Bladder cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05220	Chronic myeloid leukemia	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05222	Small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200042348	K06620	ko05223	Non-small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMT200091921	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMT200091921	K00517	ko00626	Naphthalene and anthracene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMT200091921	K00517	ko00903	Limonene and pinene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMT200091921	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMT200091921	K00517	ko01110	Biosynthesis of secondary metabolites	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMT200063446	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMT200063446	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMT200063446	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMT200063452	K00454	ko00591	Linoleic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMT200063452	K00454	ko00592	alpha-Linolenic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMT200063452	K00454	ko01100	Metabolic pathways	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMT200063461	K00454	ko00591	Linoleic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMT200063461	K00454	ko00592	alpha-Linolenic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMT200063461	K00454	ko01100	Metabolic pathways	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMT200063462	K00454	ko00591	Linoleic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMT200063462	K00454	ko00592	alpha-Linolenic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMT200063462	K00454	ko01100	Metabolic pathways	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMT200063468	K00454	ko00591	Linoleic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMT200063468	K00454	ko00592	alpha-Linolenic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMT200063468	K00454	ko01100	Metabolic pathways	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMT200063469	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMT200063469	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMT200063469	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMT200063475	K00454	ko00591	Linoleic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMT200063475	K00454	ko00592	alpha-Linolenic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMT200063475	K00454	ko01100	Metabolic pathways	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMT200063477	K00454	ko00591	Linoleic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMT200063477	K00454	ko00592	alpha-Linolenic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMT200063477	K00454	ko01100	Metabolic pathways	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMT200063479	K00454	ko00591	Linoleic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMT200063479	K00454	ko00592	alpha-Linolenic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMT200063479	K00454	ko01100	Metabolic pathways	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMT200063481	K02350	ko01100	Metabolic pathways	7592	0.	0.55	0.67	1.00
PGSC0003DMT200063483	K12893	ko03040	Spliceosome	254	1.7e-06	0.30	0.43	0.34
PGSC0003DMT200063484	K00020	ko00280	Valine, leucine and isoleucine degradation	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMT200063484	K00020	ko01100	Metabolic pathways	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMT200063486	K00020	ko00280	Valine, leucine and isoleucine degradation	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMT200063486	K00020	ko01100	Metabolic pathways	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMT200063493	K06634	ko03420	Nucleotide excision repair	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMT200063493	K06634	ko04110	Cell cycle	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMT200063494	K06634	ko03420	Nucleotide excision repair	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMT200063494	K06634	ko04110	Cell cycle	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMT200063495	K06634	ko03420	Nucleotide excision repair	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMT200063495	K06634	ko04110	Cell cycle	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMT200063496	K06634	ko03420	Nucleotide excision repair	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMT200063496	K06634	ko04110	Cell cycle	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMT200063497	K06634	ko03420	Nucleotide excision repair	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMT200063497	K06634	ko04110	Cell cycle	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMT200063498	K06634	ko03420	Nucleotide excision repair	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMT200063498	K06634	ko04110	Cell cycle	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMT200053412	K08247	ko00450	Selenoamino acid metabolism	6265	0.	0.70	0.84	0.99
PGSC0003DMT200053436	K02084	ko04115	p53 signaling pathway	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko04210	Apoptosis	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko05010	Alzheimer's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko05012	Parkinson's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko05016	Huntington's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053436	K02084	ko05222	Small cell lung cancer	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMT200053452	K02084	ko04115	p53 signaling pathway	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko04210	Apoptosis	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko05010	Alzheimer's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko05012	Parkinson's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko05016	Huntington's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200053452	K02084	ko05222	Small cell lung cancer	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMT200071719	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMT200071719	K00517	ko00626	Naphthalene and anthracene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMT200071719	K00517	ko00903	Limonene and pinene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMT200071719	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMT200071719	K00517	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMT200071721	K10878	ko04113	Meiosis - yeast	2979	1.8e-158	0.85	0.91	1.00
PGSC0003DMT200071725	K02930	ko03010	Ribosome	2898	5.3e-154	0.84	0.91	1.00
PGSC0003DMT200071737	K00939	ko00230	Purine metabolism	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMT200071737	K00939	ko01100	Metabolic pathways	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMT200071737	K00939	ko01110	Biosynthesis of secondary metabolites	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMT200071757	K03142	ko03022	Basal transcription factors	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMT200071757	K03142	ko03420	Nucleotide excision repair	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMT200071761	K00423	ko00053	Ascorbate and aldarate metabolism	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMT200071761	K00423	ko01100	Metabolic pathways	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMT200020450	K02184	ko04320	Dorso-ventral axis formation	710	2.3e-32	0.34	0.39	0.82
PGSC0003DMT200020451	K02184	ko04320	Dorso-ventral axis formation	901	5.4e-43	0.29	0.42	0.77
PGSC0003DMT200020452	K04512	ko04310	Wnt signaling pathway	230	4.1e-06	0.29	0.52	0.98
PGSC0003DMT200020453	K05740	ko04510	Focal adhesion	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMT200020453	K05740	ko04810	Regulation of actin cytoskeleton	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMT200020453	K05740	ko05131	Shigellosis	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMT200020454	K01246	ko03410	Base excision repair	296	1.7e-10	0.62	0.76	0.98
PGSC0003DMT200020455	K01246	ko03410	Base excision repair	2155	5.0e-113	0.72	0.80	1.00
PGSC0003DMT200020456	K05391	ko04626	Plant-pathogen interaction	4312	5.4e-232	0.76	0.85	0.99
PGSC0003DMT200020457	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMT200020458	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMT200020459	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMT200020461	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMT200020461	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMT200020462	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMT200020462	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMT200020464	K03260	ko05416	Viral myocarditis	2329	1.3e-122	0.47	0.63	0.89
PGSC0003DMT200020465	K03260	ko05416	Viral myocarditis	1019	2.3e-50	0.44	0.58	0.93
PGSC0003DMT200020466	K12356	ko00940	Phenylpropanoid biosynthesis	243	2.6e-07	0.50	0.65	0.22
PGSC0003DMT200020467	K12356	ko00940	Phenylpropanoid biosynthesis	379	4.5e-15	0.41	0.63	0.92
PGSC0003DMT200010375	K03456	ko04111	Cell cycle - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04113	Meiosis - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04114	Oocyte meiosis	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04310	Wnt signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04350	TGF-beta signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04530	Tight junction	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko04730	Long-term depression	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010375	K03456	ko05142	Chagas disease	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMT200010402	K05863	ko04020	Calcium signaling pathway	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMT200010402	K05863	ko05012	Parkinson's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMT200010402	K05863	ko05016	Huntington's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMT200010404	K05863	ko04020	Calcium signaling pathway	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMT200010404	K05863	ko05012	Parkinson's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMT200010404	K05863	ko05016	Huntington's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMT200010406	K05748	ko04520	Adherens junction	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMT200010406	K05748	ko04666	Fc gamma R-mediated phagocytosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMT200010406	K05748	ko04810	Regulation of actin cytoskeleton	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMT200010406	K05748	ko05100	Bacterial invasion of epithelial cells	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMT200010406	K05748	ko05131	Shigellosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMT200010411	K01126	ko00564	Glycerophospholipid metabolism	2616	1.9e-138	0.76	0.87	0.99
PGSC0003DMT200008479	K10591	ko04120	Ubiquitin mediated proteolysis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMT200008479	K10591	ko04144	Endocytosis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMT200008481	K10591	ko04120	Ubiquitin mediated proteolysis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMT200008481	K10591	ko04144	Endocytosis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMT200008483	K10591	ko04120	Ubiquitin mediated proteolysis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMT200008483	K10591	ko04144	Endocytosis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMT200008504	K09754	ko00360	Phenylalanine metabolism	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008504	K09754	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008504	K09754	ko00941	Flavonoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008504	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008504	K09754	ko01100	Metabolic pathways	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008504	K09754	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMT200008507	K02969	ko03010	Ribosome	985	1.7e-48	0.97	0.98	0.98
PGSC0003DMT200008508	K12878	ko03040	Spliceosome	3260	5.7e-174	0.66	0.75	1.00
PGSC0003DMT200008509	K12878	ko03040	Spliceosome	4122	1.6e-221	0.79	0.89	1.00
PGSC0003DMT200028987	K02377	ko00051	Fructose and mannose metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMT200028987	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMT200028987	K02377	ko01100	Metabolic pathways	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMT200028988	K01951	ko00230	Purine metabolism	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMT200028988	K01951	ko00983	Drug metabolism - other enzymes	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMT200028988	K01951	ko01100	Metabolic pathways	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMT200029017	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMT200029017	K02367	ko01100	Metabolic pathways	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMT200029019	K03022	ko00230	Purine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMT200029019	K03022	ko00240	Pyrimidine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMT200029019	K03022	ko01100	Metabolic pathways	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMT200029019	K03022	ko03020	RNA polymerase	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMT200029019	K03022	ko04623	Cytosolic DNA-sensing pathway	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMT200029020	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029020	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029020	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029020	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029020	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029021	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029021	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029021	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029021	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029021	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMT200029025	K02267	ko00190	Oxidative phosphorylation	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029025	K02267	ko01100	Metabolic pathways	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029025	K02267	ko04260	Cardiac muscle contraction	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029025	K02267	ko05010	Alzheimer's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029025	K02267	ko05012	Parkinson's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029025	K02267	ko05016	Huntington's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMT200029026	K02267	ko00190	Oxidative phosphorylation	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200029026	K02267	ko01100	Metabolic pathways	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200029026	K02267	ko04260	Cardiac muscle contraction	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200029026	K02267	ko05010	Alzheimer's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200029026	K02267	ko05012	Parkinson's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200029026	K02267	ko05016	Huntington's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMT200089886	K10760	ko00908	Zeatin biosynthesis	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMT200089886	K10760	ko01100	Metabolic pathways	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMT200089886	K10760	ko01110	Biosynthesis of secondary metabolites	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMT200055323	K08339	ko04140	Regulation of autophagy	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMT200055323	K08339	ko04622	RIG-I-like receptor signaling pathway	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMT200055323	K08339	ko05131	Shigellosis	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMT200055327	K08339	ko04140	Regulation of autophagy	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMT200055327	K08339	ko04622	RIG-I-like receptor signaling pathway	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMT200055327	K08339	ko05131	Shigellosis	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMT200055329	K08339	ko04140	Regulation of autophagy	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMT200055329	K08339	ko04622	RIG-I-like receptor signaling pathway	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMT200055329	K08339	ko05131	Shigellosis	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMT200055331	K05933	ko00270	Cysteine and methionine metabolism	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMT200055331	K05933	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMT200055332	K05933	ko00270	Cysteine and methionine metabolism	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMT200055332	K05933	ko01110	Biosynthesis of secondary metabolites	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMT200055363	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMT200055363	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMT200055365	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMT200055365	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMT200065148	K05584	ko00190	Oxidative phosphorylation	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMT200065148	K05584	ko01100	Metabolic pathways	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMT200065150	K00799	ko00480	Glutathione metabolism	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMT200065150	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMT200065150	K00799	ko00982	Drug metabolism - cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMT200065151	K00368	ko00910	Nitrogen metabolism	514	1.6e-22	0.39	0.56	0.74
PGSC0003DMT200065156	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMT200065157	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMT200065158	K02957	ko03010	Ribosome	453	3.8e-19	0.95	0.96	0.89
PGSC0003DMT200065168	K01535	ko00190	Oxidative phosphorylation	7328	0.	0.88	0.93	1.00
PGSC0003DMT200065169	K01535	ko00190	Oxidative phosphorylation	2737	4.0e-145	0.92	0.97	0.92
PGSC0003DMT200065170	K01535	ko00190	Oxidative phosphorylation	7398	0.	0.91	0.97	1.00
PGSC0003DMT200065178	K09841	ko00906	Carotenoid biosynthesis	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMT200065178	K09841	ko01100	Metabolic pathways	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMT200065178	K09841	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMT200053219	K02932	ko03010	Ribosome	2184	1.3e-114	0.84	0.93	0.99
PGSC0003DMT200073468	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073468	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073468	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073468	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073468	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073468	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073469	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMT200073475	K01184	ko00040	Pentose and glucuronate interconversions	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMT200073475	K01184	ko00500	Starch and sucrose metabolism	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMT200073475	K01184	ko01100	Metabolic pathways	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMT200073476	K02160	ko00061	Fatty acid biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073476	K02160	ko00253	Tetracycline biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073476	K02160	ko00620	Pyruvate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073476	K02160	ko00640	Propanoate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073476	K02160	ko01100	Metabolic pathways	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073476	K02160	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMT200073482	K06130	ko00564	Glycerophospholipid metabolism	623	1.6e-28	0.37	0.56	0.88
PGSC0003DMT200073483	K02265	ko00190	Oxidative phosphorylation	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073483	K02265	ko01100	Metabolic pathways	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073483	K02265	ko04260	Cardiac muscle contraction	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073483	K02265	ko05010	Alzheimer's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073483	K02265	ko05012	Parkinson's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073483	K02265	ko05016	Huntington's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMT200073491	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073491	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073491	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073491	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073491	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073491	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMT200073501	K01044	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMT200073501	K01044	ko00983	Drug metabolism - other enzymes	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMT200073501	K01044	ko01100	Metabolic pathways	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMT200073501	K01044	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMT200088687	K04428	ko04010	MAPK signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMT200088687	K04428	ko04912	GnRH signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMT200088709	K12604	ko03018	RNA degradation	316	3.5e-10	0.26	0.47	0.99
PGSC0003DMT200008729	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMT200008729	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMT200008730	K04713	ko00600	Sphingolipid metabolism	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMT200008730	K04713	ko01100	Metabolic pathways	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMT200008733	K02608	ko04110	Cell cycle	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMT200008733	K02608	ko04111	Cell cycle - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMT200008733	K02608	ko04113	Meiosis - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMT200018493	K09754	ko00360	Phenylalanine metabolism	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018493	K09754	ko00940	Phenylpropanoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018493	K09754	ko00941	Flavonoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018493	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018493	K09754	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018493	K09754	ko01110	Biosynthesis of secondary metabolites	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMT200018494	K09754	ko00360	Phenylalanine metabolism	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018494	K09754	ko00940	Phenylpropanoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018494	K09754	ko00941	Flavonoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018494	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018494	K09754	ko01100	Metabolic pathways	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018494	K09754	ko01110	Biosynthesis of secondary metabolites	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMT200018497	K09754	ko00360	Phenylalanine metabolism	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018497	K09754	ko00940	Phenylpropanoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018497	K09754	ko00941	Flavonoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018497	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018497	K09754	ko01100	Metabolic pathways	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018497	K09754	ko01110	Biosynthesis of secondary metabolites	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMT200018498	K09754	ko00360	Phenylalanine metabolism	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018498	K09754	ko00940	Phenylpropanoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018498	K09754	ko00941	Flavonoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018498	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018498	K09754	ko01100	Metabolic pathways	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018498	K09754	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMT200018503	K00558	ko00270	Cysteine and methionine metabolism	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMT200018503	K00558	ko01100	Metabolic pathways	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMT200018505	K00558	ko00270	Cysteine and methionine metabolism	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMT200018505	K00558	ko01100	Metabolic pathways	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMT200018511	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMT200018512	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMT200018513	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMT200018519	K04035	ko00860	Porphyrin and chlorophyll metabolism	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMT200018519	K04035	ko01100	Metabolic pathways	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMT200018519	K04035	ko01110	Biosynthesis of secondary metabolites	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMT200018520	K02727	ko03050	Proteasome	626	1.1e-28	0.97	0.99	0.67
PGSC0003DMT200018521	K02727	ko03050	Proteasome	2017	2.1e-105	0.94	0.99	1.00
PGSC0003DMT200018522	K02727	ko03050	Proteasome	529	2.4e-23	0.92	1.00	0.99
PGSC0003DMT200027147	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMT200027153	K10604	ko04120	Ubiquitin mediated proteolysis	615	4.4e-28	0.37	0.53	0.91
PGSC0003DMT200027155	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMT200027156	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMT200027160	K00430	ko00360	Phenylalanine metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMT200027160	K00430	ko00680	Methane metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMT200027160	K00430	ko00940	Phenylpropanoid biosynthesis	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMT200027160	K00430	ko01100	Metabolic pathways	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMT200027160	K00430	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMT200027161	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMT200027161	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMT200027161	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMT200027161	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMT200027161	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMT200027162	K08506	ko04130	SNARE interactions in vesicular transport	1750	1.1e-90	0.78	0.90	0.99
PGSC0003DMT200027167	K01199	ko00500	Starch and sucrose metabolism	1216	3.1e-61	0.49	0.69	0.88
PGSC0003DMT200027168	K01199	ko00500	Starch and sucrose metabolism	1087	4.1e-54	0.49	0.69	0.98
PGSC0003DMT200027170	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027170	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027170	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027170	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027170	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200043447	K00660	ko00941	Flavonoid biosynthesis	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMT200043447	K00660	ko01100	Metabolic pathways	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMT200043447	K00660	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMT200043447	K00660	ko04712	Circadian rhythm - plant	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMT200043449	K00660	ko00941	Flavonoid biosynthesis	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMT200043449	K00660	ko01100	Metabolic pathways	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMT200043449	K00660	ko01110	Biosynthesis of secondary metabolites	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMT200043449	K00660	ko04712	Circadian rhythm - plant	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMT200043452	K08515	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.87	0.96	0.29
PGSC0003DMT200043464	K00660	ko00941	Flavonoid biosynthesis	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMT200043464	K00660	ko01100	Metabolic pathways	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMT200043464	K00660	ko01110	Biosynthesis of secondary metabolites	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMT200043464	K00660	ko04712	Circadian rhythm - plant	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMT200043467	K00469	ko00053	Ascorbate and aldarate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMT200043467	K00469	ko00562	Inositol phosphate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMT200043470	K01404	ko05140	Leishmaniasis	5188	2.6e-280	0.72	0.82	0.95
PGSC0003DMT200067368	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMT200067369	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMT200067373	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMT200067374	K12866	ko03040	Spliceosome	247	3.0e-07	0.40	0.48	0.85
PGSC0003DMT200067377	K12866	ko03040	Spliceosome	240	7.6e-07	0.38	0.46	0.72
PGSC0003DMT200067383	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	282	1.8e-07	0.29	0.43	0.94
PGSC0003DMT200067386	K05740	ko04510	Focal adhesion	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMT200067386	K05740	ko04810	Regulation of actin cytoskeleton	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMT200067386	K05740	ko05131	Shigellosis	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMT200067403	K01177	ko00500	Starch and sucrose metabolism	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMT200067403	K01177	ko01100	Metabolic pathways	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMT200067404	K01177	ko00500	Starch and sucrose metabolism	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMT200067404	K01177	ko01100	Metabolic pathways	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMT200067405	K01177	ko00500	Starch and sucrose metabolism	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMT200067405	K01177	ko01100	Metabolic pathways	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMT200067406	K01177	ko00500	Starch and sucrose metabolism	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMT200067406	K01177	ko01100	Metabolic pathways	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMT200059249	K01509	ko00230	Purine metabolism	1521	4.7e-78	0.42	0.57	0.58
PGSC0003DMT200059250	K02957	ko03010	Ribosome	712	2.0e-33	0.87	0.90	0.64
PGSC0003DMT200059259	K02957	ko03010	Ribosome	366	2.4e-14	0.85	0.91	0.42
PGSC0003DMT200059262	K00368	ko00910	Nitrogen metabolism	437	2.9e-18	0.35	0.55	0.76
PGSC0003DMT200059264	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMT200059264	K12447	ko01100	Metabolic pathways	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMT200059265	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMT200059265	K12447	ko01100	Metabolic pathways	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMT200059270	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059270	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059271	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMT200059272	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04744	Phototransduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04916	Melanogenesis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04970	Salivary secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059272	K02183	ko05214	Glioma	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMT200059281	K01933	ko00230	Purine metabolism	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMT200059281	K01933	ko01100	Metabolic pathways	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMT200059281	K01933	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMT200093108	K01593	ko00340	Histidine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00350	Tyrosine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00360	Phenylalanine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00380	Tryptophan metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00901	Indole alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00950	Isoquinoline alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko00965	Betalain biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko01100	Metabolic pathways	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093108	K01593	ko01110	Biosynthesis of secondary metabolites	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMT200093121	K12493	ko04144	Endocytosis	924	4.0e-45	0.54	0.72	0.72
PGSC0003DMT200090964	K09481	ko03060	Protein export	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMT200090964	K09481	ko04145	Phagosome	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMT200090964	K09481	ko05110	Vibrio cholerae infection	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMT200000244	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1648	4.6e-85	0.66	0.78	0.95
PGSC0003DMT200000245	K03260	ko05416	Viral myocarditis	293	7.6e-07	0.26	0.38	0.80
PGSC0003DMT200000271	K06689	ko04120	Ubiquitin mediated proteolysis	1103	5.3e-55	0.95	0.96	0.86
PGSC0003DMT200000272	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMT200000273	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMT200030110	K07374	ko04145	Phagosome	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMT200030110	K07374	ko04540	Gap junction	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMT200030110	K07374	ko05130	Pathogenic Escherichia coli infection	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMT200030117	K00826	ko00280	Valine, leucine and isoleucine degradation	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMT200030117	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMT200030117	K00826	ko00770	Pantothenate and CoA biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMT200030117	K00826	ko01100	Metabolic pathways	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMT200030117	K00826	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMT200030118	K00826	ko00280	Valine, leucine and isoleucine degradation	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMT200030118	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMT200030118	K00826	ko00770	Pantothenate and CoA biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMT200030118	K00826	ko01100	Metabolic pathways	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMT200030118	K00826	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMT200030121	K00826	ko00280	Valine, leucine and isoleucine degradation	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMT200030121	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMT200030121	K00826	ko00770	Pantothenate and CoA biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMT200030121	K00826	ko01100	Metabolic pathways	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMT200030121	K00826	ko01110	Biosynthesis of secondary metabolites	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMT200030126	K09756	ko00940	Phenylpropanoid biosynthesis	1104	4.7e-55	0.58	0.73	0.50
PGSC0003DMT200030127	K09756	ko00940	Phenylpropanoid biosynthesis	1475	3.1e-80	0.45	0.61	0.94
PGSC0003DMT200030132	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMT200030133	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMT200030134	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMT200030140	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMT200030143	K09757	ko00940	Phenylpropanoid biosynthesis	851	4.2e-41	0.48	0.64	1.00
PGSC0003DMT200030144	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMT200030147	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMT200024360	K02151	ko00190	Oxidative phosphorylation	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024360	K02151	ko01100	Metabolic pathways	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024360	K02151	ko04145	Phagosome	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024360	K02151	ko04966	Collecting duct acid secretion	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024360	K02151	ko05110	Vibrio cholerae infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024360	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMT200024361	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024361	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024361	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024361	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024361	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024361	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024362	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024363	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMT200024367	K11160	ko00561	Glycerolipid metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMT200024367	K11160	ko00830	Retinol metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMT200024367	K11160	ko01100	Metabolic pathways	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMT200024368	K11160	ko00561	Glycerolipid metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMT200024368	K11160	ko00830	Retinol metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMT200024368	K11160	ko01100	Metabolic pathways	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMT200024369	K11160	ko00561	Glycerolipid metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMT200024369	K11160	ko00830	Retinol metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMT200024369	K11160	ko01100	Metabolic pathways	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMT200024390	K01719	ko00860	Porphyrin and chlorophyll metabolism	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMT200024390	K01719	ko01100	Metabolic pathways	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMT200024390	K01719	ko01110	Biosynthesis of secondary metabolites	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMT200016038	K04103	ko00380	Tryptophan metabolism	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMT200016038	K04103	ko01100	Metabolic pathways	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMT200040567	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMT200012896	K12667	ko00510	N-Glycan biosynthesis	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMT200012896	K12667	ko01100	Metabolic pathways	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMT200012898	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.78
PGSC0003DMT200012900	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.82
PGSC0003DMT200012902	K10717	ko00908	Zeatin biosynthesis	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMT200012902	K10717	ko01100	Metabolic pathways	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMT200012902	K10717	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMT200012909	K04121	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMT200012909	K04121	ko01100	Metabolic pathways	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMT200012909	K04121	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMT200012910	K01054	ko00561	Glycerolipid metabolism	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMT200012910	K01054	ko01100	Metabolic pathways	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMT200030799	K09828	ko00100	Steroid biosynthesis	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMT200030799	K09828	ko01100	Metabolic pathways	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMT200030799	K09828	ko01110	Biosynthesis of secondary metabolites	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMT200030812	K08064	ko04612	Antigen processing and presentation	305	5.5e-11	0.49	0.64	0.50
PGSC0003DMT200030813	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.53	0.69	0.59
PGSC0003DMT200030816	K12486	ko04144	Endocytosis	527	3.1e-23	0.37	0.55	0.64
PGSC0003DMT200039934	K04420	ko04010	MAPK signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMT200039934	K04420	ko04540	Gap junction	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMT200039934	K04420	ko04912	GnRH signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMT200039935	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.78
PGSC0003DMT200039936	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.77
PGSC0003DMT200039937	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.84
PGSC0003DMT200039941	K10260	ko04120	Ubiquitin mediated proteolysis	394	6.8e-16	0.31	0.45	0.78
PGSC0003DMT200039963	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMT200039964	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMT200006743	K01179	ko00500	Starch and sucrose metabolism	320	8.2e-12	0.67	0.78	0.58
PGSC0003DMT200006762	K00058	ko00260	Glycine, serine and threonine metabolism	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMT200006762	K00058	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMT200006763	K00100	ko00051	Fructose and mannose metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006763	K00100	ko00363	Bisphenol A degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006763	K00100	ko00591	Linoleic acid metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006763	K00100	ko00625	Tetrachloroethene degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006763	K00100	ko00650	Butanoate metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006763	K00100	ko01100	Metabolic pathways	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMT200006765	K00058	ko00260	Glycine, serine and threonine metabolism	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMT200006765	K00058	ko01100	Metabolic pathways	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMT200006766	K00058	ko00260	Glycine, serine and threonine metabolism	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMT200006766	K00058	ko01100	Metabolic pathways	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMT200006768	K02695	ko00195	Photosynthesis	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMT200006768	K02695	ko01100	Metabolic pathways	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMT200033880	K01066	ko00623	2,4-Dichlorobenzoate degradation	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMT200033880	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMT200033881	K00472	ko00330	Arginine and proline metabolism	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMT200033881	K00472	ko01100	Metabolic pathways	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMT200033882	K00472	ko00330	Arginine and proline metabolism	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMT200033882	K00472	ko01100	Metabolic pathways	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMT200033897	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033897	K01652	ko00650	Butanoate metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033897	K01652	ko00660	C5-Branched dibasic acid metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033897	K01652	ko00770	Pantothenate and CoA biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033897	K01652	ko01100	Metabolic pathways	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033897	K01652	ko01110	Biosynthesis of secondary metabolites	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMT200033902	K00166	ko00280	Valine, leucine and isoleucine degradation	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMT200033902	K00166	ko01100	Metabolic pathways	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMT200033902	K00166	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMT200033904	K00166	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMT200033904	K00166	ko01100	Metabolic pathways	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMT200033904	K00166	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMT200033905	K00166	ko00280	Valine, leucine and isoleucine degradation	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMT200033905	K00166	ko01100	Metabolic pathways	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMT200033905	K00166	ko01110	Biosynthesis of secondary metabolites	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMT200033908	K00166	ko00280	Valine, leucine and isoleucine degradation	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMT200033908	K00166	ko01100	Metabolic pathways	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMT200033908	K00166	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMT200033910	K00166	ko00280	Valine, leucine and isoleucine degradation	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMT200033910	K00166	ko01100	Metabolic pathways	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMT200033910	K00166	ko01110	Biosynthesis of secondary metabolites	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMT200033917	K12929	ko00904	Diterpenoid biosynthesis	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMT200033917	K12929	ko01110	Biosynthesis of secondary metabolites	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMT200033919	K12929	ko00904	Diterpenoid biosynthesis	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMT200033919	K12929	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMT200033926	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMT200033927	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMT200012121	K02084	ko04115	p53 signaling pathway	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko04210	Apoptosis	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko05010	Alzheimer's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko05012	Parkinson's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko05016	Huntington's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012121	K02084	ko05222	Small cell lung cancer	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMT200012128	K01051	ko00040	Pentose and glucuronate interconversions	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMT200012128	K01051	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMT200012128	K01051	ko01100	Metabolic pathways	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMT200012129	K01051	ko00040	Pentose and glucuronate interconversions	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMT200012129	K01051	ko00500	Starch and sucrose metabolism	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMT200012129	K01051	ko01100	Metabolic pathways	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMT200002905	K12393	ko04142	Lysosome	1644	7.7e-85	0.94	0.98	0.79
PGSC0003DMT200002906	K12393	ko04142	Lysosome	1749	1.2e-90	0.92	0.97	0.99
PGSC0003DMT200002907	K12393	ko04142	Lysosome	3398	1.4e-181	0.93	0.97	1.00
PGSC0003DMT200002922	K05280	ko00941	Flavonoid biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMT200002922	K05280	ko00944	Flavone and flavonol biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMT200002922	K05280	ko01100	Metabolic pathways	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMT200002922	K05280	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMT200002923	K05280	ko00941	Flavonoid biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMT200002923	K05280	ko00944	Flavone and flavonol biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMT200002923	K05280	ko01100	Metabolic pathways	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMT200002923	K05280	ko01110	Biosynthesis of secondary metabolites	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMT200002927	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002927	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002927	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002928	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002928	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002928	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002929	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002929	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002929	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMT200002933	K04077	ko03018	RNA degradation	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMT200002933	K04077	ko04940	Type I diabetes mellitus	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMT200002934	K01723	ko00592	alpha-Linolenic acid metabolism	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMT200002934	K01723	ko01100	Metabolic pathways	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMT200002939	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMT200002940	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMT200002943	K09590	ko00905	Brassinosteroid biosynthesis	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMT200002943	K09590	ko01100	Metabolic pathways	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMT200002943	K09590	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMT200086599	K02639	ko00195	Photosynthesis	650	5.1e-30	0.78	0.87	0.99
PGSC0003DMT200086603	K08243	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMT200086603	K08243	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMT200086606	K12132	ko04712	Circadian rhythm - plant	1043	1.1e-51	0.49	0.67	0.89
PGSC0003DMT200049607	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.33	0.53	0.80
PGSC0003DMT200049608	K02938	ko03010	Ribosome	2216	2.2e-116	0.97	0.99	1.00
PGSC0003DMT200049649	K12486	ko04144	Endocytosis	2659	8.0e-141	0.67	0.79	1.00
PGSC0003DMT200076598	K02377	ko00051	Fructose and mannose metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMT200076598	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMT200076598	K02377	ko01100	Metabolic pathways	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMT200076601	K04079	ko04612	Antigen processing and presentation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076601	K04079	ko04621	NOD-like receptor signaling pathway	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076601	K04079	ko04626	Plant-pathogen interaction	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076601	K04079	ko04914	Progesterone-mediated oocyte maturation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076601	K04079	ko05200	Pathways in cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076601	K04079	ko05215	Prostate cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMT200076602	K00795	ko00900	Terpenoid backbone biosynthesis	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMT200076602	K00795	ko01100	Metabolic pathways	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMT200076602	K00795	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMT200076609	K03027	ko00230	Purine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMT200076609	K03027	ko00240	Pyrimidine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMT200076609	K03027	ko01100	Metabolic pathways	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMT200076609	K03027	ko03020	RNA polymerase	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMT200076609	K03027	ko04623	Cytosolic DNA-sensing pathway	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMT200009425	K00472	ko00330	Arginine and proline metabolism	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMT200009425	K00472	ko01100	Metabolic pathways	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMT200009449	K01081	ko00230	Purine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMT200009449	K01081	ko00240	Pyrimidine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMT200009449	K01081	ko00760	Nicotinate and nicotinamide metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMT200009449	K01081	ko01100	Metabolic pathways	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMT200009449	K01081	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMT200009452	K01247	ko03410	Base excision repair	1046	7.4e-52	0.60	0.72	0.95
PGSC0003DMT200009453	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMT200009454	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMT200038385	K03094	ko04110	Cell cycle	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04111	Cell cycle - yeast	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04114	Oocyte meiosis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04120	Ubiquitin mediated proteolysis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04310	Wnt signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04350	TGF-beta signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038385	K03094	ko04710	Circadian rhythm - mammal	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMT200038400	K06674	ko04111	Cell cycle - yeast	7527	0.	0.77	0.86	1.00
PGSC0003DMT200038401	K06674	ko04111	Cell cycle - yeast	7634	0.	0.80	0.90	1.00
PGSC0003DMT200038402	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMT200038402	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMT200038402	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMT200038402	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMT200038402	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMT200026473	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMT200026473	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMT200026477	K01066	ko00623	2,4-Dichlorobenzoate degradation	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMT200026477	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMT200026480	K01046	ko00561	Glycerolipid metabolism	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMT200026480	K01046	ko01100	Metabolic pathways	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMT200026485	K01046	ko00561	Glycerolipid metabolism	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMT200026485	K01046	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMT200026489	K01046	ko00561	Glycerolipid metabolism	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMT200026489	K01046	ko01100	Metabolic pathways	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMT200026490	K01046	ko00561	Glycerolipid metabolism	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMT200026490	K01046	ko01100	Metabolic pathways	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMT200026499	K01046	ko00561	Glycerolipid metabolism	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMT200026499	K01046	ko01100	Metabolic pathways	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMT200044120	K05280	ko00941	Flavonoid biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMT200044120	K05280	ko00944	Flavone and flavonol biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMT200044120	K05280	ko01100	Metabolic pathways	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMT200044120	K05280	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMT200044121	K05280	ko00941	Flavonoid biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMT200044121	K05280	ko00944	Flavone and flavonol biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMT200044121	K05280	ko01100	Metabolic pathways	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMT200044121	K05280	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMT200044122	K05280	ko00941	Flavonoid biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMT200044122	K05280	ko00944	Flavone and flavonol biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMT200044122	K05280	ko01100	Metabolic pathways	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMT200044122	K05280	ko01110	Biosynthesis of secondary metabolites	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMT200044123	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMT200044123	K00517	ko00626	Naphthalene and anthracene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMT200044123	K00517	ko00903	Limonene and pinene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMT200044123	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMT200044123	K00517	ko01110	Biosynthesis of secondary metabolites	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMT200044137	K10589	ko04120	Ubiquitin mediated proteolysis	4751	3.3e-256	0.79	0.88	0.97
PGSC0003DMT200044138	K10589	ko04120	Ubiquitin mediated proteolysis	5308	6.3e-287	0.76	0.86	0.96
PGSC0003DMT200044143	K12153	ko00966	Glucosinolate biosynthesis	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMT200044143	K12153	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMT200044144	K11812	ko00380	Tryptophan metabolism	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMT200044144	K11812	ko00966	Glucosinolate biosynthesis	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMT200044150	K02084	ko04115	p53 signaling pathway	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko04210	Apoptosis	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko05010	Alzheimer's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko05012	Parkinson's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko05016	Huntington's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044150	K02084	ko05222	Small cell lung cancer	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMT200044152	K02084	ko04115	p53 signaling pathway	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko04210	Apoptosis	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko05010	Alzheimer's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko05012	Parkinson's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko05016	Huntington's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044152	K02084	ko05222	Small cell lung cancer	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMT200044153	K04124	ko00904	Diterpenoid biosynthesis	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMT200044153	K04124	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMT200088552	K10760	ko00908	Zeatin biosynthesis	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMT200088552	K10760	ko01100	Metabolic pathways	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMT200088552	K10760	ko01110	Biosynthesis of secondary metabolites	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMT200088558	K11818	ko00380	Tryptophan metabolism	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMT200088558	K11818	ko00966	Glucosinolate biosynthesis	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMT200088558	K11818	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMT200088564	K01528	ko04144	Endocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMT200088564	K01528	ko04666	Fc gamma R-mediated phagocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMT200088564	K01528	ko05100	Bacterial invasion of epithelial cells	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMT200080983	K00599	ko00340	Histidine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMT200080983	K00599	ko00350	Tyrosine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMT200080983	K00599	ko00450	Selenoamino acid metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMT200080983	K00599	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMT200080984	K00599	ko00340	Histidine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMT200080984	K00599	ko00350	Tyrosine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMT200080984	K00599	ko00450	Selenoamino acid metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMT200080984	K00599	ko00626	Naphthalene and anthracene degradation	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMT200080985	K00599	ko00340	Histidine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMT200080985	K00599	ko00350	Tyrosine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMT200080985	K00599	ko00450	Selenoamino acid metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMT200080985	K00599	ko00626	Naphthalene and anthracene degradation	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMT200056074	K13030	ko00460	Cyanoamino acid metabolism	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMT200056074	K13030	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMT200056076	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMT200056076	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMT200056084	K13030	ko00460	Cyanoamino acid metabolism	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMT200056084	K13030	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMT200056090	K13030	ko00460	Cyanoamino acid metabolism	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMT200056090	K13030	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMT200056096	K08139	ko04113	Meiosis - yeast	324	7.2e-12	0.41	0.60	0.62
PGSC0003DMT200056100	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.44	0.58	0.88
PGSC0003DMT200056101	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.45	0.59	0.77
PGSC0003DMT200056119	K00430	ko00360	Phenylalanine metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMT200056119	K00430	ko00680	Methane metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMT200056119	K00430	ko00940	Phenylpropanoid biosynthesis	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMT200056119	K00430	ko01100	Metabolic pathways	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMT200056119	K00430	ko01110	Biosynthesis of secondary metabolites	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMT200070798	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3901	2.5e-209	0.82	0.90	1.00
PGSC0003DMT200070802	K08387	ko04080	Neuroactive ligand-receptor interaction	842	1.3e-40	0.48	0.69	0.78
PGSC0003DMT200070803	K08387	ko04080	Neuroactive ligand-receptor interaction	568	1.7e-25	0.43	0.66	0.83
PGSC0003DMT200070804	K08387	ko04080	Neuroactive ligand-receptor interaction	1101	6.8e-55	0.44	0.66	0.89
PGSC0003DMT200070809	K12875	ko03040	Spliceosome	633	4.4e-29	0.26	0.44	0.94
PGSC0003DMT200070810	K12875	ko03040	Spliceosome	670	4.0e-31	0.27	0.45	0.93
PGSC0003DMT200070811	K12875	ko03040	Spliceosome	650	5.1e-30	0.27	0.44	0.94
PGSC0003DMT200070812	K12875	ko03040	Spliceosome	679	1.3e-31	0.29	0.44	0.77
PGSC0003DMT200070813	K12875	ko03040	Spliceosome	395	6.0e-16	0.35	0.49	0.99
PGSC0003DMT200070814	K02908	ko03010	Ribosome	867	5.5e-42	0.91	0.97	0.99
PGSC0003DMT200072824	K12356	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.32	0.48	0.93
PGSC0003DMT200072829	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMT200072829	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMT200072830	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMT200072830	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMT200072833	K02180	ko04110	Cell cycle	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMT200072833	K02180	ko04111	Cell cycle - yeast	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMT200072845	K02084	ko04115	p53 signaling pathway	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko04210	Apoptosis	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko05010	Alzheimer's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko05012	Parkinson's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko05016	Huntington's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072845	K02084	ko05222	Small cell lung cancer	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMT200072847	K10744	ko03030	DNA replication	1148	1.8e-57	0.58	0.74	0.42
PGSC0003DMT200072850	K10744	ko03030	DNA replication	1270	3.3e-64	0.57	0.72	0.83
PGSC0003DMT200072851	K10744	ko03030	DNA replication	1272	2.5e-64	0.58	0.73	0.83
PGSC0003DMT200072853	K11821	ko00380	Tryptophan metabolism	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMT200072853	K11821	ko00966	Glucosinolate biosynthesis	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMT200072853	K11821	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMT200072854	K11821	ko00380	Tryptophan metabolism	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMT200072854	K11821	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMT200072854	K11821	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMT200072856	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMT200072857	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMT200047153	K01648	ko00020	Citrate cycle (TCA cycle)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMT200047153	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMT200047153	K01648	ko01100	Metabolic pathways	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMT200047153	K01648	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMT200047154	K01648	ko00020	Citrate cycle (TCA cycle)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMT200047154	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMT200047154	K01648	ko01100	Metabolic pathways	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMT200047154	K01648	ko01110	Biosynthesis of secondary metabolites	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMT200047166	K10581	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.45	0.61	0.85
PGSC0003DMT200047175	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMT200047175	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMT200047176	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMT200047176	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMT200047178	K12855	ko03040	Spliceosome	7156	0.	0.83	0.91	1.00
PGSC0003DMT200089747	K01369	ko04142	Lysosome	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMT200089747	K01369	ko04612	Antigen processing and presentation	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMT200089754	K10577	ko04120	Ubiquitin mediated proteolysis	325	4.3e-12	0.50	0.53	0.94
PGSC0003DMT200096575	K05282	ko00904	Diterpenoid biosynthesis	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMT200096575	K05282	ko01100	Metabolic pathways	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMT200096575	K05282	ko01110	Biosynthesis of secondary metabolites	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMT200011125	K02008	ko02010	ABC transporters	458	2.0e-19	0.41	0.62	0.82
PGSC0003DMT200011126	K02008	ko02010	ABC transporters	681	1.0e-31	0.38	0.60	0.65
PGSC0003DMT200011133	K01915	ko00250	Alanine, aspartate and glutamate metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMT200011133	K01915	ko00330	Arginine and proline metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMT200011133	K01915	ko00910	Nitrogen metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMT200011133	K01915	ko01100	Metabolic pathways	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMT200011133	K01915	ko02020	Two-component system	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMT200011139	K01066	ko00623	2,4-Dichlorobenzoate degradation	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMT200011139	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMT200011140	K01066	ko00623	2,4-Dichlorobenzoate degradation	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMT200011140	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMT200011141	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMT200011141	K01061	ko00364	Fluorobenzoate degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMT200011141	K01061	ko00627	1,4-Dichlorobenzene degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMT200011141	K01061	ko01100	Metabolic pathways	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMT200011142	K01066	ko00623	2,4-Dichlorobenzoate degradation	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMT200011142	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMT200011148	K00940	ko00230	Purine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMT200011148	K00940	ko00240	Pyrimidine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMT200011148	K00940	ko01100	Metabolic pathways	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMT200011148	K00940	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMT200011150	K12620	ko03018	RNA degradation	247	8.7e-08	0.83	0.92	0.09
PGSC0003DMT200036686	K05674	ko02010	ABC transporters	2119	4.9e-111	0.41	0.56	0.99
PGSC0003DMT200036687	K05674	ko02010	ABC transporters	1962	2.2e-102	0.41	0.55	0.99
PGSC0003DMT200036688	K05674	ko02010	ABC transporters	3478	5.4e-186	0.36	0.53	1.00
PGSC0003DMT200036689	K05674	ko02010	ABC transporters	2702	3.4e-143	0.41	0.56	0.99
PGSC0003DMT200036690	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMT200036691	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMT200036695	K13065	ko00940	Phenylpropanoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMT200036695	K13065	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMT200036695	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMT200036695	K13065	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMT200036697	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMT200036697	K05287	ko01100	Metabolic pathways	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMT200036698	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMT200036698	K05287	ko01100	Metabolic pathways	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMT200036701	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036701	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036701	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036701	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036701	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036701	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMT200036702	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036702	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036702	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036702	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036702	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036702	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMT200036703	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036703	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036703	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036703	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036703	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036703	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMT200036704	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200036704	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200036704	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200036704	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200036704	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200036704	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMT200026140	K01354	ko05142	Chagas disease	710	2.5e-33	0.42	0.60	0.96
PGSC0003DMT200026141	K01354	ko05142	Chagas disease	1278	1.2e-64	0.32	0.50	0.94
PGSC0003DMT200026150	K04631	ko04744	Phototransduction	668	5.9e-31	0.35	0.52	0.39
PGSC0003DMT200026153	K00908	ko01100	Metabolic pathways	420	3.5e-17	0.27	0.45	0.77
PGSC0003DMT200028287	K00626	ko00071	Fatty acid metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00072	Synthesis and degradation of ketone bodies	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00280	Valine, leucine and isoleucine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00310	Lysine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00380	Tryptophan metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00620	Pyruvate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00632	Benzoate degradation via CoA ligation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00640	Propanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00650	Butanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko00900	Terpenoid backbone biosynthesis	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko01100	Metabolic pathways	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028287	K00626	ko02020	Two-component system	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMT200028288	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028288	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028289	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMT200028308	K00873	ko00010	Glycolysis / Gluconeogenesis	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko00230	Purine metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko00620	Pyruvate metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko00710	Carbon fixation in photosynthetic organisms	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko01100	Metabolic pathways	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko01110	Biosynthesis of secondary metabolites	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028308	K00873	ko04930	Type II diabetes mellitus	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMT200028337	K12488	ko04144	Endocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMT200028337	K12488	ko04666	Fc gamma R-mediated phagocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMT200083786	K03841	ko00010	Glycolysis / Gluconeogenesis	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko00030	Pentose phosphate pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko00051	Fructose and mannose metabolism	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko00710	Carbon fixation in photosynthetic organisms	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko01100	Metabolic pathways	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083786	K03841	ko04910	Insulin signaling pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMT200083790	K03110	ko03060	Protein export	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMT200083790	K03110	ko03070	Bacterial secretion system	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMT200083791	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMT200083791	K12567	ko05414	Dilated cardiomyopathy	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMT200083792	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMT200083792	K12567	ko05414	Dilated cardiomyopathy	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMT200083793	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMT200083793	K12567	ko05414	Dilated cardiomyopathy	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMT200083823	K13027	ko00460	Cyanoamino acid metabolism	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMT200083823	K13027	ko00966	Glucosinolate biosynthesis	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMT200083823	K13027	ko01100	Metabolic pathways	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMT200083823	K13027	ko01110	Biosynthesis of secondary metabolites	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMT200054334	K10676	ko00627	1,4-Dichlorobenzene degradation	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMT200054334	K10676	ko01100	Metabolic pathways	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMT200054335	K10676	ko00627	1,4-Dichlorobenzene degradation	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMT200054335	K10676	ko01100	Metabolic pathways	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMT200054348	K04125	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.58	0.74	0.89
PGSC0003DMT200054351	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMT200054351	K07819	ko01100	Metabolic pathways	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMT200054356	K02084	ko04115	p53 signaling pathway	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko04210	Apoptosis	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko05010	Alzheimer's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko05012	Parkinson's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko05016	Huntington's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054356	K02084	ko05222	Small cell lung cancer	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMT200054361	K02912	ko03010	Ribosome	545	3.2e-24	0.83	0.93	0.96
PGSC0003DMT200045297	K00128	ko00010	Glycolysis / Gluconeogenesis	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00053	Ascorbate and aldarate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00071	Fatty acid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00280	Valine, leucine and isoleucine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00310	Lysine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00330	Arginine and proline metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00340	Histidine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00380	Tryptophan metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00410	beta-Alanine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00561	Glycerolipid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00620	Pyruvate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00631	1,2-Dichloroethane degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00640	Propanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00641	3-Chloroacrylic acid degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00650	Butanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko00903	Limonene and pinene degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko01100	Metabolic pathways	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045297	K00128	ko01110	Biosynthesis of secondary metabolites	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMT200045300	K03862	ko00623	2,4-Dichlorobenzoate degradation	243	1.4e-07	0.44	0.61	0.24
PGSC0003DMT200045302	K03862	ko00623	2,4-Dichlorobenzoate degradation	450	5.5e-19	0.32	0.46	0.53
PGSC0003DMT200045309	K02877	ko03010	Ribosome	1697	9.2e-88	0.94	0.97	1.00
PGSC0003DMT200045310	K01881	ko00970	Aminoacyl-tRNA biosynthesis	363	8.2e-14	0.35	0.57	0.51
PGSC0003DMT200045321	K11294	ko05130	Pathogenic Escherichia coli infection	471	3.8e-20	0.37	0.56	0.71
PGSC0003DMT200045328	K10604	ko04120	Ubiquitin mediated proteolysis	586	1.7e-26	0.36	0.56	0.72
PGSC0003DMT200071076	K04734	ko04062	Chemokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04210	Apoptosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04620	Toll-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04621	NOD-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04622	RIG-I-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04623	Cytosolic DNA-sensing pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04660	T cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04662	B cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko04920	Adipocytokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05120	Epithelial cell signaling in Helicobacter pylori infection	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05131	Shigellosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05140	Leishmaniasis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05142	Chagas disease	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05200	Pathways in cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05215	Prostate cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05220	Chronic myeloid leukemia	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071076	K04734	ko05222	Small cell lung cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMT200071086	K08803	ko05200	Pathways in cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMT200071086	K08803	ko05219	Bladder cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMT200071093	K04125	ko00904	Diterpenoid biosynthesis	435	3.7e-18	0.67	0.81	0.94
PGSC0003DMT200071094	K04125	ko00904	Diterpenoid biosynthesis	1469	3.5e-75	0.52	0.67	0.99
PGSC0003DMT200071099	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200071099	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200071100	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200071100	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200071101	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200071101	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMT200088248	K10591	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMT200088248	K10591	ko04144	Endocytosis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMT200001215	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMT200001218	K02219	ko04111	Cell cycle - yeast	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMT200001218	K02219	ko05200	Pathways in cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMT200001218	K02219	ko05222	Small cell lung cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMT200001219	K10603	ko04120	Ubiquitin mediated proteolysis	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMT200001219	K10603	ko05340	Primary immunodeficiency	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMT200001234	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.36	0.54	0.87
PGSC0003DMT200001235	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.37	0.52	0.86
PGSC0003DMT200001236	K00679	ko00561	Glycerolipid metabolism	966	1.9e-47	0.41	0.59	0.65
PGSC0003DMT200001248	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMT200001248	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMT200001249	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMT200001249	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMT200041716	K06670	ko04110	Cell cycle	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMT200041716	K06670	ko04111	Cell cycle - yeast	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMT200041719	K03921	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMT200041719	K03921	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMT200041729	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	2331	9.9e-123	0.79	0.86	0.99
PGSC0003DMT200041752	K12356	ko00940	Phenylpropanoid biosynthesis	625	1.6e-30	0.31	0.48	0.94
PGSC0003DMT200041755	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.32	0.48	0.93
PGSC0003DMT200032209	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMT200032210	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMT200032211	K06672	ko04111	Cell cycle - yeast	2528	1.3e-133	0.66	0.78	1.00
PGSC0003DMT200032212	K06672	ko04111	Cell cycle - yeast	9601	0.	0.61	0.73	1.00
PGSC0003DMT200032221	K07195	ko04910	Insulin signaling pathway	2269	2.6e-119	0.47	0.66	0.98
PGSC0003DMT200032226	K07424	ko00140	Steroid hormone biosynthesis	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00591	Linoleic acid metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00830	Retinol metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00982	Drug metabolism - cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko00983	Drug metabolism - other enzymes	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032226	K07424	ko01100	Metabolic pathways	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMT200032229	K07424	ko00140	Steroid hormone biosynthesis	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00591	Linoleic acid metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00830	Retinol metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00982	Drug metabolism - cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko00983	Drug metabolism - other enzymes	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032229	K07424	ko01100	Metabolic pathways	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMT200032232	K07424	ko00140	Steroid hormone biosynthesis	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00591	Linoleic acid metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00830	Retinol metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00982	Drug metabolism - cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko00983	Drug metabolism - other enzymes	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032232	K07424	ko01100	Metabolic pathways	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMT200032233	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032233	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032234	K07424	ko00140	Steroid hormone biosynthesis	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00591	Linoleic acid metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00830	Retinol metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00982	Drug metabolism - cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko00983	Drug metabolism - other enzymes	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032234	K07424	ko01100	Metabolic pathways	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMT200032235	K07424	ko00140	Steroid hormone biosynthesis	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00591	Linoleic acid metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00830	Retinol metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00982	Drug metabolism - cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko00983	Drug metabolism - other enzymes	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032235	K07424	ko01100	Metabolic pathways	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMT200032240	K07424	ko00140	Steroid hormone biosynthesis	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00591	Linoleic acid metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00830	Retinol metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00982	Drug metabolism - cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko00983	Drug metabolism - other enzymes	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032240	K07424	ko01100	Metabolic pathways	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMT200032241	K07424	ko00140	Steroid hormone biosynthesis	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00591	Linoleic acid metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00830	Retinol metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00982	Drug metabolism - cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko00983	Drug metabolism - other enzymes	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032241	K07424	ko01100	Metabolic pathways	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMT200032242	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032242	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMT200032245	K01595	ko00620	Pyruvate metabolism	7238	0.	0.87	0.95	1.00
PGSC0003DMT200032245	K01595	ko00710	Carbon fixation in photosynthetic organisms	7238	0.	0.87	0.95	1.00
PGSC0003DMT200032245	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7238	0.	0.87	0.95	1.00
PGSC0003DMT200032245	K01595	ko01100	Metabolic pathways	7238	0.	0.87	0.95	1.00
PGSC0003DMT200032246	K03846	ko00510	N-Glycan biosynthesis	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMT200032246	K03846	ko01100	Metabolic pathways	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMT200004907	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMT200004907	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMT200004907	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMT200004908	K04120	ko00904	Diterpenoid biosynthesis	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMT200004908	K04120	ko01100	Metabolic pathways	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMT200004908	K04120	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMT200004909	K04120	ko00904	Diterpenoid biosynthesis	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMT200004909	K04120	ko01100	Metabolic pathways	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMT200004909	K04120	ko01110	Biosynthesis of secondary metabolites	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMT200004910	K04120	ko00904	Diterpenoid biosynthesis	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMT200004910	K04120	ko01100	Metabolic pathways	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMT200004910	K04120	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMT200004915	K00108	ko00260	Glycine, serine and threonine metabolism	662	1.1e-30	0.28	0.48	0.73
PGSC0003DMT200004916	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMT200004917	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMT200004918	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMT200004919	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMT200004920	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.65
PGSC0003DMT200004921	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.87
PGSC0003DMT200004929	K12400	ko04142	Lysosome	4000	8.7e-215	0.87	0.95	0.97
PGSC0003DMT200004930	K12400	ko04142	Lysosome	6108	0.	0.77	0.86	1.00
PGSC0003DMT200004931	K12400	ko04142	Lysosome	1944	2.2e-101	0.61	0.73	1.00
PGSC0003DMT200004932	K12400	ko04142	Lysosome	1552	9.1e-80	0.58	0.70	1.00
PGSC0003DMT200075164	K09754	ko00360	Phenylalanine metabolism	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075164	K09754	ko00940	Phenylpropanoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075164	K09754	ko00941	Flavonoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075164	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075164	K09754	ko01100	Metabolic pathways	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075164	K09754	ko01110	Biosynthesis of secondary metabolites	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMT200075181	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.69
PGSC0003DMT200075184	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.68
PGSC0003DMT200075200	K12127	ko04712	Circadian rhythm - plant	282	1.1e-07	0.33	0.52	0.34
PGSC0003DMT200075205	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMT200075205	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMT200075205	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMT200075205	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMT200075213	K07512	ko00062	Fatty acid elongation in mitochondria	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMT200075213	K07512	ko01100	Metabolic pathways	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMT200075214	K07512	ko00062	Fatty acid elongation in mitochondria	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMT200075214	K07512	ko01100	Metabolic pathways	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMT200075222	K13065	ko00940	Phenylpropanoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMT200075222	K13065	ko00941	Flavonoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMT200075222	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMT200075222	K13065	ko01110	Biosynthesis of secondary metabolites	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMT200075227	K07512	ko00062	Fatty acid elongation in mitochondria	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMT200075227	K07512	ko01100	Metabolic pathways	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMT200078355	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.84
PGSC0003DMT200078356	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.82
PGSC0003DMT200078358	K01807	ko00030	Pentose phosphate pathway	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMT200078358	K01807	ko00710	Carbon fixation in photosynthetic organisms	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMT200078358	K01807	ko01100	Metabolic pathways	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMT200078358	K01807	ko01110	Biosynthesis of secondary metabolites	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMT200078378	K02606	ko04110	Cell cycle	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMT200078378	K02606	ko04111	Cell cycle - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMT200078378	K02606	ko04113	Meiosis - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMT200051453	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051453	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051453	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051453	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051453	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051454	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051454	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051454	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051454	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051454	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMT200051468	K00128	ko00010	Glycolysis / Gluconeogenesis	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00053	Ascorbate and aldarate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00071	Fatty acid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00310	Lysine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00330	Arginine and proline metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00340	Histidine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00380	Tryptophan metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00410	beta-Alanine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00561	Glycerolipid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00620	Pyruvate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00631	1,2-Dichloroethane degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00640	Propanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00641	3-Chloroacrylic acid degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00650	Butanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko00903	Limonene and pinene degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko01100	Metabolic pathways	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051468	K00128	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMT200051469	K00128	ko00010	Glycolysis / Gluconeogenesis	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00053	Ascorbate and aldarate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00071	Fatty acid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00280	Valine, leucine and isoleucine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00310	Lysine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00330	Arginine and proline metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00340	Histidine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00380	Tryptophan metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00410	beta-Alanine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00561	Glycerolipid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00620	Pyruvate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00631	1,2-Dichloroethane degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00640	Propanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00641	3-Chloroacrylic acid degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00650	Butanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko00903	Limonene and pinene degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051469	K00128	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMT200051470	K00128	ko00010	Glycolysis / Gluconeogenesis	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00053	Ascorbate and aldarate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00071	Fatty acid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00280	Valine, leucine and isoleucine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00310	Lysine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00330	Arginine and proline metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00340	Histidine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00380	Tryptophan metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00410	beta-Alanine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00561	Glycerolipid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00620	Pyruvate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00631	1,2-Dichloroethane degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00640	Propanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00641	3-Chloroacrylic acid degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00650	Butanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko00903	Limonene and pinene degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko01100	Metabolic pathways	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200051470	K00128	ko01110	Biosynthesis of secondary metabolites	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMT200057147	K03531	ko04112	Cell cycle - Caulobacter	2809	4.3e-149	0.83	0.91	1.00
PGSC0003DMT200057149	K05399	ko04620	Toll-like receptor signaling pathway	985	1.7e-48	0.50	0.69	0.69
PGSC0003DMT200057150	K05399	ko04620	Toll-like receptor signaling pathway	1269	3.7e-64	0.47	0.66	0.78
PGSC0003DMT200057151	K05399	ko04620	Toll-like receptor signaling pathway	233	5.1e-07	0.61	0.75	0.31
PGSC0003DMT200057152	K05399	ko04620	Toll-like receptor signaling pathway	756	7.3e-36	0.47	0.67	0.97
PGSC0003DMT200057156	K08241	ko00592	alpha-Linolenic acid metabolism	820	2.2e-39	0.38	0.52	0.88
PGSC0003DMT200057158	K00981	ko00564	Glycerophospholipid metabolism	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMT200057158	K00981	ko01100	Metabolic pathways	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMT200057158	K00981	ko04070	Phosphatidylinositol signaling system	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMT200057164	K01179	ko00500	Starch and sucrose metabolism	1376	4.7e-70	0.43	0.62	0.98
PGSC0003DMT200057171	K04426	ko04010	MAPK signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMT200057171	K04426	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMT200057171	K04426	ko05014	Amyotrophic lateral sclerosis (ALS)	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMT200057173	K02501	ko00340	Histidine metabolism	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMT200057173	K02501	ko01100	Metabolic pathways	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMT200057173	K02501	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMT200057174	K02501	ko00340	Histidine metabolism	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMT200057174	K02501	ko01100	Metabolic pathways	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMT200057174	K02501	ko01110	Biosynthesis of secondary metabolites	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMT200057178	K02501	ko00340	Histidine metabolism	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMT200057178	K02501	ko01100	Metabolic pathways	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMT200057178	K02501	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMT200057188	K00795	ko00900	Terpenoid backbone biosynthesis	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMT200057188	K00795	ko01100	Metabolic pathways	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMT200057188	K00795	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMT200086959	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMT200086959	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMT200086959	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMT200086965	K10717	ko00908	Zeatin biosynthesis	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMT200086965	K10717	ko01100	Metabolic pathways	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMT200086965	K10717	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMT200086967	K12831	ko03040	Spliceosome	326	3.8e-12	0.51	0.61	0.72
PGSC0003DMT200048785	K01853	ko00100	Steroid biosynthesis	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMT200048785	K01853	ko01100	Metabolic pathways	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMT200048785	K01853	ko01110	Biosynthesis of secondary metabolites	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMT200048787	K01853	ko00100	Steroid biosynthesis	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMT200048787	K01853	ko01100	Metabolic pathways	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMT200048787	K01853	ko01110	Biosynthesis of secondary metabolites	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMT200048795	K01853	ko00100	Steroid biosynthesis	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMT200048795	K01853	ko01100	Metabolic pathways	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMT200048795	K01853	ko01110	Biosynthesis of secondary metabolites	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMT200048796	K01853	ko00100	Steroid biosynthesis	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMT200048796	K01853	ko01100	Metabolic pathways	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMT200048796	K01853	ko01110	Biosynthesis of secondary metabolites	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMT200048804	K13280	ko03060	Protein export	1250	4.1e-63	0.96	0.99	0.36
PGSC0003DMT200048805	K13280	ko03060	Protein export	1275	1.7e-64	0.90	0.93	0.80
PGSC0003DMT200048807	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMT200048808	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMT200048809	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMT200048818	K12929	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMT200048818	K12929	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMT200076427	K03010	ko00230	Purine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMT200076427	K03010	ko00240	Pyrimidine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMT200076427	K03010	ko01100	Metabolic pathways	9859	0.	0.96	0.98	1.00
PGSC0003DMT200076427	K03010	ko03020	RNA polymerase	9859	0.	0.96	0.98	1.00
PGSC0003DMT200076427	K03010	ko05016	Huntington's disease	9859	0.	0.96	0.98	1.00
PGSC0003DMT200076428	K03010	ko00230	Purine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMT200076428	K03010	ko00240	Pyrimidine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMT200076428	K03010	ko01100	Metabolic pathways	6353	0.	0.69	0.70	1.00
PGSC0003DMT200076428	K03010	ko03020	RNA polymerase	6353	0.	0.69	0.70	1.00
PGSC0003DMT200076428	K03010	ko05016	Huntington's disease	6353	0.	0.69	0.70	1.00
PGSC0003DMT200076430	K01834	ko00010	Glycolysis / Gluconeogenesis	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMT200076430	K01834	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMT200076430	K01834	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMT200076431	K01834	ko00010	Glycolysis / Gluconeogenesis	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMT200076431	K01834	ko01100	Metabolic pathways	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMT200076431	K01834	ko01110	Biosynthesis of secondary metabolites	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMT200076435	K10581	ko04120	Ubiquitin mediated proteolysis	2564	1.4e-135	0.40	0.57	0.95
PGSC0003DMT200006049	K01930	ko00790	Folate biosynthesis	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMT200006049	K01930	ko01100	Metabolic pathways	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMT200006050	K01930	ko00790	Folate biosynthesis	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMT200006050	K01930	ko01100	Metabolic pathways	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMT200006051	K01930	ko00790	Folate biosynthesis	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMT200006051	K01930	ko01100	Metabolic pathways	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMT200006075	K07195	ko04910	Insulin signaling pathway	2209	5.3e-116	0.48	0.67	0.97
PGSC0003DMT200033735	K12819	ko03040	Spliceosome	268	5.4e-06	0.30	0.49	0.34
PGSC0003DMT200033738	K12819	ko03040	Spliceosome	268	3.5e-08	0.30	0.49	0.72
PGSC0003DMT200033749	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMT200033749	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMT200033754	K00627	ko00010	Glycolysis / Gluconeogenesis	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMT200033754	K00627	ko00020	Citrate cycle (TCA cycle)	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMT200033754	K00627	ko00620	Pyruvate metabolism	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMT200033754	K00627	ko01100	Metabolic pathways	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMT200033754	K00627	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMT200033762	K03456	ko04111	Cell cycle - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04113	Meiosis - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04114	Oocyte meiosis	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04310	Wnt signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04350	TGF-beta signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04530	Tight junction	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko04730	Long-term depression	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200033762	K03456	ko05142	Chagas disease	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMT200012662	K09756	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.61	0.78	0.86
PGSC0003DMT200002745	K11251	ko05322	Systemic lupus erythematosus	1000	2.5e-49	0.93	0.95	0.99
PGSC0003DMT200002752	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002752	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002752	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002753	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002753	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002753	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002754	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002754	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002754	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002755	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002755	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002755	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002756	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002756	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002756	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002757	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002757	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002757	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002758	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002758	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002758	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002759	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002759	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002759	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMT200002760	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002760	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002760	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002761	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002761	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002761	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMT200002762	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMT200002762	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMT200002763	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMT200002763	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMT200002768	K02184	ko04320	Dorso-ventral axis formation	1292	2.0e-65	0.42	0.47	0.44
PGSC0003DMT200002771	K13065	ko00940	Phenylpropanoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMT200002771	K13065	ko00941	Flavonoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMT200002771	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMT200002771	K13065	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMT200002773	K13065	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMT200002773	K13065	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMT200002773	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMT200002773	K13065	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMT200002777	K06676	ko04111	Cell cycle - yeast	3594	2.2e-192	0.67	0.78	0.99
PGSC0003DMT200002779	K10528	ko00592	alpha-Linolenic acid metabolism	1870	2.6e-97	0.49	0.69	0.96
PGSC0003DMT200002780	K00748	ko00540	Lipopolysaccharide biosynthesis	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMT200002780	K00748	ko01100	Metabolic pathways	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMT200002781	K00748	ko00540	Lipopolysaccharide biosynthesis	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMT200002781	K00748	ko01100	Metabolic pathways	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMT200080759	K12356	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.30	0.45	0.85
PGSC0003DMT200080765	K10775	ko00360	Phenylalanine metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMT200080765	K10775	ko00910	Nitrogen metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMT200080765	K10775	ko00940	Phenylpropanoid biosynthesis	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMT200080765	K10775	ko01100	Metabolic pathways	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMT200080765	K10775	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMT200080769	K10571	ko04120	Ubiquitin mediated proteolysis	1876	1.2e-97	0.82	0.90	0.89
PGSC0003DMT200080770	K10571	ko04120	Ubiquitin mediated proteolysis	3824	4.4e-205	0.84	0.92	1.00
PGSC0003DMT200080771	K10571	ko04120	Ubiquitin mediated proteolysis	1303	4.9e-66	0.85	0.94	0.99
PGSC0003DMT200080772	K02894	ko03010	Ribosome	792	7.6e-38	0.92	0.95	0.42
PGSC0003DMT200065273	K09753	ko00940	Phenylpropanoid biosynthesis	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMT200065273	K09753	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMT200065273	K09753	ko01110	Biosynthesis of secondary metabolites	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMT200065274	K09753	ko00940	Phenylpropanoid biosynthesis	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMT200065274	K09753	ko01100	Metabolic pathways	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMT200065274	K09753	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMT200065275	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMT200065275	K04518	ko01100	Metabolic pathways	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMT200065276	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMT200065276	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMT200065277	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMT200065277	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMT200065278	K02154	ko00190	Oxidative phosphorylation	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko01100	Metabolic pathways	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko04142	Lysosome	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko04145	Phagosome	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko04966	Collecting duct acid secretion	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko05110	Vibrio cholerae infection	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065278	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	6059	0.	0.86	0.93	1.00
PGSC0003DMT200065283	K05915	ko00363	Bisphenol A degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMT200065283	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMT200065283	K05915	ko01100	Metabolic pathways	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMT200065286	K10643	ko03018	RNA degradation	4110	7.5e-221	0.51	0.64	1.00
PGSC0003DMT200065287	K10643	ko03018	RNA degradation	4123	1.4e-221	0.52	0.64	1.00
PGSC0003DMT200065288	K10643	ko03018	RNA degradation	4121	1.8e-221	0.51	0.64	1.00
PGSC0003DMT200065297	K01955	ko00240	Pyrimidine metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMT200065297	K01955	ko00250	Alanine, aspartate and glutamate metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMT200065297	K01955	ko01100	Metabolic pathways	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMT200065314	K10869	ko03440	Homologous recombination	1180	3.0e-59	0.67	0.84	0.97
PGSC0003DMT200065315	K10869	ko03440	Homologous recombination	787	1.4e-37	0.64	0.79	0.77
PGSC0003DMT200070078	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMT200070079	K01408	ko05010	Alzheimer's disease	1154	8.2e-58	0.69	0.79	0.89
PGSC0003DMT200070080	K01408	ko05010	Alzheimer's disease	1773	5.9e-92	0.60	0.80	0.98
PGSC0003DMT200070081	K01408	ko05010	Alzheimer's disease	407	6.0e-16	0.57	0.80	0.81
PGSC0003DMT200070087	K05768	ko04666	Fc gamma R-mediated phagocytosis	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMT200070087	K05768	ko04810	Regulation of actin cytoskeleton	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMT200070088	K05768	ko04666	Fc gamma R-mediated phagocytosis	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMT200070088	K05768	ko04810	Regulation of actin cytoskeleton	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMT200070099	K05643	ko02010	ABC transporters	2969	6.4e-158	0.33	0.48	0.99
PGSC0003DMT200070100	K05643	ko02010	ABC transporters	3229	1.1e-178	0.34	0.51	0.97
PGSC0003DMT200070103	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMT200070104	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMT200070105	K00384	ko00240	Pyrimidine metabolism	3414	1.8e-182	0.76	0.87	0.97
PGSC0003DMT200070106	K00384	ko00240	Pyrimidine metabolism	1648	4.6e-85	0.83	0.92	1.00
PGSC0003DMT200073346	K05277	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMT200073346	K05277	ko01100	Metabolic pathways	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMT200073346	K05277	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMT200073347	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073347	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073347	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073387	K00413	ko00190	Oxidative phosphorylation	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200073387	K00413	ko01100	Metabolic pathways	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200073387	K00413	ko04260	Cardiac muscle contraction	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200073387	K00413	ko05010	Alzheimer's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200073387	K00413	ko05012	Parkinson's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200073387	K00413	ko05016	Huntington's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMT200047488	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047488	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047488	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047488	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047488	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047489	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047489	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047489	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047489	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047489	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMT200047495	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.74
PGSC0003DMT200047496	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.65
PGSC0003DMT200047499	K06685	ko04111	Cell cycle - yeast	368	1.0e-10	0.26	0.42	0.75
PGSC0003DMT200047502	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047502	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047503	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047503	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko04115	p53 signaling pathway	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko04210	Apoptosis	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko05010	Alzheimer's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko05012	Parkinson's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko05016	Huntington's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047504	K02084	ko05222	Small cell lung cancer	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMT200047505	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047505	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200018651	K04124	ko00904	Diterpenoid biosynthesis	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMT200018651	K04124	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMT200018652	K04124	ko00904	Diterpenoid biosynthesis	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMT200018652	K04124	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMT200018654	K04124	ko00904	Diterpenoid biosynthesis	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMT200018654	K04124	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMT200018655	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018655	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018655	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018656	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018656	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018656	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMT200018673	K05278	ko00941	Flavonoid biosynthesis	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMT200018673	K05278	ko01100	Metabolic pathways	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMT200018673	K05278	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMT200018674	K01046	ko00561	Glycerolipid metabolism	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMT200018674	K01046	ko01100	Metabolic pathways	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMT200018676	K06316	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.90	0.95	0.98
PGSC0003DMT200018677	K06316	ko00510	N-Glycan biosynthesis	568	1.7e-25	0.68	0.82	0.99
PGSC0003DMT200018678	K06316	ko00510	N-Glycan biosynthesis	1872	2.0e-97	0.79	0.88	1.00
PGSC0003DMT200018679	K03026	ko00230	Purine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMT200018679	K03026	ko00240	Pyrimidine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMT200018679	K03026	ko01100	Metabolic pathways	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMT200018679	K03026	ko03020	RNA polymerase	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMT200018679	K03026	ko04623	Cytosolic DNA-sensing pathway	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMT200018680	K03026	ko00230	Purine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMT200018680	K03026	ko00240	Pyrimidine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMT200018680	K03026	ko01100	Metabolic pathways	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMT200018680	K03026	ko03020	RNA polymerase	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMT200018680	K03026	ko04623	Cytosolic DNA-sensing pathway	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMT200038197	K09561	ko04120	Ubiquitin mediated proteolysis	239	3.7e-07	0.49	0.67	0.15
PGSC0003DMT200038202	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038202	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038202	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038202	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038202	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038202	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038203	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038204	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038205	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMT200038206	K12611	ko03018	RNA degradation	555	8.9e-25	0.31	0.49	0.95
PGSC0003DMT200038238	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.39	0.58	0.96
PGSC0003DMT200038240	K09843	ko00906	Carotenoid biosynthesis	1015	3.8e-50	0.36	0.54	0.93
PGSC0003DMT200038242	K00615	ko00030	Pentose phosphate pathway	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMT200038242	K00615	ko00710	Carbon fixation in photosynthetic organisms	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMT200038242	K00615	ko01051	Biosynthesis of ansamycins	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMT200038242	K00615	ko01100	Metabolic pathways	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMT200038242	K00615	ko01110	Biosynthesis of secondary metabolites	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMT200038248	K01955	ko00240	Pyrimidine metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMT200038248	K01955	ko00250	Alanine, aspartate and glutamate metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMT200038248	K01955	ko01100	Metabolic pathways	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMT200038256	K09843	ko00906	Carotenoid biosynthesis	438	2.5e-18	0.39	0.60	0.84
PGSC0003DMT200027018	K04077	ko03018	RNA degradation	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMT200027018	K04077	ko04940	Type I diabetes mellitus	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMT200027019	K04077	ko03018	RNA degradation	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMT200027019	K04077	ko04940	Type I diabetes mellitus	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMT200027020	K04077	ko03018	RNA degradation	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMT200027020	K04077	ko04940	Type I diabetes mellitus	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMT200027022	K05750	ko04810	Regulation of actin cytoskeleton	6846	0.	0.87	0.94	0.99
PGSC0003DMT200027023	K05750	ko04810	Regulation of actin cytoskeleton	4758	1.4e-256	0.77	0.89	1.00
PGSC0003DMT200027024	K05750	ko04810	Regulation of actin cytoskeleton	8187	0.	0.83	0.92	1.00
PGSC0003DMT200027025	K05750	ko04810	Regulation of actin cytoskeleton	4147	6.8e-223	0.75	0.88	0.99
PGSC0003DMT200094986	K00368	ko00910	Nitrogen metabolism	633	4.4e-29	0.32	0.48	0.83
PGSC0003DMT200094997	K12412	ko04111	Cell cycle - yeast	247	8.7e-08	0.34	0.50	0.89
PGSC0003DMT200095009	K08065	ko04612	Antigen processing and presentation	611	7.3e-28	0.65	0.80	0.61
PGSC0003DMT200083296	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMT200083296	K00517	ko00626	Naphthalene and anthracene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMT200083296	K00517	ko00903	Limonene and pinene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMT200083296	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMT200083296	K00517	ko01110	Biosynthesis of secondary metabolites	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMT200083315	K05745	ko04810	Regulation of actin cytoskeleton	310	2.5e-10	0.44	0.57	0.63
PGSC0003DMT200083452	K03350	ko04110	Cell cycle	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083452	K03350	ko04111	Cell cycle - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083452	K03350	ko04113	Meiosis - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083452	K03350	ko04114	Oocyte meiosis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083452	K03350	ko04120	Ubiquitin mediated proteolysis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083452	K03350	ko04914	Progesterone-mediated oocyte maturation	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMT200083469	K06685	ko04111	Cell cycle - yeast	308	5.6e-09	0.34	0.52	0.56
PGSC0003DMT200083470	K06685	ko04111	Cell cycle - yeast	367	1.1e-11	0.33	0.50	0.55
PGSC0003DMT200083471	K06685	ko04111	Cell cycle - yeast	377	1.7e-11	0.27	0.42	0.78
PGSC0003DMT200083472	K06685	ko04111	Cell cycle - yeast	377	2.2e-11	0.27	0.42	0.70
PGSC0003DMT200063593	K02883	ko03010	Ribosome	1389	8.9e-71	0.87	0.95	0.99
PGSC0003DMT200063594	K01115	ko00564	Glycerophospholipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063594	K01115	ko00565	Ether lipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063594	K01115	ko01100	Metabolic pathways	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063594	K01115	ko04144	Endocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063594	K01115	ko04666	Fc gamma R-mediated phagocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063594	K01115	ko04912	GnRH signaling pathway	5784	0.	0.64	0.76	0.99
PGSC0003DMT200063595	K01115	ko00564	Glycerophospholipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063595	K01115	ko00565	Ether lipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063595	K01115	ko01100	Metabolic pathways	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063595	K01115	ko04144	Endocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063595	K01115	ko04666	Fc gamma R-mediated phagocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063595	K01115	ko04912	GnRH signaling pathway	6322	0.	0.68	0.82	0.99
PGSC0003DMT200063596	K01115	ko00564	Glycerophospholipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063596	K01115	ko00565	Ether lipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063596	K01115	ko01100	Metabolic pathways	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063596	K01115	ko04144	Endocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063596	K01115	ko04666	Fc gamma R-mediated phagocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063596	K01115	ko04912	GnRH signaling pathway	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMT200063597	K01115	ko00564	Glycerophospholipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063597	K01115	ko00565	Ether lipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063597	K01115	ko01100	Metabolic pathways	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063597	K01115	ko04144	Endocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063597	K01115	ko04666	Fc gamma R-mediated phagocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063597	K01115	ko04912	GnRH signaling pathway	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMT200063599	K01520	ko00240	Pyrimidine metabolism	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMT200063599	K01520	ko01100	Metabolic pathways	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMT200063602	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMT200063603	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMT200063604	K12849	ko03040	Spliceosome	2653	1.7e-140	0.80	0.87	1.00
PGSC0003DMT200063605	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMT200063605	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMT200063605	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMT200063606	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMT200063606	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMT200063606	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMT200063611	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.7e-20	0.30	0.45	0.56
PGSC0003DMT200063612	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.6e-20	0.30	0.45	0.57
PGSC0003DMT200063613	K08489	ko04130	SNARE interactions in vesicular transport	445	1.0e-18	0.77	0.84	0.93
PGSC0003DMT200063614	K08489	ko04130	SNARE interactions in vesicular transport	1075	1.9e-53	0.80	0.90	0.90
PGSC0003DMT200063615	K08489	ko04130	SNARE interactions in vesicular transport	2110	1.5e-110	0.74	0.81	0.99
PGSC0003DMT200063616	K08489	ko04130	SNARE interactions in vesicular transport	2205	8.8e-116	0.84	0.92	0.99
PGSC0003DMT200063617	K08489	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.92	0.99	0.93
PGSC0003DMT200063626	K01514	ko00230	Purine metabolism	829	6.9e-40	0.35	0.54	0.94
PGSC0003DMT200063627	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMT200045638	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMT200045638	K01491	ko00670	One carbon pool by folate	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMT200045638	K01491	ko01100	Metabolic pathways	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMT200045639	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMT200045639	K01491	ko00670	One carbon pool by folate	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMT200045639	K01491	ko01100	Metabolic pathways	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMT200045640	K01915	ko00250	Alanine, aspartate and glutamate metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMT200045640	K01915	ko00330	Arginine and proline metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMT200045640	K01915	ko00910	Nitrogen metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMT200045640	K01915	ko01100	Metabolic pathways	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMT200045640	K01915	ko02020	Two-component system	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMT200045643	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMT200045643	K02366	ko01100	Metabolic pathways	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMT200045644	K12617	ko03018	RNA degradation	4657	5.0e-251	0.69	0.81	1.00
PGSC0003DMT200045647	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMT200045647	K00457	ko00350	Tyrosine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMT200045647	K00457	ko00360	Phenylalanine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMT200045647	K00457	ko01100	Metabolic pathways	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMT200045654	K02969	ko03010	Ribosome	360	5.1e-14	0.48	0.56	0.99
PGSC0003DMT200045667	K03660	ko03410	Base excision repair	1107	3.2e-55	0.40	0.56	0.86
PGSC0003DMT200045673	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMT200045674	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMT200045675	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMT200045676	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMT200045690	K03660	ko03410	Base excision repair	798	3.5e-38	0.48	0.67	0.92
PGSC0003DMT200045691	K03660	ko03410	Base excision repair	962	3.2e-47	0.44	0.60	0.96
PGSC0003DMT200045694	K12891	ko03040	Spliceosome	1785	1.3e-92	0.80	0.88	1.00
PGSC0003DMT200071582	K10579	ko04120	Ubiquitin mediated proteolysis	1215	3.5e-61	0.92	0.97	0.66
PGSC0003DMT200071583	K10579	ko04120	Ubiquitin mediated proteolysis	1477	1.3e-75	0.91	0.96	0.99
PGSC0003DMT200071585	K03006	ko00230	Purine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMT200071585	K03006	ko00240	Pyrimidine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMT200071585	K03006	ko01100	Metabolic pathways	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMT200071585	K03006	ko03020	RNA polymerase	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMT200071585	K03006	ko05016	Huntington's disease	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMT200071590	K12356	ko00940	Phenylpropanoid biosynthesis	1696	1.0e-87	0.48	0.66	0.97
PGSC0003DMT200071591	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMT200071591	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMT200071591	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMT200071592	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMT200071592	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMT200071592	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMT200071599	K00795	ko00900	Terpenoid backbone biosynthesis	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMT200071599	K00795	ko01100	Metabolic pathways	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMT200071599	K00795	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMT200071600	K01246	ko03410	Base excision repair	1537	6.1e-79	0.57	0.72	0.98
PGSC0003DMT200096190	K02960	ko03010	Ribosome	648	6.6e-30	0.95	0.99	0.99
PGSC0003DMT200020561	K01046	ko00561	Glycerolipid metabolism	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMT200020561	K01046	ko01100	Metabolic pathways	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMT200020589	K09843	ko00906	Carotenoid biosynthesis	2668	2.6e-141	0.71	0.83	0.93
PGSC0003DMT200020590	K08764	ko00120	Primary bile acid biosynthesis	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMT200020590	K08764	ko01100	Metabolic pathways	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMT200020590	K08764	ko03320	PPAR signaling pathway	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMT200020590	K08764	ko04146	Peroxisome	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMT200020591	K01176	ko00500	Starch and sucrose metabolism	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMT200020591	K01176	ko01100	Metabolic pathways	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMT200020592	K01176	ko00500	Starch and sucrose metabolism	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMT200020592	K01176	ko01100	Metabolic pathways	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMT200020597	K11820	ko00380	Tryptophan metabolism	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMT200020597	K11820	ko00966	Glucosinolate biosynthesis	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMT200020597	K11820	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMT200020601	K12356	ko00940	Phenylpropanoid biosynthesis	394	6.8e-16	0.29	0.44	0.88
PGSC0003DMT200020604	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.30	0.46	0.91
PGSC0003DMT200020605	K12356	ko00940	Phenylpropanoid biosynthesis	349	2.1e-13	0.29	0.43	0.98
PGSC0003DMT200036505	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMT200036505	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMT200036505	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMT200036505	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMT200036510	K02537	ko04110	Cell cycle	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMT200036510	K02537	ko04111	Cell cycle - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMT200036510	K02537	ko04113	Meiosis - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMT200036510	K02537	ko04114	Oocyte meiosis	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMT200036510	K02537	ko04914	Progesterone-mediated oocyte maturation	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMT200036512	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036512	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036512	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036512	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036512	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036513	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036513	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036513	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036513	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036513	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMT200036518	K10884	ko03450	Non-homologous end-joining	1956	4.8e-102	0.80	0.89	0.99
PGSC0003DMT200036519	K10884	ko03450	Non-homologous end-joining	3237	1.1e-172	0.75	0.90	0.97
PGSC0003DMT200036520	K10884	ko03450	Non-homologous end-joining	4063	2.9e-218	0.76	0.89	1.00
PGSC0003DMT200036523	K05282	ko00904	Diterpenoid biosynthesis	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMT200036523	K05282	ko01100	Metabolic pathways	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMT200036523	K05282	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMT200036527	K12811	ko03040	Spliceosome	431	3.4e-17	0.30	0.61	0.90
PGSC0003DMT200036531	K02948	ko03010	Ribosome	806	1.3e-38	0.92	0.93	0.99
PGSC0003DMT200036532	K03040	ko00230	Purine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMT200036532	K03040	ko00240	Pyrimidine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMT200036532	K03040	ko01100	Metabolic pathways	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMT200036532	K03040	ko03020	RNA polymerase	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMT200036533	K02874	ko03010	Ribosome	779	3.9e-37	0.93	0.96	0.92
PGSC0003DMT200025526	K00844	ko00010	Glycolysis / Gluconeogenesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00051	Fructose and mannose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00052	Galactose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00500	Starch and sucrose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00521	Streptomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko00524	Butirosin and neomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko01100	Metabolic pathways	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko01110	Biosynthesis of secondary metabolites	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko04910	Insulin signaling pathway	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025526	K00844	ko04930	Type II diabetes mellitus	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMT200025527	K00844	ko00010	Glycolysis / Gluconeogenesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00051	Fructose and mannose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00052	Galactose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00500	Starch and sucrose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00521	Streptomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko00524	Butirosin and neomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko01100	Metabolic pathways	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko04910	Insulin signaling pathway	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025527	K00844	ko04930	Type II diabetes mellitus	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMT200025528	K00844	ko00010	Glycolysis / Gluconeogenesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00051	Fructose and mannose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00052	Galactose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00500	Starch and sucrose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00521	Streptomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko00524	Butirosin and neomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko01100	Metabolic pathways	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko01110	Biosynthesis of secondary metabolites	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko04910	Insulin signaling pathway	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025528	K00844	ko04930	Type II diabetes mellitus	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMT200025529	K11827	ko04144	Endocytosis	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMT200025529	K11827	ko05016	Huntington's disease	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMT200025541	K00423	ko00053	Ascorbate and aldarate metabolism	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMT200025541	K00423	ko01100	Metabolic pathways	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMT200028861	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMT200028863	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMT200085760	K11816	ko00380	Tryptophan metabolism	636	3.0e-29	0.38	0.60	0.90
PGSC0003DMT200085766	K02898	ko03010	Ribosome	1122	4.8e-56	0.90	0.98	0.99
PGSC0003DMT200078205	K00430	ko00360	Phenylalanine metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMT200078205	K00430	ko00680	Methane metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMT200078205	K00430	ko00940	Phenylpropanoid biosynthesis	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMT200078205	K00430	ko01100	Metabolic pathways	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMT200078205	K00430	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMT200078206	K07375	ko04145	Phagosome	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMT200078206	K07375	ko04540	Gap junction	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMT200078206	K07375	ko05130	Pathogenic Escherichia coli infection	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMT200078207	K04802	ko03030	DNA replication	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMT200078207	K04802	ko03410	Base excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMT200078207	K04802	ko03420	Nucleotide excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMT200078207	K04802	ko03430	Mismatch repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMT200078207	K04802	ko04110	Cell cycle	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMT200078224	K01188	ko00460	Cyanoamino acid metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMT200078224	K01188	ko00500	Starch and sucrose metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMT200078224	K01188	ko00940	Phenylpropanoid biosynthesis	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMT200078224	K01188	ko01110	Biosynthesis of secondary metabolites	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMT200078228	K02941	ko03010	Ribosome	2057	1.3e-107	0.78	0.89	1.00
PGSC0003DMT200078231	K11778	ko00900	Terpenoid backbone biosynthesis	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMT200078231	K11778	ko01110	Biosynthesis of secondary metabolites	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMT200078232	K11778	ko00900	Terpenoid backbone biosynthesis	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMT200078232	K11778	ko01110	Biosynthesis of secondary metabolites	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMT200078233	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMT200078233	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMT200050716	K10807	ko00230	Purine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMT200050716	K10807	ko00240	Pyrimidine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMT200050716	K10807	ko00480	Glutathione metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMT200050716	K10807	ko01100	Metabolic pathways	6338	0.	0.91	0.97	1.00
PGSC0003DMT200057648	K01466	ko00230	Purine metabolism	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMT200057648	K01466	ko01100	Metabolic pathways	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMT200057649	K01466	ko00230	Purine metabolism	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMT200057649	K01466	ko01100	Metabolic pathways	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMT200057652	K07456	ko03430	Mismatch repair	2409	4.9e-127	0.69	0.82	0.92
PGSC0003DMT200057653	K07456	ko03430	Mismatch repair	3429	2.7e-183	0.62	0.79	1.00
PGSC0003DMT200057686	K10145	ko04115	p53 signaling pathway	281	1.2e-09	0.32	0.48	0.66
PGSC0003DMT200097598	K03876	ko04120	Ubiquitin mediated proteolysis	251	5.2e-08	0.31	0.52	0.79
PGSC0003DMT200001058	K03283	ko03040	Spliceosome	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMT200001058	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMT200001058	K03283	ko04144	Endocytosis	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMT200001058	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMT200001063	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMT200001063	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMT200001064	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMT200001064	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMT200001071	K01710	ko00521	Streptomycin biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMT200001071	K01710	ko00523	Polyketide sugar unit biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMT200001071	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMT200001071	K01710	ko01100	Metabolic pathways	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMT200001071	K01710	ko01110	Biosynthesis of secondary metabolites	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMT200001072	K11254	ko05322	Systemic lupus erythematosus	856	2.2e-41	1.00	1.00	0.99
PGSC0003DMT200001086	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMT200001086	K02366	ko01100	Metabolic pathways	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMT200042215	K12581	ko03018	RNA degradation	1047	6.5e-52	0.51	0.67	0.98
PGSC0003DMT200042229	K08488	ko04130	SNARE interactions in vesicular transport	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMT200042229	K08488	ko04145	Phagosome	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMT200042233	K12833	ko03040	Spliceosome	977	4.7e-48	0.92	0.96	0.99
PGSC0003DMT200042234	K02884	ko03010	Ribosome	245	1.1e-07	0.37	0.53	0.33
PGSC0003DMT200042236	K02884	ko03010	Ribosome	326	3.8e-12	0.53	0.74	0.91
PGSC0003DMT200042237	K02884	ko03010	Ribosome	370	1.4e-14	0.44	0.71	0.41
PGSC0003DMT200042238	K01961	ko00061	Fatty acid biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042238	K01961	ko00253	Tetracycline biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042238	K01961	ko00620	Pyruvate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042238	K01961	ko00640	Propanoate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042238	K01961	ko01100	Metabolic pathways	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042238	K01961	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMT200042239	K01066	ko00623	2,4-Dichlorobenzoate degradation	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMT200042239	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMT200042241	K01066	ko00623	2,4-Dichlorobenzoate degradation	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMT200042241	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMT200042244	K00254	ko00240	Pyrimidine metabolism	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMT200042244	K00254	ko01100	Metabolic pathways	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMT200032030	K02684	ko00230	Purine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMT200032030	K02684	ko00240	Pyrimidine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMT200032030	K02684	ko01100	Metabolic pathways	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMT200032030	K02684	ko03030	DNA replication	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMT200032057	K04424	ko04010	MAPK signaling pathway	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMT200032057	K04424	ko04530	Tight junction	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMT200032059	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMT200032063	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMT200032063	K01687	ko00770	Pantothenate and CoA biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMT200032063	K01687	ko01100	Metabolic pathways	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMT200032063	K01687	ko01110	Biosynthesis of secondary metabolites	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMT200004211	K07750	ko00100	Steroid biosynthesis	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMT200004211	K07750	ko01100	Metabolic pathways	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMT200004212	K07750	ko00100	Steroid biosynthesis	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMT200004212	K07750	ko01100	Metabolic pathways	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMT200004213	K07750	ko00100	Steroid biosynthesis	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMT200004213	K07750	ko01100	Metabolic pathways	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMT200004214	K03358	ko04110	Cell cycle	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004214	K03358	ko04111	Cell cycle - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004214	K03358	ko04113	Meiosis - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004214	K03358	ko04114	Oocyte meiosis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004214	K03358	ko04120	Ubiquitin mediated proteolysis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004214	K03358	ko04914	Progesterone-mediated oocyte maturation	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMT200004215	K12823	ko03040	Spliceosome	242	4.7e-07	0.56	0.75	0.51
PGSC0003DMT200004216	K12823	ko03040	Spliceosome	250	1.6e-07	0.75	0.88	0.54
PGSC0003DMT200004221	K02881	ko03010	Ribosome	229	8.5e-07	0.34	0.56	0.64
PGSC0003DMT200004225	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMT200004225	K03861	ko01100	Metabolic pathways	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMT200004228	K01528	ko04144	Endocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMT200004228	K01528	ko04666	Fc gamma R-mediated phagocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMT200004228	K01528	ko05100	Bacterial invasion of epithelial cells	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMT200004230	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMT200004230	K03861	ko01100	Metabolic pathways	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMT200004231	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMT200004231	K03861	ko01100	Metabolic pathways	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMT200004235	K03955	ko00190	Oxidative phosphorylation	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMT200004235	K03955	ko01100	Metabolic pathways	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMT200004235	K03955	ko05010	Alzheimer's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMT200004235	K03955	ko05012	Parkinson's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMT200004235	K03955	ko05016	Huntington's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMT200014167	K01178	ko00500	Starch and sucrose metabolism	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMT200014167	K01178	ko01100	Metabolic pathways	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMT200014189	K00660	ko00941	Flavonoid biosynthesis	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMT200014189	K00660	ko01100	Metabolic pathways	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMT200014189	K00660	ko01110	Biosynthesis of secondary metabolites	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMT200014189	K00660	ko04712	Circadian rhythm - plant	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMT200022011	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMT200022011	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMT200092405	K01142	ko03410	Base excision repair	245	1.8e-07	0.45	0.56	0.64
PGSC0003DMT200075027	K10755	ko03030	DNA replication	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMT200075027	K10755	ko03420	Nucleotide excision repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMT200075027	K10755	ko03430	Mismatch repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMT200075057	K00522	ko00860	Porphyrin and chlorophyll metabolism	827	8.9e-40	0.59	0.76	0.71
PGSC0003DMT200075060	K12929	ko00904	Diterpenoid biosynthesis	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMT200075060	K12929	ko01110	Biosynthesis of secondary metabolites	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMT200075061	K12929	ko00904	Diterpenoid biosynthesis	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMT200075061	K12929	ko01110	Biosynthesis of secondary metabolites	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMT200075064	K12929	ko00904	Diterpenoid biosynthesis	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMT200075064	K12929	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMT200075070	K12929	ko00904	Diterpenoid biosynthesis	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMT200075070	K12929	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMT200075071	K12929	ko00904	Diterpenoid biosynthesis	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMT200075071	K12929	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMT200075072	K12929	ko00904	Diterpenoid biosynthesis	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMT200075072	K12929	ko01110	Biosynthesis of secondary metabolites	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMT200075074	K12929	ko00904	Diterpenoid biosynthesis	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMT200075074	K12929	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMT200075076	K12929	ko00904	Diterpenoid biosynthesis	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMT200075076	K12929	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMT200060899	K05768	ko04666	Fc gamma R-mediated phagocytosis	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMT200060899	K05768	ko04810	Regulation of actin cytoskeleton	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMT200060900	K05768	ko04666	Fc gamma R-mediated phagocytosis	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMT200060900	K05768	ko04810	Regulation of actin cytoskeleton	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMT200060901	K05768	ko04666	Fc gamma R-mediated phagocytosis	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMT200060901	K05768	ko04810	Regulation of actin cytoskeleton	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMT200060907	K00384	ko00240	Pyrimidine metabolism	3477	6.1e-186	0.77	0.88	0.98
PGSC0003DMT200060908	K00384	ko00240	Pyrimidine metabolism	1613	3.9e-83	0.66	0.79	0.93
PGSC0003DMT200060912	K03124	ko03022	Basal transcription factors	771	1.1e-36	0.76	0.87	0.99
PGSC0003DMT200060913	K03124	ko03022	Basal transcription factors	2044	6.7e-107	0.76	0.89	0.99
PGSC0003DMT200060914	K03124	ko03022	Basal transcription factors	1760	3.1e-91	0.75	0.89	0.98
PGSC0003DMT200060915	K03124	ko03022	Basal transcription factors	471	3.8e-20	0.75	0.90	0.74
PGSC0003DMT200060916	K03124	ko03022	Basal transcription factors	950	1.5e-46	0.74	0.91	0.84
PGSC0003DMT200060917	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMT200060917	K00517	ko00626	Naphthalene and anthracene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMT200060917	K00517	ko00903	Limonene and pinene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMT200060917	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMT200060917	K00517	ko01110	Biosynthesis of secondary metabolites	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMT200068336	K12382	ko04142	Lysosome	337	9.4e-13	0.31	0.50	0.77
PGSC0003DMT200068340	K00430	ko00360	Phenylalanine metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMT200068340	K00430	ko00680	Methane metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMT200068340	K00430	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMT200068340	K00430	ko01100	Metabolic pathways	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMT200068340	K00430	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMT200068341	K00430	ko00360	Phenylalanine metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMT200068341	K00430	ko00680	Methane metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMT200068341	K00430	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMT200068341	K00430	ko01100	Metabolic pathways	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMT200068341	K00430	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMT200068350	K11420	ko00310	Lysine degradation	681	4.7e-34	0.31	0.42	0.87
PGSC0003DMT200068351	K11420	ko00310	Lysine degradation	681	1.3e-29	0.31	0.42	0.60
PGSC0003DMT200068352	K06268	ko04010	MAPK signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04020	Calcium signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04114	Oocyte meiosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04210	Apoptosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04310	Wnt signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04360	Axon guidance	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04370	VEGF signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04650	Natural killer cell mediated cytotoxicity	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04660	T cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04662	B cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko04720	Long-term potentiation	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko05010	Alzheimer's disease	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068352	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMT200068354	K00430	ko00360	Phenylalanine metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMT200068354	K00430	ko00680	Methane metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMT200068354	K00430	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMT200068354	K00430	ko01100	Metabolic pathways	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMT200068354	K00430	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMT200068358	K03115	ko04310	Wnt signaling pathway	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMT200068358	K03115	ko04520	Adherens junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMT200068358	K03115	ko04530	Tight junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMT200068358	K03115	ko04712	Circadian rhythm - plant	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMT200068359	K03115	ko04310	Wnt signaling pathway	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMT200068359	K03115	ko04520	Adherens junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMT200068359	K03115	ko04530	Tight junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMT200068359	K03115	ko04712	Circadian rhythm - plant	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMT200068360	K03115	ko04310	Wnt signaling pathway	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMT200068360	K03115	ko04520	Adherens junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMT200068360	K03115	ko04530	Tight junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMT200068360	K03115	ko04712	Circadian rhythm - plant	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMT200068361	K03115	ko04310	Wnt signaling pathway	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMT200068361	K03115	ko04520	Adherens junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMT200068361	K03115	ko04530	Tight junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMT200068361	K03115	ko04712	Circadian rhythm - plant	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMT200020794	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020794	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020794	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020795	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020795	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020795	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMT200020828	K08681	ko00750	Vitamin B6 metabolism	1492	1.9e-76	0.72	0.83	1.00
PGSC0003DMT200020829	K08681	ko00750	Vitamin B6 metabolism	1156	6.3e-58	0.77	0.90	0.95
PGSC0003DMT200020831	K02006	ko02010	ABC transporters	910	2.3e-44	0.55	0.69	0.95
PGSC0003DMT200020832	K02006	ko02010	ABC transporters	566	2.2e-25	0.54	0.70	0.91
PGSC0003DMT200010905	K00423	ko00053	Ascorbate and aldarate metabolism	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMT200010905	K00423	ko01100	Metabolic pathways	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMT200010906	K07374	ko04145	Phagosome	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMT200010906	K07374	ko04540	Gap junction	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMT200010906	K07374	ko05130	Pathogenic Escherichia coli infection	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMT200010907	K07374	ko04145	Phagosome	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMT200010907	K07374	ko04540	Gap junction	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMT200010907	K07374	ko05130	Pathogenic Escherichia coli infection	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMT200010908	K12900	ko03040	Spliceosome	622	1.8e-28	0.40	0.54	0.86
PGSC0003DMT200010909	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMT200010910	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMT200010911	K01895	ko00010	Glycolysis / Gluconeogenesis	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010911	K01895	ko00620	Pyruvate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010911	K01895	ko00640	Propanoate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010911	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010911	K01895	ko01100	Metabolic pathways	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010911	K01895	ko01110	Biosynthesis of secondary metabolites	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMT200010912	K01895	ko00010	Glycolysis / Gluconeogenesis	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010912	K01895	ko00620	Pyruvate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010912	K01895	ko00640	Propanoate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010912	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010912	K01895	ko01100	Metabolic pathways	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010912	K01895	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMT200010913	K01895	ko00010	Glycolysis / Gluconeogenesis	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010913	K01895	ko00620	Pyruvate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010913	K01895	ko00640	Propanoate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010913	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010913	K01895	ko01100	Metabolic pathways	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010913	K01895	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMT200010914	K05277	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMT200010914	K05277	ko01100	Metabolic pathways	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMT200010914	K05277	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMT200010917	K03950	ko00190	Oxidative phosphorylation	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMT200010917	K03950	ko01100	Metabolic pathways	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMT200010917	K03950	ko05010	Alzheimer's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMT200010917	K03950	ko05012	Parkinson's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMT200010917	K03950	ko05016	Huntington's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMT200010918	K03950	ko00190	Oxidative phosphorylation	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMT200010918	K03950	ko01100	Metabolic pathways	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMT200010918	K03950	ko05010	Alzheimer's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMT200010918	K03950	ko05012	Parkinson's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMT200010918	K03950	ko05016	Huntington's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMT200010919	K03950	ko00190	Oxidative phosphorylation	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMT200010919	K03950	ko01100	Metabolic pathways	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMT200010919	K03950	ko05010	Alzheimer's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMT200010919	K03950	ko05012	Parkinson's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMT200010919	K03950	ko05016	Huntington's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMT200010920	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMT200010921	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMT200010922	K11594	ko04622	RIG-I-like receptor signaling pathway	546	2.8e-24	0.77	0.83	0.99
PGSC0003DMT200007769	K10576	ko04120	Ubiquitin mediated proteolysis	1299	8.2e-66	0.84	0.92	0.99
PGSC0003DMT200007770	K10576	ko04120	Ubiquitin mediated proteolysis	585	2.0e-26	0.75	0.88	0.99
PGSC0003DMT200007771	K10576	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.83	0.92	0.99
PGSC0003DMT200007772	K10576	ko04120	Ubiquitin mediated proteolysis	733	1.4e-34	0.93	0.97	0.81
PGSC0003DMT200007788	K01046	ko00561	Glycerolipid metabolism	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMT200007788	K01046	ko01100	Metabolic pathways	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMT200007798	K01188	ko00460	Cyanoamino acid metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMT200007798	K01188	ko00500	Starch and sucrose metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMT200007798	K01188	ko00940	Phenylpropanoid biosynthesis	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMT200007798	K01188	ko01110	Biosynthesis of secondary metabolites	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMT200007801	K01188	ko00460	Cyanoamino acid metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMT200007801	K01188	ko00500	Starch and sucrose metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMT200007801	K01188	ko00940	Phenylpropanoid biosynthesis	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMT200007801	K01188	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMT200007802	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007802	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007802	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007802	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007803	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007803	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007803	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007803	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMT200007812	K12929	ko00904	Diterpenoid biosynthesis	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMT200007812	K12929	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMT200007814	K08008	ko04145	Phagosome	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMT200007814	K08008	ko04670	Leukocyte transendothelial migration	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMT200089650	K13229	ko00402	Benzoxazinoid biosynthesis	403	2.2e-16	0.52	0.68	0.82
PGSC0003DMT200063776	K02183	ko04020	Calcium signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04070	Phosphatidylinositol signaling system	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04114	Oocyte meiosis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04270	Vascular smooth muscle contraction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04626	Plant-pathogen interaction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04720	Long-term potentiation	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04722	Neurotrophin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04740	Olfactory transduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04744	Phototransduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04745	Phototransduction - fly	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04910	Insulin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04912	GnRH signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04916	Melanogenesis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04970	Salivary secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko04971	Gastric acid secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko05010	Alzheimer's disease	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063776	K02183	ko05214	Glioma	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMT200063777	K02183	ko04020	Calcium signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04070	Phosphatidylinositol signaling system	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04114	Oocyte meiosis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04270	Vascular smooth muscle contraction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04626	Plant-pathogen interaction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04720	Long-term potentiation	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04722	Neurotrophin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04740	Olfactory transduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04744	Phototransduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04745	Phototransduction - fly	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04910	Insulin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04912	GnRH signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04916	Melanogenesis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04970	Salivary secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko04971	Gastric acid secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko05010	Alzheimer's disease	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063777	K02183	ko05214	Glioma	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMT200063802	K13289	ko04142	Lysosome	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMT200063802	K13289	ko04614	Renin-angiotensin system	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMT200063803	K13289	ko04142	Lysosome	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMT200063803	K13289	ko04614	Renin-angiotensin system	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMT200063806	K13289	ko04142	Lysosome	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMT200063806	K13289	ko04614	Renin-angiotensin system	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMT200054045	K12929	ko00904	Diterpenoid biosynthesis	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMT200054045	K12929	ko01110	Biosynthesis of secondary metabolites	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMT200054076	K00599	ko00340	Histidine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMT200054076	K00599	ko00350	Tyrosine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMT200054076	K00599	ko00450	Selenoamino acid metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMT200054076	K00599	ko00626	Naphthalene and anthracene degradation	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMT200054077	K00599	ko00340	Histidine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMT200054077	K00599	ko00350	Tyrosine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMT200054077	K00599	ko00450	Selenoamino acid metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMT200054077	K00599	ko00626	Naphthalene and anthracene degradation	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMT200054080	K00430	ko00360	Phenylalanine metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMT200054080	K00430	ko00680	Methane metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMT200054080	K00430	ko00940	Phenylpropanoid biosynthesis	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMT200054080	K00430	ko01100	Metabolic pathways	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMT200054080	K00430	ko01110	Biosynthesis of secondary metabolites	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMT200045511	K04733	ko04210	Apoptosis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMT200045511	K04733	ko04620	Toll-like receptor signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMT200045511	K04733	ko04722	Neurotrophin signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMT200045511	K04733	ko05140	Leishmaniasis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMT200045511	K04733	ko05142	Chagas disease	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMT200045538	K03043	ko00230	Purine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMT200045538	K03043	ko00240	Pyrimidine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMT200045538	K03043	ko01100	Metabolic pathways	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMT200045538	K03043	ko03020	RNA polymerase	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMT200045539	K03046	ko00230	Purine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMT200045539	K03046	ko00240	Pyrimidine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMT200045539	K03046	ko01100	Metabolic pathways	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMT200045539	K03046	ko03020	RNA polymerase	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMT200045540	K02967	ko03010	Ribosome	798	3.5e-38	0.93	0.95	0.56
PGSC0003DMT200045541	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045541	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045541	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045541	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045542	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045542	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045542	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045542	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMT200045546	K03046	ko00230	Purine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMT200045546	K03046	ko00240	Pyrimidine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMT200045546	K03046	ko01100	Metabolic pathways	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMT200045546	K03046	ko03020	RNA polymerase	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMT200088158	K00059	ko00061	Fatty acid biosynthesis	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMT200088158	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMT200088158	K00059	ko01100	Metabolic pathways	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMT200088166	K04371	ko04010	MAPK signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04012	ErbB signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04013	MAPK signaling pathway - fly	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04062	Chemokine signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04114	Oocyte meiosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04150	mTOR signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04320	Dorso-ventral axis formation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04350	TGF-beta signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04360	Axon guidance	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04370	VEGF signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04510	Focal adhesion	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04520	Adherens junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04540	Gap junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04620	Toll-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04621	NOD-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04650	Natural killer cell mediated cytotoxicity	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04660	T cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04662	B cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04664	Fc epsilon RI signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04666	Fc gamma R-mediated phagocytosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04720	Long-term potentiation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04730	Long-term depression	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04810	Regulation of actin cytoskeleton	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04910	Insulin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04912	GnRH signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04914	Progesterone-mediated oocyte maturation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04916	Melanogenesis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04930	Type II diabetes mellitus	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko04960	Aldosterone-regulated sodium reabsorption	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05010	Alzheimer's disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05020	Prion diseases	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05131	Shigellosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05140	Leishmaniasis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05142	Chagas disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05200	Pathways in cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05210	Colorectal cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05211	Renal cell carcinoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05212	Pancreatic cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05213	Endometrial cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05214	Glioma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05215	Prostate cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05216	Thyroid cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05218	Melanoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05219	Bladder cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05220	Chronic myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05221	Acute myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088166	K04371	ko05223	Non-small cell lung cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMT200088456	K06261	ko04512	ECM-receptor interaction	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMT200088456	K06261	ko04640	Hematopoietic cell lineage	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMT200088463	K13229	ko00402	Benzoxazinoid biosynthesis	937	7.6e-46	0.45	0.62	0.91
PGSC0003DMT200009226	K01735	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMT200009226	K01735	ko01100	Metabolic pathways	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMT200009226	K01735	ko01110	Biosynthesis of secondary metabolites	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMT200009228	K06689	ko04120	Ubiquitin mediated proteolysis	841	1.5e-40	0.69	0.73	0.98
PGSC0003DMT200009229	K06689	ko04120	Ubiquitin mediated proteolysis	1195	4.5e-60	0.90	0.97	0.99
PGSC0003DMT200009233	K00889	ko00562	Inositol phosphate metabolism	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009233	K00889	ko01100	Metabolic pathways	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009233	K00889	ko04070	Phosphatidylinositol signaling system	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009233	K00889	ko04144	Endocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009233	K00889	ko04666	Fc gamma R-mediated phagocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009233	K00889	ko04810	Regulation of actin cytoskeleton	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMT200009249	K03006	ko00230	Purine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMT200009249	K03006	ko00240	Pyrimidine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMT200009249	K03006	ko01100	Metabolic pathways	14720	0.	0.91	0.96	1.00
PGSC0003DMT200009249	K03006	ko03020	RNA polymerase	14720	0.	0.91	0.96	1.00
PGSC0003DMT200009249	K03006	ko05016	Huntington's disease	14720	0.	0.91	0.96	1.00
PGSC0003DMT200009250	K01115	ko00564	Glycerophospholipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009250	K01115	ko00565	Ether lipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009250	K01115	ko01100	Metabolic pathways	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009250	K01115	ko04144	Endocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009250	K01115	ko04666	Fc gamma R-mediated phagocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009250	K01115	ko04912	GnRH signaling pathway	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMT200009252	K01115	ko00564	Glycerophospholipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009252	K01115	ko00565	Ether lipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009252	K01115	ko01100	Metabolic pathways	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009252	K01115	ko04144	Endocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009252	K01115	ko04666	Fc gamma R-mediated phagocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009252	K01115	ko04912	GnRH signaling pathway	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMT200009253	K01115	ko00564	Glycerophospholipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009253	K01115	ko00565	Ether lipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009253	K01115	ko01100	Metabolic pathways	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009253	K01115	ko04144	Endocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009253	K01115	ko04666	Fc gamma R-mediated phagocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009253	K01115	ko04912	GnRH signaling pathway	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMT200009254	K12897	ko03040	Spliceosome	336	1.1e-12	0.43	0.49	0.97
PGSC0003DMT200018890	K12825	ko03040	Spliceosome	1405	1.2e-71	0.75	0.86	1.00
PGSC0003DMT200018891	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMT200018892	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMT200018905	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMT200018905	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMT200018905	K00771	ko01100	Metabolic pathways	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMT200018907	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMT200018907	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMT200018907	K00771	ko01100	Metabolic pathways	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMT200018918	K01516	ko00230	Purine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMT200018918	K01516	ko00730	Thiamine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMT200018918	K01516	ko01100	Metabolic pathways	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMT200043979	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043979	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043979	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043980	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043980	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043980	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043981	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043981	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043981	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043982	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043982	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200043982	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMT200055833	K13030	ko00460	Cyanoamino acid metabolism	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMT200055833	K13030	ko01110	Biosynthesis of secondary metabolites	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMT200055842	K13228	ko00402	Benzoxazinoid biosynthesis	760	4.4e-36	0.32	0.48	0.85
PGSC0003DMT200055845	K13228	ko00402	Benzoxazinoid biosynthesis	624	1.4e-28	0.43	0.60	0.96
PGSC0003DMT200055856	K13228	ko00402	Benzoxazinoid biosynthesis	1123	4.2e-56	0.39	0.59	0.98
PGSC0003DMT200055859	K13228	ko00402	Benzoxazinoid biosynthesis	506	4.5e-22	0.52	0.72	0.87
PGSC0003DMT200065489	K01379	ko04142	Lysosome	290	1.7e-09	0.27	0.43	0.83
PGSC0003DMT200065492	K11229	ko04011	MAPK signaling pathway - yeast	611	5.0e-27	0.37	0.56	0.73
PGSC0003DMT200065498	K00430	ko00360	Phenylalanine metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMT200065498	K00430	ko00680	Methane metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMT200065498	K00430	ko00940	Phenylpropanoid biosynthesis	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMT200065498	K00430	ko01100	Metabolic pathways	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMT200065498	K00430	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMT200052517	K07466	ko03030	DNA replication	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMT200052517	K07466	ko03420	Nucleotide excision repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMT200052517	K07466	ko03430	Mismatch repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMT200052517	K07466	ko03440	Homologous recombination	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMT200052526	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMT200052526	K06127	ko01100	Metabolic pathways	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMT200052526	K06127	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMT200052527	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMT200052527	K06127	ko01100	Metabolic pathways	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMT200052527	K06127	ko01110	Biosynthesis of secondary metabolites	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMT200052528	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMT200052528	K06127	ko01100	Metabolic pathways	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMT200052528	K06127	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMT200052529	K11090	ko05322	Systemic lupus erythematosus	328	3.0e-12	0.34	0.55	0.56
PGSC0003DMT200052531	K11090	ko05322	Systemic lupus erythematosus	359	5.8e-14	0.30	0.46	0.59
PGSC0003DMT200052545	K00430	ko00360	Phenylalanine metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMT200052545	K00430	ko00680	Methane metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMT200052545	K00430	ko00940	Phenylpropanoid biosynthesis	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMT200052545	K00430	ko01100	Metabolic pathways	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMT200052545	K00430	ko01110	Biosynthesis of secondary metabolites	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMT200052546	K12598	ko03018	RNA degradation	4700	2.1e-253	0.82	0.90	0.97
PGSC0003DMT200052547	K12598	ko03018	RNA degradation	3393	2.6e-181	0.78	0.86	0.98
PGSC0003DMT200052548	K12598	ko03018	RNA degradation	6837	0.	0.82	0.91	1.00
PGSC0003DMT200052549	K12598	ko03018	RNA degradation	5237	5.2e-283	0.82	0.90	1.00
PGSC0003DMT200052550	K12598	ko03018	RNA degradation	1602	1.6e-82	0.82	0.94	0.92
PGSC0003DMT200052558	K01184	ko00040	Pentose and glucuronate interconversions	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMT200052558	K01184	ko00500	Starch and sucrose metabolism	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMT200052558	K01184	ko01100	Metabolic pathways	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMT200047345	K00876	ko00240	Pyrimidine metabolism	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMT200047345	K00876	ko00983	Drug metabolism - other enzymes	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMT200047345	K00876	ko01100	Metabolic pathways	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMT200047346	K00876	ko00240	Pyrimidine metabolism	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMT200047346	K00876	ko00983	Drug metabolism - other enzymes	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMT200047346	K00876	ko01100	Metabolic pathways	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMT200047347	K00876	ko00240	Pyrimidine metabolism	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMT200047347	K00876	ko00983	Drug metabolism - other enzymes	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMT200047347	K00876	ko01100	Metabolic pathways	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMT200047364	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200047364	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200047364	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200047365	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200047365	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200047365	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMT200093591	K12493	ko04144	Endocytosis	581	1.4e-25	0.46	0.60	0.74
PGSC0003DMT200030665	K01051	ko00040	Pentose and glucuronate interconversions	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMT200030665	K01051	ko00500	Starch and sucrose metabolism	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMT200030665	K01051	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMT200030666	K01051	ko00040	Pentose and glucuronate interconversions	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMT200030666	K01051	ko00500	Starch and sucrose metabolism	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMT200030666	K01051	ko01100	Metabolic pathways	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMT200030670	K13228	ko00402	Benzoxazinoid biosynthesis	679	1.3e-31	0.31	0.48	0.97
PGSC0003DMT200030671	K07424	ko00140	Steroid hormone biosynthesis	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00591	Linoleic acid metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00830	Retinol metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00982	Drug metabolism - cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko00983	Drug metabolism - other enzymes	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030671	K07424	ko01100	Metabolic pathways	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMT200030672	K07424	ko00140	Steroid hormone biosynthesis	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00591	Linoleic acid metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00830	Retinol metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00982	Drug metabolism - cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko00983	Drug metabolism - other enzymes	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030672	K07424	ko01100	Metabolic pathways	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMT200030673	K07424	ko00140	Steroid hormone biosynthesis	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00591	Linoleic acid metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00830	Retinol metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00982	Drug metabolism - cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko00983	Drug metabolism - other enzymes	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030673	K07424	ko01100	Metabolic pathways	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMT200030674	K07424	ko00140	Steroid hormone biosynthesis	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00591	Linoleic acid metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00830	Retinol metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00982	Drug metabolism - cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko00983	Drug metabolism - other enzymes	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030674	K07424	ko01100	Metabolic pathways	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMT200030676	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030676	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030676	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030677	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030677	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030677	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMT200030679	K10352	ko04530	Tight junction	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMT200030679	K10352	ko05416	Viral myocarditis	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMT200030684	K01962	ko00061	Fatty acid biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200030684	K01962	ko00253	Tetracycline biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200030684	K01962	ko00620	Pyruvate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200030684	K01962	ko00640	Propanoate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200030684	K01962	ko01100	Metabolic pathways	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200030684	K01962	ko01110	Biosynthesis of secondary metabolites	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMT200023712	K10773	ko03410	Base excision repair	1556	5.5e-80	0.36	0.49	0.46
PGSC0003DMT200023718	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMT200023718	K00814	ko00710	Carbon fixation in photosynthetic organisms	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMT200023718	K00814	ko01100	Metabolic pathways	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMT200023719	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMT200023719	K00814	ko00710	Carbon fixation in photosynthetic organisms	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMT200023719	K00814	ko01100	Metabolic pathways	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMT200023721	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMT200023721	K00814	ko00710	Carbon fixation in photosynthetic organisms	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMT200023721	K00814	ko01100	Metabolic pathways	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMT200023724	K01051	ko00040	Pentose and glucuronate interconversions	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMT200023724	K01051	ko00500	Starch and sucrose metabolism	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMT200023724	K01051	ko01100	Metabolic pathways	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMT200023725	K01051	ko00040	Pentose and glucuronate interconversions	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMT200023725	K01051	ko00500	Starch and sucrose metabolism	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMT200023725	K01051	ko01100	Metabolic pathways	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMT200023726	K01051	ko00040	Pentose and glucuronate interconversions	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMT200023726	K01051	ko00500	Starch and sucrose metabolism	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMT200023726	K01051	ko01100	Metabolic pathways	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMT200023727	K01051	ko00040	Pentose and glucuronate interconversions	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMT200023727	K01051	ko00500	Starch and sucrose metabolism	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMT200023727	K01051	ko01100	Metabolic pathways	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMT200023739	K04368	ko04010	MAPK signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04012	ErbB signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04013	MAPK signaling pathway - fly	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04062	Chemokine signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04114	Oocyte meiosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04270	Vascular smooth muscle contraction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04320	Dorso-ventral axis formation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04370	VEGF signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04510	Focal adhesion	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04540	Gap junction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04620	Toll-like receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04626	Plant-pathogen interaction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04650	Natural killer cell mediated cytotoxicity	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04660	T cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04662	B cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04664	Fc epsilon RI signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04666	Fc gamma R-mediated phagocytosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04720	Long-term potentiation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04730	Long-term depression	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04810	Regulation of actin cytoskeleton	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04910	Insulin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04912	GnRH signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04914	Progesterone-mediated oocyte maturation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko04916	Melanogenesis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05020	Prion diseases	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05200	Pathways in cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05210	Colorectal cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05211	Renal cell carcinoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05212	Pancreatic cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05213	Endometrial cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05214	Glioma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05215	Prostate cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05216	Thyroid cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05218	Melanoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05219	Bladder cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05220	Chronic myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05221	Acute myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200023739	K04368	ko05223	Non-small cell lung cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMT200015845	K10590	ko04120	Ubiquitin mediated proteolysis	12254	0.	0.79	0.88	0.99
PGSC0003DMT200015847	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMT200015848	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMT200015849	K02731	ko03050	Proteasome	1990	6.3e-104	0.96	0.99	1.00
PGSC0003DMT200015865	K05765	ko04360	Axon guidance	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMT200015865	K05765	ko04666	Fc gamma R-mediated phagocytosis	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMT200015865	K05765	ko04810	Regulation of actin cytoskeleton	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMT200015879	K02936	ko03010	Ribosome	880	1.1e-42	0.77	0.82	0.99
PGSC0003DMT200066702	K08233	ko00901	Indole alkaloid biosynthesis	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMT200066702	K08233	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMT200066704	K08233	ko00901	Indole alkaloid biosynthesis	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMT200066704	K08233	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMT200066721	K02184	ko04320	Dorso-ventral axis formation	1074	7.4e-53	0.38	0.46	0.43
PGSC0003DMT200066734	K04631	ko04744	Phototransduction	534	1.3e-23	0.33	0.53	0.80
PGSC0003DMT200066736	K10260	ko04120	Ubiquitin mediated proteolysis	297	1.5e-10	0.34	0.49	0.47
PGSC0003DMT200066737	K10260	ko04120	Ubiquitin mediated proteolysis	354	1.5e-16	0.31	0.47	0.64
PGSC0003DMT200059063	K13229	ko00402	Benzoxazinoid biosynthesis	289	4.2e-10	0.39	0.52	0.94
PGSC0003DMT200059075	K02878	ko03010	Ribosome	246	9.8e-08	0.61	0.73	0.94
PGSC0003DMT200059095	K04103	ko00380	Tryptophan metabolism	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMT200059095	K04103	ko01100	Metabolic pathways	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMT200059096	K04103	ko00380	Tryptophan metabolism	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMT200059096	K04103	ko01100	Metabolic pathways	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMT200059099	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200059099	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200059099	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200059099	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200059099	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200090678	K05278	ko00941	Flavonoid biosynthesis	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMT200090678	K05278	ko01100	Metabolic pathways	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMT200090678	K05278	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMT200090689	K01199	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.54	0.71	0.92
PGSC0003DMT200090690	K10760	ko00908	Zeatin biosynthesis	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMT200090690	K10760	ko01100	Metabolic pathways	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMT200090690	K10760	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMT200095628	K10760	ko00908	Zeatin biosynthesis	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMT200095628	K10760	ko01100	Metabolic pathways	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMT200095628	K10760	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMT200094045	K01051	ko00040	Pentose and glucuronate interconversions	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMT200094045	K01051	ko00500	Starch and sucrose metabolism	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMT200094045	K01051	ko01100	Metabolic pathways	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMT200035292	K04424	ko04010	MAPK signaling pathway	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMT200035292	K04424	ko04530	Tight junction	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMT200035313	K09843	ko00906	Carotenoid biosynthesis	1009	8.1e-50	0.36	0.53	0.96
PGSC0003DMT200011544	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMT200011544	K00430	ko00680	Methane metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMT200011544	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMT200011544	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMT200011544	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMT200011573	K04733	ko04210	Apoptosis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMT200011573	K04733	ko04620	Toll-like receptor signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMT200011573	K04733	ko04722	Neurotrophin signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMT200011573	K04733	ko05140	Leishmaniasis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMT200011573	K04733	ko05142	Chagas disease	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMT200011574	K04733	ko04210	Apoptosis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMT200011574	K04733	ko04620	Toll-like receptor signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMT200011574	K04733	ko04722	Neurotrophin signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMT200011574	K04733	ko05140	Leishmaniasis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMT200011574	K04733	ko05142	Chagas disease	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMT200011575	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011575	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200011576	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMT200029574	K00949	ko00730	Thiamine metabolism	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMT200029574	K00949	ko01100	Metabolic pathways	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMT200029575	K00949	ko00730	Thiamine metabolism	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMT200029575	K00949	ko01100	Metabolic pathways	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMT200029576	K00949	ko00730	Thiamine metabolism	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMT200029576	K00949	ko01100	Metabolic pathways	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMT200029579	K10858	ko03430	Mismatch repair	3978	1.4e-213	0.56	0.71	0.99
PGSC0003DMT200029581	K05666	ko02010	ABC transporters	3402	8.4e-182	0.35	0.55	0.94
PGSC0003DMT200029582	K05666	ko02010	ABC transporters	3424	5.1e-183	0.35	0.55	0.97
PGSC0003DMT200029588	K01710	ko00521	Streptomycin biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMT200029588	K01710	ko00523	Polyketide sugar unit biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMT200029588	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMT200029588	K01710	ko01100	Metabolic pathways	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMT200029588	K01710	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMT200029589	K01710	ko00521	Streptomycin biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMT200029589	K01710	ko00523	Polyketide sugar unit biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMT200029589	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMT200029589	K01710	ko01100	Metabolic pathways	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMT200029589	K01710	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMT200029590	K01710	ko00521	Streptomycin biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMT200029590	K01710	ko00523	Polyketide sugar unit biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMT200029590	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMT200029590	K01710	ko01100	Metabolic pathways	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMT200029590	K01710	ko01110	Biosynthesis of secondary metabolites	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMT200029591	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.29
PGSC0003DMT200029592	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.40
PGSC0003DMT200029601	K08852	ko05010	Alzheimer's disease	246	1.5e-07	0.45	0.57	0.31
PGSC0003DMT200016405	K01046	ko00561	Glycerolipid metabolism	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMT200016405	K01046	ko01100	Metabolic pathways	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMT200016406	K01046	ko00561	Glycerolipid metabolism	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMT200016406	K01046	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMT200016422	K06630	ko04110	Cell cycle	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMT200016422	K06630	ko04114	Oocyte meiosis	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMT200016422	K06630	ko04722	Neurotrophin signaling pathway	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMT200016440	K05933	ko00270	Cysteine and methionine metabolism	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMT200016440	K05933	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMT200016441	K05933	ko00270	Cysteine and methionine metabolism	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMT200016441	K05933	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMT200016442	K05933	ko00270	Cysteine and methionine metabolism	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMT200016442	K05933	ko01110	Biosynthesis of secondary metabolites	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMT200016443	K05933	ko00270	Cysteine and methionine metabolism	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMT200016443	K05933	ko01110	Biosynthesis of secondary metabolites	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMT200016444	K05933	ko00270	Cysteine and methionine metabolism	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMT200016444	K05933	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMT200016445	K09458	ko00061	Fatty acid biosynthesis	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMT200016445	K09458	ko01100	Metabolic pathways	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMT200016446	K09458	ko00061	Fatty acid biosynthesis	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMT200016446	K09458	ko01100	Metabolic pathways	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMT200016447	K09458	ko00061	Fatty acid biosynthesis	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMT200016447	K09458	ko01100	Metabolic pathways	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMT200016448	K09458	ko00061	Fatty acid biosynthesis	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMT200016448	K09458	ko01100	Metabolic pathways	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMT200016449	K09458	ko00061	Fatty acid biosynthesis	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMT200016449	K09458	ko01100	Metabolic pathways	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMT200054730	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054730	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054730	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054731	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054731	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054731	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMT200054753	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMT200054754	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMT200054755	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMT200054757	K01307	ko00790	Folate biosynthesis	1944	2.2e-101	0.73	0.84	0.95
PGSC0003DMT200054759	K03504	ko00230	Purine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko00240	Pyrimidine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko01100	Metabolic pathways	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko03030	DNA replication	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko03410	Base excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko03420	Nucleotide excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko03430	Mismatch repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054759	K03504	ko03440	Homologous recombination	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMT200054760	K03504	ko00230	Purine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko00240	Pyrimidine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko01100	Metabolic pathways	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko03030	DNA replication	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko03410	Base excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko03420	Nucleotide excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko03430	Mismatch repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054760	K03504	ko03440	Homologous recombination	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko00230	Purine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko00240	Pyrimidine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko01100	Metabolic pathways	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko03030	DNA replication	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko03410	Base excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko03420	Nucleotide excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko03430	Mismatch repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054761	K03504	ko03440	Homologous recombination	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMT200054762	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200054762	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200054762	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200054763	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200054763	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200054763	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMT200081749	K00472	ko00330	Arginine and proline metabolism	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMT200081749	K00472	ko01100	Metabolic pathways	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMT200081755	K01006	ko00620	Pyruvate metabolism	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMT200081755	K01006	ko00710	Carbon fixation in photosynthetic organisms	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMT200081755	K01006	ko01100	Metabolic pathways	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMT200081757	K01006	ko00620	Pyruvate metabolism	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMT200081757	K01006	ko00710	Carbon fixation in photosynthetic organisms	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMT200081757	K01006	ko01100	Metabolic pathways	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMT200081758	K01006	ko00620	Pyruvate metabolism	6272	0.	0.87	0.95	1.00
PGSC0003DMT200081758	K01006	ko00710	Carbon fixation in photosynthetic organisms	6272	0.	0.87	0.95	1.00
PGSC0003DMT200081758	K01006	ko01100	Metabolic pathways	6272	0.	0.87	0.95	1.00
PGSC0003DMT200081769	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200081774	K01611	ko00270	Cysteine and methionine metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMT200081774	K01611	ko00330	Arginine and proline metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMT200081774	K01611	ko01100	Metabolic pathways	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMT200044868	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMT200044870	K12741	ko03040	Spliceosome	953	1.0e-46	0.52	0.65	1.00
PGSC0003DMT200044871	K12741	ko03040	Spliceosome	755	8.3e-36	0.63	0.88	0.76
PGSC0003DMT200044873	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMT200044874	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMT200044875	K10601	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.32	0.52	0.74
PGSC0003DMT200044877	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMT200044878	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMT200044880	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.30
PGSC0003DMT200044886	K00850	ko00010	Glycolysis / Gluconeogenesis	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044886	K00850	ko00030	Pentose phosphate pathway	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044886	K00850	ko00051	Fructose and mannose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044886	K00850	ko00052	Galactose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044886	K00850	ko01100	Metabolic pathways	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044886	K00850	ko01110	Biosynthesis of secondary metabolites	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMT200044893	K02084	ko04115	p53 signaling pathway	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko04210	Apoptosis	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko05010	Alzheimer's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko05012	Parkinson's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko05016	Huntington's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044893	K02084	ko05222	Small cell lung cancer	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMT200044895	K02084	ko04115	p53 signaling pathway	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko04210	Apoptosis	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko05010	Alzheimer's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko05012	Parkinson's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko05016	Huntington's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200044895	K02084	ko05222	Small cell lung cancer	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMT200072394	K03531	ko04112	Cell cycle - Caulobacter	3206	5.4e-171	0.81	0.89	1.00
PGSC0003DMT200072398	K01915	ko00250	Alanine, aspartate and glutamate metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMT200072398	K01915	ko00330	Arginine and proline metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMT200072398	K01915	ko00910	Nitrogen metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMT200072398	K01915	ko01100	Metabolic pathways	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMT200072398	K01915	ko02020	Two-component system	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMT200072408	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMT200072408	K00517	ko00626	Naphthalene and anthracene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMT200072408	K00517	ko00903	Limonene and pinene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMT200072408	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMT200072408	K00517	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMT200072409	K02527	ko00540	Lipopolysaccharide biosynthesis	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMT200072409	K02527	ko01100	Metabolic pathways	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMT200072410	K02527	ko00540	Lipopolysaccharide biosynthesis	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMT200072410	K02527	ko01100	Metabolic pathways	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMT200042984	K01426	ko00330	Arginine and proline metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042984	K01426	ko00360	Phenylalanine metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042984	K01426	ko00380	Tryptophan metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042984	K01426	ko00460	Cyanoamino acid metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042984	K01426	ko00632	Benzoate degradation via CoA ligation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042984	K01426	ko00643	Styrene degradation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMT200042985	K01426	ko00330	Arginine and proline metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200042985	K01426	ko00360	Phenylalanine metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200042985	K01426	ko00380	Tryptophan metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200042985	K01426	ko00460	Cyanoamino acid metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200042985	K01426	ko00632	Benzoate degradation via CoA ligation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200042985	K01426	ko00643	Styrene degradation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMT200043000	K01692	ko00071	Fatty acid metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00280	Valine, leucine and isoleucine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00281	Geraniol degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00310	Lysine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00380	Tryptophan metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00410	beta-Alanine metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00632	Benzoate degradation via CoA ligation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00640	Propanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00650	Butanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00903	Limonene and pinene degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko00930	Caprolactam degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko01100	Metabolic pathways	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200043000	K01692	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMT200030913	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMT200030914	K02924	ko03010	Ribosome	310	2.9e-11	0.92	0.97	0.63
PGSC0003DMT200030916	K02924	ko03010	Ribosome	439	2.2e-18	0.94	0.98	0.98
PGSC0003DMT200030917	K06237	ko04510	Focal adhesion	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMT200030917	K06237	ko04512	ECM-receptor interaction	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMT200030917	K06237	ko05146	Amoebiasis	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMT200030917	K06237	ko05200	Pathways in cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMT200030917	K06237	ko05222	Small cell lung cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMT200030923	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.36	0.52	0.92
PGSC0003DMT200030924	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	462	1.2e-19	0.31	0.49	0.65
PGSC0003DMT200030927	K01053	ko00030	Pentose phosphate pathway	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMT200030927	K01053	ko00053	Ascorbate and aldarate metabolism	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMT200030927	K01053	ko00930	Caprolactam degradation	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMT200030927	K01053	ko01100	Metabolic pathways	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMT200030927	K01053	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMT200005370	K11826	ko04144	Endocytosis	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMT200005370	K11826	ko05016	Huntington's disease	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMT200005371	K11826	ko04144	Endocytosis	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMT200005371	K11826	ko05016	Huntington's disease	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMT200086264	K10760	ko00908	Zeatin biosynthesis	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMT200086264	K10760	ko01100	Metabolic pathways	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMT200086264	K10760	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMT200077025	K12667	ko00510	N-Glycan biosynthesis	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMT200077025	K12667	ko01100	Metabolic pathways	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMT200077045	K01047	ko00564	Glycerophospholipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko00565	Ether lipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko00590	Arachidonic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko00591	Linoleic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko00592	alpha-Linolenic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko01100	Metabolic pathways	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04010	MAPK signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04270	Vascular smooth muscle contraction	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04370	VEGF signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04664	Fc epsilon RI signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04730	Long-term depression	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077045	K01047	ko04912	GnRH signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMT200077054	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMT200077054	K00517	ko00626	Naphthalene and anthracene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMT200077054	K00517	ko00903	Limonene and pinene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMT200077054	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMT200077054	K00517	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMT200077055	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMT200077055	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMT200077055	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMT200077055	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMT200077055	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMT200077065	K01834	ko00010	Glycolysis / Gluconeogenesis	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMT200077065	K01834	ko01100	Metabolic pathways	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMT200077065	K01834	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMT200077067	K05350	ko00460	Cyanoamino acid metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMT200077067	K05350	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMT200077067	K05350	ko00940	Phenylpropanoid biosynthesis	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMT200077067	K05350	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMT200077068	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMT200077068	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMT200077068	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMT200077068	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMT200077077	K01354	ko05142	Chagas disease	416	8.0e-17	0.57	0.72	0.65
PGSC0003DMT200077078	K01354	ko05142	Chagas disease	2254	1.7e-118	0.74	0.86	0.99
PGSC0003DMT200051899	K02721	ko00195	Photosynthesis	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMT200051899	K02721	ko01100	Metabolic pathways	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMT200051907	K10955	ko05110	Vibrio cholerae infection	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMT200051907	K10955	ko05146	Amoebiasis	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMT200051913	K06636	ko04110	Cell cycle	7300	0.	0.69	0.81	1.00
PGSC0003DMT200051913	K06636	ko04111	Cell cycle - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMT200051913	K06636	ko04113	Meiosis - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMT200051913	K06636	ko04114	Oocyte meiosis	7300	0.	0.69	0.81	1.00
PGSC0003DMT200051914	K06636	ko04110	Cell cycle	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMT200051914	K06636	ko04111	Cell cycle - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMT200051914	K06636	ko04113	Meiosis - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMT200051914	K06636	ko04114	Oocyte meiosis	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMT200051917	K02875	ko03010	Ribosome	1011	6.3e-50	0.90	0.95	0.99
PGSC0003DMT200051918	K01900	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMT200051918	K01900	ko00640	Propanoate metabolism	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMT200051918	K01900	ko01100	Metabolic pathways	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMT200051918	K01900	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMT200051919	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMT200051920	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.62
PGSC0003DMT200051922	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.48
PGSC0003DMT200051923	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMT200051924	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMT200051932	K02693	ko00195	Photosynthesis	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMT200051932	K02693	ko01100	Metabolic pathways	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMT200051938	K01728	ko00040	Pentose and glucuronate interconversions	2857	9.6e-152	0.80	0.89	0.87
PGSC0003DMT200041208	K10572	ko00562	Inositol phosphate metabolism	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMT200041208	K10572	ko01100	Metabolic pathways	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMT200041208	K10572	ko04070	Phosphatidylinositol signaling system	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMT200041213	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041213	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041213	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041214	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041214	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041214	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMT200041215	K00975	ko00500	Starch and sucrose metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMT200041215	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMT200041215	K00975	ko01100	Metabolic pathways	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMT200041230	K02689	ko00195	Photosynthesis	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMT200041230	K02689	ko01100	Metabolic pathways	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMT200041232	K04618	ko00052	Galactose metabolism	341	3.2e-10	0.27	0.41	0.78
PGSC0003DMT200041234	K12821	ko03040	Spliceosome	3869	1.5e-207	0.62	0.72	0.99
PGSC0003DMT200041235	K12821	ko03040	Spliceosome	3769	4.8e-202	0.69	0.82	1.00
PGSC0003DMT200041236	K12821	ko03040	Spliceosome	5200	5.7e-281	0.61	0.72	1.00
PGSC0003DMT200021743	K07199	ko04910	Insulin signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMT200021743	K07199	ko04920	Adipocytokine signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMT200021743	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMT200021744	K07199	ko04910	Insulin signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMT200021744	K07199	ko04920	Adipocytokine signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMT200021744	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMT200021745	K07199	ko04910	Insulin signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMT200021745	K07199	ko04920	Adipocytokine signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMT200021745	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMT200021750	K08300	ko03018	RNA degradation	238	2.4e-06	0.40	0.47	0.86
PGSC0003DMT200021751	K08300	ko03018	RNA degradation	241	1.6e-06	0.41	0.47	0.90
PGSC0003DMT200007157	K01358	ko04112	Cell cycle - Caulobacter	1882	5.7e-98	0.90	0.94	0.44
PGSC0003DMT200007158	K01358	ko04112	Cell cycle - Caulobacter	1964	1.7e-102	0.80	0.87	0.98
PGSC0003DMT200007165	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200007165	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200032674	K05681	ko02010	ABC transporters	1047	6.5e-52	0.32	0.52	0.88
PGSC0003DMT200032675	K05681	ko02010	ABC transporters	450	5.5e-19	0.48	0.69	0.74
PGSC0003DMT200032676	K05681	ko02010	ABC transporters	367	4.6e-14	0.29	0.49	0.83
PGSC0003DMT200032677	K05681	ko02010	ABC transporters	1132	1.3e-56	0.33	0.54	0.89
PGSC0003DMT200032678	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMT200032679	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMT200032680	K05681	ko02010	ABC transporters	1123	4.2e-56	0.34	0.55	0.87
PGSC0003DMT200032681	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMT200032681	K01626	ko01100	Metabolic pathways	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMT200032681	K01626	ko01110	Biosynthesis of secondary metabolites	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMT200032682	K02371	ko00061	Fatty acid biosynthesis	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMT200032682	K02371	ko01100	Metabolic pathways	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMT200032683	K02371	ko00061	Fatty acid biosynthesis	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMT200032683	K02371	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMT200032684	K13030	ko00460	Cyanoamino acid metabolism	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMT200032684	K13030	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMT200032685	K13030	ko00460	Cyanoamino acid metabolism	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMT200032685	K13030	ko01110	Biosynthesis of secondary metabolites	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMT200032709	K12891	ko03040	Spliceosome	1647	5.3e-85	0.76	0.84	0.99
PGSC0003DMT200001570	K00475	ko00941	Flavonoid biosynthesis	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMT200001570	K00475	ko01100	Metabolic pathways	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMT200001570	K00475	ko01110	Biosynthesis of secondary metabolites	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMT200001573	K12130	ko04712	Circadian rhythm - plant	1781	2.1e-92	0.42	0.54	1.00
PGSC0003DMT200001574	K12130	ko04712	Circadian rhythm - plant	1585	1.4e-81	0.40	0.52	0.95
PGSC0003DMT200001594	K05933	ko00270	Cysteine and methionine metabolism	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMT200001594	K05933	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMT200001598	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMT200001599	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMT200001600	K05278	ko00941	Flavonoid biosynthesis	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMT200001600	K05278	ko01100	Metabolic pathways	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMT200001600	K05278	ko01110	Biosynthesis of secondary metabolites	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMT200001601	K05282	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMT200001601	K05282	ko01100	Metabolic pathways	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMT200001601	K05282	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMT200001603	K05933	ko00270	Cysteine and methionine metabolism	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMT200001603	K05933	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMT200001604	K05933	ko00270	Cysteine and methionine metabolism	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMT200001604	K05933	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMT200001605	K05933	ko00270	Cysteine and methionine metabolism	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMT200001605	K05933	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMT200001608	K05933	ko00270	Cysteine and methionine metabolism	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMT200001608	K05933	ko01110	Biosynthesis of secondary metabolites	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMT200001611	K05933	ko00270	Cysteine and methionine metabolism	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMT200001611	K05933	ko01110	Biosynthesis of secondary metabolites	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMT200087472	K03007	ko00230	Purine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMT200087472	K03007	ko00240	Pyrimidine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMT200087472	K03007	ko01100	Metabolic pathways	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMT200087472	K03007	ko03020	RNA polymerase	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMT200087472	K03007	ko05016	Huntington's disease	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMT200087473	K00059	ko00061	Fatty acid biosynthesis	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMT200087473	K00059	ko01040	Biosynthesis of unsaturated fatty acids	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMT200087473	K00059	ko01100	Metabolic pathways	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMT200050007	K12843	ko03040	Spliceosome	1782	1.9e-92	0.37	0.52	0.94
PGSC0003DMT200050016	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.31
PGSC0003DMT200050017	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.33
PGSC0003DMT200050018	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.61	0.70	0.32
PGSC0003DMT200050027	K03006	ko00230	Purine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMT200050027	K03006	ko00240	Pyrimidine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMT200050027	K03006	ko01100	Metabolic pathways	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMT200050027	K03006	ko03020	RNA polymerase	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMT200050027	K03006	ko05016	Huntington's disease	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMT200075325	K06685	ko04111	Cell cycle - yeast	1669	3.0e-88	0.82	0.85	0.87
PGSC0003DMT200075326	K06685	ko04111	Cell cycle - yeast	1795	3.6e-93	0.95	0.99	1.00
PGSC0003DMT200075327	K06685	ko04111	Cell cycle - yeast	1739	4.4e-90	0.95	0.99	0.96
PGSC0003DMT200075345	K12125	ko04712	Circadian rhythm - plant	1607	8.4e-83	0.40	0.53	0.99
PGSC0003DMT200075346	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.40	0.51	0.84
PGSC0003DMT200075347	K12125	ko04712	Circadian rhythm - plant	819	2.5e-39	0.40	0.50	0.93
PGSC0003DMT200075348	K00850	ko00010	Glycolysis / Gluconeogenesis	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075348	K00850	ko00030	Pentose phosphate pathway	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075348	K00850	ko00051	Fructose and mannose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075348	K00850	ko00052	Galactose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075348	K00850	ko01100	Metabolic pathways	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075348	K00850	ko01110	Biosynthesis of secondary metabolites	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMT200075349	K02087	ko04110	Cell cycle	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMT200075349	K02087	ko04114	Oocyte meiosis	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMT200075349	K02087	ko04115	p53 signaling pathway	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMT200075349	K02087	ko04540	Gap junction	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMT200075349	K02087	ko04914	Progesterone-mediated oocyte maturation	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMT200037113	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMT200037114	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMT200037115	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMT200037116	K05658	ko02010	ABC transporters	1051	1.1e-55	0.43	0.61	0.94
PGSC0003DMT200037148	K08094	ko00040	Pentose and glucuronate interconversions	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMT200037148	K08094	ko00680	Methane metabolism	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMT200009772	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMT200009774	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.40
PGSC0003DMT200009775	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.37
PGSC0003DMT200009776	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMT200009777	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMT200009783	K02922	ko03010	Ribosome	465	8.2e-20	0.64	0.69	0.97
PGSC0003DMT200009790	K10143	ko04115	p53 signaling pathway	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMT200009790	K10143	ko04120	Ubiquitin mediated proteolysis	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMT200009801	K12621	ko03018	RNA degradation	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMT200009801	K12621	ko03040	Spliceosome	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMT200009804	K02358	ko04626	Plant-pathogen interaction	3395	2.0e-181	0.90	0.93	1.00
PGSC0003DMT200009814	K00754	ko00051	Fructose and mannose metabolism	335	1.6e-12	0.30	0.50	0.53
PGSC0003DMT200009821	K03025	ko00230	Purine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMT200009821	K03025	ko00240	Pyrimidine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMT200009821	K03025	ko01100	Metabolic pathways	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMT200009821	K03025	ko03020	RNA polymerase	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMT200009821	K03025	ko04623	Cytosolic DNA-sensing pathway	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMT200027803	K12275	ko03060	Protein export	2026	6.6e-106	0.79	0.87	0.92
PGSC0003DMT200027804	K12275	ko03060	Protein export	2034	2.4e-106	0.79	0.87	0.92
PGSC0003DMT200027805	K12275	ko03060	Protein export	2163	1.8e-113	0.72	0.83	0.99
PGSC0003DMT200027820	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMT200027820	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMT200027820	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMT200027820	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMT200027820	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMT200027821	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027821	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027821	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027821	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027821	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027823	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMT200027823	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMT200027823	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMT200027823	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMT200027823	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMT200027824	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027824	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027824	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027824	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027824	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMT200027831	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200027831	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200027831	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200027831	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200027831	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMT200027833	K00430	ko00360	Phenylalanine metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMT200027833	K00430	ko00680	Methane metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMT200027833	K00430	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMT200027833	K00430	ko01100	Metabolic pathways	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMT200027833	K00430	ko01110	Biosynthesis of secondary metabolites	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMT200089480	K11251	ko05322	Systemic lupus erythematosus	763	3.0e-36	0.73	0.84	0.94
PGSC0003DMT200089483	K03094	ko04110	Cell cycle	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04111	Cell cycle - yeast	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04114	Oocyte meiosis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04120	Ubiquitin mediated proteolysis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04310	Wnt signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04350	TGF-beta signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200089483	K03094	ko04710	Circadian rhythm - mammal	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMT200094418	K11644	ko05016	Huntington's disease	286	2.8e-06	0.24	0.42	0.53
PGSC0003DMT200094421	K11251	ko05322	Systemic lupus erythematosus	536	1.0e-23	0.71	0.85	0.72
PGSC0003DMT200094423	K03133	ko03022	Basal transcription factors	231	6.6e-07	0.55	0.70	0.33
PGSC0003DMT200094438	K01955	ko00240	Pyrimidine metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMT200094438	K01955	ko00250	Alanine, aspartate and glutamate metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMT200094438	K01955	ko01100	Metabolic pathways	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMT200056501	K02894	ko03010	Ribosome	179	2.6e-06	0.91	0.97	0.19
PGSC0003DMT200056519	K06110	ko04530	Tight junction	765	2.3e-36	0.28	0.44	0.83
PGSC0003DMT200056520	K06110	ko04530	Tight junction	788	1.3e-37	0.28	0.44	0.84
PGSC0003DMT200056522	K00368	ko00910	Nitrogen metabolism	878	1.4e-42	0.40	0.57	0.86
PGSC0003DMT200056523	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.88
PGSC0003DMT200056524	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.95
PGSC0003DMT200056543	K13229	ko00402	Benzoxazinoid biosynthesis	343	4.4e-13	0.42	0.57	0.91
PGSC0003DMT200056544	K13229	ko00402	Benzoxazinoid biosynthesis	649	5.8e-30	0.42	0.58	0.99
PGSC0003DMT200079643	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMT200079643	K00517	ko00626	Naphthalene and anthracene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMT200079643	K00517	ko00903	Limonene and pinene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMT200079643	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMT200079643	K00517	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMT200079644	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMT200079644	K00517	ko00626	Naphthalene and anthracene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMT200079644	K00517	ko00903	Limonene and pinene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMT200079644	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMT200079644	K00517	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMT200079645	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMT200079645	K00517	ko00626	Naphthalene and anthracene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMT200079645	K00517	ko00903	Limonene and pinene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMT200079645	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMT200079645	K00517	ko01110	Biosynthesis of secondary metabolites	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMT200079646	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMT200079646	K00517	ko00626	Naphthalene and anthracene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMT200079646	K00517	ko00903	Limonene and pinene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMT200079646	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMT200079646	K00517	ko01110	Biosynthesis of secondary metabolites	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMT200079647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMT200079647	K00517	ko00626	Naphthalene and anthracene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMT200079647	K00517	ko00903	Limonene and pinene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMT200079647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMT200079647	K00517	ko01110	Biosynthesis of secondary metabolites	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMT200074059	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMT200074059	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMT200074060	K04424	ko04010	MAPK signaling pathway	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMT200074060	K04424	ko04530	Tight junction	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMT200074061	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMT200074061	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMT200074071	K13289	ko04142	Lysosome	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMT200074071	K13289	ko04614	Renin-angiotensin system	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMT200074072	K13289	ko04142	Lysosome	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMT200074072	K13289	ko04614	Renin-angiotensin system	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMT200046737	K09680	ko00770	Pantothenate and CoA biosynthesis	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMT200046737	K09680	ko01100	Metabolic pathways	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMT200046738	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMT200046738	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMT200046739	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMT200046739	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMT200046771	K10573	ko04120	Ubiquitin mediated proteolysis	1333	1.1e-67	0.98	1.00	0.99
PGSC0003DMT200061511	K01955	ko00240	Pyrimidine metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMT200061511	K01955	ko00250	Alanine, aspartate and glutamate metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMT200061511	K01955	ko01100	Metabolic pathways	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMT200061527	K01227	ko00511	Other glycan degradation	434	6.6e-18	0.29	0.46	0.96
PGSC0003DMT200061528	K01227	ko00511	Other glycan degradation	1350	1.3e-68	0.36	0.52	0.97
PGSC0003DMT200061529	K01227	ko00511	Other glycan degradation	897	1.2e-43	0.31	0.45	0.96
PGSC0003DMT200078786	K01613	ko00564	Glycerophospholipid metabolism	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMT200078786	K01613	ko01100	Metabolic pathways	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMT200078790	K04733	ko04210	Apoptosis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMT200078790	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMT200078790	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMT200078790	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMT200078790	K04733	ko05142	Chagas disease	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMT200078798	K05349	ko00460	Cyanoamino acid metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMT200078798	K05349	ko00500	Starch and sucrose metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMT200078798	K05349	ko00940	Phenylpropanoid biosynthesis	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMT200078798	K05349	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMT200078799	K05349	ko00460	Cyanoamino acid metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMT200078799	K05349	ko00500	Starch and sucrose metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMT200078799	K05349	ko00940	Phenylpropanoid biosynthesis	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMT200078799	K05349	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMT200078806	K09880	ko00270	Cysteine and methionine metabolism	742	6.5e-35	0.27	0.44	0.93
PGSC0003DMT200056767	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMT200056767	K00517	ko00626	Naphthalene and anthracene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMT200056767	K00517	ko00903	Limonene and pinene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMT200056767	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMT200056767	K00517	ko01110	Biosynthesis of secondary metabolites	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMT200056768	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMT200056768	K00517	ko00626	Naphthalene and anthracene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMT200056768	K00517	ko00903	Limonene and pinene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMT200056768	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMT200056768	K00517	ko01110	Biosynthesis of secondary metabolites	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMT200056773	K10140	ko03420	Nucleotide excision repair	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMT200056773	K10140	ko04115	p53 signaling pathway	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMT200056773	K10140	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMT200056774	K10140	ko03420	Nucleotide excision repair	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMT200056774	K10140	ko04115	p53 signaling pathway	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMT200056774	K10140	ko04120	Ubiquitin mediated proteolysis	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMT200056780	K01582	ko00310	Lysine degradation	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMT200056780	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMT200056780	K01582	ko01100	Metabolic pathways	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMT200056780	K01582	ko01110	Biosynthesis of secondary metabolites	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMT200056784	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056784	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056784	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056784	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056784	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056784	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056785	K00106	ko00230	Purine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056785	K00106	ko00232	Caffeine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056785	K00106	ko00983	Drug metabolism - other enzymes	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056785	K00106	ko01100	Metabolic pathways	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056785	K00106	ko01110	Biosynthesis of secondary metabolites	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056785	K00106	ko04146	Peroxisome	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMT200056786	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056786	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056786	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056786	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056786	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056786	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056787	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMT200056788	K00106	ko00230	Purine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056788	K00106	ko00232	Caffeine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056788	K00106	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056788	K00106	ko01100	Metabolic pathways	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056788	K00106	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056788	K00106	ko04146	Peroxisome	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMT200056799	K00615	ko00030	Pentose phosphate pathway	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMT200056799	K00615	ko00710	Carbon fixation in photosynthetic organisms	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMT200056799	K00615	ko01051	Biosynthesis of ansamycins	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMT200056799	K00615	ko01100	Metabolic pathways	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMT200056799	K00615	ko01110	Biosynthesis of secondary metabolites	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMT200064663	K03011	ko00230	Purine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMT200064663	K03011	ko00240	Pyrimidine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMT200064663	K03011	ko01100	Metabolic pathways	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMT200064663	K03011	ko03020	RNA polymerase	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMT200064663	K03011	ko05016	Huntington's disease	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMT200064664	K03011	ko00230	Purine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMT200064664	K03011	ko00240	Pyrimidine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMT200064664	K03011	ko01100	Metabolic pathways	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMT200064664	K03011	ko03020	RNA polymerase	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMT200064664	K03011	ko05016	Huntington's disease	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMT200064669	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064669	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064669	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064669	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064670	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064670	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064670	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064670	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMT200064672	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMT200064672	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMT200064673	K04077	ko03018	RNA degradation	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMT200064673	K04077	ko04940	Type I diabetes mellitus	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMT200064674	K04077	ko03018	RNA degradation	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMT200064674	K04077	ko04940	Type I diabetes mellitus	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMT200064675	K04077	ko03018	RNA degradation	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMT200064675	K04077	ko04940	Type I diabetes mellitus	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMT200064676	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMT200064676	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMT200064699	K02183	ko04020	Calcium signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04070	Phosphatidylinositol signaling system	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04114	Oocyte meiosis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04270	Vascular smooth muscle contraction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04626	Plant-pathogen interaction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04720	Long-term potentiation	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04722	Neurotrophin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04740	Olfactory transduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04744	Phototransduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04745	Phototransduction - fly	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04910	Insulin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04912	GnRH signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04916	Melanogenesis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04970	Salivary secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko04971	Gastric acid secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko05010	Alzheimer's disease	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064699	K02183	ko05214	Glioma	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMT200064705	K01739	ko00270	Cysteine and methionine metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMT200064705	K01739	ko00450	Selenoamino acid metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMT200064705	K01739	ko00920	Sulfur metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMT200064705	K01739	ko01100	Metabolic pathways	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMT200064705	K01739	ko01110	Biosynthesis of secondary metabolites	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMT200064708	K06653	ko04111	Cell cycle - yeast	309	2.1e-10	0.30	0.46	0.98
PGSC0003DMT200073946	K12856	ko03040	Spliceosome	19338	0.	0.94	0.96	0.99
PGSC0003DMT200073947	K12856	ko03040	Spliceosome	19795	0.	0.95	0.97	1.00
PGSC0003DMT200009994	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	664	8.7e-31	0.45	0.56	0.68
PGSC0003DMT200009996	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	628	8.4e-29	0.44	0.55	0.98
PGSC0003DMT200010000	K01762	ko00270	Cysteine and methionine metabolism	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMT200010000	K01762	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMT200010023	K07750	ko00100	Steroid biosynthesis	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMT200010023	K07750	ko01100	Metabolic pathways	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMT200018003	K00430	ko00360	Phenylalanine metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMT200018003	K00430	ko00680	Methane metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMT200018003	K00430	ko00940	Phenylpropanoid biosynthesis	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMT200018003	K00430	ko01100	Metabolic pathways	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMT200018003	K00430	ko01110	Biosynthesis of secondary metabolites	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMT200018005	K00430	ko00360	Phenylalanine metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMT200018005	K00430	ko00680	Methane metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMT200018005	K00430	ko00940	Phenylpropanoid biosynthesis	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMT200018005	K00430	ko01100	Metabolic pathways	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMT200018005	K00430	ko01110	Biosynthesis of secondary metabolites	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMT200018007	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018007	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018007	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018008	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018008	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018008	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018009	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018009	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018009	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018010	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018010	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018010	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018011	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018011	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018011	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMT200018015	K13065	ko00940	Phenylpropanoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMT200018015	K13065	ko00941	Flavonoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMT200018015	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMT200018015	K13065	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMT200018016	K02183	ko04020	Calcium signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04070	Phosphatidylinositol signaling system	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04114	Oocyte meiosis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04270	Vascular smooth muscle contraction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04626	Plant-pathogen interaction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04720	Long-term potentiation	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04722	Neurotrophin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04740	Olfactory transduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04744	Phototransduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04745	Phototransduction - fly	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04910	Insulin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04912	GnRH signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04916	Melanogenesis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04970	Salivary secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko04971	Gastric acid secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko05010	Alzheimer's disease	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018016	K02183	ko05214	Glioma	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMT200018023	K06129	ko00564	Glycerophospholipid metabolism	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMT200018023	K06129	ko04142	Lysosome	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMT200018024	K03115	ko04310	Wnt signaling pathway	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMT200018024	K03115	ko04520	Adherens junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMT200018024	K03115	ko04530	Tight junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMT200018024	K03115	ko04712	Circadian rhythm - plant	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMT200018025	K03115	ko04310	Wnt signaling pathway	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMT200018025	K03115	ko04520	Adherens junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMT200018025	K03115	ko04530	Tight junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMT200018025	K03115	ko04712	Circadian rhythm - plant	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMT200018038	K02113	ko00190	Oxidative phosphorylation	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMT200018038	K02113	ko00195	Photosynthesis	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMT200018038	K02113	ko01100	Metabolic pathways	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMT200018040	K00275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMT200018040	K00275	ko01100	Metabolic pathways	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMT200027647	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMT200027647	K03785	ko01100	Metabolic pathways	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMT200027647	K03785	ko01110	Biosynthesis of secondary metabolites	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMT200027651	K04565	ko04146	Peroxisome	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMT200027651	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMT200027651	K04565	ko05016	Huntington's disease	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMT200027651	K04565	ko05020	Prion diseases	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMT200027659	K01177	ko00500	Starch and sucrose metabolism	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMT200027659	K01177	ko01100	Metabolic pathways	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMT200027660	K01177	ko00500	Starch and sucrose metabolism	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMT200027660	K01177	ko01100	Metabolic pathways	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMT200027686	K00140	ko00280	Valine, leucine and isoleucine degradation	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMT200027686	K00140	ko00562	Inositol phosphate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMT200027686	K00140	ko00640	Propanoate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMT200027686	K00140	ko01100	Metabolic pathways	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMT200027687	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027687	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027687	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027687	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027688	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027688	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027688	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027688	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMT200027691	K00140	ko00280	Valine, leucine and isoleucine degradation	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMT200027691	K00140	ko00562	Inositol phosphate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMT200027691	K00140	ko00640	Propanoate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMT200027691	K00140	ko01100	Metabolic pathways	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMT200027692	K01951	ko00230	Purine metabolism	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMT200027692	K01951	ko00983	Drug metabolism - other enzymes	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMT200027692	K01951	ko01100	Metabolic pathways	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMT200067833	K04733	ko04210	Apoptosis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMT200067833	K04733	ko04620	Toll-like receptor signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMT200067833	K04733	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMT200067833	K04733	ko05140	Leishmaniasis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMT200067833	K04733	ko05142	Chagas disease	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMT200067834	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMT200067834	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMT200067834	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMT200067834	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMT200067834	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMT200067835	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMT200067835	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMT200067835	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMT200067835	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMT200067835	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMT200057891	K03013	ko00230	Purine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMT200057891	K03013	ko00240	Pyrimidine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMT200057891	K03013	ko01100	Metabolic pathways	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMT200057891	K03013	ko03020	RNA polymerase	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMT200057891	K03013	ko05016	Huntington's disease	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMT200057892	K03013	ko00230	Purine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMT200057892	K03013	ko00240	Pyrimidine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMT200057892	K03013	ko01100	Metabolic pathways	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMT200057892	K03013	ko03020	RNA polymerase	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMT200057892	K03013	ko05016	Huntington's disease	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMT200057917	K01066	ko00623	2,4-Dichlorobenzoate degradation	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMT200057917	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMT200057919	K01066	ko00623	2,4-Dichlorobenzoate degradation	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMT200057919	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMT200057920	K03006	ko00230	Purine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMT200057920	K03006	ko00240	Pyrimidine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMT200057920	K03006	ko01100	Metabolic pathways	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMT200057920	K03006	ko03020	RNA polymerase	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMT200057920	K03006	ko05016	Huntington's disease	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMT200087375	K10760	ko00908	Zeatin biosynthesis	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMT200087375	K10760	ko01100	Metabolic pathways	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMT200087375	K10760	ko01110	Biosynthesis of secondary metabolites	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMT200087380	K10760	ko00908	Zeatin biosynthesis	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMT200087380	K10760	ko01100	Metabolic pathways	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMT200087380	K10760	ko01110	Biosynthesis of secondary metabolites	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMT200087395	K00012	ko00040	Pentose and glucuronate interconversions	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200087395	K00012	ko00053	Ascorbate and aldarate metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200087395	K00012	ko00500	Starch and sucrose metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200087395	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200087395	K00012	ko01100	Metabolic pathways	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200087395	K00012	ko01110	Biosynthesis of secondary metabolites	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMT200084723	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMT200084724	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMT200092830	K10760	ko00908	Zeatin biosynthesis	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMT200092830	K10760	ko01100	Metabolic pathways	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMT200092830	K10760	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMT200092854	K09880	ko00270	Cysteine and methionine metabolism	244	6.4e-07	0.28	0.50	0.78
PGSC0003DMT200096830	K12581	ko03018	RNA degradation	927	2.7e-45	0.51	0.67	0.94
PGSC0003DMT200041061	K07253	ko00350	Tyrosine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMT200041061	K07253	ko00360	Phenylalanine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMT200041076	K12869	ko03040	Spliceosome	828	7.8e-40	0.57	0.71	0.83
PGSC0003DMT200041084	K05583	ko00190	Oxidative phosphorylation	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMT200041084	K05583	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMT200041085	K06671	ko04110	Cell cycle	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMT200041085	K06671	ko04111	Cell cycle - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMT200041085	K06671	ko04113	Meiosis - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMT200041086	K06671	ko04110	Cell cycle	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMT200041086	K06671	ko04111	Cell cycle - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMT200041086	K06671	ko04113	Meiosis - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMT200041087	K06671	ko04110	Cell cycle	6343	0.	0.68	0.84	1.00
PGSC0003DMT200041087	K06671	ko04111	Cell cycle - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMT200041087	K06671	ko04113	Meiosis - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMT200041088	K01840	ko00051	Fructose and mannose metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMT200041088	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMT200041088	K01840	ko01100	Metabolic pathways	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMT200041088	K01840	ko01110	Biosynthesis of secondary metabolites	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMT200041096	K00908	ko01100	Metabolic pathways	268	2.2e-08	0.33	0.49	0.98
PGSC0003DMT200024880	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMT200024880	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMT200024880	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMT200024880	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMT200024880	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMT200024881	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMT200024881	K00517	ko00626	Naphthalene and anthracene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMT200024881	K00517	ko00903	Limonene and pinene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMT200024881	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMT200024881	K00517	ko01110	Biosynthesis of secondary metabolites	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMT200024882	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMT200024882	K00517	ko00626	Naphthalene and anthracene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMT200024882	K00517	ko00903	Limonene and pinene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMT200024882	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMT200024882	K00517	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMT200024886	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMT200024886	K00517	ko00626	Naphthalene and anthracene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMT200024886	K00517	ko00903	Limonene and pinene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMT200024886	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMT200024886	K00517	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMT200024887	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMT200024887	K00517	ko00626	Naphthalene and anthracene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMT200024887	K00517	ko00903	Limonene and pinene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMT200024887	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMT200024887	K00517	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMT200024893	K09755	ko00940	Phenylpropanoid biosynthesis	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMT200024893	K09755	ko01100	Metabolic pathways	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMT200024893	K09755	ko01110	Biosynthesis of secondary metabolites	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMT200024894	K09755	ko00940	Phenylpropanoid biosynthesis	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMT200024894	K09755	ko01100	Metabolic pathways	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMT200024894	K09755	ko01110	Biosynthesis of secondary metabolites	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMT200024897	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMT200024897	K00517	ko00626	Naphthalene and anthracene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMT200024897	K00517	ko00903	Limonene and pinene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMT200024897	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMT200024897	K00517	ko01110	Biosynthesis of secondary metabolites	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMT200014687	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMT200014687	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMT200014688	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMT200014688	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMT200014696	K04424	ko04010	MAPK signaling pathway	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMT200014696	K04424	ko04530	Tight junction	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMT200014697	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMT200014697	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMT200014699	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMT200014699	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMT200014704	K10746	ko03430	Mismatch repair	2459	8.6e-130	0.59	0.74	0.87
PGSC0003DMT200014706	K10746	ko03430	Mismatch repair	1046	7.4e-52	0.62	0.79	0.86
PGSC0003DMT200014712	K10529	ko00592	alpha-Linolenic acid metabolism	2785	9.0e-148	0.62	0.80	0.99
PGSC0003DMT200014713	K10529	ko00592	alpha-Linolenic acid metabolism	3217	1.3e-171	0.60	0.77	0.99
PGSC0003DMT200014714	K10529	ko00592	alpha-Linolenic acid metabolism	2288	2.3e-120	0.57	0.74	0.96
PGSC0003DMT200014715	K10529	ko00592	alpha-Linolenic acid metabolism	1982	1.8e-103	0.58	0.74	0.96
PGSC0003DMT200059705	K01771	ko00562	Inositol phosphate metabolism	271	4.1e-09	0.35	0.57	0.35
PGSC0003DMT200059740	K01590	ko00340	Histidine metabolism	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMT200059740	K01590	ko01100	Metabolic pathways	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMT200059740	K01590	ko01110	Biosynthesis of secondary metabolites	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMT200059741	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMT200059741	K01649	ko00620	Pyruvate metabolism	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMT200059741	K01649	ko01100	Metabolic pathways	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMT200059741	K01649	ko01110	Biosynthesis of secondary metabolites	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMT200069598	K12871	ko03040	Spliceosome	840	1.7e-40	0.64	0.81	0.99
PGSC0003DMT200069599	K00001	ko00010	Glycolysis / Gluconeogenesis	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00071	Fatty acid metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00350	Tyrosine metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00641	3-Chloroacrylic acid degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00830	Retinol metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko00982	Drug metabolism - cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko01100	Metabolic pathways	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069599	K00001	ko01110	Biosynthesis of secondary metabolites	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMT200069600	K00001	ko00010	Glycolysis / Gluconeogenesis	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00071	Fatty acid metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00350	Tyrosine metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00641	3-Chloroacrylic acid degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00830	Retinol metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko00982	Drug metabolism - cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko01100	Metabolic pathways	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069600	K00001	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMT200069601	K00121	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00071	Fatty acid metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00350	Tyrosine metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00624	1- and 2-Methylnaphthalene degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00641	3-Chloroacrylic acid degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00680	Methane metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00830	Retinol metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko00982	Drug metabolism - cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko01100	Metabolic pathways	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069601	K00121	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMT200069615	K07342	ko03060	Protein export	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMT200069615	K07342	ko04145	Phagosome	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMT200069615	K07342	ko05110	Vibrio cholerae infection	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMT200086167	K00942	ko00230	Purine metabolism	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMT200086167	K00942	ko01100	Metabolic pathways	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMT200048482	K08496	ko04130	SNARE interactions in vesicular transport	1230	5.3e-62	0.63	0.81	0.96
PGSC0003DMT200048497	K02866	ko03010	Ribosome	727	2.9e-34	0.44	0.60	0.80
PGSC0003DMT200048503	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMT200042819	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMT200042819	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMT200042819	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMT200042819	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMT200042819	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMT200042824	K11818	ko00380	Tryptophan metabolism	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMT200042824	K11818	ko00966	Glucosinolate biosynthesis	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMT200042824	K11818	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMT200042825	K11818	ko00380	Tryptophan metabolism	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMT200042825	K11818	ko00966	Glucosinolate biosynthesis	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMT200042825	K11818	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMT200042826	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMT200042826	K00517	ko00626	Naphthalene and anthracene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMT200042826	K00517	ko00903	Limonene and pinene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMT200042826	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMT200042826	K00517	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMT200042827	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMT200042827	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMT200042827	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMT200042827	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMT200042827	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMT200042828	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMT200042828	K00517	ko00626	Naphthalene and anthracene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMT200042828	K00517	ko00903	Limonene and pinene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMT200042828	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMT200042828	K00517	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMT200042829	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMT200042829	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMT200042829	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMT200042829	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMT200042829	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMT200042830	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMT200042830	K00517	ko00626	Naphthalene and anthracene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMT200042830	K00517	ko00903	Limonene and pinene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMT200042830	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMT200042830	K00517	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMT200042831	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMT200042831	K00517	ko00626	Naphthalene and anthracene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMT200042831	K00517	ko00903	Limonene and pinene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMT200042831	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMT200042831	K00517	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMT200042832	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMT200042832	K00517	ko00626	Naphthalene and anthracene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMT200042832	K00517	ko00903	Limonene and pinene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMT200042832	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMT200042832	K00517	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMT200042835	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMT200042835	K00517	ko00626	Naphthalene and anthracene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMT200042835	K00517	ko00903	Limonene and pinene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMT200042835	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMT200042835	K00517	ko01110	Biosynthesis of secondary metabolites	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMT200042836	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMT200042836	K00517	ko00626	Naphthalene and anthracene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMT200042836	K00517	ko00903	Limonene and pinene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMT200042836	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMT200042836	K00517	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMT200042837	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMT200042837	K00517	ko00626	Naphthalene and anthracene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMT200042837	K00517	ko00903	Limonene and pinene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMT200042837	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMT200042837	K00517	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMT200042838	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042838	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042838	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042838	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042838	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042838	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMT200042840	K00100	ko00051	Fructose and mannose metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042840	K00100	ko00363	Bisphenol A degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042840	K00100	ko00591	Linoleic acid metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042840	K00100	ko00625	Tetrachloroethene degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042840	K00100	ko00650	Butanoate metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042840	K00100	ko01100	Metabolic pathways	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMT200042841	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMT200042841	K00517	ko00626	Naphthalene and anthracene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMT200042841	K00517	ko00903	Limonene and pinene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMT200042841	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMT200042841	K00517	ko01110	Biosynthesis of secondary metabolites	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMT200042842	K00100	ko00051	Fructose and mannose metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042842	K00100	ko00363	Bisphenol A degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042842	K00100	ko00591	Linoleic acid metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042842	K00100	ko00625	Tetrachloroethene degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042842	K00100	ko00650	Butanoate metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042842	K00100	ko01100	Metabolic pathways	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMT200042843	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042843	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042843	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042843	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042843	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042843	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042844	K00100	ko00051	Fructose and mannose metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042844	K00100	ko00363	Bisphenol A degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042844	K00100	ko00591	Linoleic acid metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042844	K00100	ko00625	Tetrachloroethene degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042844	K00100	ko00650	Butanoate metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042844	K00100	ko01100	Metabolic pathways	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMT200042848	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042848	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042848	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042848	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042848	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042848	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMT200042849	K00100	ko00051	Fructose and mannose metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042849	K00100	ko00363	Bisphenol A degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042849	K00100	ko00591	Linoleic acid metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042849	K00100	ko00625	Tetrachloroethene degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042849	K00100	ko00650	Butanoate metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042849	K00100	ko01100	Metabolic pathways	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMT200042851	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMT200042851	K00517	ko00626	Naphthalene and anthracene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMT200042851	K00517	ko00903	Limonene and pinene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMT200042851	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMT200042851	K00517	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMT200042852	K05275	ko00750	Vitamin B6 metabolism	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMT200042852	K05275	ko01100	Metabolic pathways	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMT200042853	K00100	ko00051	Fructose and mannose metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042853	K00100	ko00363	Bisphenol A degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042853	K00100	ko00591	Linoleic acid metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042853	K00100	ko00625	Tetrachloroethene degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042853	K00100	ko00650	Butanoate metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042853	K00100	ko01100	Metabolic pathways	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMT200042854	K00100	ko00051	Fructose and mannose metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042854	K00100	ko00363	Bisphenol A degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042854	K00100	ko00591	Linoleic acid metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042854	K00100	ko00625	Tetrachloroethene degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042854	K00100	ko00650	Butanoate metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042854	K00100	ko01100	Metabolic pathways	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMT200042855	K00100	ko00051	Fructose and mannose metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042855	K00100	ko00363	Bisphenol A degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042855	K00100	ko00591	Linoleic acid metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042855	K00100	ko00625	Tetrachloroethene degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042855	K00100	ko00650	Butanoate metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042855	K00100	ko01100	Metabolic pathways	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMT200042856	K00100	ko00051	Fructose and mannose metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042856	K00100	ko00363	Bisphenol A degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042856	K00100	ko00591	Linoleic acid metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042856	K00100	ko00625	Tetrachloroethene degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042856	K00100	ko00650	Butanoate metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042856	K00100	ko01100	Metabolic pathways	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMT200042857	K00100	ko00051	Fructose and mannose metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042857	K00100	ko00363	Bisphenol A degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042857	K00100	ko00591	Linoleic acid metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042857	K00100	ko00625	Tetrachloroethene degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042857	K00100	ko00650	Butanoate metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042857	K00100	ko01100	Metabolic pathways	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMT200042858	K00100	ko00051	Fructose and mannose metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200042858	K00100	ko00363	Bisphenol A degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200042858	K00100	ko00591	Linoleic acid metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200042858	K00100	ko00625	Tetrachloroethene degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200042858	K00100	ko00650	Butanoate metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200042858	K00100	ko01100	Metabolic pathways	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMT200012916	K12486	ko04144	Endocytosis	469	4.9e-20	0.30	0.45	0.98
PGSC0003DMT200012917	K12486	ko04144	Endocytosis	1334	9.6e-68	0.42	0.56	1.00
PGSC0003DMT200012918	K12486	ko04144	Endocytosis	1324	3.4e-67	0.42	0.56	1.00
PGSC0003DMT200012919	K12486	ko04144	Endocytosis	1324	3.4e-67	0.43	0.57	1.00
PGSC0003DMT200012922	K12486	ko04144	Endocytosis	229	1.6e-06	0.36	0.50	0.93
PGSC0003DMT200012932	K08139	ko04113	Meiosis - yeast	910	2.3e-44	0.36	0.56	0.85
PGSC0003DMT200012934	K06627	ko04110	Cell cycle	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMT200012934	K06627	ko04914	Progesterone-mediated oocyte maturation	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMT200012954	K02536	ko00540	Lipopolysaccharide biosynthesis	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMT200012954	K02536	ko01100	Metabolic pathways	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMT200012955	K02536	ko00540	Lipopolysaccharide biosynthesis	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMT200012955	K02536	ko01100	Metabolic pathways	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMT200012957	K02536	ko00540	Lipopolysaccharide biosynthesis	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMT200012957	K02536	ko01100	Metabolic pathways	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMT200012958	K09755	ko00940	Phenylpropanoid biosynthesis	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMT200012958	K09755	ko01100	Metabolic pathways	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMT200012958	K09755	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMT200012963	K02084	ko04115	p53 signaling pathway	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko04210	Apoptosis	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko05010	Alzheimer's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko05012	Parkinson's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko05016	Huntington's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200012963	K02084	ko05222	Small cell lung cancer	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMT200023179	K01193	ko00052	Galactose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMT200023179	K01193	ko00500	Starch and sucrose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMT200023179	K01193	ko01100	Metabolic pathways	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMT200023182	K00680	ko00350	Tyrosine metabolism	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMT200023182	K00680	ko00624	1- and 2-Methylnaphthalene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMT200023182	K00680	ko00632	Benzoate degradation via CoA ligation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMT200023182	K00680	ko00642	Ethylbenzene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMT200023182	K00680	ko00903	Limonene and pinene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMT200023208	K01953	ko00250	Alanine, aspartate and glutamate metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMT200023208	K01953	ko00910	Nitrogen metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMT200023208	K01953	ko01100	Metabolic pathways	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMT200023208	K01953	ko01110	Biosynthesis of secondary metabolites	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMT200023209	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMT200023210	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.76
PGSC0003DMT200023211	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMT200038861	K04428	ko04010	MAPK signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMT200038861	K04428	ko04912	GnRH signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMT200038863	K11230	ko04011	MAPK signaling pathway - yeast	698	5.8e-32	0.39	0.58	0.76
PGSC0003DMT200038864	K04428	ko04010	MAPK signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMT200038864	K04428	ko04912	GnRH signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMT200038865	K12929	ko00904	Diterpenoid biosynthesis	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMT200038865	K12929	ko01110	Biosynthesis of secondary metabolites	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMT200038866	K12929	ko00904	Diterpenoid biosynthesis	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMT200038866	K12929	ko01110	Biosynthesis of secondary metabolites	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMT200038867	K12929	ko00904	Diterpenoid biosynthesis	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMT200038867	K12929	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMT200038889	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMT200038889	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMT200038889	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMT200038889	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMT200038889	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMT200091632	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.32	0.48	0.96
PGSC0003DMT200091639	K13030	ko00460	Cyanoamino acid metabolism	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMT200091639	K13030	ko01110	Biosynthesis of secondary metabolites	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMT200062982	K01895	ko00010	Glycolysis / Gluconeogenesis	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062982	K01895	ko00620	Pyruvate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062982	K01895	ko00640	Propanoate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062982	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062982	K01895	ko01100	Metabolic pathways	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062982	K01895	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMT200062983	K01895	ko00010	Glycolysis / Gluconeogenesis	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062983	K01895	ko00620	Pyruvate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062983	K01895	ko00640	Propanoate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062983	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062983	K01895	ko01100	Metabolic pathways	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062983	K01895	ko01110	Biosynthesis of secondary metabolites	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMT200062984	K01895	ko00010	Glycolysis / Gluconeogenesis	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062984	K01895	ko00620	Pyruvate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062984	K01895	ko00640	Propanoate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062984	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062984	K01895	ko01100	Metabolic pathways	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062984	K01895	ko01110	Biosynthesis of secondary metabolites	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMT200062986	K01689	ko00010	Glycolysis / Gluconeogenesis	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMT200062986	K01689	ko01100	Metabolic pathways	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMT200062986	K01689	ko01110	Biosynthesis of secondary metabolites	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMT200062986	K01689	ko03018	RNA degradation	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMT200062988	K01689	ko00010	Glycolysis / Gluconeogenesis	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMT200062988	K01689	ko01100	Metabolic pathways	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMT200062988	K01689	ko01110	Biosynthesis of secondary metabolites	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMT200062988	K01689	ko03018	RNA degradation	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMT200054964	K08486	ko04130	SNARE interactions in vesicular transport	1108	2.8e-55	0.73	0.84	0.92
PGSC0003DMT200054965	K08486	ko04130	SNARE interactions in vesicular transport	1887	3.0e-98	0.75	0.88	1.00
PGSC0003DMT200054985	K12811	ko03040	Spliceosome	318	5.6e-09	0.25	0.43	0.92
PGSC0003DMT200054994	K05681	ko02010	ABC transporters	1249	4.7e-63	0.36	0.54	0.81
PGSC0003DMT200072246	K02327	ko00230	Purine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko00240	Pyrimidine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko01100	Metabolic pathways	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko03030	DNA replication	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko03410	Base excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko03420	Nucleotide excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko03430	Mismatch repair	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072246	K02327	ko03440	Homologous recombination	7941	0.	0.85	0.92	1.00
PGSC0003DMT200072247	K02327	ko00230	Purine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko00240	Pyrimidine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko01100	Metabolic pathways	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko03030	DNA replication	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko03410	Base excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko03420	Nucleotide excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko03430	Mismatch repair	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072247	K02327	ko03440	Homologous recombination	8040	0.	0.86	0.93	1.00
PGSC0003DMT200072251	K01625	ko00030	Pentose phosphate pathway	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMT200072251	K01625	ko00040	Pentose and glucuronate interconversions	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMT200072251	K01625	ko00330	Arginine and proline metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMT200072251	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMT200072251	K01625	ko01100	Metabolic pathways	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMT200072252	K01625	ko00030	Pentose phosphate pathway	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMT200072252	K01625	ko00040	Pentose and glucuronate interconversions	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMT200072252	K01625	ko00330	Arginine and proline metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMT200072252	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMT200072252	K01625	ko01100	Metabolic pathways	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMT200072253	K01625	ko00030	Pentose phosphate pathway	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMT200072253	K01625	ko00040	Pentose and glucuronate interconversions	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMT200072253	K01625	ko00330	Arginine and proline metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMT200072253	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMT200072253	K01625	ko01100	Metabolic pathways	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMT200072260	K09054	ko05010	Alzheimer's disease	253	1.5e-06	0.28	0.46	0.66
PGSC0003DMT200072262	K11098	ko03040	Spliceosome	644	1.1e-29	0.85	0.95	0.99
PGSC0003DMT200072269	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMT200072269	K01563	ko00626	Naphthalene and anthracene degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMT200072269	K01563	ko00631	1,2-Dichloroethane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMT200072269	K01563	ko00641	3-Chloroacrylic acid degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMT200072269	K01563	ko01100	Metabolic pathways	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMT200072279	K00549	ko00270	Cysteine and methionine metabolism	5729	0.	0.88	0.94	1.00
PGSC0003DMT200072279	K00549	ko01100	Metabolic pathways	5729	0.	0.88	0.94	1.00
PGSC0003DMT200072279	K00549	ko01110	Biosynthesis of secondary metabolites	5729	0.	0.88	0.94	1.00
PGSC0003DMT200072284	K08486	ko04130	SNARE interactions in vesicular transport	2080	6.9e-109	0.82	0.90	1.00
PGSC0003DMT200019880	K13065	ko00940	Phenylpropanoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMT200019880	K13065	ko00941	Flavonoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMT200019880	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMT200019880	K13065	ko01110	Biosynthesis of secondary metabolites	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMT200019912	K10589	ko04120	Ubiquitin mediated proteolysis	674	3.4e-34	0.35	0.52	0.86
PGSC0003DMT200019913	K10589	ko04120	Ubiquitin mediated proteolysis	589	1.8e-29	0.36	0.55	0.79
PGSC0003DMT200019917	K02872	ko03010	Ribosome	1619	1.8e-83	0.92	0.97	1.00
PGSC0003DMT200019934	K00799	ko00480	Glutathione metabolism	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMT200019934	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMT200019934	K00799	ko00982	Drug metabolism - cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMT200011755	K13289	ko04142	Lysosome	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMT200011755	K13289	ko04614	Renin-angiotensin system	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMT200011757	K00970	ko03018	RNA degradation	1185	1.6e-59	0.37	0.56	0.86
PGSC0003DMT200011758	K00970	ko03018	RNA degradation	257	5.8e-08	0.29	0.49	0.93
PGSC0003DMT200011766	K01051	ko00040	Pentose and glucuronate interconversions	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMT200011766	K01051	ko00500	Starch and sucrose metabolism	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMT200011766	K01051	ko01100	Metabolic pathways	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMT200011767	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMT200011767	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMT200011767	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMT200011783	K01051	ko00040	Pentose and glucuronate interconversions	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMT200011783	K01051	ko00500	Starch and sucrose metabolism	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMT200011783	K01051	ko01100	Metabolic pathways	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMT200029453	K11818	ko00380	Tryptophan metabolism	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMT200029453	K11818	ko00966	Glucosinolate biosynthesis	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMT200029453	K11818	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMT200029457	K01557	ko00350	Tyrosine metabolism	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMT200029457	K01557	ko01100	Metabolic pathways	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMT200029464	K09699	ko00280	Valine, leucine and isoleucine degradation	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMT200029464	K09699	ko01100	Metabolic pathways	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMT200029464	K09699	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMT200029465	K09699	ko00280	Valine, leucine and isoleucine degradation	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMT200029465	K09699	ko01100	Metabolic pathways	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMT200029465	K09699	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMT200029466	K09699	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMT200029466	K09699	ko01100	Metabolic pathways	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMT200029466	K09699	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMT200029467	K10418	ko04962	Vasopressin-regulated water reabsorption	706	4.2e-33	0.74	0.82	0.98
PGSC0003DMT200029477	K01710	ko00521	Streptomycin biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMT200029477	K01710	ko00523	Polyketide sugar unit biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMT200029477	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMT200029477	K01710	ko01100	Metabolic pathways	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMT200029477	K01710	ko01110	Biosynthesis of secondary metabolites	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMT200029478	K01710	ko00521	Streptomycin biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMT200029478	K01710	ko00523	Polyketide sugar unit biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMT200029478	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMT200029478	K01710	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMT200029478	K01710	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMT200029480	K10599	ko03040	Spliceosome	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMT200029480	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMT200090159	K11644	ko05016	Huntington's disease	687	1.9e-31	0.59	0.71	0.55
PGSC0003DMT200090181	K07195	ko04910	Insulin signaling pathway	3008	4.5e-160	0.59	0.72	0.99
PGSC0003DMT200090184	K11816	ko00380	Tryptophan metabolism	803	1.9e-38	0.46	0.65	0.95
PGSC0003DMT200003338	K03869	ko04120	Ubiquitin mediated proteolysis	5513	3.1e-298	0.88	0.95	1.00
PGSC0003DMT200003339	K03869	ko04120	Ubiquitin mediated proteolysis	4903	1.4e-264	0.88	0.95	1.00
PGSC0003DMT200003350	K06675	ko04111	Cell cycle - yeast	5148	4.2e-278	0.77	0.89	0.98
PGSC0003DMT200003351	K06675	ko04111	Cell cycle - yeast	7990	0.	0.78	0.89	0.99
PGSC0003DMT200003355	K00703	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMT200003355	K00703	ko01100	Metabolic pathways	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMT200003356	K00703	ko00500	Starch and sucrose metabolism	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMT200003356	K00703	ko01100	Metabolic pathways	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMT200003364	K02183	ko04020	Calcium signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04070	Phosphatidylinositol signaling system	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04114	Oocyte meiosis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04270	Vascular smooth muscle contraction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04626	Plant-pathogen interaction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04720	Long-term potentiation	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04722	Neurotrophin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04740	Olfactory transduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04744	Phototransduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04745	Phototransduction - fly	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04910	Insulin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04912	GnRH signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04916	Melanogenesis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04970	Salivary secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko04971	Gastric acid secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko05010	Alzheimer's disease	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003364	K02183	ko05214	Glioma	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMT200003384	K06653	ko04111	Cell cycle - yeast	296	1.1e-09	0.31	0.49	0.77
PGSC0003DMT200089326	K00368	ko00910	Nitrogen metabolism	712	2.0e-33	0.37	0.52	0.89
PGSC0003DMT200089330	K10760	ko00908	Zeatin biosynthesis	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMT200089330	K10760	ko01100	Metabolic pathways	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMT200089330	K10760	ko01110	Biosynthesis of secondary metabolites	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMT200094581	K12356	ko00940	Phenylpropanoid biosynthesis	764	2.6e-36	0.35	0.50	0.92
PGSC0003DMT200094585	K00799	ko00480	Glutathione metabolism	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMT200094585	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMT200094585	K00799	ko00982	Drug metabolism - cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMT200009647	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009647	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009651	K04618	ko00052	Galactose metabolism	482	9.5e-21	0.29	0.45	0.87
PGSC0003DMT200009656	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMT200009661	K12383	ko04142	Lysosome	219	3.0e-06	0.35	0.45	0.43
PGSC0003DMT200009666	K01179	ko00500	Starch and sucrose metabolism	372	1.1e-14	0.50	0.72	0.86
PGSC0003DMT200009667	K01179	ko00500	Starch and sucrose metabolism	1583	1.8e-81	0.43	0.63	0.91
PGSC0003DMT200009668	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.42	0.61	0.92
PGSC0003DMT200009680	K09389	ko04110	Cell cycle	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05200	Pathways in cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05212	Pancreatic cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05214	Glioma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05215	Prostate cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05218	Melanoma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05219	Bladder cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05220	Chronic myeloid leukemia	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05222	Small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009680	K09389	ko05223	Non-small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMT200009681	K06620	ko04110	Cell cycle	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05200	Pathways in cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05212	Pancreatic cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05214	Glioma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05215	Prostate cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05218	Melanoma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05219	Bladder cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05220	Chronic myeloid leukemia	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05222	Small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009681	K06620	ko05223	Non-small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMT200009682	K06620	ko04110	Cell cycle	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05200	Pathways in cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05212	Pancreatic cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05214	Glioma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05215	Prostate cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05218	Melanoma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05219	Bladder cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05220	Chronic myeloid leukemia	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05222	Small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200009682	K06620	ko05223	Non-small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMT200017550	K05863	ko04020	Calcium signaling pathway	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMT200017550	K05863	ko05012	Parkinson's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMT200017550	K05863	ko05016	Huntington's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMT200079455	K02878	ko03010	Ribosome	525	4.0e-23	0.52	0.65	0.95
PGSC0003DMT200079464	K00558	ko00270	Cysteine and methionine metabolism	9011	0.	0.73	0.84	1.00
PGSC0003DMT200079464	K00558	ko01100	Metabolic pathways	9011	0.	0.73	0.84	1.00
PGSC0003DMT200079469	K03935	ko00190	Oxidative phosphorylation	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMT200079469	K03935	ko01100	Metabolic pathways	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMT200079469	K03935	ko05010	Alzheimer's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMT200079469	K03935	ko05012	Parkinson's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMT200079469	K03935	ko05016	Huntington's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMT200079474	K04371	ko04010	MAPK signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04012	ErbB signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04013	MAPK signaling pathway - fly	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04062	Chemokine signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04114	Oocyte meiosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04150	mTOR signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04270	Vascular smooth muscle contraction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04320	Dorso-ventral axis formation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04350	TGF-beta signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04360	Axon guidance	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04370	VEGF signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04510	Focal adhesion	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04520	Adherens junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04540	Gap junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04621	NOD-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04650	Natural killer cell mediated cytotoxicity	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04660	T cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04662	B cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04664	Fc epsilon RI signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04666	Fc gamma R-mediated phagocytosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04720	Long-term potentiation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04730	Long-term depression	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04810	Regulation of actin cytoskeleton	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04910	Insulin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04912	GnRH signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04916	Melanogenesis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04930	Type II diabetes mellitus	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko04960	Aldosterone-regulated sodium reabsorption	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05010	Alzheimer's disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05020	Prion diseases	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05131	Shigellosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05140	Leishmaniasis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05142	Chagas disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05200	Pathways in cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05210	Colorectal cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05211	Renal cell carcinoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05212	Pancreatic cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05213	Endometrial cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05214	Glioma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05215	Prostate cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05216	Thyroid cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05218	Melanoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05219	Bladder cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05220	Chronic myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05221	Acute myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079474	K04371	ko05223	Non-small cell lung cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMT200079485	K01092	ko00521	Streptomycin biosynthesis	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMT200079485	K01092	ko00562	Inositol phosphate metabolism	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMT200079485	K01092	ko01100	Metabolic pathways	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMT200079485	K01092	ko01110	Biosynthesis of secondary metabolites	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMT200079485	K01092	ko04070	Phosphatidylinositol signaling system	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMT200079486	K10685	ko04120	Ubiquitin mediated proteolysis	4207	3.3e-226	0.78	0.86	1.00
PGSC0003DMT200079488	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMT200079489	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMT200079490	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.68
PGSC0003DMT200079491	K11294	ko05130	Pathogenic Escherichia coli infection	254	4.3e-08	0.33	0.56	0.62
PGSC0003DMT200079495	K01190	ko00052	Galactose metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMT200079495	K01190	ko00511	Other glycan degradation	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMT200079495	K01190	ko00600	Sphingolipid metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMT200079495	K01190	ko01100	Metabolic pathways	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMT200079497	K01190	ko00052	Galactose metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMT200079497	K01190	ko00511	Other glycan degradation	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMT200079497	K01190	ko00600	Sphingolipid metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMT200079497	K01190	ko01100	Metabolic pathways	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMT200056381	K01076	ko00632	Benzoate degradation via CoA ligation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMT200056381	K01076	ko00903	Limonene and pinene degradation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMT200056381	K01076	ko01040	Biosynthesis of unsaturated fatty acids	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMT200056382	K01076	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMT200056382	K01076	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMT200056382	K01076	ko01040	Biosynthesis of unsaturated fatty acids	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMT200056393	K05740	ko04510	Focal adhesion	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMT200056393	K05740	ko04810	Regulation of actin cytoskeleton	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMT200056393	K05740	ko05131	Shigellosis	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMT200064160	K00765	ko00340	Histidine metabolism	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMT200064160	K00765	ko01100	Metabolic pathways	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMT200064160	K00765	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMT200064166	K02951	ko03010	Ribosome	1014	4.3e-50	0.84	0.92	0.99
PGSC0003DMT200046854	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMT200046854	K00517	ko00626	Naphthalene and anthracene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMT200046854	K00517	ko00903	Limonene and pinene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMT200046854	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMT200046854	K00517	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMT200046857	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMT200046857	K00517	ko00626	Naphthalene and anthracene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMT200046857	K00517	ko00903	Limonene and pinene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMT200046857	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMT200046857	K00517	ko01110	Biosynthesis of secondary metabolites	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMT200046860	K07466	ko03030	DNA replication	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMT200046860	K07466	ko03420	Nucleotide excision repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMT200046860	K07466	ko03430	Mismatch repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMT200046860	K07466	ko03440	Homologous recombination	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMT200046864	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMT200046864	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMT200046864	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMT200046864	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMT200046864	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMT200046904	K00991	ko00900	Terpenoid backbone biosynthesis	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMT200046904	K00991	ko01100	Metabolic pathways	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMT200046905	K00991	ko00900	Terpenoid backbone biosynthesis	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMT200046905	K00991	ko01100	Metabolic pathways	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMT200046906	K00991	ko00900	Terpenoid backbone biosynthesis	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMT200046906	K00991	ko01100	Metabolic pathways	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMT200046907	K00991	ko00900	Terpenoid backbone biosynthesis	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMT200046907	K00991	ko01100	Metabolic pathways	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMT200046910	K09753	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMT200046910	K09753	ko01100	Metabolic pathways	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMT200046910	K09753	ko01110	Biosynthesis of secondary metabolites	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMT200046912	K09753	ko00940	Phenylpropanoid biosynthesis	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMT200046912	K09753	ko01100	Metabolic pathways	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMT200046912	K09753	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMT200046913	K09753	ko00940	Phenylpropanoid biosynthesis	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMT200046913	K09753	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMT200046913	K09753	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMT200092714	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200092714	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200092714	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200092723	K01762	ko00270	Cysteine and methionine metabolism	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMT200092723	K01762	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMT200092726	K05278	ko00941	Flavonoid biosynthesis	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMT200092726	K05278	ko01100	Metabolic pathways	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMT200092726	K05278	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMT200097056	K10760	ko00908	Zeatin biosynthesis	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMT200097056	K10760	ko01100	Metabolic pathways	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMT200097056	K10760	ko01110	Biosynthesis of secondary metabolites	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMT200097070	K01051	ko00040	Pentose and glucuronate interconversions	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMT200097070	K01051	ko00500	Starch and sucrose metabolism	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMT200097070	K01051	ko01100	Metabolic pathways	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMT200025093	K04733	ko04210	Apoptosis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMT200025093	K04733	ko04620	Toll-like receptor signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMT200025093	K04733	ko04722	Neurotrophin signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMT200025093	K04733	ko05140	Leishmaniasis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMT200025093	K04733	ko05142	Chagas disease	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMT200025103	K00284	ko00910	Nitrogen metabolism	11627	0.	0.85	0.91	1.00
PGSC0003DMT200025104	K00284	ko00910	Nitrogen metabolism	11939	0.	0.86	0.93	1.00
PGSC0003DMT200025106	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMT200025106	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMT200025107	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMT200025107	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMT200015377	K12126	ko04712	Circadian rhythm - plant	319	1.1e-11	0.47	0.71	0.43
PGSC0003DMT200015396	K06685	ko04111	Cell cycle - yeast	411	2.7e-13	0.28	0.44	0.43
PGSC0003DMT200015397	K06685	ko04111	Cell cycle - yeast	425	6.4e-14	0.27	0.43	0.44
PGSC0003DMT200021967	K01426	ko00330	Arginine and proline metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021967	K01426	ko00360	Phenylalanine metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021967	K01426	ko00380	Tryptophan metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021967	K01426	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021967	K01426	ko00632	Benzoate degradation via CoA ligation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021967	K01426	ko00643	Styrene degradation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMT200021982	K00558	ko00270	Cysteine and methionine metabolism	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMT200021982	K00558	ko01100	Metabolic pathways	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMT200058594	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058594	K01580	ko00410	beta-Alanine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058594	K01580	ko00430	Taurine and hypotaurine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058594	K01580	ko00650	Butanoate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058594	K01580	ko01100	Metabolic pathways	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058594	K01580	ko04940	Type I diabetes mellitus	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMT200058609	K09659	ko00510	N-Glycan biosynthesis	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMT200058609	K09659	ko01100	Metabolic pathways	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMT200058611	K09659	ko00510	N-Glycan biosynthesis	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMT200058611	K09659	ko01100	Metabolic pathways	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMT200085217	K03094	ko04110	Cell cycle	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04111	Cell cycle - yeast	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04114	Oocyte meiosis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04120	Ubiquitin mediated proteolysis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04310	Wnt signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04350	TGF-beta signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200085217	K03094	ko04710	Circadian rhythm - mammal	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMT200013676	K01509	ko00230	Purine metabolism	824	1.4e-39	0.49	0.67	0.96
PGSC0003DMT200013677	K01509	ko00230	Purine metabolism	1483	5.8e-76	0.47	0.66	0.84
PGSC0003DMT200013678	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMT200013679	K01509	ko00230	Purine metabolism	1564	2.0e-80	0.34	0.53	0.84
PGSC0003DMT200013680	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMT200023333	K02210	ko03030	DNA replication	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMT200023333	K02210	ko04110	Cell cycle	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMT200023333	K02210	ko04111	Cell cycle - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMT200023333	K02210	ko04113	Meiosis - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMT200023370	K01897	ko00071	Fatty acid metabolism	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMT200023370	K01897	ko01100	Metabolic pathways	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMT200023370	K01897	ko03320	PPAR signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMT200023370	K01897	ko04146	Peroxisome	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMT200023370	K01897	ko04920	Adipocytokine signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMT200023371	K01897	ko00071	Fatty acid metabolism	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMT200023371	K01897	ko01100	Metabolic pathways	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMT200023371	K01897	ko03320	PPAR signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMT200023371	K01897	ko04146	Peroxisome	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMT200023371	K01897	ko04920	Adipocytokine signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMT200039661	K06636	ko04110	Cell cycle	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMT200039661	K06636	ko04111	Cell cycle - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMT200039661	K06636	ko04113	Meiosis - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMT200039661	K06636	ko04114	Oocyte meiosis	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMT200039664	K01810	ko00010	Glycolysis / Gluconeogenesis	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039664	K01810	ko00030	Pentose phosphate pathway	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039664	K01810	ko00500	Starch and sucrose metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039664	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039664	K01810	ko01100	Metabolic pathways	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039664	K01810	ko01110	Biosynthesis of secondary metabolites	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMT200039671	K05681	ko02010	ABC transporters	1201	2.1e-60	0.36	0.55	0.99
PGSC0003DMT200039676	K05681	ko02010	ABC transporters	1307	3.0e-66	0.36	0.55	0.96
PGSC0003DMT200039696	K00492	ko00340	Histidine metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00363	Bisphenol A degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00622	Toluene and xylene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00624	1- and 2-Methylnaphthalene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00626	Naphthalene and anthracene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00627	1,4-Dichlorobenzene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00680	Methane metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko00903	Limonene and pinene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko01100	Metabolic pathways	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039696	K00492	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMT200039699	K00492	ko00340	Histidine metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00363	Bisphenol A degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00622	Toluene and xylene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00624	1- and 2-Methylnaphthalene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00626	Naphthalene and anthracene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00627	1,4-Dichlorobenzene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00680	Methane metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko00903	Limonene and pinene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko01100	Metabolic pathways	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200039699	K00492	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMT200091526	K05282	ko00904	Diterpenoid biosynthesis	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMT200091526	K05282	ko01100	Metabolic pathways	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMT200091526	K05282	ko01110	Biosynthesis of secondary metabolites	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMT200091529	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMT200091529	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMT200091529	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMT200091529	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMT200091529	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMT200091533	K03133	ko03022	Basal transcription factors	315	1.5e-11	0.58	0.73	0.90
PGSC0003DMT200060397	K00430	ko00360	Phenylalanine metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMT200060397	K00430	ko00680	Methane metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMT200060397	K00430	ko00940	Phenylpropanoid biosynthesis	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMT200060397	K00430	ko01100	Metabolic pathways	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMT200060397	K00430	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMT200060426	K11717	ko00450	Selenoamino acid metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMT200060426	K11717	ko00730	Thiamine metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMT200060426	K11717	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMT200060427	K11717	ko00450	Selenoamino acid metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMT200060427	K11717	ko00730	Thiamine metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMT200060427	K11717	ko01100	Metabolic pathways	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMT200069735	K00522	ko00860	Porphyrin and chlorophyll metabolism	538	7.7e-24	0.67	0.78	0.51
PGSC0003DMT200069736	K00522	ko00860	Porphyrin and chlorophyll metabolism	823	1.5e-39	0.60	0.75	0.66
PGSC0003DMT200069737	K03103	ko00562	Inositol phosphate metabolism	401	2.8e-16	0.29	0.45	0.93
PGSC0003DMT200069738	K03103	ko00562	Inositol phosphate metabolism	566	2.2e-25	0.28	0.49	0.81
PGSC0003DMT200069739	K03103	ko00562	Inositol phosphate metabolism	562	3.7e-25	0.28	0.49	0.81
PGSC0003DMT200069740	K03103	ko00562	Inositol phosphate metabolism	530	2.1e-23	0.27	0.46	0.82
PGSC0003DMT200069750	K01100	ko00710	Carbon fixation in photosynthetic organisms	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMT200069750	K01100	ko01100	Metabolic pathways	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMT200069751	K01100	ko00710	Carbon fixation in photosynthetic organisms	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMT200069751	K01100	ko01100	Metabolic pathways	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMT200069755	K13065	ko00940	Phenylpropanoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMT200069755	K13065	ko00941	Flavonoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMT200069755	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMT200069755	K13065	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMT200069760	K05857	ko00562	Inositol phosphate metabolism	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMT200069760	K05857	ko01100	Metabolic pathways	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMT200069760	K05857	ko04020	Calcium signaling pathway	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMT200069760	K05857	ko04070	Phosphatidylinositol signaling system	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMT200069761	K05857	ko00562	Inositol phosphate metabolism	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMT200069761	K05857	ko01100	Metabolic pathways	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMT200069761	K05857	ko04020	Calcium signaling pathway	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMT200069761	K05857	ko04070	Phosphatidylinositol signaling system	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMT200047943	K04733	ko04210	Apoptosis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMT200047943	K04733	ko04620	Toll-like receptor signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMT200047943	K04733	ko04722	Neurotrophin signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMT200047943	K04733	ko05140	Leishmaniasis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMT200047943	K04733	ko05142	Chagas disease	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMT200047944	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMT200047944	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMT200047944	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMT200047944	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMT200047944	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMT200047945	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6180	0.	0.75	0.84	0.81
PGSC0003DMT200047946	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6350	0.	0.77	0.86	0.99
PGSC0003DMT200047950	K00655	ko00561	Glycerolipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMT200047950	K00655	ko00564	Glycerophospholipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMT200047950	K00655	ko01100	Metabolic pathways	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMT200047954	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047954	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047954	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047955	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047955	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047955	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMT200047969	K08242	ko00100	Steroid biosynthesis	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMT200047969	K08242	ko01110	Biosynthesis of secondary metabolites	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMT200047976	K06640	ko04110	Cell cycle	11655	0.	0.68	0.82	1.00
PGSC0003DMT200047976	K06640	ko04115	p53 signaling pathway	11655	0.	0.68	0.82	1.00
PGSC0003DMT200047980	K06640	ko04110	Cell cycle	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMT200047980	K06640	ko04115	p53 signaling pathway	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMT200047982	K04424	ko04010	MAPK signaling pathway	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMT200047982	K04424	ko04530	Tight junction	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMT200047983	K04424	ko04010	MAPK signaling pathway	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMT200047983	K04424	ko04530	Tight junction	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMT200066654	K00145	ko00330	Arginine and proline metabolism	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMT200066654	K00145	ko01100	Metabolic pathways	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMT200066654	K00145	ko01110	Biosynthesis of secondary metabolites	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMT200066656	K00145	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMT200066656	K00145	ko01100	Metabolic pathways	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMT200066656	K00145	ko01110	Biosynthesis of secondary metabolites	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMT200066664	K08233	ko00901	Indole alkaloid biosynthesis	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMT200066664	K08233	ko01110	Biosynthesis of secondary metabolites	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMT200066665	K08233	ko00901	Indole alkaloid biosynthesis	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMT200066665	K08233	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMT200066666	K08233	ko00901	Indole alkaloid biosynthesis	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMT200066666	K08233	ko01110	Biosynthesis of secondary metabolites	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMT200066667	K08233	ko00901	Indole alkaloid biosynthesis	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMT200066667	K08233	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMT200066668	K08233	ko00901	Indole alkaloid biosynthesis	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMT200066668	K08233	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMT200066669	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMT200066669	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMT200066671	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMT200066671	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMT200066674	K08233	ko00901	Indole alkaloid biosynthesis	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMT200066674	K08233	ko01110	Biosynthesis of secondary metabolites	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMT200066675	K08233	ko00901	Indole alkaloid biosynthesis	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMT200066675	K08233	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMT200066676	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMT200066676	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMT200066677	K08233	ko00901	Indole alkaloid biosynthesis	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMT200066677	K08233	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMT200066680	K08233	ko00901	Indole alkaloid biosynthesis	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMT200066680	K08233	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMT200066683	K08233	ko00901	Indole alkaloid biosynthesis	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMT200066683	K08233	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMT200066685	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMT200066685	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMT200066686	K08233	ko00901	Indole alkaloid biosynthesis	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMT200066686	K08233	ko01110	Biosynthesis of secondary metabolites	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMT200066689	K08233	ko00901	Indole alkaloid biosynthesis	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMT200066689	K08233	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMT200066691	K08233	ko00901	Indole alkaloid biosynthesis	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMT200066691	K08233	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMT200066694	K08233	ko00901	Indole alkaloid biosynthesis	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMT200066694	K08233	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMT200066695	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMT200066695	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMT200066696	K08233	ko00901	Indole alkaloid biosynthesis	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMT200066696	K08233	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMT200066699	K08233	ko00901	Indole alkaloid biosynthesis	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMT200066699	K08233	ko01110	Biosynthesis of secondary metabolites	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMT200035127	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMT200035128	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMT200035129	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMT200035150	K09680	ko00770	Pantothenate and CoA biosynthesis	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMT200035150	K09680	ko01100	Metabolic pathways	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMT200035151	K09680	ko00770	Pantothenate and CoA biosynthesis	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMT200035151	K09680	ko01100	Metabolic pathways	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMT200035152	K09680	ko00770	Pantothenate and CoA biosynthesis	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMT200035152	K09680	ko01100	Metabolic pathways	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMT200035159	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMT200035159	K01661	ko01100	Metabolic pathways	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMT200035159	K01661	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMT200035160	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMT200035160	K01661	ko01100	Metabolic pathways	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMT200035160	K01661	ko01110	Biosynthesis of secondary metabolites	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMT200035161	K01184	ko00040	Pentose and glucuronate interconversions	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMT200035161	K01184	ko00500	Starch and sucrose metabolism	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMT200035161	K01184	ko01100	Metabolic pathways	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMT200035162	K01184	ko00040	Pentose and glucuronate interconversions	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMT200035162	K01184	ko00500	Starch and sucrose metabolism	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMT200035162	K01184	ko01100	Metabolic pathways	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMT200035163	K01184	ko00040	Pentose and glucuronate interconversions	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMT200035163	K01184	ko00500	Starch and sucrose metabolism	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMT200035163	K01184	ko01100	Metabolic pathways	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMT200035164	K01184	ko00040	Pentose and glucuronate interconversions	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMT200035164	K01184	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMT200035164	K01184	ko01100	Metabolic pathways	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMT200019317	K05681	ko02010	ABC transporters	898	1.1e-43	0.42	0.68	0.70
PGSC0003DMT200019319	K05681	ko02010	ABC transporters	931	1.6e-45	0.36	0.59	0.80
PGSC0003DMT200019320	K01595	ko00620	Pyruvate metabolism	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMT200019320	K01595	ko00710	Carbon fixation in photosynthetic organisms	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMT200019320	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMT200019320	K01595	ko01100	Metabolic pathways	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMT200019321	K01595	ko00620	Pyruvate metabolism	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMT200019321	K01595	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMT200019321	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMT200019321	K01595	ko01100	Metabolic pathways	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMT200019322	K01595	ko00620	Pyruvate metabolism	7179	0.	0.80	0.89	1.00
PGSC0003DMT200019322	K01595	ko00710	Carbon fixation in photosynthetic organisms	7179	0.	0.80	0.89	1.00
PGSC0003DMT200019322	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7179	0.	0.80	0.89	1.00
PGSC0003DMT200019322	K01595	ko01100	Metabolic pathways	7179	0.	0.80	0.89	1.00
PGSC0003DMT200019323	K01595	ko00620	Pyruvate metabolism	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMT200019323	K01595	ko00710	Carbon fixation in photosynthetic organisms	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMT200019323	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMT200019323	K01595	ko01100	Metabolic pathways	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMT200019358	K00162	ko00010	Glycolysis / Gluconeogenesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko00020	Citrate cycle (TCA cycle)	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko00620	Pyruvate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko00650	Butanoate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko01100	Metabolic pathways	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200019358	K00162	ko01110	Biosynthesis of secondary metabolites	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMT200011393	K01193	ko00052	Galactose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMT200011393	K01193	ko00500	Starch and sucrose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMT200011393	K01193	ko01100	Metabolic pathways	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMT200011394	K01193	ko00052	Galactose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMT200011394	K01193	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMT200011394	K01193	ko01100	Metabolic pathways	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMT200011409	K13065	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMT200011409	K13065	ko00941	Flavonoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMT200011409	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMT200011409	K13065	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMT200011410	K13065	ko00940	Phenylpropanoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMT200011410	K13065	ko00941	Flavonoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMT200011410	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMT200011410	K13065	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMT200090518	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200090518	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200090518	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200090523	K12929	ko00904	Diterpenoid biosynthesis	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMT200090523	K12929	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMT200090528	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMT200090528	K00517	ko00626	Naphthalene and anthracene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMT200090528	K00517	ko00903	Limonene and pinene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMT200090528	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMT200090528	K00517	ko01110	Biosynthesis of secondary metabolites	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMT200095775	K00799	ko00480	Glutathione metabolism	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMT200095775	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMT200095775	K00799	ko00982	Drug metabolism - cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMT200003992	K00640	ko00270	Cysteine and methionine metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMT200003992	K00640	ko00920	Sulfur metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMT200003992	K00640	ko01100	Metabolic pathways	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMT200003993	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMT200003993	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMT200003993	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMT200003995	K01053	ko00030	Pentose phosphate pathway	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMT200003995	K01053	ko00053	Ascorbate and aldarate metabolism	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMT200003995	K01053	ko00930	Caprolactam degradation	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMT200003995	K01053	ko01100	Metabolic pathways	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMT200003995	K01053	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMT200003998	K06636	ko04110	Cell cycle	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMT200003998	K06636	ko04111	Cell cycle - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMT200003998	K06636	ko04113	Meiosis - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMT200003998	K06636	ko04114	Oocyte meiosis	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMT200004011	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMT200004011	K05284	ko01100	Metabolic pathways	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMT200004012	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMT200004012	K05284	ko01100	Metabolic pathways	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMT200004013	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMT200004013	K05284	ko01100	Metabolic pathways	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMT200004014	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMT200004014	K05284	ko01100	Metabolic pathways	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMT200004015	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMT200004015	K05284	ko01100	Metabolic pathways	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMT200062444	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMT200062444	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMT200062445	K04424	ko04010	MAPK signaling pathway	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMT200062445	K04424	ko04530	Tight junction	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMT200062446	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMT200062446	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMT200054579	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMT200054579	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMT200054579	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMT200054584	K12182	ko04144	Endocytosis	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMT200054584	K12182	ko04145	Phagosome	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMT200054599	K04733	ko04210	Apoptosis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMT200054599	K04733	ko04620	Toll-like receptor signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMT200054599	K04733	ko04722	Neurotrophin signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMT200054599	K04733	ko05140	Leishmaniasis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMT200054599	K04733	ko05142	Chagas disease	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMT200054602	K01897	ko00071	Fatty acid metabolism	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMT200054602	K01897	ko01100	Metabolic pathways	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMT200054602	K01897	ko03320	PPAR signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMT200054602	K01897	ko04146	Peroxisome	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMT200054602	K01897	ko04920	Adipocytokine signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMT200054603	K01897	ko00071	Fatty acid metabolism	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMT200054603	K01897	ko01100	Metabolic pathways	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMT200054603	K01897	ko03320	PPAR signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMT200054603	K01897	ko04146	Peroxisome	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMT200054603	K01897	ko04920	Adipocytokine signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMT200054604	K01897	ko00071	Fatty acid metabolism	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMT200054604	K01897	ko01100	Metabolic pathways	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMT200054604	K01897	ko03320	PPAR signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMT200054604	K01897	ko04146	Peroxisome	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMT200054604	K01897	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMT200054605	K02975	ko03010	Ribosome	850	4.8e-41	0.93	0.98	0.99
PGSC0003DMT200054606	K02887	ko03010	Ribosome	931	1.6e-45	0.83	0.97	0.99
PGSC0003DMT200054608	K12840	ko03040	Spliceosome	2254	1.7e-118	0.70	0.79	1.00
PGSC0003DMT200054617	K12192	ko04144	Endocytosis	1090	2.8e-54	0.64	0.81	0.95
PGSC0003DMT200045041	K03165	ko03440	Homologous recombination	2868	2.4e-152	0.75	0.82	0.94
PGSC0003DMT200045042	K03165	ko03440	Homologous recombination	2314	8.5e-122	0.72	0.84	1.00
PGSC0003DMT200045045	K00454	ko00591	Linoleic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMT200045045	K00454	ko00592	alpha-Linolenic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMT200045045	K00454	ko01100	Metabolic pathways	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMT200045046	K00454	ko00591	Linoleic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMT200045046	K00454	ko00592	alpha-Linolenic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMT200045046	K00454	ko01100	Metabolic pathways	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMT200045047	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045047	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045047	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045048	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045048	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045048	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045049	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045049	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045049	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMT200045050	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045050	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045050	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMT200045052	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200045052	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200045052	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200045055	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200045055	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200045055	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMT200063193	K00275	ko00750	Vitamin B6 metabolism	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMT200063193	K00275	ko01100	Metabolic pathways	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMT200063196	K00275	ko00750	Vitamin B6 metabolism	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMT200063196	K00275	ko01100	Metabolic pathways	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMT200063199	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMT200063199	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMT200063200	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMT200063200	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMT200063203	K00971	ko00051	Fructose and mannose metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMT200063203	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMT200063203	K00971	ko01100	Metabolic pathways	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMT200063203	K00971	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMT200063204	K00966	ko00051	Fructose and mannose metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMT200063204	K00966	ko00520	Amino sugar and nucleotide sugar metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMT200063204	K00966	ko01100	Metabolic pathways	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMT200063204	K00966	ko01110	Biosynthesis of secondary metabolites	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMT200063205	K00130	ko00260	Glycine, serine and threonine metabolism	3144	1.4e-167	0.72	0.85	0.99
PGSC0003DMT200063207	K01205	ko00531	Glycosaminoglycan degradation	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMT200063207	K01205	ko01100	Metabolic pathways	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMT200063207	K01205	ko04142	Lysosome	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMT200063227	K04392	ko04010	MAPK signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04062	Chemokine signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04145	Phagosome	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04310	Wnt signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04360	Axon guidance	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04370	VEGF signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04510	Focal adhesion	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04520	Adherens junction	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04650	Natural killer cell mediated cytotoxicity	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04662	B cell receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04664	Fc epsilon RI signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04666	Fc gamma R-mediated phagocytosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04670	Leukocyte transendothelial migration	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko04810	Regulation of actin cytoskeleton	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05100	Bacterial invasion of epithelial cells	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05131	Shigellosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05200	Pathways in cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05210	Colorectal cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05211	Renal cell carcinoma	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05212	Pancreatic cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063227	K04392	ko05416	Viral myocarditis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMT200063228	K04392	ko04010	MAPK signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04062	Chemokine signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04145	Phagosome	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04310	Wnt signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04360	Axon guidance	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04370	VEGF signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04510	Focal adhesion	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04520	Adherens junction	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04620	Toll-like receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04650	Natural killer cell mediated cytotoxicity	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04662	B cell receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04664	Fc epsilon RI signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04666	Fc gamma R-mediated phagocytosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04670	Leukocyte transendothelial migration	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04722	Neurotrophin signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko04810	Regulation of actin cytoskeleton	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05100	Bacterial invasion of epithelial cells	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05131	Shigellosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05200	Pathways in cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05210	Colorectal cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05211	Renal cell carcinoma	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05212	Pancreatic cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063228	K04392	ko05416	Viral myocarditis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMT200063229	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063229	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063230	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMT200063231	K05391	ko04626	Plant-pathogen interaction	1374	6.0e-70	0.69	0.79	0.97
PGSC0003DMT200063232	K05391	ko04626	Plant-pathogen interaction	3594	2.2e-192	0.62	0.75	0.99
PGSC0003DMT200063236	K12356	ko00940	Phenylpropanoid biosynthesis	797	4.0e-38	0.34	0.51	0.97
PGSC0003DMT200063237	K12356	ko00940	Phenylpropanoid biosynthesis	785	1.8e-37	0.34	0.50	0.99
PGSC0003DMT200082739	K00635	ko00561	Glycerolipid metabolism	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMT200082739	K00635	ko01100	Metabolic pathways	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMT200082741	K00635	ko00561	Glycerolipid metabolism	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMT200082741	K00635	ko01100	Metabolic pathways	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMT200082747	K02218	ko04340	Hedgehog signaling pathway	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMT200082747	K02218	ko04711	Circadian rhythm - fly	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMT200082760	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMT200082760	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMT200082760	K00734	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMT200044324	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMT200044324	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMT200044324	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMT200044324	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMT200044325	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044325	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044325	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044325	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044326	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044326	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044326	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044326	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMT200044339	K02218	ko04340	Hedgehog signaling pathway	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMT200044339	K02218	ko04711	Circadian rhythm - fly	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMT200072015	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072015	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072015	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072016	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMT200072016	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMT200072016	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMT200072017	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMT200072017	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMT200072017	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMT200072018	K09841	ko00906	Carotenoid biosynthesis	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMT200072018	K09841	ko01100	Metabolic pathways	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMT200072018	K09841	ko01110	Biosynthesis of secondary metabolites	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMT200072019	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072019	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072019	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMT200072021	K09841	ko00906	Carotenoid biosynthesis	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMT200072021	K09841	ko01100	Metabolic pathways	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMT200072021	K09841	ko01110	Biosynthesis of secondary metabolites	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMT200072022	K09841	ko00906	Carotenoid biosynthesis	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMT200072022	K09841	ko01100	Metabolic pathways	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMT200072022	K09841	ko01110	Biosynthesis of secondary metabolites	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMT200072043	K00616	ko00030	Pentose phosphate pathway	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMT200072043	K00616	ko01100	Metabolic pathways	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMT200072043	K00616	ko01110	Biosynthesis of secondary metabolites	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMT200072044	K00616	ko00030	Pentose phosphate pathway	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMT200072044	K00616	ko01100	Metabolic pathways	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMT200072044	K00616	ko01110	Biosynthesis of secondary metabolites	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMT200072051	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMT200072051	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMT200072052	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMT200072052	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMT200072053	K00218	ko00860	Porphyrin and chlorophyll metabolism	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMT200072053	K00218	ko01100	Metabolic pathways	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMT200072053	K00218	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMT200095880	K10760	ko00908	Zeatin biosynthesis	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMT200095880	K10760	ko01100	Metabolic pathways	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMT200095880	K10760	ko01110	Biosynthesis of secondary metabolites	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMT200095883	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMT200036045	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMT200036045	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMT200036045	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMT200036045	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMT200036045	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMT200036051	K04733	ko04210	Apoptosis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMT200036051	K04733	ko04620	Toll-like receptor signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMT200036051	K04733	ko04722	Neurotrophin signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMT200036051	K04733	ko05140	Leishmaniasis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMT200036051	K04733	ko05142	Chagas disease	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMT200036057	K10840	ko03420	Nucleotide excision repair	212	7.4e-06	0.34	0.61	0.76
PGSC0003DMT200036075	K10143	ko04115	p53 signaling pathway	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMT200036075	K10143	ko04120	Ubiquitin mediated proteolysis	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMT200036077	K10143	ko04115	p53 signaling pathway	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMT200036077	K10143	ko04120	Ubiquitin mediated proteolysis	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMT200036078	K10143	ko04115	p53 signaling pathway	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMT200036078	K10143	ko04120	Ubiquitin mediated proteolysis	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMT200036081	K05933	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMT200036081	K05933	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMT200020175	K13065	ko00940	Phenylpropanoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMT200020175	K13065	ko00941	Flavonoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMT200020175	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMT200020175	K13065	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMT200020180	K13065	ko00940	Phenylpropanoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMT200020180	K13065	ko00941	Flavonoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMT200020180	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMT200020180	K13065	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMT200020199	K06630	ko04110	Cell cycle	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMT200020199	K06630	ko04114	Oocyte meiosis	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMT200020199	K06630	ko04722	Neurotrophin signaling pathway	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMT200020200	K06630	ko04110	Cell cycle	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMT200020200	K06630	ko04114	Oocyte meiosis	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMT200020200	K06630	ko04722	Neurotrophin signaling pathway	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMT200029234	K08770	ko03320	PPAR signaling pathway	1014	4.3e-50	0.81	0.89	0.99
PGSC0003DMT200029238	K12882	ko03040	Spliceosome	3663	3.4e-196	0.77	0.88	0.96
PGSC0003DMT200029239	K12882	ko03040	Spliceosome	2196	2.8e-115	0.78	0.89	0.96
PGSC0003DMT200029240	K12882	ko03040	Spliceosome	5680	0.	0.77	0.88	1.00
PGSC0003DMT200029242	K00134	ko00010	Glycolysis / Gluconeogenesis	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMT200029242	K00134	ko01100	Metabolic pathways	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMT200029242	K00134	ko01110	Biosynthesis of secondary metabolites	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMT200029242	K00134	ko05010	Alzheimer's disease	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMT200029260	K04733	ko04210	Apoptosis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMT200029260	K04733	ko04620	Toll-like receptor signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMT200029260	K04733	ko04722	Neurotrophin signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMT200029260	K04733	ko05140	Leishmaniasis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMT200029260	K04733	ko05142	Chagas disease	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMT200029265	K07385	ko00902	Monoterpenoid biosynthesis	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMT200029265	K07385	ko01100	Metabolic pathways	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMT200029266	K07385	ko00902	Monoterpenoid biosynthesis	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMT200029266	K07385	ko01100	Metabolic pathways	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMT200029275	K12742	ko00900	Terpenoid backbone biosynthesis	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMT200029275	K12742	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMT200029279	K05282	ko00904	Diterpenoid biosynthesis	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMT200029279	K05282	ko01100	Metabolic pathways	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMT200029279	K05282	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMT200017198	K01066	ko00623	2,4-Dichlorobenzoate degradation	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMT200017198	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMT200017199	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMT200017199	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMT200017200	K12598	ko03018	RNA degradation	600	9.2e-27	0.75	0.80	0.93
PGSC0003DMT200017202	K12598	ko03018	RNA degradation	823	1.5e-39	0.83	0.93	0.81
PGSC0003DMT200017205	K11778	ko00900	Terpenoid backbone biosynthesis	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMT200017205	K11778	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMT200017206	K12929	ko00904	Diterpenoid biosynthesis	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMT200017206	K12929	ko01110	Biosynthesis of secondary metabolites	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMT200017217	K04123	ko00904	Diterpenoid biosynthesis	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMT200017217	K04123	ko01100	Metabolic pathways	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMT200017217	K04123	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMT200017218	K04123	ko00904	Diterpenoid biosynthesis	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMT200017218	K04123	ko01100	Metabolic pathways	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMT200017218	K04123	ko01110	Biosynthesis of secondary metabolites	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMT200017219	K04123	ko00904	Diterpenoid biosynthesis	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMT200017219	K04123	ko01100	Metabolic pathways	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMT200017219	K04123	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMT200017220	K04123	ko00904	Diterpenoid biosynthesis	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMT200017220	K04123	ko01100	Metabolic pathways	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMT200017220	K04123	ko01110	Biosynthesis of secondary metabolites	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMT200017221	K04123	ko00904	Diterpenoid biosynthesis	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMT200017221	K04123	ko01100	Metabolic pathways	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMT200017221	K04123	ko01110	Biosynthesis of secondary metabolites	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMT200017223	K04123	ko00904	Diterpenoid biosynthesis	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMT200017223	K04123	ko01100	Metabolic pathways	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMT200017223	K04123	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMT200017224	K04123	ko00904	Diterpenoid biosynthesis	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMT200017224	K04123	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMT200017224	K04123	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMT200086031	K03413	ko02020	Two-component system	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMT200086031	K03413	ko02030	Bacterial chemotaxis	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMT200048621	K02894	ko03010	Ribosome	346	3.0e-13	0.93	1.00	0.50
PGSC0003DMT200048627	K01757	ko00901	Indole alkaloid biosynthesis	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMT200048627	K01757	ko01100	Metabolic pathways	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMT200048627	K01757	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMT200048628	K01757	ko00901	Indole alkaloid biosynthesis	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMT200048628	K01757	ko01100	Metabolic pathways	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMT200048628	K01757	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMT200048663	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048663	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048664	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMT200048669	K02084	ko04115	p53 signaling pathway	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko04210	Apoptosis	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko05010	Alzheimer's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko05012	Parkinson's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko05016	Huntington's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200048669	K02084	ko05222	Small cell lung cancer	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMT200065880	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMT200065880	K03785	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMT200065880	K03785	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMT200065887	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065887	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065887	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065887	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065889	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMT200065889	K01061	ko00364	Fluorobenzoate degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMT200065889	K01061	ko00627	1,4-Dichlorobenzene degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMT200065889	K01061	ko01100	Metabolic pathways	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMT200065890	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065890	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065890	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065890	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065891	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065891	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065891	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065891	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMT200065922	K12600	ko03018	RNA degradation	2894	8.7e-154	0.51	0.68	0.96
PGSC0003DMT200065923	K12600	ko03018	RNA degradation	2646	4.2e-140	0.55	0.74	0.97
PGSC0003DMT200077802	K12356	ko00940	Phenylpropanoid biosynthesis	703	6.1e-33	0.36	0.56	0.94
PGSC0003DMT200077830	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMT200077831	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMT200077837	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1846	5.6e-96	0.67	0.81	1.00
PGSC0003DMT200052064	K00387	ko00920	Sulfur metabolism	2676	9.2e-142	0.76	0.87	1.00
PGSC0003DMT200052065	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMT200052065	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMT200052065	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMT200052065	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMT200052065	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMT200000601	K11253	ko05322	Systemic lupus erythematosus	660	1.4e-30	0.69	0.81	0.60
PGSC0003DMT200000602	K11253	ko05322	Systemic lupus erythematosus	863	9.2e-42	0.68	0.80	0.99
PGSC0003DMT200000613	K01897	ko00071	Fatty acid metabolism	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMT200000613	K01897	ko01100	Metabolic pathways	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMT200000613	K01897	ko03320	PPAR signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMT200000613	K01897	ko04146	Peroxisome	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMT200000613	K01897	ko04920	Adipocytokine signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMT200000614	K05391	ko04626	Plant-pathogen interaction	1959	3.3e-102	0.76	0.88	1.00
PGSC0003DMT200000631	K11422	ko00310	Lysine degradation	644	2.3e-29	0.39	0.54	0.26
PGSC0003DMT200000633	K11422	ko00310	Lysine degradation	644	2.6e-29	0.39	0.54	0.26
PGSC0003DMT200000643	K01528	ko04144	Endocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMT200000643	K01528	ko04666	Fc gamma R-mediated phagocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMT200000643	K01528	ko05100	Bacterial invasion of epithelial cells	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMT200042598	K00844	ko00010	Glycolysis / Gluconeogenesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00051	Fructose and mannose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00052	Galactose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00500	Starch and sucrose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00521	Streptomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko00524	Butirosin and neomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko01100	Metabolic pathways	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko01110	Biosynthesis of secondary metabolites	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko04910	Insulin signaling pathway	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042598	K00844	ko04930	Type II diabetes mellitus	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMT200042599	K00844	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00051	Fructose and mannose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00052	Galactose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00500	Starch and sucrose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00521	Streptomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko00524	Butirosin and neomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko01100	Metabolic pathways	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko04910	Insulin signaling pathway	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042599	K00844	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMT200042600	K00844	ko00010	Glycolysis / Gluconeogenesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00051	Fructose and mannose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00052	Galactose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00521	Streptomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko00524	Butirosin and neomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko01100	Metabolic pathways	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko04910	Insulin signaling pathway	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042600	K00844	ko04930	Type II diabetes mellitus	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMT200042601	K00844	ko00010	Glycolysis / Gluconeogenesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00051	Fructose and mannose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00052	Galactose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00500	Starch and sucrose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00521	Streptomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko00524	Butirosin and neomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko01100	Metabolic pathways	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko01110	Biosynthesis of secondary metabolites	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko04910	Insulin signaling pathway	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042601	K00844	ko04930	Type II diabetes mellitus	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMT200042602	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMT200042603	K00970	ko03018	RNA degradation	336	2.0e-12	0.39	0.61	0.44
PGSC0003DMT200042604	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMT200042620	K08139	ko04113	Meiosis - yeast	359	5.8e-14	0.37	0.61	0.68
PGSC0003DMT200031688	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200031688	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200031688	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200031698	K10143	ko04115	p53 signaling pathway	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMT200031698	K10143	ko04120	Ubiquitin mediated proteolysis	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMT200031699	K10143	ko04115	p53 signaling pathway	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMT200031699	K10143	ko04120	Ubiquitin mediated proteolysis	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMT200031700	K10143	ko04115	p53 signaling pathway	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMT200031700	K10143	ko04120	Ubiquitin mediated proteolysis	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMT200031701	K10143	ko04115	p53 signaling pathway	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMT200031701	K10143	ko04120	Ubiquitin mediated proteolysis	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMT200031702	K10143	ko04115	p53 signaling pathway	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMT200031702	K10143	ko04120	Ubiquitin mediated proteolysis	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMT200031706	K02150	ko00190	Oxidative phosphorylation	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031706	K02150	ko01100	Metabolic pathways	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031706	K02150	ko04145	Phagosome	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031706	K02150	ko04966	Collecting duct acid secretion	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031706	K02150	ko05110	Vibrio cholerae infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031706	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMT200031707	K02150	ko00190	Oxidative phosphorylation	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031707	K02150	ko01100	Metabolic pathways	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031707	K02150	ko04145	Phagosome	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031707	K02150	ko04966	Collecting duct acid secretion	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031707	K02150	ko05110	Vibrio cholerae infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031707	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMT200031714	K05666	ko02010	ABC transporters	1596	3.4e-82	0.29	0.49	0.96
PGSC0003DMT200031715	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMT200031716	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMT200005544	K00799	ko00480	Glutathione metabolism	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMT200005544	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMT200005544	K00799	ko00982	Drug metabolism - cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMT200005546	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMT200005546	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMT200005546	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMT200005547	K00799	ko00480	Glutathione metabolism	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMT200005547	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMT200005547	K00799	ko00982	Drug metabolism - cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMT200005549	K00799	ko00480	Glutathione metabolism	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMT200005549	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMT200005549	K00799	ko00982	Drug metabolism - cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMT200005551	K00799	ko00480	Glutathione metabolism	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMT200005551	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMT200005551	K00799	ko00982	Drug metabolism - cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMT200005552	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMT200005552	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMT200005552	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMT200005556	K00799	ko00480	Glutathione metabolism	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMT200005556	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMT200005556	K00799	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMT200005557	K00799	ko00480	Glutathione metabolism	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMT200005557	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMT200005557	K00799	ko00982	Drug metabolism - cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMT200005558	K00799	ko00480	Glutathione metabolism	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMT200005558	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMT200005558	K00799	ko00982	Drug metabolism - cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMT200005560	K00799	ko00480	Glutathione metabolism	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMT200005560	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMT200005560	K00799	ko00982	Drug metabolism - cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMT200005561	K00799	ko00480	Glutathione metabolism	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMT200005561	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMT200005561	K00799	ko00982	Drug metabolism - cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMT200005567	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005567	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005567	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005568	K00799	ko00480	Glutathione metabolism	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMT200005568	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMT200005568	K00799	ko00982	Drug metabolism - cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMT200005569	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005569	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005569	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMT200005571	K00799	ko00480	Glutathione metabolism	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMT200005571	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMT200005571	K00799	ko00982	Drug metabolism - cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMT200005572	K00799	ko00480	Glutathione metabolism	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMT200005572	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMT200005572	K00799	ko00982	Drug metabolism - cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMT200005574	K11808	ko00230	Purine metabolism	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMT200005574	K11808	ko01100	Metabolic pathways	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMT200005574	K11808	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMT200005578	K10532	ko00531	Glycosaminoglycan degradation	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMT200005578	K10532	ko01100	Metabolic pathways	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMT200005578	K10532	ko04142	Lysosome	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMT200050186	K12356	ko00940	Phenylpropanoid biosynthesis	620	2.3e-28	0.34	0.46	0.89
PGSC0003DMT200050193	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMT200050194	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMT200050195	K00430	ko00360	Phenylalanine metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMT200050195	K00430	ko00680	Methane metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMT200050195	K00430	ko00940	Phenylpropanoid biosynthesis	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMT200050195	K00430	ko01100	Metabolic pathways	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMT200050195	K00430	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMT200050198	K00430	ko00360	Phenylalanine metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMT200050198	K00430	ko00680	Methane metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMT200050198	K00430	ko00940	Phenylpropanoid biosynthesis	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMT200050198	K00430	ko01100	Metabolic pathways	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMT200050198	K00430	ko01110	Biosynthesis of secondary metabolites	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMT200050200	K00430	ko00360	Phenylalanine metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMT200050200	K00430	ko00680	Methane metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMT200050200	K00430	ko00940	Phenylpropanoid biosynthesis	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMT200050200	K00430	ko01100	Metabolic pathways	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMT200050200	K00430	ko01110	Biosynthesis of secondary metabolites	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMT200050203	K01193	ko00052	Galactose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMT200050203	K01193	ko00500	Starch and sucrose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMT200050203	K01193	ko01100	Metabolic pathways	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMT200050204	K01193	ko00052	Galactose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMT200050204	K01193	ko00500	Starch and sucrose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMT200050204	K01193	ko01100	Metabolic pathways	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMT200050205	K01193	ko00052	Galactose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMT200050205	K01193	ko00500	Starch and sucrose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMT200050205	K01193	ko01100	Metabolic pathways	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMT200050209	K12356	ko00940	Phenylpropanoid biosynthesis	258	9.1e-11	0.29	0.46	0.94
PGSC0003DMT200050218	K08493	ko04130	SNARE interactions in vesicular transport	1175	5.7e-59	0.78	0.89	0.99
PGSC0003DMT200050219	K08493	ko04130	SNARE interactions in vesicular transport	1512	1.5e-77	0.82	0.93	1.00
PGSC0003DMT200076029	K01867	ko00380	Tryptophan metabolism	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMT200076029	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMT200076030	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMT200076030	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMT200076031	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMT200076031	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMT200076047	K01868	ko00970	Aminoacyl-tRNA biosynthesis	1271	2.9e-64	0.74	0.87	0.98
PGSC0003DMT200076048	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4821	4.5e-260	0.82	0.91	0.99
PGSC0003DMT200076054	K00422	ko00350	Tyrosine metabolism	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMT200076054	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMT200076054	K00422	ko01100	Metabolic pathways	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMT200076054	K00422	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMT200076055	K00422	ko00350	Tyrosine metabolism	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMT200076055	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMT200076055	K00422	ko01100	Metabolic pathways	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMT200076055	K00422	ko01110	Biosynthesis of secondary metabolites	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMT200076063	K08300	ko03018	RNA degradation	346	2.0e-12	0.25	0.45	0.96
PGSC0003DMT200040831	K00472	ko00330	Arginine and proline metabolism	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMT200040831	K00472	ko01100	Metabolic pathways	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMT200040832	K00472	ko00330	Arginine and proline metabolism	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMT200040832	K00472	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMT200040833	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMT200040833	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMT200040834	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMT200040834	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMT200040848	K00100	ko00051	Fructose and mannose metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040848	K00100	ko00363	Bisphenol A degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040848	K00100	ko00591	Linoleic acid metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040848	K00100	ko00625	Tetrachloroethene degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040848	K00100	ko00650	Butanoate metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040848	K00100	ko01100	Metabolic pathways	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMT200040852	K11778	ko00900	Terpenoid backbone biosynthesis	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMT200040852	K11778	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMT200040853	K02920	ko03010	Ribosome	828	7.8e-40	0.92	0.96	0.99
PGSC0003DMT200040858	K10352	ko04530	Tight junction	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMT200040858	K10352	ko05416	Viral myocarditis	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMT200040866	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040866	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200021198	K00599	ko00340	Histidine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMT200021198	K00599	ko00350	Tyrosine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMT200021198	K00599	ko00450	Selenoamino acid metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMT200021198	K00599	ko00626	Naphthalene and anthracene degradation	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMT200021199	K00599	ko00340	Histidine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMT200021199	K00599	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMT200021199	K00599	ko00450	Selenoamino acid metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMT200021199	K00599	ko00626	Naphthalene and anthracene degradation	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMT200021200	K00599	ko00340	Histidine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMT200021200	K00599	ko00350	Tyrosine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMT200021200	K00599	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMT200021200	K00599	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMT200021231	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMT200021231	K00517	ko00626	Naphthalene and anthracene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMT200021231	K00517	ko00903	Limonene and pinene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMT200021231	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMT200021231	K00517	ko01110	Biosynthesis of secondary metabolites	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMT200007289	K12848	ko03040	Spliceosome	1422	1.4e-72	0.84	0.93	0.97
PGSC0003DMT200007294	K10901	ko03440	Homologous recombination	2561	2.0e-135	0.77	0.85	0.86
PGSC0003DMT200007295	K10901	ko03440	Homologous recombination	2035	2.1e-106	0.82	0.91	0.99
PGSC0003DMT200007296	K10901	ko03440	Homologous recombination	800	2.7e-38	0.74	0.88	0.87
PGSC0003DMT200007297	K10901	ko03440	Homologous recombination	632	5.0e-29	0.51	0.67	0.80
PGSC0003DMT200033352	K02603	ko04110	Cell cycle	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMT200033352	K02603	ko04111	Cell cycle - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMT200033352	K02603	ko04113	Meiosis - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMT200033353	K02603	ko04110	Cell cycle	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMT200033353	K02603	ko04111	Cell cycle - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMT200033353	K02603	ko04113	Meiosis - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMT200033354	K02603	ko04110	Cell cycle	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMT200033354	K02603	ko04111	Cell cycle - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMT200033354	K02603	ko04113	Meiosis - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMT200033355	K02603	ko04110	Cell cycle	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMT200033355	K02603	ko04111	Cell cycle - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMT200033355	K02603	ko04113	Meiosis - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMT200033356	K04424	ko04010	MAPK signaling pathway	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMT200033356	K04424	ko04530	Tight junction	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMT200002268	K05280	ko00941	Flavonoid biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMT200002268	K05280	ko00944	Flavone and flavonol biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMT200002268	K05280	ko01100	Metabolic pathways	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMT200002268	K05280	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMT200002291	K02911	ko03010	Ribosome	367	2.1e-14	0.85	0.88	0.93
PGSC0003DMT200002302	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMT200002302	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMT200002302	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMT200002312	K03876	ko04120	Ubiquitin mediated proteolysis	292	2.9e-10	0.31	0.49	0.67
PGSC0003DMT200096990	K03094	ko04110	Cell cycle	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04111	Cell cycle - yeast	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04114	Oocyte meiosis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04120	Ubiquitin mediated proteolysis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04310	Wnt signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04350	TGF-beta signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200096990	K03094	ko04710	Circadian rhythm - mammal	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMT200064904	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMT200064904	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMT200064904	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMT200064904	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMT200064910	K04371	ko04010	MAPK signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04012	ErbB signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04013	MAPK signaling pathway - fly	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04062	Chemokine signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04114	Oocyte meiosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04150	mTOR signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04270	Vascular smooth muscle contraction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04320	Dorso-ventral axis formation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04350	TGF-beta signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04360	Axon guidance	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04370	VEGF signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04510	Focal adhesion	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04520	Adherens junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04540	Gap junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04620	Toll-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04621	NOD-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04650	Natural killer cell mediated cytotoxicity	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04660	T cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04662	B cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04664	Fc epsilon RI signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04666	Fc gamma R-mediated phagocytosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04720	Long-term potentiation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04722	Neurotrophin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04730	Long-term depression	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04810	Regulation of actin cytoskeleton	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04910	Insulin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04912	GnRH signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04914	Progesterone-mediated oocyte maturation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04916	Melanogenesis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04930	Type II diabetes mellitus	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05010	Alzheimer's disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05020	Prion diseases	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05131	Shigellosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05140	Leishmaniasis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05142	Chagas disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05200	Pathways in cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05210	Colorectal cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05211	Renal cell carcinoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05212	Pancreatic cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05213	Endometrial cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05214	Glioma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05215	Prostate cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05216	Thyroid cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05218	Melanoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05219	Bladder cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05220	Chronic myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05221	Acute myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064910	K04371	ko05223	Non-small cell lung cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMT200064911	K05740	ko04510	Focal adhesion	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMT200064911	K05740	ko04810	Regulation of actin cytoskeleton	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMT200064911	K05740	ko05131	Shigellosis	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMT200064912	K04512	ko04310	Wnt signaling pathway	304	7.6e-08	0.32	0.52	0.35
PGSC0003DMT200064913	K05849	ko04020	Calcium signaling pathway	297	6.5e-10	0.37	0.56	0.33
PGSC0003DMT200064920	K02940	ko03010	Ribosome	1466	5.1e-75	0.91	0.96	0.99
PGSC0003DMT200064921	K01184	ko00040	Pentose and glucuronate interconversions	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMT200064921	K01184	ko00500	Starch and sucrose metabolism	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMT200064921	K01184	ko01100	Metabolic pathways	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMT200064923	K01184	ko00040	Pentose and glucuronate interconversions	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMT200064923	K01184	ko00500	Starch and sucrose metabolism	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMT200064923	K01184	ko01100	Metabolic pathways	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMT200064924	K08803	ko05200	Pathways in cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMT200064924	K08803	ko05219	Bladder cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMT200080330	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200080330	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200080330	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMT200080350	K02183	ko04020	Calcium signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04070	Phosphatidylinositol signaling system	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04114	Oocyte meiosis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04270	Vascular smooth muscle contraction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04626	Plant-pathogen interaction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04720	Long-term potentiation	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04722	Neurotrophin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04740	Olfactory transduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04744	Phototransduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04745	Phototransduction - fly	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04910	Insulin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04912	GnRH signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04916	Melanogenesis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04970	Salivary secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko04971	Gastric acid secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko05010	Alzheimer's disease	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200080350	K02183	ko05214	Glioma	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMT200073716	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMT200073716	K01687	ko00770	Pantothenate and CoA biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMT200073716	K01687	ko01100	Metabolic pathways	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMT200073716	K01687	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMT200073717	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMT200073717	K01687	ko00770	Pantothenate and CoA biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMT200073717	K01687	ko01100	Metabolic pathways	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMT200073717	K01687	ko01110	Biosynthesis of secondary metabolites	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMT200073725	K00413	ko00190	Oxidative phosphorylation	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073725	K00413	ko01100	Metabolic pathways	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073725	K00413	ko04260	Cardiac muscle contraction	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073725	K00413	ko05010	Alzheimer's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073725	K00413	ko05012	Parkinson's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073725	K00413	ko05016	Huntington's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMT200073726	K00413	ko00190	Oxidative phosphorylation	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073726	K00413	ko01100	Metabolic pathways	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073726	K00413	ko04260	Cardiac muscle contraction	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073726	K00413	ko05010	Alzheimer's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073726	K00413	ko05012	Parkinson's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073726	K00413	ko05016	Huntington's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMT200073743	K11152	ko00830	Retinol metabolism	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMT200073743	K11152	ko01100	Metabolic pathways	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMT200073749	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2360	2.5e-124	0.69	0.83	0.99
PGSC0003DMT200073750	K10256	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.78	0.90	0.98
PGSC0003DMT200073752	K13083	ko00941	Flavonoid biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMT200073752	K13083	ko00944	Flavone and flavonol biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMT200073752	K13083	ko01110	Biosynthesis of secondary metabolites	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMT200046171	K12929	ko00904	Diterpenoid biosynthesis	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMT200046171	K12929	ko01110	Biosynthesis of secondary metabolites	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMT200046176	K12929	ko00904	Diterpenoid biosynthesis	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMT200046176	K12929	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMT200046177	K12929	ko00904	Diterpenoid biosynthesis	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMT200046177	K12929	ko01110	Biosynthesis of secondary metabolites	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMT200046192	K01051	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMT200046192	K01051	ko00500	Starch and sucrose metabolism	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMT200046192	K01051	ko01100	Metabolic pathways	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMT200046193	K01051	ko00040	Pentose and glucuronate interconversions	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMT200046193	K01051	ko00500	Starch and sucrose metabolism	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMT200046193	K01051	ko01100	Metabolic pathways	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMT200046194	K10527	ko00592	alpha-Linolenic acid metabolism	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMT200046194	K10527	ko01100	Metabolic pathways	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMT200046195	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMT200046195	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMT200046196	K10527	ko00592	alpha-Linolenic acid metabolism	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMT200046196	K10527	ko01100	Metabolic pathways	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMT200046197	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMT200046197	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMT200046201	K02885	ko03010	Ribosome	1654	2.2e-85	0.93	0.96	1.00
PGSC0003DMT200046202	K01213	ko00040	Pentose and glucuronate interconversions	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMT200046202	K01213	ko00500	Starch and sucrose metabolism	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMT200046202	K01213	ko01100	Metabolic pathways	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMT200046203	K01051	ko00040	Pentose and glucuronate interconversions	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMT200046203	K01051	ko00500	Starch and sucrose metabolism	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMT200046203	K01051	ko01100	Metabolic pathways	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMT200046204	K01051	ko00040	Pentose and glucuronate interconversions	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMT200046204	K01051	ko00500	Starch and sucrose metabolism	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMT200046204	K01051	ko01100	Metabolic pathways	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMT200046208	K05849	ko04020	Calcium signaling pathway	1488	3.1e-76	0.81	0.92	0.99
PGSC0003DMT200046209	K05849	ko04020	Calcium signaling pathway	2887	2.1e-153	0.53	0.60	0.97
PGSC0003DMT200062212	K03037	ko03050	Proteasome	459	1.8e-19	0.61	0.81	0.61
PGSC0003DMT200062213	K03037	ko03050	Proteasome	2100	5.4e-110	0.93	0.97	0.99
PGSC0003DMT200062214	K03037	ko03050	Proteasome	2784	1.0e-147	0.87	0.94	1.00
PGSC0003DMT200062216	K00945	ko00240	Pyrimidine metabolism	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMT200062216	K00945	ko01100	Metabolic pathways	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMT200062217	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200062217	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200062218	K00945	ko00240	Pyrimidine metabolism	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMT200062218	K00945	ko01100	Metabolic pathways	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMT200062219	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200062219	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200062220	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200062220	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMT200037792	K00287	ko00670	One carbon pool by folate	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMT200037792	K00287	ko00790	Folate biosynthesis	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMT200037792	K00287	ko01100	Metabolic pathways	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMT200037797	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMT200037797	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMT200037797	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMT200037814	K02183	ko04020	Calcium signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04070	Phosphatidylinositol signaling system	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04114	Oocyte meiosis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04270	Vascular smooth muscle contraction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04626	Plant-pathogen interaction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04720	Long-term potentiation	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04722	Neurotrophin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04740	Olfactory transduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04744	Phototransduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04745	Phototransduction - fly	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04910	Insulin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04912	GnRH signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04916	Melanogenesis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04970	Salivary secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko04971	Gastric acid secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko05010	Alzheimer's disease	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037814	K02183	ko05214	Glioma	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMT200037822	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMT200037822	K01915	ko00330	Arginine and proline metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMT200037822	K01915	ko00910	Nitrogen metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMT200037822	K01915	ko01100	Metabolic pathways	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMT200037822	K01915	ko02020	Two-component system	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMT200037827	K04503	ko04110	Cell cycle	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko04115	p53 signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko04310	Wnt signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko04510	Focal adhesion	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko04630	Jak-STAT signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05200	Pathways in cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05210	Colorectal cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05212	Pancreatic cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05213	Endometrial cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05214	Glioma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05215	Prostate cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05216	Thyroid cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05218	Melanoma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05219	Bladder cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05220	Chronic myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05221	Acute myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05222	Small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05223	Non-small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200037827	K04503	ko05416	Viral myocarditis	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMT200018219	K07424	ko00140	Steroid hormone biosynthesis	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00591	Linoleic acid metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00830	Retinol metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00982	Drug metabolism - cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko00983	Drug metabolism - other enzymes	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018219	K07424	ko01100	Metabolic pathways	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMT200018220	K07424	ko00140	Steroid hormone biosynthesis	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00591	Linoleic acid metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00830	Retinol metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00982	Drug metabolism - cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko00983	Drug metabolism - other enzymes	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018220	K07424	ko01100	Metabolic pathways	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMT200018222	K07424	ko00140	Steroid hormone biosynthesis	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00591	Linoleic acid metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00830	Retinol metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00982	Drug metabolism - cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko00983	Drug metabolism - other enzymes	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018222	K07424	ko01100	Metabolic pathways	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMT200018223	K07424	ko00140	Steroid hormone biosynthesis	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00591	Linoleic acid metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00830	Retinol metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00982	Drug metabolism - cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko00983	Drug metabolism - other enzymes	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018223	K07424	ko01100	Metabolic pathways	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMT200018224	K07424	ko00140	Steroid hormone biosynthesis	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00591	Linoleic acid metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00830	Retinol metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko00983	Drug metabolism - other enzymes	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018224	K07424	ko01100	Metabolic pathways	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMT200018225	K07424	ko00140	Steroid hormone biosynthesis	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00591	Linoleic acid metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00830	Retinol metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00982	Drug metabolism - cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko00983	Drug metabolism - other enzymes	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018225	K07424	ko01100	Metabolic pathways	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMT200018226	K07424	ko00140	Steroid hormone biosynthesis	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00591	Linoleic acid metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00830	Retinol metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00982	Drug metabolism - cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko00983	Drug metabolism - other enzymes	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018226	K07424	ko01100	Metabolic pathways	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMT200018227	K07424	ko00140	Steroid hormone biosynthesis	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00591	Linoleic acid metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00830	Retinol metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00982	Drug metabolism - cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko00983	Drug metabolism - other enzymes	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018227	K07424	ko01100	Metabolic pathways	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMT200018228	K07424	ko00140	Steroid hormone biosynthesis	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00591	Linoleic acid metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00830	Retinol metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00982	Drug metabolism - cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko00983	Drug metabolism - other enzymes	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018228	K07424	ko01100	Metabolic pathways	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMT200018230	K07424	ko00140	Steroid hormone biosynthesis	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00591	Linoleic acid metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00830	Retinol metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00982	Drug metabolism - cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko00983	Drug metabolism - other enzymes	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018230	K07424	ko01100	Metabolic pathways	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMT200018235	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018235	K01652	ko00650	Butanoate metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018235	K01652	ko00660	C5-Branched dibasic acid metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018235	K01652	ko00770	Pantothenate and CoA biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018235	K01652	ko01100	Metabolic pathways	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018235	K01652	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMT200018236	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018236	K01652	ko00650	Butanoate metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018236	K01652	ko00660	C5-Branched dibasic acid metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018236	K01652	ko00770	Pantothenate and CoA biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018236	K01652	ko01100	Metabolic pathways	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018236	K01652	ko01110	Biosynthesis of secondary metabolites	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMT200018240	K09647	ko03060	Protein export	757	6.4e-36	0.72	0.84	0.99
PGSC0003DMT200018242	K02523	ko00900	Terpenoid backbone biosynthesis	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMT200018242	K02523	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMT200018243	K02523	ko00900	Terpenoid backbone biosynthesis	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMT200018243	K02523	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMT200018262	K00697	ko00500	Starch and sucrose metabolism	541	1.3e-23	0.64	0.77	0.96
PGSC0003DMT200027406	K08332	ko04140	Regulation of autophagy	235	1.2e-06	0.29	0.51	0.64
PGSC0003DMT200027413	K08065	ko04612	Antigen processing and presentation	614	5.0e-28	0.54	0.71	0.92
PGSC0003DMT200027414	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMT200027415	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMT200027416	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMT200027422	K12831	ko03040	Spliceosome	368	1.9e-13	0.38	0.44	0.12
PGSC0003DMT200027429	K04733	ko04210	Apoptosis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMT200027429	K04733	ko04620	Toll-like receptor signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMT200027429	K04733	ko04722	Neurotrophin signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMT200027429	K04733	ko05140	Leishmaniasis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMT200027429	K04733	ko05142	Chagas disease	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMT200027430	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMT200027430	K00517	ko00626	Naphthalene and anthracene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMT200027430	K00517	ko00903	Limonene and pinene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMT200027430	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMT200027430	K00517	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMT200027434	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMT200027435	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMT200027444	K12929	ko00904	Diterpenoid biosynthesis	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMT200027444	K12929	ko01110	Biosynthesis of secondary metabolites	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMT200027448	K12929	ko00904	Diterpenoid biosynthesis	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMT200027448	K12929	ko01110	Biosynthesis of secondary metabolites	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMT200027449	K12868	ko03040	Spliceosome	1866	4.4e-97	0.73	0.82	1.00
PGSC0003DMT200027452	K12868	ko03040	Spliceosome	742	4.3e-35	0.44	0.51	0.99
PGSC0003DMT200090787	K03715	ko00561	Glycerolipid metabolism	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMT200090787	K03715	ko01100	Metabolic pathways	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMT200002484	K00967	ko00440	Phosphonate and phosphinate metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMT200002484	K00967	ko00564	Glycerophospholipid metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMT200002484	K00967	ko01100	Metabolic pathways	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMT200002489	K00432	ko00480	Glutathione metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMT200002489	K00432	ko00590	Arachidonic acid metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMT200002490	K00432	ko00480	Glutathione metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMT200002490	K00432	ko00590	Arachidonic acid metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMT200002509	K10760	ko00908	Zeatin biosynthesis	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMT200002509	K10760	ko01100	Metabolic pathways	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMT200002509	K10760	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMT200040343	K11422	ko00310	Lysine degradation	384	1.2e-16	0.46	0.59	0.15
PGSC0003DMT200030353	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	407	5.1e-16	0.30	0.43	0.93
PGSC0003DMT200030357	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMT200030357	K12567	ko05414	Dilated cardiomyopathy	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMT200030366	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMT200030366	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMT200030366	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMT200030366	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMT200030366	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMT200030402	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMT200030402	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMT200030402	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMT200030402	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMT200030402	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMT200012575	K04371	ko04010	MAPK signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04012	ErbB signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04013	MAPK signaling pathway - fly	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04062	Chemokine signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04114	Oocyte meiosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04150	mTOR signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04270	Vascular smooth muscle contraction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04320	Dorso-ventral axis formation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04350	TGF-beta signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04360	Axon guidance	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04370	VEGF signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04510	Focal adhesion	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04520	Adherens junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04540	Gap junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04620	Toll-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04621	NOD-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04650	Natural killer cell mediated cytotoxicity	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04660	T cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04662	B cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04664	Fc epsilon RI signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04666	Fc gamma R-mediated phagocytosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04720	Long-term potentiation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04722	Neurotrophin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04730	Long-term depression	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04810	Regulation of actin cytoskeleton	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04910	Insulin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04912	GnRH signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04914	Progesterone-mediated oocyte maturation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04916	Melanogenesis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04930	Type II diabetes mellitus	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko04960	Aldosterone-regulated sodium reabsorption	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05010	Alzheimer's disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05020	Prion diseases	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05131	Shigellosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05140	Leishmaniasis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05142	Chagas disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05200	Pathways in cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05210	Colorectal cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05211	Renal cell carcinoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05212	Pancreatic cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05213	Endometrial cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05214	Glioma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05215	Prostate cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05216	Thyroid cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05218	Melanoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05219	Bladder cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05220	Chronic myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05221	Acute myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012575	K04371	ko05223	Non-small cell lung cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMT200012586	K12741	ko03040	Spliceosome	1048	5.7e-52	0.44	0.58	0.96
PGSC0003DMT200012590	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.85
PGSC0003DMT200012591	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMT200012592	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMT200012593	K00511	ko00100	Steroid biosynthesis	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMT200012593	K00511	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMT200012593	K00511	ko01110	Biosynthesis of secondary metabolites	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMT200012594	K00511	ko00100	Steroid biosynthesis	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMT200012594	K00511	ko01100	Metabolic pathways	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMT200012594	K00511	ko01110	Biosynthesis of secondary metabolites	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMT200012597	K00511	ko00100	Steroid biosynthesis	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMT200012597	K00511	ko01100	Metabolic pathways	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMT200012597	K00511	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMT200012600	K01762	ko00270	Cysteine and methionine metabolism	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMT200012600	K01762	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMT200033476	K12476	ko04144	Endocytosis	1866	4.4e-97	0.54	0.72	0.77
PGSC0003DMT200033480	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.73
PGSC0003DMT200033481	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMT200033482	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.72
PGSC0003DMT200033483	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMT200033484	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMT200033485	K08770	ko03320	PPAR signaling pathway	376	6.7e-15	0.36	0.55	0.93
PGSC0003DMT200033488	K12606	ko03018	RNA degradation	1090	2.8e-54	0.57	0.60	0.99
PGSC0003DMT200033489	K12606	ko03018	RNA degradation	2198	2.1e-115	0.94	0.97	1.00
PGSC0003DMT200033492	K00995	ko00564	Glycerophospholipid metabolism	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMT200033492	K00995	ko01100	Metabolic pathways	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMT200006347	K00679	ko00561	Glycerolipid metabolism	1312	1.6e-66	0.36	0.51	0.90
PGSC0003DMT200006348	K00679	ko00561	Glycerolipid metabolism	226	3.0e-06	0.53	0.71	0.31
PGSC0003DMT200006357	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.61	0.78	0.54
PGSC0003DMT200006358	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMT200006359	K08064	ko04612	Antigen processing and presentation	440	2.0e-18	0.40	0.61	0.91
PGSC0003DMT200006360	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMT200006361	K08064	ko04612	Antigen processing and presentation	582	2.9e-26	0.58	0.76	0.57
PGSC0003DMT200006362	K08064	ko04612	Antigen processing and presentation	483	8.3e-21	0.65	0.78	0.52
PGSC0003DMT200006366	K01733	ko00260	Glycine, serine and threonine metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMT200006366	K01733	ko00750	Vitamin B6 metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMT200006366	K01733	ko01100	Metabolic pathways	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMT200076161	K03046	ko00230	Purine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMT200076161	K03046	ko00240	Pyrimidine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMT200076161	K03046	ko01100	Metabolic pathways	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMT200076161	K03046	ko03020	RNA polymerase	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMT200076168	K01519	ko00230	Purine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMT200076168	K01519	ko00240	Pyrimidine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMT200076168	K01519	ko00983	Drug metabolism - other enzymes	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMT200076168	K01519	ko01100	Metabolic pathways	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMT200076169	K01519	ko00230	Purine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMT200076169	K01519	ko00240	Pyrimidine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMT200076169	K01519	ko00983	Drug metabolism - other enzymes	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMT200076169	K01519	ko01100	Metabolic pathways	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMT200076170	K03505	ko00230	Purine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko00240	Pyrimidine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko01100	Metabolic pathways	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko03030	DNA replication	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko03410	Base excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko03420	Nucleotide excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko03430	Mismatch repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076170	K03505	ko03440	Homologous recombination	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMT200076172	K04424	ko04010	MAPK signaling pathway	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMT200076172	K04424	ko04530	Tight junction	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMT200076173	K04424	ko04010	MAPK signaling pathway	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMT200076173	K04424	ko04530	Tight junction	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMT200076174	K04423	ko04010	MAPK signaling pathway	492	6.2e-21	0.42	0.57	0.88
PGSC0003DMT200076175	K00632	ko00071	Fatty acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko00280	Valine, leucine and isoleucine degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko00281	Geraniol degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko00362	Benzoate degradation via hydroxylation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko00592	alpha-Linolenic acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko00642	Ethylbenzene degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko01100	Metabolic pathways	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076175	K00632	ko01110	Biosynthesis of secondary metabolites	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMT200076178	K00660	ko00941	Flavonoid biosynthesis	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMT200076178	K00660	ko01100	Metabolic pathways	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMT200076178	K00660	ko01110	Biosynthesis of secondary metabolites	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMT200076178	K00660	ko04712	Circadian rhythm - plant	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMT200076179	K00660	ko00941	Flavonoid biosynthesis	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMT200076179	K00660	ko01100	Metabolic pathways	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMT200076179	K00660	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMT200076179	K00660	ko04712	Circadian rhythm - plant	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMT200076182	K02941	ko03010	Ribosome	1877	1.1e-97	0.81	0.90	0.99
PGSC0003DMT200076186	K08241	ko00592	alpha-Linolenic acid metabolism	655	1.0e-34	0.45	0.63	0.98
PGSC0003DMT200076187	K08241	ko00592	alpha-Linolenic acid metabolism	1168	1.4e-58	0.44	0.59	0.99
PGSC0003DMT200076188	K08241	ko00592	alpha-Linolenic acid metabolism	547	2.5e-24	0.49	0.60	0.99
PGSC0003DMT200076189	K08241	ko00592	alpha-Linolenic acid metabolism	471	3.8e-20	0.45	0.65	0.86
PGSC0003DMT200076192	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMT200076192	K06126	ko01100	Metabolic pathways	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMT200076192	K06126	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMT200076193	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076193	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076193	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076194	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076194	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076194	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMT200076195	K12741	ko03040	Spliceosome	463	1.1e-19	0.43	0.53	0.51
PGSC0003DMT200049113	K10845	ko03420	Nucleotide excision repair	449	6.3e-19	0.74	0.88	0.97
PGSC0003DMT200049122	K05350	ko00460	Cyanoamino acid metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMT200049122	K05350	ko00500	Starch and sucrose metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMT200049122	K05350	ko00940	Phenylpropanoid biosynthesis	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMT200049122	K05350	ko01110	Biosynthesis of secondary metabolites	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMT200049123	K05350	ko00460	Cyanoamino acid metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMT200049123	K05350	ko00500	Starch and sucrose metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMT200049123	K05350	ko00940	Phenylpropanoid biosynthesis	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMT200049123	K05350	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMT200049141	K10879	ko03440	Homologous recombination	603	2.0e-27	0.64	0.79	0.84
PGSC0003DMT200049163	K03505	ko00230	Purine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko00240	Pyrimidine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko01100	Metabolic pathways	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko03030	DNA replication	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko03410	Base excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko03420	Nucleotide excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko03430	Mismatch repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049163	K03505	ko03440	Homologous recombination	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMT200049165	K00660	ko00941	Flavonoid biosynthesis	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMT200049165	K00660	ko01100	Metabolic pathways	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMT200049165	K00660	ko01110	Biosynthesis of secondary metabolites	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMT200049165	K00660	ko04712	Circadian rhythm - plant	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMT200049166	K08241	ko00592	alpha-Linolenic acid metabolism	1074	2.1e-53	0.42	0.60	0.99
PGSC0003DMT200049170	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200049170	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200049171	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200049171	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200049172	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200049172	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMT200088849	K11816	ko00380	Tryptophan metabolism	304	4.6e-18	0.46	0.63	0.94
PGSC0003DMT200088851	K10760	ko00908	Zeatin biosynthesis	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMT200088851	K10760	ko01100	Metabolic pathways	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMT200088851	K10760	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMT200088863	K05282	ko00904	Diterpenoid biosynthesis	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMT200088863	K05282	ko01100	Metabolic pathways	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMT200088863	K05282	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMT200009024	K01103	ko00051	Fructose and mannose metabolism	393	8.9e-13	0.31	0.51	0.52
PGSC0003DMT200009025	K01103	ko00051	Fructose and mannose metabolism	385	4.5e-14	0.31	0.51	0.58
PGSC0003DMT200009026	K01103	ko00051	Fructose and mannose metabolism	393	1.5e-12	0.31	0.51	0.49
PGSC0003DMT200009027	K01103	ko00051	Fructose and mannose metabolism	393	5.8e-13	0.25	0.43	0.84
PGSC0003DMT200009032	K10702	ko00642	Ethylbenzene degradation	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMT200009032	K10702	ko01100	Metabolic pathways	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMT200009039	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMT200009040	K00368	ko00910	Nitrogen metabolism	1761	2.7e-91	0.45	0.61	0.92
PGSC0003DMT200009041	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMT200009042	K00368	ko00910	Nitrogen metabolism	1747	1.6e-90	0.46	0.62	0.88
PGSC0003DMT200009045	K01507	ko00190	Oxidative phosphorylation	1637	1.9e-84	0.90	0.94	0.99
PGSC0003DMT200009046	K01507	ko00190	Oxidative phosphorylation	1341	4.0e-68	0.90	0.94	0.88
PGSC0003DMT200009047	K00680	ko00350	Tyrosine metabolism	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMT200009047	K00680	ko00624	1- and 2-Methylnaphthalene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMT200009047	K00680	ko00632	Benzoate degradation via CoA ligation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMT200009047	K00680	ko00642	Ethylbenzene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMT200009047	K00680	ko00903	Limonene and pinene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMT200037929	K00454	ko00591	Linoleic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMT200037929	K00454	ko00592	alpha-Linolenic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMT200037929	K00454	ko01100	Metabolic pathways	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMT200037930	K00454	ko00591	Linoleic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMT200037930	K00454	ko00592	alpha-Linolenic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMT200037930	K00454	ko01100	Metabolic pathways	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMT200037931	K00454	ko00591	Linoleic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMT200037931	K00454	ko00592	alpha-Linolenic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMT200037931	K00454	ko01100	Metabolic pathways	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMT200037933	K00454	ko00591	Linoleic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMT200037933	K00454	ko00592	alpha-Linolenic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMT200037933	K00454	ko01100	Metabolic pathways	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMT200037934	K00454	ko00591	Linoleic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMT200037934	K00454	ko00592	alpha-Linolenic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMT200037934	K00454	ko01100	Metabolic pathways	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMT200037935	K00454	ko00591	Linoleic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMT200037935	K00454	ko00592	alpha-Linolenic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMT200037935	K00454	ko01100	Metabolic pathways	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMT200037938	K00454	ko00591	Linoleic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMT200037938	K00454	ko00592	alpha-Linolenic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMT200037938	K00454	ko01100	Metabolic pathways	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMT200037949	K00754	ko00051	Fructose and mannose metabolism	342	6.3e-13	0.27	0.44	0.89
PGSC0003DMT200037953	K10844	ko03420	Nucleotide excision repair	557	6.9e-25	0.86	0.93	0.90
PGSC0003DMT200037954	K10844	ko03420	Nucleotide excision repair	4707	8.8e-254	0.81	0.91	0.99
PGSC0003DMT200037955	K10844	ko03420	Nucleotide excision repair	4507	9.5e-243	0.81	0.91	0.99
PGSC0003DMT200037958	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.48	0.63	0.92
PGSC0003DMT200037966	K12890	ko03040	Spliceosome	1669	3.2e-86	0.81	0.87	0.83
PGSC0003DMT200043656	K00368	ko00910	Nitrogen metabolism	1047	6.5e-52	0.35	0.47	0.90
PGSC0003DMT200043663	K01922	ko00770	Pantothenate and CoA biosynthesis	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMT200043663	K01922	ko01100	Metabolic pathways	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMT200043666	K01922	ko00770	Pantothenate and CoA biosynthesis	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMT200043666	K01922	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMT200043667	K01922	ko00770	Pantothenate and CoA biosynthesis	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMT200043667	K01922	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMT200043668	K01922	ko00770	Pantothenate and CoA biosynthesis	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMT200043668	K01922	ko01100	Metabolic pathways	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMT200043672	K02113	ko00190	Oxidative phosphorylation	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMT200043672	K02113	ko00195	Photosynthesis	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMT200043672	K02113	ko01100	Metabolic pathways	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMT200043673	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMT200043673	K00517	ko00626	Naphthalene and anthracene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMT200043673	K00517	ko00903	Limonene and pinene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMT200043673	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMT200043673	K00517	ko01110	Biosynthesis of secondary metabolites	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMT200043680	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	444	1.2e-18	0.38	0.51	0.65
PGSC0003DMT200043686	K01179	ko00500	Starch and sucrose metabolism	291	1.6e-07	0.26	0.41	0.67
PGSC0003DMT200026930	K00026	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026930	K00026	ko00620	Pyruvate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026930	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026930	K00026	ko00710	Carbon fixation in photosynthetic organisms	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026930	K00026	ko01100	Metabolic pathways	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026930	K00026	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko00020	Citrate cycle (TCA cycle)	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko00620	Pyruvate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko00710	Carbon fixation in photosynthetic organisms	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko01100	Metabolic pathways	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026931	K00026	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMT200026932	K00026	ko00020	Citrate cycle (TCA cycle)	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026932	K00026	ko00620	Pyruvate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026932	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026932	K00026	ko00710	Carbon fixation in photosynthetic organisms	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026932	K00026	ko01100	Metabolic pathways	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026932	K00026	ko01110	Biosynthesis of secondary metabolites	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMT200026946	K10591	ko04120	Ubiquitin mediated proteolysis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMT200026946	K10591	ko04144	Endocytosis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMT200026947	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMT200026947	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMT200026948	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMT200026948	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMT200026949	K10591	ko04120	Ubiquitin mediated proteolysis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMT200026949	K10591	ko04144	Endocytosis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMT200026950	K02183	ko04020	Calcium signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04070	Phosphatidylinositol signaling system	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04114	Oocyte meiosis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04270	Vascular smooth muscle contraction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04626	Plant-pathogen interaction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04720	Long-term potentiation	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04722	Neurotrophin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04740	Olfactory transduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04744	Phototransduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04745	Phototransduction - fly	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04910	Insulin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04912	GnRH signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04916	Melanogenesis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04970	Salivary secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko04971	Gastric acid secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko05010	Alzheimer's disease	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026950	K02183	ko05214	Glioma	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMT200026963	K01809	ko00051	Fructose and mannose metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMT200026963	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMT200026963	K01809	ko01100	Metabolic pathways	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMT200026963	K01809	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMT200080480	K10609	ko03420	Nucleotide excision repair	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMT200080480	K10609	ko04120	Ubiquitin mediated proteolysis	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMT200080481	K10609	ko03420	Nucleotide excision repair	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMT200080481	K10609	ko04120	Ubiquitin mediated proteolysis	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMT200080482	K10609	ko03420	Nucleotide excision repair	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMT200080482	K10609	ko04120	Ubiquitin mediated proteolysis	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMT200080483	K10609	ko03420	Nucleotide excision repair	5917	0.	0.89	0.93	0.95
PGSC0003DMT200080483	K10609	ko04120	Ubiquitin mediated proteolysis	5917	0.	0.89	0.93	0.95
PGSC0003DMT200080490	K13034	ko00270	Cysteine and methionine metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMT200080490	K13034	ko00450	Selenoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMT200080490	K13034	ko00460	Cyanoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMT200080490	K13034	ko00920	Sulfur metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMT200080490	K13034	ko01100	Metabolic pathways	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMT200080499	K01051	ko00040	Pentose and glucuronate interconversions	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMT200080499	K01051	ko00500	Starch and sucrose metabolism	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMT200080499	K01051	ko01100	Metabolic pathways	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMT200080500	K01051	ko00040	Pentose and glucuronate interconversions	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMT200080500	K01051	ko00500	Starch and sucrose metabolism	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMT200080500	K01051	ko01100	Metabolic pathways	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMT200080501	K02964	ko03010	Ribosome	1229	6.0e-62	0.94	0.98	0.99
PGSC0003DMT200055610	K02866	ko03010	Ribosome	710	2.5e-33	0.43	0.60	0.84
PGSC0003DMT200055629	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	754	9.4e-36	0.39	0.57	0.76
PGSC0003DMT200055641	K04536	ko04062	Chemokine signaling pathway	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMT200055641	K04536	ko04742	Taste transduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMT200055641	K04536	ko04744	Phototransduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMT200055644	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMT200055645	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMT200047545	K05681	ko02010	ABC transporters	995	4.8e-49	0.36	0.56	0.99
PGSC0003DMT200047546	K05681	ko02010	ABC transporters	1415	3.3e-72	0.37	0.57	0.94
PGSC0003DMT200047547	K05681	ko02010	ABC transporters	1409	7.0e-72	0.37	0.57	0.94
PGSC0003DMT200047548	K09840	ko00906	Carotenoid biosynthesis	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMT200047548	K09840	ko01100	Metabolic pathways	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMT200047548	K09840	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMT200047553	K09840	ko00906	Carotenoid biosynthesis	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMT200047553	K09840	ko01100	Metabolic pathways	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMT200047553	K09840	ko01110	Biosynthesis of secondary metabolites	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMT200047576	K11984	ko03040	Spliceosome	370	9.6e-14	0.30	0.46	0.68
PGSC0003DMT200047578	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047578	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200047579	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMT200073302	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMT200073303	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMT200073304	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.70
PGSC0003DMT200070352	K00627	ko00010	Glycolysis / Gluconeogenesis	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMT200070352	K00627	ko00020	Citrate cycle (TCA cycle)	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMT200070352	K00627	ko00620	Pyruvate metabolism	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMT200070352	K00627	ko01100	Metabolic pathways	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMT200070352	K00627	ko01110	Biosynthesis of secondary metabolites	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMT200070353	K00627	ko00010	Glycolysis / Gluconeogenesis	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMT200070353	K00627	ko00020	Citrate cycle (TCA cycle)	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMT200070353	K00627	ko00620	Pyruvate metabolism	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMT200070353	K00627	ko01100	Metabolic pathways	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMT200070353	K00627	ko01110	Biosynthesis of secondary metabolites	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMT200070354	K00627	ko00010	Glycolysis / Gluconeogenesis	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMT200070354	K00627	ko00020	Citrate cycle (TCA cycle)	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMT200070354	K00627	ko00620	Pyruvate metabolism	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMT200070354	K00627	ko01100	Metabolic pathways	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMT200070354	K00627	ko01110	Biosynthesis of secondary metabolites	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMT200070355	K01243	ko00270	Cysteine and methionine metabolism	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMT200070355	K01243	ko01100	Metabolic pathways	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMT200070356	K01243	ko00270	Cysteine and methionine metabolism	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMT200070356	K01243	ko01100	Metabolic pathways	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMT200070359	K06276	ko03320	PPAR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko04150	mTOR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko04510	Focal adhesion	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko04910	Insulin signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko04960	Aldosterone-regulated sodium reabsorption	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko05213	Endometrial cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko05215	Prostate cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070359	K06276	ko05223	Non-small cell lung cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMT200070360	K06276	ko03320	PPAR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko04150	mTOR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko04510	Focal adhesion	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko04910	Insulin signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko05213	Endometrial cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko05215	Prostate cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070360	K06276	ko05223	Non-small cell lung cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMT200070362	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMT200070362	K02367	ko01100	Metabolic pathways	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMT200070365	K01099	ko00562	Inositol phosphate metabolism	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMT200070365	K01099	ko01100	Metabolic pathways	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMT200070365	K01099	ko04070	Phosphatidylinositol signaling system	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMT200010654	K01188	ko00460	Cyanoamino acid metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMT200010654	K01188	ko00500	Starch and sucrose metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMT200010654	K01188	ko00940	Phenylpropanoid biosynthesis	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMT200010654	K01188	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMT200010655	K01188	ko00460	Cyanoamino acid metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMT200010655	K01188	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMT200010655	K01188	ko00940	Phenylpropanoid biosynthesis	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMT200010655	K01188	ko01110	Biosynthesis of secondary metabolites	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMT200010656	K01188	ko00460	Cyanoamino acid metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMT200010656	K01188	ko00500	Starch and sucrose metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMT200010656	K01188	ko00940	Phenylpropanoid biosynthesis	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMT200010656	K01188	ko01110	Biosynthesis of secondary metabolites	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMT200010657	K01188	ko00460	Cyanoamino acid metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMT200010657	K01188	ko00500	Starch and sucrose metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMT200010657	K01188	ko00940	Phenylpropanoid biosynthesis	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMT200010657	K01188	ko01110	Biosynthesis of secondary metabolites	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMT200010665	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMT200010666	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMT200010667	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMT200010668	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2431	3.0e-128	0.72	0.86	0.97
PGSC0003DMT200010673	K03885	ko00190	Oxidative phosphorylation	3040	7.7e-162	0.72	0.84	1.00
PGSC0003DMT200010674	K03885	ko00190	Oxidative phosphorylation	2752	5.9e-146	0.72	0.83	0.92
PGSC0003DMT200010675	K03885	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.88	0.89
PGSC0003DMT200010676	K03885	ko00190	Oxidative phosphorylation	1627	6.7e-84	0.69	0.80	0.99
PGSC0003DMT200010677	K03885	ko00190	Oxidative phosphorylation	1899	6.6e-99	0.81	0.89	0.95
PGSC0003DMT200010678	K03885	ko00190	Oxidative phosphorylation	3095	7.2e-165	0.73	0.85	1.00
PGSC0003DMT200010684	K01953	ko00250	Alanine, aspartate and glutamate metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMT200010684	K01953	ko00910	Nitrogen metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMT200010684	K01953	ko01100	Metabolic pathways	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMT200010684	K01953	ko01110	Biosynthesis of secondary metabolites	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMT200010685	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMT200010685	K01953	ko00910	Nitrogen metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMT200010685	K01953	ko01100	Metabolic pathways	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMT200010685	K01953	ko01110	Biosynthesis of secondary metabolites	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMT200028767	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200028767	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200028767	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200028769	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.38	0.58	0.88
PGSC0003DMT200028800	K07375	ko04145	Phagosome	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMT200028800	K07375	ko04540	Gap junction	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMT200028800	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMT200028806	K06119	ko00561	Glycerolipid metabolism	1051	3.9e-52	0.80	0.89	0.97
PGSC0003DMT200028807	K06119	ko00561	Glycerolipid metabolism	2951	6.3e-157	0.83	0.92	0.95
PGSC0003DMT200028808	K06119	ko00561	Glycerolipid metabolism	1412	4.8e-72	0.78	0.90	0.98
PGSC0003DMT200025739	K07375	ko04145	Phagosome	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMT200025739	K07375	ko04540	Gap junction	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMT200025739	K07375	ko05130	Pathogenic Escherichia coli infection	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMT200025743	K09487	ko04621	NOD-like receptor signaling pathway	5765	0.	0.85	0.92	1.00
PGSC0003DMT200025743	K09487	ko04626	Plant-pathogen interaction	5765	0.	0.85	0.92	1.00
PGSC0003DMT200025743	K09487	ko05200	Pathways in cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMT200025743	K09487	ko05215	Prostate cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMT200025744	K09487	ko04621	NOD-like receptor signaling pathway	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMT200025744	K09487	ko04626	Plant-pathogen interaction	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMT200025744	K09487	ko05200	Pathways in cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMT200025744	K09487	ko05215	Prostate cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMT200025756	K05868	ko04110	Cell cycle	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMT200025756	K05868	ko04115	p53 signaling pathway	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMT200025756	K05868	ko04914	Progesterone-mediated oocyte maturation	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMT200025768	K03260	ko05416	Viral myocarditis	340	1.1e-09	0.28	0.38	0.63
PGSC0003DMT200025769	K03260	ko05416	Viral myocarditis	340	9.2e-12	0.28	0.38	0.79
PGSC0003DMT200025772	K00430	ko00360	Phenylalanine metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMT200025772	K00430	ko00680	Methane metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMT200025772	K00430	ko00940	Phenylpropanoid biosynthesis	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMT200025772	K00430	ko01100	Metabolic pathways	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMT200025772	K00430	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMT200025781	K00472	ko00330	Arginine and proline metabolism	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMT200025781	K00472	ko01100	Metabolic pathways	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMT200090065	K08066	ko04612	Antigen processing and presentation	404	1.9e-16	0.45	0.66	0.81
PGSC0003DMT200096268	K09487	ko04621	NOD-like receptor signaling pathway	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMT200096268	K09487	ko04626	Plant-pathogen interaction	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMT200096268	K09487	ko05200	Pathways in cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMT200096268	K09487	ko05215	Prostate cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMT200083041	K01535	ko00190	Oxidative phosphorylation	7433	0.	0.92	0.97	1.00
PGSC0003DMT200083042	K01535	ko00190	Oxidative phosphorylation	286	3.9e-09	0.73	0.86	0.96
PGSC0003DMT200083060	K05748	ko04520	Adherens junction	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMT200083060	K05748	ko04666	Fc gamma R-mediated phagocytosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMT200083060	K05748	ko04810	Regulation of actin cytoskeleton	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMT200083060	K05748	ko05100	Bacterial invasion of epithelial cells	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMT200083060	K05748	ko05131	Shigellosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMT200083063	K01601	ko00630	Glyoxylate and dicarboxylate metabolism	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMT200083063	K01601	ko00710	Carbon fixation in photosynthetic organisms	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMT200083063	K01601	ko01100	Metabolic pathways	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMT200083064	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMT200083064	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMT200083064	K02552	ko01100	Metabolic pathways	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMT200083064	K02552	ko01110	Biosynthesis of secondary metabolites	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMT200083065	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMT200083065	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMT200083065	K02552	ko01100	Metabolic pathways	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMT200083065	K02552	ko01110	Biosynthesis of secondary metabolites	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMT200083067	K10573	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.99	1.00	0.99
PGSC0003DMT200083070	K05648	ko02010	ABC transporters	286	8.5e-09	0.33	0.56	0.97
PGSC0003DMT200083071	K05643	ko02010	ABC transporters	1094	4.4e-54	0.34	0.52	0.74
PGSC0003DMT200053760	K05849	ko04020	Calcium signaling pathway	239	1.2e-06	0.41	0.54	0.90
PGSC0003DMT200053766	K06677	ko04111	Cell cycle - yeast	455	2.5e-18	0.56	0.69	0.95
PGSC0003DMT200053770	K07192	ko04910	Insulin signaling pathway	612	6.4e-28	0.49	0.67	0.98
PGSC0003DMT200053771	K07192	ko04910	Insulin signaling pathway	344	3.9e-13	0.39	0.59	0.84
PGSC0003DMT200053776	K06677	ko04111	Cell cycle - yeast	403	1.9e-15	0.62	0.74	0.81
PGSC0003DMT200053798	K12272	ko03060	Protein export	775	6.5e-37	0.49	0.60	0.97
PGSC0003DMT200053802	K02084	ko04115	p53 signaling pathway	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko04210	Apoptosis	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko05010	Alzheimer's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko05012	Parkinson's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko05016	Huntington's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053802	K02084	ko05222	Small cell lung cancer	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMT200053806	K00700	ko00500	Starch and sucrose metabolism	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMT200053806	K00700	ko01100	Metabolic pathways	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMT200053809	K02084	ko04115	p53 signaling pathway	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko04210	Apoptosis	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko05010	Alzheimer's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko05012	Parkinson's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko05016	Huntington's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200053809	K02084	ko05222	Small cell lung cancer	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMT200071482	K04733	ko04210	Apoptosis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMT200071482	K04733	ko04620	Toll-like receptor signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMT200071482	K04733	ko04722	Neurotrophin signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMT200071482	K04733	ko05140	Leishmaniasis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMT200071482	K04733	ko05142	Chagas disease	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMT200071511	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071511	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071511	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071511	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071511	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071512	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071512	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071512	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071512	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200071512	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMT200045745	K10867	ko03440	Homologous recombination	339	5.2e-10	0.25	0.42	0.86
PGSC0003DMT200045747	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045748	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045749	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045750	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045751	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045752	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMT200045757	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMT200045757	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMT200045758	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMT200045758	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMT200045766	K13030	ko00460	Cyanoamino acid metabolism	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMT200045766	K13030	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMT200045767	K13030	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMT200045767	K13030	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMT200042145	K01069	ko00620	Pyruvate metabolism	992	7.0e-49	0.48	0.64	0.80
PGSC0003DMT200042160	K03038	ko03050	Proteasome	2432	2.7e-128	0.93	0.98	1.00
PGSC0003DMT200042161	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3814	1.6e-204	0.76	0.86	1.00
PGSC0003DMT200042162	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.77	0.87	1.00
PGSC0003DMT200042163	K13065	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMT200042163	K13065	ko00941	Flavonoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMT200042163	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMT200042163	K13065	ko01110	Biosynthesis of secondary metabolites	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMT200042165	K08139	ko04113	Meiosis - yeast	1037	2.3e-51	0.33	0.51	0.90
PGSC0003DMT200004461	K10604	ko04120	Ubiquitin mediated proteolysis	603	2.0e-27	0.35	0.52	0.81
PGSC0003DMT200004488	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004488	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004488	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004488	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004488	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004489	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004489	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004489	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004489	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004489	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMT200004500	K10756	ko03030	DNA replication	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMT200004500	K10756	ko03420	Nucleotide excision repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMT200004500	K10756	ko03430	Mismatch repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMT200031812	K01951	ko00230	Purine metabolism	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMT200031812	K01951	ko00983	Drug metabolism - other enzymes	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMT200031812	K01951	ko01100	Metabolic pathways	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMT200031814	K01951	ko00230	Purine metabolism	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMT200031814	K01951	ko00983	Drug metabolism - other enzymes	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMT200031814	K01951	ko01100	Metabolic pathways	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMT200031825	K01838	ko00500	Starch and sucrose metabolism	355	9.6e-14	0.33	0.49	0.54
PGSC0003DMT200031826	K01919	ko00480	Glutathione metabolism	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMT200031826	K01919	ko01100	Metabolic pathways	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMT200031827	K01919	ko00480	Glutathione metabolism	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMT200031827	K01919	ko01100	Metabolic pathways	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMT200031836	K12298	ko00100	Steroid biosynthesis	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMT200031836	K12298	ko00561	Glycerolipid metabolism	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMT200031836	K12298	ko01100	Metabolic pathways	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMT200031838	K12298	ko00100	Steroid biosynthesis	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMT200031838	K12298	ko00561	Glycerolipid metabolism	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMT200031838	K12298	ko01100	Metabolic pathways	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMT200031839	K12298	ko00100	Steroid biosynthesis	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMT200031839	K12298	ko00561	Glycerolipid metabolism	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMT200031839	K12298	ko01100	Metabolic pathways	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMT200000811	K01759	ko00620	Pyruvate metabolism	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMT200000811	K01759	ko04011	MAPK signaling pathway - yeast	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMT200000815	K04392	ko04010	MAPK signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04062	Chemokine signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04145	Phagosome	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04310	Wnt signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04360	Axon guidance	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04370	VEGF signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04510	Focal adhesion	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04520	Adherens junction	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04620	Toll-like receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04650	Natural killer cell mediated cytotoxicity	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04662	B cell receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04664	Fc epsilon RI signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04666	Fc gamma R-mediated phagocytosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04670	Leukocyte transendothelial migration	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04722	Neurotrophin signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko04810	Regulation of actin cytoskeleton	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05100	Bacterial invasion of epithelial cells	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05131	Shigellosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05200	Pathways in cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05210	Colorectal cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05211	Renal cell carcinoma	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05212	Pancreatic cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000815	K04392	ko05416	Viral myocarditis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04010	MAPK signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04062	Chemokine signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04145	Phagosome	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04310	Wnt signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04360	Axon guidance	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04370	VEGF signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04510	Focal adhesion	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04520	Adherens junction	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04620	Toll-like receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04650	Natural killer cell mediated cytotoxicity	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04662	B cell receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04664	Fc epsilon RI signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04666	Fc gamma R-mediated phagocytosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04670	Leukocyte transendothelial migration	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04722	Neurotrophin signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko04810	Regulation of actin cytoskeleton	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05100	Bacterial invasion of epithelial cells	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05131	Shigellosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05200	Pathways in cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05210	Colorectal cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05211	Renal cell carcinoma	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05212	Pancreatic cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000816	K04392	ko05416	Viral myocarditis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMT200000817	K04392	ko04010	MAPK signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04062	Chemokine signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04145	Phagosome	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04310	Wnt signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04360	Axon guidance	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04370	VEGF signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04510	Focal adhesion	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04520	Adherens junction	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04620	Toll-like receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04650	Natural killer cell mediated cytotoxicity	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04662	B cell receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04664	Fc epsilon RI signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04666	Fc gamma R-mediated phagocytosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04670	Leukocyte transendothelial migration	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04722	Neurotrophin signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko04810	Regulation of actin cytoskeleton	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05100	Bacterial invasion of epithelial cells	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05131	Shigellosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05200	Pathways in cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05210	Colorectal cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05211	Renal cell carcinoma	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05212	Pancreatic cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000817	K04392	ko05416	Viral myocarditis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMT200000818	K04392	ko04010	MAPK signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04062	Chemokine signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04145	Phagosome	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04310	Wnt signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04360	Axon guidance	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04370	VEGF signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04510	Focal adhesion	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04520	Adherens junction	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04620	Toll-like receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04650	Natural killer cell mediated cytotoxicity	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04662	B cell receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04664	Fc epsilon RI signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04666	Fc gamma R-mediated phagocytosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04670	Leukocyte transendothelial migration	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04722	Neurotrophin signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko04810	Regulation of actin cytoskeleton	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05100	Bacterial invasion of epithelial cells	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05131	Shigellosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05200	Pathways in cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05210	Colorectal cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05211	Renal cell carcinoma	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05212	Pancreatic cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000818	K04392	ko05416	Viral myocarditis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMT200000851	K12355	ko00940	Phenylpropanoid biosynthesis	2055	1.6e-107	0.75	0.86	0.98
PGSC0003DMT200074719	K01590	ko00340	Histidine metabolism	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMT200074719	K01590	ko01100	Metabolic pathways	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMT200074719	K01590	ko01110	Biosynthesis of secondary metabolites	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMT200074720	K09834	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMT200074720	K09834	ko01100	Metabolic pathways	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMT200074720	K09834	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMT200074721	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMT200074721	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMT200074721	K10157	ko01100	Metabolic pathways	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMT200074732	K00970	ko03018	RNA degradation	1228	6.8e-62	0.41	0.59	0.83
PGSC0003DMT200074733	K00970	ko03018	RNA degradation	1093	1.9e-54	0.41	0.59	0.90
PGSC0003DMT200074744	K04124	ko00904	Diterpenoid biosynthesis	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMT200074744	K04124	ko01110	Biosynthesis of secondary metabolites	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMT200074752	K12338	ko00942	Anthocyanin biosynthesis	523	5.2e-23	0.53	0.66	0.89
PGSC0003DMT200057560	K06096	ko04530	Tight junction	223	1.8e-06	0.32	0.54	0.55
PGSC0003DMT200057561	K06236	ko04510	Focal adhesion	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMT200057561	K06236	ko04512	ECM-receptor interaction	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMT200057561	K06236	ko05146	Amoebiasis	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMT200057576	K12888	ko03040	Spliceosome	800	2.7e-38	0.31	0.49	0.68
PGSC0003DMT200057577	K12888	ko03040	Spliceosome	841	1.5e-40	0.31	0.49	0.76
PGSC0003DMT200057582	K03351	ko04110	Cell cycle	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057582	K03351	ko04111	Cell cycle - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057582	K03351	ko04113	Meiosis - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057582	K03351	ko04114	Oocyte meiosis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057582	K03351	ko04120	Ubiquitin mediated proteolysis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057582	K03351	ko04914	Progesterone-mediated oocyte maturation	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMT200057583	K04718	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMT200057583	K04718	ko01100	Metabolic pathways	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMT200057583	K04718	ko04020	Calcium signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMT200057583	K04718	ko04370	VEGF signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMT200057583	K04718	ko04666	Fc gamma R-mediated phagocytosis	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMT200057584	K04718	ko00600	Sphingolipid metabolism	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMT200057584	K04718	ko01100	Metabolic pathways	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMT200057584	K04718	ko04020	Calcium signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMT200057584	K04718	ko04370	VEGF signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMT200057584	K04718	ko04666	Fc gamma R-mediated phagocytosis	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMT200057595	K12816	ko03040	Spliceosome	4257	5.8e-229	0.82	0.90	1.00
PGSC0003DMT200057597	K01190	ko00052	Galactose metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMT200057597	K01190	ko00511	Other glycan degradation	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMT200057597	K01190	ko00600	Sphingolipid metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMT200057597	K01190	ko01100	Metabolic pathways	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMT200050967	K04733	ko04210	Apoptosis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMT200050967	K04733	ko04620	Toll-like receptor signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMT200050967	K04733	ko04722	Neurotrophin signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMT200050967	K04733	ko05140	Leishmaniasis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMT200050967	K04733	ko05142	Chagas disease	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMT200051021	K01634	ko00600	Sphingolipid metabolism	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMT200051021	K01634	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMT200051022	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMT200051022	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMT200051023	K01634	ko00600	Sphingolipid metabolism	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMT200051023	K01634	ko01100	Metabolic pathways	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMT200051024	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMT200051024	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMT200077993	K03872	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMT200077993	K03872	ko05200	Pathways in cancer	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMT200077993	K03872	ko05211	Renal cell carcinoma	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMT200085545	K10760	ko00908	Zeatin biosynthesis	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMT200085545	K10760	ko01100	Metabolic pathways	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMT200085545	K10760	ko01110	Biosynthesis of secondary metabolites	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMT200085557	K03133	ko03022	Basal transcription factors	348	2.3e-13	0.62	0.75	0.63
PGSC0003DMT200085559	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200085559	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMT200068600	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMT200068601	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMT200068602	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMT200068602	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMT200068603	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMT200068603	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMT200068616	K06668	ko04111	Cell cycle - yeast	297	1.2e-09	0.35	0.52	0.93
PGSC0003DMT200068626	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMT200068626	K00517	ko00626	Naphthalene and anthracene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMT200068626	K00517	ko00903	Limonene and pinene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMT200068626	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMT200068626	K00517	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMT200068627	K06627	ko04110	Cell cycle	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMT200068627	K06627	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMT200068629	K06626	ko04110	Cell cycle	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068629	K06626	ko04114	Oocyte meiosis	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068629	K06626	ko04115	p53 signaling pathway	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068629	K06626	ko05200	Pathways in cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068629	K06626	ko05215	Prostate cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068629	K06626	ko05222	Small cell lung cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMT200068637	K12130	ko04712	Circadian rhythm - plant	228	3.5e-06	0.37	0.55	0.38
PGSC0003DMT200060610	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1463	7.4e-75	0.77	0.87	1.00
PGSC0003DMT200060611	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMT200060612	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1516	8.8e-78	0.79	0.90	1.00
PGSC0003DMT200060613	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMT200060617	K12831	ko03040	Spliceosome	330	2.3e-12	0.51	0.61	0.73
PGSC0003DMT200060618	K12831	ko03040	Spliceosome	287	6.5e-10	0.51	0.60	0.69
PGSC0003DMT200060620	K12831	ko03040	Spliceosome	315	1.5e-11	0.51	0.60	0.70
PGSC0003DMT200060629	K04733	ko04210	Apoptosis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMT200060629	K04733	ko04620	Toll-like receptor signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMT200060629	K04733	ko04722	Neurotrophin signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMT200060629	K04733	ko05140	Leishmaniasis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMT200060629	K04733	ko05142	Chagas disease	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMT200060638	K04733	ko04210	Apoptosis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMT200060638	K04733	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMT200060638	K04733	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMT200060638	K04733	ko05140	Leishmaniasis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMT200060638	K04733	ko05142	Chagas disease	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMT200060650	K08333	ko04140	Regulation of autophagy	676	1.3e-30	0.86	0.92	0.97
PGSC0003DMT200060652	K08333	ko04140	Regulation of autophagy	9877	0.	0.75	0.85	1.00
PGSC0003DMT200060653	K08333	ko04140	Regulation of autophagy	9220	0.	0.75	0.85	1.00
PGSC0003DMT200060654	K06630	ko04110	Cell cycle	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMT200060654	K06630	ko04114	Oocyte meiosis	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMT200060654	K06630	ko04722	Neurotrophin signaling pathway	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMT200060658	K10807	ko00230	Purine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMT200060658	K10807	ko00240	Pyrimidine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMT200060658	K10807	ko00480	Glutathione metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMT200060658	K10807	ko01100	Metabolic pathways	6309	0.	0.90	0.96	1.00
PGSC0003DMT200060660	K13065	ko00940	Phenylpropanoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMT200060660	K13065	ko00941	Flavonoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMT200060660	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMT200060660	K13065	ko01110	Biosynthesis of secondary metabolites	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMT200060662	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMT200060662	K00517	ko00626	Naphthalene and anthracene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMT200060662	K00517	ko00903	Limonene and pinene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMT200060662	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMT200060662	K00517	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMT200060663	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMT200060663	K00517	ko00626	Naphthalene and anthracene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMT200060663	K00517	ko00903	Limonene and pinene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMT200060663	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMT200060663	K00517	ko01110	Biosynthesis of secondary metabolites	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMT200074959	K05656	ko02010	ABC transporters	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMT200074959	K05656	ko04142	Lysosome	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMT200074960	K05656	ko02010	ABC transporters	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMT200074960	K05656	ko04142	Lysosome	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMT200074961	K05656	ko02010	ABC transporters	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMT200074961	K05656	ko04142	Lysosome	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMT200074962	K05656	ko02010	ABC transporters	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMT200074962	K05656	ko04142	Lysosome	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMT200074963	K05656	ko02010	ABC transporters	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMT200074963	K05656	ko04142	Lysosome	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMT200074965	K09756	ko00940	Phenylpropanoid biosynthesis	1721	4.4e-89	0.47	0.66	0.95
PGSC0003DMT200074966	K09756	ko00940	Phenylpropanoid biosynthesis	1227	7.7e-62	0.47	0.65	0.93
PGSC0003DMT200074967	K09756	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.49	0.68	0.94
PGSC0003DMT200074968	K09756	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.48	0.67	0.95
PGSC0003DMT200074970	K10609	ko03420	Nucleotide excision repair	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMT200074970	K10609	ko04120	Ubiquitin mediated proteolysis	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMT200074989	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMT200074990	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMT200074993	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMT200074994	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.92	0.99
PGSC0003DMT200074995	K11252	ko05322	Systemic lupus erythematosus	718	9.1e-34	0.82	0.88	0.79
PGSC0003DMT200057437	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.73
PGSC0003DMT200057438	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.84
PGSC0003DMT200057445	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMT200057445	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMT200057446	K00700	ko00500	Starch and sucrose metabolism	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMT200057446	K00700	ko01100	Metabolic pathways	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMT200057447	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMT200057447	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMT200057448	K00658	ko00020	Citrate cycle (TCA cycle)	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMT200057448	K00658	ko00310	Lysine degradation	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMT200057448	K00658	ko01100	Metabolic pathways	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMT200057448	K00658	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMT200057449	K00658	ko00020	Citrate cycle (TCA cycle)	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMT200057449	K00658	ko00310	Lysine degradation	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMT200057449	K00658	ko01100	Metabolic pathways	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMT200057449	K00658	ko01110	Biosynthesis of secondary metabolites	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMT200057450	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057450	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057450	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057450	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057451	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057451	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057451	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057451	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMT200057456	K12741	ko03040	Spliceosome	258	2.1e-08	0.48	0.52	0.72
PGSC0003DMT200057464	K00912	ko00540	Lipopolysaccharide biosynthesis	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMT200057464	K00912	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMT200057466	K00912	ko00540	Lipopolysaccharide biosynthesis	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMT200057466	K00912	ko01100	Metabolic pathways	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMT200057467	K00912	ko00540	Lipopolysaccharide biosynthesis	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMT200057467	K00912	ko01100	Metabolic pathways	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMT200057469	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMT200092196	K02358	ko04626	Plant-pathogen interaction	3382	1.1e-180	0.84	0.90	0.99
PGSC0003DMT200022239	K12796	ko04621	NOD-like receptor signaling pathway	330	2.6e-09	0.30	0.48	0.33
PGSC0003DMT200022240	K12796	ko04621	NOD-like receptor signaling pathway	330	3.1e-09	0.30	0.48	0.29
PGSC0003DMT200022251	K00799	ko00480	Glutathione metabolism	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMT200022251	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMT200022251	K00799	ko00982	Drug metabolism - cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMT200022254	K00660	ko00941	Flavonoid biosynthesis	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMT200022254	K00660	ko01100	Metabolic pathways	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMT200022254	K00660	ko01110	Biosynthesis of secondary metabolites	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMT200022254	K00660	ko04712	Circadian rhythm - plant	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMT200022255	K00660	ko00941	Flavonoid biosynthesis	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMT200022255	K00660	ko01100	Metabolic pathways	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMT200022255	K00660	ko01110	Biosynthesis of secondary metabolites	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMT200022255	K00660	ko04712	Circadian rhythm - plant	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMT200022258	K00660	ko00941	Flavonoid biosynthesis	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMT200022258	K00660	ko01100	Metabolic pathways	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMT200022258	K00660	ko01110	Biosynthesis of secondary metabolites	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMT200022258	K00660	ko04712	Circadian rhythm - plant	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMT200022261	K00660	ko00941	Flavonoid biosynthesis	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMT200022261	K00660	ko01100	Metabolic pathways	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMT200022261	K00660	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMT200022261	K00660	ko04712	Circadian rhythm - plant	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMT200013907	K01593	ko00340	Histidine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00350	Tyrosine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00360	Phenylalanine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00380	Tryptophan metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00901	Indole alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00950	Isoquinoline alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko00965	Betalain biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko01100	Metabolic pathways	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013907	K01593	ko01110	Biosynthesis of secondary metabolites	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMT200013910	K01593	ko00340	Histidine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00350	Tyrosine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00360	Phenylalanine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00380	Tryptophan metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00901	Indole alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko00965	Betalain biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko01100	Metabolic pathways	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013910	K01593	ko01110	Biosynthesis of secondary metabolites	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMT200013913	K05277	ko00941	Flavonoid biosynthesis	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMT200013913	K05277	ko01100	Metabolic pathways	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMT200013913	K05277	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMT200013914	K08233	ko00901	Indole alkaloid biosynthesis	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMT200013914	K08233	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMT200013918	K05277	ko00941	Flavonoid biosynthesis	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMT200013918	K05277	ko01100	Metabolic pathways	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMT200013918	K05277	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMT200013919	K05277	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMT200013919	K05277	ko01100	Metabolic pathways	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMT200013919	K05277	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMT200013920	K05277	ko00941	Flavonoid biosynthesis	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMT200013920	K05277	ko01100	Metabolic pathways	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMT200013920	K05277	ko01110	Biosynthesis of secondary metabolites	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMT200013922	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMT200013922	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMT200013924	K05933	ko00270	Cysteine and methionine metabolism	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMT200013924	K05933	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMT200041940	K08099	ko00860	Porphyrin and chlorophyll metabolism	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMT200041940	K08099	ko01100	Metabolic pathways	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMT200041940	K08099	ko01110	Biosynthesis of secondary metabolites	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMT200041941	K08099	ko00860	Porphyrin and chlorophyll metabolism	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMT200041941	K08099	ko01100	Metabolic pathways	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMT200041941	K08099	ko01110	Biosynthesis of secondary metabolites	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMT200041959	K00648	ko00061	Fatty acid biosynthesis	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMT200041959	K00648	ko01100	Metabolic pathways	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMT200053933	K12591	ko03018	RNA degradation	3520	2.6e-188	0.51	0.64	1.00
PGSC0003DMT200053937	K12126	ko04712	Circadian rhythm - plant	328	1.5e-10	0.28	0.40	0.71
PGSC0003DMT200053965	K12338	ko00942	Anthocyanin biosynthesis	519	8.6e-23	0.49	0.67	0.85
PGSC0003DMT200053967	K12929	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMT200053967	K12929	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMT200053971	K12929	ko00904	Diterpenoid biosynthesis	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMT200053971	K12929	ko01110	Biosynthesis of secondary metabolites	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMT200053974	K12929	ko00904	Diterpenoid biosynthesis	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMT200053974	K12929	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMT200053980	K12338	ko00942	Anthocyanin biosynthesis	325	4.3e-12	0.48	0.69	0.98
PGSC0003DMT200053981	K12338	ko00942	Anthocyanin biosynthesis	1883	5.1e-98	0.51	0.69	0.98
PGSC0003DMT200053982	K12338	ko00942	Anthocyanin biosynthesis	502	7.5e-22	0.54	0.72	0.97
PGSC0003DMT200053983	K12338	ko00942	Anthocyanin biosynthesis	1177	4.4e-59	0.50	0.69	0.95
PGSC0003DMT200053984	K12338	ko00942	Anthocyanin biosynthesis	264	1.2e-08	0.37	0.54	0.71
PGSC0003DMT200063865	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.76
PGSC0003DMT200063866	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.87
PGSC0003DMT200063904	K02981	ko03010	Ribosome	2040	1.1e-106	0.88	0.92	1.00
PGSC0003DMT200088086	K05282	ko00904	Diterpenoid biosynthesis	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMT200088086	K05282	ko01100	Metabolic pathways	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMT200088086	K05282	ko01110	Biosynthesis of secondary metabolites	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMT200088098	K05759	ko04810	Regulation of actin cytoskeleton	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMT200088098	K05759	ko05131	Shigellosis	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMT200088107	K02894	ko03010	Ribosome	550	1.7e-24	0.93	0.94	0.99
PGSC0003DMT200071297	K04646	ko04142	Lysosome	10758	0.	0.78	0.82	1.00
PGSC0003DMT200071297	K04646	ko04144	Endocytosis	10758	0.	0.78	0.82	1.00
PGSC0003DMT200071297	K04646	ko05016	Huntington's disease	10758	0.	0.78	0.82	1.00
PGSC0003DMT200071297	K04646	ko05100	Bacterial invasion of epithelial cells	10758	0.	0.78	0.82	1.00
PGSC0003DMT200071298	K04646	ko04142	Lysosome	13479	0.	0.93	0.97	1.00
PGSC0003DMT200071298	K04646	ko04144	Endocytosis	13479	0.	0.93	0.97	1.00
PGSC0003DMT200071298	K04646	ko05016	Huntington's disease	13479	0.	0.93	0.97	1.00
PGSC0003DMT200071298	K04646	ko05100	Bacterial invasion of epithelial cells	13479	0.	0.93	0.97	1.00
PGSC0003DMT200071311	K10575	ko04120	Ubiquitin mediated proteolysis	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMT200071311	K10575	ko05012	Parkinson's disease	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMT200071313	K01710	ko00521	Streptomycin biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMT200071313	K01710	ko00523	Polyketide sugar unit biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMT200071313	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMT200071313	K01710	ko01100	Metabolic pathways	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMT200071313	K01710	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMT200071314	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200071318	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071318	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071318	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071318	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071318	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071319	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071319	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071319	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071319	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071319	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMT200071321	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMT200071321	K00517	ko00626	Naphthalene and anthracene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMT200071321	K00517	ko00903	Limonene and pinene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMT200071321	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMT200071321	K00517	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMT200008028	K01507	ko00190	Oxidative phosphorylation	2043	7.6e-107	0.81	0.86	1.00
PGSC0003DMT200008033	K02492	ko00860	Porphyrin and chlorophyll metabolism	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMT200008033	K02492	ko01100	Metabolic pathways	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMT200008033	K02492	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMT200008034	K02492	ko00860	Porphyrin and chlorophyll metabolism	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMT200008034	K02492	ko01100	Metabolic pathways	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMT200008034	K02492	ko01110	Biosynthesis of secondary metabolites	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMT200008035	K02492	ko00860	Porphyrin and chlorophyll metabolism	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMT200008035	K02492	ko01100	Metabolic pathways	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMT200008035	K02492	ko01110	Biosynthesis of secondary metabolites	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMT200008042	K12135	ko04712	Circadian rhythm - plant	319	9.3e-12	0.47	0.57	0.64
PGSC0003DMT200008044	K12135	ko04712	Circadian rhythm - plant	340	6.4e-13	0.33	0.46	0.85
PGSC0003DMT200008047	K11247	ko04144	Endocytosis	864	8.1e-42	0.64	0.79	0.95
PGSC0003DMT200008048	K11247	ko04144	Endocytosis	1464	6.5e-75	0.57	0.74	0.99
PGSC0003DMT200008049	K11247	ko04144	Endocytosis	1674	1.7e-86	0.57	0.75	0.99
PGSC0003DMT200020892	K05391	ko04626	Plant-pathogen interaction	2025	7.4e-106	0.78	0.84	0.98
PGSC0003DMT200020893	K05391	ko04626	Plant-pathogen interaction	4387	3.9e-236	0.74	0.83	0.99
PGSC0003DMT200020910	K01674	ko00910	Nitrogen metabolism	1444	8.3e-74	0.62	0.80	0.95
PGSC0003DMT200020911	K03008	ko00230	Purine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMT200020911	K03008	ko00240	Pyrimidine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMT200020911	K03008	ko01100	Metabolic pathways	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMT200020911	K03008	ko03020	RNA polymerase	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMT200020911	K03008	ko05016	Huntington's disease	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMT200028537	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMT200028537	K00517	ko00626	Naphthalene and anthracene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMT200028537	K00517	ko00903	Limonene and pinene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMT200028537	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMT200028537	K00517	ko01110	Biosynthesis of secondary metabolites	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMT200028545	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMT200028545	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMT200028545	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMT200028545	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMT200028545	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMT200028546	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMT200028546	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMT200028546	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMT200028546	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMT200028546	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMT200028549	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMT200028549	K00517	ko00626	Naphthalene and anthracene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMT200028549	K00517	ko00903	Limonene and pinene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMT200028549	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMT200028549	K00517	ko01110	Biosynthesis of secondary metabolites	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMT200028551	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMT200028551	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMT200028551	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMT200028551	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMT200028551	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMT200028555	K09755	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMT200028555	K09755	ko01100	Metabolic pathways	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMT200028555	K09755	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMT200028557	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMT200028557	K00517	ko00626	Naphthalene and anthracene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMT200028557	K00517	ko00903	Limonene and pinene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMT200028557	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMT200028557	K00517	ko01110	Biosynthesis of secondary metabolites	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMT200028561	K02308	ko04010	MAPK signaling pathway	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMT200028561	K02308	ko05014	Amyotrophic lateral sclerosis (ALS)	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMT200028566	K00680	ko00350	Tyrosine metabolism	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMT200028566	K00680	ko00624	1- and 2-Methylnaphthalene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMT200028566	K00680	ko00632	Benzoate degradation via CoA ligation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMT200028566	K00680	ko00642	Ethylbenzene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMT200028566	K00680	ko00903	Limonene and pinene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMT200028567	K05765	ko04360	Axon guidance	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMT200028567	K05765	ko04666	Fc gamma R-mediated phagocytosis	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMT200028567	K05765	ko04810	Regulation of actin cytoskeleton	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMT200028571	K12492	ko04144	Endocytosis	2717	5.1e-144	0.70	0.81	1.00
PGSC0003DMT200028572	K12492	ko04144	Endocytosis	838	2.2e-40	0.64	0.77	0.99
PGSC0003DMT200028574	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.28
PGSC0003DMT200052795	K13065	ko00940	Phenylpropanoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMT200052795	K13065	ko00941	Flavonoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMT200052795	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMT200052795	K13065	ko01110	Biosynthesis of secondary metabolites	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMT200052803	K06268	ko04010	MAPK signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04020	Calcium signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04114	Oocyte meiosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04210	Apoptosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04310	Wnt signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04360	Axon guidance	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04370	VEGF signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04650	Natural killer cell mediated cytotoxicity	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04660	T cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04662	B cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko04720	Long-term potentiation	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko05010	Alzheimer's disease	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052803	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMT200052804	K06268	ko04010	MAPK signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04020	Calcium signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04114	Oocyte meiosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04210	Apoptosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04310	Wnt signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04360	Axon guidance	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04370	VEGF signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04650	Natural killer cell mediated cytotoxicity	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04660	T cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04662	B cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko04720	Long-term potentiation	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko05010	Alzheimer's disease	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052804	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMT200052805	K06268	ko04010	MAPK signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04020	Calcium signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04114	Oocyte meiosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04210	Apoptosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04310	Wnt signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04360	Axon guidance	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04370	VEGF signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04650	Natural killer cell mediated cytotoxicity	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04660	T cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04662	B cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko04720	Long-term potentiation	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko05010	Alzheimer's disease	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052805	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMT200052806	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMT200052806	K00430	ko00680	Methane metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMT200052806	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMT200052806	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMT200052806	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMT200052807	K00430	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMT200052807	K00430	ko00680	Methane metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMT200052807	K00430	ko00940	Phenylpropanoid biosynthesis	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMT200052807	K00430	ko01100	Metabolic pathways	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMT200052807	K00430	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMT200052811	K01099	ko00562	Inositol phosphate metabolism	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMT200052811	K01099	ko01100	Metabolic pathways	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMT200052811	K01099	ko04070	Phosphatidylinositol signaling system	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMT200052812	K01099	ko00562	Inositol phosphate metabolism	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMT200052812	K01099	ko01100	Metabolic pathways	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMT200052812	K01099	ko04070	Phosphatidylinositol signaling system	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMT200052813	K01099	ko00562	Inositol phosphate metabolism	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMT200052813	K01099	ko01100	Metabolic pathways	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMT200052813	K01099	ko04070	Phosphatidylinositol signaling system	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMT200052814	K01099	ko00562	Inositol phosphate metabolism	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMT200052814	K01099	ko01100	Metabolic pathways	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMT200052814	K01099	ko04070	Phosphatidylinositol signaling system	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMT200065564	K03660	ko03410	Base excision repair	279	8.0e-09	0.42	0.56	0.62
PGSC0003DMT200065565	K03660	ko03410	Base excision repair	279	8.0e-09	0.45	0.59	0.53
PGSC0003DMT200055744	K11086	ko03040	Spliceosome	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMT200055744	K11086	ko05322	Systemic lupus erythematosus	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMT200055745	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMT200055745	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMT200055746	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMT200055746	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMT200055751	K04371	ko04010	MAPK signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04012	ErbB signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04013	MAPK signaling pathway - fly	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04062	Chemokine signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04114	Oocyte meiosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04150	mTOR signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04270	Vascular smooth muscle contraction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04320	Dorso-ventral axis formation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04350	TGF-beta signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04360	Axon guidance	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04370	VEGF signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04510	Focal adhesion	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04520	Adherens junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04540	Gap junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04620	Toll-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04621	NOD-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04650	Natural killer cell mediated cytotoxicity	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04660	T cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04662	B cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04664	Fc epsilon RI signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04666	Fc gamma R-mediated phagocytosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04720	Long-term potentiation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04722	Neurotrophin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04730	Long-term depression	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04810	Regulation of actin cytoskeleton	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04910	Insulin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04912	GnRH signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04914	Progesterone-mediated oocyte maturation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04916	Melanogenesis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04930	Type II diabetes mellitus	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05010	Alzheimer's disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05020	Prion diseases	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05131	Shigellosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05140	Leishmaniasis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05142	Chagas disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05200	Pathways in cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05210	Colorectal cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05211	Renal cell carcinoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05212	Pancreatic cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05213	Endometrial cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05214	Glioma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05215	Prostate cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05216	Thyroid cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05218	Melanoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05219	Bladder cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05220	Chronic myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05221	Acute myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055751	K04371	ko05223	Non-small cell lung cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMT200055753	K01762	ko00270	Cysteine and methionine metabolism	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMT200055753	K01762	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMT200055765	K12614	ko03018	RNA degradation	3586	5.9e-192	0.87	0.92	1.00
PGSC0003DMT200055769	K01213	ko00040	Pentose and glucuronate interconversions	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMT200055769	K01213	ko00500	Starch and sucrose metabolism	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMT200055769	K01213	ko01100	Metabolic pathways	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMT200055770	K01213	ko00040	Pentose and glucuronate interconversions	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMT200055770	K01213	ko00500	Starch and sucrose metabolism	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMT200055770	K01213	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMT200055777	K08486	ko04130	SNARE interactions in vesicular transport	1841	1.0e-95	0.76	0.86	0.96
PGSC0003DMT200073039	K00013	ko00340	Histidine metabolism	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMT200073039	K00013	ko01100	Metabolic pathways	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMT200073039	K00013	ko01110	Biosynthesis of secondary metabolites	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMT200073047	K00013	ko00340	Histidine metabolism	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMT200073047	K00013	ko01100	Metabolic pathways	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMT200073047	K00013	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMT200073051	K11093	ko03040	Spliceosome	225	1.4e-06	0.37	0.46	0.69
PGSC0003DMT200073067	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200073067	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200073068	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200073068	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200018976	K05665	ko02010	ABC transporters	1289	2.9e-65	0.35	0.54	0.91
PGSC0003DMT200018986	K00857	ko00240	Pyrimidine metabolism	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMT200018986	K00857	ko00983	Drug metabolism - other enzymes	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMT200018986	K00857	ko01100	Metabolic pathways	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMT200019000	K08139	ko04113	Meiosis - yeast	897	1.2e-43	0.33	0.52	0.96
PGSC0003DMT200019001	K00106	ko00230	Purine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019001	K00106	ko00232	Caffeine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019001	K00106	ko00983	Drug metabolism - other enzymes	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019001	K00106	ko01100	Metabolic pathways	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019001	K00106	ko01110	Biosynthesis of secondary metabolites	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019001	K00106	ko04146	Peroxisome	6366	0.	0.61	0.72	1.00
PGSC0003DMT200019005	K00106	ko00230	Purine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019005	K00106	ko00232	Caffeine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019005	K00106	ko00983	Drug metabolism - other enzymes	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019005	K00106	ko01100	Metabolic pathways	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019005	K00106	ko01110	Biosynthesis of secondary metabolites	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019005	K00106	ko04146	Peroxisome	8662	0.	0.74	0.86	1.00
PGSC0003DMT200019006	K00106	ko00230	Purine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019006	K00106	ko00232	Caffeine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019006	K00106	ko00983	Drug metabolism - other enzymes	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019006	K00106	ko01100	Metabolic pathways	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019006	K00106	ko01110	Biosynthesis of secondary metabolites	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019006	K00106	ko04146	Peroxisome	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMT200019010	K00106	ko00230	Purine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019010	K00106	ko00232	Caffeine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019010	K00106	ko00983	Drug metabolism - other enzymes	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019010	K00106	ko01100	Metabolic pathways	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019010	K00106	ko01110	Biosynthesis of secondary metabolites	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019010	K00106	ko04146	Peroxisome	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMT200019020	K00680	ko00350	Tyrosine metabolism	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMT200019020	K00680	ko00624	1- and 2-Methylnaphthalene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMT200019020	K00680	ko00632	Benzoate degradation via CoA ligation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMT200019020	K00680	ko00642	Ethylbenzene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMT200019020	K00680	ko00903	Limonene and pinene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMT200019021	K12183	ko04144	Endocytosis	231	2.0e-06	0.32	0.45	0.57
PGSC0003DMT200009126	K01623	ko00010	Glycolysis / Gluconeogenesis	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009126	K01623	ko00030	Pentose phosphate pathway	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009126	K01623	ko00051	Fructose and mannose metabolism	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009126	K01623	ko00710	Carbon fixation in photosynthetic organisms	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009126	K01623	ko01100	Metabolic pathways	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009126	K01623	ko01110	Biosynthesis of secondary metabolites	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMT200009127	K01623	ko00010	Glycolysis / Gluconeogenesis	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009127	K01623	ko00030	Pentose phosphate pathway	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009127	K01623	ko00051	Fructose and mannose metabolism	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009127	K01623	ko00710	Carbon fixation in photosynthetic organisms	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009127	K01623	ko01100	Metabolic pathways	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009127	K01623	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMT200009154	K11088	ko03040	Spliceosome	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMT200009154	K11088	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMT200009174	K00475	ko00941	Flavonoid biosynthesis	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMT200009174	K00475	ko01100	Metabolic pathways	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMT200009174	K00475	ko01110	Biosynthesis of secondary metabolites	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMT200009175	K00475	ko00941	Flavonoid biosynthesis	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMT200009175	K00475	ko01100	Metabolic pathways	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMT200009175	K00475	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMT200009176	K00475	ko00941	Flavonoid biosynthesis	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMT200009176	K00475	ko01100	Metabolic pathways	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMT200009176	K00475	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMT200043877	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043877	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043877	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043878	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043878	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043878	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043879	K06671	ko04110	Cell cycle	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMT200043879	K06671	ko04111	Cell cycle - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMT200043879	K06671	ko04113	Meiosis - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMT200043880	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMT200043881	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043881	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043881	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043882	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043882	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043882	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043883	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMT200043894	K07204	ko04150	mTOR signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMT200043894	K07204	ko04910	Insulin signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMT200043895	K07204	ko04150	mTOR signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMT200043895	K07204	ko04910	Insulin signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMT200043896	K07204	ko04150	mTOR signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMT200043896	K07204	ko04910	Insulin signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMT200043903	K01762	ko00270	Cysteine and methionine metabolism	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMT200043903	K01762	ko01110	Biosynthesis of secondary metabolites	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMT200026695	K12608	ko03018	RNA degradation	1844	7.2e-96	0.78	0.89	0.98
PGSC0003DMT200026696	K12608	ko03018	RNA degradation	1109	2.5e-55	0.79	0.90	0.89
PGSC0003DMT200026699	K08332	ko04140	Regulation of autophagy	390	1.0e-13	0.31	0.53	0.47
PGSC0003DMT200026700	K08332	ko04140	Regulation of autophagy	390	2.3e-13	0.31	0.53	0.38
PGSC0003DMT200026703	K09647	ko03060	Protein export	230	7.5e-07	0.33	0.49	0.59
PGSC0003DMT200026704	K09647	ko03060	Protein export	232	5.8e-07	0.34	0.50	0.59
PGSC0003DMT200026716	K12819	ko03040	Spliceosome	3985	5.9e-214	0.85	0.93	1.00
PGSC0003DMT200026730	K13065	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMT200026730	K13065	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMT200026730	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMT200026730	K13065	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMT200088398	K10591	ko04120	Ubiquitin mediated proteolysis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMT200088398	K10591	ko04144	Endocytosis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMT200088405	K08243	ko00941	Flavonoid biosynthesis	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMT200088405	K08243	ko01110	Biosynthesis of secondary metabolites	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMT200086753	K11821	ko00380	Tryptophan metabolism	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMT200086753	K11821	ko00966	Glucosinolate biosynthesis	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMT200086753	K11821	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMT200058799	K00430	ko00360	Phenylalanine metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMT200058799	K00430	ko00680	Methane metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMT200058799	K00430	ko00940	Phenylpropanoid biosynthesis	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMT200058799	K00430	ko01100	Metabolic pathways	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMT200058799	K00430	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMT200058800	K00430	ko00360	Phenylalanine metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMT200058800	K00430	ko00680	Methane metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMT200058800	K00430	ko00940	Phenylpropanoid biosynthesis	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMT200058800	K00430	ko01100	Metabolic pathways	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMT200058800	K00430	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMT200058801	K00430	ko00360	Phenylalanine metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMT200058801	K00430	ko00680	Methane metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMT200058801	K00430	ko00940	Phenylpropanoid biosynthesis	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMT200058801	K00430	ko01100	Metabolic pathways	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMT200058801	K00430	ko01110	Biosynthesis of secondary metabolites	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMT200058805	K00430	ko00360	Phenylalanine metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMT200058805	K00430	ko00680	Methane metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMT200058805	K00430	ko00940	Phenylpropanoid biosynthesis	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMT200058805	K00430	ko01100	Metabolic pathways	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMT200058805	K00430	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMT200058807	K00430	ko00360	Phenylalanine metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMT200058807	K00430	ko00680	Methane metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMT200058807	K00430	ko00940	Phenylpropanoid biosynthesis	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMT200058807	K00430	ko01100	Metabolic pathways	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMT200058807	K00430	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMT200058819	K11095	ko03040	Spliceosome	932	1.4e-45	0.61	0.68	0.92
PGSC0003DMT200058820	K01662	ko00900	Terpenoid backbone biosynthesis	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMT200058820	K01662	ko01100	Metabolic pathways	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMT200058820	K01662	ko01110	Biosynthesis of secondary metabolites	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMT200058821	K01662	ko00900	Terpenoid backbone biosynthesis	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMT200058821	K01662	ko01100	Metabolic pathways	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMT200058821	K01662	ko01110	Biosynthesis of secondary metabolites	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMT200066952	K12604	ko03018	RNA degradation	8425	0.	0.50	0.60	1.00
PGSC0003DMT200066960	K00026	ko00020	Citrate cycle (TCA cycle)	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066960	K00026	ko00620	Pyruvate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066960	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066960	K00026	ko00710	Carbon fixation in photosynthetic organisms	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066960	K00026	ko01100	Metabolic pathways	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066960	K00026	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMT200066961	K00026	ko00020	Citrate cycle (TCA cycle)	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066961	K00026	ko00620	Pyruvate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066961	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066961	K00026	ko00710	Carbon fixation in photosynthetic organisms	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066961	K00026	ko01100	Metabolic pathways	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066961	K00026	ko01110	Biosynthesis of secondary metabolites	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMT200066991	K05754	ko04666	Fc gamma R-mediated phagocytosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMT200066991	K05754	ko04810	Regulation of actin cytoskeleton	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMT200066991	K05754	ko05100	Bacterial invasion of epithelial cells	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMT200066991	K05754	ko05130	Pathogenic Escherichia coli infection	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMT200066991	K05754	ko05131	Shigellosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMT200066992	K05754	ko04666	Fc gamma R-mediated phagocytosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMT200066992	K05754	ko04810	Regulation of actin cytoskeleton	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMT200066992	K05754	ko05100	Bacterial invasion of epithelial cells	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMT200066992	K05754	ko05130	Pathogenic Escherichia coli infection	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMT200066992	K05754	ko05131	Shigellosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMT200066993	K02084	ko04115	p53 signaling pathway	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko04210	Apoptosis	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko05010	Alzheimer's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko05012	Parkinson's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko05016	Huntington's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200066993	K02084	ko05222	Small cell lung cancer	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMT200015596	K12126	ko04712	Circadian rhythm - plant	315	1.9e-11	0.49	0.85	0.24
PGSC0003DMT200015622	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015622	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015622	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015622	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015623	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015623	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015623	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015623	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMT200015625	K10773	ko03410	Base excision repair	275	2.5e-09	0.64	0.71	0.85
PGSC0003DMT200015626	K10773	ko03410	Base excision repair	312	2.3e-11	0.70	0.94	0.53
PGSC0003DMT200015627	K10773	ko03410	Base excision repair	1564	2.0e-80	0.59	0.71	0.99
PGSC0003DMT200015628	K10773	ko03410	Base excision repair	1153	9.3e-58	0.56	0.71	0.88
PGSC0003DMT200015632	K00660	ko00941	Flavonoid biosynthesis	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMT200015632	K00660	ko01100	Metabolic pathways	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMT200015632	K00660	ko01110	Biosynthesis of secondary metabolites	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMT200015632	K00660	ko04712	Circadian rhythm - plant	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMT200023976	K13065	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMT200023976	K13065	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMT200023976	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMT200023976	K13065	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMT200023985	K00893	ko00230	Purine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMT200023985	K00893	ko00240	Pyrimidine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMT200023986	K00599	ko00340	Histidine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMT200023986	K00599	ko00350	Tyrosine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMT200023986	K00599	ko00450	Selenoamino acid metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMT200023986	K00599	ko00626	Naphthalene and anthracene degradation	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMT200023987	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023987	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023987	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023987	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023988	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023988	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023988	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023988	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023989	K00599	ko00340	Histidine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMT200023989	K00599	ko00350	Tyrosine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMT200023989	K00599	ko00450	Selenoamino acid metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMT200023989	K00599	ko00626	Naphthalene and anthracene degradation	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMT200023990	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023990	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023990	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023990	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023991	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023991	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023991	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023991	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023992	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023992	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023992	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023992	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023993	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023993	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023993	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023993	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMT200023994	K00599	ko00340	Histidine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMT200023994	K00599	ko00350	Tyrosine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMT200023994	K00599	ko00450	Selenoamino acid metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMT200023994	K00599	ko00626	Naphthalene and anthracene degradation	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMT200040130	K12605	ko03018	RNA degradation	746	2.6e-35	0.77	0.92	0.93
PGSC0003DMT200040137	K03946	ko00190	Oxidative phosphorylation	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMT200040137	K03946	ko01100	Metabolic pathways	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMT200040137	K03946	ko05010	Alzheimer's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMT200040137	K03946	ko05012	Parkinson's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMT200040137	K03946	ko05016	Huntington's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMT200040151	K10703	ko01040	Biosynthesis of unsaturated fatty acids	614	5.0e-28	0.66	0.81	0.54
PGSC0003DMT200040152	K10703	ko01040	Biosynthesis of unsaturated fatty acids	421	2.2e-17	0.52	0.64	0.98
PGSC0003DMT200040153	K10703	ko01040	Biosynthesis of unsaturated fatty acids	530	2.1e-23	0.58	0.70	0.98
PGSC0003DMT200040154	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1070	3.5e-53	0.60	0.74	0.99
PGSC0003DMT200040155	K10703	ko01040	Biosynthesis of unsaturated fatty acids	373	9.7e-15	0.61	0.76	0.44
PGSC0003DMT200040159	K02858	ko00740	Riboflavin metabolism	2657	1.0e-140	0.84	0.92	0.94
PGSC0003DMT200040160	K02858	ko00740	Riboflavin metabolism	2618	1.5e-138	0.71	0.80	0.96
PGSC0003DMT200040161	K02858	ko00740	Riboflavin metabolism	3110	1.1e-165	0.73	0.82	0.95
PGSC0003DMT200030585	K02865	ko03010	Ribosome	1259	1.3e-63	0.89	0.92	0.44
PGSC0003DMT200030586	K02865	ko03010	Ribosome	1643	8.7e-85	0.92	0.95	1.00
PGSC0003DMT200030611	K10352	ko04530	Tight junction	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMT200030611	K10352	ko05416	Viral myocarditis	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMT200030620	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMT200030620	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMT200030620	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMT200030620	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMT200030621	K07407	ko00052	Galactose metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMT200030621	K07407	ko00561	Glycerolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMT200030621	K07407	ko00600	Sphingolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMT200030621	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMT200012437	K04554	ko04120	Ubiquitin mediated proteolysis	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMT200012437	K04554	ko05012	Parkinson's disease	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMT200012445	K03061	ko03050	Proteasome	888	3.8e-43	0.91	0.96	0.94
PGSC0003DMT200012446	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.99	1.00
PGSC0003DMT200012450	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.82
PGSC0003DMT200012452	K03061	ko03050	Proteasome	837	2.5e-40	0.87	0.91	0.97
PGSC0003DMT200012477	K00469	ko00053	Ascorbate and aldarate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMT200012477	K00469	ko00562	Inositol phosphate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMT200093400	K01051	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMT200093400	K01051	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMT200093400	K01051	ko01100	Metabolic pathways	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMT200093404	K13065	ko00940	Phenylpropanoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMT200093404	K13065	ko00941	Flavonoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMT200093404	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMT200093404	K13065	ko01110	Biosynthesis of secondary metabolites	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMT200093416	K00799	ko00480	Glutathione metabolism	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMT200093416	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMT200093416	K00799	ko00982	Drug metabolism - cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMT200093419	K03094	ko04110	Cell cycle	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04111	Cell cycle - yeast	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04114	Oocyte meiosis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04120	Ubiquitin mediated proteolysis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04310	Wnt signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04350	TGF-beta signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200093419	K03094	ko04710	Circadian rhythm - mammal	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMT200092081	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2321	3.5e-122	0.66	0.80	0.99
PGSC0003DMT200092085	K12836	ko03040	Spliceosome	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMT200092085	K12836	ko05131	Shigellosis	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMT200022417	K00795	ko00900	Terpenoid backbone biosynthesis	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMT200022417	K00795	ko01100	Metabolic pathways	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMT200022417	K00795	ko01110	Biosynthesis of secondary metabolites	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMT200022419	K00795	ko00900	Terpenoid backbone biosynthesis	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMT200022419	K00795	ko01100	Metabolic pathways	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMT200022419	K00795	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMT200022420	K00795	ko00900	Terpenoid backbone biosynthesis	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMT200022420	K00795	ko01100	Metabolic pathways	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMT200022420	K00795	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMT200022423	K12042	ko04020	Calcium signaling pathway	296	1.7e-10	0.37	0.52	0.68
PGSC0003DMT200022438	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200022442	K03283	ko03040	Spliceosome	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMT200022442	K03283	ko04010	MAPK signaling pathway	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMT200022442	K03283	ko04144	Endocytosis	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMT200022442	K03283	ko04612	Antigen processing and presentation	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMT200014584	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014584	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014586	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014586	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014587	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014587	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014588	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014588	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMT200014594	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMT200014594	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMT200014597	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMT200014597	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMT200014598	K12603	ko03018	RNA degradation	496	1.6e-21	0.35	0.57	0.56
PGSC0003DMT200014600	K12603	ko03018	RNA degradation	301	1.8e-10	0.31	0.43	0.95
PGSC0003DMT200014601	K12603	ko03018	RNA degradation	346	4.5e-13	0.36	0.50	0.69
PGSC0003DMT200014611	K10260	ko04120	Ubiquitin mediated proteolysis	558	3.3e-24	0.32	0.51	0.24
PGSC0003DMT200014612	K10260	ko04120	Ubiquitin mediated proteolysis	558	6.1e-25	0.32	0.51	0.51
PGSC0003DMT200068807	K12489	ko04144	Endocytosis	3267	2.3e-174	0.70	0.84	0.99
PGSC0003DMT200068808	K12489	ko04144	Endocytosis	634	3.9e-29	0.60	0.75	0.99
PGSC0003DMT200068809	K12489	ko04144	Endocytosis	957	6.0e-47	0.61	0.79	0.88
PGSC0003DMT200068810	K05282	ko00904	Diterpenoid biosynthesis	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMT200068810	K05282	ko01100	Metabolic pathways	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMT200068810	K05282	ko01110	Biosynthesis of secondary metabolites	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMT200061372	K00889	ko00562	Inositol phosphate metabolism	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061372	K00889	ko01100	Metabolic pathways	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061372	K00889	ko04070	Phosphatidylinositol signaling system	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061372	K00889	ko04144	Endocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061372	K00889	ko04666	Fc gamma R-mediated phagocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061372	K00889	ko04810	Regulation of actin cytoskeleton	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMT200061373	K00889	ko00562	Inositol phosphate metabolism	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061373	K00889	ko01100	Metabolic pathways	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061373	K00889	ko04070	Phosphatidylinositol signaling system	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061373	K00889	ko04144	Endocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061373	K00889	ko04666	Fc gamma R-mediated phagocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061373	K00889	ko04810	Regulation of actin cytoskeleton	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMT200061374	K02901	ko03010	Ribosome	766	2.1e-36	0.71	0.81	0.99
PGSC0003DMT200061392	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMT200061392	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMT200061392	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMT200061392	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMT200061392	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMT200074584	K01423	ko00310	Lysine degradation	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMT200074584	K01423	ko00780	Biotin metabolism	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMT200074584	K01423	ko01100	Metabolic pathways	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMT200074587	K01254	ko00590	Arachidonic acid metabolism	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMT200074587	K01254	ko01100	Metabolic pathways	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMT200074600	K02291	ko00906	Carotenoid biosynthesis	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMT200074600	K02291	ko01100	Metabolic pathways	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMT200074600	K02291	ko01110	Biosynthesis of secondary metabolites	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMT200074606	K05577	ko00190	Oxidative phosphorylation	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMT200074606	K05577	ko01100	Metabolic pathways	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMT200089951	K00002	ko00010	Glycolysis / Gluconeogenesis	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMT200089951	K00002	ko00561	Glycerolipid metabolism	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMT200089951	K00002	ko00930	Caprolactam degradation	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMT200089951	K00002	ko01100	Metabolic pathways	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMT200089951	K00002	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMT200089961	K02183	ko04020	Calcium signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04070	Phosphatidylinositol signaling system	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04114	Oocyte meiosis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04270	Vascular smooth muscle contraction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04626	Plant-pathogen interaction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04720	Long-term potentiation	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04722	Neurotrophin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04740	Olfactory transduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04744	Phototransduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04745	Phototransduction - fly	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04910	Insulin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04912	GnRH signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04916	Melanogenesis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04970	Salivary secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko04971	Gastric acid secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko05010	Alzheimer's disease	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089961	K02183	ko05214	Glioma	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMT200089964	K01051	ko00040	Pentose and glucuronate interconversions	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMT200089964	K01051	ko00500	Starch and sucrose metabolism	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMT200089964	K01051	ko01100	Metabolic pathways	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMT200008182	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMT200008182	K01904	ko00360	Phenylalanine metabolism	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMT200008182	K01904	ko00940	Phenylpropanoid biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMT200008182	K01904	ko01100	Metabolic pathways	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMT200008182	K01904	ko01110	Biosynthesis of secondary metabolites	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMT200008187	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMT200008187	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMT200008188	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMT200008188	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMT200008204	K10352	ko04530	Tight junction	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMT200008204	K10352	ko05416	Viral myocarditis	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMT200008209	K10610	ko03420	Nucleotide excision repair	8587	0.	0.93	0.97	1.00
PGSC0003DMT200008209	K10610	ko04120	Ubiquitin mediated proteolysis	8587	0.	0.93	0.97	1.00
PGSC0003DMT200008210	K10610	ko03420	Nucleotide excision repair	8568	0.	0.92	0.97	1.00
PGSC0003DMT200008210	K10610	ko04120	Ubiquitin mediated proteolysis	8568	0.	0.92	0.97	1.00
PGSC0003DMT200008212	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMT200008213	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMT200008215	K03259	ko04150	mTOR signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMT200008215	K03259	ko04910	Insulin signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMT200010466	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMT200010467	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMT200010469	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMT200010469	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMT200010469	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMT200010469	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMT200010469	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMT200010475	K10777	ko03450	Non-homologous end-joining	3820	7.4e-205	0.58	0.73	0.99
PGSC0003DMT200010476	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMT200010477	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMT200010478	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMT200010479	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMT200010480	K10777	ko03450	Non-homologous end-joining	747	2.3e-35	0.82	0.88	0.82
PGSC0003DMT200010482	K10777	ko03450	Non-homologous end-joining	2277	9.4e-120	0.83	0.92	0.94
PGSC0003DMT200020349	K02084	ko04115	p53 signaling pathway	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko04210	Apoptosis	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko05010	Alzheimer's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko05012	Parkinson's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko05016	Huntington's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020349	K02084	ko05222	Small cell lung cancer	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMT200020353	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020353	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMT200020354	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020354	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMT200020359	K02084	ko04115	p53 signaling pathway	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko04210	Apoptosis	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko05010	Alzheimer's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko05012	Parkinson's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko05016	Huntington's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020359	K02084	ko05222	Small cell lung cancer	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMT200020360	K02084	ko04115	p53 signaling pathway	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko04210	Apoptosis	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko05010	Alzheimer's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko05012	Parkinson's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko05016	Huntington's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020360	K02084	ko05222	Small cell lung cancer	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMT200020369	K03010	ko00230	Purine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMT200020369	K03010	ko00240	Pyrimidine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMT200020369	K03010	ko01100	Metabolic pathways	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMT200020369	K03010	ko03020	RNA polymerase	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMT200020369	K03010	ko05016	Huntington's disease	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMT200053548	K04706	ko04120	Ubiquitin mediated proteolysis	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMT200053548	K04706	ko04630	Jak-STAT signaling pathway	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMT200053548	K04706	ko05200	Pathways in cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMT200053548	K04706	ko05222	Small cell lung cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMT200053550	K04706	ko04120	Ubiquitin mediated proteolysis	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMT200053550	K04706	ko04630	Jak-STAT signaling pathway	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMT200053550	K04706	ko05200	Pathways in cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMT200053550	K04706	ko05222	Small cell lung cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMT200053565	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMT200053566	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMT200053567	K12812	ko03040	Spliceosome	1363	2.4e-69	0.96	0.99	0.88
PGSC0003DMT200053568	K12812	ko03040	Spliceosome	2834	1.8e-150	0.97	0.99	1.00
PGSC0003DMT200063366	K12813	ko03040	Spliceosome	657	4.6e-30	0.57	0.75	0.99
PGSC0003DMT200063367	K12813	ko03040	Spliceosome	983	2.2e-48	0.86	0.95	0.98
PGSC0003DMT200063368	K12813	ko03040	Spliceosome	2692	1.2e-142	0.92	0.96	0.99
PGSC0003DMT200063369	K12813	ko03040	Spliceosome	6693	0.	0.86	0.94	1.00
PGSC0003DMT200063370	K12813	ko03040	Spliceosome	7348	0.	0.82	0.92	1.00
PGSC0003DMT200063379	K07964	ko00531	Glycosaminoglycan degradation	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMT200063379	K07964	ko01100	Metabolic pathways	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMT200063380	K07964	ko00531	Glycosaminoglycan degradation	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMT200063380	K07964	ko01100	Metabolic pathways	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMT200063381	K07964	ko00531	Glycosaminoglycan degradation	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMT200063381	K07964	ko01100	Metabolic pathways	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMT200063391	K10849	ko03420	Nucleotide excision repair	402	2.4e-16	0.52	0.62	0.91
PGSC0003DMT200063393	K10849	ko03420	Nucleotide excision repair	557	6.9e-25	0.59	0.67	0.94
PGSC0003DMT200063394	K10849	ko03420	Nucleotide excision repair	1204	1.4e-60	0.70	0.80	0.94
PGSC0003DMT200063395	K10849	ko03420	Nucleotide excision repair	2219	1.5e-116	0.70	0.79	0.97
PGSC0003DMT200087853	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMT200087853	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMT200087873	K01051	ko00040	Pentose and glucuronate interconversions	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMT200087873	K01051	ko00500	Starch and sucrose metabolism	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMT200087873	K01051	ko01100	Metabolic pathways	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMT200045973	K08488	ko04130	SNARE interactions in vesicular transport	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMT200045973	K08488	ko04145	Phagosome	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMT200045987	K09753	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMT200045987	K09753	ko01100	Metabolic pathways	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMT200045987	K09753	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMT200045988	K13082	ko00941	Flavonoid biosynthesis	254	3.6e-08	0.32	0.55	0.95
PGSC0003DMT200046004	K02703	ko00195	Photosynthesis	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMT200046004	K02703	ko01100	Metabolic pathways	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMT200018412	K01834	ko00010	Glycolysis / Gluconeogenesis	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMT200018412	K01834	ko01100	Metabolic pathways	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMT200018412	K01834	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMT200018415	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMT200018415	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMT200018415	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMT200018416	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMT200018416	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMT200018416	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMT200018417	K01834	ko00010	Glycolysis / Gluconeogenesis	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMT200018417	K01834	ko01100	Metabolic pathways	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMT200018417	K01834	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMT200018418	K01834	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMT200018418	K01834	ko01100	Metabolic pathways	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMT200018418	K01834	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMT200018419	K01834	ko00010	Glycolysis / Gluconeogenesis	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMT200018419	K01834	ko01100	Metabolic pathways	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMT200018419	K01834	ko01110	Biosynthesis of secondary metabolites	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMT200018421	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.52
PGSC0003DMT200018422	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.70
PGSC0003DMT200018426	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.43
PGSC0003DMT200018427	K11824	ko04144	Endocytosis	7439	0.	0.86	0.91	1.00
PGSC0003DMT200018427	K11824	ko05016	Huntington's disease	7439	0.	0.86	0.91	1.00
PGSC0003DMT200018428	K11824	ko04144	Endocytosis	7490	0.	0.88	0.93	1.00
PGSC0003DMT200018428	K11824	ko05016	Huntington's disease	7490	0.	0.88	0.93	1.00
PGSC0003DMT200018431	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMT200018431	K12449	ko01100	Metabolic pathways	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMT200008781	K10643	ko03018	RNA degradation	2173	5.1e-114	0.38	0.53	1.00
PGSC0003DMT200008785	K11584	ko04113	Meiosis - yeast	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMT200008785	K11584	ko04114	Oocyte meiosis	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMT200008785	K11584	ko04310	Wnt signaling pathway	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMT200008800	K02147	ko00190	Oxidative phosphorylation	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008800	K02147	ko01100	Metabolic pathways	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008800	K02147	ko04145	Phagosome	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008800	K02147	ko04966	Collecting duct acid secretion	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008800	K02147	ko05110	Vibrio cholerae infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008800	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMT200008802	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008802	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008802	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008802	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008802	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008802	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008803	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMT200008814	K12741	ko03040	Spliceosome	334	1.4e-12	0.41	0.48	0.62
PGSC0003DMT200008815	K12741	ko03040	Spliceosome	320	8.2e-12	0.34	0.45	0.92
PGSC0003DMT200008816	K12741	ko03040	Spliceosome	318	1.1e-11	0.34	0.45	0.92
PGSC0003DMT200043537	K12929	ko00904	Diterpenoid biosynthesis	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMT200043537	K12929	ko01110	Biosynthesis of secondary metabolites	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMT200043542	K04371	ko04010	MAPK signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04012	ErbB signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04013	MAPK signaling pathway - fly	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04062	Chemokine signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04114	Oocyte meiosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04150	mTOR signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04270	Vascular smooth muscle contraction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04320	Dorso-ventral axis formation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04350	TGF-beta signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04360	Axon guidance	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04370	VEGF signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04510	Focal adhesion	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04520	Adherens junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04540	Gap junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04621	NOD-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04650	Natural killer cell mediated cytotoxicity	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04660	T cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04662	B cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04664	Fc epsilon RI signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04666	Fc gamma R-mediated phagocytosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04720	Long-term potentiation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04730	Long-term depression	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04810	Regulation of actin cytoskeleton	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04910	Insulin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04912	GnRH signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04914	Progesterone-mediated oocyte maturation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04916	Melanogenesis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04930	Type II diabetes mellitus	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko04960	Aldosterone-regulated sodium reabsorption	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05010	Alzheimer's disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05020	Prion diseases	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05131	Shigellosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05140	Leishmaniasis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05142	Chagas disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05200	Pathways in cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05210	Colorectal cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05211	Renal cell carcinoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05212	Pancreatic cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05213	Endometrial cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05214	Glioma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05215	Prostate cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05216	Thyroid cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05218	Melanoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05219	Bladder cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05220	Chronic myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05221	Acute myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200043542	K04371	ko05223	Non-small cell lung cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMT200088760	K04508	ko04310	Wnt signaling pathway	2773	4.1e-147	0.64	0.78	1.00
PGSC0003DMT200088765	K10760	ko00908	Zeatin biosynthesis	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMT200088765	K10760	ko01100	Metabolic pathways	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMT200088765	K10760	ko01110	Biosynthesis of secondary metabolites	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMT200088770	K10760	ko00908	Zeatin biosynthesis	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMT200088770	K10760	ko01100	Metabolic pathways	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMT200088770	K10760	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMT200095159	K03921	ko00061	Fatty acid biosynthesis	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMT200095159	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMT200052948	K02987	ko03010	Ribosome	1939	4.1e-101	0.92	0.98	0.98
PGSC0003DMT200052950	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMT200052951	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMT200052952	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMT200052953	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMT200052955	K02987	ko03010	Ribosome	1303	4.9e-66	0.85	0.94	0.96
PGSC0003DMT200052983	K03178	ko04120	Ubiquitin mediated proteolysis	7555	0.	0.81	0.90	1.00
PGSC0003DMT200052983	K03178	ko05012	Parkinson's disease	7555	0.	0.81	0.90	1.00
PGSC0003DMT200052984	K08059	ko04612	Antigen processing and presentation	798	3.5e-38	0.53	0.68	0.89
PGSC0003DMT200052987	K08059	ko04612	Antigen processing and presentation	974	6.9e-48	0.64	0.77	0.69
PGSC0003DMT200065050	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMT200065050	K00517	ko00626	Naphthalene and anthracene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMT200065050	K00517	ko00903	Limonene and pinene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMT200065050	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMT200065050	K00517	ko01110	Biosynthesis of secondary metabolites	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMT200065062	K08248	ko00460	Cyanoamino acid metabolism	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMT200065062	K08248	ko01100	Metabolic pathways	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMT200065063	K00008	ko00051	Fructose and mannose metabolism	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMT200065063	K00008	ko01100	Metabolic pathways	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMT200055408	K13239	ko00071	Fatty acid metabolism	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMT200055408	K13239	ko04146	Peroxisome	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMT200055428	K06627	ko04110	Cell cycle	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMT200055428	K06627	ko04914	Progesterone-mediated oocyte maturation	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMT200055429	K04503	ko04110	Cell cycle	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko04115	p53 signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko04310	Wnt signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko04510	Focal adhesion	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko04630	Jak-STAT signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05200	Pathways in cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05210	Colorectal cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05212	Pancreatic cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05213	Endometrial cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05214	Glioma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05215	Prostate cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05216	Thyroid cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05218	Melanoma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05219	Bladder cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05220	Chronic myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05221	Acute myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05222	Small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05223	Non-small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055429	K04503	ko05416	Viral myocarditis	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMT200055444	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMT200055445	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMT200055446	K12126	ko04712	Circadian rhythm - plant	289	6.7e-10	0.31	0.46	0.75
PGSC0003DMT200047759	K00001	ko00010	Glycolysis / Gluconeogenesis	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00071	Fatty acid metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00350	Tyrosine metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00641	3-Chloroacrylic acid degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00830	Retinol metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko00982	Drug metabolism - cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko01100	Metabolic pathways	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047759	K00001	ko01110	Biosynthesis of secondary metabolites	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMT200047760	K00121	ko00010	Glycolysis / Gluconeogenesis	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00071	Fatty acid metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00350	Tyrosine metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00641	3-Chloroacrylic acid degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00680	Methane metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00830	Retinol metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko00982	Drug metabolism - cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko01100	Metabolic pathways	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047760	K00121	ko01110	Biosynthesis of secondary metabolites	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMT200047762	K00121	ko00010	Glycolysis / Gluconeogenesis	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00071	Fatty acid metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00350	Tyrosine metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00624	1- and 2-Methylnaphthalene degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00641	3-Chloroacrylic acid degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00680	Methane metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00830	Retinol metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko00982	Drug metabolism - cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko01100	Metabolic pathways	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047762	K00121	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMT200047763	K02899	ko03010	Ribosome	1023	1.4e-50	0.82	0.90	0.98
PGSC0003DMT200016274	K02872	ko03010	Ribosome	279	1.5e-09	0.79	0.85	0.83
PGSC0003DMT200016296	K05280	ko00941	Flavonoid biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMT200016296	K05280	ko00944	Flavone and flavonol biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMT200016296	K05280	ko01100	Metabolic pathways	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMT200016296	K05280	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMT200016302	K05280	ko00941	Flavonoid biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMT200016302	K05280	ko00944	Flavone and flavonol biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMT200016302	K05280	ko01100	Metabolic pathways	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMT200016302	K05280	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMT200016311	K08492	ko04130	SNARE interactions in vesicular transport	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMT200016311	K08492	ko04145	Phagosome	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMT200016312	K08492	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMT200016312	K08492	ko04145	Phagosome	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMT200016313	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMT200016313	K08492	ko04145	Phagosome	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMT200016314	K01934	ko00670	One carbon pool by folate	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMT200016314	K01934	ko01100	Metabolic pathways	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMT200016315	K01934	ko00670	One carbon pool by folate	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMT200016315	K01934	ko01100	Metabolic pathways	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMT200016321	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200016321	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200016321	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200024142	K10592	ko04120	Ubiquitin mediated proteolysis	21015	0.	0.71	0.83	0.98
PGSC0003DMT200024143	K10592	ko04120	Ubiquitin mediated proteolysis	21346	0.	0.72	0.84	0.99
PGSC0003DMT200024154	K04424	ko04010	MAPK signaling pathway	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMT200024154	K04424	ko04530	Tight junction	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMT200024155	K04424	ko04010	MAPK signaling pathway	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMT200024155	K04424	ko04530	Tight junction	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMT200024156	K04424	ko04010	MAPK signaling pathway	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMT200024156	K04424	ko04530	Tight junction	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMT200030214	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMT200030214	K00517	ko00626	Naphthalene and anthracene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMT200030214	K00517	ko00903	Limonene and pinene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMT200030214	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMT200030214	K00517	ko01110	Biosynthesis of secondary metabolites	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMT200030215	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMT200030215	K00517	ko00626	Naphthalene and anthracene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMT200030215	K00517	ko00903	Limonene and pinene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMT200030215	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMT200030215	K00517	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMT200030222	K06627	ko04110	Cell cycle	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMT200030222	K06627	ko04914	Progesterone-mediated oocyte maturation	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMT200030247	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030247	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030247	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030247	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030247	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030247	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030248	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMT200030255	K11816	ko00380	Tryptophan metabolism	2536	4.9e-134	0.71	0.86	0.97
PGSC0003DMT200000004	K10610	ko03420	Nucleotide excision repair	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMT200000004	K10610	ko04120	Ubiquitin mediated proteolysis	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMT200000005	K10610	ko03420	Nucleotide excision repair	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMT200000005	K10610	ko04120	Ubiquitin mediated proteolysis	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMT200000006	K12307	ko04142	Lysosome	263	3.3e-06	0.24	0.43	0.59
PGSC0003DMT200000007	K12307	ko04142	Lysosome	348	2.7e-11	0.24	0.43	0.70
PGSC0003DMT200000008	K12307	ko04142	Lysosome	316	2.7e-09	0.24	0.43	0.68
PGSC0003DMT200000009	K12307	ko04142	Lysosome	344	1.9e-11	0.24	0.43	0.91
PGSC0003DMT200000022	K00680	ko00350	Tyrosine metabolism	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMT200000022	K00680	ko00624	1- and 2-Methylnaphthalene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMT200000022	K00680	ko00632	Benzoate degradation via CoA ligation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMT200000022	K00680	ko00642	Ethylbenzene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMT200000022	K00680	ko00903	Limonene and pinene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMT200000023	K00680	ko00350	Tyrosine metabolism	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMT200000023	K00680	ko00624	1- and 2-Methylnaphthalene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMT200000023	K00680	ko00632	Benzoate degradation via CoA ligation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMT200000023	K00680	ko00642	Ethylbenzene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMT200000023	K00680	ko00903	Limonene and pinene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMT200059582	K00558	ko00270	Cysteine and methionine metabolism	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMT200059582	K00558	ko01100	Metabolic pathways	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMT200059583	K00558	ko00270	Cysteine and methionine metabolism	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMT200059583	K00558	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMT200059595	K04124	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMT200059595	K04124	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMT200067115	K04428	ko04010	MAPK signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMT200067115	K04428	ko04912	GnRH signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMT200067116	K02216	ko04110	Cell cycle	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMT200067116	K02216	ko04111	Cell cycle - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMT200067116	K02216	ko04113	Meiosis - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMT200067116	K02216	ko04115	p53 signaling pathway	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMT200067117	K06627	ko04110	Cell cycle	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMT200067117	K06627	ko04914	Progesterone-mediated oocyte maturation	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMT200067118	K06627	ko04110	Cell cycle	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMT200067118	K06627	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMT200067119	K03130	ko03022	Basal transcription factors	4519	2.1e-243	0.79	0.88	1.00
PGSC0003DMT200067125	K08495	ko04130	SNARE interactions in vesicular transport	1456	1.8e-74	0.80	0.90	1.00
PGSC0003DMT200067129	K11228	ko04011	MAPK signaling pathway - yeast	325	2.3e-11	0.36	0.54	0.64
PGSC0003DMT200076837	K11821	ko00380	Tryptophan metabolism	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMT200076837	K11821	ko00966	Glucosinolate biosynthesis	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMT200076837	K11821	ko01110	Biosynthesis of secondary metabolites	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMT200076840	K04733	ko04210	Apoptosis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMT200076840	K04733	ko04620	Toll-like receptor signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMT200076840	K04733	ko04722	Neurotrophin signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMT200076840	K04733	ko05140	Leishmaniasis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMT200076840	K04733	ko05142	Chagas disease	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMT200076851	K00696	ko00500	Starch and sucrose metabolism	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMT200076851	K00696	ko01100	Metabolic pathways	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMT200076855	K00696	ko00500	Starch and sucrose metabolism	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMT200076855	K00696	ko01100	Metabolic pathways	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMT200076858	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMT200076858	K00517	ko00626	Naphthalene and anthracene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMT200076858	K00517	ko00903	Limonene and pinene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMT200076858	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMT200076858	K00517	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMT200076859	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200076859	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200076859	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200076859	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200076859	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMT200076862	K12489	ko04144	Endocytosis	578	4.8e-26	0.78	0.92	0.64
PGSC0003DMT200076865	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076865	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200049359	K00232	ko00071	Fatty acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049359	K00232	ko00592	alpha-Linolenic acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049359	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049359	K00232	ko01100	Metabolic pathways	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049359	K00232	ko03320	PPAR signaling pathway	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049359	K00232	ko04146	Peroxisome	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMT200049360	K04567	ko00970	Aminoacyl-tRNA biosynthesis	717	1.0e-33	0.78	0.87	0.99
PGSC0003DMT200049361	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3430	2.4e-183	0.66	0.83	1.00
PGSC0003DMT200049366	K05857	ko00562	Inositol phosphate metabolism	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMT200049366	K05857	ko01100	Metabolic pathways	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMT200049366	K05857	ko04020	Calcium signaling pathway	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMT200049366	K05857	ko04070	Phosphatidylinositol signaling system	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMT200049367	K05857	ko00562	Inositol phosphate metabolism	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMT200049367	K05857	ko01100	Metabolic pathways	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMT200049367	K05857	ko04020	Calcium signaling pathway	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMT200049367	K05857	ko04070	Phosphatidylinositol signaling system	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMT200049368	K05857	ko00562	Inositol phosphate metabolism	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMT200049368	K05857	ko01100	Metabolic pathways	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMT200049368	K05857	ko04020	Calcium signaling pathway	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMT200049368	K05857	ko04070	Phosphatidylinositol signaling system	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMT200049369	K05857	ko00562	Inositol phosphate metabolism	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMT200049369	K05857	ko01100	Metabolic pathways	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMT200049369	K05857	ko04020	Calcium signaling pathway	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMT200049369	K05857	ko04070	Phosphatidylinositol signaling system	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMT200049378	K03844	ko00510	N-Glycan biosynthesis	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMT200049378	K03844	ko01100	Metabolic pathways	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMT200049379	K03844	ko00510	N-Glycan biosynthesis	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMT200049379	K03844	ko01100	Metabolic pathways	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMT200049380	K03844	ko00510	N-Glycan biosynthesis	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMT200049380	K03844	ko01100	Metabolic pathways	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMT200091158	K04733	ko04210	Apoptosis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMT200091158	K04733	ko04620	Toll-like receptor signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMT200091158	K04733	ko04722	Neurotrophin signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMT200091158	K04733	ko05140	Leishmaniasis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMT200091158	K04733	ko05142	Chagas disease	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMT200091161	K07466	ko03030	DNA replication	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMT200091161	K07466	ko03420	Nucleotide excision repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMT200091161	K07466	ko03430	Mismatch repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMT200091161	K07466	ko03440	Homologous recombination	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMT200003198	K12135	ko04712	Circadian rhythm - plant	254	3.6e-08	0.45	0.56	0.17
PGSC0003DMT200003239	K05279	ko00944	Flavone and flavonol biosynthesis	411	7.8e-17	0.34	0.47	0.96
PGSC0003DMT200040010	K00558	ko00270	Cysteine and methionine metabolism	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMT200040010	K00558	ko01100	Metabolic pathways	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMT200040014	K01247	ko03410	Base excision repair	1708	2.3e-88	0.59	0.72	1.00
PGSC0003DMT200040021	K12126	ko04712	Circadian rhythm - plant	306	6.6e-11	0.32	0.47	0.63
PGSC0003DMT200040022	K03357	ko04110	Cell cycle	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040022	K03357	ko04111	Cell cycle - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040022	K03357	ko04113	Meiosis - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040022	K03357	ko04114	Oocyte meiosis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040022	K03357	ko04120	Ubiquitin mediated proteolysis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040022	K03357	ko04914	Progesterone-mediated oocyte maturation	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMT200040023	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040023	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040023	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040023	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040023	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040023	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040024	K03357	ko04110	Cell cycle	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040024	K03357	ko04111	Cell cycle - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040024	K03357	ko04113	Meiosis - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040024	K03357	ko04114	Oocyte meiosis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040024	K03357	ko04120	Ubiquitin mediated proteolysis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040024	K03357	ko04914	Progesterone-mediated oocyte maturation	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMT200040025	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040025	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040025	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040025	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040025	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040025	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040026	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMT200040027	K03357	ko04110	Cell cycle	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040027	K03357	ko04111	Cell cycle - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040027	K03357	ko04113	Meiosis - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040027	K03357	ko04114	Oocyte meiosis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040027	K03357	ko04120	Ubiquitin mediated proteolysis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040027	K03357	ko04914	Progesterone-mediated oocyte maturation	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMT200040028	K00368	ko00910	Nitrogen metabolism	1750	1.1e-90	0.45	0.61	0.91
PGSC0003DMT200040029	K00368	ko00910	Nitrogen metabolism	1132	1.3e-56	0.42	0.56	0.96
PGSC0003DMT200040030	K13034	ko00270	Cysteine and methionine metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMT200040030	K13034	ko00450	Selenoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMT200040030	K13034	ko00460	Cyanoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMT200040030	K13034	ko00920	Sulfur metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMT200040030	K13034	ko01100	Metabolic pathways	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMT200040036	K12883	ko03040	Spliceosome	1881	6.5e-98	0.82	0.92	0.99
PGSC0003DMT200040038	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMT200040039	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMT200040041	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040041	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040041	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040041	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040041	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040042	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040042	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040042	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040042	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200040042	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMT200012216	K00423	ko00053	Ascorbate and aldarate metabolism	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMT200012216	K00423	ko01100	Metabolic pathways	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMT200012217	K01193	ko00052	Galactose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMT200012217	K01193	ko00500	Starch and sucrose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMT200012217	K01193	ko01100	Metabolic pathways	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMT200012218	K00616	ko00030	Pentose phosphate pathway	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMT200012218	K00616	ko01100	Metabolic pathways	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMT200012218	K00616	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMT200012219	K01087	ko00500	Starch and sucrose metabolism	1444	8.3e-74	0.58	0.75	0.81
PGSC0003DMT200012233	K00016	ko00010	Glycolysis / Gluconeogenesis	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012233	K00016	ko00270	Cysteine and methionine metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012233	K00016	ko00620	Pyruvate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012233	K00016	ko00640	Propanoate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012233	K00016	ko01100	Metabolic pathways	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012233	K00016	ko01110	Biosynthesis of secondary metabolites	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMT200012239	K08341	ko04140	Regulation of autophagy	937	7.6e-46	0.95	0.97	0.95
PGSC0003DMT200012240	K08341	ko04140	Regulation of autophagy	700	9.0e-33	0.97	0.99	0.91
PGSC0003DMT200034176	K01188	ko00460	Cyanoamino acid metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMT200034176	K01188	ko00500	Starch and sucrose metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMT200034176	K01188	ko00940	Phenylpropanoid biosynthesis	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMT200034176	K01188	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMT200034177	K01188	ko00460	Cyanoamino acid metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMT200034177	K01188	ko00500	Starch and sucrose metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMT200034177	K01188	ko00940	Phenylpropanoid biosynthesis	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMT200034177	K01188	ko01110	Biosynthesis of secondary metabolites	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMT200006509	K00430	ko00360	Phenylalanine metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMT200006509	K00430	ko00680	Methane metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMT200006509	K00430	ko00940	Phenylpropanoid biosynthesis	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMT200006509	K00430	ko01100	Metabolic pathways	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMT200006509	K00430	ko01110	Biosynthesis of secondary metabolites	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMT200006512	K02922	ko03010	Ribosome	783	2.4e-37	0.93	0.98	0.99
PGSC0003DMT200006515	K00558	ko00270	Cysteine and methionine metabolism	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMT200006515	K00558	ko01100	Metabolic pathways	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMT200006516	K00558	ko00270	Cysteine and methionine metabolism	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMT200006516	K00558	ko01100	Metabolic pathways	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMT200006517	K07897	ko04144	Endocytosis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMT200006517	K07897	ko04145	Phagosome	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMT200006517	K07897	ko05146	Amoebiasis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMT200006527	K10418	ko04962	Vasopressin-regulated water reabsorption	325	4.3e-12	0.48	0.65	0.94
PGSC0003DMT200006532	K02961	ko03010	Ribosome	895	1.6e-43	0.71	0.84	0.98
PGSC0003DMT200081367	K06061	ko04330	Notch signaling pathway	837	6.5e-37	0.27	0.38	0.49
PGSC0003DMT200081368	K06061	ko04330	Notch signaling pathway	830	1.7e-36	0.26	0.38	0.49
PGSC0003DMT200081369	K06061	ko04330	Notch signaling pathway	830	2.7e-39	0.26	0.38	0.82
PGSC0003DMT200081370	K00454	ko00591	Linoleic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMT200081370	K00454	ko00592	alpha-Linolenic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMT200081370	K00454	ko01100	Metabolic pathways	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMT200081371	K00454	ko00591	Linoleic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMT200081371	K00454	ko00592	alpha-Linolenic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMT200081371	K00454	ko01100	Metabolic pathways	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMT200081374	K01054	ko00561	Glycerolipid metabolism	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMT200081374	K01054	ko01100	Metabolic pathways	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMT200081375	K01054	ko00561	Glycerolipid metabolism	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMT200081375	K01054	ko01100	Metabolic pathways	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMT200081385	K11094	ko03040	Spliceosome	528	2.8e-23	0.60	0.78	0.82
PGSC0003DMT200081386	K11094	ko03040	Spliceosome	1165	2.0e-58	0.60	0.79	0.92
PGSC0003DMT200081388	K01051	ko00040	Pentose and glucuronate interconversions	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMT200081388	K01051	ko00500	Starch and sucrose metabolism	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMT200081388	K01051	ko01100	Metabolic pathways	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMT200081389	K01139	ko00230	Purine metabolism	820	2.2e-39	0.37	0.54	0.93
PGSC0003DMT200081391	K01139	ko00230	Purine metabolism	1236	2.5e-62	0.37	0.55	0.91
PGSC0003DMT200081393	K01139	ko00230	Purine metabolism	1941	3.2e-101	0.42	0.59	0.80
PGSC0003DMT200081394	K01139	ko00230	Purine metabolism	799	3.1e-38	0.52	0.65	0.58
PGSC0003DMT200065678	K04713	ko00600	Sphingolipid metabolism	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMT200065678	K04713	ko01100	Metabolic pathways	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMT200065679	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMT200065679	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMT200065681	K04713	ko00600	Sphingolipid metabolism	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMT200065681	K04713	ko01100	Metabolic pathways	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMT200065682	K04713	ko00600	Sphingolipid metabolism	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMT200065682	K04713	ko01100	Metabolic pathways	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMT200065684	K04713	ko00600	Sphingolipid metabolism	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMT200065684	K04713	ko01100	Metabolic pathways	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMT200065689	K02964	ko03010	Ribosome	1231	4.6e-62	0.94	0.98	0.99
PGSC0003DMT200065693	K03950	ko00190	Oxidative phosphorylation	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMT200065693	K03950	ko01100	Metabolic pathways	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMT200065693	K03950	ko05010	Alzheimer's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMT200065693	K03950	ko05012	Parkinson's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMT200065693	K03950	ko05016	Huntington's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMT200065713	K01692	ko00071	Fatty acid metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00280	Valine, leucine and isoleucine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00281	Geraniol degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00310	Lysine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00380	Tryptophan metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00410	beta-Alanine metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00632	Benzoate degradation via CoA ligation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00640	Propanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00650	Butanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00903	Limonene and pinene degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko00930	Caprolactam degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko01100	Metabolic pathways	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065713	K01692	ko01110	Biosynthesis of secondary metabolites	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMT200065718	K00079	ko00590	Arachidonic acid metabolism	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMT200065718	K00079	ko01100	Metabolic pathways	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMT200047064	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMT200047064	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMT200047065	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMT200047065	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMT200047073	K04799	ko03030	DNA replication	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMT200047073	K04799	ko03410	Base excision repair	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMT200047073	K04799	ko03450	Non-homologous end-joining	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMT200047078	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMT200047079	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMT200047081	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047081	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047081	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047081	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047081	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047081	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200047082	K03358	ko04110	Cell cycle	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047082	K03358	ko04111	Cell cycle - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047082	K03358	ko04113	Meiosis - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047082	K03358	ko04114	Oocyte meiosis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047082	K03358	ko04120	Ubiquitin mediated proteolysis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047082	K03358	ko04914	Progesterone-mediated oocyte maturation	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMT200047083	K03358	ko04110	Cell cycle	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047083	K03358	ko04111	Cell cycle - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047083	K03358	ko04113	Meiosis - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047083	K03358	ko04114	Oocyte meiosis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047083	K03358	ko04120	Ubiquitin mediated proteolysis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047083	K03358	ko04914	Progesterone-mediated oocyte maturation	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMT200047089	K12929	ko00904	Diterpenoid biosynthesis	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMT200047089	K12929	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMT200047090	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200047090	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200047091	K12929	ko00904	Diterpenoid biosynthesis	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMT200047091	K12929	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMT200047092	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200047092	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200072901	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072901	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072901	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072904	K04406	ko04010	MAPK signaling pathway	516	7.2e-22	0.41	0.57	0.52
PGSC0003DMT200072905	K04411	ko04010	MAPK signaling pathway	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMT200072905	K04411	ko05200	Pathways in cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMT200072905	K04411	ko05223	Non-small cell lung cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMT200072906	K04406	ko04010	MAPK signaling pathway	369	1.3e-13	0.38	0.53	0.47
PGSC0003DMT200072911	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMT200072911	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMT200072912	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMT200072912	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMT200072919	K06027	ko04962	Vasopressin-regulated water reabsorption	2015	2.7e-105	0.47	0.65	0.89
PGSC0003DMT200072920	K06027	ko04962	Vasopressin-regulated water reabsorption	1282	7.1e-65	0.52	0.71	0.80
PGSC0003DMT200070503	K06685	ko04111	Cell cycle - yeast	433	2.4e-14	0.26	0.41	0.76
PGSC0003DMT200070523	K12890	ko03040	Spliceosome	493	2.7e-21	0.35	0.46	0.43
PGSC0003DMT200070524	K12890	ko03040	Spliceosome	407	1.3e-16	0.35	0.44	0.79
PGSC0003DMT200070532	K03364	ko04110	Cell cycle	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMT200070532	K03364	ko04111	Cell cycle - yeast	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMT200070532	K03364	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMT200070532	K03364	ko04914	Progesterone-mediated oocyte maturation	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMT200070533	K12893	ko03040	Spliceosome	445	1.0e-18	0.33	0.47	0.61
PGSC0003DMT200070557	K01768	ko00230	Purine metabolism	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMT200070557	K01768	ko04113	Meiosis - yeast	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMT200070558	K08139	ko04113	Meiosis - yeast	917	9.6e-45	0.34	0.53	0.89
PGSC0003DMT200095288	K01188	ko00460	Cyanoamino acid metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMT200095288	K01188	ko00500	Starch and sucrose metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMT200095288	K01188	ko00940	Phenylpropanoid biosynthesis	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMT200095288	K01188	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMT200095314	K07466	ko03030	DNA replication	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMT200095314	K07466	ko03420	Nucleotide excision repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMT200095314	K07466	ko03430	Mismatch repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMT200095314	K07466	ko03440	Homologous recombination	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMT200019120	K12196	ko04144	Endocytosis	1229	6.0e-62	0.92	0.96	0.90
PGSC0003DMT200019130	K01897	ko00071	Fatty acid metabolism	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMT200019130	K01897	ko01100	Metabolic pathways	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMT200019130	K01897	ko03320	PPAR signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMT200019130	K01897	ko04146	Peroxisome	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMT200019130	K01897	ko04920	Adipocytokine signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMT200019146	K00100	ko00051	Fructose and mannose metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019146	K00100	ko00363	Bisphenol A degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019146	K00100	ko00591	Linoleic acid metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019146	K00100	ko00625	Tetrachloroethene degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019146	K00100	ko00650	Butanoate metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019146	K00100	ko01100	Metabolic pathways	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMT200019147	K00100	ko00051	Fructose and mannose metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019147	K00100	ko00363	Bisphenol A degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019147	K00100	ko00591	Linoleic acid metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019147	K00100	ko00625	Tetrachloroethene degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019147	K00100	ko00650	Butanoate metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019147	K00100	ko01100	Metabolic pathways	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMT200019150	K02943	ko03010	Ribosome	749	1.8e-35	0.83	0.88	0.99
PGSC0003DMT200019156	K05658	ko02010	ABC transporters	5887	0.	0.51	0.70	0.91
PGSC0003DMT200019158	K05658	ko02010	ABC transporters	1034	3.4e-51	0.70	0.85	0.99
PGSC0003DMT200019170	K02324	ko00230	Purine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMT200019170	K02324	ko00240	Pyrimidine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMT200019170	K02324	ko01100	Metabolic pathways	14930	0.	0.78	0.88	1.00
PGSC0003DMT200019170	K02324	ko03030	DNA replication	14930	0.	0.78	0.88	1.00
PGSC0003DMT200019170	K02324	ko03410	Base excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMT200019170	K02324	ko03420	Nucleotide excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMT200038620	K12818	ko03040	Spliceosome	1489	2.7e-76	0.48	0.66	0.98
PGSC0003DMT200038623	K12818	ko03040	Spliceosome	486	2.0e-20	0.59	0.81	0.87
PGSC0003DMT200038627	K02987	ko03010	Ribosome	448	7.1e-19	0.72	0.83	0.29
PGSC0003DMT200038632	K07375	ko04145	Phagosome	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMT200038632	K07375	ko04540	Gap junction	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMT200038632	K07375	ko05130	Pathogenic Escherichia coli infection	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMT200038646	K02935	ko03010	Ribosome	397	4.6e-16	0.48	0.64	0.62
PGSC0003DMT200038648	K12356	ko00940	Phenylpropanoid biosynthesis	676	1.9e-31	0.30	0.51	0.95
PGSC0003DMT200026560	K01255	ko00480	Glutathione metabolism	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMT200026560	K01255	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMT200026572	K08271	ko04150	mTOR signaling pathway	343	4.4e-13	0.29	0.45	0.93
PGSC0003DMT200026577	K00754	ko00051	Fructose and mannose metabolism	1984	1.4e-103	0.49	0.68	0.79
PGSC0003DMT200026579	K00754	ko00051	Fructose and mannose metabolism	403	2.2e-16	0.59	0.74	0.97
PGSC0003DMT200026580	K00079	ko00590	Arachidonic acid metabolism	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMT200026580	K00079	ko01100	Metabolic pathways	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMT200026581	K00079	ko00590	Arachidonic acid metabolism	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMT200026581	K00079	ko01100	Metabolic pathways	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMT200026582	K05765	ko04360	Axon guidance	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMT200026582	K05765	ko04666	Fc gamma R-mediated phagocytosis	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMT200026582	K05765	ko04810	Regulation of actin cytoskeleton	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMT200026585	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMT200026585	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMT200026585	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMT200026585	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMT200026585	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMT200084207	K06689	ko04120	Ubiquitin mediated proteolysis	1277	1.3e-64	0.97	0.98	0.99
PGSC0003DMT200084208	K06689	ko04120	Ubiquitin mediated proteolysis	897	1.2e-43	0.98	0.99	0.75
PGSC0003DMT200084224	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1614	3.5e-83	0.68	0.81	0.92
PGSC0003DMT200084228	K01762	ko00270	Cysteine and methionine metabolism	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMT200084228	K01762	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMT200084234	K05681	ko02010	ABC transporters	883	7.2e-43	0.32	0.54	0.47
PGSC0003DMT200063997	K08738	ko04115	p53 signaling pathway	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko04210	Apoptosis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05010	Alzheimer's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05012	Parkinson's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05016	Huntington's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05200	Pathways in cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05210	Colorectal cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05222	Small cell lung cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200063997	K08738	ko05416	Viral myocarditis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMT200064027	K03083	ko04012	ErbB signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04062	Chemokine signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04110	Cell cycle	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04310	Wnt signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04340	Hedgehog signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04360	Axon guidance	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04510	Focal adhesion	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04660	T cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04662	B cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04711	Circadian rhythm - fly	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04722	Neurotrophin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04910	Insulin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko04916	Melanogenesis	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05010	Alzheimer's disease	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05200	Pathways in cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05210	Colorectal cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05213	Endometrial cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05215	Prostate cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200064027	K03083	ko05217	Basal cell carcinoma	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMT200071155	K02699	ko00195	Photosynthesis	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMT200071155	K02699	ko01100	Metabolic pathways	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMT200071160	K02879	ko03010	Ribosome	1260	1.2e-63	0.77	0.87	0.99
PGSC0003DMT200071161	K02879	ko03010	Ribosome	1271	2.9e-64	0.77	0.87	0.99
PGSC0003DMT200071167	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	1558	4.3e-80	0.91	0.96	0.99
PGSC0003DMT200071168	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2325	2.1e-122	0.86	0.93	1.00
PGSC0003DMT200071184	K01824	ko00100	Steroid biosynthesis	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMT200071184	K01824	ko01100	Metabolic pathways	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMT200071184	K01824	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMT200071189	K02183	ko04020	Calcium signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04070	Phosphatidylinositol signaling system	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04114	Oocyte meiosis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04270	Vascular smooth muscle contraction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04626	Plant-pathogen interaction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04720	Long-term potentiation	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04722	Neurotrophin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04740	Olfactory transduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04744	Phototransduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04745	Phototransduction - fly	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04910	Insulin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04912	GnRH signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04916	Melanogenesis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04970	Salivary secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko04971	Gastric acid secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko05010	Alzheimer's disease	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071189	K02183	ko05214	Glioma	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMT200071191	K13289	ko04142	Lysosome	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMT200071191	K13289	ko04614	Renin-angiotensin system	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMT200071192	K13289	ko04142	Lysosome	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMT200071192	K13289	ko04614	Renin-angiotensin system	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMT200045211	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMT200045211	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMT200045212	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMT200045212	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMT200045214	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMT200045214	K05283	ko01100	Metabolic pathways	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMT200045216	K09753	ko00940	Phenylpropanoid biosynthesis	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMT200045216	K09753	ko01100	Metabolic pathways	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMT200045216	K09753	ko01110	Biosynthesis of secondary metabolites	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMT200045218	K09753	ko00940	Phenylpropanoid biosynthesis	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMT200045218	K09753	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMT200045218	K09753	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMT200045219	K09753	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMT200045219	K09753	ko01100	Metabolic pathways	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMT200045219	K09753	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMT200045220	K09753	ko00940	Phenylpropanoid biosynthesis	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMT200045220	K09753	ko01100	Metabolic pathways	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMT200045220	K09753	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMT200045227	K00697	ko00500	Starch and sucrose metabolism	441	4.4e-18	0.65	0.77	0.92
PGSC0003DMT200045228	K00697	ko00500	Starch and sucrose metabolism	435	1.2e-17	0.79	0.88	0.84
PGSC0003DMT200045229	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMT200045230	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMT200045231	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMT200045238	K13066	ko00940	Phenylpropanoid biosynthesis	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMT200045238	K13066	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMT200045239	K13066	ko00940	Phenylpropanoid biosynthesis	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMT200045239	K13066	ko01110	Biosynthesis of secondary metabolites	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMT200045243	K00434	ko00053	Ascorbate and aldarate metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMT200045243	K00434	ko00480	Glutathione metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMT200021014	K03124	ko03022	Basal transcription factors	2346	1.5e-123	0.88	0.95	0.99
PGSC0003DMT200021018	K12356	ko00940	Phenylpropanoid biosynthesis	707	3.7e-33	0.33	0.49	0.96
PGSC0003DMT200021019	K12356	ko00940	Phenylpropanoid biosynthesis	655	2.7e-30	0.45	0.62	0.42
PGSC0003DMT200021026	K12356	ko00940	Phenylpropanoid biosynthesis	749	1.8e-35	0.33	0.49	0.90
PGSC0003DMT200021038	K03553	ko03440	Homologous recombination	1253	2.8e-63	0.48	0.68	0.98
PGSC0003DMT200021046	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMT200021047	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMT200021052	K08064	ko04612	Antigen processing and presentation	243	1.4e-07	0.56	0.68	0.63
PGSC0003DMT200021053	K08064	ko04612	Antigen processing and presentation	514	1.6e-22	0.42	0.58	0.82
PGSC0003DMT200021058	K00655	ko00561	Glycerolipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMT200021058	K00655	ko00564	Glycerophospholipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMT200021058	K00655	ko01100	Metabolic pathways	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMT200021059	K00655	ko00561	Glycerolipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMT200021059	K00655	ko00564	Glycerophospholipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMT200021059	K00655	ko01100	Metabolic pathways	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMT200036917	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMT200036917	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMT200036918	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMT200036918	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMT200036920	K08054	ko04145	Phagosome	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMT200036920	K08054	ko04612	Antigen processing and presentation	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMT200036929	K00079	ko00590	Arachidonic acid metabolism	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMT200036929	K00079	ko01100	Metabolic pathways	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMT200036931	K01880	ko00970	Aminoacyl-tRNA biosynthesis	4676	4.5e-252	0.88	0.94	0.99
PGSC0003DMT200036932	K01880	ko00970	Aminoacyl-tRNA biosynthesis	2858	8.5e-152	0.91	0.96	0.97
PGSC0003DMT200028424	K04733	ko04210	Apoptosis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMT200028424	K04733	ko04620	Toll-like receptor signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMT200028424	K04733	ko04722	Neurotrophin signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMT200028424	K04733	ko05140	Leishmaniasis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMT200028424	K04733	ko05142	Chagas disease	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMT200028436	K02084	ko04115	p53 signaling pathway	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko04210	Apoptosis	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko05010	Alzheimer's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko05012	Parkinson's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko05016	Huntington's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200028436	K02084	ko05222	Small cell lung cancer	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMT200025902	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025902	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025902	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025903	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025903	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025903	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMT200025904	K09753	ko00940	Phenylpropanoid biosynthesis	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMT200025904	K09753	ko01100	Metabolic pathways	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMT200025904	K09753	ko01110	Biosynthesis of secondary metabolites	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMT200025912	K11820	ko00380	Tryptophan metabolism	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMT200025912	K11820	ko00966	Glucosinolate biosynthesis	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMT200025912	K11820	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMT200025913	K11820	ko00380	Tryptophan metabolism	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMT200025913	K11820	ko00966	Glucosinolate biosynthesis	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMT200025913	K11820	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMT200025914	K11820	ko00380	Tryptophan metabolism	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMT200025914	K11820	ko00966	Glucosinolate biosynthesis	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMT200025914	K11820	ko01110	Biosynthesis of secondary metabolites	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMT200025917	K00895	ko00051	Fructose and mannose metabolism	2052	2.4e-107	0.85	0.90	0.89
PGSC0003DMT200025918	K00895	ko00051	Fructose and mannose metabolism	2936	4.2e-156	0.85	0.92	0.99
PGSC0003DMT200025919	K00895	ko00051	Fructose and mannose metabolism	4395	1.4e-236	0.84	0.92	0.99
PGSC0003DMT200025922	K02178	ko04110	Cell cycle	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMT200025922	K02178	ko04111	Cell cycle - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMT200025922	K02178	ko04113	Meiosis - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMT200025922	K02178	ko04114	Oocyte meiosis	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMT200025922	K02178	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMT200057229	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMT200057229	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMT200057229	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMT200057252	K02132	ko00190	Oxidative phosphorylation	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMT200057252	K02132	ko01100	Metabolic pathways	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMT200057252	K02132	ko05010	Alzheimer's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMT200057252	K02132	ko05012	Parkinson's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMT200057252	K02132	ko05016	Huntington's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMT200057257	K03541	ko00195	Photosynthesis	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMT200057257	K03541	ko01100	Metabolic pathways	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMT200051161	K00430	ko00360	Phenylalanine metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMT200051161	K00430	ko00680	Methane metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMT200051161	K00430	ko00940	Phenylpropanoid biosynthesis	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMT200051161	K00430	ko01100	Metabolic pathways	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMT200051161	K00430	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMT200051170	K01046	ko00561	Glycerolipid metabolism	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMT200051170	K01046	ko01100	Metabolic pathways	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMT200051195	K08695	ko00941	Flavonoid biosynthesis	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMT200051195	K08695	ko01110	Biosynthesis of secondary metabolites	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMT200051196	K08695	ko00941	Flavonoid biosynthesis	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMT200051196	K08695	ko01110	Biosynthesis of secondary metabolites	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMT200051197	K08695	ko00941	Flavonoid biosynthesis	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMT200051197	K08695	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMT200051201	K00499	ko00260	Glycine, serine and threonine metabolism	2264	4.9e-119	0.67	0.79	0.96
PGSC0003DMT200051203	K00499	ko00260	Glycine, serine and threonine metabolism	1396	3.7e-71	0.70	0.81	0.99
PGSC0003DMT200051205	K00499	ko00260	Glycine, serine and threonine metabolism	341	5.7e-13	0.58	0.73	0.97
PGSC0003DMT200051213	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200051213	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200051213	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200078581	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078581	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078581	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078581	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078581	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078581	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078582	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMT200078585	K08066	ko04612	Antigen processing and presentation	463	1.1e-19	0.30	0.48	0.70
PGSC0003DMT200078596	K08066	ko04612	Antigen processing and presentation	427	1.0e-17	0.34	0.48	0.89
PGSC0003DMT200078597	K08066	ko04612	Antigen processing and presentation	481	1.1e-20	0.33	0.46	0.71
PGSC0003DMT200078599	K08066	ko04612	Antigen processing and presentation	439	2.2e-18	0.37	0.53	0.58
PGSC0003DMT200078600	K08066	ko04612	Antigen processing and presentation	465	8.2e-20	0.31	0.48	0.63
PGSC0003DMT200078605	K08066	ko04612	Antigen processing and presentation	293	2.5e-10	0.28	0.43	0.84
PGSC0003DMT200078610	K02133	ko00190	Oxidative phosphorylation	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMT200078610	K02133	ko01100	Metabolic pathways	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMT200078610	K02133	ko05010	Alzheimer's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMT200078610	K02133	ko05012	Parkinson's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMT200078610	K02133	ko05016	Huntington's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMT200078611	K02133	ko00190	Oxidative phosphorylation	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMT200078611	K02133	ko01100	Metabolic pathways	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMT200078611	K02133	ko05010	Alzheimer's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMT200078611	K02133	ko05012	Parkinson's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMT200078611	K02133	ko05016	Huntington's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMT200078613	K06272	ko03320	PPAR signaling pathway	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMT200078613	K06272	ko04510	Focal adhesion	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMT200078613	K06272	ko05100	Bacterial invasion of epithelial cells	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMT200078613	K06272	ko05213	Endometrial cancer	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMT200078614	K06272	ko03320	PPAR signaling pathway	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMT200078614	K06272	ko04510	Focal adhesion	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMT200078614	K06272	ko05100	Bacterial invasion of epithelial cells	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMT200078614	K06272	ko05213	Endometrial cancer	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMT200041796	K05933	ko00270	Cysteine and methionine metabolism	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMT200041796	K05933	ko01110	Biosynthesis of secondary metabolites	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMT200041798	K05278	ko00941	Flavonoid biosynthesis	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMT200041798	K05278	ko01100	Metabolic pathways	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMT200041798	K05278	ko01110	Biosynthesis of secondary metabolites	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMT200041803	K01210	ko00500	Starch and sucrose metabolism	2022	1.1e-105	0.52	0.68	0.89
PGSC0003DMT200041805	K12818	ko03040	Spliceosome	1665	5.3e-86	0.38	0.57	0.40
PGSC0003DMT200041806	K02858	ko00740	Riboflavin metabolism	1798	2.5e-93	0.89	0.95	0.93
PGSC0003DMT200041807	K02858	ko00740	Riboflavin metabolism	3265	3.0e-174	0.76	0.84	0.95
PGSC0003DMT200041810	K06630	ko04110	Cell cycle	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMT200041810	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMT200041810	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMT200041812	K00430	ko00360	Phenylalanine metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMT200041812	K00430	ko00680	Methane metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMT200041812	K00430	ko00940	Phenylpropanoid biosynthesis	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMT200041812	K00430	ko01100	Metabolic pathways	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMT200041812	K00430	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMT200041814	K05681	ko02010	ABC transporters	1085	5.2e-54	0.32	0.54	0.96
PGSC0003DMT200041816	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMT200041816	K01626	ko01100	Metabolic pathways	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMT200041816	K01626	ko01110	Biosynthesis of secondary metabolites	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMT200041818	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMT200041818	K01626	ko01100	Metabolic pathways	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMT200041818	K01626	ko01110	Biosynthesis of secondary metabolites	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMT200041827	K01259	ko00330	Arginine and proline metabolism	312	2.3e-11	0.30	0.48	0.77
PGSC0003DMT200004655	K01528	ko04144	Endocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMT200004655	K01528	ko04666	Fc gamma R-mediated phagocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMT200004655	K01528	ko05100	Bacterial invasion of epithelial cells	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMT200004661	K02921	ko03010	Ribosome	776	5.8e-37	0.99	1.00	0.92
PGSC0003DMT200004662	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMT200004663	K03260	ko05416	Viral myocarditis	3612	2.2e-193	0.56	0.69	0.99
PGSC0003DMT200004671	K10875	ko03440	Homologous recombination	472	1.8e-17	0.27	0.45	0.43
PGSC0003DMT200004672	K10875	ko03440	Homologous recombination	770	1.2e-36	0.31	0.51	0.47
PGSC0003DMT200004673	K10875	ko03440	Homologous recombination	596	2.2e-26	0.28	0.46	0.50
PGSC0003DMT200004686	K01177	ko00500	Starch and sucrose metabolism	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMT200004686	K01177	ko01100	Metabolic pathways	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMT200004688	K08014	ko04670	Leukocyte transendothelial migration	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMT200004688	K08014	ko04720	Long-term potentiation	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMT200032484	K06096	ko04530	Tight junction	364	3.1e-14	0.34	0.53	0.85
PGSC0003DMT200032486	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMT200032488	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMT200032490	K00016	ko00010	Glycolysis / Gluconeogenesis	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032490	K00016	ko00270	Cysteine and methionine metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032490	K00016	ko00620	Pyruvate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032490	K00016	ko00640	Propanoate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032490	K00016	ko01100	Metabolic pathways	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032490	K00016	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMT200032491	K00016	ko00010	Glycolysis / Gluconeogenesis	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032491	K00016	ko00270	Cysteine and methionine metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032491	K00016	ko00620	Pyruvate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032491	K00016	ko00640	Propanoate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032491	K00016	ko01100	Metabolic pathways	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032491	K00016	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMT200032495	K09553	ko05020	Prion diseases	3725	1.3e-199	0.64	0.78	0.99
PGSC0003DMT200001457	K00951	ko00230	Purine metabolism	964	5.8e-55	0.36	0.52	0.78
PGSC0003DMT200001458	K00951	ko00230	Purine metabolism	973	1.9e-55	0.35	0.51	0.70
PGSC0003DMT200001459	K00951	ko00230	Purine metabolism	629	7.4e-29	0.48	0.65	0.48
PGSC0003DMT200001460	K00951	ko00230	Purine metabolism	768	1.6e-36	0.40	0.51	0.65
PGSC0003DMT200001461	K00951	ko00230	Purine metabolism	750	1.6e-35	0.38	0.52	0.67
PGSC0003DMT200001463	K06228	ko04340	Hedgehog signaling pathway	5770	0.	0.56	0.72	1.00
PGSC0003DMT200001463	K06228	ko05200	Pathways in cancer	5770	0.	0.56	0.72	1.00
PGSC0003DMT200001463	K06228	ko05217	Basal cell carcinoma	5770	0.	0.56	0.72	1.00
PGSC0003DMT200001464	K06228	ko04340	Hedgehog signaling pathway	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMT200001464	K06228	ko05200	Pathways in cancer	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMT200001464	K06228	ko05217	Basal cell carcinoma	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMT200001467	K03363	ko04110	Cell cycle	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMT200001467	K03363	ko04111	Cell cycle - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMT200001467	K03363	ko04113	Meiosis - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMT200001467	K03363	ko04114	Oocyte meiosis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMT200001467	K03363	ko04120	Ubiquitin mediated proteolysis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMT200001492	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001492	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001492	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001492	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001492	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001493	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001493	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001493	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001493	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200001493	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMT200097320	K00975	ko00500	Starch and sucrose metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMT200097320	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMT200097320	K00975	ko01100	Metabolic pathways	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMT200034517	K12483	ko04144	Endocytosis	1298	9.3e-66	0.56	0.74	0.97
PGSC0003DMT200034518	K11147	ko00830	Retinol metabolism	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMT200034518	K11147	ko01100	Metabolic pathways	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMT200034518	K11147	ko04146	Peroxisome	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMT200034519	K04424	ko04010	MAPK signaling pathway	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMT200034519	K04424	ko04530	Tight junction	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMT200034522	K00601	ko00230	Purine metabolism	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMT200034522	K00601	ko00670	One carbon pool by folate	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMT200034522	K00601	ko01100	Metabolic pathways	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMT200034522	K00601	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMT200034524	K02934	ko03010	Ribosome	1598	2.6e-82	0.81	0.89	1.00
PGSC0003DMT200034529	K01555	ko00350	Tyrosine metabolism	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMT200034529	K01555	ko00643	Styrene degradation	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMT200034529	K01555	ko01100	Metabolic pathways	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMT200034530	K01555	ko00350	Tyrosine metabolism	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMT200034530	K01555	ko00643	Styrene degradation	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMT200034530	K01555	ko01100	Metabolic pathways	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMT200034531	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034531	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034531	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034532	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034532	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034532	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034533	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034533	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034533	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMT200034552	K02705	ko00195	Photosynthesis	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMT200034552	K02705	ko01100	Metabolic pathways	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMT200036083	K05933	ko00270	Cysteine and methionine metabolism	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMT200036083	K05933	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMT200036092	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMT200036093	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMT200036094	K04459	ko04010	MAPK signaling pathway	1699	7.1e-88	0.74	0.84	0.99
PGSC0003DMT200036110	K12356	ko00940	Phenylpropanoid biosynthesis	512	2.1e-22	0.35	0.51	0.89
PGSC0003DMT200036114	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200036114	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200036114	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200036116	K10591	ko04120	Ubiquitin mediated proteolysis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMT200036116	K10591	ko04144	Endocytosis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMT200011663	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011663	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011663	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011664	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011664	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011664	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMT200011665	K12811	ko03040	Spliceosome	6963	0.	0.72	0.84	1.00
PGSC0003DMT200011673	K12471	ko04144	Endocytosis	640	2.4e-29	0.29	0.42	0.62
PGSC0003DMT200011674	K12471	ko04144	Endocytosis	810	7.7e-39	0.31	0.45	0.65
PGSC0003DMT200011684	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.84
PGSC0003DMT200011686	K05185	ko04080	Neuroactive ligand-receptor interaction	611	9.4e-28	0.36	0.38	0.47
PGSC0003DMT200011688	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.50
PGSC0003DMT200011693	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	764	2.6e-36	0.40	0.58	0.75
PGSC0003DMT200011703	K05658	ko02010	ABC transporters	1111	1.9e-55	0.75	0.86	0.98
PGSC0003DMT200011709	K03260	ko05416	Viral myocarditis	358	6.7e-13	0.42	0.55	0.96
PGSC0003DMT200019992	K03110	ko03060	Protein export	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMT200019992	K03110	ko03070	Bacterial secretion system	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMT200020030	K12135	ko04712	Circadian rhythm - plant	308	6.6e-11	0.33	0.47	0.34
PGSC0003DMT200020031	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.33	0.47	0.44
PGSC0003DMT200020044	K01489	ko00240	Pyrimidine metabolism	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMT200020044	K01489	ko00983	Drug metabolism - other enzymes	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMT200020044	K01489	ko01100	Metabolic pathways	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMT200017373	K01255	ko00480	Glutathione metabolism	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMT200017373	K01255	ko01100	Metabolic pathways	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMT200017390	K00279	ko00908	Zeatin biosynthesis	2766	1.0e-146	0.62	0.78	0.97
PGSC0003DMT200017391	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.77
PGSC0003DMT200017392	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.74
PGSC0003DMT200017393	K00057	ko00564	Glycerophospholipid metabolism	368	1.8e-14	0.31	0.45	0.88
PGSC0003DMT200017407	K06685	ko04111	Cell cycle - yeast	421	7.0e-14	0.26	0.41	0.83
PGSC0003DMT200017408	K06685	ko04111	Cell cycle - yeast	421	8.8e-14	0.26	0.41	0.75
PGSC0003DMT200003448	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003448	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003449	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003449	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003450	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003450	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMT200003455	K08233	ko00901	Indole alkaloid biosynthesis	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMT200003455	K08233	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMT200090096	K01516	ko00230	Purine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMT200090096	K01516	ko00730	Thiamine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMT200090096	K01516	ko01100	Metabolic pathways	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMT200090108	K04371	ko04010	MAPK signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04012	ErbB signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04013	MAPK signaling pathway - fly	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04062	Chemokine signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04114	Oocyte meiosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04150	mTOR signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04270	Vascular smooth muscle contraction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04320	Dorso-ventral axis formation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04350	TGF-beta signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04360	Axon guidance	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04370	VEGF signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04510	Focal adhesion	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04520	Adherens junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04540	Gap junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04620	Toll-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04621	NOD-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04650	Natural killer cell mediated cytotoxicity	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04660	T cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04662	B cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04664	Fc epsilon RI signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04666	Fc gamma R-mediated phagocytosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04720	Long-term potentiation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04722	Neurotrophin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04730	Long-term depression	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04810	Regulation of actin cytoskeleton	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04910	Insulin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04912	GnRH signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04914	Progesterone-mediated oocyte maturation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04916	Melanogenesis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04930	Type II diabetes mellitus	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko04960	Aldosterone-regulated sodium reabsorption	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05010	Alzheimer's disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05020	Prion diseases	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05131	Shigellosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05140	Leishmaniasis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05142	Chagas disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05200	Pathways in cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05210	Colorectal cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05211	Renal cell carcinoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05212	Pancreatic cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05213	Endometrial cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05214	Glioma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05215	Prostate cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05216	Thyroid cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05218	Melanoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05219	Bladder cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05220	Chronic myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05221	Acute myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090108	K04371	ko05223	Non-small cell lung cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMT200090114	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMT200090114	K00517	ko00626	Naphthalene and anthracene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMT200090114	K00517	ko00903	Limonene and pinene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMT200090114	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMT200090114	K00517	ko01110	Biosynthesis of secondary metabolites	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMT200093941	K09843	ko00906	Carotenoid biosynthesis	835	3.2e-40	0.39	0.56	0.98
PGSC0003DMT200093957	K00791	ko00908	Zeatin biosynthesis	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMT200093957	K00791	ko01100	Metabolic pathways	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMT200093957	K00791	ko01110	Biosynthesis of secondary metabolites	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMT200054913	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMT200054913	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMT200054913	K00734	ko01100	Metabolic pathways	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMT200063083	K07195	ko04910	Insulin signaling pathway	1887	3.0e-98	0.43	0.63	0.99
PGSC0003DMT200063089	K04458	ko04010	MAPK signaling pathway	359	5.8e-14	0.48	0.64	0.56
PGSC0003DMT200063101	K02966	ko03010	Ribosome	1065	6.6e-53	0.86	0.92	0.99
PGSC0003DMT200063103	K00901	ko00561	Glycerolipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMT200063103	K00901	ko00564	Glycerophospholipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMT200063103	K00901	ko01100	Metabolic pathways	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMT200063103	K00901	ko04070	Phosphatidylinositol signaling system	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMT200063104	K00901	ko00561	Glycerolipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMT200063104	K00901	ko00564	Glycerophospholipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMT200063104	K00901	ko01100	Metabolic pathways	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMT200063104	K00901	ko04070	Phosphatidylinositol signaling system	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMT200082779	K05894	ko00592	alpha-Linolenic acid metabolism	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMT200082779	K05894	ko01100	Metabolic pathways	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMT200082782	K10841	ko03420	Nucleotide excision repair	1276	1.5e-64	0.32	0.52	0.85
PGSC0003DMT200082806	K05863	ko04020	Calcium signaling pathway	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMT200082806	K05863	ko05012	Parkinson's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMT200082806	K05863	ko05016	Huntington's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMT200082807	K02178	ko04110	Cell cycle	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMT200082807	K02178	ko04111	Cell cycle - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMT200082807	K02178	ko04113	Meiosis - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMT200082807	K02178	ko04114	Oocyte meiosis	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMT200082807	K02178	ko04914	Progesterone-mediated oocyte maturation	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMT200082808	K02178	ko04110	Cell cycle	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMT200082808	K02178	ko04111	Cell cycle - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMT200082808	K02178	ko04113	Meiosis - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMT200082808	K02178	ko04114	Oocyte meiosis	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMT200082808	K02178	ko04914	Progesterone-mediated oocyte maturation	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMT200082809	K02178	ko04110	Cell cycle	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMT200082809	K02178	ko04111	Cell cycle - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMT200082809	K02178	ko04113	Meiosis - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMT200082809	K02178	ko04114	Oocyte meiosis	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMT200082809	K02178	ko04914	Progesterone-mediated oocyte maturation	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMT200082810	K02178	ko04110	Cell cycle	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMT200082810	K02178	ko04111	Cell cycle - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMT200082810	K02178	ko04113	Meiosis - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMT200082810	K02178	ko04114	Oocyte meiosis	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMT200082810	K02178	ko04914	Progesterone-mediated oocyte maturation	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMT200023082	K01179	ko00500	Starch and sucrose metabolism	2383	1.3e-125	0.60	0.74	0.95
PGSC0003DMT200023090	K01193	ko00052	Galactose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMT200023090	K01193	ko00500	Starch and sucrose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMT200023090	K01193	ko01100	Metabolic pathways	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMT200023091	K01193	ko00052	Galactose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMT200023091	K01193	ko00500	Starch and sucrose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMT200023091	K01193	ko01100	Metabolic pathways	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMT200023092	K01193	ko00052	Galactose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMT200023092	K01193	ko00500	Starch and sucrose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMT200023092	K01193	ko01100	Metabolic pathways	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMT200023095	K13229	ko00402	Benzoxazinoid biosynthesis	479	1.4e-20	0.34	0.54	0.96
PGSC0003DMT200023096	K13229	ko00402	Benzoxazinoid biosynthesis	1119	7.0e-56	0.42	0.60	0.95
PGSC0003DMT200023097	K13229	ko00402	Benzoxazinoid biosynthesis	482	9.5e-21	0.40	0.59	0.82
PGSC0003DMT200023098	K13229	ko00402	Benzoxazinoid biosynthesis	912	1.8e-44	0.43	0.62	0.88
PGSC0003DMT200023099	K13229	ko00402	Benzoxazinoid biosynthesis	1192	6.5e-60	0.43	0.62	0.98
PGSC0003DMT200023101	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMT200023102	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMT200023103	K13229	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.46	0.65	0.98
PGSC0003DMT200023104	K13229	ko00402	Benzoxazinoid biosynthesis	1308	2.6e-66	0.46	0.64	0.99
PGSC0003DMT200023105	K03869	ko04120	Ubiquitin mediated proteolysis	1396	3.7e-71	0.36	0.57	0.99
PGSC0003DMT200023111	K10609	ko03420	Nucleotide excision repair	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMT200023111	K10609	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMT200013024	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMT200013025	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMT200013033	K03016	ko00230	Purine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMT200013033	K03016	ko00240	Pyrimidine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMT200013033	K03016	ko01100	Metabolic pathways	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMT200013033	K03016	ko03020	RNA polymerase	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMT200013033	K03016	ko05016	Huntington's disease	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMT200013034	K03016	ko00230	Purine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMT200013034	K03016	ko00240	Pyrimidine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMT200013034	K03016	ko01100	Metabolic pathways	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMT200013034	K03016	ko03020	RNA polymerase	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMT200013034	K03016	ko05016	Huntington's disease	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMT200013037	K05350	ko00460	Cyanoamino acid metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMT200013037	K05350	ko00500	Starch and sucrose metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMT200013037	K05350	ko00940	Phenylpropanoid biosynthesis	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMT200013037	K05350	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMT200013052	K02981	ko03010	Ribosome	519	8.6e-23	0.74	0.80	0.79
PGSC0003DMT200031762	K01179	ko00500	Starch and sucrose metabolism	1950	1.0e-101	0.48	0.67	0.95
PGSC0003DMT200031763	K01179	ko00500	Starch and sucrose metabolism	467	6.4e-20	0.53	0.73	0.85
PGSC0003DMT200031764	K10878	ko04113	Meiosis - yeast	279	1.5e-09	0.33	0.53	0.77
PGSC0003DMT200031768	K01770	ko00900	Terpenoid backbone biosynthesis	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMT200031768	K01770	ko01100	Metabolic pathways	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMT200031768	K01770	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMT200031769	K01762	ko00270	Cysteine and methionine metabolism	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMT200031769	K01762	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMT200091698	K09843	ko00906	Carotenoid biosynthesis	852	3.7e-41	0.32	0.51	0.98
PGSC0003DMT200091706	K04371	ko04010	MAPK signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04012	ErbB signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04013	MAPK signaling pathway - fly	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04062	Chemokine signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04114	Oocyte meiosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04150	mTOR signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04270	Vascular smooth muscle contraction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04320	Dorso-ventral axis formation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04350	TGF-beta signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04360	Axon guidance	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04370	VEGF signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04510	Focal adhesion	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04520	Adherens junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04540	Gap junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04620	Toll-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04621	NOD-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04650	Natural killer cell mediated cytotoxicity	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04660	T cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04662	B cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04664	Fc epsilon RI signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04666	Fc gamma R-mediated phagocytosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04720	Long-term potentiation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04722	Neurotrophin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04730	Long-term depression	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04810	Regulation of actin cytoskeleton	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04910	Insulin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04912	GnRH signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04914	Progesterone-mediated oocyte maturation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04916	Melanogenesis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04930	Type II diabetes mellitus	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko04960	Aldosterone-regulated sodium reabsorption	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05010	Alzheimer's disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05020	Prion diseases	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05131	Shigellosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05140	Leishmaniasis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05142	Chagas disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05200	Pathways in cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05210	Colorectal cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05211	Renal cell carcinoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05212	Pancreatic cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05213	Endometrial cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05214	Glioma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05215	Prostate cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05216	Thyroid cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05218	Melanoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05219	Bladder cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05220	Chronic myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05221	Acute myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200091706	K04371	ko05223	Non-small cell lung cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMT200000736	K05279	ko00944	Flavone and flavonol biosynthesis	686	5.3e-32	0.41	0.59	0.92
PGSC0003DMT200000740	K08064	ko04612	Antigen processing and presentation	418	3.2e-17	0.40	0.53	0.63
PGSC0003DMT200000741	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMT200000742	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMT200000743	K08064	ko04612	Antigen processing and presentation	501	8.5e-22	0.57	0.73	0.75
PGSC0003DMT200000744	K04368	ko04010	MAPK signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04012	ErbB signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04013	MAPK signaling pathway - fly	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04062	Chemokine signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04114	Oocyte meiosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04270	Vascular smooth muscle contraction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04320	Dorso-ventral axis formation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04370	VEGF signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04510	Focal adhesion	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04540	Gap junction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04620	Toll-like receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04626	Plant-pathogen interaction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04650	Natural killer cell mediated cytotoxicity	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04660	T cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04662	B cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04664	Fc epsilon RI signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04666	Fc gamma R-mediated phagocytosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04720	Long-term potentiation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04722	Neurotrophin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04730	Long-term depression	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04810	Regulation of actin cytoskeleton	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04910	Insulin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04912	GnRH signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04914	Progesterone-mediated oocyte maturation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko04916	Melanogenesis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05020	Prion diseases	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05200	Pathways in cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05210	Colorectal cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05211	Renal cell carcinoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05212	Pancreatic cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05213	Endometrial cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05214	Glioma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05215	Prostate cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05216	Thyroid cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05218	Melanoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05219	Bladder cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05220	Chronic myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05221	Acute myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000744	K04368	ko05223	Non-small cell lung cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMT200000746	K04368	ko04010	MAPK signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04012	ErbB signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04013	MAPK signaling pathway - fly	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04062	Chemokine signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04114	Oocyte meiosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04270	Vascular smooth muscle contraction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04320	Dorso-ventral axis formation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04370	VEGF signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04510	Focal adhesion	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04540	Gap junction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04620	Toll-like receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04626	Plant-pathogen interaction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04650	Natural killer cell mediated cytotoxicity	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04660	T cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04662	B cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04664	Fc epsilon RI signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04666	Fc gamma R-mediated phagocytosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04720	Long-term potentiation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04722	Neurotrophin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04730	Long-term depression	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04810	Regulation of actin cytoskeleton	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04910	Insulin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04912	GnRH signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04914	Progesterone-mediated oocyte maturation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko04916	Melanogenesis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05020	Prion diseases	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05200	Pathways in cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05210	Colorectal cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05211	Renal cell carcinoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05212	Pancreatic cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05213	Endometrial cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05214	Glioma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05215	Prostate cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05216	Thyroid cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05218	Melanoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05219	Bladder cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05220	Chronic myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05221	Acute myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000746	K04368	ko05223	Non-small cell lung cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMT200000747	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMT200000747	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMT200000748	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMT200000748	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMT200000752	K00279	ko00908	Zeatin biosynthesis	2211	4.1e-116	0.56	0.75	0.96
PGSC0003DMT200000764	K00640	ko00270	Cysteine and methionine metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMT200000764	K00640	ko00920	Sulfur metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMT200000764	K00640	ko01100	Metabolic pathways	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMT200000765	K00640	ko00270	Cysteine and methionine metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMT200000765	K00640	ko00920	Sulfur metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMT200000765	K00640	ko01100	Metabolic pathways	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMT200000766	K00968	ko00440	Phosphonate and phosphinate metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMT200000766	K00968	ko00564	Glycerophospholipid metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMT200000766	K00968	ko01100	Metabolic pathways	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMT200000767	K00968	ko00440	Phosphonate and phosphinate metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMT200000767	K00968	ko00564	Glycerophospholipid metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMT200000767	K00968	ko01100	Metabolic pathways	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMT200000769	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200000769	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200000769	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200069516	K05658	ko02010	ABC transporters	3425	4.5e-183	0.40	0.60	0.98
PGSC0003DMT200069531	K03363	ko04110	Cell cycle	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMT200069531	K03363	ko04111	Cell cycle - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMT200069531	K03363	ko04113	Meiosis - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMT200069531	K03363	ko04114	Oocyte meiosis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMT200069531	K03363	ko04120	Ubiquitin mediated proteolysis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMT200069532	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069532	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069532	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069532	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069532	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069533	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069533	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069533	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069533	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069533	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMT200069539	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMT200069540	K10601	ko04120	Ubiquitin mediated proteolysis	2868	2.4e-152	0.67	0.77	0.97
PGSC0003DMT200069541	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMT200059818	K00058	ko00260	Glycine, serine and threonine metabolism	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMT200059818	K00058	ko01100	Metabolic pathways	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMT200059833	K02084	ko04115	p53 signaling pathway	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko04210	Apoptosis	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko05010	Alzheimer's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko05012	Parkinson's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko05016	Huntington's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059833	K02084	ko05222	Small cell lung cancer	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMT200059840	K02901	ko03010	Ribosome	490	3.4e-21	0.82	0.89	0.61
PGSC0003DMT200048579	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMT200048580	K12893	ko03040	Spliceosome	440	2.0e-18	0.35	0.51	0.93
PGSC0003DMT200048582	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMT200048583	K05280	ko00941	Flavonoid biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMT200048583	K05280	ko00944	Flavone and flavonol biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMT200048583	K05280	ko01100	Metabolic pathways	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMT200048583	K05280	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMT200048586	K04506	ko04115	p53 signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMT200048586	K04506	ko04120	Ubiquitin mediated proteolysis	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMT200048586	K04506	ko04310	Wnt signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMT200048587	K04506	ko04115	p53 signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMT200048587	K04506	ko04120	Ubiquitin mediated proteolysis	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMT200048587	K04506	ko04310	Wnt signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMT200048601	K02934	ko03010	Ribosome	227	1.1e-06	0.49	0.61	0.52
PGSC0003DMT200048610	K12132	ko04712	Circadian rhythm - plant	645	9.7e-30	0.44	0.60	0.46
PGSC0003DMT200077859	K04733	ko04210	Apoptosis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMT200077859	K04733	ko04620	Toll-like receptor signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMT200077859	K04733	ko04722	Neurotrophin signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMT200077859	K04733	ko05140	Leishmaniasis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMT200077859	K04733	ko05142	Chagas disease	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMT200077864	K04733	ko04210	Apoptosis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMT200077864	K04733	ko04620	Toll-like receptor signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMT200077864	K04733	ko04722	Neurotrophin signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMT200077864	K04733	ko05140	Leishmaniasis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMT200077864	K04733	ko05142	Chagas disease	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMT200077869	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077869	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077869	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077869	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077869	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077870	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077870	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077870	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077870	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077870	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMT200077891	K01853	ko00100	Steroid biosynthesis	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMT200077891	K01853	ko01100	Metabolic pathways	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMT200077891	K01853	ko01110	Biosynthesis of secondary metabolites	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMT200077914	K12605	ko03018	RNA degradation	4162	1.0e-223	0.74	0.82	0.97
PGSC0003DMT200077916	K12605	ko03018	RNA degradation	2793	3.3e-148	0.78	0.88	0.91
PGSC0003DMT200002401	K00889	ko00562	Inositol phosphate metabolism	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002401	K00889	ko01100	Metabolic pathways	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002401	K00889	ko04070	Phosphatidylinositol signaling system	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002401	K00889	ko04144	Endocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002401	K00889	ko04666	Fc gamma R-mediated phagocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002401	K00889	ko04810	Regulation of actin cytoskeleton	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMT200002402	K00889	ko00562	Inositol phosphate metabolism	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002402	K00889	ko01100	Metabolic pathways	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002402	K00889	ko04070	Phosphatidylinositol signaling system	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002402	K00889	ko04144	Endocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002402	K00889	ko04666	Fc gamma R-mediated phagocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002402	K00889	ko04810	Regulation of actin cytoskeleton	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMT200002421	K02717	ko00195	Photosynthesis	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMT200002421	K02717	ko01100	Metabolic pathways	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMT200002422	K02717	ko00195	Photosynthesis	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMT200002422	K02717	ko01100	Metabolic pathways	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMT200002438	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMT200002438	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMT200002438	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMT200092899	K03413	ko02020	Two-component system	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMT200092899	K03413	ko02030	Bacterial chemotaxis	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMT200096905	K10747	ko03030	DNA replication	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMT200096905	K10747	ko03410	Base excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMT200096905	K10747	ko03420	Nucleotide excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMT200096905	K10747	ko03430	Mismatch repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMT200014791	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMT200014791	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMT200014792	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMT200014792	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMT200014793	K04424	ko04010	MAPK signaling pathway	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMT200014793	K04424	ko04530	Tight junction	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMT200014794	K04424	ko04010	MAPK signaling pathway	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMT200014794	K04424	ko04530	Tight junction	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMT200014800	K02945	ko03010	Ribosome	315	8.5e-11	0.33	0.56	0.17
PGSC0003DMT200014801	K12478	ko04144	Endocytosis	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMT200014801	K12478	ko04145	Phagosome	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMT200014812	K04079	ko04612	Antigen processing and presentation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014812	K04079	ko04621	NOD-like receptor signaling pathway	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014812	K04079	ko04626	Plant-pathogen interaction	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014812	K04079	ko04914	Progesterone-mediated oocyte maturation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014812	K04079	ko05200	Pathways in cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014812	K04079	ko05215	Prostate cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMT200014816	K06689	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.97	0.99	0.99
PGSC0003DMT200024760	K00558	ko00270	Cysteine and methionine metabolism	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMT200024760	K00558	ko01100	Metabolic pathways	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMT200024775	K00888	ko00562	Inositol phosphate metabolism	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMT200024775	K00888	ko01100	Metabolic pathways	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMT200024775	K00888	ko04070	Phosphatidylinositol signaling system	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMT200024776	K00888	ko00562	Inositol phosphate metabolism	7866	0.	0.81	0.89	1.00
PGSC0003DMT200024776	K00888	ko01100	Metabolic pathways	7866	0.	0.81	0.89	1.00
PGSC0003DMT200024776	K00888	ko04070	Phosphatidylinositol signaling system	7866	0.	0.81	0.89	1.00
PGSC0003DMT200024777	K00888	ko00562	Inositol phosphate metabolism	12335	0.	0.74	0.84	1.00
PGSC0003DMT200024777	K00888	ko01100	Metabolic pathways	12335	0.	0.74	0.84	1.00
PGSC0003DMT200024777	K00888	ko04070	Phosphatidylinositol signaling system	12335	0.	0.74	0.84	1.00
PGSC0003DMT200024783	K03094	ko04110	Cell cycle	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04111	Cell cycle - yeast	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04120	Ubiquitin mediated proteolysis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04310	Wnt signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04350	TGF-beta signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024783	K03094	ko04710	Circadian rhythm - mammal	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMT200024791	K00854	ko00040	Pentose and glucuronate interconversions	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMT200024791	K00854	ko01100	Metabolic pathways	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMT200024792	K00854	ko00040	Pentose and glucuronate interconversions	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMT200024792	K00854	ko01100	Metabolic pathways	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMT200024793	K00854	ko00040	Pentose and glucuronate interconversions	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMT200024793	K00854	ko01100	Metabolic pathways	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMT200024794	K00854	ko00040	Pentose and glucuronate interconversions	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMT200024794	K00854	ko01100	Metabolic pathways	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMT200024801	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMT200024810	K08679	ko00500	Starch and sucrose metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMT200024810	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMT200024810	K08679	ko01100	Metabolic pathways	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMT200033429	K03531	ko04112	Cell cycle - Caulobacter	2289	2.0e-120	0.69	0.77	1.00
PGSC0003DMT200057989	K02936	ko03010	Ribosome	1892	1.6e-98	0.85	0.95	1.00
PGSC0003DMT200057994	K03006	ko00230	Purine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMT200057994	K03006	ko00240	Pyrimidine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMT200057994	K03006	ko01100	Metabolic pathways	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMT200057994	K03006	ko03020	RNA polymerase	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMT200057994	K03006	ko05016	Huntington's disease	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMT200057996	K03006	ko00230	Purine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMT200057996	K03006	ko00240	Pyrimidine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMT200057996	K03006	ko01100	Metabolic pathways	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMT200057996	K03006	ko03020	RNA polymerase	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMT200057996	K03006	ko05016	Huntington's disease	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMT200057997	K03006	ko00230	Purine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMT200057997	K03006	ko00240	Pyrimidine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMT200057997	K03006	ko01100	Metabolic pathways	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMT200057997	K03006	ko03020	RNA polymerase	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMT200057997	K03006	ko05016	Huntington's disease	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMT200058003	K03006	ko00230	Purine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMT200058003	K03006	ko00240	Pyrimidine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMT200058003	K03006	ko01100	Metabolic pathways	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMT200058003	K03006	ko03020	RNA polymerase	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMT200058003	K03006	ko05016	Huntington's disease	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMT200058013	K00472	ko00330	Arginine and proline metabolism	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMT200058013	K00472	ko01100	Metabolic pathways	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMT200067732	K00419	ko00190	Oxidative phosphorylation	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067732	K00419	ko01100	Metabolic pathways	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067732	K00419	ko04260	Cardiac muscle contraction	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067732	K00419	ko05010	Alzheimer's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067732	K00419	ko05012	Parkinson's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067732	K00419	ko05016	Huntington's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMT200067733	K00419	ko00190	Oxidative phosphorylation	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067733	K00419	ko01100	Metabolic pathways	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067733	K00419	ko04260	Cardiac muscle contraction	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067733	K00419	ko05010	Alzheimer's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067733	K00419	ko05012	Parkinson's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067733	K00419	ko05016	Huntington's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMT200067737	K10352	ko04530	Tight junction	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMT200067737	K10352	ko05416	Viral myocarditis	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMT200067739	K01768	ko00230	Purine metabolism	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMT200067739	K01768	ko04113	Meiosis - yeast	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMT200067743	K12655	ko04622	RIG-I-like receptor signaling pathway	411	7.8e-17	0.38	0.59	0.70
PGSC0003DMT200067744	K12655	ko04622	RIG-I-like receptor signaling pathway	559	2.0e-27	0.33	0.53	0.69
PGSC0003DMT200067745	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMT200067746	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMT200067747	K12655	ko04622	RIG-I-like receptor signaling pathway	320	8.2e-12	0.54	0.74	0.85
PGSC0003DMT200067754	K05758	ko04666	Fc gamma R-mediated phagocytosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMT200067754	K05758	ko04810	Regulation of actin cytoskeleton	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMT200067754	K05758	ko05100	Bacterial invasion of epithelial cells	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMT200067754	K05758	ko05130	Pathogenic Escherichia coli infection	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMT200067754	K05758	ko05131	Shigellosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMT200076066	K12832	ko03040	Spliceosome	603	2.0e-27	0.94	1.00	0.31
PGSC0003DMT200076068	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMT200076072	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076072	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076072	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076072	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076072	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076073	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076073	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076073	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076073	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076073	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMT200076085	K12356	ko00940	Phenylpropanoid biosynthesis	327	3.4e-12	0.43	0.56	0.84
PGSC0003DMT200076105	K12886	ko03040	Spliceosome	411	7.8e-17	0.29	0.44	0.81
PGSC0003DMT200076108	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMT200076108	K03434	ko01100	Metabolic pathways	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMT200088899	K10760	ko00908	Zeatin biosynthesis	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMT200088899	K10760	ko01100	Metabolic pathways	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMT200088899	K10760	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMT200018088	K09756	ko00940	Phenylpropanoid biosynthesis	1003	1.7e-49	0.51	0.70	0.79
PGSC0003DMT200018094	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMT200018098	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMT200018099	K09756	ko00940	Phenylpropanoid biosynthesis	1632	3.5e-84	0.48	0.67	0.86
PGSC0003DMT200018101	K13289	ko04142	Lysosome	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMT200018101	K13289	ko04614	Renin-angiotensin system	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMT200018105	K02084	ko04115	p53 signaling pathway	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko04210	Apoptosis	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko05010	Alzheimer's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko05012	Parkinson's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko05016	Huntington's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018105	K02084	ko05222	Small cell lung cancer	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMT200018134	K00368	ko00910	Nitrogen metabolism	658	1.9e-30	0.40	0.54	0.86
PGSC0003DMT200018135	K00368	ko00910	Nitrogen metabolism	1486	4.0e-76	0.43	0.58	0.91
PGSC0003DMT200009906	K00927	ko00010	Glycolysis / Gluconeogenesis	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMT200009906	K00927	ko00710	Carbon fixation in photosynthetic organisms	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMT200009906	K00927	ko01100	Metabolic pathways	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMT200009906	K00927	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMT200009907	K00927	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMT200009907	K00927	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMT200009907	K00927	ko01100	Metabolic pathways	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMT200009907	K00927	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMT200009914	K01512	ko00620	Pyruvate metabolism	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMT200009914	K01512	ko00632	Benzoate degradation via CoA ligation	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMT200009915	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMT200009915	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMT200009916	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMT200009916	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMT200009917	K01512	ko00620	Pyruvate metabolism	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMT200009917	K01512	ko00632	Benzoate degradation via CoA ligation	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMT200009924	K05658	ko02010	ABC transporters	4475	5.5e-241	0.47	0.68	0.94
PGSC0003DMT200009929	K00953	ko00740	Riboflavin metabolism	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMT200009929	K00953	ko01100	Metabolic pathways	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMT200009941	K10532	ko00531	Glycosaminoglycan degradation	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMT200009941	K10532	ko01100	Metabolic pathways	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMT200009941	K10532	ko04142	Lysosome	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMT200009945	K11584	ko04113	Meiosis - yeast	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMT200009945	K11584	ko04114	Oocyte meiosis	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMT200009945	K11584	ko04310	Wnt signaling pathway	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMT200078877	K04424	ko04010	MAPK signaling pathway	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMT200078877	K04424	ko04530	Tight junction	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMT200078878	K04424	ko04010	MAPK signaling pathway	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMT200078878	K04424	ko04530	Tight junction	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMT200078903	K04733	ko04210	Apoptosis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMT200078903	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMT200078903	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMT200078903	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMT200078903	K04733	ko05142	Chagas disease	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMT200064753	K13030	ko00460	Cyanoamino acid metabolism	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMT200064753	K13030	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMT200064754	K01176	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMT200064754	K01176	ko01100	Metabolic pathways	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMT200064755	K01176	ko00500	Starch and sucrose metabolism	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMT200064755	K01176	ko01100	Metabolic pathways	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMT200064756	K01176	ko00500	Starch and sucrose metabolism	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMT200064756	K01176	ko01100	Metabolic pathways	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMT200064760	K02965	ko03010	Ribosome	325	4.3e-12	0.45	0.67	0.85
PGSC0003DMT200064771	K01723	ko00592	alpha-Linolenic acid metabolism	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMT200064771	K01723	ko01100	Metabolic pathways	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMT200064772	K01723	ko00592	alpha-Linolenic acid metabolism	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMT200064772	K01723	ko01100	Metabolic pathways	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMT200064773	K01723	ko00592	alpha-Linolenic acid metabolism	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMT200064773	K01723	ko01100	Metabolic pathways	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMT200064783	K03527	ko00900	Terpenoid backbone biosynthesis	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMT200064783	K03527	ko01100	Metabolic pathways	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMT200064783	K03527	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMT200064784	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2697	6.4e-143	0.80	0.90	0.96
PGSC0003DMT200064785	K00680	ko00350	Tyrosine metabolism	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMT200064785	K00680	ko00624	1- and 2-Methylnaphthalene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMT200064785	K00680	ko00632	Benzoate degradation via CoA ligation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMT200064785	K00680	ko00642	Ethylbenzene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMT200064785	K00680	ko00903	Limonene and pinene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMT200056667	K03000	ko00230	Purine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMT200056667	K03000	ko00240	Pyrimidine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMT200056667	K03000	ko01100	Metabolic pathways	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMT200056667	K03000	ko03020	RNA polymerase	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMT200056668	K03000	ko00230	Purine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMT200056668	K03000	ko00240	Pyrimidine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMT200056668	K03000	ko01100	Metabolic pathways	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMT200056668	K03000	ko03020	RNA polymerase	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMT200056692	K12818	ko03040	Spliceosome	8022	0.	0.82	0.89	0.99
PGSC0003DMT200080366	K10949	ko05110	Vibrio cholerae infection	1624	9.8e-84	0.85	0.94	1.00
PGSC0003DMT200080385	K02261	ko00190	Oxidative phosphorylation	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080385	K02261	ko01100	Metabolic pathways	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080385	K02261	ko04260	Cardiac muscle contraction	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080385	K02261	ko05010	Alzheimer's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080385	K02261	ko05012	Parkinson's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080385	K02261	ko05016	Huntington's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMT200080391	K11420	ko00310	Lysine degradation	400	2.5e-15	0.39	0.54	0.33
PGSC0003DMT200080396	K11421	ko00310	Lysine degradation	311	2.9e-10	0.43	0.55	0.85
PGSC0003DMT200080398	K11420	ko00310	Lysine degradation	706	1.4e-32	0.38	0.52	0.32
PGSC0003DMT200062303	K00847	ko00051	Fructose and mannose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMT200062303	K00847	ko00500	Starch and sucrose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMT200062303	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMT200062303	K00847	ko01100	Metabolic pathways	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMT200062304	K00847	ko00051	Fructose and mannose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMT200062304	K00847	ko00500	Starch and sucrose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMT200062304	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMT200062304	K00847	ko01100	Metabolic pathways	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMT200062305	K00847	ko00051	Fructose and mannose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMT200062305	K00847	ko00500	Starch and sucrose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMT200062305	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMT200062305	K00847	ko01100	Metabolic pathways	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMT200062306	K00847	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMT200062306	K00847	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMT200062306	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMT200062306	K00847	ko01100	Metabolic pathways	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMT200062314	K05282	ko00904	Diterpenoid biosynthesis	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMT200062314	K05282	ko01100	Metabolic pathways	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMT200062314	K05282	ko01110	Biosynthesis of secondary metabolites	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMT200062315	K01835	ko00010	Glycolysis / Gluconeogenesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00030	Pentose phosphate pathway	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00052	Galactose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00230	Purine metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko00521	Streptomycin biosynthesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko01100	Metabolic pathways	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062315	K01835	ko01110	Biosynthesis of secondary metabolites	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMT200062316	K01835	ko00010	Glycolysis / Gluconeogenesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00030	Pentose phosphate pathway	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00052	Galactose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00230	Purine metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko00521	Streptomycin biosynthesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko01100	Metabolic pathways	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062316	K01835	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMT200062326	K00430	ko00360	Phenylalanine metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMT200062326	K00430	ko00680	Methane metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMT200062326	K00430	ko00940	Phenylpropanoid biosynthesis	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMT200062326	K00430	ko01100	Metabolic pathways	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMT200062326	K00430	ko01110	Biosynthesis of secondary metabolites	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMT200079498	K01190	ko00052	Galactose metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMT200079498	K01190	ko00511	Other glycan degradation	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMT200079498	K01190	ko00600	Sphingolipid metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMT200079498	K01190	ko01100	Metabolic pathways	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMT200079507	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.41
PGSC0003DMT200079508	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.49
PGSC0003DMT200079513	K03064	ko03050	Proteasome	506	4.5e-22	0.97	0.98	0.95
PGSC0003DMT200079514	K03064	ko03050	Proteasome	3154	4.0e-168	0.95	0.98	1.00
PGSC0003DMT200079532	K02154	ko00190	Oxidative phosphorylation	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko01100	Metabolic pathways	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko04142	Lysosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko04145	Phagosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko04966	Collecting duct acid secretion	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko05110	Vibrio cholerae infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079532	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMT200079533	K02212	ko03030	DNA replication	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMT200079533	K02212	ko04110	Cell cycle	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMT200079533	K02212	ko04111	Cell cycle - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMT200079533	K02212	ko04113	Meiosis - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMT200079534	K02212	ko03030	DNA replication	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMT200079534	K02212	ko04110	Cell cycle	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMT200079534	K02212	ko04111	Cell cycle - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMT200079534	K02212	ko04113	Meiosis - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMT200079535	K02212	ko03030	DNA replication	6005	0.	0.86	0.92	1.00
PGSC0003DMT200079535	K02212	ko04110	Cell cycle	6005	0.	0.86	0.92	1.00
PGSC0003DMT200079535	K02212	ko04111	Cell cycle - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMT200079535	K02212	ko04113	Meiosis - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMT200079698	K01505	ko00640	Propanoate metabolism	1280	9.2e-65	0.44	0.62	0.94
PGSC0003DMT200079699	K01505	ko00640	Propanoate metabolism	1252	3.2e-63	0.43	0.61	0.94
PGSC0003DMT200079701	K01505	ko00640	Propanoate metabolism	1253	2.8e-63	0.43	0.61	0.94
PGSC0003DMT200079706	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079706	K01580	ko00410	beta-Alanine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079706	K01580	ko00430	Taurine and hypotaurine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079706	K01580	ko00650	Butanoate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079706	K01580	ko01100	Metabolic pathways	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079706	K01580	ko04940	Type I diabetes mellitus	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMT200079707	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079707	K01580	ko00410	beta-Alanine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079707	K01580	ko00430	Taurine and hypotaurine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079707	K01580	ko00650	Butanoate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079707	K01580	ko01100	Metabolic pathways	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079707	K01580	ko04940	Type I diabetes mellitus	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMT200079708	K01580	ko00250	Alanine, aspartate and glutamate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079708	K01580	ko00410	beta-Alanine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079708	K01580	ko00430	Taurine and hypotaurine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079708	K01580	ko00650	Butanoate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079708	K01580	ko01100	Metabolic pathways	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079708	K01580	ko04940	Type I diabetes mellitus	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMT200079709	K02325	ko00230	Purine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079709	K02325	ko00240	Pyrimidine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079709	K02325	ko01100	Metabolic pathways	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079709	K02325	ko03030	DNA replication	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079709	K02325	ko03410	Base excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079709	K02325	ko03420	Nucleotide excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMT200079710	K02325	ko00230	Purine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079710	K02325	ko00240	Pyrimidine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079710	K02325	ko01100	Metabolic pathways	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079710	K02325	ko03030	DNA replication	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079710	K02325	ko03410	Base excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079710	K02325	ko03420	Nucleotide excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMT200079711	K02325	ko00230	Purine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079711	K02325	ko00240	Pyrimidine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079711	K02325	ko01100	Metabolic pathways	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079711	K02325	ko03030	DNA replication	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079711	K02325	ko03410	Base excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079711	K02325	ko03420	Nucleotide excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMT200079712	K02325	ko00230	Purine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079712	K02325	ko00240	Pyrimidine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079712	K02325	ko01100	Metabolic pathways	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079712	K02325	ko03030	DNA replication	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079712	K02325	ko03410	Base excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079712	K02325	ko03420	Nucleotide excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMT200079713	K02325	ko00230	Purine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079713	K02325	ko00240	Pyrimidine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079713	K02325	ko01100	Metabolic pathways	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079713	K02325	ko03030	DNA replication	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079713	K02325	ko03410	Base excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079713	K02325	ko03420	Nucleotide excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMT200079728	K00695	ko00500	Starch and sucrose metabolism	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMT200079728	K00695	ko01100	Metabolic pathways	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMT200079729	K01581	ko00330	Arginine and proline metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMT200079729	K01581	ko00480	Glutathione metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMT200079729	K01581	ko01100	Metabolic pathways	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMT200079729	K01581	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMT200046818	K06067	ko04110	Cell cycle	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMT200046818	K06067	ko04330	Notch signaling pathway	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMT200046818	K06067	ko05016	Huntington's disease	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMT200046818	K06067	ko05200	Pathways in cancer	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMT200046818	K06067	ko05220	Chronic myeloid leukemia	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMT200046820	K02900	ko03010	Ribosome	1132	1.3e-56	0.87	0.93	0.99
PGSC0003DMT200046821	K12823	ko03040	Spliceosome	3245	3.8e-173	0.59	0.69	0.99
PGSC0003DMT200046822	K12823	ko03040	Spliceosome	3488	1.5e-186	0.67	0.78	0.99
PGSC0003DMT200046823	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMT200046824	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMT200046837	K02358	ko04626	Plant-pathogen interaction	3409	3.4e-182	0.84	0.90	1.00
PGSC0003DMT200046838	K12132	ko04712	Circadian rhythm - plant	2130	1.2e-111	0.47	0.59	0.99
PGSC0003DMT200046840	K12132	ko04712	Circadian rhythm - plant	2133	8.2e-112	0.46	0.59	0.99
PGSC0003DMT200046841	K12132	ko04712	Circadian rhythm - plant	2157	3.9e-113	0.46	0.59	0.95
PGSC0003DMT200046848	K03517	ko00760	Nicotinate and nicotinamide metabolism	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMT200046848	K03517	ko01100	Metabolic pathways	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMT200073974	K02535	ko00540	Lipopolysaccharide biosynthesis	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMT200073974	K02535	ko01100	Metabolic pathways	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMT200073975	K02535	ko00540	Lipopolysaccharide biosynthesis	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMT200073975	K02535	ko01100	Metabolic pathways	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMT200073985	K01874	ko00450	Selenoamino acid metabolism	5739	0.	0.82	0.90	1.00
PGSC0003DMT200073985	K01874	ko00970	Aminoacyl-tRNA biosynthesis	5739	0.	0.82	0.90	1.00
PGSC0003DMT200061585	K00990	ko02020	Two-component system	230	5.3e-06	0.29	0.45	0.73
PGSC0003DMT200061587	K02259	ko00190	Oxidative phosphorylation	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMT200061587	K02259	ko00860	Porphyrin and chlorophyll metabolism	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMT200061587	K02259	ko01100	Metabolic pathways	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMT200061587	K02259	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMT200061587	K02259	ko02020	Two-component system	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMT200061600	K01597	ko00900	Terpenoid backbone biosynthesis	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMT200061600	K01597	ko01100	Metabolic pathways	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMT200061600	K01597	ko01110	Biosynthesis of secondary metabolites	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMT200061605	K11099	ko03040	Spliceosome	604	1.8e-27	0.88	0.95	0.99
PGSC0003DMT200061612	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMT200061613	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMT200037185	K08736	ko03430	Mismatch repair	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMT200037185	K08736	ko05200	Pathways in cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMT200037185	K08736	ko05210	Colorectal cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMT200037190	K08517	ko04130	SNARE interactions in vesicular transport	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMT200037190	K08517	ko04145	Phagosome	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMT200037205	K05765	ko04360	Axon guidance	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMT200037205	K05765	ko04666	Fc gamma R-mediated phagocytosis	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMT200037205	K05765	ko04810	Regulation of actin cytoskeleton	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMT200037216	K01199	ko00500	Starch and sucrose metabolism	1126	2.9e-56	0.48	0.65	0.91
PGSC0003DMT200027693	K01528	ko04144	Endocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMT200027693	K01528	ko04666	Fc gamma R-mediated phagocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMT200027693	K01528	ko05100	Bacterial invasion of epithelial cells	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMT200027697	K01528	ko04144	Endocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMT200027697	K01528	ko04666	Fc gamma R-mediated phagocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMT200027697	K01528	ko05100	Bacterial invasion of epithelial cells	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMT200027701	K04043	ko03018	RNA degradation	1298	9.3e-66	0.83	0.93	0.99
PGSC0003DMT200027702	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMT200027703	K04043	ko03018	RNA degradation	5026	2.2e-271	0.89	0.95	1.00
PGSC0003DMT200027704	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMT200027720	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMT200027720	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMT200027721	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMT200027721	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMT200027722	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMT200027722	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMT200027723	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMT200027723	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMT200027730	K12131	ko04712	Circadian rhythm - plant	222	4.7e-06	0.42	0.59	0.38
PGSC0003DMT200094485	K00472	ko00330	Arginine and proline metabolism	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMT200094485	K00472	ko01100	Metabolic pathways	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMT200058708	K05747	ko04062	Chemokine signaling pathway	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko04520	Adherens junction	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko04666	Fc gamma R-mediated phagocytosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko04810	Regulation of actin cytoskeleton	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko05100	Bacterial invasion of epithelial cells	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko05130	Pathogenic Escherichia coli infection	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058708	K05747	ko05131	Shigellosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMT200058738	K12356	ko00940	Phenylpropanoid biosynthesis	408	1.1e-16	0.34	0.48	0.80
PGSC0003DMT200058739	K12356	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.29	0.42	0.98
PGSC0003DMT200087419	K03006	ko00230	Purine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMT200087419	K03006	ko00240	Pyrimidine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMT200087419	K03006	ko01100	Metabolic pathways	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMT200087419	K03006	ko03020	RNA polymerase	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMT200087419	K03006	ko05016	Huntington's disease	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMT200075400	K12405	ko00120	Primary bile acid biosynthesis	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMT200075400	K12405	ko01100	Metabolic pathways	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMT200075400	K12405	ko04146	Peroxisome	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMT200075401	K12405	ko00120	Primary bile acid biosynthesis	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMT200075401	K12405	ko01100	Metabolic pathways	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMT200075401	K12405	ko04146	Peroxisome	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMT200075409	K00480	ko00624	1- and 2-Methylnaphthalene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMT200075409	K00480	ko00626	Naphthalene and anthracene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMT200075409	K00480	ko00628	Fluorene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMT200075409	K00480	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMT200075410	K00480	ko00624	1- and 2-Methylnaphthalene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMT200075410	K00480	ko00626	Naphthalene and anthracene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMT200075410	K00480	ko00628	Fluorene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMT200075410	K00480	ko01100	Metabolic pathways	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMT200075413	K00430	ko00360	Phenylalanine metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMT200075413	K00430	ko00680	Methane metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMT200075413	K00430	ko00940	Phenylpropanoid biosynthesis	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMT200075413	K00430	ko01100	Metabolic pathways	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMT200075413	K00430	ko01110	Biosynthesis of secondary metabolites	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMT200075415	K00430	ko00360	Phenylalanine metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMT200075415	K00430	ko00680	Methane metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMT200075415	K00430	ko00940	Phenylpropanoid biosynthesis	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMT200075415	K00430	ko01100	Metabolic pathways	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMT200075415	K00430	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMT200075422	K10591	ko04120	Ubiquitin mediated proteolysis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMT200075422	K10591	ko04144	Endocytosis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMT200075425	K07375	ko04145	Phagosome	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMT200075425	K07375	ko04540	Gap junction	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMT200075425	K07375	ko05130	Pathogenic Escherichia coli infection	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMT200075431	K10599	ko03040	Spliceosome	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMT200075431	K10599	ko04120	Ubiquitin mediated proteolysis	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMT200075433	K10599	ko03040	Spliceosome	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMT200075433	K10599	ko04120	Ubiquitin mediated proteolysis	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMT200075434	K10599	ko03040	Spliceosome	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMT200075434	K10599	ko04120	Ubiquitin mediated proteolysis	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMT200049907	K10576	ko04120	Ubiquitin mediated proteolysis	1405	1.2e-71	0.90	0.96	0.99
PGSC0003DMT200049908	K10576	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.88	0.94	0.99
PGSC0003DMT200049914	K06689	ko04120	Ubiquitin mediated proteolysis	1288	3.3e-65	0.98	0.98	0.99
PGSC0003DMT200049915	K06689	ko04120	Ubiquitin mediated proteolysis	972	8.9e-48	0.98	0.98	0.99
PGSC0003DMT200041104	K01880	ko00970	Aminoacyl-tRNA biosynthesis	5018	6.2e-271	0.86	0.93	0.99
PGSC0003DMT200041105	K00411	ko00190	Oxidative phosphorylation	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041105	K00411	ko01100	Metabolic pathways	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041105	K00411	ko04260	Cardiac muscle contraction	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041105	K00411	ko05010	Alzheimer's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041105	K00411	ko05012	Parkinson's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041105	K00411	ko05016	Huntington's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMT200041115	K01199	ko00500	Starch and sucrose metabolism	391	9.9e-16	0.31	0.51	0.92
PGSC0003DMT200041122	K13065	ko00940	Phenylpropanoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMT200041122	K13065	ko00941	Flavonoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMT200041122	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMT200041122	K13065	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMT200041136	K01692	ko00071	Fatty acid metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00280	Valine, leucine and isoleucine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00281	Geraniol degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00310	Lysine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00380	Tryptophan metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00410	beta-Alanine metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00632	Benzoate degradation via CoA ligation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00640	Propanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00650	Butanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00903	Limonene and pinene degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko00930	Caprolactam degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko01100	Metabolic pathways	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041136	K01692	ko01110	Biosynthesis of secondary metabolites	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMT200041155	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMT200041156	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMT200041158	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMT200041158	K12448	ko01100	Metabolic pathways	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMT200041159	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMT200041159	K12448	ko01100	Metabolic pathways	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMT200015495	K03070	ko03060	Protein export	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMT200015495	K03070	ko03070	Bacterial secretion system	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMT200015496	K03070	ko03060	Protein export	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMT200015496	K03070	ko03070	Bacterial secretion system	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMT200015502	K00858	ko00760	Nicotinate and nicotinamide metabolism	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMT200015502	K00858	ko01100	Metabolic pathways	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMT200015503	K00858	ko00760	Nicotinate and nicotinamide metabolism	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMT200015503	K00858	ko01100	Metabolic pathways	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMT200015504	K12865	ko03040	Spliceosome	2263	5.6e-119	0.60	0.74	0.84
PGSC0003DMT200015528	K00472	ko00330	Arginine and proline metabolism	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMT200015528	K00472	ko01100	Metabolic pathways	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMT200015529	K00472	ko00330	Arginine and proline metabolism	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMT200015529	K00472	ko01100	Metabolic pathways	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMT200021824	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2918	4.1e-155	0.76	0.83	0.99
PGSC0003DMT200021830	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMT200021830	K01817	ko01100	Metabolic pathways	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMT200021830	K01817	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMT200021832	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021832	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021832	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021833	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021833	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021833	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMT200021834	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMT200021834	K01817	ko01100	Metabolic pathways	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMT200021834	K01817	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMT200021835	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMT200021835	K01817	ko01100	Metabolic pathways	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMT200021835	K01817	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMT200021839	K02111	ko00190	Oxidative phosphorylation	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMT200021839	K02111	ko00195	Photosynthesis	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMT200021839	K02111	ko01100	Metabolic pathways	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMT200021841	K01739	ko00270	Cysteine and methionine metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMT200021841	K01739	ko00450	Selenoamino acid metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMT200021841	K01739	ko00920	Sulfur metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMT200021841	K01739	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMT200021841	K01739	ko01110	Biosynthesis of secondary metabolites	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMT200021849	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMT200021849	K03857	ko01100	Metabolic pathways	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMT200032751	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMT200032751	K02548	ko01100	Metabolic pathways	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMT200032751	K02548	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMT200032752	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMT200032752	K02548	ko01100	Metabolic pathways	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMT200032752	K02548	ko01110	Biosynthesis of secondary metabolites	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMT200032753	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMT200032753	K02548	ko01100	Metabolic pathways	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMT200032753	K02548	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMT200032754	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMT200032754	K02548	ko01100	Metabolic pathways	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMT200032754	K02548	ko01110	Biosynthesis of secondary metabolites	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMT200032758	K13030	ko00460	Cyanoamino acid metabolism	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMT200032758	K13030	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMT200032759	K13030	ko00460	Cyanoamino acid metabolism	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMT200032759	K13030	ko01110	Biosynthesis of secondary metabolites	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMT200007047	K01689	ko00010	Glycolysis / Gluconeogenesis	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMT200007047	K01689	ko01100	Metabolic pathways	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMT200007047	K01689	ko01110	Biosynthesis of secondary metabolites	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMT200007047	K01689	ko03018	RNA degradation	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMT200007048	K01689	ko00010	Glycolysis / Gluconeogenesis	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMT200007048	K01689	ko01100	Metabolic pathways	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMT200007048	K01689	ko01110	Biosynthesis of secondary metabolites	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMT200007048	K01689	ko03018	RNA degradation	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMT200007057	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMT200007057	K00517	ko00626	Naphthalene and anthracene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMT200007057	K00517	ko00903	Limonene and pinene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMT200007057	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMT200007057	K00517	ko01110	Biosynthesis of secondary metabolites	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMT200007058	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMT200007058	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMT200007058	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMT200007058	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMT200007058	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMT200007059	K09903	ko00240	Pyrimidine metabolism	1201	2.1e-60	0.61	0.76	0.46
PGSC0003DMT200007062	K02896	ko03010	Ribosome	1252	3.2e-63	0.91	0.95	0.99
PGSC0003DMT200007080	K05280	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMT200007080	K05280	ko00944	Flavone and flavonol biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMT200007080	K05280	ko01100	Metabolic pathways	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMT200007080	K05280	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMT200001674	K03106	ko03060	Protein export	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMT200001674	K03106	ko03070	Bacterial secretion system	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMT200001675	K03106	ko03060	Protein export	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMT200001675	K03106	ko03070	Bacterial secretion system	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMT200001685	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMT200001686	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMT200060498	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMT200060499	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMT200060506	K12128	ko04712	Circadian rhythm - plant	409	1.4e-16	0.26	0.45	0.63
PGSC0003DMT200060507	K12129	ko04712	Circadian rhythm - plant	426	2.7e-17	0.36	0.54	0.73
PGSC0003DMT200086197	K01052	ko00100	Steroid biosynthesis	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMT200086197	K01052	ko04142	Lysosome	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMT200086198	K09755	ko00940	Phenylpropanoid biosynthesis	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMT200086198	K09755	ko01100	Metabolic pathways	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMT200086198	K09755	ko01110	Biosynthesis of secondary metabolites	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMT200086207	K11423	ko00310	Lysine degradation	512	3.6e-21	0.37	0.53	0.83
PGSC0003DMT200086211	K13229	ko00402	Benzoxazinoid biosynthesis	247	8.7e-08	0.27	0.41	0.99
PGSC0003DMT200086221	K03469	ko03030	DNA replication	233	8.0e-07	0.34	0.53	0.27
PGSC0003DMT200066543	K00899	ko00270	Cysteine and methionine metabolism	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMT200066543	K00899	ko01100	Metabolic pathways	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMT200066544	K13068	ko00940	Phenylpropanoid biosynthesis	1950	1.0e-101	0.51	0.70	0.96
PGSC0003DMT200066557	K10151	ko04110	Cell cycle	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMT200066557	K10151	ko04115	p53 signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMT200066557	K10151	ko04310	Wnt signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMT200066557	K10151	ko04510	Focal adhesion	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMT200066557	K10151	ko04630	Jak-STAT signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMT200066559	K05402	ko04620	Toll-like receptor signaling pathway	296	1.7e-10	0.31	0.39	0.87
PGSC0003DMT200066560	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066560	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066561	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMT200066562	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066562	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066563	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMT200066564	K01110	ko00562	Inositol phosphate metabolism	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko04070	Phosphatidylinositol signaling system	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko04115	p53 signaling pathway	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko04510	Focal adhesion	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko04530	Tight junction	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05200	Pathways in cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05213	Endometrial cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05214	Glioma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05215	Prostate cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05218	Melanoma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066564	K01110	ko05222	Small cell lung cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMT200066567	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMT200051832	K13289	ko04142	Lysosome	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMT200051832	K13289	ko04614	Renin-angiotensin system	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMT200077129	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMT200077129	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMT200077144	K12200	ko04144	Endocytosis	259	1.1e-07	0.38	0.43	0.75
PGSC0003DMT200077163	K01107	ko00562	Inositol phosphate metabolism	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMT200077163	K01107	ko01100	Metabolic pathways	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMT200077163	K01107	ko04070	Phosphatidylinositol signaling system	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMT200091550	K03469	ko03030	DNA replication	223	8.1e-06	0.31	0.56	0.53
PGSC0003DMT200091561	K13066	ko00940	Phenylpropanoid biosynthesis	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMT200091561	K13066	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMT200042859	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMT200042859	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMT200042860	K05275	ko00750	Vitamin B6 metabolism	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMT200042860	K05275	ko01100	Metabolic pathways	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMT200042861	K05275	ko00750	Vitamin B6 metabolism	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMT200042861	K05275	ko01100	Metabolic pathways	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMT200042862	K00100	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042862	K00100	ko00363	Bisphenol A degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042862	K00100	ko00591	Linoleic acid metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042862	K00100	ko00625	Tetrachloroethene degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042862	K00100	ko00650	Butanoate metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042862	K00100	ko01100	Metabolic pathways	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMT200042863	K00100	ko00051	Fructose and mannose metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042863	K00100	ko00363	Bisphenol A degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042863	K00100	ko00591	Linoleic acid metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042863	K00100	ko00625	Tetrachloroethene degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042863	K00100	ko00650	Butanoate metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042863	K00100	ko01100	Metabolic pathways	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMT200042864	K00100	ko00051	Fructose and mannose metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042864	K00100	ko00363	Bisphenol A degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042864	K00100	ko00591	Linoleic acid metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042864	K00100	ko00625	Tetrachloroethene degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042864	K00100	ko00650	Butanoate metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042864	K00100	ko01100	Metabolic pathways	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMT200042865	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMT200042865	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMT200042868	K02945	ko03010	Ribosome	381	3.5e-15	0.34	0.56	0.73
PGSC0003DMT200042869	K02945	ko03010	Ribosome	488	4.4e-21	0.34	0.51	0.70
PGSC0003DMT200042871	K03165	ko03440	Homologous recombination	3946	8.3e-212	0.81	0.90	1.00
PGSC0003DMT200042872	K03165	ko03440	Homologous recombination	2161	2.3e-113	0.83	0.91	0.99
PGSC0003DMT200042873	K03165	ko03440	Homologous recombination	5715	0.	0.81	0.89	1.00
PGSC0003DMT200042874	K03165	ko03440	Homologous recombination	6074	0.	0.81	0.89	0.99
PGSC0003DMT200042875	K03165	ko03440	Homologous recombination	2145	1.8e-112	0.77	0.88	0.90
PGSC0003DMT200013784	K01768	ko00230	Purine metabolism	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMT200013784	K01768	ko04113	Meiosis - yeast	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMT200013787	K00901	ko00561	Glycerolipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMT200013787	K00901	ko00564	Glycerophospholipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMT200013787	K00901	ko01100	Metabolic pathways	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMT200013787	K00901	ko04070	Phosphatidylinositol signaling system	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMT200013811	K04718	ko00600	Sphingolipid metabolism	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMT200013811	K04718	ko01100	Metabolic pathways	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMT200013811	K04718	ko04020	Calcium signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMT200013811	K04718	ko04370	VEGF signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMT200013811	K04718	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMT200013821	K05395	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.51	0.61	0.86
PGSC0003DMT200013822	K05395	ko00270	Cysteine and methionine metabolism	274	2.8e-09	0.58	0.66	0.94
PGSC0003DMT200013826	K09567	ko03040	Spliceosome	1464	6.5e-75	0.87	0.93	0.99
PGSC0003DMT200005245	K05862	ko04020	Calcium signaling pathway	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMT200005245	K05862	ko05012	Parkinson's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMT200005245	K05862	ko05016	Huntington's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMT200005264	K12669	ko00510	N-Glycan biosynthesis	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMT200005264	K12669	ko01100	Metabolic pathways	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMT200005267	K01051	ko00040	Pentose and glucuronate interconversions	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMT200005267	K01051	ko00500	Starch and sucrose metabolism	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMT200005267	K01051	ko01100	Metabolic pathways	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMT200005268	K01051	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMT200005268	K01051	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMT200005268	K01051	ko01100	Metabolic pathways	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMT200005278	K05350	ko00460	Cyanoamino acid metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMT200005278	K05350	ko00500	Starch and sucrose metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMT200005278	K05350	ko00940	Phenylpropanoid biosynthesis	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMT200005278	K05350	ko01110	Biosynthesis of secondary metabolites	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMT200005279	K05350	ko00460	Cyanoamino acid metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMT200005279	K05350	ko00500	Starch and sucrose metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMT200005279	K05350	ko00940	Phenylpropanoid biosynthesis	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMT200005279	K05350	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMT200005280	K05350	ko00460	Cyanoamino acid metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMT200005280	K05350	ko00500	Starch and sucrose metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMT200005280	K05350	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMT200005280	K05350	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMT200005281	K05350	ko00460	Cyanoamino acid metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMT200005281	K05350	ko00500	Starch and sucrose metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMT200005281	K05350	ko00940	Phenylpropanoid biosynthesis	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMT200005281	K05350	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMT200005282	K05350	ko00460	Cyanoamino acid metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMT200005282	K05350	ko00500	Starch and sucrose metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMT200005282	K05350	ko00940	Phenylpropanoid biosynthesis	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMT200005282	K05350	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMT200005284	K05350	ko00460	Cyanoamino acid metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMT200005284	K05350	ko00500	Starch and sucrose metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMT200005284	K05350	ko00940	Phenylpropanoid biosynthesis	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMT200005284	K05350	ko01110	Biosynthesis of secondary metabolites	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMT200005285	K05350	ko00460	Cyanoamino acid metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMT200005285	K05350	ko00500	Starch and sucrose metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMT200005285	K05350	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMT200005285	K05350	ko01110	Biosynthesis of secondary metabolites	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMT200005286	K05350	ko00460	Cyanoamino acid metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMT200005286	K05350	ko00500	Starch and sucrose metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMT200005286	K05350	ko00940	Phenylpropanoid biosynthesis	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMT200005286	K05350	ko01110	Biosynthesis of secondary metabolites	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMT200005287	K05350	ko00460	Cyanoamino acid metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMT200005287	K05350	ko00500	Starch and sucrose metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMT200005287	K05350	ko00940	Phenylpropanoid biosynthesis	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMT200005287	K05350	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMT200005297	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMT200005297	K00517	ko00626	Naphthalene and anthracene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMT200005297	K00517	ko00903	Limonene and pinene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMT200005297	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMT200005297	K00517	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMT200031010	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMT200031010	K01433	ko00670	One carbon pool by folate	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMT200031011	K01613	ko00564	Glycerophospholipid metabolism	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMT200031011	K01613	ko01100	Metabolic pathways	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMT200031012	K01613	ko00564	Glycerophospholipid metabolism	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMT200031012	K01613	ko01100	Metabolic pathways	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMT200031013	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMT200031013	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMT200031014	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMT200031014	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMT200039733	K00218	ko00860	Porphyrin and chlorophyll metabolism	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMT200039733	K00218	ko01100	Metabolic pathways	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMT200039733	K00218	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMT200039734	K00218	ko00860	Porphyrin and chlorophyll metabolism	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMT200039734	K00218	ko01100	Metabolic pathways	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMT200039734	K00218	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMT200039740	K12822	ko03040	Spliceosome	341	2.2e-12	0.29	0.47	0.88
PGSC0003DMT200039744	K10581	ko04120	Ubiquitin mediated proteolysis	459	3.6e-20	0.52	0.64	0.24
PGSC0003DMT200039745	K10581	ko04120	Ubiquitin mediated proteolysis	990	9.1e-49	0.56	0.71	0.90
PGSC0003DMT200039746	K10581	ko04120	Ubiquitin mediated proteolysis	1188	3.7e-61	0.52	0.67	0.42
PGSC0003DMT200039748	K02605	ko04110	Cell cycle	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMT200039748	K02605	ko04111	Cell cycle - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMT200039748	K02605	ko04113	Meiosis - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMT200039749	K02605	ko04110	Cell cycle	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMT200039749	K02605	ko04111	Cell cycle - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMT200039749	K02605	ko04113	Meiosis - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMT200039750	K02605	ko04110	Cell cycle	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMT200039750	K02605	ko04111	Cell cycle - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMT200039750	K02605	ko04113	Meiosis - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMT200039751	K02605	ko04110	Cell cycle	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMT200039751	K02605	ko04111	Cell cycle - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMT200039751	K02605	ko04113	Meiosis - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMT200039752	K02605	ko04110	Cell cycle	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMT200039752	K02605	ko04111	Cell cycle - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMT200039752	K02605	ko04113	Meiosis - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMT200039753	K02605	ko04110	Cell cycle	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMT200039753	K02605	ko04111	Cell cycle - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMT200039753	K02605	ko04113	Meiosis - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMT200081834	K12900	ko03040	Spliceosome	310	2.9e-11	0.44	0.60	0.56
PGSC0003DMT200081835	K12900	ko03040	Spliceosome	637	2.7e-29	0.44	0.56	0.83
PGSC0003DMT200081836	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.74
PGSC0003DMT200081837	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.66
PGSC0003DMT200081838	K01199	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.35	0.52	0.65
PGSC0003DMT200081850	K11594	ko04622	RIG-I-like receptor signaling pathway	2294	1.1e-120	0.76	0.85	0.92
PGSC0003DMT200081851	K11594	ko04622	RIG-I-like receptor signaling pathway	4135	3.1e-222	0.79	0.86	1.00
PGSC0003DMT200081853	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMT200081853	K07542	ko01100	Metabolic pathways	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMT200081854	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMT200081854	K07542	ko01100	Metabolic pathways	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMT200081855	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMT200081855	K07542	ko01100	Metabolic pathways	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMT200081856	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMT200081856	K07542	ko01100	Metabolic pathways	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMT200081857	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMT200081857	K07542	ko01100	Metabolic pathways	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMT200072308	K03110	ko03060	Protein export	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMT200072308	K03110	ko03070	Bacterial secretion system	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMT200072321	K10739	ko03030	DNA replication	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMT200072321	K10739	ko03420	Nucleotide excision repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMT200072321	K10739	ko03430	Mismatch repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMT200072321	K10739	ko03440	Homologous recombination	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMT200072322	K08064	ko04612	Antigen processing and presentation	365	2.7e-14	0.42	0.58	0.68
PGSC0003DMT200072323	K08064	ko04612	Antigen processing and presentation	363	3.5e-14	0.46	0.62	0.60
PGSC0003DMT200072324	K08064	ko04612	Antigen processing and presentation	356	8.4e-14	0.49	0.64	0.60
PGSC0003DMT200072325	K08486	ko04130	SNARE interactions in vesicular transport	1923	3.1e-100	0.75	0.89	1.00
PGSC0003DMT200045008	K11584	ko04113	Meiosis - yeast	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMT200045008	K11584	ko04114	Oocyte meiosis	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMT200045008	K11584	ko04310	Wnt signaling pathway	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMT200045009	K05666	ko02010	ABC transporters	2956	3.3e-157	0.36	0.56	0.94
PGSC0003DMT200045023	K02537	ko04110	Cell cycle	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMT200045023	K02537	ko04111	Cell cycle - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMT200045023	K02537	ko04113	Meiosis - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMT200045023	K02537	ko04114	Oocyte meiosis	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMT200045023	K02537	ko04914	Progesterone-mediated oocyte maturation	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMT200045024	K02537	ko04110	Cell cycle	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMT200045024	K02537	ko04111	Cell cycle - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMT200045024	K02537	ko04113	Meiosis - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMT200045024	K02537	ko04114	Oocyte meiosis	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMT200045024	K02537	ko04914	Progesterone-mediated oocyte maturation	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMT200045025	K02537	ko04110	Cell cycle	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMT200045025	K02537	ko04111	Cell cycle - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMT200045025	K02537	ko04113	Meiosis - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMT200045025	K02537	ko04114	Oocyte meiosis	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMT200045025	K02537	ko04914	Progesterone-mediated oocyte maturation	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMT200045027	K00059	ko00061	Fatty acid biosynthesis	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMT200045027	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMT200045027	K00059	ko01100	Metabolic pathways	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMT200045028	K00059	ko00061	Fatty acid biosynthesis	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMT200045028	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMT200045028	K00059	ko01100	Metabolic pathways	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMT200045039	K03165	ko03440	Homologous recombination	644	1.1e-29	0.77	0.90	0.71
PGSC0003DMT200045040	K03165	ko03440	Homologous recombination	1490	2.4e-76	0.86	0.93	0.82
PGSC0003DMT200095682	K00021	ko00900	Terpenoid backbone biosynthesis	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMT200095682	K00021	ko01100	Metabolic pathways	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMT200095682	K00021	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMT200095704	K11251	ko05322	Systemic lupus erythematosus	643	1.2e-29	0.66	0.79	0.91
PGSC0003DMT200004107	K01771	ko00562	Inositol phosphate metabolism	246	9.8e-08	0.30	0.43	0.74
PGSC0003DMT200004112	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMT200004112	K02433	ko01100	Metabolic pathways	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMT200004113	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMT200004113	K02433	ko01100	Metabolic pathways	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMT200004133	K00660	ko00941	Flavonoid biosynthesis	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMT200004133	K00660	ko01100	Metabolic pathways	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMT200004133	K00660	ko01110	Biosynthesis of secondary metabolites	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMT200004133	K00660	ko04712	Circadian rhythm - plant	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMT200004137	K01243	ko00270	Cysteine and methionine metabolism	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMT200004137	K01243	ko01100	Metabolic pathways	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMT200035186	K01179	ko00500	Starch and sucrose metabolism	4113	5.1e-221	0.75	0.86	1.00
PGSC0003DMT200035192	K04733	ko04210	Apoptosis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMT200035192	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMT200035192	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMT200035192	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMT200035192	K04733	ko05142	Chagas disease	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMT200035208	K10447	ko04120	Ubiquitin mediated proteolysis	358	6.5e-14	0.29	0.45	0.65
PGSC0003DMT200035383	K02912	ko03010	Ribosome	980	3.2e-48	0.89	0.96	0.33
PGSC0003DMT200035393	K12356	ko00940	Phenylpropanoid biosynthesis	658	1.9e-30	0.41	0.57	0.73
PGSC0003DMT200035396	K12356	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.39	0.55	0.88
PGSC0003DMT200029482	K10599	ko03040	Spliceosome	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMT200029482	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMT200029483	K10599	ko03040	Spliceosome	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMT200029483	K10599	ko04120	Ubiquitin mediated proteolysis	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMT200029484	K10599	ko03040	Spliceosome	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMT200029484	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMT200029489	K05580	ko00190	Oxidative phosphorylation	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMT200029489	K05580	ko01100	Metabolic pathways	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMT200029490	K05576	ko00190	Oxidative phosphorylation	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMT200029490	K05576	ko01100	Metabolic pathways	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMT200029491	K05575	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMT200029491	K05575	ko01100	Metabolic pathways	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMT200016512	K13067	ko00940	Phenylpropanoid biosynthesis	1112	1.7e-55	0.62	0.79	0.95
PGSC0003DMT200016513	K08967	ko00270	Cysteine and methionine metabolism	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMT200016513	K08967	ko01100	Metabolic pathways	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMT200016514	K08967	ko00270	Cysteine and methionine metabolism	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMT200016514	K08967	ko01100	Metabolic pathways	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMT200016515	K08967	ko00270	Cysteine and methionine metabolism	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMT200016515	K08967	ko01100	Metabolic pathways	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMT200016517	K08099	ko00860	Porphyrin and chlorophyll metabolism	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMT200016517	K08099	ko01100	Metabolic pathways	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMT200016517	K08099	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMT200016518	K08099	ko00860	Porphyrin and chlorophyll metabolism	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMT200016518	K08099	ko01100	Metabolic pathways	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMT200016518	K08099	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMT200037713	K00660	ko00941	Flavonoid biosynthesis	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMT200037713	K00660	ko01100	Metabolic pathways	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMT200037713	K00660	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMT200037713	K00660	ko04712	Circadian rhythm - plant	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMT200037714	K00660	ko00941	Flavonoid biosynthesis	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMT200037714	K00660	ko01100	Metabolic pathways	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMT200037714	K00660	ko01110	Biosynthesis of secondary metabolites	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMT200037714	K00660	ko04712	Circadian rhythm - plant	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMT200037718	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3172	4.1e-169	0.72	0.84	0.92
PGSC0003DMT200037724	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMT200037725	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMT200037726	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMT200037727	K01069	ko00620	Pyruvate metabolism	297	1.6e-10	0.28	0.45	0.56
PGSC0003DMT200027529	K02084	ko04115	p53 signaling pathway	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko04210	Apoptosis	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko05010	Alzheimer's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko05012	Parkinson's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko05016	Huntington's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027529	K02084	ko05222	Small cell lung cancer	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMT200027542	K08332	ko04140	Regulation of autophagy	381	3.5e-15	0.30	0.50	0.84
PGSC0003DMT200027550	K07195	ko04910	Insulin signaling pathway	739	6.3e-35	0.31	0.55	0.98
PGSC0003DMT200027557	K09756	ko00940	Phenylpropanoid biosynthesis	1804	1.2e-93	0.48	0.67	0.96
PGSC0003DMT200027560	K09756	ko00940	Phenylpropanoid biosynthesis	1392	6.1e-71	0.48	0.68	0.93
PGSC0003DMT200027561	K09756	ko00940	Phenylpropanoid biosynthesis	1144	2.9e-57	0.44	0.59	0.99
PGSC0003DMT200027562	K09756	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.48	0.65	1.00
PGSC0003DMT200027563	K09756	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.49	0.69	1.00
PGSC0003DMT200027564	K09756	ko00940	Phenylpropanoid biosynthesis	1235	2.8e-62	0.49	0.67	0.99
PGSC0003DMT200080229	K04733	ko04210	Apoptosis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMT200080229	K04733	ko04620	Toll-like receptor signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMT200080229	K04733	ko04722	Neurotrophin signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMT200080229	K04733	ko05140	Leishmaniasis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMT200080229	K04733	ko05142	Chagas disease	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMT200080256	K06688	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.89	0.91	0.97
PGSC0003DMT200080265	K10595	ko04120	Ubiquitin mediated proteolysis	861	4.7e-40	0.34	0.51	0.41
PGSC0003DMT200046089	K06268	ko04010	MAPK signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04020	Calcium signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04114	Oocyte meiosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04210	Apoptosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04310	Wnt signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04360	Axon guidance	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04370	VEGF signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04650	Natural killer cell mediated cytotoxicity	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04660	T cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04662	B cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko04720	Long-term potentiation	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko05010	Alzheimer's disease	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046089	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMT200046096	K08967	ko00270	Cysteine and methionine metabolism	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMT200046096	K08967	ko01100	Metabolic pathways	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMT200073803	K01051	ko00040	Pentose and glucuronate interconversions	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMT200073803	K01051	ko00500	Starch and sucrose metabolism	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMT200073803	K01051	ko01100	Metabolic pathways	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMT200073806	K01051	ko00040	Pentose and glucuronate interconversions	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMT200073806	K01051	ko00500	Starch and sucrose metabolism	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMT200073806	K01051	ko01100	Metabolic pathways	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMT200073812	K11717	ko00450	Selenoamino acid metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMT200073812	K11717	ko00730	Thiamine metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMT200073812	K11717	ko01100	Metabolic pathways	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMT200073819	K03938	ko00190	Oxidative phosphorylation	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMT200073819	K03938	ko01100	Metabolic pathways	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMT200073819	K03938	ko05010	Alzheimer's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMT200073819	K03938	ko05012	Parkinson's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMT200073819	K03938	ko05016	Huntington's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMT200062101	K01115	ko00564	Glycerophospholipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062101	K01115	ko00565	Ether lipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062101	K01115	ko01100	Metabolic pathways	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062101	K01115	ko04144	Endocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062101	K01115	ko04666	Fc gamma R-mediated phagocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062101	K01115	ko04912	GnRH signaling pathway	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMT200062102	K04508	ko04310	Wnt signaling pathway	262	6.4e-19	0.44	0.60	0.66
PGSC0003DMT200062109	K05349	ko00460	Cyanoamino acid metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMT200062109	K05349	ko00500	Starch and sucrose metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMT200062109	K05349	ko00940	Phenylpropanoid biosynthesis	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMT200062109	K05349	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMT200062128	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMT200062129	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMT200062131	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMT200062136	K00660	ko00941	Flavonoid biosynthesis	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMT200062136	K00660	ko01100	Metabolic pathways	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMT200062136	K00660	ko01110	Biosynthesis of secondary metabolites	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMT200062136	K00660	ko04712	Circadian rhythm - plant	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMT200062137	K00660	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMT200062137	K00660	ko01100	Metabolic pathways	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMT200062137	K00660	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMT200062137	K00660	ko04712	Circadian rhythm - plant	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMT200062138	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMT200062138	K01602	ko00710	Carbon fixation in photosynthetic organisms	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMT200062138	K01602	ko01100	Metabolic pathways	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMT200062139	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200062139	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200062140	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200062140	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200040920	K04733	ko04210	Apoptosis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMT200040920	K04733	ko04620	Toll-like receptor signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMT200040920	K04733	ko04722	Neurotrophin signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMT200040920	K04733	ko05140	Leishmaniasis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMT200040920	K04733	ko05142	Chagas disease	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMT200040972	K01066	ko00623	2,4-Dichlorobenzoate degradation	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMT200040972	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMT200024926	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMT200024927	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMT200024928	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMT200024929	K12796	ko04621	NOD-like receptor signaling pathway	450	1.5e-16	0.31	0.47	0.57
PGSC0003DMT200021109	K00942	ko00230	Purine metabolism	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMT200021109	K00942	ko01100	Metabolic pathways	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMT200021111	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMT200021111	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMT200021112	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMT200021112	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMT200021130	K12126	ko04712	Circadian rhythm - plant	287	8.8e-10	0.31	0.50	0.52
PGSC0003DMT200021134	K00801	ko00100	Steroid biosynthesis	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMT200021134	K00801	ko01100	Metabolic pathways	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMT200021134	K00801	ko01110	Biosynthesis of secondary metabolites	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMT200033249	K02183	ko04020	Calcium signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04070	Phosphatidylinositol signaling system	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04114	Oocyte meiosis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04270	Vascular smooth muscle contraction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04626	Plant-pathogen interaction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04720	Long-term potentiation	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04722	Neurotrophin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04740	Olfactory transduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04744	Phototransduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04745	Phototransduction - fly	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04910	Insulin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04912	GnRH signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04916	Melanogenesis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04970	Salivary secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko04971	Gastric acid secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko05010	Alzheimer's disease	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033249	K02183	ko05214	Glioma	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMT200033250	K02183	ko04020	Calcium signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04070	Phosphatidylinositol signaling system	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04114	Oocyte meiosis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04270	Vascular smooth muscle contraction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04626	Plant-pathogen interaction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04720	Long-term potentiation	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04722	Neurotrophin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04740	Olfactory transduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04744	Phototransduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04745	Phototransduction - fly	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04910	Insulin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04912	GnRH signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04916	Melanogenesis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04970	Salivary secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko04971	Gastric acid secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko05010	Alzheimer's disease	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033250	K02183	ko05214	Glioma	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMT200033253	K01955	ko00240	Pyrimidine metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMT200033253	K01955	ko00250	Alanine, aspartate and glutamate metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMT200033253	K01955	ko01100	Metabolic pathways	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMT200033264	K00908	ko01100	Metabolic pathways	338	1.2e-12	0.30	0.48	0.88
PGSC0003DMT200002189	K13230	ko00402	Benzoxazinoid biosynthesis	629	7.4e-29	0.33	0.49	0.46
PGSC0003DMT200002219	K02184	ko04320	Dorso-ventral axis formation	699	3.0e-32	0.33	0.51	0.88
PGSC0003DMT200002220	K13230	ko00402	Benzoxazinoid biosynthesis	892	2.3e-43	0.37	0.56	0.97
PGSC0003DMT200002222	K13230	ko00402	Benzoxazinoid biosynthesis	419	2.8e-17	0.41	0.68	0.99
PGSC0003DMT200067858	K01809	ko00051	Fructose and mannose metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMT200067858	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMT200067858	K01809	ko01100	Metabolic pathways	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMT200067858	K01809	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMT200067870	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMT200067870	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMT200067871	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMT200067871	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMT200067873	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMT200067875	K00227	ko00100	Steroid biosynthesis	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMT200067875	K00227	ko01100	Metabolic pathways	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMT200067875	K00227	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMT200067880	K00227	ko00100	Steroid biosynthesis	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMT200067880	K00227	ko01100	Metabolic pathways	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMT200067880	K00227	ko01110	Biosynthesis of secondary metabolites	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMT200067881	K00227	ko00100	Steroid biosynthesis	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMT200067881	K00227	ko01100	Metabolic pathways	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMT200067881	K00227	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMT200067883	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMT200067884	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMT200087280	K05765	ko04360	Axon guidance	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMT200087280	K05765	ko04666	Fc gamma R-mediated phagocytosis	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMT200087280	K05765	ko04810	Regulation of actin cytoskeleton	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMT200087303	K04728	ko04110	Cell cycle	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMT200087303	K04728	ko04115	p53 signaling pathway	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMT200087303	K04728	ko04210	Apoptosis	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMT200075922	K12478	ko04144	Endocytosis	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMT200075922	K12478	ko04145	Phagosome	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMT200075949	K02489	ko02020	Two-component system	966	1.9e-47	0.31	0.46	0.67
PGSC0003DMT200075960	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075960	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075960	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075961	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075961	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075961	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMT200075962	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMT200075962	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMT200075962	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMT200075962	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMT200075962	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMT200075963	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075963	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075963	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075964	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075964	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075964	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMT200075966	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMT200075966	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMT200075966	K00734	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMT200075969	K04420	ko04010	MAPK signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMT200075969	K04420	ko04540	Gap junction	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMT200075969	K04420	ko04912	GnRH signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMT200075972	K07195	ko04910	Insulin signaling pathway	3835	1.1e-205	0.69	0.83	1.00
PGSC0003DMT200075973	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4432	1.3e-238	0.78	0.87	0.99
PGSC0003DMT200075974	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200075975	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200075976	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200050271	K12042	ko04020	Calcium signaling pathway	227	1.1e-06	0.46	0.67	0.32
PGSC0003DMT200050289	K00799	ko00480	Glutathione metabolism	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMT200050289	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMT200050289	K00799	ko00982	Drug metabolism - cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMT200050290	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	287	5.4e-10	0.64	0.72	0.27
PGSC0003DMT200050292	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	227	1.1e-06	0.50	0.56	0.53
PGSC0003DMT200050297	K04422	ko04010	MAPK signaling pathway	292	2.9e-10	0.38	0.65	0.80
PGSC0003DMT200050307	K04043	ko03018	RNA degradation	703	6.1e-33	0.81	0.91	0.88
PGSC0003DMT200000524	K08008	ko04145	Phagosome	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMT200000524	K08008	ko04670	Leukocyte transendothelial migration	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMT200000526	K08008	ko04145	Phagosome	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMT200000526	K08008	ko04670	Leukocyte transendothelial migration	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMT200000527	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000527	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000528	K08008	ko04145	Phagosome	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMT200000528	K08008	ko04670	Leukocyte transendothelial migration	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMT200000529	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000529	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000530	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000530	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000531	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000531	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000532	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000532	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMT200000533	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000533	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMT200000534	K08008	ko04145	Phagosome	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMT200000534	K08008	ko04670	Leukocyte transendothelial migration	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMT200000535	K08008	ko04145	Phagosome	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMT200000535	K08008	ko04670	Leukocyte transendothelial migration	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMT200000536	K08008	ko04145	Phagosome	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMT200000536	K08008	ko04670	Leukocyte transendothelial migration	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMT200000537	K04733	ko04210	Apoptosis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMT200000537	K04733	ko04620	Toll-like receptor signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMT200000537	K04733	ko04722	Neurotrophin signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMT200000537	K04733	ko05140	Leishmaniasis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMT200000537	K04733	ko05142	Chagas disease	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMT200000538	K01213	ko00040	Pentose and glucuronate interconversions	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMT200000538	K01213	ko00500	Starch and sucrose metabolism	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMT200000538	K01213	ko01100	Metabolic pathways	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMT200000546	K12134	ko04712	Circadian rhythm - plant	474	2.6e-20	0.53	0.70	0.30
PGSC0003DMT200000547	K04496	ko04310	Wnt signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMT200000547	K04496	ko04330	Notch signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMT200000547	K04496	ko05200	Pathways in cancer	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMT200000547	K04496	ko05220	Chronic myeloid leukemia	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMT200000553	K01762	ko00270	Cysteine and methionine metabolism	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMT200000553	K01762	ko01110	Biosynthesis of secondary metabolites	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMT200042672	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMT200042672	K00891	ko01100	Metabolic pathways	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMT200042672	K00891	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMT200042673	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042673	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042673	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042674	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042674	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042674	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMT200042675	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMT200042675	K00891	ko01100	Metabolic pathways	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMT200042675	K00891	ko01110	Biosynthesis of secondary metabolites	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMT200042702	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMT200042702	K00517	ko00626	Naphthalene and anthracene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMT200042702	K00517	ko00903	Limonene and pinene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMT200042702	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMT200042702	K00517	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMT200023215	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMT200023216	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMT200023217	K10686	ko04120	Ubiquitin mediated proteolysis	659	1.6e-30	0.80	0.89	0.89
PGSC0003DMT200023224	K05592	ko03018	RNA degradation	440	2.0e-18	0.31	0.50	0.94
PGSC0003DMT200023226	K05592	ko03018	RNA degradation	448	7.1e-19	0.36	0.55	0.76
PGSC0003DMT200005625	K01369	ko04142	Lysosome	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMT200005625	K01369	ko04612	Antigen processing and presentation	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMT200005630	K01369	ko04142	Lysosome	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMT200005630	K01369	ko04612	Antigen processing and presentation	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMT200005633	K01369	ko04142	Lysosome	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMT200005633	K01369	ko04612	Antigen processing and presentation	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMT200005639	K02140	ko00190	Oxidative phosphorylation	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMT200005639	K02140	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMT200005644	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1890	2.1e-98	0.44	0.63	0.82
PGSC0003DMT200005645	K00128	ko00010	Glycolysis / Gluconeogenesis	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00053	Ascorbate and aldarate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00071	Fatty acid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00280	Valine, leucine and isoleucine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00310	Lysine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00330	Arginine and proline metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00340	Histidine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00380	Tryptophan metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00410	beta-Alanine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00561	Glycerolipid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00620	Pyruvate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00631	1,2-Dichloroethane degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00640	Propanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00641	3-Chloroacrylic acid degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00650	Butanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko00903	Limonene and pinene degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko01100	Metabolic pathways	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005645	K00128	ko01110	Biosynthesis of secondary metabolites	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMT200005662	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005662	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005663	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMT200005668	K01184	ko00040	Pentose and glucuronate interconversions	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMT200005668	K01184	ko00500	Starch and sucrose metabolism	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMT200005668	K01184	ko01100	Metabolic pathways	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMT200005672	K11294	ko05130	Pathogenic Escherichia coli infection	242	5.2e-07	0.30	0.50	0.55
PGSC0003DMT200005677	K04416	ko04010	MAPK signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMT200005677	K04416	ko04120	Ubiquitin mediated proteolysis	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMT200005677	K04416	ko04622	RIG-I-like receptor signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMT200005677	K04416	ko04722	Neurotrophin signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMT200005677	K04416	ko04912	GnRH signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMT200005678	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMT200031598	K01509	ko00230	Purine metabolism	1073	2.4e-53	0.45	0.61	0.91
PGSC0003DMT200031601	K12667	ko00510	N-Glycan biosynthesis	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMT200031601	K12667	ko01100	Metabolic pathways	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMT200031602	K12667	ko00510	N-Glycan biosynthesis	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMT200031602	K12667	ko01100	Metabolic pathways	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMT200031608	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMT200031608	K03857	ko01100	Metabolic pathways	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMT200031611	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMT200031611	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMT200031612	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMT200031612	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMT200031613	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMT200031613	K03857	ko01100	Metabolic pathways	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMT200031617	K01950	ko00760	Nicotinate and nicotinamide metabolism	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMT200031617	K01950	ko01100	Metabolic pathways	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMT200031618	K01950	ko00760	Nicotinate and nicotinamide metabolism	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMT200031618	K01950	ko01100	Metabolic pathways	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMT200031619	K01950	ko00760	Nicotinate and nicotinamide metabolism	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMT200031619	K01950	ko01100	Metabolic pathways	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMT200031620	K01950	ko00760	Nicotinate and nicotinamide metabolism	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMT200031620	K01950	ko01100	Metabolic pathways	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMT200031625	K01950	ko00760	Nicotinate and nicotinamide metabolism	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMT200031625	K01950	ko01100	Metabolic pathways	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMT200031626	K01177	ko00500	Starch and sucrose metabolism	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMT200031626	K01177	ko01100	Metabolic pathways	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMT200031627	K01177	ko00500	Starch and sucrose metabolism	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMT200031627	K01177	ko01100	Metabolic pathways	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMT200031635	K03105	ko03060	Protein export	927	2.7e-45	0.80	0.89	0.99
PGSC0003DMT200069629	K02350	ko01100	Metabolic pathways	359	2.2e-10	0.26	0.44	0.65
PGSC0003DMT200069632	K01728	ko00040	Pentose and glucuronate interconversions	2578	2.3e-136	0.74	0.85	0.98
PGSC0003DMT200069646	K01955	ko00240	Pyrimidine metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMT200069646	K01955	ko00250	Alanine, aspartate and glutamate metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMT200069646	K01955	ko01100	Metabolic pathways	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMT200086094	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMT200086094	K00517	ko00626	Naphthalene and anthracene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMT200086094	K00517	ko00903	Limonene and pinene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMT200086094	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMT200086094	K00517	ko01110	Biosynthesis of secondary metabolites	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMT200052127	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMT200052127	K05294	ko01100	Metabolic pathways	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMT200052128	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMT200052128	K05294	ko01100	Metabolic pathways	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMT200052131	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMT200052131	K05294	ko01100	Metabolic pathways	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMT200052135	K10652	ko04622	RIG-I-like receptor signaling pathway	280	1.0e-07	0.39	0.53	0.31
PGSC0003DMT200052137	K01895	ko00010	Glycolysis / Gluconeogenesis	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052137	K01895	ko00620	Pyruvate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052137	K01895	ko00640	Propanoate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052137	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052137	K01895	ko01100	Metabolic pathways	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052137	K01895	ko01110	Biosynthesis of secondary metabolites	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMT200052139	K01895	ko00010	Glycolysis / Gluconeogenesis	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052139	K01895	ko00620	Pyruvate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052139	K01895	ko00640	Propanoate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052139	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052139	K01895	ko01100	Metabolic pathways	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052139	K01895	ko01110	Biosynthesis of secondary metabolites	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMT200052149	K03723	ko03420	Nucleotide excision repair	1273	2.2e-64	0.42	0.60	0.97
PGSC0003DMT200052150	K03723	ko03420	Nucleotide excision repair	2362	1.9e-124	0.45	0.66	0.85
PGSC0003DMT200077736	K06685	ko04111	Cell cycle - yeast	342	1.0e-09	0.27	0.43	0.93
PGSC0003DMT200095800	K04508	ko04310	Wnt signaling pathway	298	4.4e-08	0.53	0.64	0.14
PGSC0003DMT200095815	K00850	ko00010	Glycolysis / Gluconeogenesis	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200095815	K00850	ko00030	Pentose phosphate pathway	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200095815	K00850	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200095815	K00850	ko00052	Galactose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200095815	K00850	ko01100	Metabolic pathways	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200095815	K00850	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMT200035930	K01369	ko04142	Lysosome	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMT200035930	K01369	ko04612	Antigen processing and presentation	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMT200035940	K12471	ko04144	Endocytosis	627	9.5e-29	0.31	0.47	0.81
PGSC0003DMT200035956	K05853	ko04020	Calcium signaling pathway	6444	0.	0.81	0.88	0.92
PGSC0003DMT200035956	K05853	ko05010	Alzheimer's disease	6444	0.	0.81	0.88	0.92
PGSC0003DMT200035968	K02132	ko00190	Oxidative phosphorylation	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMT200035968	K02132	ko01100	Metabolic pathways	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMT200035968	K02132	ko05010	Alzheimer's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMT200035968	K02132	ko05012	Parkinson's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMT200035968	K02132	ko05016	Huntington's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMT200035981	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMT200035981	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMT200035983	K00423	ko00053	Ascorbate and aldarate metabolism	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMT200035983	K00423	ko01100	Metabolic pathways	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMT200035984	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMT200035984	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMT200029316	K00228	ko00860	Porphyrin and chlorophyll metabolism	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMT200029316	K00228	ko01100	Metabolic pathways	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMT200029318	K13066	ko00940	Phenylpropanoid biosynthesis	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMT200029318	K13066	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMT200029354	K12742	ko00900	Terpenoid backbone biosynthesis	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMT200029354	K12742	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMT200017087	K00695	ko00500	Starch and sucrose metabolism	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMT200017087	K00695	ko01100	Metabolic pathways	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMT200017088	K00695	ko00500	Starch and sucrose metabolism	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMT200017088	K00695	ko01100	Metabolic pathways	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMT200017092	K00695	ko00500	Starch and sucrose metabolism	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMT200017092	K00695	ko01100	Metabolic pathways	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMT200017093	K00695	ko00500	Starch and sucrose metabolism	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMT200017093	K00695	ko01100	Metabolic pathways	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMT200017094	K00695	ko00500	Starch and sucrose metabolism	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMT200017094	K00695	ko01100	Metabolic pathways	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMT200017106	K01066	ko00623	2,4-Dichlorobenzoate degradation	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMT200017106	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMT200017110	K00813	ko00250	Alanine, aspartate and glutamate metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00270	Cysteine and methionine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00330	Arginine and proline metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00350	Tyrosine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00360	Phenylalanine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00401	Novobiocin biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00710	Carbon fixation in photosynthetic organisms	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00950	Isoquinoline alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko01100	Metabolic pathways	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017110	K00813	ko01110	Biosynthesis of secondary metabolites	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMT200017111	K00813	ko00250	Alanine, aspartate and glutamate metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00270	Cysteine and methionine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00330	Arginine and proline metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00350	Tyrosine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00360	Phenylalanine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00401	Novobiocin biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00710	Carbon fixation in photosynthetic organisms	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00950	Isoquinoline alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko01100	Metabolic pathways	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017111	K00813	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMT200017112	K00813	ko00250	Alanine, aspartate and glutamate metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00270	Cysteine and methionine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00330	Arginine and proline metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00350	Tyrosine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00360	Phenylalanine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00401	Novobiocin biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00710	Carbon fixation in photosynthetic organisms	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00950	Isoquinoline alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko01100	Metabolic pathways	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017112	K00813	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMT200017113	K00813	ko00250	Alanine, aspartate and glutamate metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00270	Cysteine and methionine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00330	Arginine and proline metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00350	Tyrosine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00360	Phenylalanine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00401	Novobiocin biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00710	Carbon fixation in photosynthetic organisms	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00950	Isoquinoline alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko01100	Metabolic pathways	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017113	K00813	ko01110	Biosynthesis of secondary metabolites	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMT200017114	K00430	ko00360	Phenylalanine metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMT200017114	K00430	ko00680	Methane metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMT200017114	K00430	ko00940	Phenylpropanoid biosynthesis	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMT200017114	K00430	ko01100	Metabolic pathways	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMT200017114	K00430	ko01110	Biosynthesis of secondary metabolites	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMT200017118	K00430	ko00360	Phenylalanine metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMT200017118	K00430	ko00680	Methane metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMT200017118	K00430	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMT200017118	K00430	ko01100	Metabolic pathways	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMT200017118	K00430	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMT200017120	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMT200017120	K00430	ko00680	Methane metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMT200017120	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMT200017120	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMT200017120	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMT200017123	K04567	ko00970	Aminoacyl-tRNA biosynthesis	602	2.3e-27	0.60	0.68	0.48
PGSC0003DMT200082475	K02735	ko03050	Proteasome	1599	2.3e-82	0.92	0.97	1.00
PGSC0003DMT200082481	K01358	ko04112	Cell cycle - Caulobacter	1672	2.2e-86	0.83	0.91	1.00
PGSC0003DMT200082493	K02864	ko03010	Ribosome	1290	2.6e-65	0.68	0.79	0.99
PGSC0003DMT200082507	K02084	ko04115	p53 signaling pathway	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko04210	Apoptosis	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko05010	Alzheimer's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko05012	Parkinson's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko05016	Huntington's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200082507	K02084	ko05222	Small cell lung cancer	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMT200072131	K04427	ko04010	MAPK signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04310	Wnt signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04520	Adherens junction	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04620	Toll-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04621	NOD-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04622	RIG-I-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko04660	T cell receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072131	K04427	ko05140	Leishmaniasis	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMT200072132	K04427	ko04010	MAPK signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04310	Wnt signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04520	Adherens junction	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04620	Toll-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04621	NOD-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04622	RIG-I-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko04660	T cell receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072132	K04427	ko05140	Leishmaniasis	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMT200072134	K04427	ko04010	MAPK signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04310	Wnt signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04520	Adherens junction	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04620	Toll-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04621	NOD-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04622	RIG-I-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko04660	T cell receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072134	K04427	ko05140	Leishmaniasis	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMT200072137	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMT200072137	K12449	ko01100	Metabolic pathways	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMT200072139	K11254	ko05322	Systemic lupus erythematosus	390	1.1e-15	0.55	0.58	0.99
PGSC0003DMT200072157	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	612	6.4e-28	0.34	0.50	0.95
PGSC0003DMT200072158	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	544	3.6e-24	0.33	0.49	0.94
PGSC0003DMT200072159	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	530	2.1e-23	0.37	0.53	0.85
PGSC0003DMT200044239	K13229	ko00402	Benzoxazinoid biosynthesis	820	2.2e-39	0.46	0.65	0.99
PGSC0003DMT200044240	K13229	ko00402	Benzoxazinoid biosynthesis	576	6.2e-26	0.49	0.66	0.95
PGSC0003DMT200044242	K13229	ko00402	Benzoxazinoid biosynthesis	459	1.8e-19	0.45	0.63	0.99
PGSC0003DMT200044247	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMT200044248	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMT200044249	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMT200044251	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMT200044252	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMT200044255	K13229	ko00402	Benzoxazinoid biosynthesis	834	3.6e-40	0.48	0.65	0.85
PGSC0003DMT200044256	K13229	ko00402	Benzoxazinoid biosynthesis	439	2.2e-18	0.51	0.69	0.91
PGSC0003DMT200044257	K13229	ko00402	Benzoxazinoid biosynthesis	876	1.8e-42	0.47	0.64	1.00
PGSC0003DMT200044258	K13229	ko00402	Benzoxazinoid biosynthesis	621	2.0e-28	0.49	0.68	0.94
PGSC0003DMT200044259	K13229	ko00402	Benzoxazinoid biosynthesis	267	6.8e-09	0.35	0.58	0.90
PGSC0003DMT200044261	K12356	ko00940	Phenylpropanoid biosynthesis	640	1.8e-29	0.34	0.51	0.97
PGSC0003DMT200044262	K12356	ko00940	Phenylpropanoid biosynthesis	730	2.0e-34	0.34	0.50	0.98
PGSC0003DMT200054695	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMT200054695	K05290	ko01100	Metabolic pathways	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMT200054702	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMT200054702	K02433	ko01100	Metabolic pathways	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMT200054703	K02433	ko00970	Aminoacyl-tRNA biosynthesis	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMT200054703	K02433	ko01100	Metabolic pathways	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMT200054704	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMT200054704	K02433	ko01100	Metabolic pathways	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMT200054705	K02433	ko00970	Aminoacyl-tRNA biosynthesis	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMT200054705	K02433	ko01100	Metabolic pathways	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMT200054724	K10595	ko04120	Ubiquitin mediated proteolysis	472	1.5e-18	0.31	0.47	0.97
PGSC0003DMT200054725	K10615	ko04120	Ubiquitin mediated proteolysis	366	1.5e-13	0.31	0.47	0.98
PGSC0003DMT200054729	K00799	ko00480	Glutathione metabolism	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMT200054729	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMT200054729	K00799	ko00982	Drug metabolism - cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMT200062344	K12845	ko03040	Spliceosome	995	4.8e-49	0.94	0.97	0.99
PGSC0003DMT200062345	K06700	ko03050	Proteasome	1359	4.0e-69	0.57	0.65	1.00
PGSC0003DMT200062346	K06700	ko03050	Proteasome	1396	3.7e-71	0.60	0.68	1.00
PGSC0003DMT200062347	K06700	ko03050	Proteasome	1406	1.0e-71	0.60	0.69	1.00
PGSC0003DMT200062350	K05863	ko04020	Calcium signaling pathway	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMT200062350	K05863	ko05012	Parkinson's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMT200062350	K05863	ko05016	Huntington's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMT200062357	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMT200062357	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMT200062357	K00771	ko01100	Metabolic pathways	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMT200062358	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMT200062358	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMT200062358	K00771	ko01100	Metabolic pathways	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMT200062366	K02084	ko04115	p53 signaling pathway	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko04210	Apoptosis	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko05010	Alzheimer's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko05012	Parkinson's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko05016	Huntington's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062366	K02084	ko05222	Small cell lung cancer	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMT200062367	K04123	ko00904	Diterpenoid biosynthesis	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMT200062367	K04123	ko01100	Metabolic pathways	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMT200062367	K04123	ko01110	Biosynthesis of secondary metabolites	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMT200035021	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMT200035021	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMT200035022	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMT200035022	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMT200035023	K04424	ko04010	MAPK signaling pathway	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMT200035023	K04424	ko04530	Tight junction	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMT200035045	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMT200035045	K00517	ko00626	Naphthalene and anthracene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMT200035045	K00517	ko00903	Limonene and pinene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMT200035045	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMT200035045	K00517	ko01110	Biosynthesis of secondary metabolites	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMT200035051	K01875	ko00970	Aminoacyl-tRNA biosynthesis	509	3.1e-22	0.80	0.93	0.34
PGSC0003DMT200035054	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.82	0.91	1.00
PGSC0003DMT200035059	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035059	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035059	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035059	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035059	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035059	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035060	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMT200035061	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035061	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035061	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035061	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035061	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035061	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMT200035064	K01648	ko00020	Citrate cycle (TCA cycle)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMT200035064	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMT200035064	K01648	ko01100	Metabolic pathways	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMT200035064	K01648	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMT200011486	K09561	ko04120	Ubiquitin mediated proteolysis	246	9.8e-08	0.36	0.51	0.37
PGSC0003DMT200011490	K00737	ko00510	N-Glycan biosynthesis	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMT200011490	K00737	ko01100	Metabolic pathways	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMT200011491	K00737	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMT200011491	K00737	ko01100	Metabolic pathways	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMT200011510	K12356	ko00940	Phenylpropanoid biosynthesis	682	8.8e-32	0.32	0.49	0.97
PGSC0003DMT200011514	K11866	ko04144	Endocytosis	544	1.4e-23	0.29	0.45	0.91
PGSC0003DMT200011522	K02639	ko00195	Photosynthesis	802	2.1e-38	0.66	0.83	0.99
PGSC0003DMT200011523	K01115	ko00564	Glycerophospholipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200011523	K01115	ko00565	Ether lipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200011523	K01115	ko01100	Metabolic pathways	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200011523	K01115	ko04144	Endocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200011523	K01115	ko04666	Fc gamma R-mediated phagocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200011523	K01115	ko04912	GnRH signaling pathway	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMT200019231	K00111	ko00564	Glycerophospholipid metabolism	4432	1.3e-238	0.86	0.93	0.52
PGSC0003DMT200019234	K08332	ko04140	Regulation of autophagy	328	2.5e-10	0.29	0.50	0.59
PGSC0003DMT200019235	K08332	ko04140	Regulation of autophagy	328	9.4e-10	0.29	0.50	0.46
PGSC0003DMT200019237	K03094	ko04110	Cell cycle	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04111	Cell cycle - yeast	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04114	Oocyte meiosis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04120	Ubiquitin mediated proteolysis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04310	Wnt signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04350	TGF-beta signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200019237	K03094	ko04710	Circadian rhythm - mammal	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMT200003933	K01177	ko00500	Starch and sucrose metabolism	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMT200003933	K01177	ko01100	Metabolic pathways	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMT200003941	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMT200003941	K01703	ko00660	C5-Branched dibasic acid metabolism	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMT200003941	K01703	ko01100	Metabolic pathways	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMT200003941	K01703	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMT200003942	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003942	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003942	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003942	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003943	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003943	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003943	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003943	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003944	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003944	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003944	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003944	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMT200003945	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMT200003945	K01703	ko00660	C5-Branched dibasic acid metabolism	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMT200003945	K01703	ko01100	Metabolic pathways	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMT200003945	K01703	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMT200003946	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003946	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003946	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003946	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003947	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003947	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003947	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003947	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMT200003951	K02434	ko00970	Aminoacyl-tRNA biosynthesis	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMT200003951	K02434	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMT200003952	K02434	ko00970	Aminoacyl-tRNA biosynthesis	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMT200003952	K02434	ko01100	Metabolic pathways	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMT200069798	K00382	ko00010	Glycolysis / Gluconeogenesis	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko00020	Citrate cycle (TCA cycle)	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko00260	Glycine, serine and threonine metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko00280	Valine, leucine and isoleucine degradation	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko00620	Pyruvate metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko01100	Metabolic pathways	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069798	K00382	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMT200069799	K00382	ko00010	Glycolysis / Gluconeogenesis	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko00020	Citrate cycle (TCA cycle)	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko00260	Glycine, serine and threonine metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko00280	Valine, leucine and isoleucine degradation	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko00620	Pyruvate metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko01100	Metabolic pathways	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069799	K00382	ko01110	Biosynthesis of secondary metabolites	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMT200069800	K00382	ko00010	Glycolysis / Gluconeogenesis	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko00020	Citrate cycle (TCA cycle)	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko00260	Glycine, serine and threonine metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko00280	Valine, leucine and isoleucine degradation	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko00620	Pyruvate metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko01100	Metabolic pathways	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069800	K00382	ko01110	Biosynthesis of secondary metabolites	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMT200069803	K00382	ko00010	Glycolysis / Gluconeogenesis	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko00020	Citrate cycle (TCA cycle)	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko00260	Glycine, serine and threonine metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko00280	Valine, leucine and isoleucine degradation	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko00620	Pyruvate metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko01100	Metabolic pathways	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069803	K00382	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMT200069814	K00660	ko00941	Flavonoid biosynthesis	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMT200069814	K00660	ko01100	Metabolic pathways	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMT200069814	K00660	ko01110	Biosynthesis of secondary metabolites	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMT200069814	K00660	ko04712	Circadian rhythm - plant	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMT200069836	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMT200069836	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMT200069836	K03877	ko01100	Metabolic pathways	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMT200069837	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMT200069837	K07819	ko01100	Metabolic pathways	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMT200060308	K10775	ko00360	Phenylalanine metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMT200060308	K10775	ko00910	Nitrogen metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMT200060308	K10775	ko00940	Phenylpropanoid biosynthesis	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMT200060308	K10775	ko01100	Metabolic pathways	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMT200060308	K10775	ko01110	Biosynthesis of secondary metabolites	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMT200060313	K08907	ko00196	Photosynthesis - antenna proteins	1812	4.2e-94	0.84	0.91	0.99
PGSC0003DMT200060318	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060318	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060318	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060318	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060318	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060318	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060319	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMT200060320	K01054	ko00561	Glycerolipid metabolism	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMT200060320	K01054	ko01100	Metabolic pathways	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMT200060321	K01054	ko00561	Glycerolipid metabolism	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMT200060321	K01054	ko01100	Metabolic pathways	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMT200060328	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060328	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060328	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060328	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060328	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060329	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060329	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060329	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060329	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200060329	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMT200047872	K00276	ko00260	Glycine, serine and threonine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko00350	Tyrosine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko00360	Phenylalanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko00410	beta-Alanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko01100	Metabolic pathways	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047872	K00276	ko01110	Biosynthesis of secondary metabolites	5714	0.	0.82	0.90	1.00
PGSC0003DMT200047879	K12393	ko04142	Lysosome	3390	3.8e-181	0.93	0.97	1.00
PGSC0003DMT200047881	K00737	ko00510	N-Glycan biosynthesis	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMT200047881	K00737	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMT200052019	K11420	ko00310	Lysine degradation	603	2.0e-27	0.36	0.48	0.50
PGSC0003DMT200052020	K11420	ko00310	Lysine degradation	606	1.4e-27	0.36	0.48	0.43
PGSC0003DMT200052028	K01834	ko00010	Glycolysis / Gluconeogenesis	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMT200052028	K01834	ko01100	Metabolic pathways	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMT200052028	K01834	ko01110	Biosynthesis of secondary metabolites	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMT200052043	K07195	ko04910	Insulin signaling pathway	2422	9.4e-128	0.47	0.64	0.97
PGSC0003DMT200023412	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMT200023412	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMT200023412	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMT200023413	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMT200023413	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMT200023413	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMT200023414	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMT200023414	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMT200023414	K00734	ko01100	Metabolic pathways	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMT200023419	K06689	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.99	1.00	0.99
PGSC0003DMT200023444	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMT200023445	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMT200023446	K00797	ko00270	Cysteine and methionine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMT200023446	K00797	ko00330	Arginine and proline metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMT200023446	K00797	ko00410	beta-Alanine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMT200023446	K00797	ko00480	Glutathione metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMT200023446	K00797	ko01100	Metabolic pathways	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMT200023450	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMT200023451	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMT200023452	K12827	ko03040	Spliceosome	1846	5.6e-96	0.85	0.92	1.00
PGSC0003DMT200023455	K01051	ko00040	Pentose and glucuronate interconversions	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMT200023455	K01051	ko00500	Starch and sucrose metabolism	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMT200023455	K01051	ko01100	Metabolic pathways	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMT200013567	K01358	ko04112	Cell cycle - Caulobacter	689	3.6e-32	0.79	0.94	0.92
PGSC0003DMT200013568	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMT200013570	K04382	ko04111	Cell cycle - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04113	Meiosis - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04114	Oocyte meiosis	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04310	Wnt signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04350	TGF-beta signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04530	Tight junction	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko04730	Long-term depression	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013570	K04382	ko05142	Chagas disease	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMT200013571	K04382	ko04111	Cell cycle - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04113	Meiosis - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04114	Oocyte meiosis	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04310	Wnt signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04350	TGF-beta signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04530	Tight junction	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko04730	Long-term depression	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013571	K04382	ko05142	Chagas disease	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMT200013573	K04382	ko04111	Cell cycle - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04113	Meiosis - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04114	Oocyte meiosis	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04310	Wnt signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04350	TGF-beta signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04530	Tight junction	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko04730	Long-term depression	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013573	K04382	ko05142	Chagas disease	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMT200013592	K02707	ko00195	Photosynthesis	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMT200013592	K02707	ko01100	Metabolic pathways	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMT200005496	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005496	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005496	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005497	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005497	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005497	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMT200005498	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005498	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005498	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005499	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005499	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005499	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMT200005500	K12593	ko03018	RNA degradation	270	4.7e-09	0.42	0.60	0.97
PGSC0003DMT200005501	K12593	ko03018	RNA degradation	726	3.3e-34	0.57	0.67	0.97
PGSC0003DMT200005518	K07750	ko00100	Steroid biosynthesis	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMT200005518	K07750	ko01100	Metabolic pathways	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMT200005519	K07750	ko00100	Steroid biosynthesis	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMT200005519	K07750	ko01100	Metabolic pathways	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMT200005532	K00799	ko00480	Glutathione metabolism	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMT200005532	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMT200005532	K00799	ko00982	Drug metabolism - cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMT200005534	K00799	ko00480	Glutathione metabolism	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMT200005534	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMT200005534	K00799	ko00982	Drug metabolism - cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMT200005536	K00799	ko00480	Glutathione metabolism	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMT200005536	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMT200005536	K00799	ko00982	Drug metabolism - cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMT200005538	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMT200005538	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMT200005538	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMT200005542	K00799	ko00480	Glutathione metabolism	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMT200005542	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMT200005542	K00799	ko00982	Drug metabolism - cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMT200039558	K05574	ko00190	Oxidative phosphorylation	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMT200039558	K05574	ko01100	Metabolic pathways	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMT200039600	K10143	ko04115	p53 signaling pathway	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMT200039600	K10143	ko04120	Ubiquitin mediated proteolysis	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMT200039601	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMT200039601	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMT200091467	K00558	ko00270	Cysteine and methionine metabolism	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMT200091467	K00558	ko01100	Metabolic pathways	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMT200058495	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058495	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058495	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058496	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058496	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058496	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMT200058497	K05732	ko04510	Focal adhesion	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMT200058497	K05732	ko04670	Leukocyte transendothelial migration	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMT200058497	K05732	ko04810	Regulation of actin cytoskeleton	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMT200058498	K05732	ko04510	Focal adhesion	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMT200058498	K05732	ko04670	Leukocyte transendothelial migration	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMT200058498	K05732	ko04810	Regulation of actin cytoskeleton	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMT200058499	K05732	ko04510	Focal adhesion	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMT200058499	K05732	ko04670	Leukocyte transendothelial migration	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMT200058499	K05732	ko04810	Regulation of actin cytoskeleton	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMT200058518	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058518	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058518	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058519	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058519	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058519	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMT200058520	K00100	ko00051	Fructose and mannose metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058520	K00100	ko00363	Bisphenol A degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058520	K00100	ko00591	Linoleic acid metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058520	K00100	ko00625	Tetrachloroethene degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058520	K00100	ko00650	Butanoate metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058520	K00100	ko01100	Metabolic pathways	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMT200058525	K03364	ko04110	Cell cycle	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMT200058525	K03364	ko04111	Cell cycle - yeast	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMT200058525	K03364	ko04120	Ubiquitin mediated proteolysis	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMT200058525	K03364	ko04914	Progesterone-mediated oocyte maturation	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMT200058531	K01115	ko00564	Glycerophospholipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058531	K01115	ko00565	Ether lipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058531	K01115	ko01100	Metabolic pathways	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058531	K01115	ko04144	Endocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058531	K01115	ko04666	Fc gamma R-mediated phagocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058531	K01115	ko04912	GnRH signaling pathway	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMT200058532	K01115	ko00564	Glycerophospholipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058532	K01115	ko00565	Ether lipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058532	K01115	ko01100	Metabolic pathways	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058532	K01115	ko04144	Endocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058532	K01115	ko04666	Fc gamma R-mediated phagocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058532	K01115	ko04912	GnRH signaling pathway	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMT200058533	K12451	ko00520	Amino sugar and nucleotide sugar metabolism	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMT200058533	K12451	ko00523	Polyketide sugar unit biosynthesis	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMT200068048	K10260	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.29	0.46	0.68
PGSC0003DMT200068057	K00852	ko00030	Pentose phosphate pathway	803	1.9e-38	0.37	0.55	0.67
PGSC0003DMT200068058	K00852	ko00030	Pentose phosphate pathway	382	3.1e-15	0.39	0.59	0.47
PGSC0003DMT200068059	K13056	ko04114	Oocyte meiosis	311	2.6e-11	0.29	0.44	0.58
PGSC0003DMT200068072	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6057	0.	0.73	0.83	0.98
PGSC0003DMT200068073	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6484	0.	0.77	0.88	0.98
PGSC0003DMT200068074	K01872	ko00970	Aminoacyl-tRNA biosynthesis	382	1.7e-14	0.95	0.95	0.66
PGSC0003DMT200050139	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMT200050139	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMT200050139	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMT200050139	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMT200050139	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMT200050142	K00430	ko00360	Phenylalanine metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMT200050142	K00430	ko00680	Methane metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMT200050142	K00430	ko00940	Phenylpropanoid biosynthesis	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMT200050142	K00430	ko01100	Metabolic pathways	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMT200050142	K00430	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMT200050143	K00430	ko00360	Phenylalanine metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMT200050143	K00430	ko00680	Methane metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMT200050143	K00430	ko00940	Phenylpropanoid biosynthesis	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMT200050143	K00430	ko01100	Metabolic pathways	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMT200050143	K00430	ko01110	Biosynthesis of secondary metabolites	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMT200050144	K00430	ko00360	Phenylalanine metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMT200050144	K00430	ko00680	Methane metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMT200050144	K00430	ko00940	Phenylpropanoid biosynthesis	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMT200050144	K00430	ko01100	Metabolic pathways	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMT200050144	K00430	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMT200050157	K05681	ko02010	ABC transporters	269	1.7e-08	0.33	0.51	0.69
PGSC0003DMT200085166	K04123	ko00904	Diterpenoid biosynthesis	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMT200085166	K04123	ko01100	Metabolic pathways	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMT200085166	K04123	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMT200092660	K03937	ko00190	Oxidative phosphorylation	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMT200092660	K03937	ko01100	Metabolic pathways	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMT200092660	K03937	ko05010	Alzheimer's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMT200092660	K03937	ko05012	Parkinson's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMT200092660	K03937	ko05016	Huntington's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMT200097007	K11816	ko00380	Tryptophan metabolism	1375	5.3e-70	0.45	0.67	0.96
PGSC0003DMT200097008	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200015320	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMT200015320	K08081	ko01100	Metabolic pathways	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMT200015320	K08081	ko01110	Biosynthesis of secondary metabolites	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMT200015321	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMT200015321	K08081	ko01100	Metabolic pathways	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMT200015321	K08081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMT200015323	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015323	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015323	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015323	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015323	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015324	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015324	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015324	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015324	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015324	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMT200015328	K12778	ko04113	Meiosis - yeast	432	6.2e-16	0.32	0.53	0.30
PGSC0003DMT200025165	K08241	ko00592	alpha-Linolenic acid metabolism	689	3.6e-32	0.34	0.52	0.98
PGSC0003DMT200025177	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025177	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMT200025178	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025178	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMT200025179	K08241	ko00592	alpha-Linolenic acid metabolism	673	2.8e-31	0.34	0.51	0.89
PGSC0003DMT200025180	K08241	ko00592	alpha-Linolenic acid metabolism	514	1.6e-22	0.32	0.47	0.89
PGSC0003DMT200025206	K03469	ko03030	DNA replication	255	3.1e-08	0.37	0.57	0.30
PGSC0003DMT200079395	K12338	ko00942	Anthocyanin biosynthesis	245	1.7e-07	0.47	0.68	0.53
PGSC0003DMT200079398	K12607	ko03018	RNA degradation	3943	1.2e-211	0.60	0.75	1.00
PGSC0003DMT200079408	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMT200079409	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMT200064084	K01528	ko04144	Endocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMT200064084	K01528	ko04666	Fc gamma R-mediated phagocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMT200064084	K01528	ko05100	Bacterial invasion of epithelial cells	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMT200064085	K01528	ko04144	Endocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMT200064085	K01528	ko04666	Fc gamma R-mediated phagocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMT200064085	K01528	ko05100	Bacterial invasion of epithelial cells	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMT200064098	K13034	ko00270	Cysteine and methionine metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMT200064098	K13034	ko00450	Selenoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMT200064098	K13034	ko00460	Cyanoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMT200064098	K13034	ko00920	Sulfur metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMT200064098	K13034	ko01100	Metabolic pathways	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMT200064100	K03024	ko00230	Purine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMT200064100	K03024	ko00240	Pyrimidine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMT200064100	K03024	ko01100	Metabolic pathways	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMT200064100	K03024	ko03020	RNA polymerase	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMT200064100	K03024	ko04623	Cytosolic DNA-sensing pathway	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMT200064102	K07904	ko04144	Endocytosis	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMT200064102	K07904	ko04962	Vasopressin-regulated water reabsorption	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMT200064103	K05894	ko00592	alpha-Linolenic acid metabolism	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMT200064103	K05894	ko01100	Metabolic pathways	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMT200056461	K02342	ko00230	Purine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056461	K02342	ko00240	Pyrimidine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056461	K02342	ko01100	Metabolic pathways	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056461	K02342	ko03030	DNA replication	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056461	K02342	ko03430	Mismatch repair	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056461	K02342	ko03440	Homologous recombination	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMT200056465	K05666	ko02010	ABC transporters	2410	4.3e-127	0.39	0.55	0.95
PGSC0003DMT200056466	K05666	ko02010	ABC transporters	2903	2.8e-154	0.46	0.63	0.94
PGSC0003DMT200056467	K05666	ko02010	ABC transporters	2867	2.7e-152	0.46	0.63	0.91
PGSC0003DMT200056468	K05666	ko02010	ABC transporters	3193	2.8e-170	0.40	0.59	0.96
PGSC0003DMT200056469	K05666	ko02010	ABC transporters	1598	2.6e-82	0.34	0.53	0.95
PGSC0003DMT200056470	K05666	ko02010	ABC transporters	3622	6.1e-194	0.43	0.62	0.96
PGSC0003DMT200056471	K05666	ko02010	ABC transporters	3509	1.0e-187	0.43	0.63	0.97
PGSC0003DMT200056487	K02084	ko04115	p53 signaling pathway	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko04210	Apoptosis	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko05010	Alzheimer's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko05012	Parkinson's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko05016	Huntington's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056487	K02084	ko05222	Small cell lung cancer	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMT200056494	K03097	ko04310	Wnt signaling pathway	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMT200056494	K03097	ko04520	Adherens junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMT200056494	K03097	ko04530	Tight junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMT200056494	K03097	ko04712	Circadian rhythm - plant	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMT200089404	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200089404	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200017443	K00680	ko00350	Tyrosine metabolism	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMT200017443	K00680	ko00624	1- and 2-Methylnaphthalene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMT200017443	K00680	ko00632	Benzoate degradation via CoA ligation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMT200017443	K00680	ko00642	Ethylbenzene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMT200017443	K00680	ko00903	Limonene and pinene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMT200017444	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMT200017444	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMT200017444	K00820	ko01100	Metabolic pathways	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMT200017445	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017445	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017445	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017446	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017446	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017446	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017447	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017447	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017447	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMT200017456	K03087	ko05111	Vibrio cholerae pathogenic cycle	571	1.2e-25	0.47	0.69	0.75
PGSC0003DMT200017461	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMT200017461	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMT200017462	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMT200017462	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMT200009731	K03679	ko03018	RNA degradation	1883	5.1e-98	0.70	0.83	1.00
PGSC0003DMT200009751	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMT200009761	K12741	ko03040	Spliceosome	872	2.9e-42	0.43	0.57	0.98
PGSC0003DMT200009762	K12741	ko03040	Spliceosome	1352	9.8e-69	0.46	0.59	0.99
PGSC0003DMT200023890	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMT200023890	K01850	ko01100	Metabolic pathways	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMT200023890	K01850	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMT200023891	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMT200023891	K01850	ko01100	Metabolic pathways	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMT200023891	K01850	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMT200023920	K03660	ko03410	Base excision repair	2101	4.8e-110	0.70	0.81	0.96
PGSC0003DMT200023923	K06627	ko04110	Cell cycle	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMT200023923	K06627	ko04914	Progesterone-mediated oocyte maturation	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMT200015682	K08496	ko04130	SNARE interactions in vesicular transport	1250	4.1e-63	0.62	0.82	0.94
PGSC0003DMT200015698	K12132	ko04712	Circadian rhythm - plant	1304	4.4e-66	0.59	0.73	0.95
PGSC0003DMT200015700	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMT200015701	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMT200015702	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMT200015710	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4416	9.9e-238	0.77	0.85	0.98
PGSC0003DMT200015711	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2681	4.9e-142	0.87	0.95	0.99
PGSC0003DMT200015714	K01868	ko00970	Aminoacyl-tRNA biosynthesis	574	8.0e-26	0.77	0.92	0.91
PGSC0003DMT200030495	K04122	ko00904	Diterpenoid biosynthesis	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMT200030495	K04122	ko01100	Metabolic pathways	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMT200030495	K04122	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMT200030498	K03100	ko03060	Protein export	1916	7.7e-100	0.63	0.76	1.00
PGSC0003DMT200030499	K03100	ko03060	Protein export	1701	5.5e-88	0.63	0.76	1.00
PGSC0003DMT200030503	K12356	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.29	0.46	0.93
PGSC0003DMT200030504	K12356	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.29	0.46	0.93
PGSC0003DMT200030505	K03911	ko04610	Complement and coagulation cascades	635	3.4e-29	0.32	0.50	0.94
PGSC0003DMT200030506	K03911	ko04610	Complement and coagulation cascades	705	4.8e-33	0.33	0.53	0.95
PGSC0003DMT200030513	K03911	ko04610	Complement and coagulation cascades	678	1.5e-31	0.32	0.51	0.92
PGSC0003DMT200030516	K03911	ko04610	Complement and coagulation cascades	698	1.2e-32	0.34	0.53	0.89
PGSC0003DMT200034330	K04733	ko04210	Apoptosis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMT200034330	K04733	ko04620	Toll-like receptor signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMT200034330	K04733	ko04722	Neurotrophin signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMT200034330	K04733	ko05140	Leishmaniasis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMT200034330	K04733	ko05142	Chagas disease	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMT200034339	K03935	ko00190	Oxidative phosphorylation	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMT200034339	K03935	ko01100	Metabolic pathways	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMT200034339	K03935	ko05010	Alzheimer's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMT200034339	K03935	ko05012	Parkinson's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMT200034339	K03935	ko05016	Huntington's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMT200034355	K02739	ko03050	Proteasome	1315	1.1e-66	0.87	0.95	0.99
PGSC0003DMT200034361	K06675	ko04111	Cell cycle - yeast	544	2.0e-38	0.44	0.61	0.97
PGSC0003DMT200034362	K06675	ko04111	Cell cycle - yeast	502	4.9e-21	0.60	0.64	0.94
PGSC0003DMT200034363	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMT200034365	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMT200093481	K10884	ko03450	Non-homologous end-joining	446	1.2e-17	0.47	0.66	0.83
PGSC0003DMT200003250	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003250	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003250	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003250	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003250	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003250	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003251	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003252	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMT200003254	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.41	0.58	0.95
PGSC0003DMT200003257	K05280	ko00941	Flavonoid biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMT200003257	K05280	ko00944	Flavone and flavonol biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMT200003257	K05280	ko01100	Metabolic pathways	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMT200003257	K05280	ko01110	Biosynthesis of secondary metabolites	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMT200003262	K03942	ko00190	Oxidative phosphorylation	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMT200003262	K03942	ko01100	Metabolic pathways	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMT200003262	K03942	ko05010	Alzheimer's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMT200003262	K03942	ko05012	Parkinson's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMT200003262	K03942	ko05016	Huntington's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMT200066874	K01046	ko00561	Glycerolipid metabolism	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMT200066874	K01046	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMT200066897	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMT200066897	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMT200066897	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMT200066898	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMT200066898	K00800	ko01100	Metabolic pathways	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMT200066898	K00800	ko01110	Biosynthesis of secondary metabolites	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMT200066899	K01480	ko00330	Arginine and proline metabolism	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMT200066899	K01480	ko01100	Metabolic pathways	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMT200066900	K01480	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMT200066900	K01480	ko01100	Metabolic pathways	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMT200066901	K01480	ko00330	Arginine and proline metabolism	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMT200066901	K01480	ko01100	Metabolic pathways	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMT200066902	K01480	ko00330	Arginine and proline metabolism	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMT200066902	K01480	ko01100	Metabolic pathways	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMT200066903	K01476	ko00330	Arginine and proline metabolism	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMT200066903	K01476	ko01100	Metabolic pathways	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMT200066903	K01476	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMT200066903	K01476	ko05146	Amoebiasis	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMT200066904	K01480	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMT200066904	K01480	ko01100	Metabolic pathways	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMT200058893	K00128	ko00010	Glycolysis / Gluconeogenesis	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00053	Ascorbate and aldarate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00071	Fatty acid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00280	Valine, leucine and isoleucine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00310	Lysine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00330	Arginine and proline metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00340	Histidine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00380	Tryptophan metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00410	beta-Alanine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00561	Glycerolipid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00620	Pyruvate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00631	1,2-Dichloroethane degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00640	Propanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00641	3-Chloroacrylic acid degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00650	Butanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko00903	Limonene and pinene degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko01100	Metabolic pathways	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058893	K00128	ko01110	Biosynthesis of secondary metabolites	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMT200058894	K00128	ko00010	Glycolysis / Gluconeogenesis	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00053	Ascorbate and aldarate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00071	Fatty acid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00280	Valine, leucine and isoleucine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00310	Lysine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00330	Arginine and proline metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00340	Histidine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00380	Tryptophan metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00410	beta-Alanine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00561	Glycerolipid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00620	Pyruvate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00631	1,2-Dichloroethane degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00640	Propanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00641	3-Chloroacrylic acid degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00650	Butanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko00903	Limonene and pinene degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko01100	Metabolic pathways	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058894	K00128	ko01110	Biosynthesis of secondary metabolites	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMT200058895	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058895	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058896	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMT200058897	K00128	ko00010	Glycolysis / Gluconeogenesis	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00053	Ascorbate and aldarate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00071	Fatty acid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00280	Valine, leucine and isoleucine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00310	Lysine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00330	Arginine and proline metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00340	Histidine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00380	Tryptophan metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00410	beta-Alanine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00561	Glycerolipid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00620	Pyruvate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00631	1,2-Dichloroethane degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00640	Propanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00641	3-Chloroacrylic acid degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00650	Butanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko00903	Limonene and pinene degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko01100	Metabolic pathways	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058897	K00128	ko01110	Biosynthesis of secondary metabolites	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMT200058898	K12620	ko03018	RNA degradation	833	4.1e-40	0.84	0.93	0.16
PGSC0003DMT200058910	K12620	ko03018	RNA degradation	983	2.2e-48	0.91	0.96	0.99
PGSC0003DMT200058911	K12620	ko03018	RNA degradation	789	1.1e-37	0.92	0.95	0.94
PGSC0003DMT200076955	K11229	ko04011	MAPK signaling pathway - yeast	298	1.6e-09	0.38	0.55	0.99
PGSC0003DMT200076966	K00283	ko00260	Glycine, serine and threonine metabolism	7770	0.	0.86	0.92	1.00
PGSC0003DMT200076966	K00283	ko01100	Metabolic pathways	7770	0.	0.86	0.92	1.00
PGSC0003DMT200076967	K04424	ko04010	MAPK signaling pathway	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMT200076967	K04424	ko04530	Tight junction	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMT200076968	K04424	ko04010	MAPK signaling pathway	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMT200076968	K04424	ko04530	Tight junction	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMT200076969	K04424	ko04010	MAPK signaling pathway	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMT200076969	K04424	ko04530	Tight junction	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMT200076970	K04424	ko04010	MAPK signaling pathway	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMT200076970	K04424	ko04530	Tight junction	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMT200076980	K06268	ko04010	MAPK signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04020	Calcium signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04114	Oocyte meiosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04210	Apoptosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04310	Wnt signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04360	Axon guidance	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04370	VEGF signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04650	Natural killer cell mediated cytotoxicity	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04660	T cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04662	B cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko04720	Long-term potentiation	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko05010	Alzheimer's disease	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076980	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMT200076981	K06268	ko04010	MAPK signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04020	Calcium signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04114	Oocyte meiosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04210	Apoptosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04310	Wnt signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04360	Axon guidance	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04370	VEGF signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04650	Natural killer cell mediated cytotoxicity	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04660	T cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04662	B cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko04720	Long-term potentiation	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko05010	Alzheimer's disease	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076981	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMT200076982	K06268	ko04010	MAPK signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04020	Calcium signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04114	Oocyte meiosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04210	Apoptosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04310	Wnt signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04360	Axon guidance	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04370	VEGF signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04650	Natural killer cell mediated cytotoxicity	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04660	T cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04662	B cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko04720	Long-term potentiation	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko05010	Alzheimer's disease	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076982	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMT200076983	K06268	ko04010	MAPK signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04020	Calcium signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04114	Oocyte meiosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04210	Apoptosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04310	Wnt signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04360	Axon guidance	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04370	VEGF signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04650	Natural killer cell mediated cytotoxicity	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04660	T cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04662	B cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko04720	Long-term potentiation	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko05010	Alzheimer's disease	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200076983	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMT200009060	K02732	ko03050	Proteasome	1781	2.1e-92	0.93	0.97	1.00
PGSC0003DMT200009068	K04371	ko04010	MAPK signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04012	ErbB signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04013	MAPK signaling pathway - fly	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04062	Chemokine signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04114	Oocyte meiosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04150	mTOR signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04270	Vascular smooth muscle contraction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04320	Dorso-ventral axis formation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04350	TGF-beta signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04360	Axon guidance	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04370	VEGF signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04510	Focal adhesion	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04520	Adherens junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04540	Gap junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04620	Toll-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04621	NOD-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04650	Natural killer cell mediated cytotoxicity	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04660	T cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04662	B cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04664	Fc epsilon RI signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04666	Fc gamma R-mediated phagocytosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04720	Long-term potentiation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04722	Neurotrophin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04730	Long-term depression	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04810	Regulation of actin cytoskeleton	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04910	Insulin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04912	GnRH signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04914	Progesterone-mediated oocyte maturation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04916	Melanogenesis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04930	Type II diabetes mellitus	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko04960	Aldosterone-regulated sodium reabsorption	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05010	Alzheimer's disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05020	Prion diseases	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05131	Shigellosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05140	Leishmaniasis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05142	Chagas disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05200	Pathways in cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05210	Colorectal cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05211	Renal cell carcinoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05212	Pancreatic cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05213	Endometrial cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05214	Glioma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05215	Prostate cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05216	Thyroid cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05218	Melanoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05219	Bladder cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05220	Chronic myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05221	Acute myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009068	K04371	ko05223	Non-small cell lung cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMT200009078	K00430	ko00360	Phenylalanine metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMT200009078	K00430	ko00680	Methane metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMT200009078	K00430	ko00940	Phenylpropanoid biosynthesis	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMT200009078	K00430	ko01100	Metabolic pathways	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMT200009078	K00430	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMT200009079	K00430	ko00360	Phenylalanine metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMT200009079	K00430	ko00680	Methane metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMT200009079	K00430	ko00940	Phenylpropanoid biosynthesis	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMT200009079	K00430	ko01100	Metabolic pathways	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMT200009079	K00430	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMT200009080	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMT200009080	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMT200009080	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMT200009080	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMT200009080	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMT200009081	K00430	ko00360	Phenylalanine metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMT200009081	K00430	ko00680	Methane metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMT200009081	K00430	ko00940	Phenylpropanoid biosynthesis	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMT200009081	K00430	ko01100	Metabolic pathways	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMT200009081	K00430	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMT200009082	K00430	ko00360	Phenylalanine metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMT200009082	K00430	ko00680	Methane metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMT200009082	K00430	ko00940	Phenylpropanoid biosynthesis	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMT200009082	K00430	ko01100	Metabolic pathways	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMT200009082	K00430	ko01110	Biosynthesis of secondary metabolites	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMT200009083	K00430	ko00360	Phenylalanine metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMT200009083	K00430	ko00680	Methane metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMT200009083	K00430	ko00940	Phenylpropanoid biosynthesis	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMT200009083	K00430	ko01100	Metabolic pathways	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMT200009083	K00430	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMT200009084	K00430	ko00360	Phenylalanine metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMT200009084	K00430	ko00680	Methane metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMT200009084	K00430	ko00940	Phenylpropanoid biosynthesis	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMT200009084	K00430	ko01100	Metabolic pathways	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMT200009084	K00430	ko01110	Biosynthesis of secondary metabolites	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMT200019078	K01528	ko04144	Endocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMT200019078	K01528	ko04666	Fc gamma R-mediated phagocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMT200019078	K01528	ko05100	Bacterial invasion of epithelial cells	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMT200019085	K05658	ko02010	ABC transporters	5892	0.	0.50	0.70	0.92
PGSC0003DMT200019092	K13065	ko00940	Phenylpropanoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMT200019092	K13065	ko00941	Flavonoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMT200019092	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMT200019092	K13065	ko01110	Biosynthesis of secondary metabolites	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMT200019103	K10798	ko03410	Base excision repair	1485	4.5e-76	0.32	0.52	0.97
PGSC0003DMT200019109	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMT200019110	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMT200019112	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMT200019113	K12196	ko04144	Endocytosis	3374	2.9e-180	0.91	0.96	1.00
PGSC0003DMT200019115	K12196	ko04144	Endocytosis	544	3.6e-24	1.00	1.00	0.59
PGSC0003DMT200019116	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMT200019118	K12196	ko04144	Endocytosis	352	1.4e-13	1.00	1.00	0.73
PGSC0003DMT200019119	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMT200038771	K03046	ko00230	Purine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMT200038771	K03046	ko00240	Pyrimidine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMT200038771	K03046	ko01100	Metabolic pathways	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMT200038771	K03046	ko03020	RNA polymerase	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMT200038789	K10875	ko03440	Homologous recombination	599	2.5e-29	0.29	0.49	0.43
PGSC0003DMT200043784	K04733	ko04210	Apoptosis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMT200043784	K04733	ko04620	Toll-like receptor signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMT200043784	K04733	ko04722	Neurotrophin signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMT200043784	K04733	ko05140	Leishmaniasis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMT200043784	K04733	ko05142	Chagas disease	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMT200043788	K04733	ko04210	Apoptosis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMT200043788	K04733	ko04620	Toll-like receptor signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMT200043788	K04733	ko04722	Neurotrophin signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMT200043788	K04733	ko05140	Leishmaniasis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMT200043788	K04733	ko05142	Chagas disease	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMT200043789	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043789	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043789	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043789	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043789	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043790	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043790	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043790	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043790	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043790	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMT200043791	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043791	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043791	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043791	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043791	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043792	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043792	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043792	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043792	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043792	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043793	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043793	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043793	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043793	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043793	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMT200043804	K00697	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.63	0.73	0.93
PGSC0003DMT200043805	K00697	ko00500	Starch and sucrose metabolism	4638	5.6e-250	0.65	0.76	0.98
PGSC0003DMT200043806	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMT200043807	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMT200043808	K00697	ko00500	Starch and sucrose metabolism	3181	1.3e-169	0.74	0.86	0.99
PGSC0003DMT200043817	K00128	ko00010	Glycolysis / Gluconeogenesis	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00053	Ascorbate and aldarate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00071	Fatty acid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00280	Valine, leucine and isoleucine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00310	Lysine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00330	Arginine and proline metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00340	Histidine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00380	Tryptophan metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00410	beta-Alanine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00561	Glycerolipid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00620	Pyruvate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00631	1,2-Dichloroethane degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00640	Propanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00641	3-Chloroacrylic acid degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00650	Butanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko00903	Limonene and pinene degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko01100	Metabolic pathways	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200043817	K00128	ko01110	Biosynthesis of secondary metabolites	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMT200052682	K02261	ko00190	Oxidative phosphorylation	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052682	K02261	ko01100	Metabolic pathways	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052682	K02261	ko04260	Cardiac muscle contraction	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052682	K02261	ko05010	Alzheimer's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052682	K02261	ko05012	Parkinson's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052682	K02261	ko05016	Huntington's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMT200052684	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMT200052684	K00517	ko00626	Naphthalene and anthracene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMT200052684	K00517	ko00903	Limonene and pinene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMT200052684	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMT200052684	K00517	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMT200052685	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMT200052685	K00517	ko00626	Naphthalene and anthracene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMT200052685	K00517	ko00903	Limonene and pinene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMT200052685	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMT200052685	K00517	ko01110	Biosynthesis of secondary metabolites	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMT200052686	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMT200052686	K00517	ko00626	Naphthalene and anthracene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMT200052686	K00517	ko00903	Limonene and pinene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMT200052686	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMT200052686	K00517	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMT200052687	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMT200052687	K00517	ko00626	Naphthalene and anthracene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMT200052687	K00517	ko00903	Limonene and pinene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMT200052687	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMT200052687	K00517	ko01110	Biosynthesis of secondary metabolites	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMT200052689	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMT200052689	K00517	ko00626	Naphthalene and anthracene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMT200052689	K00517	ko00903	Limonene and pinene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMT200052689	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMT200052689	K00517	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMT200052693	K11229	ko04011	MAPK signaling pathway - yeast	547	2.0e-23	0.34	0.51	0.88
PGSC0003DMT200052699	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMT200052699	K00224	ko00364	Fluorobenzoate degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMT200052699	K00224	ko00628	Fluorene degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMT200052699	K00224	ko00640	Propanoate metabolism	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMT200052702	K04420	ko04010	MAPK signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMT200052702	K04420	ko04540	Gap junction	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMT200052702	K04420	ko04912	GnRH signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMT200052710	K06228	ko04340	Hedgehog signaling pathway	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMT200052710	K06228	ko05200	Pathways in cancer	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMT200052710	K06228	ko05217	Basal cell carcinoma	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMT200081470	K03006	ko00230	Purine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMT200081470	K03006	ko00240	Pyrimidine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMT200081470	K03006	ko01100	Metabolic pathways	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMT200081470	K03006	ko03020	RNA polymerase	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMT200081470	K03006	ko05016	Huntington's disease	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMT200081471	K03006	ko00230	Purine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMT200081471	K03006	ko00240	Pyrimidine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMT200081471	K03006	ko01100	Metabolic pathways	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMT200081471	K03006	ko03020	RNA polymerase	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMT200081471	K03006	ko05016	Huntington's disease	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMT200081472	K05863	ko04020	Calcium signaling pathway	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMT200081472	K05863	ko05012	Parkinson's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMT200081472	K05863	ko05016	Huntington's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMT200081475	K08332	ko04140	Regulation of autophagy	388	1.7e-13	0.33	0.52	0.38
PGSC0003DMT200081476	K08332	ko04140	Regulation of autophagy	388	3.0e-13	0.33	0.52	0.32
PGSC0003DMT200081486	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081486	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081488	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081489	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200081492	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMT200055671	K12471	ko04144	Endocytosis	751	1.4e-35	0.32	0.45	0.71
PGSC0003DMT200055673	K01046	ko00561	Glycerolipid metabolism	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMT200055673	K01046	ko01100	Metabolic pathways	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMT200055680	K02153	ko00190	Oxidative phosphorylation	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200055680	K02153	ko01100	Metabolic pathways	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200055680	K02153	ko04145	Phagosome	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200055680	K02153	ko04966	Collecting duct acid secretion	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200055680	K02153	ko05110	Vibrio cholerae infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200055680	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMT200065629	K12356	ko00940	Phenylpropanoid biosynthesis	541	5.3e-24	0.47	0.59	0.39
PGSC0003DMT200065638	K00480	ko00624	1- and 2-Methylnaphthalene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMT200065638	K00480	ko00626	Naphthalene and anthracene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMT200065638	K00480	ko00628	Fluorene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMT200065638	K00480	ko01100	Metabolic pathways	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMT200065639	K00480	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMT200065639	K00480	ko00626	Naphthalene and anthracene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMT200065639	K00480	ko00628	Fluorene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMT200065639	K00480	ko01100	Metabolic pathways	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMT200065646	K11866	ko04144	Endocytosis	364	2.0e-13	0.34	0.53	0.83
PGSC0003DMT200065650	K11866	ko04144	Endocytosis	631	1.5e-28	0.31	0.49	0.93
PGSC0003DMT200065653	K12868	ko03040	Spliceosome	522	5.9e-23	0.95	0.97	0.98
PGSC0003DMT200065655	K03661	ko00190	Oxidative phosphorylation	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065655	K03661	ko01100	Metabolic pathways	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065655	K03661	ko04142	Lysosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065655	K03661	ko04145	Phagosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065655	K03661	ko05110	Vibrio cholerae infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065655	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMT200065677	K11097	ko03040	Spliceosome	684	6.8e-32	0.94	0.95	0.99
PGSC0003DMT200089535	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMT200089535	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMT200089535	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMT200089535	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMT200089535	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMT200007945	K12121	ko04712	Circadian rhythm - plant	483	4.7e-20	0.48	0.72	0.72
PGSC0003DMT200007954	K11247	ko04144	Endocytosis	1440	1.4e-73	0.52	0.68	0.99
PGSC0003DMT200007955	K11247	ko04144	Endocytosis	706	4.2e-33	0.55	0.72	0.90
PGSC0003DMT200007957	K05658	ko02010	ABC transporters	440	1.5e-17	0.88	0.95	0.92
PGSC0003DMT200007960	K05658	ko02010	ABC transporters	8020	0.	0.77	0.90	0.99
PGSC0003DMT200007961	K05278	ko00941	Flavonoid biosynthesis	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMT200007961	K05278	ko01100	Metabolic pathways	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMT200007961	K05278	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMT200007962	K05278	ko00941	Flavonoid biosynthesis	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMT200007962	K05278	ko01100	Metabolic pathways	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMT200007962	K05278	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMT200007963	K05277	ko00941	Flavonoid biosynthesis	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMT200007963	K05277	ko01100	Metabolic pathways	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMT200007963	K05277	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMT200007964	K05277	ko00941	Flavonoid biosynthesis	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMT200007964	K05277	ko01100	Metabolic pathways	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMT200007964	K05277	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMT200007977	K12130	ko04712	Circadian rhythm - plant	315	2.0e-11	0.35	0.58	0.91
PGSC0003DMT200020977	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMT200020977	K01904	ko00360	Phenylalanine metabolism	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMT200020977	K01904	ko00940	Phenylpropanoid biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMT200020977	K01904	ko01100	Metabolic pathways	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMT200020977	K01904	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMT200020978	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMT200020978	K01904	ko00360	Phenylalanine metabolism	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMT200020978	K01904	ko00940	Phenylpropanoid biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMT200020978	K01904	ko01100	Metabolic pathways	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMT200020978	K01904	ko01110	Biosynthesis of secondary metabolites	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMT200020988	K13230	ko00402	Benzoxazinoid biosynthesis	878	1.4e-42	0.36	0.53	0.99
PGSC0003DMT200020996	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMT200020996	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMT200020996	K00771	ko01100	Metabolic pathways	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMT200020997	K00225	ko00053	Ascorbate and aldarate metabolism	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMT200020997	K00225	ko01100	Metabolic pathways	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMT200020997	K00225	ko01110	Biosynthesis of secondary metabolites	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMT200020998	K00273	ko00260	Glycine, serine and threonine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020998	K00273	ko00311	Penicillin and cephalosporin biosynthesis	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020998	K00273	ko00330	Arginine and proline metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020998	K00273	ko00472	D-Arginine and D-ornithine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020998	K00273	ko01100	Metabolic pathways	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020998	K00273	ko04146	Peroxisome	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMT200020999	K00273	ko00260	Glycine, serine and threonine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200020999	K00273	ko00311	Penicillin and cephalosporin biosynthesis	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200020999	K00273	ko00330	Arginine and proline metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200020999	K00273	ko00472	D-Arginine and D-ornithine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200020999	K00273	ko01100	Metabolic pathways	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200020999	K00273	ko04146	Peroxisome	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMT200021000	K00273	ko00260	Glycine, serine and threonine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021000	K00273	ko00311	Penicillin and cephalosporin biosynthesis	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021000	K00273	ko00330	Arginine and proline metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021000	K00273	ko00472	D-Arginine and D-ornithine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021000	K00273	ko01100	Metabolic pathways	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021000	K00273	ko04146	Peroxisome	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMT200021001	K05768	ko04666	Fc gamma R-mediated phagocytosis	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMT200021001	K05768	ko04810	Regulation of actin cytoskeleton	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMT200021009	K03124	ko03022	Basal transcription factors	2039	1.3e-106	0.77	0.88	0.99
PGSC0003DMT200021010	K03124	ko03022	Basal transcription factors	2028	5.1e-106	0.76	0.88	0.99
PGSC0003DMT200021011	K03124	ko03022	Basal transcription factors	1092	2.1e-54	0.76	0.87	0.93
PGSC0003DMT200021012	K03124	ko03022	Basal transcription factors	877	1.5e-42	0.85	0.93	0.87
PGSC0003DMT200021013	K03124	ko03022	Basal transcription factors	1296	1.2e-65	0.89	0.93	0.98
PGSC0003DMT200010704	K07203	ko04012	ErbB signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko04150	mTOR signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko04910	Insulin signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko04920	Adipocytokine signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko04930	Type II diabetes mellitus	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko05200	Pathways in cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko05214	Glioma	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko05215	Prostate cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010704	K07203	ko05221	Acute myeloid leukemia	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMT200010706	K07203	ko04012	ErbB signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko04150	mTOR signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko04910	Insulin signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko04920	Adipocytokine signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko04930	Type II diabetes mellitus	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko05200	Pathways in cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko05214	Glioma	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko05215	Prostate cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010706	K07203	ko05221	Acute myeloid leukemia	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMT200010729	K01681	ko00020	Citrate cycle (TCA cycle)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMT200010729	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMT200010729	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMT200010729	K01681	ko01100	Metabolic pathways	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMT200010729	K01681	ko01110	Biosynthesis of secondary metabolites	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMT200010758	K02901	ko03010	Ribosome	640	1.8e-29	0.75	0.84	0.48
PGSC0003DMT200010760	K02901	ko03010	Ribosome	359	5.8e-14	0.81	0.87	0.98
PGSC0003DMT200037018	K00215	ko00300	Lysine biosynthesis	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMT200037018	K00215	ko01100	Metabolic pathways	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMT200037018	K00215	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMT200037019	K00215	ko00300	Lysine biosynthesis	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMT200037019	K00215	ko01100	Metabolic pathways	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMT200037019	K00215	ko01110	Biosynthesis of secondary metabolites	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMT200037025	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMT200037025	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMT200037025	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMT200037025	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMT200037025	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMT200037026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMT200037026	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMT200037026	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMT200037026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMT200037026	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMT200037029	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMT200037029	K00517	ko00626	Naphthalene and anthracene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMT200037029	K00517	ko00903	Limonene and pinene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMT200037029	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMT200037029	K00517	ko01110	Biosynthesis of secondary metabolites	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMT200037030	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMT200037030	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMT200037030	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMT200037030	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMT200037030	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMT200037033	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMT200037033	K00517	ko00626	Naphthalene and anthracene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMT200037033	K00517	ko00903	Limonene and pinene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMT200037033	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMT200037033	K00517	ko01110	Biosynthesis of secondary metabolites	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMT200037034	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMT200037034	K00517	ko00626	Naphthalene and anthracene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMT200037034	K00517	ko00903	Limonene and pinene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMT200037034	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMT200037034	K00517	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMT200037035	K13083	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMT200037035	K13083	ko00944	Flavone and flavonol biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMT200037035	K13083	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMT200037036	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMT200037036	K00517	ko00626	Naphthalene and anthracene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMT200037036	K00517	ko00903	Limonene and pinene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMT200037036	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMT200037036	K00517	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMT200037038	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMT200037038	K00517	ko00626	Naphthalene and anthracene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMT200037038	K00517	ko00903	Limonene and pinene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMT200037038	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMT200037038	K00517	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMT200037039	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMT200037039	K00517	ko00626	Naphthalene and anthracene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMT200037039	K00517	ko00903	Limonene and pinene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMT200037039	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMT200037039	K00517	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMT200084469	K08488	ko04130	SNARE interactions in vesicular transport	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMT200084469	K08488	ko04145	Phagosome	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMT200084494	K00763	ko00760	Nicotinate and nicotinamide metabolism	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMT200084494	K00763	ko01100	Metabolic pathways	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMT200084495	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMT200084496	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMT200084497	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMT200084500	K12655	ko04622	RIG-I-like receptor signaling pathway	312	3.7e-11	0.31	0.49	0.72
PGSC0003DMT200084502	K12655	ko04622	RIG-I-like receptor signaling pathway	320	1.2e-11	0.26	0.47	0.81
PGSC0003DMT200063954	K03875	ko04110	Cell cycle	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMT200063954	K03875	ko04120	Ubiquitin mediated proteolysis	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMT200063954	K03875	ko05200	Pathways in cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMT200063954	K03875	ko05222	Small cell lung cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMT200063955	K03875	ko04110	Cell cycle	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMT200063955	K03875	ko04120	Ubiquitin mediated proteolysis	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMT200063955	K03875	ko05200	Pathways in cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMT200063955	K03875	ko05222	Small cell lung cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMT200063962	K00166	ko00280	Valine, leucine and isoleucine degradation	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMT200063962	K00166	ko01100	Metabolic pathways	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMT200063962	K00166	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMT200063966	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMT200063966	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMT200063966	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMT200063966	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMT200063966	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMT200063981	K00059	ko00061	Fatty acid biosynthesis	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMT200063981	K00059	ko01040	Biosynthesis of unsaturated fatty acids	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMT200063981	K00059	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMT200053821	K05692	ko04145	Phagosome	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04510	Focal adhesion	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04520	Adherens junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04530	Tight junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04670	Leukocyte transendothelial migration	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04745	Phototransduction - fly	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05110	Vibrio cholerae infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05131	Shigellosis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05414	Dilated cardiomyopathy	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053821	K05692	ko05416	Viral myocarditis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMT200053826	K05692	ko04145	Phagosome	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04510	Focal adhesion	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04520	Adherens junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04530	Tight junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04670	Leukocyte transendothelial migration	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04745	Phototransduction - fly	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko04810	Regulation of actin cytoskeleton	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05100	Bacterial invasion of epithelial cells	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05110	Vibrio cholerae infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05130	Pathogenic Escherichia coli infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05131	Shigellosis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05414	Dilated cardiomyopathy	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053826	K05692	ko05416	Viral myocarditis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMT200053837	K03936	ko00190	Oxidative phosphorylation	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMT200053837	K03936	ko01100	Metabolic pathways	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMT200053837	K03936	ko05010	Alzheimer's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMT200053837	K03936	ko05012	Parkinson's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMT200053837	K03936	ko05016	Huntington's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMT200053838	K03949	ko00190	Oxidative phosphorylation	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMT200053838	K03949	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMT200053838	K03949	ko05010	Alzheimer's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMT200053838	K03949	ko05012	Parkinson's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMT200053838	K03949	ko05016	Huntington's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMT200053839	K12795	ko04621	NOD-like receptor signaling pathway	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMT200053839	K12795	ko04626	Plant-pathogen interaction	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMT200053843	K12843	ko03040	Spliceosome	1138	6.2e-57	0.33	0.52	0.92
PGSC0003DMT200053854	K12356	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.31	0.48	0.96
PGSC0003DMT200053855	K12356	ko00940	Phenylpropanoid biosynthesis	581	3.3e-26	0.41	0.58	0.84
PGSC0003DMT200053859	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053859	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053859	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053859	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053859	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053860	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053860	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053860	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053860	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053860	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMT200053861	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMT200053861	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMT200053861	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMT200053861	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMT200053861	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMT200088034	K01674	ko00910	Nitrogen metabolism	1078	1.3e-53	0.57	0.74	0.65
PGSC0003DMT200088039	K10760	ko00908	Zeatin biosynthesis	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMT200088039	K10760	ko01100	Metabolic pathways	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMT200088039	K10760	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMT200088046	K10760	ko00908	Zeatin biosynthesis	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMT200088046	K10760	ko01100	Metabolic pathways	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMT200088046	K10760	ko01110	Biosynthesis of secondary metabolites	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMT200088054	K11816	ko00380	Tryptophan metabolism	1063	8.5e-53	0.42	0.66	0.98
PGSC0003DMT200001510	K00430	ko00360	Phenylalanine metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMT200001510	K00430	ko00680	Methane metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMT200001510	K00430	ko00940	Phenylpropanoid biosynthesis	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMT200001510	K00430	ko01100	Metabolic pathways	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMT200001510	K00430	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMT200001511	K13066	ko00940	Phenylpropanoid biosynthesis	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMT200001511	K13066	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMT200001512	K13066	ko00940	Phenylpropanoid biosynthesis	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMT200001512	K13066	ko01110	Biosynthesis of secondary metabolites	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMT200001516	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMT200001516	K00517	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMT200001516	K00517	ko00903	Limonene and pinene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMT200001516	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMT200001516	K00517	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMT200001518	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMT200001518	K00517	ko00626	Naphthalene and anthracene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMT200001518	K00517	ko00903	Limonene and pinene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMT200001518	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMT200001518	K00517	ko01110	Biosynthesis of secondary metabolites	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMT200001522	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMT200001522	K00517	ko00626	Naphthalene and anthracene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMT200001522	K00517	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMT200001522	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMT200001522	K00517	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMT200001528	K00356	ko00190	Oxidative phosphorylation	1068	4.5e-53	0.75	0.84	0.99
PGSC0003DMT200092283	K08243	ko00941	Flavonoid biosynthesis	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMT200092283	K08243	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMT200013988	K05658	ko02010	ABC transporters	3770	4.2e-202	0.43	0.64	0.99
PGSC0003DMT200013998	K12338	ko00942	Anthocyanin biosynthesis	539	6.8e-24	0.42	0.60	0.95
PGSC0003DMT200014003	K10775	ko00360	Phenylalanine metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMT200014003	K10775	ko00910	Nitrogen metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMT200014003	K10775	ko00940	Phenylpropanoid biosynthesis	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMT200014003	K10775	ko01100	Metabolic pathways	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMT200014003	K10775	ko01110	Biosynthesis of secondary metabolites	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMT200014006	K00103	ko00053	Ascorbate and aldarate metabolism	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMT200014006	K00103	ko01100	Metabolic pathways	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMT200014020	K10527	ko00592	alpha-Linolenic acid metabolism	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMT200014020	K10527	ko01100	Metabolic pathways	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMT200022138	K12185	ko04144	Endocytosis	1210	6.7e-61	0.67	0.81	0.97
PGSC0003DMT200022141	K05279	ko00944	Flavone and flavonol biosynthesis	984	1.9e-48	0.40	0.59	0.97
PGSC0003DMT200022142	K05279	ko00944	Flavone and flavonol biosynthesis	997	3.7e-49	0.41	0.60	0.97
PGSC0003DMT200022143	K05279	ko00944	Flavone and flavonol biosynthesis	1006	1.2e-49	0.42	0.60	0.96
PGSC0003DMT200022144	K05279	ko00944	Flavone and flavonol biosynthesis	240	2.1e-07	0.42	0.57	0.98
PGSC0003DMT200022145	K05279	ko00944	Flavone and flavonol biosynthesis	982	2.5e-48	0.41	0.59	0.96
PGSC0003DMT200022146	K05279	ko00944	Flavone and flavonol biosynthesis	264	1.0e-08	0.42	0.62	0.99
PGSC0003DMT200032619	K01641	ko00072	Synthesis and degradation of ketone bodies	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032619	K01641	ko00280	Valine, leucine and isoleucine degradation	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032619	K01641	ko00650	Butanoate metabolism	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032619	K01641	ko00900	Terpenoid backbone biosynthesis	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032619	K01641	ko01100	Metabolic pathways	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032619	K01641	ko01110	Biosynthesis of secondary metabolites	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMT200032620	K12307	ko04142	Lysosome	406	2.7e-16	0.26	0.46	0.61
PGSC0003DMT200060728	K12850	ko03040	Spliceosome	1538	5.4e-79	0.62	0.79	1.00
PGSC0003DMT200060729	K12850	ko03040	Spliceosome	2600	1.4e-137	0.70	0.84	0.99
PGSC0003DMT200060733	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMT200060733	K01915	ko00330	Arginine and proline metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMT200060733	K01915	ko00910	Nitrogen metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMT200060733	K01915	ko01100	Metabolic pathways	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMT200060733	K01915	ko02020	Two-component system	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMT200060737	K12881	ko03040	Spliceosome	1399	2.5e-71	0.65	0.78	0.99
PGSC0003DMT200060738	K12881	ko03040	Spliceosome	790	9.7e-38	0.65	0.77	0.99
PGSC0003DMT200060739	K03946	ko00190	Oxidative phosphorylation	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMT200060739	K03946	ko01100	Metabolic pathways	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMT200060739	K03946	ko05010	Alzheimer's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMT200060739	K03946	ko05012	Parkinson's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMT200060739	K03946	ko05016	Huntington's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMT200060740	K12478	ko04144	Endocytosis	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMT200060740	K12478	ko04145	Phagosome	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMT200060752	K00850	ko00010	Glycolysis / Gluconeogenesis	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060752	K00850	ko00030	Pentose phosphate pathway	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060752	K00850	ko00051	Fructose and mannose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060752	K00850	ko00052	Galactose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060752	K00850	ko01100	Metabolic pathways	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060752	K00850	ko01110	Biosynthesis of secondary metabolites	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMT200060759	K12818	ko03040	Spliceosome	1674	1.7e-86	0.35	0.56	0.44
PGSC0003DMT200068517	K08059	ko04612	Antigen processing and presentation	361	4.5e-14	0.56	0.74	0.65
PGSC0003DMT200068524	K12657	ko00330	Arginine and proline metabolism	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMT200068524	K12657	ko01100	Metabolic pathways	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMT200068525	K12657	ko00330	Arginine and proline metabolism	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMT200068525	K12657	ko01100	Metabolic pathways	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMT200068526	K12657	ko00330	Arginine and proline metabolism	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMT200068526	K12657	ko01100	Metabolic pathways	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMT200068532	K12486	ko04144	Endocytosis	509	3.1e-22	0.52	0.66	0.32
PGSC0003DMT200068533	K12486	ko04144	Endocytosis	511	2.4e-22	0.32	0.51	0.81
PGSC0003DMT200068553	K04733	ko04210	Apoptosis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMT200068553	K04733	ko04620	Toll-like receptor signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMT200068553	K04733	ko04722	Neurotrophin signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMT200068553	K04733	ko05140	Leishmaniasis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMT200068553	K04733	ko05142	Chagas disease	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMT200068556	K04733	ko04210	Apoptosis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMT200068556	K04733	ko04620	Toll-like receptor signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMT200068556	K04733	ko04722	Neurotrophin signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMT200068556	K04733	ko05140	Leishmaniasis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMT200068556	K04733	ko05142	Chagas disease	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMT200074870	K02706	ko00195	Photosynthesis	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMT200074870	K02706	ko01100	Metabolic pathways	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMT200074890	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074890	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074890	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074891	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074891	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074891	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMT200074898	K02894	ko03010	Ribosome	394	6.8e-16	0.72	0.74	0.95
PGSC0003DMT200074900	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074900	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074900	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074900	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074900	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074901	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074901	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074901	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074901	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074901	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMT200074906	K12356	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.32	0.50	0.98
PGSC0003DMT200074907	K12356	ko00940	Phenylpropanoid biosynthesis	588	1.3e-26	0.38	0.54	0.95
PGSC0003DMT200078709	K07374	ko04145	Phagosome	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMT200078709	K07374	ko04540	Gap junction	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMT200078709	K07374	ko05130	Pathogenic Escherichia coli infection	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMT200078710	K07374	ko04145	Phagosome	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMT200078710	K07374	ko04540	Gap junction	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMT200078710	K07374	ko05130	Pathogenic Escherichia coli infection	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMT200078711	K02266	ko00190	Oxidative phosphorylation	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078711	K02266	ko01100	Metabolic pathways	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078711	K02266	ko04260	Cardiac muscle contraction	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078711	K02266	ko05010	Alzheimer's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078711	K02266	ko05012	Parkinson's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078711	K02266	ko05016	Huntington's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMT200078712	K02266	ko00190	Oxidative phosphorylation	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078712	K02266	ko01100	Metabolic pathways	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078712	K02266	ko04260	Cardiac muscle contraction	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078712	K02266	ko05010	Alzheimer's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078712	K02266	ko05012	Parkinson's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078712	K02266	ko05016	Huntington's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMT200078713	K04487	ko00730	Thiamine metabolism	3187	6.0e-170	0.83	0.91	1.00
PGSC0003DMT200078720	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078720	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078721	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078721	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078726	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078726	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078727	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078727	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078728	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078728	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMT200078739	K10747	ko03030	DNA replication	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMT200078739	K10747	ko03410	Base excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMT200078739	K10747	ko03420	Nucleotide excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMT200078739	K10747	ko03430	Mismatch repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMT200078740	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078740	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078740	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078740	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078741	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078741	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078741	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078741	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078742	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078742	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078742	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078742	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078743	K10747	ko03030	DNA replication	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMT200078743	K10747	ko03410	Base excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMT200078743	K10747	ko03420	Nucleotide excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMT200078743	K10747	ko03430	Mismatch repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMT200078744	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078744	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078744	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078744	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078745	K10747	ko03030	DNA replication	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMT200078745	K10747	ko03410	Base excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMT200078745	K10747	ko03420	Nucleotide excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMT200078745	K10747	ko03430	Mismatch repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMT200078746	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078746	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078746	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078746	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078747	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078747	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078747	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200078747	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMT200061435	K07195	ko04910	Insulin signaling pathway	2729	1.1e-144	0.55	0.73	0.95
PGSC0003DMT200061436	K07195	ko04910	Insulin signaling pathway	2720	3.5e-144	0.55	0.73	0.95
PGSC0003DMT200057471	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMT200057471	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMT200057471	K00734	ko01100	Metabolic pathways	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMT200057485	K01076	ko00632	Benzoate degradation via CoA ligation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMT200057485	K01076	ko00903	Limonene and pinene degradation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMT200057485	K01076	ko01040	Biosynthesis of unsaturated fatty acids	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMT200057487	K10374	ko04260	Cardiac muscle contraction	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMT200057487	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMT200057487	K10374	ko05414	Dilated cardiomyopathy	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMT200057488	K10374	ko04260	Cardiac muscle contraction	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMT200057488	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMT200057488	K10374	ko05414	Dilated cardiomyopathy	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMT200078040	K12827	ko03040	Spliceosome	303	2.5e-10	0.52	0.65	0.47
PGSC0003DMT200078041	K00874	ko00030	Pentose phosphate pathway	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMT200078041	K00874	ko00040	Pentose and glucuronate interconversions	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMT200078041	K00874	ko01100	Metabolic pathways	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMT200078045	K06215	ko00750	Vitamin B6 metabolism	2427	5.0e-128	0.93	0.98	1.00
PGSC0003DMT200078046	K05857	ko00562	Inositol phosphate metabolism	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMT200078046	K05857	ko01100	Metabolic pathways	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMT200078046	K05857	ko04020	Calcium signaling pathway	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMT200078046	K05857	ko04070	Phosphatidylinositol signaling system	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMT200078051	K04124	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMT200078051	K04124	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMT200078069	K12854	ko03040	Spliceosome	16280	0.	0.88	0.95	1.00
PGSC0003DMT200078070	K12854	ko03040	Spliceosome	8666	0.	0.64	0.77	1.00
PGSC0003DMT200078071	K12854	ko03040	Spliceosome	847	8.1e-40	0.67	0.81	0.99
PGSC0003DMT200078075	K04103	ko00380	Tryptophan metabolism	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMT200078075	K04103	ko01100	Metabolic pathways	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMT200078081	K01103	ko00051	Fructose and mannose metabolism	5363	5.8e-290	0.85	0.91	1.00
PGSC0003DMT200078082	K01103	ko00051	Fructose and mannose metabolism	2762	1.7e-146	0.79	0.86	1.00
PGSC0003DMT200078083	K01103	ko00051	Fructose and mannose metabolism	5349	3.4e-289	0.85	0.90	1.00
PGSC0003DMT200050843	K00626	ko00071	Fatty acid metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00072	Synthesis and degradation of ketone bodies	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00280	Valine, leucine and isoleucine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00310	Lysine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00380	Tryptophan metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00620	Pyruvate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00632	Benzoate degradation via CoA ligation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00640	Propanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00650	Butanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko00900	Terpenoid backbone biosynthesis	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko01100	Metabolic pathways	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko01110	Biosynthesis of secondary metabolites	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050843	K00626	ko02020	Two-component system	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMT200050860	K01714	ko00300	Lysine biosynthesis	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMT200050860	K01714	ko01100	Metabolic pathways	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMT200050860	K01714	ko01110	Biosynthesis of secondary metabolites	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMT200050869	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	283	1.2e-19	0.35	0.51	0.74
PGSC0003DMT200050875	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMT200050876	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMT200050877	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMT200050878	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMT200050885	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.68
PGSC0003DMT200050890	K00430	ko00360	Phenylalanine metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMT200050890	K00430	ko00680	Methane metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMT200050890	K00430	ko00940	Phenylpropanoid biosynthesis	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMT200050890	K00430	ko01100	Metabolic pathways	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMT200050890	K00430	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMT200050897	K09755	ko00940	Phenylpropanoid biosynthesis	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMT200050897	K09755	ko01100	Metabolic pathways	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMT200050897	K09755	ko01110	Biosynthesis of secondary metabolites	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMT200014621	K12603	ko03018	RNA degradation	460	1.5e-19	0.30	0.47	0.77
PGSC0003DMT200014623	K12603	ko03018	RNA degradation	405	1.7e-16	0.30	0.48	0.63
PGSC0003DMT200014624	K12603	ko03018	RNA degradation	356	7.7e-15	0.31	0.51	0.65
PGSC0003DMT200014625	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.87
PGSC0003DMT200014626	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.85
PGSC0003DMT200014627	K12603	ko03018	RNA degradation	480	1.2e-20	0.30	0.46	0.72
PGSC0003DMT200014637	K04368	ko04010	MAPK signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04012	ErbB signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04013	MAPK signaling pathway - fly	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04062	Chemokine signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04114	Oocyte meiosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04270	Vascular smooth muscle contraction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04320	Dorso-ventral axis formation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04370	VEGF signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04510	Focal adhesion	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04540	Gap junction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04620	Toll-like receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04626	Plant-pathogen interaction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04650	Natural killer cell mediated cytotoxicity	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04660	T cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04662	B cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04664	Fc epsilon RI signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04666	Fc gamma R-mediated phagocytosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04720	Long-term potentiation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04722	Neurotrophin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04730	Long-term depression	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04810	Regulation of actin cytoskeleton	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04910	Insulin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04912	GnRH signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04914	Progesterone-mediated oocyte maturation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko04916	Melanogenesis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05020	Prion diseases	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05200	Pathways in cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05210	Colorectal cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05211	Renal cell carcinoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05212	Pancreatic cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05213	Endometrial cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05214	Glioma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05215	Prostate cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05216	Thyroid cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05218	Melanoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05219	Bladder cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05220	Chronic myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05221	Acute myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014637	K04368	ko05223	Non-small cell lung cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMT200014648	K03008	ko00230	Purine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMT200014648	K03008	ko00240	Pyrimidine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMT200014648	K03008	ko01100	Metabolic pathways	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMT200014648	K03008	ko03020	RNA polymerase	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMT200014648	K03008	ko05016	Huntington's disease	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMT200042058	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMT200042058	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMT200042058	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMT200042059	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042059	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042059	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042060	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042060	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042060	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMT200042062	K02183	ko04020	Calcium signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04070	Phosphatidylinositol signaling system	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04270	Vascular smooth muscle contraction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04626	Plant-pathogen interaction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04720	Long-term potentiation	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04722	Neurotrophin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04740	Olfactory transduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04744	Phototransduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04745	Phototransduction - fly	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04910	Insulin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04912	GnRH signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04916	Melanogenesis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04970	Salivary secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko04971	Gastric acid secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko05010	Alzheimer's disease	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042062	K02183	ko05214	Glioma	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMT200042063	K02183	ko04020	Calcium signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04070	Phosphatidylinositol signaling system	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04114	Oocyte meiosis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04270	Vascular smooth muscle contraction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04626	Plant-pathogen interaction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04720	Long-term potentiation	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04740	Olfactory transduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04744	Phototransduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04745	Phototransduction - fly	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04910	Insulin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04912	GnRH signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04916	Melanogenesis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04970	Salivary secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko04971	Gastric acid secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko05010	Alzheimer's disease	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042063	K02183	ko05214	Glioma	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMT200042065	K00660	ko00941	Flavonoid biosynthesis	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMT200042065	K00660	ko01100	Metabolic pathways	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMT200042065	K00660	ko01110	Biosynthesis of secondary metabolites	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMT200042065	K00660	ko04712	Circadian rhythm - plant	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMT200042075	K02958	ko03010	Ribosome	685	6.0e-32	0.94	0.99	0.96
PGSC0003DMT200042076	K02958	ko03010	Ribosome	1205	1.3e-60	0.92	0.97	0.99
PGSC0003DMT200042077	K02958	ko03010	Ribosome	521	6.7e-23	0.91	0.96	0.84
PGSC0003DMT200031880	K00001	ko00010	Glycolysis / Gluconeogenesis	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00071	Fatty acid metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00350	Tyrosine metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00641	3-Chloroacrylic acid degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00830	Retinol metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko00982	Drug metabolism - cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko01100	Metabolic pathways	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031880	K00001	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMT200031881	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031881	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031882	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMT200031883	K00001	ko00010	Glycolysis / Gluconeogenesis	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00071	Fatty acid metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00350	Tyrosine metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00641	3-Chloroacrylic acid degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00830	Retinol metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko00982	Drug metabolism - cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko01100	Metabolic pathways	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031883	K00001	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMT200031884	K00001	ko00010	Glycolysis / Gluconeogenesis	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00071	Fatty acid metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00350	Tyrosine metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00641	3-Chloroacrylic acid degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00830	Retinol metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko00982	Drug metabolism - cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko01100	Metabolic pathways	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031884	K00001	ko01110	Biosynthesis of secondary metabolites	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMT200031891	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMT200031891	K01078	ko00740	Riboflavin metabolism	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMT200031896	K01179	ko00500	Starch and sucrose metabolism	2068	3.2e-108	0.52	0.66	0.98
PGSC0003DMT200031897	K01179	ko00500	Starch and sucrose metabolism	2367	1.0e-124	0.58	0.73	0.99
PGSC0003DMT200031900	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMT200031901	K01761	ko00270	Cysteine and methionine metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMT200031901	K01761	ko00450	Selenoamino acid metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMT200004380	K07252	ko00510	N-Glycan biosynthesis	1344	2.7e-68	0.71	0.84	0.97
PGSC0003DMT200004385	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMT200004385	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMT200004386	K02706	ko00195	Photosynthesis	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMT200004386	K02706	ko01100	Metabolic pathways	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMT200004391	K02931	ko03010	Ribosome	1639	1.5e-84	0.74	0.86	1.00
PGSC0003DMT200004414	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMT200004415	K12478	ko04144	Endocytosis	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMT200004415	K12478	ko04145	Phagosome	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMT200092170	K11294	ko05130	Pathogenic Escherichia coli infection	219	3.3e-06	0.40	0.65	0.20
PGSC0003DMT200097727	K03869	ko04120	Ubiquitin mediated proteolysis	466	1.4e-19	0.43	0.62	0.84
PGSC0003DMT200097730	K11251	ko05322	Systemic lupus erythematosus	519	8.6e-23	0.68	0.83	0.72
PGSC0003DMT200000899	K01190	ko00052	Galactose metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMT200000899	K01190	ko00511	Other glycan degradation	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMT200000899	K01190	ko00600	Sphingolipid metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMT200000899	K01190	ko01100	Metabolic pathways	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMT200000900	K01190	ko00052	Galactose metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMT200000900	K01190	ko00511	Other glycan degradation	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMT200000900	K01190	ko00600	Sphingolipid metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMT200000900	K01190	ko01100	Metabolic pathways	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMT200000904	K00677	ko00540	Lipopolysaccharide biosynthesis	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMT200000904	K00677	ko01100	Metabolic pathways	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMT200000905	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMT200000905	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMT200000906	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMT200000906	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMT200000907	K00677	ko00540	Lipopolysaccharide biosynthesis	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMT200000907	K00677	ko01100	Metabolic pathways	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMT200000908	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMT200000908	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMT200000909	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMT200000909	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMT200000911	K05863	ko04020	Calcium signaling pathway	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMT200000911	K05863	ko05012	Parkinson's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMT200000911	K05863	ko05016	Huntington's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMT200000916	K12837	ko03040	Spliceosome	2859	7.5e-152	0.84	0.92	1.00
PGSC0003DMT200000917	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMT200000918	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMT200000919	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMT200000920	K12837	ko03040	Spliceosome	2672	1.5e-141	0.85	0.94	1.00
PGSC0003DMT200000921	K02910	ko03010	Ribosome	960	4.1e-47	0.95	0.98	0.99
PGSC0003DMT200083124	K00117	ko00030	Pentose phosphate pathway	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMT200083124	K00117	ko01100	Metabolic pathways	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMT200083124	K00117	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMT200083125	K00117	ko00030	Pentose phosphate pathway	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMT200083125	K00117	ko01100	Metabolic pathways	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMT200083125	K00117	ko01110	Biosynthesis of secondary metabolites	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMT200083126	K12866	ko03040	Spliceosome	745	3.0e-35	0.31	0.42	0.98
PGSC0003DMT200083135	K01728	ko00040	Pentose and glucuronate interconversions	1872	2.0e-97	0.58	0.72	0.88
PGSC0003DMT200083137	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMT200083137	K00294	ko00330	Arginine and proline metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMT200083137	K00294	ko01100	Metabolic pathways	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMT200083138	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMT200083138	K00294	ko00330	Arginine and proline metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMT200083138	K00294	ko01100	Metabolic pathways	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMT200083146	K05648	ko02010	ABC transporters	1174	8.5e-59	0.32	0.49	0.67
PGSC0003DMT200083147	K05648	ko02010	ABC transporters	1250	4.1e-63	0.32	0.51	0.68
PGSC0003DMT200083150	K02915	ko03010	Ribosome	764	2.6e-36	0.95	0.99	0.85
PGSC0003DMT200083158	K08910	ko00196	Photosynthesis - antenna proteins	1854	2.0e-96	0.85	0.93	0.99
PGSC0003DMT200045825	K13030	ko00460	Cyanoamino acid metabolism	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMT200045825	K13030	ko01110	Biosynthesis of secondary metabolites	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMT200045837	K00558	ko00270	Cysteine and methionine metabolism	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMT200045837	K00558	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMT200045838	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMT200045838	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMT200045839	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMT200045839	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMT200045844	K02933	ko03010	Ribosome	605	1.6e-27	0.84	0.95	0.92
PGSC0003DMT200045850	K00654	ko00600	Sphingolipid metabolism	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMT200045850	K00654	ko01100	Metabolic pathways	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMT200071399	K11821	ko00380	Tryptophan metabolism	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMT200071399	K11821	ko00966	Glucosinolate biosynthesis	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMT200071399	K11821	ko01110	Biosynthesis of secondary metabolites	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMT200071420	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071420	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071421	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071421	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071422	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071422	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMT200071423	K02690	ko00195	Photosynthesis	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMT200071423	K02690	ko01100	Metabolic pathways	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMT200071424	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071424	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071425	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071425	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071426	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071426	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071427	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071427	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMT200071428	K00859	ko00770	Pantothenate and CoA biosynthesis	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMT200071428	K00859	ko01100	Metabolic pathways	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMT200071429	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMT200071429	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMT200071429	K00734	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMT200036332	K05741	ko04810	Regulation of actin cytoskeleton	681	7.9e-30	0.29	0.44	0.54
PGSC0003DMT200036358	K01047	ko00564	Glycerophospholipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko00565	Ether lipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko00590	Arachidonic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko00591	Linoleic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko00592	alpha-Linolenic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko01100	Metabolic pathways	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04010	MAPK signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04370	VEGF signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04664	Fc epsilon RI signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04730	Long-term depression	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036358	K01047	ko04912	GnRH signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMT200036360	K01047	ko00564	Glycerophospholipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko00565	Ether lipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko00590	Arachidonic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko00591	Linoleic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko00592	alpha-Linolenic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko01100	Metabolic pathways	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04010	MAPK signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04270	Vascular smooth muscle contraction	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04370	VEGF signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04664	Fc epsilon RI signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04730	Long-term depression	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200036360	K01047	ko04912	GnRH signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMT200028681	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMT200028682	K02896	ko03010	Ribosome	1268	4.2e-64	0.91	0.95	0.99
PGSC0003DMT200028683	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMT200028683	K00517	ko00626	Naphthalene and anthracene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMT200028683	K00517	ko00903	Limonene and pinene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMT200028683	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMT200028683	K00517	ko01110	Biosynthesis of secondary metabolites	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMT200028684	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMT200028684	K00517	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMT200028684	K00517	ko00903	Limonene and pinene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMT200028684	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMT200028684	K00517	ko01110	Biosynthesis of secondary metabolites	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMT200028689	K01689	ko00010	Glycolysis / Gluconeogenesis	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMT200028689	K01689	ko01100	Metabolic pathways	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMT200028689	K01689	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMT200028689	K01689	ko03018	RNA degradation	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMT200028690	K01689	ko00010	Glycolysis / Gluconeogenesis	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMT200028690	K01689	ko01100	Metabolic pathways	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMT200028690	K01689	ko01110	Biosynthesis of secondary metabolites	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMT200028690	K01689	ko03018	RNA degradation	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMT200028707	K02930	ko03010	Ribosome	2846	3.9e-151	0.85	0.93	1.00
PGSC0003DMT200028711	K12134	ko04712	Circadian rhythm - plant	493	2.3e-21	0.35	0.51	0.88
PGSC0003DMT200028712	K12134	ko04712	Circadian rhythm - plant	293	6.2e-10	0.56	0.74	0.95
PGSC0003DMT200028714	K00799	ko00480	Glutathione metabolism	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMT200028714	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMT200028714	K00799	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMT200025687	K12666	ko00510	N-Glycan biosynthesis	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMT200025687	K12666	ko01100	Metabolic pathways	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMT200025700	K00100	ko00051	Fructose and mannose metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025700	K00100	ko00363	Bisphenol A degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025700	K00100	ko00591	Linoleic acid metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025700	K00100	ko00625	Tetrachloroethene degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025700	K00100	ko00650	Butanoate metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025700	K00100	ko01100	Metabolic pathways	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMT200025701	K00021	ko00900	Terpenoid backbone biosynthesis	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMT200025701	K00021	ko01100	Metabolic pathways	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMT200025701	K00021	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMT200096321	K01509	ko00230	Purine metabolism	276	1.1e-08	0.40	0.62	0.87
PGSC0003DMT200096324	K03469	ko03030	DNA replication	219	6.6e-06	0.31	0.48	0.26
PGSC0003DMT200080548	K10775	ko00360	Phenylalanine metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMT200080548	K10775	ko00910	Nitrogen metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMT200080548	K10775	ko00940	Phenylpropanoid biosynthesis	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMT200080548	K10775	ko01100	Metabolic pathways	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMT200080548	K10775	ko01110	Biosynthesis of secondary metabolites	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMT200080554	K00162	ko00010	Glycolysis / Gluconeogenesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko00020	Citrate cycle (TCA cycle)	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko00620	Pyruvate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko00650	Butanoate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko01100	Metabolic pathways	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080554	K00162	ko01110	Biosynthesis of secondary metabolites	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMT200080555	K00162	ko00010	Glycolysis / Gluconeogenesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko00020	Citrate cycle (TCA cycle)	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko00620	Pyruvate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko00650	Butanoate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko01100	Metabolic pathways	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080555	K00162	ko01110	Biosynthesis of secondary metabolites	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMT200080557	K04498	ko04110	Cell cycle	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04310	Wnt signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04330	Notch signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04350	TGF-beta signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04520	Adherens junction	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04630	Jak-STAT signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04720	Long-term potentiation	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko04916	Melanogenesis	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko05016	Huntington's disease	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko05200	Pathways in cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko05211	Renal cell carcinoma	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080557	K04498	ko05215	Prostate cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMT200080558	K04498	ko04110	Cell cycle	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04310	Wnt signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04330	Notch signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04350	TGF-beta signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04520	Adherens junction	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04630	Jak-STAT signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04720	Long-term potentiation	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko04916	Melanogenesis	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko05016	Huntington's disease	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko05200	Pathways in cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko05211	Renal cell carcinoma	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080558	K04498	ko05215	Prostate cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMT200080559	K04498	ko04110	Cell cycle	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04310	Wnt signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04330	Notch signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04350	TGF-beta signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04520	Adherens junction	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04630	Jak-STAT signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04720	Long-term potentiation	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko04916	Melanogenesis	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko05016	Huntington's disease	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko05200	Pathways in cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko05211	Renal cell carcinoma	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080559	K04498	ko05215	Prostate cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04110	Cell cycle	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04310	Wnt signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04330	Notch signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04350	TGF-beta signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04520	Adherens junction	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04630	Jak-STAT signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04720	Long-term potentiation	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko04916	Melanogenesis	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko05016	Huntington's disease	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko05200	Pathways in cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko05211	Renal cell carcinoma	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080560	K04498	ko05215	Prostate cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMT200080580	K09489	ko04612	Antigen processing and presentation	5215	8.4e-282	0.72	0.83	1.00
PGSC0003DMT200080581	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.74	0.85	1.00
PGSC0003DMT200080582	K09489	ko04612	Antigen processing and presentation	5268	1.0e-284	0.73	0.85	1.00
PGSC0003DMT200080583	K09489	ko04612	Antigen processing and presentation	5326	6.4e-288	0.74	0.85	1.00
PGSC0003DMT200080584	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.73	0.85	1.00
PGSC0003DMT200080585	K09489	ko04612	Antigen processing and presentation	5316	2.3e-287	0.74	0.85	1.00
PGSC0003DMT200080586	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMT200080587	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMT200073166	K04733	ko04210	Apoptosis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMT200073166	K04733	ko04620	Toll-like receptor signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMT200073166	K04733	ko04722	Neurotrophin signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMT200073166	K04733	ko05140	Leishmaniasis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMT200073166	K04733	ko05142	Chagas disease	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMT200073168	K04733	ko04210	Apoptosis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMT200073168	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMT200073168	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMT200073168	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMT200073168	K04733	ko05142	Chagas disease	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMT200073202	K00558	ko00270	Cysteine and methionine metabolism	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMT200073202	K00558	ko01100	Metabolic pathways	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMT200073206	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073206	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073206	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073206	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073206	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073207	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073207	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073207	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073207	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073207	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073215	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073215	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073215	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073215	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073215	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073218	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073218	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073218	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073218	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073218	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMT200073231	K04733	ko04210	Apoptosis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMT200073231	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMT200073231	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMT200073231	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMT200073231	K04733	ko05142	Chagas disease	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMT200047627	K01057	ko00030	Pentose phosphate pathway	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMT200047627	K01057	ko01100	Metabolic pathways	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMT200047627	K01057	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMT200047631	K01509	ko00230	Purine metabolism	740	5.6e-35	0.48	0.63	0.91
PGSC0003DMT200047632	K01509	ko00230	Purine metabolism	1083	6.7e-54	0.47	0.64	0.90
PGSC0003DMT200047633	K01509	ko00230	Purine metabolism	1097	1.1e-54	0.47	0.62	0.85
PGSC0003DMT200047634	K01509	ko00230	Purine metabolism	1055	2.4e-52	0.51	0.67	0.81
PGSC0003DMT200047660	K01199	ko00500	Starch and sucrose metabolism	747	2.3e-35	0.36	0.55	0.86
PGSC0003DMT200070250	K03707	ko00730	Thiamine metabolism	263	1.1e-08	0.28	0.47	0.91
PGSC0003DMT200070253	K02180	ko04110	Cell cycle	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMT200070253	K02180	ko04111	Cell cycle - yeast	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMT200070264	K01112	ko00051	Fructose and mannose metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMT200070264	K01112	ko00730	Thiamine metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMT200070264	K01112	ko00740	Riboflavin metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMT200070264	K01112	ko01100	Metabolic pathways	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMT200070265	K00873	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko00230	Purine metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko00620	Pyruvate metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko00710	Carbon fixation in photosynthetic organisms	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko01100	Metabolic pathways	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070265	K00873	ko04930	Type II diabetes mellitus	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMT200070284	K12662	ko03040	Spliceosome	296	2.3e-10	0.31	0.48	0.59
PGSC0003DMT200070285	K06685	ko04111	Cell cycle - yeast	404	4.4e-13	0.25	0.44	0.92
PGSC0003DMT200070294	K07199	ko04910	Insulin signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMT200070294	K07199	ko04920	Adipocytokine signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMT200070294	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMT200095122	K10760	ko00908	Zeatin biosynthesis	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMT200095122	K10760	ko01100	Metabolic pathways	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMT200095122	K10760	ko01110	Biosynthesis of secondary metabolites	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMT200095128	K01528	ko04144	Endocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMT200095128	K01528	ko04666	Fc gamma R-mediated phagocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMT200095128	K01528	ko05100	Bacterial invasion of epithelial cells	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMT200038031	K01885	ko00860	Porphyrin and chlorophyll metabolism	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMT200038031	K01885	ko00970	Aminoacyl-tRNA biosynthesis	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMT200038031	K01885	ko01100	Metabolic pathways	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMT200038031	K01885	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMT200038053	K00799	ko00480	Glutathione metabolism	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMT200038053	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMT200038053	K00799	ko00982	Drug metabolism - cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMT200038054	K00799	ko00480	Glutathione metabolism	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMT200038054	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMT200038054	K00799	ko00982	Drug metabolism - cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMT200038055	K00485	ko00982	Drug metabolism - cytochrome P450	644	1.1e-29	0.31	0.47	0.93
PGSC0003DMT200038056	K00485	ko00982	Drug metabolism - cytochrome P450	687	4.7e-32	0.31	0.47	0.97
PGSC0003DMT200038065	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.66
PGSC0003DMT200038066	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.67
PGSC0003DMT200026841	K10745	ko03030	DNA replication	676	1.9e-31	0.47	0.60	0.36
PGSC0003DMT200026845	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMT200026846	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMT200026850	K01363	ko04142	Lysosome	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMT200026850	K01363	ko04612	Antigen processing and presentation	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMT200026852	K01363	ko04142	Lysosome	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMT200026852	K01363	ko04612	Antigen processing and presentation	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMT200026885	K08139	ko04113	Meiosis - yeast	1002	2.0e-49	0.35	0.52	0.82
PGSC0003DMT200026888	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMT200086828	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMT200086828	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMT200086828	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMT200059624	K01738	ko00270	Cysteine and methionine metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMT200059624	K01738	ko00450	Selenoamino acid metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMT200059624	K01738	ko00920	Sulfur metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMT200059624	K01738	ko01100	Metabolic pathways	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMT200059626	K00276	ko00260	Glycine, serine and threonine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko00350	Tyrosine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko00360	Phenylalanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko00410	beta-Alanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko01100	Metabolic pathways	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059626	K00276	ko01110	Biosynthesis of secondary metabolites	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMT200059646	K12662	ko03040	Spliceosome	288	3.2e-08	0.28	0.45	0.63
PGSC0003DMT200059647	K01046	ko00561	Glycerolipid metabolism	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMT200059647	K01046	ko01100	Metabolic pathways	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMT200059650	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.41	0.57	0.89
PGSC0003DMT200059651	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.42	0.57	0.95
PGSC0003DMT200059653	K13030	ko00460	Cyanoamino acid metabolism	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMT200059653	K13030	ko01110	Biosynthesis of secondary metabolites	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMT200049042	K00696	ko00500	Starch and sucrose metabolism	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMT200049042	K00696	ko01100	Metabolic pathways	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMT200049043	K00696	ko00500	Starch and sucrose metabolism	6570	0.	0.75	0.85	1.00
PGSC0003DMT200049043	K00696	ko01100	Metabolic pathways	6570	0.	0.75	0.85	1.00
PGSC0003DMT200049045	K00696	ko00500	Starch and sucrose metabolism	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMT200049045	K00696	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMT200049046	K00696	ko00500	Starch and sucrose metabolism	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMT200049046	K00696	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMT200049047	K00696	ko00500	Starch and sucrose metabolism	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMT200049047	K00696	ko01100	Metabolic pathways	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMT200049056	K06118	ko00520	Amino sugar and nucleotide sugar metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMT200049056	K06118	ko00561	Glycerolipid metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMT200076238	K12596	ko03018	RNA degradation	246	3.4e-07	0.31	0.47	0.68
PGSC0003DMT200076251	K01728	ko00040	Pentose and glucuronate interconversions	2903	2.8e-154	0.77	0.86	0.94
PGSC0003DMT200076252	K06067	ko04110	Cell cycle	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMT200076252	K06067	ko04330	Notch signaling pathway	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMT200076252	K06067	ko05016	Huntington's disease	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMT200076252	K06067	ko05200	Pathways in cancer	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMT200076252	K06067	ko05220	Chronic myeloid leukemia	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMT200076253	K06067	ko04110	Cell cycle	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMT200076253	K06067	ko04330	Notch signaling pathway	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMT200076253	K06067	ko05016	Huntington's disease	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMT200076253	K06067	ko05200	Pathways in cancer	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMT200076253	K06067	ko05220	Chronic myeloid leukemia	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMT200076269	K12624	ko03018	RNA degradation	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMT200076269	K12624	ko03040	Spliceosome	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMT200002555	K03921	ko00061	Fatty acid biosynthesis	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMT200002555	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMT200002557	K00609	ko00240	Pyrimidine metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMT200002557	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMT200002557	K00609	ko01100	Metabolic pathways	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMT200002558	K00609	ko00240	Pyrimidine metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMT200002558	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMT200002558	K00609	ko01100	Metabolic pathways	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMT200002567	K10258	ko01040	Biosynthesis of unsaturated fatty acids	525	4.0e-23	0.33	0.53	0.95
PGSC0003DMT200002568	K10258	ko01040	Biosynthesis of unsaturated fatty acids	351	1.6e-13	0.37	0.56	0.94
PGSC0003DMT200002569	K10258	ko01040	Biosynthesis of unsaturated fatty acids	467	6.4e-20	0.36	0.51	0.91
PGSC0003DMT200002570	K10258	ko01040	Biosynthesis of unsaturated fatty acids	502	7.5e-22	0.35	0.54	0.88
PGSC0003DMT200002593	K11808	ko00230	Purine metabolism	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMT200002593	K11808	ko01100	Metabolic pathways	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMT200002593	K11808	ko01110	Biosynthesis of secondary metabolites	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMT200002595	K11808	ko00230	Purine metabolism	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMT200002595	K11808	ko01100	Metabolic pathways	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMT200002595	K11808	ko01110	Biosynthesis of secondary metabolites	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMT200093371	K02925	ko03010	Ribosome	214	6.9e-06	0.80	0.87	0.36
PGSC0003DMT200093372	K02738	ko03050	Proteasome	467	6.4e-20	0.37	0.55	0.80
PGSC0003DMT200093392	K12849	ko03040	Spliceosome	221	2.4e-06	0.30	0.49	0.90
PGSC0003DMT200090732	K00001	ko00010	Glycolysis / Gluconeogenesis	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00071	Fatty acid metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00350	Tyrosine metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00624	1- and 2-Methylnaphthalene degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00641	3-Chloroacrylic acid degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00830	Retinol metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko00982	Drug metabolism - cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko01100	Metabolic pathways	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090732	K00001	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMT200090746	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1396	3.7e-71	0.56	0.66	0.99
PGSC0003DMT200016322	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200016322	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200016322	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMT200016323	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMT200016323	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMT200016323	K10158	ko01100	Metabolic pathways	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMT200016326	K02492	ko00860	Porphyrin and chlorophyll metabolism	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMT200016326	K02492	ko01100	Metabolic pathways	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMT200016326	K02492	ko01110	Biosynthesis of secondary metabolites	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMT200016340	K00430	ko00360	Phenylalanine metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMT200016340	K00430	ko00680	Methane metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMT200016340	K00430	ko00940	Phenylpropanoid biosynthesis	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMT200016340	K00430	ko01100	Metabolic pathways	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMT200016340	K00430	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMT200016342	K12129	ko04712	Circadian rhythm - plant	248	3.4e-07	0.28	0.44	0.92
PGSC0003DMT200016351	K06100	ko04530	Tight junction	3487	1.7e-186	0.50	0.67	0.73
PGSC0003DMT200016352	K01610	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016352	K01610	ko00020	Citrate cycle (TCA cycle)	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016352	K01610	ko00620	Pyruvate metabolism	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016352	K01610	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016352	K01610	ko01100	Metabolic pathways	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016352	K01610	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMT200016353	K01610	ko00010	Glycolysis / Gluconeogenesis	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016353	K01610	ko00020	Citrate cycle (TCA cycle)	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016353	K01610	ko00620	Pyruvate metabolism	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016353	K01610	ko00710	Carbon fixation in photosynthetic organisms	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016353	K01610	ko01100	Metabolic pathways	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016353	K01610	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMT200016354	K01610	ko00010	Glycolysis / Gluconeogenesis	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200016354	K01610	ko00020	Citrate cycle (TCA cycle)	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200016354	K01610	ko00620	Pyruvate metabolism	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200016354	K01610	ko00710	Carbon fixation in photosynthetic organisms	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200016354	K01610	ko01100	Metabolic pathways	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200016354	K01610	ko01110	Biosynthesis of secondary metabolites	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMT200040247	K11820	ko00380	Tryptophan metabolism	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMT200040247	K11820	ko00966	Glucosinolate biosynthesis	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMT200040247	K11820	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMT200040255	K01199	ko00500	Starch and sucrose metabolism	767	1.8e-36	0.36	0.58	0.69
PGSC0003DMT200040259	K00430	ko00360	Phenylalanine metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMT200040259	K00430	ko00680	Methane metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMT200040259	K00430	ko00940	Phenylpropanoid biosynthesis	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMT200040259	K00430	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMT200040259	K00430	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMT200040260	K00430	ko00360	Phenylalanine metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMT200040260	K00430	ko00680	Methane metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMT200040260	K00430	ko00940	Phenylpropanoid biosynthesis	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMT200040260	K00430	ko01100	Metabolic pathways	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMT200040260	K00430	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMT200040287	K06627	ko04110	Cell cycle	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMT200040287	K06627	ko04914	Progesterone-mediated oocyte maturation	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMT200040291	K03512	ko03410	Base excision repair	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMT200040291	K03512	ko03450	Non-homologous end-joining	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMT200012494	K04354	ko04111	Cell cycle - yeast	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMT200012494	K04354	ko04530	Tight junction	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMT200012494	K04354	ko05142	Chagas disease	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMT200012495	K04354	ko04111	Cell cycle - yeast	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMT200012495	K04354	ko04530	Tight junction	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMT200012495	K04354	ko05142	Chagas disease	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMT200012498	K01955	ko00240	Pyrimidine metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMT200012498	K01955	ko00250	Alanine, aspartate and glutamate metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMT200012498	K01955	ko01100	Metabolic pathways	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMT200012499	K12309	ko00052	Galactose metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko00511	Other glycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko00531	Glycosaminoglycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko00600	Sphingolipid metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko01100	Metabolic pathways	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012499	K12309	ko04142	Lysosome	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMT200012500	K12309	ko00052	Galactose metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko00511	Other glycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko00531	Glycosaminoglycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko00600	Sphingolipid metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko01100	Metabolic pathways	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012500	K12309	ko04142	Lysosome	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMT200012501	K12309	ko00052	Galactose metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko00511	Other glycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko00531	Glycosaminoglycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko00600	Sphingolipid metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko01100	Metabolic pathways	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012501	K12309	ko04142	Lysosome	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMT200012502	K12309	ko00052	Galactose metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko00511	Other glycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko00531	Glycosaminoglycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko00600	Sphingolipid metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko01100	Metabolic pathways	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012502	K12309	ko04142	Lysosome	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMT200012520	K04733	ko04210	Apoptosis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMT200012520	K04733	ko04620	Toll-like receptor signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMT200012520	K04733	ko04722	Neurotrophin signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMT200012520	K04733	ko05140	Leishmaniasis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMT200012520	K04733	ko05142	Chagas disease	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMT200012522	K01733	ko00260	Glycine, serine and threonine metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMT200012522	K01733	ko00750	Vitamin B6 metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMT200012522	K01733	ko01100	Metabolic pathways	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMT200006264	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	246	9.8e-08	0.57	0.65	0.41
PGSC0003DMT200006293	K05350	ko00460	Cyanoamino acid metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMT200006293	K05350	ko00500	Starch and sucrose metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMT200006293	K05350	ko00940	Phenylpropanoid biosynthesis	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMT200006293	K05350	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMT200006294	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006294	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006294	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006294	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006295	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006295	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006295	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006295	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMT200006297	K05350	ko00460	Cyanoamino acid metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMT200006297	K05350	ko00500	Starch and sucrose metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMT200006297	K05350	ko00940	Phenylpropanoid biosynthesis	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMT200006297	K05350	ko01110	Biosynthesis of secondary metabolites	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMT200033585	K06630	ko04110	Cell cycle	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMT200033585	K06630	ko04114	Oocyte meiosis	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMT200033585	K06630	ko04722	Neurotrophin signaling pathway	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMT200033587	K06627	ko04110	Cell cycle	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMT200033587	K06627	ko04914	Progesterone-mediated oocyte maturation	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMT200033588	K06627	ko04110	Cell cycle	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMT200033588	K06627	ko04914	Progesterone-mediated oocyte maturation	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMT200033600	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMT200033601	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMT200022377	K04424	ko04010	MAPK signaling pathway	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMT200022377	K04424	ko04530	Tight junction	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMT200022378	K04424	ko04010	MAPK signaling pathway	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMT200022378	K04424	ko04530	Tight junction	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMT200022379	K04424	ko04010	MAPK signaling pathway	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMT200022379	K04424	ko04530	Tight junction	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMT200022382	K12897	ko03040	Spliceosome	847	7.0e-41	0.52	0.66	0.98
PGSC0003DMT200022383	K12897	ko03040	Spliceosome	252	4.6e-08	0.47	0.53	0.87
PGSC0003DMT200022384	K12897	ko03040	Spliceosome	638	2.4e-29	0.59	0.75	0.97
PGSC0003DMT200022385	K01115	ko00564	Glycerophospholipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022385	K01115	ko00565	Ether lipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022385	K01115	ko01100	Metabolic pathways	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022385	K01115	ko04144	Endocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022385	K01115	ko04666	Fc gamma R-mediated phagocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022385	K01115	ko04912	GnRH signaling pathway	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMT200022394	K12863	ko03040	Spliceosome	1674	1.7e-86	0.84	0.93	1.00
PGSC0003DMT200041871	K02988	ko03010	Ribosome	471	3.8e-20	0.39	0.62	0.31
PGSC0003DMT200041874	K03921	ko00061	Fatty acid biosynthesis	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMT200041874	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMT200041876	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMT200041876	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMT200041876	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMT200041876	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMT200041886	K00650	ko00564	Glycerophospholipid metabolism	423	1.7e-17	0.31	0.44	0.90
PGSC0003DMT200041887	K00650	ko00564	Glycerophospholipid metabolism	361	4.5e-14	0.34	0.48	0.89
PGSC0003DMT200032391	K00826	ko00280	Valine, leucine and isoleucine degradation	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMT200032391	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMT200032391	K00826	ko00770	Pantothenate and CoA biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMT200032391	K00826	ko01100	Metabolic pathways	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMT200032391	K00826	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMT200032392	K00826	ko00280	Valine, leucine and isoleucine degradation	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMT200032392	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMT200032392	K00826	ko00770	Pantothenate and CoA biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMT200032392	K00826	ko01100	Metabolic pathways	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMT200032392	K00826	ko01110	Biosynthesis of secondary metabolites	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMT200032399	K01528	ko04144	Endocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMT200032399	K01528	ko04666	Fc gamma R-mediated phagocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMT200032399	K01528	ko05100	Bacterial invasion of epithelial cells	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMT200032400	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMT200032401	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMT200032402	K10143	ko04115	p53 signaling pathway	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMT200032402	K10143	ko04120	Ubiquitin mediated proteolysis	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMT200032404	K10143	ko04115	p53 signaling pathway	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMT200032404	K10143	ko04120	Ubiquitin mediated proteolysis	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMT200032405	K10143	ko04115	p53 signaling pathway	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMT200032405	K10143	ko04120	Ubiquitin mediated proteolysis	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMT200004753	K01760	ko00270	Cysteine and methionine metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004753	K01760	ko00450	Selenoamino acid metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004753	K01760	ko00910	Nitrogen metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004753	K01760	ko00920	Sulfur metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004753	K01760	ko01100	Metabolic pathways	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004753	K01760	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMT200004760	K00680	ko00350	Tyrosine metabolism	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMT200004760	K00680	ko00624	1- and 2-Methylnaphthalene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMT200004760	K00680	ko00632	Benzoate degradation via CoA ligation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMT200004760	K00680	ko00642	Ethylbenzene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMT200004760	K00680	ko00903	Limonene and pinene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMT200004775	K05677	ko02010	ABC transporters	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMT200004775	K05677	ko04146	Peroxisome	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMT200097357	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMT200097357	K00517	ko00626	Naphthalene and anthracene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMT200097357	K00517	ko00903	Limonene and pinene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMT200097357	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMT200097357	K00517	ko01110	Biosynthesis of secondary metabolites	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMT200097378	K10592	ko04120	Ubiquitin mediated proteolysis	467	1.0e-15	0.29	0.48	0.64
PGSC0003DMT200001388	K00962	ko00230	Purine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMT200001388	K00962	ko00240	Pyrimidine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMT200001388	K00962	ko03018	RNA degradation	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMT200001389	K00962	ko00230	Purine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMT200001389	K00962	ko00240	Pyrimidine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMT200001389	K00962	ko03018	RNA degradation	6035	0.	0.74	0.85	1.00
PGSC0003DMT200001391	K12823	ko03040	Spliceosome	1968	1.0e-102	0.53	0.67	0.66
PGSC0003DMT200001392	K03083	ko04012	ErbB signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04062	Chemokine signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04110	Cell cycle	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04310	Wnt signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04340	Hedgehog signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04360	Axon guidance	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04510	Focal adhesion	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04660	T cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04662	B cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04711	Circadian rhythm - fly	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04722	Neurotrophin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04910	Insulin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko04916	Melanogenesis	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05010	Alzheimer's disease	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05200	Pathways in cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05210	Colorectal cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05213	Endometrial cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05215	Prostate cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001392	K03083	ko05217	Basal cell carcinoma	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMT200001397	K01199	ko00500	Starch and sucrose metabolism	1122	4.8e-56	0.47	0.66	1.00
PGSC0003DMT200001398	K01199	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.46	0.64	0.96
PGSC0003DMT200001400	K09753	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMT200001400	K09753	ko01100	Metabolic pathways	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMT200001400	K09753	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMT200001401	K09753	ko00940	Phenylpropanoid biosynthesis	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMT200001401	K09753	ko01100	Metabolic pathways	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMT200001401	K09753	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMT200068729	K03094	ko04110	Cell cycle	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04111	Cell cycle - yeast	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04114	Oocyte meiosis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04120	Ubiquitin mediated proteolysis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04310	Wnt signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04350	TGF-beta signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068729	K03094	ko04710	Circadian rhythm - mammal	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMT200068731	K05849	ko04020	Calcium signaling pathway	322	2.5e-11	0.33	0.52	0.92
PGSC0003DMT200068748	K13082	ko00941	Flavonoid biosynthesis	707	3.7e-33	0.39	0.61	0.85
PGSC0003DMT200068763	K03083	ko04012	ErbB signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04062	Chemokine signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04110	Cell cycle	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04310	Wnt signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04340	Hedgehog signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04360	Axon guidance	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04510	Focal adhesion	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04660	T cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04662	B cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04711	Circadian rhythm - fly	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04722	Neurotrophin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04910	Insulin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko04916	Melanogenesis	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05010	Alzheimer's disease	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05200	Pathways in cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05210	Colorectal cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05213	Endometrial cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05215	Prostate cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068763	K03083	ko05217	Basal cell carcinoma	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMT200068764	K03083	ko04012	ErbB signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04062	Chemokine signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04110	Cell cycle	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04310	Wnt signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04340	Hedgehog signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04360	Axon guidance	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04510	Focal adhesion	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04660	T cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04662	B cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04711	Circadian rhythm - fly	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04722	Neurotrophin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04910	Insulin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko04916	Melanogenesis	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05010	Alzheimer's disease	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05200	Pathways in cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05210	Colorectal cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05213	Endometrial cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05215	Prostate cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068764	K03083	ko05217	Basal cell carcinoma	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMT200068765	K03083	ko04012	ErbB signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04062	Chemokine signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04110	Cell cycle	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04310	Wnt signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04340	Hedgehog signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04360	Axon guidance	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04510	Focal adhesion	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04660	T cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04662	B cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04711	Circadian rhythm - fly	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04722	Neurotrophin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04910	Insulin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko04916	Melanogenesis	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05010	Alzheimer's disease	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05200	Pathways in cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05210	Colorectal cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05213	Endometrial cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05215	Prostate cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200068765	K03083	ko05217	Basal cell carcinoma	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMT200057318	K06611	ko00052	Galactose metabolism	228	5.2e-06	0.44	0.57	0.80
PGSC0003DMT200057319	K06611	ko00052	Galactose metabolism	505	6.9e-22	0.53	0.69	0.82
PGSC0003DMT200057320	K06611	ko00052	Galactose metabolism	2251	2.6e-118	0.42	0.60	0.96
PGSC0003DMT200057323	K12616	ko03018	RNA degradation	7528	0.	0.66	0.77	1.00
PGSC0003DMT200057325	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMT200057326	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMT200057327	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMT200057328	K03876	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.28	0.48	0.78
PGSC0003DMT200057331	K01623	ko00010	Glycolysis / Gluconeogenesis	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057331	K01623	ko00030	Pentose phosphate pathway	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057331	K01623	ko00051	Fructose and mannose metabolism	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057331	K01623	ko00710	Carbon fixation in photosynthetic organisms	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057331	K01623	ko01100	Metabolic pathways	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057331	K01623	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMT200057332	K01623	ko00010	Glycolysis / Gluconeogenesis	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057332	K01623	ko00030	Pentose phosphate pathway	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057332	K01623	ko00051	Fructose and mannose metabolism	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057332	K01623	ko00710	Carbon fixation in photosynthetic organisms	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057332	K01623	ko01100	Metabolic pathways	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057332	K01623	ko01110	Biosynthesis of secondary metabolites	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko00010	Glycolysis / Gluconeogenesis	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko00030	Pentose phosphate pathway	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko00051	Fructose and mannose metabolism	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko00710	Carbon fixation in photosynthetic organisms	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko01100	Metabolic pathways	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057333	K01623	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMT200057338	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057338	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057340	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMT200057342	K06268	ko04010	MAPK signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04020	Calcium signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04114	Oocyte meiosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04210	Apoptosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04310	Wnt signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04360	Axon guidance	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04370	VEGF signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04650	Natural killer cell mediated cytotoxicity	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04660	T cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04662	B cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko04720	Long-term potentiation	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko05010	Alzheimer's disease	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057342	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMT200057344	K06268	ko04010	MAPK signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04020	Calcium signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04114	Oocyte meiosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04210	Apoptosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04310	Wnt signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04360	Axon guidance	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04370	VEGF signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04650	Natural killer cell mediated cytotoxicity	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04660	T cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04662	B cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko04720	Long-term potentiation	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko05010	Alzheimer's disease	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200057344	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMT200078501	K12200	ko04144	Endocytosis	993	6.2e-49	0.64	0.75	0.99
PGSC0003DMT200078502	K12200	ko04144	Endocytosis	5898	0.	0.79	0.88	1.00
PGSC0003DMT200078503	K12200	ko04144	Endocytosis	4586	4.2e-247	0.83	0.92	0.96
PGSC0003DMT200078504	K12200	ko04144	Endocytosis	3967	5.8e-213	0.84	0.91	0.99
PGSC0003DMT200078506	K00523	ko00520	Amino sugar and nucleotide sugar metabolism	354	1.1e-13	0.31	0.49	0.74
PGSC0003DMT200078507	K02133	ko00190	Oxidative phosphorylation	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMT200078507	K02133	ko01100	Metabolic pathways	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMT200078507	K02133	ko05010	Alzheimer's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMT200078507	K02133	ko05012	Parkinson's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMT200078507	K02133	ko05016	Huntington's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMT200078513	K03118	ko03060	Protein export	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMT200078513	K03118	ko03070	Bacterial secretion system	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMT200078514	K03118	ko03060	Protein export	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMT200078514	K03118	ko03070	Bacterial secretion system	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMT200078515	K08730	ko00564	Glycerophospholipid metabolism	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMT200078515	K08730	ko01100	Metabolic pathways	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMT200078516	K08730	ko00564	Glycerophospholipid metabolism	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMT200078516	K08730	ko01100	Metabolic pathways	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMT200078517	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMT200078517	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMT200078518	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMT200078518	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMT200078519	K01623	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078519	K01623	ko00030	Pentose phosphate pathway	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078519	K01623	ko00051	Fructose and mannose metabolism	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078519	K01623	ko00710	Carbon fixation in photosynthetic organisms	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078519	K01623	ko01100	Metabolic pathways	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078519	K01623	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMT200078520	K01623	ko00010	Glycolysis / Gluconeogenesis	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078520	K01623	ko00030	Pentose phosphate pathway	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078520	K01623	ko00051	Fructose and mannose metabolism	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078520	K01623	ko00710	Carbon fixation in photosynthetic organisms	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078520	K01623	ko01100	Metabolic pathways	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078520	K01623	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMT200078529	K10352	ko04530	Tight junction	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMT200078529	K10352	ko05416	Viral myocarditis	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMT200078530	K10352	ko04530	Tight junction	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMT200078530	K10352	ko05416	Viral myocarditis	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMT200078533	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078533	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078533	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078533	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078533	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078533	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200051258	K00852	ko00030	Pentose phosphate pathway	315	1.5e-11	0.36	0.51	0.51
PGSC0003DMT200051260	K12886	ko03040	Spliceosome	276	2.2e-09	0.33	0.45	0.68
PGSC0003DMT200051271	K00799	ko00480	Glutathione metabolism	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMT200051271	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMT200051271	K00799	ko00982	Drug metabolism - cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMT200051283	K04424	ko04010	MAPK signaling pathway	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMT200051283	K04424	ko04530	Tight junction	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMT200008084	K02433	ko00970	Aminoacyl-tRNA biosynthesis	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMT200008084	K02433	ko01100	Metabolic pathways	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMT200008085	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMT200008085	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMT200008086	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMT200008086	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMT200008088	K02433	ko00970	Aminoacyl-tRNA biosynthesis	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMT200008088	K02433	ko01100	Metabolic pathways	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMT200008089	K02433	ko00970	Aminoacyl-tRNA biosynthesis	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMT200008089	K02433	ko01100	Metabolic pathways	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMT200008091	K01426	ko00330	Arginine and proline metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008091	K01426	ko00360	Phenylalanine metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008091	K01426	ko00380	Tryptophan metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008091	K01426	ko00460	Cyanoamino acid metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008091	K01426	ko00632	Benzoate degradation via CoA ligation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008091	K01426	ko00643	Styrene degradation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMT200008092	K02433	ko00970	Aminoacyl-tRNA biosynthesis	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMT200008092	K02433	ko01100	Metabolic pathways	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMT200008093	K01426	ko00330	Arginine and proline metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008093	K01426	ko00360	Phenylalanine metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008093	K01426	ko00380	Tryptophan metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008093	K01426	ko00460	Cyanoamino acid metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008093	K01426	ko00632	Benzoate degradation via CoA ligation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008093	K01426	ko00643	Styrene degradation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMT200008098	K04043	ko03018	RNA degradation	1261	1.0e-63	0.81	0.92	0.99
PGSC0003DMT200008099	K04043	ko03018	RNA degradation	4523	1.2e-243	0.89	0.96	1.00
PGSC0003DMT200008100	K04043	ko03018	RNA degradation	2075	1.3e-108	0.86	0.94	1.00
PGSC0003DMT200008101	K04043	ko03018	RNA degradation	4816	8.6e-260	0.86	0.93	1.00
PGSC0003DMT200008102	K01623	ko00010	Glycolysis / Gluconeogenesis	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008102	K01623	ko00030	Pentose phosphate pathway	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008102	K01623	ko00051	Fructose and mannose metabolism	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008102	K01623	ko00710	Carbon fixation in photosynthetic organisms	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008102	K01623	ko01100	Metabolic pathways	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008102	K01623	ko01110	Biosynthesis of secondary metabolites	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMT200008103	K01623	ko00010	Glycolysis / Gluconeogenesis	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200008103	K01623	ko00030	Pentose phosphate pathway	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200008103	K01623	ko00051	Fructose and mannose metabolism	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200008103	K01623	ko00710	Carbon fixation in photosynthetic organisms	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200008103	K01623	ko01100	Metabolic pathways	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200008103	K01623	ko01110	Biosynthesis of secondary metabolites	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMT200036844	K06268	ko04010	MAPK signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04020	Calcium signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04114	Oocyte meiosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04210	Apoptosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04310	Wnt signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04360	Axon guidance	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04370	VEGF signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04650	Natural killer cell mediated cytotoxicity	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04660	T cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04662	B cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko04720	Long-term potentiation	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko05010	Alzheimer's disease	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036844	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMT200036845	K06268	ko04010	MAPK signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04020	Calcium signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04114	Oocyte meiosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04210	Apoptosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04310	Wnt signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04360	Axon guidance	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04370	VEGF signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04650	Natural killer cell mediated cytotoxicity	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04660	T cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04662	B cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko04720	Long-term potentiation	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko05010	Alzheimer's disease	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036845	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMT200036847	K01507	ko00190	Oxidative phosphorylation	5947	0.	0.93	0.97	1.00
PGSC0003DMT200036855	K03283	ko03040	Spliceosome	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMT200036855	K03283	ko04010	MAPK signaling pathway	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMT200036855	K03283	ko04144	Endocytosis	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMT200036855	K03283	ko04612	Antigen processing and presentation	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMT200036856	K03283	ko03040	Spliceosome	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMT200036856	K03283	ko04010	MAPK signaling pathway	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMT200036856	K03283	ko04144	Endocytosis	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMT200036856	K03283	ko04612	Antigen processing and presentation	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMT200036857	K11229	ko04011	MAPK signaling pathway - yeast	583	1.9e-25	0.37	0.52	0.70
PGSC0003DMT200036864	K01213	ko00040	Pentose and glucuronate interconversions	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMT200036864	K01213	ko00500	Starch and sucrose metabolism	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMT200036864	K01213	ko01100	Metabolic pathways	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMT200036865	K01213	ko00040	Pentose and glucuronate interconversions	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMT200036865	K01213	ko00500	Starch and sucrose metabolism	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMT200036865	K01213	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMT200036866	K01213	ko00040	Pentose and glucuronate interconversions	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMT200036866	K01213	ko00500	Starch and sucrose metabolism	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMT200036866	K01213	ko01100	Metabolic pathways	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMT200036870	K10839	ko03420	Nucleotide excision repair	1111	1.9e-55	0.73	0.80	0.88
PGSC0003DMT200036871	K10839	ko03420	Nucleotide excision repair	2279	7.3e-120	0.70	0.79	1.00
PGSC0003DMT200028484	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMT200028499	K11423	ko00310	Lysine degradation	780	3.5e-37	0.41	0.55	0.64
PGSC0003DMT200028500	K11424	ko00310	Lysine degradation	685	6.0e-32	0.48	0.64	0.44
PGSC0003DMT200028502	K07253	ko00350	Tyrosine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMT200028502	K07253	ko00360	Phenylalanine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMT200028503	K02634	ko00195	Photosynthesis	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMT200028503	K02634	ko01100	Metabolic pathways	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMT200028514	K11424	ko00310	Lysine degradation	475	2.3e-20	0.49	0.65	0.56
PGSC0003DMT200028521	K11812	ko00380	Tryptophan metabolism	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMT200028521	K11812	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMT200026009	K02716	ko00195	Photosynthesis	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMT200026009	K02716	ko01100	Metabolic pathways	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMT200026014	K11419	ko00310	Lysine degradation	671	2.5e-30	0.35	0.50	0.17
PGSC0003DMT200026015	K11419	ko00310	Lysine degradation	242	1.9e-06	0.30	0.47	0.13
PGSC0003DMT200026025	K01784	ko00052	Galactose metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMT200026025	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMT200026025	K01784	ko01100	Metabolic pathways	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMT200096426	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200096426	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200096426	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200096426	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200096426	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200096453	K10747	ko03030	DNA replication	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMT200096453	K10747	ko03410	Base excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMT200096453	K10747	ko03420	Nucleotide excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMT200096453	K10747	ko03430	Mismatch repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMT200083963	K00207	ko00240	Pyrimidine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMT200083963	K00207	ko00410	beta-Alanine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMT200083963	K00207	ko00770	Pantothenate and CoA biosynthesis	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMT200083963	K00207	ko00983	Drug metabolism - other enzymes	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMT200083963	K00207	ko01100	Metabolic pathways	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMT200083964	K00207	ko00240	Pyrimidine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMT200083964	K00207	ko00410	beta-Alanine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMT200083964	K00207	ko00770	Pantothenate and CoA biosynthesis	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMT200083964	K00207	ko00983	Drug metabolism - other enzymes	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMT200083964	K00207	ko01100	Metabolic pathways	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMT200083967	K00207	ko00240	Pyrimidine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMT200083967	K00207	ko00410	beta-Alanine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMT200083967	K00207	ko00770	Pantothenate and CoA biosynthesis	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMT200083967	K00207	ko00983	Drug metabolism - other enzymes	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMT200083967	K00207	ko01100	Metabolic pathways	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMT200083968	K02984	ko03010	Ribosome	1960	2.9e-102	0.89	0.95	1.00
PGSC0003DMT200083971	K02183	ko04020	Calcium signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04070	Phosphatidylinositol signaling system	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04114	Oocyte meiosis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04270	Vascular smooth muscle contraction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04626	Plant-pathogen interaction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04720	Long-term potentiation	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04722	Neurotrophin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04740	Olfactory transduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04744	Phototransduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04745	Phototransduction - fly	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04910	Insulin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04912	GnRH signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04916	Melanogenesis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04970	Salivary secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko04971	Gastric acid secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko05010	Alzheimer's disease	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083971	K02183	ko05214	Glioma	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMT200083974	K01054	ko00561	Glycerolipid metabolism	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMT200083974	K01054	ko01100	Metabolic pathways	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMT200083978	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMT200083978	K01078	ko00740	Riboflavin metabolism	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMT200083984	K02904	ko03010	Ribosome	754	9.4e-36	0.78	0.88	0.72
PGSC0003DMT200083989	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMT200083990	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMT200083995	K04368	ko04010	MAPK signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04012	ErbB signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04013	MAPK signaling pathway - fly	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04062	Chemokine signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04114	Oocyte meiosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04270	Vascular smooth muscle contraction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04320	Dorso-ventral axis formation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04370	VEGF signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04510	Focal adhesion	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04540	Gap junction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04620	Toll-like receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04626	Plant-pathogen interaction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04650	Natural killer cell mediated cytotoxicity	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04660	T cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04662	B cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04664	Fc epsilon RI signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04666	Fc gamma R-mediated phagocytosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04720	Long-term potentiation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04722	Neurotrophin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04730	Long-term depression	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04810	Regulation of actin cytoskeleton	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04910	Insulin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04912	GnRH signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04914	Progesterone-mediated oocyte maturation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko04916	Melanogenesis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05020	Prion diseases	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05200	Pathways in cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05210	Colorectal cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05211	Renal cell carcinoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05212	Pancreatic cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05213	Endometrial cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05214	Glioma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05215	Prostate cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05216	Thyroid cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05218	Melanoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05219	Bladder cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05220	Chronic myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05221	Acute myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200083995	K04368	ko05223	Non-small cell lung cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMT200045133	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMT200045133	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMT200045135	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMT200045135	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMT200045138	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.29	0.48	0.93
PGSC0003DMT200045149	K01438	ko00330	Arginine and proline metabolism	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMT200045149	K01438	ko01100	Metabolic pathways	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMT200045149	K01438	ko01110	Biosynthesis of secondary metabolites	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMT200045150	K01438	ko00330	Arginine and proline metabolism	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMT200045150	K01438	ko01100	Metabolic pathways	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMT200045150	K01438	ko01110	Biosynthesis of secondary metabolites	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMT200045151	K01438	ko00330	Arginine and proline metabolism	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMT200045151	K01438	ko01100	Metabolic pathways	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMT200045151	K01438	ko01110	Biosynthesis of secondary metabolites	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMT200045152	K01438	ko00330	Arginine and proline metabolism	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMT200045152	K01438	ko01100	Metabolic pathways	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMT200045152	K01438	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMT200045157	K12493	ko04144	Endocytosis	2138	4.4e-112	0.66	0.76	1.00
PGSC0003DMT200045158	K12493	ko04144	Endocytosis	1297	1.1e-65	0.73	0.83	0.85
PGSC0003DMT200045159	K12493	ko04144	Endocytosis	2444	5.8e-129	0.72	0.84	1.00
PGSC0003DMT200045160	K12493	ko04144	Endocytosis	2439	1.1e-128	0.49	0.63	0.97
PGSC0003DMT200045166	K11294	ko05130	Pathogenic Escherichia coli infection	374	1.9e-14	0.31	0.51	0.76
PGSC0003DMT200071247	K03945	ko00190	Oxidative phosphorylation	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMT200071247	K03945	ko01100	Metabolic pathways	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMT200071247	K03945	ko05010	Alzheimer's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMT200071247	K03945	ko05012	Parkinson's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMT200071247	K03945	ko05016	Huntington's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMT200071255	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMT200071255	K00517	ko00626	Naphthalene and anthracene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMT200071255	K00517	ko00903	Limonene and pinene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMT200071255	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMT200071255	K00517	ko01110	Biosynthesis of secondary metabolites	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMT200071263	K04733	ko04210	Apoptosis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMT200071263	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMT200071263	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMT200071263	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMT200071263	K04733	ko05142	Chagas disease	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMT200071273	K13229	ko00402	Benzoxazinoid biosynthesis	986	1.5e-48	0.38	0.58	0.97
PGSC0003DMT200071281	K01955	ko00240	Pyrimidine metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMT200071281	K01955	ko00250	Alanine, aspartate and glutamate metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMT200071281	K01955	ko01100	Metabolic pathways	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMT200071283	K11188	ko00360	Phenylalanine metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMT200071283	K11188	ko00680	Methane metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMT200071283	K11188	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMT200071283	K11188	ko01100	Metabolic pathways	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMT200071283	K11188	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMT200095246	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMT200038548	K03469	ko03030	DNA replication	291	3.2e-10	0.37	0.54	0.82
PGSC0003DMT200038553	K00558	ko00270	Cysteine and methionine metabolism	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMT200038553	K00558	ko01100	Metabolic pathways	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMT200038554	K00558	ko00270	Cysteine and methionine metabolism	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMT200038554	K00558	ko01100	Metabolic pathways	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMT200038555	K11093	ko03040	Spliceosome	1256	1.9e-63	0.83	0.93	0.92
PGSC0003DMT200038556	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMT200038557	K11093	ko03040	Spliceosome	2893	9.9e-154	0.67	0.80	1.00
PGSC0003DMT200038558	K11093	ko03040	Spliceosome	2894	8.7e-154	0.67	0.80	1.00
PGSC0003DMT200038559	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMT200038570	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	393	1.5e-15	0.39	0.57	0.73
PGSC0003DMT200038571	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	473	3.0e-20	0.35	0.56	0.79
PGSC0003DMT200038576	K00234	ko00020	Citrate cycle (TCA cycle)	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko00190	Oxidative phosphorylation	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko01100	Metabolic pathways	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko01110	Biosynthesis of secondary metabolites	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko05010	Alzheimer's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko05012	Parkinson's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038576	K00234	ko05016	Huntington's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMT200038577	K09587	ko00905	Brassinosteroid biosynthesis	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMT200038577	K09587	ko01100	Metabolic pathways	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMT200038577	K09587	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMT200026641	K10841	ko03420	Nucleotide excision repair	6820	0.	0.69	0.80	1.00
PGSC0003DMT200026656	K05765	ko04360	Axon guidance	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMT200026656	K05765	ko04666	Fc gamma R-mediated phagocytosis	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMT200026656	K05765	ko04810	Regulation of actin cytoskeleton	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMT200026657	K05765	ko04360	Axon guidance	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMT200026657	K05765	ko04666	Fc gamma R-mediated phagocytosis	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMT200026657	K05765	ko04810	Regulation of actin cytoskeleton	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMT200026666	K00392	ko00450	Selenoamino acid metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMT200026666	K00392	ko00920	Sulfur metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMT200026666	K00392	ko01100	Metabolic pathways	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMT200026679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMT200026679	K00517	ko00626	Naphthalene and anthracene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMT200026679	K00517	ko00903	Limonene and pinene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMT200026679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMT200026679	K00517	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMT200052815	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052815	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052815	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052816	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052816	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052816	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMT200052818	K04123	ko00904	Diterpenoid biosynthesis	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMT200052818	K04123	ko01100	Metabolic pathways	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMT200052818	K04123	ko01110	Biosynthesis of secondary metabolites	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMT200052825	K11826	ko04144	Endocytosis	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMT200052825	K11826	ko05016	Huntington's disease	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMT200052829	K02698	ko00195	Photosynthesis	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMT200052829	K02698	ko01100	Metabolic pathways	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMT200052838	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMT200052839	K01177	ko00500	Starch and sucrose metabolism	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMT200052839	K01177	ko01100	Metabolic pathways	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMT200081272	K00688	ko00500	Starch and sucrose metabolism	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMT200081272	K00688	ko04910	Insulin signaling pathway	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMT200081273	K00688	ko00500	Starch and sucrose metabolism	5956	0.	0.83	0.92	0.81
PGSC0003DMT200081273	K00688	ko04910	Insulin signaling pathway	5956	0.	0.83	0.92	0.81
PGSC0003DMT200081287	K13230	ko00402	Benzoxazinoid biosynthesis	942	4.0e-46	0.38	0.55	0.98
PGSC0003DMT200081288	K13230	ko00402	Benzoxazinoid biosynthesis	924	4.0e-45	0.37	0.55	0.99
PGSC0003DMT200081295	K11821	ko00380	Tryptophan metabolism	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMT200081295	K11821	ko00966	Glucosinolate biosynthesis	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMT200081295	K11821	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMT200081297	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200081299	K03801	ko00785	Lipoic acid metabolism	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMT200081299	K03801	ko01100	Metabolic pathways	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMT200081305	K02891	ko03010	Ribosome	869	4.3e-42	0.83	0.91	0.99
PGSC0003DMT200081306	K02891	ko03010	Ribosome	514	1.6e-22	0.78	0.90	0.99
PGSC0003DMT200081307	K02891	ko03010	Ribosome	871	3.3e-42	0.83	0.93	0.99
PGSC0003DMT200081310	K02883	ko03010	Ribosome	1426	8.1e-73	0.90	0.95	0.99
PGSC0003DMT200072991	K01925	ko00471	D-Glutamine and D-glutamate metabolism	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMT200072991	K01925	ko00550	Peptidoglycan biosynthesis	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMT200072991	K01925	ko01100	Metabolic pathways	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMT200046953	K11866	ko04144	Endocytosis	626	3.0e-28	0.32	0.46	0.88
PGSC0003DMT200046955	K01136	ko00531	Glycosaminoglycan degradation	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMT200046955	K01136	ko01100	Metabolic pathways	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMT200046955	K01136	ko04142	Lysosome	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMT200046973	K12929	ko00904	Diterpenoid biosynthesis	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMT200046973	K12929	ko01110	Biosynthesis of secondary metabolites	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMT200046974	K12929	ko00904	Diterpenoid biosynthesis	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMT200046974	K12929	ko01110	Biosynthesis of secondary metabolites	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMT200046977	K10352	ko04530	Tight junction	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMT200046977	K10352	ko05416	Viral myocarditis	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMT200046982	K00558	ko00270	Cysteine and methionine metabolism	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMT200046982	K00558	ko01100	Metabolic pathways	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMT200070613	K00697	ko00500	Starch and sucrose metabolism	4624	3.3e-249	0.63	0.79	0.98
PGSC0003DMT200070614	K00697	ko00500	Starch and sucrose metabolism	4132	4.6e-222	0.64	0.79	0.96
PGSC0003DMT200070615	K00697	ko00500	Starch and sucrose metabolism	515	1.7e-22	0.64	0.73	0.83
PGSC0003DMT200070616	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMT200070617	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMT200070618	K01756	ko00230	Purine metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMT200070618	K01756	ko00250	Alanine, aspartate and glutamate metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMT200070618	K01756	ko01100	Metabolic pathways	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMT200070618	K01756	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMT200070628	K00901	ko00561	Glycerolipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMT200070628	K00901	ko00564	Glycerophospholipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMT200070628	K00901	ko01100	Metabolic pathways	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMT200070628	K00901	ko04070	Phosphatidylinositol signaling system	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMT200070629	K00901	ko00561	Glycerolipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMT200070629	K00901	ko00564	Glycerophospholipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMT200070629	K00901	ko01100	Metabolic pathways	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMT200070629	K00901	ko04070	Phosphatidylinositol signaling system	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMT200070632	K00558	ko00270	Cysteine and methionine metabolism	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMT200070632	K00558	ko01100	Metabolic pathways	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMT200003084	K04498	ko04110	Cell cycle	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04310	Wnt signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04330	Notch signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04350	TGF-beta signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04520	Adherens junction	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04630	Jak-STAT signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04720	Long-term potentiation	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko04916	Melanogenesis	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko05016	Huntington's disease	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko05200	Pathways in cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko05211	Renal cell carcinoma	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003084	K04498	ko05215	Prostate cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMT200003101	K02945	ko03010	Ribosome	2917	4.7e-155	0.84	0.93	1.00
PGSC0003DMT200024100	K00938	ko00900	Terpenoid backbone biosynthesis	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMT200024100	K00938	ko01100	Metabolic pathways	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMT200024100	K00938	ko01110	Biosynthesis of secondary metabolites	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMT200024102	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024102	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024102	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024103	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024103	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024103	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMT200024111	K04733	ko04210	Apoptosis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMT200024111	K04733	ko04620	Toll-like receptor signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMT200024111	K04733	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMT200024111	K04733	ko05140	Leishmaniasis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMT200024111	K04733	ko05142	Chagas disease	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMT200024123	K02084	ko04115	p53 signaling pathway	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko04210	Apoptosis	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko05010	Alzheimer's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko05012	Parkinson's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko05016	Huntington's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200024123	K02084	ko05222	Small cell lung cancer	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMT200040089	K02201	ko00770	Pantothenate and CoA biosynthesis	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMT200040089	K02201	ko01100	Metabolic pathways	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMT200040090	K02201	ko00770	Pantothenate and CoA biosynthesis	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMT200040090	K02201	ko01100	Metabolic pathways	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMT200040094	K07252	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.37	0.57	0.67
PGSC0003DMT200040096	K07252	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.38	0.56	0.67
PGSC0003DMT200040097	K07252	ko00510	N-Glycan biosynthesis	368	1.8e-14	0.35	0.53	0.70
PGSC0003DMT200040098	K07252	ko00510	N-Glycan biosynthesis	353	1.2e-13	0.37	0.56	0.68
PGSC0003DMT200040101	K00100	ko00051	Fructose and mannose metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040101	K00100	ko00363	Bisphenol A degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040101	K00100	ko00591	Linoleic acid metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040101	K00100	ko00625	Tetrachloroethene degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040101	K00100	ko00650	Butanoate metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040101	K00100	ko01100	Metabolic pathways	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMT200040102	K00102	ko00620	Pyruvate metabolism	838	2.2e-40	0.51	0.69	0.95
PGSC0003DMT200040103	K00102	ko00620	Pyruvate metabolism	836	2.8e-40	0.52	0.70	0.89
PGSC0003DMT200040117	K12127	ko04712	Circadian rhythm - plant	224	5.8e-06	0.32	0.50	0.93
PGSC0003DMT200040121	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200040122	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200040126	K12605	ko03018	RNA degradation	3598	1.3e-192	0.78	0.89	0.96
PGSC0003DMT200040127	K12605	ko03018	RNA degradation	4388	3.5e-236	0.77	0.88	1.00
PGSC0003DMT200040128	K12605	ko03018	RNA degradation	4152	3.6e-223	0.79	0.90	1.00
PGSC0003DMT200012303	K00010	ko00521	Streptomycin biosynthesis	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMT200012303	K00010	ko00562	Inositol phosphate metabolism	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMT200012303	K00010	ko01100	Metabolic pathways	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMT200012303	K00010	ko01110	Biosynthesis of secondary metabolites	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMT200012305	K12353	ko00600	Sphingolipid metabolism	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMT200012305	K12353	ko01100	Metabolic pathways	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMT200012306	K12353	ko00600	Sphingolipid metabolism	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMT200012306	K12353	ko01100	Metabolic pathways	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMT200012307	K12353	ko00600	Sphingolipid metabolism	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMT200012307	K12353	ko01100	Metabolic pathways	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMT200012308	K12353	ko00600	Sphingolipid metabolism	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMT200012308	K12353	ko01100	Metabolic pathways	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMT200012309	K12353	ko00600	Sphingolipid metabolism	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMT200012309	K12353	ko01100	Metabolic pathways	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMT200012311	K12353	ko00600	Sphingolipid metabolism	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMT200012311	K12353	ko01100	Metabolic pathways	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMT200012312	K05280	ko00941	Flavonoid biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMT200012312	K05280	ko00944	Flavone and flavonol biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMT200012312	K05280	ko01100	Metabolic pathways	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMT200012312	K05280	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMT200012313	K05280	ko00941	Flavonoid biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMT200012313	K05280	ko00944	Flavone and flavonol biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMT200012313	K05280	ko01100	Metabolic pathways	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMT200012313	K05280	ko01110	Biosynthesis of secondary metabolites	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMT200012318	K00232	ko00071	Fatty acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012318	K00232	ko00592	alpha-Linolenic acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012318	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012318	K00232	ko01100	Metabolic pathways	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012318	K00232	ko03320	PPAR signaling pathway	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012318	K00232	ko04146	Peroxisome	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMT200012322	K00232	ko00071	Fatty acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012322	K00232	ko00592	alpha-Linolenic acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012322	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012322	K00232	ko01100	Metabolic pathways	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012322	K00232	ko03320	PPAR signaling pathway	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012322	K00232	ko04146	Peroxisome	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMT200012338	K12125	ko04712	Circadian rhythm - plant	817	3.2e-39	0.31	0.45	0.96
PGSC0003DMT200012339	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMT200012340	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMT200012341	K12197	ko04144	Endocytosis	817	3.2e-39	0.87	0.94	0.99
PGSC0003DMT200012342	K12197	ko04144	Endocytosis	1478	1.1e-75	0.89	0.96	1.00
PGSC0003DMT200012343	K01112	ko00051	Fructose and mannose metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMT200012343	K01112	ko00730	Thiamine metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMT200012343	K01112	ko00740	Riboflavin metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMT200012343	K01112	ko01100	Metabolic pathways	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMT200012344	K01112	ko00051	Fructose and mannose metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMT200012344	K01112	ko00730	Thiamine metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMT200012344	K01112	ko00740	Riboflavin metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMT200012344	K01112	ko01100	Metabolic pathways	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMT200012346	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMT200012346	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMT200012346	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMT200012346	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMT200006575	K00812	ko00250	Alanine, aspartate and glutamate metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00270	Cysteine and methionine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00330	Arginine and proline metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00350	Tyrosine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00360	Phenylalanine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00401	Novobiocin biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00710	Carbon fixation in photosynthetic organisms	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00950	Isoquinoline alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko01100	Metabolic pathways	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006575	K00812	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMT200006576	K06627	ko04110	Cell cycle	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMT200006576	K06627	ko04914	Progesterone-mediated oocyte maturation	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMT200006577	K00865	ko00260	Glycine, serine and threonine metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMT200006577	K00865	ko00561	Glycerolipid metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMT200006577	K00865	ko00630	Glyoxylate and dicarboxylate metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMT200006577	K00865	ko01100	Metabolic pathways	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMT200006585	K03350	ko04110	Cell cycle	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006585	K03350	ko04111	Cell cycle - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006585	K03350	ko04113	Meiosis - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006585	K03350	ko04114	Oocyte meiosis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006585	K03350	ko04120	Ubiquitin mediated proteolysis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006585	K03350	ko04914	Progesterone-mediated oocyte maturation	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMT200006586	K03350	ko04110	Cell cycle	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006586	K03350	ko04111	Cell cycle - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006586	K03350	ko04113	Meiosis - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006586	K03350	ko04114	Oocyte meiosis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006586	K03350	ko04120	Ubiquitin mediated proteolysis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006586	K03350	ko04914	Progesterone-mediated oocyte maturation	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMT200006587	K03350	ko04110	Cell cycle	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006587	K03350	ko04111	Cell cycle - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006587	K03350	ko04113	Meiosis - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006587	K03350	ko04114	Oocyte meiosis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006587	K03350	ko04120	Ubiquitin mediated proteolysis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006587	K03350	ko04914	Progesterone-mediated oocyte maturation	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMT200006588	K03350	ko04110	Cell cycle	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006588	K03350	ko04111	Cell cycle - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006588	K03350	ko04113	Meiosis - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006588	K03350	ko04114	Oocyte meiosis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006588	K03350	ko04120	Ubiquitin mediated proteolysis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006588	K03350	ko04914	Progesterone-mediated oocyte maturation	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMT200006600	K03126	ko03022	Basal transcription factors	870	3.8e-42	0.35	0.50	0.97
PGSC0003DMT200006601	K03126	ko03022	Basal transcription factors	940	5.2e-46	0.32	0.47	0.97
PGSC0003DMT200006612	K00599	ko00340	Histidine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMT200006612	K00599	ko00350	Tyrosine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMT200006612	K00599	ko00450	Selenoamino acid metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMT200006612	K00599	ko00626	Naphthalene and anthracene degradation	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMT200034103	K08233	ko00901	Indole alkaloid biosynthesis	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMT200034103	K08233	ko01110	Biosynthesis of secondary metabolites	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMT200034106	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMT200034106	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMT200034108	K10802	ko03410	Base excision repair	459	1.8e-19	0.47	0.62	0.70
PGSC0003DMT200034109	K10802	ko03410	Base excision repair	398	4.1e-16	0.46	0.61	0.41
PGSC0003DMT200086709	K10760	ko00908	Zeatin biosynthesis	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMT200086709	K10760	ko01100	Metabolic pathways	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMT200086709	K10760	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMT200067084	K02888	ko03010	Ribosome	1021	1.8e-50	0.66	0.75	0.96
PGSC0003DMT200067085	K02888	ko03010	Ribosome	266	7.8e-09	0.48	0.59	0.83
PGSC0003DMT200067089	K09843	ko00906	Carotenoid biosynthesis	800	2.7e-38	0.40	0.62	0.97
PGSC0003DMT200067103	K11816	ko00380	Tryptophan metabolism	2048	4.0e-107	0.71	0.85	0.99
PGSC0003DMT200067106	K11816	ko00380	Tryptophan metabolism	1082	7.6e-54	0.71	0.86	0.94
PGSC0003DMT200067109	K06666	ko04111	Cell cycle - yeast	649	5.8e-30	0.26	0.41	0.92
PGSC0003DMT200067110	K06666	ko04111	Cell cycle - yeast	653	3.5e-30	0.26	0.41	0.92
PGSC0003DMT200049428	K05692	ko04145	Phagosome	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04510	Focal adhesion	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04520	Adherens junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04530	Tight junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04670	Leukocyte transendothelial migration	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04745	Phototransduction - fly	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko04810	Regulation of actin cytoskeleton	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05100	Bacterial invasion of epithelial cells	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05110	Vibrio cholerae infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05130	Pathogenic Escherichia coli infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05131	Shigellosis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05414	Dilated cardiomyopathy	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049428	K05692	ko05416	Viral myocarditis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMT200049429	K05692	ko04145	Phagosome	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04510	Focal adhesion	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04520	Adherens junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04530	Tight junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04670	Leukocyte transendothelial migration	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04745	Phototransduction - fly	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko04810	Regulation of actin cytoskeleton	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05100	Bacterial invasion of epithelial cells	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05110	Vibrio cholerae infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05130	Pathogenic Escherichia coli infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05131	Shigellosis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05414	Dilated cardiomyopathy	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049429	K05692	ko05416	Viral myocarditis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMT200049441	K03283	ko03040	Spliceosome	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMT200049441	K03283	ko04010	MAPK signaling pathway	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMT200049441	K03283	ko04144	Endocytosis	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMT200049441	K03283	ko04612	Antigen processing and presentation	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMT200049442	K12881	ko03040	Spliceosome	1021	1.8e-50	0.62	0.70	0.93
PGSC0003DMT200049443	K12881	ko03040	Spliceosome	304	6.2e-11	0.49	0.65	0.93
PGSC0003DMT200049444	K12881	ko03040	Spliceosome	1284	5.5e-65	0.66	0.74	1.00
PGSC0003DMT200049456	K02893	ko03010	Ribosome	1141	4.3e-57	0.89	0.93	0.99
PGSC0003DMT200076726	K12129	ko04712	Circadian rhythm - plant	283	3.9e-09	0.32	0.53	0.70
PGSC0003DMT200076727	K03415	ko02020	Two-component system	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMT200076727	K03415	ko02030	Bacterial chemotaxis	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMT200076736	K13228	ko00402	Benzoxazinoid biosynthesis	314	1.7e-11	0.29	0.44	0.88
PGSC0003DMT200076741	K00279	ko00908	Zeatin biosynthesis	1646	6.0e-85	0.67	0.84	0.90
PGSC0003DMT200076746	K01633	ko00790	Folate biosynthesis	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMT200076746	K01633	ko01100	Metabolic pathways	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMT200076747	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMT200076747	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMT200076748	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMT200076748	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMT200076758	K12129	ko04712	Circadian rhythm - plant	274	1.3e-08	0.32	0.53	0.70
PGSC0003DMT200067198	K04428	ko04010	MAPK signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMT200067198	K04428	ko04912	GnRH signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMT200067203	K00889	ko00562	Inositol phosphate metabolism	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067203	K00889	ko01100	Metabolic pathways	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067203	K00889	ko04070	Phosphatidylinositol signaling system	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067203	K00889	ko04144	Endocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067203	K00889	ko04666	Fc gamma R-mediated phagocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067203	K00889	ko04810	Regulation of actin cytoskeleton	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMT200067204	K00889	ko00562	Inositol phosphate metabolism	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067204	K00889	ko01100	Metabolic pathways	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067204	K00889	ko04070	Phosphatidylinositol signaling system	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067204	K00889	ko04144	Endocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067204	K00889	ko04666	Fc gamma R-mediated phagocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067204	K00889	ko04810	Regulation of actin cytoskeleton	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMT200067206	K00680	ko00350	Tyrosine metabolism	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMT200067206	K00680	ko00624	1- and 2-Methylnaphthalene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMT200067206	K00680	ko00632	Benzoate degradation via CoA ligation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMT200067206	K00680	ko00642	Ethylbenzene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMT200067206	K00680	ko00903	Limonene and pinene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMT200067208	K00876	ko00240	Pyrimidine metabolism	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMT200067208	K00876	ko00983	Drug metabolism - other enzymes	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMT200067208	K00876	ko01100	Metabolic pathways	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMT200067209	K02882	ko03010	Ribosome	1451	3.4e-74	0.93	0.98	0.99
PGSC0003DMT200067211	K11584	ko04113	Meiosis - yeast	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMT200067211	K11584	ko04114	Oocyte meiosis	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMT200067211	K11584	ko04310	Wnt signaling pathway	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMT200067222	K07192	ko04910	Insulin signaling pathway	1420	1.7e-72	0.42	0.62	1.00
PGSC0003DMT200067225	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMT200067226	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMT200067235	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMT200059484	K03966	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMT200059484	K03966	ko01100	Metabolic pathways	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMT200059484	K03966	ko05010	Alzheimer's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMT200059484	K03966	ko05012	Parkinson's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMT200059484	K03966	ko05016	Huntington's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMT200059492	K02976	ko03010	Ribosome	716	1.2e-33	0.78	0.87	0.99
PGSC0003DMT200059507	K09837	ko00906	Carotenoid biosynthesis	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMT200059507	K09837	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMT200059507	K09837	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMT200059508	K09837	ko00906	Carotenoid biosynthesis	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMT200059508	K09837	ko01100	Metabolic pathways	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMT200059508	K09837	ko01110	Biosynthesis of secondary metabolites	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMT200049192	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMT200049192	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMT200049192	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMT200049193	K05933	ko00270	Cysteine and methionine metabolism	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMT200049193	K05933	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMT200049198	K01051	ko00040	Pentose and glucuronate interconversions	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMT200049198	K01051	ko00500	Starch and sucrose metabolism	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMT200049198	K01051	ko01100	Metabolic pathways	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMT200049203	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMT200049203	K01988	ko01100	Metabolic pathways	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMT200049212	K07375	ko04145	Phagosome	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMT200049212	K07375	ko04540	Gap junction	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMT200049212	K07375	ko05130	Pathogenic Escherichia coli infection	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMT200049213	K07375	ko04145	Phagosome	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMT200049213	K07375	ko04540	Gap junction	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMT200049213	K07375	ko05130	Pathogenic Escherichia coli infection	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMT200000069	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000069	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000069	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000070	K00028	ko00620	Pyruvate metabolism	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMT200000070	K00028	ko00710	Carbon fixation in photosynthetic organisms	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMT200000070	K00028	ko01100	Metabolic pathways	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMT200000071	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000071	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000071	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMT200000077	K00079	ko00590	Arachidonic acid metabolism	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMT200000077	K00079	ko01100	Metabolic pathways	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMT200000078	K00079	ko00590	Arachidonic acid metabolism	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMT200000078	K00079	ko01100	Metabolic pathways	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMT200000080	K00079	ko00590	Arachidonic acid metabolism	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMT200000080	K00079	ko01100	Metabolic pathways	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMT200000083	K12844	ko03040	Spliceosome	2317	5.8e-122	0.64	0.75	1.00
PGSC0003DMT200000089	K01962	ko00061	Fatty acid biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000089	K01962	ko00253	Tetracycline biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000089	K01962	ko00620	Pyruvate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000089	K01962	ko00640	Propanoate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000089	K01962	ko01100	Metabolic pathways	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000089	K01962	ko01110	Biosynthesis of secondary metabolites	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMT200000090	K01962	ko00061	Fatty acid biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000090	K01962	ko00253	Tetracycline biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000090	K01962	ko00620	Pyruvate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000090	K01962	ko00640	Propanoate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000090	K01962	ko01100	Metabolic pathways	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000090	K01962	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMT200000091	K01962	ko00061	Fatty acid biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000091	K01962	ko00253	Tetracycline biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000091	K01962	ko00620	Pyruvate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000091	K01962	ko00640	Propanoate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000091	K01962	ko01100	Metabolic pathways	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000091	K01962	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko00061	Fatty acid biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko00253	Tetracycline biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko00620	Pyruvate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko00640	Propanoate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko01100	Metabolic pathways	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000092	K01962	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMT200000093	K12614	ko03018	RNA degradation	3635	1.2e-194	0.88	0.92	0.99
PGSC0003DMT200000106	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMT200000106	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMT200000108	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMT200000108	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMT200024219	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2806	6.2e-149	0.81	0.91	0.99
PGSC0003DMT200024220	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3490	1.2e-186	0.82	0.91	0.89
PGSC0003DMT200024221	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2684	3.3e-142	0.81	0.91	0.90
PGSC0003DMT200024222	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3022	7.6e-161	0.82	0.92	0.81
PGSC0003DMT200016199	K08737	ko03430	Mismatch repair	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMT200016199	K08737	ko05200	Pathways in cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMT200016199	K08737	ko05210	Colorectal cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMT200016201	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200016213	K07466	ko03030	DNA replication	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMT200016213	K07466	ko03420	Nucleotide excision repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMT200016213	K07466	ko03430	Mismatch repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMT200016213	K07466	ko03440	Homologous recombination	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMT200030309	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMT200030309	K12567	ko05414	Dilated cardiomyopathy	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMT200030315	K00059	ko00061	Fatty acid biosynthesis	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMT200030315	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMT200030315	K00059	ko01100	Metabolic pathways	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMT200030316	K00059	ko00061	Fatty acid biosynthesis	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMT200030316	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMT200030316	K00059	ko01100	Metabolic pathways	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMT200030318	K08336	ko04140	Regulation of autophagy	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMT200030318	K08336	ko04622	RIG-I-like receptor signaling pathway	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMT200030319	K08336	ko04140	Regulation of autophagy	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMT200030319	K08336	ko04622	RIG-I-like receptor signaling pathway	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMT200030342	K05658	ko02010	ABC transporters	2958	2.1e-163	0.42	0.60	0.99
PGSC0003DMT200030345	K05658	ko02010	ABC transporters	3859	5.2e-207	0.43	0.65	0.99
PGSC0003DMT200006404	K09589	ko00905	Brassinosteroid biosynthesis	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMT200006404	K09589	ko01100	Metabolic pathways	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMT200006404	K09589	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMT200006405	K09589	ko00905	Brassinosteroid biosynthesis	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMT200006405	K09589	ko01100	Metabolic pathways	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMT200006405	K09589	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMT200006419	K04354	ko04111	Cell cycle - yeast	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMT200006419	K04354	ko04530	Tight junction	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMT200006419	K04354	ko05142	Chagas disease	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMT200006425	K02957	ko03010	Ribosome	851	4.2e-41	0.75	0.91	0.69
PGSC0003DMT200053037	K06685	ko04111	Cell cycle - yeast	331	2.8e-10	0.27	0.45	0.63
PGSC0003DMT200053071	K08679	ko00500	Starch and sucrose metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMT200053071	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMT200053071	K08679	ko01100	Metabolic pathways	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMT200053079	K01897	ko00071	Fatty acid metabolism	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMT200053079	K01897	ko01100	Metabolic pathways	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMT200053079	K01897	ko03320	PPAR signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMT200053079	K01897	ko04146	Peroxisome	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMT200053079	K01897	ko04920	Adipocytokine signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMT200053080	K01897	ko00071	Fatty acid metabolism	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMT200053080	K01897	ko01100	Metabolic pathways	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMT200053080	K01897	ko03320	PPAR signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMT200053080	K01897	ko04146	Peroxisome	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMT200053080	K01897	ko04920	Adipocytokine signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMT200055490	K00856	ko00230	Purine metabolism	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMT200055490	K00856	ko01100	Metabolic pathways	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMT200055511	K13068	ko00940	Phenylpropanoid biosynthesis	883	7.2e-43	0.33	0.51	0.99
PGSC0003DMT200055512	K13068	ko00940	Phenylpropanoid biosynthesis	865	7.1e-42	0.32	0.51	0.96
PGSC0003DMT200055518	K12818	ko03040	Spliceosome	968	1.5e-47	0.52	0.65	0.93
PGSC0003DMT200064975	K05350	ko00460	Cyanoamino acid metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMT200064975	K05350	ko00500	Starch and sucrose metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMT200064975	K05350	ko00940	Phenylpropanoid biosynthesis	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMT200064975	K05350	ko01110	Biosynthesis of secondary metabolites	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMT200064976	K05350	ko00460	Cyanoamino acid metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMT200064976	K05350	ko00500	Starch and sucrose metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMT200064976	K05350	ko00940	Phenylpropanoid biosynthesis	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMT200064976	K05350	ko01110	Biosynthesis of secondary metabolites	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMT200064978	K05350	ko00460	Cyanoamino acid metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMT200064978	K05350	ko00500	Starch and sucrose metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMT200064978	K05350	ko00940	Phenylpropanoid biosynthesis	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMT200064978	K05350	ko01110	Biosynthesis of secondary metabolites	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMT200064983	K00799	ko00480	Glutathione metabolism	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMT200064983	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMT200064983	K00799	ko00982	Drug metabolism - cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMT200064986	K03002	ko00230	Purine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMT200064986	K03002	ko00240	Pyrimidine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMT200064986	K03002	ko01100	Metabolic pathways	7162	0.	0.76	0.87	1.00
PGSC0003DMT200064986	K03002	ko03020	RNA polymerase	7162	0.	0.76	0.87	1.00
PGSC0003DMT200064995	K11253	ko05322	Systemic lupus erythematosus	906	3.9e-44	0.83	0.88	0.89
PGSC0003DMT200064996	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200065000	K00600	ko00260	Glycine, serine and threonine metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200065000	K00600	ko00460	Cyanoamino acid metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200065000	K00600	ko00670	One carbon pool by folate	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200065000	K00600	ko00680	Methane metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200065000	K00600	ko01100	Metabolic pathways	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200065000	K00600	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMT200070464	K00475	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMT200070464	K00475	ko01100	Metabolic pathways	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMT200070464	K00475	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMT200070467	K00475	ko00941	Flavonoid biosynthesis	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMT200070467	K00475	ko01100	Metabolic pathways	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMT200070467	K00475	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMT200070475	K12524	ko00260	Glycine, serine and threonine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMT200070475	K12524	ko00270	Cysteine and methionine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMT200070475	K12524	ko00300	Lysine biosynthesis	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMT200070475	K12524	ko01100	Metabolic pathways	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMT200070475	K12524	ko01110	Biosynthesis of secondary metabolites	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMT200070483	K04532	ko05010	Alzheimer's disease	3133	5.7e-167	0.80	0.88	1.00
PGSC0003DMT200070485	K04532	ko05010	Alzheimer's disease	2944	1.5e-156	0.84	0.92	0.98
PGSC0003DMT200070486	K04532	ko05010	Alzheimer's disease	3680	3.9e-197	0.81	0.90	1.00
PGSC0003DMT200070487	K04532	ko05010	Alzheimer's disease	3711	7.6e-199	0.83	0.92	1.00
PGSC0003DMT200070488	K03133	ko03022	Basal transcription factors	1195	4.5e-60	0.76	0.90	0.99
PGSC0003DMT200070491	K05282	ko00904	Diterpenoid biosynthesis	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMT200070491	K05282	ko01100	Metabolic pathways	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMT200070491	K05282	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMT200070493	K05282	ko00904	Diterpenoid biosynthesis	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMT200070493	K05282	ko01100	Metabolic pathways	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMT200070493	K05282	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMT200070494	K05282	ko00904	Diterpenoid biosynthesis	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMT200070494	K05282	ko01100	Metabolic pathways	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMT200070494	K05282	ko01110	Biosynthesis of secondary metabolites	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMT200008882	K01051	ko00040	Pentose and glucuronate interconversions	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMT200008882	K01051	ko00500	Starch and sucrose metabolism	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMT200008882	K01051	ko01100	Metabolic pathways	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMT200008886	K06654	ko04111	Cell cycle - yeast	284	7.9e-10	0.33	0.55	0.70
PGSC0003DMT200008896	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.50
PGSC0003DMT200008897	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.43
PGSC0003DMT200008902	K00021	ko00900	Terpenoid backbone biosynthesis	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMT200008902	K00021	ko01100	Metabolic pathways	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMT200008902	K00021	ko01110	Biosynthesis of secondary metabolites	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMT200008907	K07407	ko00052	Galactose metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMT200008907	K07407	ko00561	Glycerolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMT200008907	K07407	ko00600	Sphingolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMT200008907	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMT200008908	K07407	ko00052	Galactose metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMT200008908	K07407	ko00561	Glycerolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMT200008908	K07407	ko00600	Sphingolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMT200008908	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMT200008912	K02936	ko03010	Ribosome	1872	2.0e-97	0.86	0.94	0.99
PGSC0003DMT200008913	K05765	ko04360	Axon guidance	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMT200008913	K05765	ko04666	Fc gamma R-mediated phagocytosis	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMT200008913	K05765	ko04810	Regulation of actin cytoskeleton	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMT200008915	K01834	ko00010	Glycolysis / Gluconeogenesis	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMT200008915	K01834	ko01100	Metabolic pathways	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMT200008915	K01834	ko01110	Biosynthesis of secondary metabolites	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMT200008916	K01834	ko00010	Glycolysis / Gluconeogenesis	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMT200008916	K01834	ko01100	Metabolic pathways	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMT200008916	K01834	ko01110	Biosynthesis of secondary metabolites	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMT200018304	K07424	ko00140	Steroid hormone biosynthesis	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00591	Linoleic acid metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00830	Retinol metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00982	Drug metabolism - cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko00983	Drug metabolism - other enzymes	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018304	K07424	ko01100	Metabolic pathways	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMT200018331	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMT200018331	K00517	ko00626	Naphthalene and anthracene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMT200018331	K00517	ko00903	Limonene and pinene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMT200018331	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMT200018331	K00517	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMT200018333	K02943	ko03010	Ribosome	814	4.6e-39	0.88	0.96	0.99
PGSC0003DMT200018334	K02943	ko03010	Ribosome	632	5.0e-29	0.87	0.96	0.72
PGSC0003DMT200018339	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMT200018339	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMT200018353	K00679	ko00561	Glycerolipid metabolism	1393	5.4e-71	0.37	0.55	0.84
PGSC0003DMT200043601	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.0e-12	0.31	0.47	0.65
PGSC0003DMT200043602	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.6e-13	0.31	0.47	0.75
PGSC0003DMT200043606	K02084	ko04115	p53 signaling pathway	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko04210	Apoptosis	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko05010	Alzheimer's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko05012	Parkinson's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko05016	Huntington's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043606	K02084	ko05222	Small cell lung cancer	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMT200043609	K02084	ko04115	p53 signaling pathway	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko04210	Apoptosis	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko05010	Alzheimer's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko05012	Parkinson's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko05016	Huntington's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043609	K02084	ko05222	Small cell lung cancer	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMT200043611	K02084	ko04115	p53 signaling pathway	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko04210	Apoptosis	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko05010	Alzheimer's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko05012	Parkinson's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko05016	Huntington's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043611	K02084	ko05222	Small cell lung cancer	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMT200043628	K02985	ko03010	Ribosome	293	2.5e-10	0.76	0.82	0.49
PGSC0003DMT200088818	K13065	ko00940	Phenylpropanoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMT200088818	K13065	ko00941	Flavonoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMT200088818	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMT200088818	K13065	ko01110	Biosynthesis of secondary metabolites	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMT200088820	K03094	ko04110	Cell cycle	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04111	Cell cycle - yeast	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04114	Oocyte meiosis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04120	Ubiquitin mediated proteolysis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04310	Wnt signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04350	TGF-beta signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088820	K03094	ko04710	Circadian rhythm - mammal	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMT200088828	K01051	ko00040	Pentose and glucuronate interconversions	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMT200088828	K01051	ko00500	Starch and sucrose metabolism	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMT200088828	K01051	ko01100	Metabolic pathways	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMT200063277	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMT200063277	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMT200063277	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMT200063279	K01757	ko00901	Indole alkaloid biosynthesis	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMT200063279	K01757	ko01100	Metabolic pathways	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMT200063279	K01757	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMT200063282	K01757	ko00901	Indole alkaloid biosynthesis	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMT200063282	K01757	ko01100	Metabolic pathways	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMT200063282	K01757	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMT200063286	K01757	ko00901	Indole alkaloid biosynthesis	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMT200063286	K01757	ko01100	Metabolic pathways	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMT200063286	K01757	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMT200063289	K00876	ko00240	Pyrimidine metabolism	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMT200063289	K00876	ko00983	Drug metabolism - other enzymes	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMT200063289	K00876	ko01100	Metabolic pathways	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMT200063308	K11821	ko00380	Tryptophan metabolism	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMT200063308	K11821	ko00966	Glucosinolate biosynthesis	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMT200063308	K11821	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMT200063309	K00754	ko00051	Fructose and mannose metabolism	1606	9.6e-83	0.40	0.60	0.95
PGSC0003DMT200053606	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053606	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053606	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053606	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053606	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053607	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053607	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053607	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053607	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053607	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053608	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053608	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053608	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053608	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053608	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMT200053609	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053609	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053609	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053609	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053609	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053611	K00430	ko00360	Phenylalanine metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMT200053611	K00430	ko00680	Methane metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMT200053611	K00430	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMT200053611	K00430	ko01100	Metabolic pathways	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMT200053611	K00430	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMT200053613	K00430	ko00360	Phenylalanine metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMT200053613	K00430	ko00680	Methane metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMT200053613	K00430	ko00940	Phenylpropanoid biosynthesis	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMT200053613	K00430	ko01100	Metabolic pathways	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMT200053613	K00430	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMT200053615	K00430	ko00360	Phenylalanine metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMT200053615	K00430	ko00680	Methane metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMT200053615	K00430	ko00940	Phenylpropanoid biosynthesis	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMT200053615	K00430	ko01100	Metabolic pathways	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMT200053615	K00430	ko01110	Biosynthesis of secondary metabolites	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMT200053618	K00430	ko00360	Phenylalanine metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMT200053618	K00430	ko00680	Methane metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMT200053618	K00430	ko00940	Phenylpropanoid biosynthesis	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMT200053618	K00430	ko01100	Metabolic pathways	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMT200053618	K00430	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMT200053626	K02995	ko03010	Ribosome	1669	3.2e-86	0.90	0.93	0.99
PGSC0003DMT200053639	K12126	ko04712	Circadian rhythm - plant	291	5.7e-08	0.30	0.54	0.38
PGSC0003DMT200053641	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMT200053641	K00517	ko00626	Naphthalene and anthracene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMT200053641	K00517	ko00903	Limonene and pinene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMT200053641	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMT200053641	K00517	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMT200053643	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMT200053643	K00517	ko00626	Naphthalene and anthracene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMT200053643	K00517	ko00903	Limonene and pinene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMT200053643	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMT200053643	K00517	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMT200053644	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMT200053644	K00517	ko00626	Naphthalene and anthracene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMT200053644	K00517	ko00903	Limonene and pinene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMT200053644	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMT200053644	K00517	ko01110	Biosynthesis of secondary metabolites	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMT200087909	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	439	2.2e-18	0.29	0.51	0.61
PGSC0003DMT200087920	K03006	ko00230	Purine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMT200087920	K03006	ko00240	Pyrimidine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMT200087920	K03006	ko01100	Metabolic pathways	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMT200087920	K03006	ko03020	RNA polymerase	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMT200087920	K03006	ko05016	Huntington's disease	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMT200090023	K08488	ko04130	SNARE interactions in vesicular transport	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMT200090023	K08488	ko04145	Phagosome	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMT200008271	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	568	1.7e-25	0.30	0.50	0.92
PGSC0003DMT200008281	K08516	ko04130	SNARE interactions in vesicular transport	1551	1.0e-79	0.90	0.94	0.99
PGSC0003DMT200008290	K12128	ko04712	Circadian rhythm - plant	405	4.5e-16	0.35	0.54	0.22
PGSC0003DMT200008291	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMT200008292	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMT200008293	K12128	ko04712	Circadian rhythm - plant	405	2.8e-16	0.35	0.54	0.25
PGSC0003DMT200008309	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	689	3.6e-32	0.32	0.54	0.86
PGSC0003DMT200008311	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	502	7.5e-22	0.37	0.57	0.97
PGSC0003DMT200020260	K12356	ko00940	Phenylpropanoid biosynthesis	677	1.7e-31	0.30	0.51	0.95
PGSC0003DMT200020261	K02706	ko00195	Photosynthesis	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMT200020261	K02706	ko01100	Metabolic pathways	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMT200020271	K03715	ko00561	Glycerolipid metabolism	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMT200020271	K03715	ko01100	Metabolic pathways	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMT200020272	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMT200020272	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMT200020273	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMT200020273	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMT200020274	K07432	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMT200020274	K07432	ko01100	Metabolic pathways	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMT200020286	K00799	ko00480	Glutathione metabolism	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMT200020286	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMT200020286	K00799	ko00982	Drug metabolism - cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMT200010532	K12391	ko04142	Lysosome	5879	0.	0.81	0.89	1.00
PGSC0003DMT200010533	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4661	3.0e-251	0.74	0.83	0.97
PGSC0003DMT200010534	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4731	4.2e-255	0.80	0.89	1.00
PGSC0003DMT200010548	K02952	ko03010	Ribosome	1117	9.0e-56	0.80	0.90	0.98
PGSC0003DMT200010554	K02960	ko03010	Ribosome	1134	1.0e-56	0.92	0.98	0.97
PGSC0003DMT200010555	K00128	ko00010	Glycolysis / Gluconeogenesis	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00053	Ascorbate and aldarate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00071	Fatty acid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00280	Valine, leucine and isoleucine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00310	Lysine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00330	Arginine and proline metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00340	Histidine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00380	Tryptophan metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00410	beta-Alanine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00561	Glycerolipid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00620	Pyruvate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00631	1,2-Dichloroethane degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00640	Propanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00641	3-Chloroacrylic acid degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00650	Butanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko00903	Limonene and pinene degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko01100	Metabolic pathways	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010555	K00128	ko01110	Biosynthesis of secondary metabolites	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMT200010556	K00128	ko00010	Glycolysis / Gluconeogenesis	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00053	Ascorbate and aldarate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00071	Fatty acid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00280	Valine, leucine and isoleucine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00310	Lysine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00330	Arginine and proline metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00340	Histidine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00380	Tryptophan metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00410	beta-Alanine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00561	Glycerolipid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00620	Pyruvate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00631	1,2-Dichloroethane degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00640	Propanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00641	3-Chloroacrylic acid degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00650	Butanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko00903	Limonene and pinene degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko01100	Metabolic pathways	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200010556	K00128	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMT200025875	K08852	ko05010	Alzheimer's disease	947	2.1e-46	0.74	0.87	0.92
PGSC0003DMT200025877	K08852	ko05010	Alzheimer's disease	3640	6.2e-195	0.53	0.67	1.00
PGSC0003DMT200025878	K08852	ko05010	Alzheimer's disease	3262	4.4e-174	0.56	0.69	0.99
PGSC0003DMT200025880	K08852	ko05010	Alzheimer's disease	1351	1.1e-68	0.43	0.58	0.97
PGSC0003DMT200025881	K05298	ko00710	Carbon fixation in photosynthetic organisms	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMT200025881	K05298	ko01100	Metabolic pathways	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMT200025900	K12741	ko03040	Spliceosome	341	5.7e-13	0.29	0.40	0.80
PGSC0003DMT200061218	K10256	ko01040	Biosynthesis of unsaturated fatty acids	776	5.8e-37	0.74	0.87	0.98
PGSC0003DMT200061220	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2416	2.0e-127	0.68	0.84	0.99
PGSC0003DMT200061221	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMT200061231	K09755	ko00940	Phenylpropanoid biosynthesis	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMT200061231	K09755	ko01100	Metabolic pathways	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMT200061231	K09755	ko01110	Biosynthesis of secondary metabolites	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMT200061232	K09755	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMT200061232	K09755	ko01100	Metabolic pathways	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMT200061232	K09755	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMT200061238	K07750	ko00100	Steroid biosynthesis	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMT200061238	K07750	ko01100	Metabolic pathways	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMT200061250	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2314	8.5e-122	0.67	0.80	1.00
PGSC0003DMT200061254	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMT200061255	K10256	ko01040	Biosynthesis of unsaturated fatty acids	802	2.1e-38	0.67	0.78	0.99
PGSC0003DMT200061256	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1081	8.7e-54	0.74	0.89	0.99
PGSC0003DMT200061257	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1658	1.3e-85	0.71	0.85	0.97
PGSC0003DMT200061258	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2390	5.5e-126	0.68	0.82	0.99
PGSC0003DMT200061259	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2393	3.8e-126	0.68	0.81	0.99
PGSC0003DMT200061265	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.82	0.98
PGSC0003DMT200061270	K00059	ko00061	Fatty acid biosynthesis	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMT200061270	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMT200061270	K00059	ko01100	Metabolic pathways	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMT200061271	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1377	4.1e-70	0.71	0.86	0.60
PGSC0003DMT200061281	K05282	ko00904	Diterpenoid biosynthesis	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMT200061281	K05282	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMT200061281	K05282	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMT200061282	K02933	ko03010	Ribosome	1507	2.8e-77	0.78	0.90	1.00
PGSC0003DMT200061283	K01955	ko00240	Pyrimidine metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMT200061283	K01955	ko00250	Alanine, aspartate and glutamate metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMT200061283	K01955	ko01100	Metabolic pathways	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMT200068898	K02084	ko04115	p53 signaling pathway	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko04210	Apoptosis	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko05010	Alzheimer's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko05012	Parkinson's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko05016	Huntington's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068898	K02084	ko05222	Small cell lung cancer	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMT200068907	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMT200068907	K00122	ko00680	Methane metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMT200068907	K00122	ko01100	Metabolic pathways	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMT200068909	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMT200068909	K00122	ko00680	Methane metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMT200068909	K00122	ko01100	Metabolic pathways	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMT200068919	K10760	ko00908	Zeatin biosynthesis	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMT200068919	K10760	ko01100	Metabolic pathways	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMT200068919	K10760	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMT200074675	K05749	ko04810	Regulation of actin cytoskeleton	5915	0.	0.83	0.93	1.00
PGSC0003DMT200074677	K05749	ko04810	Regulation of actin cytoskeleton	2319	4.5e-122	0.92	0.98	0.41
PGSC0003DMT200074678	K05749	ko04810	Regulation of actin cytoskeleton	2627	4.7e-139	0.90	0.96	0.98
PGSC0003DMT200074693	K01590	ko00340	Histidine metabolism	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMT200074693	K01590	ko01100	Metabolic pathways	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMT200074693	K01590	ko01110	Biosynthesis of secondary metabolites	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMT200074694	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMT200074694	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMT200074694	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMT200074695	K01590	ko00340	Histidine metabolism	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMT200074695	K01590	ko01100	Metabolic pathways	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMT200074695	K01590	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMT200074696	K01590	ko00340	Histidine metabolism	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMT200074696	K01590	ko01100	Metabolic pathways	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMT200074696	K01590	ko01110	Biosynthesis of secondary metabolites	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMT200074697	K01590	ko00340	Histidine metabolism	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMT200074697	K01590	ko01100	Metabolic pathways	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMT200074697	K01590	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMT200074698	K01590	ko00340	Histidine metabolism	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMT200074698	K01590	ko01100	Metabolic pathways	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMT200074698	K01590	ko01110	Biosynthesis of secondary metabolites	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMT200074699	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074699	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074699	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074702	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074702	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074702	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMT200074703	K01590	ko00340	Histidine metabolism	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMT200074703	K01590	ko01100	Metabolic pathways	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMT200074703	K01590	ko01110	Biosynthesis of secondary metabolites	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMT200074705	K01590	ko00340	Histidine metabolism	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMT200074705	K01590	ko01100	Metabolic pathways	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMT200074705	K01590	ko01110	Biosynthesis of secondary metabolites	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMT200074706	K01590	ko00340	Histidine metabolism	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMT200074706	K01590	ko01100	Metabolic pathways	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMT200074706	K01590	ko01110	Biosynthesis of secondary metabolites	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMT200074707	K01590	ko00340	Histidine metabolism	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMT200074707	K01590	ko01100	Metabolic pathways	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMT200074707	K01590	ko01110	Biosynthesis of secondary metabolites	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMT200074708	K01590	ko00340	Histidine metabolism	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMT200074708	K01590	ko01100	Metabolic pathways	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMT200074708	K01590	ko01110	Biosynthesis of secondary metabolites	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMT200074709	K01590	ko00340	Histidine metabolism	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMT200074709	K01590	ko01100	Metabolic pathways	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMT200074709	K01590	ko01110	Biosynthesis of secondary metabolites	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMT200051040	K01246	ko03410	Base excision repair	1833	2.9e-95	0.60	0.73	1.00
PGSC0003DMT200051041	K01246	ko03410	Base excision repair	605	1.6e-27	0.49	0.61	0.94
PGSC0003DMT200051043	K05391	ko04626	Plant-pathogen interaction	3983	7.5e-214	0.70	0.81	0.97
PGSC0003DMT200051049	K09753	ko00940	Phenylpropanoid biosynthesis	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMT200051049	K09753	ko01100	Metabolic pathways	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMT200051049	K09753	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMT200092021	K06631	ko04110	Cell cycle	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMT200092021	K06631	ko04114	Oocyte meiosis	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMT200092021	K06631	ko04914	Progesterone-mediated oocyte maturation	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMT200014501	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMT200014501	K00517	ko00626	Naphthalene and anthracene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMT200014501	K00517	ko00903	Limonene and pinene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMT200014501	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMT200014501	K00517	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMT200014502	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMT200014502	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMT200014502	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMT200014502	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMT200014502	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMT200014505	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMT200014505	K00517	ko00626	Naphthalene and anthracene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMT200014505	K00517	ko00903	Limonene and pinene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMT200014505	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMT200014505	K00517	ko01110	Biosynthesis of secondary metabolites	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMT200014506	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMT200014506	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMT200014506	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMT200014506	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMT200014506	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMT200014510	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMT200014510	K00517	ko00626	Naphthalene and anthracene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMT200014510	K00517	ko00903	Limonene and pinene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMT200014510	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMT200014510	K00517	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMT200014535	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMT200022504	K04077	ko03018	RNA degradation	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMT200022504	K04077	ko04940	Type I diabetes mellitus	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMT200022513	K00001	ko00010	Glycolysis / Gluconeogenesis	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00071	Fatty acid metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00350	Tyrosine metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00624	1- and 2-Methylnaphthalene degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00641	3-Chloroacrylic acid degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00830	Retinol metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko00982	Drug metabolism - cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko01100	Metabolic pathways	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022513	K00001	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMT200022514	K00001	ko00010	Glycolysis / Gluconeogenesis	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00071	Fatty acid metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00350	Tyrosine metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00641	3-Chloroacrylic acid degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00830	Retinol metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko00982	Drug metabolism - cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko01100	Metabolic pathways	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022514	K00001	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMT200022520	K01199	ko00500	Starch and sucrose metabolism	833	4.1e-40	0.34	0.59	0.74
PGSC0003DMT200022529	K04532	ko05010	Alzheimer's disease	1475	1.6e-75	0.91	0.95	0.94
PGSC0003DMT200022530	K04532	ko05010	Alzheimer's disease	1868	3.4e-97	0.76	0.87	1.00
PGSC0003DMT200022531	K04532	ko05010	Alzheimer's disease	1817	2.2e-94	0.88	0.94	0.87
PGSC0003DMT200004518	K01692	ko00071	Fatty acid metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00280	Valine, leucine and isoleucine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00281	Geraniol degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00310	Lysine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00380	Tryptophan metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00410	beta-Alanine metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00632	Benzoate degradation via CoA ligation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00640	Propanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00650	Butanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00903	Limonene and pinene degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko00930	Caprolactam degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko01100	Metabolic pathways	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004518	K01692	ko01110	Biosynthesis of secondary metabolites	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMT200004520	K01692	ko00071	Fatty acid metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00280	Valine, leucine and isoleucine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00281	Geraniol degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00310	Lysine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00380	Tryptophan metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00410	beta-Alanine metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00632	Benzoate degradation via CoA ligation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00640	Propanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00650	Butanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko00930	Caprolactam degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko01100	Metabolic pathways	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004520	K01692	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMT200004521	K01692	ko00071	Fatty acid metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00280	Valine, leucine and isoleucine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00281	Geraniol degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00310	Lysine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00380	Tryptophan metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00410	beta-Alanine metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00632	Benzoate degradation via CoA ligation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00640	Propanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00650	Butanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00903	Limonene and pinene degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko00930	Caprolactam degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko01100	Metabolic pathways	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004521	K01692	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMT200004527	K08241	ko00592	alpha-Linolenic acid metabolism	302	3.6e-16	0.39	0.53	0.90
PGSC0003DMT200004530	K00799	ko00480	Glutathione metabolism	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMT200004530	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMT200004530	K00799	ko00982	Drug metabolism - cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMT200004531	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMT200004531	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMT200004531	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMT200004532	K01923	ko00230	Purine metabolism	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMT200004532	K01923	ko01100	Metabolic pathways	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMT200004532	K01923	ko01110	Biosynthesis of secondary metabolites	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMT200004537	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMT200004537	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMT200004537	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMT200004538	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004538	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004538	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004539	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004539	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004539	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMT200004540	K00799	ko00480	Glutathione metabolism	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMT200004540	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMT200004540	K00799	ko00982	Drug metabolism - cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMT200004541	K00799	ko00480	Glutathione metabolism	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMT200004541	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMT200004541	K00799	ko00982	Drug metabolism - cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMT200004542	K00799	ko00480	Glutathione metabolism	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMT200004542	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMT200004542	K00799	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMT200047703	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.76
PGSC0003DMT200047710	K09490	ko03060	Protein export	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMT200047710	K09490	ko05020	Prion diseases	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMT200047711	K04461	ko04010	MAPK signaling pathway	474	2.6e-20	0.32	0.47	0.81
PGSC0003DMT200047713	K04461	ko04010	MAPK signaling pathway	548	2.2e-24	0.35	0.52	0.79
PGSC0003DMT200047725	K12478	ko04144	Endocytosis	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMT200047725	K12478	ko04145	Phagosome	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMT200047726	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMT200047726	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMT200047727	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMT200047727	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMT200047730	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMT200047730	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMT200047731	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMT200047731	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMT200047735	K12194	ko04144	Endocytosis	1608	7.4e-83	0.91	0.94	1.00
PGSC0003DMT200047736	K12194	ko04144	Endocytosis	971	1.0e-47	0.91	0.95	0.99
PGSC0003DMT200047737	K05759	ko04810	Regulation of actin cytoskeleton	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMT200047737	K05759	ko05131	Shigellosis	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMT200047738	K02087	ko04110	Cell cycle	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMT200047738	K02087	ko04114	Oocyte meiosis	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMT200047738	K02087	ko04115	p53 signaling pathway	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMT200047738	K02087	ko04540	Gap junction	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMT200047738	K02087	ko04914	Progesterone-mediated oocyte maturation	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMT200047739	K02087	ko04110	Cell cycle	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMT200047739	K02087	ko04114	Oocyte meiosis	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMT200047739	K02087	ko04115	p53 signaling pathway	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMT200047739	K02087	ko04540	Gap junction	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMT200047739	K02087	ko04914	Progesterone-mediated oocyte maturation	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMT200047743	K01051	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMT200047743	K01051	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMT200047743	K01051	ko01100	Metabolic pathways	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMT200055447	K00759	ko00230	Purine metabolism	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMT200055447	K00759	ko01100	Metabolic pathways	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMT200055448	K11866	ko04144	Endocytosis	271	7.3e-06	0.27	0.40	0.53
PGSC0003DMT200055455	K00599	ko00340	Histidine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMT200055455	K00599	ko00350	Tyrosine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMT200055455	K00599	ko00450	Selenoamino acid metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMT200055455	K00599	ko00626	Naphthalene and anthracene degradation	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMT200055456	K00599	ko00340	Histidine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMT200055456	K00599	ko00350	Tyrosine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMT200055456	K00599	ko00450	Selenoamino acid metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMT200055456	K00599	ko00626	Naphthalene and anthracene degradation	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMT200055457	K00599	ko00340	Histidine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMT200055457	K00599	ko00350	Tyrosine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMT200055457	K00599	ko00450	Selenoamino acid metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMT200055457	K00599	ko00626	Naphthalene and anthracene degradation	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMT200055472	K12347	ko04142	Lysosome	240	4.8e-07	0.51	0.63	0.97
PGSC0003DMT200055473	K12347	ko04142	Lysosome	3209	3.7e-171	0.76	0.86	0.94
PGSC0003DMT200055474	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMT200055474	K00517	ko00626	Naphthalene and anthracene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMT200055474	K00517	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMT200055474	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMT200055474	K00517	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMT200055475	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMT200055475	K00517	ko00626	Naphthalene and anthracene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMT200055475	K00517	ko00903	Limonene and pinene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMT200055475	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMT200055475	K00517	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMT200055477	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMT200055477	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMT200055477	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMT200055477	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMT200055477	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMT200055478	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMT200055478	K00517	ko00626	Naphthalene and anthracene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMT200055478	K00517	ko00903	Limonene and pinene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMT200055478	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMT200055478	K00517	ko01110	Biosynthesis of secondary metabolites	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMT200055480	K04508	ko04310	Wnt signaling pathway	3643	4.3e-195	0.71	0.84	1.00
PGSC0003DMT200055487	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055487	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055487	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055487	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055487	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055488	K10775	ko00360	Phenylalanine metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMT200055488	K10775	ko00910	Nitrogen metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMT200055488	K10775	ko00940	Phenylpropanoid biosynthesis	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMT200055488	K10775	ko01100	Metabolic pathways	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMT200055488	K10775	ko01110	Biosynthesis of secondary metabolites	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMT200055489	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055489	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055489	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055489	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200055489	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMT200065010	K00970	ko03018	RNA degradation	226	6.2e-06	0.30	0.50	0.71
PGSC0003DMT200065013	K02303	ko00860	Porphyrin and chlorophyll metabolism	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMT200065013	K02303	ko01100	Metabolic pathways	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMT200065013	K02303	ko01110	Biosynthesis of secondary metabolites	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMT200065014	K06670	ko04110	Cell cycle	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMT200065014	K06670	ko04111	Cell cycle - yeast	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMT200065024	K11253	ko05322	Systemic lupus erythematosus	443	1.3e-18	0.82	0.89	0.88
PGSC0003DMT200065026	K11253	ko05322	Systemic lupus erythematosus	449	6.3e-19	0.95	0.95	0.58
PGSC0003DMT200065027	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200065046	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMT200065046	K00517	ko00626	Naphthalene and anthracene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMT200065046	K00517	ko00903	Limonene and pinene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMT200065046	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMT200065046	K00517	ko01110	Biosynthesis of secondary metabolites	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMT200065047	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMT200065047	K00517	ko00626	Naphthalene and anthracene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMT200065047	K00517	ko00903	Limonene and pinene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMT200065047	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMT200065047	K00517	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMT200052919	K05577	ko00190	Oxidative phosphorylation	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMT200052919	K05577	ko01100	Metabolic pathways	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMT200052934	K05575	ko00190	Oxidative phosphorylation	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMT200052934	K05575	ko01100	Metabolic pathways	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMT200043471	K01404	ko05140	Leishmaniasis	5417	6.1e-293	0.75	0.85	0.96
PGSC0003DMT200043472	K01404	ko05140	Leishmaniasis	5219	5.1e-282	0.80	0.89	1.00
PGSC0003DMT200043474	K00754	ko00051	Fructose and mannose metabolism	293	4.9e-10	0.29	0.49	0.54
PGSC0003DMT200043484	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMT200043485	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMT200043489	K03801	ko00785	Lipoic acid metabolism	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMT200043489	K03801	ko01100	Metabolic pathways	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMT200043490	K03801	ko00785	Lipoic acid metabolism	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMT200043490	K03801	ko01100	Metabolic pathways	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMT200043491	K03801	ko00785	Lipoic acid metabolism	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMT200043491	K03801	ko01100	Metabolic pathways	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMT200043492	K03801	ko00785	Lipoic acid metabolism	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMT200043492	K03801	ko01100	Metabolic pathways	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMT200043495	K01723	ko00592	alpha-Linolenic acid metabolism	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMT200043495	K01723	ko01100	Metabolic pathways	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMT200043500	K00655	ko00561	Glycerolipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMT200043500	K00655	ko00564	Glycerophospholipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMT200043500	K00655	ko01100	Metabolic pathways	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMT200043508	K01099	ko00562	Inositol phosphate metabolism	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMT200043508	K01099	ko01100	Metabolic pathways	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMT200043508	K01099	ko04070	Phosphatidylinositol signaling system	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMT200008854	K01768	ko00230	Purine metabolism	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMT200008854	K01768	ko04113	Meiosis - yeast	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMT200008873	K11778	ko00900	Terpenoid backbone biosynthesis	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMT200008873	K11778	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMT200008874	K11778	ko00900	Terpenoid backbone biosynthesis	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMT200008874	K11778	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMT200008875	K11778	ko00900	Terpenoid backbone biosynthesis	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMT200008875	K11778	ko01110	Biosynthesis of secondary metabolites	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMT200018366	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMT200018367	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMT200018368	K10597	ko04120	Ubiquitin mediated proteolysis	6473	0.	0.77	0.86	1.00
PGSC0003DMT200018378	K12193	ko04144	Endocytosis	1571	8.2e-81	0.86	0.93	1.00
PGSC0003DMT200018401	K03368	ko00512	O-Glycan biosynthesis	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMT200018401	K03368	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMT200018401	K03368	ko00603	Glycosphingolipid biosynthesis - globo series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMT200018401	K03368	ko00604	Glycosphingolipid biosynthesis - ganglio series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMT200018401	K03368	ko01100	Metabolic pathways	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMT200088718	K06627	ko04110	Cell cycle	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMT200088718	K06627	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMT200067153	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMT200067153	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMT200067153	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMT200067159	K00939	ko00230	Purine metabolism	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMT200067159	K00939	ko01100	Metabolic pathways	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMT200067159	K00939	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMT200067162	K03800	ko00785	Lipoic acid metabolism	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMT200067162	K03800	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMT200067171	K09843	ko00906	Carotenoid biosynthesis	1011	6.3e-50	0.34	0.54	0.99
PGSC0003DMT200067187	K12876	ko03040	Spliceosome	1301	6.4e-66	0.77	0.87	0.99
PGSC0003DMT200059511	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMT200059511	K00517	ko00626	Naphthalene and anthracene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMT200059511	K00517	ko00903	Limonene and pinene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMT200059511	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMT200059511	K00517	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMT200059536	K01259	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.83	0.90	0.81
PGSC0003DMT200059537	K01259	ko00330	Arginine and proline metabolism	2374	4.2e-125	0.82	0.91	0.82
PGSC0003DMT200059544	K12821	ko03040	Spliceosome	665	8.5e-31	0.43	0.66	1.00
PGSC0003DMT200059545	K12821	ko03040	Spliceosome	3260	5.7e-174	0.53	0.68	0.96
PGSC0003DMT200030158	K10570	ko03420	Nucleotide excision repair	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMT200030158	K10570	ko04120	Ubiquitin mediated proteolysis	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMT200030159	K10570	ko03420	Nucleotide excision repair	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMT200030159	K10570	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMT200030160	K10570	ko03420	Nucleotide excision repair	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMT200030160	K10570	ko04120	Ubiquitin mediated proteolysis	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMT200030161	K08332	ko04140	Regulation of autophagy	363	3.9e-14	0.28	0.52	0.89
PGSC0003DMT200030176	K06627	ko04110	Cell cycle	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMT200030176	K06627	ko04914	Progesterone-mediated oocyte maturation	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMT200030193	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.0e-12	0.31	0.49	0.31
PGSC0003DMT200030196	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMT200030197	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMT200024170	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMT200024170	K01755	ko00330	Arginine and proline metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMT200024170	K01755	ko01100	Metabolic pathways	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMT200024170	K01755	ko01110	Biosynthesis of secondary metabolites	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMT200024171	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMT200024171	K01755	ko00330	Arginine and proline metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMT200024171	K01755	ko01100	Metabolic pathways	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMT200024171	K01755	ko01110	Biosynthesis of secondary metabolites	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMT200024181	K02893	ko03010	Ribosome	225	1.4e-06	0.29	0.45	0.85
PGSC0003DMT200024186	K12402	ko04142	Lysosome	1830	4.2e-95	0.88	0.96	1.00
PGSC0003DMT200024187	K12402	ko04142	Lysosome	2309	1.6e-121	0.86	0.94	1.00
PGSC0003DMT200024188	K12402	ko04142	Lysosome	3386	6.4e-181	0.87	0.95	1.00
PGSC0003DMT200024189	K12402	ko04142	Lysosome	3369	5.5e-180	0.87	0.94	1.00
PGSC0003DMT200024197	K03132	ko03022	Basal transcription factors	1018	2.6e-50	0.66	0.79	0.99
PGSC0003DMT200016242	K09755	ko00940	Phenylpropanoid biosynthesis	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMT200016242	K09755	ko01100	Metabolic pathways	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMT200016242	K09755	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMT200016243	K05280	ko00941	Flavonoid biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMT200016243	K05280	ko00944	Flavone and flavonol biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMT200016243	K05280	ko01100	Metabolic pathways	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMT200016243	K05280	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMT200016244	K11294	ko05130	Pathogenic Escherichia coli infection	244	2.1e-07	0.36	0.50	0.93
PGSC0003DMT200016249	K12741	ko03040	Spliceosome	647	7.5e-30	0.35	0.47	0.71
PGSC0003DMT200016261	K09755	ko00940	Phenylpropanoid biosynthesis	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMT200016261	K09755	ko01100	Metabolic pathways	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMT200016261	K09755	ko01110	Biosynthesis of secondary metabolites	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMT200016262	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMT200016262	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMT200016262	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMT200016262	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMT200016263	K05280	ko00941	Flavonoid biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMT200016263	K05280	ko00944	Flavone and flavonol biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMT200016263	K05280	ko01100	Metabolic pathways	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMT200016263	K05280	ko01110	Biosynthesis of secondary metabolites	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMT200016266	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMT200016268	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMT200093309	K01193	ko00052	Galactose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMT200093309	K01193	ko00500	Starch and sucrose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMT200093309	K01193	ko01100	Metabolic pathways	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMT200093314	K10760	ko00908	Zeatin biosynthesis	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMT200093314	K10760	ko01100	Metabolic pathways	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMT200093314	K10760	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMT200074548	K02149	ko00190	Oxidative phosphorylation	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074548	K02149	ko01100	Metabolic pathways	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074548	K02149	ko04145	Phagosome	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074548	K02149	ko04966	Collecting duct acid secretion	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074548	K02149	ko05110	Vibrio cholerae infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074548	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMT200074559	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074559	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074559	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074559	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074560	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074560	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074560	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074560	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMT200074574	K00939	ko00230	Purine metabolism	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMT200074574	K00939	ko01100	Metabolic pathways	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMT200074574	K00939	ko01110	Biosynthesis of secondary metabolites	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMT200074575	K00939	ko00230	Purine metabolism	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMT200074575	K00939	ko01100	Metabolic pathways	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMT200074575	K00939	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMT200074576	K12129	ko04712	Circadian rhythm - plant	3484	2.5e-186	0.58	0.72	0.99
PGSC0003DMT200074583	K01423	ko00310	Lysine degradation	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMT200074583	K01423	ko00780	Biotin metabolism	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMT200074583	K01423	ko01100	Metabolic pathways	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMT200061292	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMT200061292	K12567	ko05414	Dilated cardiomyopathy	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMT200061294	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMT200061294	K12567	ko05414	Dilated cardiomyopathy	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMT200061295	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMT200061295	K12567	ko05414	Dilated cardiomyopathy	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMT200061296	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMT200061296	K12567	ko05414	Dilated cardiomyopathy	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMT200061297	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMT200061297	K12567	ko05414	Dilated cardiomyopathy	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMT200061298	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	467	2.0e-19	0.31	0.44	0.99
PGSC0003DMT200061299	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMT200061299	K12567	ko05414	Dilated cardiomyopathy	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMT200061300	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	504	1.5e-21	0.31	0.44	0.90
PGSC0003DMT200061358	K01051	ko00040	Pentose and glucuronate interconversions	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMT200061358	K01051	ko00500	Starch and sucrose metabolism	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMT200061358	K01051	ko01100	Metabolic pathways	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMT200061360	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMT200061360	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMT200061361	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMT200061361	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMT200061362	K08507	ko04130	SNARE interactions in vesicular transport	263	1.1e-08	0.28	0.47	0.99
PGSC0003DMT200068827	K12657	ko00330	Arginine and proline metabolism	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMT200068827	K12657	ko01100	Metabolic pathways	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMT200068828	K12657	ko00330	Arginine and proline metabolism	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMT200068828	K12657	ko01100	Metabolic pathways	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMT200068829	K12657	ko00330	Arginine and proline metabolism	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMT200068829	K12657	ko01100	Metabolic pathways	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMT200068830	K12657	ko00330	Arginine and proline metabolism	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMT200068830	K12657	ko01100	Metabolic pathways	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMT200068836	K10760	ko00908	Zeatin biosynthesis	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMT200068836	K10760	ko01100	Metabolic pathways	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMT200068836	K10760	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMT200068840	K02704	ko00195	Photosynthesis	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMT200068840	K02704	ko01100	Metabolic pathways	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMT200068846	K11818	ko00380	Tryptophan metabolism	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMT200068846	K11818	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMT200068846	K11818	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMT200068847	K11818	ko00380	Tryptophan metabolism	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMT200068847	K11818	ko00966	Glucosinolate biosynthesis	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMT200068847	K11818	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMT200068857	K07199	ko04910	Insulin signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMT200068857	K07199	ko04920	Adipocytokine signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMT200068857	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMT200068867	K10843	ko03420	Nucleotide excision repair	4741	1.2e-255	0.75	0.84	1.00
PGSC0003DMT200068875	K01507	ko00190	Oxidative phosphorylation	2008	6.4e-105	0.78	0.86	1.00
PGSC0003DMT200014544	K07424	ko00140	Steroid hormone biosynthesis	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00591	Linoleic acid metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00830	Retinol metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00982	Drug metabolism - cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko00983	Drug metabolism - other enzymes	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014544	K07424	ko01100	Metabolic pathways	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMT200014545	K07424	ko00140	Steroid hormone biosynthesis	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00591	Linoleic acid metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00830	Retinol metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00982	Drug metabolism - cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko00983	Drug metabolism - other enzymes	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014545	K07424	ko01100	Metabolic pathways	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMT200014548	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMT200014549	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMT200014554	K04124	ko00904	Diterpenoid biosynthesis	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMT200014554	K04124	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMT200014555	K04124	ko00904	Diterpenoid biosynthesis	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMT200014555	K04124	ko01110	Biosynthesis of secondary metabolites	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMT200014568	K03136	ko03022	Basal transcription factors	2874	1.1e-152	0.73	0.85	1.00
PGSC0003DMT200014569	K03136	ko03022	Basal transcription factors	736	9.3e-35	0.61	0.75	0.99
PGSC0003DMT200014570	K03136	ko03022	Basal transcription factors	1268	4.2e-64	0.86	0.95	0.96
PGSC0003DMT200022467	K00549	ko00270	Cysteine and methionine metabolism	5723	0.	0.88	0.94	1.00
PGSC0003DMT200022467	K00549	ko01100	Metabolic pathways	5723	0.	0.88	0.94	1.00
PGSC0003DMT200022467	K00549	ko01110	Biosynthesis of secondary metabolites	5723	0.	0.88	0.94	1.00
PGSC0003DMT200022468	K00549	ko00270	Cysteine and methionine metabolism	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMT200022468	K00549	ko01100	Metabolic pathways	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMT200022468	K00549	ko01110	Biosynthesis of secondary metabolites	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMT200022472	K11817	ko00380	Tryptophan metabolism	6807	0.	0.61	0.78	0.99
PGSC0003DMT200022495	K02335	ko00230	Purine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko00240	Pyrimidine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko01100	Metabolic pathways	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko03030	DNA replication	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko03410	Base excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko03420	Nucleotide excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022495	K02335	ko03440	Homologous recombination	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMT200022496	K02335	ko00230	Purine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko00240	Pyrimidine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko01100	Metabolic pathways	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko03030	DNA replication	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko03410	Base excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko03420	Nucleotide excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022496	K02335	ko03440	Homologous recombination	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMT200022497	K02335	ko00230	Purine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko00240	Pyrimidine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko01100	Metabolic pathways	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko03030	DNA replication	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko03410	Base excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko03420	Nucleotide excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200022497	K02335	ko03440	Homologous recombination	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMT200045929	K10643	ko03018	RNA degradation	975	6.1e-48	0.65	0.79	0.99
PGSC0003DMT200045932	K02989	ko03010	Ribosome	1444	8.3e-74	0.84	0.90	0.99
PGSC0003DMT200045950	K07904	ko04144	Endocytosis	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMT200045950	K07904	ko04962	Vasopressin-regulated water reabsorption	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMT200045951	K07904	ko04144	Endocytosis	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMT200045951	K07904	ko04962	Vasopressin-regulated water reabsorption	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMT200045953	K04460	ko04010	MAPK signaling pathway	369	1.6e-14	0.36	0.54	0.36
PGSC0003DMT200045954	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMT200045954	K00517	ko00626	Naphthalene and anthracene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMT200045954	K00517	ko00903	Limonene and pinene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMT200045954	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMT200045954	K00517	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMT200087830	K13082	ko00941	Flavonoid biosynthesis	550	1.7e-24	0.39	0.64	0.98
PGSC0003DMT200063324	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMT200063324	K00517	ko00626	Naphthalene and anthracene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMT200063324	K00517	ko00903	Limonene and pinene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMT200063324	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMT200063324	K00517	ko01110	Biosynthesis of secondary metabolites	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMT200063329	K07466	ko03030	DNA replication	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMT200063329	K07466	ko03420	Nucleotide excision repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMT200063329	K07466	ko03430	Mismatch repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMT200063329	K07466	ko03440	Homologous recombination	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMT200063333	K06060	ko04330	Notch signaling pathway	827	8.9e-40	0.36	0.57	0.93
PGSC0003DMT200063334	K04505	ko04310	Wnt signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMT200063334	K04505	ko04330	Notch signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMT200063334	K04505	ko04722	Neurotrophin signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMT200063334	K04505	ko05010	Alzheimer's disease	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMT200063336	K02136	ko00190	Oxidative phosphorylation	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMT200063336	K02136	ko01100	Metabolic pathways	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMT200063336	K02136	ko05010	Alzheimer's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMT200063336	K02136	ko05012	Parkinson's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMT200063336	K02136	ko05016	Huntington's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMT200063349	K05280	ko00941	Flavonoid biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMT200063349	K05280	ko00944	Flavone and flavonol biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMT200063349	K05280	ko01100	Metabolic pathways	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMT200063349	K05280	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMT200063350	K05280	ko00941	Flavonoid biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMT200063350	K05280	ko00944	Flavone and flavonol biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMT200063350	K05280	ko01100	Metabolic pathways	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMT200063350	K05280	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMT200063351	K05280	ko00941	Flavonoid biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMT200063351	K05280	ko00944	Flavone and flavonol biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMT200063351	K05280	ko01100	Metabolic pathways	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMT200063351	K05280	ko01110	Biosynthesis of secondary metabolites	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMT200053600	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053600	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053600	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053600	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053600	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053601	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053601	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053601	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053601	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053601	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMT200053602	K00430	ko00360	Phenylalanine metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMT200053602	K00430	ko00680	Methane metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMT200053602	K00430	ko00940	Phenylpropanoid biosynthesis	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMT200053602	K00430	ko01100	Metabolic pathways	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMT200053602	K00430	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMT200053603	K00430	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMT200053603	K00430	ko00680	Methane metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMT200053603	K00430	ko00940	Phenylpropanoid biosynthesis	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMT200053603	K00430	ko01100	Metabolic pathways	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMT200053603	K00430	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMT200053604	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053604	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053604	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053604	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053604	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053605	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053605	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053605	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053605	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200053605	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMT200089934	K04508	ko04310	Wnt signaling pathway	470	3.8e-27	0.53	0.67	0.97
PGSC0003DMT200089939	K12493	ko04144	Endocytosis	760	7.9e-36	0.35	0.46	0.75
PGSC0003DMT200020297	K01115	ko00564	Glycerophospholipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020297	K01115	ko00565	Ether lipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020297	K01115	ko01100	Metabolic pathways	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020297	K01115	ko04144	Endocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020297	K01115	ko04666	Fc gamma R-mediated phagocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020297	K01115	ko04912	GnRH signaling pathway	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMT200020299	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020299	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020300	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMT200020301	K01692	ko00071	Fatty acid metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00280	Valine, leucine and isoleucine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00281	Geraniol degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00310	Lysine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00380	Tryptophan metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00410	beta-Alanine metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00632	Benzoate degradation via CoA ligation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00640	Propanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00650	Butanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko00930	Caprolactam degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko01100	Metabolic pathways	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020301	K01692	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMT200020315	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMT200020325	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMT200020325	K00053	ko00770	Pantothenate and CoA biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMT200020325	K00053	ko01100	Metabolic pathways	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMT200020325	K00053	ko01110	Biosynthesis of secondary metabolites	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMT200020336	K13066	ko00940	Phenylpropanoid biosynthesis	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMT200020336	K13066	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMT200020339	K08139	ko04113	Meiosis - yeast	1138	6.2e-57	0.36	0.61	0.86
PGSC0003DMT200010483	K02641	ko00195	Photosynthesis	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMT200010483	K02641	ko01100	Metabolic pathways	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMT200010484	K02641	ko00195	Photosynthesis	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMT200010484	K02641	ko01100	Metabolic pathways	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMT200010489	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMT200010489	K01602	ko00710	Carbon fixation in photosynthetic organisms	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMT200010489	K01602	ko01100	Metabolic pathways	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMT200010494	K01895	ko00010	Glycolysis / Gluconeogenesis	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010494	K01895	ko00620	Pyruvate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010494	K01895	ko00640	Propanoate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010494	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010494	K01895	ko01100	Metabolic pathways	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010494	K01895	ko01110	Biosynthesis of secondary metabolites	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMT200010495	K01895	ko00010	Glycolysis / Gluconeogenesis	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010495	K01895	ko00620	Pyruvate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010495	K01895	ko00640	Propanoate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010495	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010495	K01895	ko01100	Metabolic pathways	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010495	K01895	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMT200010496	K01895	ko00010	Glycolysis / Gluconeogenesis	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010496	K01895	ko00620	Pyruvate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010496	K01895	ko00640	Propanoate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010496	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010496	K01895	ko01100	Metabolic pathways	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010496	K01895	ko01110	Biosynthesis of secondary metabolites	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMT200010497	K01535	ko00190	Oxidative phosphorylation	7118	0.	0.89	0.95	0.99
PGSC0003DMT200010498	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMT200010498	K09833	ko01100	Metabolic pathways	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMT200010498	K09833	ko01110	Biosynthesis of secondary metabolites	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMT200010499	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMT200010499	K09833	ko01100	Metabolic pathways	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMT200010499	K09833	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMT200010500	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMT200010500	K09833	ko01100	Metabolic pathways	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMT200010500	K09833	ko01110	Biosynthesis of secondary metabolites	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMT200010507	K01423	ko00310	Lysine degradation	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMT200010507	K01423	ko00780	Biotin metabolism	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMT200010507	K01423	ko01100	Metabolic pathways	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMT200010509	K12115	ko04712	Circadian rhythm - plant	3939	2.0e-211	0.84	0.93	0.87
PGSC0003DMT200010510	K12115	ko04712	Circadian rhythm - plant	4455	7.0e-240	0.82	0.91	0.99
PGSC0003DMT200010512	K04733	ko04210	Apoptosis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMT200010512	K04733	ko04620	Toll-like receptor signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMT200010512	K04733	ko04722	Neurotrophin signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMT200010512	K04733	ko05140	Leishmaniasis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMT200010512	K04733	ko05142	Chagas disease	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMT200010518	K00797	ko00270	Cysteine and methionine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMT200010518	K00797	ko00330	Arginine and proline metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMT200010518	K00797	ko00410	beta-Alanine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMT200010518	K00797	ko00480	Glutathione metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMT200010518	K00797	ko01100	Metabolic pathways	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMT200010526	K00697	ko00500	Starch and sucrose metabolism	5607	0.	0.74	0.86	0.95
PGSC0003DMT200010527	K00697	ko00500	Starch and sucrose metabolism	4997	8.9e-270	0.76	0.90	0.95
PGSC0003DMT200010528	K00697	ko00500	Starch and sucrose metabolism	5058	3.8e-273	0.76	0.89	0.95
PGSC0003DMT200008147	K03939	ko00190	Oxidative phosphorylation	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMT200008147	K03939	ko01100	Metabolic pathways	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMT200008147	K03939	ko05010	Alzheimer's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMT200008147	K03939	ko05012	Parkinson's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMT200008147	K03939	ko05016	Huntington's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMT200008152	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008152	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008153	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMT200008172	K09753	ko00940	Phenylpropanoid biosynthesis	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMT200008172	K09753	ko01100	Metabolic pathways	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMT200008172	K09753	ko01110	Biosynthesis of secondary metabolites	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMT200008173	K09753	ko00940	Phenylpropanoid biosynthesis	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMT200008173	K09753	ko01100	Metabolic pathways	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMT200008173	K09753	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMT200025952	K00100	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025952	K00100	ko00363	Bisphenol A degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025952	K00100	ko00591	Linoleic acid metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025952	K00100	ko00625	Tetrachloroethene degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025952	K00100	ko00650	Butanoate metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025952	K00100	ko01100	Metabolic pathways	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMT200025953	K00100	ko00051	Fructose and mannose metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025953	K00100	ko00363	Bisphenol A degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025953	K00100	ko00591	Linoleic acid metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025953	K00100	ko00625	Tetrachloroethene degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025953	K00100	ko00650	Butanoate metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025953	K00100	ko01100	Metabolic pathways	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMT200025959	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMT200025959	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMT200025959	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMT200025972	K00423	ko00053	Ascorbate and aldarate metabolism	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMT200025972	K00423	ko01100	Metabolic pathways	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMT200025973	K00423	ko00053	Ascorbate and aldarate metabolism	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMT200025973	K00423	ko01100	Metabolic pathways	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMT200025974	K00423	ko00053	Ascorbate and aldarate metabolism	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMT200025974	K00423	ko01100	Metabolic pathways	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMT200025975	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMT200025975	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMT200025975	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMT200025975	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMT200025975	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMT200025976	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMT200025976	K00517	ko00626	Naphthalene and anthracene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMT200025976	K00517	ko00903	Limonene and pinene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMT200025976	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMT200025976	K00517	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMT200025977	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMT200025977	K00517	ko00626	Naphthalene and anthracene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMT200025977	K00517	ko00903	Limonene and pinene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMT200025977	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMT200025977	K00517	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMT200025978	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMT200025978	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMT200025978	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMT200025978	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMT200025978	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMT200025979	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMT200025979	K00517	ko00626	Naphthalene and anthracene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMT200025979	K00517	ko00903	Limonene and pinene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMT200025979	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMT200025979	K00517	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMT200025980	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMT200025980	K00517	ko00626	Naphthalene and anthracene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMT200025980	K00517	ko00903	Limonene and pinene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMT200025980	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMT200025980	K00517	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMT200028366	K03026	ko00230	Purine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMT200028366	K03026	ko00240	Pyrimidine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMT200028366	K03026	ko01100	Metabolic pathways	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMT200028366	K03026	ko03020	RNA polymerase	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMT200028366	K03026	ko04623	Cytosolic DNA-sensing pathway	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMT200028367	K03026	ko00230	Purine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMT200028367	K03026	ko00240	Pyrimidine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMT200028367	K03026	ko01100	Metabolic pathways	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMT200028367	K03026	ko03020	RNA polymerase	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMT200028367	K03026	ko04623	Cytosolic DNA-sensing pathway	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMT200028368	K03026	ko00230	Purine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMT200028368	K03026	ko00240	Pyrimidine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMT200028368	K03026	ko01100	Metabolic pathways	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMT200028368	K03026	ko03020	RNA polymerase	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMT200028368	K03026	ko04623	Cytosolic DNA-sensing pathway	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMT200021066	K13065	ko00940	Phenylpropanoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMT200021066	K13065	ko00941	Flavonoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMT200021066	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMT200021066	K13065	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMT200021073	K00088	ko00230	Purine metabolism	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMT200021073	K00088	ko00983	Drug metabolism - other enzymes	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMT200021073	K00088	ko01100	Metabolic pathways	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMT200021073	K00088	ko01110	Biosynthesis of secondary metabolites	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMT200021074	K06443	ko00906	Carotenoid biosynthesis	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMT200021074	K06443	ko01100	Metabolic pathways	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMT200021074	K06443	ko01110	Biosynthesis of secondary metabolites	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMT200021079	K02183	ko04020	Calcium signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04070	Phosphatidylinositol signaling system	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04114	Oocyte meiosis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04270	Vascular smooth muscle contraction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04626	Plant-pathogen interaction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04720	Long-term potentiation	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04722	Neurotrophin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04740	Olfactory transduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04744	Phototransduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04745	Phototransduction - fly	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04910	Insulin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04912	GnRH signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04916	Melanogenesis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04970	Salivary secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko04971	Gastric acid secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko05010	Alzheimer's disease	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021079	K02183	ko05214	Glioma	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMT200021094	K01674	ko00910	Nitrogen metabolism	1074	2.1e-53	0.49	0.68	0.98
PGSC0003DMT200036941	K03428	ko00860	Porphyrin and chlorophyll metabolism	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMT200036941	K03428	ko01100	Metabolic pathways	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMT200036941	K03428	ko01110	Biosynthesis of secondary metabolites	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMT200036942	K03428	ko00860	Porphyrin and chlorophyll metabolism	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMT200036942	K03428	ko01100	Metabolic pathways	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMT200036942	K03428	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMT200036964	K05766	ko04810	Regulation of actin cytoskeleton	403	9.3e-16	0.37	0.56	0.19
PGSC0003DMT200036965	K05766	ko04810	Regulation of actin cytoskeleton	403	3.3e-16	0.37	0.56	0.26
PGSC0003DMT200036966	K05766	ko04810	Regulation of actin cytoskeleton	403	2.2e-16	0.37	0.56	0.63
PGSC0003DMT200036971	K13289	ko04142	Lysosome	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMT200036971	K13289	ko04614	Renin-angiotensin system	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMT200036972	K13289	ko04142	Lysosome	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMT200036972	K13289	ko04614	Renin-angiotensin system	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMT200036973	K13289	ko04142	Lysosome	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMT200036973	K13289	ko04614	Renin-angiotensin system	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMT200036974	K13289	ko04142	Lysosome	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMT200036974	K13289	ko04614	Renin-angiotensin system	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMT200036975	K03015	ko00230	Purine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMT200036975	K03015	ko00240	Pyrimidine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMT200036975	K03015	ko01100	Metabolic pathways	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMT200036975	K03015	ko03020	RNA polymerase	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMT200036975	K03015	ko05016	Huntington's disease	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMT200045248	K03542	ko00195	Photosynthesis	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMT200045248	K03542	ko01100	Metabolic pathways	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMT200045267	K00889	ko00562	Inositol phosphate metabolism	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045267	K00889	ko01100	Metabolic pathways	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045267	K00889	ko04070	Phosphatidylinositol signaling system	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045267	K00889	ko04144	Endocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045267	K00889	ko04666	Fc gamma R-mediated phagocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045267	K00889	ko04810	Regulation of actin cytoskeleton	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMT200045268	K00889	ko00562	Inositol phosphate metabolism	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045268	K00889	ko01100	Metabolic pathways	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045268	K00889	ko04070	Phosphatidylinositol signaling system	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045268	K00889	ko04144	Endocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045268	K00889	ko04666	Fc gamma R-mediated phagocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045268	K00889	ko04810	Regulation of actin cytoskeleton	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMT200045295	K00128	ko00010	Glycolysis / Gluconeogenesis	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00053	Ascorbate and aldarate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00071	Fatty acid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00280	Valine, leucine and isoleucine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00310	Lysine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00330	Arginine and proline metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00340	Histidine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00380	Tryptophan metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00410	beta-Alanine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00561	Glycerolipid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00620	Pyruvate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00631	1,2-Dichloroethane degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00640	Propanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00641	3-Chloroacrylic acid degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00650	Butanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko00903	Limonene and pinene degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko01100	Metabolic pathways	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200045295	K00128	ko01110	Biosynthesis of secondary metabolites	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMT200071115	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMT200071115	K11517	ko01100	Metabolic pathways	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMT200071115	K11517	ko04146	Peroxisome	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMT200071116	K01179	ko00500	Starch and sucrose metabolism	231	2.3e-06	0.42	0.50	0.70
PGSC0003DMT200071123	K10717	ko00908	Zeatin biosynthesis	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMT200071123	K10717	ko01100	Metabolic pathways	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMT200071123	K10717	ko01110	Biosynthesis of secondary metabolites	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMT200071128	K10717	ko00908	Zeatin biosynthesis	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMT200071128	K10717	ko01100	Metabolic pathways	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMT200071128	K10717	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMT200071132	K01955	ko00240	Pyrimidine metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMT200071132	K01955	ko00250	Alanine, aspartate and glutamate metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMT200071132	K01955	ko01100	Metabolic pathways	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMT200071141	K02932	ko03010	Ribosome	2233	2.5e-117	0.86	0.94	1.00
PGSC0003DMT200071147	K05740	ko04510	Focal adhesion	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMT200071147	K05740	ko04810	Regulation of actin cytoskeleton	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMT200071147	K05740	ko05131	Shigellosis	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMT200071148	K11422	ko00310	Lysine degradation	373	7.5e-12	0.27	0.38	0.84
PGSC0003DMT200071154	K02699	ko00195	Photosynthesis	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMT200071154	K02699	ko01100	Metabolic pathways	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMT200084270	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMT200084270	K00224	ko00364	Fluorobenzoate degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMT200084270	K00224	ko00628	Fluorene degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMT200084270	K00224	ko00640	Propanoate metabolism	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMT200084271	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMT200084271	K00224	ko00364	Fluorobenzoate degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMT200084271	K00224	ko00628	Fluorene degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMT200084271	K00224	ko00640	Propanoate metabolism	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMT200084272	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMT200084272	K00224	ko00364	Fluorobenzoate degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMT200084272	K00224	ko00628	Fluorene degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMT200084272	K00224	ko00640	Propanoate metabolism	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMT200084273	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMT200084273	K00224	ko00364	Fluorobenzoate degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMT200084273	K00224	ko00628	Fluorene degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMT200084273	K00224	ko00640	Propanoate metabolism	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMT200084278	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMT200084278	K00224	ko00364	Fluorobenzoate degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMT200084278	K00224	ko00628	Fluorene degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMT200084278	K00224	ko00640	Propanoate metabolism	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMT200064028	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064028	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064029	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMT200064030	K01945	ko00230	Purine metabolism	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMT200064030	K01945	ko01100	Metabolic pathways	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMT200064030	K01945	ko01110	Biosynthesis of secondary metabolites	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMT200064031	K03283	ko03040	Spliceosome	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMT200064031	K03283	ko04010	MAPK signaling pathway	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMT200064031	K03283	ko04144	Endocytosis	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMT200064031	K03283	ko04612	Antigen processing and presentation	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMT200032507	K09553	ko05020	Prion diseases	3288	1.6e-175	0.69	0.80	0.91
PGSC0003DMT200032508	K09553	ko05020	Prion diseases	2007	7.3e-105	0.74	0.84	0.96
PGSC0003DMT200032530	K03952	ko00190	Oxidative phosphorylation	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMT200032530	K03952	ko01100	Metabolic pathways	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMT200032530	K03952	ko05010	Alzheimer's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMT200032530	K03952	ko05012	Parkinson's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMT200032530	K03952	ko05016	Huntington's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMT200004624	K00889	ko00562	Inositol phosphate metabolism	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004624	K00889	ko01100	Metabolic pathways	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004624	K00889	ko04070	Phosphatidylinositol signaling system	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004624	K00889	ko04144	Endocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004624	K00889	ko04666	Fc gamma R-mediated phagocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004624	K00889	ko04810	Regulation of actin cytoskeleton	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMT200004629	K10875	ko03440	Homologous recombination	720	7.1e-34	0.30	0.49	0.57
PGSC0003DMT200004645	K01338	ko04112	Cell cycle - Caulobacter	6472	0.	0.87	0.95	1.00
PGSC0003DMT200041776	K00560	ko00240	Pyrimidine metabolism	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMT200041776	K00560	ko00670	One carbon pool by folate	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMT200041776	K00560	ko01100	Metabolic pathways	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMT200041777	K00560	ko00240	Pyrimidine metabolism	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMT200041777	K00560	ko00670	One carbon pool by folate	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMT200041777	K00560	ko01100	Metabolic pathways	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMT200041783	K06670	ko04110	Cell cycle	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMT200041783	K06670	ko04111	Cell cycle - yeast	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMT200041786	K06670	ko04110	Cell cycle	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMT200041786	K06670	ko04111	Cell cycle - yeast	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMT200041787	K00850	ko00010	Glycolysis / Gluconeogenesis	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041787	K00850	ko00030	Pentose phosphate pathway	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041787	K00850	ko00051	Fructose and mannose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041787	K00850	ko00052	Galactose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041787	K00850	ko01100	Metabolic pathways	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041787	K00850	ko01110	Biosynthesis of secondary metabolites	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMT200041788	K00850	ko00010	Glycolysis / Gluconeogenesis	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200041788	K00850	ko00030	Pentose phosphate pathway	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200041788	K00850	ko00051	Fructose and mannose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200041788	K00850	ko00052	Galactose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200041788	K00850	ko01100	Metabolic pathways	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200041788	K00850	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMT200097344	K01193	ko00052	Galactose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMT200097344	K01193	ko00500	Starch and sucrose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMT200097344	K01193	ko01100	Metabolic pathways	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMT200097346	K10760	ko00908	Zeatin biosynthesis	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMT200097346	K10760	ko01100	Metabolic pathways	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMT200097346	K10760	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMT200001427	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001427	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001428	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001429	K00128	ko00010	Glycolysis / Gluconeogenesis	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00053	Ascorbate and aldarate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00071	Fatty acid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00310	Lysine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00330	Arginine and proline metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00340	Histidine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00380	Tryptophan metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00410	beta-Alanine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00561	Glycerolipid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00620	Pyruvate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00631	1,2-Dichloroethane degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00640	Propanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00641	3-Chloroacrylic acid degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00650	Butanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko00903	Limonene and pinene degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko01100	Metabolic pathways	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001429	K00128	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMT200001430	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001430	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMT200001431	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001431	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMT200001432	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001432	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMT200001434	K05391	ko04626	Plant-pathogen interaction	1341	4.0e-68	0.67	0.77	0.99
PGSC0003DMT200001435	K05391	ko04626	Plant-pathogen interaction	3746	8.9e-201	0.67	0.80	0.95
PGSC0003DMT200001446	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMT200001446	K00517	ko00626	Naphthalene and anthracene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMT200001446	K00517	ko00903	Limonene and pinene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMT200001446	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMT200001446	K00517	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMT200001449	K10601	ko04120	Ubiquitin mediated proteolysis	3076	8.0e-164	0.72	0.80	0.36
PGSC0003DMT200001450	K10601	ko04120	Ubiquitin mediated proteolysis	2929	1.0e-155	0.72	0.80	0.98
PGSC0003DMT200001455	K00951	ko00230	Purine metabolism	990	9.1e-49	0.38	0.53	0.61
PGSC0003DMT200001456	K00951	ko00230	Purine metabolism	800	2.7e-38	0.35	0.51	0.76
PGSC0003DMT200078625	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMT200078625	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMT200078626	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMT200078626	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMT200078627	K00604	ko00670	One carbon pool by folate	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMT200078627	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMT200078628	K00604	ko00670	One carbon pool by folate	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMT200078628	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMT200078641	K13030	ko00460	Cyanoamino acid metabolism	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMT200078641	K13030	ko01110	Biosynthesis of secondary metabolites	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMT200078642	K13030	ko00460	Cyanoamino acid metabolism	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMT200078642	K13030	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMT200078643	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMT200078643	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMT200078644	K13030	ko00460	Cyanoamino acid metabolism	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMT200078644	K13030	ko01110	Biosynthesis of secondary metabolites	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMT200078645	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMT200078645	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMT200078653	K04733	ko04210	Apoptosis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMT200078653	K04733	ko04620	Toll-like receptor signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMT200078653	K04733	ko04722	Neurotrophin signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMT200078653	K04733	ko05140	Leishmaniasis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMT200078653	K04733	ko05142	Chagas disease	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMT200078654	K02183	ko04020	Calcium signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04070	Phosphatidylinositol signaling system	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04114	Oocyte meiosis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04270	Vascular smooth muscle contraction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04626	Plant-pathogen interaction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04720	Long-term potentiation	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04722	Neurotrophin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04740	Olfactory transduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04744	Phototransduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04745	Phototransduction - fly	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04910	Insulin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04912	GnRH signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04916	Melanogenesis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04970	Salivary secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko04971	Gastric acid secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko05010	Alzheimer's disease	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200078654	K02183	ko05214	Glioma	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMT200051132	K00780	ko00512	O-Glycan biosynthesis	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMT200051132	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMT200051132	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMT200051132	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMT200051132	K00780	ko01100	Metabolic pathways	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMT200051133	K00780	ko00512	O-Glycan biosynthesis	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMT200051133	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMT200051133	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMT200051133	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMT200051133	K00780	ko01100	Metabolic pathways	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMT200051134	K00780	ko00512	O-Glycan biosynthesis	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMT200051134	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMT200051134	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMT200051134	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMT200051134	K00780	ko01100	Metabolic pathways	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMT200051137	K12126	ko04712	Circadian rhythm - plant	312	2.9e-11	0.28	0.44	0.98
PGSC0003DMT200051154	K04371	ko04010	MAPK signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04012	ErbB signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04013	MAPK signaling pathway - fly	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04062	Chemokine signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04114	Oocyte meiosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04150	mTOR signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04270	Vascular smooth muscle contraction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04320	Dorso-ventral axis formation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04350	TGF-beta signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04360	Axon guidance	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04370	VEGF signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04510	Focal adhesion	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04520	Adherens junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04540	Gap junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04620	Toll-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04621	NOD-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04650	Natural killer cell mediated cytotoxicity	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04660	T cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04662	B cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04664	Fc epsilon RI signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04666	Fc gamma R-mediated phagocytosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04720	Long-term potentiation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04722	Neurotrophin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04730	Long-term depression	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04810	Regulation of actin cytoskeleton	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04910	Insulin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04912	GnRH signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04914	Progesterone-mediated oocyte maturation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04916	Melanogenesis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04930	Type II diabetes mellitus	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko04960	Aldosterone-regulated sodium reabsorption	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05010	Alzheimer's disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05020	Prion diseases	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05131	Shigellosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05140	Leishmaniasis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05142	Chagas disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05200	Pathways in cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05210	Colorectal cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05211	Renal cell carcinoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05212	Pancreatic cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05213	Endometrial cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05214	Glioma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05215	Prostate cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05216	Thyroid cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05218	Melanoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05219	Bladder cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05220	Chronic myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05221	Acute myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200051154	K04371	ko05223	Non-small cell lung cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMT200057273	K08770	ko03320	PPAR signaling pathway	887	4.4e-43	0.97	0.97	0.95
PGSC0003DMT200057274	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMT200057275	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMT200057276	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMT200057281	K08905	ko00195	Photosynthesis	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMT200057281	K08905	ko01100	Metabolic pathways	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMT200057282	K03130	ko03022	Basal transcription factors	247	1.1e-07	0.32	0.60	0.23
PGSC0003DMT200057286	K04538	ko04062	Chemokine signaling pathway	282	1.0e-09	0.27	0.42	0.79
PGSC0003DMT200057302	K06689	ko04120	Ubiquitin mediated proteolysis	1271	2.9e-64	0.96	0.99	0.99
PGSC0003DMT200085417	K03094	ko04110	Cell cycle	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04111	Cell cycle - yeast	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04114	Oocyte meiosis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04120	Ubiquitin mediated proteolysis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04310	Wnt signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04350	TGF-beta signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200085417	K03094	ko04710	Circadian rhythm - mammal	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMT200003146	K01427	ko00230	Purine metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMT200003146	K01427	ko00330	Arginine and proline metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMT200003146	K01427	ko00791	Atrazine degradation	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMT200003147	K01427	ko00230	Purine metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMT200003147	K01427	ko00330	Arginine and proline metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMT200003147	K01427	ko00791	Atrazine degradation	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMT200003148	K01427	ko00230	Purine metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMT200003148	K01427	ko00330	Arginine and proline metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMT200003148	K01427	ko00791	Atrazine degradation	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMT200003149	K01427	ko00230	Purine metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMT200003149	K01427	ko00330	Arginine and proline metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMT200003149	K01427	ko00791	Atrazine degradation	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMT200003150	K01427	ko00230	Purine metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMT200003150	K01427	ko00330	Arginine and proline metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMT200003150	K01427	ko00791	Atrazine degradation	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMT200003151	K01427	ko00230	Purine metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMT200003151	K01427	ko00330	Arginine and proline metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMT200003151	K01427	ko00791	Atrazine degradation	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMT200003152	K00939	ko00230	Purine metabolism	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMT200003152	K00939	ko01100	Metabolic pathways	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMT200003152	K00939	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMT200003155	K04124	ko00904	Diterpenoid biosynthesis	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMT200003155	K04124	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMT200003157	K04124	ko00904	Diterpenoid biosynthesis	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMT200003157	K04124	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMT200003158	K05282	ko00904	Diterpenoid biosynthesis	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMT200003158	K05282	ko01100	Metabolic pathways	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMT200003158	K05282	ko01110	Biosynthesis of secondary metabolites	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMT200003162	K09843	ko00906	Carotenoid biosynthesis	966	1.9e-47	0.36	0.54	0.98
PGSC0003DMT200006470	K02866	ko03010	Ribosome	271	8.0e-09	0.40	0.53	0.79
PGSC0003DMT200006471	K02866	ko03010	Ribosome	671	3.6e-31	0.43	0.57	0.89
PGSC0003DMT200006474	K00844	ko00010	Glycolysis / Gluconeogenesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00051	Fructose and mannose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00052	Galactose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00500	Starch and sucrose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00521	Streptomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko00524	Butirosin and neomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko01100	Metabolic pathways	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko01110	Biosynthesis of secondary metabolites	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko04910	Insulin signaling pathway	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006474	K00844	ko04930	Type II diabetes mellitus	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMT200006501	K04077	ko03018	RNA degradation	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMT200006501	K04077	ko04940	Type I diabetes mellitus	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMT200034224	K13034	ko00270	Cysteine and methionine metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMT200034224	K13034	ko00450	Selenoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMT200034224	K13034	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMT200034224	K13034	ko00920	Sulfur metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMT200034224	K13034	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMT200034258	K13065	ko00940	Phenylpropanoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMT200034258	K13065	ko00941	Flavonoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMT200034258	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMT200034258	K13065	ko01110	Biosynthesis of secondary metabolites	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMT200034266	K07678	ko02020	Two-component system	242	1.3e-06	0.39	0.64	0.80
PGSC0003DMT200012251	K06096	ko04530	Tight junction	337	9.4e-13	0.34	0.54	0.71
PGSC0003DMT200012263	K13034	ko00270	Cysteine and methionine metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMT200012263	K13034	ko00450	Selenoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMT200012263	K13034	ko00460	Cyanoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMT200012263	K13034	ko00920	Sulfur metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMT200012263	K13034	ko01100	Metabolic pathways	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMT200012297	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMT200012297	K01433	ko00670	One carbon pool by folate	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMT200012299	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMT200012299	K01433	ko00670	One carbon pool by folate	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMT200039975	K02725	ko03050	Proteasome	729	2.3e-34	0.83	0.90	0.84
PGSC0003DMT200039976	K02725	ko03050	Proteasome	1930	1.3e-100	0.82	0.88	1.00
PGSC0003DMT200039977	K00611	ko00330	Arginine and proline metabolism	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMT200039977	K00611	ko01100	Metabolic pathways	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMT200039977	K00611	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMT200039978	K00611	ko00330	Arginine and proline metabolism	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMT200039978	K00611	ko01100	Metabolic pathways	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMT200039978	K00611	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMT200039979	K00611	ko00330	Arginine and proline metabolism	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMT200039979	K00611	ko01100	Metabolic pathways	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMT200039979	K00611	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMT200049292	K11153	ko00830	Retinol metabolism	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMT200049292	K11153	ko01100	Metabolic pathways	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMT200049298	K00889	ko00562	Inositol phosphate metabolism	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049298	K00889	ko01100	Metabolic pathways	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049298	K00889	ko04070	Phosphatidylinositol signaling system	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049298	K00889	ko04144	Endocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049298	K00889	ko04666	Fc gamma R-mediated phagocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049298	K00889	ko04810	Regulation of actin cytoskeleton	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMT200049299	K00889	ko00562	Inositol phosphate metabolism	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049299	K00889	ko01100	Metabolic pathways	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049299	K00889	ko04070	Phosphatidylinositol signaling system	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049299	K00889	ko04144	Endocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049299	K00889	ko04666	Fc gamma R-mediated phagocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049299	K00889	ko04810	Regulation of actin cytoskeleton	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMT200049300	K00889	ko00562	Inositol phosphate metabolism	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049300	K00889	ko01100	Metabolic pathways	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049300	K00889	ko04070	Phosphatidylinositol signaling system	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049300	K00889	ko04144	Endocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049300	K00889	ko04666	Fc gamma R-mediated phagocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049300	K00889	ko04810	Regulation of actin cytoskeleton	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMT200049301	K00889	ko00562	Inositol phosphate metabolism	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049301	K00889	ko01100	Metabolic pathways	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049301	K00889	ko04070	Phosphatidylinositol signaling system	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049301	K00889	ko04144	Endocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049301	K00889	ko04666	Fc gamma R-mediated phagocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049301	K00889	ko04810	Regulation of actin cytoskeleton	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMT200049305	K09840	ko00906	Carotenoid biosynthesis	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMT200049305	K09840	ko01100	Metabolic pathways	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMT200049305	K09840	ko01110	Biosynthesis of secondary metabolites	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMT200049308	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMT200049308	K01687	ko00770	Pantothenate and CoA biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMT200049308	K01687	ko01100	Metabolic pathways	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMT200049308	K01687	ko01110	Biosynthesis of secondary metabolites	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMT200049309	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMT200049309	K01687	ko00770	Pantothenate and CoA biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMT200049309	K01687	ko01100	Metabolic pathways	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMT200049309	K01687	ko01110	Biosynthesis of secondary metabolites	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMT200076866	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076866	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMT200076878	K02956	ko03010	Ribosome	590	1.0e-26	0.82	0.91	0.99
PGSC0003DMT200076880	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200076880	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200076880	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200076880	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200076880	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMT200086626	K01199	ko00500	Starch and sucrose metabolism	1243	1.0e-62	0.52	0.67	1.00
PGSC0003DMT200026511	K01952	ko00230	Purine metabolism	9021	0.	0.86	0.94	1.00
PGSC0003DMT200026511	K01952	ko01100	Metabolic pathways	9021	0.	0.86	0.94	1.00
PGSC0003DMT200026511	K01952	ko01110	Biosynthesis of secondary metabolites	9021	0.	0.86	0.94	1.00
PGSC0003DMT200026512	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026512	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026512	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026513	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026513	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026513	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMT200026516	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMT200026516	K01817	ko01100	Metabolic pathways	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMT200026516	K01817	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMT200026517	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200026517	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200026517	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200026518	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMT200026518	K01817	ko01100	Metabolic pathways	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMT200026518	K01817	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMT200026519	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMT200026519	K01817	ko01100	Metabolic pathways	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMT200026519	K01817	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMT200026520	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200026520	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200026520	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMT200019176	K06111	ko04530	Tight junction	6165	0.	0.68	0.79	0.93
PGSC0003DMT200019177	K06111	ko04530	Tight junction	6388	0.	0.73	0.84	1.00
PGSC0003DMT200019178	K06111	ko04530	Tight junction	4654	7.4e-251	0.75	0.85	0.99
PGSC0003DMT200019185	K03094	ko04110	Cell cycle	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04111	Cell cycle - yeast	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04114	Oocyte meiosis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04120	Ubiquitin mediated proteolysis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04310	Wnt signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04350	TGF-beta signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019185	K03094	ko04710	Circadian rhythm - mammal	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMT200019198	K11984	ko03040	Spliceosome	4052	1.2e-217	0.62	0.78	0.95
PGSC0003DMT200019199	K11984	ko03040	Spliceosome	2439	1.1e-128	0.70	0.84	1.00
PGSC0003DMT200019200	K11984	ko03040	Spliceosome	4381	8.4e-236	0.63	0.78	0.98
PGSC0003DMT200019201	K11984	ko03040	Spliceosome	4284	1.9e-230	0.63	0.78	0.98
PGSC0003DMT200019203	K02717	ko00195	Photosynthesis	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMT200019203	K02717	ko01100	Metabolic pathways	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMT200019204	K02717	ko00195	Photosynthesis	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMT200019204	K02717	ko01100	Metabolic pathways	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMT200019207	K02717	ko00195	Photosynthesis	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMT200019207	K02717	ko01100	Metabolic pathways	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMT200019210	K05692	ko04145	Phagosome	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04510	Focal adhesion	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04520	Adherens junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04530	Tight junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04670	Leukocyte transendothelial migration	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04745	Phototransduction - fly	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko04810	Regulation of actin cytoskeleton	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05100	Bacterial invasion of epithelial cells	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05110	Vibrio cholerae infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05130	Pathogenic Escherichia coli infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05131	Shigellosis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05414	Dilated cardiomyopathy	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019210	K05692	ko05416	Viral myocarditis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMT200019211	K02923	ko03010	Ribosome	472	3.4e-20	0.92	0.97	0.48
PGSC0003DMT200019212	K02923	ko03010	Ribosome	535	1.1e-23	0.93	0.97	0.99
PGSC0003DMT200038670	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMT200038670	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMT200038672	K07748	ko00100	Steroid biosynthesis	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMT200038672	K07748	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMT200038673	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMT200038673	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMT200038696	K12338	ko00942	Anthocyanin biosynthesis	1014	4.3e-50	0.40	0.62	0.99
PGSC0003DMT200038700	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMT200038700	K00517	ko00626	Naphthalene and anthracene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMT200038700	K00517	ko00903	Limonene and pinene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMT200038700	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMT200038700	K00517	ko01110	Biosynthesis of secondary metabolites	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMT200038701	K01719	ko00860	Porphyrin and chlorophyll metabolism	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMT200038701	K01719	ko01100	Metabolic pathways	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMT200038701	K01719	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMT200038710	K13065	ko00940	Phenylpropanoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMT200038710	K13065	ko00941	Flavonoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMT200038710	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMT200038710	K13065	ko01110	Biosynthesis of secondary metabolites	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMT200070560	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMT200070563	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMT200070567	K01066	ko00623	2,4-Dichlorobenzoate degradation	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMT200070567	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMT200070586	K07376	ko04540	Gap junction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMT200070586	K07376	ko04730	Long-term depression	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMT200070586	K07376	ko04740	Olfactory transduction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMT200070586	K07376	ko04970	Salivary secretion	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMT200070595	K01692	ko00071	Fatty acid metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00280	Valine, leucine and isoleucine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00281	Geraniol degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00310	Lysine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00380	Tryptophan metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00410	beta-Alanine metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00632	Benzoate degradation via CoA ligation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00640	Propanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00650	Butanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00903	Limonene and pinene degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko00930	Caprolactam degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko01100	Metabolic pathways	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070595	K01692	ko01110	Biosynthesis of secondary metabolites	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMT200070596	K01692	ko00071	Fatty acid metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00281	Geraniol degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00310	Lysine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00380	Tryptophan metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00410	beta-Alanine metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00632	Benzoate degradation via CoA ligation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00640	Propanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00650	Butanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00903	Limonene and pinene degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko00930	Caprolactam degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko01100	Metabolic pathways	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200070596	K01692	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMT200072860	K08493	ko04130	SNARE interactions in vesicular transport	1306	3.4e-66	0.72	0.84	1.00
PGSC0003DMT200072861	K08493	ko04130	SNARE interactions in vesicular transport	628	8.4e-29	0.78	0.88	0.99
PGSC0003DMT200072880	K07424	ko00140	Steroid hormone biosynthesis	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00591	Linoleic acid metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00830	Retinol metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00982	Drug metabolism - cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko00983	Drug metabolism - other enzymes	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072880	K07424	ko01100	Metabolic pathways	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMT200072897	K00796	ko00790	Folate biosynthesis	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMT200072897	K00796	ko01100	Metabolic pathways	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMT200072898	K00796	ko00790	Folate biosynthesis	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMT200072898	K00796	ko01100	Metabolic pathways	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMT200072899	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072899	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072899	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMT200072900	K01057	ko00030	Pentose phosphate pathway	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMT200072900	K01057	ko01100	Metabolic pathways	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMT200072900	K01057	ko01110	Biosynthesis of secondary metabolites	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMT200047095	K12929	ko00904	Diterpenoid biosynthesis	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMT200047095	K12929	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMT200047096	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMT200047096	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMT200047097	K12929	ko00904	Diterpenoid biosynthesis	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMT200047097	K12929	ko01110	Biosynthesis of secondary metabolites	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMT200047099	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMT200047099	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMT200047102	K12929	ko00904	Diterpenoid biosynthesis	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMT200047102	K12929	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMT200047105	K12929	ko00904	Diterpenoid biosynthesis	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMT200047105	K12929	ko01110	Biosynthesis of secondary metabolites	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMT200047106	K12929	ko00904	Diterpenoid biosynthesis	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMT200047106	K12929	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMT200047107	K12929	ko00904	Diterpenoid biosynthesis	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMT200047107	K12929	ko01110	Biosynthesis of secondary metabolites	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMT200047108	K12929	ko00904	Diterpenoid biosynthesis	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMT200047108	K12929	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMT200047109	K12929	ko00904	Diterpenoid biosynthesis	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMT200047109	K12929	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMT200047110	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200047110	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMT200047124	K12929	ko00904	Diterpenoid biosynthesis	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMT200047124	K12929	ko01110	Biosynthesis of secondary metabolites	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMT200047125	K12929	ko00904	Diterpenoid biosynthesis	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMT200047125	K12929	ko01110	Biosynthesis of secondary metabolites	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMT200047126	K12467	ko00902	Monoterpenoid biosynthesis	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMT200047126	K12467	ko01110	Biosynthesis of secondary metabolites	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMT200047127	K12929	ko00904	Diterpenoid biosynthesis	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMT200047127	K12929	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMT200047134	K10955	ko05110	Vibrio cholerae infection	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMT200047134	K10955	ko05146	Amoebiasis	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMT200047145	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047145	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047145	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047145	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047146	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047146	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047146	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047146	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMT200047149	K00430	ko00360	Phenylalanine metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMT200047149	K00430	ko00680	Methane metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMT200047149	K00430	ko00940	Phenylpropanoid biosynthesis	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMT200047149	K00430	ko01100	Metabolic pathways	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMT200047149	K00430	ko01110	Biosynthesis of secondary metabolites	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMT200047150	K00430	ko00360	Phenylalanine metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMT200047150	K00430	ko00680	Methane metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMT200047150	K00430	ko00940	Phenylpropanoid biosynthesis	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMT200047150	K00430	ko01100	Metabolic pathways	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMT200047150	K00430	ko01110	Biosynthesis of secondary metabolites	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMT200081402	K01679	ko00020	Citrate cycle (TCA cycle)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081402	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081402	K01679	ko01100	Metabolic pathways	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081402	K01679	ko01110	Biosynthesis of secondary metabolites	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081402	K01679	ko05200	Pathways in cancer	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081402	K01679	ko05211	Renal cell carcinoma	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMT200081403	K01679	ko00020	Citrate cycle (TCA cycle)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081403	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081403	K01679	ko01100	Metabolic pathways	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081403	K01679	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081403	K01679	ko05200	Pathways in cancer	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081403	K01679	ko05211	Renal cell carcinoma	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMT200081404	K01679	ko00020	Citrate cycle (TCA cycle)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081404	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081404	K01679	ko01100	Metabolic pathways	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081404	K01679	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081404	K01679	ko05200	Pathways in cancer	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081404	K01679	ko05211	Renal cell carcinoma	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMT200081426	K08139	ko04113	Meiosis - yeast	982	2.5e-48	0.34	0.50	0.88
PGSC0003DMT200065743	K01648	ko00020	Citrate cycle (TCA cycle)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMT200065743	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMT200065743	K01648	ko01100	Metabolic pathways	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMT200065743	K01648	ko01110	Biosynthesis of secondary metabolites	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMT200065753	K04733	ko04210	Apoptosis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMT200065753	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMT200065753	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMT200065753	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMT200065753	K04733	ko05142	Chagas disease	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMT200065761	K04733	ko04210	Apoptosis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMT200065761	K04733	ko04620	Toll-like receptor signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMT200065761	K04733	ko04722	Neurotrophin signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMT200065761	K04733	ko05140	Leishmaniasis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMT200065761	K04733	ko05142	Chagas disease	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMT200065762	K04733	ko04210	Apoptosis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMT200065762	K04733	ko04620	Toll-like receptor signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMT200065762	K04733	ko04722	Neurotrophin signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMT200065762	K04733	ko05140	Leishmaniasis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMT200065762	K04733	ko05142	Chagas disease	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMT200065768	K04733	ko04210	Apoptosis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMT200065768	K04733	ko04620	Toll-like receptor signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMT200065768	K04733	ko04722	Neurotrophin signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMT200065768	K04733	ko05140	Leishmaniasis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMT200065768	K04733	ko05142	Chagas disease	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMT200065771	K04733	ko04210	Apoptosis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMT200065771	K04733	ko04620	Toll-like receptor signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMT200065771	K04733	ko04722	Neurotrophin signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMT200065771	K04733	ko05140	Leishmaniasis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMT200065771	K04733	ko05142	Chagas disease	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMT200045768	K13030	ko00460	Cyanoamino acid metabolism	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMT200045768	K13030	ko01110	Biosynthesis of secondary metabolites	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMT200045782	K06630	ko04110	Cell cycle	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMT200045782	K06630	ko04114	Oocyte meiosis	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMT200045782	K06630	ko04722	Neurotrophin signaling pathway	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMT200045783	K02267	ko00190	Oxidative phosphorylation	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200045783	K02267	ko01100	Metabolic pathways	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200045783	K02267	ko04260	Cardiac muscle contraction	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200045783	K02267	ko05010	Alzheimer's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200045783	K02267	ko05012	Parkinson's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200045783	K02267	ko05016	Huntington's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMT200071445	K12796	ko04621	NOD-like receptor signaling pathway	327	2.3e-08	0.29	0.47	0.42
PGSC0003DMT200071462	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071462	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071462	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071462	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071462	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071462	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200071463	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMT200087976	K09754	ko00360	Phenylalanine metabolism	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087976	K09754	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087976	K09754	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087976	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087976	K09754	ko01100	Metabolic pathways	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087976	K09754	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMT200087979	K00430	ko00360	Phenylalanine metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMT200087979	K00430	ko00680	Methane metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMT200087979	K00430	ko00940	Phenylpropanoid biosynthesis	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMT200087979	K00430	ko01100	Metabolic pathways	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMT200087979	K00430	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMT200087982	K10760	ko00908	Zeatin biosynthesis	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMT200087982	K10760	ko01100	Metabolic pathways	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMT200087982	K10760	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMT200083085	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMT200083086	K12127	ko04712	Circadian rhythm - plant	2744	1.6e-145	0.63	0.77	0.98
PGSC0003DMT200083087	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMT200083088	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMT200083093	K07964	ko00531	Glycosaminoglycan degradation	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMT200083093	K07964	ko01100	Metabolic pathways	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMT200083101	K02160	ko00061	Fatty acid biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083101	K02160	ko00253	Tetracycline biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083101	K02160	ko00620	Pyruvate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083101	K02160	ko00640	Propanoate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083101	K02160	ko01100	Metabolic pathways	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083101	K02160	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMT200083109	K10643	ko03018	RNA degradation	277	1.9e-09	0.56	0.72	0.14
PGSC0003DMT200083112	K01950	ko00760	Nicotinate and nicotinamide metabolism	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMT200083112	K01950	ko01100	Metabolic pathways	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMT200083113	K01950	ko00760	Nicotinate and nicotinamide metabolism	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMT200083113	K01950	ko01100	Metabolic pathways	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMT200083114	K04688	ko04012	ErbB signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083114	K04688	ko04150	mTOR signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083114	K04688	ko04350	TGF-beta signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083114	K04688	ko04666	Fc gamma R-mediated phagocytosis	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083114	K04688	ko04910	Insulin signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083114	K04688	ko05221	Acute myeloid leukemia	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMT200083115	K04688	ko04012	ErbB signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083115	K04688	ko04150	mTOR signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083115	K04688	ko04350	TGF-beta signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083115	K04688	ko04666	Fc gamma R-mediated phagocytosis	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083115	K04688	ko04910	Insulin signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083115	K04688	ko05221	Acute myeloid leukemia	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMT200083117	K04688	ko04012	ErbB signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083117	K04688	ko04150	mTOR signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083117	K04688	ko04350	TGF-beta signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083117	K04688	ko04666	Fc gamma R-mediated phagocytosis	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083117	K04688	ko04910	Insulin signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083117	K04688	ko05221	Acute myeloid leukemia	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMT200083122	K10418	ko04962	Vasopressin-regulated water reabsorption	328	3.0e-12	0.52	0.66	0.31
PGSC0003DMT200053692	K12587	ko03018	RNA degradation	568	1.7e-25	0.38	0.63	0.79
PGSC0003DMT200053711	K12599	ko03018	RNA degradation	2479	6.8e-131	0.80	0.91	0.99
PGSC0003DMT200053712	K12599	ko03018	RNA degradation	2973	3.8e-158	0.77	0.89	0.98
PGSC0003DMT200053713	K12599	ko03018	RNA degradation	2957	2.9e-157	0.77	0.88	0.99
PGSC0003DMT200053714	K12599	ko03018	RNA degradation	3795	1.8e-203	0.80	0.90	1.00
PGSC0003DMT200053716	K12599	ko03018	RNA degradation	483	6.5e-20	0.84	0.88	0.97
PGSC0003DMT200053717	K12599	ko03018	RNA degradation	545	8.0e-24	0.53	0.73	0.94
PGSC0003DMT200053718	K12599	ko03018	RNA degradation	844	2.7e-40	0.88	0.96	0.92
PGSC0003DMT200053750	K07375	ko04145	Phagosome	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMT200053750	K07375	ko04540	Gap junction	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMT200053750	K07375	ko05130	Pathogenic Escherichia coli infection	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMT200025792	K01581	ko00330	Arginine and proline metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMT200025792	K01581	ko00480	Glutathione metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMT200025792	K01581	ko01100	Metabolic pathways	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMT200025792	K01581	ko01110	Biosynthesis of secondary metabolites	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMT200025805	K00423	ko00053	Ascorbate and aldarate metabolism	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMT200025805	K00423	ko01100	Metabolic pathways	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMT200025806	K00423	ko00053	Ascorbate and aldarate metabolism	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMT200025806	K00423	ko01100	Metabolic pathways	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMT200025808	K12349	ko00600	Sphingolipid metabolism	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMT200025808	K12349	ko01100	Metabolic pathways	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMT200028728	K02965	ko03010	Ribosome	286	6.1e-10	0.41	0.62	0.74
PGSC0003DMT200028730	K10603	ko04120	Ubiquitin mediated proteolysis	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMT200028730	K10603	ko05340	Primary immunodeficiency	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMT200028756	K00368	ko00910	Nitrogen metabolism	421	2.2e-17	0.40	0.59	0.80
PGSC0003DMT200028758	K00368	ko00910	Nitrogen metabolism	285	1.4e-09	0.43	0.58	0.94
PGSC0003DMT200028764	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMT200028764	K01602	ko00710	Carbon fixation in photosynthetic organisms	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMT200028764	K01602	ko01100	Metabolic pathways	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMT200028765	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMT200028765	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMT200028765	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMT200028766	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200028766	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200028766	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMT200010631	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMT200010631	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMT200010632	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMT200010632	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMT200010634	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMT200010634	K01657	ko01100	Metabolic pathways	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMT200010634	K01657	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMT200010650	K05857	ko00562	Inositol phosphate metabolism	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMT200010650	K05857	ko01100	Metabolic pathways	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMT200010650	K05857	ko04020	Calcium signaling pathway	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMT200010650	K05857	ko04070	Phosphatidylinositol signaling system	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMT200010651	K05857	ko00562	Inositol phosphate metabolism	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMT200010651	K05857	ko01100	Metabolic pathways	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMT200010651	K05857	ko04020	Calcium signaling pathway	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMT200010651	K05857	ko04070	Phosphatidylinositol signaling system	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMT200036307	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	972	8.9e-48	0.41	0.54	0.98
PGSC0003DMT200096227	K10760	ko00908	Zeatin biosynthesis	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMT200096227	K10760	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMT200096227	K10760	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMT200096238	K03094	ko04110	Cell cycle	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04111	Cell cycle - yeast	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04114	Oocyte meiosis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04120	Ubiquitin mediated proteolysis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04310	Wnt signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04350	TGF-beta signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096238	K03094	ko04710	Circadian rhythm - mammal	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMT200096243	K12356	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.32	0.47	0.90
PGSC0003DMT200090072	K03094	ko04110	Cell cycle	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04111	Cell cycle - yeast	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04114	Oocyte meiosis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04120	Ubiquitin mediated proteolysis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04310	Wnt signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04350	TGF-beta signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090072	K03094	ko04710	Circadian rhythm - mammal	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMT200090073	K10760	ko00908	Zeatin biosynthesis	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMT200090073	K10760	ko01100	Metabolic pathways	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMT200090073	K10760	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMT200078002	K01079	ko00260	Glycine, serine and threonine metabolism	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMT200078002	K01079	ko01100	Metabolic pathways	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMT200078003	K01079	ko00260	Glycine, serine and threonine metabolism	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMT200078003	K01079	ko01100	Metabolic pathways	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMT200078004	K01079	ko00260	Glycine, serine and threonine metabolism	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMT200078004	K01079	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMT200078005	K13228	ko00402	Benzoxazinoid biosynthesis	680	1.1e-31	0.45	0.64	0.88
PGSC0003DMT200078013	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMT200078013	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMT200078013	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMT200078013	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMT200078014	K01689	ko00010	Glycolysis / Gluconeogenesis	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMT200078014	K01689	ko01100	Metabolic pathways	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMT200078014	K01689	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMT200078014	K01689	ko03018	RNA degradation	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMT200078015	K01689	ko00010	Glycolysis / Gluconeogenesis	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMT200078015	K01689	ko01100	Metabolic pathways	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMT200078015	K01689	ko01110	Biosynthesis of secondary metabolites	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMT200078015	K01689	ko03018	RNA degradation	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMT200078016	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMT200078016	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMT200078016	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMT200078016	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMT200078017	K01689	ko00010	Glycolysis / Gluconeogenesis	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMT200078017	K01689	ko01100	Metabolic pathways	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMT200078017	K01689	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMT200078017	K01689	ko03018	RNA degradation	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMT200078019	K01689	ko00010	Glycolysis / Gluconeogenesis	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMT200078019	K01689	ko01100	Metabolic pathways	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMT200078019	K01689	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMT200078019	K01689	ko03018	RNA degradation	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMT200078020	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.37
PGSC0003DMT200078021	K12897	ko03040	Spliceosome	446	9.2e-19	0.49	0.55	0.57
PGSC0003DMT200078022	K12897	ko03040	Spliceosome	871	3.3e-42	0.54	0.61	0.67
PGSC0003DMT200078024	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.39
PGSC0003DMT200078030	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMT200078030	K00517	ko00626	Naphthalene and anthracene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMT200078030	K00517	ko00903	Limonene and pinene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMT200078030	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMT200078030	K00517	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMT200078033	K02213	ko04110	Cell cycle	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMT200078033	K02213	ko04111	Cell cycle - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMT200078033	K02213	ko04113	Meiosis - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMT200050898	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMT200050898	K00517	ko00626	Naphthalene and anthracene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMT200050898	K00517	ko00903	Limonene and pinene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMT200050898	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMT200050898	K00517	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMT200050899	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMT200050899	K00517	ko00626	Naphthalene and anthracene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMT200050899	K00517	ko00903	Limonene and pinene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMT200050899	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMT200050899	K00517	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMT200050900	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMT200050900	K00517	ko00626	Naphthalene and anthracene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMT200050900	K00517	ko00903	Limonene and pinene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMT200050900	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMT200050900	K00517	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMT200050905	K11818	ko00380	Tryptophan metabolism	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMT200050905	K11818	ko00966	Glucosinolate biosynthesis	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMT200050905	K11818	ko01110	Biosynthesis of secondary metabolites	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMT200050906	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMT200050906	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMT200050906	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMT200050906	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMT200050906	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMT200050907	K11778	ko00900	Terpenoid backbone biosynthesis	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMT200050907	K11778	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMT200050908	K12929	ko00904	Diterpenoid biosynthesis	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMT200050908	K12929	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMT200050909	K12929	ko00904	Diterpenoid biosynthesis	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMT200050909	K12929	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMT200050910	K12929	ko00904	Diterpenoid biosynthesis	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMT200050910	K12929	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMT200050911	K12929	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMT200050911	K12929	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMT200050912	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMT200050912	K00517	ko00626	Naphthalene and anthracene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMT200050912	K00517	ko00903	Limonene and pinene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMT200050912	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMT200050912	K00517	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMT200050919	K11778	ko00900	Terpenoid backbone biosynthesis	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMT200050919	K11778	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMT200050920	K11423	ko00310	Lysine degradation	2592	4.0e-137	0.52	0.63	0.46
PGSC0003DMT200050925	K11423	ko00310	Lysine degradation	2652	1.9e-140	0.54	0.66	0.41
PGSC0003DMT200050941	K12929	ko00904	Diterpenoid biosynthesis	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMT200050941	K12929	ko01110	Biosynthesis of secondary metabolites	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMT200050945	K12929	ko00904	Diterpenoid biosynthesis	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMT200050945	K12929	ko01110	Biosynthesis of secondary metabolites	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMT200050949	K12929	ko00904	Diterpenoid biosynthesis	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMT200050949	K12929	ko01110	Biosynthesis of secondary metabolites	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMT200057603	K03885	ko00190	Oxidative phosphorylation	3498	4.2e-187	0.75	0.86	1.00
PGSC0003DMT200057610	K01082	ko00920	Sulfur metabolism	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMT200057610	K01082	ko01100	Metabolic pathways	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMT200057611	K01082	ko00920	Sulfur metabolism	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMT200057611	K01082	ko01100	Metabolic pathways	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMT200057612	K01082	ko00920	Sulfur metabolism	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMT200057612	K01082	ko01100	Metabolic pathways	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMT200057613	K01082	ko00920	Sulfur metabolism	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMT200057613	K01082	ko01100	Metabolic pathways	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMT200057616	K13289	ko04142	Lysosome	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMT200057616	K13289	ko04614	Renin-angiotensin system	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMT200057619	K13289	ko04142	Lysosome	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMT200057619	K13289	ko04614	Renin-angiotensin system	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMT200057622	K05747	ko04062	Chemokine signaling pathway	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko04520	Adherens junction	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko04666	Fc gamma R-mediated phagocytosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko04810	Regulation of actin cytoskeleton	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko05100	Bacterial invasion of epithelial cells	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko05130	Pathogenic Escherichia coli infection	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057622	K05747	ko05131	Shigellosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMT200057629	K08139	ko04113	Meiosis - yeast	1108	2.8e-55	0.36	0.61	0.88
PGSC0003DMT200057630	K08726	ko00590	Arachidonic acid metabolism	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMT200057630	K08726	ko00625	Tetrachloroethene degradation	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMT200057630	K08726	ko01100	Metabolic pathways	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMT200057630	K08726	ko04146	Peroxisome	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMT200057631	K08726	ko00590	Arachidonic acid metabolism	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMT200057631	K08726	ko00625	Tetrachloroethene degradation	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMT200057631	K08726	ko01100	Metabolic pathways	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMT200057631	K08726	ko04146	Peroxisome	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMT200074769	K01838	ko00500	Starch and sucrose metabolism	272	3.6e-09	0.34	0.49	0.57
PGSC0003DMT200074770	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMT200074771	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMT200074773	K01838	ko00500	Starch and sucrose metabolism	292	2.9e-10	0.33	0.48	0.56
PGSC0003DMT200074783	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMT200074783	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMT200074783	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMT200074784	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMT200074784	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMT200074784	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMT200074798	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMT200074798	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMT200074799	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMT200074799	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMT200074800	K01243	ko00270	Cysteine and methionine metabolism	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMT200074800	K01243	ko01100	Metabolic pathways	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMT200074801	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMT200074801	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMT200074804	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMT200074804	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMT200074807	K00417	ko00190	Oxidative phosphorylation	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200074807	K00417	ko01100	Metabolic pathways	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200074807	K00417	ko04260	Cardiac muscle contraction	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200074807	K00417	ko05010	Alzheimer's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200074807	K00417	ko05012	Parkinson's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200074807	K00417	ko05016	Huntington's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMT200031846	K00799	ko00480	Glutathione metabolism	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMT200031846	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMT200031846	K00799	ko00982	Drug metabolism - cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMT200031847	K00799	ko00480	Glutathione metabolism	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMT200031847	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMT200031847	K00799	ko00982	Drug metabolism - cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMT200031848	K00799	ko00480	Glutathione metabolism	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMT200031848	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMT200031848	K00799	ko00982	Drug metabolism - cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMT200031849	K00799	ko00480	Glutathione metabolism	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMT200031849	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMT200031849	K00799	ko00982	Drug metabolism - cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMT200031852	K00799	ko00480	Glutathione metabolism	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMT200031852	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMT200031852	K00799	ko00982	Drug metabolism - cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMT200031864	K01507	ko00190	Oxidative phosphorylation	1349	1.4e-68	0.79	0.86	0.97
PGSC0003DMT200031865	K01507	ko00190	Oxidative phosphorylation	1470	3.0e-75	0.80	0.89	0.97
PGSC0003DMT200031867	K01507	ko00190	Oxidative phosphorylation	1566	1.5e-80	0.89	0.97	0.98
PGSC0003DMT200031869	K02867	ko03010	Ribosome	1346	2.1e-68	0.77	0.86	0.98
PGSC0003DMT200004435	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMT200004435	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMT200004435	K10158	ko01100	Metabolic pathways	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMT200004446	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMT200004446	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMT200004446	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMT200004446	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMT200004446	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMT200004447	K00430	ko00360	Phenylalanine metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMT200004447	K00430	ko00680	Methane metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMT200004447	K00430	ko00940	Phenylpropanoid biosynthesis	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMT200004447	K00430	ko01100	Metabolic pathways	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMT200004447	K00430	ko01110	Biosynthesis of secondary metabolites	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMT200042100	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042100	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042100	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042100	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042100	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042100	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042101	K01962	ko00061	Fatty acid biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042101	K01962	ko00253	Tetracycline biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042101	K01962	ko00620	Pyruvate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042101	K01962	ko00640	Propanoate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042101	K01962	ko01100	Metabolic pathways	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042101	K01962	ko01110	Biosynthesis of secondary metabolites	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMT200042102	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042102	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042102	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042102	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042102	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042102	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMT200042104	K09291	ko04011	MAPK signaling pathway - yeast	7204	0.	0.48	0.68	1.00
PGSC0003DMT200042104	K09291	ko05200	Pathways in cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMT200042104	K09291	ko05216	Thyroid cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMT200042105	K00797	ko00270	Cysteine and methionine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMT200042105	K00797	ko00330	Arginine and proline metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMT200042105	K00797	ko00410	beta-Alanine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMT200042105	K00797	ko00480	Glutathione metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMT200042105	K00797	ko01100	Metabolic pathways	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMT200042106	K00797	ko00270	Cysteine and methionine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMT200042106	K00797	ko00330	Arginine and proline metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMT200042106	K00797	ko00410	beta-Alanine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMT200042106	K00797	ko00480	Glutathione metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMT200042106	K00797	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMT200042118	K03921	ko00061	Fatty acid biosynthesis	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMT200042118	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMT200042121	K00624	ko04146	Peroxisome	533	1.2e-22	0.38	0.58	0.28
PGSC0003DMT200042133	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMT200042133	K01649	ko00620	Pyruvate metabolism	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMT200042133	K01649	ko01100	Metabolic pathways	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMT200042133	K01649	ko01110	Biosynthesis of secondary metabolites	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMT200000770	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200000770	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200000770	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMT200000771	K01762	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMT200000771	K01762	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMT200000775	K02140	ko00190	Oxidative phosphorylation	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMT200000775	K02140	ko01100	Metabolic pathways	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMT200000776	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMT200000778	K00469	ko00053	Ascorbate and aldarate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMT200000778	K00469	ko00562	Inositol phosphate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMT200000779	K00469	ko00053	Ascorbate and aldarate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMT200000779	K00469	ko00562	Inositol phosphate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMT200000780	K00469	ko00053	Ascorbate and aldarate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMT200000780	K00469	ko00562	Inositol phosphate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMT200000783	K00681	ko00430	Taurine and hypotaurine metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000783	K00681	ko00450	Selenoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000783	K00681	ko00460	Cyanoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000783	K00681	ko00480	Glutathione metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000783	K00681	ko00590	Arachidonic acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000783	K00681	ko01100	Metabolic pathways	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMT200000786	K05759	ko04810	Regulation of actin cytoskeleton	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMT200000786	K05759	ko05131	Shigellosis	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMT200000790	K01051	ko00040	Pentose and glucuronate interconversions	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMT200000790	K01051	ko00500	Starch and sucrose metabolism	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMT200000790	K01051	ko01100	Metabolic pathways	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMT200000791	K01051	ko00040	Pentose and glucuronate interconversions	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMT200000791	K01051	ko00500	Starch and sucrose metabolism	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMT200000791	K01051	ko01100	Metabolic pathways	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMT200000795	K00844	ko00010	Glycolysis / Gluconeogenesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00051	Fructose and mannose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00052	Galactose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00500	Starch and sucrose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00521	Streptomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko00524	Butirosin and neomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko01100	Metabolic pathways	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko01110	Biosynthesis of secondary metabolites	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko04910	Insulin signaling pathway	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000795	K00844	ko04930	Type II diabetes mellitus	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMT200000797	K00844	ko00010	Glycolysis / Gluconeogenesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00051	Fructose and mannose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00052	Galactose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00521	Streptomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko00524	Butirosin and neomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko01100	Metabolic pathways	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko04910	Insulin signaling pathway	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000797	K00844	ko04930	Type II diabetes mellitus	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMT200000809	K07151	ko00510	N-Glycan biosynthesis	5760	0.	0.87	0.93	1.00
PGSC0003DMT200000809	K07151	ko01100	Metabolic pathways	5760	0.	0.87	0.93	1.00
PGSC0003DMT200049076	K00276	ko00260	Glycine, serine and threonine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko00350	Tyrosine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko00410	beta-Alanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko01100	Metabolic pathways	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049076	K00276	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMT200049085	K00939	ko00230	Purine metabolism	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMT200049085	K00939	ko01100	Metabolic pathways	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMT200049085	K00939	ko01110	Biosynthesis of secondary metabolites	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMT200049086	K00939	ko00230	Purine metabolism	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMT200049086	K00939	ko01100	Metabolic pathways	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMT200049086	K00939	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMT200049087	K00939	ko00230	Purine metabolism	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMT200049087	K00939	ko01100	Metabolic pathways	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMT200049087	K00939	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMT200049088	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200049088	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200049088	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200049089	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200049089	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200049089	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMT200076217	K03032	ko03050	Proteasome	4568	4.1e-246	0.86	0.91	0.97
PGSC0003DMT200076218	K03032	ko03050	Proteasome	5163	6.2e-279	0.87	0.92	0.99
PGSC0003DMT200076219	K03032	ko03050	Proteasome	7089	0.	0.86	0.91	1.00
PGSC0003DMT200086879	K04733	ko04210	Apoptosis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMT200086879	K04733	ko04620	Toll-like receptor signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMT200086879	K04733	ko04722	Neurotrophin signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMT200086879	K04733	ko05140	Leishmaniasis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMT200086879	K04733	ko05142	Chagas disease	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMT200002450	K01213	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMT200002450	K01213	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMT200002450	K01213	ko01100	Metabolic pathways	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMT200002451	K01213	ko00040	Pentose and glucuronate interconversions	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMT200002451	K01213	ko00500	Starch and sucrose metabolism	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMT200002451	K01213	ko01100	Metabolic pathways	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMT200002454	K01834	ko00010	Glycolysis / Gluconeogenesis	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMT200002454	K01834	ko01100	Metabolic pathways	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMT200002454	K01834	ko01110	Biosynthesis of secondary metabolites	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMT200090761	K02893	ko03010	Ribosome	566	2.2e-25	0.97	0.99	0.99
PGSC0003DMT200006302	K05350	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMT200006302	K05350	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMT200006302	K05350	ko00940	Phenylpropanoid biosynthesis	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMT200006302	K05350	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMT200006303	K05350	ko00460	Cyanoamino acid metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMT200006303	K05350	ko00500	Starch and sucrose metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMT200006303	K05350	ko00940	Phenylpropanoid biosynthesis	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMT200006303	K05350	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMT200006305	K05350	ko00460	Cyanoamino acid metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMT200006305	K05350	ko00500	Starch and sucrose metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMT200006305	K05350	ko00940	Phenylpropanoid biosynthesis	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMT200006305	K05350	ko01110	Biosynthesis of secondary metabolites	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMT200006317	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMT200006317	K00517	ko00626	Naphthalene and anthracene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMT200006317	K00517	ko00903	Limonene and pinene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMT200006317	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMT200006317	K00517	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMT200006318	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMT200006318	K00517	ko00626	Naphthalene and anthracene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMT200006318	K00517	ko00903	Limonene and pinene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMT200006318	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMT200006318	K00517	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMT200006319	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006319	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006319	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006319	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006319	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006320	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006320	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006320	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006320	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006320	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMT200006323	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMT200006323	K00517	ko00626	Naphthalene and anthracene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMT200006323	K00517	ko00903	Limonene and pinene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMT200006323	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMT200006323	K00517	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMT200006325	K03040	ko00230	Purine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMT200006325	K03040	ko00240	Pyrimidine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMT200006325	K03040	ko01100	Metabolic pathways	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMT200006325	K03040	ko03020	RNA polymerase	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMT200006326	K01580	ko00250	Alanine, aspartate and glutamate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006326	K01580	ko00410	beta-Alanine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006326	K01580	ko00430	Taurine and hypotaurine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006326	K01580	ko00650	Butanoate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006326	K01580	ko01100	Metabolic pathways	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006326	K01580	ko04940	Type I diabetes mellitus	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMT200006337	K00688	ko00500	Starch and sucrose metabolism	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMT200006337	K00688	ko04910	Insulin signaling pathway	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMT200006338	K00688	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMT200006338	K00688	ko04910	Insulin signaling pathway	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMT200033528	K04120	ko00904	Diterpenoid biosynthesis	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMT200033528	K04120	ko01100	Metabolic pathways	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMT200033528	K04120	ko01110	Biosynthesis of secondary metabolites	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMT200033530	K08332	ko04140	Regulation of autophagy	449	8.4e-19	0.33	0.53	0.41
PGSC0003DMT200033538	K00788	ko00730	Thiamine metabolism	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMT200033538	K00788	ko01100	Metabolic pathways	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMT200033539	K00788	ko00730	Thiamine metabolism	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMT200033539	K00788	ko01100	Metabolic pathways	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMT200033559	K06654	ko04111	Cell cycle - yeast	311	2.6e-11	0.36	0.55	0.73
PGSC0003DMT200033560	K01784	ko00052	Galactose metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMT200033560	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMT200033560	K01784	ko01100	Metabolic pathways	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMT200012623	K12886	ko03040	Spliceosome	398	6.9e-16	0.28	0.41	0.56
PGSC0003DMT200012624	K00854	ko00040	Pentose and glucuronate interconversions	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMT200012624	K00854	ko01100	Metabolic pathways	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMT200012625	K00854	ko00040	Pentose and glucuronate interconversions	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMT200012625	K00854	ko01100	Metabolic pathways	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMT200012626	K00854	ko00040	Pentose and glucuronate interconversions	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMT200012626	K00854	ko01100	Metabolic pathways	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMT200012629	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMT200012629	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMT200012630	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMT200012630	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMT200012632	K00854	ko00040	Pentose and glucuronate interconversions	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMT200012632	K00854	ko01100	Metabolic pathways	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMT200012633	K00854	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMT200012633	K00854	ko01100	Metabolic pathways	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMT200012634	K00854	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMT200012634	K00854	ko01100	Metabolic pathways	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMT200012635	K00854	ko00040	Pentose and glucuronate interconversions	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMT200012635	K00854	ko01100	Metabolic pathways	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMT200012636	K09756	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.46	0.62	0.85
PGSC0003DMT200012637	K09756	ko00940	Phenylpropanoid biosynthesis	1448	5.0e-74	0.47	0.63	0.84
PGSC0003DMT200012641	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMT200012643	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMT200012651	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMT200012653	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMT200030415	K02134	ko00190	Oxidative phosphorylation	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMT200030415	K02134	ko01100	Metabolic pathways	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMT200030415	K02134	ko05010	Alzheimer's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMT200030415	K02134	ko05012	Parkinson's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMT200030415	K02134	ko05016	Huntington's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMT200030416	K02134	ko00190	Oxidative phosphorylation	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMT200030416	K02134	ko01100	Metabolic pathways	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMT200030416	K02134	ko05010	Alzheimer's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMT200030416	K02134	ko05012	Parkinson's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMT200030416	K02134	ko05016	Huntington's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMT200030417	K02134	ko00190	Oxidative phosphorylation	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMT200030417	K02134	ko01100	Metabolic pathways	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMT200030417	K02134	ko05010	Alzheimer's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMT200030417	K02134	ko05012	Parkinson's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMT200030417	K02134	ko05016	Huntington's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMT200030418	K01051	ko00040	Pentose and glucuronate interconversions	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMT200030418	K01051	ko00500	Starch and sucrose metabolism	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMT200030418	K01051	ko01100	Metabolic pathways	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMT200030423	K03006	ko00230	Purine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMT200030423	K03006	ko00240	Pyrimidine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMT200030423	K03006	ko01100	Metabolic pathways	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMT200030423	K03006	ko03020	RNA polymerase	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMT200030423	K03006	ko05016	Huntington's disease	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMT200030424	K00985	ko00230	Purine metabolism	534	1.3e-23	0.47	0.61	0.88
PGSC0003DMT200030430	K01859	ko00941	Flavonoid biosynthesis	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMT200030430	K01859	ko01100	Metabolic pathways	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMT200030430	K01859	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMT200040292	K03512	ko03410	Base excision repair	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMT200040292	K03512	ko03450	Non-homologous end-joining	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMT200040293	K03512	ko03410	Base excision repair	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMT200040293	K03512	ko03450	Non-homologous end-joining	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMT200040294	K11820	ko00380	Tryptophan metabolism	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMT200040294	K11820	ko00966	Glucosinolate biosynthesis	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMT200040294	K11820	ko01110	Biosynthesis of secondary metabolites	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMT200040295	K11820	ko00380	Tryptophan metabolism	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMT200040295	K11820	ko00966	Glucosinolate biosynthesis	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMT200040295	K11820	ko01110	Biosynthesis of secondary metabolites	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMT200040299	K08727	ko04621	NOD-like receptor signaling pathway	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMT200040299	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMT200040299	K08727	ko05131	Shigellosis	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMT200040300	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMT200040300	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMT200040300	K08727	ko05131	Shigellosis	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMT200040301	K12800	ko04621	NOD-like receptor signaling pathway	253	3.1e-07	0.31	0.47	0.74
PGSC0003DMT200040302	K08727	ko04621	NOD-like receptor signaling pathway	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMT200040302	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMT200040302	K08727	ko05131	Shigellosis	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMT200040303	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMT200040303	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMT200040303	K08727	ko05131	Shigellosis	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMT200040304	K04498	ko04110	Cell cycle	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04310	Wnt signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04330	Notch signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04350	TGF-beta signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04520	Adherens junction	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04630	Jak-STAT signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04720	Long-term potentiation	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko04916	Melanogenesis	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko05016	Huntington's disease	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko05200	Pathways in cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko05211	Renal cell carcinoma	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040304	K04498	ko05215	Prostate cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMT200040307	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMT200040307	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMT200040307	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMT200040307	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMT200040307	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMT200040308	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040308	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040308	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040308	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040309	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040309	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040309	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040309	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMT200040332	K10260	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.33	0.53	0.96
PGSC0003DMT200040333	K10260	ko04120	Ubiquitin mediated proteolysis	485	6.5e-21	0.28	0.47	0.68
PGSC0003DMT200070382	K11252	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.95	0.96	0.99
PGSC0003DMT200070383	K11252	ko05322	Systemic lupus erythematosus	1044	9.5e-52	0.88	0.91	0.99
PGSC0003DMT200070405	K01955	ko00240	Pyrimidine metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMT200070405	K01955	ko00250	Alanine, aspartate and glutamate metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMT200070405	K01955	ko01100	Metabolic pathways	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMT200070407	K02138	ko00190	Oxidative phosphorylation	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMT200070407	K02138	ko01100	Metabolic pathways	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMT200070407	K02138	ko05010	Alzheimer's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMT200070407	K02138	ko05012	Parkinson's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMT200070407	K02138	ko05016	Huntington's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMT200070419	K06685	ko04111	Cell cycle - yeast	343	2.0e-09	0.26	0.43	0.89
PGSC0003DMT200073239	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMT200073239	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMT200073239	K00771	ko01100	Metabolic pathways	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMT200073255	K02343	ko00230	Purine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073255	K02343	ko00240	Pyrimidine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073255	K02343	ko01100	Metabolic pathways	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073255	K02343	ko03030	DNA replication	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073255	K02343	ko03430	Mismatch repair	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073255	K02343	ko03440	Homologous recombination	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMT200073259	K10949	ko05110	Vibrio cholerae infection	1377	4.1e-70	0.82	0.92	0.76
PGSC0003DMT200073260	K10949	ko05110	Vibrio cholerae infection	1601	1.8e-82	0.86	0.94	1.00
PGSC0003DMT200073262	K01087	ko00500	Starch and sucrose metabolism	428	2.9e-17	0.69	0.80	0.88
PGSC0003DMT200073263	K01087	ko00500	Starch and sucrose metabolism	5572	1.7e-301	0.76	0.89	0.99
PGSC0003DMT200047585	K03363	ko04110	Cell cycle	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMT200047585	K03363	ko04111	Cell cycle - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMT200047585	K03363	ko04113	Meiosis - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMT200047585	K03363	ko04114	Oocyte meiosis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMT200047585	K03363	ko04120	Ubiquitin mediated proteolysis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMT200047586	K00558	ko00270	Cysteine and methionine metabolism	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMT200047586	K00558	ko01100	Metabolic pathways	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMT200047587	K00558	ko00270	Cysteine and methionine metabolism	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMT200047587	K00558	ko01100	Metabolic pathways	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMT200047588	K00558	ko00270	Cysteine and methionine metabolism	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMT200047588	K00558	ko01100	Metabolic pathways	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMT200047608	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.60
PGSC0003DMT200047609	K04631	ko04744	Phototransduction	692	2.5e-32	0.35	0.56	0.84
PGSC0003DMT200047610	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.45
PGSC0003DMT200047614	K12668	ko00510	N-Glycan biosynthesis	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMT200047614	K12668	ko01100	Metabolic pathways	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMT200047616	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMT200047616	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMT200047617	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMT200047617	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMT200080508	K13065	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMT200080508	K13065	ko00941	Flavonoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMT200080508	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMT200080508	K13065	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMT200080509	K01051	ko00040	Pentose and glucuronate interconversions	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMT200080509	K01051	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMT200080509	K01051	ko01100	Metabolic pathways	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMT200080511	K09903	ko00240	Pyrimidine metabolism	1915	8.7e-100	0.73	0.81	0.98
PGSC0003DMT200080512	K09903	ko00240	Pyrimidine metabolism	1987	9.3e-104	0.75	0.84	0.98
PGSC0003DMT200080529	K13068	ko00940	Phenylpropanoid biosynthesis	854	2.9e-41	0.32	0.51	0.95
PGSC0003DMT200080530	K05894	ko00592	alpha-Linolenic acid metabolism	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMT200080530	K05894	ko01100	Metabolic pathways	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMT200080531	K05894	ko00592	alpha-Linolenic acid metabolism	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMT200080531	K05894	ko01100	Metabolic pathways	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMT200080532	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080532	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080534	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080534	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080535	K05894	ko00592	alpha-Linolenic acid metabolism	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMT200080535	K05894	ko01100	Metabolic pathways	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMT200080536	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080536	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080537	K05894	ko00592	alpha-Linolenic acid metabolism	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMT200080537	K05894	ko01100	Metabolic pathways	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMT200080538	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080538	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMT200080542	K05894	ko00592	alpha-Linolenic acid metabolism	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMT200080542	K05894	ko01100	Metabolic pathways	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMT200080543	K05894	ko00592	alpha-Linolenic acid metabolism	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMT200080543	K05894	ko01100	Metabolic pathways	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMT200080547	K00856	ko00230	Purine metabolism	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMT200080547	K00856	ko01100	Metabolic pathways	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMT200055567	K00652	ko00780	Biotin metabolism	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMT200055567	K00652	ko01100	Metabolic pathways	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMT200055569	K00652	ko00780	Biotin metabolism	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMT200055569	K00652	ko01100	Metabolic pathways	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMT200055570	K00652	ko00780	Biotin metabolism	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMT200055570	K00652	ko01100	Metabolic pathways	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMT200055598	K06096	ko04530	Tight junction	381	3.5e-15	0.34	0.53	0.96
PGSC0003DMT200055602	K06096	ko04530	Tight junction	378	5.2e-15	0.34	0.53	0.96
PGSC0003DMT200055603	K06096	ko04530	Tight junction	359	5.8e-14	0.37	0.53	0.82
PGSC0003DMT200055606	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMT200055607	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMT200088867	K12356	ko00940	Phenylpropanoid biosynthesis	599	3.3e-27	0.38	0.57	0.67
PGSC0003DMT200088880	K04103	ko00380	Tryptophan metabolism	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMT200088880	K04103	ko01100	Metabolic pathways	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMT200088885	K13065	ko00940	Phenylpropanoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMT200088885	K13065	ko00941	Flavonoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMT200088885	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMT200088885	K13065	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMT200088887	K11251	ko05322	Systemic lupus erythematosus	503	6.6e-22	0.69	0.84	0.75
PGSC0003DMT200026890	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMT200026891	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMT200026893	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMT200043690	K03110	ko03060	Protein export	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMT200043690	K03110	ko03070	Bacterial secretion system	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMT200043692	K03110	ko03060	Protein export	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMT200043692	K03110	ko03070	Bacterial secretion system	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMT200043693	K03110	ko03060	Protein export	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMT200043693	K03110	ko03070	Bacterial secretion system	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMT200043694	K02739	ko03050	Proteasome	1821	1.3e-94	0.69	0.76	1.00
PGSC0003DMT200043695	K02739	ko03050	Proteasome	1956	4.8e-102	0.85	0.94	1.00
PGSC0003DMT200043704	K10260	ko04120	Ubiquitin mediated proteolysis	436	3.3e-18	0.29	0.48	0.62
PGSC0003DMT200043706	K03469	ko03030	DNA replication	249	6.7e-08	0.39	0.52	0.37
PGSC0003DMT200043719	K12796	ko04621	NOD-like receptor signaling pathway	419	1.2e-13	0.32	0.49	0.39
PGSC0003DMT200043720	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.88
PGSC0003DMT200043721	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.70
PGSC0003DMT200008982	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMT200009003	K02933	ko03010	Ribosome	847	7.0e-41	0.96	0.99	0.99
PGSC0003DMT200009005	K02292	ko00906	Carotenoid biosynthesis	1904	3.5e-99	0.51	0.67	0.95
PGSC0003DMT200009006	K02292	ko00906	Carotenoid biosynthesis	1617	2.4e-83	0.50	0.66	0.93
PGSC0003DMT200009007	K02292	ko00906	Carotenoid biosynthesis	260	4.4e-08	0.72	0.78	0.71
PGSC0003DMT200009008	K02292	ko00906	Carotenoid biosynthesis	1185	1.6e-59	0.52	0.67	0.99
PGSC0003DMT200009009	K02292	ko00906	Carotenoid biosynthesis	2151	8.4e-113	0.52	0.67	0.96
PGSC0003DMT200037979	K00454	ko00591	Linoleic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMT200037979	K00454	ko00592	alpha-Linolenic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMT200037979	K00454	ko01100	Metabolic pathways	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMT200037986	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMT200037986	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMT200037986	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMT200037990	K00799	ko00480	Glutathione metabolism	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMT200037990	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMT200037990	K00799	ko00982	Drug metabolism - cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMT200037994	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMT200037994	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMT200037994	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMT200037995	K00799	ko00480	Glutathione metabolism	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMT200037995	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMT200037995	K00799	ko00982	Drug metabolism - cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMT200037996	K00799	ko00480	Glutathione metabolism	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMT200037996	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMT200037996	K00799	ko00982	Drug metabolism - cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMT200038005	K01834	ko00010	Glycolysis / Gluconeogenesis	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMT200038005	K01834	ko01100	Metabolic pathways	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMT200038005	K01834	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMT200038006	K01834	ko00010	Glycolysis / Gluconeogenesis	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMT200038006	K01834	ko01100	Metabolic pathways	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMT200038006	K01834	ko01110	Biosynthesis of secondary metabolites	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMT200038021	K08139	ko04113	Meiosis - yeast	596	4.9e-27	0.40	0.62	0.87
PGSC0003DMT200026753	K01092	ko00521	Streptomycin biosynthesis	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMT200026753	K01092	ko00562	Inositol phosphate metabolism	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMT200026753	K01092	ko01100	Metabolic pathways	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMT200026753	K01092	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMT200026753	K01092	ko04070	Phosphatidylinositol signaling system	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMT200026755	K01092	ko00521	Streptomycin biosynthesis	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMT200026755	K01092	ko00562	Inositol phosphate metabolism	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMT200026755	K01092	ko01100	Metabolic pathways	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMT200026755	K01092	ko01110	Biosynthesis of secondary metabolites	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMT200026755	K01092	ko04070	Phosphatidylinositol signaling system	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMT200026756	K01092	ko00521	Streptomycin biosynthesis	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMT200026756	K01092	ko00562	Inositol phosphate metabolism	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMT200026756	K01092	ko01100	Metabolic pathways	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMT200026756	K01092	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMT200026756	K01092	ko04070	Phosphatidylinositol signaling system	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMT200026761	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMT200026761	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMT200043836	K00029	ko00620	Pyruvate metabolism	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMT200043836	K00029	ko00710	Carbon fixation in photosynthetic organisms	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMT200043836	K00029	ko01100	Metabolic pathways	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMT200043866	K10802	ko03410	Base excision repair	362	3.9e-14	0.44	0.62	0.81
PGSC0003DMT200043867	K10802	ko03410	Base excision repair	357	7.4e-14	0.44	0.64	0.81
PGSC0003DMT200043872	K12879	ko03040	Spliceosome	1115	5.4e-55	0.60	0.74	0.84
PGSC0003DMT200043873	K06671	ko04110	Cell cycle	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMT200043873	K06671	ko04111	Cell cycle - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMT200043873	K06671	ko04113	Meiosis - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMT200043875	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043875	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043875	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043876	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043876	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200043876	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMT200009177	K00908	ko01100	Metabolic pathways	3402	8.4e-182	0.80	0.89	0.89
PGSC0003DMT200009178	K00908	ko01100	Metabolic pathways	2377	2.9e-125	0.82	0.89	0.85
PGSC0003DMT200009188	K00908	ko01100	Metabolic pathways	807	1.1e-38	0.74	0.87	0.97
PGSC0003DMT200009192	K02641	ko00195	Photosynthesis	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMT200009192	K02641	ko01100	Metabolic pathways	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMT200009194	K02641	ko00195	Photosynthesis	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMT200009194	K02641	ko01100	Metabolic pathways	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMT200009214	K03029	ko03050	Proteasome	2477	8.7e-131	0.73	0.81	1.00
PGSC0003DMT200009215	K03029	ko03050	Proteasome	2807	5.5e-149	0.84	0.92	0.99
PGSC0003DMT200009216	K12311	ko00511	Other glycan degradation	6430	0.	0.74	0.85	1.00
PGSC0003DMT200009216	K12311	ko04142	Lysosome	6430	0.	0.74	0.85	1.00
PGSC0003DMT200018919	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018919	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018919	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018920	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018920	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018920	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMT200018921	K02958	ko03010	Ribosome	1208	8.6e-61	0.93	0.97	0.99
PGSC0003DMT200018925	K12275	ko03060	Protein export	2116	7.1e-111	0.72	0.80	0.99
PGSC0003DMT200018926	K12275	ko03060	Protein export	2216	2.2e-116	0.75	0.84	0.99
PGSC0003DMT200018927	K05666	ko02010	ABC transporters	2779	1.9e-147	0.35	0.56	0.89
PGSC0003DMT200018938	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMT200018938	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMT200018938	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMT200018938	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMT200018938	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMT200018940	K06685	ko04111	Cell cycle - yeast	490	1.3e-17	0.26	0.41	0.86
PGSC0003DMT200018946	K00655	ko00561	Glycerolipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMT200018946	K00655	ko00564	Glycerophospholipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMT200018946	K00655	ko01100	Metabolic pathways	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMT200018947	K00655	ko00561	Glycerolipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMT200018947	K00655	ko00564	Glycerophospholipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMT200018947	K00655	ko01100	Metabolic pathways	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMT200018948	K00655	ko00561	Glycerolipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMT200018948	K00655	ko00564	Glycerophospholipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMT200018948	K00655	ko01100	Metabolic pathways	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMT200018949	K00655	ko00561	Glycerolipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMT200018949	K00655	ko00564	Glycerophospholipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMT200018949	K00655	ko01100	Metabolic pathways	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMT200018950	K00655	ko00561	Glycerolipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMT200018950	K00655	ko00564	Glycerophospholipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMT200018950	K00655	ko01100	Metabolic pathways	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMT200018957	K01582	ko00310	Lysine degradation	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMT200018957	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMT200018957	K01582	ko01100	Metabolic pathways	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMT200018957	K01582	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMT200018958	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMT200018959	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMT200018960	K08064	ko04612	Antigen processing and presentation	375	7.6e-15	0.59	0.75	0.54
PGSC0003DMT200018961	K05666	ko02010	ABC transporters	2307	2.1e-121	0.34	0.55	0.88
PGSC0003DMT200018971	K05666	ko02010	ABC transporters	1627	6.7e-84	0.41	0.66	0.96
PGSC0003DMT200088362	K00657	ko00330	Arginine and proline metabolism	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMT200088362	K00657	ko01100	Metabolic pathways	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMT200073069	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200073069	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMT200073070	K10956	ko03060	Protein export	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMT200073070	K10956	ko04145	Phagosome	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMT200073070	K10956	ko05110	Vibrio cholerae infection	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMT200073071	K06636	ko04110	Cell cycle	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMT200073071	K06636	ko04111	Cell cycle - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMT200073071	K06636	ko04113	Meiosis - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMT200073071	K06636	ko04114	Oocyte meiosis	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMT200073081	K12857	ko03040	Spliceosome	254	6.1e-07	0.29	0.47	0.50
PGSC0003DMT200073091	K03083	ko04012	ErbB signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04062	Chemokine signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04110	Cell cycle	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04310	Wnt signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04340	Hedgehog signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04360	Axon guidance	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04510	Focal adhesion	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04660	T cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04662	B cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04711	Circadian rhythm - fly	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04722	Neurotrophin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04910	Insulin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko04916	Melanogenesis	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05010	Alzheimer's disease	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05200	Pathways in cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05210	Colorectal cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05213	Endometrial cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05215	Prostate cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073091	K03083	ko05217	Basal cell carcinoma	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMT200073095	K03015	ko00230	Purine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMT200073095	K03015	ko00240	Pyrimidine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMT200073095	K03015	ko01100	Metabolic pathways	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMT200073095	K03015	ko03020	RNA polymerase	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMT200073095	K03015	ko05016	Huntington's disease	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMT200055784	K08726	ko00590	Arachidonic acid metabolism	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMT200055784	K08726	ko00625	Tetrachloroethene degradation	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMT200055784	K08726	ko01100	Metabolic pathways	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMT200055784	K08726	ko04146	Peroxisome	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMT200055785	K08726	ko00590	Arachidonic acid metabolism	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMT200055785	K08726	ko00625	Tetrachloroethene degradation	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMT200055785	K08726	ko01100	Metabolic pathways	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMT200055785	K08726	ko04146	Peroxisome	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMT200055794	K03885	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.71	0.84	0.94
PGSC0003DMT200055795	K03885	ko00190	Oxidative phosphorylation	864	8.1e-42	0.82	0.89	0.98
PGSC0003DMT200055796	K03885	ko00190	Oxidative phosphorylation	3718	3.1e-199	0.75	0.87	0.99
PGSC0003DMT200055797	K03885	ko00190	Oxidative phosphorylation	585	2.0e-26	0.79	0.85	0.86
PGSC0003DMT200065512	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMT200065512	K01637	ko01100	Metabolic pathways	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMT200065513	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMT200065513	K01637	ko01100	Metabolic pathways	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMT200065516	K00430	ko00360	Phenylalanine metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMT200065516	K00430	ko00680	Methane metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMT200065516	K00430	ko00940	Phenylpropanoid biosynthesis	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMT200065516	K00430	ko01100	Metabolic pathways	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMT200065516	K00430	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMT200065517	K00430	ko00360	Phenylalanine metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMT200065517	K00430	ko00680	Methane metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMT200065517	K00430	ko00940	Phenylpropanoid biosynthesis	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMT200065517	K00430	ko01100	Metabolic pathways	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMT200065517	K00430	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMT200065518	K00430	ko00360	Phenylalanine metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMT200065518	K00430	ko00680	Methane metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMT200065518	K00430	ko00940	Phenylpropanoid biosynthesis	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMT200065518	K00430	ko01100	Metabolic pathways	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMT200065518	K00430	ko01110	Biosynthesis of secondary metabolites	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMT200065519	K08486	ko04130	SNARE interactions in vesicular transport	1880	7.4e-98	0.73	0.85	1.00
PGSC0003DMT200065520	K08486	ko04130	SNARE interactions in vesicular transport	1541	3.7e-79	0.81	0.92	0.99
PGSC0003DMT200052738	K02109	ko00190	Oxidative phosphorylation	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMT200052738	K02109	ko00195	Photosynthesis	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMT200052738	K02109	ko01100	Metabolic pathways	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMT200052739	K09755	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMT200052739	K09755	ko01100	Metabolic pathways	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMT200052739	K09755	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMT200052740	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMT200052740	K00517	ko00626	Naphthalene and anthracene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMT200052740	K00517	ko00903	Limonene and pinene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMT200052740	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMT200052740	K00517	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMT200052743	K11229	ko04011	MAPK signaling pathway - yeast	556	6.3e-24	0.34	0.51	0.88
PGSC0003DMT200052746	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMT200052746	K00224	ko00364	Fluorobenzoate degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMT200052746	K00224	ko00628	Fluorene degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMT200052746	K00224	ko00640	Propanoate metabolism	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMT200052749	K01179	ko00500	Starch and sucrose metabolism	2709	1.4e-143	0.69	0.80	0.93
PGSC0003DMT200052757	K12812	ko03040	Spliceosome	3442	5.2e-184	0.94	0.98	1.00
PGSC0003DMT200052758	K12812	ko03040	Spliceosome	2787	7.0e-148	0.96	0.98	1.00
PGSC0003DMT200052777	K02109	ko00190	Oxidative phosphorylation	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMT200052777	K02109	ko00195	Photosynthesis	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMT200052777	K02109	ko01100	Metabolic pathways	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMT200052780	K01046	ko00561	Glycerolipid metabolism	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMT200052780	K01046	ko01100	Metabolic pathways	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMT200012398	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMT200012399	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMT200012400	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMT200012404	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMT200012405	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMT200012415	K03868	ko03420	Nucleotide excision repair	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04110	Cell cycle	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04111	Cell cycle - yeast	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04114	Oocyte meiosis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04120	Ubiquitin mediated proteolysis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04310	Wnt signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04350	TGF-beta signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko04710	Circadian rhythm - mammal	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko05200	Pathways in cancer	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012415	K03868	ko05211	Renal cell carcinoma	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMT200012419	K12620	ko03018	RNA degradation	665	7.6e-31	0.80	0.88	0.22
PGSC0003DMT200012424	K12620	ko03018	RNA degradation	969	1.3e-47	0.91	0.96	0.99
PGSC0003DMT200012434	K04554	ko04120	Ubiquitin mediated proteolysis	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMT200012434	K04554	ko05012	Parkinson's disease	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMT200012435	K04554	ko04120	Ubiquitin mediated proteolysis	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMT200012435	K04554	ko05012	Parkinson's disease	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMT200012436	K04554	ko04120	Ubiquitin mediated proteolysis	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMT200012436	K04554	ko05012	Parkinson's disease	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMT200030538	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMT200030539	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMT200030563	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMT200030564	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMT200030565	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMT200024014	K10526	ko00592	alpha-Linolenic acid metabolism	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMT200024014	K10526	ko01100	Metabolic pathways	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMT200024015	K10526	ko00592	alpha-Linolenic acid metabolism	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMT200024015	K10526	ko01100	Metabolic pathways	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMT200024018	K05339	ko02020	Two-component system	297	1.5e-10	0.34	0.54	0.39
PGSC0003DMT200024020	K04428	ko04010	MAPK signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMT200024020	K04428	ko04912	GnRH signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMT200024024	K08866	ko04110	Cell cycle	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMT200024024	K08866	ko04111	Cell cycle - yeast	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMT200024028	K12189	ko04144	Endocytosis	1374	6.0e-70	0.88	0.96	0.99
PGSC0003DMT200024029	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMT200024030	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMT200024031	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMT200024032	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMT200024039	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMT200024040	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMT200015557	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMT200015557	K00517	ko00626	Naphthalene and anthracene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMT200015557	K00517	ko00903	Limonene and pinene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMT200015557	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMT200015557	K00517	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMT200015558	K05280	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMT200015558	K05280	ko00944	Flavone and flavonol biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMT200015558	K05280	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMT200015558	K05280	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMT200015560	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMT200015560	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMT200015560	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMT200015560	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMT200015560	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMT200015561	K05280	ko00941	Flavonoid biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMT200015561	K05280	ko00944	Flavone and flavonol biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMT200015561	K05280	ko01100	Metabolic pathways	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMT200015561	K05280	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMT200015562	K07424	ko00140	Steroid hormone biosynthesis	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00591	Linoleic acid metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00830	Retinol metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00982	Drug metabolism - cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko00983	Drug metabolism - other enzymes	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015562	K07424	ko01100	Metabolic pathways	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMT200015563	K07424	ko00140	Steroid hormone biosynthesis	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00591	Linoleic acid metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00830	Retinol metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00982	Drug metabolism - cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko00983	Drug metabolism - other enzymes	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015563	K07424	ko01100	Metabolic pathways	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMT200015564	K07424	ko00140	Steroid hormone biosynthesis	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00591	Linoleic acid metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00830	Retinol metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00982	Drug metabolism - cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko00983	Drug metabolism - other enzymes	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015564	K07424	ko01100	Metabolic pathways	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMT200015565	K07424	ko00140	Steroid hormone biosynthesis	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00591	Linoleic acid metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00830	Retinol metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00982	Drug metabolism - cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko00983	Drug metabolism - other enzymes	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015565	K07424	ko01100	Metabolic pathways	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMT200015574	K00873	ko00010	Glycolysis / Gluconeogenesis	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko00230	Purine metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko00620	Pyruvate metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko00710	Carbon fixation in photosynthetic organisms	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko01100	Metabolic pathways	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015574	K00873	ko04930	Type II diabetes mellitus	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMT200015585	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMT200015585	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMT200015586	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMT200015586	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMT200040177	K08008	ko04145	Phagosome	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMT200040177	K08008	ko04670	Leukocyte transendothelial migration	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMT200040178	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMT200040178	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMT200040179	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMT200040179	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMT200040182	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200040185	K04733	ko04210	Apoptosis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMT200040185	K04733	ko04620	Toll-like receptor signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMT200040185	K04733	ko04722	Neurotrophin signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMT200040185	K04733	ko05140	Leishmaniasis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMT200040185	K04733	ko05142	Chagas disease	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMT200040186	K00430	ko00360	Phenylalanine metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMT200040186	K00430	ko00680	Methane metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMT200040186	K00430	ko00940	Phenylpropanoid biosynthesis	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMT200040186	K00430	ko01100	Metabolic pathways	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMT200040186	K00430	ko01110	Biosynthesis of secondary metabolites	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMT200040199	K00660	ko00941	Flavonoid biosynthesis	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMT200040199	K00660	ko01100	Metabolic pathways	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMT200040199	K00660	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMT200040199	K00660	ko04712	Circadian rhythm - plant	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMT200040200	K07195	ko04910	Insulin signaling pathway	2046	5.2e-107	0.47	0.64	0.99
PGSC0003DMT200040201	K07195	ko04910	Insulin signaling pathway	1905	3.1e-99	0.51	0.67	0.88
PGSC0003DMT200091268	K01366	ko04142	Lysosome	418	3.2e-17	0.35	0.51	0.80
PGSC0003DMT200091271	K10760	ko00908	Zeatin biosynthesis	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMT200091271	K10760	ko01100	Metabolic pathways	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMT200091271	K10760	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMT200091294	K11433	ko00310	Lysine degradation	227	1.1e-06	0.30	0.44	0.69
PGSC0003DMT200093449	K08506	ko04130	SNARE interactions in vesicular transport	261	1.5e-08	0.38	0.44	0.99
PGSC0003DMT200086770	K03094	ko04110	Cell cycle	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04111	Cell cycle - yeast	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04114	Oocyte meiosis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04120	Ubiquitin mediated proteolysis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04310	Wnt signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04350	TGF-beta signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086770	K03094	ko04710	Circadian rhythm - mammal	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMT200086792	K06544	ko04514	Cell adhesion molecules (CAMs)	302	8.0e-11	0.27	0.55	0.96
PGSC0003DMT200066997	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066997	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200066999	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMT200067001	K01074	ko00062	Fatty acid elongation in mitochondria	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMT200067001	K01074	ko01100	Metabolic pathways	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMT200067001	K01074	ko04142	Lysosome	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMT200067002	K01074	ko00062	Fatty acid elongation in mitochondria	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMT200067002	K01074	ko01100	Metabolic pathways	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMT200067002	K01074	ko04142	Lysosome	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMT200067003	K01074	ko00062	Fatty acid elongation in mitochondria	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMT200067003	K01074	ko01100	Metabolic pathways	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMT200067003	K01074	ko04142	Lysosome	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMT200067004	K01074	ko00062	Fatty acid elongation in mitochondria	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMT200067004	K01074	ko01100	Metabolic pathways	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMT200067004	K01074	ko04142	Lysosome	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMT200067005	K01074	ko00062	Fatty acid elongation in mitochondria	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMT200067005	K01074	ko01100	Metabolic pathways	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMT200067005	K01074	ko04142	Lysosome	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMT200058754	K12132	ko04712	Circadian rhythm - plant	1034	3.4e-51	0.48	0.67	0.85
PGSC0003DMT200058757	K04712	ko00600	Sphingolipid metabolism	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMT200058757	K04712	ko01100	Metabolic pathways	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMT200058775	K10352	ko04530	Tight junction	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMT200058775	K10352	ko05416	Viral myocarditis	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMT200058778	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200013831	K05395	ko00270	Cysteine and methionine metabolism	491	3.0e-21	0.46	0.59	0.86
PGSC0003DMT200013832	K05395	ko00270	Cysteine and methionine metabolism	486	5.7e-21	0.47	0.61	0.92
PGSC0003DMT200013884	K06671	ko04110	Cell cycle	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMT200013884	K06671	ko04111	Cell cycle - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMT200013884	K06671	ko04113	Meiosis - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMT200013886	K07203	ko04012	ErbB signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko04150	mTOR signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko04910	Insulin signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko04920	Adipocytokine signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko04930	Type II diabetes mellitus	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko05200	Pathways in cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko05214	Glioma	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko05215	Prostate cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200013886	K07203	ko05221	Acute myeloid leukemia	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMT200022276	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2405	8.2e-127	0.75	0.84	1.00
PGSC0003DMT200022286	K01955	ko00240	Pyrimidine metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMT200022286	K01955	ko00250	Alanine, aspartate and glutamate metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMT200022286	K01955	ko01100	Metabolic pathways	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMT200022287	K05278	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMT200022287	K05278	ko01100	Metabolic pathways	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMT200022287	K05278	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMT200022301	K04392	ko04010	MAPK signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04062	Chemokine signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04145	Phagosome	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04310	Wnt signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04360	Axon guidance	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04370	VEGF signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04510	Focal adhesion	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04520	Adherens junction	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04620	Toll-like receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04650	Natural killer cell mediated cytotoxicity	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04662	B cell receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04664	Fc epsilon RI signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04666	Fc gamma R-mediated phagocytosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04670	Leukocyte transendothelial migration	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04722	Neurotrophin signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko04810	Regulation of actin cytoskeleton	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05100	Bacterial invasion of epithelial cells	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05131	Shigellosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05200	Pathways in cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05210	Colorectal cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05211	Renal cell carcinoma	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05212	Pancreatic cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022301	K04392	ko05416	Viral myocarditis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMT200022302	K04392	ko04010	MAPK signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04062	Chemokine signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04145	Phagosome	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04310	Wnt signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04360	Axon guidance	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04370	VEGF signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04510	Focal adhesion	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04520	Adherens junction	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04620	Toll-like receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04650	Natural killer cell mediated cytotoxicity	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04662	B cell receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04664	Fc epsilon RI signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04666	Fc gamma R-mediated phagocytosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04670	Leukocyte transendothelial migration	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04722	Neurotrophin signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko04810	Regulation of actin cytoskeleton	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05100	Bacterial invasion of epithelial cells	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05131	Shigellosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05200	Pathways in cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05210	Colorectal cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05211	Renal cell carcinoma	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05212	Pancreatic cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022302	K04392	ko05416	Viral myocarditis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMT200022304	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022304	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022304	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022305	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022305	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022305	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022306	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022306	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022306	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022307	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022307	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022307	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022308	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022308	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022308	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMT200022310	K07191	ko04910	Insulin signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMT200022310	K07191	ko04920	Adipocytokine signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMT200022310	K07191	ko04930	Type II diabetes mellitus	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMT200022311	K07191	ko04910	Insulin signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMT200022311	K07191	ko04920	Adipocytokine signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMT200022311	K07191	ko04930	Type II diabetes mellitus	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMT200041980	K10886	ko03450	Non-homologous end-joining	522	5.9e-23	0.51	0.71	0.98
PGSC0003DMT200041981	K10886	ko03450	Non-homologous end-joining	1258	1.5e-63	0.65	0.77	0.90
PGSC0003DMT200041982	K08486	ko04130	SNARE interactions in vesicular transport	2053	2.1e-107	0.81	0.90	1.00
PGSC0003DMT200041987	K13229	ko00402	Benzoxazinoid biosynthesis	1147	2.0e-57	0.43	0.62	0.99
PGSC0003DMT200041989	K13229	ko00402	Benzoxazinoid biosynthesis	1224	1.1e-61	0.44	0.65	0.99
PGSC0003DMT200041991	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.20
PGSC0003DMT200041993	K13229	ko00402	Benzoxazinoid biosynthesis	800	2.7e-38	0.51	0.71	0.85
PGSC0003DMT200041996	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041996	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMT200041998	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041998	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMT200041999	K06269	ko04113	Meiosis - yeast	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04114	Oocyte meiosis	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04270	Vascular smooth muscle contraction	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04510	Focal adhesion	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04720	Long-term potentiation	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04810	Regulation of actin cytoskeleton	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200041999	K06269	ko04910	Insulin signaling pathway	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMT200057400	K01051	ko00040	Pentose and glucuronate interconversions	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMT200057400	K01051	ko00500	Starch and sucrose metabolism	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMT200057400	K01051	ko01100	Metabolic pathways	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMT200057418	K01126	ko00564	Glycerophospholipid metabolism	455	5.1e-19	0.29	0.51	0.43
PGSC0003DMT200057420	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMT200057421	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMT200057422	K03131	ko03022	Basal transcription factors	3141	2.1e-167	0.68	0.80	1.00
PGSC0003DMT200057423	K08503	ko04130	SNARE interactions in vesicular transport	1360	3.5e-69	0.70	0.85	1.00
PGSC0003DMT200057424	K12199	ko04144	Endocytosis	2502	3.7e-132	0.71	0.80	1.00
PGSC0003DMT200057425	K12199	ko04144	Endocytosis	1213	4.5e-61	0.65	0.76	0.98
PGSC0003DMT200057436	K12477	ko04144	Endocytosis	655	2.7e-30	0.50	0.69	0.95
PGSC0003DMT200074912	K03935	ko00190	Oxidative phosphorylation	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMT200074912	K03935	ko01100	Metabolic pathways	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMT200074912	K03935	ko05010	Alzheimer's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMT200074912	K03935	ko05012	Parkinson's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMT200074912	K03935	ko05016	Huntington's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMT200074914	K03935	ko00190	Oxidative phosphorylation	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMT200074914	K03935	ko01100	Metabolic pathways	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMT200074914	K03935	ko05010	Alzheimer's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMT200074914	K03935	ko05012	Parkinson's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMT200074914	K03935	ko05016	Huntington's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMT200074916	K01696	ko00260	Glycine, serine and threonine metabolism	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMT200074916	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMT200074916	K01696	ko01100	Metabolic pathways	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMT200074916	K01696	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMT200074929	K02866	ko03010	Ribosome	806	1.3e-38	0.47	0.64	0.79
PGSC0003DMT200085575	K12881	ko03040	Spliceosome	1114	1.3e-55	0.72	0.79	0.87
PGSC0003DMT200060554	K12741	ko03040	Spliceosome	1187	1.2e-59	0.40	0.56	0.98
PGSC0003DMT200060556	K12462	ko04722	Neurotrophin signaling pathway	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMT200060556	K12462	ko04962	Vasopressin-regulated water reabsorption	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMT200060604	K00558	ko00270	Cysteine and methionine metabolism	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMT200060604	K00558	ko01100	Metabolic pathways	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMT200068649	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMT200068651	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMT200068652	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMT200068654	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMT200068664	K01640	ko00072	Synthesis and degradation of ketone bodies	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko00280	Valine, leucine and isoleucine degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko00281	Geraniol degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko00650	Butanoate metabolism	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko01100	Metabolic pathways	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068664	K01640	ko04146	Peroxisome	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMT200068665	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMT200068666	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMT200068667	K01640	ko00072	Synthesis and degradation of ketone bodies	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko00280	Valine, leucine and isoleucine degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko00281	Geraniol degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko00650	Butanoate metabolism	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko01100	Metabolic pathways	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068667	K01640	ko04146	Peroxisome	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMT200068668	K01640	ko00072	Synthesis and degradation of ketone bodies	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko00280	Valine, leucine and isoleucine degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko00281	Geraniol degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko00650	Butanoate metabolism	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko01100	Metabolic pathways	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068668	K01640	ko04146	Peroxisome	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMT200068669	K01640	ko00072	Synthesis and degradation of ketone bodies	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko00280	Valine, leucine and isoleucine degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko00281	Geraniol degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko00650	Butanoate metabolism	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko01100	Metabolic pathways	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068669	K01640	ko04146	Peroxisome	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMT200068670	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMT200068681	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.72
PGSC0003DMT200068682	K09866	ko04962	Vasopressin-regulated water reabsorption	456	2.6e-19	0.35	0.54	0.87
PGSC0003DMT200068683	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.71
PGSC0003DMT200089563	K03133	ko03022	Basal transcription factors	335	1.2e-12	0.62	0.74	0.72
PGSC0003DMT200028615	K08269	ko04140	Regulation of autophagy	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMT200028615	K08269	ko04150	mTOR signaling pathway	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMT200028616	K08269	ko04140	Regulation of autophagy	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMT200028616	K08269	ko04150	mTOR signaling pathway	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMT200028617	K08269	ko04140	Regulation of autophagy	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMT200028617	K08269	ko04150	mTOR signaling pathway	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMT200028618	K00799	ko00480	Glutathione metabolism	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMT200028618	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMT200028618	K00799	ko00982	Drug metabolism - cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMT200028619	K00799	ko00480	Glutathione metabolism	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMT200028619	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMT200028619	K00799	ko00982	Drug metabolism - cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMT200028621	K04714	ko00600	Sphingolipid metabolism	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMT200028621	K04714	ko01100	Metabolic pathways	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMT200028629	K00368	ko00910	Nitrogen metabolism	1703	4.3e-88	0.45	0.60	0.89
PGSC0003DMT200028640	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200028640	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200028640	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200028640	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200028640	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200028640	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMT200020843	K02736	ko03050	Proteasome	1888	2.7e-98	0.89	0.96	1.00
PGSC0003DMT200020845	K02736	ko03050	Proteasome	495	1.8e-21	0.92	1.00	0.77
PGSC0003DMT200020857	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMT200020857	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMT200020858	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMT200020858	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMT200020871	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMT200010866	K01641	ko00072	Synthesis and degradation of ketone bodies	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010866	K01641	ko00280	Valine, leucine and isoleucine degradation	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010866	K01641	ko00650	Butanoate metabolism	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010866	K01641	ko00900	Terpenoid backbone biosynthesis	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010866	K01641	ko01100	Metabolic pathways	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010866	K01641	ko01110	Biosynthesis of secondary metabolites	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMT200010871	K12307	ko04142	Lysosome	349	2.3e-11	0.25	0.46	0.60
PGSC0003DMT200010872	K12307	ko04142	Lysosome	351	1.6e-11	0.25	0.46	0.60
PGSC0003DMT200010873	K12307	ko04142	Lysosome	351	2.4e-12	0.25	0.46	0.84
PGSC0003DMT200010874	K12307	ko04142	Lysosome	347	3.1e-11	0.24	0.45	0.60
PGSC0003DMT200010875	K12307	ko04142	Lysosome	349	3.7e-12	0.25	0.46	0.84
PGSC0003DMT200007987	K05933	ko00270	Cysteine and methionine metabolism	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMT200007987	K05933	ko01110	Biosynthesis of secondary metabolites	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMT200007990	K05277	ko00941	Flavonoid biosynthesis	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMT200007990	K05277	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMT200007990	K05277	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMT200007992	K05278	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMT200007992	K05278	ko01100	Metabolic pathways	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMT200007992	K05278	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMT200007993	K05278	ko00941	Flavonoid biosynthesis	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMT200007993	K05278	ko01100	Metabolic pathways	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMT200007993	K05278	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMT200007999	K05278	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMT200007999	K05278	ko01100	Metabolic pathways	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMT200007999	K05278	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMT200008000	K05278	ko00941	Flavonoid biosynthesis	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMT200008000	K05278	ko01100	Metabolic pathways	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMT200008000	K05278	ko01110	Biosynthesis of secondary metabolites	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMT200008001	K05278	ko00941	Flavonoid biosynthesis	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMT200008001	K05278	ko01100	Metabolic pathways	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMT200008001	K05278	ko01110	Biosynthesis of secondary metabolites	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMT200008002	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMT200008002	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMT200008002	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMT200008004	K05277	ko00941	Flavonoid biosynthesis	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMT200008004	K05277	ko01100	Metabolic pathways	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMT200008004	K05277	ko01110	Biosynthesis of secondary metabolites	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMT200008005	K05278	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMT200008005	K05278	ko01100	Metabolic pathways	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMT200008005	K05278	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMT200008006	K05278	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMT200008006	K05278	ko01100	Metabolic pathways	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMT200008006	K05278	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMT200008007	K05278	ko00941	Flavonoid biosynthesis	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMT200008007	K05278	ko01100	Metabolic pathways	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMT200008007	K05278	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMT200008009	K05278	ko00941	Flavonoid biosynthesis	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMT200008009	K05278	ko01100	Metabolic pathways	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMT200008009	K05278	ko01110	Biosynthesis of secondary metabolites	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMT200008011	K04124	ko00904	Diterpenoid biosynthesis	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMT200008011	K04124	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMT200008016	K04124	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMT200008016	K04124	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMT200008019	K04124	ko00904	Diterpenoid biosynthesis	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMT200008019	K04124	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMT200008024	K00064	ko00053	Ascorbate and aldarate metabolism	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMT200008024	K00064	ko01100	Metabolic pathways	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMT200008024	K00064	ko01110	Biosynthesis of secondary metabolites	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMT200008025	K00064	ko00053	Ascorbate and aldarate metabolism	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMT200008025	K00064	ko01100	Metabolic pathways	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMT200008025	K00064	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMT200008027	K01507	ko00190	Oxidative phosphorylation	796	4.5e-38	0.69	0.75	0.67
PGSC0003DMT200071330	K01803	ko00010	Glycolysis / Gluconeogenesis	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071330	K01803	ko00051	Fructose and mannose metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071330	K01803	ko00562	Inositol phosphate metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071330	K01803	ko00710	Carbon fixation in photosynthetic organisms	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071330	K01803	ko01100	Metabolic pathways	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071330	K01803	ko01110	Biosynthesis of secondary metabolites	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMT200071331	K05692	ko04145	Phagosome	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04510	Focal adhesion	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04520	Adherens junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04530	Tight junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04670	Leukocyte transendothelial migration	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04745	Phototransduction - fly	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko04810	Regulation of actin cytoskeleton	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05100	Bacterial invasion of epithelial cells	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05110	Vibrio cholerae infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05130	Pathogenic Escherichia coli infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05131	Shigellosis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05414	Dilated cardiomyopathy	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071331	K05692	ko05416	Viral myocarditis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMT200071337	K03283	ko03040	Spliceosome	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMT200071337	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMT200071337	K03283	ko04144	Endocytosis	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMT200071337	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMT200071339	K05765	ko04360	Axon guidance	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMT200071339	K05765	ko04666	Fc gamma R-mediated phagocytosis	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMT200071339	K05765	ko04810	Regulation of actin cytoskeleton	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMT200071343	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMT200071343	K00517	ko00626	Naphthalene and anthracene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMT200071343	K00517	ko00903	Limonene and pinene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMT200071343	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMT200071343	K00517	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMT200071364	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMT200088063	K07424	ko00140	Steroid hormone biosynthesis	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00591	Linoleic acid metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00830	Retinol metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00982	Drug metabolism - cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko00983	Drug metabolism - other enzymes	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088063	K07424	ko01100	Metabolic pathways	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMT200088079	K03094	ko04110	Cell cycle	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04111	Cell cycle - yeast	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04114	Oocyte meiosis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04120	Ubiquitin mediated proteolysis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04310	Wnt signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04350	TGF-beta signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088079	K03094	ko04710	Circadian rhythm - mammal	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMT200088084	K12493	ko04144	Endocytosis	658	6.1e-30	0.41	0.59	0.69
PGSC0003DMT200063828	K00430	ko00360	Phenylalanine metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMT200063828	K00430	ko00680	Methane metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMT200063828	K00430	ko00940	Phenylpropanoid biosynthesis	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMT200063828	K00430	ko01100	Metabolic pathways	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMT200063828	K00430	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMT200063833	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMT200063833	K02367	ko01100	Metabolic pathways	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMT200063857	K04420	ko04010	MAPK signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMT200063857	K04420	ko04540	Gap junction	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMT200063857	K04420	ko04912	GnRH signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMT200063858	K04421	ko04010	MAPK signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMT200063858	K04421	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMT200063858	K04421	ko04912	GnRH signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMT200053987	K12338	ko00942	Anthocyanin biosynthesis	280	1.3e-09	0.55	0.76	0.91
PGSC0003DMT200054003	K00679	ko00561	Glycerolipid metabolism	1118	7.9e-56	0.35	0.50	0.96
PGSC0003DMT200054004	K00679	ko00561	Glycerolipid metabolism	1285	4.9e-65	0.37	0.52	0.87
PGSC0003DMT200054019	K01199	ko00500	Starch and sucrose metabolism	280	1.3e-09	0.36	0.63	0.44
PGSC0003DMT200066601	K01966	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMT200066601	K01966	ko00640	Propanoate metabolism	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMT200066601	K01966	ko01100	Metabolic pathways	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMT200066602	K01966	ko00280	Valine, leucine and isoleucine degradation	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMT200066602	K01966	ko00640	Propanoate metabolism	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMT200066602	K01966	ko01100	Metabolic pathways	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMT200066603	K09054	ko05010	Alzheimer's disease	259	4.8e-06	0.34	0.50	0.41
PGSC0003DMT200066610	K02183	ko04020	Calcium signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04070	Phosphatidylinositol signaling system	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04114	Oocyte meiosis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04270	Vascular smooth muscle contraction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04626	Plant-pathogen interaction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04720	Long-term potentiation	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04722	Neurotrophin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04740	Olfactory transduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04744	Phototransduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04745	Phototransduction - fly	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04910	Insulin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04912	GnRH signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04916	Melanogenesis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04970	Salivary secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko04971	Gastric acid secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko05010	Alzheimer's disease	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066610	K02183	ko05214	Glioma	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMT200066624	K13289	ko04142	Lysosome	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMT200066624	K13289	ko04614	Renin-angiotensin system	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMT200066625	K13289	ko04142	Lysosome	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMT200066625	K13289	ko04614	Renin-angiotensin system	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMT200066626	K13289	ko04142	Lysosome	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMT200066626	K13289	ko04614	Renin-angiotensin system	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMT200066627	K13289	ko04142	Lysosome	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMT200066627	K13289	ko04614	Renin-angiotensin system	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMT200066628	K13289	ko04142	Lysosome	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMT200066628	K13289	ko04614	Renin-angiotensin system	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMT200066630	K13289	ko04142	Lysosome	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMT200066630	K13289	ko04614	Renin-angiotensin system	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMT200066638	K13289	ko04142	Lysosome	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMT200066638	K13289	ko04614	Renin-angiotensin system	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMT200066639	K13289	ko04142	Lysosome	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMT200066639	K13289	ko04614	Renin-angiotensin system	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMT200066640	K13289	ko04142	Lysosome	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMT200066640	K13289	ko04614	Renin-angiotensin system	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMT200066643	K13289	ko04142	Lysosome	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMT200066643	K13289	ko04614	Renin-angiotensin system	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMT200047917	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMT200047917	K00814	ko00710	Carbon fixation in photosynthetic organisms	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMT200047917	K00814	ko01100	Metabolic pathways	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMT200047918	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMT200047918	K00814	ko00710	Carbon fixation in photosynthetic organisms	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMT200047918	K00814	ko01100	Metabolic pathways	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMT200047920	K00430	ko00360	Phenylalanine metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMT200047920	K00430	ko00680	Methane metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMT200047920	K00430	ko00940	Phenylpropanoid biosynthesis	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMT200047920	K00430	ko01100	Metabolic pathways	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMT200047920	K00430	ko01110	Biosynthesis of secondary metabolites	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMT200047923	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMT200047942	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMT200047942	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMT200047942	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMT200047942	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMT200047942	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMT200069698	K10881	ko03050	Proteasome	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMT200069698	K10881	ko03440	Homologous recombination	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMT200069707	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069707	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069707	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069707	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069707	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069707	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069708	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMT200069727	K00368	ko00910	Nitrogen metabolism	1918	5.9e-100	0.47	0.60	0.89
PGSC0003DMT200069728	K00368	ko00910	Nitrogen metabolism	1945	1.9e-101	0.48	0.60	0.89
PGSC0003DMT200069729	K00368	ko00910	Nitrogen metabolism	1928	1.7e-100	0.47	0.60	0.91
PGSC0003DMT200060435	K12896	ko03040	Spliceosome	1927	1.9e-100	0.75	0.81	0.96
PGSC0003DMT200060436	K12896	ko03040	Spliceosome	1601	1.8e-82	0.72	0.78	0.95
PGSC0003DMT200060438	K12843	ko03040	Spliceosome	4858	4.1e-262	0.80	0.90	1.00
PGSC0003DMT200060439	K12843	ko03040	Spliceosome	3203	7.9e-171	0.72	0.87	0.93
PGSC0003DMT200060440	K12843	ko03040	Spliceosome	3292	9.8e-176	0.53	0.66	1.00
PGSC0003DMT200060441	K04733	ko04210	Apoptosis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMT200060441	K04733	ko04620	Toll-like receptor signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMT200060441	K04733	ko04722	Neurotrophin signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMT200060441	K04733	ko05140	Leishmaniasis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMT200060441	K04733	ko05142	Chagas disease	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMT200060442	K04733	ko04210	Apoptosis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMT200060442	K04733	ko04620	Toll-like receptor signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMT200060442	K04733	ko04722	Neurotrophin signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMT200060442	K04733	ko05140	Leishmaniasis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMT200060442	K04733	ko05142	Chagas disease	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMT200060445	K12460	ko04722	Neurotrophin signaling pathway	337	1.3e-11	0.40	0.56	0.39
PGSC0003DMT200060446	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.63
PGSC0003DMT200060447	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.57
PGSC0003DMT200060448	K07195	ko04910	Insulin signaling pathway	2335	5.9e-123	0.49	0.67	0.99
PGSC0003DMT200060449	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.96	0.99
PGSC0003DMT200039602	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMT200039602	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMT200039609	K00908	ko01100	Metabolic pathways	429	3.0e-17	0.31	0.50	0.46
PGSC0003DMT200039613	K04424	ko04010	MAPK signaling pathway	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMT200039613	K04424	ko04530	Tight junction	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMT200039614	K04424	ko04010	MAPK signaling pathway	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMT200039614	K04424	ko04530	Tight junction	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMT200039615	K04424	ko04010	MAPK signaling pathway	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMT200039615	K04424	ko04530	Tight junction	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMT200039616	K04424	ko04010	MAPK signaling pathway	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMT200039616	K04424	ko04530	Tight junction	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMT200039617	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMT200039617	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMT200039618	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMT200039618	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMT200039619	K02863	ko03010	Ribosome	736	9.3e-35	0.47	0.60	0.58
PGSC0003DMT200039620	K02863	ko03010	Ribosome	745	3.0e-35	0.47	0.62	0.56
PGSC0003DMT200039639	K00451	ko00350	Tyrosine metabolism	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMT200039639	K00451	ko00643	Styrene degradation	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMT200039639	K00451	ko01100	Metabolic pathways	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMT200039640	K00451	ko00350	Tyrosine metabolism	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMT200039640	K00451	ko00643	Styrene degradation	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMT200039640	K00451	ko01100	Metabolic pathways	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMT200039641	K00451	ko00350	Tyrosine metabolism	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMT200039641	K00451	ko00643	Styrene degradation	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMT200039641	K00451	ko01100	Metabolic pathways	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMT200023304	K00975	ko00500	Starch and sucrose metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMT200023304	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMT200023304	K00975	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMT200023305	K00975	ko00500	Starch and sucrose metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMT200023305	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMT200023305	K00975	ko01100	Metabolic pathways	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMT200023313	K01937	ko00240	Pyrimidine metabolism	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMT200023313	K01937	ko01100	Metabolic pathways	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMT200023314	K01937	ko00240	Pyrimidine metabolism	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMT200023314	K01937	ko01100	Metabolic pathways	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMT200023325	K05349	ko00460	Cyanoamino acid metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMT200023325	K05349	ko00500	Starch and sucrose metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMT200023325	K05349	ko00940	Phenylpropanoid biosynthesis	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMT200023325	K05349	ko01110	Biosynthesis of secondary metabolites	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMT200023328	K08737	ko03430	Mismatch repair	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMT200023328	K08737	ko05200	Pathways in cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMT200023328	K08737	ko05210	Colorectal cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMT200023329	K08737	ko03430	Mismatch repair	7323	0.	0.69	0.81	1.00
PGSC0003DMT200023329	K08737	ko05200	Pathways in cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMT200023329	K08737	ko05210	Colorectal cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMT200013692	K05546	ko00510	N-Glycan biosynthesis	6249	0.	0.77	0.87	1.00
PGSC0003DMT200013692	K05546	ko01100	Metabolic pathways	6249	0.	0.77	0.87	1.00
PGSC0003DMT200013695	K12619	ko03018	RNA degradation	2575	3.4e-136	0.53	0.60	0.98
PGSC0003DMT200013696	K12619	ko03018	RNA degradation	4234	1.1e-227	0.52	0.62	1.00
PGSC0003DMT200013700	K06065	ko04330	Notch signaling pathway	438	4.9e-14	0.25	0.41	0.71
PGSC0003DMT200013702	K06065	ko04330	Notch signaling pathway	438	5.8e-14	0.25	0.41	0.63
PGSC0003DMT200013708	K08057	ko04145	Phagosome	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMT200013708	K08057	ko04612	Antigen processing and presentation	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMT200013708	K08057	ko05142	Chagas disease	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMT200013709	K08057	ko04145	Phagosome	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMT200013709	K08057	ko04612	Antigen processing and presentation	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMT200013709	K08057	ko05142	Chagas disease	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMT200013711	K11866	ko04144	Endocytosis	445	5.6e-18	0.28	0.41	0.92
PGSC0003DMT200013716	K04371	ko04010	MAPK signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04012	ErbB signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04013	MAPK signaling pathway - fly	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04062	Chemokine signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04114	Oocyte meiosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04150	mTOR signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04270	Vascular smooth muscle contraction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04320	Dorso-ventral axis formation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04350	TGF-beta signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04360	Axon guidance	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04370	VEGF signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04510	Focal adhesion	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04520	Adherens junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04540	Gap junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04620	Toll-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04621	NOD-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04650	Natural killer cell mediated cytotoxicity	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04660	T cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04662	B cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04664	Fc epsilon RI signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04666	Fc gamma R-mediated phagocytosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04720	Long-term potentiation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04722	Neurotrophin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04730	Long-term depression	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04810	Regulation of actin cytoskeleton	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04910	Insulin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04912	GnRH signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04914	Progesterone-mediated oocyte maturation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04916	Melanogenesis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04930	Type II diabetes mellitus	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko04960	Aldosterone-regulated sodium reabsorption	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05010	Alzheimer's disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05020	Prion diseases	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05131	Shigellosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05140	Leishmaniasis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05142	Chagas disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05200	Pathways in cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05210	Colorectal cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05211	Renal cell carcinoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05212	Pancreatic cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05213	Endometrial cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05214	Glioma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05215	Prostate cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05216	Thyroid cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05218	Melanoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05219	Bladder cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05220	Chronic myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05221	Acute myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013716	K04371	ko05223	Non-small cell lung cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMT200013717	K05740	ko04510	Focal adhesion	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMT200013717	K05740	ko04810	Regulation of actin cytoskeleton	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMT200013717	K05740	ko05131	Shigellosis	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMT200013718	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMT200013718	K00517	ko00626	Naphthalene and anthracene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMT200013718	K00517	ko00903	Limonene and pinene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMT200013718	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMT200013718	K00517	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMT200013729	K01076	ko00632	Benzoate degradation via CoA ligation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMT200013729	K01076	ko00903	Limonene and pinene degradation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMT200013729	K01076	ko01040	Biosynthesis of unsaturated fatty acids	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMT200013730	K02689	ko00195	Photosynthesis	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMT200013730	K02689	ko01100	Metabolic pathways	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMT200091494	K03094	ko04110	Cell cycle	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04111	Cell cycle - yeast	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04114	Oocyte meiosis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04120	Ubiquitin mediated proteolysis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04310	Wnt signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04350	TGF-beta signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091494	K03094	ko04710	Circadian rhythm - mammal	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMT200091500	K04733	ko04210	Apoptosis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMT200091500	K04733	ko04620	Toll-like receptor signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMT200091500	K04733	ko04722	Neurotrophin signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMT200091500	K04733	ko05140	Leishmaniasis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMT200091500	K04733	ko05142	Chagas disease	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMT200091503	K10760	ko00908	Zeatin biosynthesis	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMT200091503	K10760	ko01100	Metabolic pathways	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMT200091503	K10760	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMT200045097	K12472	ko04144	Endocytosis	437	6.5e-15	0.23	0.39	0.91
PGSC0003DMT200045098	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMT200045098	K03858	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMT200045099	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMT200045099	K03858	ko01100	Metabolic pathways	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMT200045111	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMT200045111	K05291	ko01100	Metabolic pathways	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMT200045112	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMT200045112	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMT200045113	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMT200045113	K05291	ko01100	Metabolic pathways	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMT200045114	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMT200045114	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMT200054522	K01230	ko00510	N-Glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMT200054522	K01230	ko00513	High-mannose type N-glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMT200054522	K01230	ko01100	Metabolic pathways	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMT200054523	K02729	ko03050	Proteasome	1922	3.6e-100	0.97	1.00	1.00
PGSC0003DMT200054529	K10609	ko03420	Nucleotide excision repair	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMT200054529	K10609	ko04120	Ubiquitin mediated proteolysis	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMT200054530	K10609	ko03420	Nucleotide excision repair	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMT200054530	K10609	ko04120	Ubiquitin mediated proteolysis	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMT200054539	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMT200054540	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMT200054541	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMT200054542	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMT200054543	K02987	ko03010	Ribosome	2095	1.0e-109	0.92	0.99	0.98
PGSC0003DMT200062473	K01674	ko00910	Nitrogen metabolism	515	1.4e-22	0.53	0.76	0.63
PGSC0003DMT200062490	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062490	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062492	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062492	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062493	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062493	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062494	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200062494	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMT200011350	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMT200011351	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMT200011352	K01052	ko00100	Steroid biosynthesis	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMT200011352	K01052	ko04142	Lysosome	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMT200011353	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMT200011353	K12567	ko05414	Dilated cardiomyopathy	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMT200011355	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMT200011355	K12567	ko05414	Dilated cardiomyopathy	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMT200011357	K13065	ko00940	Phenylpropanoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMT200011357	K13065	ko00941	Flavonoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMT200011357	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMT200011357	K13065	ko01110	Biosynthesis of secondary metabolites	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMT200019359	K00162	ko00010	Glycolysis / Gluconeogenesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko00020	Citrate cycle (TCA cycle)	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko00620	Pyruvate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko00650	Butanoate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko01100	Metabolic pathways	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019359	K00162	ko01110	Biosynthesis of secondary metabolites	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMT200019360	K01590	ko00340	Histidine metabolism	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMT200019360	K01590	ko01100	Metabolic pathways	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMT200019360	K01590	ko01110	Biosynthesis of secondary metabolites	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMT200019370	K03133	ko03022	Basal transcription factors	1023	1.4e-50	0.66	0.80	0.99
PGSC0003DMT200019371	K03133	ko03022	Basal transcription factors	737	8.2e-35	0.72	0.83	0.85
PGSC0003DMT200019372	K03133	ko03022	Basal transcription factors	1044	9.5e-52	0.68	0.82	0.99
PGSC0003DMT200019375	K02154	ko00190	Oxidative phosphorylation	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko01100	Metabolic pathways	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko04142	Lysosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko04145	Phagosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko04966	Collecting duct acid secretion	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko05110	Vibrio cholerae infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019375	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMT200019377	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019377	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko00190	Oxidative phosphorylation	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko01100	Metabolic pathways	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko04142	Lysosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko04145	Phagosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko04966	Collecting duct acid secretion	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko05110	Vibrio cholerae infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019378	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019379	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMT200019380	K02154	ko00190	Oxidative phosphorylation	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko01100	Metabolic pathways	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko04142	Lysosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko04145	Phagosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko04966	Collecting duct acid secretion	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko05110	Vibrio cholerae infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019380	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko00190	Oxidative phosphorylation	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko01100	Metabolic pathways	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko04142	Lysosome	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko04145	Phagosome	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko04966	Collecting duct acid secretion	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko05110	Vibrio cholerae infection	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019381	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5946	0.	0.85	0.92	1.00
PGSC0003DMT200019382	K02154	ko00190	Oxidative phosphorylation	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko01100	Metabolic pathways	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko04142	Lysosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko04145	Phagosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko04966	Collecting duct acid secretion	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko05110	Vibrio cholerae infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019382	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMT200019383	K02154	ko00190	Oxidative phosphorylation	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko01100	Metabolic pathways	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko04142	Lysosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko04145	Phagosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko04966	Collecting duct acid secretion	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko05110	Vibrio cholerae infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019383	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMT200019384	K02154	ko00190	Oxidative phosphorylation	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko01100	Metabolic pathways	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko04142	Lysosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko04145	Phagosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko04966	Collecting duct acid secretion	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko05110	Vibrio cholerae infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019384	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMT200019410	K01955	ko00240	Pyrimidine metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMT200019410	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMT200019410	K01955	ko01100	Metabolic pathways	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMT200019411	K01955	ko00240	Pyrimidine metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMT200019411	K01955	ko00250	Alanine, aspartate and glutamate metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMT200019411	K01955	ko01100	Metabolic pathways	7779	0.	0.73	0.83	1.00
PGSC0003DMT200019412	K01955	ko00240	Pyrimidine metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMT200019412	K01955	ko00250	Alanine, aspartate and glutamate metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMT200019412	K01955	ko01100	Metabolic pathways	8293	0.	0.83	0.90	1.00
PGSC0003DMT200035098	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035098	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035098	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035098	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035098	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035099	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035099	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035099	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035099	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035099	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMT200035101	K01184	ko00040	Pentose and glucuronate interconversions	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMT200035101	K01184	ko00500	Starch and sucrose metabolism	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMT200035101	K01184	ko01100	Metabolic pathways	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMT200035105	K04733	ko04210	Apoptosis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMT200035105	K04733	ko04620	Toll-like receptor signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMT200035105	K04733	ko04722	Neurotrophin signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMT200035105	K04733	ko05140	Leishmaniasis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMT200035105	K04733	ko05142	Chagas disease	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMT200035106	K04733	ko04210	Apoptosis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMT200035106	K04733	ko04620	Toll-like receptor signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMT200035106	K04733	ko04722	Neurotrophin signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMT200035106	K04733	ko05140	Leishmaniasis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMT200035106	K04733	ko05142	Chagas disease	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMT200035108	K03660	ko03410	Base excision repair	593	7.1e-27	0.35	0.52	0.96
PGSC0003DMT200035112	K08065	ko04612	Antigen processing and presentation	512	2.1e-22	0.44	0.60	0.82
PGSC0003DMT200035114	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMT200035115	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMT200035116	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMT200035117	K08065	ko04612	Antigen processing and presentation	508	3.5e-22	0.57	0.78	0.59
PGSC0003DMT200035119	K08065	ko04612	Antigen processing and presentation	308	3.7e-11	0.38	0.58	0.70
PGSC0003DMT200035125	K08065	ko04612	Antigen processing and presentation	382	3.1e-15	0.44	0.62	0.56
PGSC0003DMT200004041	K01803	ko00010	Glycolysis / Gluconeogenesis	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004041	K01803	ko00051	Fructose and mannose metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004041	K01803	ko00562	Inositol phosphate metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004041	K01803	ko00710	Carbon fixation in photosynthetic organisms	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004041	K01803	ko01100	Metabolic pathways	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004041	K01803	ko01110	Biosynthesis of secondary metabolites	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMT200004042	K01803	ko00010	Glycolysis / Gluconeogenesis	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004042	K01803	ko00051	Fructose and mannose metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004042	K01803	ko00562	Inositol phosphate metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004042	K01803	ko00710	Carbon fixation in photosynthetic organisms	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004042	K01803	ko01100	Metabolic pathways	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004042	K01803	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMT200004043	K01193	ko00052	Galactose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMT200004043	K01193	ko00500	Starch and sucrose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMT200004043	K01193	ko01100	Metabolic pathways	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMT200004044	K10949	ko05110	Vibrio cholerae infection	478	1.6e-20	0.39	0.62	0.79
PGSC0003DMT200004045	K10949	ko05110	Vibrio cholerae infection	550	1.7e-24	0.38	0.59	0.82
PGSC0003DMT200095744	K10760	ko00908	Zeatin biosynthesis	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMT200095744	K10760	ko01100	Metabolic pathways	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMT200095744	K10760	ko01110	Biosynthesis of secondary metabolites	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMT200095756	K12338	ko00942	Anthocyanin biosynthesis	350	1.8e-13	0.39	0.52	0.66
PGSC0003DMT200090563	K12828	ko03040	Spliceosome	630	7.4e-29	0.54	0.70	0.81
PGSC0003DMT200090568	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	275	2.5e-09	0.53	0.72	0.70
PGSC0003DMT200090575	K04428	ko04010	MAPK signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMT200090575	K04428	ko04912	GnRH signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMT200046924	K08008	ko04145	Phagosome	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMT200046924	K08008	ko04670	Leukocyte transendothelial migration	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMT200046925	K08008	ko04145	Phagosome	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMT200046925	K08008	ko04670	Leukocyte transendothelial migration	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMT200046930	K01179	ko00500	Starch and sucrose metabolism	4121	1.8e-221	0.75	0.85	1.00
PGSC0003DMT200046948	K01885	ko00860	Porphyrin and chlorophyll metabolism	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMT200046948	K01885	ko00970	Aminoacyl-tRNA biosynthesis	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMT200046948	K01885	ko01100	Metabolic pathways	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMT200046948	K01885	ko01110	Biosynthesis of secondary metabolites	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMT200046949	K01885	ko00860	Porphyrin and chlorophyll metabolism	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMT200046949	K01885	ko00970	Aminoacyl-tRNA biosynthesis	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMT200046949	K01885	ko01100	Metabolic pathways	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMT200046949	K01885	ko01110	Biosynthesis of secondary metabolites	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMT200046951	K11866	ko04144	Endocytosis	629	2.0e-28	0.32	0.46	0.88
PGSC0003DMT200046952	K11866	ko04144	Endocytosis	604	5.4e-27	0.33	0.46	0.85
PGSC0003DMT200064191	K03097	ko04310	Wnt signaling pathway	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMT200064191	K03097	ko04520	Adherens junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMT200064191	K03097	ko04530	Tight junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMT200064191	K03097	ko04712	Circadian rhythm - plant	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMT200064198	K00472	ko00330	Arginine and proline metabolism	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMT200064198	K00472	ko01100	Metabolic pathways	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMT200064199	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMT200064199	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMT200064200	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMT200064200	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMT200064201	K00472	ko00330	Arginine and proline metabolism	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMT200064201	K00472	ko01100	Metabolic pathways	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMT200064203	K00472	ko00330	Arginine and proline metabolism	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMT200064203	K00472	ko01100	Metabolic pathways	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMT200064210	K01066	ko00623	2,4-Dichlorobenzoate degradation	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMT200064210	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMT200064211	K01066	ko00623	2,4-Dichlorobenzoate degradation	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMT200064211	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMT200064212	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMT200064213	K00908	ko01100	Metabolic pathways	396	4.1e-13	0.27	0.47	0.40
PGSC0003DMT200064214	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMT200064215	K00658	ko00020	Citrate cycle (TCA cycle)	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMT200064215	K00658	ko00310	Lysine degradation	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMT200064215	K00658	ko01100	Metabolic pathways	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMT200064215	K00658	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMT200064219	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMT200064219	K00517	ko00626	Naphthalene and anthracene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMT200064219	K00517	ko00903	Limonene and pinene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMT200064219	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMT200064219	K00517	ko01110	Biosynthesis of secondary metabolites	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMT200064220	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMT200064220	K00517	ko00626	Naphthalene and anthracene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMT200064220	K00517	ko00903	Limonene and pinene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMT200064220	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMT200064220	K00517	ko01110	Biosynthesis of secondary metabolites	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMT200064221	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMT200064221	K00517	ko00626	Naphthalene and anthracene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMT200064221	K00517	ko00903	Limonene and pinene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMT200064221	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMT200064221	K00517	ko01110	Biosynthesis of secondary metabolites	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMT200056315	K11818	ko00380	Tryptophan metabolism	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMT200056315	K11818	ko00966	Glucosinolate biosynthesis	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMT200056315	K11818	ko01110	Biosynthesis of secondary metabolites	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMT200056321	K11818	ko00380	Tryptophan metabolism	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMT200056321	K11818	ko00966	Glucosinolate biosynthesis	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMT200056321	K11818	ko01110	Biosynthesis of secondary metabolites	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMT200056342	K01057	ko00030	Pentose phosphate pathway	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMT200056342	K01057	ko01100	Metabolic pathways	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMT200056342	K01057	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMT200056343	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200056343	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200056343	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200056344	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200056344	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200056344	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMT200079432	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.88
PGSC0003DMT200079433	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.93
PGSC0003DMT200079435	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.92
PGSC0003DMT200079436	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.89
PGSC0003DMT200094553	K01952	ko00230	Purine metabolism	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMT200094553	K01952	ko01100	Metabolic pathways	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMT200094553	K01952	ko01110	Biosynthesis of secondary metabolites	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMT200094562	K01213	ko00040	Pentose and glucuronate interconversions	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMT200094562	K01213	ko00500	Starch and sucrose metabolism	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMT200094562	K01213	ko01100	Metabolic pathways	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMT200089372	K00764	ko00230	Purine metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMT200089372	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMT200089372	K00764	ko01100	Metabolic pathways	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMT200089372	K00764	ko01110	Biosynthesis of secondary metabolites	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMT200017579	K00262	ko00250	Alanine, aspartate and glutamate metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMT200017579	K00262	ko00330	Arginine and proline metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMT200017579	K00262	ko00910	Nitrogen metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMT200017579	K00262	ko01100	Metabolic pathways	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMT200017581	K00262	ko00250	Alanine, aspartate and glutamate metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMT200017581	K00262	ko00330	Arginine and proline metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMT200017581	K00262	ko00910	Nitrogen metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMT200017581	K00262	ko01100	Metabolic pathways	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMT200017587	K10960	ko00860	Porphyrin and chlorophyll metabolism	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMT200017587	K10960	ko00900	Terpenoid backbone biosynthesis	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMT200017587	K10960	ko01100	Metabolic pathways	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMT200017587	K10960	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMT200017592	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMT200017593	K09842	ko00906	Carotenoid biosynthesis	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMT200017593	K09842	ko01100	Metabolic pathways	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMT200017593	K09842	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMT200009606	K00430	ko00360	Phenylalanine metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMT200009606	K00430	ko00680	Methane metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMT200009606	K00430	ko00940	Phenylpropanoid biosynthesis	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMT200009606	K00430	ko01100	Metabolic pathways	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMT200009606	K00430	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMT200009619	K10688	ko04120	Ubiquitin mediated proteolysis	445	1.0e-18	0.98	1.00	0.98
PGSC0003DMT200009620	K10688	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.94	0.97	0.99
PGSC0003DMT200009621	K00279	ko00908	Zeatin biosynthesis	3146	1.1e-167	0.71	0.82	0.99
PGSC0003DMT200009622	K00279	ko00908	Zeatin biosynthesis	2539	3.3e-134	0.73	0.84	0.99
PGSC0003DMT200009632	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200009632	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200009633	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200009633	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200009634	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200009634	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMT200085198	K02943	ko03010	Ribosome	461	1.4e-19	0.60	0.69	0.99
PGSC0003DMT200058626	K00697	ko00500	Starch and sucrose metabolism	4377	1.4e-235	0.67	0.81	0.99
PGSC0003DMT200058627	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMT200058628	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMT200058630	K08241	ko00592	alpha-Linolenic acid metabolism	453	3.8e-19	0.41	0.55	0.74
PGSC0003DMT200058632	K08241	ko00592	alpha-Linolenic acid metabolism	684	6.8e-32	0.34	0.51	0.88
PGSC0003DMT200058635	K00928	ko00260	Glycine, serine and threonine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMT200058635	K00928	ko00270	Cysteine and methionine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMT200058635	K00928	ko00300	Lysine biosynthesis	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMT200058635	K00928	ko01100	Metabolic pathways	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMT200058635	K00928	ko01110	Biosynthesis of secondary metabolites	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMT200058637	K00928	ko00260	Glycine, serine and threonine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMT200058637	K00928	ko00270	Cysteine and methionine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMT200058637	K00928	ko00300	Lysine biosynthesis	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMT200058637	K00928	ko01100	Metabolic pathways	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMT200058637	K00928	ko01110	Biosynthesis of secondary metabolites	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMT200058638	K00928	ko00260	Glycine, serine and threonine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMT200058638	K00928	ko00270	Cysteine and methionine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMT200058638	K00928	ko00300	Lysine biosynthesis	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMT200058638	K00928	ko01100	Metabolic pathways	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMT200058638	K00928	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMT200058647	K02084	ko04115	p53 signaling pathway	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko04210	Apoptosis	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko05010	Alzheimer's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko05012	Parkinson's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko05016	Huntington's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200058647	K02084	ko05222	Small cell lung cancer	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMT200067936	K13229	ko00402	Benzoxazinoid biosynthesis	1097	1.1e-54	0.44	0.61	0.98
PGSC0003DMT200067948	K04711	ko00600	Sphingolipid metabolism	983	2.2e-48	0.77	0.85	0.99
PGSC0003DMT200067949	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMT200067950	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMT200067951	K00696	ko00500	Starch and sucrose metabolism	7278	0.	0.80	0.89	1.00
PGSC0003DMT200067951	K00696	ko01100	Metabolic pathways	7278	0.	0.80	0.89	1.00
PGSC0003DMT200067954	K01190	ko00052	Galactose metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMT200067954	K01190	ko00511	Other glycan degradation	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMT200067954	K01190	ko00600	Sphingolipid metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMT200067954	K01190	ko01100	Metabolic pathways	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMT200067955	K01190	ko00052	Galactose metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMT200067955	K01190	ko00511	Other glycan degradation	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMT200067955	K01190	ko00600	Sphingolipid metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMT200067955	K01190	ko01100	Metabolic pathways	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMT200067956	K01190	ko00052	Galactose metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMT200067956	K01190	ko00511	Other glycan degradation	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMT200067956	K01190	ko00600	Sphingolipid metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMT200067956	K01190	ko01100	Metabolic pathways	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMT200067957	K01190	ko00052	Galactose metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMT200067957	K01190	ko00511	Other glycan degradation	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMT200067957	K01190	ko00600	Sphingolipid metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMT200067957	K01190	ko01100	Metabolic pathways	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMT200097093	K11245	ko04011	MAPK signaling pathway - yeast	269	5.3e-09	0.44	0.62	0.44
PGSC0003DMT200097110	K10760	ko00908	Zeatin biosynthesis	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMT200097110	K10760	ko01100	Metabolic pathways	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMT200097110	K10760	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMT200092688	K00071	ko00140	Steroid hormone biosynthesis	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMT200092688	K00071	ko01100	Metabolic pathways	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMT200092688	K00071	ko04960	Aldosterone-regulated sodium reabsorption	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMT200092702	K05915	ko00363	Bisphenol A degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMT200092702	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMT200092702	K05915	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMT200021899	K01490	ko00230	Purine metabolism	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMT200021899	K01490	ko01100	Metabolic pathways	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMT200021899	K01490	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMT200021900	K01490	ko00230	Purine metabolism	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMT200021900	K01490	ko01100	Metabolic pathways	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMT200021900	K01490	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMT200021901	K01490	ko00230	Purine metabolism	5987	0.	0.82	0.89	0.99
PGSC0003DMT200021901	K01490	ko01100	Metabolic pathways	5987	0.	0.82	0.89	0.99
PGSC0003DMT200021901	K01490	ko01110	Biosynthesis of secondary metabolites	5987	0.	0.82	0.89	0.99
PGSC0003DMT200021915	K10802	ko03410	Base excision repair	665	7.6e-31	0.79	0.87	0.85
PGSC0003DMT200021916	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMT200021917	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMT200021918	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMT200015411	K10760	ko00908	Zeatin biosynthesis	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMT200015411	K10760	ko01100	Metabolic pathways	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMT200015411	K10760	ko01110	Biosynthesis of secondary metabolites	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMT200015424	K06627	ko04110	Cell cycle	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMT200015424	K06627	ko04914	Progesterone-mediated oocyte maturation	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMT200015429	K04733	ko04210	Apoptosis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMT200015429	K04733	ko04620	Toll-like receptor signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMT200015429	K04733	ko04722	Neurotrophin signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMT200015429	K04733	ko05140	Leishmaniasis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMT200015429	K04733	ko05142	Chagas disease	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMT200015430	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMT200015430	K00517	ko00626	Naphthalene and anthracene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMT200015430	K00517	ko00903	Limonene and pinene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMT200015430	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMT200015430	K00517	ko01110	Biosynthesis of secondary metabolites	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMT200015433	K11818	ko00380	Tryptophan metabolism	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMT200015433	K11818	ko00966	Glucosinolate biosynthesis	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMT200015433	K11818	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMT200015435	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMT200015435	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMT200015453	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMT200015453	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMT200015454	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMT200015454	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMT200025029	K12471	ko04144	Endocytosis	270	1.1e-08	0.26	0.43	0.97
PGSC0003DMT200025044	K01803	ko00010	Glycolysis / Gluconeogenesis	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025044	K01803	ko00051	Fructose and mannose metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025044	K01803	ko00562	Inositol phosphate metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025044	K01803	ko00710	Carbon fixation in photosynthetic organisms	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025044	K01803	ko01100	Metabolic pathways	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025044	K01803	ko01110	Biosynthesis of secondary metabolites	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMT200025045	K00854	ko00040	Pentose and glucuronate interconversions	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMT200025045	K00854	ko01100	Metabolic pathways	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMT200033300	K09292	ko05200	Pathways in cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMT200033300	K09292	ko05216	Thyroid cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMT200033302	K12929	ko00904	Diterpenoid biosynthesis	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMT200033302	K12929	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMT200033307	K10601	ko04120	Ubiquitin mediated proteolysis	245	1.7e-07	0.31	0.50	0.81
PGSC0003DMT200033309	K05280	ko00941	Flavonoid biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMT200033309	K05280	ko00944	Flavone and flavonol biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMT200033309	K05280	ko01100	Metabolic pathways	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMT200033309	K05280	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMT200033310	K05280	ko00941	Flavonoid biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMT200033310	K05280	ko00944	Flavone and flavonol biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMT200033310	K05280	ko01100	Metabolic pathways	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMT200033310	K05280	ko01110	Biosynthesis of secondary metabolites	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMT200033311	K09755	ko00940	Phenylpropanoid biosynthesis	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMT200033311	K09755	ko01100	Metabolic pathways	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMT200033311	K09755	ko01110	Biosynthesis of secondary metabolites	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMT200033312	K09755	ko00940	Phenylpropanoid biosynthesis	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMT200033312	K09755	ko01100	Metabolic pathways	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMT200033312	K09755	ko01110	Biosynthesis of secondary metabolites	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMT200033313	K09755	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMT200033313	K09755	ko01100	Metabolic pathways	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMT200033313	K09755	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMT200033314	K09755	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMT200033314	K09755	ko01100	Metabolic pathways	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMT200033314	K09755	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMT200033315	K01509	ko00230	Purine metabolism	343	1.9e-12	0.39	0.61	0.92
PGSC0003DMT200033319	K06123	ko00564	Glycerophospholipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMT200033319	K06123	ko00565	Ether lipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMT200033319	K06123	ko01100	Metabolic pathways	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMT200033327	K00827	ko00250	Alanine, aspartate and glutamate metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMT200033327	K00827	ko00260	Glycine, serine and threonine metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMT200033328	K00827	ko00250	Alanine, aspartate and glutamate metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMT200033328	K00827	ko00260	Glycine, serine and threonine metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMT200033332	K09755	ko00940	Phenylpropanoid biosynthesis	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMT200033332	K09755	ko01100	Metabolic pathways	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMT200033332	K09755	ko01110	Biosynthesis of secondary metabolites	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMT200033335	K09755	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMT200033335	K09755	ko01100	Metabolic pathways	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMT200033335	K09755	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMT200033336	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMT200033336	K00517	ko00626	Naphthalene and anthracene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMT200033336	K00517	ko00903	Limonene and pinene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMT200033336	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMT200033336	K00517	ko01110	Biosynthesis of secondary metabolites	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMT200007348	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMT200007349	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMT200007372	K04618	ko00052	Galactose metabolism	387	2.6e-13	0.28	0.43	0.77
PGSC0003DMT200021237	K05863	ko04020	Calcium signaling pathway	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMT200021237	K05863	ko05012	Parkinson's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMT200021237	K05863	ko05016	Huntington's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMT200021238	K05863	ko04020	Calcium signaling pathway	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMT200021238	K05863	ko05012	Parkinson's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMT200021238	K05863	ko05016	Huntington's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMT200021261	K01423	ko00310	Lysine degradation	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMT200021261	K01423	ko00780	Biotin metabolism	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMT200021261	K01423	ko01100	Metabolic pathways	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMT200021262	K01423	ko00310	Lysine degradation	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMT200021262	K01423	ko00780	Biotin metabolism	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMT200021262	K01423	ko01100	Metabolic pathways	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMT200021263	K01423	ko00310	Lysine degradation	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMT200021263	K01423	ko00780	Biotin metabolism	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMT200021263	K01423	ko01100	Metabolic pathways	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMT200021264	K01423	ko00310	Lysine degradation	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMT200021264	K01423	ko00780	Biotin metabolism	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMT200021264	K01423	ko01100	Metabolic pathways	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMT200021265	K01423	ko00310	Lysine degradation	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMT200021265	K01423	ko00780	Biotin metabolism	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMT200021265	K01423	ko01100	Metabolic pathways	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMT200021286	K03133	ko03022	Basal transcription factors	364	3.1e-14	0.62	0.78	0.94
PGSC0003DMT200021293	K02920	ko03010	Ribosome	816	3.6e-39	0.91	0.95	0.99
PGSC0003DMT200021299	K10955	ko05110	Vibrio cholerae infection	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMT200021299	K10955	ko05146	Amoebiasis	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMT200021303	K00964	ko00052	Galactose metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMT200021303	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMT200021303	K00964	ko01100	Metabolic pathways	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMT200021304	K00964	ko00052	Galactose metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMT200021304	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMT200021304	K00964	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMT200021305	K00964	ko00052	Galactose metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMT200021305	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMT200021305	K00964	ko01100	Metabolic pathways	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMT200021306	K00964	ko00052	Galactose metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMT200021306	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMT200021306	K00964	ko01100	Metabolic pathways	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMT200040867	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040867	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMT200040868	K00430	ko00360	Phenylalanine metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMT200040868	K00430	ko00680	Methane metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMT200040868	K00430	ko00940	Phenylpropanoid biosynthesis	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMT200040868	K00430	ko01100	Metabolic pathways	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMT200040868	K00430	ko01110	Biosynthesis of secondary metabolites	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMT200040869	K11229	ko04011	MAPK signaling pathway - yeast	1028	2.2e-50	0.32	0.47	0.71
PGSC0003DMT200040872	K03062	ko03050	Proteasome	3617	1.2e-193	0.97	0.99	1.00
PGSC0003DMT200040875	K04424	ko04010	MAPK signaling pathway	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMT200040875	K04424	ko04530	Tight junction	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMT200040876	K00632	ko00071	Fatty acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko00280	Valine, leucine and isoleucine degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko00281	Geraniol degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko00362	Benzoate degradation via hydroxylation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko00592	alpha-Linolenic acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko00642	Ethylbenzene degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko01100	Metabolic pathways	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040876	K00632	ko01110	Biosynthesis of secondary metabolites	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMT200040893	K01728	ko00040	Pentose and glucuronate interconversions	2930	9.0e-156	0.76	0.86	1.00
PGSC0003DMT200040912	K04424	ko04010	MAPK signaling pathway	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMT200040912	K04424	ko04530	Tight junction	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMT200040918	K04733	ko04210	Apoptosis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMT200040918	K04733	ko04620	Toll-like receptor signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMT200040918	K04733	ko04722	Neurotrophin signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMT200040918	K04733	ko05140	Leishmaniasis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMT200040918	K04733	ko05142	Chagas disease	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMT200096944	K05280	ko00941	Flavonoid biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMT200096944	K05280	ko00944	Flavone and flavonol biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMT200096944	K05280	ko01100	Metabolic pathways	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMT200096944	K05280	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMT200002315	K03876	ko04120	Ubiquitin mediated proteolysis	291	3.2e-10	0.37	0.57	0.71
PGSC0003DMT200002320	K12796	ko04621	NOD-like receptor signaling pathway	407	5.4e-13	0.31	0.47	0.30
PGSC0003DMT200002336	K01897	ko00071	Fatty acid metabolism	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMT200002336	K01897	ko01100	Metabolic pathways	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMT200002336	K01897	ko03320	PPAR signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMT200002336	K01897	ko04146	Peroxisome	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMT200002336	K01897	ko04920	Adipocytokine signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMT200002337	K01897	ko00071	Fatty acid metabolism	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMT200002337	K01897	ko01100	Metabolic pathways	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMT200002337	K01897	ko03320	PPAR signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMT200002337	K01897	ko04146	Peroxisome	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMT200002337	K01897	ko04920	Adipocytokine signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMT200002340	K02897	ko03010	Ribosome	1380	2.8e-70	0.72	0.84	0.90
PGSC0003DMT200002341	K00434	ko00053	Ascorbate and aldarate metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMT200002341	K00434	ko00480	Glutathione metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMT200002343	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.75
PGSC0003DMT200002344	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.68
PGSC0003DMT200002345	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.53
PGSC0003DMT200002346	K09291	ko04011	MAPK signaling pathway - yeast	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMT200002346	K09291	ko05200	Pathways in cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMT200002346	K09291	ko05216	Thyroid cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMT200002348	K09291	ko04011	MAPK signaling pathway - yeast	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMT200002348	K09291	ko05200	Pathways in cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMT200002348	K09291	ko05216	Thyroid cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMT200075977	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200075978	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200075979	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMT200075980	K05391	ko04626	Plant-pathogen interaction	4363	8.3e-235	0.72	0.82	1.00
PGSC0003DMT200075999	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	7028	0.	0.83	0.92	0.99
PGSC0003DMT200075999	K12446	ko01100	Metabolic pathways	7028	0.	0.83	0.92	0.99
PGSC0003DMT200076000	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMT200076000	K12446	ko01100	Metabolic pathways	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMT200076001	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	5740	0.	0.84	0.92	0.99
PGSC0003DMT200076001	K12446	ko01100	Metabolic pathways	5740	0.	0.84	0.92	0.99
PGSC0003DMT200076008	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMT200076008	K12446	ko01100	Metabolic pathways	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMT200076016	K02991	ko03010	Ribosome	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMT200076016	K02991	ko04150	mTOR signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMT200076016	K02991	ko04910	Insulin signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMT200076017	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076017	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076017	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076018	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076018	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076018	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076019	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076019	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076019	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMT200076023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMT200076023	K00517	ko00626	Naphthalene and anthracene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMT200076023	K00517	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMT200076023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMT200076023	K00517	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMT200050232	K08910	ko00196	Photosynthesis - antenna proteins	1890	2.1e-98	0.86	0.93	0.99
PGSC0003DMT200050234	K10960	ko00860	Porphyrin and chlorophyll metabolism	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMT200050234	K10960	ko00900	Terpenoid backbone biosynthesis	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMT200050234	K10960	ko01100	Metabolic pathways	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMT200050234	K10960	ko01110	Biosynthesis of secondary metabolites	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMT200050235	K00026	ko00020	Citrate cycle (TCA cycle)	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050235	K00026	ko00620	Pyruvate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050235	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050235	K00026	ko00710	Carbon fixation in photosynthetic organisms	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050235	K00026	ko01100	Metabolic pathways	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050235	K00026	ko01110	Biosynthesis of secondary metabolites	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMT200050245	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	195	5.2e-09	0.40	0.49	0.79
PGSC0003DMT200050246	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	197	4.0e-09	0.39	0.48	0.38
PGSC0003DMT200050249	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	218	3.4e-06	0.53	0.64	0.26
PGSC0003DMT200050251	K12127	ko04712	Circadian rhythm - plant	1436	2.3e-73	0.61	0.75	0.98
PGSC0003DMT200050252	K12127	ko04712	Circadian rhythm - plant	2920	3.2e-155	0.67	0.78	0.98
PGSC0003DMT200050253	K02342	ko00230	Purine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050253	K02342	ko00240	Pyrimidine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050253	K02342	ko01100	Metabolic pathways	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050253	K02342	ko03030	DNA replication	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050253	K02342	ko03430	Mismatch repair	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050253	K02342	ko03440	Homologous recombination	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMT200050255	K01783	ko00030	Pentose phosphate pathway	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMT200050255	K01783	ko00040	Pentose and glucuronate interconversions	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMT200050255	K01783	ko00710	Carbon fixation in photosynthetic organisms	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMT200050255	K01783	ko01100	Metabolic pathways	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMT200050255	K01783	ko01110	Biosynthesis of secondary metabolites	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMT200050256	K01783	ko00030	Pentose phosphate pathway	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMT200050256	K01783	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMT200050256	K01783	ko00710	Carbon fixation in photosynthetic organisms	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMT200050256	K01783	ko01100	Metabolic pathways	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMT200050256	K01783	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMT200087256	K00600	ko00260	Glycine, serine and threonine metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200087256	K00600	ko00460	Cyanoamino acid metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200087256	K00600	ko00670	One carbon pool by folate	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200087256	K00600	ko00680	Methane metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200087256	K00600	ko01100	Metabolic pathways	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200087256	K00600	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMT200027459	K12929	ko00904	Diterpenoid biosynthesis	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMT200027459	K12929	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMT200027464	K12929	ko00904	Diterpenoid biosynthesis	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMT200027464	K12929	ko01110	Biosynthesis of secondary metabolites	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMT200027490	K07424	ko00140	Steroid hormone biosynthesis	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00591	Linoleic acid metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00830	Retinol metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko00983	Drug metabolism - other enzymes	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027490	K07424	ko01100	Metabolic pathways	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMT200027494	K07424	ko00140	Steroid hormone biosynthesis	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00591	Linoleic acid metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00830	Retinol metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00982	Drug metabolism - cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko00983	Drug metabolism - other enzymes	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027494	K07424	ko01100	Metabolic pathways	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMT200027495	K07424	ko00140	Steroid hormone biosynthesis	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00591	Linoleic acid metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00830	Retinol metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00982	Drug metabolism - cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko00983	Drug metabolism - other enzymes	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027495	K07424	ko01100	Metabolic pathways	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMT200027500	K12817	ko03040	Spliceosome	1669	3.2e-86	0.57	0.69	0.98
PGSC0003DMT200027505	K12817	ko03040	Spliceosome	1762	2.4e-91	0.57	0.71	0.98
PGSC0003DMT200027507	K01509	ko00230	Purine metabolism	380	5.5e-39	0.42	0.60	0.63
PGSC0003DMT200037747	K10760	ko00908	Zeatin biosynthesis	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMT200037747	K10760	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMT200037747	K10760	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMT200037749	K10760	ko00908	Zeatin biosynthesis	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMT200037749	K10760	ko01100	Metabolic pathways	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMT200037749	K10760	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMT200037754	K12127	ko04712	Circadian rhythm - plant	225	3.9e-06	0.55	0.76	0.70
PGSC0003DMT200037755	K12135	ko04712	Circadian rhythm - plant	239	3.6e-07	0.38	0.52	0.32
PGSC0003DMT200037760	K11294	ko05130	Pathogenic Escherichia coli infection	283	1.0e-07	0.31	0.42	0.82
PGSC0003DMT200037767	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMT200037767	K01886	ko01100	Metabolic pathways	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMT200037768	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5679	0.	0.82	0.92	1.00
PGSC0003DMT200037768	K01886	ko01100	Metabolic pathways	5679	0.	0.82	0.92	1.00
PGSC0003DMT200037775	K10144	ko04115	p53 signaling pathway	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMT200037775	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMT200037776	K10144	ko04115	p53 signaling pathway	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMT200037776	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMT200018179	K07424	ko00140	Steroid hormone biosynthesis	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00591	Linoleic acid metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00830	Retinol metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00982	Drug metabolism - cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko00983	Drug metabolism - other enzymes	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018179	K07424	ko01100	Metabolic pathways	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMT200018181	K01859	ko00941	Flavonoid biosynthesis	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMT200018181	K01859	ko01100	Metabolic pathways	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMT200018181	K01859	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMT200018184	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMT200018185	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMT200018186	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMT200018191	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4771	2.6e-257	0.83	0.89	1.00
PGSC0003DMT200018192	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5055	5.6e-273	0.86	0.94	1.00
PGSC0003DMT200018193	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	3970	3.9e-213	0.86	0.94	0.99
PGSC0003DMT200018194	K00858	ko00760	Nicotinate and nicotinamide metabolism	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMT200018194	K00858	ko01100	Metabolic pathways	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMT200018195	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.95
PGSC0003DMT200018196	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.67
PGSC0003DMT200018198	K02871	ko03010	Ribosome	1545	2.2e-79	0.76	0.86	1.00
PGSC0003DMT200018199	K01710	ko00521	Streptomycin biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMT200018199	K01710	ko00523	Polyketide sugar unit biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMT200018199	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMT200018199	K01710	ko01100	Metabolic pathways	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMT200018199	K01710	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMT200018203	K01307	ko00790	Folate biosynthesis	1771	7.6e-92	0.67	0.80	0.98
PGSC0003DMT200018204	K01307	ko00790	Folate biosynthesis	2051	2.7e-107	0.71	0.83	0.97
PGSC0003DMT200018205	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018205	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018205	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018205	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018206	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018206	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018206	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200018206	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMT200094689	K10760	ko00908	Zeatin biosynthesis	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMT200094689	K10760	ko01100	Metabolic pathways	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMT200094689	K10760	ko01110	Biosynthesis of secondary metabolites	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMT200062232	K12130	ko04712	Circadian rhythm - plant	278	6.0e-07	0.24	0.50	0.56
PGSC0003DMT200062236	K01099	ko00562	Inositol phosphate metabolism	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMT200062236	K01099	ko01100	Metabolic pathways	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMT200062236	K01099	ko04070	Phosphatidylinositol signaling system	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMT200062238	K00873	ko00010	Glycolysis / Gluconeogenesis	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko00230	Purine metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko00620	Pyruvate metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko00710	Carbon fixation in photosynthetic organisms	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko01100	Metabolic pathways	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko01110	Biosynthesis of secondary metabolites	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200062238	K00873	ko04930	Type II diabetes mellitus	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMT200046116	K12823	ko03040	Spliceosome	1880	7.4e-98	0.53	0.66	0.69
PGSC0003DMT200046117	K12823	ko03040	Spliceosome	1986	1.1e-103	0.52	0.65	0.44
PGSC0003DMT200046120	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.85
PGSC0003DMT200046121	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.84
PGSC0003DMT200046146	K02266	ko00190	Oxidative phosphorylation	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046146	K02266	ko01100	Metabolic pathways	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046146	K02266	ko04260	Cardiac muscle contraction	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046146	K02266	ko05010	Alzheimer's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046146	K02266	ko05012	Parkinson's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046146	K02266	ko05016	Huntington's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMT200046148	K07374	ko04145	Phagosome	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMT200046148	K07374	ko04540	Gap junction	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMT200046148	K07374	ko05130	Pathogenic Escherichia coli infection	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMT200046152	K03006	ko00230	Purine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMT200046152	K03006	ko00240	Pyrimidine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMT200046152	K03006	ko01100	Metabolic pathways	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMT200046152	K03006	ko03020	RNA polymerase	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMT200046152	K03006	ko05016	Huntington's disease	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMT200046156	K03006	ko00230	Purine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMT200046156	K03006	ko00240	Pyrimidine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMT200046156	K03006	ko01100	Metabolic pathways	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMT200046156	K03006	ko03020	RNA polymerase	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMT200046156	K03006	ko05016	Huntington's disease	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMT200073753	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMT200073753	K00517	ko00626	Naphthalene and anthracene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMT200073753	K00517	ko00903	Limonene and pinene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMT200073753	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMT200073753	K00517	ko01110	Biosynthesis of secondary metabolites	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMT200073765	K11717	ko00450	Selenoamino acid metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMT200073765	K11717	ko00730	Thiamine metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMT200073765	K11717	ko01100	Metabolic pathways	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMT200073768	K11717	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMT200073768	K11717	ko00730	Thiamine metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMT200073768	K11717	ko01100	Metabolic pathways	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMT200073770	K11717	ko00450	Selenoamino acid metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMT200073770	K11717	ko00730	Thiamine metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMT200073770	K11717	ko01100	Metabolic pathways	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMT200073771	K00888	ko00562	Inositol phosphate metabolism	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMT200073771	K00888	ko01100	Metabolic pathways	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMT200073771	K00888	ko04070	Phosphatidylinositol signaling system	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMT200073772	K00888	ko00562	Inositol phosphate metabolism	6496	0.	0.73	0.83	0.99
PGSC0003DMT200073772	K00888	ko01100	Metabolic pathways	6496	0.	0.73	0.83	0.99
PGSC0003DMT200073772	K00888	ko04070	Phosphatidylinositol signaling system	6496	0.	0.73	0.83	0.99
PGSC0003DMT200073773	K00888	ko00562	Inositol phosphate metabolism	6998	0.	0.74	0.84	1.00
PGSC0003DMT200073773	K00888	ko01100	Metabolic pathways	6998	0.	0.74	0.84	1.00
PGSC0003DMT200073773	K00888	ko04070	Phosphatidylinositol signaling system	6998	0.	0.74	0.84	1.00
PGSC0003DMT200073788	K04420	ko04010	MAPK signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMT200073788	K04420	ko04540	Gap junction	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMT200073788	K04420	ko04912	GnRH signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMT200073796	K13068	ko00940	Phenylpropanoid biosynthesis	873	2.6e-42	0.33	0.51	0.99
PGSC0003DMT200073799	K13068	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.32	0.52	0.98
PGSC0003DMT200064869	K12670	ko00510	N-Glycan biosynthesis	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMT200064869	K12670	ko01100	Metabolic pathways	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMT200064870	K12670	ko00510	N-Glycan biosynthesis	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMT200064870	K12670	ko01100	Metabolic pathways	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMT200080269	K05666	ko02010	ABC transporters	1395	4.2e-71	0.44	0.64	0.98
PGSC0003DMT200080270	K05665	ko02010	ABC transporters	3070	1.7e-163	0.35	0.55	0.97
PGSC0003DMT200080276	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080276	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080277	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMT200080287	K04127	ko00311	Penicillin and cephalosporin biosynthesis	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMT200080287	K04127	ko01100	Metabolic pathways	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMT200080287	K04127	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMT200080291	K02915	ko03010	Ribosome	972	8.9e-48	0.96	0.98	0.99
PGSC0003DMT200093880	K01426	ko00330	Arginine and proline metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200093880	K01426	ko00360	Phenylalanine metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200093880	K01426	ko00380	Tryptophan metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200093880	K01426	ko00460	Cyanoamino acid metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200093880	K01426	ko00632	Benzoate degradation via CoA ligation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200093880	K01426	ko00643	Styrene degradation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMT200017258	K05391	ko04626	Plant-pathogen interaction	3648	2.3e-195	0.66	0.74	0.99
PGSC0003DMT200017259	K05391	ko04626	Plant-pathogen interaction	4219	7.3e-227	0.72	0.82	0.99
PGSC0003DMT200017265	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMT200017265	K01649	ko00620	Pyruvate metabolism	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMT200017265	K01649	ko01100	Metabolic pathways	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMT200017265	K01649	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMT200017269	K01590	ko00340	Histidine metabolism	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMT200017269	K01590	ko01100	Metabolic pathways	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMT200017269	K01590	ko01110	Biosynthesis of secondary metabolites	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMT200017277	K12859	ko03040	Spliceosome	1211	5.9e-61	0.97	1.00	0.99
PGSC0003DMT200017278	K12859	ko03040	Spliceosome	858	1.7e-41	0.97	1.00	0.99
PGSC0003DMT200017286	K12338	ko00942	Anthocyanin biosynthesis	1481	7.5e-76	0.36	0.48	0.99
PGSC0003DMT200017289	K06269	ko04113	Meiosis - yeast	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04114	Oocyte meiosis	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04270	Vascular smooth muscle contraction	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04510	Focal adhesion	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04720	Long-term potentiation	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04810	Regulation of actin cytoskeleton	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017289	K06269	ko04910	Insulin signaling pathway	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMT200017290	K06269	ko04113	Meiosis - yeast	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04114	Oocyte meiosis	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04270	Vascular smooth muscle contraction	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04510	Focal adhesion	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04720	Long-term potentiation	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04810	Regulation of actin cytoskeleton	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200017290	K06269	ko04910	Insulin signaling pathway	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMT200029282	K05282	ko00904	Diterpenoid biosynthesis	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMT200029282	K05282	ko01100	Metabolic pathways	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMT200029282	K05282	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMT200029293	K01488	ko00230	Purine metabolism	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMT200029293	K01488	ko01100	Metabolic pathways	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMT200029293	K01488	ko05340	Primary immunodeficiency	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMT200029294	K01488	ko00230	Purine metabolism	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMT200029294	K01488	ko01100	Metabolic pathways	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMT200029294	K01488	ko05340	Primary immunodeficiency	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMT200029296	K00995	ko00564	Glycerophospholipid metabolism	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMT200029296	K00995	ko01100	Metabolic pathways	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMT200029297	K08744	ko00564	Glycerophospholipid metabolism	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMT200029297	K08744	ko01100	Metabolic pathways	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMT200035987	K01193	ko00052	Galactose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMT200035987	K01193	ko00500	Starch and sucrose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMT200035987	K01193	ko01100	Metabolic pathways	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMT200035989	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMT200035990	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMT200035991	K01087	ko00500	Starch and sucrose metabolism	1364	2.1e-69	0.62	0.75	0.80
PGSC0003DMT200035999	K02261	ko00190	Oxidative phosphorylation	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200035999	K02261	ko01100	Metabolic pathways	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200035999	K02261	ko04260	Cardiac muscle contraction	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200035999	K02261	ko05010	Alzheimer's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200035999	K02261	ko05012	Parkinson's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200035999	K02261	ko05016	Huntington's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMT200036004	K02261	ko00190	Oxidative phosphorylation	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036004	K02261	ko01100	Metabolic pathways	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036004	K02261	ko04260	Cardiac muscle contraction	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036004	K02261	ko05010	Alzheimer's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036004	K02261	ko05012	Parkinson's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036004	K02261	ko05016	Huntington's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMT200036011	K02878	ko03010	Ribosome	253	4.0e-08	0.63	0.75	0.94
PGSC0003DMT200036017	K12124	ko04712	Circadian rhythm - plant	453	2.4e-18	0.59	0.75	0.97
PGSC0003DMT200036019	K08241	ko00592	alpha-Linolenic acid metabolism	381	3.5e-15	0.40	0.61	0.86
PGSC0003DMT200020118	K00454	ko00591	Linoleic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMT200020118	K00454	ko00592	alpha-Linolenic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMT200020118	K00454	ko01100	Metabolic pathways	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMT200020126	K03260	ko05416	Viral myocarditis	1183	9.0e-59	0.34	0.49	0.79
PGSC0003DMT200020128	K01647	ko00020	Citrate cycle (TCA cycle)	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMT200020128	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMT200020128	K01647	ko01100	Metabolic pathways	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMT200020128	K01647	ko01110	Biosynthesis of secondary metabolites	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMT200072055	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMT200072055	K01649	ko00620	Pyruvate metabolism	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMT200072055	K01649	ko01100	Metabolic pathways	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMT200072055	K01649	ko01110	Biosynthesis of secondary metabolites	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMT200072056	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMT200072056	K01649	ko00620	Pyruvate metabolism	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMT200072056	K01649	ko01100	Metabolic pathways	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMT200072056	K01649	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMT200072057	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMT200072057	K01649	ko00620	Pyruvate metabolism	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMT200072057	K01649	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMT200072057	K01649	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMT200072087	K01179	ko00500	Starch and sucrose metabolism	1751	9.6e-91	0.47	0.61	0.97
PGSC0003DMT200072090	K09841	ko00906	Carotenoid biosynthesis	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMT200072090	K09841	ko01100	Metabolic pathways	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMT200072090	K09841	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMT200072097	K05280	ko00941	Flavonoid biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMT200072097	K05280	ko00944	Flavone and flavonol biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMT200072097	K05280	ko01100	Metabolic pathways	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMT200072097	K05280	ko01110	Biosynthesis of secondary metabolites	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMT200072098	K05280	ko00941	Flavonoid biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMT200072098	K05280	ko00944	Flavone and flavonol biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMT200072098	K05280	ko01100	Metabolic pathways	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMT200072098	K05280	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMT200072099	K05280	ko00941	Flavonoid biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMT200072099	K05280	ko00944	Flavone and flavonol biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMT200072099	K05280	ko01100	Metabolic pathways	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMT200072099	K05280	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMT200072103	K05280	ko00941	Flavonoid biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMT200072103	K05280	ko00944	Flavone and flavonol biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMT200072103	K05280	ko01100	Metabolic pathways	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMT200072103	K05280	ko01110	Biosynthesis of secondary metabolites	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMT200072104	K05280	ko00941	Flavonoid biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMT200072104	K05280	ko00944	Flavone and flavonol biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMT200072104	K05280	ko01100	Metabolic pathways	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMT200072104	K05280	ko01110	Biosynthesis of secondary metabolites	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMT200072105	K05280	ko00941	Flavonoid biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMT200072105	K05280	ko00944	Flavone and flavonol biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMT200072105	K05280	ko01100	Metabolic pathways	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMT200072105	K05280	ko01110	Biosynthesis of secondary metabolites	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMT200044280	K10599	ko03040	Spliceosome	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMT200044280	K10599	ko04120	Ubiquitin mediated proteolysis	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMT200044284	K05758	ko04666	Fc gamma R-mediated phagocytosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMT200044284	K05758	ko04810	Regulation of actin cytoskeleton	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMT200044284	K05758	ko05100	Bacterial invasion of epithelial cells	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMT200044284	K05758	ko05130	Pathogenic Escherichia coli infection	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMT200044284	K05758	ko05131	Shigellosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMT200044285	K05758	ko04666	Fc gamma R-mediated phagocytosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMT200044285	K05758	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMT200044285	K05758	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMT200044285	K05758	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMT200044285	K05758	ko05131	Shigellosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMT200044286	K05758	ko04666	Fc gamma R-mediated phagocytosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMT200044286	K05758	ko04810	Regulation of actin cytoskeleton	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMT200044286	K05758	ko05100	Bacterial invasion of epithelial cells	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMT200044286	K05758	ko05130	Pathogenic Escherichia coli infection	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMT200044286	K05758	ko05131	Shigellosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMT200044287	K05758	ko04666	Fc gamma R-mediated phagocytosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMT200044287	K05758	ko04810	Regulation of actin cytoskeleton	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMT200044287	K05758	ko05100	Bacterial invasion of epithelial cells	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMT200044287	K05758	ko05130	Pathogenic Escherichia coli infection	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMT200044287	K05758	ko05131	Shigellosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMT200044303	K00276	ko00260	Glycine, serine and threonine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko00350	Tyrosine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko00360	Phenylalanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko00410	beta-Alanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko00950	Isoquinoline alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko01100	Metabolic pathways	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044303	K00276	ko01110	Biosynthesis of secondary metabolites	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMT200044304	K00276	ko00260	Glycine, serine and threonine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko00350	Tyrosine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko00360	Phenylalanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko00410	beta-Alanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko01100	Metabolic pathways	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044304	K00276	ko01110	Biosynthesis of secondary metabolites	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMT200044305	K00276	ko00260	Glycine, serine and threonine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko00350	Tyrosine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko00360	Phenylalanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko00410	beta-Alanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko01100	Metabolic pathways	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200044305	K00276	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMT200063168	K01934	ko00670	One carbon pool by folate	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMT200063168	K01934	ko01100	Metabolic pathways	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMT200063169	K01934	ko00670	One carbon pool by folate	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMT200063169	K01934	ko01100	Metabolic pathways	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMT200063170	K01934	ko00670	One carbon pool by folate	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMT200063170	K01934	ko01100	Metabolic pathways	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMT200063186	K05740	ko04510	Focal adhesion	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMT200063186	K05740	ko04810	Regulation of actin cytoskeleton	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMT200063186	K05740	ko05131	Shigellosis	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMT200063187	K03413	ko02020	Two-component system	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMT200063187	K03413	ko02030	Bacterial chemotaxis	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMT200063188	K03415	ko02020	Two-component system	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMT200063188	K03415	ko02030	Bacterial chemotaxis	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMT200063189	K03355	ko04110	Cell cycle	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200063189	K03355	ko04111	Cell cycle - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200063189	K03355	ko04113	Meiosis - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200063189	K03355	ko04114	Oocyte meiosis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200063189	K03355	ko04120	Ubiquitin mediated proteolysis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200063189	K03355	ko04914	Progesterone-mediated oocyte maturation	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMT200082709	K00434	ko00053	Ascorbate and aldarate metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMT200082709	K00434	ko00480	Glutathione metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMT200082710	K00434	ko00053	Ascorbate and aldarate metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMT200082710	K00434	ko00480	Glutathione metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMT200082711	K00434	ko00053	Ascorbate and aldarate metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMT200082711	K00434	ko00480	Glutathione metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMT200082712	K00434	ko00053	Ascorbate and aldarate metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMT200082712	K00434	ko00480	Glutathione metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMT200000644	K01528	ko04144	Endocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMT200000644	K01528	ko04666	Fc gamma R-mediated phagocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMT200000644	K01528	ko05100	Bacterial invasion of epithelial cells	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMT200000645	K01528	ko04144	Endocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMT200000645	K01528	ko04666	Fc gamma R-mediated phagocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMT200000645	K01528	ko05100	Bacterial invasion of epithelial cells	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMT200000646	K01528	ko04144	Endocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMT200000646	K01528	ko04666	Fc gamma R-mediated phagocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMT200000646	K01528	ko05100	Bacterial invasion of epithelial cells	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMT200000648	K04506	ko04115	p53 signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMT200000648	K04506	ko04120	Ubiquitin mediated proteolysis	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMT200000648	K04506	ko04310	Wnt signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMT200000649	K04506	ko04115	p53 signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMT200000649	K04506	ko04120	Ubiquitin mediated proteolysis	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMT200000649	K04506	ko04310	Wnt signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMT200000662	K12667	ko00510	N-Glycan biosynthesis	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMT200000662	K12667	ko01100	Metabolic pathways	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMT200000665	K05305	ko00051	Fructose and mannose metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMT200000665	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMT200000665	K05305	ko01100	Metabolic pathways	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMT200000666	K05305	ko00051	Fructose and mannose metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMT200000666	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMT200000666	K05305	ko01100	Metabolic pathways	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMT200000667	K05305	ko00051	Fructose and mannose metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMT200000667	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMT200000667	K05305	ko01100	Metabolic pathways	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMT200000672	K12891	ko03040	Spliceosome	226	1.2e-06	0.39	0.50	0.89
PGSC0003DMT200000673	K12890	ko03040	Spliceosome	305	5.5e-11	0.33	0.45	0.91
PGSC0003DMT200000674	K12890	ko03040	Spliceosome	297	2.5e-16	0.43	0.54	0.64
PGSC0003DMT200000679	K09561	ko04120	Ubiquitin mediated proteolysis	254	2.6e-07	0.31	0.48	0.18
PGSC0003DMT200005593	K02540	ko03030	DNA replication	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMT200005593	K02540	ko04110	Cell cycle	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMT200005593	K02540	ko04111	Cell cycle - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMT200005593	K02540	ko04113	Meiosis - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMT200005594	K02540	ko03030	DNA replication	6932	0.	0.85	0.93	1.00
PGSC0003DMT200005594	K02540	ko04110	Cell cycle	6932	0.	0.85	0.93	1.00
PGSC0003DMT200005594	K02540	ko04111	Cell cycle - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMT200005594	K02540	ko04113	Meiosis - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMT200005602	K00705	ko00500	Starch and sucrose metabolism	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMT200005602	K00705	ko01100	Metabolic pathways	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMT200005603	K00705	ko00500	Starch and sucrose metabolism	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMT200005603	K00705	ko01100	Metabolic pathways	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMT200005604	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMT200005604	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMT200005605	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMT200005605	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMT200005607	K00030	ko00020	Citrate cycle (TCA cycle)	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMT200005607	K00030	ko01100	Metabolic pathways	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMT200005607	K00030	ko01110	Biosynthesis of secondary metabolites	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMT200005610	K00600	ko00260	Glycine, serine and threonine metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005610	K00600	ko00460	Cyanoamino acid metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005610	K00600	ko00670	One carbon pool by folate	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005610	K00600	ko00680	Methane metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005610	K00600	ko01100	Metabolic pathways	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005610	K00600	ko01110	Biosynthesis of secondary metabolites	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMT200005611	K00600	ko00260	Glycine, serine and threonine metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005611	K00600	ko00460	Cyanoamino acid metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005611	K00600	ko00670	One carbon pool by folate	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005611	K00600	ko00680	Methane metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005611	K00600	ko01100	Metabolic pathways	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005611	K00600	ko01110	Biosynthesis of secondary metabolites	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMT200005612	K01772	ko00860	Porphyrin and chlorophyll metabolism	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMT200005612	K01772	ko01100	Metabolic pathways	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMT200005612	K01772	ko01110	Biosynthesis of secondary metabolites	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMT200005613	K01772	ko00860	Porphyrin and chlorophyll metabolism	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMT200005613	K01772	ko01100	Metabolic pathways	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMT200005613	K01772	ko01110	Biosynthesis of secondary metabolites	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMT200005614	K02128	ko00190	Oxidative phosphorylation	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMT200005614	K02128	ko01100	Metabolic pathways	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMT200005614	K02128	ko05010	Alzheimer's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMT200005614	K02128	ko05012	Parkinson's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMT200005614	K02128	ko05016	Huntington's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMT200031648	K02990	ko03010	Ribosome	221	2.4e-06	0.40	0.55	0.50
PGSC0003DMT200031650	K10601	ko04120	Ubiquitin mediated proteolysis	246	2.1e-07	0.29	0.50	0.80
PGSC0003DMT200031681	K03217	ko03060	Protein export	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMT200031681	K03217	ko03070	Bacterial secretion system	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMT200031682	K03217	ko03060	Protein export	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMT200031682	K03217	ko03070	Bacterial secretion system	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMT200031683	K01897	ko00071	Fatty acid metabolism	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMT200031683	K01897	ko01100	Metabolic pathways	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMT200031683	K01897	ko03320	PPAR signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMT200031683	K01897	ko04146	Peroxisome	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMT200031683	K01897	ko04920	Adipocytokine signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMT200031684	K01897	ko00071	Fatty acid metabolism	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMT200031684	K01897	ko01100	Metabolic pathways	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMT200031684	K01897	ko03320	PPAR signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMT200031684	K01897	ko04146	Peroxisome	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMT200031684	K01897	ko04920	Adipocytokine signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMT200031687	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200031687	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200031687	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMT200042639	K02922	ko03010	Ribosome	700	9.0e-33	0.96	0.99	0.75
PGSC0003DMT200042640	K02922	ko03010	Ribosome	775	6.5e-37	0.93	0.98	0.99
PGSC0003DMT200042644	K05282	ko00904	Diterpenoid biosynthesis	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMT200042644	K05282	ko01100	Metabolic pathways	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMT200042644	K05282	ko01110	Biosynthesis of secondary metabolites	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMT200052094	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMT200052094	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMT200052097	K06670	ko04110	Cell cycle	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMT200052097	K06670	ko04111	Cell cycle - yeast	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMT200052098	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMT200052098	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMT200052104	K00413	ko00190	Oxidative phosphorylation	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052104	K00413	ko01100	Metabolic pathways	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052104	K00413	ko04260	Cardiac muscle contraction	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052104	K00413	ko05010	Alzheimer's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052104	K00413	ko05012	Parkinson's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052104	K00413	ko05016	Huntington's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMT200052114	K11584	ko04113	Meiosis - yeast	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMT200052114	K11584	ko04114	Oocyte meiosis	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMT200052114	K11584	ko04310	Wnt signaling pathway	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMT200052115	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052115	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052115	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052116	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052116	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052116	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMT200052118	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMT200052118	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMT200052119	K01066	ko00623	2,4-Dichlorobenzoate degradation	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMT200052119	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMT200052121	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMT200052121	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMT200052122	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMT200052122	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMT200077762	K08241	ko00592	alpha-Linolenic acid metabolism	517	1.1e-22	0.36	0.55	0.93
PGSC0003DMT200077764	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.37	0.53	0.96
PGSC0003DMT200077766	K08241	ko00592	alpha-Linolenic acid metabolism	705	4.8e-33	0.33	0.53	0.98
PGSC0003DMT200077767	K08241	ko00592	alpha-Linolenic acid metabolism	707	3.7e-33	0.33	0.53	0.99
PGSC0003DMT200077768	K08241	ko00592	alpha-Linolenic acid metabolism	711	2.2e-33	0.33	0.53	0.99
PGSC0003DMT200077774	K01719	ko00860	Porphyrin and chlorophyll metabolism	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMT200077774	K01719	ko01100	Metabolic pathways	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMT200077774	K01719	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMT200077781	K07374	ko04145	Phagosome	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMT200077781	K07374	ko04540	Gap junction	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMT200077781	K07374	ko05130	Pathogenic Escherichia coli infection	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMT200077785	K02266	ko00190	Oxidative phosphorylation	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200077785	K02266	ko01100	Metabolic pathways	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200077785	K02266	ko04260	Cardiac muscle contraction	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200077785	K02266	ko05010	Alzheimer's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200077785	K02266	ko05012	Parkinson's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200077785	K02266	ko05016	Huntington's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMT200065924	K12600	ko03018	RNA degradation	5837	0.	0.61	0.78	0.98
PGSC0003DMT200065925	K12600	ko03018	RNA degradation	4120	2.1e-221	0.58	0.75	0.95
PGSC0003DMT200065926	K03132	ko03022	Basal transcription factors	1058	1.6e-52	0.84	0.97	0.92
PGSC0003DMT200065927	K03132	ko03022	Basal transcription factors	651	4.5e-30	0.70	0.80	0.99
PGSC0003DMT200065928	K03132	ko03022	Basal transcription factors	1236	2.5e-62	0.75	0.88	0.99
PGSC0003DMT200065933	K10352	ko04530	Tight junction	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMT200065933	K10352	ko05416	Viral myocarditis	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMT200065950	K10591	ko04120	Ubiquitin mediated proteolysis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMT200065950	K10591	ko04144	Endocytosis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMT200065951	K10591	ko04120	Ubiquitin mediated proteolysis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMT200065951	K10591	ko04144	Endocytosis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMT200065968	K09756	ko00940	Phenylpropanoid biosynthesis	1262	9.0e-64	0.41	0.57	0.80
PGSC0003DMT200065969	K09756	ko00940	Phenylpropanoid biosynthesis	1607	8.4e-83	0.45	0.62	0.99
PGSC0003DMT200048671	K10527	ko00592	alpha-Linolenic acid metabolism	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMT200048671	K10527	ko01100	Metabolic pathways	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMT200048672	K10527	ko00592	alpha-Linolenic acid metabolism	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMT200048672	K10527	ko01100	Metabolic pathways	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMT200048679	K00422	ko00350	Tyrosine metabolism	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMT200048679	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMT200048679	K00422	ko01100	Metabolic pathways	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMT200048679	K00422	ko01110	Biosynthesis of secondary metabolites	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMT200048681	K00422	ko00350	Tyrosine metabolism	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMT200048681	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMT200048681	K00422	ko01100	Metabolic pathways	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMT200048681	K00422	ko01110	Biosynthesis of secondary metabolites	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMT200048684	K00422	ko00350	Tyrosine metabolism	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMT200048684	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMT200048684	K00422	ko01100	Metabolic pathways	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMT200048684	K00422	ko01110	Biosynthesis of secondary metabolites	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMT200048685	K00422	ko00350	Tyrosine metabolism	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMT200048685	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMT200048685	K00422	ko01100	Metabolic pathways	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMT200048685	K00422	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMT200048690	K00422	ko00350	Tyrosine metabolism	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMT200048690	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMT200048690	K00422	ko01100	Metabolic pathways	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMT200048690	K00422	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMT200048692	K00422	ko00350	Tyrosine metabolism	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMT200048692	K00422	ko00950	Isoquinoline alkaloid biosynthesis	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMT200048692	K00422	ko01100	Metabolic pathways	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMT200048692	K00422	ko01110	Biosynthesis of secondary metabolites	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMT200048703	K00422	ko00350	Tyrosine metabolism	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMT200048703	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMT200048703	K00422	ko01100	Metabolic pathways	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMT200048703	K00422	ko01110	Biosynthesis of secondary metabolites	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMT200048706	K00422	ko00350	Tyrosine metabolism	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMT200048706	K00422	ko00950	Isoquinoline alkaloid biosynthesis	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMT200048706	K00422	ko01100	Metabolic pathways	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMT200048706	K00422	ko01110	Biosynthesis of secondary metabolites	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMT200086060	K11294	ko05130	Pathogenic Escherichia coli infection	315	2.3e-11	0.28	0.49	0.56
PGSC0003DMT200086067	K02951	ko03010	Ribosome	328	3.0e-12	0.49	0.60	0.58
PGSC0003DMT200075284	K07195	ko04910	Insulin signaling pathway	3992	2.4e-214	0.70	0.85	1.00
PGSC0003DMT200075291	K02991	ko03010	Ribosome	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMT200075291	K02991	ko04150	mTOR signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMT200075291	K02991	ko04910	Insulin signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMT200050076	K01807	ko00030	Pentose phosphate pathway	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMT200050076	K01807	ko00710	Carbon fixation in photosynthetic organisms	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMT200050076	K01807	ko01100	Metabolic pathways	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMT200050076	K01807	ko01110	Biosynthesis of secondary metabolites	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMT200032637	K13065	ko00940	Phenylpropanoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMT200032637	K13065	ko00941	Flavonoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMT200032637	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMT200032637	K13065	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMT200032639	K13065	ko00940	Phenylpropanoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMT200032639	K13065	ko00941	Flavonoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMT200032639	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMT200032639	K13065	ko01110	Biosynthesis of secondary metabolites	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMT200032640	K13065	ko00940	Phenylpropanoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMT200032640	K13065	ko00941	Flavonoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMT200032640	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMT200032640	K13065	ko01110	Biosynthesis of secondary metabolites	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMT200032641	K13065	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMT200032641	K13065	ko00941	Flavonoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMT200032641	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMT200032641	K13065	ko01110	Biosynthesis of secondary metabolites	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMT200032643	K13065	ko00940	Phenylpropanoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMT200032643	K13065	ko00941	Flavonoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMT200032643	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMT200032643	K13065	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMT200032651	K13065	ko00940	Phenylpropanoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMT200032651	K13065	ko00941	Flavonoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMT200032651	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMT200032651	K13065	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMT200032664	K05849	ko04020	Calcium signaling pathway	240	1.1e-06	0.37	0.54	0.39
PGSC0003DMT200032670	K05681	ko02010	ABC transporters	1176	5.0e-59	0.36	0.53	0.90
PGSC0003DMT200007173	K01507	ko00190	Oxidative phosphorylation	5592	0.	0.89	0.95	1.00
PGSC0003DMT200007177	K08057	ko04145	Phagosome	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMT200007177	K08057	ko04612	Antigen processing and presentation	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMT200007177	K08057	ko05142	Chagas disease	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMT200007182	K00382	ko00010	Glycolysis / Gluconeogenesis	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko00020	Citrate cycle (TCA cycle)	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko00260	Glycine, serine and threonine metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko00280	Valine, leucine and isoleucine degradation	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko00620	Pyruvate metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko01100	Metabolic pathways	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007182	K00382	ko01110	Biosynthesis of secondary metabolites	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMT200007189	K02716	ko00195	Photosynthesis	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMT200007189	K02716	ko01100	Metabolic pathways	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMT200021752	K00963	ko00040	Pentose and glucuronate interconversions	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021752	K00963	ko00052	Galactose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021752	K00963	ko00500	Starch and sucrose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021752	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021752	K00963	ko01100	Metabolic pathways	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021752	K00963	ko01110	Biosynthesis of secondary metabolites	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMT200021753	K02934	ko03010	Ribosome	1575	4.9e-81	0.79	0.89	1.00
PGSC0003DMT200021758	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021758	K01580	ko00410	beta-Alanine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021758	K01580	ko00430	Taurine and hypotaurine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021758	K01580	ko00650	Butanoate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021758	K01580	ko01100	Metabolic pathways	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021758	K01580	ko04940	Type I diabetes mellitus	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMT200021759	K01580	ko00250	Alanine, aspartate and glutamate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021759	K01580	ko00410	beta-Alanine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021759	K01580	ko00430	Taurine and hypotaurine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021759	K01580	ko00650	Butanoate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021759	K01580	ko01100	Metabolic pathways	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021759	K01580	ko04940	Type I diabetes mellitus	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMT200021760	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021760	K01580	ko00410	beta-Alanine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021760	K01580	ko00430	Taurine and hypotaurine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021760	K01580	ko00650	Butanoate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021760	K01580	ko01100	Metabolic pathways	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021760	K01580	ko04940	Type I diabetes mellitus	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMT200021796	K03004	ko00230	Purine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMT200021796	K03004	ko00240	Pyrimidine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMT200021796	K03004	ko01100	Metabolic pathways	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMT200021796	K03004	ko03020	RNA polymerase	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMT200021797	K03004	ko00230	Purine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMT200021797	K03004	ko00240	Pyrimidine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMT200021797	K03004	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMT200021797	K03004	ko03020	RNA polymerase	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMT200021798	K08272	ko04150	mTOR signaling pathway	2402	1.2e-126	0.85	0.94	0.99
PGSC0003DMT200021800	K12462	ko04722	Neurotrophin signaling pathway	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMT200021800	K12462	ko04962	Vasopressin-regulated water reabsorption	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMT200021801	K10591	ko04120	Ubiquitin mediated proteolysis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMT200021801	K10591	ko04144	Endocytosis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMT200021802	K10591	ko04120	Ubiquitin mediated proteolysis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMT200021802	K10591	ko04144	Endocytosis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMT200041244	K02990	ko03010	Ribosome	352	1.4e-13	0.34	0.55	0.48
PGSC0003DMT200041254	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMT200041254	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMT200041254	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMT200041254	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMT200041255	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMT200041255	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMT200041255	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMT200041255	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMT200041256	K05350	ko00460	Cyanoamino acid metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMT200041256	K05350	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMT200041256	K05350	ko00940	Phenylpropanoid biosynthesis	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMT200041256	K05350	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMT200041257	K05350	ko00460	Cyanoamino acid metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMT200041257	K05350	ko00500	Starch and sucrose metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMT200041257	K05350	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMT200041257	K05350	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMT200041258	K05350	ko00460	Cyanoamino acid metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMT200041258	K05350	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMT200041258	K05350	ko00940	Phenylpropanoid biosynthesis	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMT200041258	K05350	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMT200041259	K05350	ko00460	Cyanoamino acid metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMT200041259	K05350	ko00500	Starch and sucrose metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMT200041259	K05350	ko00940	Phenylpropanoid biosynthesis	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMT200041259	K05350	ko01110	Biosynthesis of secondary metabolites	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMT200041266	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMT200041266	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMT200001620	K10595	ko04120	Ubiquitin mediated proteolysis	300	4.6e-08	0.43	0.58	0.27
PGSC0003DMT200001637	K01184	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMT200001637	K01184	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMT200001637	K01184	ko01100	Metabolic pathways	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMT200001638	K01184	ko00040	Pentose and glucuronate interconversions	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMT200001638	K01184	ko00500	Starch and sucrose metabolism	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMT200001638	K01184	ko01100	Metabolic pathways	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMT200001650	K01115	ko00564	Glycerophospholipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001650	K01115	ko00565	Ether lipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001650	K01115	ko01100	Metabolic pathways	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001650	K01115	ko04144	Endocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001650	K01115	ko04666	Fc gamma R-mediated phagocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001650	K01115	ko04912	GnRH signaling pathway	5605	0.	0.77	0.90	1.00
PGSC0003DMT200001651	K01115	ko00564	Glycerophospholipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200001651	K01115	ko00565	Ether lipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200001651	K01115	ko01100	Metabolic pathways	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200001651	K01115	ko04144	Endocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200001651	K01115	ko04666	Fc gamma R-mediated phagocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200001651	K01115	ko04912	GnRH signaling pathway	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMT200061538	K10875	ko03440	Homologous recombination	630	6.5e-29	0.29	0.48	0.83
PGSC0003DMT200061539	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMT200061540	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMT200061542	K00368	ko00910	Nitrogen metabolism	1965	1.5e-102	0.47	0.61	0.92
PGSC0003DMT200061547	K02160	ko00061	Fatty acid biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061547	K02160	ko00253	Tetracycline biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061547	K02160	ko00620	Pyruvate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061547	K02160	ko00640	Propanoate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061547	K02160	ko01100	Metabolic pathways	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061547	K02160	ko01110	Biosynthesis of secondary metabolites	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMT200061552	K12586	ko03018	RNA degradation	534	1.1e-22	0.52	0.69	0.95
PGSC0003DMT200061553	K12586	ko03018	RNA degradation	828	3.6e-39	0.43	0.59	0.95
PGSC0003DMT200061577	K10743	ko03030	DNA replication	2030	3.9e-106	0.81	0.90	1.00
PGSC0003DMT200046698	K00058	ko00260	Glycine, serine and threonine metabolism	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMT200046698	K00058	ko01100	Metabolic pathways	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMT200046700	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMT200046700	K00517	ko00626	Naphthalene and anthracene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMT200046700	K00517	ko00903	Limonene and pinene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMT200046700	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMT200046700	K00517	ko01110	Biosynthesis of secondary metabolites	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMT200046701	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMT200046701	K00517	ko00626	Naphthalene and anthracene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMT200046701	K00517	ko00903	Limonene and pinene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMT200046701	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMT200046701	K00517	ko01110	Biosynthesis of secondary metabolites	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMT200046704	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMT200046704	K00517	ko00626	Naphthalene and anthracene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMT200046704	K00517	ko00903	Limonene and pinene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMT200046704	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMT200046704	K00517	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMT200046706	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMT200046706	K00517	ko00626	Naphthalene and anthracene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMT200046706	K00517	ko00903	Limonene and pinene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMT200046706	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMT200046706	K00517	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMT200046707	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMT200046707	K00517	ko00626	Naphthalene and anthracene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMT200046707	K00517	ko00903	Limonene and pinene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMT200046707	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMT200046707	K00517	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMT200046710	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMT200046710	K00517	ko00626	Naphthalene and anthracene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMT200046710	K00517	ko00903	Limonene and pinene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMT200046710	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMT200046710	K00517	ko01110	Biosynthesis of secondary metabolites	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMT200046711	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMT200046711	K00517	ko00626	Naphthalene and anthracene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMT200046711	K00517	ko00903	Limonene and pinene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMT200046711	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMT200046711	K00517	ko01110	Biosynthesis of secondary metabolites	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMT200046712	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMT200046712	K00517	ko00626	Naphthalene and anthracene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMT200046712	K00517	ko00903	Limonene and pinene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMT200046712	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMT200046712	K00517	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMT200046713	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMT200046713	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMT200046713	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMT200046713	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMT200046713	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMT200046714	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMT200046714	K00517	ko00626	Naphthalene and anthracene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMT200046714	K00517	ko00903	Limonene and pinene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMT200046714	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMT200046714	K00517	ko01110	Biosynthesis of secondary metabolites	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMT200046715	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMT200046715	K00517	ko00626	Naphthalene and anthracene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMT200046715	K00517	ko00903	Limonene and pinene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMT200046715	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMT200046715	K00517	ko01110	Biosynthesis of secondary metabolites	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMT200046716	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMT200046716	K00517	ko00626	Naphthalene and anthracene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMT200046716	K00517	ko00903	Limonene and pinene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMT200046716	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMT200046716	K00517	ko01110	Biosynthesis of secondary metabolites	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMT200046718	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMT200046718	K00517	ko00626	Naphthalene and anthracene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMT200046718	K00517	ko00903	Limonene and pinene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMT200046718	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMT200046718	K00517	ko01110	Biosynthesis of secondary metabolites	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMT200046720	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMT200046720	K00517	ko00626	Naphthalene and anthracene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMT200046720	K00517	ko00903	Limonene and pinene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMT200046720	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMT200046720	K00517	ko01110	Biosynthesis of secondary metabolites	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMT200046721	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMT200046721	K00517	ko00626	Naphthalene and anthracene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMT200046721	K00517	ko00903	Limonene and pinene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMT200046721	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMT200046721	K00517	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMT200046722	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMT200046722	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMT200046722	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMT200046722	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMT200046722	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMT200046723	K01728	ko00040	Pentose and glucuronate interconversions	1843	8.1e-96	0.56	0.71	0.90
PGSC0003DMT200046724	K05648	ko02010	ABC transporters	1155	7.9e-58	0.32	0.49	0.63
PGSC0003DMT200046727	K05648	ko02010	ABC transporters	1267	4.8e-64	0.32	0.50	0.73
PGSC0003DMT200046731	K04728	ko04110	Cell cycle	14735	0.	0.61	0.75	0.96
PGSC0003DMT200046731	K04728	ko04115	p53 signaling pathway	14735	0.	0.61	0.75	0.96
PGSC0003DMT200046731	K04728	ko04210	Apoptosis	14735	0.	0.61	0.75	0.96
PGSC0003DMT200046736	K09680	ko00770	Pantothenate and CoA biosynthesis	6275	0.	0.84	0.90	0.98
PGSC0003DMT200046736	K09680	ko01100	Metabolic pathways	6275	0.	0.84	0.90	0.98
PGSC0003DMT200074098	K02183	ko04020	Calcium signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04070	Phosphatidylinositol signaling system	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04114	Oocyte meiosis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04270	Vascular smooth muscle contraction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04626	Plant-pathogen interaction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04720	Long-term potentiation	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04722	Neurotrophin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04740	Olfactory transduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04744	Phototransduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04745	Phototransduction - fly	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04910	Insulin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04912	GnRH signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04916	Melanogenesis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04970	Salivary secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko04971	Gastric acid secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko05010	Alzheimer's disease	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074098	K02183	ko05214	Glioma	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMT200074099	K05929	ko00564	Glycerophospholipid metabolism	767	1.8e-36	0.41	0.60	0.51
PGSC0003DMT200074100	K01613	ko00564	Glycerophospholipid metabolism	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMT200074100	K01613	ko01100	Metabolic pathways	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMT200074106	K12311	ko00511	Other glycan degradation	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMT200074106	K12311	ko04142	Lysosome	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMT200074107	K12311	ko00511	Other glycan degradation	6314	0.	0.73	0.84	0.98
PGSC0003DMT200074107	K12311	ko04142	Lysosome	6314	0.	0.73	0.84	0.98
PGSC0003DMT200074110	K10757	ko00944	Flavone and flavonol biosynthesis	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMT200074110	K10757	ko01100	Metabolic pathways	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMT200074110	K10757	ko01110	Biosynthesis of secondary metabolites	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMT200074113	K12617	ko03018	RNA degradation	4534	3.1e-244	0.68	0.79	1.00
PGSC0003DMT200074117	K13229	ko00402	Benzoxazinoid biosynthesis	988	1.2e-48	0.48	0.66	1.00
PGSC0003DMT200074120	K13229	ko00402	Benzoxazinoid biosynthesis	1238	1.9e-62	0.44	0.62	0.99
PGSC0003DMT200074121	K13229	ko00402	Benzoxazinoid biosynthesis	535	1.1e-23	0.41	0.62	0.96
PGSC0003DMT200056545	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMT200056546	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMT200056552	K02084	ko04115	p53 signaling pathway	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko04210	Apoptosis	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko05010	Alzheimer's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko05012	Parkinson's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko05016	Huntington's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056552	K02084	ko05222	Small cell lung cancer	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMT200056562	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMT200056562	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMT200056563	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMT200056563	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMT200056572	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMT200056573	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMT200079581	K04733	ko04210	Apoptosis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMT200079581	K04733	ko04620	Toll-like receptor signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMT200079581	K04733	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMT200079581	K04733	ko05140	Leishmaniasis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMT200079581	K04733	ko05142	Chagas disease	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMT200079590	K04424	ko04010	MAPK signaling pathway	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMT200079590	K04424	ko04530	Tight junction	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMT200079605	K07466	ko03030	DNA replication	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMT200079605	K07466	ko03420	Nucleotide excision repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMT200079605	K07466	ko03430	Mismatch repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMT200079605	K07466	ko03440	Homologous recombination	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMT200079606	K00001	ko00010	Glycolysis / Gluconeogenesis	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00071	Fatty acid metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00350	Tyrosine metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00624	1- and 2-Methylnaphthalene degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00641	3-Chloroacrylic acid degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00830	Retinol metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko00982	Drug metabolism - cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko01100	Metabolic pathways	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079606	K00001	ko01110	Biosynthesis of secondary metabolites	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMT200079611	K08766	ko00071	Fatty acid metabolism	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMT200079611	K08766	ko03320	PPAR signaling pathway	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMT200027851	K04392	ko04010	MAPK signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04062	Chemokine signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04145	Phagosome	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04310	Wnt signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04360	Axon guidance	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04370	VEGF signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04510	Focal adhesion	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04520	Adherens junction	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04620	Toll-like receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04650	Natural killer cell mediated cytotoxicity	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04662	B cell receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04664	Fc epsilon RI signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04666	Fc gamma R-mediated phagocytosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04670	Leukocyte transendothelial migration	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04722	Neurotrophin signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko04810	Regulation of actin cytoskeleton	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05100	Bacterial invasion of epithelial cells	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05131	Shigellosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05200	Pathways in cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05210	Colorectal cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05211	Renal cell carcinoma	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05212	Pancreatic cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027851	K04392	ko05416	Viral myocarditis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMT200027852	K04392	ko04010	MAPK signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04062	Chemokine signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04145	Phagosome	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04310	Wnt signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04360	Axon guidance	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04370	VEGF signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04510	Focal adhesion	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04520	Adherens junction	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04620	Toll-like receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04650	Natural killer cell mediated cytotoxicity	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04662	B cell receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04664	Fc epsilon RI signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04666	Fc gamma R-mediated phagocytosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04670	Leukocyte transendothelial migration	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04722	Neurotrophin signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko04810	Regulation of actin cytoskeleton	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05100	Bacterial invasion of epithelial cells	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05131	Shigellosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05200	Pathways in cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05210	Colorectal cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05211	Renal cell carcinoma	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05212	Pancreatic cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027852	K04392	ko05416	Viral myocarditis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMT200027856	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMT200027856	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMT200027857	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMT200027857	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMT200027859	K07203	ko04012	ErbB signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko04150	mTOR signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko04910	Insulin signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko04920	Adipocytokine signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko04930	Type II diabetes mellitus	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko05200	Pathways in cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko05214	Glioma	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko05215	Prostate cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027859	K07203	ko05221	Acute myeloid leukemia	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMT200027861	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027861	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027863	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027863	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027864	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027864	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027865	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027865	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMT200027867	K07203	ko04012	ErbB signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko04150	mTOR signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko04910	Insulin signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko04920	Adipocytokine signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko04930	Type II diabetes mellitus	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko05200	Pathways in cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko05214	Glioma	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko05215	Prostate cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027867	K07203	ko05221	Acute myeloid leukemia	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMT200027869	K06677	ko04111	Cell cycle - yeast	329	2.6e-11	0.41	0.61	0.84
PGSC0003DMT200027870	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027870	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMT200027871	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200027871	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMT200037070	K12614	ko03018	RNA degradation	797	2.2e-37	0.30	0.51	0.92
PGSC0003DMT200037073	K01553	ko00230	Purine metabolism	439	1.2e-17	0.29	0.49	0.90
PGSC0003DMT200037075	K10846	ko03420	Nucleotide excision repair	543	8.7e-32	0.33	0.47	0.76
PGSC0003DMT200037081	K12478	ko04144	Endocytosis	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMT200037081	K12478	ko04145	Phagosome	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMT200037082	K12478	ko04144	Endocytosis	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMT200037082	K12478	ko04145	Phagosome	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMT200037093	K07375	ko04145	Phagosome	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMT200037093	K07375	ko04540	Gap junction	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMT200037093	K07375	ko05130	Pathogenic Escherichia coli infection	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMT200037094	K07375	ko04145	Phagosome	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMT200037094	K07375	ko04540	Gap junction	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMT200037094	K07375	ko05130	Pathogenic Escherichia coli infection	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMT200037095	K07375	ko04145	Phagosome	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMT200037095	K07375	ko04540	Gap junction	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMT200037095	K07375	ko05130	Pathogenic Escherichia coli infection	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMT200037099	K02957	ko03010	Ribosome	898	1.1e-43	0.86	0.87	0.99
PGSC0003DMT200037104	K10717	ko00908	Zeatin biosynthesis	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMT200037104	K10717	ko01100	Metabolic pathways	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMT200037104	K10717	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMT200009831	K01046	ko00561	Glycerolipid metabolism	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMT200009831	K01046	ko01100	Metabolic pathways	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMT200009841	K12818	ko03040	Spliceosome	1259	1.3e-63	0.43	0.58	0.99
PGSC0003DMT200009842	K12818	ko03040	Spliceosome	1537	6.1e-79	0.52	0.70	0.99
PGSC0003DMT200094453	K07466	ko03030	DNA replication	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMT200094453	K07466	ko03420	Nucleotide excision repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMT200094453	K07466	ko03430	Mismatch repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMT200094453	K07466	ko03440	Homologous recombination	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMT200089461	K03094	ko04110	Cell cycle	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04111	Cell cycle - yeast	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04114	Oocyte meiosis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04120	Ubiquitin mediated proteolysis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04310	Wnt signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04350	TGF-beta signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200089461	K03094	ko04710	Circadian rhythm - mammal	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMT200072411	K00873	ko00010	Glycolysis / Gluconeogenesis	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko00230	Purine metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko00620	Pyruvate metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko00710	Carbon fixation in photosynthetic organisms	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko01100	Metabolic pathways	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072411	K00873	ko04930	Type II diabetes mellitus	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMT200072415	K12185	ko04144	Endocytosis	992	7.0e-49	0.48	0.57	0.99
PGSC0003DMT200072416	K12185	ko04144	Endocytosis	452	4.3e-19	0.55	0.68	0.74
PGSC0003DMT200072417	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMT200072418	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMT200072419	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMT200072420	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMT200072421	K09837	ko00906	Carotenoid biosynthesis	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMT200072421	K09837	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMT200072421	K09837	ko01110	Biosynthesis of secondary metabolites	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMT200072422	K09837	ko00906	Carotenoid biosynthesis	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMT200072422	K09837	ko01100	Metabolic pathways	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMT200072422	K09837	ko01110	Biosynthesis of secondary metabolites	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMT200072423	K09837	ko00906	Carotenoid biosynthesis	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMT200072423	K09837	ko01100	Metabolic pathways	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMT200072423	K09837	ko01110	Biosynthesis of secondary metabolites	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMT200072424	K10603	ko04120	Ubiquitin mediated proteolysis	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMT200072424	K10603	ko05340	Primary immunodeficiency	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMT200072425	K10603	ko04120	Ubiquitin mediated proteolysis	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMT200072425	K10603	ko05340	Primary immunodeficiency	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMT200072426	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMT200072426	K10603	ko05340	Primary immunodeficiency	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMT200072427	K10603	ko04120	Ubiquitin mediated proteolysis	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMT200072427	K10603	ko05340	Primary immunodeficiency	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMT200072428	K10603	ko04120	Ubiquitin mediated proteolysis	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMT200072428	K10603	ko05340	Primary immunodeficiency	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMT200072430	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMT200072430	K10603	ko05340	Primary immunodeficiency	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMT200072437	K00953	ko00740	Riboflavin metabolism	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMT200072437	K00953	ko01100	Metabolic pathways	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMT200072438	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMT200072438	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMT200072439	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMT200072439	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMT200072441	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMT200072441	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMT200072442	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMT200072442	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMT200072444	K00953	ko00740	Riboflavin metabolism	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMT200072444	K00953	ko01100	Metabolic pathways	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMT200044833	K02881	ko03010	Ribosome	728	2.6e-34	0.73	0.88	0.99
PGSC0003DMT200044860	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044860	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044860	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044860	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044860	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044861	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044861	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044861	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044861	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044861	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMT200044863	K12741	ko03040	Spliceosome	618	3.0e-28	0.44	0.51	0.99
PGSC0003DMT200044865	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMT200044866	K12741	ko03040	Spliceosome	1586	1.2e-81	0.54	0.67	0.76
PGSC0003DMT200044867	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMT200054789	K01599	ko00860	Porphyrin and chlorophyll metabolism	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMT200054789	K01599	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMT200054790	K01599	ko00860	Porphyrin and chlorophyll metabolism	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMT200054790	K01599	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMT200054791	K01595	ko00620	Pyruvate metabolism	7497	0.	0.91	0.96	1.00
PGSC0003DMT200054791	K01595	ko00710	Carbon fixation in photosynthetic organisms	7497	0.	0.91	0.96	1.00
PGSC0003DMT200054791	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7497	0.	0.91	0.96	1.00
PGSC0003DMT200054791	K01595	ko01100	Metabolic pathways	7497	0.	0.91	0.96	1.00
PGSC0003DMT200054795	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMT200054809	K06236	ko04510	Focal adhesion	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMT200054809	K06236	ko04512	ECM-receptor interaction	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMT200054809	K06236	ko05146	Amoebiasis	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMT200054814	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMT200054814	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMT200054815	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMT200054815	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMT200081533	K12153	ko00966	Glucosinolate biosynthesis	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMT200081533	K12153	ko01110	Biosynthesis of secondary metabolites	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMT200081715	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMT200081715	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMT200081725	K01239	ko00230	Purine metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMT200081725	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMT200081725	K01239	ko01100	Metabolic pathways	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMT200081726	K01239	ko00230	Purine metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMT200081726	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMT200081726	K01239	ko01100	Metabolic pathways	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMT200081727	K01239	ko00230	Purine metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMT200081727	K01239	ko00760	Nicotinate and nicotinamide metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMT200081727	K01239	ko01100	Metabolic pathways	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMT200094004	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.58	0.66	0.84
PGSC0003DMT200090653	K04428	ko04010	MAPK signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMT200090653	K04428	ko04912	GnRH signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMT200016472	K00100	ko00051	Fructose and mannose metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016472	K00100	ko00363	Bisphenol A degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016472	K00100	ko00591	Linoleic acid metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016472	K00100	ko00625	Tetrachloroethene degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016472	K00100	ko00650	Butanoate metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016472	K00100	ko01100	Metabolic pathways	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMT200016473	K00100	ko00051	Fructose and mannose metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016473	K00100	ko00363	Bisphenol A degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016473	K00100	ko00591	Linoleic acid metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016473	K00100	ko00625	Tetrachloroethene degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016473	K00100	ko00650	Butanoate metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016473	K00100	ko01100	Metabolic pathways	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMT200016479	K05275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMT200016479	K05275	ko01100	Metabolic pathways	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMT200016480	K00100	ko00051	Fructose and mannose metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016480	K00100	ko00363	Bisphenol A degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016480	K00100	ko00591	Linoleic acid metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016480	K00100	ko00625	Tetrachloroethene degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016480	K00100	ko00650	Butanoate metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016480	K00100	ko01100	Metabolic pathways	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMT200016481	K00100	ko00051	Fructose and mannose metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016481	K00100	ko00363	Bisphenol A degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016481	K00100	ko00591	Linoleic acid metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016481	K00100	ko00625	Tetrachloroethene degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016481	K00100	ko00650	Butanoate metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016481	K00100	ko01100	Metabolic pathways	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMT200016482	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016482	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016482	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016482	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016482	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016482	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMT200016483	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016483	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016483	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016483	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016483	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016483	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMT200016484	K00100	ko00051	Fructose and mannose metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016484	K00100	ko00363	Bisphenol A degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016484	K00100	ko00591	Linoleic acid metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016484	K00100	ko00625	Tetrachloroethene degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016484	K00100	ko00650	Butanoate metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016484	K00100	ko01100	Metabolic pathways	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko00051	Fructose and mannose metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko00363	Bisphenol A degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko00591	Linoleic acid metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko00625	Tetrachloroethene degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko00650	Butanoate metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016485	K00100	ko01100	Metabolic pathways	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMT200016486	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016486	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016486	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016486	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016486	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016486	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMT200016488	K00100	ko00051	Fructose and mannose metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016488	K00100	ko00363	Bisphenol A degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016488	K00100	ko00591	Linoleic acid metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016488	K00100	ko00625	Tetrachloroethene degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016488	K00100	ko00650	Butanoate metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016488	K00100	ko01100	Metabolic pathways	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMT200016492	K11251	ko05322	Systemic lupus erythematosus	521	6.7e-23	0.88	0.92	0.96
PGSC0003DMT200016493	K11251	ko05322	Systemic lupus erythematosus	1042	1.2e-51	0.91	0.92	0.99
PGSC0003DMT200029607	K03869	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.36	0.56	0.98
PGSC0003DMT200029608	K08065	ko04612	Antigen processing and presentation	564	2.8e-25	0.57	0.74	0.85
PGSC0003DMT200029617	K06632	ko04110	Cell cycle	843	5.6e-50	0.76	0.86	0.90
PGSC0003DMT200029618	K06632	ko04110	Cell cycle	2330	1.1e-122	0.79	0.89	0.94
PGSC0003DMT200029619	K06632	ko04110	Cell cycle	2132	9.3e-112	0.79	0.89	0.92
PGSC0003DMT200029621	K00416	ko00190	Oxidative phosphorylation	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029621	K00416	ko01100	Metabolic pathways	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029621	K00416	ko04260	Cardiac muscle contraction	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029621	K00416	ko05010	Alzheimer's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029621	K00416	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029621	K00416	ko05016	Huntington's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMT200029622	K00416	ko00190	Oxidative phosphorylation	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029622	K00416	ko01100	Metabolic pathways	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029622	K00416	ko04260	Cardiac muscle contraction	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029622	K00416	ko05010	Alzheimer's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029622	K00416	ko05012	Parkinson's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029622	K00416	ko05016	Huntington's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMT200029623	K00416	ko00190	Oxidative phosphorylation	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029623	K00416	ko01100	Metabolic pathways	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029623	K00416	ko04260	Cardiac muscle contraction	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029623	K00416	ko05010	Alzheimer's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029623	K00416	ko05012	Parkinson's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029623	K00416	ko05016	Huntington's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMT200029624	K00416	ko00190	Oxidative phosphorylation	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029624	K00416	ko01100	Metabolic pathways	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029624	K00416	ko04260	Cardiac muscle contraction	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029624	K00416	ko05010	Alzheimer's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029624	K00416	ko05012	Parkinson's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029624	K00416	ko05016	Huntington's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMT200029626	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMT200029626	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMT200029627	K03845	ko00510	N-Glycan biosynthesis	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMT200029627	K03845	ko01100	Metabolic pathways	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMT200029628	K03845	ko00510	N-Glycan biosynthesis	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMT200029628	K03845	ko01100	Metabolic pathways	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMT200029629	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMT200029629	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMT200029630	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMT200029630	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMT200029631	K03845	ko00510	N-Glycan biosynthesis	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMT200029631	K03845	ko01100	Metabolic pathways	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMT200029632	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMT200029632	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMT200035250	K01853	ko00100	Steroid biosynthesis	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMT200035250	K01853	ko01100	Metabolic pathways	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMT200035250	K01853	ko01110	Biosynthesis of secondary metabolites	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMT200035260	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMT200035260	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMT200035261	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMT200035261	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMT200035262	K00695	ko00500	Starch and sucrose metabolism	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMT200035262	K00695	ko01100	Metabolic pathways	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMT200035263	K00695	ko00500	Starch and sucrose metabolism	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMT200035263	K00695	ko01100	Metabolic pathways	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMT200035264	K00695	ko00500	Starch and sucrose metabolism	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMT200035264	K00695	ko01100	Metabolic pathways	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMT200035268	K08008	ko04145	Phagosome	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMT200035268	K08008	ko04670	Leukocyte transendothelial migration	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMT200035269	K08008	ko04145	Phagosome	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMT200035269	K08008	ko04670	Leukocyte transendothelial migration	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMT200035270	K08008	ko04145	Phagosome	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMT200035270	K08008	ko04670	Leukocyte transendothelial migration	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMT200035274	K01051	ko00040	Pentose and glucuronate interconversions	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMT200035274	K01051	ko00500	Starch and sucrose metabolism	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMT200035274	K01051	ko01100	Metabolic pathways	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMT200035281	K12356	ko00940	Phenylpropanoid biosynthesis	461	1.4e-19	0.47	0.65	0.93
PGSC0003DMT200035285	K10595	ko04120	Ubiquitin mediated proteolysis	731	1.5e-34	0.35	0.51	0.97
PGSC0003DMT200035288	K00161	ko00010	Glycolysis / Gluconeogenesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko00620	Pyruvate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko00650	Butanoate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko01100	Metabolic pathways	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200035288	K00161	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMT200011582	K08490	ko04130	SNARE interactions in vesicular transport	1791	6.0e-93	0.75	0.83	0.99
PGSC0003DMT200011583	K08490	ko04130	SNARE interactions in vesicular transport	465	8.2e-20	0.71	0.83	0.67
PGSC0003DMT200011584	K08490	ko04130	SNARE interactions in vesicular transport	2178	2.7e-114	0.76	0.85	1.00
PGSC0003DMT200011587	K02877	ko03010	Ribosome	337	9.4e-13	0.65	0.75	0.83
PGSC0003DMT200011609	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011609	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011609	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011610	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMT200011610	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMT200011610	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMT200011611	K11755	ko00340	Histidine metabolism	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMT200011611	K11755	ko01100	Metabolic pathways	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMT200011611	K11755	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMT200011612	K11755	ko00340	Histidine metabolism	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMT200011612	K11755	ko01100	Metabolic pathways	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMT200011612	K11755	ko01110	Biosynthesis of secondary metabolites	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMT200011613	K11755	ko00340	Histidine metabolism	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMT200011613	K11755	ko01100	Metabolic pathways	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMT200011613	K11755	ko01110	Biosynthesis of secondary metabolites	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMT200011614	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011614	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011614	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMT200011616	K11755	ko00340	Histidine metabolism	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMT200011616	K11755	ko01100	Metabolic pathways	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMT200011616	K11755	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMT200051939	K01728	ko00040	Pentose and glucuronate interconversions	2893	9.9e-154	0.78	0.87	0.97
PGSC0003DMT200051940	K12859	ko03040	Spliceosome	403	2.2e-16	0.41	0.58	0.89
PGSC0003DMT200051951	K10782	ko00061	Fatty acid biosynthesis	2144	2.0e-112	0.76	0.87	0.90
PGSC0003DMT200051953	K03007	ko00230	Purine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMT200051953	K03007	ko00240	Pyrimidine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMT200051953	K03007	ko01100	Metabolic pathways	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMT200051953	K03007	ko03020	RNA polymerase	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMT200051953	K03007	ko05016	Huntington's disease	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMT200051954	K03007	ko00230	Purine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMT200051954	K03007	ko00240	Pyrimidine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMT200051954	K03007	ko01100	Metabolic pathways	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMT200051954	K03007	ko03020	RNA polymerase	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMT200051954	K03007	ko05016	Huntington's disease	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMT200051962	K10949	ko05110	Vibrio cholerae infection	489	3.9e-21	0.33	0.55	0.82
PGSC0003DMT200051966	K10949	ko05110	Vibrio cholerae infection	512	2.1e-22	0.35	0.57	0.82
PGSC0003DMT200051967	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMT200051967	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMT200051967	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMT200051967	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMT200051967	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMT200051968	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMT200051968	K00517	ko00626	Naphthalene and anthracene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMT200051968	K00517	ko00903	Limonene and pinene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMT200051968	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMT200051968	K00517	ko01110	Biosynthesis of secondary metabolites	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMT200051969	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMT200051969	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMT200051969	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMT200051969	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMT200051969	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMT200077010	K01184	ko00040	Pentose and glucuronate interconversions	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMT200077010	K01184	ko00500	Starch and sucrose metabolism	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMT200077010	K01184	ko01100	Metabolic pathways	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMT200077023	K12667	ko00510	N-Glycan biosynthesis	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMT200077023	K12667	ko01100	Metabolic pathways	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMT200077024	K12667	ko00510	N-Glycan biosynthesis	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMT200077024	K12667	ko01100	Metabolic pathways	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMT200066501	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066501	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066501	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066501	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066502	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066502	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066502	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066502	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066503	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066503	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066503	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066503	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMT200066504	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066504	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066504	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066504	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMT200066505	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMT200066505	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMT200066505	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMT200066505	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMT200066507	K13065	ko00940	Phenylpropanoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMT200066507	K13065	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMT200066507	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMT200066507	K13065	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMT200066517	K10352	ko04530	Tight junction	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMT200066517	K10352	ko05416	Viral myocarditis	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMT200066521	K01952	ko00230	Purine metabolism	6579	0.	0.84	0.92	1.00
PGSC0003DMT200066521	K01952	ko01100	Metabolic pathways	6579	0.	0.84	0.92	1.00
PGSC0003DMT200066521	K01952	ko01110	Biosynthesis of secondary metabolites	6579	0.	0.84	0.92	1.00
PGSC0003DMT200086307	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2276	1.1e-119	0.64	0.79	1.00
PGSC0003DMT200086310	K10760	ko00908	Zeatin biosynthesis	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMT200086310	K10760	ko01100	Metabolic pathways	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMT200086310	K10760	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMT200005407	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMT200005407	K00517	ko00626	Naphthalene and anthracene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMT200005407	K00517	ko00903	Limonene and pinene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMT200005407	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMT200005407	K00517	ko01110	Biosynthesis of secondary metabolites	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMT200005421	K08505	ko04130	SNARE interactions in vesicular transport	764	2.6e-36	0.68	0.82	0.99
PGSC0003DMT200005425	K02971	ko03010	Ribosome	658	1.9e-30	0.91	0.98	0.99
PGSC0003DMT200005427	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMT200005428	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMT200005429	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMT200005448	K01507	ko00190	Oxidative phosphorylation	812	6.0e-39	0.86	0.93	0.76
PGSC0003DMT200030871	K12356	ko00940	Phenylpropanoid biosynthesis	221	5.5e-06	0.35	0.47	0.52
PGSC0003DMT200030895	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	785	1.8e-37	0.36	0.53	0.87
PGSC0003DMT200030898	K02209	ko03030	DNA replication	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMT200030898	K02209	ko04110	Cell cycle	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMT200030898	K02209	ko04111	Cell cycle - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMT200030898	K02209	ko04113	Meiosis - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMT200030907	K01535	ko00190	Oxidative phosphorylation	6718	0.	0.84	0.92	1.00
PGSC0003DMT200030908	K01535	ko00190	Oxidative phosphorylation	6702	0.	0.84	0.92	1.00
PGSC0003DMT200030909	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMT200030910	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMT200030911	K01535	ko00190	Oxidative phosphorylation	6693	0.	0.84	0.92	1.00
PGSC0003DMT200030912	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMT200043013	K10802	ko03410	Base excision repair	533	1.5e-23	0.48	0.64	0.93
PGSC0003DMT200043026	K03885	ko00190	Oxidative phosphorylation	2389	6.2e-126	0.75	0.86	0.84
PGSC0003DMT200043027	K03885	ko00190	Oxidative phosphorylation	2660	7.0e-141	0.75	0.86	0.98
PGSC0003DMT200043028	K03885	ko00190	Oxidative phosphorylation	2915	6.1e-155	0.75	0.87	1.00
PGSC0003DMT200043029	K03885	ko00190	Oxidative phosphorylation	1087	4.1e-54	0.75	0.87	0.73
PGSC0003DMT200043030	K03885	ko00190	Oxidative phosphorylation	2984	9.5e-159	0.74	0.86	0.89
PGSC0003DMT200043031	K03885	ko00190	Oxidative phosphorylation	453	3.8e-19	0.77	0.88	0.99
PGSC0003DMT200043032	K05752	ko04810	Regulation of actin cytoskeleton	618	3.0e-28	0.90	0.99	0.97
PGSC0003DMT200038828	K05743	ko04360	Axon guidance	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMT200038828	K05743	ko04666	Fc gamma R-mediated phagocytosis	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMT200038828	K05743	ko04810	Regulation of actin cytoskeleton	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMT200038835	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038835	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038836	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMT200038845	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.64
PGSC0003DMT200038846	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.61
PGSC0003DMT200042758	K02084	ko04115	p53 signaling pathway	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko04210	Apoptosis	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko05010	Alzheimer's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko05012	Parkinson's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko05016	Huntington's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042758	K02084	ko05222	Small cell lung cancer	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMT200042790	K12126	ko04712	Circadian rhythm - plant	322	4.3e-11	0.29	0.47	0.68
PGSC0003DMT200042791	K12126	ko04712	Circadian rhythm - plant	322	1.4e-10	0.29	0.47	0.66
PGSC0003DMT200042793	K05275	ko00750	Vitamin B6 metabolism	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMT200042793	K05275	ko01100	Metabolic pathways	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMT200042795	K00100	ko00051	Fructose and mannose metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042795	K00100	ko00363	Bisphenol A degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042795	K00100	ko00591	Linoleic acid metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042795	K00100	ko00625	Tetrachloroethene degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042795	K00100	ko00650	Butanoate metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042795	K00100	ko01100	Metabolic pathways	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMT200042796	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042796	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042796	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042796	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042796	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042796	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042797	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042798	K05275	ko00750	Vitamin B6 metabolism	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMT200042798	K05275	ko01100	Metabolic pathways	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMT200042799	K00100	ko00051	Fructose and mannose metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042799	K00100	ko00363	Bisphenol A degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042799	K00100	ko00591	Linoleic acid metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042799	K00100	ko00625	Tetrachloroethene degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042799	K00100	ko00650	Butanoate metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042799	K00100	ko01100	Metabolic pathways	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko00051	Fructose and mannose metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko00363	Bisphenol A degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko00591	Linoleic acid metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko00625	Tetrachloroethene degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko00650	Butanoate metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042800	K00100	ko01100	Metabolic pathways	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMT200042801	K00100	ko00051	Fructose and mannose metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042801	K00100	ko00363	Bisphenol A degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042801	K00100	ko00591	Linoleic acid metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042801	K00100	ko00625	Tetrachloroethene degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042801	K00100	ko00650	Butanoate metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042801	K00100	ko01100	Metabolic pathways	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMT200042802	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042802	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042802	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042802	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042802	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042802	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMT200042803	K00100	ko00051	Fructose and mannose metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042803	K00100	ko00363	Bisphenol A degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042803	K00100	ko00591	Linoleic acid metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042803	K00100	ko00625	Tetrachloroethene degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042803	K00100	ko00650	Butanoate metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042803	K00100	ko01100	Metabolic pathways	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMT200042804	K12356	ko00940	Phenylpropanoid biosynthesis	642	1.4e-29	0.41	0.59	0.90
PGSC0003DMT200042816	K01007	ko00620	Pyruvate metabolism	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMT200042816	K01007	ko00720	Reductive carboxylate cycle (CO2 fixation)	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMT200042816	K01007	ko01100	Metabolic pathways	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMT200023124	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMT200023125	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMT200023126	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMT200023130	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMT200023131	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMT200023134	K10575	ko04120	Ubiquitin mediated proteolysis	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMT200023134	K10575	ko05012	Parkinson's disease	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMT200023140	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMT200023140	K00517	ko00626	Naphthalene and anthracene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMT200023140	K00517	ko00903	Limonene and pinene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMT200023140	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMT200023140	K00517	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMT200023141	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMT200023141	K00517	ko00626	Naphthalene and anthracene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMT200023141	K00517	ko00903	Limonene and pinene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMT200023141	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMT200023141	K00517	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMT200023144	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMT200023144	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMT200023144	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMT200023145	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMT200023145	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMT200023145	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMT200023148	K03126	ko03022	Basal transcription factors	2276	1.1e-119	0.55	0.66	1.00
PGSC0003DMT200012970	K01509	ko00230	Purine metabolism	1248	5.3e-63	0.32	0.45	0.62
PGSC0003DMT200012971	K01509	ko00230	Purine metabolism	1292	2.0e-65	0.32	0.46	0.63
PGSC0003DMT200012973	K04718	ko00600	Sphingolipid metabolism	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMT200012973	K04718	ko01100	Metabolic pathways	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMT200012973	K04718	ko04020	Calcium signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMT200012973	K04718	ko04370	VEGF signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMT200012973	K04718	ko04666	Fc gamma R-mediated phagocytosis	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMT200012974	K04718	ko00600	Sphingolipid metabolism	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMT200012974	K04718	ko01100	Metabolic pathways	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMT200012974	K04718	ko04020	Calcium signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMT200012974	K04718	ko04370	VEGF signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMT200012974	K04718	ko04666	Fc gamma R-mediated phagocytosis	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMT200012975	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012975	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012975	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012975	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012975	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012976	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012976	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012976	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012976	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012976	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMT200012977	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012977	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012977	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012977	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012977	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012978	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012978	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012978	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012978	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012978	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMT200012985	K13065	ko00940	Phenylpropanoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMT200012985	K13065	ko00941	Flavonoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMT200012985	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMT200012985	K13065	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMT200012991	K13065	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMT200012991	K13065	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMT200012991	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMT200012991	K13065	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMT200012995	K00430	ko00360	Phenylalanine metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMT200012995	K00430	ko00680	Methane metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMT200012995	K00430	ko00940	Phenylpropanoid biosynthesis	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMT200012995	K00430	ko01100	Metabolic pathways	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMT200012995	K00430	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMT200013000	K08695	ko00941	Flavonoid biosynthesis	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMT200013000	K08695	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMT200048431	K00558	ko00270	Cysteine and methionine metabolism	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMT200048431	K00558	ko01100	Metabolic pathways	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMT200048460	K02219	ko04111	Cell cycle - yeast	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMT200048460	K02219	ko05200	Pathways in cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMT200048460	K02219	ko05222	Small cell lung cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMT200069552	K10352	ko04530	Tight junction	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMT200069552	K10352	ko05416	Viral myocarditis	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMT200069566	K04649	ko04120	Ubiquitin mediated proteolysis	1368	1.3e-69	0.82	0.92	0.99
PGSC0003DMT200069567	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.62
PGSC0003DMT200069568	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMT200069569	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMT200069571	K00680	ko00350	Tyrosine metabolism	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMT200069571	K00680	ko00624	1- and 2-Methylnaphthalene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMT200069571	K00680	ko00632	Benzoate degradation via CoA ligation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMT200069571	K00680	ko00642	Ethylbenzene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMT200069571	K00680	ko00903	Limonene and pinene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMT200069575	K02984	ko03010	Ribosome	1973	5.5e-103	0.90	0.95	1.00
PGSC0003DMT200069582	K11097	ko03040	Spliceosome	698	1.2e-32	0.95	0.98	0.99
PGSC0003DMT200069583	K00599	ko00340	Histidine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMT200069583	K00599	ko00350	Tyrosine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMT200069583	K00599	ko00450	Selenoamino acid metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMT200069583	K00599	ko00626	Naphthalene and anthracene degradation	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMT200069584	K00599	ko00340	Histidine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMT200069584	K00599	ko00350	Tyrosine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMT200069584	K00599	ko00450	Selenoamino acid metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMT200069584	K00599	ko00626	Naphthalene and anthracene degradation	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMT200059766	K12874	ko03040	Spliceosome	2349	3.1e-125	0.78	0.83	0.90
PGSC0003DMT200059768	K12874	ko03040	Spliceosome	1236	2.5e-62	0.89	0.94	0.84
PGSC0003DMT200059779	K02138	ko00190	Oxidative phosphorylation	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMT200059779	K02138	ko01100	Metabolic pathways	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMT200059779	K02138	ko05010	Alzheimer's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMT200059779	K02138	ko05012	Parkinson's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMT200059779	K02138	ko05016	Huntington's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMT200059780	K02138	ko00190	Oxidative phosphorylation	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMT200059780	K02138	ko01100	Metabolic pathways	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMT200059780	K02138	ko05010	Alzheimer's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMT200059780	K02138	ko05012	Parkinson's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMT200059780	K02138	ko05016	Huntington's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMT200059781	K02138	ko00190	Oxidative phosphorylation	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMT200059781	K02138	ko01100	Metabolic pathways	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMT200059781	K02138	ko05010	Alzheimer's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMT200059781	K02138	ko05012	Parkinson's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMT200059781	K02138	ko05016	Huntington's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMT200059783	K02084	ko04115	p53 signaling pathway	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko04210	Apoptosis	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko05010	Alzheimer's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko05012	Parkinson's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko05016	Huntington's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059783	K02084	ko05222	Small cell lung cancer	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMT200059792	K10591	ko04120	Ubiquitin mediated proteolysis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMT200059792	K10591	ko04144	Endocytosis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMT200059794	K10591	ko04120	Ubiquitin mediated proteolysis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMT200059794	K10591	ko04144	Endocytosis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMT200086139	K04124	ko00904	Diterpenoid biosynthesis	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMT200086139	K04124	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMT200086140	K02639	ko00195	Photosynthesis	845	9.0e-41	0.71	0.81	0.99
PGSC0003DMT200029397	K12133	ko04712	Circadian rhythm - plant	2050	3.1e-107	0.44	0.55	1.00
PGSC0003DMT200029402	K12130	ko04712	Circadian rhythm - plant	1396	3.7e-71	0.40	0.53	0.96
PGSC0003DMT200029404	K00558	ko00270	Cysteine and methionine metabolism	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMT200029404	K00558	ko01100	Metabolic pathways	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMT200029427	K10527	ko00592	alpha-Linolenic acid metabolism	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMT200029427	K10527	ko01100	Metabolic pathways	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMT200029439	K02971	ko03010	Ribosome	645	9.7e-30	0.89	0.95	0.99
PGSC0003DMT200011716	K01275	ko04142	Lysosome	283	9.9e-10	0.34	0.46	0.77
PGSC0003DMT200011717	K01365	ko04142	Lysosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMT200011717	K01365	ko04145	Phagosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMT200011717	K01365	ko04612	Antigen processing and presentation	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMT200011736	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMT200011737	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMT200011741	K00382	ko00010	Glycolysis / Gluconeogenesis	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko00020	Citrate cycle (TCA cycle)	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko00260	Glycine, serine and threonine metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko00280	Valine, leucine and isoleucine degradation	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko00620	Pyruvate metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko01100	Metabolic pathways	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011741	K00382	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMT200011742	K02945	ko03010	Ribosome	2753	5.2e-146	0.80	0.90	1.00
PGSC0003DMT200019942	K00121	ko00010	Glycolysis / Gluconeogenesis	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00071	Fatty acid metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00350	Tyrosine metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00624	1- and 2-Methylnaphthalene degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00641	3-Chloroacrylic acid degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00680	Methane metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00830	Retinol metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko00982	Drug metabolism - cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko01100	Metabolic pathways	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019942	K00121	ko01110	Biosynthesis of secondary metabolites	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMT200019945	K09553	ko05020	Prion diseases	286	1.4e-09	0.36	0.51	0.65
PGSC0003DMT200019946	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMT200019947	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMT200019948	K06061	ko04330	Notch signaling pathway	337	2.0e-09	0.28	0.42	0.49
PGSC0003DMT200019974	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMT200019975	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMT200019977	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMT200019977	K05288	ko01100	Metabolic pathways	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMT200019980	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMT200019980	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMT200019981	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMT200019981	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMT200034366	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMT200034367	K06675	ko04111	Cell cycle - yeast	329	3.3e-11	0.87	0.89	0.81
PGSC0003DMT200034383	K13065	ko00940	Phenylpropanoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMT200034383	K13065	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMT200034383	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMT200034383	K13065	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMT200034385	K13065	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMT200034385	K13065	ko00941	Flavonoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMT200034385	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMT200034385	K13065	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMT200034396	K12929	ko00904	Diterpenoid biosynthesis	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMT200034396	K12929	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMT200034406	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMT200034406	K00517	ko00626	Naphthalene and anthracene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMT200034406	K00517	ko00903	Limonene and pinene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMT200034406	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMT200034406	K00517	ko01110	Biosynthesis of secondary metabolites	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMT200034407	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMT200034407	K00517	ko00626	Naphthalene and anthracene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMT200034407	K00517	ko00903	Limonene and pinene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMT200034407	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMT200034407	K00517	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMT200034421	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMT200034421	K01915	ko00330	Arginine and proline metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMT200034421	K01915	ko00910	Nitrogen metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMT200034421	K01915	ko01100	Metabolic pathways	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMT200034421	K01915	ko02020	Two-component system	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMT200090193	K02940	ko03010	Ribosome	293	2.5e-10	0.62	0.72	0.65
PGSC0003DMT200090198	K05282	ko00904	Diterpenoid biosynthesis	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMT200090198	K05282	ko01100	Metabolic pathways	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMT200090198	K05282	ko01110	Biosynthesis of secondary metabolites	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMT200072205	K00059	ko00061	Fatty acid biosynthesis	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMT200072205	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMT200072205	K00059	ko01100	Metabolic pathways	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMT200072206	K00059	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMT200072206	K00059	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMT200072206	K00059	ko01100	Metabolic pathways	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMT200072207	K00059	ko00061	Fatty acid biosynthesis	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMT200072207	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMT200072207	K00059	ko01100	Metabolic pathways	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMT200072211	K05868	ko04110	Cell cycle	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMT200072211	K05868	ko04115	p53 signaling pathway	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMT200072211	K05868	ko04914	Progesterone-mediated oocyte maturation	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMT200072212	K05868	ko04110	Cell cycle	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMT200072212	K05868	ko04115	p53 signaling pathway	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMT200072212	K05868	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMT200072214	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMT200072214	K01491	ko00670	One carbon pool by folate	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMT200072214	K01491	ko01100	Metabolic pathways	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMT200072215	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMT200072215	K01491	ko00670	One carbon pool by folate	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMT200072215	K01491	ko01100	Metabolic pathways	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMT200072216	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMT200072216	K01491	ko00670	One carbon pool by folate	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMT200072216	K01491	ko01100	Metabolic pathways	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMT200072222	K08503	ko04130	SNARE interactions in vesicular transport	1180	3.0e-59	0.62	0.81	1.00
PGSC0003DMT200072223	K12828	ko03040	Spliceosome	7426	0.	0.72	0.80	0.98
PGSC0003DMT200072226	K02727	ko03050	Proteasome	2013	3.4e-105	0.95	0.98	1.00
PGSC0003DMT200072228	K10583	ko04120	Ubiquitin mediated proteolysis	632	5.0e-29	0.85	0.93	0.92
PGSC0003DMT200072229	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMT200072230	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMT200072233	K10583	ko04120	Ubiquitin mediated proteolysis	792	7.6e-38	0.67	0.77	0.99
PGSC0003DMT200054936	K10591	ko04120	Ubiquitin mediated proteolysis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMT200054936	K10591	ko04144	Endocytosis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMT200054943	K09480	ko00561	Glycerolipid metabolism	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMT200054943	K09480	ko01100	Metabolic pathways	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMT200054944	K09480	ko00561	Glycerolipid metabolism	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMT200054944	K09480	ko01100	Metabolic pathways	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMT200063056	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMT200063056	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMT200063057	K02717	ko00195	Photosynthesis	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMT200063057	K02717	ko01100	Metabolic pathways	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMT200063058	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMT200063058	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMT200063059	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMT200063060	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMT200063061	K05657	ko02010	ABC transporters	916	1.1e-44	0.38	0.56	0.95
PGSC0003DMT200063067	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMT200089009	K07385	ko00902	Monoterpenoid biosynthesis	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMT200089009	K07385	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMT200027616	K06096	ko04530	Tight junction	288	4.8e-10	0.26	0.45	0.80
PGSC0003DMT200027619	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMT200027620	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMT200027640	K07200	ko04910	Insulin signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMT200027640	K07200	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMT200027640	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMT200027641	K07200	ko04910	Insulin signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMT200027641	K07200	ko04920	Adipocytokine signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMT200027641	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMT200027642	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027642	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027642	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027643	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027643	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027643	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMT200027646	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMT200027646	K03785	ko01100	Metabolic pathways	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMT200027646	K03785	ko01110	Biosynthesis of secondary metabolites	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMT200018049	K04506	ko04115	p53 signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMT200018049	K04506	ko04120	Ubiquitin mediated proteolysis	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMT200018049	K04506	ko04310	Wnt signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMT200018050	K01528	ko04144	Endocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMT200018050	K01528	ko04666	Fc gamma R-mediated phagocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMT200018050	K01528	ko05100	Bacterial invasion of epithelial cells	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMT200018051	K01528	ko04144	Endocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMT200018051	K01528	ko04666	Fc gamma R-mediated phagocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMT200018051	K01528	ko05100	Bacterial invasion of epithelial cells	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMT200018059	K13082	ko00941	Flavonoid biosynthesis	1058	1.6e-52	0.44	0.63	0.97
PGSC0003DMT200018060	K08679	ko00500	Starch and sucrose metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMT200018060	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMT200018060	K08679	ko01100	Metabolic pathways	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMT200018061	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMT200018061	K00800	ko01100	Metabolic pathways	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMT200018061	K00800	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMT200018062	K00615	ko00030	Pentose phosphate pathway	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMT200018062	K00615	ko00710	Carbon fixation in photosynthetic organisms	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMT200018062	K00615	ko01051	Biosynthesis of ansamycins	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMT200018062	K00615	ko01100	Metabolic pathways	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMT200018062	K00615	ko01110	Biosynthesis of secondary metabolites	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMT200018063	K10870	ko03440	Homologous recombination	1117	9.0e-56	0.46	0.66	0.91
PGSC0003DMT200018069	K06636	ko04110	Cell cycle	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMT200018069	K06636	ko04111	Cell cycle - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMT200018069	K06636	ko04113	Meiosis - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMT200018069	K06636	ko04114	Oocyte meiosis	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMT200018078	K01178	ko00500	Starch and sucrose metabolism	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMT200018078	K01178	ko01100	Metabolic pathways	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMT200009947	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009947	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009948	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009948	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009949	K10144	ko04115	p53 signaling pathway	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMT200009949	K10144	ko04120	Ubiquitin mediated proteolysis	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMT200009950	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009950	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMT200009953	K00889	ko00562	Inositol phosphate metabolism	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009953	K00889	ko01100	Metabolic pathways	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009953	K00889	ko04070	Phosphatidylinositol signaling system	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009953	K00889	ko04144	Endocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009953	K00889	ko04666	Fc gamma R-mediated phagocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009953	K00889	ko04810	Regulation of actin cytoskeleton	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMT200009954	K00889	ko00562	Inositol phosphate metabolism	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009954	K00889	ko01100	Metabolic pathways	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009954	K00889	ko04070	Phosphatidylinositol signaling system	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009954	K00889	ko04144	Endocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009954	K00889	ko04666	Fc gamma R-mediated phagocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009954	K00889	ko04810	Regulation of actin cytoskeleton	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMT200009955	K00889	ko00562	Inositol phosphate metabolism	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009955	K00889	ko01100	Metabolic pathways	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009955	K00889	ko04070	Phosphatidylinositol signaling system	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009955	K00889	ko04144	Endocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009955	K00889	ko04666	Fc gamma R-mediated phagocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009955	K00889	ko04810	Regulation of actin cytoskeleton	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMT200009956	K00889	ko00562	Inositol phosphate metabolism	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009956	K00889	ko01100	Metabolic pathways	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009956	K00889	ko04070	Phosphatidylinositol signaling system	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009956	K00889	ko04144	Endocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009956	K00889	ko04666	Fc gamma R-mediated phagocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009956	K00889	ko04810	Regulation of actin cytoskeleton	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMT200009967	K10603	ko04120	Ubiquitin mediated proteolysis	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMT200009967	K10603	ko05340	Primary immunodeficiency	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMT200009969	K10603	ko04120	Ubiquitin mediated proteolysis	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMT200009969	K10603	ko05340	Primary immunodeficiency	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMT200009971	K10603	ko04120	Ubiquitin mediated proteolysis	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMT200009971	K10603	ko05340	Primary immunodeficiency	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMT200009973	K10352	ko04530	Tight junction	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMT200009973	K10352	ko05416	Viral myocarditis	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMT200009981	K10527	ko00592	alpha-Linolenic acid metabolism	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMT200009981	K10527	ko01100	Metabolic pathways	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMT200009982	K10527	ko00592	alpha-Linolenic acid metabolism	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMT200009982	K10527	ko01100	Metabolic pathways	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMT200009983	K10527	ko00592	alpha-Linolenic acid metabolism	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMT200009983	K10527	ko01100	Metabolic pathways	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMT200073909	K03707	ko00730	Thiamine metabolism	342	5.0e-13	0.40	0.55	0.30
PGSC0003DMT200073910	K03707	ko00730	Thiamine metabolism	473	3.0e-20	0.38	0.52	0.37
PGSC0003DMT200073919	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMT200073920	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMT200064712	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064712	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064712	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064712	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064712	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064712	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064713	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMT200064715	K00754	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.34	0.52	0.81
PGSC0003DMT200064716	K00754	ko00051	Fructose and mannose metabolism	1418	2.2e-72	0.41	0.59	0.88
PGSC0003DMT200064717	K00754	ko00051	Fructose and mannose metabolism	377	5.9e-15	0.48	0.67	0.95
PGSC0003DMT200064718	K07198	ko04140	Regulation of autophagy	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMT200064718	K07198	ko04150	mTOR signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMT200064718	K07198	ko04910	Insulin signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMT200064718	K07198	ko04920	Adipocytokine signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMT200064718	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMT200064729	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMT200064731	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMT200064738	K12741	ko03040	Spliceosome	336	1.1e-12	0.35	0.41	0.85
PGSC0003DMT200056710	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3012	2.7e-160	0.59	0.79	1.00
PGSC0003DMT200056711	K03660	ko03410	Base excision repair	880	1.1e-42	0.47	0.63	0.76
PGSC0003DMT200056719	K09843	ko00906	Carotenoid biosynthesis	442	1.5e-18	0.33	0.49	0.97
PGSC0003DMT200056731	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMT200056731	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMT200056732	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMT200056732	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMT200056733	K04103	ko00380	Tryptophan metabolism	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMT200056733	K04103	ko01100	Metabolic pathways	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMT200056734	K04103	ko00380	Tryptophan metabolism	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMT200056734	K04103	ko01100	Metabolic pathways	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMT200078748	K08241	ko00592	alpha-Linolenic acid metabolism	751	1.4e-35	0.35	0.52	0.89
PGSC0003DMT200078749	K08241	ko00592	alpha-Linolenic acid metabolism	390	1.1e-15	0.35	0.52	0.84
PGSC0003DMT200078754	K01358	ko04112	Cell cycle - Caulobacter	451	4.9e-19	0.63	0.74	0.99
PGSC0003DMT200078755	K01358	ko04112	Cell cycle - Caulobacter	467	6.4e-20	0.91	0.98	0.82
PGSC0003DMT200078756	K01358	ko04112	Cell cycle - Caulobacter	1776	4.0e-92	0.66	0.80	1.00
PGSC0003DMT200078763	K00868	ko00750	Vitamin B6 metabolism	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMT200078763	K00868	ko01100	Metabolic pathways	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMT200078764	K00868	ko00750	Vitamin B6 metabolism	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMT200078764	K00868	ko01100	Metabolic pathways	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMT200078775	K08332	ko04140	Regulation of autophagy	322	9.7e-12	0.27	0.47	0.96
PGSC0003DMT200078778	K02183	ko04020	Calcium signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04070	Phosphatidylinositol signaling system	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04114	Oocyte meiosis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04626	Plant-pathogen interaction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04720	Long-term potentiation	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04722	Neurotrophin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04740	Olfactory transduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04744	Phototransduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04745	Phototransduction - fly	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04910	Insulin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04912	GnRH signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04916	Melanogenesis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04970	Salivary secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko04971	Gastric acid secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko05010	Alzheimer's disease	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078778	K02183	ko05214	Glioma	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMT200078779	K00847	ko00051	Fructose and mannose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMT200078779	K00847	ko00500	Starch and sucrose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMT200078779	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMT200078779	K00847	ko01100	Metabolic pathways	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMT200078780	K00847	ko00051	Fructose and mannose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMT200078780	K00847	ko00500	Starch and sucrose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMT200078780	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMT200078780	K00847	ko01100	Metabolic pathways	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMT200096855	K03469	ko03030	DNA replication	253	4.0e-08	0.39	0.58	0.60
PGSC0003DMT200096863	K03006	ko00230	Purine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMT200096863	K03006	ko00240	Pyrimidine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMT200096863	K03006	ko01100	Metabolic pathways	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMT200096863	K03006	ko03020	RNA polymerase	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMT200096863	K03006	ko05016	Huntington's disease	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMT200092814	K06678	ko04111	Cell cycle - yeast	310	1.3e-07	0.26	0.47	0.40
PGSC0003DMT200041027	K10839	ko03420	Nucleotide excision repair	2574	3.9e-136	0.75	0.85	1.00
PGSC0003DMT200041034	K03456	ko04111	Cell cycle - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04113	Meiosis - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04114	Oocyte meiosis	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04310	Wnt signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04350	TGF-beta signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04530	Tight junction	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko04730	Long-term depression	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041034	K03456	ko05142	Chagas disease	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMT200041035	K03456	ko04111	Cell cycle - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04113	Meiosis - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04114	Oocyte meiosis	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04310	Wnt signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04350	TGF-beta signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04530	Tight junction	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko04730	Long-term depression	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041035	K03456	ko05142	Chagas disease	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMT200041036	K03456	ko04111	Cell cycle - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04113	Meiosis - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04114	Oocyte meiosis	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04310	Wnt signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04350	TGF-beta signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04530	Tight junction	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko04730	Long-term depression	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041036	K03456	ko05142	Chagas disease	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMT200041037	K03456	ko04111	Cell cycle - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04113	Meiosis - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04114	Oocyte meiosis	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04310	Wnt signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04350	TGF-beta signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04530	Tight junction	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko04730	Long-term depression	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041037	K03456	ko05142	Chagas disease	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMT200041038	K03456	ko04111	Cell cycle - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04113	Meiosis - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04114	Oocyte meiosis	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04310	Wnt signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04350	TGF-beta signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04530	Tight junction	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko04730	Long-term depression	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041038	K03456	ko05142	Chagas disease	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMT200041039	K03456	ko04111	Cell cycle - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04113	Meiosis - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04114	Oocyte meiosis	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04310	Wnt signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04350	TGF-beta signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04530	Tight junction	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko04730	Long-term depression	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041039	K03456	ko05142	Chagas disease	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMT200041054	K01187	ko00052	Galactose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMT200041054	K01187	ko00500	Starch and sucrose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMT200041054	K01187	ko01100	Metabolic pathways	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMT200014742	K02183	ko04020	Calcium signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04070	Phosphatidylinositol signaling system	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04114	Oocyte meiosis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04626	Plant-pathogen interaction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04720	Long-term potentiation	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04740	Olfactory transduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04744	Phototransduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04745	Phototransduction - fly	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04910	Insulin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04912	GnRH signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04916	Melanogenesis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04970	Salivary secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko04971	Gastric acid secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko05010	Alzheimer's disease	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014742	K02183	ko05214	Glioma	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMT200014743	K12831	ko03040	Spliceosome	1407	9.1e-72	0.69	0.77	0.99
PGSC0003DMT200014744	K12831	ko03040	Spliceosome	2591	4.5e-137	0.79	0.85	0.99
PGSC0003DMT200014748	K05929	ko00564	Glycerophospholipid metabolism	611	7.3e-28	0.41	0.57	0.99
PGSC0003DMT200014749	K05929	ko00564	Glycerophospholipid metabolism	741	4.9e-35	0.41	0.59	0.51
PGSC0003DMT200014750	K00599	ko00340	Histidine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMT200014750	K00599	ko00350	Tyrosine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMT200014750	K00599	ko00450	Selenoamino acid metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMT200014750	K00599	ko00626	Naphthalene and anthracene degradation	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMT200014754	K01613	ko00564	Glycerophospholipid metabolism	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMT200014754	K01613	ko01100	Metabolic pathways	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMT200014757	K01426	ko00330	Arginine and proline metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014757	K01426	ko00360	Phenylalanine metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014757	K01426	ko00380	Tryptophan metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014757	K01426	ko00460	Cyanoamino acid metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014757	K01426	ko00632	Benzoate degradation via CoA ligation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014757	K01426	ko00643	Styrene degradation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMT200014761	K01785	ko00010	Glycolysis / Gluconeogenesis	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMT200014761	K01785	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMT200014762	K01785	ko00010	Glycolysis / Gluconeogenesis	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMT200014762	K01785	ko01110	Biosynthesis of secondary metabolites	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMT200014763	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko00363	Bisphenol A degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko00624	1- and 2-Methylnaphthalene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko00626	Naphthalene and anthracene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko00632	Benzoate degradation via CoA ligation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko00903	Limonene and pinene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko01100	Metabolic pathways	7384	0.	0.66	0.78	0.99
PGSC0003DMT200014763	K00120	ko01110	Biosynthesis of secondary metabolites	7384	0.	0.66	0.78	0.99
PGSC0003DMT200024816	K01915	ko00250	Alanine, aspartate and glutamate metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMT200024816	K01915	ko00330	Arginine and proline metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMT200024816	K01915	ko00910	Nitrogen metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMT200024816	K01915	ko01100	Metabolic pathways	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMT200024816	K01915	ko02020	Two-component system	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMT200024828	K01115	ko00564	Glycerophospholipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024828	K01115	ko00565	Ether lipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024828	K01115	ko01100	Metabolic pathways	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024828	K01115	ko04144	Endocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024828	K01115	ko04666	Fc gamma R-mediated phagocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024828	K01115	ko04912	GnRH signaling pathway	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMT200024829	K01115	ko00564	Glycerophospholipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024829	K01115	ko00565	Ether lipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024829	K01115	ko01100	Metabolic pathways	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024829	K01115	ko04144	Endocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024829	K01115	ko04666	Fc gamma R-mediated phagocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024829	K01115	ko04912	GnRH signaling pathway	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko00564	Glycerophospholipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko00565	Ether lipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko01100	Metabolic pathways	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko04144	Endocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko04666	Fc gamma R-mediated phagocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024831	K01115	ko04912	GnRH signaling pathway	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMT200024833	K01115	ko00564	Glycerophospholipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024833	K01115	ko00565	Ether lipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024833	K01115	ko01100	Metabolic pathways	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024833	K01115	ko04144	Endocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024833	K01115	ko04666	Fc gamma R-mediated phagocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024833	K01115	ko04912	GnRH signaling pathway	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMT200024834	K10260	ko04120	Ubiquitin mediated proteolysis	327	3.4e-12	0.28	0.43	0.72
PGSC0003DMT200024836	K01759	ko00620	Pyruvate metabolism	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMT200024836	K01759	ko04011	MAPK signaling pathway - yeast	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMT200024841	K01179	ko00500	Starch and sucrose metabolism	306	3.0e-08	0.25	0.42	0.65
PGSC0003DMT200024843	K00894	ko00564	Glycerophospholipid metabolism	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMT200024843	K00894	ko01100	Metabolic pathways	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMT200024844	K00894	ko00564	Glycerophospholipid metabolism	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMT200024844	K00894	ko01100	Metabolic pathways	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMT200024845	K00894	ko00564	Glycerophospholipid metabolism	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMT200024845	K00894	ko01100	Metabolic pathways	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMT200024846	K00894	ko00564	Glycerophospholipid metabolism	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMT200024846	K00894	ko01100	Metabolic pathways	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMT200084504	K12655	ko04622	RIG-I-like receptor signaling pathway	292	5.5e-10	0.33	0.55	0.49
PGSC0003DMT200084507	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084507	K01652	ko00650	Butanoate metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084507	K01652	ko00660	C5-Branched dibasic acid metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084507	K01652	ko00770	Pantothenate and CoA biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084507	K01652	ko01100	Metabolic pathways	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084507	K01652	ko01110	Biosynthesis of secondary metabolites	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMT200084521	K12467	ko00902	Monoterpenoid biosynthesis	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMT200084521	K12467	ko01110	Biosynthesis of secondary metabolites	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMT200084522	K12929	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMT200084522	K12929	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMT200084531	K02112	ko00190	Oxidative phosphorylation	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMT200084531	K02112	ko00195	Photosynthesis	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMT200084531	K02112	ko01100	Metabolic pathways	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMT200084688	K07385	ko00902	Monoterpenoid biosynthesis	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMT200084688	K07385	ko01100	Metabolic pathways	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMT200084697	K03064	ko03050	Proteasome	306	4.8e-11	0.82	0.95	0.60
PGSC0003DMT200084699	K03064	ko03050	Proteasome	324	4.9e-12	0.87	0.91	0.74
PGSC0003DMT200057935	K04424	ko04010	MAPK signaling pathway	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMT200057935	K04424	ko04530	Tight junction	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMT200057936	K01520	ko00240	Pyrimidine metabolism	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMT200057936	K01520	ko01100	Metabolic pathways	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMT200057937	K01738	ko00270	Cysteine and methionine metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMT200057937	K01738	ko00450	Selenoamino acid metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMT200057937	K01738	ko00920	Sulfur metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMT200057937	K01738	ko01100	Metabolic pathways	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMT200057946	K01738	ko00270	Cysteine and methionine metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMT200057946	K01738	ko00450	Selenoamino acid metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMT200057946	K01738	ko00920	Sulfur metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMT200057946	K01738	ko01100	Metabolic pathways	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMT200057947	K01738	ko00270	Cysteine and methionine metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMT200057947	K01738	ko00450	Selenoamino acid metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMT200057947	K01738	ko00920	Sulfur metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMT200057947	K01738	ko01100	Metabolic pathways	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMT200057948	K01738	ko00270	Cysteine and methionine metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMT200057948	K01738	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMT200057948	K01738	ko00920	Sulfur metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMT200057948	K01738	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMT200057950	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057950	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057950	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057950	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057951	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057951	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057951	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057951	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMT200057952	K01738	ko00270	Cysteine and methionine metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMT200057952	K01738	ko00450	Selenoamino acid metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMT200057952	K01738	ko00920	Sulfur metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMT200057952	K01738	ko01100	Metabolic pathways	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMT200057954	K01738	ko00270	Cysteine and methionine metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMT200057954	K01738	ko00450	Selenoamino acid metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMT200057954	K01738	ko00920	Sulfur metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMT200057954	K01738	ko01100	Metabolic pathways	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMT200057974	K02974	ko03010	Ribosome	883	7.2e-43	0.88	0.90	0.37
PGSC0003DMT200057975	K01487	ko00230	Purine metabolism	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMT200057975	K01487	ko01100	Metabolic pathways	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMT200057978	K12132	ko04712	Circadian rhythm - plant	911	2.1e-44	0.42	0.59	1.00
PGSC0003DMT200057980	K12132	ko04712	Circadian rhythm - plant	3753	3.7e-201	0.63	0.75	1.00
PGSC0003DMT200057981	K12132	ko04712	Circadian rhythm - plant	2200	1.7e-115	0.53	0.68	1.00
PGSC0003DMT200057987	K01808	ko00030	Pentose phosphate pathway	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMT200057987	K01808	ko00710	Carbon fixation in photosynthetic organisms	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMT200057987	K01808	ko01100	Metabolic pathways	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMT200057987	K01808	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMT200057988	K01092	ko00521	Streptomycin biosynthesis	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMT200057988	K01092	ko00562	Inositol phosphate metabolism	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMT200057988	K01092	ko01100	Metabolic pathways	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMT200057988	K01092	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMT200057988	K01092	ko04070	Phosphatidylinositol signaling system	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMT200067767	K02326	ko00230	Purine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067767	K02326	ko00240	Pyrimidine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067767	K02326	ko01100	Metabolic pathways	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067767	K02326	ko03030	DNA replication	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067767	K02326	ko03410	Base excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067767	K02326	ko03420	Nucleotide excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMT200067770	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.34	0.55	0.79
PGSC0003DMT200067771	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.55	0.88
PGSC0003DMT200067773	K01199	ko00500	Starch and sucrose metabolism	620	2.3e-28	0.35	0.54	0.87
PGSC0003DMT200067774	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMT200067775	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMT200067776	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMT200067777	K02865	ko03010	Ribosome	1581	2.3e-81	0.88	0.94	1.00
PGSC0003DMT200067778	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMT200067779	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMT200067789	K13065	ko00940	Phenylpropanoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMT200067789	K13065	ko00941	Flavonoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMT200067789	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMT200067789	K13065	ko01110	Biosynthesis of secondary metabolites	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMT200067792	K13065	ko00940	Phenylpropanoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMT200067792	K13065	ko00941	Flavonoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMT200067792	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMT200067792	K13065	ko01110	Biosynthesis of secondary metabolites	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMT200087341	K10591	ko04120	Ubiquitin mediated proteolysis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMT200087341	K10591	ko04144	Endocytosis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMT200087364	K11251	ko05322	Systemic lupus erythematosus	629	7.4e-29	0.63	0.77	0.92
PGSC0003DMT200070642	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMT200070642	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMT200070642	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMT200070642	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMT200070649	K10757	ko00944	Flavone and flavonol biosynthesis	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMT200070649	K10757	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMT200070649	K10757	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMT200070664	K03660	ko03410	Base excision repair	586	1.7e-26	0.34	0.52	0.91
PGSC0003DMT200070665	K04733	ko04210	Apoptosis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMT200070665	K04733	ko04620	Toll-like receptor signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMT200070665	K04733	ko04722	Neurotrophin signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMT200070665	K04733	ko05140	Leishmaniasis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMT200070665	K04733	ko05142	Chagas disease	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMT200070667	K03660	ko03410	Base excision repair	309	1.6e-10	0.39	0.51	0.58
PGSC0003DMT200070670	K10956	ko03060	Protein export	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMT200070670	K10956	ko04145	Phagosome	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMT200070670	K10956	ko05110	Vibrio cholerae infection	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMT200070672	K10956	ko03060	Protein export	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMT200070672	K10956	ko04145	Phagosome	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMT200070672	K10956	ko05110	Vibrio cholerae infection	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMT200070680	K12135	ko04712	Circadian rhythm - plant	450	5.5e-19	0.31	0.49	0.59
PGSC0003DMT200070684	K01805	ko00040	Pentose and glucuronate interconversions	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMT200070684	K01805	ko00051	Fructose and mannose metabolism	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMT200070684	K01805	ko01100	Metabolic pathways	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMT200047011	K02343	ko00230	Purine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047011	K02343	ko00240	Pyrimidine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047011	K02343	ko01100	Metabolic pathways	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047011	K02343	ko03030	DNA replication	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047011	K02343	ko03430	Mismatch repair	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047011	K02343	ko03440	Homologous recombination	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMT200047012	K01892	ko00970	Aminoacyl-tRNA biosynthesis	3949	5.7e-212	0.59	0.74	0.99
PGSC0003DMT200047022	K04733	ko04210	Apoptosis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMT200047022	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMT200047022	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMT200047022	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMT200047022	K04733	ko05142	Chagas disease	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMT200047047	K01800	ko00350	Tyrosine metabolism	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMT200047047	K01800	ko00643	Styrene degradation	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMT200047047	K01800	ko01100	Metabolic pathways	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMT200072940	K06630	ko04110	Cell cycle	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMT200072940	K06630	ko04114	Oocyte meiosis	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMT200072940	K06630	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMT200072941	K06630	ko04110	Cell cycle	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMT200072941	K06630	ko04114	Oocyte meiosis	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMT200072941	K06630	ko04722	Neurotrophin signaling pathway	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMT200072954	K12605	ko03018	RNA degradation	925	3.5e-45	0.40	0.60	0.90
PGSC0003DMT200072955	K12605	ko03018	RNA degradation	683	7.8e-32	0.47	0.66	0.96
PGSC0003DMT200072960	K00688	ko00500	Starch and sucrose metabolism	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMT200072960	K00688	ko04910	Insulin signaling pathway	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMT200072961	K00688	ko00500	Starch and sucrose metabolism	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMT200072961	K00688	ko04910	Insulin signaling pathway	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMT200072962	K00688	ko00500	Starch and sucrose metabolism	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMT200072962	K00688	ko04910	Insulin signaling pathway	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMT200072963	K00688	ko00500	Starch and sucrose metabolism	6170	0.	0.75	0.87	0.99
PGSC0003DMT200072963	K00688	ko04910	Insulin signaling pathway	6170	0.	0.75	0.87	0.99
PGSC0003DMT200081312	K01051	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMT200081312	K01051	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMT200081312	K01051	ko01100	Metabolic pathways	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMT200081314	K01179	ko00500	Starch and sucrose metabolism	2420	1.2e-127	0.60	0.74	0.95
PGSC0003DMT200081324	K02885	ko03010	Ribosome	1619	1.8e-83	0.90	0.93	1.00
PGSC0003DMT200081327	K01213	ko00040	Pentose and glucuronate interconversions	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMT200081327	K01213	ko00500	Starch and sucrose metabolism	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMT200081327	K01213	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMT200081328	K01213	ko00040	Pentose and glucuronate interconversions	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMT200081328	K01213	ko00500	Starch and sucrose metabolism	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMT200081328	K01213	ko01100	Metabolic pathways	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMT200081329	K01213	ko00040	Pentose and glucuronate interconversions	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMT200081329	K01213	ko00500	Starch and sucrose metabolism	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMT200081329	K01213	ko01100	Metabolic pathways	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMT200081334	K08489	ko04130	SNARE interactions in vesicular transport	1549	1.3e-79	0.67	0.80	0.88
PGSC0003DMT200081335	K08489	ko04130	SNARE interactions in vesicular transport	1783	1.7e-92	0.69	0.82	1.00
PGSC0003DMT200081354	K01897	ko00071	Fatty acid metabolism	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMT200081354	K01897	ko01100	Metabolic pathways	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMT200081354	K01897	ko03320	PPAR signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMT200081354	K01897	ko04146	Peroxisome	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMT200081354	K01897	ko04920	Adipocytokine signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMT200081356	K01897	ko00071	Fatty acid metabolism	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMT200081356	K01897	ko01100	Metabolic pathways	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMT200081356	K01897	ko03320	PPAR signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMT200081356	K01897	ko04146	Peroxisome	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMT200081356	K01897	ko04920	Adipocytokine signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMT200052892	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.97
PGSC0003DMT200052894	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.93
PGSC0003DMT200095217	K12338	ko00942	Anthocyanin biosynthesis	641	1.6e-29	0.35	0.51	0.96
PGSC0003DMT200026602	K01115	ko00564	Glycerophospholipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026602	K01115	ko00565	Ether lipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026602	K01115	ko01100	Metabolic pathways	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026602	K01115	ko04144	Endocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026602	K01115	ko04666	Fc gamma R-mediated phagocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026602	K01115	ko04912	GnRH signaling pathway	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMT200026604	K00847	ko00051	Fructose and mannose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMT200026604	K00847	ko00500	Starch and sucrose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMT200026604	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMT200026604	K00847	ko01100	Metabolic pathways	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMT200026605	K00847	ko00051	Fructose and mannose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMT200026605	K00847	ko00500	Starch and sucrose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMT200026605	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMT200026605	K00847	ko01100	Metabolic pathways	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMT200026609	K09480	ko00561	Glycerolipid metabolism	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMT200026609	K09480	ko01100	Metabolic pathways	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMT200026610	K09480	ko00561	Glycerolipid metabolism	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMT200026610	K09480	ko01100	Metabolic pathways	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMT200026611	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMT200026612	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMT200026615	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026615	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026616	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMT200026617	K04424	ko04010	MAPK signaling pathway	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMT200026617	K04424	ko04530	Tight junction	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMT200026618	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMT200026618	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMT200026619	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMT200026619	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMT200026622	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMT200026622	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMT200026622	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMT200026625	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.60	0.73	0.97
PGSC0003DMT200026640	K02875	ko03010	Ribosome	1015	3.8e-50	0.89	0.95	0.99
PGSC0003DMT200038579	K09587	ko00905	Brassinosteroid biosynthesis	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMT200038579	K09587	ko01100	Metabolic pathways	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMT200038579	K09587	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMT200038580	K09587	ko00905	Brassinosteroid biosynthesis	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMT200038580	K09587	ko01100	Metabolic pathways	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMT200038580	K09587	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMT200038581	K09587	ko00905	Brassinosteroid biosynthesis	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMT200038581	K09587	ko01100	Metabolic pathways	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMT200038581	K09587	ko01110	Biosynthesis of secondary metabolites	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMT200038582	K09587	ko00905	Brassinosteroid biosynthesis	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMT200038582	K09587	ko01100	Metabolic pathways	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMT200038582	K09587	ko01110	Biosynthesis of secondary metabolites	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMT200038588	K03124	ko03022	Basal transcription factors	2146	1.6e-112	0.78	0.87	0.77
PGSC0003DMT200038592	K01228	ko00510	N-Glycan biosynthesis	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMT200038592	K01228	ko01100	Metabolic pathways	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMT200038593	K01228	ko00510	N-Glycan biosynthesis	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMT200038593	K01228	ko01100	Metabolic pathways	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMT200038594	K01228	ko00510	N-Glycan biosynthesis	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMT200038594	K01228	ko01100	Metabolic pathways	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMT200038595	K01228	ko00510	N-Glycan biosynthesis	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMT200038595	K01228	ko01100	Metabolic pathways	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMT200038596	K01199	ko00500	Starch and sucrose metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMT200038598	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMT200038599	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMT200038600	K01199	ko00500	Starch and sucrose metabolism	629	7.4e-29	0.32	0.53	0.71
PGSC0003DMT200076777	K01757	ko00901	Indole alkaloid biosynthesis	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMT200076777	K01757	ko01100	Metabolic pathways	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMT200076777	K01757	ko01110	Biosynthesis of secondary metabolites	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMT200076801	K11086	ko03040	Spliceosome	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMT200076801	K11086	ko05322	Systemic lupus erythematosus	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMT200076802	K00819	ko00330	Arginine and proline metabolism	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMT200076802	K00819	ko01100	Metabolic pathways	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMT200076802	K00819	ko01110	Biosynthesis of secondary metabolites	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMT200076803	K00819	ko00330	Arginine and proline metabolism	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMT200076803	K00819	ko01100	Metabolic pathways	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMT200076803	K00819	ko01110	Biosynthesis of secondary metabolites	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMT200049383	K00368	ko00910	Nitrogen metabolism	1661	8.9e-86	0.44	0.59	0.89
PGSC0003DMT200049384	K05278	ko00941	Flavonoid biosynthesis	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMT200049384	K05278	ko01100	Metabolic pathways	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMT200049384	K05278	ko01110	Biosynthesis of secondary metabolites	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMT200049388	K02728	ko03050	Proteasome	1859	1.1e-96	0.88	0.96	1.00
PGSC0003DMT200049390	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049390	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049390	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049391	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049391	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049391	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049392	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049392	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049392	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMT200049394	K03841	ko00010	Glycolysis / Gluconeogenesis	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko00030	Pentose phosphate pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko00051	Fructose and mannose metabolism	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko00710	Carbon fixation in photosynthetic organisms	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko01100	Metabolic pathways	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko01110	Biosynthesis of secondary metabolites	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049394	K03841	ko04910	Insulin signaling pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMT200049395	K03841	ko00010	Glycolysis / Gluconeogenesis	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko00030	Pentose phosphate pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko00051	Fructose and mannose metabolism	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko00710	Carbon fixation in photosynthetic organisms	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko01100	Metabolic pathways	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko01110	Biosynthesis of secondary metabolites	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049395	K03841	ko04910	Insulin signaling pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMT200049397	K04714	ko00600	Sphingolipid metabolism	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMT200049397	K04714	ko01100	Metabolic pathways	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMT200049398	K04714	ko00600	Sphingolipid metabolism	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMT200049398	K04714	ko01100	Metabolic pathways	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMT200049413	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMT200049413	K08081	ko01100	Metabolic pathways	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMT200049413	K08081	ko01110	Biosynthesis of secondary metabolites	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMT200049415	K01051	ko00040	Pentose and glucuronate interconversions	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMT200049415	K01051	ko00500	Starch and sucrose metabolism	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMT200049415	K01051	ko01100	Metabolic pathways	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMT200049417	K01051	ko00040	Pentose and glucuronate interconversions	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMT200049417	K01051	ko00500	Starch and sucrose metabolism	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMT200049417	K01051	ko01100	Metabolic pathways	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMT200049423	K12343	ko00140	Steroid hormone biosynthesis	1319	6.5e-67	0.64	0.78	1.00
PGSC0003DMT200049424	K11866	ko04144	Endocytosis	429	4.4e-17	0.37	0.54	0.76
PGSC0003DMT200049425	K11866	ko04144	Endocytosis	653	8.3e-30	0.31	0.47	0.84
PGSC0003DMT200049426	K11866	ko04144	Endocytosis	541	2.1e-23	0.31	0.47	0.94
PGSC0003DMT200086681	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMT200086681	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMT200086681	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMT200086695	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMT200086695	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMT200086695	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMT200086695	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMT200086695	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMT200067039	K01879	ko00970	Aminoacyl-tRNA biosynthesis	5673	0.	0.71	0.84	0.98
PGSC0003DMT200067040	K01879	ko00970	Aminoacyl-tRNA biosynthesis	4120	2.1e-221	0.67	0.83	1.00
PGSC0003DMT200067041	K01879	ko00970	Aminoacyl-tRNA biosynthesis	6292	0.	0.70	0.83	1.00
PGSC0003DMT200067044	K05278	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMT200067044	K05278	ko01100	Metabolic pathways	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMT200067044	K05278	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMT200067057	K06685	ko04111	Cell cycle - yeast	356	8.6e-11	0.31	0.47	0.52
PGSC0003DMT200067058	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMT200067059	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMT200067060	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMT200067061	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMT200067067	K00680	ko00350	Tyrosine metabolism	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMT200067067	K00680	ko00624	1- and 2-Methylnaphthalene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMT200067067	K00680	ko00632	Benzoate degradation via CoA ligation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMT200067067	K00680	ko00642	Ethylbenzene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMT200067067	K00680	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMT200091184	K06627	ko04110	Cell cycle	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMT200091184	K06627	ko04914	Progesterone-mediated oocyte maturation	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMT200091186	K11251	ko05322	Systemic lupus erythematosus	694	1.9e-32	0.69	0.80	0.94
PGSC0003DMT200091189	K05681	ko02010	ABC transporters	301	2.6e-10	0.59	0.73	0.78
PGSC0003DMT200091205	K05282	ko00904	Diterpenoid biosynthesis	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMT200091205	K05282	ko01100	Metabolic pathways	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMT200091205	K05282	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMT200003039	K01692	ko00071	Fatty acid metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00280	Valine, leucine and isoleucine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00281	Geraniol degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00310	Lysine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00380	Tryptophan metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00410	beta-Alanine metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00632	Benzoate degradation via CoA ligation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00640	Propanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00650	Butanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00903	Limonene and pinene degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko00930	Caprolactam degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko01100	Metabolic pathways	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003039	K01692	ko01110	Biosynthesis of secondary metabolites	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMT200003049	K05350	ko00460	Cyanoamino acid metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMT200003049	K05350	ko00500	Starch and sucrose metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMT200003049	K05350	ko00940	Phenylpropanoid biosynthesis	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMT200003049	K05350	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMT200003050	K05350	ko00460	Cyanoamino acid metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMT200003050	K05350	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMT200003050	K05350	ko00940	Phenylpropanoid biosynthesis	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMT200003050	K05350	ko01110	Biosynthesis of secondary metabolites	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMT200003056	K06630	ko04110	Cell cycle	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMT200003056	K06630	ko04114	Oocyte meiosis	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMT200003056	K06630	ko04722	Neurotrophin signaling pathway	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMT200034160	K00889	ko00562	Inositol phosphate metabolism	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034160	K00889	ko01100	Metabolic pathways	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034160	K00889	ko04070	Phosphatidylinositol signaling system	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034160	K00889	ko04144	Endocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034160	K00889	ko04666	Fc gamma R-mediated phagocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034160	K00889	ko04810	Regulation of actin cytoskeleton	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMT200034161	K00889	ko00562	Inositol phosphate metabolism	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034161	K00889	ko01100	Metabolic pathways	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034161	K00889	ko04070	Phosphatidylinositol signaling system	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034161	K00889	ko04144	Endocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034161	K00889	ko04666	Fc gamma R-mediated phagocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034161	K00889	ko04810	Regulation of actin cytoskeleton	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMT200034163	K02921	ko03010	Ribosome	551	1.5e-24	1.00	1.00	0.98
PGSC0003DMT200034164	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMT200006574	K00812	ko00250	Alanine, aspartate and glutamate metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00270	Cysteine and methionine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00330	Arginine and proline metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00350	Tyrosine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00360	Phenylalanine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00401	Novobiocin biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00710	Carbon fixation in photosynthetic organisms	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00950	Isoquinoline alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko01100	Metabolic pathways	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200006574	K00812	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMT200012347	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMT200012347	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMT200012347	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMT200012347	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMT200012348	K01112	ko00051	Fructose and mannose metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMT200012348	K01112	ko00730	Thiamine metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMT200012348	K01112	ko00740	Riboflavin metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMT200012348	K01112	ko01100	Metabolic pathways	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMT200012349	K01112	ko00051	Fructose and mannose metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMT200012349	K01112	ko00730	Thiamine metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMT200012349	K01112	ko00740	Riboflavin metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMT200012349	K01112	ko01100	Metabolic pathways	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMT200012350	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012350	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012350	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012350	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012351	K01112	ko00051	Fructose and mannose metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMT200012351	K01112	ko00730	Thiamine metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMT200012351	K01112	ko00740	Riboflavin metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMT200012351	K01112	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMT200012352	K01112	ko00051	Fructose and mannose metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMT200012352	K01112	ko00730	Thiamine metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMT200012352	K01112	ko00740	Riboflavin metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMT200012352	K01112	ko01100	Metabolic pathways	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMT200012353	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012353	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012353	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012353	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMT200012357	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012357	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012357	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012357	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012358	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012358	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012358	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012358	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMT200012359	K01190	ko00052	Galactose metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMT200012359	K01190	ko00511	Other glycan degradation	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMT200012359	K01190	ko00600	Sphingolipid metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMT200012359	K01190	ko01100	Metabolic pathways	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMT200012360	K01190	ko00052	Galactose metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMT200012360	K01190	ko00511	Other glycan degradation	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMT200012360	K01190	ko00600	Sphingolipid metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMT200012360	K01190	ko01100	Metabolic pathways	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMT200012364	K08248	ko00460	Cyanoamino acid metabolism	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMT200012364	K08248	ko01100	Metabolic pathways	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMT200012369	K12741	ko03040	Spliceosome	1268	4.2e-64	0.46	0.61	0.86
PGSC0003DMT200012372	K12741	ko03040	Spliceosome	934	1.1e-45	0.46	0.63	0.99
PGSC0003DMT200012376	K03787	ko00230	Purine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMT200012376	K03787	ko00240	Pyrimidine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMT200012376	K03787	ko00760	Nicotinate and nicotinamide metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMT200012376	K03787	ko01100	Metabolic pathways	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMT200012376	K03787	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMT200012377	K03787	ko00230	Purine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMT200012377	K03787	ko00240	Pyrimidine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMT200012377	K03787	ko00760	Nicotinate and nicotinamide metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMT200012377	K03787	ko01100	Metabolic pathways	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMT200012377	K03787	ko01110	Biosynthesis of secondary metabolites	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMT200012378	K03787	ko00230	Purine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMT200012378	K03787	ko00240	Pyrimidine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMT200012378	K03787	ko00760	Nicotinate and nicotinamide metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMT200012378	K03787	ko01100	Metabolic pathways	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMT200012378	K03787	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMT200012379	K02914	ko03010	Ribosome	263	1.1e-08	0.70	0.91	0.29
PGSC0003DMT200012385	K02218	ko04340	Hedgehog signaling pathway	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMT200012385	K02218	ko04711	Circadian rhythm - fly	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMT200024060	K02084	ko04115	p53 signaling pathway	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko04210	Apoptosis	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko05010	Alzheimer's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko05012	Parkinson's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko05016	Huntington's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024060	K02084	ko05222	Small cell lung cancer	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMT200024071	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMT200024071	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMT200024071	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMT200024071	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMT200024071	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMT200024073	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMT200024073	K00517	ko00626	Naphthalene and anthracene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMT200024073	K00517	ko00903	Limonene and pinene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMT200024073	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMT200024073	K00517	ko01110	Biosynthesis of secondary metabolites	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMT200024080	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMT200024080	K00517	ko00626	Naphthalene and anthracene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMT200024080	K00517	ko00903	Limonene and pinene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMT200024080	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMT200024080	K00517	ko01110	Biosynthesis of secondary metabolites	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMT200024081	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMT200024081	K00517	ko00626	Naphthalene and anthracene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMT200024081	K00517	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMT200024081	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMT200024081	K00517	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMT200024086	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMT200024086	K00517	ko00626	Naphthalene and anthracene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMT200024086	K00517	ko00903	Limonene and pinene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMT200024086	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMT200024086	K00517	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMT200024087	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMT200024087	K00517	ko00626	Naphthalene and anthracene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMT200024087	K00517	ko00903	Limonene and pinene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMT200024087	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMT200024087	K00517	ko01110	Biosynthesis of secondary metabolites	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMT200024088	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMT200024088	K00517	ko00626	Naphthalene and anthracene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMT200024088	K00517	ko00903	Limonene and pinene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMT200024088	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMT200024088	K00517	ko01110	Biosynthesis of secondary metabolites	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMT200024090	K00855	ko00710	Carbon fixation in photosynthetic organisms	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMT200024090	K00855	ko01100	Metabolic pathways	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMT200040054	K04371	ko04010	MAPK signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04012	ErbB signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04013	MAPK signaling pathway - fly	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04062	Chemokine signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04114	Oocyte meiosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04150	mTOR signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04270	Vascular smooth muscle contraction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04320	Dorso-ventral axis formation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04350	TGF-beta signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04360	Axon guidance	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04370	VEGF signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04510	Focal adhesion	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04520	Adherens junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04540	Gap junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04620	Toll-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04621	NOD-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04650	Natural killer cell mediated cytotoxicity	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04660	T cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04662	B cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04664	Fc epsilon RI signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04666	Fc gamma R-mediated phagocytosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04720	Long-term potentiation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04722	Neurotrophin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04730	Long-term depression	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04810	Regulation of actin cytoskeleton	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04910	Insulin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04912	GnRH signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04914	Progesterone-mediated oocyte maturation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04916	Melanogenesis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04930	Type II diabetes mellitus	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko04960	Aldosterone-regulated sodium reabsorption	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05010	Alzheimer's disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05020	Prion diseases	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05131	Shigellosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05140	Leishmaniasis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05142	Chagas disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05200	Pathways in cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05210	Colorectal cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05211	Renal cell carcinoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05212	Pancreatic cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05213	Endometrial cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05214	Glioma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05215	Prostate cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05216	Thyroid cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05218	Melanoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05219	Bladder cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05220	Chronic myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05221	Acute myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040054	K04371	ko05223	Non-small cell lung cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMT200040058	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMT200040059	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMT200040061	K01718	ko00240	Pyrimidine metabolism	432	5.4e-18	0.42	0.54	0.92
PGSC0003DMT200040062	K00430	ko00360	Phenylalanine metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMT200040062	K00430	ko00680	Methane metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMT200040062	K00430	ko00940	Phenylpropanoid biosynthesis	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMT200040062	K00430	ko01100	Metabolic pathways	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMT200040062	K00430	ko01110	Biosynthesis of secondary metabolites	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMT200040067	K12837	ko03040	Spliceosome	3943	1.2e-211	0.81	0.89	1.00
PGSC0003DMT200040068	K12837	ko03040	Spliceosome	2717	5.1e-144	0.88	0.93	1.00
PGSC0003DMT200040069	K12837	ko03040	Spliceosome	2321	3.5e-122	0.88	0.93	1.00
PGSC0003DMT200040070	K03107	ko03060	Protein export	3934	3.8e-211	0.78	0.88	0.98
PGSC0003DMT200040071	K03107	ko03060	Protein export	3338	2.8e-178	0.80	0.91	1.00
PGSC0003DMT200040072	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMT200040073	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMT200040081	K00558	ko00270	Cysteine and methionine metabolism	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMT200040081	K00558	ko01100	Metabolic pathways	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMT200040083	K13065	ko00940	Phenylpropanoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMT200040083	K13065	ko00941	Flavonoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMT200040083	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMT200040083	K13065	ko01110	Biosynthesis of secondary metabolites	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMT200051214	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200051214	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200051214	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMT200051216	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMT200051216	K01904	ko00360	Phenylalanine metabolism	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMT200051216	K01904	ko00940	Phenylpropanoid biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMT200051216	K01904	ko01100	Metabolic pathways	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMT200051216	K01904	ko01110	Biosynthesis of secondary metabolites	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMT200051218	K02937	ko03010	Ribosome	1756	5.1e-91	0.84	0.93	1.00
PGSC0003DMT200051225	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMT200051226	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMT200051237	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.74
PGSC0003DMT200051238	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.73
PGSC0003DMT200051239	K11818	ko00380	Tryptophan metabolism	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMT200051239	K11818	ko00966	Glucosinolate biosynthesis	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMT200051239	K11818	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMT200051243	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMT200051243	K00517	ko00626	Naphthalene and anthracene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMT200051243	K00517	ko00903	Limonene and pinene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMT200051243	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMT200051243	K00517	ko01110	Biosynthesis of secondary metabolites	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMT200051257	K00847	ko00051	Fructose and mannose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMT200051257	K00847	ko00500	Starch and sucrose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMT200051257	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMT200051257	K00847	ko01100	Metabolic pathways	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMT200078534	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078534	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078534	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078534	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078534	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078534	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMT200078535	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078535	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078535	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078535	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078535	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078535	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078536	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078537	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078538	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMT200078553	K00052	ko00290	Valine, leucine and isoleucine biosynthesis	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMT200078553	K00052	ko01100	Metabolic pathways	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMT200078553	K00052	ko01110	Biosynthesis of secondary metabolites	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMT200078577	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200078577	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200078577	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200078577	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200078577	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200078577	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMT200057370	K10592	ko04120	Ubiquitin mediated proteolysis	591	2.9e-25	0.92	0.99	0.75
PGSC0003DMT200057371	K10592	ko04120	Ubiquitin mediated proteolysis	1984	1.6e-102	0.68	0.79	0.97
PGSC0003DMT200057372	K10592	ko04120	Ubiquitin mediated proteolysis	18212	0.	0.62	0.75	1.00
PGSC0003DMT200057379	K08065	ko04612	Antigen processing and presentation	311	2.6e-11	0.49	0.70	0.48
PGSC0003DMT200057389	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	651	8.3e-30	0.32	0.46	0.86
PGSC0003DMT200057390	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	691	3.6e-32	0.31	0.44	0.87
PGSC0003DMT200057391	K01738	ko00270	Cysteine and methionine metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMT200057391	K01738	ko00450	Selenoamino acid metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMT200057391	K01738	ko00920	Sulfur metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMT200057391	K01738	ko01100	Metabolic pathways	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMT200057393	K01738	ko00270	Cysteine and methionine metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMT200057393	K01738	ko00450	Selenoamino acid metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMT200057393	K01738	ko00920	Sulfur metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMT200057393	K01738	ko01100	Metabolic pathways	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMT200085489	K08066	ko04612	Antigen processing and presentation	313	2.0e-11	0.51	0.77	0.73
PGSC0003DMT200085496	K01593	ko00340	Histidine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00350	Tyrosine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00360	Phenylalanine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00380	Tryptophan metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00901	Indole alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00950	Isoquinoline alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko00965	Betalain biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko01100	Metabolic pathways	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200085496	K01593	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMT200068691	K01066	ko00623	2,4-Dichlorobenzoate degradation	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMT200068691	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMT200068700	K05576	ko00190	Oxidative phosphorylation	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMT200068700	K05576	ko01100	Metabolic pathways	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMT200068702	K12868	ko03040	Spliceosome	1982	1.8e-103	0.74	0.82	1.00
PGSC0003DMT200068704	K02147	ko00190	Oxidative phosphorylation	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068704	K02147	ko01100	Metabolic pathways	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068704	K02147	ko04145	Phagosome	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068704	K02147	ko04966	Collecting duct acid secretion	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068704	K02147	ko05110	Vibrio cholerae infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068704	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMT200068713	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068713	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068713	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068714	K03094	ko04110	Cell cycle	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04111	Cell cycle - yeast	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04114	Oocyte meiosis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04120	Ubiquitin mediated proteolysis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04310	Wnt signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04350	TGF-beta signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068714	K03094	ko04710	Circadian rhythm - mammal	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMT200068715	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068715	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068715	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068716	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068716	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068716	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMT200068717	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068717	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068717	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMT200068720	K03094	ko04110	Cell cycle	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04111	Cell cycle - yeast	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04114	Oocyte meiosis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04120	Ubiquitin mediated proteolysis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04310	Wnt signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04350	TGF-beta signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068720	K03094	ko04710	Circadian rhythm - mammal	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMT200068726	K03094	ko04110	Cell cycle	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04111	Cell cycle - yeast	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04114	Oocyte meiosis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04120	Ubiquitin mediated proteolysis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04310	Wnt signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04350	TGF-beta signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068726	K03094	ko04710	Circadian rhythm - mammal	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMT200068727	K03094	ko04110	Cell cycle	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04111	Cell cycle - yeast	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04114	Oocyte meiosis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04120	Ubiquitin mediated proteolysis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04310	Wnt signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04350	TGF-beta signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200068727	K03094	ko04710	Circadian rhythm - mammal	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMT200004715	K01838	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.40	0.60	0.90
PGSC0003DMT200004716	K01838	ko00500	Starch and sucrose metabolism	256	2.8e-08	0.39	0.66	0.76
PGSC0003DMT200004717	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMT200004718	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMT200004736	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMT200004736	K01953	ko00910	Nitrogen metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMT200004736	K01953	ko01100	Metabolic pathways	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMT200004736	K01953	ko01110	Biosynthesis of secondary metabolites	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMT200004737	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMT200004737	K01953	ko00910	Nitrogen metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMT200004737	K01953	ko01100	Metabolic pathways	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMT200004737	K01953	ko01110	Biosynthesis of secondary metabolites	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMT200032411	K10418	ko04962	Vasopressin-regulated water reabsorption	314	1.7e-11	0.42	0.61	0.72
PGSC0003DMT200032442	K06685	ko04111	Cell cycle - yeast	295	1.0e-06	0.27	0.45	0.46
PGSC0003DMT200032443	K06685	ko04111	Cell cycle - yeast	295	5.0e-07	0.27	0.45	0.67
PGSC0003DMT200022316	K00004	ko00650	Butanoate metabolism	888	3.8e-43	0.58	0.70	0.98
PGSC0003DMT200022317	K00004	ko00650	Butanoate metabolism	644	1.1e-29	0.89	0.98	0.59
PGSC0003DMT200022318	K00004	ko00650	Butanoate metabolism	416	4.1e-17	0.89	0.94	0.61
PGSC0003DMT200022319	K00004	ko00650	Butanoate metabolism	2749	8.7e-146	0.86	0.94	1.00
PGSC0003DMT200022320	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMT200022321	K00004	ko00650	Butanoate metabolism	2544	1.8e-134	0.73	0.83	0.95
PGSC0003DMT200022322	K00004	ko00650	Butanoate metabolism	3605	5.3e-193	0.76	0.85	1.00
PGSC0003DMT200022323	K00004	ko00650	Butanoate metabolism	1364	2.1e-69	0.66	0.76	0.99
PGSC0003DMT200022324	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMT200022325	K00004	ko00650	Butanoate metabolism	1688	2.9e-87	0.86	0.94	0.92
PGSC0003DMT200022327	K01046	ko00561	Glycerolipid metabolism	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMT200022327	K01046	ko01100	Metabolic pathways	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMT200022329	K01046	ko00561	Glycerolipid metabolism	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMT200022329	K01046	ko01100	Metabolic pathways	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMT200022352	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1613	3.9e-83	0.72	0.85	0.91
PGSC0003DMT200041845	K00423	ko00053	Ascorbate and aldarate metabolism	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMT200041845	K00423	ko01100	Metabolic pathways	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMT200041850	K12373	ko00511	Other glycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko00531	Glycosaminoglycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko01100	Metabolic pathways	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041850	K12373	ko04142	Lysosome	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMT200041856	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041856	K01653	ko00650	Butanoate metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041856	K01653	ko00660	C5-Branched dibasic acid metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041856	K01653	ko00770	Pantothenate and CoA biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041856	K01653	ko01100	Metabolic pathways	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041856	K01653	ko01110	Biosynthesis of secondary metabolites	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMT200041868	K05350	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMT200041868	K05350	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMT200041868	K05350	ko00940	Phenylpropanoid biosynthesis	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMT200041868	K05350	ko01110	Biosynthesis of secondary metabolites	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMT200041869	K05350	ko00460	Cyanoamino acid metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMT200041869	K05350	ko00500	Starch and sucrose metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMT200041869	K05350	ko00940	Phenylpropanoid biosynthesis	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMT200041869	K05350	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMT200041870	K05350	ko00460	Cyanoamino acid metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMT200041870	K05350	ko00500	Starch and sucrose metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMT200041870	K05350	ko00940	Phenylpropanoid biosynthesis	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMT200041870	K05350	ko01110	Biosynthesis of secondary metabolites	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMT200001350	K10529	ko00592	alpha-Linolenic acid metabolism	4061	3.8e-218	0.74	0.86	0.99
PGSC0003DMT200001353	K10529	ko00592	alpha-Linolenic acid metabolism	3756	2.5e-201	0.70	0.81	0.99
PGSC0003DMT200001354	K10529	ko00592	alpha-Linolenic acid metabolism	3989	3.5e-214	0.73	0.85	0.99
PGSC0003DMT200001355	K10529	ko00592	alpha-Linolenic acid metabolism	3951	4.4e-212	0.72	0.85	0.99
PGSC0003DMT200001356	K10529	ko00592	alpha-Linolenic acid metabolism	410	1.0e-16	0.77	0.89	0.86
PGSC0003DMT200001357	K10529	ko00592	alpha-Linolenic acid metabolism	1884	4.5e-98	0.67	0.81	0.96
PGSC0003DMT200001358	K10529	ko00592	alpha-Linolenic acid metabolism	3810	2.6e-204	0.71	0.83	0.99
PGSC0003DMT200001359	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMT200001360	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMT200001361	K03469	ko03030	DNA replication	365	2.7e-14	0.42	0.61	0.42
PGSC0003DMT200001362	K03469	ko03030	DNA replication	364	3.1e-14	0.43	0.61	0.43
PGSC0003DMT200001363	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.42
PGSC0003DMT200001364	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.82
PGSC0003DMT200001365	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMT200001368	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMT200001368	K05285	ko01100	Metabolic pathways	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMT200001369	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	6030	0.	0.72	0.85	0.99
PGSC0003DMT200001369	K05285	ko01100	Metabolic pathways	6030	0.	0.72	0.85	0.99
PGSC0003DMT200001371	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMT200001371	K05285	ko01100	Metabolic pathways	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMT200001374	K00430	ko00360	Phenylalanine metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMT200001374	K00430	ko00680	Methane metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMT200001374	K00430	ko00940	Phenylpropanoid biosynthesis	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMT200001374	K00430	ko01100	Metabolic pathways	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMT200001374	K00430	ko01110	Biosynthesis of secondary metabolites	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMT200001375	K00430	ko00360	Phenylalanine metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMT200001375	K00430	ko00680	Methane metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMT200001375	K00430	ko00940	Phenylpropanoid biosynthesis	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMT200001375	K00430	ko01100	Metabolic pathways	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMT200001375	K00430	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMT200001378	K06611	ko00052	Galactose metabolism	4630	1.6e-249	0.68	0.81	1.00
PGSC0003DMT200097407	K13065	ko00940	Phenylpropanoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMT200097407	K13065	ko00941	Flavonoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMT200097407	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMT200097407	K13065	ko01110	Biosynthesis of secondary metabolites	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMT200097413	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMT200071195	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071195	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071199	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071199	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071200	K13289	ko04142	Lysosome	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMT200071200	K13289	ko04614	Renin-angiotensin system	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMT200071201	K13289	ko04142	Lysosome	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMT200071201	K13289	ko04614	Renin-angiotensin system	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMT200071202	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071202	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMT200071203	K13289	ko04142	Lysosome	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMT200071203	K13289	ko04614	Renin-angiotensin system	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMT200071211	K00967	ko00440	Phosphonate and phosphinate metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMT200071211	K00967	ko00564	Glycerophospholipid metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMT200071211	K00967	ko01100	Metabolic pathways	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMT200071212	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071212	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071212	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071213	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071213	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071213	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMT200071219	K02183	ko04020	Calcium signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04070	Phosphatidylinositol signaling system	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04114	Oocyte meiosis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04270	Vascular smooth muscle contraction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04626	Plant-pathogen interaction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04720	Long-term potentiation	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04722	Neurotrophin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04740	Olfactory transduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04744	Phototransduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04745	Phototransduction - fly	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04910	Insulin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04912	GnRH signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04916	Melanogenesis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04970	Salivary secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko04971	Gastric acid secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko05010	Alzheimer's disease	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200071219	K02183	ko05214	Glioma	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMT200045175	K05658	ko02010	ABC transporters	262	1.3e-07	0.38	0.55	0.82
PGSC0003DMT200045176	K05658	ko02010	ABC transporters	4433	1.1e-238	0.46	0.66	0.98
PGSC0003DMT200045180	K05658	ko02010	ABC transporters	2008	6.4e-105	0.72	0.89	0.99
PGSC0003DMT200045181	K05658	ko02010	ABC transporters	1260	1.2e-63	0.74	0.87	0.88
PGSC0003DMT200045187	K02882	ko03010	Ribosome	517	1.1e-22	0.84	0.87	0.94
PGSC0003DMT200045200	K02639	ko00195	Photosynthesis	1138	6.2e-57	0.72	0.82	0.99
PGSC0003DMT200045201	K02639	ko00195	Photosynthesis	1319	6.5e-67	0.80	0.90	0.99
PGSC0003DMT200084201	K00029	ko00620	Pyruvate metabolism	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMT200084201	K00029	ko00710	Carbon fixation in photosynthetic organisms	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMT200084201	K00029	ko01100	Metabolic pathways	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMT200026026	K04072	ko00010	Glycolysis / Gluconeogenesis	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00071	Fatty acid metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00350	Tyrosine metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00620	Pyruvate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00641	3-Chloroacrylic acid degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko00650	Butanoate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko01100	Metabolic pathways	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026026	K04072	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMT200026038	K11599	ko03050	Proteasome	946	2.4e-46	0.77	0.90	0.99
PGSC0003DMT200026052	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200026052	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200026052	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200026053	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200026053	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200026053	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMT200028453	K05577	ko00190	Oxidative phosphorylation	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMT200028453	K05577	ko01100	Metabolic pathways	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMT200028457	K06666	ko04111	Cell cycle - yeast	338	1.2e-09	0.26	0.42	0.43
PGSC0003DMT200028462	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMT200028463	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMT200028468	K06666	ko04111	Cell cycle - yeast	326	1.3e-08	0.26	0.41	0.48
PGSC0003DMT200028469	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMT200028470	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMT200028472	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMT200028480	K04733	ko04210	Apoptosis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMT200028480	K04733	ko04620	Toll-like receptor signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMT200028480	K04733	ko04722	Neurotrophin signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMT200028480	K04733	ko05140	Leishmaniasis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMT200028480	K04733	ko05142	Chagas disease	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMT200028483	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMT200036877	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036877	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036877	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036878	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036878	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036878	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036879	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMT200036879	K01602	ko00710	Carbon fixation in photosynthetic organisms	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMT200036879	K01602	ko01100	Metabolic pathways	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMT200036880	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036880	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036880	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMT200036886	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMT200036886	K01904	ko00360	Phenylalanine metabolism	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMT200036886	K01904	ko00940	Phenylpropanoid biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMT200036886	K01904	ko01100	Metabolic pathways	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMT200036886	K01904	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMT200036887	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMT200036887	K01904	ko00360	Phenylalanine metabolism	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMT200036887	K01904	ko00940	Phenylpropanoid biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMT200036887	K01904	ko01100	Metabolic pathways	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMT200036887	K01904	ko01110	Biosynthesis of secondary metabolites	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMT200036899	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMT200036900	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMT200008104	K01179	ko00500	Starch and sucrose metabolism	1271	2.9e-64	0.69	0.87	0.98
PGSC0003DMT200008105	K01179	ko00500	Starch and sucrose metabolism	3084	2.9e-164	0.73	0.88	0.94
PGSC0003DMT200008106	K01179	ko00500	Starch and sucrose metabolism	1165	2.0e-58	0.71	0.87	0.98
PGSC0003DMT200008113	K00801	ko00100	Steroid biosynthesis	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMT200008113	K00801	ko01100	Metabolic pathways	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMT200008113	K00801	ko01110	Biosynthesis of secondary metabolites	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMT200008126	K12489	ko04144	Endocytosis	684	6.8e-32	0.69	0.82	0.53
PGSC0003DMT200008128	K08737	ko03430	Mismatch repair	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMT200008128	K08737	ko05200	Pathways in cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMT200008128	K08737	ko05210	Colorectal cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMT200008132	K08737	ko03430	Mismatch repair	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMT200008132	K08737	ko05200	Pathways in cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMT200008132	K08737	ko05210	Colorectal cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMT200008136	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMT200008136	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMT200008136	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMT200008136	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMT200008136	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMT200008138	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMT200008138	K00517	ko00626	Naphthalene and anthracene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMT200008138	K00517	ko00903	Limonene and pinene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMT200008138	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMT200008138	K00517	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMT200008140	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008140	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008140	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008140	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008140	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008141	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008141	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008141	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008141	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200008141	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMT200096396	K11252	ko05322	Systemic lupus erythematosus	414	5.3e-17	0.43	0.67	0.95
PGSC0003DMT200096405	K10760	ko00908	Zeatin biosynthesis	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMT200096405	K10760	ko01100	Metabolic pathways	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMT200096405	K10760	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMT200096420	K12493	ko04144	Endocytosis	300	8.7e-10	0.49	0.70	0.49
PGSC0003DMT200089988	K12581	ko03018	RNA degradation	904	5.0e-44	0.50	0.65	0.94
PGSC0003DMT200025838	K00162	ko00010	Glycolysis / Gluconeogenesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko00020	Citrate cycle (TCA cycle)	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko00620	Pyruvate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko00650	Butanoate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko01100	Metabolic pathways	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025838	K00162	ko01110	Biosynthesis of secondary metabolites	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMT200025841	K01300	ko04610	Complement and coagulation cascades	259	1.9e-08	0.35	0.50	0.47
PGSC0003DMT200025842	K00721	ko00510	N-Glycan biosynthesis	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMT200025842	K00721	ko01100	Metabolic pathways	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMT200025843	K00721	ko00510	N-Glycan biosynthesis	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMT200025843	K00721	ko01100	Metabolic pathways	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMT200025845	K00700	ko00500	Starch and sucrose metabolism	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMT200025845	K00700	ko01100	Metabolic pathways	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMT200025846	K00700	ko00500	Starch and sucrose metabolism	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMT200025846	K00700	ko01100	Metabolic pathways	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMT200025853	K05868	ko04110	Cell cycle	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMT200025853	K05868	ko04115	p53 signaling pathway	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMT200025853	K05868	ko04914	Progesterone-mediated oocyte maturation	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMT200025854	K05868	ko04110	Cell cycle	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMT200025854	K05868	ko04115	p53 signaling pathway	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMT200025854	K05868	ko04914	Progesterone-mediated oocyte maturation	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMT200025856	K12385	ko04142	Lysosome	8598	0.	0.82	0.90	0.95
PGSC0003DMT200025857	K12385	ko04142	Lysosome	2386	9.1e-126	0.82	0.91	0.99
PGSC0003DMT200025858	K12385	ko04142	Lysosome	4213	1.6e-226	0.85	0.93	1.00
PGSC0003DMT200025859	K12385	ko04142	Lysosome	963	2.8e-47	0.91	0.95	0.98
PGSC0003DMT200025860	K12385	ko04142	Lysosome	694	6.9e-32	0.88	0.95	0.96
PGSC0003DMT200010575	K00134	ko00010	Glycolysis / Gluconeogenesis	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMT200010575	K00134	ko01100	Metabolic pathways	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMT200010575	K00134	ko01110	Biosynthesis of secondary metabolites	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMT200010575	K00134	ko05010	Alzheimer's disease	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMT200010597	K01955	ko00240	Pyrimidine metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMT200010597	K01955	ko00250	Alanine, aspartate and glutamate metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMT200010597	K01955	ko01100	Metabolic pathways	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMT200020223	K08679	ko00500	Starch and sucrose metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMT200020223	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMT200020223	K08679	ko01100	Metabolic pathways	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMT200020225	K07297	ko04920	Adipocytokine signaling pathway	1700	6.3e-88	0.54	0.70	0.95
PGSC0003DMT200020226	K07297	ko04920	Adipocytokine signaling pathway	1744	2.3e-90	0.58	0.74	0.95
PGSC0003DMT200020231	K00939	ko00230	Purine metabolism	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMT200020231	K00939	ko01100	Metabolic pathways	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMT200020231	K00939	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMT200020232	K12128	ko04712	Circadian rhythm - plant	413	9.8e-17	0.34	0.51	0.29
PGSC0003DMT200020233	K12128	ko04712	Circadian rhythm - plant	413	1.1e-16	0.34	0.51	0.28
PGSC0003DMT200020240	K01658	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMT200020240	K01658	ko01100	Metabolic pathways	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMT200020240	K01658	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMT200020244	K12126	ko04712	Circadian rhythm - plant	326	4.1e-12	0.51	0.81	0.19
PGSC0003DMT200020254	K01255	ko00480	Glutathione metabolism	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMT200020254	K01255	ko01100	Metabolic pathways	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMT200008242	K00754	ko00051	Fructose and mannose metabolism	1312	1.6e-66	0.37	0.53	0.84
PGSC0003DMT200008243	K00754	ko00051	Fructose and mannose metabolism	1283	6.3e-65	0.44	0.61	0.97
PGSC0003DMT200008245	K01199	ko00500	Starch and sucrose metabolism	668	5.2e-31	0.35	0.52	0.71
PGSC0003DMT200087883	K12478	ko04144	Endocytosis	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMT200087883	K12478	ko04145	Phagosome	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMT200087889	K04733	ko04210	Apoptosis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMT200087889	K04733	ko04620	Toll-like receptor signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMT200087889	K04733	ko04722	Neurotrophin signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMT200087889	K04733	ko05140	Leishmaniasis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMT200087889	K04733	ko05142	Chagas disease	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMT200053653	K02937	ko03010	Ribosome	1768	1.1e-91	0.86	0.94	0.99
PGSC0003DMT200053666	K00602	ko00230	Purine metabolism	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMT200053666	K00602	ko00670	One carbon pool by folate	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMT200053666	K00602	ko01100	Metabolic pathways	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMT200053666	K00602	ko01110	Biosynthesis of secondary metabolites	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMT200053673	K11866	ko04144	Endocytosis	301	6.8e-10	0.45	0.60	0.94
PGSC0003DMT200053681	K03020	ko00230	Purine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMT200053681	K03020	ko00240	Pyrimidine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMT200053681	K03020	ko01100	Metabolic pathways	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMT200053681	K03020	ko03020	RNA polymerase	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMT200053681	K03020	ko04623	Cytosolic DNA-sensing pathway	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMT200053682	K03015	ko00230	Purine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMT200053682	K03015	ko00240	Pyrimidine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMT200053682	K03015	ko01100	Metabolic pathways	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMT200053682	K03015	ko03020	RNA polymerase	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMT200053682	K03015	ko05016	Huntington's disease	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMT200053683	K06269	ko04113	Meiosis - yeast	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04114	Oocyte meiosis	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04270	Vascular smooth muscle contraction	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04510	Focal adhesion	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04720	Long-term potentiation	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04810	Regulation of actin cytoskeleton	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053683	K06269	ko04910	Insulin signaling pathway	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMT200053684	K06269	ko04113	Meiosis - yeast	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04114	Oocyte meiosis	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04270	Vascular smooth muscle contraction	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04510	Focal adhesion	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04720	Long-term potentiation	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04810	Regulation of actin cytoskeleton	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200053684	K06269	ko04910	Insulin signaling pathway	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMT200063241	K04424	ko04010	MAPK signaling pathway	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMT200063241	K04424	ko04530	Tight junction	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMT200063261	K02183	ko04020	Calcium signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04070	Phosphatidylinositol signaling system	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04114	Oocyte meiosis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04270	Vascular smooth muscle contraction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04626	Plant-pathogen interaction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04720	Long-term potentiation	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04722	Neurotrophin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04740	Olfactory transduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04744	Phototransduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04745	Phototransduction - fly	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04910	Insulin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04912	GnRH signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04916	Melanogenesis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04970	Salivary secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko04971	Gastric acid secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko05010	Alzheimer's disease	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063261	K02183	ko05214	Glioma	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMT200063273	K10712	ko00430	Taurine and hypotaurine metabolism	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMT200063273	K10712	ko01100	Metabolic pathways	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMT200063274	K01757	ko00901	Indole alkaloid biosynthesis	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMT200063274	K01757	ko01100	Metabolic pathways	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMT200063274	K01757	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMT200063275	K01757	ko00901	Indole alkaloid biosynthesis	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMT200063275	K01757	ko01100	Metabolic pathways	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMT200063275	K01757	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMT200092049	K02638	ko00195	Photosynthesis	945	2.8e-46	0.69	0.82	0.99
PGSC0003DMT200092060	K13065	ko00940	Phenylpropanoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMT200092060	K13065	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMT200092060	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMT200092060	K13065	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMT200004558	K00142	ko00300	Lysine biosynthesis	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMT200004558	K00142	ko00310	Lysine degradation	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMT200004558	K00142	ko01100	Metabolic pathways	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMT200004561	K04780	ko01053	Biosynthesis of siderophore group nonribosomal peptides	849	7.6e-40	0.30	0.48	0.83
PGSC0003DMT200004563	K10601	ko04120	Ubiquitin mediated proteolysis	249	6.7e-08	0.40	0.58	0.24
PGSC0003DMT200004564	K08241	ko00592	alpha-Linolenic acid metabolism	535	2.4e-28	0.38	0.63	0.97
PGSC0003DMT200004567	K01692	ko00071	Fatty acid metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00280	Valine, leucine and isoleucine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00281	Geraniol degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00310	Lysine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00380	Tryptophan metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00410	beta-Alanine metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00632	Benzoate degradation via CoA ligation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00640	Propanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00650	Butanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00903	Limonene and pinene degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko00930	Caprolactam degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko01100	Metabolic pathways	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004567	K01692	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMT200004569	K08241	ko00592	alpha-Linolenic acid metabolism	605	1.6e-27	0.49	0.65	0.69
PGSC0003DMT200004570	K08241	ko00592	alpha-Linolenic acid metabolism	683	7.8e-32	0.32	0.47	0.88
PGSC0003DMT200004571	K08241	ko00592	alpha-Linolenic acid metabolism	1012	5.5e-50	0.42	0.62	0.99
PGSC0003DMT200004572	K08241	ko00592	alpha-Linolenic acid metabolism	1018	2.6e-50	0.39	0.60	0.97
PGSC0003DMT200004573	K08241	ko00592	alpha-Linolenic acid metabolism	612	6.4e-28	0.49	0.65	0.82
PGSC0003DMT200004574	K08241	ko00592	alpha-Linolenic acid metabolism	326	3.8e-12	0.30	0.59	0.97
PGSC0003DMT200004578	K08241	ko00592	alpha-Linolenic acid metabolism	841	1.5e-40	0.45	0.61	0.90
PGSC0003DMT200004579	K08241	ko00592	alpha-Linolenic acid metabolism	989	1.0e-48	0.44	0.62	0.93
PGSC0003DMT200004581	K08241	ko00592	alpha-Linolenic acid metabolism	1142	3.7e-57	0.44	0.63	0.92
PGSC0003DMT200004585	K01692	ko00071	Fatty acid metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00280	Valine, leucine and isoleucine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00281	Geraniol degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00310	Lysine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00380	Tryptophan metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00410	beta-Alanine metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00632	Benzoate degradation via CoA ligation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00640	Propanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00650	Butanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00903	Limonene and pinene degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko00930	Caprolactam degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko01100	Metabolic pathways	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004585	K01692	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMT200004590	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMT200004590	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMT200004591	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMT200004591	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMT200004592	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMT200004592	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMT200004593	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMT200004593	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMT200004596	K04123	ko00904	Diterpenoid biosynthesis	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMT200004596	K04123	ko01100	Metabolic pathways	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMT200004596	K04123	ko01110	Biosynthesis of secondary metabolites	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMT200004597	K04123	ko00904	Diterpenoid biosynthesis	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMT200004597	K04123	ko01100	Metabolic pathways	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMT200004597	K04123	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMT200022532	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMT200022533	K04532	ko05010	Alzheimer's disease	3743	1.3e-200	0.83	0.93	1.00
PGSC0003DMT200022534	K04532	ko05010	Alzheimer's disease	1487	3.5e-76	0.91	0.96	0.91
PGSC0003DMT200022535	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMT200022536	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022536	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022536	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022537	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022537	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022537	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMT200022547	K01681	ko00020	Citrate cycle (TCA cycle)	7220	0.	0.87	0.93	1.00
PGSC0003DMT200022547	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7220	0.	0.87	0.93	1.00
PGSC0003DMT200022547	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7220	0.	0.87	0.93	1.00
PGSC0003DMT200022547	K01681	ko01100	Metabolic pathways	7220	0.	0.87	0.93	1.00
PGSC0003DMT200022547	K01681	ko01110	Biosynthesis of secondary metabolites	7220	0.	0.87	0.93	1.00
PGSC0003DMT200022548	K01681	ko00020	Citrate cycle (TCA cycle)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMT200022548	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMT200022548	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMT200022548	K01681	ko01100	Metabolic pathways	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMT200022548	K01681	ko01110	Biosynthesis of secondary metabolites	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMT200022549	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMT200022549	K00517	ko00626	Naphthalene and anthracene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMT200022549	K00517	ko00903	Limonene and pinene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMT200022549	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMT200022549	K00517	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMT200022555	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMT200022555	K00122	ko00680	Methane metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMT200022555	K00122	ko01100	Metabolic pathways	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMT200022563	K07466	ko03030	DNA replication	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMT200022563	K07466	ko03420	Nucleotide excision repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMT200022563	K07466	ko03430	Mismatch repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMT200022563	K07466	ko03440	Homologous recombination	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMT200022570	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMT200022570	K00517	ko00626	Naphthalene and anthracene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMT200022570	K00517	ko00903	Limonene and pinene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMT200022570	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMT200022570	K00517	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMT200022574	K07374	ko04145	Phagosome	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMT200022574	K07374	ko04540	Gap junction	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMT200022574	K07374	ko05130	Pathogenic Escherichia coli infection	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMT200022576	K05666	ko02010	ABC transporters	3353	2.3e-184	0.35	0.55	0.76
PGSC0003DMT200022577	K05666	ko02010	ABC transporters	3778	1.5e-202	0.34	0.54	0.85
PGSC0003DMT200022578	K05667	ko02010	ABC transporters	2276	1.1e-119	0.35	0.54	0.94
PGSC0003DMT200022579	K02912	ko03010	Ribosome	1051	3.9e-52	0.91	0.96	0.99
PGSC0003DMT200014466	K07375	ko04145	Phagosome	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMT200014466	K07375	ko04540	Gap junction	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMT200014466	K07375	ko05130	Pathogenic Escherichia coli infection	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMT200014487	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMT200014489	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMT200014490	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMT200014500	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMT200014500	K00517	ko00626	Naphthalene and anthracene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMT200014500	K00517	ko00903	Limonene and pinene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMT200014500	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMT200014500	K00517	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMT200051074	K09481	ko03060	Protein export	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMT200051074	K09481	ko04145	Phagosome	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMT200051074	K09481	ko05110	Vibrio cholerae infection	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMT200051077	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMT200051077	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMT200051078	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMT200051078	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMT200051079	K03648	ko03410	Base excision repair	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMT200051079	K03648	ko05340	Primary immunodeficiency	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMT200051097	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051097	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051098	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051098	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051099	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051099	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051100	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051100	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMT200051101	K08139	ko04113	Meiosis - yeast	389	1.3e-15	0.36	0.53	0.86
PGSC0003DMT200051117	K02148	ko00190	Oxidative phosphorylation	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200051117	K02148	ko01100	Metabolic pathways	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200051117	K02148	ko04145	Phagosome	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200051117	K02148	ko04966	Collecting duct acid secretion	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200051117	K02148	ko05110	Vibrio cholerae infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200051117	K02148	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMT200074632	K12128	ko04712	Circadian rhythm - plant	270	5.9e-09	0.38	0.56	0.38
PGSC0003DMT200074633	K00927	ko00010	Glycolysis / Gluconeogenesis	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMT200074633	K00927	ko00710	Carbon fixation in photosynthetic organisms	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMT200074633	K00927	ko01100	Metabolic pathways	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMT200074633	K00927	ko01110	Biosynthesis of secondary metabolites	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMT200074636	K01431	ko00240	Pyrimidine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMT200074636	K01431	ko00410	beta-Alanine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMT200074636	K01431	ko00770	Pantothenate and CoA biosynthesis	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMT200074636	K01431	ko00983	Drug metabolism - other enzymes	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMT200074636	K01431	ko01100	Metabolic pathways	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMT200074637	K01431	ko00240	Pyrimidine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMT200074637	K01431	ko00410	beta-Alanine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMT200074637	K01431	ko00770	Pantothenate and CoA biosynthesis	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMT200074637	K01431	ko00983	Drug metabolism - other enzymes	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMT200074637	K01431	ko01100	Metabolic pathways	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMT200074638	K01431	ko00240	Pyrimidine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMT200074638	K01431	ko00410	beta-Alanine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMT200074638	K01431	ko00770	Pantothenate and CoA biosynthesis	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMT200074638	K01431	ko00983	Drug metabolism - other enzymes	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMT200074638	K01431	ko01100	Metabolic pathways	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMT200074648	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMT200074648	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMT200074648	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMT200074657	K05278	ko00941	Flavonoid biosynthesis	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMT200074657	K05278	ko01100	Metabolic pathways	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMT200074657	K05278	ko01110	Biosynthesis of secondary metabolites	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMT200074658	K05282	ko00904	Diterpenoid biosynthesis	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMT200074658	K05282	ko01100	Metabolic pathways	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMT200074658	K05282	ko01110	Biosynthesis of secondary metabolites	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMT200074659	K00889	ko00562	Inositol phosphate metabolism	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074659	K00889	ko01100	Metabolic pathways	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074659	K00889	ko04070	Phosphatidylinositol signaling system	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074659	K00889	ko04144	Endocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074659	K00889	ko04666	Fc gamma R-mediated phagocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074659	K00889	ko04810	Regulation of actin cytoskeleton	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMT200074663	K01942	ko00780	Biotin metabolism	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMT200074663	K01942	ko01100	Metabolic pathways	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMT200074664	K01942	ko00780	Biotin metabolism	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMT200074664	K01942	ko01100	Metabolic pathways	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMT200074666	K08866	ko04110	Cell cycle	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMT200074666	K08866	ko04111	Cell cycle - yeast	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMT200074667	K08866	ko04110	Cell cycle	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMT200074667	K08866	ko04111	Cell cycle - yeast	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMT200074668	K08866	ko04110	Cell cycle	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMT200074668	K08866	ko04111	Cell cycle - yeast	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMT200074669	K08866	ko04110	Cell cycle	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMT200074669	K08866	ko04111	Cell cycle - yeast	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMT200074670	K08866	ko04110	Cell cycle	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMT200074670	K08866	ko04111	Cell cycle - yeast	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMT200068951	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00270	Cysteine and methionine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00350	Tyrosine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00401	Novobiocin biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko01100	Metabolic pathways	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068951	K00815	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMT200068952	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00270	Cysteine and methionine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00350	Tyrosine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00360	Phenylalanine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00401	Novobiocin biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00950	Isoquinoline alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko01100	Metabolic pathways	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068952	K00815	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMT200068953	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068953	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068954	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068955	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMT200068957	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00350	Tyrosine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00360	Phenylalanine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00401	Novobiocin biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko01100	Metabolic pathways	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200068957	K00815	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMT200061177	K10246	ko01040	Biosynthesis of unsaturated fatty acids	397	4.6e-16	0.38	0.52	0.95
PGSC0003DMT200061189	K09588	ko01100	Metabolic pathways	1826	7.0e-95	0.72	0.82	0.98
PGSC0003DMT200061190	K09588	ko01100	Metabolic pathways	2484	3.6e-131	0.74	0.83	0.82
PGSC0003DMT200061199	K00970	ko03018	RNA degradation	339	7.4e-12	0.37	0.54	0.58
PGSC0003DMT200006437	K00599	ko00340	Histidine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMT200006437	K00599	ko00350	Tyrosine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMT200006437	K00599	ko00450	Selenoamino acid metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMT200006437	K00599	ko00626	Naphthalene and anthracene degradation	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMT200006439	K00599	ko00340	Histidine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMT200006439	K00599	ko00350	Tyrosine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMT200006439	K00599	ko00450	Selenoamino acid metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMT200006439	K00599	ko00626	Naphthalene and anthracene degradation	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMT200006440	K00599	ko00340	Histidine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMT200006440	K00599	ko00350	Tyrosine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMT200006440	K00599	ko00450	Selenoamino acid metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMT200006440	K00599	ko00626	Naphthalene and anthracene degradation	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMT200030265	K04077	ko03018	RNA degradation	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMT200030265	K04077	ko04940	Type I diabetes mellitus	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMT200030272	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMT200030272	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMT200030272	K00771	ko01100	Metabolic pathways	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMT200030279	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMT200030279	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMT200030280	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMT200030280	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMT200030288	K00441	ko00790	Folate biosynthesis	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMT200030288	K00441	ko01100	Metabolic pathways	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMT200030289	K00441	ko00790	Folate biosynthesis	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMT200030289	K00441	ko01100	Metabolic pathways	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMT200030293	K00356	ko00190	Oxidative phosphorylation	1097	1.1e-54	0.87	0.92	0.99
PGSC0003DMT200016160	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMT200016170	K05350	ko00460	Cyanoamino acid metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMT200016170	K05350	ko00500	Starch and sucrose metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMT200016170	K05350	ko00940	Phenylpropanoid biosynthesis	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMT200016170	K05350	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMT200016171	K05350	ko00460	Cyanoamino acid metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMT200016171	K05350	ko00500	Starch and sucrose metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMT200016171	K05350	ko00940	Phenylpropanoid biosynthesis	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMT200016171	K05350	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMT200024260	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00270	Cysteine and methionine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00350	Tyrosine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00360	Phenylalanine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00401	Novobiocin biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko01100	Metabolic pathways	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024260	K00815	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMT200024262	K07466	ko03030	DNA replication	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMT200024262	K07466	ko03420	Nucleotide excision repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMT200024262	K07466	ko03430	Mismatch repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMT200024262	K07466	ko03440	Homologous recombination	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMT200024265	K12826	ko03040	Spliceosome	346	3.0e-13	0.29	0.41	0.78
PGSC0003DMT200024266	K12826	ko03040	Spliceosome	342	5.0e-13	0.33	0.44	0.85
PGSC0003DMT200024281	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMT200024281	K00517	ko00626	Naphthalene and anthracene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMT200024281	K00517	ko00903	Limonene and pinene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMT200024281	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMT200024281	K00517	ko01110	Biosynthesis of secondary metabolites	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMT200000033	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.67
PGSC0003DMT200000034	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.65
PGSC0003DMT200000035	K05282	ko00904	Diterpenoid biosynthesis	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMT200000035	K05282	ko01100	Metabolic pathways	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMT200000035	K05282	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMT200000036	K05282	ko00904	Diterpenoid biosynthesis	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMT200000036	K05282	ko01100	Metabolic pathways	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMT200000036	K05282	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMT200000043	K01692	ko00071	Fatty acid metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00280	Valine, leucine and isoleucine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00281	Geraniol degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00310	Lysine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00380	Tryptophan metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00410	beta-Alanine metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00632	Benzoate degradation via CoA ligation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00640	Propanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00650	Butanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00903	Limonene and pinene degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko00930	Caprolactam degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000043	K01692	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMT200000046	K01692	ko00071	Fatty acid metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00280	Valine, leucine and isoleucine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00281	Geraniol degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00310	Lysine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00380	Tryptophan metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00410	beta-Alanine metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00632	Benzoate degradation via CoA ligation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00640	Propanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00650	Butanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00903	Limonene and pinene degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko00930	Caprolactam degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko01100	Metabolic pathways	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000046	K01692	ko01110	Biosynthesis of secondary metabolites	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMT200000048	K01692	ko00071	Fatty acid metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00280	Valine, leucine and isoleucine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00281	Geraniol degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00310	Lysine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00380	Tryptophan metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00410	beta-Alanine metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00632	Benzoate degradation via CoA ligation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00640	Propanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00650	Butanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00903	Limonene and pinene degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko00930	Caprolactam degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko01100	Metabolic pathways	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000048	K01692	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMT200000054	K01692	ko00071	Fatty acid metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00280	Valine, leucine and isoleucine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00281	Geraniol degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00310	Lysine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00410	beta-Alanine metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00632	Benzoate degradation via CoA ligation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00640	Propanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00650	Butanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00903	Limonene and pinene degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko00930	Caprolactam degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko01100	Metabolic pathways	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000054	K01692	ko01110	Biosynthesis of secondary metabolites	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMT200000055	K01692	ko00071	Fatty acid metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00280	Valine, leucine and isoleucine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00281	Geraniol degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00310	Lysine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00380	Tryptophan metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00410	beta-Alanine metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00632	Benzoate degradation via CoA ligation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00640	Propanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00650	Butanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00903	Limonene and pinene degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko00930	Caprolactam degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko01100	Metabolic pathways	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000055	K01692	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMT200000056	K01692	ko00071	Fatty acid metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00280	Valine, leucine and isoleucine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00281	Geraniol degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00310	Lysine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00380	Tryptophan metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00410	beta-Alanine metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00632	Benzoate degradation via CoA ligation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00640	Propanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00650	Butanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00903	Limonene and pinene degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko00930	Caprolactam degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko01100	Metabolic pathways	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000056	K01692	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMT200000064	K00067	ko00521	Streptomycin biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMT200000064	K00067	ko00523	Polyketide sugar unit biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMT200000064	K00067	ko01100	Metabolic pathways	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMT200000064	K00067	ko01110	Biosynthesis of secondary metabolites	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMT200000065	K00067	ko00521	Streptomycin biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMT200000065	K00067	ko00523	Polyketide sugar unit biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMT200000065	K00067	ko01100	Metabolic pathways	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMT200000065	K00067	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMT200000066	K00028	ko00620	Pyruvate metabolism	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMT200000066	K00028	ko00710	Carbon fixation in photosynthetic organisms	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMT200000066	K00028	ko01100	Metabolic pathways	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMT200000067	K00079	ko00590	Arachidonic acid metabolism	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMT200000067	K00079	ko01100	Metabolic pathways	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMT200000068	K00079	ko00590	Arachidonic acid metabolism	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMT200000068	K00079	ko01100	Metabolic pathways	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMT200093258	K12356	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.30	0.44	0.88
PGSC0003DMT200049234	K04618	ko00052	Galactose metabolism	526	1.0e-22	0.29	0.41	0.95
PGSC0003DMT200049256	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMT200049256	K01602	ko00710	Carbon fixation in photosynthetic organisms	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMT200049256	K01602	ko01100	Metabolic pathways	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMT200059417	K04565	ko04146	Peroxisome	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMT200059417	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMT200059417	K04565	ko05016	Huntington's disease	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMT200059417	K04565	ko05020	Prion diseases	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMT200059420	K01515	ko00230	Purine metabolism	243	1.4e-07	0.35	0.57	0.81
PGSC0003DMT200059435	K01110	ko00562	Inositol phosphate metabolism	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko04070	Phosphatidylinositol signaling system	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko04115	p53 signaling pathway	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko04510	Focal adhesion	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko04530	Tight junction	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05200	Pathways in cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05213	Endometrial cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05214	Glioma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05215	Prostate cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05218	Melanoma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059435	K01110	ko05222	Small cell lung cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMT200059443	K07466	ko03030	DNA replication	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMT200059443	K07466	ko03420	Nucleotide excision repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMT200059443	K07466	ko03430	Mismatch repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMT200059443	K07466	ko03440	Homologous recombination	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMT200059452	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMT200059452	K05292	ko01100	Metabolic pathways	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMT200059452	K05292	ko01110	Biosynthesis of secondary metabolites	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMT200059453	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMT200059453	K05292	ko01100	Metabolic pathways	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMT200059453	K05292	ko01110	Biosynthesis of secondary metabolites	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMT200067237	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067237	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067237	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067238	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067238	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067238	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067241	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMT200067243	K04428	ko04010	MAPK signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMT200067243	K04428	ko04912	GnRH signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMT200067244	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067244	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067244	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMT200067245	K01057	ko00030	Pentose phosphate pathway	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMT200067245	K01057	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMT200067245	K01057	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMT200067246	K01057	ko00030	Pentose phosphate pathway	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMT200067246	K01057	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMT200067246	K01057	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMT200067247	K01057	ko00030	Pentose phosphate pathway	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMT200067247	K01057	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMT200067247	K01057	ko01110	Biosynthesis of secondary metabolites	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMT200067248	K01057	ko00030	Pentose phosphate pathway	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMT200067248	K01057	ko01100	Metabolic pathways	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMT200067248	K01057	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMT200067268	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMT200067268	K01078	ko00740	Riboflavin metabolism	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMT200043551	K06276	ko03320	PPAR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043551	K06276	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMT200043552	K06276	ko03320	PPAR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko04150	mTOR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko04510	Focal adhesion	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko04910	Insulin signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko05213	Endometrial cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko05215	Prostate cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043552	K06276	ko05223	Non-small cell lung cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMT200043558	K01728	ko00040	Pentose and glucuronate interconversions	2088	2.5e-109	0.63	0.77	0.76
PGSC0003DMT200043578	K11252	ko05322	Systemic lupus erythematosus	1101	6.8e-55	0.93	0.94	0.99
PGSC0003DMT200043580	K12897	ko03040	Spliceosome	376	6.7e-15	0.37	0.46	0.93
PGSC0003DMT200043581	K12885	ko03040	Spliceosome	469	4.9e-20	0.34	0.45	0.97
PGSC0003DMT200018263	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMT200018264	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMT200018266	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMT200018267	K00697	ko00500	Starch and sucrose metabolism	1792	5.3e-93	0.79	0.86	0.99
PGSC0003DMT200018268	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMT200018282	K03006	ko00230	Purine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMT200018282	K03006	ko00240	Pyrimidine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMT200018282	K03006	ko01100	Metabolic pathways	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMT200018282	K03006	ko03020	RNA polymerase	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMT200018282	K03006	ko05016	Huntington's disease	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMT200008944	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.92
PGSC0003DMT200008945	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.93
PGSC0003DMT200008951	K09658	ko00510	N-Glycan biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMT200008951	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMT200008951	K09658	ko01100	Metabolic pathways	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMT200008955	K01184	ko00040	Pentose and glucuronate interconversions	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMT200008955	K01184	ko00500	Starch and sucrose metabolism	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMT200008955	K01184	ko01100	Metabolic pathways	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMT200008956	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008956	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008956	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008957	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008957	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008957	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMT200008961	K12885	ko03040	Spliceosome	424	1.5e-17	0.30	0.39	0.90
PGSC0003DMT200008970	K00688	ko00500	Starch and sucrose metabolism	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMT200008970	K00688	ko04910	Insulin signaling pathway	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMT200008974	K02982	ko03010	Ribosome	576	6.2e-26	0.91	0.97	0.99
PGSC0003DMT200008977	K02982	ko03010	Ribosome	487	5.0e-21	0.90	0.98	0.91
PGSC0003DMT200008980	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMT200008981	K12189	ko04144	Endocytosis	1357	5.2e-69	0.87	0.96	0.99
PGSC0003DMT200070433	K02183	ko04020	Calcium signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04070	Phosphatidylinositol signaling system	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04114	Oocyte meiosis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04270	Vascular smooth muscle contraction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04626	Plant-pathogen interaction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04720	Long-term potentiation	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04722	Neurotrophin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04740	Olfactory transduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04744	Phototransduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04745	Phototransduction - fly	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04910	Insulin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04912	GnRH signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04916	Melanogenesis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04970	Salivary secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko04971	Gastric acid secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko05010	Alzheimer's disease	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070433	K02183	ko05214	Glioma	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMT200070434	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMT200070437	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070437	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200070438	K02183	ko04020	Calcium signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04070	Phosphatidylinositol signaling system	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04114	Oocyte meiosis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04270	Vascular smooth muscle contraction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04626	Plant-pathogen interaction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04720	Long-term potentiation	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04722	Neurotrophin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04740	Olfactory transduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04744	Phototransduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04745	Phototransduction - fly	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04910	Insulin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04912	GnRH signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04916	Melanogenesis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04970	Salivary secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko04971	Gastric acid secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko05010	Alzheimer's disease	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070438	K02183	ko05214	Glioma	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMT200070439	K02183	ko04020	Calcium signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04070	Phosphatidylinositol signaling system	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04114	Oocyte meiosis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04270	Vascular smooth muscle contraction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04626	Plant-pathogen interaction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04720	Long-term potentiation	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04722	Neurotrophin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04740	Olfactory transduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04744	Phototransduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04745	Phototransduction - fly	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04910	Insulin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04912	GnRH signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04916	Melanogenesis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04970	Salivary secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko04971	Gastric acid secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko05010	Alzheimer's disease	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070439	K02183	ko05214	Glioma	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMT200070440	K01199	ko00500	Starch and sucrose metabolism	621	2.0e-28	0.32	0.51	0.92
PGSC0003DMT200070454	K00475	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMT200070454	K00475	ko01100	Metabolic pathways	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMT200070454	K00475	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMT200070456	K00475	ko00941	Flavonoid biosynthesis	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMT200070456	K00475	ko01100	Metabolic pathways	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMT200070456	K00475	ko01110	Biosynthesis of secondary metabolites	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMT200070458	K05278	ko00941	Flavonoid biosynthesis	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMT200070458	K05278	ko01100	Metabolic pathways	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMT200070458	K05278	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMT200070459	K05277	ko00941	Flavonoid biosynthesis	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMT200070459	K05277	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMT200070459	K05277	ko01110	Biosynthesis of secondary metabolites	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMT200070461	K05277	ko00941	Flavonoid biosynthesis	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMT200070461	K05277	ko01100	Metabolic pathways	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMT200070461	K05277	ko01110	Biosynthesis of secondary metabolites	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMT200070462	K00475	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMT200070462	K00475	ko01100	Metabolic pathways	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMT200070462	K00475	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMT200064930	K11090	ko05322	Systemic lupus erythematosus	318	1.1e-11	0.36	0.55	0.50
PGSC0003DMT200064931	K11090	ko05322	Systemic lupus erythematosus	331	2.0e-12	0.29	0.45	0.59
PGSC0003DMT200064932	K00794	ko00740	Riboflavin metabolism	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMT200064932	K00794	ko01100	Metabolic pathways	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMT200064933	K00794	ko00740	Riboflavin metabolism	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMT200064933	K00794	ko01100	Metabolic pathways	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMT200064936	K00975	ko00500	Starch and sucrose metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMT200064936	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMT200064936	K00975	ko01100	Metabolic pathways	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMT200064937	K13065	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMT200064937	K13065	ko00941	Flavonoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMT200064937	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMT200064937	K13065	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMT200064939	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMT200064939	K00517	ko00626	Naphthalene and anthracene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMT200064939	K00517	ko00903	Limonene and pinene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMT200064939	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMT200064939	K00517	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMT200064940	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMT200064940	K00517	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMT200064940	K00517	ko00903	Limonene and pinene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMT200064940	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMT200064940	K00517	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMT200064942	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMT200064942	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMT200064943	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMT200064943	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMT200064944	K04424	ko04010	MAPK signaling pathway	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMT200064944	K04424	ko04530	Tight junction	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMT200064947	K01190	ko00052	Galactose metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMT200064947	K01190	ko00511	Other glycan degradation	6612	0.	0.67	0.80	1.00
PGSC0003DMT200064947	K01190	ko00600	Sphingolipid metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMT200064947	K01190	ko01100	Metabolic pathways	6612	0.	0.67	0.80	1.00
PGSC0003DMT200064948	K01190	ko00052	Galactose metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMT200064948	K01190	ko00511	Other glycan degradation	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMT200064948	K01190	ko00600	Sphingolipid metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMT200064948	K01190	ko01100	Metabolic pathways	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMT200064949	K01190	ko00052	Galactose metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMT200064949	K01190	ko00511	Other glycan degradation	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMT200064949	K01190	ko00600	Sphingolipid metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMT200064949	K01190	ko01100	Metabolic pathways	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMT200064953	K01099	ko00562	Inositol phosphate metabolism	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMT200064953	K01099	ko01100	Metabolic pathways	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMT200064953	K01099	ko04070	Phosphatidylinositol signaling system	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMT200064957	K00599	ko00340	Histidine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMT200064957	K00599	ko00350	Tyrosine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMT200064957	K00599	ko00450	Selenoamino acid metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMT200064957	K00599	ko00626	Naphthalene and anthracene degradation	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMT200064959	K00599	ko00340	Histidine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMT200064959	K00599	ko00350	Tyrosine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMT200064959	K00599	ko00450	Selenoamino acid metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMT200064959	K00599	ko00626	Naphthalene and anthracene degradation	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMT200055527	K11294	ko05130	Pathogenic Escherichia coli infection	478	1.6e-20	0.35	0.52	0.84
PGSC0003DMT200055529	K10775	ko00360	Phenylalanine metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMT200055529	K10775	ko00910	Nitrogen metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMT200055529	K10775	ko00940	Phenylpropanoid biosynthesis	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMT200055529	K10775	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMT200055529	K10775	ko01110	Biosynthesis of secondary metabolites	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMT200055531	K10775	ko00360	Phenylalanine metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMT200055531	K10775	ko00910	Nitrogen metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMT200055531	K10775	ko00940	Phenylpropanoid biosynthesis	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMT200055531	K10775	ko01100	Metabolic pathways	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMT200055531	K10775	ko01110	Biosynthesis of secondary metabolites	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMT200055535	K05681	ko02010	ABC transporters	905	8.0e-44	0.30	0.49	0.44
PGSC0003DMT200055539	K05681	ko02010	ABC transporters	921	5.8e-45	0.30	0.49	0.56
PGSC0003DMT200055540	K12356	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.92
PGSC0003DMT200055542	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMT200055543	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMT200055547	K01358	ko04112	Cell cycle - Caulobacter	489	3.9e-21	0.80	0.94	0.94
PGSC0003DMT200055550	K01051	ko00040	Pentose and glucuronate interconversions	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMT200055550	K01051	ko00500	Starch and sucrose metabolism	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMT200055550	K01051	ko01100	Metabolic pathways	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMT200055551	K01051	ko00040	Pentose and glucuronate interconversions	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMT200055551	K01051	ko00500	Starch and sucrose metabolism	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMT200055551	K01051	ko01100	Metabolic pathways	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMT200055558	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMT200055558	K00517	ko00626	Naphthalene and anthracene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMT200055558	K00517	ko00903	Limonene and pinene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMT200055558	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMT200055558	K00517	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMT200052995	K01955	ko00240	Pyrimidine metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMT200052995	K01955	ko00250	Alanine, aspartate and glutamate metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMT200052995	K01955	ko01100	Metabolic pathways	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMT200053000	K02976	ko03010	Ribosome	981	2.8e-48	0.88	0.91	0.99
PGSC0003DMT200053003	K10579	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.71	0.81	0.97
PGSC0003DMT200053006	K06689	ko04120	Ubiquitin mediated proteolysis	1231	4.6e-62	0.83	0.83	0.99
PGSC0003DMT200053007	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMT200053010	K03063	ko03050	Proteasome	3209	3.7e-171	0.93	0.96	1.00
PGSC0003DMT200053011	K03063	ko03050	Proteasome	573	9.1e-26	0.95	0.97	0.94
PGSC0003DMT200053018	K01251	ko00270	Cysteine and methionine metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMT200053018	K01251	ko00450	Selenoamino acid metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMT200053018	K01251	ko01100	Metabolic pathways	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMT200053019	K01251	ko00270	Cysteine and methionine metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMT200053019	K01251	ko00450	Selenoamino acid metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMT200053019	K01251	ko01100	Metabolic pathways	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMT200053020	K01251	ko00270	Cysteine and methionine metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMT200053020	K01251	ko00450	Selenoamino acid metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMT200053020	K01251	ko01100	Metabolic pathways	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMT200053021	K01516	ko00230	Purine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMT200053021	K01516	ko00730	Thiamine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMT200053021	K01516	ko01100	Metabolic pathways	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMT200053028	K06685	ko04111	Cell cycle - yeast	331	2.1e-10	0.27	0.45	0.69
PGSC0003DMT200088007	K09590	ko00905	Brassinosteroid biosynthesis	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMT200088007	K09590	ko01100	Metabolic pathways	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMT200088007	K09590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMT200088016	K05933	ko00270	Cysteine and methionine metabolism	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMT200088016	K05933	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMT200088017	K01199	ko00500	Starch and sucrose metabolism	480	1.2e-20	0.56	0.81	0.99
PGSC0003DMT200084282	K01358	ko04112	Cell cycle - Caulobacter	1652	2.8e-85	0.73	0.82	1.00
PGSC0003DMT200084285	K03941	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMT200084285	K03941	ko01100	Metabolic pathways	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMT200084285	K03941	ko05010	Alzheimer's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMT200084285	K03941	ko05012	Parkinson's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMT200084285	K03941	ko05016	Huntington's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMT200084300	K12879	ko03040	Spliceosome	11430	0.	0.74	0.83	1.00
PGSC0003DMT200084301	K12879	ko03040	Spliceosome	6858	0.	0.71	0.80	1.00
PGSC0003DMT200084302	K12879	ko03040	Spliceosome	3449	2.1e-184	0.61	0.73	1.00
PGSC0003DMT200084303	K12879	ko03040	Spliceosome	5317	2.0e-287	0.69	0.78	1.00
PGSC0003DMT200084314	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMT200084314	K00517	ko00626	Naphthalene and anthracene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMT200084314	K00517	ko00903	Limonene and pinene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMT200084314	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMT200084314	K00517	ko01110	Biosynthesis of secondary metabolites	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMT200053862	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMT200053862	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMT200053862	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMT200053862	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMT200053862	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMT200053863	K04733	ko04210	Apoptosis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMT200053863	K04733	ko04620	Toll-like receptor signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMT200053863	K04733	ko04722	Neurotrophin signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMT200053863	K04733	ko05140	Leishmaniasis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMT200053863	K04733	ko05142	Chagas disease	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMT200053864	K12356	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.32	0.50	0.89
PGSC0003DMT200053866	K12356	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.48	0.97
PGSC0003DMT200053872	K12356	ko00940	Phenylpropanoid biosynthesis	672	3.1e-31	0.32	0.49	0.92
PGSC0003DMT200063933	K12479	ko04144	Endocytosis	1614	3.5e-83	0.49	0.72	0.96
PGSC0003DMT200063934	K12479	ko04144	Endocytosis	2125	2.3e-111	0.47	0.71	1.00
PGSC0003DMT200063936	K00001	ko00010	Glycolysis / Gluconeogenesis	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00071	Fatty acid metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00350	Tyrosine metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00641	3-Chloroacrylic acid degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00830	Retinol metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko00982	Drug metabolism - cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko01100	Metabolic pathways	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063936	K00001	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMT200063937	K00001	ko00010	Glycolysis / Gluconeogenesis	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00071	Fatty acid metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00350	Tyrosine metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00641	3-Chloroacrylic acid degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00830	Retinol metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko00982	Drug metabolism - cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko01100	Metabolic pathways	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200063937	K00001	ko01110	Biosynthesis of secondary metabolites	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMT200010772	K02703	ko00195	Photosynthesis	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMT200010772	K02703	ko01100	Metabolic pathways	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMT200010796	K01046	ko00561	Glycerolipid metabolism	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMT200010796	K01046	ko01100	Metabolic pathways	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMT200010801	K04708	ko00600	Sphingolipid metabolism	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMT200010801	K04708	ko01100	Metabolic pathways	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMT200010802	K04708	ko00600	Sphingolipid metabolism	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMT200010802	K04708	ko01100	Metabolic pathways	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMT200020927	K04499	ko04310	Wnt signaling pathway	3459	6.0e-185	0.92	0.96	1.00
PGSC0003DMT200020928	K04499	ko04310	Wnt signaling pathway	2089	2.2e-109	0.91	0.97	1.00
PGSC0003DMT200020937	K07359	ko04920	Adipocytokine signaling pathway	2192	4.6e-115	0.65	0.78	1.00
PGSC0003DMT200020938	K07359	ko04920	Adipocytokine signaling pathway	2505	2.5e-132	0.74	0.85	0.98
PGSC0003DMT200020941	K01190	ko00052	Galactose metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMT200020941	K01190	ko00511	Other glycan degradation	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMT200020941	K01190	ko00600	Sphingolipid metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMT200020941	K01190	ko01100	Metabolic pathways	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMT200020942	K01190	ko00052	Galactose metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMT200020942	K01190	ko00511	Other glycan degradation	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMT200020942	K01190	ko00600	Sphingolipid metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMT200020942	K01190	ko01100	Metabolic pathways	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMT200020943	K01190	ko00052	Galactose metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMT200020943	K01190	ko00511	Other glycan degradation	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMT200020943	K01190	ko00600	Sphingolipid metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMT200020943	K01190	ko01100	Metabolic pathways	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMT200020944	K01190	ko00052	Galactose metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMT200020944	K01190	ko00511	Other glycan degradation	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMT200020944	K01190	ko00600	Sphingolipid metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMT200020944	K01190	ko01100	Metabolic pathways	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMT200020946	K08506	ko04130	SNARE interactions in vesicular transport	460	1.5e-19	0.78	0.94	0.99
PGSC0003DMT200020947	K08506	ko04130	SNARE interactions in vesicular transport	828	7.8e-40	0.59	0.77	0.99
PGSC0003DMT200020948	K08506	ko04130	SNARE interactions in vesicular transport	1385	1.5e-70	0.64	0.81	1.00
PGSC0003DMT200020954	K00253	ko00280	Valine, leucine and isoleucine degradation	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMT200020954	K00253	ko01100	Metabolic pathways	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMT200020955	K00253	ko00280	Valine, leucine and isoleucine degradation	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMT200020955	K00253	ko01100	Metabolic pathways	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMT200020958	K00253	ko00280	Valine, leucine and isoleucine degradation	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMT200020958	K00253	ko01100	Metabolic pathways	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMT200020960	K04706	ko04120	Ubiquitin mediated proteolysis	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMT200020960	K04706	ko04630	Jak-STAT signaling pathway	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMT200020960	K04706	ko05200	Pathways in cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMT200020960	K04706	ko05222	Small cell lung cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMT200020961	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020961	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020961	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020961	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020962	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020962	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020962	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020962	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMT200020963	K04706	ko04120	Ubiquitin mediated proteolysis	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMT200020963	K04706	ko04630	Jak-STAT signaling pathway	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMT200020963	K04706	ko05200	Pathways in cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMT200020963	K04706	ko05222	Small cell lung cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMT200036990	K08967	ko00270	Cysteine and methionine metabolism	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMT200036990	K08967	ko01100	Metabolic pathways	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMT200037008	K11329	ko02020	Two-component system	300	2.7e-10	0.32	0.51	0.35
PGSC0003DMT200037010	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMT200037012	K12893	ko03040	Spliceosome	492	2.7e-21	0.30	0.45	1.00
PGSC0003DMT200037013	K12891	ko03040	Spliceosome	457	2.3e-19	0.35	0.45	0.83
PGSC0003DMT200037014	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMT200037016	K00215	ko00300	Lysine biosynthesis	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMT200037016	K00215	ko01100	Metabolic pathways	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMT200037016	K00215	ko01110	Biosynthesis of secondary metabolites	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMT200037017	K00215	ko00300	Lysine biosynthesis	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMT200037017	K00215	ko01100	Metabolic pathways	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMT200037017	K00215	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMT200007942	K12123	ko04712	Circadian rhythm - plant	3877	4.5e-210	0.68	0.80	0.94
PGSC0003DMT200007943	K12123	ko04712	Circadian rhythm - plant	5792	0.	0.63	0.78	0.96
PGSC0003DMT200007944	K12123	ko04712	Circadian rhythm - plant	5781	0.	0.63	0.78	0.96
PGSC0003DMT200078666	K00600	ko00260	Glycine, serine and threonine metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078666	K00600	ko00460	Cyanoamino acid metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078666	K00600	ko00670	One carbon pool by folate	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078666	K00600	ko00680	Methane metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078666	K00600	ko01100	Metabolic pathways	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078666	K00600	ko01110	Biosynthesis of secondary metabolites	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMT200078683	K00703	ko00500	Starch and sucrose metabolism	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMT200078683	K00703	ko01100	Metabolic pathways	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMT200078688	K00703	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMT200078688	K00703	ko01100	Metabolic pathways	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMT200078696	K12126	ko04712	Circadian rhythm - plant	255	9.2e-07	0.28	0.49	0.65
PGSC0003DMT200078697	K12126	ko04712	Circadian rhythm - plant	218	9.1e-06	0.40	0.68	0.48
PGSC0003DMT200078698	K12126	ko04712	Circadian rhythm - plant	220	6.9e-06	0.29	0.46	0.88
PGSC0003DMT200078702	K00844	ko00010	Glycolysis / Gluconeogenesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00051	Fructose and mannose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00052	Galactose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00500	Starch and sucrose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00521	Streptomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko00524	Butirosin and neomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko01100	Metabolic pathways	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko01110	Biosynthesis of secondary metabolites	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko04910	Insulin signaling pathway	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078702	K00844	ko04930	Type II diabetes mellitus	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMT200078703	K00844	ko00010	Glycolysis / Gluconeogenesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00051	Fructose and mannose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00052	Galactose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00500	Starch and sucrose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00521	Streptomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko00524	Butirosin and neomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko01100	Metabolic pathways	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko01110	Biosynthesis of secondary metabolites	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko04910	Insulin signaling pathway	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078703	K00844	ko04930	Type II diabetes mellitus	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMT200078704	K00844	ko00010	Glycolysis / Gluconeogenesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00051	Fructose and mannose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00052	Galactose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00500	Starch and sucrose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00521	Streptomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko00524	Butirosin and neomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko01100	Metabolic pathways	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko04910	Insulin signaling pathway	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200078704	K00844	ko04930	Type II diabetes mellitus	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMT200074815	K06573	ko04966	Collecting duct acid secretion	323	3.1e-11	0.33	0.49	0.47
PGSC0003DMT200074816	K06573	ko04966	Collecting duct acid secretion	636	3.3e-29	0.26	0.43	0.92
PGSC0003DMT200074817	K01662	ko00900	Terpenoid backbone biosynthesis	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMT200074817	K01662	ko01100	Metabolic pathways	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMT200074817	K01662	ko01110	Biosynthesis of secondary metabolites	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMT200074818	K01662	ko00900	Terpenoid backbone biosynthesis	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMT200074818	K01662	ko01100	Metabolic pathways	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMT200074818	K01662	ko01110	Biosynthesis of secondary metabolites	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMT200074841	K08066	ko04612	Antigen processing and presentation	234	4.5e-07	0.33	0.61	0.75
PGSC0003DMT200074843	K12778	ko04113	Meiosis - yeast	343	8.2e-11	0.34	0.56	0.32
PGSC0003DMT200074844	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMT200074846	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMT200074847	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMT200074847	K00517	ko00626	Naphthalene and anthracene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMT200074847	K00517	ko00903	Limonene and pinene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMT200074847	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMT200074847	K00517	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMT200068561	K01623	ko00010	Glycolysis / Gluconeogenesis	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068561	K01623	ko00030	Pentose phosphate pathway	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068561	K01623	ko00051	Fructose and mannose metabolism	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068561	K01623	ko00710	Carbon fixation in photosynthetic organisms	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068561	K01623	ko01100	Metabolic pathways	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068561	K01623	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMT200068569	K01623	ko00010	Glycolysis / Gluconeogenesis	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068569	K01623	ko00030	Pentose phosphate pathway	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068569	K01623	ko00051	Fructose and mannose metabolism	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068569	K01623	ko00710	Carbon fixation in photosynthetic organisms	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068569	K01623	ko01100	Metabolic pathways	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068569	K01623	ko01110	Biosynthesis of secondary metabolites	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMT200068571	K01623	ko00010	Glycolysis / Gluconeogenesis	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068571	K01623	ko00030	Pentose phosphate pathway	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068571	K01623	ko00051	Fructose and mannose metabolism	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068571	K01623	ko00710	Carbon fixation in photosynthetic organisms	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068571	K01623	ko01100	Metabolic pathways	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068571	K01623	ko01110	Biosynthesis of secondary metabolites	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMT200068572	K01623	ko00010	Glycolysis / Gluconeogenesis	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068572	K01623	ko00030	Pentose phosphate pathway	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068572	K01623	ko00051	Fructose and mannose metabolism	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068572	K01623	ko00710	Carbon fixation in photosynthetic organisms	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068572	K01623	ko01100	Metabolic pathways	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068572	K01623	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMT200068573	K01623	ko00010	Glycolysis / Gluconeogenesis	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068573	K01623	ko00030	Pentose phosphate pathway	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068573	K01623	ko00051	Fructose and mannose metabolism	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068573	K01623	ko00710	Carbon fixation in photosynthetic organisms	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068573	K01623	ko01100	Metabolic pathways	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068573	K01623	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMT200068575	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMT200068575	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMT200068576	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMT200068576	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMT200068577	K02717	ko00195	Photosynthesis	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMT200068577	K02717	ko01100	Metabolic pathways	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMT200060664	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMT200060664	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMT200060664	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMT200060664	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMT200060664	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMT200060666	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMT200060666	K00517	ko00626	Naphthalene and anthracene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMT200060666	K00517	ko00903	Limonene and pinene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMT200060666	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMT200060666	K00517	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMT200060681	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060681	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060681	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060681	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060681	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060682	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060682	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060682	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060682	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060682	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060683	K01092	ko00521	Streptomycin biosynthesis	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMT200060683	K01092	ko00562	Inositol phosphate metabolism	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMT200060683	K01092	ko01100	Metabolic pathways	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMT200060683	K01092	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMT200060683	K01092	ko04070	Phosphatidylinositol signaling system	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMT200060684	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060684	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060684	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060684	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060684	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMT200060696	K01555	ko00350	Tyrosine metabolism	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMT200060696	K01555	ko00643	Styrene degradation	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMT200060696	K01555	ko01100	Metabolic pathways	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMT200060697	K02934	ko03010	Ribosome	1580	2.6e-81	0.81	0.89	1.00
PGSC0003DMT200060698	K04424	ko04010	MAPK signaling pathway	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMT200060698	K04424	ko04530	Tight junction	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMT200060701	K11147	ko00830	Retinol metabolism	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMT200060701	K11147	ko01100	Metabolic pathways	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMT200060701	K11147	ko04146	Peroxisome	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMT200060705	K11147	ko00830	Retinol metabolism	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMT200060705	K11147	ko01100	Metabolic pathways	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMT200060705	K11147	ko04146	Peroxisome	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMT200060727	K12850	ko03040	Spliceosome	1292	2.0e-65	0.60	0.78	1.00
PGSC0003DMT200092288	K10760	ko00908	Zeatin biosynthesis	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMT200092288	K10760	ko01100	Metabolic pathways	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMT200092288	K10760	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMT200092299	K03094	ko04110	Cell cycle	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04111	Cell cycle - yeast	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04114	Oocyte meiosis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04120	Ubiquitin mediated proteolysis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04310	Wnt signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04350	TGF-beta signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200092299	K03094	ko04710	Circadian rhythm - mammal	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMT200001533	K05743	ko04360	Axon guidance	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMT200001533	K05743	ko04666	Fc gamma R-mediated phagocytosis	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMT200001533	K05743	ko04810	Regulation of actin cytoskeleton	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMT200001534	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMT200001536	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMT200001539	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMT200001540	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMT200001541	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMT200001551	K07456	ko03430	Mismatch repair	1498	8.7e-77	0.34	0.52	0.93
PGSC0003DMT200001554	K07456	ko03430	Mismatch repair	1016	1.8e-53	0.54	0.72	0.73
PGSC0003DMT200001556	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMT200001557	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMT200001558	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMT200001559	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMT200001560	K07456	ko03430	Mismatch repair	1101	6.8e-55	0.35	0.54	0.88
PGSC0003DMT200001561	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.99
PGSC0003DMT200001562	K07456	ko03430	Mismatch repair	1562	2.6e-80	0.35	0.54	0.93
PGSC0003DMT200001563	K09880	ko00270	Cysteine and methionine metabolism	266	3.2e-08	0.42	0.52	0.97
PGSC0003DMT200032536	K06685	ko04111	Cell cycle - yeast	439	2.7e-14	0.25	0.41	0.40
PGSC0003DMT200032539	K06685	ko04111	Cell cycle - yeast	344	7.5e-10	0.25	0.41	0.93
PGSC0003DMT200032540	K06685	ko04111	Cell cycle - yeast	444	2.6e-15	0.25	0.42	0.89
PGSC0003DMT200032547	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMT200032547	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMT200032548	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMT200032548	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMT200032565	K02291	ko00906	Carotenoid biosynthesis	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMT200032565	K02291	ko01100	Metabolic pathways	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMT200032565	K02291	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMT200032572	K12589	ko03018	RNA degradation	1840	1.2e-95	0.78	0.90	0.99
PGSC0003DMT200022182	K01136	ko00531	Glycosaminoglycan degradation	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMT200022182	K01136	ko01100	Metabolic pathways	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMT200022182	K01136	ko04142	Lysosome	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMT200022189	K11253	ko05322	Systemic lupus erythematosus	920	6.6e-45	0.96	0.99	0.98
PGSC0003DMT200022194	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.31
PGSC0003DMT200022195	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.27
PGSC0003DMT200013943	K10147	ko04115	p53 signaling pathway	271	9.6e-09	0.37	0.51	0.59
PGSC0003DMT200013947	K01358	ko04112	Cell cycle - Caulobacter	702	7.0e-33	0.47	0.63	0.53
PGSC0003DMT200013958	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMT200013963	K01509	ko00230	Purine metabolism	1106	3.6e-55	0.46	0.62	0.85
PGSC0003DMT200013966	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013966	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013966	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013967	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013967	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013967	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMT200013972	K04371	ko04010	MAPK signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04012	ErbB signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04013	MAPK signaling pathway - fly	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04062	Chemokine signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04114	Oocyte meiosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04150	mTOR signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04270	Vascular smooth muscle contraction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04320	Dorso-ventral axis formation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04350	TGF-beta signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04360	Axon guidance	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04370	VEGF signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04510	Focal adhesion	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04520	Adherens junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04540	Gap junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04620	Toll-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04621	NOD-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04650	Natural killer cell mediated cytotoxicity	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04660	T cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04662	B cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04664	Fc epsilon RI signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04666	Fc gamma R-mediated phagocytosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04720	Long-term potentiation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04722	Neurotrophin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04730	Long-term depression	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04810	Regulation of actin cytoskeleton	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04910	Insulin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04912	GnRH signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04914	Progesterone-mediated oocyte maturation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04916	Melanogenesis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04930	Type II diabetes mellitus	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko04960	Aldosterone-regulated sodium reabsorption	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05010	Alzheimer's disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05020	Prion diseases	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05131	Shigellosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05140	Leishmaniasis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05142	Chagas disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05200	Pathways in cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05210	Colorectal cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05211	Renal cell carcinoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05212	Pancreatic cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05213	Endometrial cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05214	Glioma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05215	Prostate cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05216	Thyroid cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05218	Melanoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05219	Bladder cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05220	Chronic myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05221	Acute myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013972	K04371	ko05223	Non-small cell lung cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMT200013977	K01762	ko00270	Cysteine and methionine metabolism	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMT200013977	K01762	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMT200076911	K05765	ko04360	Axon guidance	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMT200076911	K05765	ko04666	Fc gamma R-mediated phagocytosis	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMT200076911	K05765	ko04810	Regulation of actin cytoskeleton	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMT200076912	K03023	ko00230	Purine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMT200076912	K03023	ko00240	Pyrimidine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMT200076912	K03023	ko01100	Metabolic pathways	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMT200076912	K03023	ko03020	RNA polymerase	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMT200076912	K03023	ko04623	Cytosolic DNA-sensing pathway	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMT200076913	K03023	ko00230	Purine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMT200076913	K03023	ko00240	Pyrimidine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMT200076913	K03023	ko01100	Metabolic pathways	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMT200076913	K03023	ko03020	RNA polymerase	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMT200076913	K03023	ko04623	Cytosolic DNA-sensing pathway	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMT200076936	K00287	ko00670	One carbon pool by folate	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMT200076936	K00287	ko00790	Folate biosynthesis	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMT200076936	K00287	ko01100	Metabolic pathways	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMT200076938	K07375	ko04145	Phagosome	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMT200076938	K07375	ko04540	Gap junction	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMT200076938	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMT200076941	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMT200076942	K03094	ko04110	Cell cycle	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04111	Cell cycle - yeast	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04114	Oocyte meiosis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04120	Ubiquitin mediated proteolysis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04310	Wnt signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04350	TGF-beta signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076942	K03094	ko04710	Circadian rhythm - mammal	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMT200076944	K03094	ko04110	Cell cycle	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04111	Cell cycle - yeast	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04114	Oocyte meiosis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04120	Ubiquitin mediated proteolysis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04310	Wnt signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04350	TGF-beta signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076944	K03094	ko04710	Circadian rhythm - mammal	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMT200076946	K11229	ko04011	MAPK signaling pathway - yeast	1058	4.1e-52	0.31	0.47	0.75
PGSC0003DMT200076947	K11229	ko04011	MAPK signaling pathway - yeast	897	5.9e-43	0.30	0.46	0.97
PGSC0003DMT200058832	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMT200058833	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMT200058863	K00475	ko00941	Flavonoid biosynthesis	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMT200058863	K00475	ko01100	Metabolic pathways	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMT200058863	K00475	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMT200058873	K11927	ko03018	RNA degradation	757	6.4e-36	0.34	0.54	0.61
PGSC0003DMT200066917	K00981	ko00564	Glycerophospholipid metabolism	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMT200066917	K00981	ko01100	Metabolic pathways	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMT200066917	K00981	ko04070	Phosphatidylinositol signaling system	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMT200066918	K00981	ko00564	Glycerophospholipid metabolism	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMT200066918	K00981	ko01100	Metabolic pathways	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMT200066918	K00981	ko04070	Phosphatidylinositol signaling system	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMT200066920	K06096	ko04530	Tight junction	342	5.0e-13	0.35	0.54	0.69
PGSC0003DMT200066922	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMT200066923	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMT200066925	K06653	ko04111	Cell cycle - yeast	330	1.4e-11	0.30	0.55	0.70
PGSC0003DMT200066927	K03514	ko03018	RNA degradation	567	1.5e-24	0.31	0.49	0.26
PGSC0003DMT200066928	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMT200066929	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMT200066931	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMT200066934	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMT200066935	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMT200066949	K06654	ko04111	Cell cycle - yeast	290	3.7e-10	0.38	0.57	0.61
PGSC0003DMT200066950	K12604	ko03018	RNA degradation	5926	0.	0.64	0.79	0.99
PGSC0003DMT200066951	K12604	ko03018	RNA degradation	12708	0.	0.66	0.79	1.00
PGSC0003DMT200034288	K01955	ko00240	Pyrimidine metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMT200034288	K01955	ko00250	Alanine, aspartate and glutamate metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMT200034288	K01955	ko01100	Metabolic pathways	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMT200034292	K10144	ko04115	p53 signaling pathway	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMT200034292	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMT200034293	K10144	ko04115	p53 signaling pathway	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMT200034293	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMT200034299	K00844	ko00010	Glycolysis / Gluconeogenesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00051	Fructose and mannose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00052	Galactose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00500	Starch and sucrose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00521	Streptomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko00524	Butirosin and neomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko01100	Metabolic pathways	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko01110	Biosynthesis of secondary metabolites	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko04910	Insulin signaling pathway	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034299	K00844	ko04930	Type II diabetes mellitus	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMT200034300	K10756	ko03030	DNA replication	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMT200034300	K10756	ko03420	Nucleotide excision repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMT200034300	K10756	ko03430	Mismatch repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMT200034306	K01952	ko00230	Purine metabolism	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMT200034306	K01952	ko01100	Metabolic pathways	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMT200034306	K01952	ko01110	Biosynthesis of secondary metabolites	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMT200030445	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMT200030445	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMT200030445	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMT200030457	K11294	ko05130	Pathogenic Escherichia coli infection	331	2.9e-09	0.28	0.45	0.38
PGSC0003DMT200030458	K11294	ko05130	Pathogenic Escherichia coli infection	296	6.0e-10	0.27	0.44	0.89
PGSC0003DMT200030487	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030487	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030487	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030488	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030488	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030488	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030490	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030490	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030490	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMT200030491	K04122	ko00904	Diterpenoid biosynthesis	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMT200030491	K04122	ko01100	Metabolic pathways	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMT200030491	K04122	ko01110	Biosynthesis of secondary metabolites	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMT200030493	K04122	ko00904	Diterpenoid biosynthesis	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMT200030493	K04122	ko01100	Metabolic pathways	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMT200030493	K04122	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMT200015633	K00660	ko00941	Flavonoid biosynthesis	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMT200015633	K00660	ko01100	Metabolic pathways	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMT200015633	K00660	ko01110	Biosynthesis of secondary metabolites	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMT200015633	K00660	ko04712	Circadian rhythm - plant	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMT200015661	K00981	ko00564	Glycerophospholipid metabolism	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMT200015661	K00981	ko01100	Metabolic pathways	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMT200015661	K00981	ko04070	Phosphatidylinositol signaling system	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMT200015664	K07424	ko00140	Steroid hormone biosynthesis	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00591	Linoleic acid metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00830	Retinol metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00982	Drug metabolism - cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko00983	Drug metabolism - other enzymes	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200015664	K07424	ko01100	Metabolic pathways	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMT200023938	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023938	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023938	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023939	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023939	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023939	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023940	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023940	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023940	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMT200023954	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMT200003310	K01728	ko00040	Pentose and glucuronate interconversions	1763	2.1e-91	0.53	0.69	0.89
PGSC0003DMT200003312	K10570	ko03420	Nucleotide excision repair	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMT200003312	K10570	ko04120	Ubiquitin mediated proteolysis	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMT200003317	K10712	ko00430	Taurine and hypotaurine metabolism	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMT200003317	K10712	ko01100	Metabolic pathways	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMT200003318	K10712	ko00430	Taurine and hypotaurine metabolism	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMT200003318	K10712	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMT200003320	K10573	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.98	1.00	0.76
PGSC0003DMT200003324	K01785	ko00010	Glycolysis / Gluconeogenesis	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMT200003324	K01785	ko01110	Biosynthesis of secondary metabolites	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMT200003325	K01785	ko00010	Glycolysis / Gluconeogenesis	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMT200003325	K01785	ko01110	Biosynthesis of secondary metabolites	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMT200003326	K01785	ko00010	Glycolysis / Gluconeogenesis	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMT200003326	K01785	ko01110	Biosynthesis of secondary metabolites	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMT200003327	K01785	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMT200003327	K01785	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMT200003328	K01785	ko00010	Glycolysis / Gluconeogenesis	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMT200003328	K01785	ko01110	Biosynthesis of secondary metabolites	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMT200003329	K01785	ko00010	Glycolysis / Gluconeogenesis	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMT200003329	K01785	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMT200003330	K01785	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMT200003330	K01785	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMT200003331	K01785	ko00010	Glycolysis / Gluconeogenesis	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMT200003331	K01785	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMT200003336	K07374	ko04145	Phagosome	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMT200003336	K07374	ko04540	Gap junction	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMT200003336	K07374	ko05130	Pathogenic Escherichia coli infection	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMT200003337	K03869	ko04120	Ubiquitin mediated proteolysis	450	8.8e-19	0.86	0.89	0.85
PGSC0003DMT200093491	K10760	ko00908	Zeatin biosynthesis	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMT200093491	K10760	ko01100	Metabolic pathways	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMT200093491	K10760	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMT200081433	K00797	ko00270	Cysteine and methionine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMT200081433	K00797	ko00330	Arginine and proline metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMT200081433	K00797	ko00410	beta-Alanine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMT200081433	K00797	ko00480	Glutathione metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMT200081433	K00797	ko01100	Metabolic pathways	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMT200081435	K00276	ko00260	Glycine, serine and threonine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko00350	Tyrosine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko00360	Phenylalanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko00410	beta-Alanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko00950	Isoquinoline alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko01100	Metabolic pathways	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081435	K00276	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMT200081436	K00276	ko00260	Glycine, serine and threonine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko00360	Phenylalanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko00410	beta-Alanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko00950	Isoquinoline alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko01100	Metabolic pathways	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081436	K00276	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMT200081437	K00276	ko00260	Glycine, serine and threonine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko00350	Tyrosine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko00360	Phenylalanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko00410	beta-Alanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko01100	Metabolic pathways	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081437	K00276	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMT200081441	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.27	0.43	0.78
PGSC0003DMT200081446	K01066	ko00623	2,4-Dichlorobenzoate degradation	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMT200081446	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMT200081447	K01046	ko00561	Glycerolipid metabolism	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMT200081447	K01046	ko01100	Metabolic pathways	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMT200081457	K00454	ko00591	Linoleic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMT200081457	K00454	ko00592	alpha-Linolenic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMT200081457	K00454	ko01100	Metabolic pathways	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMT200065579	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065579	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065580	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMT200065581	K02084	ko04115	p53 signaling pathway	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko04210	Apoptosis	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko05010	Alzheimer's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko05012	Parkinson's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko05016	Huntington's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065581	K02084	ko05222	Small cell lung cancer	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMT200065601	K12125	ko04712	Circadian rhythm - plant	1390	7.9e-71	0.38	0.50	1.00
PGSC0003DMT200065602	K12125	ko04712	Circadian rhythm - plant	539	6.8e-24	0.34	0.50	0.98
PGSC0003DMT200065603	K12125	ko04712	Circadian rhythm - plant	1316	9.5e-67	0.37	0.51	0.99
PGSC0003DMT200065606	K03940	ko00190	Oxidative phosphorylation	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMT200065606	K03940	ko01100	Metabolic pathways	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMT200065606	K03940	ko05010	Alzheimer's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMT200065606	K03940	ko05012	Parkinson's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMT200065606	K03940	ko05016	Huntington's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMT200065607	K01528	ko04144	Endocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMT200065607	K01528	ko04666	Fc gamma R-mediated phagocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMT200065607	K01528	ko05100	Bacterial invasion of epithelial cells	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMT200065615	K00558	ko00270	Cysteine and methionine metabolism	9363	0.	0.72	0.83	0.99
PGSC0003DMT200065615	K00558	ko01100	Metabolic pathways	9363	0.	0.72	0.83	0.99
PGSC0003DMT200055707	K05894	ko00592	alpha-Linolenic acid metabolism	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMT200055707	K05894	ko01100	Metabolic pathways	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMT200055708	K05894	ko00592	alpha-Linolenic acid metabolism	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMT200055708	K05894	ko01100	Metabolic pathways	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMT200055713	K01184	ko00040	Pentose and glucuronate interconversions	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMT200055713	K01184	ko00500	Starch and sucrose metabolism	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMT200055713	K01184	ko01100	Metabolic pathways	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMT200055717	K08770	ko03320	PPAR signaling pathway	418	3.2e-17	0.71	0.85	0.94
PGSC0003DMT200055720	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMT200055720	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMT200055720	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMT200055720	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMT200055722	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055722	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055722	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055722	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055723	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055723	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055723	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200055723	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMT200052643	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMT200052648	K00430	ko00360	Phenylalanine metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMT200052648	K00430	ko00680	Methane metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMT200052648	K00430	ko00940	Phenylpropanoid biosynthesis	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMT200052648	K00430	ko01100	Metabolic pathways	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMT200052648	K00430	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMT200052649	K00430	ko00360	Phenylalanine metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMT200052649	K00430	ko00680	Methane metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMT200052649	K00430	ko00940	Phenylpropanoid biosynthesis	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMT200052649	K00430	ko01100	Metabolic pathways	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMT200052649	K00430	ko01110	Biosynthesis of secondary metabolites	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMT200052651	K10880	ko03440	Homologous recombination	1172	8.3e-59	0.51	0.71	0.98
PGSC0003DMT200052656	K02726	ko03050	Proteasome	1634	2.7e-84	0.86	0.89	1.00
PGSC0003DMT200052657	K02726	ko03050	Proteasome	1851	2.9e-96	0.95	0.97	1.00
PGSC0003DMT200052673	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMT200052673	K00053	ko00770	Pantothenate and CoA biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMT200052673	K00053	ko01100	Metabolic pathways	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMT200052673	K00053	ko01110	Biosynthesis of secondary metabolites	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMT200052674	K12843	ko03040	Spliceosome	1344	2.7e-68	0.35	0.55	0.94
PGSC0003DMT200043732	K06685	ko04111	Cell cycle - yeast	330	1.3e-08	0.32	0.45	0.29
PGSC0003DMT200043764	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043764	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043764	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043764	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043764	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043765	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043765	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043765	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043765	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043765	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043766	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043766	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043766	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043766	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043766	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMT200043775	K07195	ko04910	Insulin signaling pathway	3587	5.2e-192	0.82	0.89	0.93
PGSC0003DMT200043778	K04733	ko04210	Apoptosis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMT200043778	K04733	ko04620	Toll-like receptor signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMT200043778	K04733	ko04722	Neurotrophin signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMT200043778	K04733	ko05140	Leishmaniasis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMT200043778	K04733	ko05142	Chagas disease	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMT200043779	K04733	ko04210	Apoptosis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMT200043779	K04733	ko04620	Toll-like receptor signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMT200043779	K04733	ko04722	Neurotrophin signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMT200043779	K04733	ko05140	Leishmaniasis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMT200043779	K04733	ko05142	Chagas disease	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMT200043783	K04733	ko04210	Apoptosis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMT200043783	K04733	ko04620	Toll-like receptor signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMT200043783	K04733	ko04722	Neurotrophin signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMT200043783	K04733	ko05140	Leishmaniasis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMT200043783	K04733	ko05142	Chagas disease	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMT200019022	K12603	ko03018	RNA degradation	345	6.8e-13	0.31	0.44	0.31
PGSC0003DMT200019028	K00660	ko00941	Flavonoid biosynthesis	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMT200019028	K00660	ko01100	Metabolic pathways	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMT200019028	K00660	ko01110	Biosynthesis of secondary metabolites	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMT200019028	K00660	ko04712	Circadian rhythm - plant	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMT200019031	K08912	ko00196	Photosynthesis - antenna proteins	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMT200019031	K08912	ko01100	Metabolic pathways	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMT200019041	K03352	ko04110	Cell cycle	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019041	K03352	ko04111	Cell cycle - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019041	K03352	ko04113	Meiosis - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019041	K03352	ko04114	Oocyte meiosis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019041	K03352	ko04120	Ubiquitin mediated proteolysis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019041	K03352	ko04914	Progesterone-mediated oocyte maturation	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMT200019043	K03352	ko04110	Cell cycle	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019043	K03352	ko04111	Cell cycle - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019043	K03352	ko04113	Meiosis - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019043	K03352	ko04114	Oocyte meiosis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019043	K03352	ko04120	Ubiquitin mediated proteolysis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019043	K03352	ko04914	Progesterone-mediated oocyte maturation	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMT200019055	K02084	ko04115	p53 signaling pathway	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko04210	Apoptosis	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko05010	Alzheimer's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko05012	Parkinson's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko05016	Huntington's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200019055	K02084	ko05222	Small cell lung cancer	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMT200009085	K00430	ko00360	Phenylalanine metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMT200009085	K00430	ko00680	Methane metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMT200009085	K00430	ko00940	Phenylpropanoid biosynthesis	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMT200009085	K00430	ko01100	Metabolic pathways	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMT200009085	K00430	ko01110	Biosynthesis of secondary metabolites	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMT200009086	K00430	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMT200009086	K00430	ko00680	Methane metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMT200009086	K00430	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMT200009086	K00430	ko01100	Metabolic pathways	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMT200009086	K00430	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMT200009087	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009087	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009087	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009087	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009087	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009088	K00430	ko00360	Phenylalanine metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMT200009088	K00430	ko00680	Methane metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMT200009088	K00430	ko00940	Phenylpropanoid biosynthesis	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMT200009088	K00430	ko01100	Metabolic pathways	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMT200009088	K00430	ko01110	Biosynthesis of secondary metabolites	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMT200009089	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009089	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009089	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009089	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009089	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMT200009090	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMT200009090	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMT200009090	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMT200009090	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMT200009090	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMT200009094	K12637	ko00905	Brassinosteroid biosynthesis	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMT200009094	K12637	ko01100	Metabolic pathways	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMT200009094	K12637	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMT200009095	K12637	ko00905	Brassinosteroid biosynthesis	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMT200009095	K12637	ko01100	Metabolic pathways	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMT200009095	K12637	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMT200009096	K01190	ko00052	Galactose metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMT200009096	K01190	ko00511	Other glycan degradation	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMT200009096	K01190	ko00600	Sphingolipid metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMT200009096	K01190	ko01100	Metabolic pathways	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMT200009121	K09755	ko00940	Phenylpropanoid biosynthesis	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMT200009121	K09755	ko01100	Metabolic pathways	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMT200009121	K09755	ko01110	Biosynthesis of secondary metabolites	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMT200009122	K09755	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMT200009122	K09755	ko01100	Metabolic pathways	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMT200009122	K09755	ko01110	Biosynthesis of secondary metabolites	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMT200038711	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	260	9.3e-08	0.42	0.58	0.97
PGSC0003DMT200038718	K03066	ko03050	Proteasome	2770	6.0e-147	0.81	0.86	1.00
PGSC0003DMT200038719	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMT200038720	K03066	ko03050	Proteasome	1292	2.0e-65	0.98	0.99	0.99
PGSC0003DMT200038727	K10615	ko04120	Ubiquitin mediated proteolysis	814	4.6e-39	0.35	0.53	0.89
PGSC0003DMT200038736	K00655	ko00561	Glycerolipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMT200038736	K00655	ko00564	Glycerophospholipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMT200038736	K00655	ko01100	Metabolic pathways	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMT200038737	K00655	ko00561	Glycerolipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMT200038737	K00655	ko00564	Glycerophospholipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMT200038737	K00655	ko01100	Metabolic pathways	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMT200038738	K02737	ko03050	Proteasome	827	8.9e-40	0.82	0.89	0.98
PGSC0003DMT200038739	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMT200038740	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMT200038742	K02328	ko00230	Purine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko00240	Pyrimidine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko01100	Metabolic pathways	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko03030	DNA replication	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko03410	Base excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko03420	Nucleotide excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko03430	Mismatch repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038742	K02328	ko03440	Homologous recombination	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMT200038743	K02328	ko00230	Purine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko00240	Pyrimidine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko01100	Metabolic pathways	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko03030	DNA replication	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko03410	Base excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko03420	Nucleotide excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko03430	Mismatch repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200038743	K02328	ko03440	Homologous recombination	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMT200088320	K10760	ko00908	Zeatin biosynthesis	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMT200088320	K10760	ko01100	Metabolic pathways	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMT200088320	K10760	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMT200095094	K13229	ko00402	Benzoxazinoid biosynthesis	228	9.7e-07	0.40	0.57	0.52
PGSC0003DMT200026826	K00650	ko00564	Glycerophospholipid metabolism	358	6.5e-14	0.29	0.43	0.68
PGSC0003DMT200026827	K00650	ko00564	Glycerophospholipid metabolism	353	1.2e-13	0.31	0.47	0.74
PGSC0003DMT200026828	K08906	ko00195	Photosynthesis	901	7.4e-44	0.72	0.81	0.81
PGSC0003DMT200038070	K00726	ko00510	N-Glycan biosynthesis	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMT200038070	K00726	ko01100	Metabolic pathways	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMT200038071	K00726	ko00510	N-Glycan biosynthesis	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMT200038071	K00726	ko01100	Metabolic pathways	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMT200038072	K00726	ko00510	N-Glycan biosynthesis	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMT200038072	K00726	ko01100	Metabolic pathways	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMT200038073	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMT200038073	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMT200038074	K00726	ko00510	N-Glycan biosynthesis	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMT200038074	K00726	ko01100	Metabolic pathways	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMT200038075	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMT200038075	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMT200038076	K00726	ko00510	N-Glycan biosynthesis	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMT200038076	K00726	ko01100	Metabolic pathways	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMT200038077	K00726	ko00510	N-Glycan biosynthesis	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMT200038077	K00726	ko01100	Metabolic pathways	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMT200038079	K00726	ko00510	N-Glycan biosynthesis	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMT200038079	K00726	ko01100	Metabolic pathways	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMT200038080	K09680	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMT200038080	K09680	ko01100	Metabolic pathways	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMT200038081	K09680	ko00770	Pantothenate and CoA biosynthesis	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMT200038081	K09680	ko01100	Metabolic pathways	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMT200038082	K01436	ko00330	Arginine and proline metabolism	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMT200038082	K01436	ko01100	Metabolic pathways	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMT200038082	K01436	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMT200038084	K01436	ko00330	Arginine and proline metabolism	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMT200038084	K01436	ko01100	Metabolic pathways	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMT200038084	K01436	ko01110	Biosynthesis of secondary metabolites	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMT200038092	K05279	ko00944	Flavone and flavonol biosynthesis	1346	2.1e-68	0.49	0.67	0.99
PGSC0003DMT200038095	K06236	ko04510	Focal adhesion	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMT200038095	K06236	ko04512	ECM-receptor interaction	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMT200038095	K06236	ko05146	Amoebiasis	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMT200070302	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMT200070302	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMT200070302	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMT200070309	K12929	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMT200070309	K12929	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMT200070310	K12929	ko00904	Diterpenoid biosynthesis	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMT200070310	K12929	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMT200070311	K12356	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.36	0.53	0.71
PGSC0003DMT200070316	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMT200070316	K00517	ko00626	Naphthalene and anthracene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMT200070316	K00517	ko00903	Limonene and pinene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMT200070316	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMT200070316	K00517	ko01110	Biosynthesis of secondary metabolites	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMT200070317	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMT200070317	K00517	ko00626	Naphthalene and anthracene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMT200070317	K00517	ko00903	Limonene and pinene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMT200070317	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMT200070317	K00517	ko01110	Biosynthesis of secondary metabolites	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMT200070321	K10773	ko03410	Base excision repair	2638	1.5e-148	0.38	0.51	0.69
PGSC0003DMT200070324	K05592	ko03018	RNA degradation	245	4.1e-06	0.31	0.53	0.45
PGSC0003DMT200070328	K00873	ko00010	Glycolysis / Gluconeogenesis	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko00230	Purine metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko00620	Pyruvate metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko00710	Carbon fixation in photosynthetic organisms	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko01100	Metabolic pathways	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070328	K00873	ko04930	Type II diabetes mellitus	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMT200070332	K00873	ko00010	Glycolysis / Gluconeogenesis	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko00230	Purine metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko00620	Pyruvate metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko00710	Carbon fixation in photosynthetic organisms	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko01100	Metabolic pathways	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200070332	K00873	ko04930	Type II diabetes mellitus	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMT200047686	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMT200047700	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.58
PGSC0003DMT200047702	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.49
PGSC0003DMT200073139	K04424	ko04010	MAPK signaling pathway	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMT200073139	K04424	ko04530	Tight junction	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMT200073140	K04424	ko04010	MAPK signaling pathway	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMT200073140	K04424	ko04530	Tight junction	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMT200080588	K09489	ko04612	Antigen processing and presentation	5305	9.2e-287	0.74	0.85	1.00
PGSC0003DMT200080599	K02690	ko00195	Photosynthesis	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMT200080599	K02690	ko01100	Metabolic pathways	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMT200080601	K11866	ko04144	Endocytosis	594	2.0e-26	0.33	0.43	0.69
PGSC0003DMT200080602	K11866	ko04144	Endocytosis	361	2.9e-13	0.33	0.43	0.96
PGSC0003DMT200080603	K11866	ko04144	Endocytosis	645	2.4e-29	0.34	0.46	0.86
PGSC0003DMT200080607	K03083	ko04012	ErbB signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04062	Chemokine signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04110	Cell cycle	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04310	Wnt signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04340	Hedgehog signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04360	Axon guidance	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04510	Focal adhesion	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04660	T cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04662	B cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04711	Circadian rhythm - fly	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04722	Neurotrophin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04910	Insulin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko04916	Melanogenesis	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05010	Alzheimer's disease	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05200	Pathways in cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05210	Colorectal cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05213	Endometrial cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05215	Prostate cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080607	K03083	ko05217	Basal cell carcinoma	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMT200080613	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMT200080614	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMT200080615	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMT200080615	K00766	ko01100	Metabolic pathways	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMT200080615	K00766	ko01110	Biosynthesis of secondary metabolites	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMT200080616	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMT200080616	K00766	ko01100	Metabolic pathways	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMT200080616	K00766	ko01110	Biosynthesis of secondary metabolites	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMT200080618	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMT200080618	K00766	ko01100	Metabolic pathways	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMT200080618	K00766	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMT200080628	K02717	ko00195	Photosynthesis	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMT200080628	K02717	ko01100	Metabolic pathways	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMT200080629	K02149	ko00190	Oxidative phosphorylation	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080629	K02149	ko01100	Metabolic pathways	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080629	K02149	ko04145	Phagosome	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080629	K02149	ko04966	Collecting duct acid secretion	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080629	K02149	ko05110	Vibrio cholerae infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080629	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMT200080635	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMT200080635	K12448	ko01100	Metabolic pathways	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMT200080636	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMT200080636	K12448	ko01100	Metabolic pathways	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMT200080637	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMT200080637	K12448	ko01100	Metabolic pathways	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMT200090713	K03094	ko04110	Cell cycle	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04111	Cell cycle - yeast	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04114	Oocyte meiosis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04120	Ubiquitin mediated proteolysis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04310	Wnt signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04350	TGF-beta signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200090713	K03094	ko04710	Circadian rhythm - mammal	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMT200093338	K03094	ko04110	Cell cycle	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04111	Cell cycle - yeast	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04114	Oocyte meiosis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04310	Wnt signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04350	TGF-beta signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093338	K03094	ko04710	Circadian rhythm - mammal	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMT200093342	K13065	ko00940	Phenylpropanoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMT200093342	K13065	ko00941	Flavonoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMT200093342	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMT200093342	K13065	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMT200093361	K10760	ko00908	Zeatin biosynthesis	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMT200093361	K10760	ko01100	Metabolic pathways	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMT200093361	K10760	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMT200002536	K02969	ko03010	Ribosome	999	2.9e-49	0.97	0.99	0.99
PGSC0003DMT200002549	K01955	ko00240	Pyrimidine metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMT200002549	K01955	ko00250	Alanine, aspartate and glutamate metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMT200002549	K01955	ko01100	Metabolic pathways	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMT200002554	K00423	ko00053	Ascorbate and aldarate metabolism	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMT200002554	K00423	ko01100	Metabolic pathways	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMT200033609	K09756	ko00940	Phenylpropanoid biosynthesis	1534	9.0e-79	0.45	0.59	0.88
PGSC0003DMT200033610	K09756	ko00940	Phenylpropanoid biosynthesis	1685	4.2e-87	0.49	0.62	0.99
PGSC0003DMT200033619	K01810	ko00010	Glycolysis / Gluconeogenesis	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033619	K01810	ko00030	Pentose phosphate pathway	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033619	K01810	ko00500	Starch and sucrose metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033619	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033619	K01810	ko01100	Metabolic pathways	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033619	K01810	ko01110	Biosynthesis of secondary metabolites	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMT200033620	K01810	ko00010	Glycolysis / Gluconeogenesis	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200033620	K01810	ko00030	Pentose phosphate pathway	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200033620	K01810	ko00500	Starch and sucrose metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200033620	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200033620	K01810	ko01100	Metabolic pathways	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200033620	K01810	ko01110	Biosynthesis of secondary metabolites	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMT200006218	K10246	ko01040	Biosynthesis of unsaturated fatty acids	450	5.5e-19	0.32	0.52	0.97
PGSC0003DMT200006224	K00002	ko00010	Glycolysis / Gluconeogenesis	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMT200006224	K00002	ko00561	Glycerolipid metabolism	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMT200006224	K00002	ko00930	Caprolactam degradation	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMT200006224	K00002	ko01100	Metabolic pathways	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMT200006224	K00002	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMT200006250	K03005	ko00230	Purine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMT200006250	K03005	ko00240	Pyrimidine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMT200006250	K03005	ko01100	Metabolic pathways	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMT200006250	K03005	ko03020	RNA polymerase	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMT200012531	K00679	ko00561	Glycerolipid metabolism	376	1.0e-14	0.41	0.59	0.97
PGSC0003DMT200012539	K07195	ko04910	Insulin signaling pathway	3473	1.0e-185	0.69	0.80	1.00
PGSC0003DMT200012541	K08517	ko04130	SNARE interactions in vesicular transport	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMT200012541	K08517	ko04145	Phagosome	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMT200012542	K08517	ko04130	SNARE interactions in vesicular transport	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMT200012542	K08517	ko04145	Phagosome	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMT200012543	K08517	ko04130	SNARE interactions in vesicular transport	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMT200012543	K08517	ko04145	Phagosome	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMT200012549	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMT200012549	K00814	ko00710	Carbon fixation in photosynthetic organisms	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMT200012549	K00814	ko01100	Metabolic pathways	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMT200012556	K03061	ko03050	Proteasome	518	9.8e-23	0.92	0.97	0.94
PGSC0003DMT200016362	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016362	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016362	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016362	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016362	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016362	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016363	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMT200016373	K08139	ko04113	Meiosis - yeast	853	3.3e-41	0.33	0.51	0.99
PGSC0003DMT200016374	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.55	0.89
PGSC0003DMT200016397	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMT200016398	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMT200040216	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMT200040217	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMT200040218	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMT200040237	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMT200040238	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMT200040239	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMT200040240	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMT200076287	K01051	ko00040	Pentose and glucuronate interconversions	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMT200076287	K01051	ko00500	Starch and sucrose metabolism	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMT200076287	K01051	ko01100	Metabolic pathways	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMT200076290	K02872	ko03010	Ribosome	1598	2.6e-82	0.90	0.97	1.00
PGSC0003DMT200076297	K00383	ko00480	Glutathione metabolism	2512	3.6e-142	0.83	0.90	1.00
PGSC0003DMT200076298	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMT200076299	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMT200048984	K01366	ko04142	Lysosome	2191	5.2e-115	0.73	0.84	1.00
PGSC0003DMT200048986	K00866	ko00564	Glycerophospholipid metabolism	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMT200048986	K00866	ko01100	Metabolic pathways	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMT200048991	K04125	ko00904	Diterpenoid biosynthesis	1465	5.7e-75	0.56	0.72	0.89
PGSC0003DMT200049021	K03004	ko00230	Purine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMT200049021	K03004	ko00240	Pyrimidine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMT200049021	K03004	ko01100	Metabolic pathways	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMT200049021	K03004	ko03020	RNA polymerase	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMT200086821	K02942	ko03010	Ribosome	532	1.7e-23	0.60	0.77	0.99
PGSC0003DMT200059654	K13030	ko00460	Cyanoamino acid metabolism	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMT200059654	K13030	ko01110	Biosynthesis of secondary metabolites	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMT200059655	K13030	ko00460	Cyanoamino acid metabolism	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMT200059655	K13030	ko01110	Biosynthesis of secondary metabolites	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMT200059667	K09841	ko00906	Carotenoid biosynthesis	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMT200059667	K09841	ko01100	Metabolic pathways	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMT200059667	K09841	ko01110	Biosynthesis of secondary metabolites	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMT200059671	K11927	ko03018	RNA degradation	921	5.8e-45	0.36	0.55	0.71
PGSC0003DMT200059672	K11927	ko03018	RNA degradation	428	9.0e-18	0.34	0.52	0.86
PGSC0003DMT200004335	K03849	ko00510	N-Glycan biosynthesis	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMT200004335	K03849	ko01100	Metabolic pathways	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMT200004336	K03849	ko00510	N-Glycan biosynthesis	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMT200004336	K03849	ko01100	Metabolic pathways	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMT200004340	K03260	ko05416	Viral myocarditis	6741	0.	0.53	0.65	1.00
PGSC0003DMT200004341	K03260	ko05416	Viral myocarditis	7201	0.	0.52	0.64	1.00
PGSC0003DMT200004353	K03115	ko04310	Wnt signaling pathway	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMT200004353	K03115	ko04520	Adherens junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMT200004353	K03115	ko04530	Tight junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMT200004353	K03115	ko04712	Circadian rhythm - plant	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMT200004365	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMT200004366	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMT200004367	K10590	ko04120	Ubiquitin mediated proteolysis	6966	0.	0.57	0.73	1.00
PGSC0003DMT200004368	K10590	ko04120	Ubiquitin mediated proteolysis	6297	0.	0.55	0.72	1.00
PGSC0003DMT200031917	K12132	ko04712	Circadian rhythm - plant	1614	3.5e-83	0.54	0.69	0.66
PGSC0003DMT200031918	K12132	ko04712	Circadian rhythm - plant	1738	5.0e-90	0.54	0.68	0.68
PGSC0003DMT200031929	K00599	ko00340	Histidine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMT200031929	K00599	ko00350	Tyrosine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMT200031929	K00599	ko00450	Selenoamino acid metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMT200031929	K00599	ko00626	Naphthalene and anthracene degradation	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMT200031931	K00599	ko00340	Histidine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMT200031931	K00599	ko00350	Tyrosine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMT200031931	K00599	ko00450	Selenoamino acid metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMT200031931	K00599	ko00626	Naphthalene and anthracene degradation	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMT200031932	K00599	ko00340	Histidine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMT200031932	K00599	ko00350	Tyrosine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMT200031932	K00599	ko00450	Selenoamino acid metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMT200031932	K00599	ko00626	Naphthalene and anthracene degradation	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMT200031935	K01194	ko00500	Starch and sucrose metabolism	2228	4.7e-117	0.67	0.82	1.00
PGSC0003DMT200031937	K09490	ko03060	Protein export	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMT200031937	K09490	ko05020	Prion diseases	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMT200014656	K12126	ko04712	Circadian rhythm - plant	300	1.5e-10	0.34	0.54	0.59
PGSC0003DMT200014671	K10144	ko04115	p53 signaling pathway	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMT200014671	K10144	ko04120	Ubiquitin mediated proteolysis	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMT200014672	K10144	ko04115	p53 signaling pathway	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMT200014672	K10144	ko04120	Ubiquitin mediated proteolysis	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMT200014680	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014680	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014680	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014680	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014680	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014681	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014681	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014681	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014681	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014681	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMT200014682	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014682	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014682	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014682	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014682	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014683	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014683	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014683	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014683	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200014683	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMT200042031	K03104	ko03060	Protein export	689	3.6e-32	0.70	0.83	0.94
PGSC0003DMT200042032	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1331	1.4e-67	0.58	0.69	0.91
PGSC0003DMT200042033	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	799	3.1e-38	0.63	0.79	0.99
PGSC0003DMT200042035	K03005	ko00230	Purine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMT200042035	K03005	ko00240	Pyrimidine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMT200042035	K03005	ko01100	Metabolic pathways	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMT200042035	K03005	ko03020	RNA polymerase	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMT200000852	K12355	ko00940	Phenylpropanoid biosynthesis	3144	1.4e-167	0.75	0.86	0.99
PGSC0003DMT200000857	K12486	ko04144	Endocytosis	488	4.4e-21	0.26	0.40	0.94
PGSC0003DMT200000867	K12191	ko04144	Endocytosis	1731	1.2e-89	0.95	0.98	1.00
PGSC0003DMT200000868	K01897	ko00071	Fatty acid metabolism	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMT200000868	K01897	ko01100	Metabolic pathways	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMT200000868	K01897	ko03320	PPAR signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMT200000868	K01897	ko04146	Peroxisome	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMT200000868	K01897	ko04920	Adipocytokine signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMT200000871	K12602	ko03018	RNA degradation	1970	8.0e-103	0.71	0.84	1.00
PGSC0003DMT200000878	K06444	ko00906	Carotenoid biosynthesis	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMT200000878	K06444	ko01100	Metabolic pathways	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMT200000878	K06444	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMT200000879	K06444	ko00906	Carotenoid biosynthesis	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMT200000879	K06444	ko01100	Metabolic pathways	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMT200000879	K06444	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMT200000880	K06444	ko00906	Carotenoid biosynthesis	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMT200000880	K06444	ko01100	Metabolic pathways	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMT200000880	K06444	ko01110	Biosynthesis of secondary metabolites	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMT200000883	K00279	ko00908	Zeatin biosynthesis	1858	1.2e-96	0.56	0.76	0.57
PGSC0003DMT200000889	K01956	ko00240	Pyrimidine metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMT200000889	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMT200000889	K01956	ko01100	Metabolic pathways	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMT200000890	K01956	ko00240	Pyrimidine metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMT200000890	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMT200000890	K01956	ko01100	Metabolic pathways	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMT200000896	K01190	ko00052	Galactose metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMT200000896	K01190	ko00511	Other glycan degradation	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMT200000896	K01190	ko00600	Sphingolipid metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMT200000896	K01190	ko01100	Metabolic pathways	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMT200000897	K01190	ko00052	Galactose metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMT200000897	K01190	ko00511	Other glycan degradation	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMT200000897	K01190	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMT200000897	K01190	ko01100	Metabolic pathways	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMT200000898	K01190	ko00052	Galactose metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMT200000898	K01190	ko00511	Other glycan degradation	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMT200000898	K01190	ko00600	Sphingolipid metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMT200000898	K01190	ko01100	Metabolic pathways	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMT200097757	K01199	ko00500	Starch and sucrose metabolism	873	2.6e-42	0.37	0.58	0.99
PGSC0003DMT200092159	K07466	ko03030	DNA replication	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMT200092159	K07466	ko03420	Nucleotide excision repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMT200092159	K07466	ko03430	Mismatch repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMT200092159	K07466	ko03440	Homologous recombination	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMT200050810	K00850	ko00010	Glycolysis / Gluconeogenesis	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050810	K00850	ko00030	Pentose phosphate pathway	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050810	K00850	ko00051	Fructose and mannose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050810	K00850	ko00052	Galactose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050810	K00850	ko01100	Metabolic pathways	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050810	K00850	ko01110	Biosynthesis of secondary metabolites	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMT200050811	K01199	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.38	0.56	0.65
PGSC0003DMT200050812	K01199	ko00500	Starch and sucrose metabolism	543	4.1e-24	0.38	0.56	0.60
PGSC0003DMT200050813	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	1951	9.0e-102	0.75	0.89	0.99
PGSC0003DMT200050821	K02084	ko04115	p53 signaling pathway	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko04210	Apoptosis	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko05010	Alzheimer's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko05012	Parkinson's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko05016	Huntington's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050821	K02084	ko05222	Small cell lung cancer	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMT200050827	K03012	ko00230	Purine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMT200050827	K03012	ko00240	Pyrimidine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMT200050827	K03012	ko01100	Metabolic pathways	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMT200050827	K03012	ko03020	RNA polymerase	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMT200050827	K03012	ko05016	Huntington's disease	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMT200050829	K03012	ko00230	Purine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMT200050829	K03012	ko00240	Pyrimidine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMT200050829	K03012	ko01100	Metabolic pathways	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMT200050829	K03012	ko03020	RNA polymerase	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMT200050829	K03012	ko05016	Huntington's disease	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMT200050839	K10352	ko04530	Tight junction	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMT200050839	K10352	ko05416	Viral myocarditis	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMT200050842	K00626	ko00071	Fatty acid metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00072	Synthesis and degradation of ketone bodies	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00280	Valine, leucine and isoleucine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00310	Lysine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00380	Tryptophan metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00620	Pyruvate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00632	Benzoate degradation via CoA ligation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00640	Propanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00650	Butanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko00900	Terpenoid backbone biosynthesis	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko01100	Metabolic pathways	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200050842	K00626	ko02020	Two-component system	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMT200078100	K12741	ko03040	Spliceosome	358	6.5e-14	0.41	0.44	0.63
PGSC0003DMT200078103	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMT200078104	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMT200078121	K00430	ko00360	Phenylalanine metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMT200078121	K00430	ko00680	Methane metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMT200078121	K00430	ko00940	Phenylpropanoid biosynthesis	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMT200078121	K00430	ko01100	Metabolic pathways	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMT200078121	K00430	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMT200057521	K00430	ko00360	Phenylalanine metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMT200057521	K00430	ko00680	Methane metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMT200057521	K00430	ko00940	Phenylpropanoid biosynthesis	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMT200057521	K00430	ko01100	Metabolic pathways	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMT200057521	K00430	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMT200057522	K00430	ko00360	Phenylalanine metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMT200057522	K00430	ko00680	Methane metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMT200057522	K00430	ko00940	Phenylpropanoid biosynthesis	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMT200057522	K00430	ko01100	Metabolic pathways	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMT200057522	K00430	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMT200085610	K02966	ko03010	Ribosome	341	5.7e-13	0.66	0.75	0.71
PGSC0003DMT200085614	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200085614	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200085614	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200061466	K12843	ko03040	Spliceosome	4209	2.6e-226	0.70	0.83	0.97
PGSC0003DMT200061467	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMT200061468	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMT200061469	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMT200061470	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMT200061471	K12896	ko03040	Spliceosome	1740	3.9e-90	0.71	0.78	0.95
PGSC0003DMT200061481	K01099	ko00562	Inositol phosphate metabolism	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMT200061481	K01099	ko01100	Metabolic pathways	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMT200061481	K01099	ko04070	Phosphatidylinositol signaling system	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMT200061482	K01099	ko00562	Inositol phosphate metabolism	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMT200061482	K01099	ko01100	Metabolic pathways	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMT200061482	K01099	ko04070	Phosphatidylinositol signaling system	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMT200061483	K01778	ko00300	Lysine biosynthesis	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMT200061483	K01778	ko01100	Metabolic pathways	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMT200061483	K01778	ko01110	Biosynthesis of secondary metabolites	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMT200061484	K02893	ko03010	Ribosome	1134	1.0e-56	0.88	0.95	0.99
PGSC0003DMT200061485	K13229	ko00402	Benzoxazinoid biosynthesis	312	2.3e-11	0.43	0.61	0.97
PGSC0003DMT200061487	K13229	ko00402	Benzoxazinoid biosynthesis	370	1.4e-14	0.36	0.53	0.86
PGSC0003DMT200061490	K01710	ko00521	Streptomycin biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMT200061490	K01710	ko00523	Polyketide sugar unit biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMT200061490	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMT200061490	K01710	ko01100	Metabolic pathways	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMT200061490	K01710	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMT200061491	K01710	ko00521	Streptomycin biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMT200061491	K01710	ko00523	Polyketide sugar unit biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMT200061491	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMT200061491	K01710	ko01100	Metabolic pathways	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMT200061491	K01710	ko01110	Biosynthesis of secondary metabolites	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMT200061493	K01710	ko00521	Streptomycin biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMT200061493	K01710	ko00523	Polyketide sugar unit biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMT200061493	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMT200061493	K01710	ko01100	Metabolic pathways	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMT200061493	K01710	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMT200061494	K07195	ko04910	Insulin signaling pathway	2668	2.6e-141	0.54	0.72	0.97
PGSC0003DMT200061495	K01728	ko00040	Pentose and glucuronate interconversions	2056	1.5e-107	0.73	0.86	0.90
PGSC0003DMT200025713	K08913	ko00196	Photosynthesis - antenna proteins	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMT200025713	K08913	ko01100	Metabolic pathways	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMT200025714	K08913	ko00196	Photosynthesis - antenna proteins	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMT200025714	K08913	ko01100	Metabolic pathways	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMT200025715	K08913	ko00196	Photosynthesis - antenna proteins	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMT200025715	K08913	ko01100	Metabolic pathways	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMT200025736	K01193	ko00052	Galactose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMT200025736	K01193	ko00500	Starch and sucrose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMT200025736	K01193	ko01100	Metabolic pathways	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMT200028641	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028641	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028641	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028641	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028641	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028641	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMT200028645	K07964	ko00531	Glycosaminoglycan degradation	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMT200028645	K07964	ko01100	Metabolic pathways	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMT200028646	K07964	ko00531	Glycosaminoglycan degradation	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMT200028646	K07964	ko01100	Metabolic pathways	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMT200028648	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.39	0.59	0.88
PGSC0003DMT200028649	K13228	ko00402	Benzoxazinoid biosynthesis	783	2.4e-37	0.46	0.65	0.88
PGSC0003DMT200028650	K13228	ko00402	Benzoxazinoid biosynthesis	804	1.6e-38	0.34	0.55	0.93
PGSC0003DMT200028652	K13228	ko00402	Benzoxazinoid biosynthesis	613	5.6e-28	0.41	0.59	0.87
PGSC0003DMT200028653	K13228	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.34	0.55	0.91
PGSC0003DMT200028655	K13228	ko00402	Benzoxazinoid biosynthesis	805	1.4e-38	0.46	0.67	0.88
PGSC0003DMT200028656	K13228	ko00402	Benzoxazinoid biosynthesis	1033	3.9e-51	0.39	0.58	0.88
PGSC0003DMT200028657	K02184	ko04320	Dorso-ventral axis formation	502	4.3e-21	0.41	0.46	0.44
PGSC0003DMT200028670	K01193	ko00052	Galactose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMT200028670	K01193	ko00500	Starch and sucrose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMT200028670	K01193	ko01100	Metabolic pathways	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMT200028675	K09841	ko00906	Carotenoid biosynthesis	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMT200028675	K09841	ko01100	Metabolic pathways	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMT200028675	K09841	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMT200028678	K12382	ko04142	Lysosome	267	8.7e-09	0.28	0.49	0.71
PGSC0003DMT200028679	K12382	ko04142	Lysosome	270	5.8e-09	0.29	0.50	0.76
PGSC0003DMT200028680	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMT200036369	K13065	ko00940	Phenylpropanoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMT200036369	K13065	ko00941	Flavonoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMT200036369	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMT200036369	K13065	ko01110	Biosynthesis of secondary metabolites	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMT200036374	K13065	ko00940	Phenylpropanoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMT200036374	K13065	ko00941	Flavonoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMT200036374	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMT200036374	K13065	ko01110	Biosynthesis of secondary metabolites	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMT200036379	K03469	ko03030	DNA replication	239	1.6e-06	0.38	0.54	0.13
PGSC0003DMT200036383	K13065	ko00940	Phenylpropanoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMT200036383	K13065	ko00941	Flavonoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMT200036383	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMT200036383	K13065	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMT200036389	K01772	ko00860	Porphyrin and chlorophyll metabolism	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMT200036389	K01772	ko01100	Metabolic pathways	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMT200036389	K01772	ko01110	Biosynthesis of secondary metabolites	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMT200036390	K05280	ko00941	Flavonoid biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMT200036390	K05280	ko00944	Flavone and flavonol biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMT200036390	K05280	ko01100	Metabolic pathways	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMT200036390	K05280	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMT200036391	K05280	ko00941	Flavonoid biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMT200036391	K05280	ko00944	Flavone and flavonol biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMT200036391	K05280	ko01100	Metabolic pathways	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMT200036391	K05280	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMT200036392	K05280	ko00941	Flavonoid biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMT200036392	K05280	ko00944	Flavone and flavonol biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMT200036392	K05280	ko01100	Metabolic pathways	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMT200036392	K05280	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMT200036393	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036393	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036393	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036393	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036393	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036394	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036394	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036394	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036394	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036394	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMT200036395	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMT200036395	K00517	ko00626	Naphthalene and anthracene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMT200036395	K00517	ko00903	Limonene and pinene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMT200036395	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMT200036395	K00517	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMT200036396	K11868	ko00380	Tryptophan metabolism	512	2.1e-22	0.34	0.59	0.99
PGSC0003DMT200036397	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMT200036397	K00517	ko00626	Naphthalene and anthracene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMT200036397	K00517	ko00903	Limonene and pinene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMT200036397	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMT200036397	K00517	ko01110	Biosynthesis of secondary metabolites	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMT200036398	K09755	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMT200036398	K09755	ko01100	Metabolic pathways	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMT200036398	K09755	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMT200036399	K05280	ko00941	Flavonoid biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMT200036399	K05280	ko00944	Flavone and flavonol biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMT200036399	K05280	ko01100	Metabolic pathways	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMT200036399	K05280	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMT200036400	K05280	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMT200036400	K05280	ko00944	Flavone and flavonol biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMT200036400	K05280	ko01100	Metabolic pathways	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMT200036400	K05280	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMT200096297	K01051	ko00040	Pentose and glucuronate interconversions	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMT200096297	K01051	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMT200096297	K01051	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMT200071365	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMT200071380	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMT200071380	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMT200071381	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071381	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071382	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071382	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071383	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMT200071383	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMT200071384	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071384	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMT200071385	K03110	ko03060	Protein export	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMT200071385	K03110	ko03070	Bacterial secretion system	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMT200045873	K01509	ko00230	Purine metabolism	1249	4.7e-63	0.32	0.47	0.76
PGSC0003DMT200045874	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.79
PGSC0003DMT200045875	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMT200045876	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMT200083164	K12126	ko04712	Circadian rhythm - plant	395	6.0e-16	0.47	0.64	0.29
PGSC0003DMT200083165	K08509	ko04130	SNARE interactions in vesicular transport	581	3.3e-26	0.67	0.80	0.95
PGSC0003DMT200083166	K08509	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.62	0.75	1.00
PGSC0003DMT200083179	K00059	ko00061	Fatty acid biosynthesis	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMT200083179	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMT200083179	K00059	ko01100	Metabolic pathways	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMT200083180	K00059	ko00061	Fatty acid biosynthesis	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMT200083180	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMT200083180	K00059	ko01100	Metabolic pathways	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMT200083187	K00012	ko00040	Pentose and glucuronate interconversions	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083187	K00012	ko00053	Ascorbate and aldarate metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083187	K00012	ko00500	Starch and sucrose metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083187	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083187	K00012	ko01100	Metabolic pathways	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083187	K00012	ko01110	Biosynthesis of secondary metabolites	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMT200083193	K10604	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.40	0.57	0.69
PGSC0003DMT200083199	K01640	ko00072	Synthesis and degradation of ketone bodies	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko00280	Valine, leucine and isoleucine degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko00281	Geraniol degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko00650	Butanoate metabolism	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko01100	Metabolic pathways	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083199	K01640	ko04146	Peroxisome	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMT200083200	K01640	ko00072	Synthesis and degradation of ketone bodies	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko00280	Valine, leucine and isoleucine degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko00281	Geraniol degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko00650	Butanoate metabolism	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko01100	Metabolic pathways	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083200	K01640	ko04146	Peroxisome	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMT200083201	K01640	ko00072	Synthesis and degradation of ketone bodies	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko00280	Valine, leucine and isoleucine degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko00281	Geraniol degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko00650	Butanoate metabolism	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko01100	Metabolic pathways	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko01110	Biosynthesis of secondary metabolites	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200083201	K01640	ko04146	Peroxisome	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMT200077646	K00360	ko00910	Nitrogen metabolism	2956	3.3e-157	0.78	0.89	1.00
PGSC0003DMT200077647	K00360	ko00910	Nitrogen metabolism	3072	1.3e-163	0.78	0.90	1.00
PGSC0003DMT200077648	K00360	ko00910	Nitrogen metabolism	6070	0.	0.76	0.86	1.00
PGSC0003DMT200077667	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMT200077667	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMT200077667	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMT200077668	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMT200077668	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMT200077668	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMT200077689	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.37	0.60	0.53
PGSC0003DMT200052172	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052172	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052172	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052173	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMT200052173	K00891	ko01100	Metabolic pathways	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMT200052173	K00891	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMT200052174	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052174	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052174	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052175	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052175	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052175	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052176	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052176	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052176	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMT200052177	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMT200052177	K00891	ko01100	Metabolic pathways	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMT200052177	K00891	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMT200052178	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMT200052178	K00891	ko01100	Metabolic pathways	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMT200052178	K00891	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMT200065835	K12128	ko04712	Circadian rhythm - plant	428	1.2e-17	0.29	0.46	0.60
PGSC0003DMT200065841	K01581	ko00330	Arginine and proline metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMT200065841	K01581	ko00480	Glutathione metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMT200065841	K01581	ko01100	Metabolic pathways	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMT200065841	K01581	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMT200065850	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.83
PGSC0003DMT200065851	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.85
PGSC0003DMT200065867	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMT200065867	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMT200065868	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMT200065868	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMT200069661	K04354	ko04111	Cell cycle - yeast	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMT200069661	K04354	ko04530	Tight junction	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMT200069661	K04354	ko05142	Chagas disease	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMT200069662	K04354	ko04111	Cell cycle - yeast	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMT200069662	K04354	ko04530	Tight junction	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMT200069662	K04354	ko05142	Chagas disease	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMT200069663	K04354	ko04111	Cell cycle - yeast	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMT200069663	K04354	ko04530	Tight junction	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMT200069663	K04354	ko05142	Chagas disease	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMT200069664	K04354	ko04111	Cell cycle - yeast	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMT200069664	K04354	ko04530	Tight junction	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMT200069664	K04354	ko05142	Chagas disease	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMT200069666	K04354	ko04111	Cell cycle - yeast	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMT200069666	K04354	ko04530	Tight junction	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMT200069666	K04354	ko05142	Chagas disease	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMT200069667	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMT200069667	K00766	ko01100	Metabolic pathways	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMT200069667	K00766	ko01110	Biosynthesis of secondary metabolites	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMT200069671	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMT200069674	K06573	ko04966	Collecting duct acid secretion	491	9.7e-21	0.29	0.48	0.72
PGSC0003DMT200069676	K06573	ko04966	Collecting duct acid secretion	307	2.5e-10	0.38	0.57	0.80
PGSC0003DMT200069678	K06573	ko04966	Collecting duct acid secretion	752	1.2e-35	0.29	0.46	0.84
PGSC0003DMT200069679	K06573	ko04966	Collecting duct acid secretion	228	6.7e-06	0.26	0.47	0.88
PGSC0003DMT200069686	K03681	ko03018	RNA degradation	1546	2.0e-79	0.81	0.90	0.97
PGSC0003DMT200086114	K08271	ko04150	mTOR signaling pathway	346	3.0e-13	0.30	0.45	0.63
PGSC0003DMT200086131	K12581	ko03018	RNA degradation	982	2.5e-48	0.52	0.68	0.94
PGSC0003DMT200000572	K01068	ko01040	Biosynthesis of unsaturated fatty acids	792	7.6e-38	0.57	0.66	0.99
PGSC0003DMT200000574	K12604	ko03018	RNA degradation	2187	8.6e-115	0.59	0.77	0.97
PGSC0003DMT200000575	K12604	ko03018	RNA degradation	571	1.6e-24	0.45	0.63	0.83
PGSC0003DMT200000576	K12604	ko03018	RNA degradation	2739	3.1e-145	0.57	0.75	0.99
PGSC0003DMT200000577	K12604	ko03018	RNA degradation	555	1.6e-23	0.48	0.65	0.95
PGSC0003DMT200000578	K12604	ko03018	RNA degradation	760	6.5e-35	0.50	0.65	0.95
PGSC0003DMT200000579	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMT200000580	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMT200000581	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMT200000582	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMT200000584	K12604	ko03018	RNA degradation	2339	3.6e-123	0.58	0.76	0.99
PGSC0003DMT200000592	K11600	ko03018	RNA degradation	1787	1.0e-92	0.90	0.95	0.98
PGSC0003DMT200031568	K00703	ko00500	Starch and sucrose metabolism	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMT200031568	K00703	ko01100	Metabolic pathways	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMT200031569	K00703	ko00500	Starch and sucrose metabolism	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMT200031569	K00703	ko01100	Metabolic pathways	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMT200031570	K01199	ko00500	Starch and sucrose metabolism	744	3.4e-35	0.35	0.54	0.80
PGSC0003DMT200005679	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMT200005685	K00975	ko00500	Starch and sucrose metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMT200005685	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMT200005685	K00975	ko01100	Metabolic pathways	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMT200005688	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005688	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005688	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005689	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005689	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005689	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMT200005690	K00975	ko00500	Starch and sucrose metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMT200005690	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMT200005690	K00975	ko01100	Metabolic pathways	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMT200005691	K12842	ko03040	Spliceosome	4915	3.0e-265	0.71	0.79	0.97
PGSC0003DMT200005692	K12842	ko03040	Spliceosome	1543	2.9e-79	0.84	0.93	0.96
PGSC0003DMT200005693	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMT200005694	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMT200005695	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMT200005710	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMT200005710	K02367	ko01100	Metabolic pathways	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMT200005711	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMT200005711	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMT200005712	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMT200005712	K02367	ko01100	Metabolic pathways	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMT200005713	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMT200005713	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMT200042739	K00705	ko00500	Starch and sucrose metabolism	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMT200042739	K00705	ko01100	Metabolic pathways	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMT200042740	K00705	ko00500	Starch and sucrose metabolism	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMT200042740	K00705	ko01100	Metabolic pathways	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMT200042741	K00705	ko00500	Starch and sucrose metabolism	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMT200042741	K00705	ko01100	Metabolic pathways	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMT200023277	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMT200023278	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMT200023280	K06611	ko00052	Galactose metabolism	2939	2.9e-156	0.44	0.60	1.00
PGSC0003DMT200023282	K10581	ko04120	Ubiquitin mediated proteolysis	591	1.8e-26	0.36	0.54	0.82
PGSC0003DMT200023283	K12820	ko03040	Spliceosome	3968	5.1e-213	0.89	0.95	0.99
PGSC0003DMT200023284	K12820	ko03040	Spliceosome	5626	0.	0.90	0.94	1.00
PGSC0003DMT200023285	K12820	ko03040	Spliceosome	3975	2.1e-213	0.89	0.95	0.93
PGSC0003DMT200023288	K04125	ko00904	Diterpenoid biosynthesis	869	4.3e-42	0.47	0.63	0.89
PGSC0003DMT200023289	K04125	ko00904	Diterpenoid biosynthesis	1117	9.0e-56	0.47	0.63	0.93
PGSC0003DMT200044201	K12837	ko03040	Spliceosome	780	1.0e-41	0.35	0.51	0.45
PGSC0003DMT200044202	K02902	ko03010	Ribosome	431	6.2e-18	0.68	0.85	0.50
PGSC0003DMT200044217	K00026	ko00020	Citrate cycle (TCA cycle)	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044217	K00026	ko00620	Pyruvate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044217	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044217	K00026	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044217	K00026	ko01100	Metabolic pathways	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044217	K00026	ko01110	Biosynthesis of secondary metabolites	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMT200044218	K05765	ko04360	Axon guidance	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMT200044218	K05765	ko04666	Fc gamma R-mediated phagocytosis	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMT200044218	K05765	ko04810	Regulation of actin cytoskeleton	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMT200044219	K12119	ko04712	Circadian rhythm - plant	3751	4.7e-201	0.69	0.82	0.98
PGSC0003DMT200044220	K12119	ko04712	Circadian rhythm - plant	2548	1.1e-134	0.66	0.79	0.99
PGSC0003DMT200044237	K13229	ko00402	Benzoxazinoid biosynthesis	1093	1.9e-54	0.45	0.59	0.98
PGSC0003DMT200044238	K13229	ko00402	Benzoxazinoid biosynthesis	413	6.1e-17	0.50	0.68	0.95
PGSC0003DMT200072165	K02084	ko04115	p53 signaling pathway	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko04210	Apoptosis	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko05010	Alzheimer's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko05012	Parkinson's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko05016	Huntington's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072165	K02084	ko05222	Small cell lung cancer	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMT200072197	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMT200072197	K00517	ko00626	Naphthalene and anthracene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMT200072197	K00517	ko00903	Limonene and pinene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMT200072197	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMT200072197	K00517	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMT200072202	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMT200072202	K00517	ko00626	Naphthalene and anthracene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMT200072202	K00517	ko00903	Limonene and pinene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMT200072202	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMT200072202	K00517	ko01110	Biosynthesis of secondary metabolites	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMT200072204	K00059	ko00061	Fatty acid biosynthesis	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMT200072204	K00059	ko01040	Biosynthesis of unsaturated fatty acids	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMT200072204	K00059	ko01100	Metabolic pathways	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMT200082442	K12859	ko03040	Spliceosome	861	1.2e-41	0.97	1.00	0.99
PGSC0003DMT200082446	K01845	ko00860	Porphyrin and chlorophyll metabolism	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMT200082446	K01845	ko01100	Metabolic pathways	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMT200082446	K01845	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMT200082447	K01845	ko00860	Porphyrin and chlorophyll metabolism	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMT200082447	K01845	ko01100	Metabolic pathways	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMT200082447	K01845	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMT200082448	K01845	ko00860	Porphyrin and chlorophyll metabolism	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMT200082448	K01845	ko01100	Metabolic pathways	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMT200082448	K01845	ko01110	Biosynthesis of secondary metabolites	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMT200082452	K02084	ko04115	p53 signaling pathway	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko04210	Apoptosis	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko05010	Alzheimer's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko05012	Parkinson's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko05016	Huntington's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082452	K02084	ko05222	Small cell lung cancer	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMT200082459	K00995	ko00564	Glycerophospholipid metabolism	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMT200082459	K00995	ko01100	Metabolic pathways	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMT200082460	K00995	ko00564	Glycerophospholipid metabolism	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMT200082460	K00995	ko01100	Metabolic pathways	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMT200082464	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMT200082465	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMT200082467	K10643	ko03018	RNA degradation	941	4.6e-46	0.32	0.49	0.92
PGSC0003DMT200082468	K10643	ko03018	RNA degradation	2311	1.3e-121	0.37	0.52	1.00
PGSC0003DMT200093829	K02084	ko04115	p53 signaling pathway	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko04210	Apoptosis	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko05010	Alzheimer's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko05012	Parkinson's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko05016	Huntington's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093829	K02084	ko05222	Small cell lung cancer	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMT200093845	K12833	ko03040	Spliceosome	421	2.2e-17	0.75	0.81	0.99
PGSC0003DMT200017150	K02685	ko00230	Purine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMT200017150	K02685	ko00240	Pyrimidine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMT200017150	K02685	ko01100	Metabolic pathways	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMT200017150	K02685	ko03030	DNA replication	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMT200017153	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMT200017153	K00517	ko00626	Naphthalene and anthracene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMT200017153	K00517	ko00903	Limonene and pinene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMT200017153	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMT200017153	K00517	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMT200017157	K12467	ko00902	Monoterpenoid biosynthesis	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMT200017157	K12467	ko01110	Biosynthesis of secondary metabolites	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMT200017159	K13066	ko00940	Phenylpropanoid biosynthesis	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMT200017159	K13066	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMT200017165	K12182	ko04144	Endocytosis	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMT200017165	K12182	ko04145	Phagosome	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMT200017174	K08905	ko00195	Photosynthesis	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMT200017174	K08905	ko01100	Metabolic pathways	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMT200029363	K01696	ko00260	Glycine, serine and threonine metabolism	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMT200029363	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMT200029363	K01696	ko01100	Metabolic pathways	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMT200029363	K01696	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMT200029364	K12184	ko04144	Endocytosis	748	2.0e-35	0.58	0.70	0.75
PGSC0003DMT200029370	K01246	ko03410	Base excision repair	865	7.1e-42	0.53	0.66	1.00
PGSC0003DMT200029371	K01246	ko03410	Base excision repair	578	4.8e-26	0.69	0.92	0.96
PGSC0003DMT200029372	K01246	ko03410	Base excision repair	1680	8.0e-87	0.59	0.73	0.99
PGSC0003DMT200029386	K05277	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMT200029386	K05277	ko01100	Metabolic pathways	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMT200029386	K05277	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMT200029389	K05277	ko00941	Flavonoid biosynthesis	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMT200029389	K05277	ko01100	Metabolic pathways	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMT200029389	K05277	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMT200029394	K12134	ko04712	Circadian rhythm - plant	480	1.2e-20	0.90	0.98	0.86
PGSC0003DMT200029395	K12133	ko04712	Circadian rhythm - plant	1266	5.4e-64	0.43	0.56	0.85
PGSC0003DMT200029396	K12133	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.44	0.55	0.98
PGSC0003DMT200035900	K06063	ko03040	Spliceosome	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMT200035900	K06063	ko04330	Notch signaling pathway	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMT200035904	K01369	ko04142	Lysosome	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMT200035904	K01369	ko04612	Antigen processing and presentation	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMT200035905	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMT200035905	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMT200035906	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMT200035906	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMT200035907	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMT200035907	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMT200035908	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMT200035908	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMT200035911	K12125	ko04712	Circadian rhythm - plant	664	8.7e-31	0.41	0.51	0.98
PGSC0003DMT200035912	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.37	0.53	0.99
PGSC0003DMT200035913	K12125	ko04712	Circadian rhythm - plant	859	1.5e-41	0.40	0.56	0.98
PGSC0003DMT200035914	K12125	ko04712	Circadian rhythm - plant	1636	2.1e-84	0.40	0.54	0.99
PGSC0003DMT200035921	K12194	ko04144	Endocytosis	1410	6.2e-72	0.84	0.87	0.56
PGSC0003DMT200035922	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMT200035923	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMT200035924	K01369	ko04142	Lysosome	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMT200035924	K01369	ko04612	Antigen processing and presentation	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMT200035925	K01369	ko04142	Lysosome	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMT200035925	K01369	ko04612	Antigen processing and presentation	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMT200035926	K01369	ko04142	Lysosome	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMT200035926	K01369	ko04612	Antigen processing and presentation	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMT200062141	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200062141	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMT200062153	K06630	ko04110	Cell cycle	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMT200062153	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMT200062153	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMT200062156	K03715	ko00561	Glycerolipid metabolism	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMT200062156	K03715	ko01100	Metabolic pathways	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMT200062159	K10839	ko03420	Nucleotide excision repair	2475	1.1e-130	0.76	0.84	1.00
PGSC0003DMT200062163	K00075	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMT200062163	K00075	ko00550	Peptidoglycan biosynthesis	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMT200062163	K00075	ko01100	Metabolic pathways	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMT200062175	K01915	ko00250	Alanine, aspartate and glutamate metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMT200062175	K01915	ko00330	Arginine and proline metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMT200062175	K01915	ko00910	Nitrogen metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMT200062175	K01915	ko01100	Metabolic pathways	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMT200062175	K01915	ko02020	Two-component system	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMT200062180	K02084	ko04115	p53 signaling pathway	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko04210	Apoptosis	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko05010	Alzheimer's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko05012	Parkinson's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko05016	Huntington's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062180	K02084	ko05222	Small cell lung cancer	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMT200062187	K00949	ko00730	Thiamine metabolism	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMT200062187	K00949	ko01100	Metabolic pathways	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMT200073842	K00599	ko00340	Histidine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMT200073842	K00599	ko00350	Tyrosine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMT200073842	K00599	ko00450	Selenoamino acid metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMT200073842	K00599	ko00626	Naphthalene and anthracene degradation	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMT200073858	K01853	ko00100	Steroid biosynthesis	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMT200073858	K01853	ko01100	Metabolic pathways	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMT200073858	K01853	ko01110	Biosynthesis of secondary metabolites	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMT200073861	K01853	ko00100	Steroid biosynthesis	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMT200073861	K01853	ko01100	Metabolic pathways	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMT200073861	K01853	ko01110	Biosynthesis of secondary metabolites	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMT200073881	K07573	ko03018	RNA degradation	1318	7.4e-67	0.84	0.90	0.96
PGSC0003DMT200046008	K12493	ko04144	Endocytosis	1499	7.6e-77	0.41	0.57	0.93
PGSC0003DMT200046009	K12493	ko04144	Endocytosis	412	4.7e-16	0.32	0.51	0.99
PGSC0003DMT200046019	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMT200046019	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMT200046019	K00771	ko01100	Metabolic pathways	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMT200046030	K04424	ko04010	MAPK signaling pathway	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMT200046030	K04424	ko04530	Tight junction	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMT200080193	K05863	ko04020	Calcium signaling pathway	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMT200080193	K05863	ko05012	Parkinson's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMT200080193	K05863	ko05016	Huntington's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMT200027581	K02183	ko04020	Calcium signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04070	Phosphatidylinositol signaling system	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04114	Oocyte meiosis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04270	Vascular smooth muscle contraction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04626	Plant-pathogen interaction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04720	Long-term potentiation	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04722	Neurotrophin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04740	Olfactory transduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04744	Phototransduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04745	Phototransduction - fly	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04910	Insulin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04912	GnRH signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04916	Melanogenesis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04970	Salivary secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko04971	Gastric acid secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko05010	Alzheimer's disease	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027581	K02183	ko05214	Glioma	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMT200027593	K06443	ko00906	Carotenoid biosynthesis	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMT200027593	K06443	ko01100	Metabolic pathways	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMT200027593	K06443	ko01110	Biosynthesis of secondary metabolites	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMT200027594	K00599	ko00340	Histidine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMT200027594	K00599	ko00350	Tyrosine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMT200027594	K00599	ko00450	Selenoamino acid metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMT200027594	K00599	ko00626	Naphthalene and anthracene degradation	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMT200027609	K03013	ko00230	Purine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMT200027609	K03013	ko00240	Pyrimidine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMT200027609	K03013	ko01100	Metabolic pathways	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMT200027609	K03013	ko03020	RNA polymerase	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMT200027609	K03013	ko05016	Huntington's disease	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMT200037696	K01187	ko00052	Galactose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMT200037696	K01187	ko00500	Starch and sucrose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMT200037696	K01187	ko01100	Metabolic pathways	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMT200037702	K01054	ko00561	Glycerolipid metabolism	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMT200037702	K01054	ko01100	Metabolic pathways	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMT200037705	K02876	ko03010	Ribosome	1568	1.2e-80	0.77	0.85	0.92
PGSC0003DMT200050326	K06671	ko04110	Cell cycle	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMT200050326	K06671	ko04111	Cell cycle - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMT200050326	K06671	ko04113	Meiosis - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMT200050328	K06671	ko04110	Cell cycle	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMT200050328	K06671	ko04111	Cell cycle - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMT200050328	K06671	ko04113	Meiosis - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMT200050329	K06671	ko04110	Cell cycle	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMT200050329	K06671	ko04111	Cell cycle - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMT200050329	K06671	ko04113	Meiosis - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMT200050330	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.39	0.53	0.69
PGSC0003DMT200050332	K10352	ko04530	Tight junction	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMT200050332	K10352	ko05416	Viral myocarditis	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMT200050333	K10352	ko04530	Tight junction	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMT200050333	K10352	ko05416	Viral myocarditis	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMT200050335	K02985	ko03010	Ribosome	1782	1.9e-92	0.93	0.96	0.95
PGSC0003DMT200050336	K00797	ko00270	Cysteine and methionine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMT200050336	K00797	ko00330	Arginine and proline metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMT200050336	K00797	ko00410	beta-Alanine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMT200050336	K00797	ko00480	Glutathione metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMT200050336	K00797	ko01100	Metabolic pathways	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMT200050343	K04733	ko04210	Apoptosis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMT200050343	K04733	ko04620	Toll-like receptor signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMT200050343	K04733	ko04722	Neurotrophin signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMT200050343	K04733	ko05140	Leishmaniasis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMT200050343	K04733	ko05142	Chagas disease	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMT200050345	K07424	ko00140	Steroid hormone biosynthesis	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00591	Linoleic acid metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00830	Retinol metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00982	Drug metabolism - cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko00983	Drug metabolism - other enzymes	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050345	K07424	ko01100	Metabolic pathways	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMT200050357	K01501	ko00380	Tryptophan metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050357	K01501	ko00460	Cyanoamino acid metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050357	K01501	ko00632	Benzoate degradation via CoA ligation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050357	K01501	ko00643	Styrene degradation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050357	K01501	ko00910	Nitrogen metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050357	K01501	ko01100	Metabolic pathways	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMT200050359	K01501	ko00380	Tryptophan metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200050359	K01501	ko00460	Cyanoamino acid metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200050359	K01501	ko00632	Benzoate degradation via CoA ligation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200050359	K01501	ko00643	Styrene degradation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200050359	K01501	ko00910	Nitrogen metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200050359	K01501	ko01100	Metabolic pathways	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMT200075900	K05868	ko04110	Cell cycle	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMT200075900	K05868	ko04115	p53 signaling pathway	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMT200075900	K05868	ko04914	Progesterone-mediated oocyte maturation	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMT200075906	K12128	ko04712	Circadian rhythm - plant	406	1.5e-16	0.35	0.55	0.67
PGSC0003DMT200075907	K12128	ko04712	Circadian rhythm - plant	406	2.0e-16	0.35	0.55	0.27
PGSC0003DMT200075908	K12128	ko04712	Circadian rhythm - plant	406	1.9e-16	0.35	0.55	0.27
PGSC0003DMT200075910	K10352	ko04530	Tight junction	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMT200075910	K10352	ko05416	Viral myocarditis	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMT200075911	K10866	ko03440	Homologous recombination	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMT200075911	K10866	ko03450	Non-homologous end-joining	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMT200075913	K10352	ko04530	Tight junction	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMT200075913	K10352	ko05416	Viral myocarditis	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMT200075915	K13229	ko00402	Benzoxazinoid biosynthesis	1103	5.3e-55	0.41	0.60	0.95
PGSC0003DMT200075921	K12478	ko04144	Endocytosis	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMT200075921	K12478	ko04145	Phagosome	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMT200067900	K01054	ko00561	Glycerolipid metabolism	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMT200067900	K01054	ko01100	Metabolic pathways	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMT200067904	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMT200067904	K01602	ko00710	Carbon fixation in photosynthetic organisms	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMT200067904	K01602	ko01100	Metabolic pathways	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMT200067905	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067905	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067905	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067906	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067906	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067906	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067907	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067907	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067907	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMT200067914	K12845	ko03040	Spliceosome	989	1.0e-48	0.93	0.97	0.99
PGSC0003DMT200067915	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.63
PGSC0003DMT200067916	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMT200067917	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMT200067918	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMT200067922	K12831	ko03040	Spliceosome	231	7.1e-07	0.37	0.43	0.57
PGSC0003DMT200007431	K02997	ko03010	Ribosome	1585	1.4e-81	0.94	0.99	0.99
PGSC0003DMT200007464	K07297	ko04920	Adipocytokine signaling pathway	534	1.3e-23	0.59	0.77	0.63
PGSC0003DMT200033214	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMT200033214	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMT200033220	K01046	ko00561	Glycerolipid metabolism	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMT200033220	K01046	ko01100	Metabolic pathways	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMT200033221	K01955	ko00240	Pyrimidine metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMT200033221	K01955	ko00250	Alanine, aspartate and glutamate metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMT200033221	K01955	ko01100	Metabolic pathways	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMT200033230	K10885	ko03450	Non-homologous end-joining	4138	2.1e-222	0.70	0.85	0.97
PGSC0003DMT200033231	K01800	ko00350	Tyrosine metabolism	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMT200033231	K01800	ko00643	Styrene degradation	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMT200033231	K01800	ko01100	Metabolic pathways	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMT200033232	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMT200033232	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMT200033232	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMT200033233	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMT200033233	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMT200033233	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMT200033234	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033234	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033234	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033235	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033235	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033235	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMT200033236	K07750	ko00100	Steroid biosynthesis	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMT200033236	K07750	ko01100	Metabolic pathways	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMT200033237	K08272	ko04150	mTOR signaling pathway	1897	8.5e-99	0.80	0.88	0.98
PGSC0003DMT200033238	K08272	ko04150	mTOR signaling pathway	2273	1.6e-119	0.80	0.89	0.99
PGSC0003DMT200033239	K08272	ko04150	mTOR signaling pathway	1998	2.3e-104	0.80	0.89	0.99
PGSC0003DMT200033240	K08272	ko04150	mTOR signaling pathway	1279	1.0e-64	0.79	0.88	0.94
PGSC0003DMT200021161	K00599	ko00340	Histidine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMT200021161	K00599	ko00350	Tyrosine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMT200021161	K00599	ko00450	Selenoamino acid metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMT200021161	K00599	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMT200021162	K00599	ko00340	Histidine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMT200021162	K00599	ko00350	Tyrosine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMT200021162	K00599	ko00450	Selenoamino acid metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMT200021162	K00599	ko00626	Naphthalene and anthracene degradation	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMT200040974	K12194	ko04144	Endocytosis	424	7.9e-17	0.46	0.66	0.13
PGSC0003DMT200040975	K12194	ko04144	Endocytosis	424	3.7e-17	0.46	0.66	0.17
PGSC0003DMT200040982	K00655	ko00561	Glycerolipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMT200040982	K00655	ko00564	Glycerophospholipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMT200040982	K00655	ko01100	Metabolic pathways	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMT200041003	K02703	ko00195	Photosynthesis	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMT200041003	K02703	ko01100	Metabolic pathways	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMT200041021	K01179	ko00500	Starch and sucrose metabolism	224	3.4e-06	0.53	0.69	0.57
PGSC0003DMT200024981	K02729	ko03050	Proteasome	1652	2.8e-85	0.96	1.00	0.95
PGSC0003DMT200024982	K02729	ko03050	Proteasome	1923	3.1e-100	0.97	1.00	1.00
PGSC0003DMT200024992	K12812	ko03040	Spliceosome	541	5.3e-24	0.73	0.88	0.56
PGSC0003DMT200024993	K12812	ko03040	Spliceosome	2689	1.8e-142	0.89	0.92	0.59
PGSC0003DMT200024994	K12812	ko03040	Spliceosome	2806	6.2e-149	0.96	0.99	1.00
PGSC0003DMT200024995	K12812	ko03040	Spliceosome	3452	1.5e-184	0.94	0.99	1.00
PGSC0003DMT200025007	K11821	ko00380	Tryptophan metabolism	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMT200025007	K11821	ko00966	Glucosinolate biosynthesis	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMT200025007	K11821	ko01110	Biosynthesis of secondary metabolites	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMT200025010	K02471	ko02010	ABC transporters	766	2.1e-36	0.43	0.64	0.74
PGSC0003DMT200025011	K02471	ko02010	ABC transporters	1473	2.1e-75	0.41	0.58	0.98
PGSC0003DMT200025012	K02471	ko02010	ABC transporters	309	7.7e-11	0.43	0.66	0.97
PGSC0003DMT200025015	K02471	ko02010	ABC transporters	338	1.0e-12	0.60	0.73	0.86
PGSC0003DMT200002237	K03129	ko03022	Basal transcription factors	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMT200002237	K03129	ko05016	Huntington's disease	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMT200002241	K01728	ko00040	Pentose and glucuronate interconversions	1820	1.5e-94	0.53	0.69	0.92
PGSC0003DMT200002242	K13289	ko04142	Lysosome	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMT200002242	K13289	ko04614	Renin-angiotensin system	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMT200002243	K13289	ko04142	Lysosome	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMT200002243	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMT200002244	K13289	ko04142	Lysosome	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMT200002244	K13289	ko04614	Renin-angiotensin system	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMT200002245	K13289	ko04142	Lysosome	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMT200002245	K13289	ko04614	Renin-angiotensin system	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMT200002246	K13289	ko04142	Lysosome	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMT200002246	K13289	ko04614	Renin-angiotensin system	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMT200002247	K13289	ko04142	Lysosome	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMT200002247	K13289	ko04614	Renin-angiotensin system	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMT200002248	K13289	ko04142	Lysosome	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMT200002248	K13289	ko04614	Renin-angiotensin system	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMT200002249	K13289	ko04142	Lysosome	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMT200002249	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMT200002250	K13289	ko04142	Lysosome	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMT200002250	K13289	ko04614	Renin-angiotensin system	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMT200002261	K05862	ko04020	Calcium signaling pathway	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMT200002261	K05862	ko05012	Parkinson's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMT200002261	K05862	ko05016	Huntington's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMT200097031	K08241	ko00592	alpha-Linolenic acid metabolism	625	1.2e-28	0.33	0.53	0.88
PGSC0003DMT200097052	K10352	ko04530	Tight junction	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMT200097052	K10352	ko05416	Viral myocarditis	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMT200092617	K11816	ko00380	Tryptophan metabolism	497	1.4e-21	0.47	0.66	0.98
PGSC0003DMT200092625	K12586	ko03018	RNA degradation	244	4.5e-11	0.53	0.72	0.48
PGSC0003DMT200007213	K12608	ko03018	RNA degradation	551	1.5e-24	0.80	0.84	0.78
PGSC0003DMT200007214	K12608	ko03018	RNA degradation	631	5.7e-29	0.80	0.86	0.99
PGSC0003DMT200007215	K12608	ko03018	RNA degradation	2391	4.8e-126	0.87	0.92	1.00
PGSC0003DMT200025131	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMT200025131	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMT200025132	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMT200025132	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMT200025134	K01114	ko00562	Inositol phosphate metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMT200025134	K01114	ko00564	Glycerophospholipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMT200025134	K01114	ko00565	Ether lipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMT200025134	K01114	ko01100	Metabolic pathways	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMT200025135	K01955	ko00240	Pyrimidine metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMT200025135	K01955	ko00250	Alanine, aspartate and glutamate metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMT200025135	K01955	ko01100	Metabolic pathways	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMT200025139	K05278	ko00941	Flavonoid biosynthesis	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMT200025139	K05278	ko01100	Metabolic pathways	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMT200025139	K05278	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMT200025142	K01955	ko00240	Pyrimidine metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMT200025142	K01955	ko00250	Alanine, aspartate and glutamate metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMT200025142	K01955	ko01100	Metabolic pathways	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMT200025148	K05278	ko00941	Flavonoid biosynthesis	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMT200025148	K05278	ko01100	Metabolic pathways	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMT200025148	K05278	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMT200025150	K05278	ko00941	Flavonoid biosynthesis	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMT200025150	K05278	ko01100	Metabolic pathways	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMT200025150	K05278	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMT200015349	K08332	ko04140	Regulation of autophagy	388	1.6e-13	0.30	0.51	0.49
PGSC0003DMT200015363	K12200	ko04144	Endocytosis	5739	0.	0.75	0.86	1.00
PGSC0003DMT200015364	K12200	ko04144	Endocytosis	5413	1.0e-292	0.75	0.85	1.00
PGSC0003DMT200015365	K02133	ko00190	Oxidative phosphorylation	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMT200015365	K02133	ko01100	Metabolic pathways	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMT200015365	K02133	ko05010	Alzheimer's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMT200015365	K02133	ko05012	Parkinson's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMT200015365	K02133	ko05016	Huntington's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMT200015367	K08730	ko00564	Glycerophospholipid metabolism	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMT200015367	K08730	ko01100	Metabolic pathways	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMT200015371	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.21
PGSC0003DMT200015373	K12135	ko04712	Circadian rhythm - plant	296	1.9e-10	0.45	0.62	0.17
PGSC0003DMT200015374	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.27
PGSC0003DMT200085117	K07374	ko04145	Phagosome	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMT200085117	K07374	ko04540	Gap junction	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMT200085117	K07374	ko05130	Pathogenic Escherichia coli infection	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMT200050082	K00100	ko00051	Fructose and mannose metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050082	K00100	ko00363	Bisphenol A degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050082	K00100	ko00591	Linoleic acid metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050082	K00100	ko00625	Tetrachloroethene degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050082	K00100	ko00650	Butanoate metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050082	K00100	ko01100	Metabolic pathways	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMT200050083	K00100	ko00051	Fructose and mannose metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050083	K00100	ko00363	Bisphenol A degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050083	K00100	ko00591	Linoleic acid metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050083	K00100	ko00625	Tetrachloroethene degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050083	K00100	ko00650	Butanoate metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050083	K00100	ko01100	Metabolic pathways	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMT200050084	K00100	ko00051	Fructose and mannose metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050084	K00100	ko00363	Bisphenol A degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050084	K00100	ko00591	Linoleic acid metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050084	K00100	ko00625	Tetrachloroethene degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050084	K00100	ko00650	Butanoate metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050084	K00100	ko01100	Metabolic pathways	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMT200050085	K00100	ko00051	Fructose and mannose metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050085	K00100	ko00363	Bisphenol A degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050085	K00100	ko00591	Linoleic acid metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050085	K00100	ko00625	Tetrachloroethene degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050085	K00100	ko00650	Butanoate metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050085	K00100	ko01100	Metabolic pathways	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMT200050086	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050086	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050086	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050086	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050086	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050086	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMT200050087	K00100	ko00051	Fructose and mannose metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050087	K00100	ko00363	Bisphenol A degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050087	K00100	ko00591	Linoleic acid metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050087	K00100	ko00625	Tetrachloroethene degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050087	K00100	ko00650	Butanoate metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050087	K00100	ko01100	Metabolic pathways	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMT200050088	K00100	ko00051	Fructose and mannose metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050088	K00100	ko00363	Bisphenol A degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050088	K00100	ko00591	Linoleic acid metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050088	K00100	ko00625	Tetrachloroethene degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050088	K00100	ko00650	Butanoate metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050088	K00100	ko01100	Metabolic pathways	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko00051	Fructose and mannose metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko00363	Bisphenol A degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko00591	Linoleic acid metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko00625	Tetrachloroethene degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko00650	Butanoate metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050089	K00100	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMT200050090	K00100	ko00051	Fructose and mannose metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050090	K00100	ko00363	Bisphenol A degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050090	K00100	ko00591	Linoleic acid metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050090	K00100	ko00625	Tetrachloroethene degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050090	K00100	ko00650	Butanoate metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050090	K00100	ko01100	Metabolic pathways	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMT200050093	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050093	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050093	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050093	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050094	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050094	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050094	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050094	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMT200050096	K04371	ko04010	MAPK signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04012	ErbB signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04013	MAPK signaling pathway - fly	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04062	Chemokine signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04114	Oocyte meiosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04150	mTOR signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04270	Vascular smooth muscle contraction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04320	Dorso-ventral axis formation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04350	TGF-beta signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04360	Axon guidance	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04370	VEGF signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04510	Focal adhesion	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04520	Adherens junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04540	Gap junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04620	Toll-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04621	NOD-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04650	Natural killer cell mediated cytotoxicity	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04660	T cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04662	B cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04664	Fc epsilon RI signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04666	Fc gamma R-mediated phagocytosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04720	Long-term potentiation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04722	Neurotrophin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04730	Long-term depression	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04810	Regulation of actin cytoskeleton	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04910	Insulin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04912	GnRH signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04914	Progesterone-mediated oocyte maturation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04916	Melanogenesis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04930	Type II diabetes mellitus	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko04960	Aldosterone-regulated sodium reabsorption	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05010	Alzheimer's disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05020	Prion diseases	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05131	Shigellosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05140	Leishmaniasis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05142	Chagas disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05200	Pathways in cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05210	Colorectal cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05211	Renal cell carcinoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05212	Pancreatic cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05213	Endometrial cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05214	Glioma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05215	Prostate cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05216	Thyroid cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05218	Melanoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05219	Bladder cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05220	Chronic myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05221	Acute myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050096	K04371	ko05223	Non-small cell lung cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMT200050097	K03116	ko03060	Protein export	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMT200050097	K03116	ko03070	Bacterial secretion system	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMT200050099	K03116	ko03060	Protein export	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMT200050099	K03116	ko03070	Bacterial secretion system	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMT200050105	K08803	ko05200	Pathways in cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMT200050105	K08803	ko05219	Bladder cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMT200050113	K09553	ko05020	Prion diseases	313	3.4e-11	0.40	0.52	0.39
PGSC0003DMT200050119	K08769	ko03320	PPAR signaling pathway	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMT200050119	K08769	ko05016	Huntington's disease	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMT200068011	K01889	ko00970	Aminoacyl-tRNA biosynthesis	425	3.7e-26	0.85	0.95	0.83
PGSC0003DMT200068027	K00029	ko00620	Pyruvate metabolism	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMT200068027	K00029	ko00710	Carbon fixation in photosynthetic organisms	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMT200068027	K00029	ko01100	Metabolic pathways	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMT200058535	K03952	ko00190	Oxidative phosphorylation	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMT200058535	K03952	ko01100	Metabolic pathways	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMT200058535	K03952	ko05010	Alzheimer's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMT200058535	K03952	ko05012	Parkinson's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMT200058535	K03952	ko05016	Huntington's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMT200058536	K03952	ko00190	Oxidative phosphorylation	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMT200058536	K03952	ko01100	Metabolic pathways	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMT200058536	K03952	ko05010	Alzheimer's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMT200058536	K03952	ko05012	Parkinson's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMT200058536	K03952	ko05016	Huntington's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMT200058543	K00818	ko00330	Arginine and proline metabolism	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMT200058543	K00818	ko01100	Metabolic pathways	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMT200058543	K00818	ko01110	Biosynthesis of secondary metabolites	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMT200058544	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMT200058544	K00517	ko00626	Naphthalene and anthracene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMT200058544	K00517	ko00903	Limonene and pinene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMT200058544	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMT200058544	K00517	ko01110	Biosynthesis of secondary metabolites	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMT200058545	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMT200058545	K00517	ko00626	Naphthalene and anthracene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMT200058545	K00517	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMT200058545	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMT200058545	K00517	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMT200058546	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMT200058546	K00517	ko00626	Naphthalene and anthracene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMT200058546	K00517	ko00903	Limonene and pinene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMT200058546	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMT200058546	K00517	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMT200058554	K05277	ko00941	Flavonoid biosynthesis	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMT200058554	K05277	ko01100	Metabolic pathways	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMT200058554	K05277	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMT200058561	K01641	ko00072	Synthesis and degradation of ketone bodies	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058561	K01641	ko00280	Valine, leucine and isoleucine degradation	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058561	K01641	ko00650	Butanoate metabolism	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058561	K01641	ko00900	Terpenoid backbone biosynthesis	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058561	K01641	ko01100	Metabolic pathways	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058561	K01641	ko01110	Biosynthesis of secondary metabolites	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMT200058564	K01641	ko00072	Synthesis and degradation of ketone bodies	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058564	K01641	ko00280	Valine, leucine and isoleucine degradation	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058564	K01641	ko00650	Butanoate metabolism	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058564	K01641	ko00900	Terpenoid backbone biosynthesis	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058564	K01641	ko01100	Metabolic pathways	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058564	K01641	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMT200058566	K08248	ko00460	Cyanoamino acid metabolism	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMT200058566	K08248	ko01100	Metabolic pathways	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMT200058568	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMT200058569	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMT200058570	K12307	ko04142	Lysosome	360	3.4e-12	0.24	0.45	0.61
PGSC0003DMT200058571	K12307	ko04142	Lysosome	358	4.9e-12	0.24	0.45	0.61
PGSC0003DMT200058572	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMT200058575	K03006	ko00230	Purine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMT200058575	K03006	ko00240	Pyrimidine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMT200058575	K03006	ko01100	Metabolic pathways	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMT200058575	K03006	ko03020	RNA polymerase	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMT200058575	K03006	ko05016	Huntington's disease	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMT200089407	K05280	ko00941	Flavonoid biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMT200089407	K05280	ko00944	Flavone and flavonol biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMT200089407	K05280	ko01100	Metabolic pathways	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMT200089407	K05280	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMT200089418	K12356	ko00940	Phenylpropanoid biosynthesis	637	2.7e-29	0.29	0.48	0.94
PGSC0003DMT200089434	K00801	ko00100	Steroid biosynthesis	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMT200089434	K00801	ko01100	Metabolic pathways	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMT200089434	K00801	ko01110	Biosynthesis of secondary metabolites	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMT200009701	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMT200009701	K01061	ko00364	Fluorobenzoate degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMT200009701	K01061	ko00627	1,4-Dichlorobenzene degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMT200009701	K01061	ko01100	Metabolic pathways	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMT200017463	K09753	ko00940	Phenylpropanoid biosynthesis	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMT200017463	K09753	ko01100	Metabolic pathways	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMT200017463	K09753	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMT200017464	K09753	ko00940	Phenylpropanoid biosynthesis	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMT200017464	K09753	ko01100	Metabolic pathways	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMT200017464	K09753	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMT200017465	K09753	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMT200017465	K09753	ko01100	Metabolic pathways	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMT200017465	K09753	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMT200017467	K09753	ko00940	Phenylpropanoid biosynthesis	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMT200017467	K09753	ko01100	Metabolic pathways	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMT200017467	K09753	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMT200017468	K09753	ko00940	Phenylpropanoid biosynthesis	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMT200017468	K09753	ko01100	Metabolic pathways	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMT200017468	K09753	ko01110	Biosynthesis of secondary metabolites	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMT200017471	K01205	ko00531	Glycosaminoglycan degradation	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMT200017471	K01205	ko01100	Metabolic pathways	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMT200017471	K01205	ko04142	Lysosome	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMT200017472	K01205	ko00531	Glycosaminoglycan degradation	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMT200017472	K01205	ko01100	Metabolic pathways	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMT200017472	K01205	ko04142	Lysosome	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMT200017473	K01205	ko00531	Glycosaminoglycan degradation	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMT200017473	K01205	ko01100	Metabolic pathways	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMT200017473	K01205	ko04142	Lysosome	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMT200017475	K01205	ko00531	Glycosaminoglycan degradation	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMT200017475	K01205	ko01100	Metabolic pathways	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMT200017475	K01205	ko04142	Lysosome	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMT200017479	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	301	1.3e-10	0.40	0.63	0.34
PGSC0003DMT200017480	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	437	2.9e-18	0.45	0.69	0.52
PGSC0003DMT200056408	K00948	ko00030	Pentose phosphate pathway	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMT200056408	K00948	ko00230	Purine metabolism	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMT200056408	K00948	ko01100	Metabolic pathways	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMT200056408	K00948	ko01110	Biosynthesis of secondary metabolites	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMT200056411	K00948	ko00030	Pentose phosphate pathway	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMT200056411	K00948	ko00230	Purine metabolism	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMT200056411	K00948	ko01100	Metabolic pathways	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMT200056411	K00948	ko01110	Biosynthesis of secondary metabolites	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMT200056412	K00948	ko00030	Pentose phosphate pathway	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMT200056412	K00948	ko00230	Purine metabolism	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMT200056412	K00948	ko01100	Metabolic pathways	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMT200056412	K00948	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMT200056413	K05665	ko02010	ABC transporters	2752	5.9e-146	0.31	0.50	0.93
PGSC0003DMT200056433	K02291	ko00906	Carotenoid biosynthesis	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMT200056433	K02291	ko01100	Metabolic pathways	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMT200056433	K02291	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMT200056438	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.98
PGSC0003DMT200056441	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.83
PGSC0003DMT200056449	K05768	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMT200056449	K05768	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMT200056450	K05768	ko04666	Fc gamma R-mediated phagocytosis	5694	0.	0.67	0.83	1.00
PGSC0003DMT200056450	K05768	ko04810	Regulation of actin cytoskeleton	5694	0.	0.67	0.83	1.00
PGSC0003DMT200064116	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMT200064117	K02925	ko03010	Ribosome	2597	2.1e-137	0.91	0.98	0.94
PGSC0003DMT200064119	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMT200079356	K05894	ko00592	alpha-Linolenic acid metabolism	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMT200079356	K05894	ko01100	Metabolic pathways	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMT200079357	K06611	ko00052	Galactose metabolism	2157	3.9e-113	0.39	0.57	0.86
PGSC0003DMT200079358	K06611	ko00052	Galactose metabolism	273	1.5e-08	0.30	0.47	0.87
PGSC0003DMT200079359	K02183	ko04020	Calcium signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04070	Phosphatidylinositol signaling system	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04114	Oocyte meiosis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04270	Vascular smooth muscle contraction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04626	Plant-pathogen interaction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04720	Long-term potentiation	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04722	Neurotrophin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04740	Olfactory transduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04744	Phototransduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04745	Phototransduction - fly	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04910	Insulin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04912	GnRH signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04916	Melanogenesis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04970	Salivary secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko04971	Gastric acid secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko05010	Alzheimer's disease	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079359	K02183	ko05214	Glioma	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMT200079376	K00737	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMT200079376	K00737	ko01100	Metabolic pathways	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMT200019274	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019274	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019275	K07203	ko04012	ErbB signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko04150	mTOR signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko04910	Insulin signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko04920	Adipocytokine signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko04930	Type II diabetes mellitus	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko05200	Pathways in cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko05214	Glioma	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko05215	Prostate cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019275	K07203	ko05221	Acute myeloid leukemia	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMT200019277	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019277	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019278	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019279	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019280	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMT200019281	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019281	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019282	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMT200019283	K07203	ko04012	ErbB signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko04150	mTOR signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko04910	Insulin signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko04920	Adipocytokine signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko04930	Type II diabetes mellitus	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko05200	Pathways in cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko05214	Glioma	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko05215	Prostate cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019283	K07203	ko05221	Acute myeloid leukemia	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMT200019284	K07203	ko04012	ErbB signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko04150	mTOR signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko04910	Insulin signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko04920	Adipocytokine signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko04930	Type II diabetes mellitus	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko05200	Pathways in cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko05214	Glioma	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko05215	Prostate cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019284	K07203	ko05221	Acute myeloid leukemia	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMT200019290	K00558	ko00270	Cysteine and methionine metabolism	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMT200019290	K00558	ko01100	Metabolic pathways	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMT200019291	K02183	ko04020	Calcium signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04070	Phosphatidylinositol signaling system	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04114	Oocyte meiosis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04270	Vascular smooth muscle contraction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04626	Plant-pathogen interaction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04720	Long-term potentiation	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04722	Neurotrophin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04740	Olfactory transduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04744	Phototransduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04745	Phototransduction - fly	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04910	Insulin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04912	GnRH signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04916	Melanogenesis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04970	Salivary secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko04971	Gastric acid secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko05010	Alzheimer's disease	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200019291	K02183	ko05214	Glioma	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMT200011429	K01054	ko00561	Glycerolipid metabolism	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMT200011429	K01054	ko01100	Metabolic pathways	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMT200011430	K01054	ko00561	Glycerolipid metabolism	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMT200011430	K01054	ko01100	Metabolic pathways	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMT200011443	K05768	ko04666	Fc gamma R-mediated phagocytosis	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMT200011443	K05768	ko04810	Regulation of actin cytoskeleton	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMT200011456	K01190	ko00052	Galactose metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMT200011456	K01190	ko00511	Other glycan degradation	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMT200011456	K01190	ko00600	Sphingolipid metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMT200011456	K01190	ko01100	Metabolic pathways	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMT200011458	K01190	ko00052	Galactose metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMT200011458	K01190	ko00511	Other glycan degradation	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMT200011458	K01190	ko00600	Sphingolipid metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMT200011458	K01190	ko01100	Metabolic pathways	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMT200011466	K12356	ko00940	Phenylpropanoid biosynthesis	2032	3.1e-106	0.54	0.72	0.99
PGSC0003DMT200011467	K12356	ko00940	Phenylpropanoid biosynthesis	2029	4.5e-106	0.53	0.73	0.99
PGSC0003DMT200011469	K12356	ko00940	Phenylpropanoid biosynthesis	1927	1.9e-100	0.53	0.73	0.97
PGSC0003DMT200011470	K03006	ko00230	Purine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMT200011470	K03006	ko00240	Pyrimidine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMT200011470	K03006	ko01100	Metabolic pathways	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMT200011470	K03006	ko03020	RNA polymerase	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMT200011470	K03006	ko05016	Huntington's disease	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMT200011481	K07203	ko04012	ErbB signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko04150	mTOR signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko04910	Insulin signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko04920	Adipocytokine signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko04930	Type II diabetes mellitus	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko05200	Pathways in cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko05214	Glioma	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko05215	Prostate cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200011481	K07203	ko05221	Acute myeloid leukemia	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMT200034979	K00981	ko00564	Glycerophospholipid metabolism	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMT200034979	K00981	ko01100	Metabolic pathways	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMT200034979	K00981	ko04070	Phosphatidylinositol signaling system	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMT200034994	K10594	ko04120	Ubiquitin mediated proteolysis	793	2.8e-36	0.31	0.49	0.62
PGSC0003DMT200035000	K12741	ko03040	Spliceosome	2738	3.5e-145	0.69	0.79	1.00
PGSC0003DMT200035003	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMT200035003	K01703	ko00660	C5-Branched dibasic acid metabolism	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMT200035003	K01703	ko01100	Metabolic pathways	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMT200035003	K01703	ko01110	Biosynthesis of secondary metabolites	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMT200035005	K08912	ko00196	Photosynthesis - antenna proteins	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMT200035005	K08912	ko01100	Metabolic pathways	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMT200035006	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200035006	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200035007	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200035007	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMT200090609	K03094	ko04110	Cell cycle	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04111	Cell cycle - yeast	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04114	Oocyte meiosis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04310	Wnt signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04350	TGF-beta signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200090609	K03094	ko04710	Circadian rhythm - mammal	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMT200003956	K11420	ko00310	Lysine degradation	490	3.4e-21	0.32	0.47	0.38
PGSC0003DMT200003959	K01091	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMT200003959	K01091	ko01100	Metabolic pathways	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMT200003983	K10802	ko03410	Base excision repair	837	2.5e-40	0.69	0.79	0.99
PGSC0003DMT200003986	K03781	ko00380	Tryptophan metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMT200003986	K03781	ko00680	Methane metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMT200003986	K03781	ko01100	Metabolic pathways	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMT200003986	K03781	ko04146	Peroxisome	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMT200003986	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMT200003989	K06267	ko04512	ECM-receptor interaction	594	5.6e-25	0.26	0.49	0.88
PGSC0003DMT200003990	K00640	ko00270	Cysteine and methionine metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMT200003990	K00640	ko00920	Sulfur metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMT200003990	K00640	ko01100	Metabolic pathways	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMT200003991	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMT200003991	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMT200003991	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMT200062376	K01852	ko00100	Steroid biosynthesis	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMT200062376	K01852	ko01100	Metabolic pathways	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMT200062376	K01852	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMT200062382	K01593	ko00340	Histidine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00350	Tyrosine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00360	Phenylalanine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00380	Tryptophan metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00901	Indole alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko00965	Betalain biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko01100	Metabolic pathways	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062382	K01593	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMT200062390	K00679	ko00561	Glycerolipid metabolism	413	6.1e-17	0.34	0.48	0.48
PGSC0003DMT200062391	K00679	ko00561	Glycerolipid metabolism	293	6.6e-10	0.36	0.52	0.79
PGSC0003DMT200062393	K00679	ko00561	Glycerolipid metabolism	531	1.9e-23	0.29	0.43	0.75
PGSC0003DMT200062394	K00679	ko00561	Glycerolipid metabolism	516	1.3e-22	0.30	0.46	0.88
PGSC0003DMT200062402	K00430	ko00360	Phenylalanine metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMT200062402	K00430	ko00680	Methane metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMT200062402	K00430	ko00940	Phenylpropanoid biosynthesis	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMT200062402	K00430	ko01100	Metabolic pathways	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMT200062402	K00430	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMT200062403	K00430	ko00360	Phenylalanine metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMT200062403	K00430	ko00680	Methane metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMT200062403	K00430	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMT200062403	K00430	ko01100	Metabolic pathways	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMT200062403	K00430	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMT200062415	K13065	ko00940	Phenylpropanoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMT200062415	K13065	ko00941	Flavonoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMT200062415	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMT200062415	K13065	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMT200062419	K12462	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMT200062419	K12462	ko04962	Vasopressin-regulated water reabsorption	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMT200062425	K00119	ko00362	Benzoate degradation via hydroxylation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMT200062425	K00119	ko00440	Phosphonate and phosphinate metabolism	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMT200062425	K00119	ko00903	Limonene and pinene degradation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMT200062425	K00119	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMT200054637	K01955	ko00240	Pyrimidine metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMT200054637	K01955	ko00250	Alanine, aspartate and glutamate metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMT200054637	K01955	ko01100	Metabolic pathways	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMT200039514	K09587	ko00905	Brassinosteroid biosynthesis	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMT200039514	K09587	ko01100	Metabolic pathways	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMT200039514	K09587	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMT200039534	K03126	ko03022	Basal transcription factors	395	1.1e-14	0.30	0.41	0.16
PGSC0003DMT200039552	K05573	ko00190	Oxidative phosphorylation	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMT200039552	K05573	ko01100	Metabolic pathways	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMT200005457	K00287	ko00670	One carbon pool by folate	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMT200005457	K00287	ko00790	Folate biosynthesis	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMT200005457	K00287	ko01100	Metabolic pathways	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMT200005458	K00287	ko00670	One carbon pool by folate	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMT200005458	K00287	ko00790	Folate biosynthesis	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMT200005458	K00287	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMT200005459	K00287	ko00670	One carbon pool by folate	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMT200005459	K00287	ko00790	Folate biosynthesis	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMT200005459	K00287	ko01100	Metabolic pathways	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMT200005461	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMT200005461	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMT200005461	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMT200013603	K05746	ko04810	Regulation of actin cytoskeleton	224	9.0e-06	0.40	0.55	0.34
PGSC0003DMT200013613	K01509	ko00230	Purine metabolism	724	1.6e-61	0.41	0.61	0.82
PGSC0003DMT200013622	K02939	ko03010	Ribosome	716	1.2e-33	0.51	0.64	0.96
PGSC0003DMT200013623	K02939	ko03010	Ribosome	1023	1.4e-50	0.58	0.72	1.00
PGSC0003DMT200013624	K12135	ko04712	Circadian rhythm - plant	263	1.1e-08	0.37	0.52	0.24
PGSC0003DMT200013645	K10609	ko03420	Nucleotide excision repair	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMT200013645	K10609	ko04120	Ubiquitin mediated proteolysis	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMT200013646	K08852	ko05010	Alzheimer's disease	244	3.7e-06	0.40	0.55	0.24
PGSC0003DMT200023372	K01897	ko00071	Fatty acid metabolism	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMT200023372	K01897	ko01100	Metabolic pathways	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMT200023372	K01897	ko03320	PPAR signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMT200023372	K01897	ko04146	Peroxisome	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMT200023372	K01897	ko04920	Adipocytokine signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMT200023373	K01897	ko00071	Fatty acid metabolism	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMT200023373	K01897	ko01100	Metabolic pathways	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMT200023373	K01897	ko03320	PPAR signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMT200023373	K01897	ko04146	Peroxisome	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMT200023373	K01897	ko04920	Adipocytokine signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMT200023374	K01897	ko00071	Fatty acid metabolism	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMT200023374	K01897	ko01100	Metabolic pathways	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMT200023374	K01897	ko03320	PPAR signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMT200023374	K01897	ko04146	Peroxisome	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMT200023374	K01897	ko04920	Adipocytokine signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMT200023394	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMT200023394	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMT200023394	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMT200023395	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMT200023395	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMT200023395	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMT200023396	K00619	ko00330	Arginine and proline metabolism	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMT200023396	K00619	ko01100	Metabolic pathways	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMT200023396	K00619	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMT200023397	K00619	ko00330	Arginine and proline metabolism	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMT200023397	K00619	ko01100	Metabolic pathways	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMT200023397	K00619	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMT200023398	K00619	ko00330	Arginine and proline metabolism	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMT200023398	K00619	ko01100	Metabolic pathways	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMT200023398	K00619	ko01110	Biosynthesis of secondary metabolites	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMT200023399	K00619	ko00330	Arginine and proline metabolism	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMT200023399	K00619	ko01100	Metabolic pathways	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMT200023399	K00619	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMT200023405	K02898	ko03010	Ribosome	1137	7.1e-57	0.90	0.99	0.99
PGSC0003DMT200023406	K12867	ko03040	Spliceosome	532	4.0e-23	0.64	0.75	0.96
PGSC0003DMT200023411	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMT200023411	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMT200023411	K00734	ko01100	Metabolic pathways	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMT200091422	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.45	0.63	0.89
PGSC0003DMT200091436	K01148	ko03018	RNA degradation	378	5.2e-15	0.50	0.66	0.59
PGSC0003DMT200051980	K12126	ko04712	Circadian rhythm - plant	308	3.2e-09	0.28	0.50	0.51
PGSC0003DMT200051981	K09561	ko04120	Ubiquitin mediated proteolysis	388	1.4e-15	0.77	0.89	0.67
PGSC0003DMT200051983	K09561	ko04120	Ubiquitin mediated proteolysis	1780	2.4e-92	0.77	0.86	0.98
PGSC0003DMT200051986	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMT200051987	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	487	5.0e-21	0.88	0.90	0.99
PGSC0003DMT200051988	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMT200047811	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMT200047811	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMT200047811	K10158	ko01100	Metabolic pathways	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMT200047812	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMT200047812	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMT200047812	K10157	ko01100	Metabolic pathways	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMT200047819	K00826	ko00280	Valine, leucine and isoleucine degradation	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMT200047819	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMT200047819	K00826	ko00770	Pantothenate and CoA biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMT200047819	K00826	ko01100	Metabolic pathways	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMT200047819	K00826	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMT200047820	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047820	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047820	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047820	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047820	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047821	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047821	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047821	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047821	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047821	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMT200047822	K00826	ko00280	Valine, leucine and isoleucine degradation	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMT200047822	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMT200047822	K00826	ko00770	Pantothenate and CoA biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMT200047822	K00826	ko01100	Metabolic pathways	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMT200047822	K00826	ko01110	Biosynthesis of secondary metabolites	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMT200047823	K00826	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMT200047823	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMT200047823	K00826	ko00770	Pantothenate and CoA biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMT200047823	K00826	ko01100	Metabolic pathways	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMT200047823	K00826	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMT200047824	K00826	ko00280	Valine, leucine and isoleucine degradation	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMT200047824	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMT200047824	K00826	ko00770	Pantothenate and CoA biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMT200047824	K00826	ko01100	Metabolic pathways	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMT200047824	K00826	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMT200047834	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200047834	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200047835	K00079	ko00590	Arachidonic acid metabolism	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMT200047835	K00079	ko01100	Metabolic pathways	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMT200047836	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200047836	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200047837	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200047837	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMT200060352	K00423	ko00053	Ascorbate and aldarate metabolism	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMT200060352	K00423	ko01100	Metabolic pathways	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMT200060353	K02923	ko03010	Ribosome	524	4.6e-23	0.90	0.97	0.22
PGSC0003DMT200060354	K02923	ko03010	Ribosome	491	3.0e-21	0.91	0.97	0.84
PGSC0003DMT200060369	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMT200060369	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMT200060369	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMT200060369	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMT200060370	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.63	0.80	0.46
PGSC0003DMT200060372	K01728	ko00040	Pentose and glucuronate interconversions	1752	8.5e-91	0.64	0.80	0.93
PGSC0003DMT200060373	K01728	ko00040	Pentose and glucuronate interconversions	1274	2.0e-64	0.60	0.78	0.88
PGSC0003DMT200060374	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.60	0.76	0.81
PGSC0003DMT200069770	K13030	ko00460	Cyanoamino acid metabolism	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMT200069770	K13030	ko01110	Biosynthesis of secondary metabolites	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMT200069771	K13030	ko00460	Cyanoamino acid metabolism	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMT200069771	K13030	ko01110	Biosynthesis of secondary metabolites	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMT200069772	K12356	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.38	0.57	0.94
PGSC0003DMT200069773	K13030	ko00460	Cyanoamino acid metabolism	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMT200069773	K13030	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMT200069775	K12356	ko00940	Phenylpropanoid biosynthesis	464	9.3e-20	0.39	0.55	0.97
PGSC0003DMT200084757	K01834	ko00010	Glycolysis / Gluconeogenesis	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMT200084757	K01834	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMT200084757	K01834	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMT200076109	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMT200076109	K03434	ko01100	Metabolic pathways	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMT200076112	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.36	0.56	0.67
PGSC0003DMT200076123	K01509	ko00230	Purine metabolism	3627	3.3e-194	0.38	0.56	1.00
PGSC0003DMT200076125	K01509	ko00230	Purine metabolism	300	1.7e-09	0.52	0.68	0.57
PGSC0003DMT200067682	K11820	ko00380	Tryptophan metabolism	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMT200067682	K11820	ko00966	Glucosinolate biosynthesis	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMT200067682	K11820	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMT200067683	K11820	ko00380	Tryptophan metabolism	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMT200067683	K11820	ko00966	Glucosinolate biosynthesis	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMT200067683	K11820	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMT200067684	K11820	ko00380	Tryptophan metabolism	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMT200067684	K11820	ko00966	Glucosinolate biosynthesis	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMT200067684	K11820	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMT200067686	K04733	ko04210	Apoptosis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMT200067686	K04733	ko04620	Toll-like receptor signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMT200067686	K04733	ko04722	Neurotrophin signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMT200067686	K04733	ko05140	Leishmaniasis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMT200067686	K04733	ko05142	Chagas disease	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMT200067687	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067687	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067687	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067687	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067687	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067688	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067688	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067688	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067688	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067688	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMT200067694	K12857	ko03040	Spliceosome	2641	7.9e-140	0.88	0.94	1.00
PGSC0003DMT200067695	K13035	ko00460	Cyanoamino acid metabolism	2637	1.3e-139	0.87	0.93	1.00
PGSC0003DMT200067716	K12251	ko00330	Arginine and proline metabolism	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMT200067716	K12251	ko01100	Metabolic pathways	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMT200058049	K11424	ko00310	Lysine degradation	328	1.3e-08	0.44	0.53	0.12
PGSC0003DMT200058061	K00430	ko00360	Phenylalanine metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMT200058061	K00430	ko00680	Methane metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMT200058061	K00430	ko00940	Phenylpropanoid biosynthesis	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMT200058061	K00430	ko01100	Metabolic pathways	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMT200058061	K00430	ko01110	Biosynthesis of secondary metabolites	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMT200058084	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMT200058084	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMT200096923	K12356	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.31	0.45	0.97
PGSC0003DMT200096927	K05282	ko00904	Diterpenoid biosynthesis	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMT200096927	K05282	ko01100	Metabolic pathways	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMT200096927	K05282	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMT200092860	K05282	ko00904	Diterpenoid biosynthesis	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMT200092860	K05282	ko01100	Metabolic pathways	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMT200092860	K05282	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMT200002365	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.81
PGSC0003DMT200002366	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.79
PGSC0003DMT200002367	K12585	ko03018	RNA degradation	1536	1.9e-81	0.35	0.51	0.75
PGSC0003DMT200002372	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002372	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002372	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002373	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002373	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002373	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMT200002381	K05366	ko00550	Peptidoglycan biosynthesis	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMT200002381	K05366	ko01100	Metabolic pathways	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMT200002382	K05366	ko00550	Peptidoglycan biosynthesis	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMT200002382	K05366	ko01100	Metabolic pathways	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMT200002385	K05366	ko00550	Peptidoglycan biosynthesis	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMT200002385	K05366	ko01100	Metabolic pathways	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMT200002389	K03217	ko03060	Protein export	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMT200002389	K03217	ko03070	Bacterial secretion system	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMT200002392	K03217	ko03060	Protein export	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMT200002392	K03217	ko03070	Bacterial secretion system	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMT200033430	K03531	ko04112	Cell cycle - Caulobacter	1193	5.8e-60	0.75	0.83	0.92
PGSC0003DMT200033431	K03531	ko04112	Cell cycle - Caulobacter	2656	1.2e-140	0.79	0.86	1.00
PGSC0003DMT200033439	K00278	ko00250	Alanine, aspartate and glutamate metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMT200033439	K00278	ko00760	Nicotinate and nicotinamide metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMT200033439	K00278	ko01100	Metabolic pathways	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMT200033440	K00278	ko00250	Alanine, aspartate and glutamate metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMT200033440	K00278	ko00760	Nicotinate and nicotinamide metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMT200033440	K00278	ko01100	Metabolic pathways	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMT200033441	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033441	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033441	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033442	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033442	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033442	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033443	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033443	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033443	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMT200033445	K08241	ko00592	alpha-Linolenic acid metabolism	799	3.1e-38	0.36	0.52	0.96
PGSC0003DMT200033461	K01126	ko00564	Glycerophospholipid metabolism	224	1.6e-06	0.38	0.50	0.42
PGSC0003DMT200033463	K01126	ko00564	Glycerophospholipid metabolism	448	1.3e-18	0.31	0.47	0.79
PGSC0003DMT200033466	K08503	ko04130	SNARE interactions in vesicular transport	943	3.5e-46	0.62	0.76	0.72
PGSC0003DMT200033467	K08503	ko04130	SNARE interactions in vesicular transport	1190	8.4e-60	0.63	0.82	1.00
PGSC0003DMT200014828	K00940	ko00230	Purine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMT200014828	K00940	ko00240	Pyrimidine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMT200014828	K00940	ko01100	Metabolic pathways	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMT200014828	K00940	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMT200014829	K00940	ko00230	Purine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMT200014829	K00940	ko00240	Pyrimidine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMT200014829	K00940	ko01100	Metabolic pathways	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMT200014829	K00940	ko01110	Biosynthesis of secondary metabolites	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMT200062257	K00558	ko00270	Cysteine and methionine metabolism	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMT200062257	K00558	ko01100	Metabolic pathways	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMT200062260	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	1739	4.4e-90	0.76	0.87	0.95
PGSC0003DMT200062261	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	2578	2.3e-136	0.76	0.87	0.98
PGSC0003DMT200062262	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	3071	1.5e-163	0.76	0.87	1.00
PGSC0003DMT200062264	K00948	ko00030	Pentose phosphate pathway	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMT200062264	K00948	ko00230	Purine metabolism	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMT200062264	K00948	ko01100	Metabolic pathways	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMT200062264	K00948	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMT200062265	K00948	ko00030	Pentose phosphate pathway	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMT200062265	K00948	ko00230	Purine metabolism	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMT200062265	K00948	ko01100	Metabolic pathways	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMT200062265	K00948	ko01110	Biosynthesis of secondary metabolites	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMT200062272	K02084	ko04115	p53 signaling pathway	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko04210	Apoptosis	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko05010	Alzheimer's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko05012	Parkinson's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko05016	Huntington's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062272	K02084	ko05222	Small cell lung cancer	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMT200062273	K00797	ko00270	Cysteine and methionine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMT200062273	K00797	ko00330	Arginine and proline metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMT200062273	K00797	ko00410	beta-Alanine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMT200062273	K00797	ko00480	Glutathione metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMT200062273	K00797	ko01100	Metabolic pathways	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMT200062295	K13065	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMT200062295	K13065	ko00941	Flavonoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMT200062295	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMT200062295	K13065	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMT200056625	K06627	ko04110	Cell cycle	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMT200056625	K06627	ko04914	Progesterone-mediated oocyte maturation	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMT200056635	K02693	ko00195	Photosynthesis	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMT200056635	K02693	ko01100	Metabolic pathways	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMT200056636	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMT200056636	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMT200056636	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMT200056637	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMT200056637	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMT200056637	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMT200056644	K11816	ko00380	Tryptophan metabolism	2608	5.2e-138	0.72	0.86	0.99
PGSC0003DMT200056645	K11816	ko00380	Tryptophan metabolism	999	2.9e-49	0.41	0.51	0.94
PGSC0003DMT200064786	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064786	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064786	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064786	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064786	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064787	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064787	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064787	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064787	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064787	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMT200064817	K01897	ko00071	Fatty acid metabolism	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMT200064817	K01897	ko01100	Metabolic pathways	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMT200064817	K01897	ko03320	PPAR signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMT200064817	K01897	ko04146	Peroxisome	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMT200064817	K01897	ko04920	Adipocytokine signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMT200064818	K01897	ko00071	Fatty acid metabolism	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMT200064818	K01897	ko01100	Metabolic pathways	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMT200064818	K01897	ko03320	PPAR signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMT200064818	K01897	ko04146	Peroxisome	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMT200064818	K01897	ko04920	Adipocytokine signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMT200064819	K01897	ko00071	Fatty acid metabolism	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMT200064819	K01897	ko01100	Metabolic pathways	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMT200064819	K01897	ko03320	PPAR signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMT200064819	K01897	ko04146	Peroxisome	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMT200064819	K01897	ko04920	Adipocytokine signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMT200064820	K01897	ko00071	Fatty acid metabolism	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMT200064820	K01897	ko01100	Metabolic pathways	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMT200064820	K01897	ko03320	PPAR signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMT200064820	K01897	ko04146	Peroxisome	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMT200064820	K01897	ko04920	Adipocytokine signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMT200064821	K01897	ko00071	Fatty acid metabolism	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMT200064821	K01897	ko01100	Metabolic pathways	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMT200064821	K01897	ko03320	PPAR signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMT200064821	K01897	ko04146	Peroxisome	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMT200064821	K01897	ko04920	Adipocytokine signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMT200064823	K01897	ko00071	Fatty acid metabolism	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMT200064823	K01897	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMT200064823	K01897	ko03320	PPAR signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMT200064823	K01897	ko04146	Peroxisome	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMT200064823	K01897	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMT200080403	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMT200080404	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMT200080406	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMT200080410	K06654	ko04111	Cell cycle - yeast	332	1.8e-12	0.35	0.53	0.74
PGSC0003DMT200080445	K06685	ko04111	Cell cycle - yeast	312	4.7e-09	0.31	0.49	0.65
PGSC0003DMT200078832	K01613	ko00564	Glycerophospholipid metabolism	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMT200078832	K01613	ko01100	Metabolic pathways	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMT200078835	K01507	ko00190	Oxidative phosphorylation	5771	0.	0.91	0.95	1.00
PGSC0003DMT200078837	K12586	ko03018	RNA degradation	923	1.4e-44	0.42	0.57	0.86
PGSC0003DMT200088933	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMT200088933	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMT200088950	K10760	ko00908	Zeatin biosynthesis	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMT200088950	K10760	ko01100	Metabolic pathways	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMT200088950	K10760	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMT200037886	K13068	ko00940	Phenylpropanoid biosynthesis	1919	5.2e-100	0.51	0.69	0.94
PGSC0003DMT200037893	K12235	ko00260	Glycine, serine and threonine metabolism	1973	5.5e-103	0.72	0.84	0.99
PGSC0003DMT200037896	K12235	ko00260	Glycine, serine and threonine metabolism	340	6.4e-13	0.67	0.80	0.95
PGSC0003DMT200037903	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMT200037903	K01649	ko00620	Pyruvate metabolism	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMT200037903	K01649	ko01100	Metabolic pathways	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMT200037903	K01649	ko01110	Biosynthesis of secondary metabolites	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMT200037908	K02358	ko04626	Plant-pathogen interaction	2244	6.2e-118	0.88	0.92	0.94
PGSC0003DMT200037909	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMT200037910	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMT200037918	K00799	ko00480	Glutathione metabolism	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMT200037918	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMT200037918	K00799	ko00982	Drug metabolism - cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMT200009869	K01728	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.65	0.77	0.83
PGSC0003DMT200009873	K12826	ko03040	Spliceosome	2641	7.9e-140	0.84	0.89	1.00
PGSC0003DMT200018139	K08770	ko03320	PPAR signaling pathway	289	8.8e-10	0.30	0.51	0.37
PGSC0003DMT200018162	K02926	ko03010	Ribosome	1383	1.9e-70	0.73	0.84	0.66
PGSC0003DMT200018175	K12831	ko03040	Spliceosome	247	9.6e-08	0.43	0.54	0.39
PGSC0003DMT200063113	K08509	ko04130	SNARE interactions in vesicular transport	1532	1.2e-78	0.63	0.77	1.00
PGSC0003DMT200063116	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.65
PGSC0003DMT200063117	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.61
PGSC0003DMT200063123	K00485	ko00982	Drug metabolism - cytochrome P450	1382	2.2e-70	0.53	0.70	0.97
PGSC0003DMT200063124	K00485	ko00982	Drug metabolism - cytochrome P450	1611	5.1e-83	0.52	0.69	0.96
PGSC0003DMT200063125	K00485	ko00982	Drug metabolism - cytochrome P450	1737	5.7e-90	0.50	0.67	0.95
PGSC0003DMT200063126	K00485	ko00982	Drug metabolism - cytochrome P450	688	4.1e-32	0.50	0.65	0.92
PGSC0003DMT200063129	K01956	ko00240	Pyrimidine metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMT200063129	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMT200063129	K01956	ko01100	Metabolic pathways	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMT200063140	K02184	ko04320	Dorso-ventral axis formation	1938	4.7e-101	0.31	0.44	0.76
PGSC0003DMT200063141	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMT200063143	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMT200063145	K02184	ko04320	Dorso-ventral axis formation	1912	1.3e-99	0.31	0.44	0.76
PGSC0003DMT200063146	K02184	ko04320	Dorso-ventral axis formation	1928	1.7e-100	0.31	0.44	0.76
PGSC0003DMT200063147	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMT200063148	K02184	ko04320	Dorso-ventral axis formation	1922	3.6e-100	0.31	0.44	0.76
PGSC0003DMT200063149	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMT200063151	K07198	ko04140	Regulation of autophagy	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMT200063151	K07198	ko04150	mTOR signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMT200063151	K07198	ko04910	Insulin signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMT200063151	K07198	ko04920	Adipocytokine signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMT200063151	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMT200063152	K07198	ko04140	Regulation of autophagy	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMT200063152	K07198	ko04150	mTOR signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMT200063152	K07198	ko04910	Insulin signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMT200063152	K07198	ko04920	Adipocytokine signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMT200063152	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMT200063153	K07198	ko04140	Regulation of autophagy	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMT200063153	K07198	ko04150	mTOR signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMT200063153	K07198	ko04910	Insulin signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMT200063153	K07198	ko04920	Adipocytokine signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMT200063153	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMT200063154	K07198	ko04140	Regulation of autophagy	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMT200063154	K07198	ko04150	mTOR signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMT200063154	K07198	ko04910	Insulin signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMT200063154	K07198	ko04920	Adipocytokine signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMT200063154	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMT200054816	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00270	Cysteine and methionine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00350	Tyrosine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00360	Phenylalanine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00401	Novobiocin biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko01100	Metabolic pathways	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054816	K00815	ko01110	Biosynthesis of secondary metabolites	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMT200054817	K07466	ko03030	DNA replication	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMT200054817	K07466	ko03420	Nucleotide excision repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMT200054817	K07466	ko03430	Mismatch repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMT200054817	K07466	ko03440	Homologous recombination	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMT200054824	K10955	ko05110	Vibrio cholerae infection	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMT200054824	K10955	ko05146	Amoebiasis	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMT200054828	K00948	ko00030	Pentose phosphate pathway	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMT200054828	K00948	ko00230	Purine metabolism	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMT200054828	K00948	ko01100	Metabolic pathways	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMT200054828	K00948	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMT200054829	K00948	ko00030	Pentose phosphate pathway	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMT200054829	K00948	ko00230	Purine metabolism	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMT200054829	K00948	ko01100	Metabolic pathways	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMT200054829	K00948	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMT200054836	K08909	ko00196	Photosynthesis - antenna proteins	2026	6.6e-106	0.86	0.94	1.00
PGSC0003DMT200054839	K03009	ko00230	Purine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMT200054839	K03009	ko00240	Pyrimidine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMT200054839	K03009	ko01100	Metabolic pathways	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMT200054839	K03009	ko03020	RNA polymerase	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMT200054839	K03009	ko05016	Huntington's disease	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMT200054840	K03009	ko00230	Purine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMT200054840	K03009	ko00240	Pyrimidine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMT200054840	K03009	ko01100	Metabolic pathways	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMT200054840	K03009	ko03020	RNA polymerase	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMT200054840	K03009	ko05016	Huntington's disease	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMT200054848	K04125	ko00904	Diterpenoid biosynthesis	1547	1.7e-79	0.59	0.74	0.99
PGSC0003DMT200083010	K12741	ko03040	Spliceosome	322	6.3e-12	0.52	0.87	0.60
PGSC0003DMT200083025	K00130	ko00260	Glycine, serine and threonine metabolism	3163	1.3e-168	0.72	0.87	0.99
PGSC0003DMT200083036	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMT200083036	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMT200083036	K03877	ko01100	Metabolic pathways	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMT200083037	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMT200083037	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMT200083037	K03877	ko01100	Metabolic pathways	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMT200017294	K04354	ko04111	Cell cycle - yeast	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMT200017294	K04354	ko04530	Tight junction	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMT200017294	K04354	ko05142	Chagas disease	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMT200017295	K04354	ko04111	Cell cycle - yeast	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMT200017295	K04354	ko04530	Tight junction	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMT200017295	K04354	ko05142	Chagas disease	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMT200017302	K10875	ko03440	Homologous recombination	610	8.3e-28	0.29	0.47	0.75
PGSC0003DMT200017313	K10875	ko03440	Homologous recombination	678	1.1e-36	0.31	0.51	0.42
PGSC0003DMT200017328	K10841	ko03420	Nucleotide excision repair	1469	3.5e-75	0.31	0.47	0.85
PGSC0003DMT200017340	K10260	ko04120	Ubiquitin mediated proteolysis	335	1.2e-12	0.29	0.46	0.80
PGSC0003DMT200036144	K02335	ko00230	Purine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko00240	Pyrimidine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko01100	Metabolic pathways	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko03030	DNA replication	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko03410	Base excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko03420	Nucleotide excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036144	K02335	ko03440	Homologous recombination	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMT200036146	K02335	ko00230	Purine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko00240	Pyrimidine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko01100	Metabolic pathways	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko03030	DNA replication	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko03410	Base excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko03420	Nucleotide excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036146	K02335	ko03440	Homologous recombination	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMT200036183	K08769	ko03320	PPAR signaling pathway	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMT200036183	K08769	ko05016	Huntington's disease	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMT200036185	K08769	ko03320	PPAR signaling pathway	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMT200036185	K08769	ko05016	Huntington's disease	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMT200036186	K08769	ko03320	PPAR signaling pathway	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMT200036186	K08769	ko05016	Huntington's disease	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMT200036189	K05280	ko00941	Flavonoid biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMT200036189	K05280	ko00944	Flavone and flavonol biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMT200036189	K05280	ko01100	Metabolic pathways	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMT200036189	K05280	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMT200036200	K00939	ko00230	Purine metabolism	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMT200036200	K00939	ko01100	Metabolic pathways	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMT200036200	K00939	ko01110	Biosynthesis of secondary metabolites	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMT200036202	K00939	ko00230	Purine metabolism	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMT200036202	K00939	ko01100	Metabolic pathways	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMT200036202	K00939	ko01110	Biosynthesis of secondary metabolites	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMT200036205	K01239	ko00230	Purine metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMT200036205	K01239	ko00760	Nicotinate and nicotinamide metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMT200036205	K01239	ko01100	Metabolic pathways	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMT200020068	K12197	ko04144	Endocytosis	1314	1.2e-66	0.79	0.90	1.00
PGSC0003DMT200020094	K00688	ko00500	Starch and sucrose metabolism	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMT200020094	K00688	ko04910	Insulin signaling pathway	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMT200020098	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMT200020098	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMT200020098	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMT200020099	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMT200020099	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMT200020099	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMT200020100	K08909	ko00196	Photosynthesis - antenna proteins	2011	4.4e-105	0.84	0.91	1.00
PGSC0003DMT200011618	K05755	ko04666	Fc gamma R-mediated phagocytosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMT200011618	K05755	ko04810	Regulation of actin cytoskeleton	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMT200011618	K05755	ko05100	Bacterial invasion of epithelial cells	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMT200011618	K05755	ko05130	Pathogenic Escherichia coli infection	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMT200011618	K05755	ko05131	Shigellosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMT200011620	K05755	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMT200011620	K05755	ko04810	Regulation of actin cytoskeleton	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMT200011620	K05755	ko05100	Bacterial invasion of epithelial cells	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMT200011620	K05755	ko05130	Pathogenic Escherichia coli infection	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMT200011620	K05755	ko05131	Shigellosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMT200011623	K01251	ko00270	Cysteine and methionine metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMT200011623	K01251	ko00450	Selenoamino acid metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMT200011623	K01251	ko01100	Metabolic pathways	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMT200011624	K01251	ko00270	Cysteine and methionine metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMT200011624	K01251	ko00450	Selenoamino acid metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMT200011624	K01251	ko01100	Metabolic pathways	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMT200011625	K01251	ko00270	Cysteine and methionine metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMT200011625	K01251	ko00450	Selenoamino acid metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMT200011625	K01251	ko01100	Metabolic pathways	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMT200011626	K12338	ko00942	Anthocyanin biosynthesis	451	4.9e-19	0.46	0.66	0.85
PGSC0003DMT200011627	K12338	ko00942	Anthocyanin biosynthesis	1669	3.2e-86	0.47	0.65	0.98
PGSC0003DMT200011628	K12338	ko00942	Anthocyanin biosynthesis	1225	9.9e-62	0.48	0.64	0.97
PGSC0003DMT200011629	K12338	ko00942	Anthocyanin biosynthesis	937	7.6e-46	0.46	0.65	0.98
PGSC0003DMT200011630	K12338	ko00942	Anthocyanin biosynthesis	1408	8.0e-72	0.41	0.62	0.97
PGSC0003DMT200011650	K12126	ko04712	Circadian rhythm - plant	314	2.2e-11	0.29	0.47	0.72
PGSC0003DMT200011651	K12126	ko04712	Circadian rhythm - plant	314	6.5e-11	0.29	0.47	0.66
PGSC0003DMT200011652	K12462	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMT200011652	K12462	ko04962	Vasopressin-regulated water reabsorption	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMT200034471	K00454	ko00591	Linoleic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMT200034471	K00454	ko00592	alpha-Linolenic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMT200034471	K00454	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMT200034472	K00454	ko00591	Linoleic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMT200034472	K00454	ko00592	alpha-Linolenic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMT200034472	K00454	ko01100	Metabolic pathways	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMT200034473	K00454	ko00591	Linoleic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMT200034473	K00454	ko00592	alpha-Linolenic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMT200034473	K00454	ko01100	Metabolic pathways	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMT200034474	K00454	ko00591	Linoleic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMT200034474	K00454	ko00592	alpha-Linolenic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMT200034474	K00454	ko01100	Metabolic pathways	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMT200093966	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200093966	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200093966	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMT200093973	K05868	ko04110	Cell cycle	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMT200093973	K05868	ko04115	p53 signaling pathway	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMT200093973	K05868	ko04914	Progesterone-mediated oocyte maturation	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMT200090131	K03006	ko00230	Purine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMT200090131	K03006	ko00240	Pyrimidine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMT200090131	K03006	ko01100	Metabolic pathways	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMT200090131	K03006	ko03020	RNA polymerase	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMT200090131	K03006	ko05016	Huntington's disease	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMT200003461	K04733	ko04210	Apoptosis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMT200003461	K04733	ko04620	Toll-like receptor signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMT200003461	K04733	ko04722	Neurotrophin signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMT200003461	K04733	ko05140	Leishmaniasis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMT200003461	K04733	ko05142	Chagas disease	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMT200003462	K04733	ko04210	Apoptosis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMT200003462	K04733	ko04620	Toll-like receptor signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMT200003462	K04733	ko04722	Neurotrophin signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMT200003462	K04733	ko05140	Leishmaniasis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMT200003462	K04733	ko05142	Chagas disease	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMT200003463	K04733	ko04210	Apoptosis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMT200003463	K04733	ko04620	Toll-like receptor signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMT200003463	K04733	ko04722	Neurotrophin signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMT200003463	K04733	ko05140	Leishmaniasis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMT200003463	K04733	ko05142	Chagas disease	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMT200003464	K04733	ko04210	Apoptosis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMT200003464	K04733	ko04620	Toll-like receptor signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMT200003464	K04733	ko04722	Neurotrophin signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMT200003464	K04733	ko05140	Leishmaniasis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMT200003464	K04733	ko05142	Chagas disease	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMT200003465	K04733	ko04210	Apoptosis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMT200003465	K04733	ko04620	Toll-like receptor signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMT200003465	K04733	ko04722	Neurotrophin signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMT200003465	K04733	ko05140	Leishmaniasis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMT200003465	K04733	ko05142	Chagas disease	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMT200003477	K12640	ko00905	Brassinosteroid biosynthesis	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMT200003477	K12640	ko01100	Metabolic pathways	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMT200003477	K12640	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMT200003487	K05746	ko04810	Regulation of actin cytoskeleton	461	2.7e-19	0.38	0.44	0.59
PGSC0003DMT200077917	K12605	ko03018	RNA degradation	2418	1.6e-127	0.79	0.90	0.98
PGSC0003DMT200077918	K12605	ko03018	RNA degradation	4346	7.2e-234	0.78	0.86	1.00
PGSC0003DMT200077919	K12605	ko03018	RNA degradation	4598	9.1e-248	0.80	0.88	1.00
PGSC0003DMT200077922	K12605	ko03018	RNA degradation	482	9.5e-21	0.81	0.91	0.72
PGSC0003DMT200077939	K11252	ko05322	Systemic lupus erythematosus	1138	6.2e-57	0.95	0.97	0.99
PGSC0003DMT200077940	K01227	ko00511	Other glycan degradation	414	5.0e-16	0.29	0.47	0.73
PGSC0003DMT200077954	K05692	ko04145	Phagosome	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04510	Focal adhesion	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04520	Adherens junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04530	Tight junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04670	Leukocyte transendothelial migration	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04745	Phototransduction - fly	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko04810	Regulation of actin cytoskeleton	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05100	Bacterial invasion of epithelial cells	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05110	Vibrio cholerae infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05130	Pathogenic Escherichia coli infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05131	Shigellosis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05414	Dilated cardiomyopathy	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077954	K05692	ko05416	Viral myocarditis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04145	Phagosome	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04510	Focal adhesion	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04520	Adherens junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04530	Tight junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04670	Leukocyte transendothelial migration	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04745	Phototransduction - fly	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko04810	Regulation of actin cytoskeleton	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05100	Bacterial invasion of epithelial cells	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05110	Vibrio cholerae infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05130	Pathogenic Escherichia coli infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05131	Shigellosis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05414	Dilated cardiomyopathy	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200077955	K05692	ko05416	Viral myocarditis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMT200048528	K01444	ko00511	Other glycan degradation	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMT200048528	K01444	ko04142	Lysosome	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMT200048529	K01444	ko00511	Other glycan degradation	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMT200048529	K01444	ko04142	Lysosome	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMT200048530	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMT200048530	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMT200048531	K01444	ko00511	Other glycan degradation	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMT200048531	K01444	ko04142	Lysosome	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMT200048532	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMT200048532	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMT200048533	K01444	ko00511	Other glycan degradation	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMT200048533	K01444	ko04142	Lysosome	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMT200048534	K05732	ko04510	Focal adhesion	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMT200048534	K05732	ko04670	Leukocyte transendothelial migration	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMT200048534	K05732	ko04810	Regulation of actin cytoskeleton	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMT200048538	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMT200048550	K01066	ko00623	2,4-Dichlorobenzoate degradation	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMT200048550	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMT200059880	K01190	ko00052	Galactose metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMT200059880	K01190	ko00511	Other glycan degradation	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMT200059880	K01190	ko00600	Sphingolipid metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMT200059880	K01190	ko01100	Metabolic pathways	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMT200059890	K06611	ko00052	Galactose metabolism	426	2.9e-17	0.37	0.55	0.91
PGSC0003DMT200059896	K12796	ko04621	NOD-like receptor signaling pathway	396	5.0e-15	0.31	0.47	0.95
PGSC0003DMT200069470	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMT200069473	K06172	ko04330	Notch signaling pathway	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMT200069473	K06172	ko05010	Alzheimer's disease	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMT200069474	K06172	ko04330	Notch signaling pathway	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMT200069474	K06172	ko05010	Alzheimer's disease	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMT200069477	K02964	ko03010	Ribosome	1223	1.3e-61	0.93	0.98	0.66
PGSC0003DMT200069486	K10206	ko00300	Lysine biosynthesis	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMT200069486	K10206	ko01110	Biosynthesis of secondary metabolites	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMT200069487	K10206	ko00300	Lysine biosynthesis	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMT200069487	K10206	ko01110	Biosynthesis of secondary metabolites	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMT200069498	K12135	ko04712	Circadian rhythm - plant	318	1.1e-11	0.31	0.49	0.83
PGSC0003DMT200038901	K08734	ko03430	Mismatch repair	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMT200038901	K08734	ko05200	Pathways in cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMT200038901	K08734	ko05210	Colorectal cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMT200038901	K08734	ko05213	Endometrial cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMT200038902	K08734	ko03430	Mismatch repair	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMT200038902	K08734	ko05200	Pathways in cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMT200038902	K08734	ko05210	Colorectal cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMT200038902	K08734	ko05213	Endometrial cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMT200038903	K08734	ko03430	Mismatch repair	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMT200038903	K08734	ko05200	Pathways in cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMT200038903	K08734	ko05210	Colorectal cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMT200038903	K08734	ko05213	Endometrial cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMT200038904	K08734	ko03430	Mismatch repair	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMT200038904	K08734	ko05200	Pathways in cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMT200038904	K08734	ko05210	Colorectal cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMT200038904	K08734	ko05213	Endometrial cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMT200038905	K08734	ko03430	Mismatch repair	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMT200038905	K08734	ko05200	Pathways in cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMT200038905	K08734	ko05210	Colorectal cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMT200038905	K08734	ko05213	Endometrial cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMT200038914	K11821	ko00380	Tryptophan metabolism	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMT200038914	K11821	ko00966	Glucosinolate biosynthesis	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMT200038914	K11821	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMT200038915	K11821	ko00380	Tryptophan metabolism	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMT200038915	K11821	ko00966	Glucosinolate biosynthesis	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMT200038915	K11821	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMT200038934	K02948	ko03010	Ribosome	569	1.5e-25	0.87	0.90	0.57
PGSC0003DMT200038937	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMT200038937	K00517	ko00626	Naphthalene and anthracene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMT200038937	K00517	ko00903	Limonene and pinene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMT200038937	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMT200038937	K00517	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMT200038938	K02704	ko00195	Photosynthesis	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMT200038938	K02704	ko01100	Metabolic pathways	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMT200031773	K04371	ko04010	MAPK signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04012	ErbB signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04013	MAPK signaling pathway - fly	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04062	Chemokine signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04114	Oocyte meiosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04150	mTOR signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04270	Vascular smooth muscle contraction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04320	Dorso-ventral axis formation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04350	TGF-beta signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04360	Axon guidance	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04370	VEGF signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04510	Focal adhesion	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04520	Adherens junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04540	Gap junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04620	Toll-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04621	NOD-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04650	Natural killer cell mediated cytotoxicity	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04660	T cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04662	B cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04664	Fc epsilon RI signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04666	Fc gamma R-mediated phagocytosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04720	Long-term potentiation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04722	Neurotrophin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04730	Long-term depression	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04810	Regulation of actin cytoskeleton	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04910	Insulin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04912	GnRH signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04914	Progesterone-mediated oocyte maturation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04916	Melanogenesis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04930	Type II diabetes mellitus	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05010	Alzheimer's disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05020	Prion diseases	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05131	Shigellosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05140	Leishmaniasis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05142	Chagas disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05200	Pathways in cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05210	Colorectal cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05211	Renal cell carcinoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05212	Pancreatic cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05213	Endometrial cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05214	Glioma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05215	Prostate cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05216	Thyroid cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05218	Melanoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05219	Bladder cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05220	Chronic myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05221	Acute myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031773	K04371	ko05223	Non-small cell lung cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMT200031777	K01834	ko00010	Glycolysis / Gluconeogenesis	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMT200031777	K01834	ko01100	Metabolic pathways	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMT200031777	K01834	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMT200031778	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMT200031778	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMT200031778	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMT200031779	K01834	ko00010	Glycolysis / Gluconeogenesis	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMT200031779	K01834	ko01100	Metabolic pathways	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMT200031779	K01834	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMT200031784	K12392	ko04142	Lysosome	6726	0.	0.90	0.94	1.00
PGSC0003DMT200031794	K10576	ko04120	Ubiquitin mediated proteolysis	1429	5.6e-73	0.89	0.94	0.99
PGSC0003DMT200031795	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMT200031795	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMT200031796	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMT200031796	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMT200031797	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMT200031797	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMT200031798	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMT200031798	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMT200031801	K03006	ko00230	Purine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMT200031801	K03006	ko00240	Pyrimidine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMT200031801	K03006	ko01100	Metabolic pathways	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMT200031801	K03006	ko03020	RNA polymerase	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMT200031801	K03006	ko05016	Huntington's disease	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMT200031802	K03006	ko00230	Purine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMT200031802	K03006	ko00240	Pyrimidine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMT200031802	K03006	ko01100	Metabolic pathways	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMT200031802	K03006	ko03020	RNA polymerase	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMT200031802	K03006	ko05016	Huntington's disease	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMT200031804	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMT200031804	K00517	ko00626	Naphthalene and anthracene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMT200031804	K00517	ko00903	Limonene and pinene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMT200031804	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMT200031804	K00517	ko01110	Biosynthesis of secondary metabolites	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMT200031805	K04421	ko04010	MAPK signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMT200031805	K04421	ko04722	Neurotrophin signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMT200031805	K04421	ko04912	GnRH signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMT200013072	K08775	ko03440	Homologous recombination	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMT200013072	K08775	ko05200	Pathways in cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMT200013072	K08775	ko05212	Pancreatic cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMT200013082	K00511	ko00100	Steroid biosynthesis	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMT200013082	K00511	ko01100	Metabolic pathways	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMT200013082	K00511	ko01110	Biosynthesis of secondary metabolites	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMT200013085	K00511	ko00100	Steroid biosynthesis	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMT200013085	K00511	ko01100	Metabolic pathways	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMT200013085	K00511	ko01110	Biosynthesis of secondary metabolites	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMT200023036	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMT200023036	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMT200023037	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMT200023037	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMT200023037	K00771	ko01100	Metabolic pathways	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMT200023039	K03283	ko03040	Spliceosome	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMT200023039	K03283	ko04010	MAPK signaling pathway	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMT200023039	K03283	ko04144	Endocytosis	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMT200023039	K03283	ko04612	Antigen processing and presentation	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMT200023040	K12862	ko03040	Spliceosome	2006	8.3e-105	0.76	0.85	0.98
PGSC0003DMT200023046	K12492	ko04144	Endocytosis	2778	2.2e-147	0.71	0.80	1.00
PGSC0003DMT200023047	K03014	ko00230	Purine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMT200023047	K03014	ko00240	Pyrimidine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMT200023047	K03014	ko01100	Metabolic pathways	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMT200023047	K03014	ko03020	RNA polymerase	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMT200023047	K03014	ko05016	Huntington's disease	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMT200023048	K03014	ko00230	Purine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMT200023048	K03014	ko00240	Pyrimidine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMT200023048	K03014	ko01100	Metabolic pathways	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMT200023048	K03014	ko03020	RNA polymerase	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMT200023048	K03014	ko05016	Huntington's disease	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMT200023060	K05765	ko04360	Axon guidance	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMT200023060	K05765	ko04666	Fc gamma R-mediated phagocytosis	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMT200023060	K05765	ko04810	Regulation of actin cytoskeleton	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMT200023061	K05765	ko04360	Axon guidance	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMT200023061	K05765	ko04666	Fc gamma R-mediated phagocytosis	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMT200023061	K05765	ko04810	Regulation of actin cytoskeleton	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMT200023064	K11251	ko05322	Systemic lupus erythematosus	1112	1.7e-55	0.95	0.97	0.97
PGSC0003DMT200023067	K01507	ko00190	Oxidative phosphorylation	288	4.8e-10	0.85	0.93	0.78
PGSC0003DMT200023068	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMT200023069	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMT200023075	K12831	ko03040	Spliceosome	2631	2.8e-139	0.80	0.87	1.00
PGSC0003DMT200000680	K09561	ko04120	Ubiquitin mediated proteolysis	254	1.3e-07	0.31	0.48	0.26
PGSC0003DMT200000685	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMT200000685	K00517	ko00626	Naphthalene and anthracene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMT200000685	K00517	ko00903	Limonene and pinene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMT200000685	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMT200000685	K00517	ko01110	Biosynthesis of secondary metabolites	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMT200000688	K00697	ko00500	Starch and sucrose metabolism	1672	2.2e-86	0.65	0.81	0.46
PGSC0003DMT200000695	K02942	ko03010	Ribosome	400	3.2e-16	0.74	0.84	0.97
PGSC0003DMT200000717	K05279	ko00944	Flavone and flavonol biosynthesis	505	5.1e-22	0.36	0.54	0.84
PGSC0003DMT200000718	K05279	ko00944	Flavone and flavonol biosynthesis	764	2.6e-36	0.37	0.56	0.84
PGSC0003DMT200000720	K05279	ko00944	Flavone and flavonol biosynthesis	699	1.0e-32	0.41	0.59	0.92
PGSC0003DMT200000725	K05279	ko00944	Flavone and flavonol biosynthesis	687	4.7e-32	0.38	0.56	0.75
PGSC0003DMT200091657	K03094	ko04110	Cell cycle	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04111	Cell cycle - yeast	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04114	Oocyte meiosis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04120	Ubiquitin mediated proteolysis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04310	Wnt signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04350	TGF-beta signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091657	K03094	ko04710	Circadian rhythm - mammal	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMT200091664	K13229	ko00402	Benzoxazinoid biosynthesis	521	6.7e-23	0.49	0.67	0.84
PGSC0003DMT200091590	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	343	3.1e-12	0.33	0.44	0.78
PGSC0003DMT200039788	K00026	ko00020	Citrate cycle (TCA cycle)	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039788	K00026	ko00620	Pyruvate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039788	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039788	K00026	ko00710	Carbon fixation in photosynthetic organisms	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039788	K00026	ko01100	Metabolic pathways	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039788	K00026	ko01110	Biosynthesis of secondary metabolites	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMT200039790	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMT200039790	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMT200039790	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMT200039791	K00791	ko00908	Zeatin biosynthesis	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMT200039791	K00791	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMT200039791	K00791	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMT200039793	K00791	ko00908	Zeatin biosynthesis	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMT200039793	K00791	ko01100	Metabolic pathways	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMT200039793	K00791	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMT200039794	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMT200039794	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMT200039794	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMT200039795	K00791	ko00908	Zeatin biosynthesis	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMT200039795	K00791	ko01100	Metabolic pathways	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMT200039795	K00791	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMT200030970	K07204	ko04150	mTOR signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMT200030970	K07204	ko04910	Insulin signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMT200030971	K07204	ko04150	mTOR signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMT200030971	K07204	ko04910	Insulin signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMT200030972	K07204	ko04150	mTOR signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMT200030972	K07204	ko04910	Insulin signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMT200030973	K07204	ko04150	mTOR signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMT200030973	K07204	ko04910	Insulin signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMT200030974	K07204	ko04150	mTOR signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMT200030974	K07204	ko04910	Insulin signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMT200030976	K00827	ko00250	Alanine, aspartate and glutamate metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMT200030976	K00827	ko00260	Glycine, serine and threonine metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMT200031009	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMT200031009	K01433	ko00670	One carbon pool by folate	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMT200005298	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMT200005298	K00517	ko00626	Naphthalene and anthracene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMT200005298	K00517	ko00903	Limonene and pinene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMT200005298	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMT200005298	K00517	ko01110	Biosynthesis of secondary metabolites	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMT200005299	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMT200005299	K00517	ko00626	Naphthalene and anthracene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMT200005299	K00517	ko00903	Limonene and pinene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMT200005299	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMT200005299	K00517	ko01110	Biosynthesis of secondary metabolites	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMT200005307	K00558	ko00270	Cysteine and methionine metabolism	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMT200005307	K00558	ko01100	Metabolic pathways	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMT200005343	K01051	ko00040	Pentose and glucuronate interconversions	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMT200005343	K01051	ko00500	Starch and sucrose metabolism	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMT200005343	K01051	ko01100	Metabolic pathways	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMT200005344	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMT200005345	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMT200042921	K03413	ko02020	Two-component system	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMT200042921	K03413	ko02030	Bacterial chemotaxis	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMT200042922	K03413	ko02020	Two-component system	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMT200042922	K03413	ko02030	Bacterial chemotaxis	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMT200042923	K00057	ko00564	Glycerophospholipid metabolism	405	1.7e-16	0.41	0.57	0.59
PGSC0003DMT200042924	K00057	ko00564	Glycerophospholipid metabolism	677	1.7e-31	0.43	0.67	0.62
PGSC0003DMT200042925	K00057	ko00564	Glycerophospholipid metabolism	854	2.9e-41	0.43	0.66	0.74
PGSC0003DMT200042926	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.68
PGSC0003DMT200042927	K00057	ko00564	Glycerophospholipid metabolism	920	6.6e-45	0.45	0.62	0.96
PGSC0003DMT200042928	K00057	ko00564	Glycerophospholipid metabolism	1002	2.0e-49	0.45	0.62	0.78
PGSC0003DMT200042929	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.67
PGSC0003DMT200042930	K00057	ko00564	Glycerophospholipid metabolism	421	2.2e-17	0.47	0.70	0.93
PGSC0003DMT200042937	K04564	ko04146	Peroxisome	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMT200042937	K04564	ko05016	Huntington's disease	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMT200013755	K02993	ko03010	Ribosome	696	1.5e-32	0.89	0.99	0.91
PGSC0003DMT200013756	K02993	ko03010	Ribosome	1111	1.9e-55	0.84	0.96	0.91
PGSC0003DMT200013757	K02993	ko03010	Ribosome	1419	2.0e-72	0.87	0.97	0.99
PGSC0003DMT200013765	K12126	ko04712	Circadian rhythm - plant	267	1.3e-08	0.30	0.47	0.96
PGSC0003DMT200013766	K12126	ko04712	Circadian rhythm - plant	297	2.2e-10	0.31	0.47	0.77
PGSC0003DMT200013769	K02183	ko04020	Calcium signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04070	Phosphatidylinositol signaling system	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04114	Oocyte meiosis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04270	Vascular smooth muscle contraction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04626	Plant-pathogen interaction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04720	Long-term potentiation	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04722	Neurotrophin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04740	Olfactory transduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04744	Phototransduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04745	Phototransduction - fly	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04910	Insulin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04912	GnRH signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04916	Melanogenesis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04970	Salivary secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko04971	Gastric acid secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko05010	Alzheimer's disease	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013769	K02183	ko05214	Glioma	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMT200013774	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.28	0.41	0.75
PGSC0003DMT200077079	K01354	ko05142	Chagas disease	1919	5.2e-100	0.87	0.94	0.70
PGSC0003DMT200077080	K01354	ko05142	Chagas disease	2818	1.4e-149	0.74	0.86	0.99
PGSC0003DMT200077081	K01354	ko05142	Chagas disease	4837	6.0e-261	0.78	0.88	1.00
PGSC0003DMT200077099	K01199	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.46	0.62	0.96
PGSC0003DMT200077104	K05681	ko02010	ABC transporters	978	4.2e-48	0.38	0.60	0.88
PGSC0003DMT200077105	K05681	ko02010	ABC transporters	1116	1.0e-55	0.36	0.58	0.89
PGSC0003DMT200077106	K05681	ko02010	ABC transporters	1163	2.6e-58	0.36	0.56	0.86
PGSC0003DMT200077109	K05681	ko02010	ABC transporters	1147	2.0e-57	0.34	0.52	0.89
PGSC0003DMT200077128	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMT200077128	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMT200051860	K08332	ko04140	Regulation of autophagy	465	9.2e-20	0.34	0.53	0.41
PGSC0003DMT200051861	K08332	ko04140	Regulation of autophagy	465	8.2e-20	0.34	0.53	0.51
PGSC0003DMT200051865	K08332	ko04140	Regulation of autophagy	390	1.1e-15	0.34	0.55	0.60
PGSC0003DMT200051883	K11087	ko03040	Spliceosome	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMT200051883	K11087	ko05322	Systemic lupus erythematosus	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMT200051891	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMT200051892	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMT200051893	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMT200051894	K00648	ko00061	Fatty acid biosynthesis	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMT200051894	K00648	ko01100	Metabolic pathways	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMT200066568	K12356	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.36	0.51	0.65
PGSC0003DMT200066569	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMT200066570	K12356	ko00940	Phenylpropanoid biosynthesis	765	2.3e-36	0.33	0.48	0.98
PGSC0003DMT200066572	K12356	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.33	0.51	0.97
PGSC0003DMT200066573	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.45	0.59	0.90
PGSC0003DMT200066576	K12356	ko00940	Phenylpropanoid biosynthesis	783	2.4e-37	0.32	0.51	0.99
PGSC0003DMT200066582	K00635	ko00561	Glycerolipid metabolism	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMT200066582	K00635	ko01100	Metabolic pathways	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMT200066583	K00588	ko00360	Phenylalanine metabolism	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066583	K00588	ko00940	Phenylpropanoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066583	K00588	ko00941	Flavonoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066583	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066583	K00588	ko01100	Metabolic pathways	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066583	K00588	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMT200066585	K00588	ko00360	Phenylalanine metabolism	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066585	K00588	ko00940	Phenylpropanoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066585	K00588	ko00941	Flavonoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066585	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066585	K00588	ko01100	Metabolic pathways	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066585	K00588	ko01110	Biosynthesis of secondary metabolites	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMT200066597	K01966	ko00280	Valine, leucine and isoleucine degradation	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMT200066597	K01966	ko00640	Propanoate metabolism	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMT200066597	K01966	ko01100	Metabolic pathways	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMT200066598	K01966	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMT200066598	K01966	ko00640	Propanoate metabolism	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMT200066598	K01966	ko01100	Metabolic pathways	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMT200066599	K01966	ko00280	Valine, leucine and isoleucine degradation	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMT200066599	K01966	ko00640	Propanoate metabolism	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMT200066599	K01966	ko01100	Metabolic pathways	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMT200066600	K01966	ko00280	Valine, leucine and isoleucine degradation	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMT200066600	K01966	ko00640	Propanoate metabolism	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMT200066600	K01966	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMT200060463	K03128	ko03022	Basal transcription factors	660	3.4e-29	0.52	0.68	0.59
PGSC0003DMT200060466	K00164	ko00020	Citrate cycle (TCA cycle)	7847	0.	0.88	0.95	1.00
PGSC0003DMT200060466	K00164	ko00310	Lysine degradation	7847	0.	0.88	0.95	1.00
PGSC0003DMT200060466	K00164	ko00380	Tryptophan metabolism	7847	0.	0.88	0.95	1.00
PGSC0003DMT200060466	K00164	ko01100	Metabolic pathways	7847	0.	0.88	0.95	1.00
PGSC0003DMT200060466	K00164	ko01110	Biosynthesis of secondary metabolites	7847	0.	0.88	0.95	1.00
PGSC0003DMT200060471	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200060472	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200060473	K01710	ko00521	Streptomycin biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMT200060473	K01710	ko00523	Polyketide sugar unit biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMT200060473	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMT200060473	K01710	ko01100	Metabolic pathways	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMT200060473	K01710	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMT200060478	K10575	ko04120	Ubiquitin mediated proteolysis	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMT200060478	K10575	ko05012	Parkinson's disease	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMT200060479	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060479	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060480	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060480	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060481	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060481	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060482	K10575	ko04120	Ubiquitin mediated proteolysis	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMT200060482	K10575	ko05012	Parkinson's disease	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMT200060483	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060483	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMT200060494	K00729	ko00510	N-Glycan biosynthesis	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMT200060494	K00729	ko01100	Metabolic pathways	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMT200060495	K00729	ko00510	N-Glycan biosynthesis	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMT200060495	K00729	ko01100	Metabolic pathways	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMT200060496	K00729	ko00510	N-Glycan biosynthesis	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMT200060496	K00729	ko01100	Metabolic pathways	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMT200086229	K03094	ko04110	Cell cycle	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04111	Cell cycle - yeast	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04114	Oocyte meiosis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04120	Ubiquitin mediated proteolysis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04310	Wnt signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04350	TGF-beta signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086229	K03094	ko04710	Circadian rhythm - mammal	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMT200086245	K04733	ko04210	Apoptosis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMT200086245	K04733	ko04620	Toll-like receptor signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMT200086245	K04733	ko04722	Neurotrophin signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMT200086245	K04733	ko05140	Leishmaniasis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMT200086245	K04733	ko05142	Chagas disease	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMT200004076	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMT200004076	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMT200004080	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMT200004080	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMT200004094	K09578	ko04622	RIG-I-like receptor signaling pathway	839	1.9e-40	0.80	0.92	0.99
PGSC0003DMT200004095	K00764	ko00230	Purine metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMT200004095	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMT200004095	K00764	ko01100	Metabolic pathways	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMT200004095	K00764	ko01110	Biosynthesis of secondary metabolites	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMT200004096	K12345	ko00140	Steroid hormone biosynthesis	1455	2.0e-74	0.55	0.66	1.00
PGSC0003DMT200004097	K12345	ko00140	Steroid hormone biosynthesis	1692	1.7e-87	0.63	0.75	0.96
PGSC0003DMT200004098	K12345	ko00140	Steroid hormone biosynthesis	1554	7.1e-80	0.65	0.77	0.80
PGSC0003DMT200004100	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMT200004101	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMT200004106	K01771	ko00562	Inositol phosphate metabolism	232	2.4e-06	0.29	0.44	0.70
PGSC0003DMT200094070	K12828	ko03040	Spliceosome	1823	1.0e-94	0.92	0.95	0.82
PGSC0003DMT200094080	K10591	ko04120	Ubiquitin mediated proteolysis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMT200094080	K10591	ko04144	Endocytosis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMT200095716	K01051	ko00040	Pentose and glucuronate interconversions	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMT200095716	K01051	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMT200095716	K01051	ko01100	Metabolic pathways	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMT200095725	K00660	ko00941	Flavonoid biosynthesis	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMT200095725	K00660	ko01100	Metabolic pathways	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMT200095725	K00660	ko01110	Biosynthesis of secondary metabolites	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMT200095725	K00660	ko04712	Circadian rhythm - plant	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMT200016549	K12194	ko04144	Endocytosis	415	4.7e-17	0.48	0.68	0.24
PGSC0003DMT200016568	K02704	ko00195	Photosynthesis	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMT200016568	K02704	ko01100	Metabolic pathways	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMT200016581	K10577	ko04120	Ubiquitin mediated proteolysis	1204	1.4e-60	0.93	0.98	0.83
PGSC0003DMT200029559	K00799	ko00480	Glutathione metabolism	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMT200029559	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMT200029559	K00799	ko00982	Drug metabolism - cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMT200029561	K00799	ko00480	Glutathione metabolism	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMT200029561	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMT200029561	K00799	ko00982	Drug metabolism - cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMT200029563	K00799	ko00480	Glutathione metabolism	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMT200029563	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMT200029563	K00799	ko00982	Drug metabolism - cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMT200035333	K00485	ko00982	Drug metabolism - cytochrome P450	652	4.0e-30	0.29	0.47	0.99
PGSC0003DMT200035344	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMT200035344	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMT200035345	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMT200035345	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMT200035380	K05863	ko04020	Calcium signaling pathway	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMT200035380	K05863	ko05012	Parkinson's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMT200035380	K05863	ko05016	Huntington's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMT200035217	K00703	ko00500	Starch and sucrose metabolism	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMT200035217	K00703	ko01100	Metabolic pathways	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMT200035218	K00703	ko00500	Starch and sucrose metabolism	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMT200035218	K00703	ko01100	Metabolic pathways	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMT200035219	K00703	ko00500	Starch and sucrose metabolism	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMT200035219	K00703	ko01100	Metabolic pathways	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMT200035220	K00703	ko00500	Starch and sucrose metabolism	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMT200035220	K00703	ko01100	Metabolic pathways	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMT200044917	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMT200044917	K00457	ko00350	Tyrosine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMT200044917	K00457	ko00360	Phenylalanine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMT200044917	K00457	ko01100	Metabolic pathways	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMT200044918	K05278	ko00941	Flavonoid biosynthesis	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMT200044918	K05278	ko01100	Metabolic pathways	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMT200044918	K05278	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMT200044934	K13065	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMT200044934	K13065	ko00941	Flavonoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMT200044934	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMT200044934	K13065	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMT200044938	K05666	ko02010	ABC transporters	2942	2.0e-156	0.33	0.53	0.94
PGSC0003DMT200044944	K00134	ko00010	Glycolysis / Gluconeogenesis	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMT200044944	K00134	ko01100	Metabolic pathways	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMT200044944	K00134	ko01110	Biosynthesis of secondary metabolites	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMT200044944	K00134	ko05010	Alzheimer's disease	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMT200044945	K00134	ko00010	Glycolysis / Gluconeogenesis	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMT200044945	K00134	ko01100	Metabolic pathways	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMT200044945	K00134	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMT200044945	K00134	ko05010	Alzheimer's disease	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMT200044950	K05665	ko02010	ABC transporters	322	5.8e-11	0.62	0.73	0.70
PGSC0003DMT200044957	K02321	ko00230	Purine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMT200044957	K02321	ko00240	Pyrimidine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMT200044957	K02321	ko01100	Metabolic pathways	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMT200044957	K02321	ko03030	DNA replication	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMT200044958	K02321	ko00230	Purine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMT200044958	K02321	ko00240	Pyrimidine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMT200044958	K02321	ko01100	Metabolic pathways	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMT200044958	K02321	ko03030	DNA replication	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMT200044962	K06688	ko04120	Ubiquitin mediated proteolysis	279	1.5e-09	0.94	0.97	0.18
PGSC0003DMT200072333	K07195	ko04910	Insulin signaling pathway	3637	9.1e-195	0.68	0.83	0.99
PGSC0003DMT200072343	K08488	ko04130	SNARE interactions in vesicular transport	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMT200072343	K08488	ko04145	Phagosome	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMT200072344	K08488	ko04130	SNARE interactions in vesicular transport	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMT200072344	K08488	ko04145	Phagosome	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMT200072364	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMT200081790	K00031	ko00020	Citrate cycle (TCA cycle)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200081790	K00031	ko00480	Glutathione metabolism	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200081790	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200081790	K00031	ko01100	Metabolic pathways	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200081790	K00031	ko01110	Biosynthesis of secondary metabolites	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200081790	K00031	ko04146	Peroxisome	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMT200027759	K09839	ko00906	Carotenoid biosynthesis	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMT200027759	K09839	ko01100	Metabolic pathways	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMT200027759	K09839	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMT200027760	K09839	ko00906	Carotenoid biosynthesis	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMT200027760	K09839	ko01100	Metabolic pathways	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMT200027760	K09839	ko01110	Biosynthesis of secondary metabolites	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMT200027762	K09839	ko00906	Carotenoid biosynthesis	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMT200027762	K09839	ko01100	Metabolic pathways	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMT200027762	K09839	ko01110	Biosynthesis of secondary metabolites	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMT200027763	K09839	ko00906	Carotenoid biosynthesis	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMT200027763	K09839	ko01100	Metabolic pathways	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMT200027763	K09839	ko01110	Biosynthesis of secondary metabolites	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMT200027765	K04733	ko04210	Apoptosis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMT200027765	K04733	ko04620	Toll-like receptor signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMT200027765	K04733	ko04722	Neurotrophin signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMT200027765	K04733	ko05140	Leishmaniasis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMT200027765	K04733	ko05142	Chagas disease	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMT200027785	K08064	ko04612	Antigen processing and presentation	519	8.6e-23	0.40	0.54	0.73
PGSC0003DMT200027799	K04733	ko04210	Apoptosis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMT200027799	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMT200027799	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMT200027799	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMT200027799	K04733	ko05142	Chagas disease	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMT200027802	K12275	ko03060	Protein export	2035	2.1e-106	0.79	0.88	0.92
PGSC0003DMT200037179	K05747	ko04062	Chemokine signaling pathway	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko04520	Adherens junction	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko04666	Fc gamma R-mediated phagocytosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko04810	Regulation of actin cytoskeleton	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko05100	Bacterial invasion of epithelial cells	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko05130	Pathogenic Escherichia coli infection	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200037179	K05747	ko05131	Shigellosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMT200061619	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMT200061619	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMT200061619	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMT200061621	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMT200061621	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMT200061621	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMT200061642	K00697	ko00500	Starch and sucrose metabolism	5633	0.	0.76	0.88	0.99
PGSC0003DMT200061643	K12391	ko04142	Lysosome	2536	4.9e-134	0.71	0.82	0.97
PGSC0003DMT200061644	K12391	ko04142	Lysosome	4771	2.6e-257	0.85	0.93	0.95
PGSC0003DMT200061645	K12391	ko04142	Lysosome	5866	0.	0.80	0.90	1.00
PGSC0003DMT200061650	K00480	ko00624	1- and 2-Methylnaphthalene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMT200061650	K00480	ko00626	Naphthalene and anthracene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMT200061650	K00480	ko00628	Fluorene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMT200061650	K00480	ko01100	Metabolic pathways	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMT200061651	K00480	ko00624	1- and 2-Methylnaphthalene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMT200061651	K00480	ko00626	Naphthalene and anthracene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMT200061651	K00480	ko00628	Fluorene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMT200061651	K00480	ko01100	Metabolic pathways	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMT200074018	K11252	ko05322	Systemic lupus erythematosus	714	1.5e-33	0.61	0.72	0.42
PGSC0003DMT200074020	K11252	ko05322	Systemic lupus erythematosus	830	6.1e-40	0.80	0.87	0.96
PGSC0003DMT200074028	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMT200074028	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMT200074028	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMT200074028	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMT200074044	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMT200074044	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMT200074051	K02993	ko03010	Ribosome	1454	2.3e-74	0.88	0.97	0.99
PGSC0003DMT200074054	K00799	ko00480	Glutathione metabolism	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMT200074054	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMT200074054	K00799	ko00982	Drug metabolism - cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMT200074055	K00799	ko00480	Glutathione metabolism	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMT200074055	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMT200074055	K00799	ko00982	Drug metabolism - cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMT200074056	K04424	ko04010	MAPK signaling pathway	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMT200074056	K04424	ko04530	Tight junction	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMT200074057	K04424	ko04010	MAPK signaling pathway	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMT200074057	K04424	ko04530	Tight junction	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMT200074058	K04424	ko04010	MAPK signaling pathway	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMT200074058	K04424	ko04530	Tight junction	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMT200046775	K10577	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.75	0.86	0.99
PGSC0003DMT200046776	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.44
PGSC0003DMT200046777	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.39
PGSC0003DMT200046781	K12609	ko03018	RNA degradation	414	4.4e-13	0.26	0.40	0.47
PGSC0003DMT200046782	K12831	ko03040	Spliceosome	324	4.8e-11	0.37	0.42	0.12
PGSC0003DMT200046811	K11152	ko00830	Retinol metabolism	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMT200046811	K11152	ko01100	Metabolic pathways	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMT200079664	K01762	ko00270	Cysteine and methionine metabolism	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMT200079664	K01762	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMT200079674	K01206	ko00511	Other glycan degradation	657	2.1e-30	0.68	0.84	0.99
PGSC0003DMT200079675	K01206	ko00511	Other glycan degradation	3091	1.2e-164	0.74	0.86	0.98
PGSC0003DMT200079681	K08243	ko00941	Flavonoid biosynthesis	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMT200079681	K08243	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMT200079682	K00100	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079682	K00100	ko00363	Bisphenol A degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079682	K00100	ko00591	Linoleic acid metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079682	K00100	ko00625	Tetrachloroethene degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079682	K00100	ko00650	Butanoate metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079682	K00100	ko01100	Metabolic pathways	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMT200079683	K00100	ko00051	Fructose and mannose metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079683	K00100	ko00363	Bisphenol A degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079683	K00100	ko00591	Linoleic acid metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079683	K00100	ko00625	Tetrachloroethene degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079683	K00100	ko00650	Butanoate metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079683	K00100	ko01100	Metabolic pathways	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMT200079684	K00100	ko00051	Fructose and mannose metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079684	K00100	ko00363	Bisphenol A degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079684	K00100	ko00591	Linoleic acid metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079684	K00100	ko00625	Tetrachloroethene degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079684	K00100	ko00650	Butanoate metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079684	K00100	ko01100	Metabolic pathways	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMT200079693	K01199	ko00500	Starch and sucrose metabolism	501	8.5e-22	0.33	0.50	0.95
PGSC0003DMT200079695	K01505	ko00640	Propanoate metabolism	1109	2.5e-55	0.41	0.57	0.89
PGSC0003DMT200079697	K01505	ko00640	Propanoate metabolism	1278	1.2e-64	0.44	0.62	0.94
PGSC0003DMT200079549	K07432	ko00510	N-Glycan biosynthesis	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMT200079549	K07432	ko01100	Metabolic pathways	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMT200079550	K07432	ko00510	N-Glycan biosynthesis	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMT200079550	K07432	ko01100	Metabolic pathways	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMT200079551	K07432	ko00510	N-Glycan biosynthesis	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMT200079551	K07432	ko01100	Metabolic pathways	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMT200079552	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMT200079553	K12822	ko03040	Spliceosome	4410	2.1e-237	0.58	0.73	0.99
PGSC0003DMT200079554	K12822	ko03040	Spliceosome	4433	1.1e-238	0.59	0.73	0.99
PGSC0003DMT200079555	K12822	ko03040	Spliceosome	476	7.5e-20	0.41	0.50	0.91
PGSC0003DMT200079556	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMT200079558	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMT200079559	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMT200079560	K12619	ko03018	RNA degradation	280	2.9e-06	0.24	0.40	0.62
PGSC0003DMT200079570	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMT200079571	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMT200079574	K08065	ko04612	Antigen processing and presentation	314	1.7e-11	0.49	0.66	0.60
PGSC0003DMT200007095	K01184	ko00040	Pentose and glucuronate interconversions	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMT200007095	K01184	ko00500	Starch and sucrose metabolism	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMT200007095	K01184	ko01100	Metabolic pathways	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMT200007101	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007101	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007101	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007101	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007102	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007102	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007102	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007102	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007103	K00036	ko00030	Pentose phosphate pathway	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMT200007103	K00036	ko00480	Glutathione metabolism	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMT200007103	K00036	ko01100	Metabolic pathways	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMT200007103	K00036	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMT200007104	K00036	ko00030	Pentose phosphate pathway	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMT200007104	K00036	ko00480	Glutathione metabolism	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMT200007104	K00036	ko01100	Metabolic pathways	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMT200007104	K00036	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMT200007105	K00036	ko00030	Pentose phosphate pathway	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMT200007105	K00036	ko00480	Glutathione metabolism	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMT200007105	K00036	ko01100	Metabolic pathways	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMT200007105	K00036	ko01110	Biosynthesis of secondary metabolites	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMT200007106	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007106	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007106	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007106	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMT200007122	K12398	ko04142	Lysosome	2911	1.0e-154	0.83	0.94	1.00
PGSC0003DMT200007123	K12398	ko04142	Lysosome	2169	8.5e-114	0.83	0.94	1.00
PGSC0003DMT200007124	K12398	ko04142	Lysosome	1612	4.5e-83	0.83	0.95	0.90
PGSC0003DMT200007125	K01193	ko00052	Galactose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMT200007125	K01193	ko00500	Starch and sucrose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMT200007125	K01193	ko01100	Metabolic pathways	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMT200032718	K02372	ko00061	Fatty acid biosynthesis	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMT200032718	K02372	ko01100	Metabolic pathways	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMT200032737	K02858	ko00740	Riboflavin metabolism	2143	2.3e-112	0.68	0.79	0.93
PGSC0003DMT200032738	K02858	ko00740	Riboflavin metabolism	2374	4.2e-125	0.82	0.90	0.97
PGSC0003DMT200032739	K02858	ko00740	Riboflavin metabolism	3357	2.5e-179	0.74	0.84	0.99
PGSC0003DMT200021851	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMT200021851	K03857	ko01100	Metabolic pathways	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMT200021854	K04040	ko00860	Porphyrin and chlorophyll metabolism	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMT200021854	K04040	ko01100	Metabolic pathways	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMT200021854	K04040	ko01110	Biosynthesis of secondary metabolites	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMT200021871	K08915	ko00196	Photosynthesis - antenna proteins	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMT200021871	K08915	ko01100	Metabolic pathways	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMT200021872	K09648	ko03060	Protein export	498	1.2e-21	0.75	0.83	0.82
PGSC0003DMT200021873	K09648	ko03060	Protein export	434	4.2e-18	0.65	0.79	0.99
PGSC0003DMT200021874	K09648	ko03060	Protein export	965	2.2e-47	0.68	0.80	0.96
PGSC0003DMT200021875	K09648	ko03060	Protein export	799	3.1e-38	0.69	0.80	0.89
PGSC0003DMT200021880	K02085	ko04310	Wnt signaling pathway	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021880	K02085	ko04810	Regulation of actin cytoskeleton	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021880	K02085	ko05200	Pathways in cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021880	K02085	ko05210	Colorectal cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021880	K02085	ko05213	Endometrial cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021880	K02085	ko05217	Basal cell carcinoma	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMT200021881	K02085	ko04310	Wnt signaling pathway	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200021881	K02085	ko04810	Regulation of actin cytoskeleton	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200021881	K02085	ko05200	Pathways in cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200021881	K02085	ko05210	Colorectal cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200021881	K02085	ko05213	Endometrial cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200021881	K02085	ko05217	Basal cell carcinoma	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMT200041160	K12617	ko03018	RNA degradation	470	9.4e-20	0.50	0.59	0.79
PGSC0003DMT200041161	K12617	ko03018	RNA degradation	847	7.0e-41	0.73	0.84	0.99
PGSC0003DMT200041162	K12617	ko03018	RNA degradation	247	4.4e-07	0.51	0.63	0.81
PGSC0003DMT200041173	K00889	ko00562	Inositol phosphate metabolism	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041173	K00889	ko01100	Metabolic pathways	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041173	K00889	ko04070	Phosphatidylinositol signaling system	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041173	K00889	ko04144	Endocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041173	K00889	ko04666	Fc gamma R-mediated phagocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041173	K00889	ko04810	Regulation of actin cytoskeleton	7079	0.	0.53	0.64	1.00
PGSC0003DMT200041174	K00889	ko00562	Inositol phosphate metabolism	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041174	K00889	ko01100	Metabolic pathways	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041174	K00889	ko04070	Phosphatidylinositol signaling system	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041174	K00889	ko04144	Endocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041174	K00889	ko04666	Fc gamma R-mediated phagocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041174	K00889	ko04810	Regulation of actin cytoskeleton	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMT200041175	K00889	ko00562	Inositol phosphate metabolism	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041175	K00889	ko01100	Metabolic pathways	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041175	K00889	ko04070	Phosphatidylinositol signaling system	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041175	K00889	ko04144	Endocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041175	K00889	ko04666	Fc gamma R-mediated phagocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041175	K00889	ko04810	Regulation of actin cytoskeleton	8889	0.	0.61	0.74	1.00
PGSC0003DMT200041176	K01051	ko00040	Pentose and glucuronate interconversions	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMT200041176	K01051	ko00500	Starch and sucrose metabolism	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMT200041176	K01051	ko01100	Metabolic pathways	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMT200041179	K00290	ko00300	Lysine biosynthesis	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMT200041179	K00290	ko00310	Lysine degradation	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMT200041179	K00290	ko01100	Metabolic pathways	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMT200041179	K00290	ko01110	Biosynthesis of secondary metabolites	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMT200041180	K00292	ko00310	Lysine degradation	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMT200041180	K00292	ko01100	Metabolic pathways	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMT200041180	K00292	ko01110	Biosynthesis of secondary metabolites	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMT200041181	K00292	ko00310	Lysine degradation	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMT200041181	K00292	ko01100	Metabolic pathways	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMT200041181	K00292	ko01110	Biosynthesis of secondary metabolites	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMT200041184	K00292	ko00310	Lysine degradation	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMT200041184	K00292	ko01100	Metabolic pathways	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMT200041184	K00292	ko01110	Biosynthesis of secondary metabolites	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMT200041193	K01051	ko00040	Pentose and glucuronate interconversions	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMT200041193	K01051	ko00500	Starch and sucrose metabolism	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMT200041193	K01051	ko01100	Metabolic pathways	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMT200041195	K10134	ko04115	p53 signaling pathway	242	1.6e-07	0.32	0.44	0.69
PGSC0003DMT200015455	K01509	ko00230	Purine metabolism	2089	2.2e-109	0.41	0.57	0.98
PGSC0003DMT200015459	K12394	ko04142	Lysosome	723	4.8e-34	0.66	0.82	0.86
PGSC0003DMT200015460	K12394	ko04142	Lysosome	219	3.0e-06	0.68	0.85	0.47
PGSC0003DMT200015461	K12394	ko04142	Lysosome	936	8.6e-46	0.73	0.88	0.90
PGSC0003DMT200015483	K10755	ko03030	DNA replication	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMT200015483	K10755	ko03420	Nucleotide excision repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMT200015483	K10755	ko03430	Mismatch repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMT200015489	K03070	ko03060	Protein export	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMT200015489	K03070	ko03070	Bacterial secretion system	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMT200015490	K03070	ko03060	Protein export	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMT200015490	K03070	ko03070	Bacterial secretion system	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMT200015491	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMT200015491	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMT200015492	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMT200015492	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMT200015493	K03070	ko03060	Protein export	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMT200015493	K03070	ko03070	Bacterial secretion system	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMT200015494	K03070	ko03060	Protein export	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMT200015494	K03070	ko03070	Bacterial secretion system	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMT200001709	K00507	ko01040	Biosynthesis of unsaturated fatty acids	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMT200001709	K00507	ko03320	PPAR signaling pathway	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMT200001713	K06666	ko04111	Cell cycle - yeast	318	9.8e-09	0.27	0.42	0.52
PGSC0003DMT200001736	K01757	ko00901	Indole alkaloid biosynthesis	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMT200001736	K01757	ko01100	Metabolic pathways	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMT200001736	K01757	ko01110	Biosynthesis of secondary metabolites	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMT200001740	K05280	ko00941	Flavonoid biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMT200001740	K05280	ko00944	Flavone and flavonol biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMT200001740	K05280	ko01100	Metabolic pathways	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMT200001740	K05280	ko01110	Biosynthesis of secondary metabolites	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMT200001745	K10536	ko00330	Arginine and proline metabolism	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMT200001745	K10536	ko01100	Metabolic pathways	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMT200092772	K12356	ko00940	Phenylpropanoid biosynthesis	596	4.9e-27	0.33	0.49	0.95
PGSC0003DMT200092778	K11816	ko00380	Tryptophan metabolism	1143	3.3e-57	0.42	0.60	0.98
PGSC0003DMT200092793	K03681	ko03018	RNA degradation	503	6.6e-22	0.67	0.80	0.59
PGSC0003DMT200085274	K04705	ko04144	Endocytosis	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMT200085274	K04705	ko04630	Jak-STAT signaling pathway	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMT200085281	K11294	ko05130	Pathogenic Escherichia coli infection	245	4.7e-07	0.53	0.59	0.81
PGSC0003DMT200085288	K04733	ko04210	Apoptosis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMT200085288	K04733	ko04620	Toll-like receptor signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMT200085288	K04733	ko04722	Neurotrophin signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMT200085288	K04733	ko05140	Leishmaniasis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMT200085288	K04733	ko05142	Chagas disease	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMT200049951	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049951	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMT200049952	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049952	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMT200049953	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049953	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMT200049974	K04733	ko04210	Apoptosis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMT200049974	K04733	ko04620	Toll-like receptor signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMT200049974	K04733	ko04722	Neurotrophin signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMT200049974	K04733	ko05140	Leishmaniasis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMT200049974	K04733	ko05142	Chagas disease	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMT200049986	K02635	ko00195	Photosynthesis	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMT200049986	K02635	ko01100	Metabolic pathways	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMT200075360	K00895	ko00051	Fructose and mannose metabolism	4420	6.0e-238	0.83	0.92	1.00
PGSC0003DMT200075380	K05868	ko04110	Cell cycle	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMT200075380	K05868	ko04115	p53 signaling pathway	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMT200075380	K05868	ko04914	Progesterone-mediated oocyte maturation	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMT200075387	K10591	ko04120	Ubiquitin mediated proteolysis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMT200075387	K10591	ko04144	Endocytosis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMT200075394	K10526	ko00592	alpha-Linolenic acid metabolism	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMT200075394	K10526	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMT200075398	K00423	ko00053	Ascorbate and aldarate metabolism	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMT200075398	K00423	ko01100	Metabolic pathways	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMT200075399	K00423	ko00053	Ascorbate and aldarate metabolism	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMT200075399	K00423	ko01100	Metabolic pathways	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMT200058661	K01099	ko00562	Inositol phosphate metabolism	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMT200058661	K01099	ko01100	Metabolic pathways	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMT200058661	K01099	ko04070	Phosphatidylinositol signaling system	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMT200058676	K08241	ko00592	alpha-Linolenic acid metabolism	529	2.4e-23	0.36	0.51	0.83
PGSC0003DMT200058680	K00133	ko00260	Glycine, serine and threonine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMT200058680	K00133	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMT200058680	K00133	ko00300	Lysine biosynthesis	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMT200058680	K00133	ko01100	Metabolic pathways	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMT200058680	K00133	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMT200087455	K00797	ko00270	Cysteine and methionine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMT200087455	K00797	ko00330	Arginine and proline metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMT200087455	K00797	ko00410	beta-Alanine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMT200087455	K00797	ko00480	Glutathione metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMT200087455	K00797	ko01100	Metabolic pathways	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMT200026230	K13065	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMT200026230	K13065	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMT200026230	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMT200026230	K13065	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMT200026231	K13065	ko00940	Phenylpropanoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMT200026231	K13065	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMT200026231	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMT200026231	K13065	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMT200026253	K08008	ko04145	Phagosome	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMT200026253	K08008	ko04670	Leukocyte transendothelial migration	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMT200026254	K08008	ko04145	Phagosome	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMT200026254	K08008	ko04670	Leukocyte transendothelial migration	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMT200007815	K08008	ko04145	Phagosome	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMT200007815	K08008	ko04670	Leukocyte transendothelial migration	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMT200007816	K08008	ko04145	Phagosome	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMT200007816	K08008	ko04670	Leukocyte transendothelial migration	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMT200007823	K02084	ko04115	p53 signaling pathway	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko04210	Apoptosis	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko05010	Alzheimer's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko05012	Parkinson's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko05016	Huntington's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007823	K02084	ko05222	Small cell lung cancer	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMT200007840	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMT200007840	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMT200007840	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMT200007840	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMT200007840	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMT200007841	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMT200007841	K00517	ko00626	Naphthalene and anthracene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMT200007841	K00517	ko00903	Limonene and pinene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMT200007841	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMT200007841	K00517	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMT200007842	K05293	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMT200007842	K05293	ko01100	Metabolic pathways	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMT200007847	K09843	ko00906	Carotenoid biosynthesis	385	2.1e-15	0.34	0.58	0.82
PGSC0003DMT200007849	K09587	ko00905	Brassinosteroid biosynthesis	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMT200007849	K09587	ko01100	Metabolic pathways	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMT200007849	K09587	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMT200007850	K04424	ko04010	MAPK signaling pathway	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMT200007850	K04424	ko04530	Tight junction	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMT200020660	K00759	ko00230	Purine metabolism	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMT200020660	K00759	ko01100	Metabolic pathways	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMT200020670	K09054	ko05010	Alzheimer's disease	288	9.7e-08	0.31	0.47	0.48
PGSC0003DMT200020671	K09054	ko05010	Alzheimer's disease	280	3.0e-07	0.31	0.47	0.46
PGSC0003DMT200020686	K09756	ko00940	Phenylpropanoid biosynthesis	694	1.8e-40	0.45	0.67	0.88
PGSC0003DMT200020688	K09756	ko00940	Phenylpropanoid biosynthesis	1585	1.4e-81	0.45	0.62	0.99
PGSC0003DMT200011046	K01728	ko00040	Pentose and glucuronate interconversions	1359	4.0e-69	0.61	0.77	0.85
PGSC0003DMT200011048	K02704	ko00195	Photosynthesis	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMT200011048	K02704	ko01100	Metabolic pathways	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMT200011071	K00162	ko00010	Glycolysis / Gluconeogenesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko00020	Citrate cycle (TCA cycle)	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko00620	Pyruvate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko00650	Butanoate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko01100	Metabolic pathways	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011071	K00162	ko01110	Biosynthesis of secondary metabolites	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMT200011072	K00162	ko00010	Glycolysis / Gluconeogenesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko00020	Citrate cycle (TCA cycle)	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko00620	Pyruvate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko00650	Butanoate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko01100	Metabolic pathways	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200011072	K00162	ko01110	Biosynthesis of secondary metabolites	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMT200089703	K05282	ko00904	Diterpenoid biosynthesis	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMT200089703	K05282	ko01100	Metabolic pathways	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMT200089703	K05282	ko01110	Biosynthesis of secondary metabolites	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMT200088204	K00901	ko00561	Glycerolipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMT200088204	K00901	ko00564	Glycerophospholipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMT200088204	K00901	ko01100	Metabolic pathways	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMT200088204	K00901	ko04070	Phosphatidylinositol signaling system	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMT200063671	K08065	ko04612	Antigen processing and presentation	470	4.3e-20	0.53	0.76	0.76
PGSC0003DMT200063673	K11984	ko03040	Spliceosome	1080	9.9e-54	0.51	0.64	0.93
PGSC0003DMT200063674	K11984	ko03040	Spliceosome	869	4.3e-42	0.52	0.64	0.93
PGSC0003DMT200063677	K11251	ko05322	Systemic lupus erythematosus	999	2.9e-49	0.79	0.86	0.99
PGSC0003DMT200063686	K00799	ko00480	Glutathione metabolism	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMT200063686	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMT200063686	K00799	ko00982	Drug metabolism - cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMT200063688	K08008	ko04145	Phagosome	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMT200063688	K08008	ko04670	Leukocyte transendothelial migration	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMT200063697	K02947	ko03010	Ribosome	1488	3.1e-76	0.92	0.96	0.98
PGSC0003DMT200063701	K12890	ko03040	Spliceosome	1333	1.1e-67	0.85	0.91	0.54
PGSC0003DMT200063703	K12890	ko03040	Spliceosome	1629	5.2e-84	0.73	0.79	0.98
PGSC0003DMT200063704	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMT200054225	K02965	ko03010	Ribosome	520	7.6e-23	0.68	0.80	0.96
PGSC0003DMT200004989	K02703	ko00195	Photosynthesis	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMT200004989	K02703	ko01100	Metabolic pathways	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMT200004995	K00469	ko00053	Ascorbate and aldarate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMT200004995	K00469	ko00562	Inositol phosphate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMT200004996	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.68
PGSC0003DMT200004997	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.96
PGSC0003DMT200004999	K02183	ko04020	Calcium signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04070	Phosphatidylinositol signaling system	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04114	Oocyte meiosis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04270	Vascular smooth muscle contraction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04626	Plant-pathogen interaction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04720	Long-term potentiation	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04740	Olfactory transduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04744	Phototransduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04745	Phototransduction - fly	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04910	Insulin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04912	GnRH signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04916	Melanogenesis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04970	Salivary secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko04971	Gastric acid secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko05010	Alzheimer's disease	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200004999	K02183	ko05214	Glioma	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMT200005001	K00365	ko00230	Purine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMT200005001	K00365	ko00232	Caffeine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMT200005001	K00365	ko01100	Metabolic pathways	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMT200005002	K03885	ko00190	Oxidative phosphorylation	474	3.4e-20	0.33	0.45	0.90
PGSC0003DMT200005006	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko04210	Apoptosis	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko05016	Huntington's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005006	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMT200005011	K02084	ko04115	p53 signaling pathway	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko04210	Apoptosis	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko05010	Alzheimer's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko05012	Parkinson's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko05016	Huntington's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005011	K02084	ko05222	Small cell lung cancer	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMT200005012	K02084	ko04115	p53 signaling pathway	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko04210	Apoptosis	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko05010	Alzheimer's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko05012	Parkinson's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko05016	Huntington's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005012	K02084	ko05222	Small cell lung cancer	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMT200005013	K02084	ko04115	p53 signaling pathway	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko04210	Apoptosis	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko05010	Alzheimer's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko05012	Parkinson's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko05016	Huntington's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005013	K02084	ko05222	Small cell lung cancer	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMT200005017	K02084	ko04115	p53 signaling pathway	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko04210	Apoptosis	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko05010	Alzheimer's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko05012	Parkinson's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko05016	Huntington's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005017	K02084	ko05222	Small cell lung cancer	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMT200005018	K12198	ko04144	Endocytosis	1692	1.7e-87	0.86	0.94	1.00
PGSC0003DMT200005025	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005025	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005025	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005025	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200005025	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMT200014021	K10527	ko00592	alpha-Linolenic acid metabolism	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMT200014021	K10527	ko01100	Metabolic pathways	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMT200014022	K10527	ko00592	alpha-Linolenic acid metabolism	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMT200014022	K10527	ko01100	Metabolic pathways	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMT200014023	K10527	ko00592	alpha-Linolenic acid metabolism	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMT200014023	K10527	ko01100	Metabolic pathways	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMT200014024	K10527	ko00592	alpha-Linolenic acid metabolism	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMT200014024	K10527	ko01100	Metabolic pathways	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMT200014025	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014025	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014025	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014026	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014026	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014026	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014027	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014027	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014027	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMT200014051	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMT200014052	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMT200014053	K01199	ko00500	Starch and sucrose metabolism	707	3.7e-33	0.34	0.54	0.67
PGSC0003DMT200014067	K00423	ko00053	Ascorbate and aldarate metabolism	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMT200014067	K00423	ko01100	Metabolic pathways	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMT200014068	K00423	ko00053	Ascorbate and aldarate metabolism	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMT200014068	K00423	ko01100	Metabolic pathways	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMT200022103	K01593	ko00340	Histidine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00350	Tyrosine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00360	Phenylalanine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00380	Tryptophan metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00901	Indole alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko00965	Betalain biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko01100	Metabolic pathways	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022103	K01593	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMT200022104	K01593	ko00340	Histidine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00350	Tyrosine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00360	Phenylalanine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00380	Tryptophan metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00901	Indole alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00950	Isoquinoline alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko00965	Betalain biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko01100	Metabolic pathways	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022104	K01593	ko01110	Biosynthesis of secondary metabolites	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMT200022105	K01593	ko00340	Histidine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00350	Tyrosine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00360	Phenylalanine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00380	Tryptophan metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00901	Indole alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko00965	Betalain biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko01100	Metabolic pathways	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022105	K01593	ko01110	Biosynthesis of secondary metabolites	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMT200022107	K05666	ko02010	ABC transporters	3248	2.6e-173	0.37	0.56	0.89
PGSC0003DMT200022108	K05666	ko02010	ABC transporters	3310	9.9e-177	0.36	0.55	0.91
PGSC0003DMT200022109	K05673	ko02010	ABC transporters	1972	6.2e-103	0.36	0.54	0.78
PGSC0003DMT200022110	K05666	ko02010	ABC transporters	484	7.4e-20	0.35	0.52	0.94
PGSC0003DMT200022111	K05666	ko02010	ABC transporters	1473	2.1e-75	0.47	0.70	0.96
PGSC0003DMT200022113	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022113	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022113	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022113	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022113	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022114	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022114	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022114	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022114	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022114	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMT200022117	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.50
PGSC0003DMT200022118	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.40
PGSC0003DMT200022121	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	465	2.5e-19	0.37	0.49	0.85
PGSC0003DMT200022131	K08903	ko00195	Photosynthesis	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMT200022131	K08903	ko01100	Metabolic pathways	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMT200022135	K01768	ko00230	Purine metabolism	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMT200022135	K01768	ko04113	Meiosis - yeast	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMT200097539	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097539	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMT200097550	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMT200097550	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMT200097550	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMT200097550	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMT200097550	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMT200097557	K01754	ko00260	Glycine, serine and threonine metabolism	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMT200097557	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMT200097557	K01754	ko01100	Metabolic pathways	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMT200097557	K01754	ko01110	Biosynthesis of secondary metabolites	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMT200097562	K10760	ko00908	Zeatin biosynthesis	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMT200097562	K10760	ko01100	Metabolic pathways	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMT200097562	K10760	ko01110	Biosynthesis of secondary metabolites	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMT200092352	K12836	ko03040	Spliceosome	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMT200092352	K12836	ko05131	Shigellosis	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMT200092364	K01051	ko00040	Pentose and glucuronate interconversions	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMT200092364	K01051	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMT200092364	K01051	ko01100	Metabolic pathways	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMT200051581	K01853	ko00100	Steroid biosynthesis	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMT200051581	K01853	ko01100	Metabolic pathways	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMT200051581	K01853	ko01110	Biosynthesis of secondary metabolites	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMT200051584	K01853	ko00100	Steroid biosynthesis	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMT200051584	K01853	ko01100	Metabolic pathways	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMT200051584	K01853	ko01110	Biosynthesis of secondary metabolites	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMT200051586	K01590	ko00340	Histidine metabolism	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMT200051586	K01590	ko01100	Metabolic pathways	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMT200051586	K01590	ko01110	Biosynthesis of secondary metabolites	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMT200051614	K12621	ko03018	RNA degradation	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMT200051614	K12621	ko03040	Spliceosome	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMT200051616	K12621	ko03018	RNA degradation	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMT200051616	K12621	ko03040	Spliceosome	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMT200051635	K04120	ko00904	Diterpenoid biosynthesis	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMT200051635	K04120	ko01100	Metabolic pathways	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMT200051635	K04120	ko01110	Biosynthesis of secondary metabolites	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMT200051640	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMT200060784	K04733	ko04210	Apoptosis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMT200060784	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMT200060784	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMT200060784	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMT200060784	K04733	ko05142	Chagas disease	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMT200060796	K03035	ko03050	Proteasome	3171	4.6e-169	0.86	0.94	1.00
PGSC0003DMT200060798	K02084	ko04115	p53 signaling pathway	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko04210	Apoptosis	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko05010	Alzheimer's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko05012	Parkinson's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko05016	Huntington's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200060798	K02084	ko05222	Small cell lung cancer	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMT200068479	K03405	ko00860	Porphyrin and chlorophyll metabolism	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMT200068479	K03405	ko01100	Metabolic pathways	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMT200068479	K03405	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMT200068480	K03405	ko00860	Porphyrin and chlorophyll metabolism	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMT200068480	K03405	ko01100	Metabolic pathways	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMT200068480	K03405	ko01110	Biosynthesis of secondary metabolites	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMT200068482	K13065	ko00940	Phenylpropanoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMT200068482	K13065	ko00941	Flavonoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMT200068482	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMT200068482	K13065	ko01110	Biosynthesis of secondary metabolites	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMT200068490	K13065	ko00940	Phenylpropanoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMT200068490	K13065	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMT200068490	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMT200068490	K13065	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMT200068514	K03178	ko04120	Ubiquitin mediated proteolysis	7544	0.	0.80	0.90	1.00
PGSC0003DMT200068514	K03178	ko05012	Parkinson's disease	7544	0.	0.80	0.90	1.00
PGSC0003DMT200068515	K08059	ko04612	Antigen processing and presentation	802	2.1e-38	0.48	0.67	0.84
PGSC0003DMT200068516	K08059	ko04612	Antigen processing and presentation	442	1.5e-18	0.43	0.63	0.90
PGSC0003DMT200075085	K04382	ko04111	Cell cycle - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04113	Meiosis - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04114	Oocyte meiosis	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04310	Wnt signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04350	TGF-beta signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04530	Tight junction	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko04730	Long-term depression	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075085	K04382	ko05142	Chagas disease	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMT200075092	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMT200075092	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMT200075092	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMT200075092	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMT200075092	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMT200075098	K01728	ko00040	Pentose and glucuronate interconversions	1586	1.2e-81	0.67	0.83	0.82
PGSC0003DMT200075101	K09755	ko00940	Phenylpropanoid biosynthesis	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMT200075101	K09755	ko01100	Metabolic pathways	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMT200075101	K09755	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMT200075106	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMT200075106	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMT200075107	K07748	ko00100	Steroid biosynthesis	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMT200075107	K07748	ko01100	Metabolic pathways	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMT200075108	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMT200075108	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMT200075109	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMT200075109	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMT200093554	K02155	ko00190	Oxidative phosphorylation	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko01100	Metabolic pathways	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko04142	Lysosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko04145	Phagosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko04966	Collecting duct acid secretion	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko05110	Vibrio cholerae infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093554	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMT200093573	K03094	ko04110	Cell cycle	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04111	Cell cycle - yeast	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04114	Oocyte meiosis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04120	Ubiquitin mediated proteolysis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04310	Wnt signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04350	TGF-beta signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200093573	K03094	ko04710	Circadian rhythm - mammal	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMT200006828	K05581	ko00190	Oxidative phosphorylation	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMT200006828	K05581	ko01100	Metabolic pathways	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMT200006851	K09054	ko05010	Alzheimer's disease	276	5.5e-07	0.30	0.44	0.65
PGSC0003DMT200006854	K03531	ko04112	Cell cycle - Caulobacter	2227	5.4e-117	0.79	0.88	0.97
PGSC0003DMT200006855	K03531	ko04112	Cell cycle - Caulobacter	1025	1.1e-50	0.89	0.94	0.99
PGSC0003DMT200006856	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMT200006857	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMT200023831	K00627	ko00010	Glycolysis / Gluconeogenesis	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMT200023831	K00627	ko00020	Citrate cycle (TCA cycle)	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMT200023831	K00627	ko00620	Pyruvate metabolism	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMT200023831	K00627	ko01100	Metabolic pathways	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMT200023831	K00627	ko01110	Biosynthesis of secondary metabolites	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMT200023843	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMT200023843	K03434	ko01100	Metabolic pathways	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMT200023844	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMT200023844	K03434	ko01100	Metabolic pathways	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMT200023851	K01190	ko00052	Galactose metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMT200023851	K01190	ko00511	Other glycan degradation	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMT200023851	K01190	ko00600	Sphingolipid metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMT200023851	K01190	ko01100	Metabolic pathways	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMT200023852	K01190	ko00052	Galactose metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMT200023852	K01190	ko00511	Other glycan degradation	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMT200023852	K01190	ko00600	Sphingolipid metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMT200023852	K01190	ko01100	Metabolic pathways	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMT200023862	K01190	ko00052	Galactose metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMT200023862	K01190	ko00511	Other glycan degradation	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMT200023862	K01190	ko00600	Sphingolipid metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMT200023862	K01190	ko01100	Metabolic pathways	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMT200023863	K01190	ko00052	Galactose metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMT200023863	K01190	ko00511	Other glycan degradation	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMT200023863	K01190	ko00600	Sphingolipid metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMT200023863	K01190	ko01100	Metabolic pathways	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMT200023864	K01190	ko00052	Galactose metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMT200023864	K01190	ko00511	Other glycan degradation	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMT200023864	K01190	ko00600	Sphingolipid metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMT200023864	K01190	ko01100	Metabolic pathways	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMT200015725	K11644	ko05016	Huntington's disease	236	3.8e-06	0.27	0.47	0.65
PGSC0003DMT200015734	K04079	ko04612	Antigen processing and presentation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015734	K04079	ko04621	NOD-like receptor signaling pathway	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015734	K04079	ko04626	Plant-pathogen interaction	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015734	K04079	ko04914	Progesterone-mediated oocyte maturation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015734	K04079	ko05200	Pathways in cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015734	K04079	ko05215	Prostate cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMT200015735	K04079	ko04612	Antigen processing and presentation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015735	K04079	ko04621	NOD-like receptor signaling pathway	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015735	K04079	ko04626	Plant-pathogen interaction	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015735	K04079	ko04914	Progesterone-mediated oocyte maturation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015735	K04079	ko05200	Pathways in cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015735	K04079	ko05215	Prostate cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMT200015737	K00059	ko00061	Fatty acid biosynthesis	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMT200015737	K00059	ko01040	Biosynthesis of unsaturated fatty acids	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMT200015737	K00059	ko01100	Metabolic pathways	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMT200015740	K08913	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMT200015740	K08913	ko01100	Metabolic pathways	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMT200030710	K01213	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMT200030710	K01213	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMT200030710	K01213	ko01100	Metabolic pathways	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMT200030711	K01213	ko00040	Pentose and glucuronate interconversions	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMT200030711	K01213	ko00500	Starch and sucrose metabolism	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMT200030711	K01213	ko01100	Metabolic pathways	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMT200030733	K01809	ko00051	Fructose and mannose metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMT200030733	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMT200030733	K01809	ko01100	Metabolic pathways	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMT200030733	K01809	ko01110	Biosynthesis of secondary metabolites	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMT200030735	K12929	ko00904	Diterpenoid biosynthesis	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMT200030735	K12929	ko01110	Biosynthesis of secondary metabolites	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMT200030737	K12929	ko00904	Diterpenoid biosynthesis	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMT200030737	K12929	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMT200030739	K12929	ko00904	Diterpenoid biosynthesis	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMT200030739	K12929	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMT200030740	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMT200030740	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMT200030741	K12929	ko00904	Diterpenoid biosynthesis	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMT200030741	K12929	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMT200030742	K12929	ko00904	Diterpenoid biosynthesis	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMT200030742	K12929	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMT200030743	K12929	ko00904	Diterpenoid biosynthesis	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMT200030743	K12929	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMT200030744	K12929	ko00904	Diterpenoid biosynthesis	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMT200030744	K12929	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMT200030745	K12929	ko00904	Diterpenoid biosynthesis	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMT200030745	K12929	ko01110	Biosynthesis of secondary metabolites	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMT200030746	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMT200030746	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMT200030747	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMT200030747	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMT200030748	K12929	ko00904	Diterpenoid biosynthesis	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMT200030748	K12929	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMT200030750	K10756	ko03030	DNA replication	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMT200030750	K10756	ko03420	Nucleotide excision repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMT200030750	K10756	ko03430	Mismatch repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMT200049718	K00547	ko00270	Cysteine and methionine metabolism	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMT200049718	K00547	ko01100	Metabolic pathways	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMT200049718	K00547	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMT200049719	K00547	ko00270	Cysteine and methionine metabolism	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMT200049719	K00547	ko01100	Metabolic pathways	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMT200049719	K00547	ko01110	Biosynthesis of secondary metabolites	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMT200049720	K00547	ko00270	Cysteine and methionine metabolism	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMT200049720	K00547	ko01100	Metabolic pathways	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMT200049720	K00547	ko01110	Biosynthesis of secondary metabolites	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMT200049726	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049726	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049726	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049727	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049727	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049727	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMT200049728	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMT200049728	K00517	ko00626	Naphthalene and anthracene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMT200049728	K00517	ko00903	Limonene and pinene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMT200049728	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMT200049728	K00517	ko01110	Biosynthesis of secondary metabolites	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMT200066821	K01509	ko00230	Purine metabolism	1308	2.6e-66	0.42	0.58	0.91
PGSC0003DMT200066841	K08332	ko04140	Regulation of autophagy	376	5.2e-12	0.30	0.46	0.47
PGSC0003DMT200066847	K12585	ko03018	RNA degradation	239	1.6e-06	0.54	0.62	0.82
PGSC0003DMT200058920	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMT200058920	K11517	ko01100	Metabolic pathways	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMT200058920	K11517	ko04146	Peroxisome	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMT200058921	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMT200058921	K11517	ko01100	Metabolic pathways	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMT200058921	K11517	ko04146	Peroxisome	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMT200058922	K09458	ko00061	Fatty acid biosynthesis	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMT200058922	K09458	ko01100	Metabolic pathways	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMT200058923	K09458	ko00061	Fatty acid biosynthesis	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMT200058923	K09458	ko01100	Metabolic pathways	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMT200058924	K09458	ko00061	Fatty acid biosynthesis	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMT200058924	K09458	ko01100	Metabolic pathways	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMT200058927	K05280	ko00941	Flavonoid biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMT200058927	K05280	ko00944	Flavone and flavonol biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMT200058927	K05280	ko01100	Metabolic pathways	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMT200058927	K05280	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMT200058928	K05280	ko00941	Flavonoid biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMT200058928	K05280	ko00944	Flavone and flavonol biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMT200058928	K05280	ko01100	Metabolic pathways	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMT200058928	K05280	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMT200058930	K05280	ko00941	Flavonoid biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMT200058930	K05280	ko00944	Flavone and flavonol biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMT200058930	K05280	ko01100	Metabolic pathways	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMT200058930	K05280	ko01110	Biosynthesis of secondary metabolites	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMT200058932	K00454	ko00591	Linoleic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMT200058932	K00454	ko00592	alpha-Linolenic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMT200058932	K00454	ko01100	Metabolic pathways	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMT200058933	K00454	ko00591	Linoleic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMT200058933	K00454	ko00592	alpha-Linolenic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMT200058933	K00454	ko01100	Metabolic pathways	5702	0.	0.72	0.84	1.00
PGSC0003DMT200058934	K00454	ko00591	Linoleic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMT200058934	K00454	ko00592	alpha-Linolenic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMT200058934	K00454	ko01100	Metabolic pathways	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMT200058946	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMT200058947	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMT200058949	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMT200058949	K11517	ko01100	Metabolic pathways	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMT200058949	K11517	ko04146	Peroxisome	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMT200058950	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMT200058950	K11517	ko01100	Metabolic pathways	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMT200058950	K11517	ko04146	Peroxisome	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMT200058951	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMT200058951	K11517	ko01100	Metabolic pathways	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMT200058951	K11517	ko04146	Peroxisome	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMT200058954	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMT200058954	K11517	ko01100	Metabolic pathways	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMT200058954	K11517	ko04146	Peroxisome	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMT200058955	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMT200058955	K11517	ko01100	Metabolic pathways	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMT200058955	K11517	ko04146	Peroxisome	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMT200058956	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMT200058956	K11517	ko01100	Metabolic pathways	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMT200058956	K11517	ko04146	Peroxisome	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMT200088493	K05350	ko00460	Cyanoamino acid metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMT200088493	K05350	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMT200088493	K05350	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMT200088493	K05350	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMT200044024	K08269	ko04140	Regulation of autophagy	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMT200044024	K08269	ko04150	mTOR signaling pathway	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMT200044025	K08269	ko04140	Regulation of autophagy	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMT200044025	K08269	ko04150	mTOR signaling pathway	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMT200044026	K02183	ko04020	Calcium signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04070	Phosphatidylinositol signaling system	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04114	Oocyte meiosis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04270	Vascular smooth muscle contraction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04626	Plant-pathogen interaction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04720	Long-term potentiation	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04722	Neurotrophin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04740	Olfactory transduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04744	Phototransduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04745	Phototransduction - fly	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04910	Insulin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04912	GnRH signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04916	Melanogenesis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04970	Salivary secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko04971	Gastric acid secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko05010	Alzheimer's disease	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044026	K02183	ko05214	Glioma	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMT200044033	K03456	ko04111	Cell cycle - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04113	Meiosis - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04114	Oocyte meiosis	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04310	Wnt signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04350	TGF-beta signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04530	Tight junction	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko04730	Long-term depression	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044033	K03456	ko05142	Chagas disease	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMT200044062	K00849	ko00052	Galactose metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMT200044062	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMT200044062	K00849	ko01100	Metabolic pathways	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMT200044063	K00001	ko00010	Glycolysis / Gluconeogenesis	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00071	Fatty acid metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00350	Tyrosine metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00624	1- and 2-Methylnaphthalene degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00641	3-Chloroacrylic acid degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00830	Retinol metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko00982	Drug metabolism - cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko01100	Metabolic pathways	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200044063	K00001	ko01110	Biosynthesis of secondary metabolites	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMT200009334	K03544	ko04112	Cell cycle - Caulobacter	299	1.5e-14	0.48	0.67	0.88
PGSC0003DMT200009339	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009339	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMT200009345	K01711	ko00051	Fructose and mannose metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMT200009345	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMT200009345	K01711	ko01100	Metabolic pathways	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMT200009352	K01179	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.47	0.72	0.88
PGSC0003DMT200009353	K01179	ko00500	Starch and sucrose metabolism	1027	8.3e-51	0.46	0.63	0.96
PGSC0003DMT200009354	K01179	ko00500	Starch and sucrose metabolism	674	2.4e-31	0.44	0.60	0.90
PGSC0003DMT200009355	K01179	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.44	0.62	0.95
PGSC0003DMT200009356	K01179	ko00500	Starch and sucrose metabolism	1001	2.2e-49	0.47	0.64	0.89
PGSC0003DMT200018730	K10875	ko03440	Homologous recombination	4786	3.9e-258	0.69	0.79	0.91
PGSC0003DMT200018731	K10875	ko03440	Homologous recombination	5464	1.6e-295	0.74	0.84	0.92
PGSC0003DMT200018755	K01823	ko00900	Terpenoid backbone biosynthesis	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMT200018755	K01823	ko01100	Metabolic pathways	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMT200018755	K01823	ko01110	Biosynthesis of secondary metabolites	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMT200018774	K04751	ko02020	Two-component system	512	2.1e-22	0.59	0.78	0.55
PGSC0003DMT200052559	K01184	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMT200052559	K01184	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMT200052559	K01184	ko01100	Metabolic pathways	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMT200052561	K01184	ko00040	Pentose and glucuronate interconversions	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMT200052561	K01184	ko00500	Starch and sucrose metabolism	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMT200052561	K01184	ko01100	Metabolic pathways	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMT200052563	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMT200052563	K01873	ko00970	Aminoacyl-tRNA biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMT200052564	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMT200052564	K01873	ko00970	Aminoacyl-tRNA biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMT200052565	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMT200052565	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMT200052566	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMT200052566	K01873	ko00970	Aminoacyl-tRNA biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMT200052569	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMT200052569	K02367	ko01100	Metabolic pathways	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMT200052574	K01239	ko00230	Purine metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMT200052574	K01239	ko00760	Nicotinate and nicotinamide metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMT200052574	K01239	ko01100	Metabolic pathways	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMT200052576	K01239	ko00230	Purine metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMT200052576	K01239	ko00760	Nicotinate and nicotinamide metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMT200052576	K01239	ko01100	Metabolic pathways	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMT200052597	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00270	Cysteine and methionine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00330	Arginine and proline metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00350	Tyrosine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00360	Phenylalanine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00401	Novobiocin biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00710	Carbon fixation in photosynthetic organisms	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko01100	Metabolic pathways	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052597	K00813	ko01110	Biosynthesis of secondary metabolites	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMT200052599	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMT200052599	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMT200055960	K11820	ko00380	Tryptophan metabolism	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMT200055960	K11820	ko00966	Glucosinolate biosynthesis	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMT200055960	K11820	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMT200055961	K01501	ko00380	Tryptophan metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055961	K01501	ko00460	Cyanoamino acid metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055961	K01501	ko00632	Benzoate degradation via CoA ligation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055961	K01501	ko00643	Styrene degradation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055961	K01501	ko00910	Nitrogen metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055961	K01501	ko01100	Metabolic pathways	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMT200055962	K01501	ko00380	Tryptophan metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055962	K01501	ko00460	Cyanoamino acid metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055962	K01501	ko00632	Benzoate degradation via CoA ligation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055962	K01501	ko00643	Styrene degradation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055962	K01501	ko00910	Nitrogen metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055962	K01501	ko01100	Metabolic pathways	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMT200055963	K01501	ko00380	Tryptophan metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055963	K01501	ko00460	Cyanoamino acid metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055963	K01501	ko00632	Benzoate degradation via CoA ligation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055963	K01501	ko00643	Styrene degradation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055963	K01501	ko00910	Nitrogen metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055963	K01501	ko01100	Metabolic pathways	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMT200055965	K04424	ko04010	MAPK signaling pathway	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMT200055965	K04424	ko04530	Tight junction	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMT200055975	K02950	ko03010	Ribosome	639	2.1e-29	0.64	0.81	0.78
PGSC0003DMT200055981	K08803	ko05200	Pathways in cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMT200055981	K08803	ko05219	Bladder cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMT200055982	K08064	ko04612	Antigen processing and presentation	557	6.9e-25	0.61	0.79	0.53
PGSC0003DMT200055983	K08064	ko04612	Antigen processing and presentation	669	4.6e-31	0.45	0.65	0.70
PGSC0003DMT200056000	K00797	ko00270	Cysteine and methionine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMT200056000	K00797	ko00330	Arginine and proline metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMT200056000	K00797	ko00410	beta-Alanine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMT200056000	K00797	ko00480	Glutathione metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMT200056000	K00797	ko01100	Metabolic pathways	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMT200056001	K00797	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMT200056001	K00797	ko00330	Arginine and proline metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMT200056001	K00797	ko00410	beta-Alanine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMT200056001	K00797	ko00480	Glutathione metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMT200056001	K00797	ko01100	Metabolic pathways	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMT200056002	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMT200056003	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMT200056004	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMT200056005	K02985	ko03010	Ribosome	1798	2.5e-93	0.92	0.95	1.00
PGSC0003DMT200065364	K00162	ko00010	Glycolysis / Gluconeogenesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko00020	Citrate cycle (TCA cycle)	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko00620	Pyruvate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko00650	Butanoate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko01100	Metabolic pathways	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065364	K00162	ko01110	Biosynthesis of secondary metabolites	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMT200065365	K00162	ko00010	Glycolysis / Gluconeogenesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko00020	Citrate cycle (TCA cycle)	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko00620	Pyruvate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko00650	Butanoate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko01100	Metabolic pathways	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065365	K00162	ko01110	Biosynthesis of secondary metabolites	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMT200065366	K00162	ko00010	Glycolysis / Gluconeogenesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko00020	Citrate cycle (TCA cycle)	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko00620	Pyruvate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko00650	Butanoate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko01100	Metabolic pathways	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065366	K00162	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMT200065371	K01692	ko00071	Fatty acid metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00280	Valine, leucine and isoleucine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00281	Geraniol degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00310	Lysine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00380	Tryptophan metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00410	beta-Alanine metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00632	Benzoate degradation via CoA ligation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00640	Propanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00650	Butanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00903	Limonene and pinene degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko00930	Caprolactam degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko01100	Metabolic pathways	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065371	K01692	ko01110	Biosynthesis of secondary metabolites	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMT200065377	K12135	ko04712	Circadian rhythm - plant	316	1.4e-11	0.38	0.57	0.21
PGSC0003DMT200065388	K03654	ko03018	RNA degradation	2345	1.7e-123	0.63	0.76	0.94
PGSC0003DMT200065390	K03654	ko03018	RNA degradation	4503	1.6e-242	0.60	0.76	1.00
PGSC0003DMT200065391	K03654	ko03018	RNA degradation	1799	2.2e-93	0.48	0.64	0.94
PGSC0003DMT200065392	K03654	ko03018	RNA degradation	3061	5.4e-163	0.74	0.88	0.99
PGSC0003DMT200065393	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMT200065394	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMT200065395	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMT200073391	K05933	ko00270	Cysteine and methionine metabolism	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMT200073391	K05933	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMT200073397	K09753	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMT200073397	K09753	ko01100	Metabolic pathways	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMT200073397	K09753	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMT200073398	K09753	ko00940	Phenylpropanoid biosynthesis	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMT200073398	K09753	ko01100	Metabolic pathways	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMT200073398	K09753	ko01110	Biosynthesis of secondary metabolites	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMT200073399	K09753	ko00940	Phenylpropanoid biosynthesis	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMT200073399	K09753	ko01100	Metabolic pathways	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMT200073399	K09753	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMT200073431	K02937	ko03010	Ribosome	1389	8.9e-71	0.67	0.83	1.00
PGSC0003DMT200047416	K12796	ko04621	NOD-like receptor signaling pathway	369	8.8e-11	0.31	0.46	0.40
PGSC0003DMT200047435	K08901	ko00195	Photosynthesis	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMT200047435	K08901	ko01100	Metabolic pathways	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMT200047436	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMT200047436	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMT200047437	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMT200047437	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMT200047444	K03349	ko04110	Cell cycle	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047444	K03349	ko04111	Cell cycle - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047444	K03349	ko04113	Meiosis - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047444	K03349	ko04114	Oocyte meiosis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047444	K03349	ko04120	Ubiquitin mediated proteolysis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047444	K03349	ko04914	Progesterone-mediated oocyte maturation	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMT200047460	K13030	ko00460	Cyanoamino acid metabolism	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMT200047460	K13030	ko01110	Biosynthesis of secondary metabolites	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMT200047461	K13030	ko00460	Cyanoamino acid metabolism	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMT200047461	K13030	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMT200070214	K12356	ko00940	Phenylpropanoid biosynthesis	732	1.5e-34	0.32	0.51	0.95
PGSC0003DMT200070215	K12356	ko00940	Phenylpropanoid biosynthesis	647	7.5e-30	0.41	0.62	0.69
PGSC0003DMT200070218	K12356	ko00940	Phenylpropanoid biosynthesis	755	8.3e-36	0.36	0.52	0.84
PGSC0003DMT200070230	K13066	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMT200070230	K13066	ko01110	Biosynthesis of secondary metabolites	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMT200070232	K05849	ko04020	Calcium signaling pathway	422	4.9e-17	0.34	0.55	0.50
PGSC0003DMT200070240	K03006	ko00230	Purine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMT200070240	K03006	ko00240	Pyrimidine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMT200070240	K03006	ko01100	Metabolic pathways	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMT200070240	K03006	ko03020	RNA polymerase	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMT200070240	K03006	ko05016	Huntington's disease	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMT200053284	K10418	ko04962	Vasopressin-regulated water reabsorption	327	3.4e-12	0.54	0.69	0.34
PGSC0003DMT200053285	K12929	ko00904	Diterpenoid biosynthesis	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMT200053285	K12929	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMT200053307	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053307	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053307	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053308	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053308	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053308	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMT200053309	K00967	ko00440	Phosphonate and phosphinate metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMT200053309	K00967	ko00564	Glycerophospholipid metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMT200053309	K00967	ko01100	Metabolic pathways	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMT200053310	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	302	8.0e-11	0.59	0.69	0.66
PGSC0003DMT200053311	K10352	ko04530	Tight junction	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMT200053311	K10352	ko05416	Viral myocarditis	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMT200080700	K08504	ko04130	SNARE interactions in vesicular transport	784	2.1e-37	0.81	0.93	0.62
PGSC0003DMT200080717	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080717	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080717	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080717	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080717	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080717	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080718	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMT200080722	K01184	ko00040	Pentose and glucuronate interconversions	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMT200080722	K01184	ko00500	Starch and sucrose metabolism	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMT200080722	K01184	ko01100	Metabolic pathways	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMT200080723	K11778	ko00900	Terpenoid backbone biosynthesis	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMT200080723	K11778	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMT200080724	K00806	ko00900	Terpenoid backbone biosynthesis	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMT200080724	K00806	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMT200080729	K12929	ko00904	Diterpenoid biosynthesis	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMT200080729	K12929	ko01110	Biosynthesis of secondary metabolites	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMT200080737	K12192	ko04144	Endocytosis	1021	1.8e-50	0.77	0.92	0.89
PGSC0003DMT200080738	K12192	ko04144	Endocytosis	1275	1.7e-64	0.75	0.91	0.99
PGSC0003DMT200027057	K01937	ko00240	Pyrimidine metabolism	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMT200027057	K01937	ko01100	Metabolic pathways	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMT200027059	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMT200027060	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMT200027069	K00286	ko00330	Arginine and proline metabolism	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMT200027069	K00286	ko01100	Metabolic pathways	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMT200027069	K00286	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMT200027070	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027070	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027070	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027071	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027071	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027071	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMT200027072	K00286	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMT200027072	K00286	ko01100	Metabolic pathways	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMT200027072	K00286	ko01110	Biosynthesis of secondary metabolites	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMT200027083	K04424	ko04010	MAPK signaling pathway	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMT200027083	K04424	ko04530	Tight junction	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMT200027086	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMT200027086	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMT200027087	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMT200027087	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMT200038174	K00213	ko00100	Steroid biosynthesis	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMT200038174	K00213	ko01100	Metabolic pathways	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMT200038174	K00213	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMT200038179	K00430	ko00360	Phenylalanine metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMT200038179	K00430	ko00680	Methane metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMT200038179	K00430	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMT200038179	K00430	ko01100	Metabolic pathways	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMT200038179	K00430	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMT200038182	K00430	ko00360	Phenylalanine metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMT200038182	K00430	ko00680	Methane metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMT200038182	K00430	ko00940	Phenylpropanoid biosynthesis	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMT200038182	K00430	ko01100	Metabolic pathways	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMT200038182	K00430	ko01110	Biosynthesis of secondary metabolites	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMT200038185	K00430	ko00360	Phenylalanine metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMT200038185	K00430	ko00680	Methane metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMT200038185	K00430	ko00940	Phenylpropanoid biosynthesis	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMT200038185	K00430	ko01100	Metabolic pathways	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMT200038185	K00430	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMT200038188	K00430	ko00360	Phenylalanine metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMT200038188	K00430	ko00680	Methane metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMT200038188	K00430	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMT200038188	K00430	ko01100	Metabolic pathways	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMT200038188	K00430	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMT200038194	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200038194	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200038194	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMT200094912	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMT200094912	K00517	ko00626	Naphthalene and anthracene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMT200094912	K00517	ko00903	Limonene and pinene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMT200094912	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMT200094912	K00517	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMT200094923	K11816	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.64	0.95
PGSC0003DMT200048854	K03936	ko00190	Oxidative phosphorylation	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMT200048854	K03936	ko01100	Metabolic pathways	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMT200048854	K03936	ko05010	Alzheimer's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMT200048854	K03936	ko05012	Parkinson's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMT200048854	K03936	ko05016	Huntington's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMT200048876	K01051	ko00040	Pentose and glucuronate interconversions	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMT200048876	K01051	ko00500	Starch and sucrose metabolism	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMT200048876	K01051	ko01100	Metabolic pathways	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMT200076361	K02152	ko00190	Oxidative phosphorylation	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076361	K02152	ko01100	Metabolic pathways	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076361	K02152	ko04145	Phagosome	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076361	K02152	ko04966	Collecting duct acid secretion	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076361	K02152	ko05110	Vibrio cholerae infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076361	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMT200076362	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMT200076362	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMT200076363	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMT200076363	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMT200076377	K12821	ko03040	Spliceosome	247	4.8e-07	0.31	0.40	0.79
PGSC0003DMT200076383	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMT200076384	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMT200076389	K02988	ko03010	Ribosome	1806	8.9e-94	0.72	0.83	1.00
PGSC0003DMT200086986	K12854	ko03040	Spliceosome	440	2.7e-17	0.84	0.90	0.95
PGSC0003DMT200086988	K00588	ko00360	Phenylalanine metabolism	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086988	K00588	ko00940	Phenylpropanoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086988	K00588	ko00941	Flavonoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086988	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086988	K00588	ko01100	Metabolic pathways	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086988	K00588	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMT200086998	K10760	ko00908	Zeatin biosynthesis	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMT200086998	K10760	ko01100	Metabolic pathways	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMT200086998	K10760	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMT200067462	K00492	ko00340	Histidine metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00363	Bisphenol A degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00622	Toluene and xylene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00624	1- and 2-Methylnaphthalene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00626	Naphthalene and anthracene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00627	1,4-Dichlorobenzene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00680	Methane metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko00903	Limonene and pinene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko01100	Metabolic pathways	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067462	K00492	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMT200067465	K01692	ko00071	Fatty acid metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00280	Valine, leucine and isoleucine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00281	Geraniol degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00310	Lysine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00380	Tryptophan metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00410	beta-Alanine metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00632	Benzoate degradation via CoA ligation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00640	Propanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00650	Butanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00903	Limonene and pinene degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko00930	Caprolactam degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko01100	Metabolic pathways	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067465	K01692	ko01110	Biosynthesis of secondary metabolites	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMT200067466	K01692	ko00071	Fatty acid metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00280	Valine, leucine and isoleucine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00281	Geraniol degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00310	Lysine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00380	Tryptophan metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00410	beta-Alanine metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00632	Benzoate degradation via CoA ligation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00640	Propanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00650	Butanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00903	Limonene and pinene degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko00930	Caprolactam degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko01100	Metabolic pathways	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067466	K01692	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMT200067467	K01692	ko00071	Fatty acid metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00280	Valine, leucine and isoleucine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00281	Geraniol degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00310	Lysine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00380	Tryptophan metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00410	beta-Alanine metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00632	Benzoate degradation via CoA ligation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00640	Propanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00650	Butanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko00930	Caprolactam degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko01100	Metabolic pathways	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067467	K01692	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMT200067468	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00310	Lysine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067468	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMT200067481	K01074	ko00062	Fatty acid elongation in mitochondria	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMT200067481	K01074	ko01100	Metabolic pathways	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMT200067481	K01074	ko04142	Lysosome	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMT200012785	K09841	ko00906	Carotenoid biosynthesis	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMT200012785	K09841	ko01100	Metabolic pathways	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMT200012785	K09841	ko01110	Biosynthesis of secondary metabolites	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMT200012799	K06689	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.86	0.88	0.99
PGSC0003DMT200012800	K06689	ko04120	Ubiquitin mediated proteolysis	1290	2.6e-65	0.98	0.99	0.99
PGSC0003DMT200012806	K01178	ko00500	Starch and sucrose metabolism	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMT200012806	K01178	ko01100	Metabolic pathways	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMT200012809	K01179	ko00500	Starch and sucrose metabolism	1397	3.2e-71	0.41	0.57	0.75
PGSC0003DMT200012814	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMT200012814	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMT200012814	K00771	ko01100	Metabolic pathways	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMT200012826	K01784	ko00052	Galactose metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMT200012826	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMT200012826	K01784	ko01100	Metabolic pathways	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMT200012828	K01784	ko00052	Galactose metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMT200012828	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMT200012828	K01784	ko01100	Metabolic pathways	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMT200012829	K01784	ko00052	Galactose metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMT200012829	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMT200012829	K01784	ko01100	Metabolic pathways	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMT200012831	K01784	ko00052	Galactose metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMT200012831	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMT200012831	K01784	ko01100	Metabolic pathways	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMT200006113	K01918	ko00410	beta-Alanine metabolism	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMT200006113	K01918	ko00770	Pantothenate and CoA biosynthesis	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMT200006113	K01918	ko01100	Metabolic pathways	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMT200006113	K01918	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMT200006114	K12843	ko03040	Spliceosome	3543	1.4e-189	0.76	0.84	0.69
PGSC0003DMT200006133	K00588	ko00360	Phenylalanine metabolism	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006133	K00588	ko00940	Phenylpropanoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006133	K00588	ko00941	Flavonoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006133	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006133	K00588	ko01100	Metabolic pathways	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006133	K00588	ko01110	Biosynthesis of secondary metabolites	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMT200006134	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006134	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006134	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006134	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006134	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006134	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMT200006135	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006135	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006135	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006135	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006135	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006135	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMT200006136	K00588	ko00360	Phenylalanine metabolism	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200006136	K00588	ko00940	Phenylpropanoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200006136	K00588	ko00941	Flavonoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200006136	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200006136	K00588	ko01100	Metabolic pathways	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200006136	K00588	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMT200033698	K12580	ko03018	RNA degradation	5263	1.9e-284	0.71	0.82	1.00
PGSC0003DMT200033699	K12580	ko03018	RNA degradation	5252	7.7e-284	0.71	0.81	1.00
PGSC0003DMT200033701	K05280	ko00941	Flavonoid biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMT200033701	K05280	ko00944	Flavone and flavonol biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMT200033701	K05280	ko01100	Metabolic pathways	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMT200033701	K05280	ko01110	Biosynthesis of secondary metabolites	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMT200033716	K09755	ko00940	Phenylpropanoid biosynthesis	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMT200033716	K09755	ko01100	Metabolic pathways	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMT200033716	K09755	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMT200033717	K09755	ko00940	Phenylpropanoid biosynthesis	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMT200033717	K09755	ko01100	Metabolic pathways	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMT200033717	K09755	ko01110	Biosynthesis of secondary metabolites	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMT200033729	K02974	ko03010	Ribosome	378	5.2e-15	0.83	0.93	0.96
PGSC0003DMT200024462	K01464	ko00240	Pyrimidine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMT200024462	K01464	ko00410	beta-Alanine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMT200024462	K01464	ko00770	Pantothenate and CoA biosynthesis	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMT200024462	K01464	ko00983	Drug metabolism - other enzymes	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMT200024462	K01464	ko01100	Metabolic pathways	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMT200024463	K01464	ko00240	Pyrimidine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMT200024463	K01464	ko00410	beta-Alanine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMT200024463	K01464	ko00770	Pantothenate and CoA biosynthesis	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMT200024463	K01464	ko00983	Drug metabolism - other enzymes	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMT200024463	K01464	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMT200040463	K01199	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.38	0.58	0.53
PGSC0003DMT200040464	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMT200040465	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMT200040474	K10838	ko03420	Nucleotide excision repair	3553	3.9e-190	0.52	0.68	0.97
PGSC0003DMT200040485	K00795	ko00900	Terpenoid backbone biosynthesis	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMT200040485	K00795	ko01100	Metabolic pathways	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMT200040485	K00795	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMT200000326	K00635	ko00561	Glycerolipid metabolism	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMT200000326	K00635	ko01100	Metabolic pathways	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMT200000336	K08770	ko03320	PPAR signaling pathway	324	8.0e-12	0.30	0.49	0.52
PGSC0003DMT200000337	K08770	ko03320	PPAR signaling pathway	324	4.9e-12	0.30	0.49	0.64
PGSC0003DMT200000351	K12132	ko04712	Circadian rhythm - plant	1860	9.4e-97	0.54	0.70	0.62
PGSC0003DMT200002609	K08738	ko04115	p53 signaling pathway	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko04210	Apoptosis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05010	Alzheimer's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05012	Parkinson's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05016	Huntington's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05200	Pathways in cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05210	Colorectal cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05222	Small cell lung cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002609	K08738	ko05416	Viral myocarditis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMT200002626	K01066	ko00623	2,4-Dichlorobenzoate degradation	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMT200002626	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMT200002627	K01066	ko00623	2,4-Dichlorobenzoate degradation	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMT200002627	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMT200090890	K10591	ko04120	Ubiquitin mediated proteolysis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMT200090890	K10591	ko04144	Endocytosis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMT200090896	K03260	ko05416	Viral myocarditis	316	1.0e-08	0.25	0.41	0.93
PGSC0003DMT200090899	K12183	ko04144	Endocytosis	254	9.6e-08	0.37	0.45	0.61
PGSC0003DMT200057781	K00422	ko00350	Tyrosine metabolism	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMT200057781	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMT200057781	K00422	ko01100	Metabolic pathways	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMT200057781	K00422	ko01110	Biosynthesis of secondary metabolites	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMT200057783	K12829	ko03040	Spliceosome	4163	8.9e-224	0.84	0.91	0.98
PGSC0003DMT200057784	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMT200057784	K01988	ko01100	Metabolic pathways	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMT200057794	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMT200057795	K12837	ko03040	Spliceosome	1395	4.2e-71	0.61	0.76	0.97
PGSC0003DMT200057796	K12837	ko03040	Spliceosome	2403	1.1e-126	0.57	0.70	0.99
PGSC0003DMT200078167	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMT200078168	K08332	ko04140	Regulation of autophagy	310	8.7e-09	0.30	0.52	0.46
PGSC0003DMT200078169	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMT200078178	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMT200078178	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMT200078178	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMT200078178	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMT200078178	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMT200078179	K01199	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.35	0.57	0.70
PGSC0003DMT200078183	K03006	ko00230	Purine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMT200078183	K03006	ko00240	Pyrimidine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMT200078183	K03006	ko01100	Metabolic pathways	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMT200078183	K03006	ko03020	RNA polymerase	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMT200078183	K03006	ko05016	Huntington's disease	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMT200078188	K00368	ko00910	Nitrogen metabolism	1682	6.2e-87	0.43	0.58	0.94
PGSC0003DMT200078192	K03122	ko03022	Basal transcription factors	2033	2.7e-106	0.65	0.73	0.83
PGSC0003DMT200078193	K03122	ko03022	Basal transcription factors	2369	7.9e-125	0.70	0.79	1.00
PGSC0003DMT200078195	K07750	ko00100	Steroid biosynthesis	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMT200078195	K07750	ko01100	Metabolic pathways	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMT200078196	K07750	ko00100	Steroid biosynthesis	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMT200078196	K07750	ko01100	Metabolic pathways	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMT200078197	K03006	ko00230	Purine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMT200078197	K03006	ko00240	Pyrimidine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMT200078197	K03006	ko01100	Metabolic pathways	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMT200078197	K03006	ko03020	RNA polymerase	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMT200078197	K03006	ko05016	Huntington's disease	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMT200078199	K06269	ko04113	Meiosis - yeast	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04114	Oocyte meiosis	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04270	Vascular smooth muscle contraction	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04510	Focal adhesion	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04720	Long-term potentiation	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04810	Regulation of actin cytoskeleton	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200078199	K06269	ko04910	Insulin signaling pathway	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMT200050736	K03035	ko03050	Proteasome	3109	1.2e-165	0.81	0.88	1.00
PGSC0003DMT200050737	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMT200050738	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMT200050748	K00454	ko00591	Linoleic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMT200050748	K00454	ko00592	alpha-Linolenic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMT200050748	K00454	ko01100	Metabolic pathways	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMT200050752	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050752	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050752	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050752	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050752	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050753	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050753	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050753	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050753	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200050753	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMT200085794	K08233	ko00901	Indole alkaloid biosynthesis	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMT200085794	K08233	ko01110	Biosynthesis of secondary metabolites	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMT200085799	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.32	0.50	0.95
PGSC0003DMT200069179	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3734	4.1e-200	0.79	0.87	0.97
PGSC0003DMT200069182	K04567	ko00970	Aminoacyl-tRNA biosynthesis	402	2.4e-16	0.90	0.98	0.77
PGSC0003DMT200069184	K02940	ko03010	Ribosome	1358	4.6e-69	0.88	0.93	0.99
PGSC0003DMT200069185	K02901	ko03010	Ribosome	1053	3.0e-52	0.90	0.98	0.99
PGSC0003DMT200069189	K01784	ko00052	Galactose metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMT200069189	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMT200069189	K01784	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMT200069191	K01784	ko00052	Galactose metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMT200069191	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMT200069191	K01784	ko01100	Metabolic pathways	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMT200069194	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04744	Phototransduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04916	Melanogenesis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04970	Salivary secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069194	K02183	ko05214	Glioma	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMT200069195	K02183	ko04020	Calcium signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04070	Phosphatidylinositol signaling system	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04114	Oocyte meiosis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04270	Vascular smooth muscle contraction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04626	Plant-pathogen interaction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04720	Long-term potentiation	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04722	Neurotrophin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04740	Olfactory transduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04744	Phototransduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04745	Phototransduction - fly	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04910	Insulin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04912	GnRH signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04916	Melanogenesis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04970	Salivary secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko04971	Gastric acid secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko05010	Alzheimer's disease	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069195	K02183	ko05214	Glioma	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMT200069198	K00847	ko00051	Fructose and mannose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMT200069198	K00847	ko00500	Starch and sucrose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMT200069198	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMT200069198	K00847	ko01100	Metabolic pathways	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMT200069218	K00475	ko00941	Flavonoid biosynthesis	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMT200069218	K00475	ko01100	Metabolic pathways	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMT200069218	K00475	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMT200069219	K00475	ko00941	Flavonoid biosynthesis	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMT200069219	K00475	ko01100	Metabolic pathways	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMT200069219	K00475	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMT200097696	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200097696	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200097696	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMT200000937	K02111	ko00190	Oxidative phosphorylation	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMT200000937	K02111	ko00195	Photosynthesis	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMT200000937	K02111	ko01100	Metabolic pathways	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMT200000943	K01199	ko00500	Starch and sucrose metabolism	962	3.2e-47	0.39	0.61	0.67
PGSC0003DMT200000946	K01887	ko00970	Aminoacyl-tRNA biosynthesis	2133	8.2e-112	0.82	0.93	0.99
PGSC0003DMT200000947	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMT200000948	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMT200000949	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMT200000961	K00029	ko00620	Pyruvate metabolism	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMT200000961	K00029	ko00710	Carbon fixation in photosynthetic organisms	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMT200000961	K00029	ko01100	Metabolic pathways	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMT200031994	K01784	ko00052	Galactose metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMT200031994	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMT200031994	K01784	ko01100	Metabolic pathways	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMT200031995	K01784	ko00052	Galactose metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMT200031995	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMT200031995	K01784	ko01100	Metabolic pathways	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMT200031997	K00940	ko00230	Purine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMT200031997	K00940	ko00240	Pyrimidine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMT200031997	K00940	ko01100	Metabolic pathways	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMT200031997	K00940	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMT200032020	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032020	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032020	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032021	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032021	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032021	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMT200032028	K01179	ko00500	Starch and sucrose metabolism	1878	9.5e-98	0.48	0.64	0.79
PGSC0003DMT200004245	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMT200004251	K10717	ko00908	Zeatin biosynthesis	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMT200004251	K10717	ko01100	Metabolic pathways	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMT200004251	K10717	ko01110	Biosynthesis of secondary metabolites	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMT200004252	K10717	ko00908	Zeatin biosynthesis	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMT200004252	K10717	ko01100	Metabolic pathways	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMT200004252	K10717	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMT200004253	K10717	ko00908	Zeatin biosynthesis	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMT200004253	K10717	ko01100	Metabolic pathways	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMT200004253	K10717	ko01110	Biosynthesis of secondary metabolites	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMT200004256	K11294	ko05130	Pathogenic Escherichia coli infection	320	1.4e-11	0.28	0.45	0.97
PGSC0003DMT200004291	K10742	ko03030	DNA replication	5770	0.	0.60	0.74	0.84
PGSC0003DMT200004293	K10742	ko03030	DNA replication	3296	5.9e-176	0.69	0.81	0.99
PGSC0003DMT200022803	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMT200022804	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMT200022810	K11153	ko00830	Retinol metabolism	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMT200022810	K11153	ko01100	Metabolic pathways	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMT200022811	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022811	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022811	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022811	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022811	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022811	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022812	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMT200022813	K11153	ko00830	Retinol metabolism	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMT200022813	K11153	ko01100	Metabolic pathways	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMT200022816	K00620	ko00330	Arginine and proline metabolism	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMT200022816	K00620	ko01100	Metabolic pathways	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMT200022816	K00620	ko01110	Biosynthesis of secondary metabolites	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMT200042256	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042256	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042256	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042257	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042257	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042257	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMT200042260	K03469	ko03030	DNA replication	296	6.8e-10	0.35	0.51	0.21
PGSC0003DMT200042263	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.61
PGSC0003DMT200042264	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMT200042265	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMT200042266	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.52
PGSC0003DMT200042267	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMT200042268	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.48
PGSC0003DMT200045610	K00599	ko00340	Histidine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMT200045610	K00599	ko00350	Tyrosine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMT200045610	K00599	ko00450	Selenoamino acid metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMT200045610	K00599	ko00626	Naphthalene and anthracene degradation	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMT200045611	K00599	ko00340	Histidine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMT200045611	K00599	ko00350	Tyrosine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMT200045611	K00599	ko00450	Selenoamino acid metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMT200045611	K00599	ko00626	Naphthalene and anthracene degradation	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMT200045633	K02183	ko04020	Calcium signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04070	Phosphatidylinositol signaling system	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04114	Oocyte meiosis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04270	Vascular smooth muscle contraction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04626	Plant-pathogen interaction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04720	Long-term potentiation	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04722	Neurotrophin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04740	Olfactory transduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04744	Phototransduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04745	Phototransduction - fly	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04910	Insulin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04912	GnRH signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04916	Melanogenesis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04970	Salivary secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko04971	Gastric acid secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko05010	Alzheimer's disease	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045633	K02183	ko05214	Glioma	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMT200045636	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMT200045636	K01491	ko00670	One carbon pool by folate	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMT200045636	K01491	ko01100	Metabolic pathways	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMT200071651	K00658	ko00020	Citrate cycle (TCA cycle)	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMT200071651	K00658	ko00310	Lysine degradation	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMT200071651	K00658	ko01100	Metabolic pathways	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMT200071651	K00658	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMT200071652	K00658	ko00020	Citrate cycle (TCA cycle)	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMT200071652	K00658	ko00310	Lysine degradation	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMT200071652	K00658	ko01100	Metabolic pathways	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMT200071652	K00658	ko01110	Biosynthesis of secondary metabolites	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMT200071653	K00658	ko00020	Citrate cycle (TCA cycle)	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMT200071653	K00658	ko00310	Lysine degradation	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMT200071653	K00658	ko01100	Metabolic pathways	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMT200071653	K00658	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMT200071654	K00658	ko00020	Citrate cycle (TCA cycle)	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMT200071654	K00658	ko00310	Lysine degradation	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMT200071654	K00658	ko01100	Metabolic pathways	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMT200071654	K00658	ko01110	Biosynthesis of secondary metabolites	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMT200071655	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMT200071655	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMT200071655	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMT200071658	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMT200071658	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMT200071658	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMT200071659	K02115	ko00190	Oxidative phosphorylation	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMT200071659	K02115	ko00195	Photosynthesis	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMT200071659	K02115	ko01100	Metabolic pathways	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMT200071667	K10373	ko04260	Cardiac muscle contraction	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMT200071667	K10373	ko05410	Hypertrophic cardiomyopathy (HCM)	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMT200071667	K10373	ko05414	Dilated cardiomyopathy	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMT200083244	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMT200083244	K02367	ko01100	Metabolic pathways	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMT200083245	K13230	ko00402	Benzoxazinoid biosynthesis	895	1.6e-43	0.36	0.57	0.97
PGSC0003DMT200083252	K01193	ko00052	Galactose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMT200083252	K01193	ko00500	Starch and sucrose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMT200083252	K01193	ko01100	Metabolic pathways	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMT200083253	K01193	ko00052	Galactose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMT200083253	K01193	ko00500	Starch and sucrose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMT200083253	K01193	ko01100	Metabolic pathways	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMT200083254	K01193	ko00052	Galactose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMT200083254	K01193	ko00500	Starch and sucrose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMT200083254	K01193	ko01100	Metabolic pathways	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMT200083256	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMT200083262	K13230	ko00402	Benzoxazinoid biosynthesis	496	1.6e-21	0.33	0.51	0.94
PGSC0003DMT200083267	K02084	ko04115	p53 signaling pathway	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko04210	Apoptosis	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko05010	Alzheimer's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko05012	Parkinson's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko05016	Huntington's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200083267	K02084	ko05222	Small cell lung cancer	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMT200096096	K13065	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMT200096096	K13065	ko00941	Flavonoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMT200096096	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMT200096096	K13065	ko01110	Biosynthesis of secondary metabolites	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMT200096125	K07424	ko00140	Steroid hormone biosynthesis	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00591	Linoleic acid metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00830	Retinol metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00982	Drug metabolism - cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko00983	Drug metabolism - other enzymes	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200096125	K07424	ko01100	Metabolic pathways	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMT200028915	K00131	ko00010	Glycolysis / Gluconeogenesis	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMT200028915	K00131	ko01100	Metabolic pathways	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMT200028917	K12126	ko04712	Circadian rhythm - plant	338	2.2e-12	0.51	0.76	0.18
PGSC0003DMT200028923	K10255	ko01040	Biosynthesis of unsaturated fatty acids	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMT200028923	K10255	ko02020	Two-component system	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMT200028928	K00655	ko00561	Glycerolipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMT200028928	K00655	ko00564	Glycerophospholipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMT200028928	K00655	ko01100	Metabolic pathways	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMT200028929	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028929	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028929	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028930	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028930	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028930	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMT200028932	K05391	ko04626	Plant-pathogen interaction	4777	1.2e-257	0.79	0.87	0.98
PGSC0003DMT200025648	K09561	ko04120	Ubiquitin mediated proteolysis	253	1.4e-07	0.35	0.51	0.25
PGSC0003DMT200025653	K03781	ko00380	Tryptophan metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMT200025653	K03781	ko00680	Methane metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMT200025653	K03781	ko01100	Metabolic pathways	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMT200025653	K03781	ko04146	Peroxisome	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMT200025653	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMT200008565	K01136	ko00531	Glycosaminoglycan degradation	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMT200008565	K01136	ko01100	Metabolic pathways	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMT200008565	K01136	ko04142	Lysosome	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMT200008570	K01199	ko00500	Starch and sucrose metabolism	738	7.2e-35	0.35	0.56	0.69
PGSC0003DMT200008572	K00860	ko00230	Purine metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMT200008572	K00860	ko00450	Selenoamino acid metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMT200008572	K00860	ko00920	Sulfur metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMT200008572	K00860	ko01100	Metabolic pathways	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMT200008573	K00860	ko00230	Purine metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMT200008573	K00860	ko00450	Selenoamino acid metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMT200008573	K00860	ko00920	Sulfur metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMT200008573	K00860	ko01100	Metabolic pathways	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMT200008582	K01684	ko00052	Galactose metabolism	273	3.2e-09	0.31	0.45	0.83
PGSC0003DMT200008583	K12741	ko03040	Spliceosome	667	5.9e-31	0.46	0.67	0.31
PGSC0003DMT200008585	K00511	ko00100	Steroid biosynthesis	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMT200008585	K00511	ko01100	Metabolic pathways	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMT200008585	K00511	ko01110	Biosynthesis of secondary metabolites	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMT200008586	K00511	ko00100	Steroid biosynthesis	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMT200008586	K00511	ko01100	Metabolic pathways	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMT200008586	K00511	ko01110	Biosynthesis of secondary metabolites	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMT200008587	K01762	ko00270	Cysteine and methionine metabolism	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMT200008587	K01762	ko01110	Biosynthesis of secondary metabolites	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMT200008593	K02918	ko03010	Ribosome	553	1.1e-24	0.89	0.91	0.86
PGSC0003DMT200036483	K01593	ko00340	Histidine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00350	Tyrosine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00360	Phenylalanine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00380	Tryptophan metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00901	Indole alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko00965	Betalain biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko01100	Metabolic pathways	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036483	K01593	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMT200036487	K00430	ko00360	Phenylalanine metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMT200036487	K00430	ko00680	Methane metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMT200036487	K00430	ko00940	Phenylpropanoid biosynthesis	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMT200036487	K00430	ko01100	Metabolic pathways	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMT200036487	K00430	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMT200026324	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMT200026324	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMT200026326	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026326	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026327	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026327	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026328	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026328	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMT200026329	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMT200026329	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMT200026330	K12842	ko03040	Spliceosome	6229	0.	0.77	0.88	1.00
PGSC0003DMT200026331	K12842	ko03040	Spliceosome	5627	0.	0.77	0.88	1.00
PGSC0003DMT200026332	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMT200026333	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMT200038501	K01593	ko00340	Histidine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00350	Tyrosine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00360	Phenylalanine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00380	Tryptophan metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00901	Indole alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko00965	Betalain biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko01100	Metabolic pathways	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038501	K01593	ko01110	Biosynthesis of secondary metabolites	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMT200038514	K00430	ko00360	Phenylalanine metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMT200038514	K00430	ko00680	Methane metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMT200038514	K00430	ko00940	Phenylpropanoid biosynthesis	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMT200038514	K00430	ko01100	Metabolic pathways	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMT200038514	K00430	ko01110	Biosynthesis of secondary metabolites	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMT200038519	K05741	ko04810	Regulation of actin cytoskeleton	653	1.9e-28	0.29	0.43	0.60
PGSC0003DMT200038521	K00001	ko00010	Glycolysis / Gluconeogenesis	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00071	Fatty acid metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00350	Tyrosine metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00624	1- and 2-Methylnaphthalene degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00641	3-Chloroacrylic acid degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00830	Retinol metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko00982	Drug metabolism - cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko01100	Metabolic pathways	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038521	K00001	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMT200038523	K00121	ko00010	Glycolysis / Gluconeogenesis	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00071	Fatty acid metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00350	Tyrosine metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00641	3-Chloroacrylic acid degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00680	Methane metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00830	Retinol metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko00982	Drug metabolism - cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko01100	Metabolic pathways	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038523	K00121	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMT200038524	K00121	ko00010	Glycolysis / Gluconeogenesis	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00071	Fatty acid metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00350	Tyrosine metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00641	3-Chloroacrylic acid degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00680	Methane metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00830	Retinol metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko00982	Drug metabolism - cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko01100	Metabolic pathways	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038524	K00121	ko01110	Biosynthesis of secondary metabolites	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMT200038525	K00121	ko00010	Glycolysis / Gluconeogenesis	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00071	Fatty acid metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00350	Tyrosine metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00641	3-Chloroacrylic acid degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00680	Methane metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00830	Retinol metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko00982	Drug metabolism - cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko01100	Metabolic pathways	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038525	K00121	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMT200038526	K00121	ko00010	Glycolysis / Gluconeogenesis	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00071	Fatty acid metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00350	Tyrosine metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00641	3-Chloroacrylic acid degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00680	Methane metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00830	Retinol metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko00982	Drug metabolism - cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko01100	Metabolic pathways	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038526	K00121	ko01110	Biosynthesis of secondary metabolites	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMT200038529	K00121	ko00010	Glycolysis / Gluconeogenesis	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00071	Fatty acid metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00350	Tyrosine metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00641	3-Chloroacrylic acid degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00680	Methane metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00830	Retinol metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko00982	Drug metabolism - cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko01100	Metabolic pathways	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038529	K00121	ko01110	Biosynthesis of secondary metabolites	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMT200038532	K12846	ko03040	Spliceosome	792	7.6e-38	0.33	0.51	0.97
PGSC0003DMT200038534	K04733	ko04210	Apoptosis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMT200038534	K04733	ko04620	Toll-like receptor signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMT200038534	K04733	ko04722	Neurotrophin signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMT200038534	K04733	ko05140	Leishmaniasis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMT200038534	K04733	ko05142	Chagas disease	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMT200038535	K04733	ko04210	Apoptosis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMT200038535	K04733	ko04620	Toll-like receptor signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMT200038535	K04733	ko04722	Neurotrophin signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMT200038535	K04733	ko05140	Leishmaniasis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMT200038535	K04733	ko05142	Chagas disease	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMT200038536	K03097	ko04310	Wnt signaling pathway	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMT200038536	K03097	ko04520	Adherens junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMT200038536	K03097	ko04530	Tight junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMT200038536	K03097	ko04712	Circadian rhythm - plant	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMT200095385	K10760	ko00908	Zeatin biosynthesis	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMT200095385	K10760	ko01100	Metabolic pathways	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMT200095385	K10760	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMT200072691	K11584	ko04113	Meiosis - yeast	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMT200072691	K11584	ko04114	Oocyte meiosis	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMT200072691	K11584	ko04310	Wnt signaling pathway	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMT200072701	K00789	ko00270	Cysteine and methionine metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMT200072701	K00789	ko00450	Selenoamino acid metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMT200072701	K00789	ko01100	Metabolic pathways	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMT200072701	K00789	ko01110	Biosynthesis of secondary metabolites	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMT200047262	K00793	ko00740	Riboflavin metabolism	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMT200047262	K00793	ko01100	Metabolic pathways	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMT200047263	K00218	ko00860	Porphyrin and chlorophyll metabolism	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMT200047263	K00218	ko01100	Metabolic pathways	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMT200047263	K00218	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMT200047264	K00218	ko00860	Porphyrin and chlorophyll metabolism	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMT200047264	K00218	ko01100	Metabolic pathways	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMT200047264	K00218	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMT200047276	K01593	ko00340	Histidine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00350	Tyrosine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00360	Phenylalanine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00380	Tryptophan metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00901	Indole alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko00965	Betalain biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko01100	Metabolic pathways	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047276	K01593	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00340	Histidine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00350	Tyrosine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00360	Phenylalanine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00380	Tryptophan metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00901	Indole alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko00965	Betalain biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko01100	Metabolic pathways	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047278	K01593	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMT200047279	K01593	ko00340	Histidine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00350	Tyrosine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00360	Phenylalanine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00380	Tryptophan metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00901	Indole alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko00965	Betalain biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko01100	Metabolic pathways	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047279	K01593	ko01110	Biosynthesis of secondary metabolites	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMT200047280	K08902	ko00195	Photosynthesis	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMT200047280	K08902	ko01100	Metabolic pathways	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMT200047283	K10352	ko04530	Tight junction	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMT200047283	K10352	ko05416	Viral myocarditis	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMT200047287	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMT200047287	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMT200047287	K00771	ko01100	Metabolic pathways	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMT200047288	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMT200047288	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMT200047288	K00771	ko01100	Metabolic pathways	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMT200070773	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	380	2.6e-14	0.29	0.43	0.97
PGSC0003DMT200070774	K10569	ko03410	Base excision repair	412	6.9e-17	0.42	0.56	0.42
PGSC0003DMT200070779	K01188	ko00460	Cyanoamino acid metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMT200070779	K01188	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMT200070779	K01188	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMT200070779	K01188	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMT200070780	K01188	ko00460	Cyanoamino acid metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMT200070780	K01188	ko00500	Starch and sucrose metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMT200070780	K01188	ko00940	Phenylpropanoid biosynthesis	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMT200070780	K01188	ko01110	Biosynthesis of secondary metabolites	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMT200081239	K03801	ko00785	Lipoic acid metabolism	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMT200081239	K03801	ko01100	Metabolic pathways	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMT200081243	K01066	ko00623	2,4-Dichlorobenzoate degradation	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMT200081243	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMT200081244	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMT200081244	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMT200081245	K01066	ko00623	2,4-Dichlorobenzoate degradation	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMT200081245	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMT200081246	K01066	ko00623	2,4-Dichlorobenzoate degradation	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMT200081246	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMT200081247	K01066	ko00623	2,4-Dichlorobenzoate degradation	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMT200081247	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMT200081248	K01066	ko00623	2,4-Dichlorobenzoate degradation	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMT200081248	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMT200081250	K01066	ko00623	2,4-Dichlorobenzoate degradation	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMT200081250	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMT200081271	K00688	ko00500	Starch and sucrose metabolism	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMT200081271	K00688	ko04910	Insulin signaling pathway	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMT200012086	K00759	ko00230	Purine metabolism	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMT200012086	K00759	ko01100	Metabolic pathways	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMT200012087	K00759	ko00230	Purine metabolism	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMT200012087	K00759	ko01100	Metabolic pathways	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMT200006613	K00599	ko00340	Histidine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMT200006613	K00599	ko00350	Tyrosine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMT200006613	K00599	ko00450	Selenoamino acid metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMT200006613	K00599	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMT200006614	K00599	ko00340	Histidine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMT200006614	K00599	ko00350	Tyrosine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMT200006614	K00599	ko00450	Selenoamino acid metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMT200006614	K00599	ko00626	Naphthalene and anthracene degradation	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMT200006616	K00599	ko00340	Histidine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMT200006616	K00599	ko00350	Tyrosine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMT200006616	K00599	ko00450	Selenoamino acid metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMT200006616	K00599	ko00626	Naphthalene and anthracene degradation	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMT200006623	K08959	ko04340	Hedgehog signaling pathway	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMT200006623	K08959	ko04540	Gap junction	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMT200006623	K08959	ko04710	Circadian rhythm - mammal	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMT200006625	K02218	ko04340	Hedgehog signaling pathway	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMT200006625	K02218	ko04711	Circadian rhythm - fly	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMT200006626	K02218	ko04340	Hedgehog signaling pathway	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMT200006626	K02218	ko04711	Circadian rhythm - fly	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMT200006632	K03787	ko00230	Purine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMT200006632	K03787	ko00240	Pyrimidine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMT200006632	K03787	ko00760	Nicotinate and nicotinamide metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMT200006632	K03787	ko01100	Metabolic pathways	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMT200006632	K03787	ko01110	Biosynthesis of secondary metabolites	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMT200006633	K00020	ko00280	Valine, leucine and isoleucine degradation	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMT200006633	K00020	ko01100	Metabolic pathways	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMT200006634	K00020	ko00280	Valine, leucine and isoleucine degradation	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMT200006634	K00020	ko01100	Metabolic pathways	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMT200006635	K12741	ko03040	Spliceosome	1112	1.7e-55	0.49	0.64	0.97
PGSC0003DMT200006636	K12741	ko03040	Spliceosome	1331	1.4e-67	0.51	0.66	0.99
PGSC0003DMT200006637	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMT200006638	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMT200006639	K01193	ko00052	Galactose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMT200006639	K01193	ko00500	Starch and sucrose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMT200006639	K01193	ko01100	Metabolic pathways	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMT200006642	K04077	ko03018	RNA degradation	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMT200006642	K04077	ko04940	Type I diabetes mellitus	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMT200006644	K08248	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMT200006644	K08248	ko01100	Metabolic pathways	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMT200006646	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMT200006646	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMT200006647	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMT200006647	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMT200006652	K01190	ko00052	Galactose metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMT200006652	K01190	ko00511	Other glycan degradation	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMT200006652	K01190	ko00600	Sphingolipid metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMT200006652	K01190	ko01100	Metabolic pathways	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMT200034052	K01193	ko00052	Galactose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMT200034052	K01193	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMT200034052	K01193	ko01100	Metabolic pathways	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMT200034053	K01193	ko00052	Galactose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMT200034053	K01193	ko00500	Starch and sucrose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMT200034053	K01193	ko01100	Metabolic pathways	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMT200034054	K01193	ko00052	Galactose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMT200034054	K01193	ko00500	Starch and sucrose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMT200034054	K01193	ko01100	Metabolic pathways	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMT200034057	K04125	ko00904	Diterpenoid biosynthesis	689	3.6e-32	0.51	0.66	0.93
PGSC0003DMT200034089	K06260	ko04512	ECM-receptor interaction	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMT200034089	K06260	ko04640	Hematopoietic cell lineage	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMT200015933	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMT200015933	K12567	ko05414	Dilated cardiomyopathy	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMT200015936	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMT200015936	K12567	ko05414	Dilated cardiomyopathy	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMT200015937	K03110	ko03060	Protein export	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMT200015937	K03110	ko03070	Bacterial secretion system	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMT200015939	K03110	ko03060	Protein export	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMT200015939	K03110	ko03070	Bacterial secretion system	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMT200015940	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMT200015940	K12567	ko05414	Dilated cardiomyopathy	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMT200015941	K03110	ko03060	Protein export	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMT200015941	K03110	ko03070	Bacterial secretion system	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMT200015942	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.86
PGSC0003DMT200015943	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMT200015945	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMT200015946	K01115	ko00564	Glycerophospholipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015946	K01115	ko00565	Ether lipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015946	K01115	ko01100	Metabolic pathways	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015946	K01115	ko04144	Endocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015946	K01115	ko04666	Fc gamma R-mediated phagocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015946	K01115	ko04912	GnRH signaling pathway	6722	0.	0.79	0.90	0.97
PGSC0003DMT200015947	K01115	ko00564	Glycerophospholipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015947	K01115	ko00565	Ether lipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015947	K01115	ko01100	Metabolic pathways	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015947	K01115	ko04144	Endocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015947	K01115	ko04666	Fc gamma R-mediated phagocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015947	K01115	ko04912	GnRH signaling pathway	7548	0.	0.78	0.88	1.00
PGSC0003DMT200015954	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.71
PGSC0003DMT200015955	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.72
PGSC0003DMT200039801	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMT200039802	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMT200039803	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.68
PGSC0003DMT200039805	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.40
PGSC0003DMT200039807	K01595	ko00620	Pyruvate metabolism	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMT200039807	K01595	ko00710	Carbon fixation in photosynthetic organisms	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMT200039807	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMT200039807	K01595	ko01100	Metabolic pathways	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMT200039808	K01595	ko00620	Pyruvate metabolism	5747	0.	0.91	0.96	1.00
PGSC0003DMT200039808	K01595	ko00710	Carbon fixation in photosynthetic organisms	5747	0.	0.91	0.96	1.00
PGSC0003DMT200039808	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5747	0.	0.91	0.96	1.00
PGSC0003DMT200039808	K01595	ko01100	Metabolic pathways	5747	0.	0.91	0.96	1.00
PGSC0003DMT200039809	K01595	ko00620	Pyruvate metabolism	7521	0.	0.91	0.96	1.00
PGSC0003DMT200039809	K01595	ko00710	Carbon fixation in photosynthetic organisms	7521	0.	0.91	0.96	1.00
PGSC0003DMT200039809	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7521	0.	0.91	0.96	1.00
PGSC0003DMT200039809	K01595	ko01100	Metabolic pathways	7521	0.	0.91	0.96	1.00
PGSC0003DMT200039810	K01595	ko00620	Pyruvate metabolism	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMT200039810	K01595	ko00710	Carbon fixation in photosynthetic organisms	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMT200039810	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMT200039810	K01595	ko01100	Metabolic pathways	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMT200039814	K03353	ko04110	Cell cycle	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039814	K03353	ko04111	Cell cycle - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039814	K03353	ko04113	Meiosis - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039814	K03353	ko04114	Oocyte meiosis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039814	K03353	ko04120	Ubiquitin mediated proteolysis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039814	K03353	ko04914	Progesterone-mediated oocyte maturation	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMT200039815	K06636	ko04110	Cell cycle	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMT200039815	K06636	ko04111	Cell cycle - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMT200039815	K06636	ko04113	Meiosis - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMT200039815	K06636	ko04114	Oocyte meiosis	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMT200039823	K02871	ko03010	Ribosome	1513	1.3e-77	0.74	0.85	1.00
PGSC0003DMT200039833	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMT200039833	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMT200039833	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMT200039833	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMT200039833	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMT200039835	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMT200039835	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMT200039835	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMT200039835	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMT200039835	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMT200039836	K06627	ko04110	Cell cycle	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMT200039836	K06627	ko04914	Progesterone-mediated oocyte maturation	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMT200039837	K06627	ko04110	Cell cycle	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMT200039837	K06627	ko04914	Progesterone-mediated oocyte maturation	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMT200039838	K06627	ko04110	Cell cycle	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMT200039838	K06627	ko04914	Progesterone-mediated oocyte maturation	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMT200039839	K06627	ko04110	Cell cycle	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMT200039839	K06627	ko04914	Progesterone-mediated oocyte maturation	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMT200039840	K10577	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.86	0.96	0.99
PGSC0003DMT200002946	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMT200002947	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMT200002955	K12493	ko04144	Endocytosis	2515	7.0e-133	0.74	0.87	1.00
PGSC0003DMT200002993	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMT200002993	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMT200002994	K01066	ko00623	2,4-Dichlorobenzoate degradation	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMT200002994	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMT200093662	K08242	ko00100	Steroid biosynthesis	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMT200093662	K08242	ko01110	Biosynthesis of secondary metabolites	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMT200049463	K03469	ko03030	DNA replication	253	4.0e-08	0.42	0.61	0.41
PGSC0003DMT200049468	K05581	ko00190	Oxidative phosphorylation	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMT200049468	K05581	ko01100	Metabolic pathways	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMT200049487	K00754	ko00051	Fructose and mannose metabolism	1372	7.7e-70	0.41	0.59	0.81
PGSC0003DMT200049488	K05740	ko04510	Focal adhesion	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMT200049488	K05740	ko04810	Regulation of actin cytoskeleton	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMT200049488	K05740	ko05131	Shigellosis	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMT200049498	K05350	ko00460	Cyanoamino acid metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMT200049498	K05350	ko00500	Starch and sucrose metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMT200049498	K05350	ko00940	Phenylpropanoid biosynthesis	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMT200049498	K05350	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMT200049502	K01188	ko00460	Cyanoamino acid metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMT200049502	K01188	ko00500	Starch and sucrose metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMT200049502	K01188	ko00940	Phenylpropanoid biosynthesis	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMT200049502	K01188	ko01110	Biosynthesis of secondary metabolites	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMT200076693	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.45	0.63	0.98
PGSC0003DMT200076694	K12356	ko00940	Phenylpropanoid biosynthesis	216	9.7e-06	0.37	0.58	0.87
PGSC0003DMT200076695	K12356	ko00940	Phenylpropanoid biosynthesis	584	2.2e-26	0.42	0.60	0.96
PGSC0003DMT200076705	K01199	ko00500	Starch and sucrose metabolism	1489	2.7e-76	0.57	0.74	0.96
PGSC0003DMT200076709	K02183	ko04020	Calcium signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04070	Phosphatidylinositol signaling system	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04114	Oocyte meiosis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04270	Vascular smooth muscle contraction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04626	Plant-pathogen interaction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04720	Long-term potentiation	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04722	Neurotrophin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04740	Olfactory transduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04744	Phototransduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04745	Phototransduction - fly	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04910	Insulin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04912	GnRH signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04916	Melanogenesis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04970	Salivary secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko04971	Gastric acid secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko05010	Alzheimer's disease	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076709	K02183	ko05214	Glioma	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMT200076712	K06677	ko04111	Cell cycle - yeast	8161	0.	0.76	0.85	0.98
PGSC0003DMT200076713	K01760	ko00270	Cysteine and methionine metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076713	K01760	ko00450	Selenoamino acid metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076713	K01760	ko00910	Nitrogen metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076713	K01760	ko00920	Sulfur metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076713	K01760	ko01100	Metabolic pathways	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076713	K01760	ko01110	Biosynthesis of secondary metabolites	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMT200076718	K01760	ko00270	Cysteine and methionine metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200076718	K01760	ko00450	Selenoamino acid metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200076718	K01760	ko00910	Nitrogen metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200076718	K01760	ko00920	Sulfur metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200076718	K01760	ko01100	Metabolic pathways	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200076718	K01760	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMT200086496	K02992	ko03010	Ribosome	636	3.0e-29	0.99	0.99	0.22
PGSC0003DMT200086504	K05282	ko00904	Diterpenoid biosynthesis	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMT200086504	K05282	ko01100	Metabolic pathways	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMT200086504	K05282	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMT200086511	K02995	ko03010	Ribosome	1268	4.2e-64	0.74	0.80	0.97
PGSC0003DMT200086515	K03094	ko04110	Cell cycle	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04111	Cell cycle - yeast	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04114	Oocyte meiosis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04120	Ubiquitin mediated proteolysis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04310	Wnt signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04350	TGF-beta signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086515	K03094	ko04710	Circadian rhythm - mammal	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMT200086520	K13230	ko00402	Benzoxazinoid biosynthesis	381	3.5e-15	0.35	0.49	0.99
PGSC0003DMT200059166	K11423	ko00310	Lysine degradation	770	1.2e-36	0.39	0.56	0.89
PGSC0003DMT200059174	K02959	ko03010	Ribosome	429	7.9e-18	0.55	0.78	0.78
PGSC0003DMT200059194	K01866	ko00970	Aminoacyl-tRNA biosynthesis	1800	1.9e-93	0.76	0.88	1.00
PGSC0003DMT200059195	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2707	1.8e-143	0.66	0.79	1.00
PGSC0003DMT200059198	K11423	ko00310	Lysine degradation	735	1.1e-34	0.36	0.53	0.95
PGSC0003DMT200097473	K00795	ko00900	Terpenoid backbone biosynthesis	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMT200097473	K00795	ko01100	Metabolic pathways	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMT200097473	K00795	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMT200092455	K02947	ko03010	Ribosome	315	1.5e-11	0.74	0.79	0.56
PGSC0003DMT200092462	K02866	ko03010	Ribosome	243	3.4e-07	0.59	0.78	0.54
PGSC0003DMT200001262	K00031	ko00020	Citrate cycle (TCA cycle)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001262	K00031	ko00480	Glutathione metabolism	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001262	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001262	K00031	ko01100	Metabolic pathways	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001262	K00031	ko01110	Biosynthesis of secondary metabolites	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001262	K00031	ko04146	Peroxisome	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMT200001265	K00031	ko00020	Citrate cycle (TCA cycle)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001265	K00031	ko00480	Glutathione metabolism	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001265	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001265	K00031	ko01100	Metabolic pathways	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001265	K00031	ko01110	Biosynthesis of secondary metabolites	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001265	K00031	ko04146	Peroxisome	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMT200001279	K08232	ko00053	Ascorbate and aldarate metabolism	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMT200001279	K08232	ko01100	Metabolic pathways	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMT200001280	K08232	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMT200001280	K08232	ko01100	Metabolic pathways	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMT200001281	K08232	ko00053	Ascorbate and aldarate metabolism	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMT200001281	K08232	ko01100	Metabolic pathways	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMT200001282	K02935	ko03010	Ribosome	1061	1.1e-52	0.72	0.85	0.99
PGSC0003DMT200001283	K02935	ko03010	Ribosome	1059	1.4e-52	0.73	0.87	0.99
PGSC0003DMT200001284	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200001284	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200001284	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200001285	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200001285	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200001285	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMT200032331	K00979	ko00540	Lipopolysaccharide biosynthesis	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMT200032331	K00979	ko01100	Metabolic pathways	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMT200032346	K10615	ko04120	Ubiquitin mediated proteolysis	609	1.0e-27	0.32	0.49	0.76
PGSC0003DMT200032349	K10614	ko04120	Ubiquitin mediated proteolysis	290	2.7e-09	0.39	0.58	0.94
PGSC0003DMT200032358	K00790	ko00520	Amino sugar and nucleotide sugar metabolism	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMT200032358	K00790	ko00550	Peptidoglycan biosynthesis	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMT200032358	K00790	ko01100	Metabolic pathways	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMT200032363	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMT200032363	K07819	ko01100	Metabolic pathways	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMT200032365	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMT200032365	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMT200032365	K00734	ko01100	Metabolic pathways	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMT200032367	K10603	ko04120	Ubiquitin mediated proteolysis	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMT200032367	K10603	ko05340	Primary immunodeficiency	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMT200032369	K10603	ko04120	Ubiquitin mediated proteolysis	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMT200032369	K10603	ko05340	Primary immunodeficiency	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMT200032370	K12843	ko03040	Spliceosome	1511	1.7e-77	0.36	0.55	0.96
PGSC0003DMT200004788	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMT200004788	K00517	ko00626	Naphthalene and anthracene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMT200004788	K00517	ko00903	Limonene and pinene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMT200004788	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMT200004788	K00517	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMT200004789	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMT200004789	K00517	ko00626	Naphthalene and anthracene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMT200004789	K00517	ko00903	Limonene and pinene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMT200004789	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMT200004789	K00517	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMT200004790	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMT200004790	K00517	ko00626	Naphthalene and anthracene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMT200004790	K00517	ko00903	Limonene and pinene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMT200004790	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMT200004790	K00517	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMT200004798	K04424	ko04010	MAPK signaling pathway	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMT200004798	K04424	ko04530	Tight junction	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMT200004799	K04424	ko04010	MAPK signaling pathway	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMT200004799	K04424	ko04530	Tight junction	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMT200004806	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMT200004806	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMT200004806	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMT200004806	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMT200004807	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMT200004807	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMT200004807	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMT200004807	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMT200004808	K01835	ko00010	Glycolysis / Gluconeogenesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00030	Pentose phosphate pathway	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00052	Galactose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00230	Purine metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00500	Starch and sucrose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko00521	Streptomycin biosynthesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko01100	Metabolic pathways	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004808	K01835	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMT200004810	K12929	ko00904	Diterpenoid biosynthesis	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMT200004810	K12929	ko01110	Biosynthesis of secondary metabolites	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMT200004816	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMT200004816	K00517	ko00626	Naphthalene and anthracene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMT200004816	K00517	ko00903	Limonene and pinene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMT200004816	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMT200004816	K00517	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMT200004821	K04371	ko04010	MAPK signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04012	ErbB signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04013	MAPK signaling pathway - fly	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04062	Chemokine signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04114	Oocyte meiosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04150	mTOR signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04270	Vascular smooth muscle contraction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04320	Dorso-ventral axis formation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04350	TGF-beta signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04360	Axon guidance	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04370	VEGF signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04510	Focal adhesion	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04520	Adherens junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04540	Gap junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04620	Toll-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04621	NOD-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04650	Natural killer cell mediated cytotoxicity	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04660	T cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04662	B cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04664	Fc epsilon RI signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04666	Fc gamma R-mediated phagocytosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04720	Long-term potentiation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04722	Neurotrophin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04730	Long-term depression	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04810	Regulation of actin cytoskeleton	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04910	Insulin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04912	GnRH signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04914	Progesterone-mediated oocyte maturation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04916	Melanogenesis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04930	Type II diabetes mellitus	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko04960	Aldosterone-regulated sodium reabsorption	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05010	Alzheimer's disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05020	Prion diseases	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05131	Shigellosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05140	Leishmaniasis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05142	Chagas disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05200	Pathways in cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05210	Colorectal cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05211	Renal cell carcinoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05212	Pancreatic cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05213	Endometrial cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05214	Glioma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05215	Prostate cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05216	Thyroid cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05218	Melanoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05219	Bladder cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05220	Chronic myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05221	Acute myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004821	K04371	ko05223	Non-small cell lung cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMT200004822	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMT200004822	K02551	ko01100	Metabolic pathways	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMT200004822	K02551	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMT200004823	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMT200004823	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMT200004823	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMT200004824	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMT200004824	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMT200004824	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMT200004825	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMT200004825	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMT200004825	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMT200004826	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMT200004826	K08680	ko01100	Metabolic pathways	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMT200004826	K08680	ko01110	Biosynthesis of secondary metabolites	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMT200004829	K12126	ko04712	Circadian rhythm - plant	341	5.7e-13	0.25	0.41	0.89
PGSC0003DMT200014247	K12929	ko00904	Diterpenoid biosynthesis	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMT200014247	K12929	ko01110	Biosynthesis of secondary metabolites	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMT200014256	K00059	ko00061	Fatty acid biosynthesis	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMT200014256	K00059	ko01040	Biosynthesis of unsaturated fatty acids	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMT200014256	K00059	ko01100	Metabolic pathways	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMT200014261	K10577	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.98	1.00	0.53
PGSC0003DMT200014262	K12929	ko00904	Diterpenoid biosynthesis	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMT200014262	K12929	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMT200014272	K12929	ko00904	Diterpenoid biosynthesis	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMT200014272	K12929	ko01110	Biosynthesis of secondary metabolites	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMT200014295	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMT200041617	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMT200041618	K11644	ko05016	Huntington's disease	284	2.5e-06	0.28	0.43	0.46
PGSC0003DMT200041619	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMT200041621	K10703	ko01040	Biosynthesis of unsaturated fatty acids	715	1.3e-33	0.56	0.61	0.94
PGSC0003DMT200041628	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1515	1.0e-77	0.33	0.49	0.95
PGSC0003DMT200041629	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	584	5.2e-26	0.42	0.62	0.93
PGSC0003DMT200041634	K06630	ko04110	Cell cycle	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMT200041634	K06630	ko04114	Oocyte meiosis	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMT200041634	K06630	ko04722	Neurotrophin signaling pathway	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMT200041637	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMT200041637	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMT200041637	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMT200041638	K04503	ko04110	Cell cycle	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko04115	p53 signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko04310	Wnt signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko04510	Focal adhesion	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko04630	Jak-STAT signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05200	Pathways in cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05210	Colorectal cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05212	Pancreatic cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05213	Endometrial cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05214	Glioma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05215	Prostate cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05216	Thyroid cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05218	Melanoma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05219	Bladder cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05220	Chronic myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05221	Acute myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05222	Small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05223	Non-small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041638	K04503	ko05416	Viral myocarditis	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMT200041639	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMT200041639	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMT200041639	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMT200057113	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.93
PGSC0003DMT200057114	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.94
PGSC0003DMT200057115	K12132	ko04712	Circadian rhythm - plant	862	1.0e-41	0.64	0.80	0.94
PGSC0003DMT200057116	K12132	ko04712	Circadian rhythm - plant	531	1.9e-23	0.66	0.82	0.84
PGSC0003DMT200057122	K02995	ko03010	Ribosome	1666	4.7e-86	0.90	0.95	0.99
PGSC0003DMT200057128	K03714	ko00510	N-Glycan biosynthesis	2686	2.6e-142	0.60	0.72	1.00
PGSC0003DMT200057129	K08272	ko04150	mTOR signaling pathway	1325	3.0e-67	0.81	0.92	0.85
PGSC0003DMT200057130	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMT200057131	K08272	ko04150	mTOR signaling pathway	1997	2.6e-104	0.71	0.84	0.82
PGSC0003DMT200057132	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMT200057145	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMT200057145	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMT200057145	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMT200057145	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMT200057145	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMT200057146	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMT200057146	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMT200057146	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMT200057146	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMT200057146	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMT200078472	K08332	ko04140	Regulation of autophagy	297	3.1e-10	0.26	0.51	1.00
PGSC0003DMT200078473	K08332	ko04140	Regulation of autophagy	308	1.8e-08	0.28	0.49	0.48
PGSC0003DMT200078492	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMT200078492	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMT200078492	K00771	ko01100	Metabolic pathways	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMT200051327	K09578	ko04622	RIG-I-like receptor signaling pathway	782	2.7e-37	0.77	0.91	0.93
PGSC0003DMT200051329	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.72
PGSC0003DMT200051330	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.73
PGSC0003DMT200051336	K11088	ko03040	Spliceosome	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMT200051336	K11088	ko05322	Systemic lupus erythematosus	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMT200051352	K13082	ko00941	Flavonoid biosynthesis	1125	3.2e-56	0.46	0.66	0.95
PGSC0003DMT200051353	K13082	ko00941	Flavonoid biosynthesis	973	7.9e-48	0.45	0.68	0.95
PGSC0003DMT200060984	K12586	ko03018	RNA degradation	1683	5.4e-87	0.83	0.91	0.76
PGSC0003DMT200060985	K12586	ko03018	RNA degradation	2015	2.7e-105	0.82	0.90	1.00
PGSC0003DMT200061002	K12356	ko00940	Phenylpropanoid biosynthesis	645	9.7e-30	0.37	0.55	0.95
PGSC0003DMT200028157	K00454	ko00591	Linoleic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMT200028157	K00454	ko00592	alpha-Linolenic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMT200028157	K00454	ko01100	Metabolic pathways	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMT200028158	K00454	ko00591	Linoleic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMT200028158	K00454	ko00592	alpha-Linolenic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMT200028158	K00454	ko01100	Metabolic pathways	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMT200026120	K05280	ko00941	Flavonoid biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMT200026120	K05280	ko00944	Flavone and flavonol biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMT200026120	K05280	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMT200026120	K05280	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMT200026121	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMT200026121	K00517	ko00626	Naphthalene and anthracene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMT200026121	K00517	ko00903	Limonene and pinene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMT200026121	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMT200026121	K00517	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMT200026122	K05280	ko00941	Flavonoid biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMT200026122	K05280	ko00944	Flavone and flavonol biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMT200026122	K05280	ko01100	Metabolic pathways	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMT200026122	K05280	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMT200026123	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMT200026123	K00517	ko00626	Naphthalene and anthracene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMT200026123	K00517	ko00903	Limonene and pinene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMT200026123	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMT200026123	K00517	ko01110	Biosynthesis of secondary metabolites	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMT200026128	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMT200026128	K00517	ko00626	Naphthalene and anthracene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMT200026128	K00517	ko00903	Limonene and pinene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMT200026128	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMT200026128	K00517	ko01110	Biosynthesis of secondary metabolites	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMT200026129	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMT200026129	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMT200026129	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMT200026129	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMT200026129	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMT200036807	K02937	ko03010	Ribosome	1363	2.4e-69	0.65	0.83	1.00
PGSC0003DMT200036828	K07192	ko04910	Insulin signaling pathway	1395	4.2e-71	0.41	0.61	0.98
PGSC0003DMT200036833	K07192	ko04910	Insulin signaling pathway	1399	2.5e-71	0.41	0.61	0.98
PGSC0003DMT200036835	K02906	ko03010	Ribosome	1559	3.8e-80	0.71	0.84	0.81
PGSC0003DMT200045431	K01176	ko00500	Starch and sucrose metabolism	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMT200045431	K01176	ko01100	Metabolic pathways	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMT200045432	K01176	ko00500	Starch and sucrose metabolism	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMT200045432	K01176	ko01100	Metabolic pathways	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMT200045436	K01728	ko00040	Pentose and glucuronate interconversions	1759	3.5e-91	0.57	0.73	0.77
PGSC0003DMT200045437	K01728	ko00040	Pentose and glucuronate interconversions	604	1.8e-27	0.53	0.72	0.95
PGSC0003DMT200045438	K01728	ko00040	Pentose and glucuronate interconversions	1291	2.3e-65	0.55	0.71	1.00
PGSC0003DMT200045463	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045463	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045463	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045464	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045464	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045464	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMT200045465	K01490	ko00230	Purine metabolism	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMT200045465	K01490	ko01100	Metabolic pathways	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMT200045465	K01490	ko01110	Biosynthesis of secondary metabolites	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMT200045467	K10615	ko04120	Ubiquitin mediated proteolysis	610	2.3e-27	0.32	0.47	0.93
PGSC0003DMT200045468	K10615	ko04120	Ubiquitin mediated proteolysis	615	1.2e-27	0.32	0.48	0.94
PGSC0003DMT200070949	K03015	ko00230	Purine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMT200070949	K03015	ko00240	Pyrimidine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMT200070949	K03015	ko01100	Metabolic pathways	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMT200070949	K03015	ko03020	RNA polymerase	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMT200070949	K03015	ko05016	Huntington's disease	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMT200070951	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070951	K00261	ko00330	Arginine and proline metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070951	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070951	K00261	ko00910	Nitrogen metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070951	K00261	ko01100	Metabolic pathways	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070951	K00261	ko04964	Proximal tubule bicarbonate reclamation	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMT200070952	K02134	ko00190	Oxidative phosphorylation	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMT200070952	K02134	ko01100	Metabolic pathways	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMT200070952	K02134	ko05010	Alzheimer's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMT200070952	K02134	ko05012	Parkinson's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMT200070952	K02134	ko05016	Huntington's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMT200070961	K01069	ko00620	Pyruvate metabolism	1683	5.4e-87	0.75	0.85	0.99
PGSC0003DMT200070963	K08233	ko00901	Indole alkaloid biosynthesis	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMT200070963	K08233	ko01110	Biosynthesis of secondary metabolites	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMT200070964	K03413	ko02020	Two-component system	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMT200070964	K03413	ko02030	Bacterial chemotaxis	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMT200070965	K01874	ko00450	Selenoamino acid metabolism	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMT200070965	K01874	ko00970	Aminoacyl-tRNA biosynthesis	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMT200070966	K01874	ko00450	Selenoamino acid metabolism	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMT200070966	K01874	ko00970	Aminoacyl-tRNA biosynthesis	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMT200070967	K01874	ko00450	Selenoamino acid metabolism	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMT200070967	K01874	ko00970	Aminoacyl-tRNA biosynthesis	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMT200070974	K01599	ko00860	Porphyrin and chlorophyll metabolism	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMT200070974	K01599	ko01110	Biosynthesis of secondary metabolites	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMT200083921	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMT200083921	K01061	ko00364	Fluorobenzoate degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMT200083921	K01061	ko00627	1,4-Dichlorobenzene degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMT200083921	K01061	ko01100	Metabolic pathways	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMT200083926	K01509	ko00230	Purine metabolism	1626	1.0e-117	0.40	0.57	0.80
PGSC0003DMT200083928	K04421	ko04010	MAPK signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMT200083928	K04421	ko04722	Neurotrophin signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMT200083928	K04421	ko04912	GnRH signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMT200083956	K04631	ko04744	Phototransduction	745	3.0e-35	0.33	0.55	0.45
PGSC0003DMT200087715	K02639	ko00195	Photosynthesis	517	1.1e-22	0.58	0.81	0.97
PGSC0003DMT200083727	K02183	ko04020	Calcium signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04070	Phosphatidylinositol signaling system	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04114	Oocyte meiosis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04270	Vascular smooth muscle contraction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04626	Plant-pathogen interaction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04720	Long-term potentiation	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04722	Neurotrophin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04740	Olfactory transduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04744	Phototransduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04745	Phototransduction - fly	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04910	Insulin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04912	GnRH signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04916	Melanogenesis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04970	Salivary secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko04971	Gastric acid secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko05010	Alzheimer's disease	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083727	K02183	ko05214	Glioma	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMT200083729	K05933	ko00270	Cysteine and methionine metabolism	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMT200083729	K05933	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMT200083730	K00475	ko00941	Flavonoid biosynthesis	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMT200083730	K00475	ko01100	Metabolic pathways	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMT200083730	K00475	ko01110	Biosynthesis of secondary metabolites	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMT200083731	K05277	ko00941	Flavonoid biosynthesis	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMT200083731	K05277	ko01100	Metabolic pathways	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMT200083731	K05277	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMT200083732	K05277	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMT200083732	K05277	ko01100	Metabolic pathways	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMT200083732	K05277	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMT200083733	K05277	ko00941	Flavonoid biosynthesis	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMT200083733	K05277	ko01100	Metabolic pathways	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMT200083733	K05277	ko01110	Biosynthesis of secondary metabolites	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMT200063513	K10901	ko03440	Homologous recombination	707	1.9e-32	0.32	0.44	0.91
PGSC0003DMT200063514	K03654	ko03018	RNA degradation	763	3.0e-36	0.34	0.47	0.95
PGSC0003DMT200063515	K03654	ko03018	RNA degradation	1044	9.5e-52	0.32	0.46	0.73
PGSC0003DMT200063524	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMT200063531	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMT200063541	K05745	ko04810	Regulation of actin cytoskeleton	432	3.7e-17	0.30	0.48	0.83
PGSC0003DMT200063542	K05740	ko04510	Focal adhesion	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMT200063542	K05740	ko04810	Regulation of actin cytoskeleton	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMT200063542	K05740	ko05131	Shigellosis	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMT200063543	K09490	ko03060	Protein export	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMT200063543	K09490	ko05020	Prion diseases	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMT200053367	K12598	ko03018	RNA degradation	6767	0.	0.81	0.90	1.00
PGSC0003DMT200053368	K12598	ko03018	RNA degradation	6959	0.	0.83	0.92	1.00
PGSC0003DMT200053369	K06638	ko04110	Cell cycle	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMT200053369	K06638	ko04914	Progesterone-mediated oocyte maturation	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMT200053370	K06638	ko04110	Cell cycle	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMT200053370	K06638	ko04914	Progesterone-mediated oocyte maturation	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMT200053385	K12839	ko03040	Spliceosome	1797	2.8e-93	0.74	0.85	0.99
PGSC0003DMT200053386	K12839	ko03040	Spliceosome	582	2.9e-26	0.69	0.79	0.98
PGSC0003DMT200053387	K12839	ko03040	Spliceosome	1413	4.2e-72	0.74	0.85	0.98
PGSC0003DMT200053391	K03544	ko04112	Cell cycle - Caulobacter	499	1.1e-21	0.55	0.69	0.99
PGSC0003DMT200053392	K03544	ko04112	Cell cycle - Caulobacter	233	1.1e-06	0.42	0.55	0.88
PGSC0003DMT200053393	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMT200053394	K03544	ko04112	Cell cycle - Caulobacter	2945	1.3e-156	0.62	0.74	0.91
PGSC0003DMT200053395	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMT200053396	K03544	ko04112	Cell cycle - Caulobacter	1134	1.0e-56	0.53	0.63	0.77
PGSC0003DMT200053398	K11294	ko05130	Pathogenic Escherichia coli infection	285	4.8e-07	0.30	0.48	0.24
PGSC0003DMT200053399	K11294	ko05130	Pathogenic Escherichia coli infection	285	1.7e-08	0.30	0.48	0.54
PGSC0003DMT200008343	K02112	ko00190	Oxidative phosphorylation	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMT200008343	K02112	ko00195	Photosynthesis	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMT200008343	K02112	ko01100	Metabolic pathways	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMT200008347	K12890	ko03040	Spliceosome	1651	3.2e-85	0.87	0.94	0.66
PGSC0003DMT200008349	K12890	ko03040	Spliceosome	1850	3.3e-96	0.80	0.88	0.98
PGSC0003DMT200008350	K12890	ko03040	Spliceosome	1847	4.9e-96	0.81	0.89	0.98
PGSC0003DMT200020471	K02144	ko00190	Oxidative phosphorylation	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020471	K02144	ko01100	Metabolic pathways	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020471	K02144	ko04142	Lysosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020471	K02144	ko04145	Phagosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020471	K02144	ko05110	Vibrio cholerae infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020471	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMT200020475	K01507	ko00190	Oxidative phosphorylation	5827	0.	0.91	0.96	1.00
PGSC0003DMT200020476	K01613	ko00564	Glycerophospholipid metabolism	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMT200020476	K01613	ko01100	Metabolic pathways	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMT200020477	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMT200020477	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMT200020478	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMT200020478	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMT200010358	K11423	ko00310	Lysine degradation	451	7.8e-18	0.29	0.47	0.83
PGSC0003DMT200010366	K02150	ko00190	Oxidative phosphorylation	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010366	K02150	ko01100	Metabolic pathways	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010366	K02150	ko04145	Phagosome	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010366	K02150	ko04966	Collecting duct acid secretion	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010366	K02150	ko05110	Vibrio cholerae infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010366	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMT200010369	K02866	ko03010	Ribosome	292	4.7e-10	0.70	0.85	0.87
PGSC0003DMT200010372	K03902	ko04610	Complement and coagulation cascades	373	1.8e-13	0.38	0.46	0.97
PGSC0003DMT200036593	K01081	ko00230	Purine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMT200036593	K01081	ko00240	Pyrimidine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMT200036593	K01081	ko00760	Nicotinate and nicotinamide metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMT200036593	K01081	ko01100	Metabolic pathways	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMT200036593	K01081	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMT200036594	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036594	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036594	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036594	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036594	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036596	K00430	ko00360	Phenylalanine metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMT200036596	K00430	ko00680	Methane metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMT200036596	K00430	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMT200036596	K00430	ko01100	Metabolic pathways	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMT200036596	K00430	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMT200036605	K01915	ko00250	Alanine, aspartate and glutamate metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMT200036605	K01915	ko00330	Arginine and proline metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMT200036605	K01915	ko00910	Nitrogen metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMT200036605	K01915	ko01100	Metabolic pathways	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMT200036605	K01915	ko02020	Two-component system	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMT200036620	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMT200036621	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMT200036636	K01535	ko00190	Oxidative phosphorylation	4939	1.4e-266	0.85	0.92	1.00
PGSC0003DMT200078274	K03843	ko00510	N-Glycan biosynthesis	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMT200078274	K03843	ko01100	Metabolic pathways	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMT200078287	K00487	ko00360	Phenylalanine metabolism	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078287	K00487	ko00940	Phenylpropanoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078287	K00487	ko00941	Flavonoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078287	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078287	K00487	ko01100	Metabolic pathways	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078287	K00487	ko01110	Biosynthesis of secondary metabolites	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMT200078288	K00487	ko00360	Phenylalanine metabolism	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078288	K00487	ko00940	Phenylpropanoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078288	K00487	ko00941	Flavonoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078288	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078288	K00487	ko01100	Metabolic pathways	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078288	K00487	ko01110	Biosynthesis of secondary metabolites	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMT200078289	K00487	ko00360	Phenylalanine metabolism	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078289	K00487	ko00940	Phenylpropanoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078289	K00487	ko00941	Flavonoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078289	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078289	K00487	ko01100	Metabolic pathways	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078289	K00487	ko01110	Biosynthesis of secondary metabolites	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko00360	Phenylalanine metabolism	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko00940	Phenylpropanoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko00941	Flavonoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko01100	Metabolic pathways	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078290	K00487	ko01110	Biosynthesis of secondary metabolites	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMT200078295	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMT200078296	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMT200078301	K03063	ko03050	Proteasome	3214	2.0e-171	0.93	0.95	0.99
PGSC0003DMT200061096	K00941	ko00730	Thiamine metabolism	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMT200061096	K00941	ko01100	Metabolic pathways	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMT200061097	K00941	ko00730	Thiamine metabolism	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMT200061097	K00941	ko01100	Metabolic pathways	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMT200061098	K00941	ko00730	Thiamine metabolism	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMT200061098	K00941	ko01100	Metabolic pathways	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMT200061101	K00941	ko00730	Thiamine metabolism	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMT200061101	K00941	ko01100	Metabolic pathways	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMT200061105	K02365	ko04110	Cell cycle	7297	0.	0.46	0.63	1.00
PGSC0003DMT200061105	K02365	ko04111	Cell cycle - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMT200061105	K02365	ko04113	Meiosis - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMT200061105	K02365	ko04114	Oocyte meiosis	7297	0.	0.46	0.63	1.00
PGSC0003DMT200069029	K02873	ko03010	Ribosome	954	8.8e-47	0.81	0.91	0.99
PGSC0003DMT200069030	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1802	1.5e-93	0.70	0.80	0.91
PGSC0003DMT200069033	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.82	0.98
PGSC0003DMT200069034	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.80	0.98
PGSC0003DMT200069038	K00012	ko00040	Pentose and glucuronate interconversions	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069038	K00012	ko00053	Ascorbate and aldarate metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069038	K00012	ko00500	Starch and sucrose metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069038	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069038	K00012	ko01100	Metabolic pathways	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069038	K00012	ko01110	Biosynthesis of secondary metabolites	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMT200069039	K12829	ko03040	Spliceosome	3879	4.1e-208	0.80	0.88	1.00
PGSC0003DMT200069041	K12829	ko03040	Spliceosome	2509	1.5e-132	0.90	0.97	1.00
PGSC0003DMT200069042	K12829	ko03040	Spliceosome	4097	3.9e-220	0.83	0.91	1.00
PGSC0003DMT200069043	K02184	ko04320	Dorso-ventral axis formation	490	8.6e-19	0.30	0.43	0.56
PGSC0003DMT200069044	K05740	ko04510	Focal adhesion	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMT200069044	K05740	ko04810	Regulation of actin cytoskeleton	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMT200069044	K05740	ko05131	Shigellosis	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMT200069053	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.61
PGSC0003DMT200069054	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.43
PGSC0003DMT200069056	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMT200069057	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.85
PGSC0003DMT200069058	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMT200069059	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMT200069060	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMT200069067	K04733	ko04210	Apoptosis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMT200069067	K04733	ko04620	Toll-like receptor signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMT200069067	K04733	ko04722	Neurotrophin signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMT200069067	K04733	ko05140	Leishmaniasis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMT200069067	K04733	ko05142	Chagas disease	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMT200069075	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMT200069075	K01657	ko01100	Metabolic pathways	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMT200069075	K01657	ko01110	Biosynthesis of secondary metabolites	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMT200074374	K04079	ko04612	Antigen processing and presentation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074374	K04079	ko04621	NOD-like receptor signaling pathway	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074374	K04079	ko04626	Plant-pathogen interaction	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074374	K04079	ko04914	Progesterone-mediated oocyte maturation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074374	K04079	ko05200	Pathways in cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074374	K04079	ko05215	Prostate cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMT200074375	K04079	ko04612	Antigen processing and presentation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074375	K04079	ko04621	NOD-like receptor signaling pathway	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074375	K04079	ko04626	Plant-pathogen interaction	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074375	K04079	ko04914	Progesterone-mediated oocyte maturation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074375	K04079	ko05200	Pathways in cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074375	K04079	ko05215	Prostate cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMT200074376	K04079	ko04612	Antigen processing and presentation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074376	K04079	ko04621	NOD-like receptor signaling pathway	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074376	K04079	ko04626	Plant-pathogen interaction	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074376	K04079	ko04914	Progesterone-mediated oocyte maturation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074376	K04079	ko05200	Pathways in cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074376	K04079	ko05215	Prostate cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMT200074377	K04079	ko04612	Antigen processing and presentation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074377	K04079	ko04621	NOD-like receptor signaling pathway	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074377	K04079	ko04626	Plant-pathogen interaction	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074377	K04079	ko04914	Progesterone-mediated oocyte maturation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074377	K04079	ko05200	Pathways in cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074377	K04079	ko05215	Prostate cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMT200074409	K08008	ko04145	Phagosome	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMT200074409	K08008	ko04670	Leukocyte transendothelial migration	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMT200074411	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMT200074411	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMT200074412	K08008	ko04145	Phagosome	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMT200074412	K08008	ko04670	Leukocyte transendothelial migration	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMT200032126	K10843	ko03420	Nucleotide excision repair	5489	6.5e-297	0.89	0.93	0.98
PGSC0003DMT200032127	K10843	ko03420	Nucleotide excision repair	5851	0.	0.90	0.94	0.99
PGSC0003DMT200032131	K02202	ko03420	Nucleotide excision repair	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMT200032131	K02202	ko04110	Cell cycle	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMT200032133	K11153	ko00830	Retinol metabolism	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMT200032133	K11153	ko01100	Metabolic pathways	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMT200032138	K01928	ko00300	Lysine biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMT200032138	K01928	ko00550	Peptidoglycan biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMT200014378	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMT200014379	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMT200014380	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMT200014381	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMT200014384	K02993	ko03010	Ribosome	1467	4.5e-75	0.90	0.97	0.99
PGSC0003DMT200014386	K11866	ko04144	Endocytosis	365	2.7e-14	0.76	0.88	0.94
PGSC0003DMT200014387	K11866	ko04144	Endocytosis	1417	2.5e-72	0.55	0.69	0.92
PGSC0003DMT200014388	K11866	ko04144	Endocytosis	2742	2.1e-145	0.65	0.78	0.99
PGSC0003DMT200014389	K11866	ko04144	Endocytosis	2432	2.7e-128	0.65	0.77	1.00
PGSC0003DMT200014393	K01892	ko00970	Aminoacyl-tRNA biosynthesis	2067	3.6e-108	0.83	0.95	1.00
PGSC0003DMT200014395	K12396	ko04142	Lysosome	4696	3.6e-253	0.63	0.76	1.00
PGSC0003DMT200014397	K02183	ko04020	Calcium signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04070	Phosphatidylinositol signaling system	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04114	Oocyte meiosis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04270	Vascular smooth muscle contraction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04626	Plant-pathogen interaction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04720	Long-term potentiation	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04722	Neurotrophin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04740	Olfactory transduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04744	Phototransduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04745	Phototransduction - fly	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04910	Insulin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04912	GnRH signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04916	Melanogenesis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04970	Salivary secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko04971	Gastric acid secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko05010	Alzheimer's disease	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014397	K02183	ko05214	Glioma	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMT200014398	K02183	ko04020	Calcium signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04070	Phosphatidylinositol signaling system	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04114	Oocyte meiosis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04270	Vascular smooth muscle contraction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04626	Plant-pathogen interaction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04720	Long-term potentiation	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04722	Neurotrophin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04740	Olfactory transduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04744	Phototransduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04745	Phototransduction - fly	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04910	Insulin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04912	GnRH signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04916	Melanogenesis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04970	Salivary secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko04971	Gastric acid secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko05010	Alzheimer's disease	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014398	K02183	ko05214	Glioma	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMT200014414	K05350	ko00460	Cyanoamino acid metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMT200014414	K05350	ko00500	Starch and sucrose metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMT200014414	K05350	ko00940	Phenylpropanoid biosynthesis	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMT200014414	K05350	ko01110	Biosynthesis of secondary metabolites	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMT200014415	K05350	ko00460	Cyanoamino acid metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMT200014415	K05350	ko00500	Starch and sucrose metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMT200014415	K05350	ko00940	Phenylpropanoid biosynthesis	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMT200014415	K05350	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMT200022644	K00368	ko00910	Nitrogen metabolism	1216	3.1e-61	0.45	0.57	0.86
PGSC0003DMT200022652	K05579	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMT200022652	K05579	ko01100	Metabolic pathways	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMT200022653	K05572	ko00190	Oxidative phosphorylation	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMT200022653	K05572	ko01100	Metabolic pathways	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMT200022657	K09841	ko00906	Carotenoid biosynthesis	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMT200022657	K09841	ko01100	Metabolic pathways	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMT200022657	K09841	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMT200022659	K09841	ko00906	Carotenoid biosynthesis	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMT200022659	K09841	ko01100	Metabolic pathways	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMT200022659	K09841	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMT200022660	K09841	ko00906	Carotenoid biosynthesis	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMT200022660	K09841	ko01100	Metabolic pathways	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMT200022660	K09841	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMT200022663	K00522	ko00860	Porphyrin and chlorophyll metabolism	817	3.2e-39	0.59	0.74	0.67
PGSC0003DMT200022665	K13065	ko00940	Phenylpropanoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMT200022665	K13065	ko00941	Flavonoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMT200022665	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMT200022665	K13065	ko01110	Biosynthesis of secondary metabolites	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMT200022674	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMT200022676	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMT200001145	K13065	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMT200001145	K13065	ko00941	Flavonoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMT200001145	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMT200001145	K13065	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMT200001148	K12356	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.33	0.50	0.94
PGSC0003DMT200001149	K12356	ko00940	Phenylpropanoid biosynthesis	751	1.4e-35	0.32	0.49	0.93
PGSC0003DMT200001150	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMT200001150	K12449	ko01100	Metabolic pathways	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMT200001151	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMT200001151	K12449	ko01100	Metabolic pathways	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMT200001156	K11824	ko04144	Endocytosis	7361	0.	0.85	0.90	1.00
PGSC0003DMT200001156	K11824	ko05016	Huntington's disease	7361	0.	0.85	0.90	1.00
PGSC0003DMT200001157	K11824	ko04144	Endocytosis	7394	0.	0.87	0.92	1.00
PGSC0003DMT200001157	K11824	ko05016	Huntington's disease	7394	0.	0.87	0.92	1.00
PGSC0003DMT200001159	K11824	ko04144	Endocytosis	7426	0.	0.87	0.92	1.00
PGSC0003DMT200001159	K11824	ko05016	Huntington's disease	7426	0.	0.87	0.92	1.00
PGSC0003DMT200001169	K05692	ko04145	Phagosome	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04510	Focal adhesion	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04520	Adherens junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04530	Tight junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04670	Leukocyte transendothelial migration	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04745	Phototransduction - fly	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko04810	Regulation of actin cytoskeleton	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05100	Bacterial invasion of epithelial cells	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05110	Vibrio cholerae infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05130	Pathogenic Escherichia coli infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05131	Shigellosis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05414	Dilated cardiomyopathy	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200001169	K05692	ko05416	Viral myocarditis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMT200092009	K10532	ko00531	Glycosaminoglycan degradation	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMT200092009	K10532	ko01100	Metabolic pathways	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMT200092009	K10532	ko04142	Lysosome	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMT200076484	K01613	ko00564	Glycerophospholipid metabolism	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMT200076484	K01613	ko01100	Metabolic pathways	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMT200076487	K01613	ko00564	Glycerophospholipid metabolism	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMT200076487	K01613	ko01100	Metabolic pathways	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMT200067333	K01768	ko00230	Purine metabolism	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMT200067333	K01768	ko04113	Meiosis - yeast	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMT200067334	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMT200067334	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMT200067335	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMT200067335	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMT200067336	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.85
PGSC0003DMT200067337	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.54
PGSC0003DMT200059349	K02997	ko03010	Ribosome	1579	3.0e-81	0.93	0.99	0.99
PGSC0003DMT200059350	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059350	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059350	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059350	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059350	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059351	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059351	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059351	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059351	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059351	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMT200059356	K10594	ko04120	Ubiquitin mediated proteolysis	766	2.7e-33	0.32	0.48	0.51
PGSC0003DMT200093187	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMT200093187	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMT200093215	K03062	ko03050	Proteasome	235	1.8e-06	0.33	0.54	0.83
PGSC0003DMT200002818	K13027	ko00460	Cyanoamino acid metabolism	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMT200002818	K13027	ko00966	Glucosinolate biosynthesis	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMT200002818	K13027	ko01100	Metabolic pathways	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMT200002818	K13027	ko01110	Biosynthesis of secondary metabolites	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMT200002828	K11594	ko04622	RIG-I-like receptor signaling pathway	4180	1.0e-224	0.78	0.87	1.00
PGSC0003DMT200002830	K04717	ko00600	Sphingolipid metabolism	484	7.3e-21	0.30	0.46	0.91
PGSC0003DMT200002842	K12124	ko04712	Circadian rhythm - plant	367	1.6e-13	0.49	0.68	0.84
PGSC0003DMT200000125	K12862	ko03040	Spliceosome	3273	1.1e-174	0.78	0.87	1.00
PGSC0003DMT200000128	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2537	4.3e-134	0.69	0.84	0.99
PGSC0003DMT200000129	K01068	ko01040	Biosynthesis of unsaturated fatty acids	417	3.6e-17	0.66	0.85	0.95
PGSC0003DMT200000155	K13034	ko00270	Cysteine and methionine metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMT200000155	K13034	ko00450	Selenoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMT200000155	K13034	ko00460	Cyanoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMT200000155	K13034	ko00920	Sulfur metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMT200000155	K13034	ko01100	Metabolic pathways	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMT200000156	K13034	ko00270	Cysteine and methionine metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMT200000156	K13034	ko00450	Selenoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMT200000156	K13034	ko00460	Cyanoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMT200000156	K13034	ko00920	Sulfur metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMT200000156	K13034	ko01100	Metabolic pathways	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMT200000157	K13034	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMT200000157	K13034	ko00450	Selenoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMT200000157	K13034	ko00460	Cyanoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMT200000157	K13034	ko00920	Sulfur metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMT200000157	K13034	ko01100	Metabolic pathways	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMT200000158	K12604	ko03018	RNA degradation	1434	3.7e-73	0.45	0.61	0.97
PGSC0003DMT200000160	K12604	ko03018	RNA degradation	365	4.5e-13	0.54	0.79	0.86
PGSC0003DMT200033819	K05714	ko00360	Phenylalanine metabolism	214	5.7e-06	0.36	0.54	0.45
PGSC0003DMT200033820	K10702	ko00642	Ethylbenzene degradation	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMT200033820	K10702	ko01100	Metabolic pathways	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMT200024330	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMT200024331	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMT200024335	K13068	ko00940	Phenylpropanoid biosynthesis	673	2.8e-31	0.29	0.49	0.99
PGSC0003DMT200024337	K13068	ko00940	Phenylpropanoid biosynthesis	750	1.6e-35	0.30	0.51	0.97
PGSC0003DMT200024338	K13068	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.28	0.49	0.98
PGSC0003DMT200024342	K13068	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.30	0.49	0.97
PGSC0003DMT200024348	K00558	ko00270	Cysteine and methionine metabolism	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMT200024348	K00558	ko01100	Metabolic pathways	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMT200016068	K05666	ko02010	ABC transporters	2647	3.7e-140	0.34	0.53	0.86
PGSC0003DMT200016069	K05666	ko02010	ABC transporters	3378	1.8e-180	0.39	0.61	0.88
PGSC0003DMT200016070	K05666	ko02010	ABC transporters	1802	5.5e-97	0.31	0.53	0.87
PGSC0003DMT200016084	K01239	ko00230	Purine metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMT200016084	K01239	ko00760	Nicotinate and nicotinamide metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMT200016084	K01239	ko01100	Metabolic pathways	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMT200016085	K01239	ko00230	Purine metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMT200016085	K01239	ko00760	Nicotinate and nicotinamide metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMT200016085	K01239	ko01100	Metabolic pathways	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMT200016087	K02084	ko04115	p53 signaling pathway	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko04210	Apoptosis	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko05010	Alzheimer's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko05012	Parkinson's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko05016	Huntington's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016087	K02084	ko05222	Small cell lung cancer	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMT200016089	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMT200016089	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMT200016090	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMT200016090	K01870	ko00970	Aminoacyl-tRNA biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMT200016091	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMT200016091	K01870	ko00970	Aminoacyl-tRNA biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMT200016094	K02706	ko00195	Photosynthesis	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMT200016094	K02706	ko01100	Metabolic pathways	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMT200029974	K00817	ko00340	Histidine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko00350	Tyrosine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko00360	Phenylalanine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko00401	Novobiocin biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko01100	Metabolic pathways	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029974	K00817	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMT200029978	K00817	ko00340	Histidine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko00350	Tyrosine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko00360	Phenylalanine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko00401	Novobiocin biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko01100	Metabolic pathways	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029978	K00817	ko01110	Biosynthesis of secondary metabolites	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMT200029996	K11753	ko00740	Riboflavin metabolism	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMT200029996	K11753	ko01100	Metabolic pathways	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMT200029997	K11753	ko00740	Riboflavin metabolism	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMT200029997	K11753	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMT200030010	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030010	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030011	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMT200030012	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030012	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030012	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030012	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030012	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030012	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMT200030013	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030013	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030013	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030013	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030013	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030013	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMT200030019	K02084	ko04115	p53 signaling pathway	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko04210	Apoptosis	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko05010	Alzheimer's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko05012	Parkinson's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko05016	Huntington's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200030019	K02084	ko05222	Small cell lung cancer	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMT200053081	K01897	ko00071	Fatty acid metabolism	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMT200053081	K01897	ko01100	Metabolic pathways	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMT200053081	K01897	ko03320	PPAR signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMT200053081	K01897	ko04146	Peroxisome	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMT200053081	K01897	ko04920	Adipocytokine signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMT200053084	K12929	ko00904	Diterpenoid biosynthesis	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMT200053084	K12929	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMT200053108	K01176	ko00500	Starch and sucrose metabolism	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMT200053108	K01176	ko01100	Metabolic pathways	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMT200053109	K01176	ko00500	Starch and sucrose metabolism	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMT200053109	K01176	ko01100	Metabolic pathways	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMT200053110	K01176	ko00500	Starch and sucrose metabolism	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMT200053110	K01176	ko01100	Metabolic pathways	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMT200053111	K01176	ko00500	Starch and sucrose metabolism	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMT200053111	K01176	ko01100	Metabolic pathways	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMT200053112	K01176	ko00500	Starch and sucrose metabolism	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMT200053112	K01176	ko01100	Metabolic pathways	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMT200080885	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.33	0.51	0.89
PGSC0003DMT200080887	K01590	ko00340	Histidine metabolism	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMT200080887	K01590	ko01100	Metabolic pathways	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMT200080887	K01590	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMT200055303	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055303	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055303	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055304	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055304	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055304	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055309	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055309	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055309	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055311	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055311	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055311	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055312	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055312	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055312	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055313	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055313	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055313	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055315	K02602	ko04114	Oocyte meiosis	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMT200055315	K02602	ko04320	Dorso-ventral axis formation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMT200055315	K02602	ko04914	Progesterone-mediated oocyte maturation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMT200055316	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055316	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200055316	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMT200065212	K05862	ko04020	Calcium signaling pathway	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMT200065212	K05862	ko05012	Parkinson's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMT200065212	K05862	ko05016	Huntington's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMT200065213	K05862	ko04020	Calcium signaling pathway	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMT200065213	K05862	ko05012	Parkinson's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMT200065213	K05862	ko05016	Huntington's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMT200065214	K05862	ko04020	Calcium signaling pathway	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMT200065214	K05862	ko05012	Parkinson's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMT200065214	K05862	ko05016	Huntington's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMT200065215	K05862	ko04020	Calcium signaling pathway	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMT200065215	K05862	ko05012	Parkinson's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMT200065215	K05862	ko05016	Huntington's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMT200065217	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065217	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065218	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065218	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065219	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065219	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMT200065220	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMT200065221	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMT200088598	K11644	ko05016	Huntington's disease	461	1.2e-18	0.35	0.50	0.73
PGSC0003DMT200088620	K03660	ko03410	Base excision repair	463	2.9e-19	0.31	0.50	0.97
PGSC0003DMT200088621	K03094	ko04110	Cell cycle	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04111	Cell cycle - yeast	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04114	Oocyte meiosis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04120	Ubiquitin mediated proteolysis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04310	Wnt signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04350	TGF-beta signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088621	K03094	ko04710	Circadian rhythm - mammal	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMT200088624	K02738	ko03050	Proteasome	456	2.6e-19	0.38	0.58	0.85
PGSC0003DMT200043313	K02923	ko03010	Ribosome	521	6.7e-23	0.90	0.96	0.99
PGSC0003DMT200043314	K06236	ko04510	Focal adhesion	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMT200043314	K06236	ko04512	ECM-receptor interaction	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMT200043314	K06236	ko05146	Amoebiasis	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMT200043315	K01213	ko00040	Pentose and glucuronate interconversions	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMT200043315	K01213	ko00500	Starch and sucrose metabolism	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMT200043315	K01213	ko01100	Metabolic pathways	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMT200043338	K00030	ko00020	Citrate cycle (TCA cycle)	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMT200043338	K00030	ko01100	Metabolic pathways	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMT200043338	K00030	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMT200043345	K09680	ko00770	Pantothenate and CoA biosynthesis	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMT200043345	K09680	ko01100	Metabolic pathways	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMT200043347	K09680	ko00770	Pantothenate and CoA biosynthesis	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMT200043347	K09680	ko01100	Metabolic pathways	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMT200008656	K01509	ko00230	Purine metabolism	264	8.2e-26	0.47	0.67	0.62
PGSC0003DMT200008659	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMT200008660	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMT200008661	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMT200008662	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMT200008665	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMT200008665	K02367	ko01100	Metabolic pathways	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMT200008687	K02870	ko03010	Ribosome	1326	2.7e-67	0.95	0.99	0.99
PGSC0003DMT200018531	K12815	ko03040	Spliceosome	8555	0.	0.81	0.88	0.99
PGSC0003DMT200018532	K12815	ko03040	Spliceosome	427	8.0e-17	0.96	0.98	0.95
PGSC0003DMT200018533	K12815	ko03040	Spliceosome	363	3.0e-13	0.90	0.98	0.80
PGSC0003DMT200018544	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMT200018544	K00517	ko00626	Naphthalene and anthracene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMT200018544	K00517	ko00903	Limonene and pinene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMT200018544	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMT200018544	K00517	ko01110	Biosynthesis of secondary metabolites	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMT200018545	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMT200018545	K00517	ko00626	Naphthalene and anthracene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMT200018545	K00517	ko00903	Limonene and pinene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMT200018545	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMT200018545	K00517	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMT200018546	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMT200018546	K00517	ko00626	Naphthalene and anthracene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMT200018546	K00517	ko00903	Limonene and pinene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMT200018546	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMT200018546	K00517	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMT200018554	K02723	ko00195	Photosynthesis	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMT200018554	K02723	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMT200018560	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1380	2.8e-70	0.38	0.55	0.96
PGSC0003DMT200018569	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018569	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMT200018570	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	368	4.4e-14	0.30	0.47	0.93
PGSC0003DMT200018571	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	380	8.8e-15	0.29	0.46	0.92
PGSC0003DMT200018572	K12486	ko04144	Endocytosis	285	5.8e-07	0.26	0.39	0.60
PGSC0003DMT200038324	K02218	ko04340	Hedgehog signaling pathway	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMT200038324	K02218	ko04711	Circadian rhythm - fly	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMT200038325	K02218	ko04340	Hedgehog signaling pathway	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMT200038325	K02218	ko04711	Circadian rhythm - fly	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMT200038326	K02218	ko04340	Hedgehog signaling pathway	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMT200038326	K02218	ko04711	Circadian rhythm - fly	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMT200038343	K12668	ko00510	N-Glycan biosynthesis	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMT200038343	K12668	ko01100	Metabolic pathways	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMT200038345	K00630	ko00561	Glycerolipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMT200038345	K00630	ko00564	Glycerophospholipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMT200038345	K00630	ko01100	Metabolic pathways	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMT200007644	K05894	ko00592	alpha-Linolenic acid metabolism	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMT200007644	K05894	ko01100	Metabolic pathways	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMT200007649	K05894	ko00592	alpha-Linolenic acid metabolism	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMT200007649	K05894	ko01100	Metabolic pathways	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMT200007661	K01757	ko00901	Indole alkaloid biosynthesis	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMT200007661	K01757	ko01100	Metabolic pathways	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMT200007661	K01757	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMT200007674	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMT200007684	K02256	ko00190	Oxidative phosphorylation	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200007684	K02256	ko01100	Metabolic pathways	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200007684	K02256	ko04260	Cardiac muscle contraction	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200007684	K02256	ko05010	Alzheimer's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200007684	K02256	ko05012	Parkinson's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200007684	K02256	ko05016	Huntington's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMT200014920	K12235	ko00260	Glycine, serine and threonine metabolism	1160	3.8e-58	0.73	0.85	0.98
PGSC0003DMT200014921	K12235	ko00260	Glycine, serine and threonine metabolism	1966	1.3e-102	0.71	0.84	0.99
PGSC0003DMT200014922	K12235	ko00260	Glycine, serine and threonine metabolism	2007	7.3e-105	0.73	0.86	0.99
PGSC0003DMT200014923	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMT200014932	K01762	ko00270	Cysteine and methionine metabolism	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMT200014932	K01762	ko01110	Biosynthesis of secondary metabolites	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMT200014935	K04706	ko04120	Ubiquitin mediated proteolysis	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMT200014935	K04706	ko04630	Jak-STAT signaling pathway	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMT200014935	K04706	ko05200	Pathways in cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMT200014935	K04706	ko05222	Small cell lung cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMT200014936	K04706	ko04120	Ubiquitin mediated proteolysis	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMT200014936	K04706	ko04630	Jak-STAT signaling pathway	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMT200014936	K04706	ko05200	Pathways in cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMT200014936	K04706	ko05222	Small cell lung cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMT200014945	K02150	ko00190	Oxidative phosphorylation	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200014945	K02150	ko01100	Metabolic pathways	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200014945	K02150	ko04145	Phagosome	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200014945	K02150	ko04966	Collecting duct acid secretion	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200014945	K02150	ko05110	Vibrio cholerae infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200014945	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMT200024615	K11820	ko00380	Tryptophan metabolism	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMT200024615	K11820	ko00966	Glucosinolate biosynthesis	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMT200024615	K11820	ko01110	Biosynthesis of secondary metabolites	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMT200024619	K11820	ko00380	Tryptophan metabolism	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMT200024619	K11820	ko00966	Glucosinolate biosynthesis	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMT200024619	K11820	ko01110	Biosynthesis of secondary metabolites	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMT200024622	K11820	ko00380	Tryptophan metabolism	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMT200024622	K11820	ko00966	Glucosinolate biosynthesis	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMT200024622	K11820	ko01110	Biosynthesis of secondary metabolites	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMT200024624	K11820	ko00380	Tryptophan metabolism	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMT200024624	K11820	ko00966	Glucosinolate biosynthesis	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMT200024624	K11820	ko01110	Biosynthesis of secondary metabolites	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMT200024628	K11820	ko00380	Tryptophan metabolism	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMT200024628	K11820	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMT200024628	K11820	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMT200024634	K00658	ko00020	Citrate cycle (TCA cycle)	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMT200024634	K00658	ko00310	Lysine degradation	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMT200024634	K00658	ko01100	Metabolic pathways	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMT200024634	K00658	ko01110	Biosynthesis of secondary metabolites	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMT200024641	K11820	ko00380	Tryptophan metabolism	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMT200024641	K11820	ko00966	Glucosinolate biosynthesis	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMT200024641	K11820	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMT200092927	K08912	ko00196	Photosynthesis - antenna proteins	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMT200092927	K08912	ko01100	Metabolic pathways	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMT200092935	K00368	ko00910	Nitrogen metabolism	699	1.0e-32	0.36	0.54	0.83
PGSC0003DMT200096732	K02704	ko00195	Photosynthesis	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMT200096732	K02704	ko01100	Metabolic pathways	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMT200050523	K08337	ko04140	Regulation of autophagy	423	3.0e-17	0.77	0.81	0.97
PGSC0003DMT200050524	K08337	ko04140	Regulation of autophagy	4693	5.2e-253	0.77	0.87	1.00
PGSC0003DMT200050536	K01206	ko00511	Other glycan degradation	2801	1.2e-148	0.74	0.86	0.93
PGSC0003DMT200050537	K01206	ko00511	Other glycan degradation	1713	1.2e-88	0.66	0.82	0.95
PGSC0003DMT200050540	K01354	ko05142	Chagas disease	600	2.9e-27	0.37	0.59	0.80
PGSC0003DMT200050542	K01354	ko05142	Chagas disease	679	1.3e-31	0.48	0.67	0.98
PGSC0003DMT200050545	K01354	ko05142	Chagas disease	269	2.0e-08	0.56	0.69	0.91
PGSC0003DMT200050551	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.34	0.48	0.95
PGSC0003DMT200050552	K12356	ko00940	Phenylpropanoid biosynthesis	698	1.2e-32	0.33	0.48	0.97
PGSC0003DMT200050556	K04079	ko04612	Antigen processing and presentation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200050556	K04079	ko04621	NOD-like receptor signaling pathway	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200050556	K04079	ko04626	Plant-pathogen interaction	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200050556	K04079	ko04914	Progesterone-mediated oocyte maturation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200050556	K04079	ko05200	Pathways in cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200050556	K04079	ko05215	Prostate cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMT200058122	K10772	ko03410	Base excision repair	1846	5.6e-96	0.55	0.66	0.99
PGSC0003DMT200058123	K10772	ko03410	Base excision repair	2985	8.4e-159	0.61	0.72	0.99
PGSC0003DMT200058126	K00908	ko01100	Metabolic pathways	3426	4.0e-183	0.83	0.92	0.85
PGSC0003DMT200058127	K00908	ko01100	Metabolic pathways	2034	2.4e-106	0.84	0.93	0.87
PGSC0003DMT200058131	K11088	ko03040	Spliceosome	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMT200058131	K11088	ko05322	Systemic lupus erythematosus	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMT200058134	K00430	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMT200058134	K00430	ko00680	Methane metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMT200058134	K00430	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMT200058134	K00430	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMT200058134	K00430	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMT200058139	K02732	ko03050	Proteasome	1743	2.7e-90	0.91	0.96	1.00
PGSC0003DMT200058163	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMT200058163	K00224	ko00364	Fluorobenzoate degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMT200058163	K00224	ko00628	Fluorene degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMT200058163	K00224	ko00640	Propanoate metabolism	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMT200058167	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.46
PGSC0003DMT200058169	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.44
PGSC0003DMT200058187	K04371	ko04010	MAPK signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04012	ErbB signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04013	MAPK signaling pathway - fly	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04062	Chemokine signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04114	Oocyte meiosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04150	mTOR signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04270	Vascular smooth muscle contraction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04320	Dorso-ventral axis formation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04350	TGF-beta signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04360	Axon guidance	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04370	VEGF signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04510	Focal adhesion	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04520	Adherens junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04540	Gap junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04620	Toll-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04621	NOD-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04650	Natural killer cell mediated cytotoxicity	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04660	T cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04662	B cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04664	Fc epsilon RI signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04666	Fc gamma R-mediated phagocytosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04720	Long-term potentiation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04722	Neurotrophin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04730	Long-term depression	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04810	Regulation of actin cytoskeleton	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04910	Insulin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04912	GnRH signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04914	Progesterone-mediated oocyte maturation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04916	Melanogenesis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04930	Type II diabetes mellitus	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko04960	Aldosterone-regulated sodium reabsorption	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05010	Alzheimer's disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05020	Prion diseases	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05131	Shigellosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05140	Leishmaniasis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05142	Chagas disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05200	Pathways in cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05210	Colorectal cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05211	Renal cell carcinoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05212	Pancreatic cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05213	Endometrial cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05214	Glioma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05215	Prostate cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05216	Thyroid cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05218	Melanoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05219	Bladder cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05220	Chronic myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05221	Acute myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200058187	K04371	ko05223	Non-small cell lung cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMT200067609	K03715	ko00561	Glycerolipid metabolism	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMT200067609	K03715	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMT200067611	K01528	ko04144	Endocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMT200067611	K01528	ko04666	Fc gamma R-mediated phagocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMT200067611	K01528	ko05100	Bacterial invasion of epithelial cells	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMT200067612	K01528	ko04144	Endocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMT200067612	K01528	ko04666	Fc gamma R-mediated phagocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMT200067612	K01528	ko05100	Bacterial invasion of epithelial cells	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMT200067613	K01528	ko04144	Endocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMT200067613	K01528	ko04666	Fc gamma R-mediated phagocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMT200067613	K01528	ko05100	Bacterial invasion of epithelial cells	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMT200067614	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067614	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067614	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067615	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067615	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067615	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMT200067629	K02956	ko03010	Ribosome	293	2.5e-10	0.30	0.46	0.84
PGSC0003DMT200067630	K02956	ko03010	Ribosome	774	7.4e-37	0.38	0.54	0.87
PGSC0003DMT200067631	K02956	ko03010	Ribosome	1118	7.9e-56	0.45	0.59	0.88
PGSC0003DMT200067634	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMT200067634	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMT200067634	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMT200017914	K01673	ko00910	Nitrogen metabolism	865	7.1e-42	0.72	0.85	0.97
PGSC0003DMT200017915	K01673	ko00910	Nitrogen metabolism	592	8.1e-27	0.72	0.84	0.96
PGSC0003DMT200017916	K01673	ko00910	Nitrogen metabolism	217	3.9e-06	0.55	0.71	0.81
PGSC0003DMT200017917	K01673	ko00910	Nitrogen metabolism	301	9.1e-11	0.54	0.71	0.88
PGSC0003DMT200017918	K01673	ko00910	Nitrogen metabolism	292	2.9e-10	0.60	0.72	0.98
PGSC0003DMT200017920	K05289	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMT200017920	K05289	ko01100	Metabolic pathways	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMT200017925	K00876	ko00240	Pyrimidine metabolism	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMT200017925	K00876	ko00983	Drug metabolism - other enzymes	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMT200017925	K00876	ko01100	Metabolic pathways	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMT200010121	K12182	ko04144	Endocytosis	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMT200010121	K12182	ko04145	Phagosome	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMT200089130	K11294	ko05130	Pathogenic Escherichia coli infection	283	2.6e-09	0.32	0.50	0.92
PGSC0003DMT200078927	K05756	ko04666	Fc gamma R-mediated phagocytosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMT200078927	K05756	ko04810	Regulation of actin cytoskeleton	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMT200078927	K05756	ko05100	Bacterial invasion of epithelial cells	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMT200078927	K05756	ko05130	Pathogenic Escherichia coli infection	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMT200078927	K05756	ko05131	Shigellosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMT200078929	K03715	ko00561	Glycerolipid metabolism	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMT200078929	K03715	ko01100	Metabolic pathways	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMT200078930	K03715	ko00561	Glycerolipid metabolism	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMT200078930	K03715	ko01100	Metabolic pathways	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMT200078934	K07964	ko00531	Glycosaminoglycan degradation	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMT200078934	K07964	ko01100	Metabolic pathways	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMT200078935	K07964	ko00531	Glycosaminoglycan degradation	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMT200078935	K07964	ko01100	Metabolic pathways	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMT200078946	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMT200078946	K00517	ko00626	Naphthalene and anthracene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMT200078946	K00517	ko00903	Limonene and pinene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMT200078946	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMT200078946	K00517	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMT200078952	K05864	ko04020	Calcium signaling pathway	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMT200078952	K05864	ko05012	Parkinson's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMT200078952	K05864	ko05016	Huntington's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMT200078953	K05864	ko04020	Calcium signaling pathway	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMT200078953	K05864	ko05012	Parkinson's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMT200078953	K05864	ko05016	Huntington's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMT200078963	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200078963	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200078963	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200078964	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200078964	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200078964	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMT200064536	K02945	ko03010	Ribosome	321	7.2e-12	0.72	0.87	0.90
PGSC0003DMT200064537	K02945	ko03010	Ribosome	1241	1.3e-62	0.59	0.68	0.99
PGSC0003DMT200064538	K02945	ko03010	Ribosome	2631	2.8e-139	0.66	0.77	0.99
PGSC0003DMT200064541	K01528	ko04144	Endocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMT200064541	K01528	ko04666	Fc gamma R-mediated phagocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMT200064541	K01528	ko05100	Bacterial invasion of epithelial cells	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMT200064542	K01528	ko04144	Endocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMT200064542	K01528	ko04666	Fc gamma R-mediated phagocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMT200064542	K01528	ko05100	Bacterial invasion of epithelial cells	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMT200064545	K00866	ko00564	Glycerophospholipid metabolism	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMT200064545	K00866	ko01100	Metabolic pathways	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMT200064547	K00866	ko00564	Glycerophospholipid metabolism	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMT200064547	K00866	ko01100	Metabolic pathways	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMT200064551	K00430	ko00360	Phenylalanine metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMT200064551	K00430	ko00680	Methane metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMT200064551	K00430	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMT200064551	K00430	ko01100	Metabolic pathways	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMT200064551	K00430	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMT200064552	K00430	ko00360	Phenylalanine metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMT200064552	K00430	ko00680	Methane metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMT200064552	K00430	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMT200064552	K00430	ko01100	Metabolic pathways	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMT200064552	K00430	ko01110	Biosynthesis of secondary metabolites	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMT200064553	K00430	ko00360	Phenylalanine metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMT200064553	K00430	ko00680	Methane metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMT200064553	K00430	ko00940	Phenylpropanoid biosynthesis	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMT200064553	K00430	ko01100	Metabolic pathways	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMT200064553	K00430	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMT200064554	K00430	ko00360	Phenylalanine metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMT200064554	K00430	ko00680	Methane metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMT200064554	K00430	ko00940	Phenylpropanoid biosynthesis	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMT200064554	K00430	ko01100	Metabolic pathways	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMT200064554	K00430	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMT200064555	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMT200064555	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMT200064555	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMT200064555	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMT200064555	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMT200064557	K01507	ko00190	Oxidative phosphorylation	6009	0.	0.90	0.95	1.00
PGSC0003DMT200064558	K01507	ko00190	Oxidative phosphorylation	5748	0.	0.89	0.95	1.00
PGSC0003DMT200064566	K05280	ko00941	Flavonoid biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMT200064566	K05280	ko00944	Flavone and flavonol biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMT200064566	K05280	ko01100	Metabolic pathways	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMT200064566	K05280	ko01110	Biosynthesis of secondary metabolites	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMT200056910	K12831	ko03040	Spliceosome	214	9.1e-06	0.40	0.51	0.80
PGSC0003DMT200056917	K03553	ko03440	Homologous recombination	2643	6.1e-140	0.81	0.90	0.94
PGSC0003DMT200003533	K01231	ko00510	N-Glycan biosynthesis	7172	0.	0.71	0.83	1.00
PGSC0003DMT200003533	K01231	ko01100	Metabolic pathways	7172	0.	0.71	0.83	1.00
PGSC0003DMT200003537	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.28	0.46	0.79
PGSC0003DMT200003538	K11644	ko05016	Huntington's disease	6729	0.	0.61	0.74	0.99
PGSC0003DMT200003539	K11644	ko05016	Huntington's disease	6993	0.	0.62	0.75	1.00
PGSC0003DMT200003540	K11644	ko05016	Huntington's disease	847	2.3e-40	0.38	0.54	0.96
PGSC0003DMT200003544	K11644	ko05016	Huntington's disease	1210	6.7e-61	0.46	0.58	0.96
PGSC0003DMT200003545	K11644	ko05016	Huntington's disease	1265	6.2e-64	0.47	0.60	0.96
PGSC0003DMT200003546	K05658	ko02010	ABC transporters	4157	1.9e-223	0.45	0.66	0.99
PGSC0003DMT200003547	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMT200003547	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMT200003547	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMT200003548	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMT200003548	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMT200003548	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMT200003551	K00472	ko00330	Arginine and proline metabolism	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMT200003551	K00472	ko01100	Metabolic pathways	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMT200003562	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMT200003562	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMT200003562	K00771	ko01100	Metabolic pathways	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMT200090311	K01213	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMT200090311	K01213	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMT200090311	K01213	ko01100	Metabolic pathways	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMT200090318	K10760	ko00908	Zeatin biosynthesis	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMT200090318	K10760	ko01100	Metabolic pathways	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMT200090318	K10760	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMT200034558	K08272	ko04150	mTOR signaling pathway	2462	5.9e-130	0.88	0.94	0.99
PGSC0003DMT200034559	K08272	ko04150	mTOR signaling pathway	344	3.9e-13	0.80	0.87	0.95
PGSC0003DMT200034561	K01092	ko00521	Streptomycin biosynthesis	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMT200034561	K01092	ko00562	Inositol phosphate metabolism	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMT200034561	K01092	ko01100	Metabolic pathways	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMT200034561	K01092	ko01110	Biosynthesis of secondary metabolites	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMT200034561	K01092	ko04070	Phosphatidylinositol signaling system	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMT200034562	K01092	ko00521	Streptomycin biosynthesis	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMT200034562	K01092	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMT200034562	K01092	ko01100	Metabolic pathways	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMT200034562	K01092	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMT200034562	K01092	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMT200034564	K08332	ko04140	Regulation of autophagy	288	1.2e-07	0.30	0.45	0.76
PGSC0003DMT200034565	K08332	ko04140	Regulation of autophagy	288	9.6e-08	0.30	0.46	0.75
PGSC0003DMT200034569	K00857	ko00240	Pyrimidine metabolism	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMT200034569	K00857	ko00983	Drug metabolism - other enzymes	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMT200034569	K00857	ko01100	Metabolic pathways	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMT200034570	K00857	ko00240	Pyrimidine metabolism	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMT200034570	K00857	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMT200034570	K00857	ko01100	Metabolic pathways	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMT200011877	K01516	ko00230	Purine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMT200011877	K01516	ko00730	Thiamine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMT200011877	K01516	ko01100	Metabolic pathways	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMT200011878	K01516	ko00230	Purine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMT200011878	K01516	ko00730	Thiamine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMT200011878	K01516	ko01100	Metabolic pathways	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMT200011880	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011880	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011880	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011881	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011881	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011881	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011882	K01516	ko00230	Purine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMT200011882	K01516	ko00730	Thiamine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMT200011882	K01516	ko01100	Metabolic pathways	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMT200011883	K01516	ko00230	Purine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMT200011883	K01516	ko00730	Thiamine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMT200011883	K01516	ko01100	Metabolic pathways	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMT200011885	K01516	ko00230	Purine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMT200011885	K01516	ko00730	Thiamine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMT200011885	K01516	ko01100	Metabolic pathways	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMT200011886	K01516	ko00230	Purine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMT200011886	K01516	ko00730	Thiamine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMT200011886	K01516	ko01100	Metabolic pathways	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMT200011887	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011887	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011887	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011888	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011888	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011888	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011889	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011889	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011889	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMT200011892	K12338	ko00942	Anthocyanin biosynthesis	548	2.2e-24	0.57	0.75	0.96
PGSC0003DMT200011895	K12338	ko00942	Anthocyanin biosynthesis	716	1.2e-33	0.40	0.60	0.96
PGSC0003DMT200011906	K08246	ko00100	Steroid biosynthesis	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMT200011906	K08246	ko01100	Metabolic pathways	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMT200011906	K08246	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMT200011907	K08246	ko00100	Steroid biosynthesis	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMT200011907	K08246	ko01100	Metabolic pathways	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMT200011907	K08246	ko01110	Biosynthesis of secondary metabolites	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMT200019744	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.74
PGSC0003DMT200019745	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.69
PGSC0003DMT200019746	K00970	ko03018	RNA degradation	2726	1.6e-144	0.68	0.81	0.72
PGSC0003DMT200019747	K01590	ko00340	Histidine metabolism	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMT200019747	K01590	ko01100	Metabolic pathways	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMT200019747	K01590	ko01110	Biosynthesis of secondary metabolites	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMT200019751	K01590	ko00340	Histidine metabolism	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMT200019751	K01590	ko01100	Metabolic pathways	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMT200019751	K01590	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMT200019769	K09755	ko00940	Phenylpropanoid biosynthesis	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMT200019769	K09755	ko01100	Metabolic pathways	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMT200019769	K09755	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMT200019770	K09755	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMT200019770	K09755	ko01100	Metabolic pathways	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMT200019770	K09755	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMT200019771	K13083	ko00941	Flavonoid biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMT200019771	K13083	ko00944	Flavone and flavonol biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMT200019771	K13083	ko01110	Biosynthesis of secondary metabolites	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMT200019772	K05280	ko00941	Flavonoid biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMT200019772	K05280	ko00944	Flavone and flavonol biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMT200019772	K05280	ko01100	Metabolic pathways	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMT200019772	K05280	ko01110	Biosynthesis of secondary metabolites	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMT200019773	K05280	ko00941	Flavonoid biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMT200019773	K05280	ko00944	Flavone and flavonol biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMT200019773	K05280	ko01100	Metabolic pathways	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMT200019773	K05280	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMT200019777	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMT200019777	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMT200019777	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMT200019777	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMT200019777	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMT200019779	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200019779	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200019779	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200019779	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMT200019782	K13025	ko03040	Spliceosome	3032	2.1e-161	0.89	0.93	1.00
PGSC0003DMT200019783	K13025	ko03040	Spliceosome	3163	1.3e-168	0.92	0.96	1.00
PGSC0003DMT200055120	K00343	ko00190	Oxidative phosphorylation	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMT200055120	K00343	ko01100	Metabolic pathways	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMT200062863	K08332	ko04140	Regulation of autophagy	266	3.5e-06	0.32	0.47	0.40
PGSC0003DMT200062864	K10773	ko03410	Base excision repair	1417	2.5e-72	0.61	0.78	0.89
PGSC0003DMT200062878	K02183	ko04020	Calcium signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04070	Phosphatidylinositol signaling system	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04114	Oocyte meiosis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04270	Vascular smooth muscle contraction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04626	Plant-pathogen interaction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04720	Long-term potentiation	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04722	Neurotrophin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04740	Olfactory transduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04744	Phototransduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04745	Phototransduction - fly	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04910	Insulin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04912	GnRH signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04916	Melanogenesis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04970	Salivary secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko04971	Gastric acid secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko05010	Alzheimer's disease	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062878	K02183	ko05214	Glioma	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMT200062879	K02183	ko04020	Calcium signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04070	Phosphatidylinositol signaling system	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04114	Oocyte meiosis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04270	Vascular smooth muscle contraction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04626	Plant-pathogen interaction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04720	Long-term potentiation	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04722	Neurotrophin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04740	Olfactory transduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04744	Phototransduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04745	Phototransduction - fly	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04910	Insulin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04912	GnRH signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04916	Melanogenesis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04970	Salivary secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko04971	Gastric acid secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko05010	Alzheimer's disease	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062879	K02183	ko05214	Glioma	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMT200062880	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062880	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062881	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMT200062883	K02183	ko04020	Calcium signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04070	Phosphatidylinositol signaling system	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04114	Oocyte meiosis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04270	Vascular smooth muscle contraction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04626	Plant-pathogen interaction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04720	Long-term potentiation	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04722	Neurotrophin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04740	Olfactory transduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04744	Phototransduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04745	Phototransduction - fly	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04910	Insulin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04912	GnRH signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04916	Melanogenesis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04970	Salivary secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko04971	Gastric acid secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko05010	Alzheimer's disease	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062883	K02183	ko05214	Glioma	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMT200062885	K02183	ko04020	Calcium signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04114	Oocyte meiosis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04270	Vascular smooth muscle contraction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04626	Plant-pathogen interaction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04720	Long-term potentiation	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04722	Neurotrophin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04740	Olfactory transduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04744	Phototransduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04745	Phototransduction - fly	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04910	Insulin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04912	GnRH signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04916	Melanogenesis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04970	Salivary secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko04971	Gastric acid secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko05010	Alzheimer's disease	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200062885	K02183	ko05214	Glioma	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMT200091735	K00002	ko00010	Glycolysis / Gluconeogenesis	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMT200091735	K00002	ko00561	Glycerolipid metabolism	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMT200091735	K00002	ko00930	Caprolactam degradation	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMT200091735	K00002	ko01100	Metabolic pathways	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMT200091735	K00002	ko01110	Biosynthesis of secondary metabolites	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMT200005929	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005929	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005929	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005932	K00292	ko00310	Lysine degradation	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMT200005932	K00292	ko01100	Metabolic pathways	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMT200005932	K00292	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMT200005933	K01199	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.37	0.58	0.65
PGSC0003DMT200005946	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMT200005947	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMT200005948	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMT200005956	K03541	ko00195	Photosynthesis	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMT200005956	K03541	ko01100	Metabolic pathways	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMT200005957	K03541	ko00195	Photosynthesis	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMT200005957	K03541	ko01100	Metabolic pathways	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMT200005965	K10955	ko05110	Vibrio cholerae infection	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMT200005965	K10955	ko05146	Amoebiasis	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMT200005970	K05933	ko00270	Cysteine and methionine metabolism	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMT200005970	K05933	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMT200005971	K05933	ko00270	Cysteine and methionine metabolism	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMT200005971	K05933	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMT200039022	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMT200039023	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMT200039024	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1914	9.9e-100	0.68	0.79	0.99
PGSC0003DMT200039025	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1948	1.3e-101	0.69	0.79	0.99
PGSC0003DMT200039026	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	361	2.2e-13	0.37	0.52	0.91
PGSC0003DMT200039028	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	546	2.8e-24	0.74	0.79	0.97
PGSC0003DMT200039033	K04503	ko04110	Cell cycle	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko04115	p53 signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko04310	Wnt signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko04510	Focal adhesion	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko04630	Jak-STAT signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05200	Pathways in cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05210	Colorectal cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05212	Pancreatic cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05213	Endometrial cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05214	Glioma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05215	Prostate cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05216	Thyroid cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05218	Melanoma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05219	Bladder cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05220	Chronic myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05221	Acute myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05222	Small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05223	Non-small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039033	K04503	ko05416	Viral myocarditis	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMT200039051	K00971	ko00051	Fructose and mannose metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMT200039051	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMT200039051	K00971	ko01100	Metabolic pathways	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMT200039051	K00971	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMT200039054	K09840	ko00906	Carotenoid biosynthesis	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMT200039054	K09840	ko01100	Metabolic pathways	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMT200039054	K09840	ko01110	Biosynthesis of secondary metabolites	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMT200022952	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022952	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022952	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022952	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022952	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMT200022953	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022953	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022953	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022953	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022953	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022954	K00002	ko00010	Glycolysis / Gluconeogenesis	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMT200022954	K00002	ko00561	Glycerolipid metabolism	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMT200022954	K00002	ko00930	Caprolactam degradation	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMT200022954	K00002	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMT200022954	K00002	ko01110	Biosynthesis of secondary metabolites	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMT200022955	K00002	ko00010	Glycolysis / Gluconeogenesis	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMT200022955	K00002	ko00561	Glycerolipid metabolism	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMT200022955	K00002	ko00930	Caprolactam degradation	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMT200022955	K00002	ko01100	Metabolic pathways	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMT200022955	K00002	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMT200022956	K00002	ko00010	Glycolysis / Gluconeogenesis	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMT200022956	K00002	ko00561	Glycerolipid metabolism	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMT200022956	K00002	ko00930	Caprolactam degradation	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMT200022956	K00002	ko01100	Metabolic pathways	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMT200022956	K00002	ko01110	Biosynthesis of secondary metabolites	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMT200022957	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022957	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022957	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022957	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022957	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMT200022958	K00002	ko00010	Glycolysis / Gluconeogenesis	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMT200022958	K00002	ko00561	Glycerolipid metabolism	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMT200022958	K00002	ko00930	Caprolactam degradation	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMT200022958	K00002	ko01100	Metabolic pathways	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMT200022958	K00002	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMT200022959	K00002	ko00010	Glycolysis / Gluconeogenesis	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMT200022959	K00002	ko00561	Glycerolipid metabolism	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMT200022959	K00002	ko00930	Caprolactam degradation	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMT200022959	K00002	ko01100	Metabolic pathways	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMT200022959	K00002	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMT200022960	K00971	ko00051	Fructose and mannose metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMT200022960	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMT200022960	K00971	ko01100	Metabolic pathways	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMT200022960	K00971	ko01110	Biosynthesis of secondary metabolites	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMT200022961	K00971	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMT200022961	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMT200022961	K00971	ko01100	Metabolic pathways	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMT200022961	K00971	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMT200022967	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMT200022968	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMT200022970	K10594	ko04120	Ubiquitin mediated proteolysis	460	6.4e-23	0.33	0.49	0.67
PGSC0003DMT200022971	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMT200022972	K10594	ko04120	Ubiquitin mediated proteolysis	460	1.7e-22	0.32	0.49	0.67
PGSC0003DMT200022973	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMT200022973	K08081	ko01100	Metabolic pathways	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMT200022973	K08081	ko01110	Biosynthesis of secondary metabolites	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMT200022974	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMT200022974	K08081	ko01100	Metabolic pathways	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMT200022974	K08081	ko01110	Biosynthesis of secondary metabolites	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMT200022984	K00368	ko00910	Nitrogen metabolism	1587	1.1e-81	0.42	0.57	0.91
PGSC0003DMT200022992	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.91
PGSC0003DMT200022993	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.98
PGSC0003DMT200022994	K00368	ko00910	Nitrogen metabolism	812	6.0e-39	0.40	0.54	0.88
PGSC0003DMT200013176	K10717	ko00908	Zeatin biosynthesis	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMT200013176	K10717	ko01100	Metabolic pathways	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMT200013176	K10717	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMT200013177	K07424	ko00140	Steroid hormone biosynthesis	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00591	Linoleic acid metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00830	Retinol metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00982	Drug metabolism - cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko00983	Drug metabolism - other enzymes	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013177	K07424	ko01100	Metabolic pathways	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMT200013189	K00430	ko00360	Phenylalanine metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMT200013189	K00430	ko00680	Methane metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMT200013189	K00430	ko00940	Phenylpropanoid biosynthesis	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMT200013189	K00430	ko01100	Metabolic pathways	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMT200013189	K00430	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMT200052381	K12586	ko03018	RNA degradation	901	2.6e-43	0.45	0.62	0.68
PGSC0003DMT200052409	K13065	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMT200052409	K13065	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMT200052409	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMT200052409	K13065	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMT200052413	K00368	ko00910	Nitrogen metabolism	1706	2.9e-88	0.45	0.59	0.90
PGSC0003DMT200069374	K00059	ko00061	Fatty acid biosynthesis	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMT200069374	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMT200069374	K00059	ko01100	Metabolic pathways	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMT200069383	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMT200069384	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMT200069385	K02880	ko03010	Ribosome	1341	4.0e-68	0.90	0.94	0.99
PGSC0003DMT200069387	K02880	ko03010	Ribosome	526	3.5e-23	0.90	0.96	0.93
PGSC0003DMT200069390	K02880	ko03010	Ribosome	534	1.3e-23	0.91	0.97	0.93
PGSC0003DMT200069392	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMT200069392	K00517	ko00626	Naphthalene and anthracene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMT200069392	K00517	ko00903	Limonene and pinene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMT200069392	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMT200069392	K00517	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMT200069393	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMT200069393	K00517	ko00626	Naphthalene and anthracene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMT200069393	K00517	ko00903	Limonene and pinene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMT200069393	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMT200069393	K00517	ko01110	Biosynthesis of secondary metabolites	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMT200069394	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMT200069394	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMT200069394	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMT200069394	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMT200069394	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMT200069397	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMT200069397	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMT200069397	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMT200069397	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMT200069397	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMT200069398	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMT200069398	K00517	ko00626	Naphthalene and anthracene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMT200069398	K00517	ko00903	Limonene and pinene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMT200069398	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMT200069398	K00517	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMT200069399	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMT200069399	K00517	ko00626	Naphthalene and anthracene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMT200069399	K00517	ko00903	Limonene and pinene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMT200069399	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMT200069399	K00517	ko01110	Biosynthesis of secondary metabolites	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMT200069400	K12132	ko04712	Circadian rhythm - plant	1960	2.9e-102	0.53	0.63	0.67
PGSC0003DMT200069401	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMT200069402	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMT200069403	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMT200069406	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMT200069407	K12132	ko04712	Circadian rhythm - plant	437	4.2e-18	0.57	0.80	0.27
PGSC0003DMT200059967	K01889	ko00970	Aminoacyl-tRNA biosynthesis	1792	5.3e-93	0.89	0.96	1.00
PGSC0003DMT200059968	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3057	8.9e-163	0.80	0.89	1.00
PGSC0003DMT200059971	K08057	ko04145	Phagosome	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMT200059971	K08057	ko04612	Antigen processing and presentation	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMT200059971	K08057	ko05142	Chagas disease	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMT200059972	K08057	ko04145	Phagosome	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMT200059972	K08057	ko04612	Antigen processing and presentation	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMT200059972	K08057	ko05142	Chagas disease	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMT200059981	K02737	ko03050	Proteasome	2029	4.5e-106	0.89	0.93	0.99
PGSC0003DMT200059982	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059982	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059982	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059983	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059983	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059983	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059984	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059984	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059984	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMT200059985	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059985	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059985	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMT200059987	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMT200059987	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMT200059988	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMT200059988	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMT200048262	K04424	ko04010	MAPK signaling pathway	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMT200048262	K04424	ko04530	Tight junction	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMT200048265	K00875	ko00040	Pentose and glucuronate interconversions	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMT200048265	K00875	ko01100	Metabolic pathways	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMT200048267	K00875	ko00040	Pentose and glucuronate interconversions	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMT200048267	K00875	ko01100	Metabolic pathways	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMT200048268	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.36	0.55	0.70
PGSC0003DMT200048279	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.52	0.94
PGSC0003DMT200048280	K08139	ko04113	Meiosis - yeast	886	4.9e-43	0.34	0.52	0.90
PGSC0003DMT200066335	K09843	ko00906	Carotenoid biosynthesis	2395	2.9e-126	0.70	0.85	0.93
PGSC0003DMT200066337	K09843	ko00906	Carotenoid biosynthesis	2807	5.5e-149	0.71	0.85	0.96
PGSC0003DMT200066338	K09843	ko00906	Carotenoid biosynthesis	973	7.9e-48	0.69	0.85	0.98
PGSC0003DMT200066354	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMT200066354	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMT200066354	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMT200066354	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMT200066354	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMT200051772	K06666	ko04111	Cell cycle - yeast	508	4.3e-22	0.26	0.41	0.65
PGSC0003DMT200051773	K05279	ko00944	Flavone and flavonol biosynthesis	1379	3.2e-70	0.51	0.71	0.97
PGSC0003DMT200051777	K05279	ko00944	Flavone and flavonol biosynthesis	646	8.5e-30	0.47	0.66	0.99
PGSC0003DMT200051781	K05279	ko00944	Flavone and flavonol biosynthesis	1389	8.9e-71	0.51	0.71	0.96
PGSC0003DMT200051785	K05279	ko00944	Flavone and flavonol biosynthesis	1413	4.2e-72	0.51	0.71	0.97
PGSC0003DMT200051795	K00754	ko00051	Fructose and mannose metabolism	3078	6.2e-164	0.65	0.79	1.00
PGSC0003DMT200051801	K01495	ko00790	Folate biosynthesis	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMT200051801	K01495	ko01100	Metabolic pathways	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMT200051802	K01495	ko00790	Folate biosynthesis	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMT200051802	K01495	ko01100	Metabolic pathways	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMT200051810	K02995	ko03010	Ribosome	1432	3.8e-73	0.88	0.91	0.98
PGSC0003DMT200051811	K02995	ko03010	Ribosome	1653	2.5e-85	0.89	0.92	1.00
PGSC0003DMT200077205	K08332	ko04140	Regulation of autophagy	311	1.3e-08	0.35	0.51	0.36
PGSC0003DMT200077208	K02178	ko04110	Cell cycle	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMT200077208	K02178	ko04111	Cell cycle - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMT200077208	K02178	ko04113	Meiosis - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMT200077208	K02178	ko04114	Oocyte meiosis	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMT200077208	K02178	ko04914	Progesterone-mediated oocyte maturation	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMT200070042	K01188	ko00460	Cyanoamino acid metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMT200070042	K01188	ko00500	Starch and sucrose metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMT200070042	K01188	ko00940	Phenylpropanoid biosynthesis	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMT200070042	K01188	ko01110	Biosynthesis of secondary metabolites	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMT200070043	K01188	ko00460	Cyanoamino acid metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMT200070043	K01188	ko00500	Starch and sucrose metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMT200070043	K01188	ko00940	Phenylpropanoid biosynthesis	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMT200070043	K01188	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMT200070054	K08695	ko00941	Flavonoid biosynthesis	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMT200070054	K08695	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMT200070055	K08695	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMT200070055	K08695	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMT200070056	K08695	ko00941	Flavonoid biosynthesis	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMT200070056	K08695	ko01110	Biosynthesis of secondary metabolites	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMT200070057	K08695	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMT200070057	K08695	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMT200070060	K08695	ko00941	Flavonoid biosynthesis	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMT200070060	K08695	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMT200070070	K01408	ko05010	Alzheimer's disease	3765	8.0e-202	0.77	0.88	0.98
PGSC0003DMT200070071	K01408	ko05010	Alzheimer's disease	6332	0.	0.76	0.88	0.99
PGSC0003DMT200070072	K01408	ko05010	Alzheimer's disease	2736	4.5e-145	0.73	0.85	0.99
PGSC0003DMT200070073	K01408	ko05010	Alzheimer's disease	3203	7.9e-171	0.64	0.80	0.98
PGSC0003DMT200070074	K01408	ko05010	Alzheimer's disease	5464	1.6e-295	0.67	0.81	0.99
PGSC0003DMT200070075	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMT200070076	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMT200070077	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMT200086432	K05282	ko00904	Diterpenoid biosynthesis	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMT200086432	K05282	ko01100	Metabolic pathways	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMT200086432	K05282	ko01110	Biosynthesis of secondary metabolites	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMT200086433	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2260	8.1e-119	0.65	0.80	0.99
PGSC0003DMT200005183	K04446	ko04310	Wnt signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005183	K04446	ko04360	Axon guidance	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005183	K04446	ko04370	VEGF signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005183	K04446	ko04650	Natural killer cell mediated cytotoxicity	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005183	K04446	ko04660	T cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005183	K04446	ko04662	B cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMT200005184	K04498	ko04110	Cell cycle	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04310	Wnt signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04330	Notch signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04350	TGF-beta signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04520	Adherens junction	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04630	Jak-STAT signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04720	Long-term potentiation	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko04916	Melanogenesis	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko05016	Huntington's disease	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko05200	Pathways in cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko05211	Renal cell carcinoma	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005184	K04498	ko05215	Prostate cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMT200005199	K03123	ko03022	Basal transcription factors	810	7.7e-39	0.92	0.94	0.99
PGSC0003DMT200005238	K06611	ko00052	Galactose metabolism	1731	1.2e-89	0.41	0.58	0.97
PGSC0003DMT200005239	K06611	ko00052	Galactose metabolism	2118	5.5e-111	0.40	0.57	0.97
PGSC0003DMT200005240	K12603	ko03018	RNA degradation	3577	1.9e-191	0.53	0.59	1.00
PGSC0003DMT200005241	K12603	ko03018	RNA degradation	4248	1.8e-228	0.82	0.91	1.00
PGSC0003DMT200005242	K12603	ko03018	RNA degradation	3263	3.9e-174	0.81	0.91	0.96
PGSC0003DMT200031066	K02084	ko04115	p53 signaling pathway	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko04210	Apoptosis	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko05010	Alzheimer's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko05012	Parkinson's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko05016	Huntington's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031066	K02084	ko05222	Small cell lung cancer	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMT200031093	K06130	ko00564	Glycerophospholipid metabolism	382	3.1e-15	0.36	0.50	0.79
PGSC0003DMT200031099	K12524	ko00260	Glycine, serine and threonine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMT200031099	K12524	ko00270	Cysteine and methionine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMT200031099	K12524	ko00300	Lysine biosynthesis	6121	0.	0.80	0.89	1.00
PGSC0003DMT200031099	K12524	ko01100	Metabolic pathways	6121	0.	0.80	0.89	1.00
PGSC0003DMT200031099	K12524	ko01110	Biosynthesis of secondary metabolites	6121	0.	0.80	0.89	1.00
PGSC0003DMT200031109	K01597	ko00900	Terpenoid backbone biosynthesis	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMT200031109	K01597	ko01100	Metabolic pathways	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMT200031109	K01597	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMT200031116	K02084	ko04115	p53 signaling pathway	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko04210	Apoptosis	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko05010	Alzheimer's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko05012	Parkinson's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko05016	Huntington's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031116	K02084	ko05222	Small cell lung cancer	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMT200031130	K01597	ko00900	Terpenoid backbone biosynthesis	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMT200031130	K01597	ko01100	Metabolic pathways	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMT200031130	K01597	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMT200043159	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMT200043159	K08081	ko01100	Metabolic pathways	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMT200043159	K08081	ko01110	Biosynthesis of secondary metabolites	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMT200043176	K08065	ko04612	Antigen processing and presentation	578	4.8e-26	0.62	0.81	0.58
PGSC0003DMT200043191	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMT200043191	K00517	ko00626	Naphthalene and anthracene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMT200043191	K00517	ko00903	Limonene and pinene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMT200043191	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMT200043191	K00517	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMT200043192	K09754	ko00360	Phenylalanine metabolism	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043192	K09754	ko00940	Phenylpropanoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043192	K09754	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043192	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043192	K09754	ko01100	Metabolic pathways	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043192	K09754	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMT200043211	K08488	ko04130	SNARE interactions in vesicular transport	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMT200043211	K08488	ko04145	Phagosome	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMT200043212	K08488	ko04130	SNARE interactions in vesicular transport	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMT200043212	K08488	ko04145	Phagosome	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMT200043213	K08488	ko04130	SNARE interactions in vesicular transport	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMT200043213	K08488	ko04145	Phagosome	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMT200023667	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200023667	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200023667	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMT200023670	K02293	ko00906	Carotenoid biosynthesis	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMT200023670	K02293	ko01100	Metabolic pathways	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMT200023670	K02293	ko01110	Biosynthesis of secondary metabolites	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMT200023671	K02293	ko00906	Carotenoid biosynthesis	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMT200023671	K02293	ko01100	Metabolic pathways	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMT200023671	K02293	ko01110	Biosynthesis of secondary metabolites	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMT200023673	K08248	ko00460	Cyanoamino acid metabolism	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMT200023673	K08248	ko01100	Metabolic pathways	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMT200023675	K00058	ko00260	Glycine, serine and threonine metabolism	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMT200023675	K00058	ko01100	Metabolic pathways	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMT200023678	K00058	ko00260	Glycine, serine and threonine metabolism	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMT200023678	K00058	ko01100	Metabolic pathways	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMT200072566	K08488	ko04130	SNARE interactions in vesicular transport	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMT200072566	K08488	ko04145	Phagosome	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMT200072572	K01714	ko00300	Lysine biosynthesis	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMT200072572	K01714	ko01100	Metabolic pathways	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMT200072572	K01714	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMT200072573	K01714	ko00300	Lysine biosynthesis	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMT200072573	K01714	ko01100	Metabolic pathways	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMT200072573	K01714	ko01110	Biosynthesis of secondary metabolites	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMT200072583	K02962	ko03010	Ribosome	971	1.0e-47	0.82	0.89	0.97
PGSC0003DMT200072589	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMT200072590	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMT200072591	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMT200072592	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMT200072595	K11294	ko05130	Pathogenic Escherichia coli infection	255	3.1e-08	0.50	0.76	0.67
PGSC0003DMT200044644	K07424	ko00140	Steroid hormone biosynthesis	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00591	Linoleic acid metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00830	Retinol metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00982	Drug metabolism - cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko00983	Drug metabolism - other enzymes	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044644	K07424	ko01100	Metabolic pathways	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMT200044650	K07424	ko00140	Steroid hormone biosynthesis	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00591	Linoleic acid metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00830	Retinol metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00982	Drug metabolism - cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko00983	Drug metabolism - other enzymes	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044650	K07424	ko01100	Metabolic pathways	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMT200044652	K07424	ko00140	Steroid hormone biosynthesis	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00591	Linoleic acid metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00830	Retinol metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00982	Drug metabolism - cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko00983	Drug metabolism - other enzymes	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044652	K07424	ko01100	Metabolic pathways	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMT200044654	K07424	ko00140	Steroid hormone biosynthesis	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00591	Linoleic acid metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00830	Retinol metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00982	Drug metabolism - cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko00983	Drug metabolism - other enzymes	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044654	K07424	ko01100	Metabolic pathways	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMT200044657	K07424	ko00140	Steroid hormone biosynthesis	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00591	Linoleic acid metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00830	Retinol metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00982	Drug metabolism - cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko00983	Drug metabolism - other enzymes	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044657	K07424	ko01100	Metabolic pathways	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMT200044659	K07424	ko00140	Steroid hormone biosynthesis	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00591	Linoleic acid metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00830	Retinol metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00982	Drug metabolism - cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko00983	Drug metabolism - other enzymes	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044659	K07424	ko01100	Metabolic pathways	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMT200044665	K11251	ko05322	Systemic lupus erythematosus	241	1.9e-07	0.48	0.58	0.93
PGSC0003DMT200044684	K01757	ko00901	Indole alkaloid biosynthesis	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMT200044684	K01757	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMT200044684	K01757	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMT200044685	K01757	ko00901	Indole alkaloid biosynthesis	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMT200044685	K01757	ko01100	Metabolic pathways	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMT200044685	K01757	ko01110	Biosynthesis of secondary metabolites	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMT200044690	K01647	ko00020	Citrate cycle (TCA cycle)	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMT200044690	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMT200044690	K01647	ko01100	Metabolic pathways	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMT200044690	K01647	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMT200044691	K01647	ko00020	Citrate cycle (TCA cycle)	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMT200044691	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMT200044691	K01647	ko01100	Metabolic pathways	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMT200044691	K01647	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMT200044692	K01647	ko00020	Citrate cycle (TCA cycle)	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMT200044692	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMT200044692	K01647	ko01100	Metabolic pathways	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMT200044692	K01647	ko01110	Biosynthesis of secondary metabolites	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMT200044693	K01647	ko00020	Citrate cycle (TCA cycle)	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMT200044693	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMT200044693	K01647	ko01100	Metabolic pathways	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMT200044693	K01647	ko01110	Biosynthesis of secondary metabolites	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMT200044696	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMT200044696	K00591	ko01100	Metabolic pathways	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMT200044696	K00591	ko01110	Biosynthesis of secondary metabolites	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMT200044697	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMT200044697	K00591	ko01100	Metabolic pathways	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMT200044697	K00591	ko01110	Biosynthesis of secondary metabolites	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMT200044699	K04460	ko04010	MAPK signaling pathway	3754	3.2e-201	0.81	0.87	1.00
PGSC0003DMT200081876	K08342	ko04140	Regulation of autophagy	1608	7.4e-83	0.66	0.79	0.98
PGSC0003DMT200081877	K08342	ko04140	Regulation of autophagy	650	5.1e-30	0.50	0.62	0.85
PGSC0003DMT200081878	K08342	ko04140	Regulation of autophagy	2369	7.9e-125	0.61	0.73	0.98
PGSC0003DMT200081879	K08342	ko04140	Regulation of autophagy	2304	3.0e-121	0.57	0.69	0.98
PGSC0003DMT200081881	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMT200081881	K01938	ko00670	One carbon pool by folate	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMT200081881	K01938	ko01100	Metabolic pathways	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMT200081882	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMT200081882	K01938	ko00670	One carbon pool by folate	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMT200081882	K01938	ko01100	Metabolic pathways	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMT200081883	K00430	ko00360	Phenylalanine metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMT200081883	K00430	ko00680	Methane metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMT200081883	K00430	ko00940	Phenylpropanoid biosynthesis	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMT200081883	K00430	ko01100	Metabolic pathways	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMT200081883	K00430	ko01110	Biosynthesis of secondary metabolites	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMT200081898	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMT200081899	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMT200081904	K00208	ko00061	Fatty acid biosynthesis	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMT200081904	K00208	ko01100	Metabolic pathways	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMT200029815	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMT200029815	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMT200029815	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMT200029815	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMT200029815	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMT200029817	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMT200029817	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMT200029817	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMT200029817	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMT200029817	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMT200029825	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMT200029825	K05290	ko01100	Metabolic pathways	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMT200029827	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMT200029827	K05290	ko01100	Metabolic pathways	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMT200029838	K12843	ko03040	Spliceosome	4379	1.1e-235	0.75	0.85	0.99
PGSC0003DMT200029857	K02913	ko03010	Ribosome	332	1.8e-12	0.70	0.78	0.98
PGSC0003DMT200029859	K10581	ko04120	Ubiquitin mediated proteolysis	477	9.4e-20	0.28	0.39	0.63
PGSC0003DMT200016646	K13034	ko00270	Cysteine and methionine metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMT200016646	K13034	ko00450	Selenoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMT200016646	K13034	ko00460	Cyanoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMT200016646	K13034	ko00920	Sulfur metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMT200016646	K13034	ko01100	Metabolic pathways	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMT200016665	K00228	ko00860	Porphyrin and chlorophyll metabolism	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMT200016665	K00228	ko01100	Metabolic pathways	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMT200016672	K00423	ko00053	Ascorbate and aldarate metabolism	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMT200016672	K00423	ko01100	Metabolic pathways	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMT200016674	K01692	ko00071	Fatty acid metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00280	Valine, leucine and isoleucine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00281	Geraniol degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00310	Lysine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00380	Tryptophan metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00410	beta-Alanine metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00632	Benzoate degradation via CoA ligation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00640	Propanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00650	Butanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00903	Limonene and pinene degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko00930	Caprolactam degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko01100	Metabolic pathways	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016674	K01692	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMT200016675	K01692	ko00071	Fatty acid metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00281	Geraniol degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00310	Lysine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00380	Tryptophan metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00410	beta-Alanine metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00632	Benzoate degradation via CoA ligation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00640	Propanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00650	Butanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko00930	Caprolactam degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko01100	Metabolic pathways	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016675	K01692	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMT200016676	K01692	ko00071	Fatty acid metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00280	Valine, leucine and isoleucine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00281	Geraniol degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00310	Lysine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00380	Tryptophan metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00410	beta-Alanine metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00632	Benzoate degradation via CoA ligation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00640	Propanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00650	Butanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00903	Limonene and pinene degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko00930	Caprolactam degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko01100	Metabolic pathways	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200016676	K01692	ko01110	Biosynthesis of secondary metabolites	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMT200035446	K05849	ko04020	Calcium signaling pathway	409	2.7e-16	0.35	0.51	0.51
PGSC0003DMT200035453	K06685	ko04111	Cell cycle - yeast	372	6.5e-11	0.29	0.46	0.39
PGSC0003DMT200035456	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMT200035456	K00517	ko00626	Naphthalene and anthracene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMT200035456	K00517	ko00903	Limonene and pinene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMT200035456	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMT200035456	K00517	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMT200035460	K01246	ko03410	Base excision repair	2203	1.1e-115	0.67	0.78	1.00
PGSC0003DMT200035461	K01246	ko03410	Base excision repair	928	2.4e-45	0.58	0.68	0.88
PGSC0003DMT200035464	K02542	ko03030	DNA replication	5593	0.	0.77	0.86	1.00
PGSC0003DMT200035464	K02542	ko04110	Cell cycle	5593	0.	0.77	0.86	1.00
PGSC0003DMT200035464	K02542	ko04111	Cell cycle - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMT200035464	K02542	ko04113	Meiosis - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMT200035465	K02542	ko03030	DNA replication	5664	0.	0.80	0.89	1.00
PGSC0003DMT200035465	K02542	ko04110	Cell cycle	5664	0.	0.80	0.89	1.00
PGSC0003DMT200035465	K02542	ko04111	Cell cycle - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMT200035465	K02542	ko04113	Meiosis - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMT200035466	K01937	ko00240	Pyrimidine metabolism	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMT200035466	K01937	ko01100	Metabolic pathways	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMT200035467	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMT200035467	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMT200035468	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMT200035468	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMT200095542	K00412	ko00190	Oxidative phosphorylation	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095542	K00412	ko01100	Metabolic pathways	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095542	K00412	ko04260	Cardiac muscle contraction	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095542	K00412	ko05010	Alzheimer's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095542	K00412	ko05012	Parkinson's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095542	K00412	ko05016	Huntington's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMT200095546	K00797	ko00270	Cysteine and methionine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMT200095546	K00797	ko00330	Arginine and proline metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMT200095546	K00797	ko00410	beta-Alanine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMT200095546	K00797	ko00480	Glutathione metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMT200095546	K00797	ko01100	Metabolic pathways	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMT200046521	K11812	ko00380	Tryptophan metabolism	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMT200046521	K11812	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMT200046522	K13027	ko00460	Cyanoamino acid metabolism	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMT200046522	K13027	ko00966	Glucosinolate biosynthesis	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMT200046522	K13027	ko01100	Metabolic pathways	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMT200046522	K13027	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMT200046523	K12153	ko00966	Glucosinolate biosynthesis	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMT200046523	K12153	ko01110	Biosynthesis of secondary metabolites	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMT200046531	K13030	ko00460	Cyanoamino acid metabolism	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMT200046531	K13030	ko01110	Biosynthesis of secondary metabolites	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMT200046533	K13030	ko00460	Cyanoamino acid metabolism	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMT200046533	K13030	ko01110	Biosynthesis of secondary metabolites	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMT200046534	K05280	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMT200046534	K05280	ko00944	Flavone and flavonol biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMT200046534	K05280	ko01100	Metabolic pathways	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMT200046534	K05280	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMT200046535	K05280	ko00941	Flavonoid biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMT200046535	K05280	ko00944	Flavone and flavonol biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMT200046535	K05280	ko01100	Metabolic pathways	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMT200046535	K05280	ko01110	Biosynthesis of secondary metabolites	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMT200046538	K12929	ko00904	Diterpenoid biosynthesis	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMT200046538	K12929	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMT200046546	K02917	ko03010	Ribosome	430	7.0e-18	0.77	0.83	0.58
PGSC0003DMT200046567	K10712	ko00430	Taurine and hypotaurine metabolism	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMT200046567	K10712	ko01100	Metabolic pathways	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMT200074270	K00889	ko00562	Inositol phosphate metabolism	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074270	K00889	ko01100	Metabolic pathways	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074270	K00889	ko04070	Phosphatidylinositol signaling system	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074270	K00889	ko04144	Endocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074270	K00889	ko04666	Fc gamma R-mediated phagocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074270	K00889	ko04810	Regulation of actin cytoskeleton	9812	0.	0.65	0.75	1.00
PGSC0003DMT200074271	K00889	ko00562	Inositol phosphate metabolism	9925	0.	0.67	0.78	1.00
PGSC0003DMT200074271	K00889	ko01100	Metabolic pathways	9925	0.	0.67	0.78	1.00
PGSC0003DMT200074271	K00889	ko04070	Phosphatidylinositol signaling system	9925	0.	0.67	0.78	1.00
PGSC0003DMT200074271	K00889	ko04144	Endocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMT200074271	K00889	ko04666	Fc gamma R-mediated phagocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMT200074271	K00889	ko04810	Regulation of actin cytoskeleton	9925	0.	0.67	0.78	1.00
PGSC0003DMT200061700	K04077	ko03018	RNA degradation	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMT200061700	K04077	ko04940	Type I diabetes mellitus	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMT200061701	K04077	ko03018	RNA degradation	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMT200061701	K04077	ko04940	Type I diabetes mellitus	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMT200061710	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061710	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061710	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061710	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061711	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061711	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061711	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061711	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMT200061712	K12121	ko04712	Circadian rhythm - plant	8059	0.	0.84	0.92	0.99
PGSC0003DMT200061713	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMT200061713	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMT200061714	K04424	ko04010	MAPK signaling pathway	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMT200061714	K04424	ko04530	Tight junction	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMT200061715	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMT200061715	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMT200061716	K00430	ko00360	Phenylalanine metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMT200061716	K00430	ko00680	Methane metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMT200061716	K00430	ko00940	Phenylpropanoid biosynthesis	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMT200061716	K00430	ko01100	Metabolic pathways	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMT200061716	K00430	ko01110	Biosynthesis of secondary metabolites	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMT200061736	K11251	ko05322	Systemic lupus erythematosus	945	2.8e-46	0.85	0.88	0.99
PGSC0003DMT200061737	K08773	ko05200	Pathways in cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMT200061737	K08773	ko05212	Pancreatic cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMT200061738	K08773	ko05200	Pathways in cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMT200061738	K08773	ko05212	Pancreatic cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMT200079754	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMT200079755	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMT200079756	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMT200079757	K00654	ko00600	Sphingolipid metabolism	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMT200079757	K00654	ko01100	Metabolic pathways	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMT200079758	K00654	ko00600	Sphingolipid metabolism	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMT200079758	K00654	ko01100	Metabolic pathways	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMT200079764	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMT200079764	K00517	ko00626	Naphthalene and anthracene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMT200079764	K00517	ko00903	Limonene and pinene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMT200079764	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMT200079764	K00517	ko01110	Biosynthesis of secondary metabolites	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMT200079767	K00026	ko00020	Citrate cycle (TCA cycle)	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079767	K00026	ko00620	Pyruvate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079767	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079767	K00026	ko00710	Carbon fixation in photosynthetic organisms	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079767	K00026	ko01100	Metabolic pathways	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079767	K00026	ko01110	Biosynthesis of secondary metabolites	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMT200079768	K00026	ko00020	Citrate cycle (TCA cycle)	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079768	K00026	ko00620	Pyruvate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079768	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079768	K00026	ko00710	Carbon fixation in photosynthetic organisms	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079768	K00026	ko01100	Metabolic pathways	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079768	K00026	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMT200079769	K00423	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMT200079769	K00423	ko01100	Metabolic pathways	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMT200079774	K01728	ko00040	Pentose and glucuronate interconversions	2086	3.2e-109	0.65	0.80	0.93
PGSC0003DMT200079776	K01728	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.63	0.79	0.78
PGSC0003DMT200079777	K01373	ko04142	Lysosome	2119	4.9e-111	0.74	0.86	0.84
PGSC0003DMT200079783	K12929	ko00904	Diterpenoid biosynthesis	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMT200079783	K12929	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMT200079785	K12929	ko00904	Diterpenoid biosynthesis	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMT200079785	K12929	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMT200094329	K10760	ko00908	Zeatin biosynthesis	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMT200094329	K10760	ko01100	Metabolic pathways	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMT200094329	K10760	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMT200028013	K00036	ko00030	Pentose phosphate pathway	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMT200028013	K00036	ko00480	Glutathione metabolism	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMT200028013	K00036	ko01100	Metabolic pathways	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMT200028013	K00036	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMT200028014	K00036	ko00030	Pentose phosphate pathway	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMT200028014	K00036	ko00480	Glutathione metabolism	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMT200028014	K00036	ko01100	Metabolic pathways	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMT200028014	K00036	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMT200028015	K00036	ko00030	Pentose phosphate pathway	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMT200028015	K00036	ko00480	Glutathione metabolism	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMT200028015	K00036	ko01100	Metabolic pathways	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMT200028015	K00036	ko01110	Biosynthesis of secondary metabolites	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMT200028016	K00036	ko00030	Pentose phosphate pathway	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMT200028016	K00036	ko00480	Glutathione metabolism	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMT200028016	K00036	ko01100	Metabolic pathways	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMT200028016	K00036	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMT200028017	K00071	ko00140	Steroid hormone biosynthesis	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMT200028017	K00071	ko01100	Metabolic pathways	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMT200028017	K00071	ko04960	Aldosterone-regulated sodium reabsorption	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMT200028018	K00071	ko00140	Steroid hormone biosynthesis	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMT200028018	K00071	ko01100	Metabolic pathways	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMT200028018	K00071	ko04960	Aldosterone-regulated sodium reabsorption	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMT200028026	K01962	ko00061	Fatty acid biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028026	K01962	ko00253	Tetracycline biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028026	K01962	ko00620	Pyruvate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028026	K01962	ko00640	Propanoate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028026	K01962	ko01100	Metabolic pathways	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028026	K01962	ko01110	Biosynthesis of secondary metabolites	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMT200028031	K01051	ko00040	Pentose and glucuronate interconversions	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMT200028031	K01051	ko00500	Starch and sucrose metabolism	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMT200028031	K01051	ko01100	Metabolic pathways	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMT200028037	K13030	ko00460	Cyanoamino acid metabolism	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMT200028037	K13030	ko01110	Biosynthesis of secondary metabolites	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMT200028038	K01051	ko00040	Pentose and glucuronate interconversions	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMT200028038	K01051	ko00500	Starch and sucrose metabolism	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMT200028038	K01051	ko01100	Metabolic pathways	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMT200037236	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037236	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037236	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037239	K00795	ko00900	Terpenoid backbone biosynthesis	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMT200037239	K00795	ko01100	Metabolic pathways	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMT200037239	K00795	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMT200037240	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037240	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037240	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMT200037243	K06268	ko04010	MAPK signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04020	Calcium signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04114	Oocyte meiosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04210	Apoptosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04310	Wnt signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04360	Axon guidance	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04370	VEGF signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04650	Natural killer cell mediated cytotoxicity	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04660	T cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04662	B cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko04720	Long-term potentiation	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko05010	Alzheimer's disease	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037243	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMT200037244	K06268	ko04010	MAPK signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04020	Calcium signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04114	Oocyte meiosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04210	Apoptosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04310	Wnt signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04360	Axon guidance	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04370	VEGF signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04650	Natural killer cell mediated cytotoxicity	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04660	T cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04662	B cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko04720	Long-term potentiation	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko05010	Alzheimer's disease	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037244	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMT200037245	K06268	ko04010	MAPK signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04020	Calcium signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04114	Oocyte meiosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04210	Apoptosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04310	Wnt signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04360	Axon guidance	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04370	VEGF signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04650	Natural killer cell mediated cytotoxicity	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04660	T cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04662	B cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko04720	Long-term potentiation	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko05010	Alzheimer's disease	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037245	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMT200037252	K00876	ko00240	Pyrimidine metabolism	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMT200037252	K00876	ko00983	Drug metabolism - other enzymes	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMT200037252	K00876	ko01100	Metabolic pathways	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMT200037253	K00876	ko00240	Pyrimidine metabolism	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMT200037253	K00876	ko00983	Drug metabolism - other enzymes	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMT200037253	K00876	ko01100	Metabolic pathways	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMT200037254	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037254	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037254	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037255	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037255	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037255	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMT200037256	K03141	ko03022	Basal transcription factors	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMT200037256	K03141	ko03420	Nucleotide excision repair	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMT200037257	K03141	ko03022	Basal transcription factors	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMT200037257	K03141	ko03420	Nucleotide excision repair	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMT200037258	K03141	ko03022	Basal transcription factors	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMT200037258	K03141	ko03420	Nucleotide excision repair	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMT200037259	K03141	ko03022	Basal transcription factors	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMT200037259	K03141	ko03420	Nucleotide excision repair	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMT200037262	K12616	ko03018	RNA degradation	7363	0.	0.64	0.77	1.00
PGSC0003DMT200037269	K02946	ko03010	Ribosome	1035	3.0e-51	0.67	0.78	0.99
PGSC0003DMT200037270	K00640	ko00270	Cysteine and methionine metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMT200037270	K00640	ko00920	Sulfur metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMT200037270	K00640	ko01100	Metabolic pathways	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMT200075456	K13068	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.49	0.70	0.95
PGSC0003DMT200075458	K13068	ko00940	Phenylpropanoid biosynthesis	1770	8.6e-92	0.48	0.69	0.95
PGSC0003DMT200075459	K01076	ko00632	Benzoate degradation via CoA ligation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMT200075459	K01076	ko00903	Limonene and pinene degradation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMT200075459	K01076	ko01040	Biosynthesis of unsaturated fatty acids	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMT200075460	K11820	ko00380	Tryptophan metabolism	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMT200075460	K11820	ko00966	Glucosinolate biosynthesis	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMT200075460	K11820	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMT200075461	K11820	ko00380	Tryptophan metabolism	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMT200075461	K11820	ko00966	Glucosinolate biosynthesis	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMT200075461	K11820	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMT200075462	K13068	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.55	0.73	0.79
PGSC0003DMT200075463	K11820	ko00380	Tryptophan metabolism	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMT200075463	K11820	ko00966	Glucosinolate biosynthesis	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMT200075463	K11820	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMT200075464	K11820	ko00380	Tryptophan metabolism	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMT200075464	K11820	ko00966	Glucosinolate biosynthesis	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMT200075464	K11820	ko01110	Biosynthesis of secondary metabolites	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMT200075467	K11820	ko00380	Tryptophan metabolism	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMT200075467	K11820	ko00966	Glucosinolate biosynthesis	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMT200075467	K11820	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMT200075471	K07512	ko00062	Fatty acid elongation in mitochondria	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMT200075471	K07512	ko01100	Metabolic pathways	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMT200075475	K07512	ko00062	Fatty acid elongation in mitochondria	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMT200075475	K07512	ko01100	Metabolic pathways	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMT200075476	K07512	ko00062	Fatty acid elongation in mitochondria	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMT200075476	K07512	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMT200075489	K01184	ko00040	Pentose and glucuronate interconversions	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMT200075489	K01184	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMT200075489	K01184	ko01100	Metabolic pathways	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMT200049873	K10143	ko04115	p53 signaling pathway	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMT200049873	K10143	ko04120	Ubiquitin mediated proteolysis	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMT200049874	K10143	ko04115	p53 signaling pathway	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMT200049874	K10143	ko04120	Ubiquitin mediated proteolysis	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMT200049886	K10775	ko00360	Phenylalanine metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMT200049886	K10775	ko00910	Nitrogen metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMT200049886	K10775	ko00940	Phenylpropanoid biosynthesis	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMT200049886	K10775	ko01100	Metabolic pathways	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMT200049886	K10775	ko01110	Biosynthesis of secondary metabolites	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMT200087633	K03130	ko03022	Basal transcription factors	235	7.4e-07	0.26	0.49	0.37
PGSC0003DMT200001824	K00368	ko00910	Nitrogen metabolism	2161	2.3e-113	0.51	0.66	0.92
PGSC0003DMT200001829	K02942	ko03010	Ribosome	504	5.8e-22	0.60	0.74	0.96
PGSC0003DMT200021601	K10352	ko04530	Tight junction	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMT200021601	K10352	ko05416	Viral myocarditis	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMT200021611	K04424	ko04010	MAPK signaling pathway	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMT200021611	K04424	ko04530	Tight junction	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMT200021612	K04424	ko04010	MAPK signaling pathway	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMT200021612	K04424	ko04530	Tight junction	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMT200021613	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMT200021613	K04424	ko04530	Tight junction	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMT200021614	K04424	ko04010	MAPK signaling pathway	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMT200021614	K04424	ko04530	Tight junction	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMT200021616	K12183	ko04144	Endocytosis	2365	1.3e-124	0.69	0.81	0.99
PGSC0003DMT200021617	K01692	ko00071	Fatty acid metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00280	Valine, leucine and isoleucine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00281	Geraniol degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00310	Lysine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00380	Tryptophan metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00410	beta-Alanine metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00632	Benzoate degradation via CoA ligation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00640	Propanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00650	Butanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00903	Limonene and pinene degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko00930	Caprolactam degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko01100	Metabolic pathways	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021617	K01692	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMT200021619	K01193	ko00052	Galactose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMT200021619	K01193	ko00500	Starch and sucrose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMT200021619	K01193	ko01100	Metabolic pathways	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMT200032789	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMT200032789	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMT200032789	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMT200032789	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMT200032789	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMT200032790	K08917	ko00196	Photosynthesis - antenna proteins	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMT200032790	K08917	ko01100	Metabolic pathways	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMT200032791	K08917	ko00196	Photosynthesis - antenna proteins	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMT200032791	K08917	ko01100	Metabolic pathways	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMT200032810	K12741	ko03040	Spliceosome	1347	1.8e-68	0.50	0.57	0.94
PGSC0003DMT200032811	K12741	ko03040	Spliceosome	2122	3.3e-111	0.67	0.78	0.95
PGSC0003DMT200007018	K00700	ko00500	Starch and sucrose metabolism	5670	0.	0.75	0.84	0.98
PGSC0003DMT200007018	K00700	ko01100	Metabolic pathways	5670	0.	0.75	0.84	0.98
PGSC0003DMT200007035	K04424	ko04010	MAPK signaling pathway	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMT200007035	K04424	ko04530	Tight junction	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMT200007036	K04424	ko04010	MAPK signaling pathway	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMT200007036	K04424	ko04530	Tight junction	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMT200007038	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.68
PGSC0003DMT200007040	K10773	ko03410	Base excision repair	2136	5.6e-112	0.43	0.57	0.77
PGSC0003DMT200007041	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.70
PGSC0003DMT200007042	K00222	ko00100	Steroid biosynthesis	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMT200007042	K00222	ko01100	Metabolic pathways	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMT200007042	K00222	ko01110	Biosynthesis of secondary metabolites	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMT200007043	K00222	ko00100	Steroid biosynthesis	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMT200007043	K00222	ko01100	Metabolic pathways	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMT200007043	K00222	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMT200007044	K00222	ko00100	Steroid biosynthesis	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMT200007044	K00222	ko01100	Metabolic pathways	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMT200007044	K00222	ko01110	Biosynthesis of secondary metabolites	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMT200007045	K00222	ko00100	Steroid biosynthesis	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMT200007045	K00222	ko01100	Metabolic pathways	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMT200007045	K00222	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMT200041450	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMT200041450	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMT200041452	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMT200041452	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMT200041464	K02894	ko03010	Ribosome	499	1.1e-21	0.91	0.94	0.98
PGSC0003DMT200041481	K12602	ko03018	RNA degradation	1946	1.7e-101	0.70	0.84	1.00
PGSC0003DMT200041483	K02861	ko04210	Apoptosis	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMT200041483	K02861	ko04620	Toll-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMT200041483	K02861	ko04622	RIG-I-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMT200041483	K02861	ko04623	Cytosolic DNA-sensing pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMT200025455	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMT200025456	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMT200025470	K12929	ko00904	Diterpenoid biosynthesis	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMT200025470	K12929	ko01110	Biosynthesis of secondary metabolites	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMT200025473	K12929	ko00904	Diterpenoid biosynthesis	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMT200025473	K12929	ko01110	Biosynthesis of secondary metabolites	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMT200025478	K11813	ko00380	Tryptophan metabolism	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMT200025478	K11813	ko00966	Glucosinolate biosynthesis	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMT200025480	K12153	ko00966	Glucosinolate biosynthesis	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMT200025480	K12153	ko01110	Biosynthesis of secondary metabolites	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMT200025481	K12153	ko00966	Glucosinolate biosynthesis	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMT200025481	K12153	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMT200025484	K02908	ko03010	Ribosome	878	1.4e-42	0.90	0.98	0.99
PGSC0003DMT200025485	K02908	ko03010	Ribosome	886	4.9e-43	0.91	0.98	0.99
PGSC0003DMT200025492	K01835	ko00010	Glycolysis / Gluconeogenesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00030	Pentose phosphate pathway	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00052	Galactose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00230	Purine metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00500	Starch and sucrose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko00521	Streptomycin biosynthesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko01100	Metabolic pathways	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025492	K01835	ko01110	Biosynthesis of secondary metabolites	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMT200025495	K10577	ko04120	Ubiquitin mediated proteolysis	905	4.4e-44	0.88	0.94	0.97
PGSC0003DMT200025496	K10577	ko04120	Ubiquitin mediated proteolysis	449	6.3e-19	0.94	0.98	0.50
PGSC0003DMT200025497	K10577	ko04120	Ubiquitin mediated proteolysis	901	7.4e-44	0.90	0.95	0.78
PGSC0003DMT200025502	K01810	ko00010	Glycolysis / Gluconeogenesis	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200025502	K01810	ko00030	Pentose phosphate pathway	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200025502	K01810	ko00500	Starch and sucrose metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200025502	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200025502	K01810	ko01100	Metabolic pathways	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200025502	K01810	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMT200005756	K12489	ko04144	Endocytosis	5562	6.1e-301	0.80	0.89	1.00
PGSC0003DMT200005758	K04733	ko04210	Apoptosis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMT200005758	K04733	ko04620	Toll-like receptor signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMT200005758	K04733	ko04722	Neurotrophin signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMT200005758	K04733	ko05140	Leishmaniasis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMT200005758	K04733	ko05142	Chagas disease	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMT200031460	K12824	ko03040	Spliceosome	483	2.5e-18	0.30	0.39	0.57
PGSC0003DMT200031464	K03260	ko05416	Viral myocarditis	313	2.4e-08	0.27	0.43	0.92
PGSC0003DMT200031469	K13030	ko00460	Cyanoamino acid metabolism	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMT200031469	K13030	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMT200031482	K06199	ko01100	Metabolic pathways	220	2.7e-06	0.35	0.51	0.42
PGSC0003DMT200031485	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMT200031486	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMT200031487	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMT200031488	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMT200039269	K01493	ko00240	Pyrimidine metabolism	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMT200039269	K01493	ko01100	Metabolic pathways	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMT200039270	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMT200039270	K00517	ko00626	Naphthalene and anthracene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMT200039270	K00517	ko00903	Limonene and pinene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMT200039270	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMT200039270	K00517	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMT200039271	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMT200039271	K00517	ko00626	Naphthalene and anthracene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMT200039271	K00517	ko00903	Limonene and pinene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMT200039271	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMT200039271	K00517	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMT200039272	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMT200039272	K00517	ko00626	Naphthalene and anthracene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMT200039272	K00517	ko00903	Limonene and pinene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMT200039272	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMT200039272	K00517	ko01110	Biosynthesis of secondary metabolites	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMT200039275	K00939	ko00230	Purine metabolism	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMT200039275	K00939	ko01100	Metabolic pathways	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMT200039275	K00939	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMT200039281	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMT200039281	K01904	ko00360	Phenylalanine metabolism	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMT200039281	K01904	ko00940	Phenylpropanoid biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMT200039281	K01904	ko01100	Metabolic pathways	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMT200039281	K01904	ko01110	Biosynthesis of secondary metabolites	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMT200039283	K01638	ko00620	Pyruvate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMT200039283	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMT200039283	K01638	ko01100	Metabolic pathways	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMT200039285	K01638	ko00620	Pyruvate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMT200039285	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMT200039285	K01638	ko01100	Metabolic pathways	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMT200039286	K01638	ko00620	Pyruvate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMT200039286	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMT200039286	K01638	ko01100	Metabolic pathways	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMT200039287	K01638	ko00620	Pyruvate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMT200039287	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMT200039287	K01638	ko01100	Metabolic pathways	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMT200039311	K07342	ko03060	Protein export	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMT200039311	K07342	ko04145	Phagosome	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMT200039311	K07342	ko05110	Vibrio cholerae infection	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMT200042482	K00423	ko00053	Ascorbate and aldarate metabolism	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMT200042482	K00423	ko01100	Metabolic pathways	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMT200042483	K00423	ko00053	Ascorbate and aldarate metabolism	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMT200042483	K00423	ko01100	Metabolic pathways	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMT200042484	K01199	ko00500	Starch and sucrose metabolism	699	1.0e-32	0.31	0.52	0.67
PGSC0003DMT200042492	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMT200042492	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMT200042494	K08341	ko04140	Regulation of autophagy	927	2.7e-45	0.91	0.98	0.94
PGSC0003DMT200042496	K00703	ko00500	Starch and sucrose metabolism	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMT200042496	K00703	ko01100	Metabolic pathways	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMT200042497	K00703	ko00500	Starch and sucrose metabolism	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMT200042497	K00703	ko01100	Metabolic pathways	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMT200042499	K02115	ko00190	Oxidative phosphorylation	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMT200042499	K02115	ko00195	Photosynthesis	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMT200042499	K02115	ko01100	Metabolic pathways	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMT200042500	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMT200042501	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMT200013293	K03137	ko03022	Basal transcription factors	1921	4.1e-100	0.83	0.90	0.99
PGSC0003DMT200013297	K03110	ko03060	Protein export	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMT200013297	K03110	ko03070	Bacterial secretion system	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMT200013305	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMT200013318	K09753	ko00940	Phenylpropanoid biosynthesis	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMT200013318	K09753	ko01100	Metabolic pathways	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMT200013318	K09753	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMT200013319	K09753	ko00940	Phenylpropanoid biosynthesis	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMT200013319	K09753	ko01100	Metabolic pathways	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMT200013319	K09753	ko01110	Biosynthesis of secondary metabolites	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMT200013320	K08341	ko04140	Regulation of autophagy	582	2.9e-26	0.59	0.77	0.97
PGSC0003DMT200013321	K02977	ko03010	Ribosome	1314	1.2e-66	0.99	0.99	0.99
PGSC0003DMT200000479	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2576	3.0e-136	0.70	0.85	1.00
PGSC0003DMT200000480	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2469	2.4e-130	0.70	0.86	0.99
PGSC0003DMT200000482	K11086	ko03040	Spliceosome	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMT200000482	K11086	ko05322	Systemic lupus erythematosus	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMT200000483	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMT200000485	K01177	ko00500	Starch and sucrose metabolism	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMT200000485	K01177	ko01100	Metabolic pathways	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMT200000486	K01177	ko00500	Starch and sucrose metabolism	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMT200000486	K01177	ko01100	Metabolic pathways	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMT200000500	K02607	ko04110	Cell cycle	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMT200000500	K02607	ko04111	Cell cycle - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMT200000500	K02607	ko04113	Meiosis - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMT200000504	K10576	ko04120	Ubiquitin mediated proteolysis	286	6.1e-10	0.78	0.89	0.81
PGSC0003DMT200000505	K10576	ko04120	Ubiquitin mediated proteolysis	1478	1.1e-75	0.91	0.96	0.99
PGSC0003DMT200000506	K10576	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.90	0.96	0.99
PGSC0003DMT200091887	K12796	ko04621	NOD-like receptor signaling pathway	353	2.7e-10	0.33	0.51	0.32
PGSC0003DMT200066160	K02180	ko04110	Cell cycle	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMT200066160	K02180	ko04111	Cell cycle - yeast	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMT200066177	K11422	ko00310	Lysine degradation	413	7.8e-16	0.33	0.43	0.92
PGSC0003DMT200052250	K00036	ko00030	Pentose phosphate pathway	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMT200052250	K00036	ko00480	Glutathione metabolism	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMT200052250	K00036	ko01100	Metabolic pathways	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMT200052250	K00036	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMT200052281	K03575	ko03410	Base excision repair	2302	3.9e-121	0.65	0.79	0.92
PGSC0003DMT200077570	K10872	ko04113	Meiosis - yeast	2474	1.3e-130	0.95	0.98	0.92
PGSC0003DMT200077595	K01728	ko00040	Pentose and glucuronate interconversions	2407	6.3e-127	0.83	0.92	0.97
PGSC0003DMT200077596	K01728	ko00040	Pentose and glucuronate interconversions	338	8.3e-13	0.64	0.82	0.84
PGSC0003DMT200077597	K01054	ko00561	Glycerolipid metabolism	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMT200077597	K01054	ko01100	Metabolic pathways	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMT200077598	K01054	ko00561	Glycerolipid metabolism	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMT200077598	K01054	ko01100	Metabolic pathways	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMT200077599	K03075	ko03060	Protein export	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMT200077599	K03075	ko03070	Bacterial secretion system	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMT200077600	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMT200077600	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMT200077600	K00771	ko01100	Metabolic pathways	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMT200060086	K11584	ko04113	Meiosis - yeast	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMT200060086	K11584	ko04114	Oocyte meiosis	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMT200060086	K11584	ko04310	Wnt signaling pathway	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMT200060096	K11252	ko05322	Systemic lupus erythematosus	1143	3.3e-57	0.95	0.97	0.99
PGSC0003DMT200060099	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMT200060099	K02367	ko01100	Metabolic pathways	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMT200060106	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMT200060106	K00517	ko00626	Naphthalene and anthracene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMT200060106	K00517	ko00903	Limonene and pinene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMT200060106	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMT200060106	K00517	ko01110	Biosynthesis of secondary metabolites	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMT200029103	K03260	ko05416	Viral myocarditis	2361	2.2e-124	0.48	0.63	0.88
PGSC0003DMT200029104	K03283	ko03040	Spliceosome	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMT200029104	K03283	ko04010	MAPK signaling pathway	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMT200029104	K03283	ko04144	Endocytosis	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMT200029104	K03283	ko04612	Antigen processing and presentation	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMT200029132	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMT200029132	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMT200029132	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMT200029133	K10754	ko03030	DNA replication	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMT200029133	K10754	ko03420	Nucleotide excision repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMT200029133	K10754	ko03430	Mismatch repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMT200029134	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMT200029134	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMT200029134	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMT200029135	K10754	ko03030	DNA replication	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMT200029135	K10754	ko03420	Nucleotide excision repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMT200029135	K10754	ko03430	Mismatch repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMT200029145	K02144	ko00190	Oxidative phosphorylation	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029145	K02144	ko01100	Metabolic pathways	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029145	K02144	ko04142	Lysosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029145	K02144	ko04145	Phagosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029145	K02144	ko05110	Vibrio cholerae infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029145	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMT200029146	K02144	ko00190	Oxidative phosphorylation	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029146	K02144	ko01100	Metabolic pathways	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029146	K02144	ko04142	Lysosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029146	K02144	ko04145	Phagosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029146	K02144	ko05110	Vibrio cholerae infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029146	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMT200029147	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029147	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029147	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029147	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029147	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029147	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200029148	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMT200017064	K01126	ko00564	Glycerophospholipid metabolism	446	9.2e-19	0.29	0.53	0.88
PGSC0003DMT200017065	K01126	ko00564	Glycerophospholipid metabolism	302	1.8e-10	0.29	0.52	0.89
PGSC0003DMT200017066	K01126	ko00564	Glycerophospholipid metabolism	269	1.4e-08	0.27	0.54	0.90
PGSC0003DMT200034757	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.97
PGSC0003DMT200034758	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.98
PGSC0003DMT200035788	K12130	ko04712	Circadian rhythm - plant	266	2.3e-08	0.31	0.49	0.79
PGSC0003DMT200035793	K12130	ko04712	Circadian rhythm - plant	282	2.0e-07	0.27	0.47	0.77
PGSC0003DMT200035809	K10739	ko03030	DNA replication	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMT200035809	K10739	ko03420	Nucleotide excision repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMT200035809	K10739	ko03430	Mismatch repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMT200035809	K10739	ko03440	Homologous recombination	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMT200035819	K06085	ko04520	Adherens junction	527	3.1e-23	0.29	0.52	0.92
PGSC0003DMT200035845	K04733	ko04210	Apoptosis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMT200035845	K04733	ko04620	Toll-like receptor signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMT200035845	K04733	ko04722	Neurotrophin signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMT200035845	K04733	ko05140	Leishmaniasis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMT200035845	K04733	ko05142	Chagas disease	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMT200096014	K07466	ko03030	DNA replication	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMT200096014	K07466	ko03420	Nucleotide excision repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMT200096014	K07466	ko03430	Mismatch repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMT200096014	K07466	ko03440	Homologous recombination	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMT200096032	K02183	ko04020	Calcium signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04070	Phosphatidylinositol signaling system	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04114	Oocyte meiosis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04270	Vascular smooth muscle contraction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04626	Plant-pathogen interaction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04720	Long-term potentiation	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04722	Neurotrophin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04740	Olfactory transduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04744	Phototransduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04745	Phototransduction - fly	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04910	Insulin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04912	GnRH signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04916	Melanogenesis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04970	Salivary secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko04971	Gastric acid secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko05010	Alzheimer's disease	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200096032	K02183	ko05214	Glioma	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMT200093770	K10760	ko00908	Zeatin biosynthesis	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMT200093770	K10760	ko01100	Metabolic pathways	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMT200093770	K10760	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMT200093785	K00650	ko00564	Glycerophospholipid metabolism	266	9.1e-09	0.27	0.45	0.88
PGSC0003DMT200003655	K00754	ko00051	Fructose and mannose metabolism	674	2.4e-31	0.51	0.67	0.95
PGSC0003DMT200003657	K00754	ko00051	Fructose and mannose metabolism	1413	4.2e-72	0.42	0.59	0.83
PGSC0003DMT200003666	K00012	ko00040	Pentose and glucuronate interconversions	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003666	K00012	ko00053	Ascorbate and aldarate metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003666	K00012	ko00500	Starch and sucrose metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003666	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003666	K00012	ko01100	Metabolic pathways	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003666	K00012	ko01110	Biosynthesis of secondary metabolites	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMT200003670	K13068	ko00940	Phenylpropanoid biosynthesis	833	4.1e-40	0.31	0.53	0.98
PGSC0003DMT200003672	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.35
PGSC0003DMT200003673	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.67
PGSC0003DMT200003685	K12741	ko03040	Spliceosome	659	1.6e-30	0.41	0.56	0.86
PGSC0003DMT200003687	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMT200003688	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMT200071863	K01066	ko00623	2,4-Dichlorobenzoate degradation	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMT200071863	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMT200071866	K05282	ko00904	Diterpenoid biosynthesis	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMT200071866	K05282	ko01100	Metabolic pathways	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMT200071866	K05282	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMT200071872	K03660	ko03410	Base excision repair	951	1.3e-46	0.55	0.71	0.72
PGSC0003DMT200071906	K03876	ko04120	Ubiquitin mediated proteolysis	254	3.6e-08	0.31	0.56	0.74
PGSC0003DMT200071911	K02085	ko04310	Wnt signaling pathway	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071911	K02085	ko04810	Regulation of actin cytoskeleton	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071911	K02085	ko05200	Pathways in cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071911	K02085	ko05210	Colorectal cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071911	K02085	ko05213	Endometrial cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071911	K02085	ko05217	Basal cell carcinoma	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMT200071912	K02085	ko04310	Wnt signaling pathway	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200071912	K02085	ko04810	Regulation of actin cytoskeleton	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200071912	K02085	ko05200	Pathways in cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200071912	K02085	ko05210	Colorectal cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200071912	K02085	ko05213	Endometrial cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200071912	K02085	ko05217	Basal cell carcinoma	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMT200044444	K12356	ko00940	Phenylpropanoid biosynthesis	615	4.4e-28	0.33	0.50	0.96
PGSC0003DMT200044446	K12356	ko00940	Phenylpropanoid biosynthesis	357	7.4e-14	0.42	0.65	0.91
PGSC0003DMT200044452	K08504	ko04130	SNARE interactions in vesicular transport	530	2.1e-23	0.65	0.88	0.80
PGSC0003DMT200044453	K08504	ko04130	SNARE interactions in vesicular transport	741	4.9e-35	0.65	0.86	0.96
PGSC0003DMT200044462	K02706	ko00195	Photosynthesis	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMT200044462	K02706	ko01100	Metabolic pathways	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMT200082365	K12842	ko03040	Spliceosome	383	1.4e-14	0.55	0.65	0.69
PGSC0003DMT200082388	K00423	ko00053	Ascorbate and aldarate metabolism	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMT200082388	K00423	ko01100	Metabolic pathways	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMT200082389	K12356	ko00940	Phenylpropanoid biosynthesis	646	8.5e-30	0.34	0.53	0.93
PGSC0003DMT200082390	K12356	ko00940	Phenylpropanoid biosynthesis	653	3.5e-30	0.32	0.52	0.74
PGSC0003DMT200027265	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMT200027266	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMT200027267	K11752	ko00740	Riboflavin metabolism	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMT200027267	K11752	ko01100	Metabolic pathways	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMT200027268	K11752	ko00740	Riboflavin metabolism	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMT200027268	K11752	ko01100	Metabolic pathways	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMT200027269	K11752	ko00740	Riboflavin metabolism	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMT200027269	K11752	ko01100	Metabolic pathways	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMT200027291	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMT200027291	K00517	ko00626	Naphthalene and anthracene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMT200027291	K00517	ko00903	Limonene and pinene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMT200027291	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMT200027291	K00517	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMT200027292	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMT200027292	K00517	ko00626	Naphthalene and anthracene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMT200027292	K00517	ko00903	Limonene and pinene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMT200027292	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMT200027292	K00517	ko01110	Biosynthesis of secondary metabolites	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMT200027295	K06685	ko04111	Cell cycle - yeast	291	1.4e-06	0.33	0.55	0.19
PGSC0003DMT200037559	K10144	ko04115	p53 signaling pathway	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMT200037559	K10144	ko04120	Ubiquitin mediated proteolysis	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMT200037560	K10144	ko04115	p53 signaling pathway	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMT200037560	K10144	ko04120	Ubiquitin mediated proteolysis	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMT200037582	K00128	ko00010	Glycolysis / Gluconeogenesis	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00053	Ascorbate and aldarate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00071	Fatty acid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00280	Valine, leucine and isoleucine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00310	Lysine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00330	Arginine and proline metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00340	Histidine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00380	Tryptophan metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00410	beta-Alanine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00561	Glycerolipid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00620	Pyruvate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00631	1,2-Dichloroethane degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00640	Propanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00641	3-Chloroacrylic acid degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00650	Butanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko00903	Limonene and pinene degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko01100	Metabolic pathways	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037582	K00128	ko01110	Biosynthesis of secondary metabolites	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMT200037585	K12401	ko04142	Lysosome	1726	2.3e-89	0.39	0.60	0.79
PGSC0003DMT200037590	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.97
PGSC0003DMT200037591	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.76
PGSC0003DMT200037594	K02899	ko03010	Ribosome	584	2.2e-26	0.86	0.91	0.95
PGSC0003DMT200037595	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMT200037595	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMT200037595	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMT200037595	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMT200037595	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMT200037599	K11294	ko05130	Pathogenic Escherichia coli infection	246	2.3e-07	0.27	0.43	0.86
PGSC0003DMT200037605	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.5e-08	0.29	0.47	0.92
PGSC0003DMT200037606	K08490	ko04130	SNARE interactions in vesicular transport	2314	8.5e-122	0.82	0.90	1.00
PGSC0003DMT200046322	K13065	ko00940	Phenylpropanoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMT200046322	K13065	ko00941	Flavonoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMT200046322	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMT200046322	K13065	ko01110	Biosynthesis of secondary metabolites	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMT200046325	K13065	ko00940	Phenylpropanoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMT200046325	K13065	ko00941	Flavonoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMT200046325	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMT200046325	K13065	ko01110	Biosynthesis of secondary metabolites	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMT200046331	K02895	ko03010	Ribosome	396	5.2e-16	0.52	0.71	0.61
PGSC0003DMT200046332	K13065	ko00940	Phenylpropanoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMT200046332	K13065	ko00941	Flavonoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMT200046332	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMT200046332	K13065	ko01110	Biosynthesis of secondary metabolites	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMT200046333	K08334	ko04140	Regulation of autophagy	2565	1.2e-135	0.80	0.90	0.99
PGSC0003DMT200046334	K08334	ko04140	Regulation of autophagy	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMT200046335	K08334	ko04140	Regulation of autophagy	3625	4.2e-194	0.81	0.90	1.00
PGSC0003DMT200046336	K05391	ko04626	Plant-pathogen interaction	2665	3.7e-141	0.64	0.79	0.99
PGSC0003DMT200046337	K05391	ko04626	Plant-pathogen interaction	3638	8.1e-195	0.61	0.77	0.99
PGSC0003DMT200046338	K05391	ko04626	Plant-pathogen interaction	3182	1.1e-169	0.56	0.71	0.99
PGSC0003DMT200046339	K05391	ko04626	Plant-pathogen interaction	2241	9.1e-118	0.66	0.82	0.99
PGSC0003DMT200046340	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMT200046341	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMT200046343	K05391	ko04626	Plant-pathogen interaction	1919	5.2e-100	0.61	0.79	0.85
PGSC0003DMT200046344	K05391	ko04626	Plant-pathogen interaction	513	1.8e-22	0.42	0.57	0.93
PGSC0003DMT200046345	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMT200046346	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMT200046347	K05391	ko04626	Plant-pathogen interaction	2823	7.2e-150	0.66	0.81	0.99
PGSC0003DMT200046348	K05391	ko04626	Plant-pathogen interaction	1819	1.7e-94	0.69	0.87	0.99
PGSC0003DMT200046349	K05391	ko04626	Plant-pathogen interaction	1670	2.8e-86	0.60	0.78	0.99
PGSC0003DMT200046350	K05391	ko04626	Plant-pathogen interaction	557	6.9e-25	0.42	0.59	0.97
PGSC0003DMT200046352	K03108	ko03060	Protein export	1014	4.3e-50	0.60	0.76	0.95
PGSC0003DMT200046356	K05277	ko00941	Flavonoid biosynthesis	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMT200046356	K05277	ko01100	Metabolic pathways	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMT200046356	K05277	ko01110	Biosynthesis of secondary metabolites	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMT200046367	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMT200046367	K00517	ko00626	Naphthalene and anthracene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMT200046367	K00517	ko00903	Limonene and pinene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMT200046367	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMT200046367	K00517	ko01110	Biosynthesis of secondary metabolites	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMT200046368	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMT200046368	K00517	ko00626	Naphthalene and anthracene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMT200046368	K00517	ko00903	Limonene and pinene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMT200046368	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMT200046368	K00517	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMT200073600	K00215	ko00300	Lysine biosynthesis	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMT200073600	K00215	ko01100	Metabolic pathways	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMT200073600	K00215	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMT200073601	K00215	ko00300	Lysine biosynthesis	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMT200073601	K00215	ko01100	Metabolic pathways	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMT200073601	K00215	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMT200073603	K11232	ko04011	MAPK signaling pathway - yeast	210	9.5e-06	0.33	0.52	0.79
PGSC0003DMT200073616	K01937	ko00240	Pyrimidine metabolism	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMT200073616	K01937	ko01100	Metabolic pathways	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMT200073623	K08739	ko03430	Mismatch repair	281	1.0e-08	0.65	0.87	0.74
PGSC0003DMT200073624	K01920	ko00480	Glutathione metabolism	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMT200073624	K01920	ko01100	Metabolic pathways	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMT200073626	K01920	ko00480	Glutathione metabolism	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMT200073626	K01920	ko01100	Metabolic pathways	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMT200073627	K01920	ko00480	Glutathione metabolism	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMT200073627	K01920	ko01100	Metabolic pathways	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMT200062070	K01704	ko00290	Valine, leucine and isoleucine biosynthesis	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMT200062070	K01704	ko00660	C5-Branched dibasic acid metabolism	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMT200062070	K01704	ko01100	Metabolic pathways	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMT200062070	K01704	ko01110	Biosynthesis of secondary metabolites	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMT200062087	K00492	ko00340	Histidine metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00363	Bisphenol A degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00622	Toluene and xylene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00624	1- and 2-Methylnaphthalene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00626	Naphthalene and anthracene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00627	1,4-Dichlorobenzene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00680	Methane metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko00903	Limonene and pinene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko01100	Metabolic pathways	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062087	K00492	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMT200062088	K00480	ko00624	1- and 2-Methylnaphthalene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMT200062088	K00480	ko00626	Naphthalene and anthracene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMT200062088	K00480	ko00628	Fluorene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMT200062088	K00480	ko01100	Metabolic pathways	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMT200062099	K04952	ko04740	Olfactory transduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMT200062099	K04952	ko04744	Phototransduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMT200079142	K02981	ko03010	Ribosome	1791	6.0e-93	0.80	0.84	1.00
PGSC0003DMT200079143	K02981	ko03010	Ribosome	1285	4.9e-65	0.90	0.93	0.84
PGSC0003DMT200079148	K13030	ko00460	Cyanoamino acid metabolism	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMT200079148	K13030	ko01110	Biosynthesis of secondary metabolites	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMT200079149	K13030	ko00460	Cyanoamino acid metabolism	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMT200079149	K13030	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMT200079150	K13068	ko00940	Phenylpropanoid biosynthesis	426	1.2e-17	0.46	0.60	0.83
PGSC0003DMT200079152	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMT200079153	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMT200079154	K13030	ko00460	Cyanoamino acid metabolism	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMT200079154	K13030	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMT200079161	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMT200079161	K01626	ko01100	Metabolic pathways	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMT200079161	K01626	ko01110	Biosynthesis of secondary metabolites	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMT200079172	K06630	ko04110	Cell cycle	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMT200079172	K06630	ko04114	Oocyte meiosis	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMT200079172	K06630	ko04722	Neurotrophin signaling pathway	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMT200079173	K00121	ko00010	Glycolysis / Gluconeogenesis	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00071	Fatty acid metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00350	Tyrosine metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00641	3-Chloroacrylic acid degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00680	Methane metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00830	Retinol metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko00982	Drug metabolism - cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko01100	Metabolic pathways	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200079173	K00121	ko01110	Biosynthesis of secondary metabolites	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMT200080100	K08233	ko00901	Indole alkaloid biosynthesis	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMT200080100	K08233	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMT200080101	K08233	ko00901	Indole alkaloid biosynthesis	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMT200080101	K08233	ko01110	Biosynthesis of secondary metabolites	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMT200080104	K01199	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.35	0.58	0.59
PGSC0003DMT200080106	K01199	ko00500	Starch and sucrose metabolism	289	4.2e-10	0.37	0.64	0.54
PGSC0003DMT200093069	K02878	ko03010	Ribosome	379	4.5e-15	0.51	0.76	0.74
PGSC0003DMT200002156	K13081	ko00941	Flavonoid biosynthesis	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMT200002156	K13081	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMT200002161	K00754	ko00051	Fructose and mannose metabolism	423	1.7e-17	0.27	0.47	0.81
PGSC0003DMT200002181	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMT200002182	K12874	ko03040	Spliceosome	2078	8.9e-109	0.66	0.74	1.00
PGSC0003DMT200002183	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMT200021433	K09647	ko03060	Protein export	837	2.5e-40	0.64	0.80	0.94
PGSC0003DMT200021435	K09647	ko03060	Protein export	863	9.2e-42	0.59	0.77	0.99
PGSC0003DMT200021444	K00703	ko00500	Starch and sucrose metabolism	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMT200021444	K00703	ko01100	Metabolic pathways	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMT200021462	K03107	ko03060	Protein export	3995	1.6e-214	0.80	0.91	0.98
PGSC0003DMT200033123	K00279	ko00908	Zeatin biosynthesis	2036	1.8e-106	0.67	0.82	0.91
PGSC0003DMT200033133	K01001	ko00510	N-Glycan biosynthesis	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMT200033133	K01001	ko01100	Metabolic pathways	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMT200033135	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMT200033136	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMT200033137	K01142	ko03410	Base excision repair	808	9.9e-39	0.42	0.60	0.96
PGSC0003DMT200033141	K01930	ko00790	Folate biosynthesis	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMT200033141	K01930	ko01100	Metabolic pathways	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMT200033142	K01930	ko00790	Folate biosynthesis	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMT200033142	K01930	ko01100	Metabolic pathways	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMT200033144	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMT200033144	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMT200033145	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMT200033145	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMT200033146	K01930	ko00790	Folate biosynthesis	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMT200033146	K01930	ko01100	Metabolic pathways	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMT200033147	K01930	ko00790	Folate biosynthesis	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMT200033147	K01930	ko01100	Metabolic pathways	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMT200033148	K13030	ko00460	Cyanoamino acid metabolism	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMT200033148	K13030	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMT200007510	K01051	ko00040	Pentose and glucuronate interconversions	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMT200007510	K01051	ko00500	Starch and sucrose metabolism	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMT200007510	K01051	ko01100	Metabolic pathways	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMT200007514	K08908	ko00196	Photosynthesis - antenna proteins	1717	7.2e-89	0.75	0.82	1.00
PGSC0003DMT200007516	K08908	ko00196	Photosynthesis - antenna proteins	1130	1.7e-56	0.81	0.88	0.99
PGSC0003DMT200007520	K02730	ko03050	Proteasome	1922	3.6e-100	0.91	0.98	1.00
PGSC0003DMT200007521	K02634	ko00195	Photosynthesis	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMT200007521	K02634	ko01100	Metabolic pathways	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMT200007543	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	464	5.4e-19	0.30	0.47	1.00
PGSC0003DMT200040716	K12338	ko00942	Anthocyanin biosynthesis	1378	3.6e-70	0.41	0.62	0.98
PGSC0003DMT200040717	K00600	ko00260	Glycine, serine and threonine metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040717	K00600	ko00460	Cyanoamino acid metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040717	K00600	ko00670	One carbon pool by folate	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040717	K00600	ko00680	Methane metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040717	K00600	ko01100	Metabolic pathways	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040717	K00600	ko01110	Biosynthesis of secondary metabolites	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMT200040718	K08679	ko00500	Starch and sucrose metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMT200040718	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMT200040718	K08679	ko01100	Metabolic pathways	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMT200040720	K11984	ko03040	Spliceosome	509	1.5e-21	0.28	0.48	0.83
PGSC0003DMT200040721	K11984	ko03040	Spliceosome	508	1.7e-21	0.30	0.51	0.78
PGSC0003DMT200040722	K04711	ko00600	Sphingolipid metabolism	1519	6.0e-78	0.69	0.78	1.00
PGSC0003DMT200040723	K04711	ko00600	Sphingolipid metabolism	1728	1.8e-89	0.76	0.87	1.00
PGSC0003DMT200040742	K10866	ko03440	Homologous recombination	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMT200040742	K10866	ko03450	Non-homologous end-joining	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMT200040743	K10866	ko03440	Homologous recombination	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMT200040743	K10866	ko03450	Non-homologous end-joining	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMT200015056	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMT200015057	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMT200015058	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMT200015059	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMT200015063	K08515	ko04130	SNARE interactions in vesicular transport	1384	1.7e-70	0.83	0.92	0.86
PGSC0003DMT200015064	K08515	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.86	0.94	1.00
PGSC0003DMT200015066	K06443	ko00906	Carotenoid biosynthesis	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMT200015066	K06443	ko01100	Metabolic pathways	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMT200015066	K06443	ko01110	Biosynthesis of secondary metabolites	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMT200015069	K12655	ko04622	RIG-I-like receptor signaling pathway	820	2.2e-39	0.39	0.57	0.61
PGSC0003DMT200015070	K12655	ko04622	RIG-I-like receptor signaling pathway	914	1.4e-44	0.36	0.55	0.64
PGSC0003DMT200015071	K12655	ko04622	RIG-I-like receptor signaling pathway	842	1.3e-40	0.39	0.57	0.62
PGSC0003DMT200015072	K12655	ko04622	RIG-I-like receptor signaling pathway	456	2.6e-19	0.34	0.50	0.57
PGSC0003DMT200015074	K12611	ko03018	RNA degradation	577	5.5e-26	0.29	0.51	0.95
PGSC0003DMT200015076	K10352	ko04530	Tight junction	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMT200015076	K10352	ko05416	Viral myocarditis	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMT200075801	K02183	ko04020	Calcium signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04070	Phosphatidylinositol signaling system	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04114	Oocyte meiosis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04270	Vascular smooth muscle contraction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04626	Plant-pathogen interaction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04720	Long-term potentiation	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04722	Neurotrophin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04740	Olfactory transduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04744	Phototransduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04745	Phototransduction - fly	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04910	Insulin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04912	GnRH signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04916	Melanogenesis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04970	Salivary secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko04971	Gastric acid secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko05010	Alzheimer's disease	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075801	K02183	ko05214	Glioma	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMT200075814	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMT200075814	K00517	ko00626	Naphthalene and anthracene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMT200075814	K00517	ko00903	Limonene and pinene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMT200075814	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMT200075814	K00517	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMT200075815	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMT200075815	K00517	ko00626	Naphthalene and anthracene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMT200075815	K00517	ko00903	Limonene and pinene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMT200075815	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMT200075815	K00517	ko01110	Biosynthesis of secondary metabolites	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMT200075816	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMT200075816	K00517	ko00626	Naphthalene and anthracene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMT200075816	K00517	ko00903	Limonene and pinene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMT200075816	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMT200075816	K00517	ko01110	Biosynthesis of secondary metabolites	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMT200075818	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.35	0.55	0.66
PGSC0003DMT200050405	K02894	ko03010	Ribosome	573	9.1e-26	0.93	0.96	0.97
PGSC0003DMT200050427	K04506	ko04115	p53 signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMT200050427	K04506	ko04120	Ubiquitin mediated proteolysis	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMT200050427	K04506	ko04310	Wnt signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMT200050428	K06268	ko04010	MAPK signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04020	Calcium signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04114	Oocyte meiosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04210	Apoptosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04310	Wnt signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04360	Axon guidance	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04370	VEGF signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04650	Natural killer cell mediated cytotoxicity	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04660	T cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04662	B cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko04720	Long-term potentiation	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko05010	Alzheimer's disease	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050428	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMT200050429	K06268	ko04010	MAPK signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04020	Calcium signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04114	Oocyte meiosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04210	Apoptosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04310	Wnt signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04360	Axon guidance	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04370	VEGF signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04650	Natural killer cell mediated cytotoxicity	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04660	T cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04662	B cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko04720	Long-term potentiation	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko05010	Alzheimer's disease	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050429	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMT200050430	K06268	ko04010	MAPK signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04020	Calcium signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04114	Oocyte meiosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04210	Apoptosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04310	Wnt signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04360	Axon guidance	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04370	VEGF signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04650	Natural killer cell mediated cytotoxicity	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04660	T cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04662	B cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko04720	Long-term potentiation	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko05010	Alzheimer's disease	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050430	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMT200050431	K06268	ko04010	MAPK signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04020	Calcium signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04114	Oocyte meiosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04210	Apoptosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04310	Wnt signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04360	Axon guidance	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04370	VEGF signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04650	Natural killer cell mediated cytotoxicity	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04660	T cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04662	B cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko04720	Long-term potentiation	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko05010	Alzheimer's disease	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050431	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMT200050433	K07466	ko03030	DNA replication	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMT200050433	K07466	ko03420	Nucleotide excision repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMT200050433	K07466	ko03430	Mismatch repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMT200050433	K07466	ko03440	Homologous recombination	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMT200050434	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050434	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050434	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050434	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050435	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050435	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050435	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200050435	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMT200058266	K00799	ko00480	Glutathione metabolism	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMT200058266	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMT200058266	K00799	ko00982	Drug metabolism - cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMT200058268	K00799	ko00480	Glutathione metabolism	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMT200058268	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMT200058268	K00799	ko00982	Drug metabolism - cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMT200058270	K00799	ko00480	Glutathione metabolism	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMT200058270	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMT200058270	K00799	ko00982	Drug metabolism - cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMT200058271	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMT200058271	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMT200058271	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMT200087137	K03065	ko03050	Proteasome	528	2.8e-23	0.62	0.65	0.75
PGSC0003DMT200087142	K05298	ko00710	Carbon fixation in photosynthetic organisms	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMT200087142	K05298	ko01100	Metabolic pathways	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMT200087143	K12126	ko04712	Circadian rhythm - plant	303	1.0e-10	0.27	0.44	0.95
PGSC0003DMT200075651	K01186	ko00511	Other glycan degradation	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMT200075651	K01186	ko00600	Sphingolipid metabolism	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMT200075651	K01186	ko04142	Lysosome	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMT200075666	K03963	ko00190	Oxidative phosphorylation	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMT200075666	K03963	ko01100	Metabolic pathways	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMT200075666	K03963	ko05010	Alzheimer's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMT200075666	K03963	ko05012	Parkinson's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMT200075666	K03963	ko05016	Huntington's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMT200058461	K00919	ko00900	Terpenoid backbone biosynthesis	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMT200058461	K00919	ko01100	Metabolic pathways	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMT200058461	K00919	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMT200058462	K00919	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMT200058462	K00919	ko01100	Metabolic pathways	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMT200058462	K00919	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMT200058463	K00919	ko00900	Terpenoid backbone biosynthesis	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMT200058463	K00919	ko01100	Metabolic pathways	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMT200058463	K00919	ko01110	Biosynthesis of secondary metabolites	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMT200058479	K05396	ko00270	Cysteine and methionine metabolism	362	3.9e-14	0.29	0.49	0.73
PGSC0003DMT200058486	K00423	ko00053	Ascorbate and aldarate metabolism	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMT200058486	K00423	ko01100	Metabolic pathways	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMT200058487	K00423	ko00053	Ascorbate and aldarate metabolism	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMT200058487	K00423	ko01100	Metabolic pathways	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMT200058490	K01114	ko00562	Inositol phosphate metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMT200058490	K01114	ko00564	Glycerophospholipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMT200058490	K01114	ko00565	Ether lipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMT200058490	K01114	ko01100	Metabolic pathways	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMT200068094	K00071	ko00140	Steroid hormone biosynthesis	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMT200068094	K00071	ko01100	Metabolic pathways	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMT200068094	K00071	ko04960	Aldosterone-regulated sodium reabsorption	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMT200068111	K03087	ko05111	Vibrio cholerae pathogenic cycle	687	4.7e-32	0.40	0.64	0.95
PGSC0003DMT200032987	K10717	ko00908	Zeatin biosynthesis	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMT200032987	K10717	ko01100	Metabolic pathways	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMT200032987	K10717	ko01110	Biosynthesis of secondary metabolites	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMT200032988	K10717	ko00908	Zeatin biosynthesis	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMT200032988	K10717	ko01100	Metabolic pathways	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMT200032988	K10717	ko01110	Biosynthesis of secondary metabolites	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMT200032989	K10717	ko00908	Zeatin biosynthesis	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMT200032989	K10717	ko01100	Metabolic pathways	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMT200032989	K10717	ko01110	Biosynthesis of secondary metabolites	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMT200032990	K10717	ko00908	Zeatin biosynthesis	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMT200032990	K10717	ko01100	Metabolic pathways	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMT200032990	K10717	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMT200032993	K00660	ko00941	Flavonoid biosynthesis	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMT200032993	K00660	ko01100	Metabolic pathways	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMT200032993	K00660	ko01110	Biosynthesis of secondary metabolites	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMT200032993	K00660	ko04712	Circadian rhythm - plant	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMT200032994	K03848	ko00510	N-Glycan biosynthesis	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMT200032994	K03848	ko01100	Metabolic pathways	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMT200032996	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMT200032996	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMT200032997	K03848	ko00510	N-Glycan biosynthesis	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMT200032997	K03848	ko01100	Metabolic pathways	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMT200032998	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMT200032998	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMT200033010	K01066	ko00623	2,4-Dichlorobenzoate degradation	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMT200033010	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMT200015269	K00889	ko00562	Inositol phosphate metabolism	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015269	K00889	ko01100	Metabolic pathways	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015269	K00889	ko04070	Phosphatidylinositol signaling system	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015269	K00889	ko04144	Endocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015269	K00889	ko04666	Fc gamma R-mediated phagocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015269	K00889	ko04810	Regulation of actin cytoskeleton	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMT200015270	K00889	ko00562	Inositol phosphate metabolism	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015270	K00889	ko01100	Metabolic pathways	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015270	K00889	ko04070	Phosphatidylinositol signaling system	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015270	K00889	ko04144	Endocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015270	K00889	ko04666	Fc gamma R-mediated phagocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015270	K00889	ko04810	Regulation of actin cytoskeleton	7831	0.	0.60	0.72	0.99
PGSC0003DMT200015282	K01807	ko00030	Pentose phosphate pathway	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMT200015282	K01807	ko00710	Carbon fixation in photosynthetic organisms	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMT200015282	K01807	ko01100	Metabolic pathways	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMT200015282	K01807	ko01110	Biosynthesis of secondary metabolites	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMT200025207	K11866	ko04144	Endocytosis	1149	1.5e-57	0.62	0.76	0.94
PGSC0003DMT200025208	K11866	ko04144	Endocytosis	935	9.8e-46	0.54	0.65	0.93
PGSC0003DMT200025211	K11866	ko04144	Endocytosis	432	5.4e-18	0.69	0.78	0.99
PGSC0003DMT200025215	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMT200025215	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMT200025216	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025216	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025217	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025217	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025218	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025218	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMT200025219	K00846	ko00051	Fructose and mannose metabolism	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMT200025219	K00846	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMT200025220	K00847	ko00051	Fructose and mannose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMT200025220	K00847	ko00500	Starch and sucrose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMT200025220	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMT200025220	K00847	ko01100	Metabolic pathways	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMT200025236	K05849	ko04020	Calcium signaling pathway	312	9.2e-11	0.36	0.54	0.60
PGSC0003DMT200001914	K03941	ko00190	Oxidative phosphorylation	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMT200001914	K03941	ko01100	Metabolic pathways	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMT200001914	K03941	ko05010	Alzheimer's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMT200001914	K03941	ko05012	Parkinson's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMT200001914	K03941	ko05016	Huntington's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMT200001929	K01055	ko00362	Benzoate degradation via hydroxylation	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMT200001929	K01055	ko01100	Metabolic pathways	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMT200001933	K08486	ko04130	SNARE interactions in vesicular transport	1400	2.2e-71	0.59	0.79	0.99
PGSC0003DMT200001935	K00975	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMT200001935	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMT200001935	K00975	ko01100	Metabolic pathways	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMT200001936	K00975	ko00500	Starch and sucrose metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMT200001936	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMT200001936	K00975	ko01100	Metabolic pathways	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMT200001937	K00560	ko00240	Pyrimidine metabolism	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMT200001937	K00560	ko00670	One carbon pool by folate	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMT200001937	K00560	ko01100	Metabolic pathways	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMT200001938	K00560	ko00240	Pyrimidine metabolism	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMT200001938	K00560	ko00670	One carbon pool by folate	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMT200001938	K00560	ko01100	Metabolic pathways	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMT200001939	K01586	ko00300	Lysine biosynthesis	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMT200001939	K01586	ko01100	Metabolic pathways	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMT200001939	K01586	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMT200001947	K05391	ko04626	Plant-pathogen interaction	1253	2.8e-63	0.83	0.89	0.92
PGSC0003DMT200001948	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMT200001949	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMT200001949	K00517	ko00626	Naphthalene and anthracene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMT200001949	K00517	ko00903	Limonene and pinene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMT200001949	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMT200001949	K00517	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMT200092576	K10760	ko00908	Zeatin biosynthesis	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMT200092576	K10760	ko01100	Metabolic pathways	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMT200092576	K10760	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMT200097225	K04427	ko04010	MAPK signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04310	Wnt signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04520	Adherens junction	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04620	Toll-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04621	NOD-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04622	RIG-I-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko04660	T cell receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097225	K04427	ko05140	Leishmaniasis	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMT200097234	K05282	ko00904	Diterpenoid biosynthesis	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMT200097234	K05282	ko01100	Metabolic pathways	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMT200097234	K05282	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMT200061826	K00430	ko00360	Phenylalanine metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMT200061826	K00430	ko00680	Methane metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMT200061826	K00430	ko00940	Phenylpropanoid biosynthesis	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMT200061826	K00430	ko01100	Metabolic pathways	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMT200061826	K00430	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMT200061839	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMT200061840	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMT200061845	K02291	ko00906	Carotenoid biosynthesis	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMT200061845	K02291	ko01100	Metabolic pathways	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMT200061845	K02291	ko01110	Biosynthesis of secondary metabolites	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMT200061846	K02291	ko00906	Carotenoid biosynthesis	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMT200061846	K02291	ko01100	Metabolic pathways	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMT200061846	K02291	ko01110	Biosynthesis of secondary metabolites	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMT200079259	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMT200079260	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMT200079284	K07466	ko03030	DNA replication	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMT200079284	K07466	ko03420	Nucleotide excision repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMT200079284	K07466	ko03430	Mismatch repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMT200079284	K07466	ko03440	Homologous recombination	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMT200079285	K07466	ko03030	DNA replication	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMT200079285	K07466	ko03420	Nucleotide excision repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMT200079285	K07466	ko03430	Mismatch repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMT200079285	K07466	ko03440	Homologous recombination	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMT200064364	K00059	ko00061	Fatty acid biosynthesis	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMT200064364	K00059	ko01040	Biosynthesis of unsaturated fatty acids	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMT200064364	K00059	ko01100	Metabolic pathways	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMT200064369	K00218	ko00860	Porphyrin and chlorophyll metabolism	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMT200064369	K00218	ko01100	Metabolic pathways	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMT200064369	K00218	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMT200064372	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.76	0.84	0.98
PGSC0003DMT200064373	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3534	4.4e-189	0.83	0.92	0.98
PGSC0003DMT200064379	K11251	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.98	0.98	0.99
PGSC0003DMT200064380	K02895	ko03010	Ribosome	1088	3.6e-54	0.57	0.65	1.00
PGSC0003DMT200064381	K02895	ko03010	Ribosome	1223	1.3e-61	0.77	0.88	0.99
PGSC0003DMT200056128	K13082	ko00941	Flavonoid biosynthesis	827	8.9e-40	0.41	0.61	0.97
PGSC0003DMT200056130	K11251	ko05322	Systemic lupus erythematosus	505	5.1e-22	0.98	0.98	0.78
PGSC0003DMT200056131	K11251	ko05322	Systemic lupus erythematosus	1026	9.4e-51	0.96	0.97	0.99
PGSC0003DMT200056134	K11228	ko04011	MAPK signaling pathway - yeast	317	5.7e-11	0.30	0.47	0.77
PGSC0003DMT200056136	K13082	ko00941	Flavonoid biosynthesis	823	1.5e-39	0.41	0.61	0.97
PGSC0003DMT200056137	K03083	ko04012	ErbB signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04062	Chemokine signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04110	Cell cycle	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04310	Wnt signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04340	Hedgehog signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04360	Axon guidance	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04510	Focal adhesion	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04660	T cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04662	B cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04711	Circadian rhythm - fly	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04722	Neurotrophin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko04916	Melanogenesis	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05010	Alzheimer's disease	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05200	Pathways in cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05210	Colorectal cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05213	Endometrial cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05215	Prostate cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056137	K03083	ko05217	Basal cell carcinoma	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMT200056138	K13082	ko00941	Flavonoid biosynthesis	1017	2.9e-50	0.42	0.62	0.97
PGSC0003DMT200056141	K11294	ko05130	Pathogenic Escherichia coli infection	239	3.5e-07	0.36	0.55	0.68
PGSC0003DMT200056142	K02938	ko03010	Ribosome	2196	2.8e-115	0.96	0.99	0.99
PGSC0003DMT200056143	K11866	ko04144	Endocytosis	459	9.1e-19	0.28	0.43	0.85
PGSC0003DMT200056144	K11866	ko04144	Endocytosis	481	5.2e-20	0.29	0.43	0.90
PGSC0003DMT200056145	K08099	ko00860	Porphyrin and chlorophyll metabolism	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMT200056145	K08099	ko01100	Metabolic pathways	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMT200056145	K08099	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMT200079968	K04713	ko00600	Sphingolipid metabolism	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMT200079968	K04713	ko01100	Metabolic pathways	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMT200079994	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	460	1.5e-19	0.32	0.47	0.94
PGSC0003DMT200037425	K09755	ko00940	Phenylpropanoid biosynthesis	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMT200037425	K09755	ko01100	Metabolic pathways	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMT200037425	K09755	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMT200037426	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMT200037426	K00517	ko00626	Naphthalene and anthracene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMT200037426	K00517	ko00903	Limonene and pinene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMT200037426	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMT200037426	K00517	ko01110	Biosynthesis of secondary metabolites	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMT200037439	K12489	ko04144	Endocytosis	3346	1.0e-178	0.56	0.67	0.96
PGSC0003DMT200037441	K12489	ko04144	Endocytosis	1727	2.0e-89	0.62	0.72	0.99
PGSC0003DMT200037442	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMT200037443	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMT200037444	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMT200037445	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMT200037446	K02949	ko03010	Ribosome	970	1.2e-47	0.76	0.82	0.99
PGSC0003DMT200037448	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200037449	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200037450	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200037451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200037452	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMT200037457	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMT200037457	K01915	ko00330	Arginine and proline metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMT200037457	K01915	ko00910	Nitrogen metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMT200037457	K01915	ko01100	Metabolic pathways	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMT200037457	K01915	ko02020	Two-component system	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMT200017725	K01136	ko00531	Glycosaminoglycan degradation	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMT200017725	K01136	ko01100	Metabolic pathways	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMT200017725	K01136	ko04142	Lysosome	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMT200017726	K12867	ko03040	Spliceosome	6303	0.	0.81	0.89	1.00
PGSC0003DMT200017754	K05862	ko04020	Calcium signaling pathway	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMT200017754	K05862	ko05012	Parkinson's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMT200017754	K05862	ko05016	Huntington's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMT200017761	K00472	ko00330	Arginine and proline metabolism	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMT200017761	K00472	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMT200017762	K00472	ko00330	Arginine and proline metabolism	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMT200017762	K00472	ko01100	Metabolic pathways	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMT200009458	K10955	ko05110	Vibrio cholerae infection	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMT200009458	K10955	ko05146	Amoebiasis	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMT200009459	K01051	ko00040	Pentose and glucuronate interconversions	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMT200009459	K01051	ko00500	Starch and sucrose metabolism	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMT200009459	K01051	ko01100	Metabolic pathways	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMT200009465	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMT200009465	K00224	ko00364	Fluorobenzoate degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMT200009465	K00224	ko00628	Fluorene degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMT200009465	K00224	ko00640	Propanoate metabolism	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMT200009466	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMT200009466	K00224	ko00364	Fluorobenzoate degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMT200009466	K00224	ko00628	Fluorene degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMT200009466	K00224	ko00640	Propanoate metabolism	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMT200009467	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMT200009467	K00224	ko00364	Fluorobenzoate degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMT200009467	K00224	ko00628	Fluorene degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMT200009467	K00224	ko00640	Propanoate metabolism	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMT200009468	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMT200009468	K00224	ko00364	Fluorobenzoate degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMT200009468	K00224	ko00628	Fluorene degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMT200009468	K00224	ko00640	Propanoate metabolism	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMT200009469	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMT200009469	K00224	ko00364	Fluorobenzoate degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMT200009469	K00224	ko00628	Fluorene degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMT200009469	K00224	ko00640	Propanoate metabolism	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMT200009470	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMT200009470	K00224	ko00364	Fluorobenzoate degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMT200009470	K00224	ko00628	Fluorene degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMT200009470	K00224	ko00640	Propanoate metabolism	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMT200009471	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMT200009471	K00224	ko00364	Fluorobenzoate degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMT200009471	K00224	ko00628	Fluorene degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMT200009471	K00224	ko00640	Propanoate metabolism	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMT200009472	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMT200009472	K00224	ko00364	Fluorobenzoate degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMT200009472	K00224	ko00628	Fluorene degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMT200009472	K00224	ko00640	Propanoate metabolism	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMT200009473	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMT200009473	K00224	ko00364	Fluorobenzoate degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMT200009473	K00224	ko00628	Fluorene degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMT200009473	K00224	ko00640	Propanoate metabolism	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMT200009474	K00680	ko00350	Tyrosine metabolism	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMT200009474	K00680	ko00624	1- and 2-Methylnaphthalene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMT200009474	K00680	ko00632	Benzoate degradation via CoA ligation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMT200009474	K00680	ko00642	Ethylbenzene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMT200009474	K00680	ko00903	Limonene and pinene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMT200009476	K00847	ko00051	Fructose and mannose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMT200009476	K00847	ko00500	Starch and sucrose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMT200009476	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMT200009476	K00847	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMT200009481	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.72
PGSC0003DMT200009482	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.87
PGSC0003DMT200009484	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009484	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009484	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009485	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMT200009485	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMT200009485	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMT200009486	K10572	ko00562	Inositol phosphate metabolism	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMT200009486	K10572	ko01100	Metabolic pathways	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMT200009486	K10572	ko04070	Phosphatidylinositol signaling system	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMT200009487	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009487	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009487	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMT200009488	K10572	ko00562	Inositol phosphate metabolism	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMT200009488	K10572	ko01100	Metabolic pathways	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMT200009488	K10572	ko04070	Phosphatidylinositol signaling system	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMT200009491	K04371	ko04010	MAPK signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04012	ErbB signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04013	MAPK signaling pathway - fly	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04062	Chemokine signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04114	Oocyte meiosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04150	mTOR signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04270	Vascular smooth muscle contraction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04320	Dorso-ventral axis formation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04350	TGF-beta signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04360	Axon guidance	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04370	VEGF signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04510	Focal adhesion	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04520	Adherens junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04540	Gap junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04620	Toll-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04621	NOD-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04650	Natural killer cell mediated cytotoxicity	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04660	T cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04662	B cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04664	Fc epsilon RI signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04666	Fc gamma R-mediated phagocytosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04720	Long-term potentiation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04722	Neurotrophin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04730	Long-term depression	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04810	Regulation of actin cytoskeleton	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04910	Insulin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04912	GnRH signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04914	Progesterone-mediated oocyte maturation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04916	Melanogenesis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04930	Type II diabetes mellitus	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05010	Alzheimer's disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05020	Prion diseases	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05131	Shigellosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05140	Leishmaniasis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05142	Chagas disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05200	Pathways in cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05210	Colorectal cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05211	Renal cell carcinoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05212	Pancreatic cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05213	Endometrial cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05214	Glioma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05215	Prostate cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05216	Thyroid cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05218	Melanoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05219	Bladder cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05220	Chronic myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05221	Acute myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200009491	K04371	ko05223	Non-small cell lung cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMT200089253	K10773	ko03410	Base excision repair	1542	3.2e-79	0.32	0.46	0.82
PGSC0003DMT200054373	K06093	ko04144	Endocytosis	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMT200054373	K06093	ko04530	Tight junction	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMT200062668	K02152	ko00190	Oxidative phosphorylation	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062668	K02152	ko01100	Metabolic pathways	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062668	K02152	ko04145	Phagosome	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062668	K02152	ko04966	Collecting duct acid secretion	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062668	K02152	ko05110	Vibrio cholerae infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062668	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMT200062680	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMT200062680	K01736	ko01100	Metabolic pathways	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMT200062680	K01736	ko01110	Biosynthesis of secondary metabolites	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMT200082071	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082071	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082071	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082072	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082072	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082072	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082073	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082073	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082073	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMT200082075	K02734	ko03050	Proteasome	1533	1.0e-78	0.87	0.94	0.99
PGSC0003DMT200082096	K01371	ko04142	Lysosome	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMT200082096	K01371	ko04620	Toll-like receptor signaling pathway	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMT200003888	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1479	9.7e-76	0.67	0.80	0.91
PGSC0003DMT200090449	K01087	ko00500	Starch and sucrose metabolism	1190	8.4e-60	0.54	0.70	0.98
PGSC0003DMT200090450	K12338	ko00942	Anthocyanin biosynthesis	910	2.3e-44	0.46	0.65	0.96
PGSC0003DMT200016815	K00100	ko00051	Fructose and mannose metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016815	K00100	ko00363	Bisphenol A degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016815	K00100	ko00591	Linoleic acid metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016815	K00100	ko00625	Tetrachloroethene degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016815	K00100	ko00650	Butanoate metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016815	K00100	ko01100	Metabolic pathways	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMT200016816	K05275	ko00750	Vitamin B6 metabolism	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMT200016816	K05275	ko01100	Metabolic pathways	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMT200016817	K05275	ko00750	Vitamin B6 metabolism	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMT200016817	K05275	ko01100	Metabolic pathways	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMT200016819	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016819	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016819	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016819	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016819	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016819	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMT200016820	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016820	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016820	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016820	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016820	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016820	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016821	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016822	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016823	K05275	ko00750	Vitamin B6 metabolism	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMT200016823	K05275	ko01100	Metabolic pathways	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMT200016824	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016824	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016824	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016824	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016824	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016824	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMT200016825	K05275	ko00750	Vitamin B6 metabolism	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMT200016825	K05275	ko01100	Metabolic pathways	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMT200034892	K08912	ko00196	Photosynthesis - antenna proteins	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMT200034892	K08912	ko01100	Metabolic pathways	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMT200034893	K08912	ko00196	Photosynthesis - antenna proteins	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMT200034893	K08912	ko01100	Metabolic pathways	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMT200034894	K08912	ko00196	Photosynthesis - antenna proteins	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMT200034894	K08912	ko01100	Metabolic pathways	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMT200034895	K08912	ko00196	Photosynthesis - antenna proteins	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMT200034895	K08912	ko01100	Metabolic pathways	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMT200034896	K08912	ko00196	Photosynthesis - antenna proteins	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMT200034896	K08912	ko01100	Metabolic pathways	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMT200034897	K08912	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMT200034897	K08912	ko01100	Metabolic pathways	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMT200034898	K08912	ko00196	Photosynthesis - antenna proteins	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMT200034898	K08912	ko01100	Metabolic pathways	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMT200034899	K08912	ko00196	Photosynthesis - antenna proteins	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMT200034899	K08912	ko01100	Metabolic pathways	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMT200034900	K08912	ko00196	Photosynthesis - antenna proteins	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMT200034900	K08912	ko01100	Metabolic pathways	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMT200034901	K08912	ko00196	Photosynthesis - antenna proteins	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMT200034901	K08912	ko01100	Metabolic pathways	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMT200034902	K08912	ko00196	Photosynthesis - antenna proteins	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMT200034902	K08912	ko01100	Metabolic pathways	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMT200034903	K07441	ko00510	N-Glycan biosynthesis	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMT200034903	K07441	ko01100	Metabolic pathways	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMT200034905	K07441	ko00510	N-Glycan biosynthesis	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMT200034905	K07441	ko01100	Metabolic pathways	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMT200034906	K07441	ko00510	N-Glycan biosynthesis	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMT200034906	K07441	ko01100	Metabolic pathways	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMT200034907	K07441	ko00510	N-Glycan biosynthesis	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMT200034907	K07441	ko01100	Metabolic pathways	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMT200034908	K05658	ko02010	ABC transporters	6882	0.	0.67	0.83	1.00
PGSC0003DMT200034911	K03259	ko04150	mTOR signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMT200034911	K03259	ko04910	Insulin signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMT200034912	K03259	ko04150	mTOR signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMT200034912	K03259	ko04910	Insulin signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMT200034918	K00599	ko00340	Histidine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMT200034918	K00599	ko00350	Tyrosine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMT200034918	K00599	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMT200034918	K00599	ko00626	Naphthalene and anthracene degradation	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMT200034920	K00599	ko00340	Histidine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMT200034920	K00599	ko00350	Tyrosine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMT200034920	K00599	ko00450	Selenoamino acid metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMT200034920	K00599	ko00626	Naphthalene and anthracene degradation	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMT200035672	K06685	ko04111	Cell cycle - yeast	536	3.5e-20	0.25	0.42	0.82
PGSC0003DMT200035678	K02140	ko00190	Oxidative phosphorylation	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMT200035678	K02140	ko01100	Metabolic pathways	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMT200035686	K11247	ko04144	Endocytosis	1697	9.2e-88	0.58	0.76	0.99
PGSC0003DMT200035687	K11247	ko04144	Endocytosis	1070	3.5e-53	0.59	0.76	0.98
PGSC0003DMT200035688	K11247	ko04144	Endocytosis	578	4.8e-26	0.53	0.74	0.81
PGSC0003DMT200035694	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035694	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035694	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035694	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035694	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035695	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035695	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035695	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035695	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035695	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200011175	K08517	ko04130	SNARE interactions in vesicular transport	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMT200011175	K08517	ko04145	Phagosome	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMT200011177	K08517	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMT200011177	K08517	ko04145	Phagosome	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMT200011193	K12349	ko00600	Sphingolipid metabolism	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMT200011193	K12349	ko01100	Metabolic pathways	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMT200011212	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	541	5.3e-24	0.63	0.74	0.80
PGSC0003DMT200011214	K05033	ko02010	ABC transporters	684	4.7e-31	0.54	0.75	0.89
PGSC0003DMT200011215	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMT200011217	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMT200019583	K02695	ko00195	Photosynthesis	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMT200019583	K02695	ko01100	Metabolic pathways	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMT200019584	K00058	ko00260	Glycine, serine and threonine metabolism	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMT200019584	K00058	ko01100	Metabolic pathways	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMT200019585	K00100	ko00051	Fructose and mannose metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019585	K00100	ko00363	Bisphenol A degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019585	K00100	ko00591	Linoleic acid metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019585	K00100	ko00625	Tetrachloroethene degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019585	K00100	ko00650	Butanoate metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019585	K00100	ko01100	Metabolic pathways	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMT200019586	K00058	ko00260	Glycine, serine and threonine metabolism	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMT200019586	K00058	ko01100	Metabolic pathways	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMT200019593	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019593	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019594	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019595	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019596	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019597	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019598	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019599	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200019600	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMT200077415	K01590	ko00340	Histidine metabolism	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMT200077415	K01590	ko01100	Metabolic pathways	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMT200077415	K01590	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMT200077428	K02087	ko04110	Cell cycle	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMT200077428	K02087	ko04114	Oocyte meiosis	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMT200077428	K02087	ko04115	p53 signaling pathway	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMT200077428	K02087	ko04540	Gap junction	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMT200077428	K02087	ko04914	Progesterone-mediated oocyte maturation	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMT200077429	K02087	ko04110	Cell cycle	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMT200077429	K02087	ko04114	Oocyte meiosis	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMT200077429	K02087	ko04115	p53 signaling pathway	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMT200077429	K02087	ko04540	Gap junction	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMT200077429	K02087	ko04914	Progesterone-mediated oocyte maturation	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMT200077452	K00029	ko00620	Pyruvate metabolism	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMT200077452	K00029	ko00710	Carbon fixation in photosynthetic organisms	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMT200077452	K00029	ko01100	Metabolic pathways	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMT200069840	K00382	ko00010	Glycolysis / Gluconeogenesis	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko00020	Citrate cycle (TCA cycle)	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko00260	Glycine, serine and threonine metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko00280	Valine, leucine and isoleucine degradation	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko00620	Pyruvate metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko01100	Metabolic pathways	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069840	K00382	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMT200069847	K02905	ko03010	Ribosome	469	4.9e-20	0.87	0.95	0.98
PGSC0003DMT200069851	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.60	0.91
PGSC0003DMT200069855	K04077	ko03018	RNA degradation	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMT200069855	K04077	ko04940	Type I diabetes mellitus	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMT200069858	K00878	ko00730	Thiamine metabolism	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMT200069858	K00878	ko01100	Metabolic pathways	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMT200069859	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMT200069859	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMT200069859	K00771	ko01100	Metabolic pathways	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMT200069860	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMT200069860	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMT200069860	K00771	ko01100	Metabolic pathways	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMT200069866	K00368	ko00910	Nitrogen metabolism	1934	7.8e-101	0.48	0.62	0.89
PGSC0003DMT200069878	K01510	ko00230	Purine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMT200069878	K01510	ko00240	Pyrimidine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMT200069879	K04646	ko04142	Lysosome	10939	0.	0.79	0.82	1.00
PGSC0003DMT200069879	K04646	ko04144	Endocytosis	10939	0.	0.79	0.82	1.00
PGSC0003DMT200069879	K04646	ko05016	Huntington's disease	10939	0.	0.79	0.82	1.00
PGSC0003DMT200069879	K04646	ko05100	Bacterial invasion of epithelial cells	10939	0.	0.79	0.82	1.00
PGSC0003DMT200069880	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMT200069880	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMT200069880	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMT200069880	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMT200069884	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.97
PGSC0003DMT200060274	K00166	ko00280	Valine, leucine and isoleucine degradation	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMT200060274	K00166	ko01100	Metabolic pathways	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMT200060274	K00166	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMT200060275	K00166	ko00280	Valine, leucine and isoleucine degradation	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMT200060275	K00166	ko01100	Metabolic pathways	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMT200060275	K00166	ko01110	Biosynthesis of secondary metabolites	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMT200060296	K02160	ko00061	Fatty acid biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060296	K02160	ko00253	Tetracycline biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060296	K02160	ko00620	Pyruvate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060296	K02160	ko00640	Propanoate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060296	K02160	ko01100	Metabolic pathways	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060296	K02160	ko01110	Biosynthesis of secondary metabolites	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMT200060304	K03955	ko00190	Oxidative phosphorylation	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMT200060304	K03955	ko01100	Metabolic pathways	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMT200060304	K03955	ko05010	Alzheimer's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMT200060304	K03955	ko05012	Parkinson's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMT200060304	K03955	ko05016	Huntington's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMT200060305	K03955	ko00190	Oxidative phosphorylation	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMT200060305	K03955	ko01100	Metabolic pathways	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMT200060305	K03955	ko05010	Alzheimer's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMT200060305	K03955	ko05012	Parkinson's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMT200060305	K03955	ko05016	Huntington's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMT200048063	K05868	ko04110	Cell cycle	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMT200048063	K05868	ko04115	p53 signaling pathway	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMT200048063	K05868	ko04914	Progesterone-mediated oocyte maturation	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMT200048075	K00021	ko00900	Terpenoid backbone biosynthesis	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMT200048075	K00021	ko01100	Metabolic pathways	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMT200048075	K00021	ko01110	Biosynthesis of secondary metabolites	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMT200048091	K10802	ko03410	Base excision repair	684	6.8e-32	0.72	0.82	0.68
PGSC0003DMT200048092	K10802	ko03410	Base excision repair	819	2.5e-39	0.70	0.79	0.99
PGSC0003DMT200048095	K00588	ko00360	Phenylalanine metabolism	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048095	K00588	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048095	K00588	ko00941	Flavonoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048095	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048095	K00588	ko01100	Metabolic pathways	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048095	K00588	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMT200048100	K00588	ko00360	Phenylalanine metabolism	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200048100	K00588	ko00940	Phenylpropanoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200048100	K00588	ko00941	Flavonoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200048100	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200048100	K00588	ko01100	Metabolic pathways	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200048100	K00588	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMT200091380	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	273	3.2e-09	0.53	0.72	0.70
PGSC0003DMT200031316	K05681	ko02010	ABC transporters	888	1.0e-44	0.34	0.53	0.48
PGSC0003DMT200031320	K00634	ko00650	Butanoate metabolism	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMT200031320	K00634	ko01100	Metabolic pathways	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMT200031328	K06626	ko04110	Cell cycle	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031328	K06626	ko04114	Oocyte meiosis	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031328	K06626	ko04115	p53 signaling pathway	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031328	K06626	ko05200	Pathways in cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031328	K06626	ko05215	Prostate cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031328	K06626	ko05222	Small cell lung cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMT200031329	K02220	ko04111	Cell cycle - yeast	291	3.9e-10	0.34	0.55	0.47
PGSC0003DMT200031339	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMT200031340	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMT200031342	K01178	ko00500	Starch and sucrose metabolism	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMT200031342	K01178	ko01100	Metabolic pathways	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMT200031351	K01623	ko00010	Glycolysis / Gluconeogenesis	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031351	K01623	ko00030	Pentose phosphate pathway	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031351	K01623	ko00051	Fructose and mannose metabolism	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031351	K01623	ko00710	Carbon fixation in photosynthetic organisms	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031351	K01623	ko01100	Metabolic pathways	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031351	K01623	ko01110	Biosynthesis of secondary metabolites	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMT200031364	K08332	ko04140	Regulation of autophagy	294	8.3e-08	0.25	0.48	0.62
PGSC0003DMT200031366	K13230	ko00402	Benzoxazinoid biosynthesis	702	7.0e-33	0.34	0.52	0.96
PGSC0003DMT200031369	K13230	ko00402	Benzoxazinoid biosynthesis	645	9.7e-30	0.38	0.54	0.96
PGSC0003DMT200031370	K13230	ko00402	Benzoxazinoid biosynthesis	668	5.2e-31	0.39	0.55	0.96
PGSC0003DMT200039412	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMT200039412	K00517	ko00626	Naphthalene and anthracene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMT200039412	K00517	ko00903	Limonene and pinene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMT200039412	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMT200039412	K00517	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMT200039421	K02880	ko03010	Ribosome	1347	1.8e-68	0.91	0.95	0.99
PGSC0003DMT200039422	K07199	ko04910	Insulin signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMT200039422	K07199	ko04920	Adipocytokine signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMT200039422	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMT200039423	K07199	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMT200039423	K07199	ko04920	Adipocytokine signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMT200039423	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMT200039437	K00059	ko00061	Fatty acid biosynthesis	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMT200039437	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMT200039437	K00059	ko01100	Metabolic pathways	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMT200039449	K00134	ko00010	Glycolysis / Gluconeogenesis	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMT200039449	K00134	ko01100	Metabolic pathways	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMT200039449	K00134	ko01110	Biosynthesis of secondary metabolites	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMT200039449	K00134	ko05010	Alzheimer's disease	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMT200039453	K00940	ko00230	Purine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMT200039453	K00940	ko00240	Pyrimidine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMT200039453	K00940	ko01100	Metabolic pathways	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMT200039453	K00940	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMT200039464	K02970	ko03010	Ribosome	215	5.0e-06	0.51	0.70	0.22
PGSC0003DMT200039466	K02970	ko03010	Ribosome	219	3.0e-06	0.51	0.69	0.33
PGSC0003DMT200023456	K01051	ko00040	Pentose and glucuronate interconversions	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMT200023456	K01051	ko00500	Starch and sucrose metabolism	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMT200023456	K01051	ko01100	Metabolic pathways	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMT200023457	K01051	ko00040	Pentose and glucuronate interconversions	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMT200023457	K01051	ko00500	Starch and sucrose metabolism	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMT200023457	K01051	ko01100	Metabolic pathways	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMT200023472	K01228	ko00510	N-Glycan biosynthesis	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMT200023472	K01228	ko01100	Metabolic pathways	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMT200023479	K07297	ko04920	Adipocytokine signaling pathway	1096	1.3e-54	0.75	0.87	0.99
PGSC0003DMT200023480	K07297	ko04920	Adipocytokine signaling pathway	2314	8.5e-122	0.66	0.80	0.97
PGSC0003DMT200023483	K05862	ko04020	Calcium signaling pathway	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMT200023483	K05862	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMT200023483	K05862	ko05016	Huntington's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMT200023484	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMT200023484	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMT200023484	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMT200023486	K05033	ko02010	ABC transporters	415	5.2e-16	0.51	0.67	0.84
PGSC0003DMT200023487	K05666	ko02010	ABC transporters	3162	1.4e-168	0.38	0.59	0.82
PGSC0003DMT200023488	K05666	ko02010	ABC transporters	1344	2.7e-68	0.44	0.66	0.97
PGSC0003DMT200013506	K01509	ko00230	Purine metabolism	194	1.1e-09	0.50	0.71	0.40
PGSC0003DMT200013520	K00430	ko00360	Phenylalanine metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMT200013520	K00430	ko00680	Methane metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMT200013520	K00430	ko00940	Phenylpropanoid biosynthesis	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMT200013520	K00430	ko01100	Metabolic pathways	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMT200013520	K00430	ko01110	Biosynthesis of secondary metabolites	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMT200013528	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMT200013528	K03785	ko01100	Metabolic pathways	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMT200013528	K03785	ko01110	Biosynthesis of secondary metabolites	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMT200013529	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMT200013529	K03785	ko01100	Metabolic pathways	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMT200013529	K03785	ko01110	Biosynthesis of secondary metabolites	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMT200028815	K11778	ko00900	Terpenoid backbone biosynthesis	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMT200028815	K11778	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMT200028816	K11778	ko00900	Terpenoid backbone biosynthesis	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMT200028816	K11778	ko01110	Biosynthesis of secondary metabolites	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMT200028817	K11778	ko00900	Terpenoid backbone biosynthesis	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMT200028817	K11778	ko01110	Biosynthesis of secondary metabolites	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMT200028818	K11778	ko00900	Terpenoid backbone biosynthesis	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMT200028818	K11778	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMT200028819	K11778	ko00900	Terpenoid backbone biosynthesis	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMT200028819	K11778	ko01110	Biosynthesis of secondary metabolites	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMT200028820	K11778	ko00900	Terpenoid backbone biosynthesis	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMT200028820	K11778	ko01110	Biosynthesis of secondary metabolites	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMT200028822	K11778	ko00900	Terpenoid backbone biosynthesis	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMT200028822	K11778	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMT200028827	K05933	ko00270	Cysteine and methionine metabolism	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMT200028827	K05933	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMT200028828	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMT200028828	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMT200028828	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMT200028837	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMT200028837	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMT200028837	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMT200028838	K01921	ko00473	D-Alanine metabolism	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMT200028838	K01921	ko00550	Peptidoglycan biosynthesis	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMT200028838	K01921	ko01100	Metabolic pathways	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMT200028839	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMT200028839	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMT200028839	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMT200025560	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMT200025560	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMT200025561	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMT200025561	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMT200025576	K08766	ko00071	Fatty acid metabolism	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMT200025576	K08766	ko03320	PPAR signaling pathway	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMT200025577	K08766	ko00071	Fatty acid metabolism	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMT200025577	K08766	ko03320	PPAR signaling pathway	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMT200020615	K00510	ko00860	Porphyrin and chlorophyll metabolism	981	2.8e-48	0.49	0.68	0.58
PGSC0003DMT200020624	K13289	ko04142	Lysosome	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMT200020624	K13289	ko04614	Renin-angiotensin system	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMT200020625	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020625	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020625	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020626	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020626	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020626	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMT200020639	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMT200020640	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMT200020644	K02084	ko04115	p53 signaling pathway	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko04210	Apoptosis	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko05010	Alzheimer's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko05012	Parkinson's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko05016	Huntington's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020644	K02084	ko05222	Small cell lung cancer	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMT200020645	K02084	ko04115	p53 signaling pathway	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko04210	Apoptosis	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko05010	Alzheimer's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko05012	Parkinson's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko05016	Huntington's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020645	K02084	ko05222	Small cell lung cancer	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMT200020648	K06627	ko04110	Cell cycle	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMT200020648	K06627	ko04914	Progesterone-mediated oocyte maturation	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMT200020651	K01136	ko00531	Glycosaminoglycan degradation	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMT200020651	K01136	ko01100	Metabolic pathways	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMT200020651	K01136	ko04142	Lysosome	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMT200036565	K05278	ko00941	Flavonoid biosynthesis	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMT200036565	K05278	ko01100	Metabolic pathways	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMT200036565	K05278	ko01110	Biosynthesis of secondary metabolites	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMT200036566	K00059	ko00061	Fatty acid biosynthesis	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMT200036566	K00059	ko01040	Biosynthesis of unsaturated fatty acids	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMT200036566	K00059	ko01100	Metabolic pathways	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMT200036568	K00059	ko00061	Fatty acid biosynthesis	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMT200036568	K00059	ko01040	Biosynthesis of unsaturated fatty acids	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMT200036568	K00059	ko01100	Metabolic pathways	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMT200036569	K00059	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMT200036569	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMT200036569	K00059	ko01100	Metabolic pathways	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMT200036574	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036574	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036574	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036575	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036575	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036575	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMT200036578	K04725	ko04120	Ubiquitin mediated proteolysis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036578	K04725	ko04210	Apoptosis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036578	K04725	ko04510	Focal adhesion	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036578	K04725	ko04621	NOD-like receptor signaling pathway	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036578	K04725	ko05200	Pathways in cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036578	K04725	ko05222	Small cell lung cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMT200036591	K01081	ko00230	Purine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMT200036591	K01081	ko00240	Pyrimidine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMT200036591	K01081	ko00760	Nicotinate and nicotinamide metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMT200036591	K01081	ko01100	Metabolic pathways	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMT200036591	K01081	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMT200036592	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036592	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036592	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036592	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200036592	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMT200071540	K00249	ko00071	Fatty acid metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko00280	Valine, leucine and isoleucine degradation	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko00410	beta-Alanine metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko00640	Propanoate metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko01100	Metabolic pathways	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko01110	Biosynthesis of secondary metabolites	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071540	K00249	ko03320	PPAR signaling pathway	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMT200071541	K00249	ko00071	Fatty acid metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko00280	Valine, leucine and isoleucine degradation	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko00410	beta-Alanine metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko00640	Propanoate metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko01100	Metabolic pathways	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko01110	Biosynthesis of secondary metabolites	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071541	K00249	ko03320	PPAR signaling pathway	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMT200071544	K01051	ko00040	Pentose and glucuronate interconversions	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMT200071544	K01051	ko00500	Starch and sucrose metabolism	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMT200071544	K01051	ko01100	Metabolic pathways	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMT200071547	K11253	ko05322	Systemic lupus erythematosus	282	1.0e-09	0.97	0.97	0.67
PGSC0003DMT200071566	K01051	ko00040	Pentose and glucuronate interconversions	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMT200071566	K01051	ko00500	Starch and sucrose metabolism	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMT200071566	K01051	ko01100	Metabolic pathways	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMT200071571	K11253	ko05322	Systemic lupus erythematosus	787	1.4e-37	0.92	0.94	0.95
PGSC0003DMT200045710	K01507	ko00190	Oxidative phosphorylation	489	3.9e-21	0.59	0.66	0.73
PGSC0003DMT200045715	K04733	ko04210	Apoptosis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMT200045715	K04733	ko04620	Toll-like receptor signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMT200045715	K04733	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMT200045715	K04733	ko05140	Leishmaniasis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMT200045715	K04733	ko05142	Chagas disease	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMT200083480	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMT200083493	K11090	ko05322	Systemic lupus erythematosus	260	1.7e-08	0.31	0.50	0.39
PGSC0003DMT200063628	K01514	ko00230	Purine metabolism	827	8.9e-40	0.35	0.54	0.93
PGSC0003DMT200063629	K01514	ko00230	Purine metabolism	903	5.7e-44	0.35	0.54	0.87
PGSC0003DMT200063630	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMT200063638	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMT200063638	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMT200063641	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMT200063641	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMT200063642	K01192	ko00511	Other glycan degradation	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMT200063642	K01192	ko04142	Lysosome	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMT200063654	K00454	ko00591	Linoleic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMT200063654	K00454	ko00592	alpha-Linolenic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMT200063654	K00454	ko01100	Metabolic pathways	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMT200063659	K07200	ko04910	Insulin signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMT200063659	K07200	ko04920	Adipocytokine signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMT200063659	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMT200063662	K10609	ko03420	Nucleotide excision repair	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMT200063662	K10609	ko04120	Ubiquitin mediated proteolysis	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMT200001018	K10527	ko00592	alpha-Linolenic acid metabolism	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMT200001018	K10527	ko01100	Metabolic pathways	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMT200001021	K03100	ko03060	Protein export	1729	1.6e-89	0.67	0.76	0.98
PGSC0003DMT200001024	K00558	ko00270	Cysteine and methionine metabolism	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMT200001024	K00558	ko01100	Metabolic pathways	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMT200001033	K02184	ko04320	Dorso-ventral axis formation	1261	1.0e-63	0.42	0.46	0.48
PGSC0003DMT200001041	K12471	ko04144	Endocytosis	344	3.9e-13	0.33	0.57	0.63
PGSC0003DMT200001042	K12471	ko04144	Endocytosis	226	3.4e-06	0.33	0.56	0.87
PGSC0003DMT200001049	K08332	ko04140	Regulation of autophagy	304	3.3e-08	0.29	0.52	0.45
PGSC0003DMT200001050	K08332	ko04140	Regulation of autophagy	304	1.2e-10	0.29	0.52	0.96
PGSC0003DMT200004156	K10352	ko04530	Tight junction	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMT200004156	K10352	ko05416	Viral myocarditis	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMT200004181	K01583	ko00330	Arginine and proline metabolism	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMT200004181	K01583	ko01100	Metabolic pathways	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMT200004193	K02257	ko00190	Oxidative phosphorylation	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMT200004193	K02257	ko00860	Porphyrin and chlorophyll metabolism	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMT200004193	K02257	ko01100	Metabolic pathways	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMT200004193	K02257	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMT200004194	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMT200004194	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMT200004194	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMT200004194	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMT200004195	K02257	ko00190	Oxidative phosphorylation	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMT200004195	K02257	ko00860	Porphyrin and chlorophyll metabolism	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMT200004195	K02257	ko01100	Metabolic pathways	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMT200004195	K02257	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMT200004196	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMT200004196	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMT200004196	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMT200004196	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMT200032067	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMT200032067	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMT200032067	K00734	ko01100	Metabolic pathways	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMT200032081	K10456	ko04120	Ubiquitin mediated proteolysis	301	3.5e-08	0.30	0.47	0.42
PGSC0003DMT200032082	K10456	ko04120	Ubiquitin mediated proteolysis	301	1.5e-08	0.30	0.47	0.50
PGSC0003DMT200032088	K08008	ko04145	Phagosome	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMT200032088	K08008	ko04670	Leukocyte transendothelial migration	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMT200032089	K08008	ko04145	Phagosome	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMT200032089	K08008	ko04670	Leukocyte transendothelial migration	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMT200032096	K01762	ko00270	Cysteine and methionine metabolism	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMT200032096	K01762	ko01110	Biosynthesis of secondary metabolites	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMT200032098	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMT200032098	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMT200032099	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMT200032099	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMT200032103	K01213	ko00040	Pentose and glucuronate interconversions	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMT200032103	K01213	ko00500	Starch and sucrose metabolism	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMT200032103	K01213	ko01100	Metabolic pathways	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMT200032104	K01213	ko00040	Pentose and glucuronate interconversions	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMT200032104	K01213	ko00500	Starch and sucrose metabolism	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMT200032104	K01213	ko01100	Metabolic pathways	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMT200042179	K04498	ko04110	Cell cycle	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04310	Wnt signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04330	Notch signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04350	TGF-beta signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04520	Adherens junction	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04630	Jak-STAT signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04720	Long-term potentiation	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko04916	Melanogenesis	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko05016	Huntington's disease	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko05200	Pathways in cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko05211	Renal cell carcinoma	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042179	K04498	ko05215	Prostate cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04110	Cell cycle	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04310	Wnt signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04330	Notch signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04350	TGF-beta signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04520	Adherens junction	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04630	Jak-STAT signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04720	Long-term potentiation	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko04916	Melanogenesis	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko05016	Huntington's disease	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko05200	Pathways in cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko05211	Renal cell carcinoma	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042180	K04498	ko05215	Prostate cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04110	Cell cycle	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04310	Wnt signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04330	Notch signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04350	TGF-beta signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04520	Adherens junction	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04630	Jak-STAT signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04720	Long-term potentiation	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko04916	Melanogenesis	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko05016	Huntington's disease	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko05200	Pathways in cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko05211	Renal cell carcinoma	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042181	K04498	ko05215	Prostate cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04110	Cell cycle	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04310	Wnt signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04330	Notch signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04350	TGF-beta signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04520	Adherens junction	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04630	Jak-STAT signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04720	Long-term potentiation	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko04916	Melanogenesis	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko05016	Huntington's disease	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko05200	Pathways in cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko05211	Renal cell carcinoma	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042182	K04498	ko05215	Prostate cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMT200042183	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMT200042184	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMT200042185	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMT200042186	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMT200042189	K01046	ko00561	Glycerolipid metabolism	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMT200042189	K01046	ko01100	Metabolic pathways	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMT200042190	K01046	ko00561	Glycerolipid metabolism	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMT200042190	K01046	ko01100	Metabolic pathways	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMT200042192	K00430	ko00360	Phenylalanine metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMT200042192	K00430	ko00680	Methane metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMT200042192	K00430	ko00940	Phenylpropanoid biosynthesis	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMT200042192	K00430	ko01100	Metabolic pathways	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMT200042192	K00430	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMT200042194	K02084	ko04115	p53 signaling pathway	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko04210	Apoptosis	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko05010	Alzheimer's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko05012	Parkinson's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko05016	Huntington's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042194	K02084	ko05222	Small cell lung cancer	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMT200042202	K00814	ko00250	Alanine, aspartate and glutamate metabolism	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMT200042202	K00814	ko00710	Carbon fixation in photosynthetic organisms	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMT200042202	K00814	ko01100	Metabolic pathways	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMT200042204	K13065	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMT200042204	K13065	ko00941	Flavonoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMT200042204	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMT200042204	K13065	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMT200042211	K03531	ko04112	Cell cycle - Caulobacter	308	1.5e-10	0.28	0.48	0.32
PGSC0003DMT200042212	K03531	ko04112	Cell cycle - Caulobacter	304	2.6e-10	0.27	0.49	0.32
PGSC0003DMT200057693	K01082	ko00920	Sulfur metabolism	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMT200057693	K01082	ko01100	Metabolic pathways	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMT200057694	K01107	ko00562	Inositol phosphate metabolism	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMT200057694	K01107	ko01100	Metabolic pathways	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMT200057694	K01107	ko04070	Phosphatidylinositol signaling system	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMT200057695	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057695	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057695	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057696	K01107	ko00562	Inositol phosphate metabolism	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMT200057696	K01107	ko01100	Metabolic pathways	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMT200057696	K01107	ko04070	Phosphatidylinositol signaling system	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMT200057697	K01082	ko00920	Sulfur metabolism	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMT200057697	K01082	ko01100	Metabolic pathways	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMT200057698	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057698	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057698	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMT200057699	K01107	ko00562	Inositol phosphate metabolism	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMT200057699	K01107	ko01100	Metabolic pathways	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMT200057699	K01107	ko04070	Phosphatidylinositol signaling system	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMT200057700	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057700	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057701	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057701	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057702	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057702	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMT200057703	K01082	ko00920	Sulfur metabolism	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMT200057703	K01082	ko01100	Metabolic pathways	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMT200057704	K01082	ko00920	Sulfur metabolism	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMT200057704	K01082	ko01100	Metabolic pathways	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMT200057705	K01082	ko00920	Sulfur metabolism	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMT200057705	K01082	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMT200057709	K08139	ko04113	Meiosis - yeast	994	5.5e-49	0.37	0.56	0.87
PGSC0003DMT200057712	K03885	ko00190	Oxidative phosphorylation	3993	2.1e-214	0.79	0.90	1.00
PGSC0003DMT200057717	K00861	ko00740	Riboflavin metabolism	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMT200057717	K00861	ko01100	Metabolic pathways	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMT200057718	K00861	ko00740	Riboflavin metabolism	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMT200057718	K00861	ko01100	Metabolic pathways	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMT200057719	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMT200057719	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMT200057720	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMT200057720	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMT200050625	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050626	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050627	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050630	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050632	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050635	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMT200050652	K01528	ko04144	Endocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMT200050652	K01528	ko04666	Fc gamma R-mediated phagocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMT200050652	K01528	ko05100	Bacterial invasion of epithelial cells	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMT200050665	K04663	ko04340	Hedgehog signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMT200050665	K04663	ko04350	TGF-beta signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMT200078243	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMT200078243	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMT200078243	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMT200078244	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMT200078244	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMT200078244	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMT200078247	K01188	ko00460	Cyanoamino acid metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMT200078247	K01188	ko00500	Starch and sucrose metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMT200078247	K01188	ko00940	Phenylpropanoid biosynthesis	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMT200078247	K01188	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMT200078253	K13030	ko00460	Cyanoamino acid metabolism	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMT200078253	K13030	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMT200078254	K13068	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.27	0.50	0.98
PGSC0003DMT200078255	K13068	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.27	0.50	0.98
PGSC0003DMT200078256	K01955	ko00240	Pyrimidine metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMT200078256	K01955	ko00250	Alanine, aspartate and glutamate metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMT200078256	K01955	ko01100	Metabolic pathways	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMT200078261	K11094	ko03040	Spliceosome	435	3.7e-18	0.77	0.97	0.98
PGSC0003DMT200078262	K11094	ko03040	Spliceosome	1491	2.1e-76	0.73	0.87	0.99
PGSC0003DMT200078264	K01955	ko00240	Pyrimidine metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMT200078264	K01955	ko00250	Alanine, aspartate and glutamate metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMT200078264	K01955	ko01100	Metabolic pathways	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMT200078265	K01955	ko00240	Pyrimidine metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMT200078265	K01955	ko00250	Alanine, aspartate and glutamate metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMT200078265	K01955	ko01100	Metabolic pathways	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMT200078267	K12132	ko04712	Circadian rhythm - plant	1349	1.4e-68	0.41	0.55	0.93
PGSC0003DMT200078268	K12132	ko04712	Circadian rhythm - plant	1826	7.0e-95	0.58	0.70	0.84
PGSC0003DMT200078269	K12132	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.46	0.60	0.93
PGSC0003DMT200078271	K03843	ko00510	N-Glycan biosynthesis	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMT200078271	K03843	ko01100	Metabolic pathways	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMT200078272	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMT200078272	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMT200078273	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMT200078273	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMT200012703	K00826	ko00280	Valine, leucine and isoleucine degradation	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMT200012703	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMT200012703	K00826	ko00770	Pantothenate and CoA biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMT200012703	K00826	ko01100	Metabolic pathways	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMT200012703	K00826	ko01110	Biosynthesis of secondary metabolites	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMT200012709	K00826	ko00280	Valine, leucine and isoleucine degradation	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMT200012709	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMT200012709	K00826	ko00770	Pantothenate and CoA biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMT200012709	K00826	ko01100	Metabolic pathways	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMT200012709	K00826	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMT200012731	K07374	ko04145	Phagosome	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMT200012731	K07374	ko04540	Gap junction	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMT200012731	K07374	ko05130	Pathogenic Escherichia coli infection	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMT200012732	K07374	ko04145	Phagosome	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMT200012732	K07374	ko04540	Gap junction	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMT200012732	K07374	ko05130	Pathogenic Escherichia coli infection	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMT200033779	K10588	ko04120	Ubiquitin mediated proteolysis	1646	6.0e-85	0.31	0.48	0.98
PGSC0003DMT200033780	K10588	ko04120	Ubiquitin mediated proteolysis	1613	3.9e-83	0.42	0.59	0.67
PGSC0003DMT200033781	K10588	ko04120	Ubiquitin mediated proteolysis	1693	1.5e-87	0.32	0.48	0.98
PGSC0003DMT200033796	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMT200033796	K02366	ko01100	Metabolic pathways	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMT200033797	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMT200033797	K02366	ko01100	Metabolic pathways	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMT200033801	K01754	ko00260	Glycine, serine and threonine metabolism	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMT200033801	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMT200033801	K01754	ko01100	Metabolic pathways	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMT200033801	K01754	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMT200006014	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.52	0.68	0.92
PGSC0003DMT200006015	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMT200006016	K01199	ko00500	Starch and sucrose metabolism	718	9.1e-34	0.48	0.62	0.99
PGSC0003DMT200006017	K01199	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.50	0.64	0.94
PGSC0003DMT200006018	K01199	ko00500	Starch and sucrose metabolism	1296	1.2e-65	0.50	0.66	1.00
PGSC0003DMT200006019	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMT200006020	K01199	ko00500	Starch and sucrose metabolism	939	5.9e-46	0.51	0.66	0.93
PGSC0003DMT200006021	K01199	ko00500	Starch and sucrose metabolism	701	7.9e-33	0.49	0.65	0.98
PGSC0003DMT200006022	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMT200006023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMT200006023	K00517	ko00626	Naphthalene and anthracene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMT200006023	K00517	ko00903	Limonene and pinene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMT200006023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMT200006023	K00517	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMT200006026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMT200006026	K00517	ko00626	Naphthalene and anthracene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMT200006026	K00517	ko00903	Limonene and pinene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMT200006026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMT200006026	K00517	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMT200006027	K01199	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.46	0.67	0.97
PGSC0003DMT200006028	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.45	0.67	0.94
PGSC0003DMT200006029	K01199	ko00500	Starch and sucrose metabolism	1155	7.2e-58	0.47	0.68	0.96
PGSC0003DMT200006033	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMT200006033	K00517	ko00626	Naphthalene and anthracene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMT200006033	K00517	ko00903	Limonene and pinene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMT200006033	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMT200006033	K00517	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMT200006034	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMT200006034	K00517	ko00626	Naphthalene and anthracene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMT200006034	K00517	ko00903	Limonene and pinene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMT200006034	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMT200006034	K00517	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMT200006042	K07424	ko00140	Steroid hormone biosynthesis	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00591	Linoleic acid metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00830	Retinol metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00982	Drug metabolism - cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko00983	Drug metabolism - other enzymes	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006042	K07424	ko01100	Metabolic pathways	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMT200006043	K07424	ko00140	Steroid hormone biosynthesis	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00591	Linoleic acid metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00830	Retinol metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00982	Drug metabolism - cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko00983	Drug metabolism - other enzymes	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006043	K07424	ko01100	Metabolic pathways	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMT200006044	K07424	ko00140	Steroid hormone biosynthesis	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00591	Linoleic acid metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00830	Retinol metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00982	Drug metabolism - cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko00983	Drug metabolism - other enzymes	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006044	K07424	ko01100	Metabolic pathways	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMT200006045	K07424	ko00140	Steroid hormone biosynthesis	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00591	Linoleic acid metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00830	Retinol metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko00983	Drug metabolism - other enzymes	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006045	K07424	ko01100	Metabolic pathways	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMT200006046	K01930	ko00790	Folate biosynthesis	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMT200006046	K01930	ko01100	Metabolic pathways	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMT200006047	K01930	ko00790	Folate biosynthesis	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMT200006047	K01930	ko01100	Metabolic pathways	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMT200006048	K01930	ko00790	Folate biosynthesis	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMT200006048	K01930	ko01100	Metabolic pathways	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMT200040385	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00270	Cysteine and methionine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00330	Arginine and proline metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00350	Tyrosine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00360	Phenylalanine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00401	Novobiocin biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00710	Carbon fixation in photosynthetic organisms	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko01100	Metabolic pathways	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040385	K00813	ko01110	Biosynthesis of secondary metabolites	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMT200040392	K02906	ko03010	Ribosome	1689	2.5e-87	0.73	0.83	1.00
PGSC0003DMT200040406	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040406	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040406	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040406	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040407	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040407	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040407	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040407	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040408	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040408	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040408	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040408	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040409	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040409	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040409	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040409	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMT200040410	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040410	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040410	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040410	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMT200040411	K00971	ko00051	Fructose and mannose metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMT200040411	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMT200040411	K00971	ko01100	Metabolic pathways	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMT200040411	K00971	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMT200040417	K04646	ko04142	Lysosome	11637	0.	0.83	0.87	1.00
PGSC0003DMT200040417	K04646	ko04144	Endocytosis	11637	0.	0.83	0.87	1.00
PGSC0003DMT200040417	K04646	ko05016	Huntington's disease	11637	0.	0.83	0.87	1.00
PGSC0003DMT200040417	K04646	ko05100	Bacterial invasion of epithelial cells	11637	0.	0.83	0.87	1.00
PGSC0003DMT200040418	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMT200040418	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMT200040418	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMT200040418	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMT200040419	K04646	ko04142	Lysosome	12750	0.	0.94	0.97	1.00
PGSC0003DMT200040419	K04646	ko04144	Endocytosis	12750	0.	0.94	0.97	1.00
PGSC0003DMT200040419	K04646	ko05016	Huntington's disease	12750	0.	0.94	0.97	1.00
PGSC0003DMT200040419	K04646	ko05100	Bacterial invasion of epithelial cells	12750	0.	0.94	0.97	1.00
PGSC0003DMT200040422	K13065	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMT200040422	K13065	ko00941	Flavonoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMT200040422	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMT200040422	K13065	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMT200090837	K03094	ko04110	Cell cycle	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04111	Cell cycle - yeast	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04114	Oocyte meiosis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04310	Wnt signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04350	TGF-beta signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200090837	K03094	ko04710	Circadian rhythm - mammal	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMT200002721	K01696	ko00260	Glycine, serine and threonine metabolism	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMT200002721	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMT200002721	K01696	ko01100	Metabolic pathways	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMT200002721	K01696	ko01110	Biosynthesis of secondary metabolites	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMT200002722	K01696	ko00260	Glycine, serine and threonine metabolism	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMT200002722	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMT200002722	K01696	ko01100	Metabolic pathways	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMT200002722	K01696	ko01110	Biosynthesis of secondary metabolites	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMT200002731	K07203	ko04012	ErbB signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko04150	mTOR signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko04910	Insulin signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko04920	Adipocytokine signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko04930	Type II diabetes mellitus	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko05200	Pathways in cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko05214	Glioma	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko05215	Prostate cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002731	K07203	ko05221	Acute myeloid leukemia	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMT200002734	K00660	ko00941	Flavonoid biosynthesis	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMT200002734	K00660	ko01100	Metabolic pathways	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMT200002734	K00660	ko01110	Biosynthesis of secondary metabolites	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMT200002734	K00660	ko04712	Circadian rhythm - plant	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMT200002738	K07424	ko00140	Steroid hormone biosynthesis	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00591	Linoleic acid metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00830	Retinol metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00982	Drug metabolism - cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko00983	Drug metabolism - other enzymes	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002738	K07424	ko01100	Metabolic pathways	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMT200002739	K06130	ko00564	Glycerophospholipid metabolism	587	1.5e-26	0.38	0.55	0.87
PGSC0003DMT200076437	K02888	ko03010	Ribosome	520	7.6e-23	0.41	0.57	0.81
PGSC0003DMT200076468	K05349	ko00460	Cyanoamino acid metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMT200076468	K05349	ko00500	Starch and sucrose metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMT200076468	K05349	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMT200076468	K05349	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMT200076469	K05349	ko00460	Cyanoamino acid metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMT200076469	K05349	ko00500	Starch and sucrose metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMT200076469	K05349	ko00940	Phenylpropanoid biosynthesis	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMT200076469	K05349	ko01110	Biosynthesis of secondary metabolites	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMT200076470	K05349	ko00460	Cyanoamino acid metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMT200076470	K05349	ko00500	Starch and sucrose metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMT200076470	K05349	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMT200076470	K05349	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMT200076471	K06027	ko04962	Vasopressin-regulated water reabsorption	895	1.6e-43	0.49	0.59	0.93
PGSC0003DMT200076472	K06027	ko04962	Vasopressin-regulated water reabsorption	4721	1.5e-254	0.73	0.84	1.00
PGSC0003DMT200076476	K06027	ko04962	Vasopressin-regulated water reabsorption	4994	1.3e-269	0.80	0.91	1.00
PGSC0003DMT200048721	K13065	ko00940	Phenylpropanoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMT200048721	K13065	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMT200048721	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMT200048721	K13065	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMT200048727	K08242	ko00100	Steroid biosynthesis	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMT200048727	K08242	ko01110	Biosynthesis of secondary metabolites	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMT200048730	K04424	ko04010	MAPK signaling pathway	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMT200048730	K04424	ko04530	Tight junction	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMT200048741	K00958	ko00230	Purine metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMT200048741	K00958	ko00450	Selenoamino acid metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMT200048741	K00958	ko00920	Sulfur metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMT200048741	K00958	ko01100	Metabolic pathways	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMT200048742	K02950	ko03010	Ribosome	280	1.3e-09	0.65	0.87	0.65
PGSC0003DMT200048749	K03144	ko03022	Basal transcription factors	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMT200048749	K03144	ko03420	Nucleotide excision repair	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMT200048750	K03144	ko03022	Basal transcription factors	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMT200048750	K03144	ko03420	Nucleotide excision repair	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMT200048754	K12126	ko04712	Circadian rhythm - plant	768	1.6e-36	0.35	0.48	0.85
PGSC0003DMT200048755	K12126	ko04712	Circadian rhythm - plant	301	1.3e-10	0.28	0.42	0.97
PGSC0003DMT200048756	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.76
PGSC0003DMT200048757	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.80
PGSC0003DMT200086943	K00235	ko00020	Citrate cycle (TCA cycle)	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko00190	Oxidative phosphorylation	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko01100	Metabolic pathways	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko05010	Alzheimer's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko05012	Parkinson's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200086943	K00235	ko05016	Huntington's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMT200026984	K12343	ko00140	Steroid hormone biosynthesis	384	2.4e-15	0.29	0.49	0.82
PGSC0003DMT200026987	K02183	ko04020	Calcium signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04070	Phosphatidylinositol signaling system	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04114	Oocyte meiosis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04270	Vascular smooth muscle contraction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04626	Plant-pathogen interaction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04720	Long-term potentiation	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04722	Neurotrophin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04740	Olfactory transduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04744	Phototransduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04745	Phototransduction - fly	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04910	Insulin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04912	GnRH signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04916	Melanogenesis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04970	Salivary secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko04971	Gastric acid secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko05010	Alzheimer's disease	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026987	K02183	ko05214	Glioma	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMT200026988	K04733	ko04210	Apoptosis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMT200026988	K04733	ko04620	Toll-like receptor signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMT200026988	K04733	ko04722	Neurotrophin signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMT200026988	K04733	ko05140	Leishmaniasis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMT200026988	K04733	ko05142	Chagas disease	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMT200026990	K04733	ko04210	Apoptosis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMT200026990	K04733	ko04620	Toll-like receptor signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMT200026990	K04733	ko04722	Neurotrophin signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMT200026990	K04733	ko05140	Leishmaniasis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMT200026990	K04733	ko05142	Chagas disease	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMT200026995	K00227	ko00100	Steroid biosynthesis	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMT200026995	K00227	ko01100	Metabolic pathways	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMT200026995	K00227	ko01110	Biosynthesis of secondary metabolites	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMT200026997	K01054	ko00561	Glycerolipid metabolism	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMT200026997	K01054	ko01100	Metabolic pathways	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMT200026998	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMT200026998	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMT200026999	K01054	ko00561	Glycerolipid metabolism	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMT200026999	K01054	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMT200027000	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMT200027000	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMT200018697	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMT200018698	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMT200018699	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMT200018710	K10746	ko03430	Mismatch repair	2508	1.7e-132	0.47	0.62	1.00
PGSC0003DMT200038282	K00680	ko00350	Tyrosine metabolism	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMT200038282	K00680	ko00624	1- and 2-Methylnaphthalene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMT200038282	K00680	ko00632	Benzoate degradation via CoA ligation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMT200038282	K00680	ko00642	Ethylbenzene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMT200038282	K00680	ko00903	Limonene and pinene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMT200038283	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMT200038283	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMT200038283	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMT200038283	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMT200038283	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMT200038284	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMT200038284	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMT200038284	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMT200038284	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMT200038284	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMT200038286	K00680	ko00350	Tyrosine metabolism	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMT200038286	K00680	ko00624	1- and 2-Methylnaphthalene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMT200038286	K00680	ko00632	Benzoate degradation via CoA ligation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMT200038286	K00680	ko00642	Ethylbenzene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMT200038286	K00680	ko00903	Limonene and pinene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMT200038291	K00680	ko00350	Tyrosine metabolism	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMT200038291	K00680	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMT200038291	K00680	ko00632	Benzoate degradation via CoA ligation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMT200038291	K00680	ko00642	Ethylbenzene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMT200038291	K00680	ko00903	Limonene and pinene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMT200038293	K00680	ko00350	Tyrosine metabolism	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMT200038293	K00680	ko00624	1- and 2-Methylnaphthalene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMT200038293	K00680	ko00632	Benzoate degradation via CoA ligation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMT200038293	K00680	ko00642	Ethylbenzene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMT200038293	K00680	ko00903	Limonene and pinene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMT200038294	K01590	ko00340	Histidine metabolism	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMT200038294	K01590	ko01100	Metabolic pathways	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMT200038294	K01590	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMT200038296	K01590	ko00340	Histidine metabolism	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMT200038296	K01590	ko01100	Metabolic pathways	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMT200038296	K01590	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMT200038297	K01590	ko00340	Histidine metabolism	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMT200038297	K01590	ko01100	Metabolic pathways	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMT200038297	K01590	ko01110	Biosynthesis of secondary metabolites	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMT200094975	K07188	ko04910	Insulin signaling pathway	306	1.9e-10	0.28	0.47	0.91
PGSC0003DMT200047506	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047506	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMT200047507	K02084	ko04115	p53 signaling pathway	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko04210	Apoptosis	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko05010	Alzheimer's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko05012	Parkinson's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko05016	Huntington's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047507	K02084	ko05222	Small cell lung cancer	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMT200047509	K02084	ko04115	p53 signaling pathway	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko04210	Apoptosis	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko05010	Alzheimer's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko05012	Parkinson's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko05016	Huntington's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047509	K02084	ko05222	Small cell lung cancer	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMT200047510	K02084	ko04115	p53 signaling pathway	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko04210	Apoptosis	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko05010	Alzheimer's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko05012	Parkinson's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko05016	Huntington's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047510	K02084	ko05222	Small cell lung cancer	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMT200047511	K02084	ko04115	p53 signaling pathway	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko04210	Apoptosis	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko05010	Alzheimer's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko05012	Parkinson's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko05016	Huntington's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047511	K02084	ko05222	Small cell lung cancer	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMT200047512	K02084	ko04115	p53 signaling pathway	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko04210	Apoptosis	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko05010	Alzheimer's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko05012	Parkinson's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko05016	Huntington's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047512	K02084	ko05222	Small cell lung cancer	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMT200047533	K04121	ko00904	Diterpenoid biosynthesis	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMT200047533	K04121	ko01100	Metabolic pathways	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMT200047533	K04121	ko01110	Biosynthesis of secondary metabolites	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMT200047537	K09843	ko00906	Carotenoid biosynthesis	2995	2.3e-159	0.76	0.87	0.99
PGSC0003DMT200047538	K09843	ko00906	Carotenoid biosynthesis	2598	1.9e-137	0.80	0.90	0.99
PGSC0003DMT200073328	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMT200073329	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMT200073336	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3834	1.2e-205	0.87	0.95	0.96
PGSC0003DMT200073338	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.49
PGSC0003DMT200073341	K05278	ko00941	Flavonoid biosynthesis	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMT200073341	K05278	ko01100	Metabolic pathways	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMT200073341	K05278	ko01110	Biosynthesis of secondary metabolites	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMT200073342	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMT200073342	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMT200073342	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMT200073343	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073343	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073343	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMT200073344	K05277	ko00941	Flavonoid biosynthesis	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMT200073344	K05277	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMT200073344	K05277	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMT200073345	K05278	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMT200073345	K05278	ko01100	Metabolic pathways	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMT200073345	K05278	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMT200070122	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.43	0.63	0.89
PGSC0003DMT200070125	K12356	ko00940	Phenylpropanoid biosynthesis	711	2.2e-33	0.33	0.51	0.88
PGSC0003DMT200070130	K08249	ko00460	Cyanoamino acid metabolism	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMT200070130	K08249	ko01100	Metabolic pathways	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMT200070131	K08249	ko00460	Cyanoamino acid metabolism	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMT200070131	K08249	ko01100	Metabolic pathways	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMT200070136	K03955	ko00190	Oxidative phosphorylation	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMT200070136	K03955	ko01100	Metabolic pathways	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMT200070136	K03955	ko05010	Alzheimer's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMT200070136	K03955	ko05012	Parkinson's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMT200070136	K03955	ko05016	Huntington's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMT200080843	K10879	ko03440	Homologous recombination	332	1.8e-12	0.35	0.43	0.93
PGSC0003DMT200080844	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.76
PGSC0003DMT200080845	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.92
PGSC0003DMT200080846	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.80
PGSC0003DMT200080853	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMT200080853	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMT200080853	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMT200080853	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMT200080853	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMT200065316	K10869	ko03440	Homologous recombination	1059	1.4e-52	0.67	0.83	0.96
PGSC0003DMT200065317	K10869	ko03440	Homologous recombination	537	8.8e-24	0.61	0.75	0.70
PGSC0003DMT200065318	K10869	ko03440	Homologous recombination	323	5.6e-12	0.65	0.86	0.75
PGSC0003DMT200065320	K10869	ko03440	Homologous recombination	349	2.1e-13	0.65	0.78	0.97
PGSC0003DMT200065323	K10955	ko05110	Vibrio cholerae infection	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMT200065323	K10955	ko05146	Amoebiasis	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMT200065339	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMT200065345	K01955	ko00240	Pyrimidine metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMT200065345	K01955	ko00250	Alanine, aspartate and glutamate metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMT200065345	K01955	ko01100	Metabolic pathways	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMT200065346	K01955	ko00240	Pyrimidine metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMT200065346	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMT200065346	K01955	ko01100	Metabolic pathways	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMT200047304	K11423	ko00310	Lysine degradation	273	8.3e-06	0.26	0.44	0.76
PGSC0003DMT200047318	K00901	ko00561	Glycerolipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMT200047318	K00901	ko00564	Glycerophospholipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMT200047318	K00901	ko01100	Metabolic pathways	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMT200047318	K00901	ko04070	Phosphatidylinositol signaling system	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMT200047319	K00901	ko00561	Glycerolipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMT200047319	K00901	ko00564	Glycerophospholipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMT200047319	K00901	ko01100	Metabolic pathways	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMT200047319	K00901	ko04070	Phosphatidylinositol signaling system	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMT200047320	K00901	ko00561	Glycerolipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMT200047320	K00901	ko00564	Glycerophospholipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMT200047320	K00901	ko01100	Metabolic pathways	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMT200047320	K00901	ko04070	Phosphatidylinositol signaling system	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMT200047323	K00889	ko00562	Inositol phosphate metabolism	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047323	K00889	ko01100	Metabolic pathways	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047323	K00889	ko04070	Phosphatidylinositol signaling system	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047323	K00889	ko04144	Endocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047323	K00889	ko04666	Fc gamma R-mediated phagocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047323	K00889	ko04810	Regulation of actin cytoskeleton	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMT200047324	K00889	ko00562	Inositol phosphate metabolism	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047324	K00889	ko01100	Metabolic pathways	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047324	K00889	ko04070	Phosphatidylinositol signaling system	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047324	K00889	ko04144	Endocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047324	K00889	ko04666	Fc gamma R-mediated phagocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047324	K00889	ko04810	Regulation of actin cytoskeleton	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMT200047325	K00889	ko00562	Inositol phosphate metabolism	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047325	K00889	ko01100	Metabolic pathways	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047325	K00889	ko04070	Phosphatidylinositol signaling system	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047325	K00889	ko04144	Endocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047325	K00889	ko04666	Fc gamma R-mediated phagocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047325	K00889	ko04810	Regulation of actin cytoskeleton	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMT200047329	K08490	ko04130	SNARE interactions in vesicular transport	1723	3.4e-89	0.64	0.77	0.99
PGSC0003DMT200052472	K04714	ko00600	Sphingolipid metabolism	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMT200052472	K04714	ko01100	Metabolic pathways	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMT200052483	K01425	ko00250	Alanine, aspartate and glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052483	K01425	ko00330	Arginine and proline metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052483	K01425	ko00471	D-Glutamine and D-glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052483	K01425	ko00910	Nitrogen metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052483	K01425	ko01100	Metabolic pathways	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052483	K01425	ko04964	Proximal tubule bicarbonate reclamation	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMT200052485	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMT200052485	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMT200052486	K04424	ko04010	MAPK signaling pathway	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMT200052486	K04424	ko04530	Tight junction	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMT200052487	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMT200052487	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMT200052488	K04424	ko04010	MAPK signaling pathway	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMT200052488	K04424	ko04530	Tight junction	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMT200052489	K04424	ko04010	MAPK signaling pathway	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMT200052489	K04424	ko04530	Tight junction	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMT200052490	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052490	K01653	ko00650	Butanoate metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052490	K01653	ko00660	C5-Branched dibasic acid metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052490	K01653	ko00770	Pantothenate and CoA biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052490	K01653	ko01100	Metabolic pathways	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052490	K01653	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMT200052491	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052491	K01653	ko00650	Butanoate metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052491	K01653	ko00660	C5-Branched dibasic acid metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052491	K01653	ko00770	Pantothenate and CoA biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052491	K01653	ko01100	Metabolic pathways	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052491	K01653	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMT200052492	K01184	ko00040	Pentose and glucuronate interconversions	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMT200052492	K01184	ko00500	Starch and sucrose metabolism	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMT200052492	K01184	ko01100	Metabolic pathways	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMT200052493	K01184	ko00040	Pentose and glucuronate interconversions	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMT200052493	K01184	ko00500	Starch and sucrose metabolism	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMT200052493	K01184	ko01100	Metabolic pathways	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMT200052495	K01184	ko00040	Pentose and glucuronate interconversions	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMT200052495	K01184	ko00500	Starch and sucrose metabolism	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMT200052495	K01184	ko01100	Metabolic pathways	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMT200052499	K01099	ko00562	Inositol phosphate metabolism	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMT200052499	K01099	ko01100	Metabolic pathways	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMT200052499	K01099	ko04070	Phosphatidylinositol signaling system	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMT200065441	K12831	ko03040	Spliceosome	350	1.8e-13	0.45	0.53	0.73
PGSC0003DMT200065447	K00850	ko00010	Glycolysis / Gluconeogenesis	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065447	K00850	ko00030	Pentose phosphate pathway	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065447	K00850	ko00051	Fructose and mannose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065447	K00850	ko00052	Galactose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065447	K00850	ko01100	Metabolic pathways	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065447	K00850	ko01110	Biosynthesis of secondary metabolites	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMT200065449	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065449	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065449	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065449	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065449	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065449	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065450	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMT200065451	K00850	ko00010	Glycolysis / Gluconeogenesis	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065451	K00850	ko00030	Pentose phosphate pathway	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065451	K00850	ko00051	Fructose and mannose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065451	K00850	ko00052	Galactose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065451	K00850	ko01100	Metabolic pathways	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065451	K00850	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMT200065452	K00850	ko00010	Glycolysis / Gluconeogenesis	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065452	K00850	ko00030	Pentose phosphate pathway	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065452	K00850	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065452	K00850	ko00052	Galactose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065452	K00850	ko01100	Metabolic pathways	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065452	K00850	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMT200065456	K07195	ko04910	Insulin signaling pathway	2559	2.6e-135	0.53	0.69	0.99
PGSC0003DMT200065457	K00654	ko00600	Sphingolipid metabolism	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMT200065457	K00654	ko01100	Metabolic pathways	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMT200065459	K00654	ko00600	Sphingolipid metabolism	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMT200065459	K00654	ko01100	Metabolic pathways	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMT200065464	K05759	ko04810	Regulation of actin cytoskeleton	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMT200065464	K05759	ko05131	Shigellosis	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMT200065466	K11481	ko04114	Oocyte meiosis	2035	2.1e-106	0.88	0.93	0.99
PGSC0003DMT200065468	K11481	ko04114	Oocyte meiosis	1409	7.0e-72	0.86	0.90	0.98
PGSC0003DMT200065470	K11481	ko04114	Oocyte meiosis	2258	1.0e-118	0.87	0.93	0.99
PGSC0003DMT200055862	K13228	ko00402	Benzoxazinoid biosynthesis	602	2.3e-27	0.35	0.53	0.85
PGSC0003DMT200055883	K06236	ko04510	Focal adhesion	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMT200055883	K06236	ko04512	ECM-receptor interaction	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMT200055883	K06236	ko05146	Amoebiasis	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMT200055890	K07385	ko00902	Monoterpenoid biosynthesis	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMT200055890	K07385	ko01100	Metabolic pathways	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMT200055897	K07385	ko00902	Monoterpenoid biosynthesis	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMT200055897	K07385	ko01100	Metabolic pathways	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMT200095474	K01087	ko00500	Starch and sucrose metabolism	739	6.3e-35	0.43	0.53	0.93
PGSC0003DMT200088433	K12338	ko00942	Anthocyanin biosynthesis	415	4.7e-17	0.38	0.61	0.99
PGSC0003DMT200043927	K10846	ko03420	Nucleotide excision repair	395	1.8e-26	0.43	0.55	0.96
PGSC0003DMT200043932	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMT200043933	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMT200043934	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMT200043935	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMT200043936	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMT200043937	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	0.93
PGSC0003DMT200043938	K12897	ko03040	Spliceosome	287	5.4e-10	0.35	0.48	0.90
PGSC0003DMT200043950	K06677	ko04111	Cell cycle - yeast	291	6.7e-11	0.49	0.58	0.63
PGSC0003DMT200043952	K06671	ko04110	Cell cycle	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMT200043952	K06671	ko04111	Cell cycle - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMT200043952	K06671	ko04113	Meiosis - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMT200043956	K02084	ko04115	p53 signaling pathway	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko04210	Apoptosis	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko05010	Alzheimer's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko05012	Parkinson's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko05016	Huntington's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200043956	K02084	ko05222	Small cell lung cancer	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMT200018846	K01213	ko00040	Pentose and glucuronate interconversions	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMT200018846	K01213	ko00500	Starch and sucrose metabolism	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMT200018846	K01213	ko01100	Metabolic pathways	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMT200018847	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018847	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018847	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018848	K01213	ko00040	Pentose and glucuronate interconversions	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMT200018848	K01213	ko00500	Starch and sucrose metabolism	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMT200018848	K01213	ko01100	Metabolic pathways	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMT200018849	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018849	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018849	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMT200018850	K04733	ko04210	Apoptosis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMT200018850	K04733	ko04620	Toll-like receptor signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMT200018850	K04733	ko04722	Neurotrophin signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMT200018850	K04733	ko05140	Leishmaniasis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMT200018850	K04733	ko05142	Chagas disease	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMT200018851	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMT200018852	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMT200018853	K07748	ko00100	Steroid biosynthesis	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMT200018853	K07748	ko01100	Metabolic pathways	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMT200018854	K13065	ko00940	Phenylpropanoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMT200018854	K13065	ko00941	Flavonoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMT200018854	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMT200018854	K13065	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMT200018860	K13065	ko00940	Phenylpropanoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMT200018860	K13065	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMT200018860	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMT200018860	K13065	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMT200018864	K13065	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMT200018864	K13065	ko00941	Flavonoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMT200018864	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMT200018864	K13065	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMT200009262	K04424	ko04010	MAPK signaling pathway	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMT200009262	K04424	ko04530	Tight junction	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMT200009265	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMT200009266	K12399	ko04142	Lysosome	739	6.3e-35	0.60	0.74	0.99
PGSC0003DMT200009267	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMT200009268	K12399	ko04142	Lysosome	895	1.6e-43	0.74	0.89	0.89
PGSC0003DMT200009269	K12399	ko04142	Lysosome	939	5.9e-46	0.70	0.86	0.98
PGSC0003DMT200009282	K08486	ko04130	SNARE interactions in vesicular transport	1591	6.4e-82	0.64	0.84	1.00
PGSC0003DMT200009287	K13082	ko00941	Flavonoid biosynthesis	2077	1.0e-108	0.73	0.87	0.85
PGSC0003DMT200009289	K07252	ko00510	N-Glycan biosynthesis	327	3.4e-12	0.40	0.57	0.69
PGSC0003DMT200009290	K07252	ko00510	N-Glycan biosynthesis	332	1.8e-12	0.37	0.54	0.66
PGSC0003DMT200009291	K07252	ko00510	N-Glycan biosynthesis	310	2.9e-11	0.38	0.54	0.74
PGSC0003DMT200009292	K07252	ko00510	N-Glycan biosynthesis	325	4.3e-12	0.36	0.53	0.54
PGSC0003DMT200009294	K07252	ko00510	N-Glycan biosynthesis	323	5.6e-12	0.36	0.53	0.47
PGSC0003DMT200009295	K08241	ko00592	alpha-Linolenic acid metabolism	614	5.0e-28	0.48	0.67	0.85
PGSC0003DMT200009296	K08241	ko00592	alpha-Linolenic acid metabolism	1032	4.4e-51	0.40	0.60	0.95
PGSC0003DMT200009297	K04123	ko00904	Diterpenoid biosynthesis	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMT200009297	K04123	ko01100	Metabolic pathways	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMT200009297	K04123	ko01110	Biosynthesis of secondary metabolites	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMT200059015	K08233	ko00901	Indole alkaloid biosynthesis	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMT200059015	K08233	ko01110	Biosynthesis of secondary metabolites	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMT200059016	K08233	ko00901	Indole alkaloid biosynthesis	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMT200059016	K08233	ko01110	Biosynthesis of secondary metabolites	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMT200059017	K08233	ko00901	Indole alkaloid biosynthesis	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMT200059017	K08233	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMT200059018	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMT200059018	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMT200059019	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMT200059019	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMT200059024	K02183	ko04020	Calcium signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04070	Phosphatidylinositol signaling system	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04114	Oocyte meiosis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04270	Vascular smooth muscle contraction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04626	Plant-pathogen interaction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04720	Long-term potentiation	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04722	Neurotrophin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04740	Olfactory transduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04744	Phototransduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04745	Phototransduction - fly	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04910	Insulin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04912	GnRH signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04916	Melanogenesis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04970	Salivary secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko04971	Gastric acid secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko05010	Alzheimer's disease	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059024	K02183	ko05214	Glioma	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMT200059025	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059025	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059025	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059025	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059025	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059026	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059026	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059026	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059026	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059026	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMT200059031	K10206	ko00300	Lysine biosynthesis	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMT200059031	K10206	ko01110	Biosynthesis of secondary metabolites	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMT200059038	K09054	ko05010	Alzheimer's disease	246	4.8e-06	0.34	0.48	0.52
PGSC0003DMT200059039	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMT200059040	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMT200059045	K05349	ko00460	Cyanoamino acid metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMT200059045	K05349	ko00500	Starch and sucrose metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMT200059045	K05349	ko00940	Phenylpropanoid biosynthesis	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMT200059045	K05349	ko01110	Biosynthesis of secondary metabolites	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMT200059046	K05349	ko00460	Cyanoamino acid metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMT200059046	K05349	ko00500	Starch and sucrose metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMT200059046	K05349	ko00940	Phenylpropanoid biosynthesis	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMT200059046	K05349	ko01110	Biosynthesis of secondary metabolites	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMT200059047	K03514	ko03018	RNA degradation	257	2.4e-08	0.31	0.48	0.85
PGSC0003DMT200066741	K03006	ko00230	Purine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMT200066741	K03006	ko00240	Pyrimidine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMT200066741	K03006	ko01100	Metabolic pathways	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMT200066741	K03006	ko03020	RNA polymerase	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMT200066741	K03006	ko05016	Huntington's disease	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMT200066770	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMT200066775	K06636	ko04110	Cell cycle	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMT200066775	K06636	ko04111	Cell cycle - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMT200066775	K06636	ko04113	Meiosis - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMT200066775	K06636	ko04114	Oocyte meiosis	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMT200093619	K05282	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMT200093619	K05282	ko01100	Metabolic pathways	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMT200093619	K05282	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMT200093628	K04508	ko04310	Wnt signaling pathway	2067	3.6e-108	0.65	0.79	1.00
PGSC0003DMT200015799	K00434	ko00053	Ascorbate and aldarate metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMT200015799	K00434	ko00480	Glutathione metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMT200015806	K02731	ko03050	Proteasome	1362	2.8e-69	0.85	0.90	0.99
PGSC0003DMT200015825	K03094	ko04110	Cell cycle	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04111	Cell cycle - yeast	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04114	Oocyte meiosis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04120	Ubiquitin mediated proteolysis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04310	Wnt signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04350	TGF-beta signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015825	K03094	ko04710	Circadian rhythm - mammal	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMT200015826	K03094	ko04110	Cell cycle	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04111	Cell cycle - yeast	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04114	Oocyte meiosis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04120	Ubiquitin mediated proteolysis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04310	Wnt signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04350	TGF-beta signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015826	K03094	ko04710	Circadian rhythm - mammal	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMT200015827	K03094	ko04110	Cell cycle	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04111	Cell cycle - yeast	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04114	Oocyte meiosis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04120	Ubiquitin mediated proteolysis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04310	Wnt signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04350	TGF-beta signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015827	K03094	ko04710	Circadian rhythm - mammal	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMT200015828	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMT200015828	K00015	ko01100	Metabolic pathways	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMT200015836	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015836	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015837	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMT200015841	K01190	ko00052	Galactose metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMT200015841	K01190	ko00511	Other glycan degradation	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMT200015841	K01190	ko00600	Sphingolipid metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMT200015841	K01190	ko01100	Metabolic pathways	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMT200023749	K02135	ko00190	Oxidative phosphorylation	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMT200023749	K02135	ko01100	Metabolic pathways	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMT200023749	K02135	ko05010	Alzheimer's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMT200023749	K02135	ko05012	Parkinson's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMT200023749	K02135	ko05016	Huntington's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMT200023753	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023753	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023753	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023754	K01230	ko00510	N-Glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMT200023754	K01230	ko00513	High-mannose type N-glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMT200023754	K01230	ko01100	Metabolic pathways	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMT200023755	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023755	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023755	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMT200023774	K12828	ko03040	Spliceosome	1790	6.8e-93	0.76	0.82	0.85
PGSC0003DMT200030622	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMT200030622	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMT200030622	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMT200030622	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMT200030623	K03517	ko00760	Nicotinate and nicotinamide metabolism	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMT200030623	K03517	ko01100	Metabolic pathways	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMT200030624	K03517	ko00760	Nicotinate and nicotinamide metabolism	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMT200030624	K03517	ko01100	Metabolic pathways	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMT200030625	K03517	ko00760	Nicotinate and nicotinamide metabolism	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMT200030625	K03517	ko01100	Metabolic pathways	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMT200030631	K00799	ko00480	Glutathione metabolism	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMT200030631	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMT200030631	K00799	ko00982	Drug metabolism - cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMT200030642	K11099	ko03040	Spliceosome	444	1.2e-18	0.88	0.94	0.79
PGSC0003DMT200030651	K02901	ko03010	Ribosome	1046	7.4e-52	0.90	0.96	0.99
PGSC0003DMT200068373	K07424	ko00140	Steroid hormone biosynthesis	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00591	Linoleic acid metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00830	Retinol metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00982	Drug metabolism - cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko00983	Drug metabolism - other enzymes	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068373	K07424	ko01100	Metabolic pathways	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00140	Steroid hormone biosynthesis	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00591	Linoleic acid metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00830	Retinol metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00982	Drug metabolism - cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko00983	Drug metabolism - other enzymes	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068388	K07424	ko01100	Metabolic pathways	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMT200068394	K00948	ko00030	Pentose phosphate pathway	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMT200068394	K00948	ko00230	Purine metabolism	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMT200068394	K00948	ko01100	Metabolic pathways	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMT200068394	K00948	ko01110	Biosynthesis of secondary metabolites	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMT200068395	K00948	ko00030	Pentose phosphate pathway	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMT200068395	K00948	ko00230	Purine metabolism	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMT200068395	K00948	ko01100	Metabolic pathways	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMT200068395	K00948	ko01110	Biosynthesis of secondary metabolites	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMT200068413	K02132	ko00190	Oxidative phosphorylation	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMT200068413	K02132	ko01100	Metabolic pathways	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMT200068413	K02132	ko05010	Alzheimer's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMT200068413	K02132	ko05012	Parkinson's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMT200068413	K02132	ko05016	Huntington's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMT200060883	K01939	ko00230	Purine metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMT200060883	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMT200060883	K01939	ko01100	Metabolic pathways	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMT200060892	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMT200060893	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMT200060894	K00559	ko00100	Steroid biosynthesis	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMT200060894	K00559	ko01100	Metabolic pathways	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMT200060894	K00559	ko01110	Biosynthesis of secondary metabolites	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMT200060895	K02996	ko03010	Ribosome	1992	4.9e-104	0.63	0.74	1.00
PGSC0003DMT200075008	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMT200075008	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMT200075008	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMT200075008	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMT200075008	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMT200075009	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMT200075009	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMT200075009	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMT200075009	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMT200075009	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMT200075021	K01648	ko00020	Citrate cycle (TCA cycle)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMT200075021	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMT200075021	K01648	ko01100	Metabolic pathways	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMT200075021	K01648	ko01110	Biosynthesis of secondary metabolites	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMT200075023	K08233	ko00901	Indole alkaloid biosynthesis	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMT200075023	K08233	ko01110	Biosynthesis of secondary metabolites	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMT200022038	K12118	ko04712	Circadian rhythm - plant	3105	2.0e-165	0.85	0.94	0.91
PGSC0003DMT200022039	K12118	ko04712	Circadian rhythm - plant	4157	1.9e-223	0.83	0.91	0.99
PGSC0003DMT200022041	K12118	ko04712	Circadian rhythm - plant	502	7.5e-22	0.68	0.77	0.95
PGSC0003DMT200022052	K11262	ko00061	Fatty acid biosynthesis	14832	0.	0.80	0.87	1.00
PGSC0003DMT200022052	K11262	ko00620	Pyruvate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMT200022052	K11262	ko00640	Propanoate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMT200022052	K11262	ko01100	Metabolic pathways	14832	0.	0.80	0.87	1.00
PGSC0003DMT200022052	K11262	ko04910	Insulin signaling pathway	14832	0.	0.80	0.87	1.00
PGSC0003DMT200022054	K11262	ko00061	Fatty acid biosynthesis	16040	0.	0.84	0.92	0.99
PGSC0003DMT200022054	K11262	ko00620	Pyruvate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMT200022054	K11262	ko00640	Propanoate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMT200022054	K11262	ko01100	Metabolic pathways	16040	0.	0.84	0.92	0.99
PGSC0003DMT200022054	K11262	ko04910	Insulin signaling pathway	16040	0.	0.84	0.92	0.99
PGSC0003DMT200022056	K01210	ko00500	Starch and sucrose metabolism	2599	1.6e-137	0.64	0.77	0.92
PGSC0003DMT200022063	K13030	ko00460	Cyanoamino acid metabolism	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMT200022063	K13030	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMT200014123	K02183	ko04020	Calcium signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04070	Phosphatidylinositol signaling system	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04114	Oocyte meiosis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04270	Vascular smooth muscle contraction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04626	Plant-pathogen interaction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04720	Long-term potentiation	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04722	Neurotrophin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04740	Olfactory transduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04744	Phototransduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04745	Phototransduction - fly	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04910	Insulin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04912	GnRH signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04916	Melanogenesis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04970	Salivary secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko04971	Gastric acid secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko05010	Alzheimer's disease	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014123	K02183	ko05214	Glioma	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMT200014133	K07199	ko04910	Insulin signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMT200014133	K07199	ko04920	Adipocytokine signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMT200014133	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMT200014150	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMT200014150	K00517	ko00626	Naphthalene and anthracene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMT200014150	K00517	ko00903	Limonene and pinene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMT200014150	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMT200014150	K00517	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMT200014151	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMT200014151	K00517	ko00626	Naphthalene and anthracene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMT200014151	K00517	ko00903	Limonene and pinene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMT200014151	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMT200014151	K00517	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMT200014152	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMT200014152	K00517	ko00626	Naphthalene and anthracene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMT200014152	K00517	ko00903	Limonene and pinene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMT200014152	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMT200014152	K00517	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMT200014153	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMT200014153	K00517	ko00626	Naphthalene and anthracene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMT200014153	K00517	ko00903	Limonene and pinene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMT200014153	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMT200014153	K00517	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMT200014155	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMT200014155	K00517	ko00626	Naphthalene and anthracene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMT200014155	K00517	ko00903	Limonene and pinene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMT200014155	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMT200014155	K00517	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMT200014160	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMT200014160	K00517	ko00626	Naphthalene and anthracene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMT200014160	K00517	ko00903	Limonene and pinene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMT200014160	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMT200014160	K00517	ko01110	Biosynthesis of secondary metabolites	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMT200014166	K01178	ko00500	Starch and sucrose metabolism	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMT200014166	K01178	ko01100	Metabolic pathways	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMT200092406	K11229	ko04011	MAPK signaling pathway - yeast	572	7.9e-25	0.35	0.57	0.79
PGSC0003DMT200092412	K00799	ko00480	Glutathione metabolism	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMT200092412	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMT200092412	K00799	ko00982	Drug metabolism - cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMT200092434	K00059	ko00061	Fatty acid biosynthesis	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMT200092434	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMT200092434	K00059	ko01100	Metabolic pathways	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMT200088122	K10781	ko00061	Fatty acid biosynthesis	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMT200088122	K10781	ko01100	Metabolic pathways	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMT200088127	K12338	ko00942	Anthocyanin biosynthesis	489	3.9e-21	0.49	0.63	0.83
PGSC0003DMT200045472	K04618	ko00052	Galactose metabolism	474	9.6e-20	0.28	0.43	1.00
PGSC0003DMT200045505	K06666	ko04111	Cell cycle - yeast	459	2.0e-19	0.25	0.39	0.89
PGSC0003DMT200045506	K06666	ko04111	Cell cycle - yeast	496	2.1e-21	0.27	0.43	0.68
PGSC0003DMT200054129	K09839	ko00906	Carotenoid biosynthesis	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMT200054129	K09839	ko01100	Metabolic pathways	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMT200054129	K09839	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMT200063765	K02342	ko00230	Purine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063765	K02342	ko00240	Pyrimidine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063765	K02342	ko01100	Metabolic pathways	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063765	K02342	ko03030	DNA replication	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063765	K02342	ko03430	Mismatch repair	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063765	K02342	ko03440	Homologous recombination	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMT200063766	K02342	ko00230	Purine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063766	K02342	ko00240	Pyrimidine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063766	K02342	ko01100	Metabolic pathways	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063766	K02342	ko03030	DNA replication	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063766	K02342	ko03430	Mismatch repair	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063766	K02342	ko03440	Homologous recombination	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMT200063770	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.29	0.47	0.74
PGSC0003DMT200007736	K02183	ko04020	Calcium signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04070	Phosphatidylinositol signaling system	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04114	Oocyte meiosis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04270	Vascular smooth muscle contraction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04626	Plant-pathogen interaction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04720	Long-term potentiation	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04722	Neurotrophin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04740	Olfactory transduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04744	Phototransduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04745	Phototransduction - fly	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04910	Insulin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04912	GnRH signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04916	Melanogenesis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04970	Salivary secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko04971	Gastric acid secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko05010	Alzheimer's disease	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007736	K02183	ko05214	Glioma	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMT200007737	K02183	ko04020	Calcium signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04070	Phosphatidylinositol signaling system	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04114	Oocyte meiosis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04270	Vascular smooth muscle contraction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04626	Plant-pathogen interaction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04720	Long-term potentiation	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04722	Neurotrophin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04740	Olfactory transduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04744	Phototransduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04745	Phototransduction - fly	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04910	Insulin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04912	GnRH signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04916	Melanogenesis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04970	Salivary secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko04971	Gastric acid secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko05010	Alzheimer's disease	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200007737	K02183	ko05214	Glioma	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMT200010938	K13065	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMT200010938	K13065	ko00941	Flavonoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMT200010938	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMT200010938	K13065	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMT200010941	K00558	ko00270	Cysteine and methionine metabolism	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMT200010941	K00558	ko01100	Metabolic pathways	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMT200010948	K04506	ko04115	p53 signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMT200010948	K04506	ko04120	Ubiquitin mediated proteolysis	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMT200010948	K04506	ko04310	Wnt signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMT200010949	K11424	ko00310	Lysine degradation	854	2.9e-41	0.55	0.68	0.88
PGSC0003DMT200010951	K11424	ko00310	Lysine degradation	819	2.5e-39	0.49	0.62	0.95
PGSC0003DMT200010952	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMT200010953	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMT200010954	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMT200010955	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMT200010977	K08065	ko04612	Antigen processing and presentation	639	2.1e-29	0.62	0.78	0.79
PGSC0003DMT200020760	K11228	ko04011	MAPK signaling pathway - yeast	967	1.7e-47	0.36	0.50	0.73
PGSC0003DMT200020761	K11228	ko04011	MAPK signaling pathway - yeast	893	2.0e-43	0.34	0.48	0.73
PGSC0003DMT200020762	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMT200020762	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMT200020763	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMT200020763	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMT200020764	K04420	ko04010	MAPK signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMT200020764	K04420	ko04540	Gap junction	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMT200020764	K04420	ko04912	GnRH signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMT200020780	K05681	ko02010	ABC transporters	905	4.4e-44	0.31	0.51	0.55
PGSC0003DMT200096683	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMT200096683	K00224	ko00364	Fluorobenzoate degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMT200096683	K00224	ko00628	Fluorene degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMT200096683	K00224	ko00640	Propanoate metabolism	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMT200089628	K08243	ko00941	Flavonoid biosynthesis	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMT200089628	K08243	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMT200089640	K10760	ko00908	Zeatin biosynthesis	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMT200089640	K10760	ko01100	Metabolic pathways	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMT200089640	K10760	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMT200088656	K10591	ko04120	Ubiquitin mediated proteolysis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMT200088656	K10591	ko04144	Endocytosis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMT200088659	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMT200088659	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMT200088663	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMT200088667	K06268	ko04010	MAPK signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04020	Calcium signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04114	Oocyte meiosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04210	Apoptosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04310	Wnt signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04360	Axon guidance	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04370	VEGF signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04650	Natural killer cell mediated cytotoxicity	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04660	T cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04662	B cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko04720	Long-term potentiation	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko05010	Alzheimer's disease	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088667	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMT200088678	K12338	ko00942	Anthocyanin biosynthesis	303	7.1e-11	0.33	0.62	0.87
PGSC0003DMT200043408	K09841	ko00906	Carotenoid biosynthesis	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMT200043408	K09841	ko01100	Metabolic pathways	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMT200043408	K09841	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMT200027172	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027172	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027172	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027172	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027172	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMT200027173	K00858	ko00760	Nicotinate and nicotinamide metabolism	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMT200027173	K00858	ko01100	Metabolic pathways	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMT200027174	K00858	ko00760	Nicotinate and nicotinamide metabolism	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMT200027174	K00858	ko01100	Metabolic pathways	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMT200027175	K00858	ko00760	Nicotinate and nicotinamide metabolism	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMT200027175	K00858	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMT200027176	K00858	ko00760	Nicotinate and nicotinamide metabolism	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMT200027176	K00858	ko01100	Metabolic pathways	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMT200027178	K09753	ko00940	Phenylpropanoid biosynthesis	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMT200027178	K09753	ko01100	Metabolic pathways	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMT200027178	K09753	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMT200027179	K09753	ko00940	Phenylpropanoid biosynthesis	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMT200027179	K09753	ko01100	Metabolic pathways	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMT200027179	K09753	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMT200027180	K09753	ko00940	Phenylpropanoid biosynthesis	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMT200027180	K09753	ko01100	Metabolic pathways	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMT200027180	K09753	ko01110	Biosynthesis of secondary metabolites	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMT200027181	K09753	ko00940	Phenylpropanoid biosynthesis	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMT200027181	K09753	ko01100	Metabolic pathways	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMT200027181	K09753	ko01110	Biosynthesis of secondary metabolites	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMT200027183	K09753	ko00940	Phenylpropanoid biosynthesis	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMT200027183	K09753	ko01100	Metabolic pathways	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMT200027183	K09753	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMT200027184	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027184	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027184	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027185	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027185	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027185	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMT200027186	K09753	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMT200027186	K09753	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMT200027186	K09753	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMT200027187	K09753	ko00940	Phenylpropanoid biosynthesis	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMT200027187	K09753	ko01100	Metabolic pathways	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMT200027187	K09753	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMT200027189	K09753	ko00940	Phenylpropanoid biosynthesis	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMT200027189	K09753	ko01100	Metabolic pathways	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMT200027189	K09753	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMT200027190	K09753	ko00940	Phenylpropanoid biosynthesis	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMT200027190	K09753	ko01100	Metabolic pathways	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMT200027190	K09753	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMT200027191	K03066	ko03050	Proteasome	3166	8.7e-169	0.90	0.92	1.00
PGSC0003DMT200027192	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMT200027198	K01199	ko00500	Starch and sucrose metabolism	449	6.3e-19	0.54	0.78	0.99
PGSC0003DMT200027199	K01199	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.55	0.79	0.99
PGSC0003DMT200027200	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMT200027201	K01199	ko00500	Starch and sucrose metabolism	1335	8.5e-68	0.51	0.70	0.98
PGSC0003DMT200027202	K01199	ko00500	Starch and sucrose metabolism	1342	3.5e-68	0.51	0.68	1.00
PGSC0003DMT200027203	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMT200018441	K13065	ko00940	Phenylpropanoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMT200018441	K13065	ko00941	Flavonoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMT200018441	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMT200018441	K13065	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMT200018455	K11252	ko05322	Systemic lupus erythematosus	1039	1.8e-51	0.89	0.92	0.99
PGSC0003DMT200018456	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.94	0.99
PGSC0003DMT200018463	K00902	ko00510	N-Glycan biosynthesis	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMT200018463	K00902	ko01100	Metabolic pathways	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMT200018465	K00902	ko00510	N-Glycan biosynthesis	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMT200018465	K00902	ko01100	Metabolic pathways	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMT200018466	K00902	ko00510	N-Glycan biosynthesis	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMT200018466	K00902	ko01100	Metabolic pathways	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMT200018472	K00059	ko00061	Fatty acid biosynthesis	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMT200018472	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMT200018472	K00059	ko01100	Metabolic pathways	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMT200018473	K00059	ko00061	Fatty acid biosynthesis	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMT200018473	K00059	ko01040	Biosynthesis of unsaturated fatty acids	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMT200018473	K00059	ko01100	Metabolic pathways	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMT200018474	K00059	ko00061	Fatty acid biosynthesis	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMT200018474	K00059	ko01040	Biosynthesis of unsaturated fatty acids	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMT200018474	K00059	ko01100	Metabolic pathways	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMT200018478	K13065	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMT200018478	K13065	ko00941	Flavonoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMT200018478	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMT200018478	K13065	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMT200018480	K05868	ko04110	Cell cycle	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMT200018480	K05868	ko04115	p53 signaling pathway	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMT200018480	K05868	ko04914	Progesterone-mediated oocyte maturation	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMT200018481	K06027	ko04962	Vasopressin-regulated water reabsorption	2042	8.6e-107	0.46	0.64	0.77
PGSC0003DMT200018482	K06027	ko04962	Vasopressin-regulated water reabsorption	2109	1.7e-110	0.44	0.61	0.79
PGSC0003DMT200018483	K06027	ko04962	Vasopressin-regulated water reabsorption	1386	1.3e-70	0.45	0.63	0.98
PGSC0003DMT200008747	K03950	ko00190	Oxidative phosphorylation	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMT200008747	K03950	ko01100	Metabolic pathways	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMT200008747	K03950	ko05010	Alzheimer's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMT200008747	K03950	ko05012	Parkinson's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMT200008747	K03950	ko05016	Huntington's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMT200008766	K04733	ko04210	Apoptosis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMT200008766	K04733	ko04620	Toll-like receptor signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMT200008766	K04733	ko04722	Neurotrophin signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMT200008766	K04733	ko05140	Leishmaniasis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMT200008766	K04733	ko05142	Chagas disease	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMT200008768	K00801	ko00100	Steroid biosynthesis	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMT200008768	K00801	ko01100	Metabolic pathways	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMT200008768	K00801	ko01110	Biosynthesis of secondary metabolites	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMT200008769	K00801	ko00100	Steroid biosynthesis	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMT200008769	K00801	ko01100	Metabolic pathways	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMT200008769	K00801	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMT200008770	K00801	ko00100	Steroid biosynthesis	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMT200008770	K00801	ko01100	Metabolic pathways	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMT200008770	K00801	ko01110	Biosynthesis of secondary metabolites	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMT200008780	K10643	ko03018	RNA degradation	1666	4.7e-86	0.39	0.53	0.98
PGSC0003DMT200073535	K01695	ko00260	Glycine, serine and threonine metabolism	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMT200073535	K01695	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMT200073535	K01695	ko01100	Metabolic pathways	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMT200073535	K01695	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMT200073541	K01834	ko00010	Glycolysis / Gluconeogenesis	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMT200073541	K01834	ko01100	Metabolic pathways	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMT200073541	K01834	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMT200073543	K01834	ko00010	Glycolysis / Gluconeogenesis	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMT200073543	K01834	ko01100	Metabolic pathways	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMT200073543	K01834	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMT200073545	K01834	ko00010	Glycolysis / Gluconeogenesis	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMT200073545	K01834	ko01100	Metabolic pathways	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMT200073545	K01834	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMT200073546	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073546	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073546	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073547	K01834	ko00010	Glycolysis / Gluconeogenesis	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMT200073547	K01834	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMT200073547	K01834	ko01110	Biosynthesis of secondary metabolites	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMT200073548	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073548	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073548	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMT200073551	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMT200073551	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMT200073551	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMT200053166	K02866	ko03010	Ribosome	638	2.4e-29	0.44	0.57	0.91
PGSC0003DMT200053171	K02866	ko03010	Ribosome	1447	5.6e-74	0.92	0.95	0.99
PGSC0003DMT200053172	K02995	ko03010	Ribosome	1676	1.3e-86	0.89	0.94	0.99
PGSC0003DMT200053175	K11820	ko00380	Tryptophan metabolism	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMT200053175	K11820	ko00966	Glucosinolate biosynthesis	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMT200053175	K11820	ko01110	Biosynthesis of secondary metabolites	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMT200053178	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMT200053179	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMT200053180	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2306	2.4e-121	0.85	0.92	1.00
PGSC0003DMT200053192	K10949	ko05110	Vibrio cholerae infection	466	7.2e-20	0.31	0.54	0.82
PGSC0003DMT200053193	K10949	ko05110	Vibrio cholerae infection	511	2.4e-22	0.34	0.58	0.81
PGSC0003DMT200065094	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065094	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065095	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMT200065096	K07407	ko00052	Galactose metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMT200065096	K07407	ko00561	Glycerolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMT200065096	K07407	ko00600	Sphingolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMT200065096	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMT200065098	K12832	ko03040	Spliceosome	617	3.4e-28	0.97	1.00	0.92
PGSC0003DMT200065099	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMT200065100	K01929	ko00300	Lysine biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMT200065100	K01929	ko00550	Peptidoglycan biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMT200065100	K01929	ko01100	Metabolic pathways	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMT200065101	K01929	ko00300	Lysine biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMT200065101	K01929	ko00550	Peptidoglycan biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMT200065101	K01929	ko01100	Metabolic pathways	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMT200065103	K10802	ko03410	Base excision repair	493	2.3e-21	0.43	0.61	0.73
PGSC0003DMT200065104	K10802	ko03410	Base excision repair	507	4.0e-22	0.45	0.69	0.66
PGSC0003DMT200065105	K02976	ko03010	Ribosome	989	1.0e-48	0.88	0.91	0.99
PGSC0003DMT200065107	K13082	ko00941	Flavonoid biosynthesis	1070	3.5e-53	0.45	0.64	0.94
PGSC0003DMT200065110	K00872	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMT200065110	K00872	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMT200065115	K12824	ko03040	Spliceosome	4375	1.8e-235	0.65	0.78	1.00
PGSC0003DMT200065117	K12824	ko03040	Spliceosome	4842	3.2e-261	0.58	0.71	1.00
PGSC0003DMT200065118	K12824	ko03040	Spliceosome	4853	7.8e-262	0.58	0.71	1.00
PGSC0003DMT200065121	K11423	ko00310	Lysine degradation	2609	4.6e-138	0.54	0.67	0.47
PGSC0003DMT200055372	K08486	ko04130	SNARE interactions in vesicular transport	293	2.5e-10	0.62	0.75	0.76
PGSC0003DMT200055373	K08486	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.88	0.94	0.50
PGSC0003DMT200055374	K08486	ko04130	SNARE interactions in vesicular transport	2079	7.8e-109	0.82	0.90	1.00
PGSC0003DMT200055375	K01937	ko00240	Pyrimidine metabolism	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMT200055375	K01937	ko01100	Metabolic pathways	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMT200055376	K01937	ko00240	Pyrimidine metabolism	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMT200055376	K01937	ko01100	Metabolic pathways	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMT200055377	K01937	ko00240	Pyrimidine metabolism	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMT200055377	K01937	ko01100	Metabolic pathways	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMT200055378	K01937	ko00240	Pyrimidine metabolism	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMT200055378	K01937	ko01100	Metabolic pathways	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMT200055394	K03129	ko03022	Basal transcription factors	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMT200055394	K03129	ko05016	Huntington's disease	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMT200055395	K04446	ko04310	Wnt signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200055395	K04446	ko04360	Axon guidance	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200055395	K04446	ko04370	VEGF signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200055395	K04446	ko04650	Natural killer cell mediated cytotoxicity	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200055395	K04446	ko04660	T cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200055395	K04446	ko04662	B cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMT200090967	K02183	ko04020	Calcium signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04070	Phosphatidylinositol signaling system	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04114	Oocyte meiosis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04270	Vascular smooth muscle contraction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04626	Plant-pathogen interaction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04720	Long-term potentiation	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04722	Neurotrophin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04740	Olfactory transduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04744	Phototransduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04745	Phototransduction - fly	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04910	Insulin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04912	GnRH signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04916	Melanogenesis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04970	Salivary secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko04971	Gastric acid secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko05010	Alzheimer's disease	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090967	K02183	ko05214	Glioma	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMT200090970	K11251	ko05322	Systemic lupus erythematosus	594	6.3e-27	0.59	0.71	0.94
PGSC0003DMT200090992	K10875	ko03440	Homologous recombination	290	1.6e-09	0.30	0.49	0.78
PGSC0003DMT200012834	K00166	ko00280	Valine, leucine and isoleucine degradation	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMT200012834	K00166	ko01100	Metabolic pathways	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMT200012834	K00166	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMT200012835	K00166	ko00280	Valine, leucine and isoleucine degradation	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMT200012835	K00166	ko01100	Metabolic pathways	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMT200012835	K00166	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMT200012836	K00166	ko00280	Valine, leucine and isoleucine degradation	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMT200012836	K00166	ko01100	Metabolic pathways	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMT200012836	K00166	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMT200012837	K00166	ko00280	Valine, leucine and isoleucine degradation	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMT200012837	K00166	ko01100	Metabolic pathways	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMT200012837	K00166	ko01110	Biosynthesis of secondary metabolites	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMT200012838	K00166	ko00280	Valine, leucine and isoleucine degradation	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMT200012838	K00166	ko01100	Metabolic pathways	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMT200012838	K00166	ko01110	Biosynthesis of secondary metabolites	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMT200012840	K00166	ko00280	Valine, leucine and isoleucine degradation	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMT200012840	K00166	ko01100	Metabolic pathways	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMT200012840	K00166	ko01110	Biosynthesis of secondary metabolites	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMT200012843	K01507	ko00190	Oxidative phosphorylation	1594	4.4e-82	0.86	0.94	1.00
PGSC0003DMT200012864	K01762	ko00270	Cysteine and methionine metabolism	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMT200012864	K01762	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMT200012869	K10852	ko00311	Penicillin and cephalosporin biosynthesis	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMT200012869	K10852	ko01100	Metabolic pathways	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMT200012869	K10852	ko01110	Biosynthesis of secondary metabolites	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMT200012872	K12869	ko03040	Spliceosome	4306	1.2e-231	0.51	0.64	1.00
PGSC0003DMT200012873	K12869	ko03040	Spliceosome	5274	4.7e-285	0.86	0.93	1.00
PGSC0003DMT200015998	K07385	ko00902	Monoterpenoid biosynthesis	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMT200015998	K07385	ko01100	Metabolic pathways	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMT200015999	K07385	ko00902	Monoterpenoid biosynthesis	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMT200015999	K07385	ko01100	Metabolic pathways	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMT200024402	K00968	ko00440	Phosphonate and phosphinate metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMT200024402	K00968	ko00564	Glycerophospholipid metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMT200024402	K00968	ko01100	Metabolic pathways	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMT200024406	K12847	ko03040	Spliceosome	3713	5.9e-199	0.78	0.86	1.00
PGSC0003DMT200024407	K12847	ko03040	Spliceosome	738	7.2e-35	0.98	0.99	0.93
PGSC0003DMT200040633	K11866	ko04144	Endocytosis	329	1.8e-11	0.37	0.55	0.77
PGSC0003DMT200040634	K11866	ko04144	Endocytosis	601	8.0e-27	0.31	0.48	0.89
PGSC0003DMT200040635	K11866	ko04144	Endocytosis	435	2.0e-17	0.38	0.55	0.68
PGSC0003DMT200040650	K12603	ko03018	RNA degradation	388	1.4e-15	0.34	0.45	0.94
PGSC0003DMT200040652	K12603	ko03018	RNA degradation	629	7.4e-29	0.33	0.47	0.98
PGSC0003DMT200040655	K11866	ko04144	Endocytosis	380	7.6e-16	0.33	0.49	0.66
PGSC0003DMT200040656	K11866	ko04144	Endocytosis	427	5.7e-17	0.34	0.50	0.90
PGSC0003DMT200040657	K11866	ko04144	Endocytosis	545	1.2e-23	0.32	0.48	0.97
PGSC0003DMT200000217	K01259	ko00330	Arginine and proline metabolism	946	2.4e-46	0.47	0.65	0.79
PGSC0003DMT200000218	K01259	ko00330	Arginine and proline metabolism	1607	8.4e-83	0.48	0.67	0.85
PGSC0003DMT200000219	K01259	ko00330	Arginine and proline metabolism	1128	2.2e-56	0.46	0.65	0.81
PGSC0003DMT200000233	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1635	2.4e-84	0.64	0.76	0.99
PGSC0003DMT200000234	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1642	9.9e-85	0.64	0.76	0.99
PGSC0003DMT200087082	K05765	ko04360	Axon guidance	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMT200087082	K05765	ko04666	Fc gamma R-mediated phagocytosis	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMT200087082	K05765	ko04810	Regulation of actin cytoskeleton	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMT200087085	K10760	ko00908	Zeatin biosynthesis	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMT200087085	K10760	ko01100	Metabolic pathways	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMT200087085	K10760	ko01110	Biosynthesis of secondary metabolites	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMT200059215	K08679	ko00500	Starch and sucrose metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMT200059215	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMT200059215	K08679	ko01100	Metabolic pathways	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMT200059216	K08679	ko00500	Starch and sucrose metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMT200059216	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMT200059216	K08679	ko01100	Metabolic pathways	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMT200059239	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMT200059240	K02183	ko04020	Calcium signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04070	Phosphatidylinositol signaling system	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04114	Oocyte meiosis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04270	Vascular smooth muscle contraction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04626	Plant-pathogen interaction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04720	Long-term potentiation	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04722	Neurotrophin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04740	Olfactory transduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04744	Phototransduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04745	Phototransduction - fly	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04910	Insulin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04912	GnRH signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04916	Melanogenesis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04970	Salivary secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko04971	Gastric acid secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko05010	Alzheimer's disease	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059240	K02183	ko05214	Glioma	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMT200059246	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.94
PGSC0003DMT200059247	K01509	ko00230	Purine metabolism	1516	8.8e-78	0.43	0.57	0.94
PGSC0003DMT200059248	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.96
PGSC0003DMT200067433	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMT200067434	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMT200067435	K10848	ko03420	Nucleotide excision repair	5254	6.0e-284	0.67	0.79	1.00
PGSC0003DMT200067436	K10848	ko03420	Nucleotide excision repair	3551	5.1e-190	0.69	0.80	0.95
PGSC0003DMT200067451	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMT200067452	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMT200067453	K01358	ko04112	Cell cycle - Caulobacter	1399	2.5e-71	0.71	0.80	0.94
PGSC0003DMT200022729	K00901	ko00561	Glycerolipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMT200022729	K00901	ko00564	Glycerophospholipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMT200022729	K00901	ko01100	Metabolic pathways	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMT200022729	K00901	ko04070	Phosphatidylinositol signaling system	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMT200022745	K12813	ko03040	Spliceosome	860	1.3e-41	0.60	0.64	0.99
PGSC0003DMT200022751	K00368	ko00910	Nitrogen metabolism	1576	4.3e-81	0.42	0.57	0.91
PGSC0003DMT200022752	K01673	ko00910	Nitrogen metabolism	1395	4.2e-71	0.60	0.71	0.99
PGSC0003DMT200022753	K01673	ko00910	Nitrogen metabolism	509	3.1e-22	0.66	0.83	0.87
PGSC0003DMT200022754	K01673	ko00910	Nitrogen metabolism	1342	3.5e-68	0.67	0.80	0.98
PGSC0003DMT200022755	K01673	ko00910	Nitrogen metabolism	618	3.0e-28	0.68	0.76	0.98
PGSC0003DMT200014303	K01054	ko00561	Glycerolipid metabolism	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMT200014303	K01054	ko01100	Metabolic pathways	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMT200014325	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMT200014326	K03128	ko03022	Basal transcription factors	2277	9.4e-120	0.47	0.60	0.99
PGSC0003DMT200014327	K03128	ko03022	Basal transcription factors	6464	0.	0.62	0.73	1.00
PGSC0003DMT200014328	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMT200014335	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014335	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014335	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014335	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014335	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014335	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200014336	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMT200042381	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMT200042381	K01869	ko00970	Aminoacyl-tRNA biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMT200042382	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMT200042382	K01869	ko00970	Aminoacyl-tRNA biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMT200042383	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMT200042383	K01869	ko00970	Aminoacyl-tRNA biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMT200042395	K01728	ko00040	Pentose and glucuronate interconversions	1981	2.0e-103	0.64	0.74	0.98
PGSC0003DMT200042396	K01728	ko00040	Pentose and glucuronate interconversions	1811	4.7e-94	0.57	0.72	0.96
PGSC0003DMT200042406	K00605	ko00260	Glycine, serine and threonine metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMT200042406	K00605	ko00670	One carbon pool by folate	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMT200042406	K00605	ko00910	Nitrogen metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMT200042406	K00605	ko01100	Metabolic pathways	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMT200091937	K00804	ko00900	Terpenoid backbone biosynthesis	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMT200091937	K00804	ko01100	Metabolic pathways	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMT200091937	K00804	ko01110	Biosynthesis of secondary metabolites	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMT200057797	K12837	ko03040	Spliceosome	2004	1.1e-104	0.69	0.83	0.99
PGSC0003DMT200057798	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMT200057802	K03144	ko03022	Basal transcription factors	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMT200057802	K03144	ko03420	Nucleotide excision repair	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMT200057803	K03144	ko03022	Basal transcription factors	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMT200057803	K03144	ko03420	Nucleotide excision repair	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMT200057804	K03144	ko03022	Basal transcription factors	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMT200057804	K03144	ko03420	Nucleotide excision repair	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMT200057805	K03144	ko03022	Basal transcription factors	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMT200057805	K03144	ko03420	Nucleotide excision repair	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMT200057806	K03144	ko03022	Basal transcription factors	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMT200057806	K03144	ko03420	Nucleotide excision repair	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMT200057807	K03144	ko03022	Basal transcription factors	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMT200057807	K03144	ko03420	Nucleotide excision repair	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMT200057808	K03144	ko03022	Basal transcription factors	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMT200057808	K03144	ko03420	Nucleotide excision repair	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMT200057809	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMT200057809	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMT200057810	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMT200057810	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMT200057829	K01955	ko00240	Pyrimidine metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMT200057829	K01955	ko00250	Alanine, aspartate and glutamate metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMT200057829	K01955	ko01100	Metabolic pathways	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMT200057834	K06096	ko04530	Tight junction	350	1.8e-13	0.27	0.44	0.98
PGSC0003DMT200085869	K10760	ko00908	Zeatin biosynthesis	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMT200085869	K10760	ko01100	Metabolic pathways	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMT200085869	K10760	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMT200085888	K03347	ko04110	Cell cycle	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04111	Cell cycle - yeast	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04114	Oocyte meiosis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04120	Ubiquitin mediated proteolysis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04310	Wnt signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04350	TGF-beta signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200085888	K03347	ko04710	Circadian rhythm - mammal	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMT200069127	K12356	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.48	0.60	0.87
PGSC0003DMT200069131	K11294	ko05130	Pathogenic Escherichia coli infection	403	2.2e-16	0.36	0.50	0.70
PGSC0003DMT200069137	K01692	ko00071	Fatty acid metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00280	Valine, leucine and isoleucine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00281	Geraniol degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00310	Lysine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00380	Tryptophan metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00410	beta-Alanine metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00632	Benzoate degradation via CoA ligation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00640	Propanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00650	Butanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00903	Limonene and pinene degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko00930	Caprolactam degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko01100	Metabolic pathways	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069137	K01692	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMT200069148	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMT200069148	K00517	ko00626	Naphthalene and anthracene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMT200069148	K00517	ko00903	Limonene and pinene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMT200069148	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMT200069148	K00517	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMT200069152	K00253	ko00280	Valine, leucine and isoleucine degradation	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMT200069152	K00253	ko01100	Metabolic pathways	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMT200069160	K01012	ko00780	Biotin metabolism	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMT200069160	K01012	ko01100	Metabolic pathways	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMT200069161	K00432	ko00480	Glutathione metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMT200069161	K00432	ko00590	Arachidonic acid metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMT200069166	K10773	ko03410	Base excision repair	840	1.7e-40	0.90	0.91	0.99
PGSC0003DMT200069168	K10773	ko03410	Base excision repair	242	1.6e-07	0.42	0.64	0.77
PGSC0003DMT200069169	K10773	ko03410	Base excision repair	665	7.6e-31	0.53	0.66	0.98
PGSC0003DMT200069178	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3866	2.1e-207	0.78	0.87	0.96
PGSC0003DMT200061013	K11229	ko04011	MAPK signaling pathway - yeast	867	3.0e-43	0.43	0.59	0.97
PGSC0003DMT200061014	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMT200061015	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMT200061041	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMT200061042	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMT200074468	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMT200074469	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMT200074477	K12194	ko04144	Endocytosis	1453	2.6e-74	0.93	0.97	0.99
PGSC0003DMT200074478	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMT200074479	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMT200074483	K12868	ko03040	Spliceosome	585	2.0e-26	0.86	0.95	0.72
PGSC0003DMT200074488	K12591	ko03018	RNA degradation	899	9.5e-44	0.37	0.51	0.49
PGSC0003DMT200074489	K01681	ko00020	Citrate cycle (TCA cycle)	7302	0.	0.86	0.92	1.00
PGSC0003DMT200074489	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7302	0.	0.86	0.92	1.00
PGSC0003DMT200074489	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7302	0.	0.86	0.92	1.00
PGSC0003DMT200074489	K01681	ko01100	Metabolic pathways	7302	0.	0.86	0.92	1.00
PGSC0003DMT200074489	K01681	ko01110	Biosynthesis of secondary metabolites	7302	0.	0.86	0.92	1.00
PGSC0003DMT200074496	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMT200074496	K00517	ko00626	Naphthalene and anthracene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMT200074496	K00517	ko00903	Limonene and pinene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMT200074496	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMT200074496	K00517	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMT200029052	K05745	ko04810	Regulation of actin cytoskeleton	545	1.7e-23	0.30	0.57	0.99
PGSC0003DMT200029053	K04512	ko04310	Wnt signaling pathway	545	1.4e-23	0.31	0.58	0.96
PGSC0003DMT200029054	K02184	ko04320	Dorso-ventral axis formation	1304	6.8e-66	0.30	0.42	0.76
PGSC0003DMT200029055	K02184	ko04320	Dorso-ventral axis formation	1051	2.0e-51	0.31	0.41	0.69
PGSC0003DMT200008427	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMT200008427	K00224	ko00364	Fluorobenzoate degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMT200008427	K00224	ko00628	Fluorene degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMT200008427	K00224	ko00640	Propanoate metabolism	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMT200008428	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMT200008428	K00224	ko00364	Fluorobenzoate degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMT200008428	K00224	ko00628	Fluorene degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMT200008428	K00224	ko00640	Propanoate metabolism	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMT200008432	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMT200008432	K00517	ko00626	Naphthalene and anthracene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMT200008432	K00517	ko00903	Limonene and pinene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMT200008432	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMT200008432	K00517	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMT200008433	K09843	ko00906	Carotenoid biosynthesis	344	3.9e-13	0.49	0.62	0.81
PGSC0003DMT200008459	K05756	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMT200008459	K05756	ko04810	Regulation of actin cytoskeleton	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMT200008459	K05756	ko05100	Bacterial invasion of epithelial cells	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMT200008459	K05756	ko05130	Pathogenic Escherichia coli infection	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMT200008459	K05756	ko05131	Shigellosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMT200008461	K01126	ko00564	Glycerophospholipid metabolism	400	8.6e-16	0.30	0.47	0.40
PGSC0003DMT200008464	K01126	ko00564	Glycerophospholipid metabolism	455	4.6e-19	0.32	0.50	0.60
PGSC0003DMT200008465	K01126	ko00564	Glycerophospholipid metabolism	455	4.4e-19	0.32	0.50	0.61
PGSC0003DMT200010420	K01379	ko04142	Lysosome	288	1.3e-08	0.26	0.42	0.86
PGSC0003DMT200010421	K01379	ko04142	Lysosome	273	3.2e-09	0.28	0.43	0.94
PGSC0003DMT200010422	K08735	ko03430	Mismatch repair	6438	0.	0.80	0.92	0.99
PGSC0003DMT200010422	K08735	ko05200	Pathways in cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMT200010422	K08735	ko05210	Colorectal cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMT200020399	K04460	ko04010	MAPK signaling pathway	433	3.0e-22	0.36	0.51	0.73
PGSC0003DMT200020414	K01535	ko00190	Oxidative phosphorylation	6457	0.	0.83	0.91	0.99
PGSC0003DMT200020416	K12834	ko03040	Spliceosome	1004	1.5e-49	1.00	1.00	0.99
PGSC0003DMT200020433	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMT200020435	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMT200020436	K00754	ko00051	Fructose and mannose metabolism	982	2.5e-48	0.35	0.55	0.94
PGSC0003DMT200020437	K00754	ko00051	Fructose and mannose metabolism	1378	3.6e-70	0.38	0.56	0.86
PGSC0003DMT200020438	K00754	ko00051	Fructose and mannose metabolism	1376	4.7e-70	0.38	0.57	0.96
PGSC0003DMT200020439	K00754	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.42	0.60	0.91
PGSC0003DMT200089882	K12356	ko00940	Phenylpropanoid biosynthesis	737	8.2e-35	0.43	0.58	1.00
PGSC0003DMT200087767	K04454	ko04010	MAPK signaling pathway	230	1.1e-06	0.32	0.52	0.91
PGSC0003DMT200087773	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMT200087773	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMT200087773	K00771	ko01100	Metabolic pathways	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMT200087784	K13065	ko00940	Phenylpropanoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMT200087784	K13065	ko00941	Flavonoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMT200087784	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMT200087784	K13065	ko01110	Biosynthesis of secondary metabolites	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMT200071762	K00423	ko00053	Ascorbate and aldarate metabolism	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMT200071762	K00423	ko01100	Metabolic pathways	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMT200071763	K00423	ko00053	Ascorbate and aldarate metabolism	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMT200071763	K00423	ko01100	Metabolic pathways	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMT200071770	K01858	ko00521	Streptomycin biosynthesis	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMT200071770	K01858	ko00562	Inositol phosphate metabolism	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMT200071770	K01858	ko01100	Metabolic pathways	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMT200071770	K01858	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMT200071774	K02342	ko00230	Purine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071774	K02342	ko00240	Pyrimidine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071774	K02342	ko01100	Metabolic pathways	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071774	K02342	ko03030	DNA replication	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071774	K02342	ko03430	Mismatch repair	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071774	K02342	ko03440	Homologous recombination	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMT200071776	K00812	ko00250	Alanine, aspartate and glutamate metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00270	Cysteine and methionine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00330	Arginine and proline metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00350	Tyrosine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00360	Phenylalanine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00401	Novobiocin biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00710	Carbon fixation in photosynthetic organisms	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00950	Isoquinoline alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko01100	Metabolic pathways	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071776	K00812	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMT200071784	K01193	ko00052	Galactose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMT200071784	K01193	ko00500	Starch and sucrose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMT200071784	K01193	ko01100	Metabolic pathways	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMT200071807	K00696	ko00500	Starch and sucrose metabolism	7380	0.	0.81	0.91	1.00
PGSC0003DMT200071807	K00696	ko01100	Metabolic pathways	7380	0.	0.81	0.91	1.00
PGSC0003DMT200071808	K07297	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.68	0.87	0.98
PGSC0003DMT200071809	K07297	ko04920	Adipocytokine signaling pathway	1944	2.2e-101	0.60	0.74	0.98
PGSC0003DMT200053473	K02084	ko04115	p53 signaling pathway	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko04210	Apoptosis	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko05010	Alzheimer's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko05012	Parkinson's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko05016	Huntington's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200053473	K02084	ko05222	Small cell lung cancer	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMT200063401	K10352	ko04530	Tight junction	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMT200063401	K10352	ko05416	Viral myocarditis	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMT200063408	K04733	ko04210	Apoptosis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMT200063408	K04733	ko04620	Toll-like receptor signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMT200063408	K04733	ko04722	Neurotrophin signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMT200063408	K04733	ko05140	Leishmaniasis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMT200063408	K04733	ko05142	Chagas disease	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMT200063427	K08901	ko00195	Photosynthesis	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMT200063427	K08901	ko01100	Metabolic pathways	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMT200063433	K01897	ko00071	Fatty acid metabolism	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMT200063433	K01897	ko01100	Metabolic pathways	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMT200063433	K01897	ko03320	PPAR signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMT200063433	K01897	ko04146	Peroxisome	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMT200063433	K01897	ko04920	Adipocytokine signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMT200063438	K01897	ko00071	Fatty acid metabolism	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMT200063438	K01897	ko01100	Metabolic pathways	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMT200063438	K01897	ko03320	PPAR signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMT200063438	K01897	ko04146	Peroxisome	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMT200063438	K01897	ko04920	Adipocytokine signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMT200063441	K00454	ko00591	Linoleic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMT200063441	K00454	ko00592	alpha-Linolenic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMT200063441	K00454	ko01100	Metabolic pathways	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMT200063442	K00454	ko00591	Linoleic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMT200063442	K00454	ko00592	alpha-Linolenic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMT200063442	K00454	ko01100	Metabolic pathways	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMT200063443	K00454	ko00591	Linoleic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMT200063443	K00454	ko00592	alpha-Linolenic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMT200063443	K00454	ko01100	Metabolic pathways	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMT200063445	K00454	ko00591	Linoleic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMT200063445	K00454	ko00592	alpha-Linolenic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMT200063445	K00454	ko01100	Metabolic pathways	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMT200088269	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.50	0.63	0.91
PGSC0003DMT200088273	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMT200088273	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMT200088273	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMT200088273	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMT200088273	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMT200088293	K06611	ko00052	Galactose metabolism	311	1.1e-10	0.48	0.66	0.83
PGSC0003DMT200071040	K04125	ko00904	Diterpenoid biosynthesis	480	1.2e-20	0.51	0.64	0.99
PGSC0003DMT200071041	K04125	ko00904	Diterpenoid biosynthesis	1094	1.7e-54	0.56	0.70	0.92
PGSC0003DMT200071042	K04125	ko00904	Diterpenoid biosynthesis	1001	2.2e-49	0.65	0.79	0.98
PGSC0003DMT200071043	K04125	ko00904	Diterpenoid biosynthesis	1516	8.8e-78	0.59	0.73	0.99
PGSC0003DMT200071044	K04125	ko00904	Diterpenoid biosynthesis	1076	1.6e-53	0.54	0.71	0.90
PGSC0003DMT200071045	K04125	ko00904	Diterpenoid biosynthesis	1521	4.7e-78	0.57	0.73	0.98
PGSC0003DMT200071046	K04125	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.48	0.65	0.99
PGSC0003DMT200071047	K04125	ko00904	Diterpenoid biosynthesis	1036	2.6e-51	0.65	0.78	0.97
PGSC0003DMT200071048	K09840	ko00906	Carotenoid biosynthesis	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMT200071048	K09840	ko01100	Metabolic pathways	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMT200071048	K09840	ko01110	Biosynthesis of secondary metabolites	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMT200071057	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMT200071057	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMT200071057	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMT200071059	K00799	ko00480	Glutathione metabolism	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMT200071059	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMT200071059	K00799	ko00982	Drug metabolism - cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMT200045336	K10352	ko04530	Tight junction	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMT200045336	K10352	ko05416	Viral myocarditis	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMT200045337	K10352	ko04530	Tight junction	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMT200045337	K10352	ko05416	Viral myocarditis	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMT200045338	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMT200045342	K12129	ko04712	Circadian rhythm - plant	1893	1.4e-98	0.43	0.59	0.98
PGSC0003DMT200045343	K12129	ko04712	Circadian rhythm - plant	2125	2.3e-111	0.45	0.62	0.98
PGSC0003DMT200045357	K01710	ko00521	Streptomycin biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMT200045357	K01710	ko00523	Polyketide sugar unit biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMT200045357	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMT200045357	K01710	ko01100	Metabolic pathways	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMT200045357	K01710	ko01110	Biosynthesis of secondary metabolites	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMT200045358	K01710	ko00521	Streptomycin biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMT200045358	K01710	ko00523	Polyketide sugar unit biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMT200045358	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMT200045358	K01710	ko01100	Metabolic pathways	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMT200045358	K01710	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMT200045363	K01754	ko00260	Glycine, serine and threonine metabolism	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMT200045363	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMT200045363	K01754	ko01100	Metabolic pathways	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMT200045363	K01754	ko01110	Biosynthesis of secondary metabolites	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMT200045381	K02930	ko03010	Ribosome	2911	1.0e-154	0.84	0.92	1.00
PGSC0003DMT200083859	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2432	2.7e-128	0.69	0.84	0.99
PGSC0003DMT200083869	K09755	ko00940	Phenylpropanoid biosynthesis	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMT200083869	K09755	ko01100	Metabolic pathways	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMT200083869	K09755	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMT200083875	K12823	ko03040	Spliceosome	2249	3.3e-118	0.91	0.95	0.91
PGSC0003DMT200083876	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMT200083877	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMT200083878	K12823	ko03040	Spliceosome	3780	1.2e-202	0.87	0.93	1.00
PGSC0003DMT200054276	K11818	ko00380	Tryptophan metabolism	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMT200054276	K11818	ko00966	Glucosinolate biosynthesis	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMT200054276	K11818	ko01110	Biosynthesis of secondary metabolites	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMT200054278	K11818	ko00380	Tryptophan metabolism	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMT200054278	K11818	ko00966	Glucosinolate biosynthesis	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMT200054278	K11818	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMT200054280	K11818	ko00380	Tryptophan metabolism	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMT200054280	K11818	ko00966	Glucosinolate biosynthesis	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMT200054280	K11818	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMT200054285	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMT200054285	K00517	ko00626	Naphthalene and anthracene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMT200054285	K00517	ko00903	Limonene and pinene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMT200054285	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMT200054285	K00517	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMT200054299	K02183	ko04020	Calcium signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04070	Phosphatidylinositol signaling system	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04114	Oocyte meiosis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04270	Vascular smooth muscle contraction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04626	Plant-pathogen interaction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04720	Long-term potentiation	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04722	Neurotrophin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04740	Olfactory transduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04744	Phototransduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04745	Phototransduction - fly	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04910	Insulin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04912	GnRH signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04916	Melanogenesis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04970	Salivary secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko04971	Gastric acid secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko05010	Alzheimer's disease	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054299	K02183	ko05214	Glioma	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMT200054301	K09658	ko00510	N-Glycan biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMT200054301	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMT200054301	K09658	ko01100	Metabolic pathways	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMT200054311	K01692	ko00071	Fatty acid metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00280	Valine, leucine and isoleucine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00281	Geraniol degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00310	Lysine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00380	Tryptophan metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00410	beta-Alanine metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00632	Benzoate degradation via CoA ligation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00640	Propanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00650	Butanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00903	Limonene and pinene degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko00930	Caprolactam degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko01100	Metabolic pathways	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054311	K01692	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMT200054325	K09755	ko00940	Phenylpropanoid biosynthesis	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMT200054325	K09755	ko01100	Metabolic pathways	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMT200054325	K09755	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMT200096524	K10760	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMT200096524	K10760	ko01100	Metabolic pathways	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMT200096524	K10760	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMT200096534	K03012	ko00230	Purine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMT200096534	K03012	ko00240	Pyrimidine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMT200096534	K03012	ko01100	Metabolic pathways	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMT200096534	K03012	ko03020	RNA polymerase	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMT200096534	K03012	ko05016	Huntington's disease	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMT200096535	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMT200096535	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMT200096535	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMT200096535	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMT200096535	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMT200096536	K00059	ko00061	Fatty acid biosynthesis	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMT200096536	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMT200096536	K00059	ko01100	Metabolic pathways	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMT200096541	K03122	ko03022	Basal transcription factors	335	1.2e-12	0.35	0.52	0.90
PGSC0003DMT200089778	K01051	ko00040	Pentose and glucuronate interconversions	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMT200089778	K01051	ko00500	Starch and sucrose metabolism	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMT200089778	K01051	ko01100	Metabolic pathways	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMT200089793	K03094	ko04110	Cell cycle	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04111	Cell cycle - yeast	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04114	Oocyte meiosis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04120	Ubiquitin mediated proteolysis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04310	Wnt signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04350	TGF-beta signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200089793	K03094	ko04710	Circadian rhythm - mammal	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMT200028241	K02084	ko04115	p53 signaling pathway	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko04210	Apoptosis	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko05010	Alzheimer's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko05012	Parkinson's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko05016	Huntington's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028241	K02084	ko05222	Small cell lung cancer	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMT200028243	K02084	ko04115	p53 signaling pathway	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko04210	Apoptosis	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko05010	Alzheimer's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko05012	Parkinson's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko05016	Huntington's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028243	K02084	ko05222	Small cell lung cancer	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMT200028258	K08504	ko04130	SNARE interactions in vesicular transport	815	4.1e-39	0.85	0.92	0.99
PGSC0003DMT200028259	K08504	ko04130	SNARE interactions in vesicular transport	835	3.2e-40	0.83	0.92	0.99
PGSC0003DMT200028264	K02084	ko04115	p53 signaling pathway	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko04210	Apoptosis	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko05010	Alzheimer's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko05012	Parkinson's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko05016	Huntington's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028264	K02084	ko05222	Small cell lung cancer	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMT200028274	K01553	ko00230	Purine metabolism	529	1.3e-20	0.25	0.43	0.95
PGSC0003DMT200028283	K08065	ko04612	Antigen processing and presentation	395	6.0e-16	0.55	0.75	0.84
PGSC0003DMT200028285	K01528	ko04144	Endocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMT200028285	K01528	ko04666	Fc gamma R-mediated phagocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMT200028285	K01528	ko05100	Bacterial invasion of epithelial cells	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMT200028286	K01528	ko04144	Endocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMT200028286	K01528	ko04666	Fc gamma R-mediated phagocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMT200028286	K01528	ko05100	Bacterial invasion of epithelial cells	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMT200026177	K00754	ko00051	Fructose and mannose metabolism	300	1.9e-10	0.30	0.48	0.56
PGSC0003DMT200026182	K04498	ko04110	Cell cycle	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04310	Wnt signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04330	Notch signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04350	TGF-beta signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04520	Adherens junction	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04630	Jak-STAT signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04720	Long-term potentiation	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko04916	Melanogenesis	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko05016	Huntington's disease	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko05200	Pathways in cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko05211	Renal cell carcinoma	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026182	K04498	ko05215	Prostate cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMT200026190	K09753	ko00940	Phenylpropanoid biosynthesis	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMT200026190	K09753	ko01100	Metabolic pathways	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMT200026190	K09753	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMT200026191	K09753	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMT200026191	K09753	ko01100	Metabolic pathways	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMT200026191	K09753	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMT200026192	K09753	ko00940	Phenylpropanoid biosynthesis	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMT200026192	K09753	ko01100	Metabolic pathways	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMT200026192	K09753	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMT200026193	K00558	ko00270	Cysteine and methionine metabolism	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMT200026193	K00558	ko01100	Metabolic pathways	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMT200026208	K10872	ko04113	Meiosis - yeast	245	4.1e-07	0.32	0.50	0.55
PGSC0003DMT200011094	K13230	ko00402	Benzoxazinoid biosynthesis	687	4.7e-32	0.38	0.54	0.99
PGSC0003DMT200011095	K13230	ko00402	Benzoxazinoid biosynthesis	410	8.9e-17	0.45	0.62	0.95
PGSC0003DMT200011096	K13230	ko00402	Benzoxazinoid biosynthesis	683	7.8e-32	0.47	0.64	0.97
PGSC0003DMT200011097	K13230	ko00402	Benzoxazinoid biosynthesis	640	1.8e-29	0.48	0.63	0.93
PGSC0003DMT200011101	K13230	ko00402	Benzoxazinoid biosynthesis	382	3.1e-15	0.53	0.70	0.76
PGSC0003DMT200011102	K13230	ko00402	Benzoxazinoid biosynthesis	380	4.0e-15	0.56	0.71	0.98
PGSC0003DMT200011116	K00526	ko00230	Purine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMT200011116	K00526	ko00240	Pyrimidine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMT200011116	K00526	ko01100	Metabolic pathways	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMT200011117	K00526	ko00230	Purine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMT200011117	K00526	ko00240	Pyrimidine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMT200011117	K00526	ko01100	Metabolic pathways	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMT200036717	K07750	ko00100	Steroid biosynthesis	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMT200036717	K07750	ko01100	Metabolic pathways	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMT200036729	K11092	ko03040	Spliceosome	1739	4.4e-90	0.75	0.84	1.00
PGSC0003DMT200036732	K10798	ko03410	Base excision repair	6008	0.	0.71	0.84	1.00
PGSC0003DMT200036734	K08008	ko04145	Phagosome	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMT200036734	K08008	ko04670	Leukocyte transendothelial migration	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMT200036737	K07200	ko04910	Insulin signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMT200036737	K07200	ko04920	Adipocytokine signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMT200036737	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMT200036738	K07200	ko04910	Insulin signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMT200036738	K07200	ko04920	Adipocytokine signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMT200036738	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMT200036758	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMT200036759	K12489	ko04144	Endocytosis	1744	2.3e-90	0.73	0.85	0.96
PGSC0003DMT200036760	K12489	ko04144	Endocytosis	3901	2.5e-209	0.70	0.81	0.97
PGSC0003DMT200036761	K12489	ko04144	Endocytosis	4336	2.6e-233	0.66	0.77	0.99
PGSC0003DMT200057191	K01681	ko00020	Citrate cycle (TCA cycle)	6607	0.	0.78	0.87	1.00
PGSC0003DMT200057191	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	6607	0.	0.78	0.87	1.00
PGSC0003DMT200057191	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	6607	0.	0.78	0.87	1.00
PGSC0003DMT200057191	K01681	ko01100	Metabolic pathways	6607	0.	0.78	0.87	1.00
PGSC0003DMT200057191	K01681	ko01110	Biosynthesis of secondary metabolites	6607	0.	0.78	0.87	1.00
PGSC0003DMT200057192	K01681	ko00020	Citrate cycle (TCA cycle)	5900	0.	0.78	0.87	0.99
PGSC0003DMT200057192	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5900	0.	0.78	0.87	0.99
PGSC0003DMT200057192	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5900	0.	0.78	0.87	0.99
PGSC0003DMT200057192	K01681	ko01100	Metabolic pathways	5900	0.	0.78	0.87	0.99
PGSC0003DMT200057192	K01681	ko01110	Biosynthesis of secondary metabolites	5900	0.	0.78	0.87	0.99
PGSC0003DMT200057193	K01681	ko00020	Citrate cycle (TCA cycle)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMT200057193	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMT200057193	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMT200057193	K01681	ko01100	Metabolic pathways	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMT200057193	K01681	ko01110	Biosynthesis of secondary metabolites	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMT200057194	K01681	ko00020	Citrate cycle (TCA cycle)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMT200057194	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMT200057194	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMT200057194	K01681	ko01100	Metabolic pathways	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMT200057194	K01681	ko01110	Biosynthesis of secondary metabolites	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMT200057210	K09843	ko00906	Carotenoid biosynthesis	806	1.3e-38	0.41	0.61	0.98
PGSC0003DMT200057211	K09588	ko01100	Metabolic pathways	325	4.3e-12	0.35	0.53	0.77
PGSC0003DMT200057212	K09843	ko00906	Carotenoid biosynthesis	1028	7.3e-51	0.35	0.55	1.00
PGSC0003DMT200057219	K02978	ko03010	Ribosome	534	1.3e-23	0.78	0.84	0.85
PGSC0003DMT200057224	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMT200057224	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMT200057224	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMT200057225	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057225	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057225	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057226	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057226	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057226	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMT200057227	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMT200057227	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMT200057227	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMT200057228	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMT200057228	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMT200057228	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMT200051412	K01408	ko05010	Alzheimer's disease	2201	2.1e-120	0.37	0.57	0.93
PGSC0003DMT200051416	K12116	ko04712	Circadian rhythm - plant	4269	1.3e-229	0.85	0.91	0.91
PGSC0003DMT200051417	K01528	ko04144	Endocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMT200051417	K01528	ko04666	Fc gamma R-mediated phagocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMT200051417	K01528	ko05100	Bacterial invasion of epithelial cells	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMT200051422	K12343	ko00140	Steroid hormone biosynthesis	232	5.8e-07	0.34	0.49	0.89
PGSC0003DMT200051423	K12343	ko00140	Steroid hormone biosynthesis	356	8.4e-14	0.32	0.52	0.85
PGSC0003DMT200051424	K12343	ko00140	Steroid hormone biosynthesis	372	1.1e-14	0.29	0.50	0.81
PGSC0003DMT200051425	K10352	ko04530	Tight junction	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMT200051425	K10352	ko05416	Viral myocarditis	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMT200051439	K11866	ko04144	Endocytosis	350	1.2e-12	0.50	0.59	0.77
PGSC0003DMT200051440	K11866	ko04144	Endocytosis	479	6.7e-20	0.31	0.44	0.96
PGSC0003DMT200051441	K11866	ko04144	Endocytosis	414	3.1e-16	0.40	0.52	0.79
PGSC0003DMT200051443	K11866	ko04144	Endocytosis	366	1.5e-13	0.30	0.44	0.96
PGSC0003DMT200078388	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMT200078389	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMT200078392	K00970	ko03018	RNA degradation	3056	1.0e-162	0.71	0.81	0.72
PGSC0003DMT200078393	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.72
PGSC0003DMT200078394	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.71
PGSC0003DMT200078412	K04715	ko00600	Sphingolipid metabolism	405	1.7e-16	0.43	0.63	0.47
PGSC0003DMT200078413	K04715	ko00600	Sphingolipid metabolism	932	1.4e-45	0.32	0.47	0.79
PGSC0003DMT200078414	K04715	ko00600	Sphingolipid metabolism	504	5.8e-22	0.34	0.48	0.91
PGSC0003DMT200078416	K01080	ko00561	Glycerolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078416	K01080	ko00564	Glycerophospholipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078416	K01080	ko00565	Ether lipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078416	K01080	ko00600	Sphingolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078416	K01080	ko01100	Metabolic pathways	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078416	K01080	ko04666	Fc gamma R-mediated phagocytosis	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMT200078417	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078417	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078417	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078417	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078417	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078417	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMT200078418	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078418	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078418	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078418	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078418	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078418	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMT200078422	K12816	ko03040	Spliceosome	2118	5.5e-111	0.84	0.92	0.98
PGSC0003DMT200085376	K00021	ko00900	Terpenoid backbone biosynthesis	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMT200085376	K00021	ko01100	Metabolic pathways	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMT200085376	K00021	ko01110	Biosynthesis of secondary metabolites	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMT200075241	K01184	ko00040	Pentose and glucuronate interconversions	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMT200075241	K01184	ko00500	Starch and sucrose metabolism	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMT200075241	K01184	ko01100	Metabolic pathways	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMT200075242	K02940	ko03010	Ribosome	1401	1.9e-71	0.90	0.96	0.99
PGSC0003DMT200075259	K11090	ko05322	Systemic lupus erythematosus	338	8.3e-13	0.35	0.56	0.32
PGSC0003DMT200075264	K00794	ko00740	Riboflavin metabolism	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMT200075264	K00794	ko01100	Metabolic pathways	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMT200075267	K02947	ko03010	Ribosome	1482	6.6e-76	0.92	0.95	0.98
PGSC0003DMT200075275	K03134	ko03022	Basal transcription factors	979	3.7e-48	0.79	0.91	0.99
PGSC0003DMT200075283	K12811	ko03040	Spliceosome	335	2.4e-11	0.27	0.45	0.97
PGSC0003DMT200001180	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001180	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001180	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001180	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001181	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001181	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001181	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001181	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMT200001182	K03283	ko03040	Spliceosome	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMT200001182	K03283	ko04010	MAPK signaling pathway	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMT200001182	K03283	ko04144	Endocytosis	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMT200001182	K03283	ko04612	Antigen processing and presentation	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMT200001194	K12193	ko04144	Endocytosis	1587	1.1e-81	0.87	0.93	1.00
PGSC0003DMT200001195	K12193	ko04144	Endocytosis	747	2.3e-35	0.83	0.91	0.99
PGSC0003DMT200001201	K12272	ko03060	Protein export	944	3.1e-46	0.71	0.86	0.97
PGSC0003DMT200001202	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMT200001203	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMT200001204	K10747	ko03030	DNA replication	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMT200001204	K10747	ko03410	Base excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMT200001204	K10747	ko03420	Nucleotide excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMT200001204	K10747	ko03430	Mismatch repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMT200001205	K10747	ko03030	DNA replication	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMT200001205	K10747	ko03410	Base excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMT200001205	K10747	ko03420	Nucleotide excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMT200001205	K10747	ko03430	Mismatch repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMT200001207	K10747	ko03030	DNA replication	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMT200001207	K10747	ko03410	Base excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMT200001207	K10747	ko03420	Nucleotide excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMT200001207	K10747	ko03430	Mismatch repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMT200001214	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMT200097535	K10760	ko00908	Zeatin biosynthesis	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMT200097535	K10760	ko01100	Metabolic pathways	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMT200097535	K10760	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMT200004879	K09564	ko03040	Spliceosome	465	8.2e-20	0.58	0.74	0.47
PGSC0003DMT200004880	K09564	ko03040	Spliceosome	520	7.6e-23	0.48	0.65	0.80
PGSC0003DMT200004881	K12153	ko00966	Glucosinolate biosynthesis	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMT200004881	K12153	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMT200004882	K11812	ko00380	Tryptophan metabolism	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMT200004882	K11812	ko00966	Glucosinolate biosynthesis	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMT200004883	K11812	ko00380	Tryptophan metabolism	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMT200004883	K11812	ko00966	Glucosinolate biosynthesis	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMT200004888	K12153	ko00966	Glucosinolate biosynthesis	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMT200004888	K12153	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMT200004890	K12153	ko00966	Glucosinolate biosynthesis	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMT200004890	K12153	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMT200004892	K12153	ko00966	Glucosinolate biosynthesis	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMT200004892	K12153	ko01110	Biosynthesis of secondary metabolites	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMT200004893	K13027	ko00460	Cyanoamino acid metabolism	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMT200004893	K13027	ko00966	Glucosinolate biosynthesis	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMT200004893	K13027	ko01100	Metabolic pathways	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMT200004893	K13027	ko01110	Biosynthesis of secondary metabolites	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMT200004895	K01246	ko03410	Base excision repair	529	2.4e-23	0.73	0.92	0.99
PGSC0003DMT200004897	K04120	ko00904	Diterpenoid biosynthesis	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMT200004897	K04120	ko01100	Metabolic pathways	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMT200004897	K04120	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMT200004898	K04120	ko00904	Diterpenoid biosynthesis	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMT200004898	K04120	ko01100	Metabolic pathways	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMT200004898	K04120	ko01110	Biosynthesis of secondary metabolites	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMT200004899	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMT200004899	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMT200004899	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMT200004900	K04120	ko00904	Diterpenoid biosynthesis	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMT200004900	K04120	ko01100	Metabolic pathways	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMT200004900	K04120	ko01110	Biosynthesis of secondary metabolites	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMT200004901	K04120	ko00904	Diterpenoid biosynthesis	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMT200004901	K04120	ko01100	Metabolic pathways	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMT200004901	K04120	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMT200004902	K04120	ko00904	Diterpenoid biosynthesis	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMT200004902	K04120	ko01100	Metabolic pathways	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMT200004902	K04120	ko01110	Biosynthesis of secondary metabolites	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMT200004903	K04120	ko00904	Diterpenoid biosynthesis	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMT200004903	K04120	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMT200004903	K04120	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMT200004904	K04120	ko00904	Diterpenoid biosynthesis	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMT200004904	K04120	ko01100	Metabolic pathways	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMT200004904	K04120	ko01110	Biosynthesis of secondary metabolites	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMT200004905	K04120	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMT200004905	K04120	ko01100	Metabolic pathways	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMT200004905	K04120	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMT200004906	K04120	ko00904	Diterpenoid biosynthesis	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMT200004906	K04120	ko01100	Metabolic pathways	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMT200004906	K04120	ko01110	Biosynthesis of secondary metabolites	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMT200032247	K03846	ko00510	N-Glycan biosynthesis	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMT200032247	K03846	ko01100	Metabolic pathways	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMT200032248	K03846	ko00510	N-Glycan biosynthesis	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMT200032248	K03846	ko01100	Metabolic pathways	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMT200032251	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMT200032256	K12741	ko03040	Spliceosome	337	9.4e-13	0.29	0.47	0.85
PGSC0003DMT200032266	K00026	ko00020	Citrate cycle (TCA cycle)	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032266	K00026	ko00620	Pyruvate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032266	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032266	K00026	ko00710	Carbon fixation in photosynthetic organisms	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032266	K00026	ko01100	Metabolic pathways	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032266	K00026	ko01110	Biosynthesis of secondary metabolites	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMT200032272	K01681	ko00020	Citrate cycle (TCA cycle)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMT200032272	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMT200032272	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMT200032272	K01681	ko01100	Metabolic pathways	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMT200032272	K01681	ko01110	Biosynthesis of secondary metabolites	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMT200032278	K06027	ko04962	Vasopressin-regulated water reabsorption	939	4.0e-45	0.45	0.63	0.16
PGSC0003DMT200032285	K02968	ko03010	Ribosome	310	2.9e-11	0.53	0.66	0.46
PGSC0003DMT200041686	K01838	ko00500	Starch and sucrose metabolism	306	1.8e-13	0.39	0.54	0.52
PGSC0003DMT200041687	K01838	ko00500	Starch and sucrose metabolism	266	2.6e-11	0.39	0.58	0.45
PGSC0003DMT200041701	K00297	ko00670	One carbon pool by folate	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMT200041701	K00297	ko00680	Methane metabolism	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMT200041701	K00297	ko01100	Metabolic pathways	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMT200041703	K01179	ko00500	Starch and sucrose metabolism	1024	1.2e-50	0.54	0.69	0.94
PGSC0003DMT200041704	K01179	ko00500	Starch and sucrose metabolism	3033	1.9e-161	0.57	0.72	0.99
PGSC0003DMT200041705	K01179	ko00500	Starch and sucrose metabolism	2257	1.2e-118	0.55	0.71	0.95
PGSC0003DMT200041706	K01099	ko00562	Inositol phosphate metabolism	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMT200041706	K01099	ko01100	Metabolic pathways	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMT200041706	K01099	ko04070	Phosphatidylinositol signaling system	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMT200041707	K01099	ko00562	Inositol phosphate metabolism	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMT200041707	K01099	ko01100	Metabolic pathways	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMT200041707	K01099	ko04070	Phosphatidylinositol signaling system	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMT200041708	K01099	ko00562	Inositol phosphate metabolism	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMT200041708	K01099	ko01100	Metabolic pathways	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMT200041708	K01099	ko04070	Phosphatidylinositol signaling system	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMT200041715	K06670	ko04110	Cell cycle	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMT200041715	K06670	ko04111	Cell cycle - yeast	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMT200076643	K12741	ko03040	Spliceosome	1428	6.3e-73	0.46	0.59	0.99
PGSC0003DMT200049559	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200049559	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200049559	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200049559	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200049559	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200049561	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMT200049562	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMT200049564	K01051	ko00040	Pentose and glucuronate interconversions	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMT200049564	K01051	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMT200049564	K01051	ko01100	Metabolic pathways	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMT200049566	K01051	ko00040	Pentose and glucuronate interconversions	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMT200049566	K01051	ko00500	Starch and sucrose metabolism	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMT200049566	K01051	ko01100	Metabolic pathways	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMT200049571	K01051	ko00040	Pentose and glucuronate interconversions	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMT200049571	K01051	ko00500	Starch and sucrose metabolism	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMT200049571	K01051	ko01100	Metabolic pathways	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMT200049576	K05658	ko02010	ABC transporters	3935	3.3e-211	0.42	0.62	0.99
PGSC0003DMT200049589	K12844	ko03040	Spliceosome	2375	3.7e-125	0.65	0.77	0.98
PGSC0003DMT200049597	K02895	ko03010	Ribosome	1113	1.5e-55	0.74	0.83	0.99
PGSC0003DMT200049598	K02895	ko03010	Ribosome	1190	8.4e-60	0.76	0.86	0.99
PGSC0003DMT200086558	K13065	ko00940	Phenylpropanoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMT200086558	K13065	ko00941	Flavonoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMT200086558	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMT200086558	K13065	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMT200086560	K00797	ko00270	Cysteine and methionine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMT200086560	K00797	ko00330	Arginine and proline metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMT200086560	K00797	ko00410	beta-Alanine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMT200086560	K00797	ko00480	Glutathione metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMT200086560	K00797	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMT200086561	K10760	ko00908	Zeatin biosynthesis	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMT200086561	K10760	ko01100	Metabolic pathways	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMT200086561	K10760	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMT200086579	K01509	ko00230	Purine metabolism	688	4.1e-32	0.35	0.55	0.89
PGSC0003DMT200012164	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMT200012164	K02366	ko01100	Metabolic pathways	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMT200012165	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMT200012165	K02366	ko01100	Metabolic pathways	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMT200012169	K12844	ko03040	Spliceosome	3586	5.9e-192	0.89	0.96	1.00
PGSC0003DMT200012170	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMT200012171	K00852	ko00030	Pentose phosphate pathway	248	7.6e-08	0.31	0.52	0.97
PGSC0003DMT200012175	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMT200012182	K05280	ko00941	Flavonoid biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMT200012182	K05280	ko00944	Flavone and flavonol biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMT200012182	K05280	ko01100	Metabolic pathways	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMT200012182	K05280	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMT200012185	K05280	ko00941	Flavonoid biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMT200012185	K05280	ko00944	Flavone and flavonol biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMT200012185	K05280	ko01100	Metabolic pathways	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMT200012185	K05280	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMT200012187	K05280	ko00941	Flavonoid biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMT200012187	K05280	ko00944	Flavone and flavonol biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMT200012187	K05280	ko01100	Metabolic pathways	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMT200012187	K05280	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMT200012190	K05280	ko00941	Flavonoid biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMT200012190	K05280	ko00944	Flavone and flavonol biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMT200012190	K05280	ko01100	Metabolic pathways	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMT200012190	K05280	ko01110	Biosynthesis of secondary metabolites	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMT200012193	K05280	ko00941	Flavonoid biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMT200012193	K05280	ko00944	Flavone and flavonol biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMT200012193	K05280	ko01100	Metabolic pathways	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMT200012193	K05280	ko01110	Biosynthesis of secondary metabolites	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMT200012194	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMT200012194	K00517	ko00626	Naphthalene and anthracene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMT200012194	K00517	ko00903	Limonene and pinene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMT200012194	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMT200012194	K00517	ko01110	Biosynthesis of secondary metabolites	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMT200012195	K05280	ko00941	Flavonoid biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMT200012195	K05280	ko00944	Flavone and flavonol biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMT200012195	K05280	ko01100	Metabolic pathways	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMT200012195	K05280	ko01110	Biosynthesis of secondary metabolites	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMT200012196	K05280	ko00941	Flavonoid biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMT200012196	K05280	ko00944	Flavone and flavonol biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMT200012196	K05280	ko01100	Metabolic pathways	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMT200012196	K05280	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMT200012197	K05280	ko00941	Flavonoid biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMT200012197	K05280	ko00944	Flavone and flavonol biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMT200012197	K05280	ko01100	Metabolic pathways	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMT200012197	K05280	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMT200012208	K09553	ko05020	Prion diseases	3875	6.8e-208	0.78	0.88	1.00
PGSC0003DMT200033936	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.66
PGSC0003DMT200033937	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.69
PGSC0003DMT200006723	K00029	ko00620	Pyruvate metabolism	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMT200006723	K00029	ko00710	Carbon fixation in photosynthetic organisms	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMT200006723	K00029	ko01100	Metabolic pathways	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMT200006724	K00029	ko00620	Pyruvate metabolism	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMT200006724	K00029	ko00710	Carbon fixation in photosynthetic organisms	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMT200006724	K00029	ko01100	Metabolic pathways	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMT200006725	K00029	ko00620	Pyruvate metabolism	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMT200006725	K00029	ko00710	Carbon fixation in photosynthetic organisms	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMT200006725	K00029	ko01100	Metabolic pathways	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMT200006726	K00029	ko00620	Pyruvate metabolism	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMT200006726	K00029	ko00710	Carbon fixation in photosynthetic organisms	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMT200006726	K00029	ko01100	Metabolic pathways	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMT200006728	K00029	ko00620	Pyruvate metabolism	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMT200006728	K00029	ko00710	Carbon fixation in photosynthetic organisms	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMT200006728	K00029	ko01100	Metabolic pathways	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMT200039889	K04508	ko04310	Wnt signaling pathway	394	6.8e-16	0.74	0.88	0.98
PGSC0003DMT200039892	K04508	ko04310	Wnt signaling pathway	2724	2.1e-144	0.63	0.79	0.67
PGSC0003DMT200039895	K04508	ko04310	Wnt signaling pathway	2907	1.7e-154	0.66	0.80	0.94
PGSC0003DMT200039899	K01136	ko00531	Glycosaminoglycan degradation	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMT200039899	K01136	ko01100	Metabolic pathways	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMT200039899	K01136	ko04142	Lysosome	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMT200039904	K04503	ko04110	Cell cycle	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko04115	p53 signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko04310	Wnt signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko04510	Focal adhesion	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko04630	Jak-STAT signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05200	Pathways in cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05210	Colorectal cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05212	Pancreatic cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05213	Endometrial cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05214	Glioma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05215	Prostate cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05216	Thyroid cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05218	Melanoma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05219	Bladder cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05220	Chronic myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05221	Acute myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05222	Small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05223	Non-small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039904	K04503	ko05416	Viral myocarditis	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMT200039926	K00091	ko00941	Flavonoid biosynthesis	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMT200039926	K00091	ko01100	Metabolic pathways	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMT200039926	K00091	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMT200030830	K02641	ko00195	Photosynthesis	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMT200030830	K02641	ko01100	Metabolic pathways	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMT200030832	K04708	ko00600	Sphingolipid metabolism	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMT200030832	K04708	ko01100	Metabolic pathways	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMT200030833	K04708	ko00600	Sphingolipid metabolism	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMT200030833	K04708	ko01100	Metabolic pathways	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMT200030835	K12420	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.42	0.59	0.75
PGSC0003DMT200030843	K02692	ko00195	Photosynthesis	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMT200030843	K02692	ko01100	Metabolic pathways	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMT200030854	K02992	ko03010	Ribosome	1163	2.6e-58	0.97	0.99	0.99
PGSC0003DMT200030857	K03787	ko00230	Purine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMT200030857	K03787	ko00240	Pyrimidine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMT200030857	K03787	ko00760	Nicotinate and nicotinamide metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMT200030857	K03787	ko01100	Metabolic pathways	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMT200030857	K03787	ko01110	Biosynthesis of secondary metabolites	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMT200030858	K03787	ko00230	Purine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMT200030858	K03787	ko00240	Pyrimidine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMT200030858	K03787	ko00760	Nicotinate and nicotinamide metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMT200030858	K03787	ko01100	Metabolic pathways	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMT200030858	K03787	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMT200030859	K03787	ko00230	Purine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMT200030859	K03787	ko00240	Pyrimidine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMT200030859	K03787	ko00760	Nicotinate and nicotinamide metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMT200030859	K03787	ko01100	Metabolic pathways	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMT200030859	K03787	ko01110	Biosynthesis of secondary metabolites	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMT200030860	K03787	ko00230	Purine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMT200030860	K03787	ko00240	Pyrimidine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMT200030860	K03787	ko00760	Nicotinate and nicotinamide metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMT200030860	K03787	ko01100	Metabolic pathways	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMT200030860	K03787	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMT200030861	K03787	ko00230	Purine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMT200030861	K03787	ko00240	Pyrimidine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMT200030861	K03787	ko00760	Nicotinate and nicotinamide metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMT200030861	K03787	ko01100	Metabolic pathways	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMT200030861	K03787	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMT200091065	K00799	ko00480	Glutathione metabolism	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMT200091065	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMT200091065	K00799	ko00982	Drug metabolism - cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMT200091077	K03026	ko00230	Purine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMT200091077	K03026	ko00240	Pyrimidine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMT200091077	K03026	ko01100	Metabolic pathways	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMT200091077	K03026	ko03020	RNA polymerase	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMT200091077	K03026	ko04623	Cytosolic DNA-sensing pathway	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMT200002865	K00231	ko00860	Porphyrin and chlorophyll metabolism	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMT200002865	K00231	ko01100	Metabolic pathways	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMT200002865	K00231	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMT200002866	K00231	ko00860	Porphyrin and chlorophyll metabolism	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMT200002866	K00231	ko01100	Metabolic pathways	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMT200002866	K00231	ko01110	Biosynthesis of secondary metabolites	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMT200002867	K00231	ko00860	Porphyrin and chlorophyll metabolism	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMT200002867	K00231	ko01100	Metabolic pathways	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMT200002867	K00231	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMT200002868	K00231	ko00860	Porphyrin and chlorophyll metabolism	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMT200002868	K00231	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMT200002868	K00231	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMT200002869	K00680	ko00350	Tyrosine metabolism	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMT200002869	K00680	ko00624	1- and 2-Methylnaphthalene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMT200002869	K00680	ko00632	Benzoate degradation via CoA ligation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMT200002869	K00680	ko00642	Ethylbenzene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMT200002869	K00680	ko00903	Limonene and pinene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMT200002870	K11253	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.99	1.00	0.99
PGSC0003DMT200002873	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002873	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002873	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002874	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002874	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002874	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMT200002877	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMT200002877	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMT200002878	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMT200002878	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMT200002889	K02958	ko03010	Ribosome	514	1.6e-22	0.88	0.94	0.95
PGSC0003DMT200002890	K02958	ko03010	Ribosome	1198	3.1e-60	0.91	0.97	0.99
PGSC0003DMT200002891	K03015	ko00230	Purine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMT200002891	K03015	ko00240	Pyrimidine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMT200002891	K03015	ko01100	Metabolic pathways	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMT200002891	K03015	ko03020	RNA polymerase	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMT200002891	K03015	ko05016	Huntington's disease	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMT200002892	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200002892	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200002892	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200002893	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200002893	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200002893	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMT200047199	K00603	ko00340	Histidine metabolism	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMT200047199	K00603	ko00670	One carbon pool by folate	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMT200047199	K00603	ko01100	Metabolic pathways	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMT200047200	K00603	ko00340	Histidine metabolism	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMT200047200	K00603	ko00670	One carbon pool by folate	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMT200047200	K00603	ko01100	Metabolic pathways	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMT200047202	K00603	ko00340	Histidine metabolism	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMT200047202	K00603	ko00670	One carbon pool by folate	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMT200047202	K00603	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMT200047208	K03644	ko00785	Lipoic acid metabolism	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMT200047208	K03644	ko01100	Metabolic pathways	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMT200047210	K03885	ko00190	Oxidative phosphorylation	1973	5.5e-103	0.73	0.87	0.99
PGSC0003DMT200047221	K03006	ko00230	Purine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMT200047221	K03006	ko00240	Pyrimidine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMT200047221	K03006	ko01100	Metabolic pathways	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMT200047221	K03006	ko03020	RNA polymerase	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMT200047221	K03006	ko05016	Huntington's disease	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMT200072790	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMT200072790	K00517	ko00626	Naphthalene and anthracene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMT200072790	K00517	ko00903	Limonene and pinene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMT200072790	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMT200072790	K00517	ko01110	Biosynthesis of secondary metabolites	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMT200072797	K08509	ko04130	SNARE interactions in vesicular transport	1215	3.5e-61	0.59	0.73	1.00
PGSC0003DMT200072798	K08509	ko04130	SNARE interactions in vesicular transport	1240	1.5e-62	0.60	0.73	1.00
PGSC0003DMT200072799	K07964	ko00531	Glycosaminoglycan degradation	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMT200072799	K07964	ko01100	Metabolic pathways	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMT200072801	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	349	1.0e-12	0.32	0.46	0.85
PGSC0003DMT200072802	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	360	3.7e-13	0.27	0.44	0.95
PGSC0003DMT200070818	K02975	ko03010	Ribosome	614	5.0e-28	0.91	0.97	0.98
PGSC0003DMT200070827	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070827	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070829	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070829	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070830	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070830	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMT200070831	K01922	ko00770	Pantothenate and CoA biosynthesis	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMT200070831	K01922	ko01100	Metabolic pathways	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMT200070848	K00850	ko00010	Glycolysis / Gluconeogenesis	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200070848	K00850	ko00030	Pentose phosphate pathway	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200070848	K00850	ko00051	Fructose and mannose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200070848	K00850	ko00052	Galactose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200070848	K00850	ko01100	Metabolic pathways	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200070848	K00850	ko01110	Biosynthesis of secondary metabolites	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMT200081136	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMT200081136	K00517	ko00626	Naphthalene and anthracene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMT200081136	K00517	ko00903	Limonene and pinene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMT200081136	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMT200081136	K00517	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMT200081157	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMT200081173	K03064	ko03050	Proteasome	941	4.6e-46	0.93	0.97	0.99
PGSC0003DMT200081179	K10747	ko03030	DNA replication	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMT200081179	K10747	ko03410	Base excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMT200081179	K10747	ko03420	Nucleotide excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMT200081179	K10747	ko03430	Mismatch repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMT200081180	K10747	ko03030	DNA replication	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMT200081180	K10747	ko03410	Base excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMT200081180	K10747	ko03420	Nucleotide excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMT200081180	K10747	ko03430	Mismatch repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMT200081181	K10747	ko03030	DNA replication	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMT200081181	K10747	ko03410	Base excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMT200081181	K10747	ko03420	Nucleotide excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMT200081181	K10747	ko03430	Mismatch repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMT200081182	K13065	ko00940	Phenylpropanoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMT200081182	K13065	ko00941	Flavonoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMT200081182	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMT200081182	K13065	ko01110	Biosynthesis of secondary metabolites	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMT200081183	K13065	ko00940	Phenylpropanoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMT200081183	K13065	ko00941	Flavonoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMT200081183	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMT200081183	K13065	ko01110	Biosynthesis of secondary metabolites	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMT200056068	K06102	ko04530	Tight junction	355	1.0e-10	0.26	0.45	0.99
PGSC0003DMT200056069	K06102	ko04530	Tight junction	328	2.6e-09	0.26	0.46	0.97
PGSC0003DMT200044162	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMT200044162	K00135	ko00350	Tyrosine metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMT200044162	K00135	ko00650	Butanoate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMT200044162	K00135	ko01100	Metabolic pathways	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMT200044163	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044163	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044163	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044163	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044164	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044164	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044164	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044164	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMT200044167	K00797	ko00270	Cysteine and methionine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMT200044167	K00797	ko00330	Arginine and proline metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMT200044167	K00797	ko00410	beta-Alanine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMT200044167	K00797	ko00480	Glutathione metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMT200044167	K00797	ko01100	Metabolic pathways	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMT200044172	K12587	ko03018	RNA degradation	330	2.6e-11	0.35	0.54	0.45
PGSC0003DMT200044174	K12127	ko04712	Circadian rhythm - plant	223	7.5e-08	0.34	0.50	0.63
PGSC0003DMT200044180	K11420	ko00310	Lysine degradation	610	4.0e-27	0.35	0.47	0.48
PGSC0003DMT200044184	K02894	ko03010	Ribosome	1184	1.8e-59	0.99	1.00	0.99
PGSC0003DMT200044185	K02866	ko03010	Ribosome	609	9.4e-28	0.40	0.59	0.83
PGSC0003DMT200044186	K03259	ko04150	mTOR signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMT200044186	K03259	ko04910	Insulin signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMT200044187	K03259	ko04150	mTOR signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMT200044187	K03259	ko04910	Insulin signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMT200044194	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMT200044195	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMT200044196	K00276	ko00260	Glycine, serine and threonine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko00350	Tyrosine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko00360	Phenylalanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko00410	beta-Alanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko00950	Isoquinoline alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko01100	Metabolic pathways	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044196	K00276	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMT200044197	K00276	ko00260	Glycine, serine and threonine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko00350	Tyrosine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko00360	Phenylalanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko00410	beta-Alanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko01100	Metabolic pathways	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044197	K00276	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMT200044200	K01725	ko00910	Nitrogen metabolism	1087	4.1e-54	0.82	0.92	0.97
PGSC0003DMT200026427	K04424	ko04010	MAPK signaling pathway	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMT200026427	K04424	ko04530	Tight junction	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMT200026428	K04424	ko04010	MAPK signaling pathway	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMT200026428	K04424	ko04530	Tight junction	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMT200026429	K04424	ko04010	MAPK signaling pathway	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMT200026429	K04424	ko04530	Tight junction	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMT200009377	K00434	ko00053	Ascorbate and aldarate metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMT200009377	K00434	ko00480	Glutathione metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMT200009378	K00434	ko00053	Ascorbate and aldarate metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMT200009378	K00434	ko00480	Glutathione metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMT200009380	K00434	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMT200009380	K00434	ko00480	Glutathione metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMT200009381	K06662	ko04111	Cell cycle - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMT200009381	K06662	ko04113	Meiosis - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMT200009382	K06662	ko04111	Cell cycle - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMT200009382	K06662	ko04113	Meiosis - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMT200009383	K06662	ko04111	Cell cycle - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMT200009383	K06662	ko04113	Meiosis - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMT200009384	K06662	ko04111	Cell cycle - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMT200009384	K06662	ko04113	Meiosis - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMT200009399	K00430	ko00360	Phenylalanine metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMT200009399	K00430	ko00680	Methane metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMT200009399	K00430	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMT200009399	K00430	ko01100	Metabolic pathways	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMT200009399	K00430	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMT200009400	K00430	ko00360	Phenylalanine metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMT200009400	K00430	ko00680	Methane metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMT200009400	K00430	ko00940	Phenylpropanoid biosynthesis	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMT200009400	K00430	ko01100	Metabolic pathways	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMT200009400	K00430	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMT200009402	K00430	ko00360	Phenylalanine metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMT200009402	K00430	ko00680	Methane metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMT200009402	K00430	ko00940	Phenylpropanoid biosynthesis	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMT200009402	K00430	ko01100	Metabolic pathways	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMT200009402	K00430	ko01110	Biosynthesis of secondary metabolites	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMT200009403	K00430	ko00360	Phenylalanine metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMT200009403	K00430	ko00680	Methane metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMT200009403	K00430	ko00940	Phenylpropanoid biosynthesis	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMT200009403	K00430	ko01100	Metabolic pathways	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMT200009403	K00430	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMT200009404	K00430	ko00360	Phenylalanine metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMT200009404	K00430	ko00680	Methane metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMT200009404	K00430	ko00940	Phenylpropanoid biosynthesis	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMT200009404	K00430	ko01100	Metabolic pathways	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMT200009404	K00430	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMT200038432	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMT200038432	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMT200038432	K00734	ko01100	Metabolic pathways	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMT200088585	K01535	ko00190	Oxidative phosphorylation	6228	0.	0.78	0.88	0.99
PGSC0003DMT200088587	K05391	ko04626	Plant-pathogen interaction	3510	9.2e-188	0.64	0.78	0.99
PGSC0003DMT200088591	K00599	ko00340	Histidine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMT200088591	K00599	ko00350	Tyrosine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMT200088591	K00599	ko00450	Selenoamino acid metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMT200088591	K00599	ko00626	Naphthalene and anthracene degradation	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMT200001875	K12399	ko04142	Lysosome	704	5.4e-33	0.57	0.72	0.99
PGSC0003DMT200001876	K12399	ko04142	Lysosome	999	2.9e-49	0.73	0.87	0.98
PGSC0003DMT200001878	K12399	ko04142	Lysosome	411	7.8e-17	0.69	0.89	0.99
PGSC0003DMT200001884	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMT200001884	K08680	ko01100	Metabolic pathways	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMT200001884	K08680	ko01110	Biosynthesis of secondary metabolites	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMT200001885	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMT200001885	K08680	ko01100	Metabolic pathways	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMT200001885	K08680	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMT200001886	K12126	ko04712	Circadian rhythm - plant	319	1.9e-10	0.30	0.46	0.62
PGSC0003DMT200001888	K12126	ko04712	Circadian rhythm - plant	319	2.8e-10	0.30	0.46	0.60
PGSC0003DMT200001890	K01051	ko00040	Pentose and glucuronate interconversions	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMT200001890	K01051	ko00500	Starch and sucrose metabolism	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMT200001890	K01051	ko01100	Metabolic pathways	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMT200001904	K07897	ko04144	Endocytosis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMT200001904	K07897	ko04145	Phagosome	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMT200001904	K07897	ko05146	Amoebiasis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMT200001906	K04536	ko04062	Chemokine signaling pathway	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMT200001906	K04536	ko04742	Taste transduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMT200001906	K04536	ko04744	Phototransduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMT200001908	K01199	ko00500	Starch and sucrose metabolism	869	4.3e-42	0.38	0.57	0.71
PGSC0003DMT200097239	K03094	ko04110	Cell cycle	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04111	Cell cycle - yeast	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04114	Oocyte meiosis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04310	Wnt signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097239	K03094	ko04710	Circadian rhythm - mammal	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMT200097242	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMT200097242	K00517	ko00626	Naphthalene and anthracene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMT200097242	K00517	ko00903	Limonene and pinene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMT200097242	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMT200097242	K00517	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMT200097258	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	350	7.7e-11	0.26	0.44	0.69
PGSC0003DMT200021686	K01179	ko00500	Starch and sucrose metabolism	1467	4.5e-75	0.60	0.73	0.93
PGSC0003DMT200021687	K01179	ko00500	Starch and sucrose metabolism	2482	4.6e-131	0.62	0.77	0.95
PGSC0003DMT200021688	K01179	ko00500	Starch and sucrose metabolism	1060	1.2e-52	0.56	0.70	0.99
PGSC0003DMT200021696	K00817	ko00340	Histidine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko00350	Tyrosine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko00360	Phenylalanine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko00401	Novobiocin biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko01100	Metabolic pathways	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021696	K00817	ko01110	Biosynthesis of secondary metabolites	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMT200021697	K08735	ko03430	Mismatch repair	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMT200021697	K08735	ko05200	Pathways in cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMT200021697	K08735	ko05210	Colorectal cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMT200021699	K08735	ko03430	Mismatch repair	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMT200021699	K08735	ko05200	Pathways in cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMT200021699	K08735	ko05210	Colorectal cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMT200021706	K02929	ko03010	Ribosome	840	1.7e-40	0.92	0.95	0.36
PGSC0003DMT200006938	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006938	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006938	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006939	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006939	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006939	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006940	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006940	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006940	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMT200006941	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMT200006941	K00517	ko00626	Naphthalene and anthracene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMT200006941	K00517	ko00903	Limonene and pinene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMT200006941	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMT200006941	K00517	ko01110	Biosynthesis of secondary metabolites	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMT200006942	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMT200006942	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMT200006942	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMT200006942	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMT200006945	K00873	ko00010	Glycolysis / Gluconeogenesis	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko00230	Purine metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko00620	Pyruvate metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko00710	Carbon fixation in photosynthetic organisms	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko01100	Metabolic pathways	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko01110	Biosynthesis of secondary metabolites	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006945	K00873	ko04930	Type II diabetes mellitus	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMT200006953	K12626	ko03018	RNA degradation	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMT200006953	K12626	ko03040	Spliceosome	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMT200032862	K00235	ko00020	Citrate cycle (TCA cycle)	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko00190	Oxidative phosphorylation	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko01100	Metabolic pathways	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko05010	Alzheimer's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko05012	Parkinson's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032862	K00235	ko05016	Huntington's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMT200032863	K12386	ko04142	Lysosome	807	1.1e-38	0.82	0.88	0.88
PGSC0003DMT200032864	K12386	ko04142	Lysosome	1685	4.2e-87	0.76	0.84	0.97
PGSC0003DMT200032875	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032875	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032875	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032877	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032877	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032877	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMT200032880	K06665	ko04111	Cell cycle - yeast	295	1.6e-09	0.27	0.44	0.87
PGSC0003DMT200041351	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMT200041351	K01736	ko01100	Metabolic pathways	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMT200041351	K01736	ko01110	Biosynthesis of secondary metabolites	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMT200041352	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMT200041352	K01736	ko01100	Metabolic pathways	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMT200041352	K01736	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMT200041354	K01187	ko00052	Galactose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMT200041354	K01187	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMT200041354	K01187	ko01100	Metabolic pathways	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMT200041355	K01187	ko00052	Galactose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMT200041355	K01187	ko00500	Starch and sucrose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMT200041355	K01187	ko01100	Metabolic pathways	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMT200041356	K01187	ko00052	Galactose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMT200041356	K01187	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMT200041356	K01187	ko01100	Metabolic pathways	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMT200041357	K01187	ko00052	Galactose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMT200041357	K01187	ko00500	Starch and sucrose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMT200041357	K01187	ko01100	Metabolic pathways	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMT200041358	K01187	ko00052	Galactose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMT200041358	K01187	ko00500	Starch and sucrose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMT200041358	K01187	ko01100	Metabolic pathways	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMT200041360	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1759	3.5e-91	0.50	0.67	0.91
PGSC0003DMT200041389	K01213	ko00040	Pentose and glucuronate interconversions	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMT200041389	K01213	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMT200041389	K01213	ko01100	Metabolic pathways	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMT200049809	K08099	ko00860	Porphyrin and chlorophyll metabolism	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMT200049809	K08099	ko01100	Metabolic pathways	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMT200049809	K08099	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMT200049817	K01968	ko00280	Valine, leucine and isoleucine degradation	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMT200049817	K01968	ko01100	Metabolic pathways	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMT200049818	K01968	ko00280	Valine, leucine and isoleucine degradation	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMT200049818	K01968	ko01100	Metabolic pathways	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMT200049819	K01968	ko00280	Valine, leucine and isoleucine degradation	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMT200049819	K01968	ko01100	Metabolic pathways	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMT200075548	K02937	ko03010	Ribosome	1803	1.3e-93	0.87	0.94	1.00
PGSC0003DMT200075554	K06001	ko00260	Glycine, serine and threonine metabolism	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMT200075554	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMT200075554	K06001	ko01100	Metabolic pathways	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMT200075554	K06001	ko01110	Biosynthesis of secondary metabolites	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMT200075555	K06001	ko00260	Glycine, serine and threonine metabolism	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMT200075555	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMT200075555	K06001	ko01100	Metabolic pathways	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMT200075555	K06001	ko01110	Biosynthesis of secondary metabolites	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMT200075556	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMT200075557	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMT200075569	K00600	ko00260	Glycine, serine and threonine metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075569	K00600	ko00460	Cyanoamino acid metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075569	K00600	ko00670	One carbon pool by folate	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075569	K00600	ko00680	Methane metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075569	K00600	ko01100	Metabolic pathways	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075569	K00600	ko01110	Biosynthesis of secondary metabolites	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMT200075570	K00600	ko00260	Glycine, serine and threonine metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200075570	K00600	ko00460	Cyanoamino acid metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200075570	K00600	ko00670	One carbon pool by folate	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200075570	K00600	ko00680	Methane metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200075570	K00600	ko01100	Metabolic pathways	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200075570	K00600	ko01110	Biosynthesis of secondary metabolites	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMT200094391	K01051	ko00040	Pentose and glucuronate interconversions	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMT200094391	K01051	ko00500	Starch and sucrose metabolism	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMT200094391	K01051	ko01100	Metabolic pathways	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMT200094406	K01178	ko00500	Starch and sucrose metabolism	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMT200094406	K01178	ko01100	Metabolic pathways	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMT200094413	K01051	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMT200094413	K01051	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMT200094413	K01051	ko01100	Metabolic pathways	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMT200027924	K04733	ko04210	Apoptosis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMT200027924	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMT200027924	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMT200027924	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMT200027924	K04733	ko05142	Chagas disease	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMT200027930	K00850	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027930	K00850	ko00030	Pentose phosphate pathway	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027930	K00850	ko00051	Fructose and mannose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027930	K00850	ko00052	Galactose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027930	K00850	ko01100	Metabolic pathways	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027930	K00850	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMT200027931	K00850	ko00010	Glycolysis / Gluconeogenesis	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027931	K00850	ko00030	Pentose phosphate pathway	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027931	K00850	ko00051	Fructose and mannose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027931	K00850	ko00052	Galactose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027931	K00850	ko01100	Metabolic pathways	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027931	K00850	ko01110	Biosynthesis of secondary metabolites	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMT200027955	K01728	ko00040	Pentose and glucuronate interconversions	2645	4.7e-140	0.74	0.86	0.99
PGSC0003DMT200037319	K00754	ko00051	Fructose and mannose metabolism	1386	1.3e-70	0.39	0.59	0.98
PGSC0003DMT200037320	K00754	ko00051	Fructose and mannose metabolism	1383	1.9e-70	0.42	0.60	0.83
PGSC0003DMT200037324	K08901	ko00195	Photosynthesis	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMT200037324	K08901	ko01100	Metabolic pathways	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMT200037325	K08901	ko00195	Photosynthesis	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMT200037325	K08901	ko01100	Metabolic pathways	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMT200037326	K08901	ko00195	Photosynthesis	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMT200037326	K08901	ko01100	Metabolic pathways	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMT200037327	K11238	ko04011	MAPK signaling pathway - yeast	498	1.6e-20	0.38	0.44	0.38
PGSC0003DMT200037335	K04079	ko04612	Antigen processing and presentation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037335	K04079	ko04621	NOD-like receptor signaling pathway	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037335	K04079	ko04626	Plant-pathogen interaction	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037335	K04079	ko04914	Progesterone-mediated oocyte maturation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037335	K04079	ko05200	Pathways in cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037335	K04079	ko05215	Prostate cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMT200037336	K04079	ko04612	Antigen processing and presentation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200037336	K04079	ko04621	NOD-like receptor signaling pathway	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200037336	K04079	ko04626	Plant-pathogen interaction	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200037336	K04079	ko04914	Progesterone-mediated oocyte maturation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200037336	K04079	ko05200	Pathways in cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200037336	K04079	ko05215	Prostate cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMT200017763	K00472	ko00330	Arginine and proline metabolism	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMT200017763	K00472	ko01100	Metabolic pathways	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMT200017765	K00599	ko00340	Histidine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMT200017765	K00599	ko00350	Tyrosine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMT200017765	K00599	ko00450	Selenoamino acid metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMT200017765	K00599	ko00626	Naphthalene and anthracene degradation	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMT200017767	K00599	ko00340	Histidine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMT200017767	K00599	ko00350	Tyrosine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMT200017767	K00599	ko00450	Selenoamino acid metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMT200017767	K00599	ko00626	Naphthalene and anthracene degradation	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMT200017771	K11644	ko05016	Huntington's disease	6353	0.	0.60	0.73	0.95
PGSC0003DMT200017773	K11644	ko05016	Huntington's disease	7395	0.	0.64	0.78	1.00
PGSC0003DMT200017774	K11644	ko05016	Huntington's disease	7378	0.	0.64	0.77	1.00
PGSC0003DMT200017775	K11644	ko05016	Huntington's disease	7304	0.	0.64	0.77	1.00
PGSC0003DMT200017785	K01184	ko00040	Pentose and glucuronate interconversions	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMT200017785	K01184	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMT200017785	K01184	ko01100	Metabolic pathways	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMT200017786	K01184	ko00040	Pentose and glucuronate interconversions	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMT200017786	K01184	ko00500	Starch and sucrose metabolism	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMT200017786	K01184	ko01100	Metabolic pathways	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMT200017787	K01184	ko00040	Pentose and glucuronate interconversions	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMT200017787	K01184	ko00500	Starch and sucrose metabolism	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMT200017787	K01184	ko01100	Metabolic pathways	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMT200017799	K10846	ko03420	Nucleotide excision repair	5547	4.1e-300	0.50	0.64	1.00
PGSC0003DMT200017805	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200017805	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200017805	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200017806	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200017806	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200017806	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMT200074177	K01213	ko00040	Pentose and glucuronate interconversions	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMT200074177	K01213	ko00500	Starch and sucrose metabolism	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMT200074177	K01213	ko01100	Metabolic pathways	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMT200074178	K01213	ko00040	Pentose and glucuronate interconversions	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMT200074178	K01213	ko00500	Starch and sucrose metabolism	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMT200074178	K01213	ko01100	Metabolic pathways	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMT200074179	K01213	ko00040	Pentose and glucuronate interconversions	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMT200074179	K01213	ko00500	Starch and sucrose metabolism	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMT200074179	K01213	ko01100	Metabolic pathways	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMT200074180	K01213	ko00040	Pentose and glucuronate interconversions	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMT200074180	K01213	ko00500	Starch and sucrose metabolism	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMT200074180	K01213	ko01100	Metabolic pathways	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMT200074181	K01213	ko00040	Pentose and glucuronate interconversions	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMT200074181	K01213	ko00500	Starch and sucrose metabolism	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMT200074181	K01213	ko01100	Metabolic pathways	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMT200074192	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMT200074193	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMT200074197	K02145	ko00190	Oxidative phosphorylation	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074197	K02145	ko01100	Metabolic pathways	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074197	K02145	ko04145	Phagosome	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074197	K02145	ko04966	Collecting duct acid secretion	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074197	K02145	ko05110	Vibrio cholerae infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074197	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMT200074204	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.43	0.64	0.97
PGSC0003DMT200074206	K02135	ko00190	Oxidative phosphorylation	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMT200074206	K02135	ko01100	Metabolic pathways	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMT200074206	K02135	ko05010	Alzheimer's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMT200074206	K02135	ko05012	Parkinson's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMT200074206	K02135	ko05016	Huntington's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMT200046609	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMT200046609	K00766	ko01100	Metabolic pathways	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMT200046609	K00766	ko01110	Biosynthesis of secondary metabolites	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMT200046620	K04733	ko04210	Apoptosis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMT200046620	K04733	ko04620	Toll-like receptor signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMT200046620	K04733	ko04722	Neurotrophin signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMT200046620	K04733	ko05140	Leishmaniasis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMT200046620	K04733	ko05142	Chagas disease	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMT200046636	K06611	ko00052	Galactose metabolism	3566	7.5e-191	0.68	0.82	0.97
PGSC0003DMT200046639	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMT200046640	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMT200046641	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMT200046642	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMT200046643	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMT200046644	K01955	ko00240	Pyrimidine metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMT200046644	K01955	ko00250	Alanine, aspartate and glutamate metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMT200046644	K01955	ko01100	Metabolic pathways	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMT200046646	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMT200046646	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMT200046647	K08008	ko04145	Phagosome	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMT200046647	K08008	ko04670	Leukocyte transendothelial migration	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMT200046648	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMT200046648	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMT200061786	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061786	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061786	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061787	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061787	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061787	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMT200061789	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMT200061789	K03785	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMT200061789	K03785	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMT200061790	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMT200061790	K03785	ko01100	Metabolic pathways	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMT200061790	K03785	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMT200061791	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMT200061791	K03785	ko01100	Metabolic pathways	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMT200061791	K03785	ko01110	Biosynthesis of secondary metabolites	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMT200061799	K10144	ko04115	p53 signaling pathway	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMT200061799	K10144	ko04120	Ubiquitin mediated proteolysis	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMT200061800	K10144	ko04115	p53 signaling pathway	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMT200061800	K10144	ko04120	Ubiquitin mediated proteolysis	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMT200061801	K03869	ko04120	Ubiquitin mediated proteolysis	1769	9.8e-92	0.36	0.56	0.99
PGSC0003DMT200061802	K03869	ko04120	Ubiquitin mediated proteolysis	1809	6.1e-94	0.36	0.57	0.99
PGSC0003DMT200061821	K01051	ko00040	Pentose and glucuronate interconversions	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMT200061821	K01051	ko00500	Starch and sucrose metabolism	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMT200061821	K01051	ko01100	Metabolic pathways	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMT200061823	K06672	ko04111	Cell cycle - yeast	236	6.6e-06	0.46	0.59	0.80
PGSC0003DMT200064384	K02938	ko03010	Ribosome	836	2.8e-40	0.99	1.00	0.99
PGSC0003DMT200064385	K02938	ko03010	Ribosome	2210	4.7e-116	0.96	0.99	1.00
PGSC0003DMT200064412	K05391	ko04626	Plant-pathogen interaction	1999	2.0e-104	0.79	0.89	1.00
PGSC0003DMT200064413	K05391	ko04626	Plant-pathogen interaction	3466	2.5e-185	0.65	0.77	0.90
PGSC0003DMT200064424	K12486	ko04144	Endocytosis	434	4.2e-18	0.61	0.75	0.93
PGSC0003DMT200064425	K12486	ko04144	Endocytosis	2301	4.5e-121	0.60	0.73	1.00
PGSC0003DMT200064426	K04733	ko04210	Apoptosis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMT200064426	K04733	ko04620	Toll-like receptor signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMT200064426	K04733	ko04722	Neurotrophin signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMT200064426	K04733	ko05140	Leishmaniasis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMT200064426	K04733	ko05142	Chagas disease	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMT200064427	K04733	ko04210	Apoptosis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMT200064427	K04733	ko04620	Toll-like receptor signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMT200064427	K04733	ko04722	Neurotrophin signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMT200064427	K04733	ko05140	Leishmaniasis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMT200064427	K04733	ko05142	Chagas disease	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMT200079839	K00799	ko00480	Glutathione metabolism	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMT200079839	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMT200079839	K00799	ko00982	Drug metabolism - cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMT200079840	K00799	ko00480	Glutathione metabolism	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMT200079840	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMT200079840	K00799	ko00982	Drug metabolism - cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMT200079841	K00799	ko00480	Glutathione metabolism	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMT200079841	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMT200079841	K00799	ko00982	Drug metabolism - cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMT200079842	K00799	ko00480	Glutathione metabolism	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMT200079842	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMT200079842	K00799	ko00982	Drug metabolism - cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMT200029711	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029711	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029713	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMT200029716	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029716	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029717	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200029718	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMT200016765	K03869	ko04120	Ubiquitin mediated proteolysis	5531	3.1e-299	0.89	0.95	1.00
PGSC0003DMT200016766	K04713	ko00600	Sphingolipid metabolism	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMT200016766	K04713	ko01100	Metabolic pathways	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMT200016780	K04733	ko04210	Apoptosis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMT200016780	K04733	ko04620	Toll-like receptor signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMT200016780	K04733	ko04722	Neurotrophin signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMT200016780	K04733	ko05140	Leishmaniasis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMT200016780	K04733	ko05142	Chagas disease	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMT200016782	K04733	ko04210	Apoptosis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMT200016782	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMT200016782	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMT200016782	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMT200016782	K04733	ko05142	Chagas disease	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMT200016783	K04733	ko04210	Apoptosis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMT200016783	K04733	ko04620	Toll-like receptor signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMT200016783	K04733	ko04722	Neurotrophin signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMT200016783	K04733	ko05140	Leishmaniasis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMT200016783	K04733	ko05142	Chagas disease	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMT200035516	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMT200035516	K00517	ko00626	Naphthalene and anthracene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMT200035516	K00517	ko00903	Limonene and pinene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMT200035516	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMT200035516	K00517	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMT200035521	K00430	ko00360	Phenylalanine metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMT200035521	K00430	ko00680	Methane metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMT200035521	K00430	ko00940	Phenylpropanoid biosynthesis	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMT200035521	K00430	ko01100	Metabolic pathways	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMT200035521	K00430	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMT200035531	K04460	ko04010	MAPK signaling pathway	790	9.7e-38	0.40	0.55	0.73
PGSC0003DMT200035541	K00021	ko00900	Terpenoid backbone biosynthesis	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMT200035541	K00021	ko01100	Metabolic pathways	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMT200035541	K00021	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMT200035542	K00021	ko00900	Terpenoid backbone biosynthesis	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMT200035542	K00021	ko01100	Metabolic pathways	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMT200035542	K00021	ko01110	Biosynthesis of secondary metabolites	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMT200035545	K11594	ko04622	RIG-I-like receptor signaling pathway	244	1.3e-07	0.36	0.47	0.82
PGSC0003DMT200035552	K12585	ko03018	RNA degradation	6391	0.	0.80	0.89	1.00
PGSC0003DMT200019607	K10418	ko04962	Vasopressin-regulated water reabsorption	332	1.8e-12	0.49	0.67	0.94
PGSC0003DMT200019620	K07424	ko00140	Steroid hormone biosynthesis	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00591	Linoleic acid metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00830	Retinol metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00982	Drug metabolism - cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko00983	Drug metabolism - other enzymes	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019620	K07424	ko01100	Metabolic pathways	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMT200019624	K01528	ko04144	Endocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMT200019624	K01528	ko04666	Fc gamma R-mediated phagocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMT200019624	K01528	ko05100	Bacterial invasion of epithelial cells	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMT200019625	K01528	ko04144	Endocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMT200019625	K01528	ko04666	Fc gamma R-mediated phagocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMT200019625	K01528	ko05100	Bacterial invasion of epithelial cells	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMT200095598	K10591	ko04120	Ubiquitin mediated proteolysis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMT200095598	K10591	ko04144	Endocytosis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMT200044745	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044745	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044746	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMT200044764	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMT200044765	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMT200044777	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044777	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200044778	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMT200072491	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072491	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMT200072494	K04505	ko04310	Wnt signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMT200072494	K04505	ko04330	Notch signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMT200072494	K04505	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMT200072494	K04505	ko05010	Alzheimer's disease	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMT200072501	K11294	ko05130	Pathogenic Escherichia coli infection	383	2.7e-15	0.31	0.49	0.62
PGSC0003DMT200072515	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMT200072516	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMT200072522	K02146	ko00190	Oxidative phosphorylation	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072522	K02146	ko01100	Metabolic pathways	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072522	K02146	ko04142	Lysosome	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072522	K02146	ko04966	Collecting duct acid secretion	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072522	K02146	ko05110	Vibrio cholerae infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072522	K02146	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMT200072524	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMT200072524	K00517	ko00626	Naphthalene and anthracene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMT200072524	K00517	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMT200072524	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMT200072524	K00517	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMT200072530	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMT200072530	K08081	ko01100	Metabolic pathways	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMT200072530	K08081	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMT200072531	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMT200072531	K08081	ko01100	Metabolic pathways	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMT200072531	K08081	ko01110	Biosynthesis of secondary metabolites	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMT200062699	K07424	ko00140	Steroid hormone biosynthesis	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00591	Linoleic acid metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00830	Retinol metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00982	Drug metabolism - cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko00983	Drug metabolism - other enzymes	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062699	K07424	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMT200062701	K07424	ko00140	Steroid hormone biosynthesis	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00591	Linoleic acid metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00830	Retinol metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko00983	Drug metabolism - other enzymes	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062701	K07424	ko01100	Metabolic pathways	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMT200062725	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062725	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062726	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062726	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062727	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062727	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMT200062735	K02976	ko03010	Ribosome	564	2.8e-25	0.73	0.83	0.86
PGSC0003DMT200062744	K12929	ko00904	Diterpenoid biosynthesis	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMT200062744	K12929	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMT200062746	K12929	ko00904	Diterpenoid biosynthesis	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMT200062746	K12929	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMT200081940	K04567	ko00970	Aminoacyl-tRNA biosynthesis	674	2.4e-31	0.79	0.90	0.99
PGSC0003DMT200081941	K04567	ko00970	Aminoacyl-tRNA biosynthesis	2006	8.3e-105	0.82	0.91	1.00
PGSC0003DMT200081942	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3907	1.2e-209	0.80	0.89	0.99
PGSC0003DMT200081973	K04382	ko04111	Cell cycle - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04113	Meiosis - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04114	Oocyte meiosis	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04310	Wnt signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04350	TGF-beta signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04530	Tight junction	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko04730	Long-term depression	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200081973	K04382	ko05142	Chagas disease	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMT200031185	K04392	ko04010	MAPK signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04062	Chemokine signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04145	Phagosome	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04310	Wnt signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04360	Axon guidance	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04370	VEGF signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04510	Focal adhesion	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04520	Adherens junction	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04620	Toll-like receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04650	Natural killer cell mediated cytotoxicity	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04662	B cell receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04664	Fc epsilon RI signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04666	Fc gamma R-mediated phagocytosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04670	Leukocyte transendothelial migration	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko04810	Regulation of actin cytoskeleton	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05100	Bacterial invasion of epithelial cells	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05131	Shigellosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05200	Pathways in cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05210	Colorectal cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05211	Renal cell carcinoma	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05212	Pancreatic cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031185	K04392	ko05416	Viral myocarditis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMT200031186	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031186	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031187	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMT200031188	K04392	ko04010	MAPK signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04062	Chemokine signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04145	Phagosome	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04310	Wnt signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04360	Axon guidance	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04370	VEGF signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04510	Focal adhesion	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04520	Adherens junction	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04620	Toll-like receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04664	Fc epsilon RI signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04666	Fc gamma R-mediated phagocytosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04670	Leukocyte transendothelial migration	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko04810	Regulation of actin cytoskeleton	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05100	Bacterial invasion of epithelial cells	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05131	Shigellosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05200	Pathways in cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05210	Colorectal cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05211	Renal cell carcinoma	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05212	Pancreatic cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031188	K04392	ko05416	Viral myocarditis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMT200031189	K10590	ko04120	Ubiquitin mediated proteolysis	6211	0.	0.73	0.83	0.99
PGSC0003DMT200031190	K10590	ko04120	Ubiquitin mediated proteolysis	5226	2.1e-282	0.77	0.86	0.97
PGSC0003DMT200031191	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMT200031192	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMT200031195	K00430	ko00360	Phenylalanine metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMT200031195	K00430	ko00680	Methane metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMT200031195	K00430	ko00940	Phenylpropanoid biosynthesis	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMT200031195	K00430	ko01100	Metabolic pathways	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMT200031195	K00430	ko01110	Biosynthesis of secondary metabolites	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMT200031198	K02639	ko00195	Photosynthesis	859	1.5e-41	0.70	0.86	0.98
PGSC0003DMT200005081	K00606	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMT200005081	K00606	ko01100	Metabolic pathways	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMT200005081	K00606	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMT200005082	K00606	ko00770	Pantothenate and CoA biosynthesis	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMT200005082	K00606	ko01100	Metabolic pathways	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMT200005082	K00606	ko01110	Biosynthesis of secondary metabolites	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMT200005083	K00606	ko00770	Pantothenate and CoA biosynthesis	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMT200005083	K00606	ko01100	Metabolic pathways	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMT200005083	K00606	ko01110	Biosynthesis of secondary metabolites	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMT200005104	K00799	ko00480	Glutathione metabolism	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMT200005104	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMT200005104	K00799	ko00982	Drug metabolism - cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMT200005105	K00799	ko00480	Glutathione metabolism	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMT200005105	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMT200005105	K00799	ko00982	Drug metabolism - cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMT200005106	K01426	ko00330	Arginine and proline metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005106	K01426	ko00360	Phenylalanine metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005106	K01426	ko00380	Tryptophan metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005106	K01426	ko00460	Cyanoamino acid metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005106	K01426	ko00632	Benzoate degradation via CoA ligation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005106	K01426	ko00643	Styrene degradation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMT200005108	K02433	ko00970	Aminoacyl-tRNA biosynthesis	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMT200005108	K02433	ko01100	Metabolic pathways	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMT200043087	K05933	ko00270	Cysteine and methionine metabolism	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMT200043087	K05933	ko01110	Biosynthesis of secondary metabolites	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMT200043088	K05933	ko00270	Cysteine and methionine metabolism	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMT200043088	K05933	ko01110	Biosynthesis of secondary metabolites	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMT200043089	K05933	ko00270	Cysteine and methionine metabolism	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMT200043089	K05933	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMT200043093	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-34	0.31	0.49	0.54
PGSC0003DMT200043094	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-32	0.31	0.49	0.47
PGSC0003DMT200043098	K02016	ko02010	ABC transporters	326	3.8e-12	0.26	0.44	0.92
PGSC0003DMT200043099	K02016	ko02010	ABC transporters	310	2.9e-11	0.28	0.45	0.86
PGSC0003DMT200043101	K12858	ko03040	Spliceosome	5141	1.0e-277	0.86	0.92	1.00
PGSC0003DMT200043102	K02291	ko00906	Carotenoid biosynthesis	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMT200043102	K02291	ko01100	Metabolic pathways	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMT200043102	K02291	ko01110	Biosynthesis of secondary metabolites	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMT200043103	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043103	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043103	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043104	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043104	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043104	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMT200043105	K00799	ko00480	Glutathione metabolism	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMT200043105	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMT200043105	K00799	ko00982	Drug metabolism - cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMT200043111	K00895	ko00051	Fructose and mannose metabolism	3888	1.3e-208	0.82	0.90	0.99
PGSC0003DMT200066399	K00366	ko00910	Nitrogen metabolism	4199	9.2e-226	0.82	0.92	1.00
PGSC0003DMT200066402	K08233	ko00901	Indole alkaloid biosynthesis	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMT200066402	K08233	ko01110	Biosynthesis of secondary metabolites	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMT200066403	K08233	ko00901	Indole alkaloid biosynthesis	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMT200066403	K08233	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMT200066404	K08233	ko00901	Indole alkaloid biosynthesis	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMT200066404	K08233	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMT200066405	K08233	ko00901	Indole alkaloid biosynthesis	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMT200066405	K08233	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMT200066409	K01692	ko00071	Fatty acid metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00280	Valine, leucine and isoleucine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00281	Geraniol degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00310	Lysine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00380	Tryptophan metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00410	beta-Alanine metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00640	Propanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00650	Butanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00903	Limonene and pinene degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko00930	Caprolactam degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko01100	Metabolic pathways	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066409	K01692	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMT200066411	K01692	ko00071	Fatty acid metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00280	Valine, leucine and isoleucine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00281	Geraniol degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00310	Lysine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00380	Tryptophan metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00410	beta-Alanine metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00632	Benzoate degradation via CoA ligation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00640	Propanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00650	Butanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00903	Limonene and pinene degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko00930	Caprolactam degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko01100	Metabolic pathways	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066411	K01692	ko01110	Biosynthesis of secondary metabolites	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMT200066412	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00310	Lysine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066412	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMT200066414	K01692	ko00071	Fatty acid metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00280	Valine, leucine and isoleucine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00281	Geraniol degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00310	Lysine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00380	Tryptophan metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00410	beta-Alanine metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00632	Benzoate degradation via CoA ligation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00640	Propanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00650	Butanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00903	Limonene and pinene degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko00930	Caprolactam degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko01100	Metabolic pathways	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066414	K01692	ko01110	Biosynthesis of secondary metabolites	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMT200066416	K01692	ko00071	Fatty acid metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00280	Valine, leucine and isoleucine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00281	Geraniol degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00310	Lysine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00380	Tryptophan metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00410	beta-Alanine metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00632	Benzoate degradation via CoA ligation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00640	Propanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00650	Butanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00903	Limonene and pinene degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko00930	Caprolactam degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko01100	Metabolic pathways	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066416	K01692	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMT200066419	K01692	ko00071	Fatty acid metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00280	Valine, leucine and isoleucine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00281	Geraniol degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00310	Lysine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00380	Tryptophan metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00410	beta-Alanine metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00632	Benzoate degradation via CoA ligation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00640	Propanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00650	Butanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00903	Limonene and pinene degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko00930	Caprolactam degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko01100	Metabolic pathways	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066419	K01692	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMT200066420	K01692	ko00071	Fatty acid metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00281	Geraniol degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00310	Lysine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00380	Tryptophan metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00410	beta-Alanine metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00632	Benzoate degradation via CoA ligation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00640	Propanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00650	Butanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00903	Limonene and pinene degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko00930	Caprolactam degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko01100	Metabolic pathways	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066420	K01692	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMT200066421	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066421	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066423	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMT200066424	K01692	ko00071	Fatty acid metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00280	Valine, leucine and isoleucine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00281	Geraniol degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00310	Lysine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00380	Tryptophan metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00410	beta-Alanine metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00632	Benzoate degradation via CoA ligation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00640	Propanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00650	Butanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00903	Limonene and pinene degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko00930	Caprolactam degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko01100	Metabolic pathways	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066424	K01692	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMT200066425	K01692	ko00071	Fatty acid metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00280	Valine, leucine and isoleucine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00281	Geraniol degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00310	Lysine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00380	Tryptophan metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00410	beta-Alanine metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00632	Benzoate degradation via CoA ligation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00640	Propanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00650	Butanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00903	Limonene and pinene degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko00930	Caprolactam degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko01100	Metabolic pathways	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200066425	K01692	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMT200077285	K00434	ko00053	Ascorbate and aldarate metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMT200077285	K00434	ko00480	Glutathione metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMT200077286	K00434	ko00053	Ascorbate and aldarate metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMT200077286	K00434	ko00480	Glutathione metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMT200077291	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMT200077292	K11247	ko04144	Endocytosis	653	3.5e-30	0.59	0.79	0.71
PGSC0003DMT200077293	K11247	ko04144	Endocytosis	1121	5.4e-56	0.59	0.77	1.00
PGSC0003DMT200077294	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMT200077295	K11247	ko04144	Endocytosis	1744	2.3e-90	0.59	0.76	0.99
PGSC0003DMT200077302	K10798	ko03410	Base excision repair	3038	1.2e-167	0.54	0.70	0.98
PGSC0003DMT200077303	K10798	ko03410	Base excision repair	2868	2.4e-152	0.61	0.72	0.99
PGSC0003DMT200077329	K11419	ko00310	Lysine degradation	634	3.9e-29	0.37	0.51	0.38
PGSC0003DMT200051686	K12819	ko03040	Spliceosome	4030	1.9e-216	0.86	0.93	1.00
PGSC0003DMT200051687	K12819	ko03040	Spliceosome	3478	5.4e-186	0.88	0.94	0.97
PGSC0003DMT200051688	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMT200051713	K11816	ko00380	Tryptophan metabolism	2650	2.5e-140	0.73	0.86	0.99
PGSC0003DMT200051717	K00384	ko00240	Pyrimidine metabolism	222	9.6e-13	0.45	0.58	0.48
PGSC0003DMT200086374	K01760	ko00270	Cysteine and methionine metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200086374	K01760	ko00450	Selenoamino acid metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200086374	K01760	ko00910	Nitrogen metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200086374	K01760	ko00920	Sulfur metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200086374	K01760	ko01100	Metabolic pathways	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200086374	K01760	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMT200048225	K00627	ko00010	Glycolysis / Gluconeogenesis	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMT200048225	K00627	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMT200048225	K00627	ko00620	Pyruvate metabolism	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMT200048225	K00627	ko01100	Metabolic pathways	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMT200048225	K00627	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMT200048226	K00833	ko00780	Biotin metabolism	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMT200048226	K00833	ko01100	Metabolic pathways	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMT200048227	K00833	ko00780	Biotin metabolism	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMT200048227	K00833	ko01100	Metabolic pathways	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMT200048228	K00833	ko00780	Biotin metabolism	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMT200048228	K00833	ko01100	Metabolic pathways	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMT200048229	K03125	ko03022	Basal transcription factors	7537	0.	0.53	0.67	1.00
PGSC0003DMT200048230	K03125	ko03022	Basal transcription factors	6049	0.	0.58	0.73	0.98
PGSC0003DMT200048231	K03125	ko03022	Basal transcription factors	5968	0.	0.59	0.74	0.99
PGSC0003DMT200048232	K03125	ko03022	Basal transcription factors	7634	0.	0.54	0.69	1.00
PGSC0003DMT200048233	K03125	ko03022	Basal transcription factors	7627	0.	0.54	0.69	1.00
PGSC0003DMT200048234	K02183	ko04020	Calcium signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04070	Phosphatidylinositol signaling system	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04114	Oocyte meiosis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04270	Vascular smooth muscle contraction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04626	Plant-pathogen interaction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04720	Long-term potentiation	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04722	Neurotrophin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04740	Olfactory transduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04744	Phototransduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04745	Phototransduction - fly	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04910	Insulin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04912	GnRH signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04916	Melanogenesis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04970	Salivary secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko04971	Gastric acid secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko05010	Alzheimer's disease	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048234	K02183	ko05214	Glioma	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMT200048236	K02183	ko04020	Calcium signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04070	Phosphatidylinositol signaling system	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04114	Oocyte meiosis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04270	Vascular smooth muscle contraction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04626	Plant-pathogen interaction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04720	Long-term potentiation	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04722	Neurotrophin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04740	Olfactory transduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04744	Phototransduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04745	Phototransduction - fly	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04910	Insulin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04912	GnRH signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04916	Melanogenesis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04970	Salivary secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko04971	Gastric acid secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko05010	Alzheimer's disease	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048236	K02183	ko05214	Glioma	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMT200048249	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMT200048249	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMT200048249	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMT200048249	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMT200048249	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMT200066217	K00083	ko00940	Phenylpropanoid biosynthesis	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMT200066217	K00083	ko01100	Metabolic pathways	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMT200066217	K00083	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMT200060032	K03553	ko03440	Homologous recombination	2528	1.3e-133	0.69	0.77	1.00
PGSC0003DMT200060033	K03553	ko03440	Homologous recombination	2623	7.7e-139	0.76	0.85	1.00
PGSC0003DMT200060039	K01823	ko00900	Terpenoid backbone biosynthesis	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMT200060039	K01823	ko01100	Metabolic pathways	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMT200060039	K01823	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMT200060044	K00297	ko00670	One carbon pool by folate	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMT200060044	K00297	ko00680	Methane metabolism	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMT200060044	K00297	ko01100	Metabolic pathways	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMT200060045	K00297	ko00670	One carbon pool by folate	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMT200060045	K00297	ko00680	Methane metabolism	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMT200060045	K00297	ko01100	Metabolic pathways	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMT200060046	K00297	ko00670	One carbon pool by folate	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMT200060046	K00297	ko00680	Methane metabolism	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMT200060046	K00297	ko01100	Metabolic pathways	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMT200060066	K00599	ko00340	Histidine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMT200060066	K00599	ko00350	Tyrosine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMT200060066	K00599	ko00450	Selenoamino acid metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMT200060066	K00599	ko00626	Naphthalene and anthracene degradation	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMT200060067	K00599	ko00340	Histidine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMT200060067	K00599	ko00350	Tyrosine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMT200060067	K00599	ko00450	Selenoamino acid metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMT200060067	K00599	ko00626	Naphthalene and anthracene degradation	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMT200069264	K00162	ko00010	Glycolysis / Gluconeogenesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko00020	Citrate cycle (TCA cycle)	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko00620	Pyruvate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko00650	Butanoate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko01100	Metabolic pathways	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069264	K00162	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMT200069271	K02904	ko03010	Ribosome	761	3.9e-36	0.80	0.91	0.69
PGSC0003DMT200069276	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMT200069276	K01078	ko00740	Riboflavin metabolism	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMT200069295	K01099	ko00562	Inositol phosphate metabolism	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMT200069295	K01099	ko01100	Metabolic pathways	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMT200069295	K01099	ko04070	Phosphatidylinositol signaling system	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMT200069298	K01099	ko00562	Inositol phosphate metabolism	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMT200069298	K01099	ko01100	Metabolic pathways	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMT200069298	K01099	ko04070	Phosphatidylinositol signaling system	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMT200069300	K00863	ko00561	Glycerolipid metabolism	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMT200069300	K00863	ko01100	Metabolic pathways	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMT200069300	K00863	ko04622	RIG-I-like receptor signaling pathway	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMT200069301	K00863	ko00561	Glycerolipid metabolism	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMT200069301	K00863	ko01100	Metabolic pathways	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMT200069301	K00863	ko04622	RIG-I-like receptor signaling pathway	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMT200069302	K00863	ko00561	Glycerolipid metabolism	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMT200069302	K00863	ko01100	Metabolic pathways	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMT200069302	K00863	ko04622	RIG-I-like receptor signaling pathway	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMT200069311	K00654	ko00600	Sphingolipid metabolism	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMT200069311	K00654	ko01100	Metabolic pathways	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMT200048342	K02132	ko00190	Oxidative phosphorylation	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMT200048342	K02132	ko01100	Metabolic pathways	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMT200048342	K02132	ko05010	Alzheimer's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMT200048342	K02132	ko05012	Parkinson's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMT200048342	K02132	ko05016	Huntington's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMT200048344	K05894	ko00592	alpha-Linolenic acid metabolism	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMT200048344	K05894	ko01100	Metabolic pathways	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMT200048345	K05894	ko00592	alpha-Linolenic acid metabolism	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMT200048345	K05894	ko01100	Metabolic pathways	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMT200048347	K01046	ko00561	Glycerolipid metabolism	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMT200048347	K01046	ko01100	Metabolic pathways	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMT200048348	K01046	ko00561	Glycerolipid metabolism	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMT200048348	K01046	ko01100	Metabolic pathways	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMT200048357	K01066	ko00623	2,4-Dichlorobenzoate degradation	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMT200048357	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMT200048364	K12124	ko04712	Circadian rhythm - plant	6214	0.	0.77	0.87	1.00
PGSC0003DMT200048365	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMT200048366	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMT200048370	K12124	ko04712	Circadian rhythm - plant	5479	2.3e-296	0.75	0.85	1.00
PGSC0003DMT200048372	K12124	ko04712	Circadian rhythm - plant	536	5.1e-23	0.86	0.89	0.53
PGSC0003DMT200048379	K05658	ko02010	ABC transporters	3664	3.0e-196	0.45	0.65	1.00
PGSC0003DMT200091776	K12639	ko00905	Brassinosteroid biosynthesis	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMT200091776	K12639	ko01100	Metabolic pathways	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMT200091776	K12639	ko01110	Biosynthesis of secondary metabolites	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMT200091804	K04428	ko04010	MAPK signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMT200091804	K04428	ko04912	GnRH signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMT200039122	K01522	ko00230	Purine metabolism	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMT200039122	K01522	ko05222	Small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMT200039122	K01522	ko05223	Non-small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMT200039123	K01522	ko00230	Purine metabolism	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMT200039123	K01522	ko05222	Small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMT200039123	K01522	ko05223	Non-small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMT200039137	K10756	ko03030	DNA replication	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMT200039137	K10756	ko03420	Nucleotide excision repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMT200039137	K10756	ko03430	Mismatch repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMT200039153	K00901	ko00561	Glycerolipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMT200039153	K00901	ko00564	Glycerophospholipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMT200039153	K00901	ko01100	Metabolic pathways	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMT200039153	K00901	ko04070	Phosphatidylinositol signaling system	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMT200039176	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMT200039176	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMT200039176	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMT200039176	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMT200039176	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMT200039179	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMT200039179	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMT200039179	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMT200039179	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMT200039179	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMT200039185	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMT200039185	K00517	ko00626	Naphthalene and anthracene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMT200039185	K00517	ko00903	Limonene and pinene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMT200039185	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMT200039185	K00517	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMT200013242	K02084	ko04115	p53 signaling pathway	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko04210	Apoptosis	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko05010	Alzheimer's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko05012	Parkinson's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko05016	Huntington's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013242	K02084	ko05222	Small cell lung cancer	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMT200013258	K08233	ko00901	Indole alkaloid biosynthesis	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMT200013258	K08233	ko01110	Biosynthesis of secondary metabolites	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMT200013259	K08233	ko00901	Indole alkaloid biosynthesis	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMT200013259	K08233	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMT200013260	K08233	ko00901	Indole alkaloid biosynthesis	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMT200013260	K08233	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMT200013262	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013262	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013262	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013262	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013262	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013262	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013263	K01501	ko00380	Tryptophan metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013263	K01501	ko00460	Cyanoamino acid metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013263	K01501	ko00632	Benzoate degradation via CoA ligation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013263	K01501	ko00643	Styrene degradation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013263	K01501	ko00910	Nitrogen metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013263	K01501	ko01100	Metabolic pathways	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMT200013264	K01501	ko00380	Tryptophan metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013264	K01501	ko00460	Cyanoamino acid metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013264	K01501	ko00632	Benzoate degradation via CoA ligation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013264	K01501	ko00643	Styrene degradation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013264	K01501	ko00910	Nitrogen metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013264	K01501	ko01100	Metabolic pathways	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMT200013265	K01501	ko00380	Tryptophan metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013265	K01501	ko00460	Cyanoamino acid metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013265	K01501	ko00632	Benzoate degradation via CoA ligation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013265	K01501	ko00643	Styrene degradation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013265	K01501	ko00910	Nitrogen metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013265	K01501	ko01100	Metabolic pathways	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMT200013267	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013267	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013267	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013267	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013267	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200013267	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMT200022864	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMT200022865	K10609	ko03420	Nucleotide excision repair	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMT200022865	K10609	ko04120	Ubiquitin mediated proteolysis	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMT200022871	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMT200022872	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMT200022873	K13229	ko00402	Benzoxazinoid biosynthesis	951	1.3e-46	0.44	0.61	0.95
PGSC0003DMT200022884	K03106	ko03060	Protein export	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMT200022884	K03106	ko03070	Bacterial secretion system	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMT200022885	K03106	ko03060	Protein export	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMT200022885	K03106	ko03070	Bacterial secretion system	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMT200044607	K07424	ko00140	Steroid hormone biosynthesis	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00591	Linoleic acid metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00830	Retinol metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00982	Drug metabolism - cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko00983	Drug metabolism - other enzymes	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044607	K07424	ko01100	Metabolic pathways	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMT200044611	K06685	ko04111	Cell cycle - yeast	417	1.6e-13	0.29	0.47	0.36
PGSC0003DMT200044621	K07424	ko00140	Steroid hormone biosynthesis	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00591	Linoleic acid metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00830	Retinol metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00982	Drug metabolism - cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko00983	Drug metabolism - other enzymes	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044621	K07424	ko01100	Metabolic pathways	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMT200044628	K07424	ko00140	Steroid hormone biosynthesis	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00591	Linoleic acid metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00830	Retinol metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00982	Drug metabolism - cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko00983	Drug metabolism - other enzymes	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044628	K07424	ko01100	Metabolic pathways	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMT200044631	K07424	ko00140	Steroid hormone biosynthesis	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00591	Linoleic acid metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00830	Retinol metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00982	Drug metabolism - cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko00983	Drug metabolism - other enzymes	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044631	K07424	ko01100	Metabolic pathways	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMT200044632	K07424	ko00140	Steroid hormone biosynthesis	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00591	Linoleic acid metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00830	Retinol metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00982	Drug metabolism - cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko00983	Drug metabolism - other enzymes	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044632	K07424	ko01100	Metabolic pathways	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMT200044635	K07424	ko00140	Steroid hormone biosynthesis	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00591	Linoleic acid metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00830	Retinol metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00982	Drug metabolism - cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko00983	Drug metabolism - other enzymes	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044635	K07424	ko01100	Metabolic pathways	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMT200044636	K07424	ko00140	Steroid hormone biosynthesis	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00591	Linoleic acid metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00830	Retinol metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00982	Drug metabolism - cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko00983	Drug metabolism - other enzymes	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044636	K07424	ko01100	Metabolic pathways	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMT200044637	K07424	ko00140	Steroid hormone biosynthesis	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00591	Linoleic acid metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00830	Retinol metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00982	Drug metabolism - cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko00983	Drug metabolism - other enzymes	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044637	K07424	ko01100	Metabolic pathways	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMT200044638	K07424	ko00140	Steroid hormone biosynthesis	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00591	Linoleic acid metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00830	Retinol metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00982	Drug metabolism - cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko00983	Drug metabolism - other enzymes	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044638	K07424	ko01100	Metabolic pathways	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00140	Steroid hormone biosynthesis	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00591	Linoleic acid metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00830	Retinol metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00982	Drug metabolism - cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko00983	Drug metabolism - other enzymes	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044639	K07424	ko01100	Metabolic pathways	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMT200044640	K07424	ko00140	Steroid hormone biosynthesis	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00591	Linoleic acid metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00830	Retinol metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00982	Drug metabolism - cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko00983	Drug metabolism - other enzymes	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044640	K07424	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMT200044641	K07424	ko00140	Steroid hormone biosynthesis	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00591	Linoleic acid metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00830	Retinol metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00982	Drug metabolism - cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko00983	Drug metabolism - other enzymes	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044641	K07424	ko01100	Metabolic pathways	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMT200044643	K07424	ko00140	Steroid hormone biosynthesis	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00591	Linoleic acid metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00830	Retinol metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00982	Drug metabolism - cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko00983	Drug metabolism - other enzymes	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200044643	K07424	ko01100	Metabolic pathways	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMT200062953	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062953	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062953	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062954	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062954	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062954	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMT200062955	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMT200062955	K06125	ko01100	Metabolic pathways	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMT200062955	K06125	ko01110	Biosynthesis of secondary metabolites	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMT200062956	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMT200062956	K06125	ko01100	Metabolic pathways	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMT200062956	K06125	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMT200062957	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMT200062957	K06125	ko01100	Metabolic pathways	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMT200062957	K06125	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMT200062959	K04424	ko04010	MAPK signaling pathway	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMT200062959	K04424	ko04530	Tight junction	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMT200062965	K00099	ko00900	Terpenoid backbone biosynthesis	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMT200062965	K00099	ko01100	Metabolic pathways	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMT200062965	K00099	ko01110	Biosynthesis of secondary metabolites	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMT200062966	K00099	ko00900	Terpenoid backbone biosynthesis	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMT200062966	K00099	ko01100	Metabolic pathways	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMT200062966	K00099	ko01110	Biosynthesis of secondary metabolites	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMT200062967	K00099	ko00900	Terpenoid backbone biosynthesis	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMT200062967	K00099	ko01100	Metabolic pathways	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMT200062967	K00099	ko01110	Biosynthesis of secondary metabolites	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMT200055011	K12356	ko00940	Phenylpropanoid biosynthesis	824	1.3e-39	0.33	0.49	0.92
PGSC0003DMT200096037	K10760	ko00908	Zeatin biosynthesis	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMT200096037	K10760	ko01100	Metabolic pathways	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMT200096037	K10760	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMT200096044	K08233	ko00901	Indole alkaloid biosynthesis	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMT200096044	K08233	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMT200090250	K06063	ko03040	Spliceosome	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMT200090250	K06063	ko04330	Notch signaling pathway	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMT200003643	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMT200003643	K01850	ko01100	Metabolic pathways	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMT200003643	K01850	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMT200003644	K12356	ko00940	Phenylpropanoid biosynthesis	494	2.1e-21	0.31	0.52	0.92
PGSC0003DMT200003646	K10597	ko04120	Ubiquitin mediated proteolysis	1181	2.6e-59	0.80	0.93	0.94
PGSC0003DMT200003647	K10597	ko04120	Ubiquitin mediated proteolysis	3905	1.5e-209	0.88	0.95	0.98
PGSC0003DMT200003648	K10597	ko04120	Ubiquitin mediated proteolysis	6972	0.	0.81	0.89	0.99
PGSC0003DMT200003649	K10597	ko04120	Ubiquitin mediated proteolysis	5800	0.	0.80	0.88	1.00
PGSC0003DMT200003650	K05391	ko04626	Plant-pathogen interaction	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMT200003651	K05391	ko04626	Plant-pathogen interaction	4645	2.3e-250	0.75	0.84	1.00
PGSC0003DMT200034642	K06171	ko04330	Notch signaling pathway	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMT200034642	K06171	ko05010	Alzheimer's disease	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMT200034643	K06171	ko04330	Notch signaling pathway	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMT200034643	K06171	ko05010	Alzheimer's disease	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMT200034644	K06171	ko04330	Notch signaling pathway	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMT200034644	K06171	ko05010	Alzheimer's disease	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMT200034672	K00735	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMT200034672	K00735	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMT200034672	K00735	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMT200019851	K01046	ko00561	Glycerolipid metabolism	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMT200019851	K01046	ko01100	Metabolic pathways	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMT200019852	K01046	ko00561	Glycerolipid metabolism	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMT200019852	K01046	ko01100	Metabolic pathways	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMT200019853	K01046	ko00561	Glycerolipid metabolism	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMT200019853	K01046	ko01100	Metabolic pathways	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMT200019854	K01046	ko00561	Glycerolipid metabolism	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMT200019854	K01046	ko01100	Metabolic pathways	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMT200019867	K02984	ko03010	Ribosome	1934	7.8e-101	0.88	0.94	1.00
PGSC0003DMT200019869	K09553	ko05020	Prion diseases	265	1.3e-08	0.28	0.50	0.63
PGSC0003DMT200019870	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.38
PGSC0003DMT200019871	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.73
PGSC0003DMT200011792	K10527	ko00592	alpha-Linolenic acid metabolism	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMT200011792	K10527	ko01100	Metabolic pathways	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMT200011795	K01710	ko00521	Streptomycin biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMT200011795	K01710	ko00523	Polyketide sugar unit biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMT200011795	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMT200011795	K01710	ko01100	Metabolic pathways	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMT200011795	K01710	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMT200011817	K03644	ko00785	Lipoic acid metabolism	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMT200011817	K03644	ko01100	Metabolic pathways	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMT200011827	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMT200011827	K00517	ko00626	Naphthalene and anthracene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMT200011827	K00517	ko00903	Limonene and pinene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMT200011827	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMT200011827	K00517	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMT200011828	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMT200011828	K00517	ko00626	Naphthalene and anthracene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMT200011828	K00517	ko00903	Limonene and pinene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMT200011828	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMT200011828	K00517	ko01110	Biosynthesis of secondary metabolites	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMT200046466	K01051	ko00040	Pentose and glucuronate interconversions	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMT200046466	K01051	ko00500	Starch and sucrose metabolism	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMT200046466	K01051	ko01100	Metabolic pathways	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMT200046467	K01051	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMT200046467	K01051	ko00500	Starch and sucrose metabolism	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMT200046467	K01051	ko01100	Metabolic pathways	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMT200046471	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046471	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046471	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046472	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046472	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046472	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046473	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046473	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046473	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMT200046474	K01939	ko00230	Purine metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMT200046474	K01939	ko00250	Alanine, aspartate and glutamate metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMT200046474	K01939	ko01100	Metabolic pathways	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMT200046494	K02084	ko04115	p53 signaling pathway	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko04210	Apoptosis	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko05010	Alzheimer's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko05012	Parkinson's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko05016	Huntington's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046494	K02084	ko05222	Small cell lung cancer	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMT200046500	K07195	ko04910	Insulin signaling pathway	576	6.2e-26	0.88	0.97	0.61
PGSC0003DMT200046502	K07195	ko04910	Insulin signaling pathway	424	1.5e-17	0.83	0.92	0.97
PGSC0003DMT200079020	K02343	ko00230	Purine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079020	K02343	ko00240	Pyrimidine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079020	K02343	ko01100	Metabolic pathways	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079020	K02343	ko03030	DNA replication	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079020	K02343	ko03430	Mismatch repair	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079020	K02343	ko03440	Homologous recombination	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMT200079032	K01046	ko00561	Glycerolipid metabolism	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMT200079032	K01046	ko01100	Metabolic pathways	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMT200079033	K01046	ko00561	Glycerolipid metabolism	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMT200079033	K01046	ko01100	Metabolic pathways	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMT200079037	K10144	ko04115	p53 signaling pathway	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMT200079037	K10144	ko04120	Ubiquitin mediated proteolysis	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMT200079039	K10144	ko04115	p53 signaling pathway	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMT200079039	K10144	ko04120	Ubiquitin mediated proteolysis	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMT200079041	K00430	ko00360	Phenylalanine metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMT200079041	K00430	ko00680	Methane metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMT200079041	K00430	ko00940	Phenylpropanoid biosynthesis	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMT200079041	K00430	ko01100	Metabolic pathways	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMT200079041	K00430	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMT200079043	K01611	ko00270	Cysteine and methionine metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMT200079043	K01611	ko00330	Arginine and proline metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMT200079043	K01611	ko01100	Metabolic pathways	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMT200056816	K03364	ko04110	Cell cycle	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMT200056816	K03364	ko04111	Cell cycle - yeast	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMT200056816	K03364	ko04120	Ubiquitin mediated proteolysis	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMT200056816	K03364	ko04914	Progesterone-mediated oocyte maturation	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMT200056817	K03469	ko03030	DNA replication	245	1.1e-07	0.36	0.53	0.52
PGSC0003DMT200056821	K09756	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.42	0.59	0.99
PGSC0003DMT200056827	K01184	ko00040	Pentose and glucuronate interconversions	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMT200056827	K01184	ko00500	Starch and sucrose metabolism	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMT200056827	K01184	ko01100	Metabolic pathways	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMT200056828	K01184	ko00040	Pentose and glucuronate interconversions	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMT200056828	K01184	ko00500	Starch and sucrose metabolism	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMT200056828	K01184	ko01100	Metabolic pathways	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMT200056839	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMT200056839	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMT200056839	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMT200056851	K04121	ko00904	Diterpenoid biosynthesis	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMT200056851	K04121	ko01100	Metabolic pathways	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMT200056851	K04121	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMT200056852	K04121	ko00904	Diterpenoid biosynthesis	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMT200056852	K04121	ko01100	Metabolic pathways	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMT200056852	K04121	ko01110	Biosynthesis of secondary metabolites	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMT200064608	K02114	ko00190	Oxidative phosphorylation	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMT200064608	K02114	ko00195	Photosynthesis	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMT200064608	K02114	ko01100	Metabolic pathways	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMT200064657	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMT200064657	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMT200064657	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMT200064658	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMT200064658	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMT200064658	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMT200064659	K03011	ko00230	Purine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMT200064659	K03011	ko00240	Pyrimidine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMT200064659	K03011	ko01100	Metabolic pathways	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMT200064659	K03011	ko03020	RNA polymerase	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMT200064659	K03011	ko05016	Huntington's disease	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMT200064660	K01859	ko00941	Flavonoid biosynthesis	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMT200064660	K01859	ko01100	Metabolic pathways	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMT200064660	K01859	ko01110	Biosynthesis of secondary metabolites	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMT200064661	K00430	ko00360	Phenylalanine metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMT200064661	K00430	ko00680	Methane metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMT200064661	K00430	ko00940	Phenylpropanoid biosynthesis	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMT200064661	K00430	ko01100	Metabolic pathways	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMT200064661	K00430	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMT200010041	K00276	ko00260	Glycine, serine and threonine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko00350	Tyrosine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko00360	Phenylalanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko00410	beta-Alanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko01100	Metabolic pathways	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010041	K00276	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMT200010042	K00276	ko00260	Glycine, serine and threonine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko00350	Tyrosine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko00360	Phenylalanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko00410	beta-Alanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko00950	Isoquinoline alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko01100	Metabolic pathways	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010042	K00276	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMT200010063	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.60
PGSC0003DMT200010065	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.46
PGSC0003DMT200010066	K01515	ko00230	Purine metabolism	253	4.0e-08	0.41	0.54	0.50
PGSC0003DMT200017964	K02970	ko03010	Ribosome	228	9.7e-07	0.51	0.71	0.32
PGSC0003DMT200017976	K05582	ko00190	Oxidative phosphorylation	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMT200017976	K05582	ko01100	Metabolic pathways	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMT200017978	K12870	ko03040	Spliceosome	2149	1.1e-112	0.85	0.92	1.00
PGSC0003DMT200017986	K02953	ko03010	Ribosome	1220	1.9e-61	0.95	0.99	0.99
PGSC0003DMT200017987	K00485	ko00982	Drug metabolism - cytochrome P450	845	9.0e-41	0.35	0.46	0.95
PGSC0003DMT200017988	K00485	ko00982	Drug metabolism - cytochrome P450	1606	9.6e-83	0.49	0.65	0.98
PGSC0003DMT200017989	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200017990	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200017991	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200017992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200017993	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200017994	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMT200094846	K11251	ko05322	Systemic lupus erythematosus	713	1.7e-33	0.68	0.81	0.94
PGSC0003DMT200094849	K07466	ko03030	DNA replication	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMT200094849	K07466	ko03420	Nucleotide excision repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMT200094849	K07466	ko03430	Mismatch repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMT200094849	K07466	ko03440	Homologous recombination	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMT200094861	K12581	ko03018	RNA degradation	470	4.3e-20	0.54	0.70	0.68
PGSC0003DMT200084876	K12843	ko03040	Spliceosome	1707	2.6e-88	0.39	0.55	0.94
PGSC0003DMT200084902	K10760	ko00908	Zeatin biosynthesis	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMT200084902	K10760	ko01100	Metabolic pathways	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMT200084902	K10760	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMT200067544	K00846	ko00051	Fructose and mannose metabolism	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMT200067544	K00846	ko01100	Metabolic pathways	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMT200067545	K00847	ko00051	Fructose and mannose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMT200067545	K00847	ko00500	Starch and sucrose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMT200067545	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMT200067545	K00847	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMT200067547	K00852	ko00030	Pentose phosphate pathway	336	1.1e-12	0.30	0.45	0.85
PGSC0003DMT200067549	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMT200067550	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMT200067554	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.94
PGSC0003DMT200067557	K00846	ko00051	Fructose and mannose metabolism	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMT200067557	K00846	ko01100	Metabolic pathways	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMT200067558	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.85
PGSC0003DMT200067559	K00852	ko00030	Pentose phosphate pathway	346	3.0e-13	0.31	0.45	0.94
PGSC0003DMT200058248	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMT200058249	K01358	ko04112	Cell cycle - Caulobacter	422	1.9e-17	0.77	0.90	0.94
PGSC0003DMT200058251	K10676	ko00627	1,4-Dichlorobenzene degradation	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMT200058251	K10676	ko01100	Metabolic pathways	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMT200058252	K10676	ko00627	1,4-Dichlorobenzene degradation	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMT200058252	K10676	ko01100	Metabolic pathways	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMT200058253	K10676	ko00627	1,4-Dichlorobenzene degradation	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMT200058253	K10676	ko01100	Metabolic pathways	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMT200058254	K10676	ko00627	1,4-Dichlorobenzene degradation	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMT200058254	K10676	ko01100	Metabolic pathways	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMT200058255	K10676	ko00627	1,4-Dichlorobenzene degradation	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMT200058255	K10676	ko01100	Metabolic pathways	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMT200021489	K00236	ko00020	Citrate cycle (TCA cycle)	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko00190	Oxidative phosphorylation	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko01100	Metabolic pathways	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko05010	Alzheimer's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko05012	Parkinson's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021489	K00236	ko05016	Huntington's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMT200021494	K03657	ko03420	Nucleotide excision repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMT200021494	K03657	ko03430	Mismatch repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMT200021495	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMT200021495	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMT200021496	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMT200021496	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMT200021507	K02354	ko04310	Wnt signaling pathway	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMT200021507	K02354	ko04916	Melanogenesis	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMT200021507	K02354	ko05200	Pathways in cancer	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMT200021507	K02354	ko05217	Basal cell carcinoma	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMT200021509	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021509	K00261	ko00330	Arginine and proline metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021509	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021509	K00261	ko00910	Nitrogen metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021509	K00261	ko01100	Metabolic pathways	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021509	K00261	ko04964	Proximal tubule bicarbonate reclamation	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMT200021510	K00261	ko00250	Alanine, aspartate and glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200021510	K00261	ko00330	Arginine and proline metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200021510	K00261	ko00471	D-Glutamine and D-glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200021510	K00261	ko00910	Nitrogen metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200021510	K00261	ko01100	Metabolic pathways	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200021510	K00261	ko04964	Proximal tubule bicarbonate reclamation	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMT200024526	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMT200024527	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMT200024532	K05349	ko00460	Cyanoamino acid metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMT200024532	K05349	ko00500	Starch and sucrose metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMT200024532	K05349	ko00940	Phenylpropanoid biosynthesis	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMT200024532	K05349	ko01110	Biosynthesis of secondary metabolites	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMT200024533	K05349	ko00460	Cyanoamino acid metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMT200024533	K05349	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMT200024533	K05349	ko00940	Phenylpropanoid biosynthesis	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMT200024533	K05349	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMT200024535	K05349	ko00460	Cyanoamino acid metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMT200024535	K05349	ko00500	Starch and sucrose metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMT200024535	K05349	ko00940	Phenylpropanoid biosynthesis	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMT200024535	K05349	ko01110	Biosynthesis of secondary metabolites	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMT200024541	K05349	ko00460	Cyanoamino acid metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMT200024541	K05349	ko00500	Starch and sucrose metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMT200024541	K05349	ko00940	Phenylpropanoid biosynthesis	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMT200024541	K05349	ko01110	Biosynthesis of secondary metabolites	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMT200024558	K08008	ko04145	Phagosome	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMT200024558	K08008	ko04670	Leukocyte transendothelial migration	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMT200024560	K09540	ko03060	Protein export	2534	6.3e-134	0.72	0.86	0.97
PGSC0003DMT200024561	K09540	ko03060	Protein export	2272	1.8e-119	0.64	0.78	0.99
PGSC0003DMT200015012	K01507	ko00190	Oxidative phosphorylation	1477	1.3e-75	0.90	0.95	0.98
PGSC0003DMT200015022	K02927	ko03010	Ribosome	1015	3.8e-50	0.99	1.00	0.92
PGSC0003DMT200015023	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMT200015024	K01761	ko00270	Cysteine and methionine metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMT200015024	K01761	ko00450	Selenoamino acid metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMT200015039	K00028	ko00620	Pyruvate metabolism	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMT200015039	K00028	ko00710	Carbon fixation in photosynthetic organisms	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMT200015039	K00028	ko01100	Metabolic pathways	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMT200015040	K00028	ko00620	Pyruvate metabolism	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMT200015040	K00028	ko00710	Carbon fixation in photosynthetic organisms	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMT200015040	K00028	ko01100	Metabolic pathways	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMT200015043	K00430	ko00360	Phenylalanine metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMT200015043	K00430	ko00680	Methane metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMT200015043	K00430	ko00940	Phenylpropanoid biosynthesis	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMT200015043	K00430	ko01100	Metabolic pathways	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMT200015043	K00430	ko01110	Biosynthesis of secondary metabolites	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMT200015046	K13228	ko00402	Benzoxazinoid biosynthesis	309	3.3e-11	0.44	0.69	0.95
PGSC0003DMT200092998	K13230	ko00402	Benzoxazinoid biosynthesis	220	2.9e-06	0.45	0.62	0.86
PGSC0003DMT200096803	K02489	ko02020	Two-component system	264	5.4e-08	0.42	0.58	0.83
PGSC0003DMT200091323	K10760	ko00908	Zeatin biosynthesis	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMT200091323	K10760	ko01100	Metabolic pathways	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMT200091323	K10760	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMT200039315	K00680	ko00350	Tyrosine metabolism	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMT200039315	K00680	ko00624	1- and 2-Methylnaphthalene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMT200039315	K00680	ko00632	Benzoate degradation via CoA ligation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMT200039315	K00680	ko00642	Ethylbenzene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMT200039315	K00680	ko00903	Limonene and pinene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMT200039327	K04368	ko04010	MAPK signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04012	ErbB signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04013	MAPK signaling pathway - fly	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04062	Chemokine signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04114	Oocyte meiosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04270	Vascular smooth muscle contraction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04320	Dorso-ventral axis formation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04370	VEGF signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04510	Focal adhesion	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04540	Gap junction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04620	Toll-like receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04626	Plant-pathogen interaction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04650	Natural killer cell mediated cytotoxicity	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04660	T cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04662	B cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04664	Fc epsilon RI signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04666	Fc gamma R-mediated phagocytosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04720	Long-term potentiation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04722	Neurotrophin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04730	Long-term depression	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04810	Regulation of actin cytoskeleton	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04910	Insulin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04912	GnRH signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04914	Progesterone-mediated oocyte maturation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko04916	Melanogenesis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05020	Prion diseases	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05200	Pathways in cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05210	Colorectal cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05211	Renal cell carcinoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05212	Pancreatic cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05213	Endometrial cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05214	Glioma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05215	Prostate cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05216	Thyroid cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05218	Melanoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05219	Bladder cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05220	Chronic myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05221	Acute myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039327	K04368	ko05223	Non-small cell lung cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMT200039328	K04368	ko04010	MAPK signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04012	ErbB signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04013	MAPK signaling pathway - fly	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04062	Chemokine signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04114	Oocyte meiosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04270	Vascular smooth muscle contraction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04320	Dorso-ventral axis formation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04370	VEGF signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04510	Focal adhesion	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04540	Gap junction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04620	Toll-like receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04626	Plant-pathogen interaction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04650	Natural killer cell mediated cytotoxicity	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04660	T cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04662	B cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04664	Fc epsilon RI signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04666	Fc gamma R-mediated phagocytosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04720	Long-term potentiation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04722	Neurotrophin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04730	Long-term depression	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04810	Regulation of actin cytoskeleton	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04910	Insulin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04912	GnRH signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04914	Progesterone-mediated oocyte maturation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko04916	Melanogenesis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05020	Prion diseases	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05200	Pathways in cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05210	Colorectal cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05211	Renal cell carcinoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05212	Pancreatic cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05213	Endometrial cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05214	Glioma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05215	Prostate cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05216	Thyroid cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05218	Melanoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05219	Bladder cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05220	Chronic myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05221	Acute myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039328	K04368	ko05223	Non-small cell lung cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMT200039329	K04368	ko04010	MAPK signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04012	ErbB signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04013	MAPK signaling pathway - fly	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04062	Chemokine signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04114	Oocyte meiosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04270	Vascular smooth muscle contraction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04320	Dorso-ventral axis formation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04370	VEGF signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04510	Focal adhesion	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04540	Gap junction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04620	Toll-like receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04626	Plant-pathogen interaction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04650	Natural killer cell mediated cytotoxicity	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04660	T cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04662	B cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04664	Fc epsilon RI signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04666	Fc gamma R-mediated phagocytosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04720	Long-term potentiation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04722	Neurotrophin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04730	Long-term depression	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04810	Regulation of actin cytoskeleton	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04910	Insulin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04912	GnRH signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04914	Progesterone-mediated oocyte maturation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko04916	Melanogenesis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05020	Prion diseases	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05200	Pathways in cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05210	Colorectal cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05211	Renal cell carcinoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05212	Pancreatic cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05213	Endometrial cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05214	Glioma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05215	Prostate cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05216	Thyroid cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05218	Melanoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05219	Bladder cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05220	Chronic myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05221	Acute myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039329	K04368	ko05223	Non-small cell lung cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMT200039331	K04368	ko04010	MAPK signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04012	ErbB signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04013	MAPK signaling pathway - fly	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04062	Chemokine signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04114	Oocyte meiosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04270	Vascular smooth muscle contraction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04320	Dorso-ventral axis formation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04370	VEGF signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04510	Focal adhesion	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04540	Gap junction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04620	Toll-like receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04626	Plant-pathogen interaction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04650	Natural killer cell mediated cytotoxicity	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04660	T cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04662	B cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04664	Fc epsilon RI signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04666	Fc gamma R-mediated phagocytosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04720	Long-term potentiation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04722	Neurotrophin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04730	Long-term depression	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04810	Regulation of actin cytoskeleton	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04910	Insulin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04912	GnRH signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04914	Progesterone-mediated oocyte maturation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko04916	Melanogenesis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05020	Prion diseases	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05200	Pathways in cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05210	Colorectal cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05211	Renal cell carcinoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05212	Pancreatic cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05213	Endometrial cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05214	Glioma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05215	Prostate cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05216	Thyroid cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05218	Melanoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05219	Bladder cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05220	Chronic myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05221	Acute myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039331	K04368	ko05223	Non-small cell lung cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMT200039333	K01190	ko00052	Galactose metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMT200039333	K01190	ko00511	Other glycan degradation	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMT200039333	K01190	ko00600	Sphingolipid metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMT200039333	K01190	ko01100	Metabolic pathways	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMT200039334	K01190	ko00052	Galactose metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMT200039334	K01190	ko00511	Other glycan degradation	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMT200039334	K01190	ko00600	Sphingolipid metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMT200039334	K01190	ko01100	Metabolic pathways	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMT200039341	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3843	4.0e-206	0.78	0.88	1.00
PGSC0003DMT200039342	K01893	ko00970	Aminoacyl-tRNA biosynthesis	2285	3.4e-120	0.72	0.82	0.97
PGSC0003DMT200039354	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMT200039354	K00517	ko00626	Naphthalene and anthracene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMT200039354	K00517	ko00903	Limonene and pinene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMT200039354	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMT200039354	K00517	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMT200043215	K04499	ko04310	Wnt signaling pathway	3478	5.4e-186	0.92	0.96	1.00
PGSC0003DMT200043219	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.31	0.48	0.94
PGSC0003DMT200043221	K05282	ko00904	Diterpenoid biosynthesis	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMT200043221	K05282	ko01100	Metabolic pathways	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMT200043221	K05282	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMT200043223	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMT200043223	K00517	ko00626	Naphthalene and anthracene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMT200043223	K00517	ko00903	Limonene and pinene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMT200043223	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMT200043223	K00517	ko01110	Biosynthesis of secondary metabolites	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMT200043224	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMT200043224	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMT200043224	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMT200043224	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMT200043224	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMT200043225	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMT200043225	K00517	ko00626	Naphthalene and anthracene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMT200043225	K00517	ko00903	Limonene and pinene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMT200043225	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMT200043225	K00517	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMT200043227	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMT200043227	K00517	ko00626	Naphthalene and anthracene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMT200043227	K00517	ko00903	Limonene and pinene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMT200043227	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMT200043227	K00517	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMT200043228	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMT200043228	K00517	ko00626	Naphthalene and anthracene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMT200043228	K00517	ko00903	Limonene and pinene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMT200043228	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMT200043228	K00517	ko01110	Biosynthesis of secondary metabolites	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMT200043232	K00938	ko00900	Terpenoid backbone biosynthesis	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMT200043232	K00938	ko01100	Metabolic pathways	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMT200043232	K00938	ko01110	Biosynthesis of secondary metabolites	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMT200043241	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMT200043241	K00224	ko00364	Fluorobenzoate degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMT200043241	K00224	ko00628	Fluorene degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMT200043241	K00224	ko00640	Propanoate metabolism	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMT200043242	K09658	ko00510	N-Glycan biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMT200043242	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMT200043242	K09658	ko01100	Metabolic pathways	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMT200043244	K00485	ko00982	Drug metabolism - cytochrome P450	1703	4.3e-88	0.60	0.75	0.96
PGSC0003DMT200043245	K00485	ko00982	Drug metabolism - cytochrome P450	2268	2.9e-119	0.59	0.75	0.97
PGSC0003DMT200043246	K00485	ko00982	Drug metabolism - cytochrome P450	1006	1.2e-49	0.58	0.72	0.91
PGSC0003DMT200043254	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMT200013431	K07195	ko04910	Insulin signaling pathway	2471	1.9e-130	0.50	0.67	0.99
PGSC0003DMT200013446	K04564	ko04146	Peroxisome	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMT200013446	K04564	ko05016	Huntington's disease	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMT200013447	K04564	ko04146	Peroxisome	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMT200013447	K04564	ko05016	Huntington's disease	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMT200013458	K01046	ko00561	Glycerolipid metabolism	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMT200013458	K01046	ko01100	Metabolic pathways	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMT200013459	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko00903	Limonene and pinene degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko00930	Caprolactam degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko01100	Metabolic pathways	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013459	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko00903	Limonene and pinene degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko00930	Caprolactam degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko01100	Metabolic pathways	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200013460	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMT200023535	K00264	ko00250	Alanine, aspartate and glutamate metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMT200023535	K00264	ko00910	Nitrogen metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMT200023535	K00264	ko01100	Metabolic pathways	16388	0.	0.87	0.94	1.00
PGSC0003DMT200023535	K00264	ko01110	Biosynthesis of secondary metabolites	16388	0.	0.87	0.94	1.00
PGSC0003DMT200023545	K11422	ko00310	Lysine degradation	644	1.0e-28	0.39	0.54	0.92
PGSC0003DMT200023547	K11422	ko00310	Lysine degradation	605	5.0e-27	0.51	0.67	0.14
PGSC0003DMT200023562	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMT200023563	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMT200023566	K06268	ko04010	MAPK signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04020	Calcium signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04114	Oocyte meiosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04210	Apoptosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04310	Wnt signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04360	Axon guidance	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04370	VEGF signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04650	Natural killer cell mediated cytotoxicity	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04660	T cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04662	B cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko04720	Long-term potentiation	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko05010	Alzheimer's disease	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023566	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMT200023568	K06268	ko04010	MAPK signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04020	Calcium signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04114	Oocyte meiosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04210	Apoptosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04310	Wnt signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04360	Axon guidance	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04370	VEGF signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04650	Natural killer cell mediated cytotoxicity	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04660	T cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04662	B cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko04720	Long-term potentiation	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko05010	Alzheimer's disease	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023568	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMT200023571	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMT200023572	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMT200023575	K04506	ko04115	p53 signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMT200023575	K04506	ko04120	Ubiquitin mediated proteolysis	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMT200023575	K04506	ko04310	Wnt signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMT200023576	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMT200023577	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMT200060197	K12373	ko00511	Other glycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko00531	Glycosaminoglycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko01100	Metabolic pathways	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060197	K12373	ko04142	Lysosome	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMT200060204	K04733	ko04210	Apoptosis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMT200060204	K04733	ko04620	Toll-like receptor signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMT200060204	K04733	ko04722	Neurotrophin signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMT200060204	K04733	ko05140	Leishmaniasis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMT200060204	K04733	ko05142	Chagas disease	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMT200060209	K01874	ko00450	Selenoamino acid metabolism	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMT200060209	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMT200060210	K01874	ko00450	Selenoamino acid metabolism	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMT200060210	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMT200060211	K01874	ko00450	Selenoamino acid metabolism	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMT200060211	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMT200060214	K02941	ko03010	Ribosome	2342	2.4e-123	0.88	0.95	1.00
PGSC0003DMT200060224	K10258	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.85	0.95	1.00
PGSC0003DMT200060225	K05692	ko04145	Phagosome	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04510	Focal adhesion	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04520	Adherens junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04530	Tight junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04670	Leukocyte transendothelial migration	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04745	Phototransduction - fly	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko04810	Regulation of actin cytoskeleton	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05100	Bacterial invasion of epithelial cells	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05110	Vibrio cholerae infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05130	Pathogenic Escherichia coli infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05131	Shigellosis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05414	Dilated cardiomyopathy	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200060225	K05692	ko05416	Viral myocarditis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMT200069929	K01930	ko00790	Folate biosynthesis	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMT200069929	K01930	ko01100	Metabolic pathways	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMT200069930	K01930	ko00790	Folate biosynthesis	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMT200069930	K01930	ko01100	Metabolic pathways	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMT200069936	K10594	ko04120	Ubiquitin mediated proteolysis	487	3.1e-28	0.33	0.50	0.88
PGSC0003DMT200069953	K12356	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.47	0.62	0.83
PGSC0003DMT200069954	K03039	ko03050	Proteasome	2840	8.3e-151	0.88	0.95	1.00
PGSC0003DMT200086438	K12338	ko00942	Anthocyanin biosynthesis	259	2.4e-08	0.48	0.62	0.47
PGSC0003DMT200086452	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMT200086452	K00517	ko00626	Naphthalene and anthracene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMT200086452	K00517	ko00903	Limonene and pinene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMT200086452	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMT200086452	K00517	ko01110	Biosynthesis of secondary metabolites	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMT200047988	K05279	ko00944	Flavone and flavonol biosynthesis	795	5.2e-38	0.40	0.56	0.85
PGSC0003DMT200047989	K05279	ko00944	Flavone and flavonol biosynthesis	668	5.2e-31	0.37	0.53	0.86
PGSC0003DMT200048000	K00423	ko00053	Ascorbate and aldarate metabolism	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMT200048000	K00423	ko01100	Metabolic pathways	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMT200048014	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.57
PGSC0003DMT200048015	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.55
PGSC0003DMT200048018	K00485	ko00982	Drug metabolism - cytochrome P450	703	6.1e-33	0.33	0.47	0.85
PGSC0003DMT200048020	K00485	ko00982	Drug metabolism - cytochrome P450	743	3.8e-35	0.31	0.49	0.98
PGSC0003DMT200048021	K00485	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.38	0.52	0.91
PGSC0003DMT200048022	K00485	ko00982	Drug metabolism - cytochrome P450	517	1.1e-22	0.38	0.52	0.87
PGSC0003DMT200048023	K00485	ko00982	Drug metabolism - cytochrome P450	680	1.1e-31	0.29	0.47	0.94
PGSC0003DMT200090493	K10760	ko00908	Zeatin biosynthesis	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMT200090493	K10760	ko01100	Metabolic pathways	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMT200090493	K10760	ko01110	Biosynthesis of secondary metabolites	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMT200090495	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200090495	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200090495	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200090495	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200090495	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMT200090510	K00600	ko00260	Glycine, serine and threonine metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200090510	K00600	ko00460	Cyanoamino acid metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200090510	K00600	ko00670	One carbon pool by folate	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200090510	K00600	ko00680	Methane metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200090510	K00600	ko01100	Metabolic pathways	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200090510	K00600	ko01110	Biosynthesis of secondary metabolites	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMT200003789	K08737	ko03430	Mismatch repair	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMT200003789	K08737	ko05200	Pathways in cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMT200003789	K08737	ko05210	Colorectal cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMT200003790	K08497	ko04130	SNARE interactions in vesicular transport	1337	6.6e-68	0.52	0.61	1.00
PGSC0003DMT200003791	K08497	ko04130	SNARE interactions in vesicular transport	1252	3.2e-63	0.73	0.83	0.99
PGSC0003DMT200003792	K08497	ko04130	SNARE interactions in vesicular transport	1523	3.6e-78	0.67	0.79	1.00
PGSC0003DMT200003807	K08852	ko05010	Alzheimer's disease	2230	3.7e-117	0.50	0.64	0.92
PGSC0003DMT200003808	K08852	ko05010	Alzheimer's disease	2813	2.6e-149	0.53	0.67	0.94
PGSC0003DMT200003809	K08852	ko05010	Alzheimer's disease	3432	1.9e-183	0.57	0.71	0.99
PGSC0003DMT200003810	K08852	ko05010	Alzheimer's disease	3789	3.8e-203	0.57	0.70	0.94
PGSC0003DMT200003817	K10615	ko04120	Ubiquitin mediated proteolysis	644	1.1e-29	0.33	0.50	0.94
PGSC0003DMT200003819	K02867	ko03010	Ribosome	516	1.3e-22	0.46	0.66	0.90
PGSC0003DMT200003825	K08739	ko03430	Mismatch repair	2798	1.7e-148	0.39	0.53	1.00
PGSC0003DMT200003826	K08739	ko03430	Mismatch repair	845	9.0e-41	0.31	0.45	0.98
PGSC0003DMT200003827	K08739	ko03430	Mismatch repair	761	6.8e-36	0.31	0.44	0.98
PGSC0003DMT200003828	K08739	ko03430	Mismatch repair	399	4.0e-13	0.28	0.40	0.95
PGSC0003DMT200029881	K12843	ko03040	Spliceosome	4554	2.4e-245	0.75	0.85	0.99
PGSC0003DMT200029916	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.46	0.68
PGSC0003DMT200029918	K12356	ko00940	Phenylpropanoid biosynthesis	479	1.4e-20	0.29	0.47	0.92
PGSC0003DMT200029921	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMT200029922	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMT200029923	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMT200034809	K00939	ko00230	Purine metabolism	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMT200034809	K00939	ko01100	Metabolic pathways	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMT200034809	K00939	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMT200034810	K00939	ko00230	Purine metabolism	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMT200034810	K00939	ko01100	Metabolic pathways	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMT200034810	K00939	ko01110	Biosynthesis of secondary metabolites	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMT200034814	K11584	ko04113	Meiosis - yeast	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMT200034814	K11584	ko04114	Oocyte meiosis	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMT200034814	K11584	ko04310	Wnt signaling pathway	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMT200034831	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	251	7.6e-08	0.36	0.54	0.86
PGSC0003DMT200034832	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMT200034832	K12502	ko01100	Metabolic pathways	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMT200034832	K12502	ko01110	Biosynthesis of secondary metabolites	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMT200034833	K02183	ko04020	Calcium signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04070	Phosphatidylinositol signaling system	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04114	Oocyte meiosis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04270	Vascular smooth muscle contraction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04626	Plant-pathogen interaction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04720	Long-term potentiation	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04722	Neurotrophin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04740	Olfactory transduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04744	Phototransduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04745	Phototransduction - fly	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04910	Insulin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04912	GnRH signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04916	Melanogenesis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04970	Salivary secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko04971	Gastric acid secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko05010	Alzheimer's disease	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034833	K02183	ko05214	Glioma	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMT200034838	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMT200034839	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMT200034840	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMT200034842	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.33
PGSC0003DMT200019465	K04371	ko04010	MAPK signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04012	ErbB signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04013	MAPK signaling pathway - fly	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04062	Chemokine signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04114	Oocyte meiosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04150	mTOR signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04270	Vascular smooth muscle contraction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04320	Dorso-ventral axis formation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04350	TGF-beta signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04360	Axon guidance	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04370	VEGF signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04510	Focal adhesion	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04520	Adherens junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04540	Gap junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04620	Toll-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04621	NOD-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04650	Natural killer cell mediated cytotoxicity	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04660	T cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04662	B cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04664	Fc epsilon RI signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04666	Fc gamma R-mediated phagocytosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04720	Long-term potentiation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04722	Neurotrophin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04730	Long-term depression	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04810	Regulation of actin cytoskeleton	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04910	Insulin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04912	GnRH signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04914	Progesterone-mediated oocyte maturation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04916	Melanogenesis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04930	Type II diabetes mellitus	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko04960	Aldosterone-regulated sodium reabsorption	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05010	Alzheimer's disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05020	Prion diseases	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05131	Shigellosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05140	Leishmaniasis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05142	Chagas disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05200	Pathways in cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05210	Colorectal cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05211	Renal cell carcinoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05212	Pancreatic cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05213	Endometrial cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05214	Glioma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05215	Prostate cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05216	Thyroid cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05218	Melanoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05219	Bladder cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05220	Chronic myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05221	Acute myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019465	K04371	ko05223	Non-small cell lung cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMT200019490	K02721	ko00195	Photosynthesis	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMT200019490	K02721	ko01100	Metabolic pathways	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMT200019491	K00383	ko00480	Glutathione metabolism	3788	4.3e-203	0.82	0.90	1.00
PGSC0003DMT200019494	K10532	ko00531	Glycosaminoglycan degradation	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMT200019494	K10532	ko01100	Metabolic pathways	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMT200019494	K10532	ko04142	Lysosome	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMT200019497	K10532	ko00531	Glycosaminoglycan degradation	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMT200019497	K10532	ko01100	Metabolic pathways	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMT200019497	K10532	ko04142	Lysosome	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMT200019498	K12623	ko03018	RNA degradation	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMT200019498	K12623	ko03040	Spliceosome	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMT200019501	K12623	ko03018	RNA degradation	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMT200019501	K12623	ko03040	Spliceosome	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMT200011275	K00799	ko00480	Glutathione metabolism	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMT200011275	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMT200011275	K00799	ko00982	Drug metabolism - cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMT200011278	K12132	ko04712	Circadian rhythm - plant	895	1.6e-43	0.36	0.53	0.99
PGSC0003DMT200011279	K12132	ko04712	Circadian rhythm - plant	1964	1.7e-102	0.46	0.61	0.97
PGSC0003DMT200011287	K08139	ko04113	Meiosis - yeast	986	1.5e-48	0.35	0.56	0.95
PGSC0003DMT200011294	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011294	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMT200011302	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMT200011303	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMT200072601	K01528	ko04144	Endocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMT200072601	K01528	ko04666	Fc gamma R-mediated phagocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMT200072601	K01528	ko05100	Bacterial invasion of epithelial cells	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMT200072606	K01193	ko00052	Galactose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMT200072606	K01193	ko00500	Starch and sucrose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMT200072606	K01193	ko01100	Metabolic pathways	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMT200072607	K01193	ko00052	Galactose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMT200072607	K01193	ko00500	Starch and sucrose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMT200072607	K01193	ko01100	Metabolic pathways	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMT200072608	K01193	ko00052	Galactose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMT200072608	K01193	ko00500	Starch and sucrose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMT200072608	K01193	ko01100	Metabolic pathways	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMT200072623	K10591	ko04120	Ubiquitin mediated proteolysis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMT200072623	K10591	ko04144	Endocytosis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMT200072624	K10591	ko04120	Ubiquitin mediated proteolysis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMT200072624	K10591	ko04144	Endocytosis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMT200072625	K10591	ko04120	Ubiquitin mediated proteolysis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMT200072625	K10591	ko04144	Endocytosis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMT200072631	K01623	ko00010	Glycolysis / Gluconeogenesis	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072631	K01623	ko00030	Pentose phosphate pathway	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072631	K01623	ko00051	Fructose and mannose metabolism	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072631	K01623	ko00710	Carbon fixation in photosynthetic organisms	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072631	K01623	ko01100	Metabolic pathways	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072631	K01623	ko01110	Biosynthesis of secondary metabolites	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMT200072632	K01623	ko00010	Glycolysis / Gluconeogenesis	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072632	K01623	ko00030	Pentose phosphate pathway	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072632	K01623	ko00051	Fructose and mannose metabolism	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072632	K01623	ko00710	Carbon fixation in photosynthetic organisms	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072632	K01623	ko01100	Metabolic pathways	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072632	K01623	ko01110	Biosynthesis of secondary metabolites	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMT200072634	K04424	ko04010	MAPK signaling pathway	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMT200072634	K04424	ko04530	Tight junction	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMT200072635	K10773	ko03410	Base excision repair	2266	1.1e-125	0.33	0.47	0.85
PGSC0003DMT200072636	K10773	ko03410	Base excision repair	2728	4.4e-151	0.34	0.48	0.80
PGSC0003DMT200072638	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200072638	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200072639	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200072639	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200072640	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200072640	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMT200062559	K00490	ko00590	Arachidonic acid metabolism	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMT200062559	K00490	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMT200062560	K00490	ko00590	Arachidonic acid metabolism	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMT200062560	K00490	ko01100	Metabolic pathways	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMT200062565	K00001	ko00010	Glycolysis / Gluconeogenesis	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00071	Fatty acid metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00350	Tyrosine metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00641	3-Chloroacrylic acid degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00830	Retinol metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko00982	Drug metabolism - cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko01100	Metabolic pathways	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062565	K00001	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMT200062579	K00826	ko00280	Valine, leucine and isoleucine degradation	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMT200062579	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMT200062579	K00826	ko00770	Pantothenate and CoA biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMT200062579	K00826	ko01100	Metabolic pathways	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMT200062579	K00826	ko01110	Biosynthesis of secondary metabolites	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMT200062580	K00826	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMT200062580	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMT200062580	K00826	ko00770	Pantothenate and CoA biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMT200062580	K00826	ko01100	Metabolic pathways	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMT200062580	K00826	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMT200062581	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062581	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062581	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062581	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062581	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062582	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062582	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062582	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062582	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062582	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMT200062583	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMT200062593	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMT200062594	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMT200062597	K11093	ko03040	Spliceosome	273	4.5e-09	0.30	0.45	0.96
PGSC0003DMT200054445	K01187	ko00052	Galactose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMT200054445	K01187	ko00500	Starch and sucrose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMT200054445	K01187	ko01100	Metabolic pathways	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMT200054446	K01187	ko00052	Galactose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMT200054446	K01187	ko00500	Starch and sucrose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMT200054446	K01187	ko01100	Metabolic pathways	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMT200054453	K01807	ko00030	Pentose phosphate pathway	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMT200054453	K01807	ko00710	Carbon fixation in photosynthetic organisms	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMT200054453	K01807	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMT200054453	K01807	ko01110	Biosynthesis of secondary metabolites	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMT200054454	K01807	ko00030	Pentose phosphate pathway	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMT200054454	K01807	ko00710	Carbon fixation in photosynthetic organisms	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMT200054454	K01807	ko01100	Metabolic pathways	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMT200054454	K01807	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMT200054455	K01807	ko00030	Pentose phosphate pathway	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMT200054455	K01807	ko00710	Carbon fixation in photosynthetic organisms	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMT200054455	K01807	ko01100	Metabolic pathways	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMT200054455	K01807	ko01110	Biosynthesis of secondary metabolites	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMT200054457	K09843	ko00906	Carotenoid biosynthesis	777	5.1e-37	0.32	0.51	0.99
PGSC0003DMT200054459	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMT200054459	K12448	ko01100	Metabolic pathways	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMT200054462	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMT200054462	K12448	ko01100	Metabolic pathways	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMT200054464	K01514	ko00230	Purine metabolism	378	5.7e-14	0.36	0.54	0.13
PGSC0003DMT200054476	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054476	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054476	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054477	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054477	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054477	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMT200054478	K09828	ko00100	Steroid biosynthesis	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMT200054478	K09828	ko01100	Metabolic pathways	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMT200054478	K09828	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMT200054480	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMT200054480	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMT200054481	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMT200054481	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMT200054482	K02694	ko00195	Photosynthesis	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMT200054482	K02694	ko01100	Metabolic pathways	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMT200028048	K00660	ko00941	Flavonoid biosynthesis	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMT200028048	K00660	ko01100	Metabolic pathways	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMT200028048	K00660	ko01110	Biosynthesis of secondary metabolites	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMT200028048	K00660	ko04712	Circadian rhythm - plant	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMT200028067	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028067	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028068	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028069	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMT200028070	K02183	ko04020	Calcium signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04070	Phosphatidylinositol signaling system	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04114	Oocyte meiosis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04270	Vascular smooth muscle contraction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04626	Plant-pathogen interaction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04720	Long-term potentiation	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04722	Neurotrophin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04740	Olfactory transduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04744	Phototransduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04745	Phototransduction - fly	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04910	Insulin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04912	GnRH signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04916	Melanogenesis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04970	Salivary secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko04971	Gastric acid secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko05010	Alzheimer's disease	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200028070	K02183	ko05214	Glioma	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMT200009548	K10352	ko04530	Tight junction	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMT200009548	K10352	ko05416	Viral myocarditis	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMT200009549	K10352	ko04530	Tight junction	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMT200009549	K10352	ko05416	Viral myocarditis	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMT200009550	K12619	ko03018	RNA degradation	6361	0.	0.68	0.78	1.00
PGSC0003DMT200017646	K02863	ko03010	Ribosome	1169	1.2e-58	0.59	0.79	0.69
PGSC0003DMT200017668	K00559	ko00100	Steroid biosynthesis	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMT200017668	K00559	ko01100	Metabolic pathways	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMT200017668	K00559	ko01110	Biosynthesis of secondary metabolites	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMT200017677	K12900	ko03040	Spliceosome	258	1.6e-07	0.37	0.53	0.16
PGSC0003DMT200017678	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMT200089309	K12606	ko03018	RNA degradation	422	1.9e-17	0.33	0.49	0.66
PGSC0003DMT200089311	K13065	ko00940	Phenylpropanoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMT200089311	K13065	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMT200089311	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMT200089311	K13065	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMT200074311	K00423	ko00053	Ascorbate and aldarate metabolism	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMT200074311	K00423	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMT200074312	K00423	ko00053	Ascorbate and aldarate metabolism	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMT200074312	K00423	ko01100	Metabolic pathways	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMT200074313	K00423	ko00053	Ascorbate and aldarate metabolism	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMT200074313	K00423	ko01100	Metabolic pathways	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMT200074314	K00423	ko00053	Ascorbate and aldarate metabolism	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMT200074314	K00423	ko01100	Metabolic pathways	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMT200074315	K01148	ko03018	RNA degradation	494	2.1e-21	0.30	0.48	0.57
PGSC0003DMT200074317	K01148	ko03018	RNA degradation	528	2.8e-23	0.30	0.47	0.61
PGSC0003DMT200074318	K03153	ko00730	Thiamine metabolism	300	1.0e-10	0.32	0.50	0.78
PGSC0003DMT200074319	K00303	ko00260	Glycine, serine and threonine metabolism	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMT200074319	K00303	ko01100	Metabolic pathways	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMT200074322	K00454	ko00591	Linoleic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMT200074322	K00454	ko00592	alpha-Linolenic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMT200074322	K00454	ko01100	Metabolic pathways	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMT200074323	K00454	ko00591	Linoleic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMT200074323	K00454	ko00592	alpha-Linolenic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMT200074323	K00454	ko01100	Metabolic pathways	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMT200074324	K00454	ko00591	Linoleic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMT200074324	K00454	ko00592	alpha-Linolenic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMT200074324	K00454	ko01100	Metabolic pathways	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMT200079174	K00121	ko00010	Glycolysis / Gluconeogenesis	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00071	Fatty acid metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00350	Tyrosine metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00641	3-Chloroacrylic acid degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00680	Methane metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00830	Retinol metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko00982	Drug metabolism - cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko01100	Metabolic pathways	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079174	K00121	ko01110	Biosynthesis of secondary metabolites	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMT200079175	K00121	ko00010	Glycolysis / Gluconeogenesis	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00071	Fatty acid metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00350	Tyrosine metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00641	3-Chloroacrylic acid degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00680	Methane metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00830	Retinol metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko00982	Drug metabolism - cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko01100	Metabolic pathways	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079175	K00121	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMT200079179	K02267	ko00190	Oxidative phosphorylation	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079179	K02267	ko01100	Metabolic pathways	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079179	K02267	ko04260	Cardiac muscle contraction	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079179	K02267	ko05010	Alzheimer's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079179	K02267	ko05012	Parkinson's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079179	K02267	ko05016	Huntington's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMT200079182	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2152	7.4e-113	0.73	0.83	0.89
PGSC0003DMT200079183	K01875	ko00970	Aminoacyl-tRNA biosynthesis	1108	2.8e-55	0.84	0.92	0.97
PGSC0003DMT200079184	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2726	1.6e-144	0.85	0.92	0.99
PGSC0003DMT200079185	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3338	2.8e-178	0.78	0.87	0.99
PGSC0003DMT200079197	K13030	ko00460	Cyanoamino acid metabolism	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMT200079197	K13030	ko01110	Biosynthesis of secondary metabolites	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMT200079198	K13030	ko00460	Cyanoamino acid metabolism	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMT200079198	K13030	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMT200079199	K13030	ko00460	Cyanoamino acid metabolism	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMT200079199	K13030	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMT200079200	K13030	ko00460	Cyanoamino acid metabolism	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMT200079200	K13030	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMT200079201	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMT200079201	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMT200079202	K13030	ko00460	Cyanoamino acid metabolism	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMT200079202	K13030	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMT200079203	K13030	ko00460	Cyanoamino acid metabolism	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMT200079203	K13030	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMT200056220	K04733	ko04210	Apoptosis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMT200056220	K04733	ko04620	Toll-like receptor signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMT200056220	K04733	ko04722	Neurotrophin signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMT200056220	K04733	ko05140	Leishmaniasis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMT200056220	K04733	ko05142	Chagas disease	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMT200056235	K01199	ko00500	Starch and sucrose metabolism	916	1.1e-44	0.44	0.59	0.93
PGSC0003DMT200056247	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056247	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056247	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056247	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056247	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056247	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056248	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMT200056249	K00232	ko00071	Fatty acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056249	K00232	ko00592	alpha-Linolenic acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056249	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056249	K00232	ko01100	Metabolic pathways	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056249	K00232	ko03320	PPAR signaling pathway	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056249	K00232	ko04146	Peroxisome	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMT200056250	K13230	ko00402	Benzoxazinoid biosynthesis	973	7.9e-48	0.39	0.56	0.97
PGSC0003DMT200064261	K03955	ko00190	Oxidative phosphorylation	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMT200064261	K03955	ko01100	Metabolic pathways	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMT200064261	K03955	ko05010	Alzheimer's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMT200064261	K03955	ko05012	Parkinson's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMT200064261	K03955	ko05016	Huntington's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMT200064263	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMT200064263	K01455	ko00910	Nitrogen metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMT200064264	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMT200064264	K01455	ko00910	Nitrogen metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMT200064269	K00430	ko00360	Phenylalanine metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMT200064269	K00430	ko00680	Methane metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMT200064269	K00430	ko00940	Phenylpropanoid biosynthesis	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMT200064269	K00430	ko01100	Metabolic pathways	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMT200064269	K00430	ko01110	Biosynthesis of secondary metabolites	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMT200064270	K00430	ko00360	Phenylalanine metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMT200064270	K00430	ko00680	Methane metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMT200064270	K00430	ko00940	Phenylpropanoid biosynthesis	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMT200064270	K00430	ko01100	Metabolic pathways	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMT200064270	K00430	ko01110	Biosynthesis of secondary metabolites	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMT200064279	K00235	ko00020	Citrate cycle (TCA cycle)	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko00190	Oxidative phosphorylation	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko01100	Metabolic pathways	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko01110	Biosynthesis of secondary metabolites	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko05010	Alzheimer's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko05012	Parkinson's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064279	K00235	ko05016	Huntington's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMT200064286	K12347	ko04142	Lysosome	3012	2.7e-160	0.80	0.89	0.93
PGSC0003DMT200064287	K12347	ko04142	Lysosome	3273	1.1e-174	0.77	0.89	0.97
PGSC0003DMT200041521	K01610	ko00010	Glycolysis / Gluconeogenesis	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041521	K01610	ko00020	Citrate cycle (TCA cycle)	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041521	K01610	ko00620	Pyruvate metabolism	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041521	K01610	ko00710	Carbon fixation in photosynthetic organisms	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041521	K01610	ko01100	Metabolic pathways	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041521	K01610	ko01110	Biosynthesis of secondary metabolites	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMT200041528	K13065	ko00940	Phenylpropanoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMT200041528	K13065	ko00941	Flavonoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMT200041528	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMT200041528	K13065	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMT200041539	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMT200041541	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMT200041547	K13289	ko04142	Lysosome	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMT200041547	K13289	ko04614	Renin-angiotensin system	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMT200025294	K12606	ko03018	RNA degradation	236	3.5e-07	0.49	0.56	0.96
PGSC0003DMT200025311	K02738	ko03050	Proteasome	1695	1.2e-87	0.85	0.94	0.97
PGSC0003DMT200025317	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMT200025317	K12446	ko01100	Metabolic pathways	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMT200025319	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMT200025319	K12446	ko01100	Metabolic pathways	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMT200025320	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMT200025320	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMT200025321	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMT200025321	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMT200025322	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMT200025322	K12446	ko01100	Metabolic pathways	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMT200025327	K01665	ko00790	Folate biosynthesis	2272	1.8e-119	0.43	0.55	0.90
PGSC0003DMT200025328	K01665	ko00790	Folate biosynthesis	1635	2.4e-84	0.49	0.62	0.84
PGSC0003DMT200025330	K01665	ko00790	Folate biosynthesis	1156	6.3e-58	0.63	0.74	0.91
PGSC0003DMT200025331	K01665	ko00790	Folate biosynthesis	794	5.9e-38	0.65	0.76	0.96
PGSC0003DMT200015171	K00419	ko00190	Oxidative phosphorylation	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015171	K00419	ko01100	Metabolic pathways	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015171	K00419	ko04260	Cardiac muscle contraction	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015171	K00419	ko05010	Alzheimer's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015171	K00419	ko05012	Parkinson's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015171	K00419	ko05016	Huntington's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMT200015172	K00419	ko00190	Oxidative phosphorylation	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015172	K00419	ko01100	Metabolic pathways	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015172	K00419	ko04260	Cardiac muscle contraction	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015172	K00419	ko05010	Alzheimer's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015172	K00419	ko05012	Parkinson's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015172	K00419	ko05016	Huntington's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMT200015174	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMT200015174	K00517	ko00626	Naphthalene and anthracene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMT200015174	K00517	ko00903	Limonene and pinene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMT200015174	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMT200015174	K00517	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMT200015175	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMT200015175	K00517	ko00626	Naphthalene and anthracene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMT200015175	K00517	ko00903	Limonene and pinene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMT200015175	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMT200015175	K00517	ko01110	Biosynthesis of secondary metabolites	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMT200015187	K06620	ko04110	Cell cycle	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05200	Pathways in cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05212	Pancreatic cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05214	Glioma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05215	Prostate cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05218	Melanoma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05219	Bladder cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05220	Chronic myeloid leukemia	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05222	Small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015187	K06620	ko05223	Non-small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMT200015188	K06620	ko04110	Cell cycle	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05200	Pathways in cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05212	Pancreatic cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05214	Glioma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05215	Prostate cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05218	Melanoma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05219	Bladder cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05220	Chronic myeloid leukemia	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05222	Small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015188	K06620	ko05223	Non-small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMT200015198	K01757	ko00901	Indole alkaloid biosynthesis	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMT200015198	K01757	ko01100	Metabolic pathways	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMT200015198	K01757	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMT200015199	K01757	ko00901	Indole alkaloid biosynthesis	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMT200015199	K01757	ko01100	Metabolic pathways	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMT200015199	K01757	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMT200092508	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMT200092508	K00517	ko00626	Naphthalene and anthracene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMT200092508	K00517	ko00903	Limonene and pinene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMT200092508	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMT200092508	K00517	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMT200097172	K05692	ko04145	Phagosome	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04510	Focal adhesion	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04520	Adherens junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04530	Tight junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04670	Leukocyte transendothelial migration	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04745	Phototransduction - fly	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko04810	Regulation of actin cytoskeleton	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05100	Bacterial invasion of epithelial cells	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05110	Vibrio cholerae infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05130	Pathogenic Escherichia coli infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05131	Shigellosis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05414	Dilated cardiomyopathy	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097172	K05692	ko05416	Viral myocarditis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMT200097175	K12356	ko00940	Phenylpropanoid biosynthesis	1279	1.0e-64	0.58	0.74	0.97
PGSC0003DMT200085003	K05279	ko00944	Flavone and flavonol biosynthesis	410	8.9e-17	0.42	0.58	0.98
PGSC0003DMT200085014	K10760	ko00908	Zeatin biosynthesis	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMT200085014	K10760	ko01100	Metabolic pathways	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMT200085014	K10760	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMT200085020	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085020	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085020	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085020	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085020	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085020	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMT200085022	K10760	ko00908	Zeatin biosynthesis	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMT200085022	K10760	ko01100	Metabolic pathways	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMT200085022	K10760	ko01110	Biosynthesis of secondary metabolites	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMT200085023	K00430	ko00360	Phenylalanine metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMT200085023	K00430	ko00680	Methane metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMT200085023	K00430	ko00940	Phenylpropanoid biosynthesis	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMT200085023	K00430	ko01100	Metabolic pathways	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMT200085023	K00430	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMT200068169	K12117	ko04712	Circadian rhythm - plant	319	1.9e-11	0.34	0.50	0.93
PGSC0003DMT200068170	K12115	ko04712	Circadian rhythm - plant	622	1.8e-28	0.33	0.48	0.91
PGSC0003DMT200068177	K12135	ko04712	Circadian rhythm - plant	210	9.5e-06	0.35	0.53	0.30
PGSC0003DMT200058377	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	337	6.5e-12	0.33	0.49	0.94
PGSC0003DMT200058379	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMT200058380	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMT200058381	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMT200058382	K03869	ko04120	Ubiquitin mediated proteolysis	1307	3.0e-66	0.33	0.52	0.97
PGSC0003DMT200058384	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMT200058385	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMT200058391	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMT200058393	K03869	ko04120	Ubiquitin mediated proteolysis	1310	2.0e-66	0.33	0.53	0.97
PGSC0003DMT200058396	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMT200058397	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMT200058398	K10609	ko03420	Nucleotide excision repair	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMT200058398	K10609	ko04120	Ubiquitin mediated proteolysis	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMT200058399	K10609	ko03420	Nucleotide excision repair	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMT200058399	K10609	ko04120	Ubiquitin mediated proteolysis	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMT200058400	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMT200058401	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMT200058402	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMT200058403	K03869	ko04120	Ubiquitin mediated proteolysis	1601	1.8e-82	0.33	0.52	0.98
PGSC0003DMT200058404	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMT200058405	K03869	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.33	0.53	0.97
PGSC0003DMT200058414	K08065	ko04612	Antigen processing and presentation	547	2.5e-24	0.59	0.78	0.80
PGSC0003DMT200087643	K07466	ko03030	DNA replication	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMT200087643	K07466	ko03420	Nucleotide excision repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMT200087643	K07466	ko03430	Mismatch repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMT200087643	K07466	ko03440	Homologous recombination	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMT200087655	K00799	ko00480	Glutathione metabolism	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMT200087655	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMT200087655	K00799	ko00982	Drug metabolism - cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMT200087656	K01087	ko00500	Starch and sucrose metabolism	313	9.7e-11	0.80	0.90	0.63
PGSC0003DMT200087662	K07466	ko03030	DNA replication	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMT200087662	K07466	ko03420	Nucleotide excision repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMT200087662	K07466	ko03430	Mismatch repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMT200087662	K07466	ko03440	Homologous recombination	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMT200087664	K12356	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.41	0.59	0.66
PGSC0003DMT200050487	K12581	ko03018	RNA degradation	1200	2.4e-60	0.56	0.73	0.94
PGSC0003DMT200050490	K01591	ko00240	Pyrimidine metabolism	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMT200050490	K01591	ko01100	Metabolic pathways	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMT200050509	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050509	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050510	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMT200050512	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050512	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMT200050513	K06620	ko04110	Cell cycle	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05200	Pathways in cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05212	Pancreatic cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05214	Glioma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05215	Prostate cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05218	Melanoma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05219	Bladder cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05220	Chronic myeloid leukemia	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05222	Small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050513	K06620	ko05223	Non-small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMT200050514	K04682	ko04110	Cell cycle	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMT200050514	K04682	ko04350	TGF-beta signaling pathway	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMT200050515	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050515	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMT200050518	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMT200050519	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMT200075714	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.50	0.62	0.99
PGSC0003DMT200075719	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMT200075719	K01078	ko00740	Riboflavin metabolism	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMT200087189	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMT200087189	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMT200087197	K06237	ko04510	Focal adhesion	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMT200087197	K06237	ko04512	ECM-receptor interaction	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMT200087197	K06237	ko05146	Amoebiasis	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMT200087197	K06237	ko05200	Pathways in cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMT200087197	K06237	ko05222	Small cell lung cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMT200087202	K01509	ko00230	Purine metabolism	255	2.1e-07	0.74	0.83	0.70
PGSC0003DMT200002058	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMT200002058	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMT200002058	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMT200002059	K01590	ko00340	Histidine metabolism	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMT200002059	K01590	ko01100	Metabolic pathways	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMT200002059	K01590	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMT200002061	K05681	ko02010	ABC transporters	1191	7.4e-60	0.33	0.53	0.86
PGSC0003DMT200002081	K10595	ko04120	Ubiquitin mediated proteolysis	752	7.2e-32	0.34	0.51	0.43
PGSC0003DMT200002088	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMT200002088	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMT200002089	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMT200002089	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMT200002090	K04424	ko04010	MAPK signaling pathway	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMT200002090	K04424	ko04530	Tight junction	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMT200002092	K04424	ko04010	MAPK signaling pathway	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMT200002092	K04424	ko04530	Tight junction	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMT200002095	K09843	ko00906	Carotenoid biosynthesis	1068	4.5e-53	0.37	0.57	0.94
PGSC0003DMT200002098	K09843	ko00906	Carotenoid biosynthesis	260	2.9e-08	0.40	0.65	0.88
PGSC0003DMT200021362	K02882	ko03010	Ribosome	1469	3.5e-75	0.94	0.98	0.99
PGSC0003DMT200021372	K02084	ko04115	p53 signaling pathway	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko04210	Apoptosis	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko05010	Alzheimer's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko05012	Parkinson's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko05016	Huntington's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200021372	K02084	ko05222	Small cell lung cancer	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMT200007594	K01213	ko00040	Pentose and glucuronate interconversions	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMT200007594	K01213	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMT200007594	K01213	ko01100	Metabolic pathways	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMT200007595	K01213	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMT200007595	K01213	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMT200007595	K01213	ko01100	Metabolic pathways	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMT200007604	K03868	ko03420	Nucleotide excision repair	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04110	Cell cycle	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04111	Cell cycle - yeast	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04114	Oocyte meiosis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04120	Ubiquitin mediated proteolysis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04310	Wnt signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04350	TGF-beta signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko04710	Circadian rhythm - mammal	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko05200	Pathways in cancer	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007604	K03868	ko05211	Renal cell carcinoma	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMT200007605	K03868	ko03420	Nucleotide excision repair	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04110	Cell cycle	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04111	Cell cycle - yeast	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04114	Oocyte meiosis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04120	Ubiquitin mediated proteolysis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04310	Wnt signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04350	TGF-beta signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko04710	Circadian rhythm - mammal	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko05200	Pathways in cancer	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007605	K03868	ko05211	Renal cell carcinoma	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMT200007615	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2186	9.8e-115	0.63	0.78	0.99
PGSC0003DMT200007618	K12130	ko04712	Circadian rhythm - plant	267	1.4e-08	0.31	0.46	0.92
PGSC0003DMT200033027	K10525	ko00592	alpha-Linolenic acid metabolism	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMT200033027	K10525	ko01100	Metabolic pathways	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMT200033040	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMT200033041	K12837	ko03040	Spliceosome	3856	7.6e-207	0.80	0.89	0.99
PGSC0003DMT200033042	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMT200033053	K12356	ko00940	Phenylpropanoid biosynthesis	651	4.5e-30	0.47	0.63	0.93
PGSC0003DMT200033059	K12356	ko00940	Phenylpropanoid biosynthesis	769	1.4e-36	0.50	0.63	0.93
PGSC0003DMT200040794	K02897	ko03010	Ribosome	1284	5.5e-65	0.75	0.87	0.88
PGSC0003DMT200073683	K02295	ko04710	Circadian rhythm - mammal	3588	4.6e-192	0.76	0.86	0.99
PGSC0003DMT200073684	K02295	ko04710	Circadian rhythm - mammal	3802	7.3e-204	0.80	0.90	0.99
PGSC0003DMT200073685	K02295	ko04710	Circadian rhythm - mammal	1409	7.0e-72	0.76	0.90	0.98
PGSC0003DMT200073686	K02265	ko00190	Oxidative phosphorylation	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073686	K02265	ko01100	Metabolic pathways	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073686	K02265	ko04260	Cardiac muscle contraction	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073686	K02265	ko05010	Alzheimer's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073686	K02265	ko05012	Parkinson's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073686	K02265	ko05016	Huntington's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMT200073687	K06130	ko00564	Glycerophospholipid metabolism	567	1.9e-25	0.36	0.55	0.87
PGSC0003DMT200073698	K03106	ko03060	Protein export	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMT200073698	K03106	ko03070	Bacterial secretion system	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMT200073699	K03106	ko03060	Protein export	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMT200073699	K03106	ko03070	Bacterial secretion system	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMT200073701	K03106	ko03060	Protein export	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMT200073701	K03106	ko03070	Bacterial secretion system	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMT200073707	K02951	ko03010	Ribosome	1021	1.8e-50	0.86	0.92	0.99
PGSC0003DMT200073709	K12356	ko00940	Phenylpropanoid biosynthesis	779	3.9e-37	0.33	0.50	0.97
PGSC0003DMT200073712	K03283	ko03040	Spliceosome	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMT200073712	K03283	ko04010	MAPK signaling pathway	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMT200073712	K03283	ko04144	Endocytosis	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMT200073712	K03283	ko04612	Antigen processing and presentation	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMT200073713	K03283	ko03040	Spliceosome	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMT200073713	K03283	ko04010	MAPK signaling pathway	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMT200073713	K03283	ko04144	Endocytosis	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMT200073713	K03283	ko04612	Antigen processing and presentation	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMT200046236	K04564	ko04146	Peroxisome	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMT200046236	K04564	ko05016	Huntington's disease	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMT200046247	K08991	ko03440	Homologous recombination	3168	6.7e-169	0.60	0.74	1.00
PGSC0003DMT200046254	K01509	ko00230	Purine metabolism	2112	1.2e-110	0.42	0.60	0.88
PGSC0003DMT200046255	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMT200046257	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMT200061949	K03841	ko00010	Glycolysis / Gluconeogenesis	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko00030	Pentose phosphate pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko00051	Fructose and mannose metabolism	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko00710	Carbon fixation in photosynthetic organisms	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko01100	Metabolic pathways	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko01110	Biosynthesis of secondary metabolites	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061949	K03841	ko04910	Insulin signaling pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMT200061950	K03841	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko00030	Pentose phosphate pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko00051	Fructose and mannose metabolism	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko00710	Carbon fixation in photosynthetic organisms	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko01100	Metabolic pathways	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061950	K03841	ko04910	Insulin signaling pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMT200061951	K03841	ko00010	Glycolysis / Gluconeogenesis	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko00030	Pentose phosphate pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko00051	Fructose and mannose metabolism	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko00710	Carbon fixation in photosynthetic organisms	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko01100	Metabolic pathways	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko01110	Biosynthesis of secondary metabolites	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061951	K03841	ko04910	Insulin signaling pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMT200061952	K03841	ko00010	Glycolysis / Gluconeogenesis	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko00030	Pentose phosphate pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko00051	Fructose and mannose metabolism	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko00710	Carbon fixation in photosynthetic organisms	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko01100	Metabolic pathways	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061952	K03841	ko04910	Insulin signaling pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMT200061953	K03841	ko00010	Glycolysis / Gluconeogenesis	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko00030	Pentose phosphate pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko00051	Fructose and mannose metabolism	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko00710	Carbon fixation in photosynthetic organisms	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko01100	Metabolic pathways	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061953	K03841	ko04910	Insulin signaling pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMT200061956	K10842	ko03420	Nucleotide excision repair	1036	2.6e-51	0.66	0.78	0.99
PGSC0003DMT200061984	K03108	ko03060	Protein export	1275	1.7e-64	0.76	0.86	0.99
PGSC0003DMT200061985	K03108	ko03060	Protein export	2544	1.8e-134	0.75	0.88	1.00
PGSC0003DMT200061988	K03108	ko03060	Protein export	2075	1.3e-108	0.74	0.85	1.00
PGSC0003DMT200061995	K03108	ko03060	Protein export	1194	5.1e-60	0.68	0.84	0.99
PGSC0003DMT200062000	K03108	ko03060	Protein export	1140	4.8e-57	0.75	0.87	0.50
PGSC0003DMT200062001	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMT200062001	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMT200062001	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMT200057049	K01148	ko03018	RNA degradation	1654	2.2e-85	0.47	0.65	0.67
PGSC0003DMT200057050	K01148	ko03018	RNA degradation	909	2.7e-44	0.45	0.66	0.60
PGSC0003DMT200057051	K01148	ko03018	RNA degradation	1601	1.8e-82	0.48	0.65	0.86
PGSC0003DMT200057054	K01148	ko03018	RNA degradation	648	6.6e-30	0.49	0.63	0.75
PGSC0003DMT200057055	K01148	ko03018	RNA degradation	1231	4.6e-62	0.51	0.67	0.83
PGSC0003DMT200057057	K00952	ko00760	Nicotinate and nicotinamide metabolism	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMT200057057	K00952	ko01100	Metabolic pathways	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMT200057058	K00952	ko00760	Nicotinate and nicotinamide metabolism	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMT200057058	K00952	ko01100	Metabolic pathways	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMT200057059	K00952	ko00760	Nicotinate and nicotinamide metabolism	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMT200057059	K00952	ko01100	Metabolic pathways	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMT200057060	K00952	ko00760	Nicotinate and nicotinamide metabolism	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMT200057060	K00952	ko01100	Metabolic pathways	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMT200057065	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMT200057066	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMT200057069	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMT200057070	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMT200057074	K01692	ko00071	Fatty acid metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00280	Valine, leucine and isoleucine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00281	Geraniol degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00310	Lysine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00380	Tryptophan metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00410	beta-Alanine metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00632	Benzoate degradation via CoA ligation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00640	Propanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00650	Butanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00903	Limonene and pinene degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko00930	Caprolactam degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko01100	Metabolic pathways	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057074	K01692	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMT200057075	K01692	ko00071	Fatty acid metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00280	Valine, leucine and isoleucine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00281	Geraniol degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00310	Lysine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00380	Tryptophan metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00410	beta-Alanine metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00632	Benzoate degradation via CoA ligation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00640	Propanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00650	Butanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00903	Limonene and pinene degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko00930	Caprolactam degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko01100	Metabolic pathways	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057075	K01692	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMT200057076	K01692	ko00071	Fatty acid metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00280	Valine, leucine and isoleucine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00281	Geraniol degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00310	Lysine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00380	Tryptophan metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00632	Benzoate degradation via CoA ligation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00640	Propanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00650	Butanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00903	Limonene and pinene degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko00930	Caprolactam degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko01100	Metabolic pathways	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200057076	K01692	ko01110	Biosynthesis of secondary metabolites	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMT200080033	K02492	ko00860	Porphyrin and chlorophyll metabolism	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMT200080033	K02492	ko01100	Metabolic pathways	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMT200080033	K02492	ko01110	Biosynthesis of secondary metabolites	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMT200080042	K00940	ko00230	Purine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMT200080042	K00940	ko00240	Pyrimidine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMT200080042	K00940	ko01100	Metabolic pathways	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMT200080042	K00940	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMT200080046	K06654	ko04111	Cell cycle - yeast	344	3.9e-13	0.33	0.50	0.83
PGSC0003DMT200089149	K08770	ko03320	PPAR signaling pathway	3748	6.9e-201	1.00	1.00	1.00
PGSC0003DMT200027371	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027371	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027372	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00140	Steroid hormone biosynthesis	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00591	Linoleic acid metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00830	Retinol metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00982	Drug metabolism - cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko00983	Drug metabolism - other enzymes	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027373	K07424	ko01100	Metabolic pathways	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMT200027375	K01087	ko00500	Starch and sucrose metabolism	5434	7.0e-294	0.69	0.82	0.98
PGSC0003DMT200027376	K01087	ko00500	Starch and sucrose metabolism	5444	2.0e-294	0.75	0.89	0.98
PGSC0003DMT200027377	K01723	ko00592	alpha-Linolenic acid metabolism	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMT200027377	K01723	ko01100	Metabolic pathways	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMT200027379	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMT200037469	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.34	0.55	0.74
PGSC0003DMT200037470	K01613	ko00564	Glycerophospholipid metabolism	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMT200037470	K01613	ko01100	Metabolic pathways	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMT200037472	K01613	ko00564	Glycerophospholipid metabolism	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMT200037472	K01613	ko01100	Metabolic pathways	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMT200037473	K05929	ko00564	Glycerophospholipid metabolism	753	1.1e-35	0.39	0.58	0.53
PGSC0003DMT200037474	K00059	ko00061	Fatty acid biosynthesis	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMT200037474	K00059	ko01040	Biosynthesis of unsaturated fatty acids	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMT200037474	K00059	ko01100	Metabolic pathways	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMT200037475	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.83	0.99
PGSC0003DMT200037478	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMT200037478	K05287	ko01100	Metabolic pathways	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMT200037479	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMT200037479	K05287	ko01100	Metabolic pathways	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMT200037483	K08243	ko00941	Flavonoid biosynthesis	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMT200037483	K08243	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMT200037485	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMT200037485	K01904	ko00360	Phenylalanine metabolism	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMT200037485	K01904	ko00940	Phenylpropanoid biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMT200037485	K01904	ko01100	Metabolic pathways	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMT200037485	K01904	ko01110	Biosynthesis of secondary metabolites	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMT200037486	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMT200037486	K01904	ko00360	Phenylalanine metabolism	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMT200037486	K01904	ko00940	Phenylpropanoid biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMT200037486	K01904	ko01100	Metabolic pathways	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMT200037486	K01904	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMT200037487	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037487	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037487	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037487	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037487	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037488	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037488	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037488	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037488	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037488	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMT200037489	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMT200037489	K01904	ko00360	Phenylalanine metabolism	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMT200037489	K01904	ko00940	Phenylpropanoid biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMT200037489	K01904	ko01100	Metabolic pathways	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMT200037489	K01904	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMT200037490	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMT200037490	K01904	ko00360	Phenylalanine metabolism	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMT200037490	K01904	ko00940	Phenylpropanoid biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMT200037490	K01904	ko01100	Metabolic pathways	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMT200037490	K01904	ko01110	Biosynthesis of secondary metabolites	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMT200037491	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMT200037492	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMT200010252	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.61
PGSC0003DMT200010253	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.57
PGSC0003DMT200010254	K00763	ko00760	Nicotinate and nicotinamide metabolism	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMT200010254	K00763	ko01100	Metabolic pathways	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMT200010273	K01046	ko00561	Glycerolipid metabolism	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMT200010273	K01046	ko01100	Metabolic pathways	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMT200010274	K01046	ko00561	Glycerolipid metabolism	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMT200010274	K01046	ko01100	Metabolic pathways	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMT200010279	K12741	ko03040	Spliceosome	549	1.9e-24	0.32	0.45	0.96
PGSC0003DMT200010280	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMT200010281	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMT200044371	K06269	ko04113	Meiosis - yeast	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04114	Oocyte meiosis	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04270	Vascular smooth muscle contraction	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04510	Focal adhesion	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04720	Long-term potentiation	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04810	Regulation of actin cytoskeleton	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044371	K06269	ko04910	Insulin signaling pathway	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMT200044372	K05746	ko04810	Regulation of actin cytoskeleton	702	7.0e-33	0.34	0.43	0.76
PGSC0003DMT200044391	K13229	ko00402	Benzoxazinoid biosynthesis	798	3.5e-38	0.42	0.60	0.91
PGSC0003DMT200071987	K00558	ko00270	Cysteine and methionine metabolism	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMT200071987	K00558	ko01100	Metabolic pathways	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMT200072002	K04420	ko04010	MAPK signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMT200072002	K04420	ko04540	Gap junction	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMT200072002	K04420	ko04912	GnRH signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMT200072012	K05894	ko00592	alpha-Linolenic acid metabolism	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMT200072012	K05894	ko01100	Metabolic pathways	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMT200055212	K06123	ko00564	Glycerophospholipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMT200055212	K06123	ko00565	Ether lipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMT200055212	K06123	ko01100	Metabolic pathways	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMT200055214	K04371	ko04010	MAPK signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04012	ErbB signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04013	MAPK signaling pathway - fly	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04062	Chemokine signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04114	Oocyte meiosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04150	mTOR signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04270	Vascular smooth muscle contraction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04320	Dorso-ventral axis formation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04350	TGF-beta signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04360	Axon guidance	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04370	VEGF signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04510	Focal adhesion	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04520	Adherens junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04540	Gap junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04620	Toll-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04621	NOD-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04650	Natural killer cell mediated cytotoxicity	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04660	T cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04662	B cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04664	Fc epsilon RI signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04666	Fc gamma R-mediated phagocytosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04720	Long-term potentiation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04722	Neurotrophin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04730	Long-term depression	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04810	Regulation of actin cytoskeleton	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04910	Insulin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04912	GnRH signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04914	Progesterone-mediated oocyte maturation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04916	Melanogenesis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04930	Type II diabetes mellitus	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko04960	Aldosterone-regulated sodium reabsorption	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05010	Alzheimer's disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05020	Prion diseases	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05131	Shigellosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05140	Leishmaniasis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05142	Chagas disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05200	Pathways in cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05210	Colorectal cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05211	Renal cell carcinoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05212	Pancreatic cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05213	Endometrial cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05214	Glioma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05215	Prostate cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05216	Thyroid cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05218	Melanoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05219	Bladder cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05220	Chronic myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05221	Acute myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055214	K04371	ko05223	Non-small cell lung cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMT200055224	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMT200055225	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMT200055226	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMT200055226	K00517	ko00626	Naphthalene and anthracene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMT200055226	K00517	ko00903	Limonene and pinene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMT200055226	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMT200055226	K00517	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMT200055227	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055227	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055227	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055227	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055227	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055228	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055228	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055228	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055228	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055228	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMT200055230	K03937	ko00190	Oxidative phosphorylation	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMT200055230	K03937	ko01100	Metabolic pathways	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMT200055230	K03937	ko05010	Alzheimer's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMT200055230	K03937	ko05012	Parkinson's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMT200055230	K03937	ko05016	Huntington's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMT200055231	K02935	ko03010	Ribosome	364	3.1e-14	0.41	0.62	0.80
PGSC0003DMT200055240	K10598	ko04120	Ubiquitin mediated proteolysis	4215	1.2e-226	0.81	0.90	1.00
PGSC0003DMT200055241	K00860	ko00230	Purine metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMT200055241	K00860	ko00450	Selenoamino acid metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMT200055241	K00860	ko00920	Sulfur metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMT200055241	K00860	ko01100	Metabolic pathways	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMT200055242	K00860	ko00230	Purine metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMT200055242	K00860	ko00450	Selenoamino acid metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMT200055242	K00860	ko00920	Sulfur metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMT200055242	K00860	ko01100	Metabolic pathways	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMT200082111	K01738	ko00270	Cysteine and methionine metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMT200082111	K01738	ko00450	Selenoamino acid metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMT200082111	K01738	ko00920	Sulfur metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMT200082111	K01738	ko01100	Metabolic pathways	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMT200082112	K01738	ko00270	Cysteine and methionine metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMT200082112	K01738	ko00450	Selenoamino acid metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMT200082112	K01738	ko00920	Sulfur metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMT200082112	K01738	ko01100	Metabolic pathways	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMT200082113	K01738	ko00270	Cysteine and methionine metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMT200082113	K01738	ko00450	Selenoamino acid metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMT200082113	K01738	ko00920	Sulfur metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMT200082113	K01738	ko01100	Metabolic pathways	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMT200029187	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMT200029187	K05286	ko01100	Metabolic pathways	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMT200016939	K05857	ko00562	Inositol phosphate metabolism	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMT200016939	K05857	ko01100	Metabolic pathways	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMT200016939	K05857	ko04020	Calcium signaling pathway	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMT200016939	K05857	ko04070	Phosphatidylinositol signaling system	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMT200016940	K05857	ko00562	Inositol phosphate metabolism	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMT200016940	K05857	ko01100	Metabolic pathways	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMT200016940	K05857	ko04020	Calcium signaling pathway	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMT200016940	K05857	ko04070	Phosphatidylinositol signaling system	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMT200016945	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016945	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016945	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016945	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016946	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016946	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016946	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016946	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMT200016950	K05857	ko00562	Inositol phosphate metabolism	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMT200016950	K05857	ko01100	Metabolic pathways	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMT200016950	K05857	ko04020	Calcium signaling pathway	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMT200016950	K05857	ko04070	Phosphatidylinositol signaling system	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMT200016961	K06675	ko04111	Cell cycle - yeast	862	1.5e-41	0.52	0.61	0.93
PGSC0003DMT200035697	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMT200035697	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMT200035697	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMT200035697	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMT200035697	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMT200035698	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035698	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035698	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035698	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035698	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035699	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035699	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035699	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035699	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035699	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMT200035714	K01768	ko00230	Purine metabolism	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMT200035714	K01768	ko04113	Meiosis - yeast	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMT200012006	K10595	ko04120	Ubiquitin mediated proteolysis	857	7.9e-40	0.33	0.49	0.80
PGSC0003DMT200012011	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMT200012012	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMT200012019	K03109	ko03060	Protein export	775	6.5e-37	0.87	0.93	0.99
PGSC0003DMT200012020	K03109	ko03060	Protein export	780	3.5e-37	0.87	0.94	0.99
PGSC0003DMT200095953	K03094	ko04110	Cell cycle	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04111	Cell cycle - yeast	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04114	Oocyte meiosis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04120	Ubiquitin mediated proteolysis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04310	Wnt signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04350	TGF-beta signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095953	K03094	ko04710	Circadian rhythm - mammal	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMT200095956	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMT200095956	K00517	ko00626	Naphthalene and anthracene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMT200095956	K00517	ko00903	Limonene and pinene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMT200095956	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMT200095956	K00517	ko01110	Biosynthesis of secondary metabolites	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMT200093696	K00804	ko00900	Terpenoid backbone biosynthesis	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMT200093696	K00804	ko01100	Metabolic pathways	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMT200093696	K00804	ko01110	Biosynthesis of secondary metabolites	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMT200093701	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMT200093701	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMT200093701	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMT200093717	K06675	ko04111	Cell cycle - yeast	243	3.0e-16	0.46	0.62	0.95
PGSC0003DMT200090346	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.49	0.96
PGSC0003DMT200090348	K11821	ko00380	Tryptophan metabolism	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMT200090348	K11821	ko00966	Glucosinolate biosynthesis	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMT200090348	K11821	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMT200066027	K08008	ko04145	Phagosome	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMT200066027	K08008	ko04670	Leukocyte transendothelial migration	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMT200066086	K08233	ko00901	Indole alkaloid biosynthesis	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMT200066086	K08233	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMT200066088	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko00363	Bisphenol A degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko00624	1- and 2-Methylnaphthalene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko00632	Benzoate degradation via CoA ligation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko00903	Limonene and pinene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko01100	Metabolic pathways	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066088	K00120	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMT200066097	K07203	ko04012	ErbB signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko04150	mTOR signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko04910	Insulin signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko04920	Adipocytokine signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko04930	Type II diabetes mellitus	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko05200	Pathways in cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko05214	Glioma	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko05215	Prostate cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066097	K07203	ko05221	Acute myeloid leukemia	17462	0.	0.84	0.91	1.00
PGSC0003DMT200066098	K07203	ko04012	ErbB signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko04150	mTOR signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko04910	Insulin signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko04920	Adipocytokine signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko04930	Type II diabetes mellitus	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko05200	Pathways in cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko05214	Glioma	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko05215	Prostate cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMT200066098	K07203	ko05221	Acute myeloid leukemia	17695	0.	0.85	0.92	1.00
PGSC0003DMT200077454	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077454	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077454	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077454	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077454	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077454	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077455	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077455	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077455	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077455	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077455	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077455	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077456	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077456	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077456	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077456	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077456	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077456	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMT200077457	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077457	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077457	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077457	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077457	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077457	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMT200077458	K01513	ko00230	Purine metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077458	K01513	ko00500	Starch and sucrose metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077458	K01513	ko00740	Riboflavin metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077458	K01513	ko00760	Nicotinate and nicotinamide metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077458	K01513	ko00770	Pantothenate and CoA biosynthesis	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077458	K01513	ko01100	Metabolic pathways	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMT200077470	K01810	ko00010	Glycolysis / Gluconeogenesis	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077470	K01810	ko00030	Pentose phosphate pathway	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077470	K01810	ko00500	Starch and sucrose metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077470	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077470	K01810	ko01100	Metabolic pathways	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077470	K01810	ko01110	Biosynthesis of secondary metabolites	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMT200077475	K00588	ko00360	Phenylalanine metabolism	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077475	K00588	ko00940	Phenylpropanoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077475	K00588	ko00941	Flavonoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077475	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077475	K00588	ko01100	Metabolic pathways	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077475	K00588	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMT200077502	K03506	ko00230	Purine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077502	K03506	ko00240	Pyrimidine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077502	K03506	ko01100	Metabolic pathways	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077502	K03506	ko03030	DNA replication	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077502	K03506	ko03410	Base excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077502	K03506	ko03420	Nucleotide excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMT200077503	K06170	ko04330	Notch signaling pathway	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMT200077503	K06170	ko05010	Alzheimer's disease	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMT200052340	K06119	ko00561	Glycerolipid metabolism	1021	1.8e-50	0.76	0.87	0.96
PGSC0003DMT200052350	K02882	ko03010	Ribosome	1442	1.1e-73	0.92	0.97	0.99
PGSC0003DMT200052352	K02882	ko03010	Ribosome	705	4.8e-33	0.93	0.98	0.99
PGSC0003DMT200052360	K01962	ko00061	Fatty acid biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052360	K01962	ko00253	Tetracycline biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052360	K01962	ko00620	Pyruvate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052360	K01962	ko00640	Propanoate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052360	K01962	ko01100	Metabolic pathways	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052360	K01962	ko01110	Biosynthesis of secondary metabolites	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMT200052361	K01962	ko00061	Fatty acid biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200052361	K01962	ko00253	Tetracycline biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200052361	K01962	ko00620	Pyruvate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200052361	K01962	ko00640	Propanoate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200052361	K01962	ko01100	Metabolic pathways	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200052361	K01962	ko01110	Biosynthesis of secondary metabolites	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMT200086002	K12356	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.31	0.52	0.96
PGSC0003DMT200086007	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	408	4.5e-16	0.33	0.44	0.92
PGSC0003DMT200031376	K12338	ko00942	Anthocyanin biosynthesis	869	4.3e-42	0.38	0.58	0.97
PGSC0003DMT200031387	K03110	ko03060	Protein export	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMT200031387	K03110	ko03070	Bacterial secretion system	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMT200031388	K02689	ko00195	Photosynthesis	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMT200031388	K02689	ko01100	Metabolic pathways	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMT200031406	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMT200031406	K00517	ko00626	Naphthalene and anthracene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMT200031406	K00517	ko00903	Limonene and pinene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMT200031406	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMT200031406	K00517	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMT200005893	K01046	ko00561	Glycerolipid metabolism	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMT200005893	K01046	ko01100	Metabolic pathways	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMT200005900	K05355	ko00900	Terpenoid backbone biosynthesis	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMT200005900	K05355	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMT200005902	K05355	ko00900	Terpenoid backbone biosynthesis	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMT200005902	K05355	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMT200005921	K00290	ko00300	Lysine biosynthesis	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMT200005921	K00290	ko00310	Lysine degradation	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMT200005921	K00290	ko01100	Metabolic pathways	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMT200005921	K00290	ko01110	Biosynthesis of secondary metabolites	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMT200005922	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005922	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005922	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005922	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005923	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005923	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005923	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005923	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005924	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005924	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005924	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005924	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMT200005925	K00290	ko00300	Lysine biosynthesis	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMT200005925	K00290	ko00310	Lysine degradation	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMT200005925	K00290	ko01100	Metabolic pathways	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMT200005925	K00290	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMT200005926	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005926	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005926	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005927	K00291	ko00300	Lysine biosynthesis	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMT200005927	K00291	ko00310	Lysine degradation	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMT200005927	K00291	ko01100	Metabolic pathways	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMT200005927	K00291	ko01110	Biosynthesis of secondary metabolites	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMT200005928	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005928	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200005928	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMT200042546	K02695	ko00195	Photosynthesis	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMT200042546	K02695	ko01100	Metabolic pathways	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMT200042566	K10803	ko03410	Base excision repair	605	1.6e-27	0.60	0.69	0.88
PGSC0003DMT200042567	K10803	ko03410	Base excision repair	1008	9.2e-50	0.55	0.71	0.94
PGSC0003DMT200042568	K10803	ko03410	Base excision repair	1458	1.4e-74	0.53	0.68	0.95
PGSC0003DMT200042569	K10803	ko03410	Base excision repair	1129	2.0e-56	0.53	0.70	0.96
PGSC0003DMT200042582	K04124	ko00904	Diterpenoid biosynthesis	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMT200042582	K04124	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMT200000387	K00970	ko03018	RNA degradation	537	5.1e-22	0.32	0.50	0.48
PGSC0003DMT200000389	K01066	ko00623	2,4-Dichlorobenzoate degradation	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMT200000389	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMT200000390	K01046	ko00561	Glycerolipid metabolism	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMT200000390	K01046	ko01100	Metabolic pathways	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMT200000397	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMT200000397	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMT200000397	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMT200000397	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMT200000397	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMT200000399	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000399	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000399	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000399	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000399	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000400	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000400	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000400	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000400	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000400	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000401	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000401	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000401	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000401	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000401	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMT200000402	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMT200000402	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMT200000402	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMT200000402	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMT200000402	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMT200000403	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMT200000403	K00517	ko00626	Naphthalene and anthracene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMT200000403	K00517	ko00903	Limonene and pinene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMT200000403	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMT200000403	K00517	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMT200000404	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMT200000404	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMT200000404	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMT200000404	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMT200000404	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMT200000405	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMT200000405	K00517	ko00626	Naphthalene and anthracene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMT200000405	K00517	ko00903	Limonene and pinene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMT200000405	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMT200000405	K00517	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMT200000406	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMT200000406	K00517	ko00626	Naphthalene and anthracene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMT200000406	K00517	ko00903	Limonene and pinene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMT200000406	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMT200000406	K00517	ko01110	Biosynthesis of secondary metabolites	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMT200000414	K11821	ko00380	Tryptophan metabolism	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMT200000414	K11821	ko00966	Glucosinolate biosynthesis	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMT200000414	K11821	ko01110	Biosynthesis of secondary metabolites	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMT200000418	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000418	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000418	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000418	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000418	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000423	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMT200000423	K00517	ko00626	Naphthalene and anthracene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMT200000423	K00517	ko00903	Limonene and pinene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMT200000423	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMT200000423	K00517	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMT200000425	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000425	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000425	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000425	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000425	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMT200000430	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMT200000430	K00517	ko00626	Naphthalene and anthracene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMT200000430	K00517	ko00903	Limonene and pinene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMT200000430	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMT200000430	K00517	ko01110	Biosynthesis of secondary metabolites	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMT200000436	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMT200000436	K00517	ko00626	Naphthalene and anthracene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMT200000436	K00517	ko00903	Limonene and pinene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMT200000436	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMT200000436	K00517	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMT200000437	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000437	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000437	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000437	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000437	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMT200000438	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMT200000438	K00517	ko00626	Naphthalene and anthracene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMT200000438	K00517	ko00903	Limonene and pinene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMT200000438	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMT200000438	K00517	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.40	0.62	0.95
